PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wang, EF; Zhang, CY; Polavaram, N; Liu, FM; Wu, G; Schroeder, MA; Lau, JS; Mukhopadhyay, D; Jiang, SW; O'Neill, BP; Datta, K; Li, JP				Wang, Enfeng; Zhang, Chunyang; Polavaram, Navatha; Liu, Fengming; Wu, Gang; Schroeder, Mark A.; Lau, Julie S.; Mukhopadhyay, Debabrata; Jiang, Shi-Wen; O'Neill, Brian Patrick; Datta, Kaustubh; Li, Jinping			The Role of Factor Inhibiting HIF (FIH-1) in Inhibiting HIF-1 Transcriptional Activity in Glioblastoma Multiforme	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; TUMOR-SUPPRESSOR PROTEIN; OXYGEN-SENSING PATHWAY; GENE-EXPRESSION; PROLINE HYDROXYLATION; MOLECULAR CHARACTERIZATION; SECONDARY GLIOBLASTOMAS; BRAIN-TUMORS; DE-NOVO; HIF-1-ALPHA	Glioblastoma multiforme (GBM) accounts for about 38% of primary brain tumors in the United States. GBM is characterized by extensive angiogenesis induced by vascular growth factors and cytokines. The transcription of these growth factors and cytokines is regulated by the Hypoxia-Inducible-Factor-1(HIF-1), which is a key regulator mediating the cellular response to hypoxia. It is known that Factor Inhibiting HIF-1, or FIH-1, is also involved in the cellular response to hypoxia and has the capability to physically interact with HIF-1 and block its transcriptional activity under normoxic conditions. Delineation of the regulatory role of FIH-1 will help us to better understand the molecular mechanism responsible for tumor growth and progression and may lead to the design of new therapies targeting cellular pathways in response to hypoxia. Previous studies have shown that the chromosomal region of 10q24 containing the FIH-1 gene is often deleted in GBM, suggesting a role for the FIH-1 in GBM tumorigenesis and progression. In the current study, we found that FIH-1 is able to inhibit HIF-mediated transcription of GLUT1 and VEGF-A, even under hypoxic conditions in human glioblastoma cells. FIH-1 has been found to be more potent in inhibiting HIF function than PTEN. This observation points to the possibility that deletion of 10q23-24 and loss or decreased expression of FIH-1 gene may lead to a constitutive activation of HIF-1 activity, an alteration of HIF-1 targets such as GLUT-1 and VEGF-A, and may contribute to the survival of cancer cells in hypoxia and the development of hypervascularization observed in GBM. Therefore FIH-1 can be potential therapeutic target for the treatment of GBM patients with poor prognosis.	[Wang, Enfeng; Wu, Gang; Lau, Julie S.; Mukhopadhyay, Debabrata; O'Neill, Brian Patrick] Mayo Clin, Ctr Canc, Dept Biochem & Mol Biol, Rochester, MN USA; [Zhang, Chunyang] Baotou Med Coll, Affiliated Hosp 1, Dept Neurosurg, Baotou, Peoples R China; [Polavaram, Navatha; Datta, Kaustubh] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Polavaram, Navatha; Datta, Kaustubh] Univ Nebraska Med Ctr, Eppley Canc Ctr, Omaha, NE USA; [Liu, Fengming] Guangxi Med Bot Inst, Dept Res & Dev, Nanning, Guangxi, Peoples R China; [Schroeder, Mark A.] Mayo Clin, Ctr Canc, Dept Radiat Oncol, Rochester, MN USA; [Jiang, Shi-Wen; Li, Jinping] Mercer Univ, Sch Med, Dept Biomed Sci, Savannah, GA USA; [Jiang, Shi-Wen; Li, Jinping] Mem Hlth Hosp, Dept Obstet & Gynecol, Savannah, GA USA	Mayo Clinic; Baotou Medical College; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Mayo Clinic; Mercer University	Datta, K (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	Kaustubh.Datta@unmc.edu; Li_J@Mercer.edu			Mayo National Institutes of Health (NIH) Brain Cancer SPORE [P50CA108961]; NIH [R01 CA140432]; American Cancer Society [RSG-07-044]; Mercer University School of Medicine; School of Medicine; Mercer University; NATIONAL CANCER INSTITUTE [R01CA140432, P50CA108961, P30CA015083] Funding Source: NIH RePORTER	Mayo National Institutes of Health (NIH) Brain Cancer SPORE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Mercer University School of Medicine; School of Medicine; Mercer University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the following funding sources: Mayo National Institutes of Health (NIH) Brain Cancer SPORE (P50CA108961, O'Neill B); NIH R01 CA140432 (Datta K); American Cancer Society Research Scholar Grant (RSG-07-044, Datta K); Research supplement from the Mercer University School of Medicine (Jiang S); Research Startup Funding from School of Medicine (Li J); Mercer University Seed grant (Li J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarosa R, 1996, AM J HUM GENET, V58, P1260; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Brat DJ, 2003, FRONT BIOSCI-LANDMRK, V8, pD100, DOI 10.2741/942; CARLSON BL, CURRENT PROTOCOLS PH, pCH14; Chao KSC, 2001, INT J RADIAT ONCOL, V49, P1171, DOI 10.1016/S0360-3016(00)01433-4; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Datta K, 2005, ONCOGENE, V24, P7850, DOI 10.1038/sj.onc.1208912; Duerr EM, 1998, ONCOGENE, V16, P2259, DOI 10.1038/sj.onc.1201756; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Evans SM, 2008, RADIAT RES, V170, P677, DOI 10.1667/RR1207.1; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Fujisawa H, 2000, LAB INVEST, V80, P65, DOI 10.1038/labinvest.3780009; Fults D, 1998, INT J ONCOL, V12, P905; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hill C, 2003, ADV ANAT PATHOL, V10, P212, DOI 10.1097/00125480-200307000-00004; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Ichimura K, 1998, GENE CHROMOSOME CANC, V22, P9, DOI 10.1002/(SICI)1098-2264(199805)22:1<9::AID-GCC2>3.0.CO;2-1; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kang SH, 2006, CANCER RES, V66, P11991, DOI 10.1158/0008-5472.CAN-06-1320; KARLBOM AE, 1993, HUM GENET, V92, P169; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Kitange GJ, 2009, NEURO-ONCOLOGY, V11, P281, DOI 10.1215/15228517-2008-090; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Linke S, 2004, J BIOL CHEM, V279, P14391, DOI 10.1074/jbc.M313614200; Luo G, 1997, GENE EXPRESSION, V6, P287; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazure NM, 2004, BIOCHEM PHARMACOL, V68, P971, DOI 10.1016/j.bcp.2004.04.022; McNeill LA, 2002, BIOCHEM J, V367, P571, DOI 10.1042/BJ20021162; Misra S, 2010, J VASC INTERV RADIOL, V21, P896, DOI 10.1016/j.jvir.2010.02.030; Ohgaki H, 2005, NEUROPATHOLOGY, V25, P1, DOI 10.1111/j.1440-1789.2004.00600.x; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Safran M, 2003, J CLIN INVEST, V111, P779, DOI 10.1172/JCI200318181; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Semenza GL, 1997, KIDNEY INT, V51, P553, DOI 10.1038/ki.1997.77; Sinha S, 2009, J BIOL CHEM, V284, P32610, DOI 10.1074/jbc.M109.058065; Sonoda Y, 1996, JPN J CANCER RES, V87, P363, DOI 10.1111/j.1349-7006.1996.tb00231.x; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Tohma Y, 1998, J NEUROPATH EXP NEUR, V57, P684, DOI 10.1097/00005072-199807000-00005; Vordermark D, 2003, INT J RADIAT ONCOL, V56, P1184, DOI 10.1016/S0360-3016(03)00289-X; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; Yeo EJ, 2004, BIOCHEM PHARMACOL, V68, P1061, DOI 10.1016/j.bcp.2004.02.040; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Yu F, 2001, CANCER RES, V61, P4136; Zundel W, 2000, GENE DEV, V14, P391	58	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86102	10.1371/journal.pone.0086102	http://dx.doi.org/10.1371/journal.pone.0086102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465898	gold, Green Submitted, Green Published			2022-12-25	WOS:000330288000052
J	van Stijn, CMW; Kim, J; Barish, GD; Tietge, UJF; Tangirala, RK				van Stijn, Caroline M. W.; Kim, Jason; Barish, Grant D.; Tietge, Uwe J. F.; Tangirala, Rajendra K.			Adiponectin Expression Protects against Angiotensin II-Mediated Inflammation and Accelerated Atherosclerosis	PLOS ONE			English	Article							DIRECTED GENE-TRANSFER; PLASMA-PROTEIN; SERUM ADIPONECTIN; ADHESION MOLECULES; ADIPOSE-TISSUE; CHOLESTEROL; RECEPTOR; DEFICIENT; HYPERTENSION; MACROPHAGES	Adiponectin (APN), an adipocytokine produced by adipose tissue, exerts pleiotropic actions regulating inflammation, metabolism and vascular homeostasis. APN levels are inversely correlated with obesity, type-2 diabetes, hypertension and cardiovascular disease. Although renin angiotensin system (RAS) activation in these interrelated metabolic syndrome components increases angiotensin II (AngII) levels leading to vascular damage, it is unknown whether APN under these conditions provides atheroprotection. We investigated whether increasing plasma APN provides atheroprotection in a hypertensive and accelerated atherosclerosis model. Using adenoviral gene transfer, sustained APN expression increased plasma levels of total and high-molecular weight APN, leading to a significant elevation of plasma HDL-cholesterol (HDL-C). Elevated APN levels were strongly atheroprotective, yet had no impact on blood pressure. Notably, gene expression analyses revealed that APN significantly inhibited the expression of pro-inflammatory and atherogenic genes while it increased the expression of the anti-inflammatory cytokine, IL-10 and the cholesterol efflux transporters, ABCA1 and ABCG1 in the artery wall. These findings suggest that increasing APN levels may be an effective therapeutic strategy to inhibit vascular inflammation and accelerated atherosclerosis associated with RAS activation in the metabolic syndrome.	[van Stijn, Caroline M. W.; Kim, Jason; Tangirala, Rajendra K.] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA; [Barish, Grant D.] Northwestern Univ, Feinberg Sch Med, Div Endocrinol, Chicago, IL 60611 USA; [Tietge, Uwe J. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, NL-9713 AV Groningen, Netherlands	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University; Feinberg School of Medicine; University of Groningen	Tangirala, RK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA.	rtangirala@mednet.ucla.edu			National Institutes of Health [HL086566, P30DK063491/DRC-Core]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health grants, HL086566 (RKT) and P30DK063491/DRC-Core (RKT) and support from Dr. Alan Fogelman, Department of Medicine, David Geffen School of Medicine at UCLA (RKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak M, 2003, AM J HYPERTENS, V16, P72, DOI 10.1016/S0895-7061(02)03197-7; Basso F, 2006, BIOCHEM BIOPH RES CO, V351, P398, DOI 10.1016/j.bbrc.2006.10.044; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Chow WS, 2007, HYPERTENSION, V49, P1455, DOI 10.1161/HYPERTENSIONAHA.107.086835; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Fisher FM, 2005, DIABETOLOGIA, V48, P1084, DOI 10.1007/s00125-005-1758-7; Furuhashi M, 2003, HYPERTENSION, V42, P76, DOI 10.1161/01.HYP.0000078490.59735.6E; Hattori Y, 2005, DIABETOLOGIA, V48, P1066, DOI 10.1007/s00125-005-1766-7; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kazumi T, 2004, METABOLISM, V53, P589, DOI 10.1016/j.metabol.2003.12.008; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Lin LY, 2004, FEBS LETT, V574, P106, DOI 10.1016/j.febslet.2004.08.012; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matavelli LC, 2011, HYPERTENSION, V57, P308, DOI 10.1161/HYPERTENSIONAHA.110.164202; Matsuura F, 2007, BIOCHEM BIOPH RES CO, V358, P1091, DOI 10.1016/j.bbrc.2007.05.040; Nawrocki AR, 2010, ARTERIOSCL THROM VAS, V30, P1159, DOI 10.1161/ATVBAHA.109.195826; Neumeier M, 2007, BIOCHEM BIOPH RES CO, V352, P543, DOI 10.1016/j.bbrc.2006.11.058; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Ohashi K, 2011, AM J HYPERTENS, V24, P263, DOI 10.1038/ajh.2010.216; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Okamoto Y, 2000, HORM METAB RES, V32, P47, DOI 10.1055/s-2007-978586; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Oku H, 2007, FEBS LETT, V581, P5029, DOI 10.1016/j.febslet.2007.09.038; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ouchi N, 2006, TRENDS CARDIOVAS MED, V16, P141, DOI 10.1016/j.tcm.2006.03.001; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouedraogo R, 2007, J CLIN INVEST, V117, P1718, DOI 10.1172/JCI29623; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Qiao LP, 2008, DIABETES, V57, P1824, DOI 10.2337/db07-0435; Ran JM, 2006, METABOLISM, V55, P478, DOI 10.1016/j.metabol.2005.10.009; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shetty S, 2009, TRENDS PHARMACOL SCI, V30, P234, DOI 10.1016/j.tips.2009.02.004; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Takata Y, 2005, CIRC RES, V97, pE88, DOI 10.1161/01.RES.0000190400.46267.7e; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Tsukamoto K, 1997, J CLIN INVEST, V100, P107, DOI 10.1172/JCI119501; Uchida T, 2008, METABOLISM, V57, P1278, DOI 10.1016/j.metabol.2008.04.024; Unger T, 2002, AM J CARDIOL, V89, p10A; Unger T, 2002, AM J CARDIOL, V89, p3A; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Watanabe S, 2006, CLIN THER, V28, P1677, DOI 10.1016/j.clinthera.2006.10.012; Weiss R, 2009, DIABETES CARE, V32, P1317, DOI 10.2337/dc09-0084; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001	64	41	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86404	10.1371/journal.pone.0086404	http://dx.doi.org/10.1371/journal.pone.0086404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466075	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100154
J	Xu, J; Ye, JY; Wu, YT; Zhang, H; Luo, Q; Han, C; Ye, XQ; Wang, HZ; He, J; Huang, HF; Liu, Y; Dong, MY				Xu, Jian; Ye, Junyi; Wu, Yanting; Zhang, Hong; Luo, Qiong; Han, Cong; Ye, Xiaoqun; Wang, Hanzhi; He, Jing; Huang, Hefeng; Liu, Yun; Dong, Minyue			Reduced Fetal Telomere Length in Gestational Diabetes	PLOS ONE			English	Article							OXIDATIVE STRESS; CORD BLOOD; CARDIOVASCULAR-DISEASE; PREECLAMPSIA; ASSOCIATION; PREGNANCY; INFANTS; BORN	Gestational diabetes mellitus (GDM) is an important complication of pregnancy that poses significant threats to women and their offspring. Telomere length shortens as cellular damage increases and is associated with metabolic diseases. Telomere length in fetal leucocytes was determined in 82 infants of women with GDM (N = 82) and 65 normal pregnant women (N = 65). Women with preeclampsia (N = 45) and gestational hypertension (N = 23) were also studied. In the GDM group, telomere length was significantly shorter than normal pregnancy (P = 0.028), but there were no significant differences in fetal telomere length between preeclampsia and normal pregnancy (P = 0.841) and between gestational hypertension and normal pregnancy (P = 0.561). Regression analysis revealed that fetal telomere length was significantly associated with intrauterine exposure to GDM (P = 0.027 after adjustment for maternal age, gestational age at delivery, birth weight and fetal gender). Shortened telomere length may increase the risk of metabolic diseases in adulthood of GDM offspring.	[Xu, Jian; Wu, Yanting; Luo, Qiong; Han, Cong; Ye, Xiaoqun; Wang, Hanzhi; He, Jing; Huang, Hefeng; Dong, Minyue] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Jian; Huang, Hefeng; Dong, Minyue] Zhejiang Univ, Minist Educ, Key Lab Reprod Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Ye, Junyi; Zhang, Hong; Liu, Yun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Liu, Yun] Fudan Univ, Dept Biochem & Mol Biol, Minist Educ, Key Lab Mol Med, Shanghai 200433, Peoples R China	Zhejiang University; Zhejiang University; Fudan University; Fudan University	Dong, MY (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	superliuyun@gmail.com; mydong.cn@hotmail.com	Huang, He-Feng/AAN-7985-2020; Xu, Jian/GQY-4944-2022; Huang, Hefeng/AAR-7184-2021; Huang, Hefeng/ABF-1117-2020	Huang, He-Feng/0000-0003-4344-8019; Wu, Yanting/0000-0002-2293-1792	National Basic Research Program of China [2012CB944903]; Natural Scientific Foundation of China [81170572]	National Basic Research Program of China(National Basic Research Program of China); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by National Basic Research Program of China (2012CB944903) (www.most.gov.cn) and Natural Scientific Foundation of China (81170572) (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins--Obstetrics, 2002, Obstet Gynecol, V99, P159; Akkad A, 2006, BJOG-INT J OBSTET GY, V113, P318, DOI 10.1111/j.1471-0528.2005.00839.x; Biron-Shental T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.036; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Cross JA, 2010, DIABETIC MED, V27, P1264, DOI 10.1111/j.1464-5491.2010.03099.x; Davis EF, 2012, CLIN SCI, V123, P53, DOI 10.1042/CS20110627; Demerath EW, 2004, HUM BIOL, V76, P127, DOI 10.1353/hub.2004.0018; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Geelhoed JJM, 2010, CIRCULATION, V122, P1192, DOI 10.1161/CIRCULATIONAHA.110.936674; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Harville Emily W, 2010, BMC Res Notes, V3, P113, DOI 10.1186/1756-0500-3-113; Howlader MZH, 2009, J TROP PEDIATRICS, V55, P363, DOI 10.1093/tropej/fmp025; Kamath U, 1998, ACTA PAEDIATR, V87, P676, DOI 10.1080/080352598750014102; Kinalski M, 2001, HORM METAB RES, V33, P227, DOI 10.1055/s-2001-14953; Kurepa D, 2012, NEONATOLOGY, V102, P163, DOI 10.1159/000339286; Lawlor DA, 2010, DIABETOLOGIA, V53, P89, DOI 10.1007/s00125-009-1560-z; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Serrano AL, 2004, CIRC RES, V94, P575, DOI 10.1161/01.RES.0000122141.18795.9C; Sobki SH, 2004, SAUDI MED J, V25, P876; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Suhail Mohd, 2009, J Clin Med Res, V1, P150, DOI 10.4021/jocmr2009.07.1252; Tastekin A, 2005, PEDIATR INT, V47, P658, DOI 10.1111/j.1442-200x.2005.02146.x	27	35	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86161	10.1371/journal.pone.0086161	http://dx.doi.org/10.1371/journal.pone.0086161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465936	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100117
J	Arai-Kichise, Y; Shiwa, Y; Ebana, K; Shibata-Hatta, M; Yoshikawa, H; Yano, M; Wakasa, K				Arai-Kichise, Yuko; Shiwa, Yuh; Ebana, Kaworu; Shibata-Hatta, Mari; Yoshikawa, Hirofumi; Yano, Masahiro; Wakasa, Kyo			Genome-Wide DNA Polymorphisms in Seven Rice Cultivars of Temperate and Tropical Japonica Groups	PLOS ONE			English	Article							SAKE-BREWING RICE; GENETIC DIVERSITY; VARIATION REVEALS; SEQUENCE; DISCOVERY; BLAST; MAP; ASSOCIATION; RESISTANCE; ALIGNMENT	Elucidation of the rice genome is expected to broaden our understanding of genes related to the agronomic characteristics and the genetic relationship among cultivars. In this study, we conducted whole-genome sequencings of 6 cultivars, including 5 temperate japonica cultivars and 1 tropical japonica cultivar (Moroberekan), by using next-generation sequencing (NGS) with Nipponbare genome as a reference. The temperate japonica cultivars contained 2 sake brewing (Yamadanishiki and Gohyakumangoku), 1 landrace (Kameji), and 2 modern cultivars (Koshihikari and Norin 8). Almost >83% of the whole genome sequences of the Nipponbare genome could be covered by sequenced short-reads of each cultivar, including Omachi, which has previously been reported to be a temperate japonica cultivar. Numerous single nucleotide polymorphisms (SNPs), insertions, and deletions were detected among the various cultivars and the Nipponbare genomes. Comparison of SNPs detected in each cultivar suggested that Moroberekan had 5-fold more SNPs than the temperate japonica cultivars. Success of the 2 approaches to improve the efficacy of sequence data by using NGS revealed that sequencing depth was directly related to sequencing coverage of coding DNA sequences: in excess of 306 genome sequencing was required to cover approximately 80% of the genes in the rice genome. Further, the contigs prepared using the assembly of unmapped reads could increase the value of NGS short-reads and, consequently, cover previously unavailable sequences. These approaches facilitated the identification of new genes in coding DNA sequences and the increase of mapping efficiency in different regions. The DNA polymorphism information between the 7 cultivars and Nipponbare are available at NGRC_Rices_Build1.0 (http://www.nodai-genome.org/oryza_sativa_en.html).	[Arai-Kichise, Yuko; Shiwa, Yuh; Shibata-Hatta, Mari; Yoshikawa, Hirofumi; Wakasa, Kyo] Tokyo Univ Agr, Nodai Res Inst, Genome Res Ctr, Setagaya Ku, Tokyo, Japan; [Ebana, Kaworu] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan; [Yoshikawa, Hirofumi; Wakasa, Kyo] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan; [Yano, Masahiro] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki, Japan	Tokyo University of Agriculture; National Institute of Agrobiological Sciences - Japan; Tokyo University of Agriculture; National Institute of Agrobiological Sciences - Japan	Arai-Kichise, Y (corresponding author), Tokyo Univ Agr, Nodai Res Inst, Genome Res Ctr, Setagaya Ku, Tokyo, Japan.	y3kichis@nodai.ac.jp	Yano, Masahiro/AAC-5441-2019		MEXT [S0801025]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S0801025). (http://www.jsps.go.jp/english/index.html) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arai-Kichise Y, 2011, PLANT CELL PHYSIOL, V52, P274, DOI 10.1093/pcp/pcr003; Ashikawa I, 2012, MOL BREEDING, V30, P485, DOI 10.1007/s11032-011-9638-y; Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Gaur R, 2012, DNA RES, V19, P357, DOI 10.1093/dnares/dss018; Hashimoto Z, 2004, THEOR APPL GENET, V109, P1586, DOI 10.1007/s00122-004-1794-6; Heuer S, 2009, PLANT BIOTECHNOL J, V7, P456, DOI 10.1111/j.1467-7652.2009.00415.x; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; McCouch SR, 2010, BREEDING SCI, V60, P524, DOI 10.1270/jsbbs.60.524; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Michel Z, 2008, SCI RES ESSAYS, V3, P416; Nagasaki H, 2010, BREEDING SCI, V60, P648, DOI 10.1270/jsbbs.60.648; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Polko JK, 2012, MOL PLANT, V5, P948, DOI 10.1093/mp/sss022; Sabot F, 2011, PLANT J, V66, P241, DOI 10.1111/j.1365-313X.2011.04492.x; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; WANG GL, 1994, GENETICS, V136, P1421; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yoshida S, 2002, BREEDING SCI, V52, P309, DOI 10.1270/jsbbs.52.309; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	34	25	27	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86312	10.1371/journal.pone.0086312	http://dx.doi.org/10.1371/journal.pone.0086312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466017	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500222
J	Harley, CM; Wagenaar, DA				Harley, Cynthia M.; Wagenaar, Daniel A.			Scanning Behavior in the Medicinal Leech Hirudo verbana	PLOS ONE			English	Article							FEEDING-BEHAVIOR; DECISION-MAKING; EYE-MOVEMENTS; VISUAL-SEARCH; STICK INSECT; LOCOMOTION; PREY; LOCALIZATION; COCKROACH; PATTERNS	While moving through their environment, medicinal leeches stop periodically and wave their head or body back and forth. This activity has been previously described as two separate behaviors: one called 'head movement' and another called 'body waving'. Here, we report that these behaviors exist on a continuum, and provide a detailed description of what we now call 'scanning'. Scanning-related behavior has been thought to be involved in orientation; its function has never before been assessed. While previous studies suggested an involvement of scanning in social behavior, or sucker placement, our behavioral studies indicate that scanning is involved in orienting the leech towards prey stimuli. When such stimuli are present, scanning behavior is used to re-orient the leech in the direction of a prey-like stimulus. Scanning, however, occurs whether or not prey is present, but in the presence of prey-like stimuli scanning becomes localized to the stimulus origin. Most likely, this behavior helps the leech to gain a more detailed picture of its prey target. The display of scanning, regardless of the presence or absence of prey stimuli, is suggestive of a behavior that is part of an internally driven motor program, which is not released by the presence of sensory stimuli. The data herein include first steps to understanding the neural mechanisms underlying this important behavior.	[Harley, Cynthia M.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Wagenaar, Daniel A.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; University of Cincinnati	Harley, CM (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	cmharley@umn.edu	Wagenaar, Daniel A/B-4035-2010	Wagenaar, Daniel A/0000-0002-6222-761X	Burroughs Wellcome Fund; Broad Foundations	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Broad Foundations	Funding for this study was provided by the Burroughs Wellcome Fund and the Broad Foundations (to D.A.W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVILA V L, 1977, Herpetologica, V33, P152; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bisson G, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00133; Blaesing B, 2004, J EXP BIOL, V207, P1273, DOI 10.1242/jeb.00888; Brown D, 2012, TRACKER VIDEO ANAL M; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; Cornford A, 2006, J EXP BIOL, V209, P493, DOI 10.1242/jeb.02030; Dahm AG, 1962, DISTRIBUTION BIOL PA, P1; Durr V, 2001, J EXP BIOL, V204, P1589; Durr V, 2001, USE ANTENNAE TACTILE, P263; Esch T, 2002, J NEUROSCI, V22, P11045; Garcia-Perez E, 2005, J NEUROSCI, V25, P2597, DOI 10.1523/JNEUROSCI.3808-04.2005; Garcia-Perez E, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07.008.2007, 10.3389/neuro.07/008.2007]; Gee W, 1913, U CALIF PUBLS ZOOL, V11, P197; GENDRON RP, 1983, AM NAT, V121, P172, DOI 10.1086/284049; Gray J, 1938, J EXP BIOL, V15, P408; Harley CM, 2009, J EXP BIOL, V212, P1463, DOI 10.1242/jeb.028381; Harley CM, 2013, J EXP BIOL, V216, P1890, DOI 10.1242/jeb.075911; Harley CM, 2011, J EXP BIOL, V214, P3801, DOI 10.1242/jeb.059618; HART A, 1984, ANIM BEHAV, V32, P1216, DOI 10.1016/S0003-3472(84)80239-0; Herter K, 1929, J COMP PHYSIOL A, V10, P272; Herter K, 1936, PHYSL HIRUDINEEN; KRETZ JR, 1976, J COMP PHYSIOL, V106, P1, DOI 10.1007/BF00606569; Land MF, 1999, J COMP PHYSIOL A, V185, P341, DOI 10.1007/s003590050393; LAND MF, 1969, J EXP BIOL, V51, P471; LAND MF, 1990, J COMP PHYSIOL A, V167, P155; LAND MF, 1988, J EXP BIOL, V140, P381; Lanyon LJ, 2004, NEURAL NETWORKS, V17, P873, DOI 10.1016/j.neunet.2004.03.012; LINDQUIST SB, 1980, HERPETOLOGICA, V36, P144; MANN KM, 1962, LEECHES HIRUDINEA TH, P79; Mazzoni A, 2005, J NEUROPHYSIOL, V93, P580, DOI 10.1152/jn.00608.2004; Mesce KA, 2008, J COMP PHYSIOL A, V194, P469, DOI 10.1007/s00359-008-0319-1; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; Naber M, 2012, J VISION, V12, DOI 10.1167/12.1.25; NOTON D, 1971, VISION RES, V11, P929, DOI 10.1016/0042-6989(71)90213-6; Okada J, 2004, J EXP BIOL, V207, P3693, DOI 10.1242/jeb.01201; Okada J, 2006, J COMP PHYSIOL A, V192, P715, DOI 10.1007/s00359-006-0106-9; Puhl JG, 2012, J NEUROSCI, V32, P17646, DOI 10.1523/JNEUROSCI.2249-12.2012; Puhl JG, 2010, J NEUROSCI, V30, P2373, DOI 10.1523/JNEUROSCI.5765-09.2010; ROSSEL S, 1980, J COMP PHYSIOL, V139, P307, DOI 10.1007/BF00610462; SAWYER R.T., 1986, LEECH BIOL BEHAV, VII; SCHEEL D, 1993, ANIM BEHAV, V46, P695, DOI 10.1006/anbe.1993.1246; STERNTOMLINSON W, 1986, J COMP PHYSIOL A, V158, P593, DOI 10.1007/BF00603803; WALLMAN J, 1985, J NEUROSCI, V5, P1418; WOLFE JM, 1992, J EXP PSYCHOL HUMAN, V18, P34, DOI 10.1037/0096-1523.18.1.34; Zeil J, 1996, J EXP BIOL, V199, P245	46	3	3	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86120	10.1371/journal.pone.0086120	http://dx.doi.org/10.1371/journal.pone.0086120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465907	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500187
J	Li, Z; He, T; Du, K; Xing, YQ; Run, YM; Yan, Y; Shen, Y				Li, Zhi; He, Tao; Du, Ke; Xing, Yi-Qiao; Run, Yuan-Min; Yan, Ying; Shen, Yin			Inhibition of Oxygen-Induced Ischemic Retinal Neovascularization with Adenoviral 15-Lipoxygenase-1 Gene Transfer via Up-Regulation of PPAR-gamma and Down-Regulation of VEGFR-2 Expression	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; ACTIVATED-RECEPTOR-GAMMA; INDUCED RETINOPATHY; DIABETIC-RETINOPATHY; MESSENGER-RNA; LINOLEIC-ACID; FATTY-ACIDS; ANGIOGENESIS; LIGANDS; LIPOXYGENASE	15-lipoxygenase-1 (15-LOX-1) plays an important role in angiogenesis, but how it works still remains a controversial subject. The aims of our study are focused on determining whether or not 15-LOX-1 inhibiting oxygen-induced ischemic retinal neovascularization (RNV) and the underlying regulatory mechanism involving of 15-LOX-1, peroxisome proliferator-activated receptor gamma (PPAR-gamma) and vascular endothelial growth factor receptor 2 (VEGFR-2) in oxygen-induced retinopathy (OIR). Recombinant adenoviral vectors that expressing the 15-LOX-1 gene (Ad-15-LOX-1-GFP) or the green fluorescence protein gene (Ad-GFP) were intravitreous injected into the OIR mice at postnatal day 12 (P12), the mice were sacrificed 5 days later (P17). Retinal 15-LOX-1 expression was significantly increased at both mRNA and protein levels after 15-LOX-1 gene transfer. Immunofluorescence staining of retinal sections revealed 15-LOX-1 expression was primarily in the outer plexiform layer (OPL), inner nuclear layer (INL) and ganglion cell layer (GCL) retina. Meanwhile, RNV was significantly inhibited indicated by fluorescein retinal angiography and quantification of the pre-retinal neovascular cells. The expression levels of PPAR-gamma were significantly up-regulated while VEGFR-2 were significantly down-regulated both in mRNA and protein levels. Our results suggested 15-LOX-1 gene transfer inhibited RNV in OIR mouse model via up-regulation of PPAR-gamma and further down-regulation of VEGFR-2 expression. This could be a potentially important regulatory mechanism involving 15-LOX-1, PPAR-gamma and VEGFR-2 during RNV in OIR. In conclusion, 15-LOX-1 may be a new therapeutic target for treating neovascularization diseases.	[Li, Zhi; He, Tao; Xing, Yi-Qiao; Shen, Yin] Wuhan Univ, Inst Eye, Renmin Hosp, Ctr Eye, Wuhan 430072, Hubei, Peoples R China; [Li, Zhi] Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Hosp Affiliated, Dept Ophthalmol, Xiangyang, Hubei, Peoples R China; [Du, Ke] Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Hosp Affiliated, Dept Oncol, Xiangyang, Hubei, Peoples R China; [Run, Yuan-Min] Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Hosp Affiliated, Clin Lab, Xiangyang, Hubei, Peoples R China; [Yan, Ying] Wuhan Gen Hosp Guangzhou Mil, Dept Ophthalmol, Wuhan, Hubei, Peoples R China	Wuhan University; Hubei University of Arts & Science; Hubei University of Arts & Science; Hubei University of Arts & Science	Xing, YQ (corresponding author), Wuhan Univ, Inst Eye, Renmin Hosp, Ctr Eye, Wuhan 430072, Hubei, Peoples R China.	xyqdr@yahoo.com.cn; yinshen@whu.edu.cn			National Natural Science Foundation of China [81000393, 81000395, 81270998, 302-164172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (81000393; 81000395; 81270998; 302-164172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2005, RETINA-J RET VIT DIS, V25, P111, DOI 10.1097/00006982-200502000-00001; Al-Shabrawey M, 2011, DIABETES, V60, P614, DOI 10.2337/db10-0008; Biscetti F, 2009, NUTR METAB CARDIOVAS, V19, P751, DOI 10.1016/j.numecd.2009.04.011; Bradley John, 2007, Angiogenesis, V10, P141, DOI 10.1007/s10456-007-9069-x; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chu K, 2006, BRAIN RES, V1093, P208, DOI 10.1016/j.brainres.2006.03.114; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FLEMING J, 1989, GENE, V79, P181, DOI 10.1016/0378-1119(89)90103-0; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Funk CD, 1996, BBA-LIPID LIPID MET, V1304, P65, DOI 10.1016/S0005-2760(96)00107-5; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Harats D, 2005, CANCER LETT, V229, P127, DOI 10.1016/j.canlet.2005.02.017; Hernandez C, 2007, EXPERT OPIN INV DRUG, V16, P1209, DOI 10.1517/13543784.16.8.1209; Hsi LC, 2001, J BIOL CHEM, V276, P34545, DOI 10.1074/jbc.M100280200; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Kelavkar UP, 2001, CARCINOGENESIS, V22, P1765, DOI 10.1093/carcin/22.11.1765; Kota BP, 2005, PHARMACOL RES, V51, P85, DOI 10.1016/j.phrs.2004.07.012; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Kuhn H, 2007, J CARDIOVASC PHARM, V50, P609, DOI 10.1097/FJC.0b013e318159f177; Liu LL, 2010, NEUROSCIENCE, V167, P1151, DOI 10.1016/j.neuroscience.2010.03.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meissner M, 2004, CIRC RES, V94, P324, DOI 10.1161/01.RES.0000113781.08139.81; Miller JW, 1997, DIABETES METAB REV, V13, P37, DOI 10.1002/(SICI)1099-0895(199703)13:1<37::AID-DMR174>3.0.CO;2-K; Mochizuki N, 2008, CIRC RES, V102, P143, DOI 10.1161/CIRCRESAHA.107.170191; Mori K, 2001, J CELL PHYSIOL, V188, P253, DOI 10.1002/jcp.1114; Murata T, 2000, INVEST OPHTH VIS SCI, V41, P2309; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nicholson BP, 2010, GRAEF ARCH CLIN EXP, V248, P915, DOI 10.1007/s00417-010-1315-z; Oshima Y, 2006, AM J OPHTHALMOL, V142, P155, DOI 10.1016/j.ajo.2006.02.015; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Park K, 2009, DIABETES, V58, P1902, DOI 10.2337/db08-1327; Peeters Louis L. H., 2005, Angiogenesis, V8, P373; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Sarayba MA, 2005, EXP EYE RES, V80, P435, DOI 10.1016/j.exer.2004.10.009; Sasaki T, 2006, VIRCHOWS ARCH, V448, P422, DOI 10.1007/s00428-005-0110-4; Sassa Y, 2004, DIABETES, V53, P1222, DOI 10.2337/diabetes.53.5.1222; Shappell SB, 1999, AM J PATHOL, V155, P235, DOI 10.1016/S0002-9440(10)65117-6; Shureiqi I, 2003, P NATL ACAD SCI USA, V100, P9968, DOI 10.1073/pnas.1631086100; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 2002, ACTA PAEDIATR, V91, P26, DOI 10.1080/08035250260095771; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P275, DOI 10.1097/00006982-200603000-00004; Stahl A, 2010, CIRC RES, V107, P495, DOI 10.1161/CIRCRESAHA.110.221317; Tawfik A, 2009, INVEST OPHTH VIS SCI, V50, P878, DOI 10.1167/iovs.08-2005; Viita H, 2008, CIRC RES, V102, P177, DOI 10.1161/CIRCRESAHA.107.155556; Viita H, 2009, HUM GENE THER, V20, P1679, DOI 10.1089/hum.2009.069; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Xin XH, 1999, J BIOL CHEM, V274, P9116, DOI 10.1074/jbc.274.13.9116; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Zhang Q, 2009, GRAEF ARCH CLIN EXP, V247, P919, DOI 10.1007/s00417-009-1066-x; Zhong XF, 2011, MOL VIS, V17, P492; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160	64	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85824	10.1371/journal.pone.0085824	http://dx.doi.org/10.1371/journal.pone.0085824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465728	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500120
J	Lu, HY; Yang, LZ; Zhang, SQ; Wu, YH				Lu, Haiying; Yang, Linzhang; Zhang, Shanqing; Wu, Yonghong			The Behavior of Organic Phosphorus under Non-Point Source Wastewater in the Presence of Phototrophic Periphyton	PLOS ONE			English	Article							AQUEOUS-SOLUTIONS; NUTRIENT-REMOVAL; BIOFILMS; ADSORPTION; KINETICS; SOIL; EQUILIBRIUM; MECHANISMS; PATTERNS	To understand the role of ubiquitous phototrophic periphyton in aquatic ecosystem on the biogeochemical cycling of organic phosphorus, the conversion and removal kinetic characteristics of organic phosphorus (Porg) such as adenosine triphosphate (ATP) were investigated in the presence of the periphyton cultured in artificial non-point source wastewater. The preliminary results showed that the periphyton was very powerful in converting P-org evidenced by the fact that inorganic phosphorus (P-inorg) content in solution increased from about 0.7 to 14.3 mg P L-1 in 48 hours in the presence of 0.6 g L-1 periphyton. This was because the periphyton could produce abundant phosphatases that benefited the conversion of P-org to P-inrog. Moreover, this conversion process was described more suitable by the pseudo-first-order kinetic model. The periphyton was also effective in removing P-org, which showed that the P-org can be completely removed even when the initial P-org concentration was as high as 13 mg P L-1 in 48 hours in the presence of 1.6 g L-1 periphyton. Furthermore, it was found that biosorption dominated the P-org removal process and exhibited the characteristics of physical adsorption. However, this biosorption process by the periphyton was significantly influenced by biomass (absorbent dosage) and temperature. This work provides insights into P-org biogeochemical circulation of aquatic ecosystem that contained the periphyton or similar microbial aggregates.	[Lu, Haiying; Yang, Linzhang; Wu, Yonghong] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Yang, Linzhang] Jiangsu Acad Agr Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Shanqing] Griffith Univ, Griffith Sch Environm, Ctr Clean Environm & Energy, Environm Futures Ctr, Nathan, Qld 4111, Australia	Chinese Academy of Sciences; Institute of Soil Science, CAS; Jiangsu Academy of Agricultural Sciences; Griffith University	Wu, YH (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	yhwu@issas.ac.cn	Zhang, Shanqing/C-2590-2008; Zhang, Shanqing/M-3663-2019; Wu, Yonghong/B-4501-2010	Zhang, Shanqing/0000-0001-5192-1844; Zhang, Shanqing/0000-0001-5192-1844; Wu, Yonghong/0000-0002-2985-219X	National Natural Science Foundation of China [41171363, 41030640]; Innovative Project of Chinese Academy of Sciences [KZCX2-EW-QN401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Project of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (41171363 and 41030640), and the Innovative Project of Chinese Academy of Sciences (KZCX2-EW-QN401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksakal O, 2010, J HAZARD MATER, V181, P666, DOI 10.1016/j.jhazmat.2010.05.064; Badawy MI, 2006, DESALINATION, V194, P166, DOI 10.1016/j.desal.2005.09.027; Balser TC, 2009, GLOBAL CHANGE BIOL, V15, P2935, DOI 10.1111/j.1365-2486.2009.01946.x; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; BENTZEN E, 1992, LIMNOL OCEANOGR, V37, P217, DOI 10.4319/lo.1992.37.2.0217; BURKHOLDER JM, 1992, NATURE, V358, P407, DOI 10.1038/358407a0; COTNER JB, 1992, LIMNOL OCEANOGR, V37, P232, DOI 10.4319/lo.1992.37.2.0232; Dawood S, 2012, WATER RES, V46, P1933, DOI 10.1016/j.watres.2012.01.009; De Beer D, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P904, DOI 10.1007/0-387-30741-9_28; de los Rios A, 2004, APPL ENVIRON MICROB, V70, P569, DOI 10.1128/AEM.70.1.569-580.2004; DEBEER D, 1994, BIOTECHNOL BIOENG, V43, P1131, DOI 10.1002/bit.260431118; Dogan M, 2006, CHEM ENG J, V124, P89, DOI 10.1016/j.cej.2006.08.016; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Ellwood NTW, 2012, WATER RES, V46, P378, DOI 10.1016/j.watres.2011.10.057; Espeland EM, 2001, MICROBIAL ECOL, V42, P328, DOI 10.1007/s002480000117; Gatidou G, 2011, ENVIRON SCI POLLUT R, V18, P949, DOI 10.1007/s11356-011-0452-1; Guzzon A, 2008, WATER RES, V42, P4357, DOI 10.1016/j.watres.2008.07.029; Hameed BH, 2008, J HAZARD MATER, V153, P701, DOI 10.1016/j.jhazmat.2007.09.019; HERBES SE, 1975, SCIENCE, V187, P432, DOI 10.1126/science.187.4175.432; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Huang CT, 1998, APPL ENVIRON MICROB, V64, P1526; JAMES GA, 1995, J IND MICROBIOL, V15, P257, DOI 10.1007/BF01569978; KAY M, 1995, CHEM PHYS LETT, V245, P311, DOI 10.1016/0009-2614(95)00975-A; Matheson FE, 2012, FRESHWATER BIOL, V57, P1617, DOI 10.1111/j.1365-2427.2012.02822.x; McCormick PV, 2006, ECOL ENG, V27, P279, DOI 10.1016/j.ecoleng.2006.05.018; McCormick PV, 2001, AQUAT BOT, V71, P119, DOI 10.1016/S0304-3770(01)00175-9; McKelvie I. D., 2005, SEPARATION PRECONCEN; MINEAR RA, 1972, ENVIRON SCI TECHNOL, V6, P431, DOI 10.1021/es60064a007; Rittmann BE, 2011, CHEMOSPHERE, V84, P846, DOI 10.1016/j.chemosphere.2011.02.001; Roeselers G, 2008, J APPL PHYCOL, V20, P227, DOI 10.1007/s10811-007-9223-2; Sabater S, 2002, HYDROBIOLOGIA, V469, P149, DOI 10.1023/A:1015549404082; Saisho D, 2001, J PLANT PHYSIOL, V158, P241, DOI 10.1078/0176-1617-00193; Sanudo-Wilhelmy SA, 2006, NATURE, V439, P25, DOI 10.1038/439025a; Scinto LJ, 2003, AQUAT BOT, V77, P203, DOI 10.1016/S0304-3770(03)00106-2; Shilton AN, 2012, CURR OPIN BIOTECH, V23, P884, DOI 10.1016/j.copbio.2012.07.002; Sun QY, 2003, WATER RES, V37, P1535, DOI 10.1016/S0043-1354(02)00520-1; Turner BL, 2005, TALANTA, V66, P294, DOI 10.1016/j.talanta.2004.11.012; Wu YH, 2012, BIORESOURCE TECHNOL, V107, P10, DOI 10.1016/j.biortech.2011.12.088; Wu YH, 2010, ENVIRON SCI TECHNOL, V44, P6319, DOI 10.1021/es903761y; Wu YH, 2010, ENVIRON POLLUT, V158, P2472, DOI 10.1016/j.envpol.2010.03.020	41	5	7	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85910	10.1371/journal.pone.0085910	http://dx.doi.org/10.1371/journal.pone.0085910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465782	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500142
J	Rojek, MJ; Walt, DR				Rojek, Marcin J.; Walt, David R.			Observing Single Enzyme Molecules Interconvert between Activity States upon Heating	PLOS ONE			English	Article							BETA-GALACTOSIDASE; INDIVIDUAL MOLECULES; HIGH-TEMPERATURES; KINETICS; DENATURATION; DEPENDENCE; STABILITY; DYNAMICS; TIME	In this paper, we demonstrate that single enzyme molecules of beta-galactosidase interconvert between different activity states upon exposure to short pulses of heat. We show that these changes in activity are the result of different enzyme conformations. Hundreds of single beta-galactosidase molecules are trapped in femtoliter reaction chambers and the individual enzymes are subjected to short heating pulses. When heating pulses are introduced into the system, the enzyme molecules switch between different activity states. Furthermore, we observe that the changes in activity are random and do not correlate with the enzyme's original activity. This study demonstrates that different stable conformations play an important role in the static heterogeneity reported previously, resulting in distinct long-lived activity states of enzyme molecules in a population.	[Rojek, Marcin J.; Walt, David R.] Tufts Univ, Dept Chem, Medford, MA 02155 USA	Tufts University	Walt, DR (corresponding author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.	david.walt@tufts.edu			Quanterix Corporation	Quanterix Corporation	This work was supported in part by an unrestricted grant from Quanterix Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arata HF, 2005, ANAL CHEM, V77, P4810, DOI 10.1021/ac050385+; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Craig DB, 2003, J PROTEIN CHEM, V22, P555, DOI 10.1081/TXR-120026914; Craig DB, 2012, BIOCHEM CELL BIOL, V90, P540, DOI [10.1139/o2012-006, 10.1139/O2012-006]; Craig DB, 2008, ELECTROPHORESIS, V29, P4298, DOI 10.1002/elps.200800482; Daniel RM, 1996, BIOCHEM J, V317, P1, DOI 10.1042/bj3170001; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Dyck AC, 2002, LUMINESCENCE, V17, P15, DOI 10.1002/bio.672; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Gorris HH, 2007, P NATL ACAD SCI USA, V104, P17680, DOI 10.1073/pnas.0705411104; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jurado E, 2004, ENZYME MICROB TECH, V34, P33, DOI 10.1016/j.enzmictec.2003.07.004; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Min W, 2005, ACCOUNTS CHEM RES, V38, P923, DOI 10.1021/ar040133f; MUGA A, 1993, ARCH BIOCHEM BIOPHYS, V300, P451, DOI 10.1006/abbi.1993.1061; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Peterson ME, 2007, BIOCHEM J, V402, P331, DOI 10.1042/BJ20061143; Rissin DM, 2008, J AM CHEM SOC, V130, P5349, DOI 10.1021/ja711414f; Rissin DM, 2006, NANO LETT, V6, P520, DOI 10.1021/nl060227d; Schotte F, 2004, J STRUCT BIOL, V147, P235, DOI 10.1016/j.jsb.2004.06.009; Thomas TM, 1998, BIOCHEM J, V330, P1087; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; XUE QF, 1995, NATURE, V373, P681, DOI 10.1038/373681a0; YOSHIOKA S, 1994, PHARMACEUT RES, V11, P1721, DOI 10.1023/A:1018955031042	26	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86224	10.1371/journal.pone.0086224	http://dx.doi.org/10.1371/journal.pone.0086224			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465972	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500209
J	Shikano, I; Cory, JS				Shikano, Ikkei; Cory, Jenny S.			Genetic Resistance to Bacillus thuringiensis Alters Feeding Behaviour in the Cabbage Looper, Trichoplusia ni	PLOS ONE			English	Article							FITNESS COSTS; DROSOPHILA-MELANOGASTER; INSECT RESISTANCE; PINK-BOLLWORM; TOXIN CRY1AC; HOST-PLANT; BT COTTON; TRADE-OFF; EVOLUTION; MOTH	Evolved resistance to xenobiotics and parasites is often associated with fitness costs when the selection pressure is absent. Resistance to the widely used microbial insecticide Bacillus thuringiensis (Bt) has evolved in several insect species through the modification of insect midgut binding sites for Bt toxins, and reports of costs associated with Bt resistance are common. Studies on the costs of Bt-resistance restrict the insect to a single artificial diet or host-plant. However, it is well documented that insects can self-select appropriate proportions of multiple nutritionally unbalanced foods to optimize life-history traits. Therefore, we examined whether Bt-resistant and susceptible cabbage loopers Trichoplusia ni differed in their nutrient intake and fitness costs when they were allowed to compose their own protein: carbohydrate diet. We found that Bt-resistant T. ni composed a higher ratio of protein to carbohydrate than susceptible T. ni. Bt-resistant males exhibited no fitness cost, while the fitness cost (reduced pupal weight) was present in resistant females. The absence of the fitness cost in resistant males was associated with increased carbohydrate consumption compared to females. We demonstrate a sex difference in a fitness cost and a new behavioural outcome associated with Bt resistance.	[Shikano, Ikkei; Cory, Jenny S.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Shikano, I (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	ishikano@sfu.ca		Shikano, Ikkei/0000-0003-4857-1294	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Alexander Graham Bell Canada Graduate Scholarship-Doctoral; Pacific Century Graduate Entrance Scholarship from the government of BC; Targeted Special Graduate Entrance Scholarship from SFU	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Alexander Graham Bell Canada Graduate Scholarship-Doctoral; Pacific Century Graduate Entrance Scholarship from the government of BC; Targeted Special Graduate Entrance Scholarship from SFU	Financial support was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to J.S.C. and an NSERC Alexander Graham Bell Canada Graduate Scholarship-Doctoral, the Pacific Century Graduate Entrance Scholarship from the government of BC and a Targeted Special Graduate Entrance Scholarship from SFU to I.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2003, J ECON ENTOMOL, V96, P1290, DOI 10.1603/0022-0493-96.4.1290; Alyokhin AV, 1999, J ECON ENTOMOL, V92, P510, DOI 10.1093/jee/92.3.510; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Carriere Y, 2005, J ECON ENTOMOL, V98, P947, DOI 10.1603/0022-0493-98.3.947; Carriere Y, 2004, J ECON ENTOMOL, V97, P1710, DOI 10.1603/0022-0493-97.5.1710; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Cory JS, 2012, EVOL APPL, V5, P455, DOI 10.1111/j.1752-4571.2012.00269.x; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; GROETERS FR, 1994, EVOLUTION, V48, P197, DOI 10.2307/2410015; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Janmaat AF, 2005, P ROY SOC B-BIOL SCI, V272, P1031, DOI 10.1098/rspb.2004.3040; Janmaat AF, 2011, J INVERTEBR PATHOL, V107, P27, DOI 10.1016/j.jip.2010.12.014; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889; Oppert B, 2000, ENTOMOL EXP APPL, V96, P281, DOI 10.1023/A:1004061222318; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Povey S, 2014, J ANIM ECOL, V83, P245, DOI 10.1111/1365-2656.12127; Rahman MM, 2004, P NATL ACAD SCI USA, V101, P2696, DOI 10.1073/pnas.0306669101; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Raymond B, 2011, HEREDITY, V106, P281, DOI 10.1038/hdy.2010.65; Raymond B, 2007, J APPL ECOL, V44, P768, DOI 10.1111/j.1365-2664.2007.01285.x; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Thompson SN, 2000, BBA-GEN SUBJECTS, V1523, P91, DOI 10.1016/S0304-4165(00)00102-1; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; Vijendravarma RK, 2009, EVOLUTION, V63, P104, DOI 10.1111/j.1558-5646.2008.00516.x; Wang P, 2007, APPL ENVIRON MICROB, V73, P1199, DOI 10.1128/AEM.01834-06; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; Williams JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021863; Zhang X., 2012, PLoS ONE, V7, pe35991, DOI 10.1371/journal.pone.0035991	30	13	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85709	10.1371/journal.pone.0085709	http://dx.doi.org/10.1371/journal.pone.0085709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465656	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500093
J	Alegre, A; Menard, F; Tafur, R; Espinoza, P; Arguelles, J; Maehara, V; Flores, O; Simier, M; Bertrand, A				Alegre, Ana; Menard, Frederic; Tafur, Ricardo; Espinoza, Pepe; Arguelles, Juan; Maehara, Victor; Flores, Oswaldo; Simier, Monique; Bertrand, Arnaud			Comprehensive Model of Jumbo Squid Dosidicus gigas Trophic Ecology in the Northern Humboldt Current System	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; CEPHALOPODA OMMASTREPHIDAE; METABOLIC SUPPRESSION; BEHAVIOR; FOOD; HYPOXIA; BIOLOGY; HABITS; FISHES; CHILE	The jumbo squid Dosidicus gigas plays an important role in marine food webs both as predator and prey. We investigated the ontogenetic and spatiotemporal variability of the diet composition of jumbo squid in the northern Humboldt Current system. For that purpose we applied several statistical methods to an extensive dataset of 3,618 jumbo squid non empty stomachs collected off Peru from 2004 to 2011. A total of 55 prey taxa was identified that we aggregated into eleven groups. Our results evidenced a large variability in prey composition as already observed in other systems. However, our data do not support the hypothesis that jumbo squids select the most abundant or energetic taxon in a prey assemblage, neglecting the other available prey. Indeed, multinomial model predictions showed that stomach fullness increased with the number of prey taxa, while most stomachs with low contents contained one or two prey taxa only. Our results therefore question the common hypothesis that predators seek locally dense aggregations of monospecific prey. In addition D. gigas consumes very few anchovy Engraulis ringens in Peru, whereas a tremendous biomass of anchovy is potentially available. It seems that D. gigas cannot reach the oxygen unsaturated waters very close to the coast, where the bulk of anchovy occurs. Indeed, even if jumbo squid can forage in hypoxic deep waters during the day, surface normoxic waters are then required to recover its maintenance respiration (or energy?). Oxygen concentration could thus limit the co-occurrence of both species and then preclude predator-prey interactions. Finally we propose a conceptual model illustrating the opportunistic foraging behaviour of jumbo squid impacted by ontogenetic migration and potentially constrained by oxygen saturation in surface waters.	[Alegre, Ana; Tafur, Ricardo; Espinoza, Pepe; Arguelles, Juan; Flores, Oswaldo] Inst Mar Peru IMARPE, Callao, Peru; [Alegre, Ana; Menard, Frederic; Simier, Monique; Bertrand, Arnaud] Inst Rech Dev, EME IFREMER IRD UM2 UMR212, Sete, France; [Maehara, Victor] Univ Nacl Agr La Molina, Lima, Peru	Instituto del Mar del Peru; Ifremer; Institut de Recherche pour le Developpement (IRD); University Nacional Agraria La Molina	Bertrand, A (corresponding author), Inst Rech Dev, EME IFREMER IRD UM2 UMR212, Sete, France.	Arnaud.Bertrand@ird.fr	Menard, Frederic/C-3913-2008; SIMIER, Monique/O-4797-2019; Bertrand, Arnaud/E-4251-2010	Menard, Frederic/0000-0003-1162-660X; Bertrand, Arnaud/0000-0003-4723-179X; ESPINOZA, Pepe/0000-0001-5149-8310; Arguelles, Juan/0000-0002-4227-0952; Simier, Monique/0000-0002-8436-5925; Espinoza, Pepe/0000-0001-8699-8411	ARTS grant from IRD	ARTS grant from IRD	This work is a contribution to the cooperative agreement between the Instituto del Mar del Peru (IMARPE), the Institut de Recherche pour le Developpement (IRD), and of the LMI DISCOH. A. Alegre was financially supported by an ARTS grant from IRD and managed by Campus France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamo V, 1987, B I MAR PERU VOL EXT; Amaratunga T., 1983, FAO Fisheries Technical Paper, V231, P379; Arguelles J, 2012, MAR BIOL, V159, P2105, DOI 10.1007/s00227-012-1998-2; Arguelles J, 2001, FISH RES, V54, P51, DOI 10.1016/S0165-7836(01)00380-0; AUSTER PJ, 1992, ENVIRON BIOL FISH, V35, P133, DOI 10.1007/BF00002187; Ballon M, 2011, PROG OCEANOGR, V91, P360, DOI 10.1016/j.pocean.2011.03.001; Barbieri M.A, 2004, Gayana (Concepc.), V68, P29; Bard FX, 2002, COLL VOL SCI PAP ICC, V54, P33; Bazzino G, 2010, PROG OCEANOGR, V86, P59, DOI 10.1016/j.pocean.2010.04.017; Bertrand A, 2002, MAR BIOL, V140, P1023, DOI 10.1007/s00227-001-0776-3; Bertrand A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029558; Bertrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010330; Bertrand A, 2008, PROG OCEANOGR, V79, P264, DOI 10.1016/j.pocean.2008.10.018; Boyle P, 2005, CEPHALOPODS: ECOLOGY AND FISHERIES, P1, DOI 10.1002/9780470995310; Breiman L., 2017, CLASSIFICATION REGRE; Budelmann BU, 1994, MAR FRESHW BEHAV PHY, V25, P13, DOI 10.1080/10236249409378905; Caddy JF, 1983, ADV ASSESSMENT WORLD, V231, P416; Chipps Steven R., 2007, P473; Chong Javier, 2005, Gayana (Concepc.), V69, P319; Cornejo R, 2006, MAR BIOL, V149, P1519, DOI 10.1007/s00227-006-0319-z; Cubillos LS, 2004, PESCA INVESTIGACION; Field JC, 2007, CAL COOP OCEAN FISH, V48, P131; Field JC, 2013, DEEP-SEA RES PT II, V95, P37, DOI 10.1016/j.dsr2.2012.09.006; FITCH JE, 1968, J FISH RES BOARD CAN, V25, P2561, DOI 10.1139/f68-227; Garcia-Godos I, 2001, B I MAR PERU, V20; Gerlotto F, 2006, ICES J MAR SCI, V63, P1405, DOI 10.1016/j.icesjms.2006.04.023; Gilly WF, 2006, MAR ECOL PROG SER, V324, P1, DOI 10.3354/meps324001; Gilly WF, 2013, ANNU REV MAR SCI, V5, P393, DOI 10.1146/annurev-marine-120710-100849; Gilly WF, 2012, J EXP BIOL, V215, P3175, DOI 10.1242/jeb.072538; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Ibanez CM, 2008, HELGOLAND MAR RES, V62, P331, DOI 10.1007/s10152-008-0120-0; Ibanez CM, 2010, REV FISH BIOL FISHER, V20, P123, DOI 10.1007/s11160-009-9129-y; Jereb P., 2010, FAO SPECIES CATALOGU, V2; Keyl F, 2011, ICES J MAR SCI, V68, P507, DOI 10.1093/icesjms/fsq167; Kuhnert PM, 2012, MAR BIOL, V159, P87, DOI 10.1007/s00227-011-1792-6; Lorrain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022194; Lundvall D, 1999, CAN J FISH AQUAT SCI, V56, P1285, DOI 10.1139/cjfas-56-7-1285; Markaida U, 2005, FISH B-NOAA, V103, P219; Markaida U, 2003, J MAR BIOL ASSOC UK, V83, P507, DOI 10.1017/S0025315403007434h; Markaida U, 2006, FISH RES, V79, P16, DOI 10.1016/j.fishres.2006.02.016; Markaida U, 2008, CAL COOP OCEAN FISH, V49, P90; Menard F, 2003, AQUAT LIVING RESOUR, V16, P231, DOI 10.1016/S0990-7440(03)00040-8; Mendez M, 1981, B I MAR PERU, V5; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nesis K.N., 1983, P215; NESIS KN, 1970, OCEANOLOGY-USSR, V10, P108; Newell G, 1963, HUTCHISON BIOL MONGR; Nigmatullin CM, 2001, FISH RES, V54, P9, DOI 10.1016/S0165-7836(01)00371-X; Potier M., 2004, Western Indian Ocean Journal of Marine Science, V3, P51; Potier M, 2008, AQUAT LIVING RESOUR, V21, P123, DOI 10.1051/alr:2008026; Rahm G, 1937, CR 12 C INT ZOOL LIS, V2, P1237; Rasero M, 1996, J MAR BIOL ASSOC UK, V76, P73, DOI 10.1017/S0025315400029027; Rodhouse PG, 1996, PHILOS T ROY SOC B, V351, P1003, DOI 10.1098/rstb.1996.0090; Roper C. F. E., 1984, FAO FISH SYNOP, V125, P1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosa R, 2010, PROG OCEANOGR, V86, P72, DOI 10.1016/j.pocean.2010.04.004; Rosas-Luis R, 2007, THESIS CIBNOR MEXICO; Ruiz-Cooley RI, 2010, MAR ECOL PROG SER, V399, P187, DOI 10.3354/meps08383; Ruiz-Cooley RI, 2006, J MAR BIOL ASSOC UK, V86, P437, DOI 10.1017/S0025315406013324; Ruiz-Cooley RI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059651; Sanchez J, 2011, THESIS U NCAL FEDERI; Seibel BA, 2013, DEEP-SEA RES PT II, V95, P139, DOI 10.1016/j.dsr2.2012.10.003; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Tafur R, 2001, FISH RES, V54, P33, DOI 10.1016/S0165-7836(01)00379-4; Trubenbach K, 2013, DEEP-SEA RES PT II, V95, P209, DOI 10.1016/j.dsr2.2012.10.001; Trubenbach K, 2013, J EXP BIOL, V216, P359, DOI 10.1242/jeb.072587; Venables W.N., 2002, MODERN APPL STAT S; Wolff C, 1984, NOAA TECHNICAL REPOR, V17, P1; Yatsu Akihiko, 1999, Bulletin of the National Research Institute of Far Seas Fisheries, V36, P55; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104	70	34	45	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85919	10.1371/journal.pone.0085919	http://dx.doi.org/10.1371/journal.pone.0085919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465788	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500089
J	Alla, RK; Cairns, BR				Alla, Ravi K.; Cairns, Bradley R.			RNA Polymerase III Transcriptomes in Human Embryonic Stem Cells and Induced Pluripotent Stem Cells, and Relationships with Pluripotency Transcription Factors	PLOS ONE			English	Article							GENOME-WIDE LOCALIZATION; SACCHAROMYCES-CEREVISIAE; POL II; CHROMATIN; MACHINERY; GENES; METHYLATION; SIGNATURES; COMPLEXES; LEUKEMIA	Recent genomic approaches have revealed that the repertoire of RNA Pol III-transcribed genes varies in different human cell types, and that this variation is likely determined by a combination of the chromatin landscape, cell-specific DNA-binding transcription factors, and collaboration with RNA Pol II. Although much is known about this regulation in differentiated human cells, there is presently little understanding of this aspect of the Pol III system in human ES cells. Here, we determine the occupancy profiles of Pol III components in human H1 ES cells, and also induced pluripotent cells, and compare to known profiles of chromatin, transcription factors, and RNA expression. We find a relatively large fraction of the Pol III repertoire occupied in human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). In ES cells we find clear correlations between Pol III occupancy and active chromatin. Interestingly, we find a highly significant fraction of Pol III-occupied genes with adjacent binding events by pluripotency factors in ES cells, especially NANOG. Notably, in human ES cells we find H3K27me3 adjacent to but not overlapping many active Pol III loci. We observe in all such cases, a peak of H3K4me3 and/or RNA Pol II, between the H3K27me3 and Pol III binding peaks, suggesting that H3K4me3 and Pol II activity may "insulate' Pol III from neighboring repressive H3K27me3. Further, we find iPSCs have a larger Pol III repertoire than their precursors. Finally, the active Pol III genome in iPSCs is not completely reprogrammed to a hESC like state and partially retains the transcriptional repertoire of the precursor. Together, our correlative results are consistent with Pol III binding and activity in human ES cells being enabled by active/permissive chromatin that is shaped in part by the pluripotency network of transcription factors and RNA Pol II activity.	[Alla, Ravi K.; Cairns, Bradley R.] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Alla, Ravi K.; Cairns, Bradley R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute	Cairns, BR (corresponding author), Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	brad.cairns@hci.utah.edu			Howard Hughes Medical Institute;  [CA24014]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); 	This work was supported by the Howard Hughes Medical Institute, and by CA24014 for core facilities. www.hhmi.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Canella D, 2010, GENOME RES, V20, P710, DOI 10.1101/gr.101337.109; Carriere L, 2012, NUCLEIC ACIDS RES, V40, P270, DOI 10.1093/nar/gkr737; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Dai B, 2007, STEM CELLS, V25, P2567, DOI 10.1634/stemcells.2007-0131; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gu TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-563; Harismendy O, 2003, EMBO J, V22, P4738, DOI 10.1093/emboj/cdg466; Hu QD, 2012, NAT STRUCT MOL BIOL, V19, P1168, DOI 10.1038/nsmb.2400; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Martini A, 2002, CANCER RES, V62, P5408; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moqtaderi Z, 2004, MOL CELL BIOL, V24, P4118, DOI 10.1128/MCB.24.10.4118-4127.2004; Moqtaderi Z, 2010, NAT STRUCT MOL BIOL, V17, P635, DOI 10.1038/nsmb.1794; Morinobu M, 2005, J EXP MED, V201, P961, DOI 10.1084/jem.20041097; Nakamoto T, 2004, GENES CELLS, V9, P575, DOI 10.1111/j.1356-9597.2004.00746.x; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Nyquist KB, 2011, CANCER GENET-NY, V204, P147, DOI 10.1016/j.cancergen.2011.01.003; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Simms TA, 2008, EUKARYOT CELL, V7, P2078, DOI 10.1128/EC.00128-08; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010	39	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85648	10.1371/journal.pone.0085648	http://dx.doi.org/10.1371/journal.pone.0085648			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465633	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500064
J	Mishra, SK; Lutman, ME				Mishra, Srikanta K.; Lutman, Mark E.			Top-Down Influences of the Medial Olivocochlear Efferent System in Speech Perception in Noise	PLOS ONE			English	Article							INTENSITY DISCRIMINATION; MOC REFLEX; RECOGNITION; SUPPRESSION; MODEL; INTELLIGIBILITY; ENHANCEMENT; EMISSIONS; LEVEL; AGE	One of the putative functions of the medial olivocochlear (MOC) system is to enhance signal detection in noise. The objective of this study was to elucidate the role of the MOC system in speech perception in noise. In normal-hearing human listeners, we examined (1) the association between magnitude of MOC inhibition and speech-in-noise performance, and (2) the association between MOC inhibition and the amount of contralateral acoustic stimulation (CAS)-induced shift in speech-in-noise acuity. MOC reflex measurements in this study considered critical measurement issues overlooked in past work by: recording relatively low-level, linear click-evoked otoacoustic emissions (CEOAEs), adopting 6 dB signal-to-noise ratio (SNR) criteria, and computing normalized CEOAE differences. We found normalized index to be a stable measure of MOC inhibition (mean = 17.21%). MOC inhibition was not related to speech-in-noise performance measured without CAS. However, CAS in a speech-in-noise task caused an SNRSP enhancement (mean = 2.45 dB), and this improvement in speech-in-noise acuity was directly related to their MOC reflex assayed by CEOAEs. Individuals do not necessarily use the available MOC-unmasking characteristic while listening to speech in noise, or do not utilize unmasking to the extent that can be shown by artificial MOC activation. It may be the case that the MOC is not actually used under natural listening conditions and the higher auditory centers recruit MOC-mediated mechanisms only in specific listening conditions-those conditions remain to be investigated.	[Mishra, Srikanta K.; Lutman, Mark E.] Univ Southampton, Inst Sound & Vibrat Res, Southampton, Hants, England; [Mishra, Srikanta K.] Butler Univ, Dept Commun Sci & Disorders, Indianapolis, IN 46208 USA	University of Southampton; Butler University	Mishra, SK (corresponding author), Univ Southampton, Inst Sound & Vibrat Res, Southampton, Hants, England.	skmishra@butler.edu			European Commission, Directorate-General for Health and Consumer Protection [2004127]; Institute of Sound and Vibration Research, University of Southampton, Southampton, UK	European Commission, Directorate-General for Health and Consumer Protection; Institute of Sound and Vibration Research, University of Southampton, Southampton, UK	This research was supported by a grant (EMFnEAR) from the European Commission, Directorate-General for Health and Consumer Protection (Grant No. 2004127) and a Rayleigh scholarship from the Institute of Sound and Vibration Research, University of Southampton, Southampton, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala C, 2009, J ACOUST SOC AM, V125, P1584, DOI 10.1121/1.3068442; Bhagat SP, 2010, NEUROSCI LETT, V485, P94, DOI 10.1016/j.neulet.2010.08.069; Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Brown GJ, 2010, J ACOUST SOC AM, V127, P943, DOI 10.1121/1.3273893; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; Clark NR, 2012, J ACOUST SOC AM, V132, P1535, DOI 10.1121/1.4742745; Cooper NP, 2003, J PHYSIOL-LONDON, V548, P307, DOI 10.1113/jphysiol.2003.039081; De Boer J, 2007, HEARING RES, V107, P83; de Boer J, 2012, J NEUROPHYSIOL, V107, P1301, DOI 10.1152/jn.00222.2011; Deeter R, 2008, J ACOUST SOC AM, V126, P2413; Feeney MP, 2003, J SPEECH LANG HEAR R, V46, P128, DOI 10.1044/1092-4388(2003/010); FOSTER J R, 1987, British Journal of Audiology, V21, P165, DOI 10.3109/03005368709076402; Garinis A, 2011, HEARING RES, V282, P128, DOI 10.1016/j.heares.2011.08.007; Garinis AC, 2011, J SPEECH LANG HEAR R, V54, P1464, DOI 10.1044/1092-4388(2011/10-0223); Giraud AL, 1997, NEUROREPORT, V8, P1779, DOI 10.1097/00001756-199705060-00042; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Guinan JJ, 2010, CURR OPIN OTOLARYNGO, V18, P447, DOI 10.1097/MOO.0b013e32833e05d6; Harkrider Ashley W, 2005, J Am Acad Audiol, V16, P530, DOI 10.3766/jaaa.16.8.2; Hartmann WM, 2002, J ACOUST SOC AM, V112, P1037, DOI 10.1121/1.1500759; KAWASE T, 1993, J NEUROPHYSIOL, V70, P2519, DOI 10.1152/jn.1993.70.6.2519; KAWASE T, 1993, J NEUROPHYSIOL, V70, P2533, DOI 10.1152/jn.1993.70.6.2533; Keefe DH, 2010, HEARING RES, V263, P52, DOI 10.1016/j.heares.2009.09.008; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Kim S, 2006, SPEECH COMMUN, V48, P855, DOI 10.1016/j.specom.2006.03.004; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Messing DP, 2009, SPEECH COMMUN, V51, P668, DOI 10.1016/j.specom.2009.02.002; MICHEYL C, 1995, ACTA OTO-LARYNGOL, V115, P178, DOI 10.3109/00016489509139286; Micheyl C, 1997, BEHAV NEUROSCI, V111, P801, DOI 10.1037/0735-7044.111.4.801; Micheyl C, 1996, J ACOUST SOC AM, V99, P1604, DOI 10.1121/1.414734; Mishra SK, 2013, EAR HEARING, V34, P789, DOI 10.1097/AUD.0b013e3182944c04; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Mukari SZMS, 2008, AUDIOL NEURO-OTOL, V13, P328, DOI 10.1159/000128978; Tokgoz-Yilmaz S, 2007, J LARYNGOL OTOL, V121, P1029, DOI 10.1017/S0022215107006883; Wagner W, 2008, ACTA OTO-LARYNGOL, V128, P53, DOI 10.1080/00016480701361954; WINSLOW RL, 1988, HEARING RES, V35, P165, DOI 10.1016/0378-5955(88)90116-5; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; YOST WA, 1988, J ACOUST SOC AM, V83, P1517, DOI 10.1121/1.395907; Zeng FG, 2000, HEARING RES, V142, P102, DOI 10.1016/S0378-5955(00)00011-3; Zhao W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018725	40	52	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85756	10.1371/journal.pone.0085756	http://dx.doi.org/10.1371/journal.pone.0085756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465686	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500069
J	Suzuki, M; Toyoda, N; Takagi, S				Suzuki, Motoshi; Toyoda, Naoya; Takagi, Shin			Pulsed Irradiation Improves Target Selectivity of Infrared Laser-Evoked Gene Operator for Single-Cell Gene Induction in the Nematode C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONES; EXPRESSION; SYSTEM; ZEBRAFISH; MIGRATION	Methods for turning on/off gene expression at the experimenter's discretion would be useful for various biological studies. Recently, we reported on a novel microscope system utilizing an infrared laser-evoked gene operator (IR-LEGO) designed for inducing heat shock response efficiently in targeted single cells in living organisms without cell damage, thereby driving expression of a transgene under the control of a heat shock promoter. Although the original IR-LEGO can be successfully used for gene induction, several limitations hinder its wider application. Here, using the nematode Caenorhabditis elegans (C. elegans) as a subject, we have made improvements in IR-LEGO. For better spatial control of heating, a pulsed irradiation method using an optical chopper was introduced. As a result, single cells of C. elegans embryos as early as the 2-cell stage and single neurons in ganglia can be induced to express genes selectively. In addition, the introduction of site-specific recombination systems to IR-LEGO enables the induction of gene expression controlled by constitutive and cell type-specific promoters. The strategies adopted here will be useful for future applications of IR-LEGO to other organisms.	[Suzuki, Motoshi; Toyoda, Naoya; Takagi, Shin] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan	Nagoya University	Takagi, S (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan.	i45116a@nucc.cc.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22300126, 25111708] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (S. T.). M. S. is a Doctoral Course (DC1) Research Fellow of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chelur DS, 2007, P NATL ACAD SCI USA, V104, P2283, DOI 10.1073/pnas.0610877104; Davis MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000028; Deguchi T, 2009, DEV GROWTH DIFFER, V51, P769, DOI 10.1111/j.1440-169X.2009.01135.x; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Halfon MS, 1997, P NATL ACAD SCI USA, V94, P6255, DOI 10.1073/pnas.94.12.6255; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Hoier EF, 2000, GENE DEV, V14, P874; Husson SJ, 2013, BIOL CELL, V105, P235, DOI [10.1111/boc.201200069, 10.1111/boc.201390011]; Kamei Y, 2009, NAT METHODS, V6, P79, DOI [10.1038/NMETH.1278, 10.1038/nmeth.1278]; Kelly WG, 1997, GENETICS, V146, P227; Kimura E, 2013, ARTERIOSCL THROM VAS, V33, P1264, DOI 10.1161/ATVBAHA.112.300602; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Mello C, 1995, METHOD CELL BIOL, V48, P451; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Ramos DM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-55; Schmitt C, 2013, PLOS ONE, V8; Shioi G, 2001, GENETICS, V157, P1611; STRINGHAM EG, 1993, J EXP ZOOL, V266, P227, DOI 10.1002/jez.1402660309; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Suzuki M, 2013, DEV GROWTH DIFFER, V55, P454, DOI 10.1111/dgd.12061; Voutev R, 2008, GENETICS, V180, P103, DOI 10.1534/genetics.108.090274; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wimmer EA, 1997, DEVELOPMENT, V124, P1509; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhu JW, 1998, GENE DEV, V12, P3809, DOI 10.1101/gad.12.24.3809	31	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85783	10.1371/journal.pone.0085783	http://dx.doi.org/10.1371/journal.pone.0085783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465705	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500073
J	Valles, H; Oxenford, HA				Valles, Henri; Oxenford, Hazel A.			Parrotfish Size: A Simple yet Useful Alternative Indicator of Fishing Effects on Caribbean Reefs?	PLOS ONE			English	Article							REGION-WIDE DECLINES; CORAL-REEFS; MARINE RESERVES; ECOLOGICAL INDICATORS; COMMUNITY STRUCTURE; ECOSYSTEM APPROACH; STRUCTURAL-CHANGE; SPATIAL-PATTERNS; PROTECTED AREAS; PREDATORY FISH	There is great need to identify simple yet reliable indicators of fishing effects within the multi-species, multi-gear, data-poor fisheries of the Caribbean. Here, we investigate links between fishing pressure and three simple fish metrics, i.e. average fish weight (an estimate of average individual fish size), fish density and fish biomass, derived from (1) the parrotfish family, a ubiquitous herbivore family across the Caribbean, and (2) three fish groups of "commercial" carnivores including snappers and groupers, which are widely-used as indicators of fishing effects. We hypothesize that, because most Caribbean reefs are being heavily fished, fish metrics derived from the less vulnerable parrotfish group would exhibit stronger relationships with fishing pressure on today's Caribbean reefs than those derived from the highly vulnerable commercial fish groups. We used data from 348 Atlantic and Gulf Rapid Reef Assessment (AGRRA) reef-surveys across the Caribbean to assess relationships between two independent indices of fishing pressure (one derived from human population density data, the other from open to fishing versus protected status) and the three fish metrics derived from the four aforementioned fish groups. We found that, although two fish metrics, average parrotfish weight and combined biomass of selected commercial species, were consistently negatively linked to the indices of fishing pressure across the Caribbean, the parrotfish metric consistently outranked the latter in the strength of the relationship, thus supporting our hypothesis. Overall, our study highlights that (assemblage-level) average parrotfish size might be a useful alternative indicator of fishing effects over the typical conditions of most Caribbean shallow reefs: moderate-to-heavy levels of fishing and low abundance of highly valued commercial species.	[Valles, Henri] Univ W Indies, Dept Biol & Chem Sci, Cave Hill, Barbados; [Oxenford, Hazel A.] Univ W Indies, Ctr Resource Management & Environm Studies CERMES, Cave Hill, Barbados	University West Indies Mona Jamaica; University West Indies Cave Hill Campus; University West Indies Mona Jamaica; University West Indies Cave Hill Campus	Valles, H (corresponding author), Univ W Indies, Dept Biol & Chem Sci, Cave Hill Campus, Cave Hill, Barbados.	hevals@gmail.com	Valles, Henri/AAC-9361-2019	Valles, Henri/0000-0002-7947-2742	European Union [244161]	European Union(European Commission)	This research was partially funded by the European Union Seventh Framework Programme (P7/2007-2013) under grant agreement no. 244161 (Future of Reefs in a Changing Environment). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Blanchard JL, 2005, ICES J MAR SCI, V62, P405, DOI 10.1016/j.icesjms.2005.01.006; Blanco-Moreno J. M., 2009, MODTTEST MODIFYING T; Bonaldo RM, 2008, MAR ECOL PROG SER, V360, P237, DOI 10.3354/meps07413; Borenstein M, 2009, INTRO METAANALYSIS, DOI [10.1002/9780470743386, DOI 10.1002/9780470743386]; Bouchon-Navaro Y, 2005, J EXP MAR BIOL ECOL, V315, P31, DOI 10.1016/j.jembe.2004.08.028; Bozec YM, 2013, OIKOS, V122, P428, DOI 10.1111/j.1600-0706.2012.20576.x; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; Bruggemann JH, 1996, MAR ECOL PROG SER, V134, P59, DOI 10.3354/meps134059; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burke L, 2004, REEFS RISK; Burke L., 2011, REEF RISK REVISITED; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; Chiappone M, 2000, MAR ECOL PROG SER, V198, P261, DOI 10.3354/meps198261; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Clua E, 2008, AQUAT LIVING RESOUR, V21, P339, DOI 10.1051/alr:2008036; Comeros-Raynal MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039825; Dalzell P., 1996, REEF FISHERIES, V20, P161, DOI [DOI 10.1007/978-94-015-8779-2, 10.1007/978-94-015-8779-2\_7.500]; Debrot D., 2008, P 60 GULF CAR FISH I, P335; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Fenner Douglas, 2012, Diversity, V4, P105, DOI 10.3390/d4010105; Ferreira CEL, 2005, CORAL REEFS, V24, P128, DOI 10.1007/s00338-004-0459-x; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Fung T, 2013, MAR ECOL PROG SER, V484, P155, DOI 10.3354/meps10305; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Green A.L., 2009, MONITORING FUNCTIONA; Greenstreet SPR, 2006, ICES J MAR SCI, V63, P573, DOI 10.1016/j.icesjms.2005.12.009; Greenstreet SPR, 2012, ICES J MAR SCI, V69, P8, DOI 10.1093/icesjms/fsr188; Gust N, 2001, MAR ECOL PROG SER, V214, P237, DOI 10.3354/meps214237; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Haughton MO, 2001, P GULF CARIBBEAN FIS, V54, P188; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Hawkins JP, 2004, BIOL CONSERV, V115, P213, DOI 10.1016/S0006-3207(03)00119-8; Hawkins JP, 2007, AQUAT CONSERV, V17, P111, DOI 10.1002/aqc.784; Howard KG, 2009, ENVIRON BIOL FISH, V85, P175, DOI 10.1007/s10641-009-9478-3; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Jackson J, GLOBAL CORAL REEF MO; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Jayewardene D, 2009, J EXP MAR BIOL ECOL, V375, P64, DOI 10.1016/j.jembe.2009.05.006; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jennings S, 2005, ICES J MAR SCI, V62, P397, DOI 10.1016/j.icesjms.2004.07.030; Jennings S, 2005, FISH FISH, V6, P212, DOI 10.1111/j.1467-2979.2005.00189.x; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Jones Geoffrey P., 2002, P221, DOI 10.1016/B978-012615185-5/50013-X; LANG JC, 2003, ATOLL RES B, V496; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; Lokrantz J, 2009, ENVIRON CONSERV, V36, P327, DOI 10.1017/S0376892910000147; Mahon R, 1997, CAN J FISH AQUAT SCI, V54, P2207, DOI 10.1139/cjfas-54-9-2207; McAfee ST, 1996, MAR BIOL, V125, P427; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; MIMURA N, 2007, CLIMATE CHANGE 2007; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Mumby PJ, 2002, ENVIRON BIOL FISH, V63, P265, DOI 10.1023/A:1014359403167; Munro JL, 1983, CARIBBEAN CORAL REEF; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Nicholson MD, 2004, ICES J MAR SCI, V61, P35, DOI 10.1016/j.icesjms.2003.09.004; NOAA, 2002, CAR COR REEF FISH WO; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Page M, 1998, BIOL REPORTS SERIES; Parenti Paolo, 2011, Smithiana Bulletin, P29; Passley D., 2010, P GULF CARIBBEAN FIS, V62, P235; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; Piet GJ, 2005, ICES J MAR SCI, V62, P214, DOI 10.1016/j.icesjms.2004.09.007; Rice J, 2003, OCEAN COAST MANAGE, V46, P235, DOI 10.1016/S0964-5691(03)00006-1; Rice JC, 2005, ICES J MAR SCI, V62, P516, DOI 10.1016/j.icesjms.2005.01.003; ROBERTS CM, 1995, CONSERV BIOL, V9, P815, DOI 10.1046/j.1523-1739.1995.09040815.x; Rogers C, 2009, P R SOC B, V276, P197, DOI 10.1098/rspb.2008.0606; Russ GR, 2003, ECOL APPL, V13, P1553, DOI 10.1890/01-5341; Sabetian A., 2010, PARROTFISH FISHERIES; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Shin YJ, 2005, ICES J MAR SCI, V62, P384, DOI 10.1016/j.icesjms.2005.01.004; Shin YJ, 2010, ICES J MAR SCI, V67, P692, DOI 10.1093/icesjms/fsp294; Shin YJ, 2010, ICES J MAR SCI, V67, P717, DOI 10.1093/icesjms/fsp287; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Stewart KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014451; Team RDC, 2010, R LANG ENV STAT COMP; Trenkel VM, 2004, ICES J MAR SCI, V61, P351, DOI 10.1016/j.icesjms.2004.01.004; Tuya F, 2006, FISH RES, V77, P24, DOI 10.1016/j.fishres.2005.07.017; Valles H, 2008, MAR ECOL PROG SER, V363, P257, DOI 10.3354/meps07432; Van Tassell J, 2012, FISHES GREATER CARIB; Wilson SK, 2010, ECOL APPL, V20, P442, DOI 10.1890/08-2205.1	98	39	40	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86291	10.1371/journal.pone.0086291	http://dx.doi.org/10.1371/journal.pone.0086291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24466009	Green Submitted, gold, Green Published			2022-12-25	WOS:000330240500126
J	Wakai, N; Takemura, K; Morita, T; Kitao, A				Wakai, Nobuhiko; Takemura, Kazuhiro; Morita, Takami; Kitao, Akio			Mechanism of Deep-Sea Fish alpha-Actin Pressure Tolerance Investigated by Molecular Dynamics Simulations	PLOS ONE			English	Article							SKELETAL-MUSCLE ACTIN; CHARGE FORCE-FIELD; ATP HYDROLYSIS; ADAPTIVE DIFFERENCES; FILAMENT NUCLEATION; PHOSPHATE RELEASE; GLOBULAR-PROTEINS; STRUCTURAL BASIS; MARINE FISHES; RATTAIL FISH	The pressure tolerance of monomeric alpha-actin proteins from the deep-sea fish Coryphaenoides armatus and C. yaquinae was compared to that of non-deep-sea fish C. acrolepis, carp, and rabbit/human/chicken actins using molecular dynamics simulations at 0.1 and 60 MPa. The amino acid sequences of actins are highly conserved across a variety of species. The actins from C. armatus and C. yaquinae have the specific substitutions Q137K/V54A and Q137K/L67P, respectively, relative to C. acrolepis, and are pressure tolerant to depths of at least 6000 m. At high pressure, we observed significant changes in the salt bridge patterns in deep-sea fish actins, and these changes are expected to stabilize ATP binding and subdomain arrangement. Salt bridges between ATP and K137, formed in deep-sea fish actins, are expected to stabilize ATP binding even at high pressure. At high pressure, deep-sea fish actins also formed a greater total number of salt bridges than non-deep-sea fish actins owing to the formation of inter-helix/strand and inter-subdomain salt bridges. Free energy analysis suggests that deep-sea fish actins are stabilized to a greater degree by the conformational energy decrease associated with pressure effect.	[Wakai, Nobuhiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Tokyo, Japan; [Takemura, Kazuhiro; Kitao, Akio] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Morita, Takami] Natl Res Inst Fisheries Sci, Fisheries Res Agcy, Res Ctr Fisheries Oceanog & Marine Ecosyst, Fukuura, Kanagawa, Japan	University of Tokyo; University of Tokyo; Japan Fisheries Research & Education Agency (FRA)	Kitao, A (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan.	kitao@iam.u-tokyo.ac.jp	Kitao, Akio/B-8371-2008	Kitao, Akio/0000-0002-5221-0806; Wakai, Nobuhiko/0000-0001-5073-8984; Takemura, Kazuhiro/0000-0001-5946-4502	Theoretical and Computational Chemistry Initiative (TCCI) in Computational Material Science Initiative (CMSI); Ministry of Education, Culture, Sports, Science and Technology of Japan [23370066, 25104002]; Japan Society for the Promotion of Science	Theoretical and Computational Chemistry Initiative (TCCI) in Computational Material Science Initiative (CMSI); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Theoretical and Computational Chemistry Initiative (TCCI) in Computational Material Science Initiative (CMSI), Grants-inAid for Science Research B (23370066), and Grants-in-Aid for Science Research in Innovative Areas (25104002), from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Japan Society for the Promotion of Science to A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bubb MR, 2002, J BIOL CHEM, V277, P20999, DOI 10.1074/jbc.M201371200; Busa J, 2010, COMPUT PHYS COMMUN, V181, P2116, DOI 10.1016/j.cpc.2010.08.032; CARLIER MF, 1986, J BIOL CHEM, V261, P778; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Collins MD, 2005, P NATL ACAD SCI USA, V102, P16668, DOI 10.1073/pnas.0508224102; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FINE RA, 1973, J CHEM PHYS, V59, P5529, DOI 10.1063/1.1679903; Freedman H, 2012, J CHEM THEORY COMPUT, V8, P3373, DOI 10.1021/ct3003282; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; GEKKO K, 1986, BIOCHEMISTRY-US, V25, P6563, DOI 10.1021/bi00369a034; GEKKO K, 1979, J PHYS CHEM-US, V83, P2706, DOI 10.1021/j100484a006; Grigera JR, 2010, BIOPHYS J, V98, P1626, DOI 10.1016/j.bpj.2009.12.4298; Harrison CB, 2012, J CHEM THEORY COMPUT, V8, P2328, DOI 10.1021/ct200886j; Hirata K, 2006, J MOL BIOL, V356, P945, DOI 10.1016/j.jmb.2005.12.031; Hochachka P. W., 1984, BIOCH ADAPTATION; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikeuchi Y, 2002, EUR J BIOCHEM, V269, P364, DOI 10.1046/j.0014-2956.2001.02664.x; IKKAI T, 1966, BIOCHEMISTRY-US, V5, P1551, DOI 10.1021/bi00869a015; Imai T, 2010, J PHYS CHEM B, V114, P2281, DOI 10.1021/jp909701j; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kalhor HR, 1999, ARCH BIOCHEM BIOPHYS, V370, P105, DOI 10.1006/abbi.1999.1370; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; KITAO A, 1991, CHEM PHYS, V158, P447, DOI 10.1016/0301-0104(91)87082-7; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee MS, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816641; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; McQuarrie DA, 2000, STAT MECH; Meinhold L, 2007, P NATL ACAD SCI USA, V104, P17261, DOI 10.1073/pnas.0708199104; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morita T, 2003, J BIOL CHEM, V278, P28060, DOI 10.1074/jbc.M302328200; Morita T, 2000, FISHERIES SCI, V66, P1150, DOI 10.1046/j.1444-2906.2000.00182.x; Morita T, 2008, J EXP BIOL, V211, P1362, DOI 10.1242/jeb.017137; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Patel S, 2004, J COMPUT CHEM, V25, P1504, DOI 10.1002/jcc.20077; Patel S, 2004, J COMPUT CHEM, V25, P1, DOI 10.1002/jcc.10355; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; RASHIN AA, 1984, BIOPOLYMERS, V23, P1605, DOI 10.1002/bip.360230813; Reutzel R, 2004, J STRUCT BIOL, V146, P291, DOI 10.1016/j.jsb.2003.12.006; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sarupria S, 2010, PROTEINS, V78, P1641, DOI 10.1002/prot.22680; SARVAZYAN AP, 1979, BIOPOLYMERS, V18, P3015, DOI 10.1002/bip.1979.360181209; Saunders MG, 2011, J MOL BIOL, V413, P279, DOI 10.1016/j.jmb.2011.07.068; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; SIEBENALLER JF, 1984, J COMP PHYSIOL, V154, P443, DOI 10.1007/BF02515148; SIEBENALLER JF, 1979, J COMP PHYSIOL, V129, P295, DOI 10.1007/BF00686984; Takemura K, 2012, J PHYS CHEM B, V116, P6279, DOI 10.1021/jp301100g; VARGAFTIK NB, 1983, J PHYS CHEM REF DATA, V12, P817, DOI 10.1063/1.555688; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wagner W, 2002, J PHYS CHEM REF DATA, V31, P387, DOI 10.1063/1.1461829; Wagoner JA, 2006, P NATL ACAD SCI USA, V103, P8331, DOI 10.1073/pnas.0600118103; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N	62	12	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85852	10.1371/journal.pone.0085852	http://dx.doi.org/10.1371/journal.pone.0085852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465747	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500079
J	Yamashita, T; Uehara, S; Udagawa, N; Li, F; Kadota, S; Esumi, H; Kobayashi, Y; Takahashi, N				Yamashita, Teruhito; Uehara, Shunsuke; Udagawa, Nobuyuki; Li, Feng; Kadota, Shigetoshi; Esumi, Hiroyasu; Kobayashi, Yasuhiro; Takahashi, Naoyuki			Arctigenin Inhibits Osteoclast Differentiation and Function by Suppressing Both Calcineurin-Dependent and Osteoblastic Cell-Dependent NFATc1 Pathways	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR RECEPTOR; GENE-EXPRESSION; NUCLEAR-FACTOR; IN-VITRO; LIGAND; OSTEOPROTEGERIN; RANKL; IDENTIFICATION; MODULATION	Arctigenin, a lignan-derived compound, is a constituent of the seeds of Arctium lappa. Arctigenin was previously shown to inhibit osteoclastogenesis; however, this inhibitory mechanism has yet to be elucidated. Here, we showed that arctigenin inhibited the action of nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), a key transcription factor for osteoclastogenesis. NFATc1 in osteoclast precursors was activated through two distinct pathways: the calcineurin-dependent and osteoblastic cell-dependent pathways. Among the several lignan-derived compounds examined, arctigenin most strongly inhibited receptor activator of nuclear factor kappa B ligand (RANKL)-induced osteoclast-like cell formation in mouse bone marrow macrophage (BMM) cultures, in which the calcineurin-dependent NFATc1 pathway was activated. Arctigenin suppressed neither the activation of nuclear factor kappa B and mitogen-activated protein kinases nor the up-regulation of c-Fos expression in BMMs treated with RANKL. However, arctigenin suppressed RANKL-induced NFATc1 expression. Interestingly, the treatment of osteoclast-like cells with arctigenin converted NFATc1 into a lower molecular weight species, which was translocated into the nucleus even in the absence of RANKL. Nevertheless, arctigenin as well as cyclosporin A (CsA), a calcineurin inhibitor, suppressed the NFAT-luciferase reporter activity induced by ionomycin and phorbol 12-myristate 13-acetate in BMMs. Chromatin immunoprecipitation analysis confirmed that arctigenin inhibited the recruitment of NFATc1 to the promoter region of the NFATc1 target gene. Arctigenin, but not CsA suppressed osteoclastlike cell formation in co-cultures of osteoblastic cells and bone marrow cells, in which the osteoblastic cell-dependent NFATc1 pathway was activated. The forced expression of constitutively active NFATc1 rescued osteoclastogenesis in BMM cultures treated with CsA, but not that treated with arctigenin. Arctigenin also suppressed the pit-forming activity of osteoclast-like cells cultured on dentin slices. These results suggest that arctigenin induces a dominant negative species of NFATc1, which inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways.	[Yamashita, Teruhito; Kobayashi, Yasuhiro; Takahashi, Naoyuki] Matsumoto Dent Univ, Inst Oral Sci, Nagano, Japan; [Uehara, Shunsuke; Udagawa, Nobuyuki] Matsumoto Dent Univ, Dept Biochem, Nagano, Japan; [Li, Feng; Kadota, Shigetoshi] Toyama Univ, Inst Nat Med, Toyama 930, Japan; [Esumi, Hiroyasu] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan	Matsumoto Dental University; Matsumoto Dental University; University of Toyama; National Cancer Center - Japan	Yamashita, T (corresponding author), Matsumoto Dent Univ, Inst Oral Sci, Nagano, Japan.	teru@po.mdu.ac.jp	KOBAYASHI, YASUHIRO/AAU-4931-2021	Kobayashi, Yasuhiro/0000-0002-0903-3226	Japan Society for the Promotion of Science [24592821, 21592378, 22390351]; Grants-in-Aid for Scientific Research [26462825, 23593054, 25670792] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (24592821, 21592378 and 22390351) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Awale S, 2006, CANCER RES, V66, P1751, DOI 10.1158/0008-5472.CAN-05-3143; Barrow AD, 2011, J CLIN INVEST, V121, P3505, DOI 10.1172/JCI45913; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Cho MK, 2004, INT IMMUNOPHARMACOL, V4, P1419, DOI 10.1016/j.intimp.2004.06.011; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huang SL, 2012, DIABETOLOGIA, V55, P1469, DOI 10.1007/s00125-011-2366-3; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ishida N, 2006, J BONE MINER RES, V21, P48, DOI 10.1359/JBMR.051001; Jeong JB, 2011, INT IMMUNOPHARMACOL, V11, P1573, DOI 10.1016/j.intimp.2011.05.016; Jimi E, 1999, J IMMUNOL, V163, P434; Kim AR, 2012, EUR J PHARMACOL, V682, P29, DOI 10.1016/j.ejphar.2012.02.026; Kim YJ, 2005, J BIOL CHEM, V280, P21515, DOI 10.1074/jbc.M502230200; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021781; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Koide M, 2009, J BONE MINER RES, V24, P1469, DOI [10.1359/JBMR.090302, 10.1359/jbmr.090302]; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kou XJ, 2011, INT IMMUNOPHARMACOL, V11, P1095, DOI 10.1016/j.intimp.2011.03.005; Kudou N, 2013, EUR J MED CHEM, V60, P76, DOI 10.1016/j.ejmech.2012.11.031; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Kuroda Y, 2012, MOL CELL BIOL, V32, P2954, DOI 10.1128/MCB.05611-11; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Mizoguchi T, 2009, J CELL BIOL, V184, P541, DOI 10.1083/jcb.200806139; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Patra AK, 2013, NAT IMMUNOL, V14, P127, DOI 10.1038/ni.2507; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takahashi Naoyuki, 2007, V135, P285; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Tang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024224; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	45	9	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85878	10.1371/journal.pone.0085878	http://dx.doi.org/10.1371/journal.pone.0085878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465763	Green Submitted, gold, Green Published			2022-12-25	WOS:000330237000071
J	Dalager-Pedersen, M; Sogaard, M; Schonheyder, HC; Thomsen, RW; Baron, JA; Nielsen, H				Dalager-Pedersen, Michael; Sogaard, Mette; Schonheyder, Henrik C.; Thomsen, Reimar W.; Baron, John A.; Nielsen, Henrik			Venous Thromboembolism after Community-Acquired Bacteraemia: A 20-year Danish Cohort Study	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; HOSPITALIZED-PATIENTS; RISK-FACTORS; MEDICAL PATIENTS; INFECTIONS; THROMBOSIS; SEPSIS	Background: Infections may increase the risk for venous thromboembolism (VTE), but little is known about VTE risk associated with community-acquired bacteraemia (CAB). We examined the risk for VTE within one year of CAB in comparison to that in matched controls. Methods: We conducted a population-based cohort study in North Denmark 1992-2011, using data from high-quality health-care databases. We included 4,213 adult CAB patients who had positive blood cultures drawn on the day of hospital admission, 20,084 matched hospitalised controls admitted for other acute medical illness, and 41,121 matched controls from the general population. We computed 0-90 and 91-365 day absolute risks for hospital-diagnosed VTE and used regression analyses with adjustment for confounding factors to compare the risk for VTE in bacteraemia patients and controls. Results: Among CAB patients, 1.1% experienced VTE within 90 days of admission and 0.5% during 91-365 days after admission. The adjusted 90-day odds ratio (OR) for VTE was 1.9 (95% CI 1.4-2.7) compared with hospitalised controls, and 23.4 (95% CI 12.9-42.6) compared with population controls. During 91-365 days after CAB admission, the VTE risk remained moderately increased (adjusted hazard ratio vs. hospitalised controls, 1.4; 95% CI 0.8-2.5, and vs. population controls, 1.9; 95% CI 1.0-3.3). Compared to hospitalised controls, the 90-day VTE risk increase was greater for Gram-positive infection (adjusted OR 2.5; 95% CI 1.6-4.1) than for Gram-negative infection (adjusted OR, 1.2; 95% CI 0.7-2.1), partly due to a high risk after Staphylococcus aureus infection (3.6%). Conclusion: The risk for VTE is substantially increased within 90 days after community-acquired bacteraemia when compared to hospitalised controls and population controls. However, the absolute risk of VTE following CAB is low.	[Dalager-Pedersen, Michael; Nielsen, Henrik] Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark; [Dalager-Pedersen, Michael; Sogaard, Mette; Thomsen, Reimar W.] Aarhus Univ Hosp, Dept Clin Epidemiol, Inst Clin Med, DK-8000 Aarhus, Denmark; [Schonheyder, Henrik C.] Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark; [Baron, John A.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA	Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Dalager-Pedersen, M (corresponding author), Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark.	midp@rn.dk		Thomsen, Reimar/0000-0001-9135-3474; Dalager-Pedersen, Michael/0000-0002-3220-2526; Sogaard, Mette/0000-0002-2830-4968	Aarhus University; Karen Elise Jensen Foundation; Heinrich Kopp Foundation; Svend Andersen Foundation; North Denmark Health Sciences Research Foundation	Aarhus University; Karen Elise Jensen Foundation; Heinrich Kopp Foundation; Svend Andersen Foundation; North Denmark Health Sciences Research Foundation	This work was supported by Aarhus University, the Karen Elise Jensen Foundation, the Heinrich Kopp Foundation, the /The Helga and Peter Korning Foundation, and the North Denmark Health Sciences Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963; Barba R, 2010, THROMB RES, V126, P276, DOI 10.1016/j.thromres.2010.06.027; Cohen AT, 2013, NEW ENGL J MED, V368, P513, DOI 10.1056/NEJMoa1111096; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Goldhaber SZ, 2010, J AM COLL CARDIOL, V56, P1, DOI 10.1016/j.jacc.2010.01.057; Herzig SJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3248; Jensen AG, 1998, ARCH INTERN MED, V158, P509, DOI 10.1001/archinte.158.5.509; Kuckleburg CJ, 2008, THROMB HAEMOSTASIS, V99, P363, DOI 10.1160/TH07-07-0474; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; Levine RL, 2008, THROMB HAEMOSTASIS, V99, P892, DOI 10.1160/TH08-01-0004; Lin MY, 2008, J CLIN MICROBIOL, V46, P1553, DOI 10.1128/JCM.02379-07; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Martin E, 2012, THROMB RES, V130, P302, DOI 10.1016/j.thromres.2012.06.013; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Schmidt M, 2012, J INTERN MED, V271, P608, DOI 10.1111/j.1365-2796.2011.02473.x; Schonheyder Henrik C, 2010, Clin Epidemiol, V2, P171; Severinsen MT, 2010, J CLIN EPIDEMIOL, V63, P223, DOI 10.1016/j.jclinepi.2009.03.018; Sogaard M, 2011, CLIN INFECT DIS, V52, P61, DOI 10.1093/cid/ciq069; Symons MJ, 2002, J CLIN EPIDEMIOL, V55, P893, DOI 10.1016/S0895-4356(02)00443-2; Tichelaar YIGV, 2012, THROMB HAEMOSTASIS, V107, P827, DOI 10.1160/TH11-09-0611; Vardakas KZ, 2013, EUR J CLIN MICROBIOL, V32, P711, DOI 10.1007/s10096-012-1807-3; Vardi M, 2013, J THROMB HAEMOST, V11, P467, DOI 10.1111/jth.12108	23	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86094	10.1371/journal.pone.0086094	http://dx.doi.org/10.1371/journal.pone.0086094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465892	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000048
J	Goldberg, J; Knapp, M; Emberson, RM; Townsend, JI; Trewick, SA				Goldberg, Julia; Knapp, Michael; Emberson, Rowan M.; Townsend, J. Ian; Trewick, Steven A.			Species Radiation of Carabid Beetles (Broscini: Mecodema) in New Zealand	PLOS ONE			English	Article							MOLECULAR EVIDENCE; CHATHAM ISLANDS; ADAPTIVE RADIATION; WETA ORTHOPTERA; SOUTH ISLAND; ANCIENT DNA; EVOLUTION; DISPERSAL; PHYLOGENY; ORIGIN	New Zealand biodiversity has often been viewed as Gondwanan in origin and age, but it is increasingly apparent from molecular studies that diversification, and in many cases origination of lineages, postdate the break-up of Gondwanaland. Relatively few studies of New Zealand animal species radiations have as yet been reported, and here we consider the species-rich genus of carabid beetles, Mecodema. Constrained stratigraphic information (emergence of the Chatham Islands) and a substitution rate for Coleoptera were separately used to calibrate Bayesian relaxed molecular clock date estimates for diversification of Mecodema. The inferred timings indicate radiation of these beetles no earlier than the mid-Miocene with most divergences being younger, dating to the Plio-Pleistocene. A shallow age for the radiation along with a complex spatial distribution of these taxa involving many instances of sympatry implicates recent ecological speciation rather than a simplistic allopatric model. This emphasises the youthful and dynamic nature of New Zealand evolution that will be further elucidated with detailed ecological and population genetic analyses.	[Goldberg, Julia] Univ Gottingen, Dept Morphol Systemat & Evolutionary Biol, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Knapp, Michael] Univ Otago, Dept Anat, Dunedin, New Zealand; [Emberson, Rowan M.] Lincoln Univ, Dept Ecol, Canterbury, New Zealand; [Trewick, Steven A.] Massey Univ, Inst Agr & Environm, Ecol Grp, Palmerston North, New Zealand	University of Gottingen; University of Otago; Lincoln University - New Zealand; Massey University	Goldberg, J (corresponding author), Univ Gottingen, Dept Morphol Systemat & Evolutionary Biol, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany.	jule.goldberg@gmail.com		Knapp, Michael/0000-0002-0937-5664; Trewick, Steven/0000-0002-4680-8457	Royal Society of New Zealand [03-GNS-302]; DFG; Gottingen University	Royal Society of New Zealand(Royal Society of New Zealand); DFG(German Research Foundation (DFG)); Gottingen University	The authors acknowledge the support for this study by the Marsden Fund of the Royal Society of New Zealand (03-GNS-302). This publication was financially supported by the Open Access Publication support programme of the DFG and the publication funds of Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arensburger P, 2004, J BIOGEOGR, V31, P1769, DOI 10.1111/j.1365-2699.2004.01098.x; Baker AJ, 2005, P NATL ACAD SCI USA, V102, P8257, DOI 10.1073/pnas.0409435102; Boon WM, 2001, SCI CONSERVATION, V176; Britton EB, 1949, T R SOC NZ, V77, P533; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Bunce M, 2005, PLOS BIOL, V3, P44, DOI 10.1371/journal.pbio.0030009; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Campbell HJ, 1998, GEOLOGICAL SOC NZ MI, V97, P15; Campbell HJ, 2007, SEARCH ANCIENT NZ LO; Campbell HJ, 2009, GEOLOGICAL SOC NZ MI, V126, P5; Campbell HJ, 2006, GEOLOGICAL SOC NZ MI, V121, P9; Cande SC, 2004, GEOPHYS J INT, V157, P399, DOI 10.1111/j.1365-246X.2004.02224.x; Chappell EM, 2012, BIOL J LINN SOC, V105, P169, DOI 10.1111/j.1095-8312.2011.01777.x; Chapple DG, 2009, MOL PHYLOGENET EVOL, V52, P470, DOI 10.1016/j.ympev.2009.03.021; Chinn WG, 2004, MOL ECOL, V13, P1507, DOI 10.1111/j.1365-294X.2004.02160.x; Christidis L, 1996, P NATL ACAD SCI USA, V93, P3898, DOI 10.1073/pnas.93.9.3898; COOPER A, 1995, P ROY SOC B-BIOL SCI, V261, P293, DOI 10.1098/rspb.1995.0150; COOPER RA, 1993, TRENDS ECOL EVOL, V8, P429, DOI 10.1016/0169-5347(93)90004-9; DAUGHERTY CH, 1993, TRENDS ECOL EVOL, V8, P437, DOI 10.1016/0169-5347(93)90006-B; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fleming C.A., 1979, GEOLOGICAL HIST NZ I; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; Goldberg J, 2010, THESIS MASSEY U PALM; Goldberg J, 2008, PHILOS T R SOC B, V363, P3319, DOI 10.1098/rstb.2008.0114; Goldberg Julia, 2011, Insects, V2, P369, DOI 10.3390/insects2030369; Goldberg J, 2011, J BIOGEOGR, V38, P285, DOI 10.1111/j.1365-2699.2010.02414.x; Heenan PB, 2010, NEW ZEAL J BOT, V48, P83, DOI 10.1080/0028825X.2010.494337; Heenan PB, 2003, J BIOGEOGR, V30, P1737, DOI 10.1046/j.1365-2699.2003.00941.x; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hutchison MAS, 2001, THESIS MASSEY U PALM; Kamp PJJ, 1992, TECTONIC ARCHITECTUR, P1; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Knapp M, 2005, PLOS BIOL, V3, P38, DOI 10.1371/journal.pbio.0030014; Landis CA, 2008, GEOL MAG, V145, P173, DOI 10.1017/S0016756807004268; Larochelle A, 2001, FAUNA NZ, V43, P44; Lee DE, 2001, AUST J BOT, V49, P341, DOI 10.1071/BT00031; Lockhart PJ, 2001, ANN MO BOT GARD, V88, P458, DOI 10.2307/3298586; Maddison DR, 1999, SYST ENTOMOL, V24, P103, DOI 10.1046/j.1365-3113.1999.00088.x; Marshall DC, 2008, MOL PHYLOGENET EVOL, V48, P1054, DOI 10.1016/j.ympev.2008.05.007; Marshall DC, 2011, SYST BIOL, V60, P482, DOI 10.1093/sysbio/syr017; Marshall DC, 2009, MOL ECOL, V18, P1995, DOI 10.1111/j.1365-294X.2009.04155.x; Marske KA, 2011, MOL PHYLOGENET EVOL, V59, P89, DOI 10.1016/j.ympev.2011.01.005; McGaughran A, 2006, J BIOGEOGR, V33, P23, DOI 10.1111/j.1365-2699.2005.01338.x; Meudt HM, 2006, BIOL J LINN SOC, V87, P479, DOI 10.1111/j.1095-8312.2006.00584.x; Millener PR, 2001, J ROY SOC NEW ZEAL, V31, P365, DOI 10.1080/03014223.2001.9517659; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Morgan-Richards M, 2001, HEREDITY, V86, P303, DOI 10.1046/j.1365-2540.2001.00828.x; Morgan-Richards M, 2010, MOL ECOL, V19, P1227, DOI 10.1111/j.1365-294X.2010.04542.x; Nielsen SV, 2011, MOL PHYLOGENET EVOL, V59, P1, DOI 10.1016/j.ympev.2010.12.007; PATERSON AM, 2006, GEOLOGICAL SOC NZ MI, V121, P27; Pawson SM, 2003, INVERTEBR SYST, V17, P625, DOI 10.1071/IS02042; Perrie L, 2007, J BIOGEOGR, V34, P2028, DOI 10.1111/j.1365-2699.2007.01748.x; Pole MS, 2010, GEOL MAG, V147, P151, DOI 10.1017/S0016756809990744; Pons J, 2005, MOL BIOL EVOL, V22, P991, DOI 10.1093/molbev/msi085; Pons J, 2011, MOL PHYLOGENET EVOL, V56, P796; Pons J, 2010, MOL PHYLOGENET EVOL, V56, P796, DOI 10.1016/j.ympev.2010.02.007; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2014, TRACER V1 6; Rambaut A, 1996, SE AL SEQUENCE ALIGN; Ribera I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-29; Roig-Junent S, 2000, B AM MUS NAT HIST, V255; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz C, 2010, MOL PHYLOGENET EVOL, V55, P358, DOI 10.1016/j.ympev.2009.10.026; Shepherd LD, 2009, J BIOGEOGR, V36, P1972, DOI 10.1111/j.1365-2699.2009.02120.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sota T, 2004, BIOL J LINN SOC, V81, P135, DOI 10.1111/j.1095-8312.2004.00277.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Townsend JI, 1971, PACIFIC ISLAND MONOG, V27, P178; Trewick SA, 2012, J ROY SOC NEW ZEAL, V42, P153, DOI 10.1080/03036758.2010.549493; Trewick SA, 2000, MOL ECOL, V9, P657, DOI 10.1046/j.1365-294x.2000.00905.x; Trewick SA, 2005, J BIOGEOGR, V32, P295, DOI 10.1111/j.1365-2699.2004.01179.x; Trewick SA, 2000, J BIOGEOGR, V27, P1189, DOI 10.1046/j.1365-2699.2000.00492.x; Trewick SA, 2009, ENCY ISLANDS, P665; Trewick SA, 2008, CLADISTICS, V24, P240, DOI 10.1111/j.1096-0031.2007.00174.x; Trewick SA, 2007, J BIOGEOGR, V34, P1, DOI 10.1111/j.1365-2699.2006.01643.x; Trewick Steven A., 2011, Insects, V2, P297, DOI 10.3390/insects2030297; Trewick SA, 2010, IBIS, V152, P226, DOI 10.1111/j.1474-919X.2010.01018.x; Vawter L, 1991, THESIS U MICHIGAN AN; Wagstaff SJ, 1998, NEW ZEAL J BOT, V36, P425, DOI 10.1080/0028825X.1998.9512581; Wallis GP, 2009, MOL ECOL, V18, P3548, DOI 10.1111/j.1365-294X.2009.04294.x; Waters JM, 2001, J FISH BIOL, V58, P1166, DOI 10.1111/j.1095-8649.2001.tb00563.x; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Winkworth RC, 2002, TRENDS ECOL EVOL, V17, P514, DOI 10.1016/S0169-5347(02)02590-9; Worthy TH, 2007, J SYST PALAEONTOL, V5, P1, DOI 10.1017/S1477201906001957	90	11	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86185	10.1371/journal.pone.0086185	http://dx.doi.org/10.1371/journal.pone.0086185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465949	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000062
J	Najjar, RP; Chiquet, C; Teikari, P; Cornut, PL; Claustrat, B; Denis, P; Cooper, HM; Gronfier, C				Najjar, Raymond P.; Chiquet, Christophe; Teikari, Petteri; Cornut, Pierre-Loic; Claustrat, Bruno; Denis, Philippe; Cooper, Howard M.; Gronfier, Claude			Aging of Non-Visual Spectral Sensitivity to Light in Humans: Compensatory Mechanisms?	PLOS ONE			English	Article							AGE-RELATED-CHANGES; RETINAL GANGLION-CELLS; INDUCED MELATONIN SUPPRESSION; HUMAN CIRCADIAN PACEMAKER; SHORT-WAVELENGTH LIGHT; CLOCK GENE-EXPRESSION; MESSENGER-RNA LEVELS; SUPRACHIASMATIC NUCLEUS; CATARACT-SURGERY; BRIGHT LIGHT	The deterioration of sleep in the older population is a prevalent feature that contributes to a decrease in quality of life. Inappropriate entrainment of the circadian clock by light is considered to contribute to the alteration of sleep structure and circadian rhythms in the elderly. The present study investigates the effects of aging on non -visual spectral sensitivity to light and tests the hypothesis that circadian disturbances are related to a decreased light transmittance. In a within-subject design, eight aged and five young subjects were exposed at night to 60 minute monochromatic light stimulations at 9 different wavelengths (420-620 nm). Individual sensitivity spectra were derived from measures of melatonin suppression. Lens density was assessed using a validated psychophysical technique. Although lens transmittance was decreased for short wavelength light in the older participants, melatonin suppression was not reduced. Peak of non-visual sensitivity was, however, shifted to longer wavelengths in the aged participants (494 nm) compared to young (484 nm). Our results indicate that increased lens filtering does not necessarily lead to a decreased non-visual sensitivity to light. The lack of age-related decrease in non-visual sensitivity to light may involve as yet undefined adaptive mechanisms.	[Najjar, Raymond P.; Chiquet, Christophe; Teikari, Petteri; Cornut, Pierre-Loic; Claustrat, Bruno; Denis, Philippe; Cooper, Howard M.; Gronfier, Claude] Stem Cell & Brain Res Inst, Inserm U846, Dept Chronobiol, Bron, France; [Najjar, Raymond P.; Teikari, Petteri; Cooper, Howard M.; Gronfier, Claude] Univ Lyon 1, F-69622 Villeurbanne, France; [Chiquet, Christophe] Univ Grenoble 1, Grenoble, France; [Chiquet, Christophe] CHU Grenoble, Dept Ophthalmol, F-38043 Grenoble, France; [Cornut, Pierre-Loic] Hop Edouard Herriot, CHU Lyon, Dept Ophthalmol, Lyon, France; [Claustrat, Bruno] Hormone Lab, Ctr Biol, Bron, France; [Denis, Philippe] Hop Croix Rousse, Dept Ophtalmol, F-69317 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Lyon; CHU Lyon	Gronfier, C (corresponding author), Stem Cell & Brain Res Inst, Inserm U846, Dept Chronobiol, Bron, France.	claude.gronfier@inserm.fr	Gronfier, Claude/C-1243-2008; Najjar, Raymond P./J-4979-2019; Teikari, Petteri/AFR-9306-2022; COOPER, HOWARD/M-7304-2014; Chiquet, Christophe/M-7426-2014	Gronfier, Claude/0000-0002-6549-799X; Najjar, Raymond P./0000-0002-3770-2300; Teikari, Petteri/0000-0003-1095-4185; Chiquet, Christophe/0000-0002-7601-4885	Ministere de l'Enseignement Superieur et de la Recherche Francais; Federation des Aveugles et Handicapes Visuels de France; Fondation de France; FP6-EUCLOCK; ANR [12-TECS-0013-01]; GIS-Vieillissement; Rhone-Alpes Cible; Rhone-Alpes Cluster HVN; Retina France;  [ANR-09-MNPS-040]	Ministere de l'Enseignement Superieur et de la Recherche Francais; Federation des Aveugles et Handicapes Visuels de France; Fondation de France(Fondation de France); FP6-EUCLOCK; ANR(French National Research Agency (ANR)); GIS-Vieillissement; Rhone-Alpes Cible(Region Auvergne-Rhone-Alpes); Rhone-Alpes Cluster HVN(Region Auvergne-Rhone-Alpes); Retina France; 	RPN was funded by "Ministere de l'Enseignement Superieur et de la Recherche Francais" and "Federation des Aveugles et Handicapes Visuels de France". CC was funded by Fondation de France (Berthe Fouassier grant). This work was supported by grants from FP6-EUCLOCK, ANR-09-MNPS-040, ANR 12-TECS-0013-01, GIS-Vieillissement, Rhone-Alpes Cible, Rhone-Alpes Cluster HVN, and Retina France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujard F, 2006, CHRONOBIOL INT, V23, P451, DOI 10.1080/07420520500482090; Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Benloucif S, 2006, NEUROBIOL AGING, V27, P1870, DOI 10.1016/j.neurobiolaging.2005.10.011; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bitsios P, 1996, AGE AGEING, V25, P432, DOI 10.1093/ageing/25.6.432; Brainard GC, 1997, J BIOL RHYTHM, V12, P537, DOI 10.1177/074873049701200608; Brainard GC, 2001, J NEUROSCI, V21, P6405; Brainard GC, 2008, J BIOL RHYTHM, V23, P379, DOI 10.1177/0748730408323089; Cajochen C, 2006, CHRONOBIOL INT, V23, P461, DOI 10.1080/07420520500545813; Carrier J, 2002, NEUROSCI LETT, V320, P1, DOI 10.1016/S0304-3940(02)00038-1; Cayetanot F, 2005, EUR J NEUROSCI, V22, P902, DOI 10.1111/j.1460-9568.2005.04268.x; Chang AM, 2012, J PHYSIOL-LONDON, V590, P3103, DOI 10.1113/jphysiol.2011.226555; Chang AM, 2011, J PHYSIOL-LONDON, V589, P1095, DOI 10.1113/jphysiol.2010.201194; Charman WN, 2003, OPHTHAL PHYSL OPT, V23, P181, DOI 10.1046/j.1475-1313.2003.00105.x; CLAUSTRAT B, 1984, BIOL PSYCHIAT, V19, P1215; Claustrat F, 2005, PATHOL BIOL, V53, P257, DOI 10.1016/j.patbio.2004.12.028; Czeisler CA, 1999, LUNG BIOL HEALTH DIS, V133, P149; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Daneault V, 2012, J BIOL RHYTHM, V27, P257, DOI 10.1177/0748730412441172; Davidson AJ, 2008, NEUROBIOL AGING, V29, P471, DOI 10.1016/j.neurobiolaging.2006.10.018; DEACON S, 1994, NEUROSCI LETT, V167, P191, DOI 10.1016/0304-3940(94)91059-6; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Dijk DJ, 2000, CHRONOBIOL INT, V17, P285, DOI 10.1081/CBI-100101049; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Duffy JF, 2007, NEUROBIOL AGING, V28, P799, DOI 10.1016/j.neurobiolaging.2006.03.005; Duffy JF, 2002, NEUROSCI LETT, V318, P117, DOI 10.1016/S0304-3940(01)02427-2; Eliasieh K, 2007, INVEST OPHTH VIS SCI, V48, P2824, DOI 10.1167/iovs.06-1228; Freund PR, 2011, DOC OPHTHALMOL, V122, P177, DOI 10.1007/s10633-011-9273-2; GADDY JR, 1993, J CLIN ENDOCR METAB, V77, P1398, DOI 10.1210/jc.77.5.1398; Gerth C, 2002, GRAEF ARCH CLIN EXP, V240, P202, DOI 10.1007/s00417-002-0442-6; Gibson EM, 2009, EXP GERONTOL, V44, P51, DOI 10.1016/j.exger.2008.05.007; Gimenez MC, 2010, J BIOL RHYTHM, V25, P123, DOI 10.1177/0748730409360888; Gronfier C, 2004, AM J PHYSIOL-ENDOC M, V287, pE174, DOI 10.1152/ajpendo.00385.2003; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; Hannibal J, 2007, NEUROREPORT, V18, P81, DOI 10.1097/WNR.0b013e328010ff56; Hannibal L, 2005, J MOL NEUROSCI, V27, P147, DOI 10.1385/JMN:27:02:147; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; Herljevic M, 2005, EXP GERONTOL, V40, P237, DOI 10.1016/j.exger.2004.12.001; Higuchi S, 2007, AM J PHYSIOL-REG I, V292, pR2352, DOI 10.1152/ajpregu.00355.2006; Hofman MA, 2000, CHRONOBIOL INT, V17, P245, DOI 10.1081/CBI-100101047; HOFMAN MA, 1994, BRAIN RES, V651, P134, DOI 10.1016/0006-8993(94)90689-0; Jelsma Tony N., 1994, Current Opinion in Neurobiology, V4, P717, DOI 10.1016/0959-4388(94)90015-9; Kawaguchi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009286; Kawakami F, 1997, NEUROSCI LETT, V222, P99, DOI 10.1016/S0304-3940(97)13355-9; Kessler BA, 2011, NEUROSCIENCE, V178, P82, DOI 10.1016/j.neuroscience.2011.01.031; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Krajnak K, 2002, BRAIN RES, V950, P297, DOI 10.1016/S0006-8993(02)03075-5; Kunz D, 1999, NEUROPSYCHOPHARMACOL, V21, P765, DOI 10.1016/S0893-133X(99)00069-X; LI ZY, 1995, J NEUROSCI, V15, P5429; Liets LC, 2006, P NATL ACAD SCI USA, V103, P12156, DOI 10.1073/pnas.0605211103; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Mure LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005991; Niggemyer KA, 2004, SLEEP, V27, P1535, DOI 10.1093/sleep/27.8.1535; Norren D Van, 1974, VISION RES, V14, P1237; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; POKORNY J, 1987, APPL OPTICS, V26, P1437, DOI 10.1364/AO.26.001437; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; ROOZENDAAL B, 1987, BRAIN RES, V409, P259, DOI 10.1016/0006-8993(87)90710-4; SAID FS, 1959, GERONTOLOGY, V3, P213, DOI 10.1159/000210900; Sakamoto K, 2004, J NEUROSCI, V24, P9693, DOI 10.1523/JNEUROSCI.2556-04.2004; SAMPLE PA, 1988, INVEST OPHTH VIS SCI, V29, P1306; Schmoll C, 2011, BRIT J OPHTHALMOL, V95, P1656, DOI 10.1136/bjophthalmol-2011-300677; Sexton T, 2012, J BIOL CHEM, V287, P1649, DOI 10.1074/jbc.R111.301226; Sharpe LT, 1998, VISION RES, V38, P3233, DOI 10.1016/S0042-6989(97)00457-4; Sitzmann BD, 2010, NEUROBIOL AGING, V31, P696, DOI 10.1016/j.neurobiolaging.2008.05.024; Sletten TL, 2009, J BIOL RHYTHM, V24, P73, DOI 10.1177/0748730408328973; Smith KA, 2004, J CLIN ENDOCR METAB, V89, P3610, DOI 10.1210/jc.2003-032100; Stringham JM, 2007, OPHTHAL PHYSL OPT, V27, P232, DOI 10.1111/j.1475-1313.2007.00462.x; Tanaka M, 2010, J PHYSIOL ANTHROPOL, V29, P219, DOI 10.2114/jpa2.29.219; Teikari P, 2012, J OPT SOC AM A, V29, P2469, DOI 10.1364/JOSAA.29.002469; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; van de Kraats J, 2007, J OPT SOC AM A, V24, P1842, DOI 10.1364/JOSAA.24.001842; Weibel L, 1997, AM J PHYSIOL-REG I, V272, pR948, DOI 10.1152/ajpregu.1997.272.3.R948; WERNER JS, 1993, J OPT SOC AM A, V10, P1509, DOI 10.1364/JOSAA.10.001509; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Wooten BR, 2007, OPHTHAL PHYSL OPT, V27, P321, DOI 10.1111/j.1475-1313.2007.00489.x; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Wulff K, 2010, J SLEEP RES, V19, P54, DOI [10.1111/j.1365-2869.2010.00868.x, DOI 10.1111/J.1365-2869.2010.00868.X]; Yoon IY, 2003, J AM GERIATR SOC, V51, P1085, DOI 10.1046/j.1532-5415.2003.51356.x; Zeitzer JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022078; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x; Zeitzer JM, 2005, AM J PHYSIOL-REG I, V289, pR839, DOI 10.1152/ajpregu.00232.2005	84	74	76	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85837	10.1371/journal.pone.0085837	http://dx.doi.org/10.1371/journal.pone.0085837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465738	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000028
J	Suzuki, Y; Morimoto, T; Miyakawa, H; Aonishi, T				Suzuki, Yoshinori; Morimoto, Takako; Miyakawa, Hiroyoshi; Aonishi, Toru			Cooperative Integration and Representation Underlying Bilateral Network of Fly Motion-Sensitive Neurons	PLOS ONE			English	Article							PLATE TANGENTIAL CELLS; INTRINSIC ELECTROPHYSIOLOGICAL CHARACTERISTICS; FLOW-FIELD SELECTIVITY; LOBULA PLATE; RECEPTIVE-FIELDS; HORIZONTAL CELLS; MOVEMENT; SYSTEM; INTERNEURONS; ORGANIZATION	How is binocular motion information integrated in the bilateral network of wide-field motion-sensitive neurons, called lobula plate tangential cells (LPTCs), in the visual system of flies? It is possible to construct an accurate model of this network because a complete picture of synaptic interactions has been experimentally identified. We investigated the cooperative behavior of the network of horizontal LPTCs underlying the integration of binocular motion information and the information representation in the bilateral LPTC network through numerical simulations on the network model. First, we qualitatively reproduced rotational motion-sensitive response of the H2 cell previously reported in vivo experiments and ascertained that it could be accounted for by the cooperative behavior of the bilateral network mainly via interhemispheric electrical coupling. We demonstrated that the response properties of single H1 and Hu cells, unlike H2 cells, are not influenced by motion stimuli in the contralateral visual hemi-field, but that the correlations between these cell activities are enhanced by the rotational motion stimulus. We next examined the whole population activity by performing principal component analysis (PCA) on the population activities of simulated LPTCs. We showed that the two orthogonal patterns of correlated population activities given by the first two principal components represent the rotational and translational motions, respectively, and similar to the H2 cell, rotational motion produces a stronger response in the network than does translational motion. Furthermore, we found that these population-coding properties are strongly influenced by the interhemispheric electrical coupling. Finally, to test the generality of our conclusions, we used a more simplified model and verified that the numerical results are not specific to the network model we constructed.	[Suzuki, Yoshinori; Aonishi, Toru] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan; [Morimoto, Takako; Miyakawa, Hiroyoshi] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan	Tokyo Institute of Technology; Tokyo University of Pharmacy & Life Sciences	Suzuki, Y (corresponding author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan.	suzuki.y.bh@m.titech.ac.jp			Japanese Society for the Promotion of Science (JSPS) [23500375]	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant (23500375 http://kaken.nii.ac.jp/d/p/23500375.en.html) from the Japanese Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aonishi T, 1999, PHYS REV LETT, V82, P2800, DOI 10.1103/PhysRevLett.82.2800; BORST A, 1988, NATURWISSENSCHAFTEN, V75, P265, DOI 10.1007/BF00378023; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; Borst A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016303; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; ECKERT H, 1983, J INSECT PHYSIOL, V29, P547, DOI 10.1016/0022-1910(83)90020-3; Elyada YM, 2009, NAT NEUROSCI, V12, P327, DOI 10.1038/nn.2269; Farrow K, 2005, J NEUROSCI, V25, P3985, DOI 10.1523/JNEUROSCI.0168-05.2005; Farrow K, 2003, J NEUROSCI, V23, P9805; Farrow K, 2006, NAT NEUROSCI, V9, P1312, DOI 10.1038/nn1769; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Gauck V, 1997, J COMP NEUROL, V381, P489; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Haag J, 1997, J NEUROSCI, V17, P4809; Haag J, 2003, J COMP PHYSIOL A, V189, P363, DOI 10.1007/s00359-003-0410-6; Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334; Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719; Haag J, 2001, J NEUROSCI, V21, P5685, DOI 10.1523/JNEUROSCI.21-15-05685.2001; Haag J, 2002, J NEUROSCI, V22, P3227, DOI 10.1523/JNEUROSCI.22-08-03227.2002; Haag J, 2008, J NEUROSCI, V28, P14435, DOI 10.1523/JNEUROSCI.3603-08.2008; HAUSEN K, 1990, J NEUROSCI, V10, P351; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; Hennig P, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00004; Horstmann W, 2000, EUR J NEUROSCI, V12, P2157, DOI 10.1046/j.1460-9568.2000.00094.x; HUBEL DH, 1970, NATURE, V225, P41, DOI 10.1038/225041a0; IBBOTSON MR, 1991, J COMP PHYSIOL A, V168, P91, DOI 10.1007/BF00217107; Ito M, 2013, CURR BIOL, V23, P644, DOI 10.1016/j.cub.2013.03.015; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Jolliffe IT, 1986, PRINCIPAL COMPONENT, V487; JONES F. R. HARDEN, 1963, JOUR EXPTL BIOL, V40, P437; Kern R, 1998, J COMP PHYSIOL A, V182, P225, DOI 10.1007/s003590050173; KERN R, 1993, VISUAL NEUROSCI, V10, P643, DOI 10.1017/S0952523800005344; Kimmerle B, 1996, NATURWISSENSCHAFTEN, V83, P380, DOI 10.1007/s001140050305; KIRCHNER WH, 1989, NATURWISSENSCHAFTEN, V76, P281, DOI 10.1007/BF00368643; Krapp HG, 2001, J NEUROPHYSIOL, V85, P724, DOI 10.1152/jn.2001.85.2.724; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Lemus L, 2007, P NATL ACAD SCI USA, V104, P17174, DOI 10.1073/pnas.0707961104; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; RAUSCHECKER JP, 1987, J NEUROSCI, V7, P943; REICHARDT W, 1979, BIOL CYBERN, V35, P81, DOI 10.1007/BF00337434; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; SCHLOTTERER GR, 1977, CAN J ZOOL, V55, P1372, DOI 10.1139/z77-179; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; Torben-Nielsen B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000932; WYLIE DR, 1990, VISUAL NEUROSCI, V5, P489, DOI 10.1017/S0952523800000614; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041	47	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85790	10.1371/journal.pone.0085790	http://dx.doi.org/10.1371/journal.pone.0085790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465711	gold, Green Submitted, Green Published			2022-12-25	WOS:000330288000025
J	Bucksch, A; Turk, G; Weitz, JS				Bucksch, Alexander; Turk, Greg; Weitz, Joshua S.			The Fiber Walk: A Model of Tip-Driven Growth with Lateral Expansion	PLOS ONE			English	Article							SELF-ORGANIZATION; ROOT; AUXIN; ARCHITECTURE; CONSTRAINTS; CYTOKININ	Tip-driven growth processes underlie the development of many plants. To date, tip-driven growth processes have been modeled as an elongating path or series of segments, without taking into account lateral expansion during elongation. Instead, models of growth often introduce an explicit thickness by expanding the area around the completed elongated path. Modeling expansion in this way can lead to contradictions in the physical plausibility of the resulting surface and to uncertainty about how the object reached certain regions of space. Here, we introduce fiber walks as a self-avoiding random walk model for tip-driven growth processes that includes lateral expansion. In 2D, the fiber walk takes place on a square lattice and the space occupied by the fiber is modeled as a lateral contraction of the lattice. This contraction influences the possible subsequent steps of the fiber walk. The boundary of the area consumed by the contraction is derived as the dual of the lattice faces adjacent to the fiber. We show that fiber walks generate fibers that have well-defined curvatures, and thus enable the identification of the process underlying the occupancy of physical space. Hence, fiber walks provide a base from which to model both the extension and expansion of physical biological objects with finite thickness.	[Bucksch, Alexander; Turk, Greg] Georgia Inst Technol, Sch Interact Comp, Atlanta, GA 30332 USA; [Bucksch, Alexander; Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Bucksch, A (corresponding author), Georgia Inst Technol, Sch Interact Comp, Atlanta, GA 30332 USA.	bucksch@gatech.edu	Bucksch, Alexander/A-6102-2009	Bucksch, Alexander/0000-0002-1071-5355	National Science Foundation, Plant Genome Research Program [0820624]; Scientific Interface from the Burroughs Wellcome Fund	National Science Foundation, Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the National Science Foundation, Plant Genome Research Program grant nos. 0820624 to J.S.W.) J.S.W. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund.	Aloni R, 2006, ANN BOT-LONDON, V97, P883, DOI 10.1093/aob/mcl027; Aloni R, 2004, PLANTA, V220, P177, DOI 10.1007/s00425-004-1381-8; Bhattacharya A, 2013, COMPUT GRAPH FORUM, V32, P11, DOI 10.1111/cgf.12088; CATMULL E, 1978, COMPUT AIDED DESIGN, V10, P350, DOI 10.1016/0010-4485(78)90110-0; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; Dey TK, 2013, COMPUTERS GRAPHICS; Dunbabin VM, 2013, PLANT SOIL, V372, P93, DOI 10.1007/s11104-013-1769-y; Dupuy L, 2010, J EXP BOT, V61, P2131, DOI 10.1093/jxb/erp389; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Hamarneh G, 2010, COMPUT MED IMAG GRAP, V34, P605, DOI 10.1016/j.compmedimag.2010.06.002; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Hund A, 2009, PLANT SOIL, V325, P335, DOI 10.1007/s11104-009-9984-2; Karch R, 1999, COMPUT BIOL MED, V29, P19, DOI 10.1016/S0010-4825(98)00045-6; Landau D.P., 2009, GUIDE MONTE CARLO SI; Leitner D, 2010, PLANT SOIL, V332, P177, DOI 10.1007/s11104-010-0284-7; Lew RR, 2011, NAT REV MICROBIOL, V9, P509, DOI 10.1038/nrmicro2591; Leyser O, 2011, CURR BIOL, V21, pR331, DOI 10.1016/j.cub.2011.02.031; LYKLEMA JW, 1984, J PHYS A-MATH GEN, V17, pL691, DOI 10.1088/0305-4470/17/13/003; Lynch JP, 1997, PLANT SOIL, V188, P139, DOI 10.1023/A:1004276724310; Madras N, 1993, SELF AVOIDING WALK P, V49, P105; Overvoorde P, 2010, COLD SPRING HARBOR P, V2; Prusinkiewicz P, 2010, J EXP BOT, V61, P2117, DOI 10.1093/jxb/erq081; RENSHAW E, 1981, J APPL PROBAB, V18, P403, DOI 10.2307/3213286; Rounds CM, 2013, ANNU REV PLANT BIOL, V64, P243, DOI 10.1146/annurev-arplant-050312-120150; Sachs T, 2004, J THEOR BIOL, V230, P197, DOI 10.1016/j.jtbi.2004.05.006; Skiena S., 1991, IMPLEMENTING DISCRET; Webster J, 1980, INTRO FUNGI, V667; Wilson R. J., 1985, INTRO GRAPH THEORY	29	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85585	10.1371/journal.pone.0085585	http://dx.doi.org/10.1371/journal.pone.0085585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465607	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100047
J	Chouchou, F; Pichot, V; Barthelemy, JC; Bastuji, H; Roche, F				Chouchou, Florian; Pichot, Vincent; Barthelemy, Jean-Claude; Bastuji, Helene; Roche, Frederic			Cardiac Sympathetic Modulation in Response to Apneas/Hypopneas through Heart Rate Variability Analysis	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; PERIODIC LEG MOVEMENTS; BLOOD-PRESSURE; AROUSAL; ACTIVATION; TIME; FRAGMENTATION; OSCILLATIONS; MECHANISMS; FREQUENCY	Autonomic dysfunction is recognized to contribute to cardiovascular consequences in obstructive sleep apnea/hypopnea syndrome (OSAHS) patients who present predominant cardiovascular sympathetic activity that persists during wakefulness. Here, we examined 1) the factors that influence sympathetic cardiac modulation in response to apneas/hypopneas; and 2) the influence of autonomic activity during apneas/hypopneas on CA. Sixteen OSAHS patients underwent in-hospital polysomnography. RR interval (RR) and RR spectral analysis using wavelet transform were used to study parasympathetic (high frequency power: HFWV) and sympathetic (low frequency power: LFWV and LFWV/HFWV ratio) activity before and after apnea/ hypopnea termination. Autonomic cardiac modulations were compared according to sleep stage, apnea/ hypopnea type and duration, arterial oxygen saturation, and presence of CA. At apnea/ hypopnea termination, RR decreased (p<0.001) while LFWV (p = 0.001) and LFWV/HFWV ratio (p = 0.001) increased. Only RR and LFWV/HFWV ratio changes were higher when apneas/hypopneas produced CA (p = 0.030 and p = 0.035, respectively) or deep hypoxia (p = 0.023 and p = 0.046, respectively). Multivariate statistical analysis showed that elevated LFWV (p = 0.006) and LFWV/HFWV ratio (p = 0.029) during apneas/hypopneas were independently related to higher CA occurrence. Both the arousal and hypoxia processes may contribute to sympathetic cardiovascular overactivity by recurrent cardiac sympathetic modulation in response to apneas/hypopneas. Sympathetic overactivity also may play an important role in the acute central response to apneas/hypopneas, and in the sleep fragmentation.	[Chouchou, Florian; Pichot, Vincent; Barthelemy, Jean-Claude; Roche, Frederic] CHU Nord, Pole NOL, Serv Physiol Clin, St Etienne, France; [Chouchou, Florian; Pichot, Vincent; Roche, Frederic] Univ St Etienne, EA 4607, SNA EPIS, PRES Lyon, St Etienne, France; [Bastuji, Helene] CNRS, Unite NeuroPain, Ctr Rech Neurosci Lyon, INSERM,U1028,UMR5292, Lyon, France	CHU de St Etienne; Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Chouchou, F (corresponding author), CHU Nord, Pole NOL, Serv Physiol Clin, St Etienne, France.	florianchouchou@gmail.com	Chouchou, Florian/AAS-5499-2021; Barthelemy, Jean-Claude/AAE-7180-2019	BASTUJI, Helene/0000-0002-6690-2707; Roche, Frederic/0000-0001-6115-7958	Novacor Ltd. (Rueil Malmaison, France)	Novacor Ltd. (Rueil Malmaison, France)	Florian Chouchou received financial support from Novacor Ltd. (Rueil Malmaison, France) during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasi A, 2003, J APPL PHYSIOL, V95, P1394, DOI 10.1152/japplphysiol.01095.2002; Bonnet MH, 1997, ELECTROEN CLIN NEURO, V102, P390, DOI 10.1016/S0921-884X(96)96070-1; Bonsignore MR, 1997, SLEEP, V20, P1167; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Camm AJ, 1996, CIRCULATION, V93, P1043; Catcheside PG, 2001, SLEEP, V24, P895, DOI 10.1093/sleep/24.8.895; Chouchou F, 2013, EUR HEART J, V34, P2122, DOI 10.1093/eurheartj/eht208; Chouchou F, 2011, EUR J PAIN, V15, P554, DOI 10.1016/j.ejpain.2010.11.011; COLE RJ, 1989, J APPL PHYSIOL, V67, P2369, DOI 10.1152/jappl.1989.67.6.2369; Dingli K, 2003, EUR RESPIR J, V22, P943, DOI 10.1183/09031936.03.00098002; Dingli K, 2002, EUR RESPIR J, V20, P733, DOI 10.1183/09031936.02.00262002; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; FEWELL JE, 1984, BRAIN RES, V311, P259, DOI 10.1016/0006-8993(84)90088-X; Guggisberg AG, 2007, SLEEP, V30, P755, DOI 10.1093/sleep/30.6.755; Guilleminault C, 2005, SLEEP MED, V6, P451, DOI 10.1016/j.sleep.2005.03.014; HEDEMARK LL, 1982, J APPL PHYSIOL, V53, P307, DOI 10.1152/jappl.1982.53.2.307; HORNE RSC, 1989, AM J PHYSIOL, V256, pH434, DOI 10.1152/ajpheart.1989.256.2.H434; Huynh N, 2006, J SLEEP RES, V15, P339, DOI 10.1111/j.1365-2869.2006.00536.x; Iber C, 2007, AASM MANUAL SCORING; Kara T, 2003, ACTA PHYSIOL SCAND, V177, P377, DOI 10.1046/j.1365-201X.2003.01083.x; Kesler B, 1999, J APPL PHYSIOL, V87, P897, DOI 10.1152/jappl.1999.87.3.897; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; MERRI M, 1990, IEEE T BIO-MED ENG, V37, P99, DOI 10.1109/10.43621; Morrell MJ, 2000, AM J RESP CRIT CARE, V162, P2091, DOI 10.1164/ajrccm.162.6.9904008; Narkiewicz K, 1998, CIRCULATION, V97, P943; Roche F, 2012, EUR RESPIR J, V40, P649, DOI 10.1183/09031936.00162710; Sforza E, 2002, CLIN NEUROPHYSIOL, V113, P883, DOI 10.1016/S1388-2457(02)00066-4; Sforza E, 2000, CLIN NEUROPHYSIOL, V111, P1611, DOI 10.1016/S1388-2457(00)00363-1; Sforza E, 2012, SLEEP MED, V13, P21, DOI 10.1016/j.sleep.2011.04.011; Smith R P, 1998, Sleep Med Rev, V2, P69, DOI 10.1016/S1087-0792(98)90001-6; SOMERS VK, 1991, J CLIN INVEST, V87, P1953, DOI 10.1172/JCI115221; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; SOMERS VK, 1993, SLEEP, V16, pS30, DOI 10.1093/sleep/16.suppl_8.S30; Spicuzza L, 2003, AM J RESP CRIT CARE, V167, P902, DOI 10.1164/rccm.200201-006OC; Taylor JA, 1998, CIRCULATION, V98, P547, DOI 10.1161/01.CIR.98.6.547; Trinder J, 2006, J SLEEP RES, V15, P174, DOI 10.1111/j.1365-2869.2006.00513.x; Veale D, 1996, EUR RESPIR J, V9, P2122, DOI 10.1183/09031936.96.09102122; ZWILLICH C, 1982, J CLIN INVEST, V69, P1286, DOI 10.1172/JCI110568	38	33	33	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86434	10.1371/journal.pone.0086434	http://dx.doi.org/10.1371/journal.pone.0086434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466093	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100163
J	Tian, W; Han, XG; Liu, B; Liu, YJ; Hu, Y; Han, X; Xu, YF; Fan, MX; Jin, HY				Tian, Wei; Han, Xiaoguang; Liu, Bo; Liu, Yajun; Hu, Ying; Han, Xiao; Xu, Yunfeng; Fan, Mingxing; Jin, Haiyang			A Robot-Assisted Surgical System Using a Force-Image Control Method for Pedicle Screw Insertion	PLOS ONE			English	Article							GUIDED SPINAL SURGERY; PLACEMENT; ACCURACY; GUIDANCE; LUMBAR; COMPLICATIONS; OPERATIONS	Objective: To introduce a robot-assisted surgical system for spinal posterior fixation that can automatically recognize the drilling state and stop potential cortical penetration with force and image information and to further evaluate the accuracy and safety of the robot for sheep vertebra pedicle screw placement. Methods: The Robotic Spinal Surgery System (RSSS) was composed of an optical tracking system, a navigation and planning system, and a surgical robot equipped with a 6-DOF force/torque sensor. The robot used the image message and force signals to sense the different operation states and to prevent potential cortical penetration in the pedicle screw insertion operation. To evaluate the accuracy and safety of the RSSS, 32 screw insertions were conducted. Furthermore, six trajectories were deliberately planned incorrectly to explore whether the robot could recognize the different drilling states and immediately prevent cortical penetration. Results: All 32 pedicle screws were placed in the pedicle without any broken pedicle walls. Compared with the preoperative planning, the average deviations of the entry points in the axial and sagittal views were 0.50+/-0.33 and 0.65+/-0.40 mm, and the average deviations of the angles in the axial and sagittal views were 1.9+/-0.82 degrees and 1.48+/-1.2 degrees. The robot successfully recognized the different drilling states and prevented potential cortical penetration. In the deliberately incorrectly planned trajectory experiments, the robot successfully prevented the cortical penetration. Conclusion: These results verified the RSSS's accuracy and safety, which supported its potential use for the spinal surgery.	[Tian, Wei; Han, Xiaoguang; Liu, Bo; Liu, Yajun; Han, Xiao; Xu, Yunfeng; Fan, Mingxing] Beijing Jishuitan Hosp, Dept Spine Surg, Beijing, Peoples R China; [Han, Xiaoguang; Xu, Yunfeng] Tsinghua Univ, Med Ctr, Beijing 100084, Peoples R China; [Hu, Ying; Jin, Haiyang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Tian, W (corresponding author), Beijing Jishuitan Hosp, Dept Spine Surg, Beijing, Peoples R China.	jstspine@126.com		Han, Xiaoguang/0000-0001-7477-3274				Barzilay Y, 2006, INT J MED ROBOT COMP, V2, P146, DOI 10.1002/rcs.90; Bertelsen A, 2013, INT J MED ROBOT COMP, V9, P407, DOI 10.1002/rcs.1469; Birkfellner W, 1998, IEEE T MED IMAGING, V17, P737, DOI 10.1109/42.736028; Castro WHM, 1996, SPINE, V21, P1320, DOI 10.1097/00007632-199606010-00008; Devito DP, 2010, SPINE, V35, P2109, DOI 10.1097/BRS.0b013e3181d323ab; Goo Bong Chung, 2005, 2005 IEEE/RSJ International Conference on Intelligent Robots and Systems, P3015; Holly LT, 2006, INT J MED ROBOT COMP, V2, P7, DOI 10.1002/rcs.69; Hu Y., 2013, MECHATRONICS IEEE AS, VPP, P1; Jutte PC, 2002, EUR SPINE J, V11, P594, DOI 10.1007/s00586-002-0469-8; Katonis P, 2003, CLIN ORTHOP RELAT R, P86, DOI 10.1097/01.blo.0000068761.86536.ld; Kim S, 2010, NEUROSURGERY, V67, P1757, DOI 10.1227/NEU.0b013e3181fa7e42; Kosmopoulos V, 2007, SPINE, V32, pE111, DOI 10.1097/01.brs.0000254048.79024.8b; L'Orsa R, 2013, NEUROSURGERY, V72, pA139, DOI 10.1227/NEU.0b013e318273a1a3; Lee JH, 2001, J PROCESS CONTR, V11, P195, DOI 10.1016/S0959-1524(00)00047-0; Lee WY, 2004, IEEE-ASME T MECH, V9, P20, DOI 10.1109/TMECH.2004.823850; Lieberman IH, 2006, NEUROSURGERY, V59, P641, DOI 10.1227/01.NEU.0000229055.00829.5B; Nottmeier EW, 2007, J SPINAL DISORD TECH, V20, P268, DOI 10.1097/01.bsd.0000211282.06519.ab; Pechlivanis I, 2009, SPINE, V34, P392, DOI 10.1097/BRS.0b013e318191ed32; Roser F, 2013, NEUROSURGERY, V72, pA12, DOI 10.1227/NEU.0b013e318270d02c; Sukovich W, 2006, INT J MED ROBOT COMP, V2, P114, DOI 10.1002/rcs.86; Togawa D, 2007, NEUROSURGERY, V60, P129, DOI 10.1227/01.NEU.0000249257.16912.AA; Wang TM, 2010, INT J MED ROBOT COMP, V6, P178, DOI 10.1002/rcs.304	22	43	55	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86346	10.1371/journal.pone.0086346	http://dx.doi.org/10.1371/journal.pone.0086346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466043	gold, Green Published			2022-12-25	WOS:000330283100145
J	Weitz, JS				Weitz, Joshua S.			Let My People Go (Home) to Spain: A Genealogical Model of Jewish Identities since 1492	PLOS ONE			English	Article							INDIVIDUALS; ANCESTRY	The Spanish government recently announced an official fast-track path to citizenship for any individual who is Jewish and whose ancestors were expelled from Spain during the inquisition-related dislocation of Spanish Jews in 1492. It would seem that this policy targets a small subset of the global Jewish population, that is, restricted to individuals who retain cultural practices associated with ancestral origins in Spain. However, the central contribution of this manuscript is to demonstrate how and why the policy is far more likely to apply to a very large fraction (i.e., the vast majority) of Jews. This claim is supported using a series of genealogical models that include transmissible "identities'' and preferential intra-group mating. Model analysis reveals that even when intra-group mating is strong and even if only a small subset of a present-day population retains cultural practices typically associated with that of an ancestral group, it is highly likely that nearly all members of that population have direct genealogical links to that ancestral group, given sufficient number of generations have elapsed. The basis for this conclusion is that not having a link to an ancestral group must be a property of all of an individual's ancestors, the probability of which declines (nearly) superexponentially with each successive generation. These findings highlight unexpected incongruities induced by genealogical dynamics between present-day and ancestral identities.	[Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Weitz, JS (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	jsweitz@gatech.edu			Burroughs Wellcome Fund	Burroughs Wellcome Fund(Burroughs Wellcome Fund)	Joshua S. Weitz holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, PAIS; Botticini M, 2007, J EUR ECON ASSOC, V5, P885, DOI 10.1162/JEEA.2007.5.5.885; Brunet E, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/01/P01006; Chang JT, 1999, ADV APPL PROBAB, V31, P1002, DOI 10.1239/aap/1029955256; DellaPergola S, 2012, AM JEWISH YB; Derrida B, 2000, J THEOR BIOL, V203, P303, DOI 10.1006/jtbi.2000.1095; Krich J., 2013, TIME; Manrubia SC, 2003, AM SCI, V91, P158, DOI 10.1511/2003.2.158; Minder R, 2013, NY TIMES; Minder Raphael, 2012, NY TIMES; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rohde DLT, 2004, NATURE, V431, P562, DOI 10.1038/nature02842; Rubinstein Y, 2013, PRIDE PREJU IN PRESS; Telushkin Joseph, 2008, JEWISH LITERACY MOST; Zangwill I, 1893, KING SCHNORRERS; Zohar Zion, 2005, SEPHARDIC MIZRAHI JE	16	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85673	10.1371/journal.pone.0085673	http://dx.doi.org/10.1371/journal.pone.0085673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	297VL	24465647	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100059
J	Atlas, WI; Palen, WJ				Atlas, William I.; Palen, Wendy J.			Prey Vulnerability Limits Top-Down Control and Alters Reciprocal Feedbacks in a Subsidized Model Food Web	PLOS ONE			English	Article							LENGTH-MASS RELATIONSHIPS; TROUT SALMO-GAIRDNERI; TERRESTRIAL INVERTEBRATES; TROPHIC CASCADES; RAINBOW-TROUT; TRADE-OFF; PREDATION; STREAM; FOREST; FISH	Resource subsidies increase the productivity of recipient food webs and can affect ecosystem dynamics. Subsidies of prey often support elevated predator biomass which may intensify top-down control and reduce the flow of reciprocal subsidies into adjacent ecosystems. However, top-down control in subsidized food webs may be limited if primary consumers posses morphological or behavioral traits that limit vulnerability to predation. In forested streams, terrestrial prey support high predator biomass creating the potential for strong top-down control, however armored primary consumers often dominate the invertebrate assemblage. Using empirically based simulation models, we tested the response of stream food webs to variations in subsidy magnitude, prey vulnerability, and the presence of two top predators. While terrestrial prey inputs increased predator biomass (+12%), the presence of armored primary consumers inhibited top-down control, and diverted most aquatic energy (similar to 75%) into the riparian forest through aquatic insect emergence. Food webs without armored invertebrates experienced strong trophic cascades, resulting in higher algal (similar to 50%) and detrital (similar to 1600%) biomass, and reduced insect emergence (-90%). These results suggest prey vulnerability can mediate food web responses to subsidies, and that top-down control can be arrested even when predator-invulnerable consumers are uncommon (20%) regardless of the level of subsidy.	[Atlas, William I.; Palen, Wendy J.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Atlas, WI (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada.	watlas@sfu.ca	Atlas, William/AAW-2528-2021		National Science and Engineering Research Council of Canada; Canada Research Chairs program	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs)	Funding was provided through the National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), and the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlas WI, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00366.1; Baxter CV, 2004, ECOLOGY, V85, P2656, DOI 10.1890/04-138; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; BENKE AC, 1980, ECOLOGY, V61, P108, DOI 10.2307/1937161; Bishop MJ, 2007, OIKOS, V116, P427, DOI 10.1111/j.2006.0030-1299.15557.x; Chase JM, 1999, AM NAT, V154, P559, DOI 10.1086/303260; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; Eberle LC, 2010, RIVER RES APPL, V26, P682, DOI 10.1002/rra.1270; Finlay JC, 2001, ECOLOGY, V82, P1052, DOI 10.2307/2679902; GALBRAIT.MG, 1967, T AM FISH SOC, V96, P1, DOI 10.1577/1548-8659(1967)96[1:SPODBR]2.0.CO;2; GRAFIUS E, 1979, ECOLOGY, V60, P433, DOI 10.2307/1937670; GUTIERREZ AP, 1984, CAN ENTOMOL, V116, P923, DOI 10.4039/Ent116923-7; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Henschel JR, 2001, OIKOS, V93, P429, DOI 10.1034/j.1600-0706.2001.930308.x; Hodar JA, 1996, ACTA OECOL, V17, P421; Holling C. S., 1959, Canadian Entomologist, V91, P385; Jennings S, 2002, MAR BIOL, V141, P1085, DOI 10.1007/s00227-002-0905-7; JOHNSON JH, 1980, CAN J ZOOL, V58, P553, DOI 10.1139/z80-077; JOHNSON MG, 1971, J FISH RES BOARD CAN, V28, P1699, DOI 10.1139/f71-253; Kawaguchi Y, 2001, FRESHWATER BIOL, V46, P303, DOI 10.1046/j.1365-2427.2001.00667.x; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Limm MP, 2011, J N AM BENTHOL SOC, V30, P485, DOI 10.1899/10-028.1; Malmqvist B, 2002, FRESHWATER BIOL, V47, P679, DOI 10.1046/j.1365-2427.2002.00895.x; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McDiffett WF, 1970, ECOLOGY, V51, P976; McNeely C, 2007, ECOLOGY, V88, P391, DOI 10.1890/0012-9658(2007)88[391:GTCACS]2.0.CO;2; McPeek MA, 2001, ECOLOGY, V82, P1535, DOI 10.1890/0012-9658(2001)082[1535:PABRTP]2.0.CO;2; Murakami M, 2002, ECOL LETT, V5, P333, DOI 10.1046/j.1461-0248.2002.00321.x; Nakano S, 1999, ECOLOGY, V80, P2435; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Parker Michael S., 1994, Northwestern Naturalist, V74, P77, DOI 10.2307/3536601; PARKER MS, 1994, COPEIA, P705, DOI 10.2307/1447187; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; POLIS GA, 1995, P NATL ACAD SCI USA, V92, P4382, DOI 10.1073/pnas.92.10.4382; Polis Gary A., 1996, P275; Power ME, 2002, ECOL RES, V17, P451, DOI 10.1046/j.1440-1703.2002.00503.x; RESETARITS WJ, 1995, OIKOS, V73, P188, DOI 10.2307/3545907; Ruetz CR, 2002, OECOLOGIA, V132, P307, DOI 10.1007/s00442-002-0953-1; Sabo JL, 2002, J N AM BENTHOL SOC, V21, P336, DOI 10.2307/1468420; Sabo JL, 2002, ECOLOGY, V83, P1860, DOI 10.2307/3071770; Schade JD, 2011, FRESHWATER BIOL, V56, P424, DOI 10.1111/j.1365-2427.2010.02509.x; van der Stap I, 2007, ECOLOGY, V88, P2474, DOI 10.1890/07-1731.1; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; WARE DM, 1972, J FISH RES BOARD CAN, V29, P1193, DOI 10.1139/f72-175; Wellborn GA, 2002, ECOLOGY, V83, P129, DOI 10.2307/2680126; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wesner JS, 2012, OIKOS, V121, P53, DOI 10.1111/j.1600-0706.2011.19413.x; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558; WURTSBAUGH WA, 1977, J FISH BIOL, V11, P87, DOI 10.1111/j.1095-8649.1977.tb04101.x; Zhang YX, 2011, AQUAT SCI, V73, P53, DOI 10.1007/s00027-010-0159-2	53	11	12	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85830	10.1371/journal.pone.0085830	http://dx.doi.org/10.1371/journal.pone.0085830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465732	Green Submitted, gold, Green Published			2022-12-25	WOS:000330244500123
J	Kannape, OA; Barre, A; Aminian, K; Blanke, O				Kannape, Oliver Alan; Barre, Arnaud; Aminian, Kamiar; Blanke, Olaf			Cognitive Loading Affects Motor Awareness and Movement Kinematics but Not Locomotor Trajectories during Goal-Directed Walking in a Virtual Reality Environment	PLOS ONE			English	Article							PARKINSONS-DISEASE; PSYCHOMETRIC FUNCTION; ORIENTED LOCOMOTION; EXECUTIVE FUNCTION; GAIT VARIABILITY; ELDERLY-PEOPLE; DUAL-TASKING; AGENCY; SELF; HUMANS	The primary purpose of this study was to investigate the effects of cognitive loading on movement kinematics and trajectory formation during goal-directed walking in a virtual reality (VR) environment. The secondary objective was to measure how participants corrected their trajectories for perturbed feedback and how participants' awareness of such perturbations changed under cognitive loading. We asked 14 healthy young adults to walk towards four different target locations in a VR environment while their movements were tracked and played back in real-time on a large projection screen. In 75% of all trials we introduced angular deviations of +/- 5 degrees to +/- 30 degrees between the veridical walking trajectory and the visual feedback. Participants performed a second experimental block under cognitive load (serial-7 subtraction, counterbalanced across participants). We measured walking kinematics (joint-angles, velocity profiles) and motor performance (end-point-compensation, trajectory-deviations). Motor awareness was determined by asking participants to rate the veracity of the feedback after every trial. In-line with previous findings in natural settings, participants displayed stereotypical walking trajectories in a VR environment. Our results extend these findings as they demonstrate that taxing cognitive resources did not affect trajectory formation and deviations although it interfered with the participants' movement kinematics, in particular walking velocity. Additionally, we report that motor awareness was selectively impaired by the secondary task in trials with high perceptual uncertainty. Compared with data on eye and arm movements our findings lend support to the hypothesis that the central nervous system (CNS) uses common mechanisms to govern goal-directed movements, including locomotion. We discuss our results with respect to the use of VR methods in gait control and rehabilitation.	[Kannape, Oliver Alan; Blanke, Olaf] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Cognit Neurosci, Lausanne, Switzerland; [Barre, Arnaud; Aminian, Kamiar] Ecole Polytech Fed Lausanne, Lab Movement Anal & Measurement, Inst Bioengn, Lausanne, Switzerland; [Blanke, Olaf] Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Sch Life Sci, Lausanne, Switzerland; [Blanke, Olaf] Univ Hosp, Dept Neurol, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Blanke, O (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Cognit Neurosci, Lausanne, Switzerland.	olaf.blanke@epfl.ch	Aminian, Kamiar/H-4568-2011; Kannape, Oliver Alan/AGK-6351-2022	Aminian, Kamiar/0000-0002-6582-5375; Kannape, Oliver Alan/0000-0002-2930-4118; Barre, annick/0000-0002-1360-8491	Swiss National Science Foundation [CRSII1-125135]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	O. Blanke and O.A. Kannape were supported by the Swiss National Science Foundation (Sinergia Grant CRSII1-125135: Balancing Self and Body, http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 2009, NEUROREHABILITATION, V25, P29, DOI 10.3233/NRE-2009-0497; Beauchet O, 2003, J AM GERIATR SOC, V51, P1187, DOI 10.1046/j.1532-5415.2003.51385.x; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; Daprati E, 1997, COGNITION, V65, P71, DOI 10.1016/S0010-0277(97)00039-5; Daprati E, 2002, NEUROPSYCHOLOGIA, V40, P1379, DOI 10.1016/S0028-3932(01)00203-2; David N, 2008, CONSCIOUS COGN, V17, P523, DOI 10.1016/j.concog.2008.03.004; Davis Iii RB, 1991, HUM MOVEMENT SCI, V10, P575; Dubost V, 2006, HUM MOVEMENT SCI, V25, P372, DOI 10.1016/j.humov.2006.03.004; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; FRITH CD, 1989, PSYCHOL MED, V19, P359, DOI 10.1017/S003329170001240X; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; Glasauer S, 1995, ACTA ASTRONAUT, V36, P423, DOI 10.1016/0094-5765(95)00127-1; Grasso R, 1996, NEUROREPORT, V7, P1170, DOI 10.1097/00001756-199604260-00015; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hausdorff JM, 2003, J GERIATR PSYCH NEUR, V16, P53, DOI 10.1177/0891988702250580; Helmholtz H., 1866, HDB PHYSL OPTIK; Hicheur H, 2007, EUR J NEUROSCI, V26, P2376, DOI 10.1111/j.1460-9568.2007.05836.x; Hollands KL, 2010, EXP BRAIN RES, V202, P591, DOI 10.1007/s00221-010-2162-1; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Huxham F, 2008, MOVEMENT DISORD, V23, P1391, DOI 10.1002/mds.21943; IDE JS, 2010, NEUROIMAGE; Jahn K, 2008, PROG BRAIN RES, V171, P353, DOI 10.1016/S0079-6123(08)00652-3; Kannape OA, 2013, J NEUROPHYSIOL, V110, P1837, DOI 10.1152/jn.01042.2012; Kannape OA, 2010, NEUROPSYCHOLOGIA, V48, P1628, DOI 10.1016/j.neuropsychologia.2010.02.005; Kannape O. A., 2012, INT J PSYCHOPHYSIOL; Knoblich G, 2004, PSYCHOL MED, V34, P1561, DOI 10.1017/S0033291704002454; Knoblich G, 2009, COGNITION, V111, P248, DOI 10.1016/j.cognition.2009.02.007; LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2; Menzer F, 2010, COGN NEUROSCI-UK, V1, P184, DOI 10.1080/17588921003743581; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Nielsen T., 1963, SCAND J PSYCHOL, V4, P6; Nutt JG, 2011, MOVEMENT DISORD, V26, P1166, DOI 10.1002/mds.23588; Papaxanthis C, 2003, NEUROSCIENCE, V117, P779, DOI 10.1016/S0306-4522(02)00964-8; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Pham QC, 2007, EUR J NEUROSCI, V26, P2391, DOI 10.1111/j.1460-9568.2007.05835.x; Pham QC, 2009, J NEUROPHYSIOL, V102, P2800, DOI 10.1152/jn.00284.2009; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2006, ACTA PSYCHOL, V121, P81, DOI 10.1016/j.actpsy.2005.06.006; Repp BH, 2007, J EXP PSYCHOL HUMAN, V33, P469, DOI 10.1037/0096-1523.33.2.469; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Schutz-Bosbach S, 2006, CURR BIOL, V16, P1830, DOI 10.1016/j.cub.2006.07.048; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Synofzik M, 2006, J NEUROPHYSIOL, V96, P1592, DOI 10.1152/jn.00104.2006; Team R. D. C, 2011, R LANG ENV STAT COMP; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2; van Iersel MB, 2007, ARCH PHYS MED REHAB, V88, P187, DOI 10.1016/j.apmr.2006.10.031; von Holst E., 1950, NATURWISSENSCHAFTEN, V20, P13; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yang YR, 2007, GAIT POSTURE, V25, P185, DOI 10.1016/j.gaitpost.2006.03.007; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	65	14	15	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85560	10.1371/journal.pone.0085560	http://dx.doi.org/10.1371/journal.pone.0085560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465601	Green Published, gold, Green Accepted			2022-12-25	WOS:000330244500075
J	Mikami, N; Sueda, K; Ogitani, Y; Otani, I; Takatsuji, M; Wada, Y; Watanabe, K; Yoshikawa, R; Nishioka, S; Hashimoto, N; Miyagi, Y; Fukada, S; Yamamoto, H; Tsujikawa, K				Mikami, Norihisa; Sueda, Kaori; Ogitani, Yusuke; Otani, Ippei; Takatsuji, Miku; Wada, Yasuko; Watanabe, Keiko; Yoshikawa, Rintaro; Nishioka, Satoshi; Hashimoto, Nagisa; Miyagi, Yayoi; Fukada, Soichiro; Yamamoto, Hiroshi; Tsujikawa, Kazutake			Calcitonin Gene-Related Peptide Regulates Type IV Hypersensitivity through Dendritic Cell Functions	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CCR2; BINDING PROTEIN; UP-REGULATION; T-CELLS; ACTIVATION; EXPRESSION; CAMP; KINASE; CD40; INTERLEUKIN-12	Dendritic cells (DCs) play essential roles in both innate and adaptive immune responses. In addition, mutual regulation of the nervous system and immune system is well studied. One of neuropeptides, calcitonin gene-related peptide (CGRP), is a potent regulator in immune responses; in particular, it has anti-inflammatory effects in innate immunity. For instance, a deficiency of the CGRP receptor component RAMP 1 (receptor activity-modifying protein 1) results in higher cytokine production in response to LPS (lipopolysaccharide). On the other hand, how CGRP affects DCs in adaptive immunity is largely unknown. In this study, we show that CGRP suppressed Th1 cell differentiation via inhibition of IL-12 production in DCs using an in vitro co-culture system and an in vivo ovalbumin-induced delayed-type hypersensitivity (DTH) model. CGRP also down-regulated the expressions of chemokine receptor CCR2 and its ligands CCL2 and CCL12 in DCs. Intriguingly, the frequency of migrating CCR2(+) DCs in draining lymph nodes of RAMP1-deficient mice was higher after DTH immunization. Moreover, these CCR2(+) DCs highly expressed IL-12 and CD80, resulting in more effective induction of Th1 differentiation compared with CCR2(-) DCs. These results indicate that CGRP regulates Th1 type reactions by regulating expression of cytokines, chemokines, and chemokine receptors in DCs.	[Mikami, Norihisa; Sueda, Kaori; Ogitani, Yusuke; Otani, Ippei; Takatsuji, Miku; Wada, Yasuko; Watanabe, Keiko; Yoshikawa, Rintaro; Nishioka, Satoshi; Hashimoto, Nagisa; Miyagi, Yayoi; Fukada, Soichiro; Yamamoto, Hiroshi; Tsujikawa, Kazutake] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Osaka, Japan	Osaka University	Fukada, S (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Osaka, Japan.	fukada@phs.osaka-u.ac.jp	Fukada, So-ichiro/AAI-9151-2020	Fukada, So-ichiro/0000-0003-4051-5108; Mikami, Norihisa/0000-0001-6360-5363	Ministry of Education, Culture, Sports, Science and Technology of Japan [22590062]; Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI); Osaka Foundation for Promotion of Clinical Immunology	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI); Osaka Foundation for Promotion of Clinical Immunology	This work was supported by a Grant-in-Aid for Scientific Research (22590062) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI), a grant from the Osaka Foundation for Promotion of Clinical Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Arron JR, 2001, J BIOL CHEM, V276, P30011, DOI 10.1074/jbc.M100414200; ASAHINA A, 1995, J IMMUNOL, V154, P3056; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BHALLA AK, 1989, ANN RHEUM DIS, V48, P1, DOI 10.1136/ard.48.1.1; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0; Brenner S, 2003, J BIOL CHEM, V278, P5597, DOI 10.1074/jbc.M207448200; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Feng WG, 2002, CELL RES, V12, P331, DOI 10.1038/sj.cr.7290135; Franco R, 2007, TRENDS IMMUNOL, V28, P400, DOI 10.1016/j.it.2007.07.005; Harzenetter MD, 2007, J IMMUNOL, V179, P607, DOI 10.4049/jimmunol.179.1.607; Horrigan LA, 2004, INT IMMUNOPHARMACOL, V4, P1409, DOI 10.1016/j.intimp.2004.06.005; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Jimenez F, 2010, J IMMUNOL, V184, P5571, DOI 10.4049/jimmunol.0803494; Jung HT, 2008, MOL CELL NEUROSCI, V37, P170, DOI 10.1016/j.mcn.2007.09.004; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Liu J, 2000, IMMUNOLOGY, V101, P61, DOI 10.1046/j.1365-2567.2000.00082.x; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mikami N, 2013, J IMMUNOL, V190, P4046, DOI 10.4049/jimmunol.1203102; Mikami N, 2012, INT IMMUNOL, V24, P681, DOI 10.1093/intimm/dxs075; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; O'Sullivan BJ, 2002, J IMMUNOL, V168, P5491, DOI 10.4049/jimmunol.168.11.5491; Ozes ON, 1999, NATURE, V401, P82; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Penton-Rol G, 1998, J IMMUNOL, V160, P3869; Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Tokoyoda K, 2004, INT IMMUNOL, V16, P643, DOI 10.1093/intimm/dxh072; Tsujikawa K, 2007, P NATL ACAD SCI USA, V104, P16702, DOI 10.1073/pnas.0705974104; VANVALEN F, 1990, NEUROSCI LETT, V119, P195, DOI 10.1016/0304-3940(90)90832-T; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Xu L, 1997, J LEUKOCYTE BIOL, V62, P653, DOI 10.1002/jlb.62.5.653; Xu LL, 2000, EUR J IMMUNOL, V30, P227, DOI 10.1002/1521-4141(200001)30:1<227::AID-IMMU227>3.0.CO;2-X; Yoon SH, 2011, J BONE MINER RES, V26, P1217, DOI 10.1002/jbmr.310; Zhang JY, 2006, MOL CELL BIOL, V26, P1223, DOI 10.1128/MCB.26.4.1223-1234.2006; Zhou YH, 1999, J LEUKOCYTE BIOL, V65, P265, DOI 10.1002/jlb.65.2.265	42	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86367	10.1371/journal.pone.0086367	http://dx.doi.org/10.1371/journal.pone.0086367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466057	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500239
J	Stevens, K; Weynberg, K; Bellas, C; Brown, S; Brownlee, C; Brown, MT; Schroeder, DC				Stevens, Kim; Weynberg, Karen; Bellas, Christopher; Brown, Sonja; Brownlee, Colin; Brown, Murray T.; Schroeder, Declan C.			A Novel Evolutionary Strategy Revealed in the Phaeoviruses	PLOS ONE			English	Article							MARINE VIRUSES; DNA VIRUS; ECTOCARPUS-SILICULOSUS; ALGAL VIRUS; BROWN-ALGAE; PHAEOPHYCEAE; GENOME; COCCOLITHOVIRUS; FASCICULATUS; INFECTION	Phaeoviruses infect the brown algae, which are major contributors to primary production of coastal waters and estuaries. They exploit a Persistent evolutionary strategy akin to a K-selected life strategy via genome integration and are the only known representatives to do so within the giant algal viruses that are typified by r-selected Acute lytic viruses. In screening the genomes of five species within the filamentous brown algal lineage, here we show an unprecedented diversity of viral gene sequence variants especially amongst the smaller phaeoviral genomes. Moreover, one variant shares features from both the two major sub-groups within the phaeoviruses. These phaeoviruses have exploited the reduction of their giant dsDNA genomes and accompanying loss of DNA proofreading capability, typical of an Acute life strategist, but uniquely retain a Persistent life strategy.	[Stevens, Kim; Weynberg, Karen; Bellas, Christopher; Brown, Sonja; Brownlee, Colin; Schroeder, Declan C.] Marine Biol Assoc UK, Cell & Mol Dept, Plymouth, Devon, England; [Stevens, Kim; Weynberg, Karen; Bellas, Christopher; Brown, Sonja; Brownlee, Colin; Brown, Murray T.] Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England	Marine Biological Association United Kingdom; University of Plymouth	Schroeder, DC (corresponding author), Marine Biol Assoc UK, Cell & Mol Dept, Plymouth, Devon, England.	dsch@mba.ac.uk	Bellas, Christopher M/C-6292-2015; Weynberg, Karen/AAW-1657-2020; Schroeder, Declan C./O-9131-2019; Brown, Murray/K-5291-2014	Weynberg, Karen/0000-0002-9856-2137; Schroeder, Declan C./0000-0001-5991-2838; Brown, Murray/0000-0003-2655-8611; Bellas, Christopher/0000-0001-5084-7830	INTERREG programme France (Channel) - England, MARINEXUS [1956/4073]; Plymouth University	INTERREG programme France (Channel) - England, MARINEXUS; Plymouth University	This research was funded by INTERREG programme France (Channel) - England, MARINEXUS (Ref: 1956/4073) and Plymouth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Brussaard CPD, 2008, ISME J, V2, P575, DOI 10.1038/ismej.2008.31; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Daee DL, 2010, P NATL ACAD SCI USA, V107, P157, DOI 10.1073/pnas.0907526106; Delaroque N, 2003, J MOL EVOL, V57, P613, DOI 10.1007/s00239-003-2501-y; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Elde NC, 2012, CELL, V150, P831, DOI 10.1016/j.cell.2012.05.049; FRIESSKLEBL AK, 1994, J PHYCOL, V30, P653, DOI 10.1111/j.0022-3646.1994.00653.x; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Ivey RG, 1996, VIROLOGY, V220, P267, DOI 10.1006/viro.1996.0314; Maier I, 1997, J PHYCOL, V33, P838, DOI 10.1111/j.0022-3646.1997.00838.x; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; MULLER DG, 1993, PROTOPLASMA, V175, P121, DOI 10.1007/BF01385009; Muller DG, 1996, J GEN VIROL, V77, P2329, DOI 10.1099/0022-1317-77-9-2329; Peters AF, 2010, PHYCOL RES, V58, P157, DOI 10.1111/j.1440-1835.2010.00574.x; Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Roossinck MJ, 2010, PHILOS T R SOC B, V365, P1899, DOI 10.1098/rstb.2010.0057; Schroeder D.C., 2011, STUDIES VIRAL ECOLOG, V1, P205, DOI [10.1002/9781118025666.ch8, DOI 10.1002/9781118025666.CH8]; Schroeder DC, 2002, ARCH VIROL, V147, P1685, DOI 10.1007/s00705-002-0841-3; Schroeder DC, 2009, VIROLOGY, V384, P223, DOI 10.1016/j.virol.2008.10.040; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Starr RC, 1993, J PHYCOL S, V29, P90; SUTTLE CA, 1990, NATURE, V347, P467, DOI 10.1038/347467a0; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Villarreal LP, 2000, VIROLOGY, V272, P1, DOI 10.1006/viro.2000.0381; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109	30	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86040	10.1371/journal.pone.0086040	http://dx.doi.org/10.1371/journal.pone.0086040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465858	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500170
J	Vanderplanck, M; Moerman, R; Rasmont, P; Lognay, G; Wathelet, B; Wattiez, R; Michez, D				Vanderplanck, Maryse; Moerman, Romain; Rasmont, Pierre; Lognay, Georges; Wathelet, Bernard; Wattiez, Ruddy; Michez, Denis			How Does Pollen Chemistry Impact Development and Feeding Behaviour of Polylectic Bees?	PLOS ONE			English	Article							APIS-MELLIFERA L; TERRESTRIS MICRO-COLONIES; BOMBUS-TERRESTRIS; AMINO-ACIDS; HONEY-BEES; NUTRITIVE-VALUE; NONHOST POLLEN; SIZE VARIATION; MAKISTERONE-A; HYMENOPTERA	Larvae and imagos of bees rely exclusively on floral rewards as a food source but host-plant range can vary greatly among bee species. While oligolectic species forage on pollen from a single family of host plants, polylectic bees, such as bumblebees, collect pollen from many families of plants. These polylectic species contend with interspecific variability in essential nutrients of their host-plants but we have only a limited understanding of the way in which chemicals and chemical combinations influence bee development and feeding behaviour. In this paper, we investigated five different pollen diets (Calluna vulgaris, Cistus sp., Cytisus scoparius, Salix caprea and Sorbus aucuparia) to determine how their chemical content affected bumblebee colony development and pollen/syrup collection. Three compounds were used to characterise pollen content: polypeptides, amino acids and sterols. Several parameters were used to determine the impact of diet on micro-colonies: (i) Number and weight of larvae (total and mean weight of larvae), (ii) weight of pollen collected, (iii) pollen efficacy (total weight of larvae divided by weight of the pollen collected) and (iv) syrup collection. Our results show that pollen collection is similar regardless of chemical variation in pollen diet while syrup collection is variable. Microcolonies fed on S. aucuparia and C. scoparius pollen produced larger larvae (i. e. better mates and winter survivors) and fed less on nectar compared to the other diets. Pollen from both of these species contains 24-methylenecholesterol and high concentrations of polypeptides/total amino acids. This pollen nutritional "theme" seems therefore to promote worker reproduction in B. terrestris micro-colonies and could be linked to high fitness for queenright colonies. As workers are able to selectively forage on pollen of high chemical quality, plants may be evolutionarily selected for their pollen content, which might attract and increase the degree of fidelity of generalist pollinators, such as bumblebees.	[Vanderplanck, Maryse; Moerman, Romain; Rasmont, Pierre; Michez, Denis] Univ Mons, Zool Lab, Res Inst Biosci, B-7000 Mons, Belgium; [Lognay, Georges] Univ Liege, Gembloux Agrobio Tech, Analyt Chem Lab, Unit Anal Qual & Risk, Gembloux, Belgium; [Wathelet, Bernard] Univ Liege, Gembloux Agrobio Tech, Unit Biol & Ind Chem, Gembloux, Belgium; [Wattiez, Ruddy] Univ Mons, Dept Prote & Prot Biochem, Res Inst Biosci, B-7000 Mons, Belgium; [Moerman, Romain] Univ Libre Brussels, Brussels, Belgium	University of Mons; University of Liege; University of Liege; University of Mons; Universite Libre de Bruxelles	Vanderplanck, M (corresponding author), Univ Mons, Zool Lab, Res Inst Biosci, B-7000 Mons, Belgium.	maryse.vanderplanck@umons.ac.be	Vanderplanck, Maryse/K-1072-2019; Michez, Denis/L-1370-2019	Vanderplanck, Maryse/0000-0002-0110-8019; Michez, Denis/0000-0001-8880-1838; wattiez, ruddy/0000-0003-2071-4310	"Fonds de la Recherche Fondamentale et Collective" (Belgium) [2.4613.10]; Belgian Fund for Scientific Research (FNRS)	"Fonds de la Recherche Fondamentale et Collective" (Belgium)(Fonds de la Recherche Scientifique - FNRS); Belgian Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This research was supported by grants from the "Fonds de la Recherche Fondamentale et Collective" (2.4613.10) (Belgium). MV is a Ph.D. student funded by the Belgian Fund for Scientific Research (FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akihisa T., 1991, PHYSL BIOCH STEROLS, P172; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Beekman M, 1998, P ROY SOC B-BIOL SCI, V265, P1535, DOI 10.1098/rspb.1998.0469; Beekman M, 1998, ENTOMOL EXP APPL, V89, P207, DOI 10.1023/A:1003595306816; Behmer ST, 2003, ADV INSECT PHYSIOL, V31, P1, DOI 10.1016/S0065-2806(03)31001-X; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Buchmann S.L., 1986, P237; Chow E. D., 2007, ELLIPSE FUNCTIONS DR; CNAANI J, 1994, INSECT SOC, V41, P301, DOI 10.1007/BF01242301; Cohen A. C., 2004, INSECT DIET SCI TECH; Couvillon MJ, 2010, INSECT SOC, V57, P193, DOI 10.1007/s00040-010-0064-7; DAY S, 1990, J APICULT RES, V29, P138, DOI 10.1080/00218839.1990.11101210; de GROOT A. P., 1953, PHYSIOL COMPARATA ET OECOL, V3, P197; De Luca PA, 2013, OECOLOGIA, V172, P805, DOI 10.1007/s00442-012-2535-1; Dietz A, 1975, HIVE HONEY BEE, P125; Dobson Heidi E.M., 1999, Plant Species Biology, V14, P153, DOI 10.1046/j.1442-1984.1999.00020.x; FELDLAUFER MF, 1986, ARCH INSECT BIOCHEM, V3, P415, DOI 10.1002/arch.940030502; FELDLAUFER MF, 1986, EXPERIENTIA, V42, P200, DOI 10.1007/BF01952468; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Free JB, 1959, BUMBLEBEES COLLINS; Genissel A, 2002, ENTOMOL EXP APPL, V104, P329, DOI 10.1023/A:1021279220995; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Goulson D, 2002, ANIM BEHAV, V64, P123, DOI 10.1006/anbe.2002.3041; Haider M, 2013, FUNCT ECOL, V27, P255, DOI 10.1111/1365-2435.12021; Hanley ME, 2008, FUNCT ECOL, V22, P592, DOI 10.1111/j.1365-2435.2008.01415.x; Hargreaves AL, 2009, BIOL REV, V84, P259, DOI 10.1111/j.1469-185X.2008.00074.x; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Herbert E.W., 1992, HIVE HONEY BEE, P197; Huang TF, 2011, PHYTOCHEMISTRY, V72, P1531, DOI 10.1016/j.phytochem.2011.03.019; HUGEL MARIE-FRANCE, 1962, ANN ABEILLE [PARIS], V5, P97, DOI 10.1051/apido:19620201; Human H, 2007, J INSECT PHYSIOL, V53, P649, DOI 10.1016/j.jinsphys.2007.04.002; KINDT R, 2005, DIVERSITY ANAL MANUA; Kitaoka TK, 2009, BEHAV ECOL SOCIOBIOL, V63, P501, DOI 10.1007/s00265-008-0684-3; Kleijn D, 2008, ECOLOGY, V89, P1811, DOI 10.1890/07-1275.1; Lee KP, 2008, FUNCT ECOL, V22, P1052, DOI 10.1111/j.1365-2435.2008.01459.x; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Leonhardt SD, 2012, APIDOLOGIE, V43, P449, DOI 10.1007/s13592-011-0112-y; Louveaux J., 1959, ANN ABEILLES, V2, P7; Mayer C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050353; Michener C.D., 2007, BEES WORLD, Vsecond; Nation J. L., 2002, INSECT PHYSL BIOCH, DOI DOI 10.1017/CBO9781107415324.004; Nicolson SW, 2011, AFR ZOOL, V46, P197, DOI 10.3377/004.046.0201; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Peat J, 2005, ECOL ENTOMOL, V30, P176, DOI 10.1111/j.0307-6946.2005.00676.x; Pereboom JJM, 2003, INSECT SOC, V50, P127, DOI 10.1007/s00040-003-0639-7; Pereboom JJM, 2000, INSECT SOC, V47, P11, DOI 10.1007/s000400050003; Pernal SF, 2002, ANIM BEHAV, V63, P369, DOI 10.1006/anbe.2001.1904; Praz CJ, 2008, ECOLOGY, V89, P795, DOI 10.1890/07-0751.1; R Development Core Team, 2005, R LANG ENV STAT COMP; R Development Core Team R, 2009, R LANG ENV STAT COMP; Rasmont P, 2005, J ECON ENTOMOL, V98, P656, DOI 10.1603/0022-0493-98.3.656; Rasmont P, 2008, ANN SOC ENTOMOL FR, V44, P243, DOI 10.1080/00379271.2008.10697559; REGALI A, 1995, APIDOLOGIE, V26, P273, DOI 10.1051/apido:19950401; Regali A., 1996, THESIS; Roberts D.W., 2010, LABDSV ORDINATION MU; Robertson AW, 1999, ECOLOGY, V80, P2594, DOI 10.1890/0012-9658(1999)080[2594:BBSOMG]2.0.CO;2; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Roulston TH, 2002, EVOL ECOL, V16, P49, DOI 10.1023/A:1016048526475; Roulston TH, 2000, ECOL MONOGR, V70, P617, DOI 10.1890/0012-9615(2000)070[0617:WGPCOP]2.0.CO;2; SCHMIDT JO, 1987, ANN ENTOMOL SOC AM, V80, P176, DOI 10.1093/aesa/80.2.176; Sedivy C, 2011, FUNCT ECOL, V25, P718, DOI 10.1111/j.1365-2435.2010.01828.x; Smeets P, 2003, APIDOLOGIE, V34, P333, DOI 10.1051/apido:2003026; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; STANDIFER LN, 1980, APIDOLOGIE, V11, P163, DOI 10.1051/apido:19800206; SVOBODA JA, 1982, LIPIDS, V17, P220, DOI 10.1007/BF02535107; SVOBODA JA, 1983, EXPERIENTIA, V39, P1120, DOI 10.1007/BF01943139; SVOBODA JA, 1978, LIPIDS, V13, P742, DOI 10.1007/BF02533755; Tasei JN, 2008, APIDOLOGIE, V39, P397, DOI 10.1051/apido:2008017; Tasei JN, 2008, J ECON ENTOMOL, V101, P1737, DOI 10.1603/0022-0493-101.6.1737; Vanderplanck M, 2013, APIDOLOGIE IN PRESS, DOI [10.1007/s13592-013-0239-0, DOI 10.1007/S13592-013-0239-0)]; Vanderplanck M, FLORAL GEN STE UNPUB; Vanderplanck M, 2011, ANAL LETT, V44, P1807, DOI 10.1080/00032719.2010.526271; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Weiner CN, 2010, APIDOLOGIE, V41, P476, DOI 10.1051/apido/2009083	74	124	129	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86209	10.1371/journal.pone.0086209	http://dx.doi.org/10.1371/journal.pone.0086209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465963	Green Published, gold			2022-12-25	WOS:000330244500205
J	Wang, JZ; Wang, BJ; Huang, SM; Song, ZT; Wu, J; Zhang, EJ; Zhu, ZN; Zhu, B; Yin, Y; Lin, Y; Xu, Y; Zheng, X; Lu, MJ; Yang, DL				Wang, Junzhong; Wang, Baoju; Huang, Shunmei; Song, Zhitao; Wu, Jun; Zhang, Ejuan; Zhu, Zhenni; Zhu, Bin; Yin, Ying; Lin, Yong; Xu, Yang; Zheng, Xin; Lu, Mengji; Yang, Dongliang			Immunosuppressive Drugs Modulate the Replication of Hepatitis B Virus (HBV) in a Hydrodynamic Injection Mouse Model	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; MYCOPHENOLIC-ACID; LIVER-TRANSPLANTATION; IN-VITRO; INFECTION; TOLERANCE; IMMUNITY; CELL; IDENTIFICATION; LYMPHOCYTES	Hepatitis B virus (HBV) reactivation and recurrence are common in patients under immunosuppression and can be controlled by hepatitis B immunoglobulin, antivirals, and hepatitis B vaccine. However, the detailed analysis of HBV infection under immunosuppression is essential for the prophylaxis and therapy for HBV reactivation and recurrence. In this study, HBV replication and T cell responses were analyzed in a HBV-transfected mouse model under immunosuppressive therapy. During the treatment, HBV replication was at a high level in mice treated with dexamethasone, cyclosporine, and cyclophosphamide, whereas was terminated in mice treated with mycophenolate mofetil. After the withdrawal, HBV replication was at low or high levels in the dexamethasone-treated mice or in both cyclosporine-and cyclophosphamide-treated mice. The early withdrawal of cyclosporine allowed the recovery of suppressed T cell responses and led to subsequent HBV clearance, while the adoptive immune transfer to the mice with HBV persistence led to HBV suppression. Taken together, long-term HBV persistence under immunosuppression depends on the immunosuppressive drugs used and on the treatment duration and is mediated by the suppressed intrahepatic CD8 T cell response. These data may be helpful for individualized immunosuppressive therapy in patients with high risk of HBV reactivation and recurrence, and the mouse system is suitable for studying HBV reactivation and recurrence under immunosuppression.	[Wang, Junzhong; Wang, Baoju; Huang, Shunmei; Song, Zhitao; Wu, Jun; Zhu, Zhenni; Zhu, Bin; Zheng, Xin; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China; [Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Zhang, Ejuan; Yin, Ying; Lin, Yong; Xu, Yang] Huazhong Univ Sci & Technol, Dept Microbiol, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; University of Duisburg Essen; Huazhong University of Science & Technology	Lu, MJ (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.	mengji.lu@uni-due.de; dlyang@mail.hust.edu.cn	Wang, Junzhong/AAS-9767-2021; Lu, Mengji/ABF-9410-2020		National Major Science and Technology Project for Infectious Diseases of China [2008ZX10002011, 2012ZX10004503]; Major State Basic Research Program of China (973 Program) [2009CB522506]; National Natural Science Foundation of China [81001313, 81101248]; International Science & Technology Cooperation Program of China [2011DFA31030]; Deutsche Forschungsgemeinschaft [TRR60]; Chinese Post-doctorial Science Foundation [20090460949]	National Major Science and Technology Project for Infectious Diseases of China; Major State Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chinese Post-doctorial Science Foundation	This work was supported by grants from National Major Science and Technology Project for Infectious Diseases of China (2008ZX10002011, 2012ZX10004503, http://www.moh.gov.cn), The Major State Basic Research Program of China (973 Program, 2009CB522506, http://www.most.gov.cn), the National Natural Science Foundation of China (81001313. 81101248, http://www.nsfc.gov.cn), the International Science & Technology Cooperation Program of China (2011DFA31030, http://www.most.gov.cn), the Deutsche Forschungsgemeinschaft (Transregio TRR60, http://www.dfg.de) and Chinese Post-doctorial Science Foundation (20090460949, http://www.chinapostdoctor.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaha P, 2003, BLOOD, V101, P2886, DOI 10.1182/blood-2002-10-3014; Cheng AL, 2003, HEPATOLOGY, V37, P1320, DOI 10.1053/jhep.2003.50220; Cholongitas E, 2013, AM J TRANSPLANT, V13, P353, DOI 10.1111/j.1600-6143.2012.04315.x; Cobleigh MA, 2010, J VIROL, V84, P7513, DOI 10.1128/JVI.00200-10; Dahmen U, 2004, TRANSPLANTATION, V77, P965, DOI 10.1097/01.TP.0000113804.35096.8E; Dell'Era L, 2011, RHEUMATOLOGY, V50, P1358, DOI 10.1093/rheumatology/ker102; Egli A, 2013, TRANSPLANTATION, V95, P448, DOI 10.1097/TP.0b013e318276a19f; Fletcher SP, 2013, HEPATOLOGY, V57, P13, DOI 10.1002/hep.25954; Frank I, 2007, J VIROL, V81, P7156, DOI 10.1128/JVI.02711-06; Halford WP, 2000, J VIROL, V74, P5957, DOI 10.1128/JVI.74.13.5957-5967.2000; Hoppe-Seyler K, 2012, HEPATOLOGY, V56, P9, DOI 10.1002/hep.25602; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; KUNKL A, 1980, J IMMUNOL, V125, P2526; Lan PX, 2013, HEPATOLOGY, V58, P73, DOI 10.1002/hep.26339; Lau GKK, 1997, HEPATOLOGY, V25, P1497, DOI 10.1002/hep.510250631; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu ML, 2005, J GEN VIROL, V86, P3263, DOI 10.1099/vir.0.81195-0; Lohr HF, 1998, LIVER, V18, P405; Londono MC, 2013, J HEPATOL; Luo Y, 2007, LIVER TRANSPLANT, V13, P71, DOI 10.1002/lt.20887; Pan QW, 2012, HEPATOLOGY, V56, P1586, DOI 10.1002/hep.25700; Pan QW, 2012, HEPATOLOGY, V55, P1673, DOI 10.1002/hep.25562; PENNA A, 1991, J EXP MED, V174, P1565, DOI 10.1084/jem.174.6.1565; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; Rahier JF, 2010, RHEUMATOLOGY, V49, P1815, DOI 10.1093/rheumatology/keq183; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Schaecher SR, 2008, VIROLOGY, V380, P312, DOI 10.1016/j.virol.2008.07.026; Wang BJ, 2011, J GEN VIROL, V92, P681, DOI 10.1099/vir.0.025023-0; Wursthorn K, 2010, GUT, V59, P1430, DOI 10.1136/gut.2009.195834; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; Yin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022524	33	9	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85832	10.1371/journal.pone.0085832	http://dx.doi.org/10.1371/journal.pone.0085832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465734	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500125
J	Gago, J; Martinez-Nunez, L; Landin, M; Flexas, J; Gallego, PP				Gago, Jorge; Martinez-Nunez, Lourdes; Landin, Mariana; Flexas, Jaume; Gallego, Pedro P.			Modeling the Effects of Light and Sucrose on In Vitro Propagated Plants: A Multiscale System Analysis Using Artificial Intelligence Technology	PLOS ONE			English	Article							GARDENIA JASMINOIDES PLANTLETS; CHLOROPHYLL FLUORESCENCE; NEUROFUZZY LOGIC; MICROPROPAGATED GRAPEVINE; CULTURE-CONDITIONS; CO2 CONCENTRATION; LEAF CONDUCTANCE; PHOTOSYSTEM-II; GROWTH; PHOTOSYNTHESIS	Background: Plant acclimation is a highly complex process, which cannot be fully understood by analysis at any one specific level (i.e. subcellular, cellular or whole plant scale). Various soft-computing techniques, such as neural networks or fuzzy logic, were designed to analyze complex multivariate data sets and might be used to model large such multiscale data sets in plant biology. Methodology and Principal Findings: In this study we assessed the effectiveness of applying neuro-fuzzy logic to modeling the effects of light intensities and sucrose content/concentration in the in vitro culture of kiwifruit on plant acclimation, by modeling multivariate data from 14 parameters at different biological scales of organization. The model provides insights through application of 14 sets of straightforward rules and indicates that plants with lower stomatal aperture areas and higher photoinhibition and photoprotective status score best for acclimation. The model suggests the best condition for obtaining higher quality acclimatized plantlets is the combination of 2.3% sucrose and photonflux of 122-130 mu mol m(-2) s(-1). Conclusions: Our results demonstrate that artificial intelligence models are not only successful in identifying complex nonlinear interactions among variables, by integrating large-scale data sets from different levels of biological organization in a holistic plant systems-biology approach, but can also be used successfully for inferring new results without further experimental work.	[Gago, Jorge; Martinez-Nunez, Lourdes; Gallego, Pedro P.] Univ Vigo, Fac Biol, Vigo 36310, Spain; [Landin, Mariana] Univ Santiago, Fac Pharm, Dept Pharm & Pharmaceut Technol, Santiago De Compostela, Spain; [Gago, Jorge; Flexas, Jaume] Univ Illes Balears, Inst Mediterraneo Estudios Avanzados UIB IMEDEA, Dept Biol, Lab Fisiol Vegetal, Palma de Mallorca, Spain	Universidade de Vigo; Universidade de Santiago de Compostela; Universitat de les Illes Balears	Gallego, PP (corresponding author), Univ Vigo, Fac Biol, Vigo 36310, Spain.	pgallego@uvigo.es	Perez, Mariana Landin/AAA-5880-2019; Gallego, Pedro Pablo/K-3591-2013; Flexas, Jaume/C-1898-2012; Gago, Jorge/N-3591-2013	Gallego, Pedro Pablo/0000-0002-4622-1728; Flexas, Jaume/0000-0002-3069-175X; Gago, Jorge/0000-0002-4293-0105; Landin, Mariana/0000-0002-2835-8958; Martinez Nunez, Lourdes/0000-0001-5491-9707	Regional Government Xunta de Galicia [PGIDIT02BTF30102PR]; Spanish MEC [AGL 2003-05877]; Spanish Ministry of Education [PR2010-0460, PR2010-0357]	Regional Government Xunta de Galicia(Xunta de Galicia); Spanish MEC(Spanish Government); Spanish Ministry of Education(Spanish Government)	This work was supported by The Regional Government Xunta de Galicia (PGIDIT02BTF30102PR) and Spanish MEC (AGL 2003-05877) to PPG. ML (PR2010-0460) and PPG (PR2010-0357) thank the Spanish Ministry of Education for their financial support during their sabbatical year at Faculty of Science, University of Utrecht, Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez C, 2012, MOL PLANT CELL TISS, V108, P1; Amancio S, 1999, PLANT CELL TISS ORG, V58, P31, DOI 10.1023/A:1006323129593; Amthor JS, 2010, NEW PHYTOL, V188, P939, DOI 10.1111/j.1469-8137.2010.03505.x; Arigita L, 2010, IN VITRO CELL DEV-PL, V46, P312, DOI 10.1007/s11627-009-9267-x; Badr A, 2011, PLANT CELL TISS ORG, V107, P13, DOI 10.1007/s11240-011-9951-5; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Band LR, 2012, PLANT CELL, V24, P3892, DOI 10.1105/tpc.112.101550; Brady SM, 2009, PLANT CELL, V21, P1034, DOI 10.1105/tpc.109.066050; CAPELLADES M, 1990, J AM SOC HORTIC SCI, V115, P141, DOI 10.21273/JASHS.115.1.141; CAPELLADES M, 1990, PHOTOSYNTHETICA, V24, P190; Carvalho LC, 2001, PLANT CELL TISS ORG, V67, P271, DOI 10.1023/A:1012722112406; CHENG TY, 1975, PLANT SCI LETT, V5, P97, DOI 10.1016/0304-4211(75)90049-8; Colbourn E., 2005, ENCY PHARM TECHNOLOG, P145; CORUZZI GM, 2009, PLANT SYSTEMS BIOL A, V35, P3; Coupe SA, 2006, J EXP BOT, V57, P329, DOI 10.1093/jxb/erj033; Demmig-Adams B, 2006, NEW PHYTOL, V172, P11, DOI 10.1111/j.1469-8137.2006.01835.x; Desjardins Y, 2009, ACTA HORTIC, V812, P29; Eckardt NA, 2012, PLANT CELL, V24, P3857, DOI 10.1105/tpc.112.241011; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Fila G, 1998, PHYSIOL PLANTARUM, V102, P411, DOI 10.1034/j.1399-3054.1998.1020309.x; Fila G, 2006, J EXP BOT, V57, P2687, DOI 10.1093/jxb/erl040; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Flexas J, 2001, AUST J PLANT PHYSIOL, V28, P755, DOI 10.1071/PP99210; Gago J, 2010, J PLANT PHYSIOL, V167, P23, DOI 10.1016/j.jplph.2009.07.007; Gago J, 2011, J PLANT PHYSIOL, V168, P1858, DOI 10.1016/j.jplph.2011.04.008; Gago J, 2010, PLANT SIGNAL BEHAV, V5, P743, DOI 10.4161/psb.5.6.11702; Gago J, 2010, PLANT SCI, V179, P241, DOI 10.1016/j.plantsci.2010.05.009; Gallego PP, 2011, ARTIFICIAL NEURAL NETWORKS - METHODOLOGICAL ADVANCES AND BIOMEDICAL APPLICATIONS, P197; GenoudGourichon C, 1996, PHOTOSYNTHETICA, V32, P263; GROUT BWW, 1987, PLANT MICROPROPAGATI, P55; Hazarika BN, 2006, SCI HORTIC-AMSTERDAM, V108, P105, DOI 10.1016/j.scienta.2006.01.038; Hazarika BN, 2003, CURR SCI INDIA, V85, P1704; Jo EA, 2009, PLANT CELL TISS ORG, V96, P307, DOI 10.1007/s11240-008-9488-4; Kadlecek P, 2003, J PLANT PHYSIOL, V160, P1017, DOI 10.1078/0176-1617-00980; Kavli T, 1994, IEE C, V136, P1; Keurentjes JJB, 2011, TRENDS PLANT SCI, V16, P183, DOI 10.1016/j.tplants.2010.12.002; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; KOZAI T, 1992, TRANSPLANT PRODUCTION SYSTEMS, P247; KOZAI T, 1991, In Vitro Cellular and Developmental Biology Plant, V27P, P47; Kozai T, 1991, MICROPROPAGATION TEC, P447; Kozai T, 1997, PLANT CELL TISS ORG, V22, P205; LAETSCH WM, 1965, AM J BOT, V52, P798, DOI 10.2307/2439760; Landin M, 2009, EUR J PHARM SCI, V38, P325, DOI 10.1016/j.ejps.2009.08.004; Langford P. J., 1988, Acta Horticulturae, P305; Le VQ, 2001, J PLANT PHYSIOL, V158, P599, DOI 10.1078/0176-1617-00315; Lee SH, 2007, PLANT CELL TISS ORG, V90, P141, DOI 10.1007/s11240-006-9191-2; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lucas M, 2011, PLANT CELL ENVIRON, V34, P535, DOI 10.1111/j.1365-3040.2010.02273.x; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mehrotra S, 2013, PLANT CELL REP, V32, P309, DOI 10.1007/s00299-012-1364-3; Middleton AM, 2012, PLANT CELL, V24, P3876, DOI 10.1105/tpc.112.101840; Moncalean P, 2007, NEW ZEAL J CROP HORT, V35, P159, DOI 10.1080/01140670709510180; Muller B, 2011, J EXP BOT, V62, P1715, DOI 10.1093/jxb/erq438; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Osmond CB, 1994, PHOTOINHIBITION PHOT, P1; PARK YI, 1995, PLANTA, V196, P401, DOI 10.1007/BF00203636; Perez- Pineiro P, 2012, TRANGENIC PLANTS ADV, P3; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Pospisilova J, 2007, ACTA HORTIC, P29, DOI 10.17660/ActaHortic.2007.748.2; Pospisilova J, 1999, BIOL PLANTARUM, V42, P481, DOI 10.1023/A:1002688208758; Saez PL, 2013, PLANT SCI, V201, P12, DOI 10.1016/j.plantsci.2012.11.008; Seko Y, 1996, PLANT CELL TISS ORG, V46, P257, DOI 10.1007/BF02307103; Serret MD, 1997, PLANT CELL TISS ORG, V47, P217, DOI 10.1007/BF02318976; Serret MD, 2000, INT J PLANT SCI, V161, P281, DOI 10.1086/314251; Serret MD, 1996, PLANT CELL TISS ORG, V45, P1, DOI 10.1007/BF00043422; Serret MD, 2001, PHOTOSYNTHETICA, V39, P67, DOI 10.1023/A:1012443919022; Shao Q, 2006, EUR J PHARM SCI, V28, P394, DOI 10.1016/j.ejps.2006.04.007; Swain SS, 2010, IN VITRO CELL DEV-PL, V46, P134, DOI 10.1007/s11627-009-9269-8; Trewavas A, 2006, PLANT CELL, V18, P2420, DOI 10.1105/tpc.106.042267; Yuan JS, 2008, TRENDS PLANT SCI, V13, P165, DOI 10.1016/j.tplants.2008.02.003; ZELITCH I, 1975, SCIENCE, V188, P626, DOI 10.1126/science.188.4188.626; Zhang MJ, 2009, HORTSCIENCE, V44, P757, DOI 10.21273/HORTSCI.44.3.757; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206; Zielinska Sylwia, 2013, Biotechnologia (Poznan), V94, P253	75	37	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85989	10.1371/journal.pone.0085989	http://dx.doi.org/10.1371/journal.pone.0085989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465829	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500098
J	Morgenthau, A; Beddek, A; Schryvers, AB				Morgenthau, Ari; Beddek, Amanda; Schryvers, Anthony B.			The Negatively Charged Regions of Lactoferrin Binding Protein B, an Adaptation against Anti-Microbial Peptides	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; STREPTOCOCCUS-PNEUMONIAE; TRANSFERRIN; RECEPTOR; LBPB; IDENTIFICATION; CATARRHALIS; SEQUENCE; MUTANTS	Lactoferrin binding protein B (LbpB) is a bi-lobed membrane bound lipoprotein that is part of the lactoferrin receptor complex in a variety of Gram-negative pathogens. Despite high sequence diversity among LbpBs from various strains and species, a cluster of negatively charged amino acids is invariably present in the protein's C-terminal lobe in all species except Moraxella bovis. The function of LbpB in iron acquisition has yet to be experimentally demonstrated, whereas in vitro studies have shown that LbpB confers protection against lactoferricin, a short cationic antimicrobial peptide released from the N-terminus of lactoferrin. In this study we demonstrate that the negatively charged regions can be removed from the Neisseria meningitidis LbpB without compromising stability, and this results in the inability of LbpB to protect against the bactericidal effects of lactoferricin. The release of LbpB from the cell surface by the autotransporter NalP reduces the protection against lactoferricin in the in vitro killing assay, attributed to removal of LbpB during washing steps, but is unlikely to have a similar impact in vivo. The protective effect of the negatively charged polysaccharide capsule in the killing assay was less than the protection conferred by LbpB, suggesting that LbpB plays a major role in protection against cationic antimicrobial peptides in vivo. The selective release of LbpB by NalP has been proposed to be a mechanism for evading the adaptive immune response, by reducing the antibody binding to the cell surface, but may also provide insights into the primary function of LbpB in vivo. Although TbpB and LbpB have been shown to be major targets of the human immune response, the selective release of LbpB suggests that unlike TbpB, LbpB may not be essential for iron acquisition, but important for protection against cationic antimicrobial peptides.	[Morgenthau, Ari; Beddek, Amanda; Schryvers, Anthony B.] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada	University of Calgary	Schryvers, AB (corresponding author), Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada.	schryver@ucalgary.ca	Schryvers, Anthony B./AAF-3417-2020		Alberta Innovates-Health Solutions Interdisciplinary Team in Vaccine Design and Implementation [200700591]; Alberta Health and Wellness; Alberta Heritage Foundation for Medical Research Endowment Fund	Alberta Innovates-Health Solutions Interdisciplinary Team in Vaccine Design and Implementation; Alberta Health and Wellness; Alberta Heritage Foundation for Medical Research Endowment Fund	This work was supported by the Alberta Innovates-Health Solutions Interdisciplinary Team in Vaccine Design and Implementation (No. 200700591), funded jointly by Alberta Health and Wellness and the Alberta Heritage Foundation for Medical Research Endowment Fund (www.aihealthsolutions.ca/)?. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiak P, 2012, BIOCHEM CELL BIOL, V90, P339, DOI [10.1139/O11-076, 10.1139/o11-076]; Anderson JE, 2003, MOL MICROBIOL, V48, P1325, DOI 10.1046/j.1365-2958.2003.03496.x; ARNOLD RR, 1982, INFECT IMMUN, V35, P792, DOI 10.1128/IAI.35.3.792-799.1982; Arutyunova E, 2012, BIOCHEM CELL BIOL, V90, P351, DOI [10.1139/o11-078, 10.1139/O11-078]; Baker EN, 2002, BIOCHEM CELL BIOL, V80, P27, DOI 10.1139/o01-153; BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; Biswas GD, 1999, INFECT IMMUN, V67, P455, DOI 10.1128/IAI.67.1.455-459.1999; Bonnah RA, 1995, MICROB PATHOGENESIS, V19, P285, DOI 10.1016/S0882-4010(96)80002-7; Bonnah RA, 1998, J BACTERIOL, V180, P3080, DOI 10.1128/JB.180.12.3080-3090.1998; Bonnah RA, 1999, INFECT IMMUN, V67, P1517, DOI 10.1128/IAI.67.3.1517-1520.1999; Calmettes C, 2012, NAT STRUCT MOL BIOL, V19, P358, DOI 10.1038/nsmb.2251; Calmettes C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206102; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Johswich KO, 2012, INFECT IMMUN, V80, P2346, DOI 10.1128/IAI.00293-12; Legrand D, 2012, BIOCHEM CELL BIOL, V90, P252, DOI [10.1139/O11-056, 10.1139/o11-056]; Moraes TF, 2009, MOL CELL, V35, P523, DOI 10.1016/j.molcel.2009.06.029; Morgenthau A, 2012, BIOCHEM CELL BIOL, V90, P417, DOI [10.1139/O11-074, 10.1139/o11-074]; Omer H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017145; Pettersson A, 2006, VACCINE, V24, P3545, DOI 10.1016/j.vaccine.2006.02.003; Pettersson A, 1998, MOL MICROBIOL, V27, P599, DOI 10.1046/j.1365-2958.1998.00707.x; Roussel-Jazede V, 2010, INFECT IMMUN, V78, P3083, DOI 10.1128/IAI.01193-09; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Shaper M, 2004, INFECT IMMUN, V72, P5031, DOI 10.1128/IAI.72.9.5031-5040.2004; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Ward PP, 2005, CELL MOL LIFE SCI, V62, P2540, DOI 10.1007/s00018-005-5369-8; Yang X, 2011, J BIOL CHEM, V286, P45165, DOI 10.1074/jbc.M110.214171; Yu RH, 1999, INFECT IMMUN, V67, P3793, DOI 10.1128/IAI.67.8.3793-3799.1999	28	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86243	10.1371/journal.pone.0086243	http://dx.doi.org/10.1371/journal.pone.0086243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465982	Green Submitted, gold, Green Published			2022-12-25	WOS:000330240500122
J	Mezzanotte, L; An, N; Mol, IM; Lowik, CWGM; Kaijzel, EL				Mezzanotte, Laura; An, Na; Mol, Isabel M.; Lowik, Clemens W. G. M.; Kaijzel, Eric L.			A New Multicolor Bioluminescence Imaging Platform to Investigate NF-kappa B Activity and Apoptosis in Human Breast Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; ACTIVATION; REPORTER; LUCIFERASE; SULFORAPHANE; CELASTROL; CURCUMIN; RED; PROLIFERATION; INHIBITION	Background: Evaluation of novel drugs for clinical development depends on screening technologies and informative preclinical models. Here we developed a multicolor bioluminescent imaging platform to simultaneously investigate transcription factor NF-kappa B signaling and apoptosis. Methods: The human breast cancer cell line (MDA-MB-231) was genetically modified to express green, red and blue light emitting luciferases to monitor cell number and viability, NF-kappa B promoter activity and to perform specific cell sorting and detection, respectively. The pro-luciferin substrate Z-DEVD-animoluciferin was employed to determine apoptotic caspase 3/7 activity. We used the cell line for the in vitro evaluation of natural compounds and in vivo optical imaging of tumor necrosis factor TNF alpha-induced NF-kappa B activation. Results: Celastrol, resveratrol, sulphoraphane and curcumin inhibited the NF-kappa B promoter activity significantly and in a dose dependent manner. All compounds except resveratrol induced caspase 3/7 dependent apoptosis. Multicolor bioluminescence in vivo imaging allowed the investigation of tumor growth and NF-kappa B induction in a mouse model of breast cancer. Conclusion: Our new method provides an imaging platform for the identification, validation, screening and optimization of compounds acting on NF-kappa B signaling and apoptosis both in vitro and in vivo.	[Mezzanotte, Laura; An, Na; Lowik, Clemens W. G. M.; Kaijzel, Eric L.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Mol, Isabel M.] Leiden Univ, Dept Endocrinol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kaijzel, EL (corresponding author), Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands.	e.l.kaijzel@lumc.nl	Kaijzel, Eric/GZN-2333-2022	Mezzanotte, Laura/0000-0001-5592-8904; Kaijzel, Eric/0000-0003-3118-9910	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands; 130 partners; China Scholarship Council	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands; 130 partners; China Scholarship Council(China Scholarship Council)	This work is supported in part by NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners and the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Badr CE, 2009, MOL IMAGING, V8, P278, DOI 10.2310/7290.2009.00026; Bartfeld S., 2010, BMC CELL BIOL, V2010, P11; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Branchini BR, 2010, ANAL BIOCHEM, V396, P290, DOI 10.1016/j.ab.2009.09.009; BRASIER AR, 1992, METHOD ENZYMOL, V216, P386; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Castillo-Pichardo L, 2009, CLIN EXP METASTAS, V26, P505, DOI 10.1007/s10585-009-9250-2; Chiu TL, 2009, INT J MOL MED, V23, P469, DOI 10.3892/ijmm_00000153; Contag CH, 2000, NEOPLASIA, V2, P41, DOI 10.1038/sj.neo.7900079; De A, 2003, MOL THER, V7, P681, DOI 10.1016/S1525-0016(03)00070-4; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Gammon STM, 2006, ANAL CHEM, V78, P1520, DOI 10.1021/ac051999h; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Haefner B, 2006, CANC TREAT, V130, P219; Hosseinkhani S, 2011, CELL MOL LIFE SCI, V68, P1167, DOI 10.1007/s00018-010-0607-0; Huber MA, 2004, CELL CYCLE, V3, P1477, DOI 10.4161/cc.3.12.1280; Jacobsen, 2009, BIOTECHNIQUES, V47, P826, DOI 10.2144/000113254; Jeong WS, 2004, PHARM RES-DORDR, V21, P661, DOI 10.1023/B:PHAM.0000022413.43212.cf; Kallifatidis G, 2009, GUT, V58, P949, DOI 10.1136/gut.2008.149039; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kasperczyk H, 2005, ONCOGENE, V24, P6945, DOI 10.1038/sj.onc.1208842; Katula KS, 2005, J MED FOOD, V8, P269, DOI 10.1089/jmf.2005.8.269; Kim SR, 2012, ENDOCRINOLOGY, V153, P554, DOI 10.1210/en.2011-1413; Kwon H, 2010, BIOTECHNIQUES, V48, P460, DOI 10.2144/000113419; Lampe JW, 2009, GUT, V58, P900, DOI 10.1136/gut.2008.166694; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Liu M, 2010, CANCER RES, V70, P10464, DOI 10.1158/0008-5472.CAN-10-0732; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; Maddox Clinton B, 2008, JALA Charlottesv Va, V13, P168, DOI 10.1016/j.jala.2008.02.002; Meeran SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037748; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Michelini E, 2008, ANAL CHEM, V80, P260, DOI 10.1021/ac7016579; Michelini E, 2010, ANAL BIOANAL CHEM, V398, P227, DOI 10.1007/s00216-010-3933-z; Moon DO, 2009, CANCER LETT, V274, P132, DOI 10.1016/j.canlet.2008.09.013; Na IK, 2010, BLOOD, V116, pE18, DOI 10.1182/blood-2009-12-259432; Nakajima Y, 2005, BIOTECHNIQUES, V38, P891, DOI 10.2144/05386ST03; Nguyen TH, 2008, INT J ONCOL, V33, P81; Pozo-Guisado E, 2005, INT J CANCER, V116, P1004, DOI 10.1002/ijc.21209; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Ralhan Ranju, 2009, Front Biosci (Schol Ed), V1, P45; Robbins D, 2011, METHODS MOL BIOL, V716, P169, DOI 10.1007/978-1-61779-012-6_10; Scabini M, 2011, APOPTOSIS, V16, P198, DOI 10.1007/s10495-010-0553-1; Scarlatti F, 2003, FASEB J, V17, P2339, DOI 10.1096/fj.03-0292fje; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Stell A, 2007, Q J NUCL MED MOL IM, V51, P127; Sun AM, 2009, BIOORG MED CHEM LETT, V19, P6627, DOI 10.1016/j.bmcl.2009.10.023; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Tang HY, 2006, MOL CANCER THER, V5, P2034, DOI 10.1158/1535-7163.MCT-06-0216; Thamake SI, 2012, BIOMATERIALS, V33, P7164, DOI 10.1016/j.biomaterials.2012.06.026; WOOD KV, 1990, J BIOLUM CHEMILUM, V5, P107, DOI 10.1002/bio.1170050206; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yallapu MM, 2010, J COLLOID INTERF SCI, V351, P19, DOI 10.1016/j.jcis.2010.05.022; Yamagishi K, 2006, ANAL BIOCHEM, V354, P15, DOI 10.1016/j.ab.2006.03.031; Zong H, 2012, MOL BIOL REP, V39, P4803, DOI 10.1007/s11033-011-1273-5	61	28	28	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85550	10.1371/journal.pone.0085550	http://dx.doi.org/10.1371/journal.pone.0085550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465597	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000044
J	Meng, HQ; Li, CQ; Wang, Y; Chen, GJ				Meng, Hongqing; Li, Chaoqun; Wang, Yan; Chen, Guangju			Molecular Dynamics Simulation of the Allosteric Regulation of eIF4A Protein from the Open to Closed State, Induced by ATP and RNA Substrates	PLOS ONE			English	Article							INITIATION-FACTOR 4A; EUKARYOTIC TRANSLATION INITIATION; AMBER FORCE-FIELD; CRYSTAL-STRUCTURE; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL-CHANGES; CONTINUUM SOLVENT; HELICASE; COMPLEX	Background: Eukaryotic initiation factor 4A (eIF4A) plays a key role in the process of protein translation initiation by facilitating the melting of the 59 proximal secondary structure of eukaryotic mRNA for ribosomal subunit attachment. It was experimentally postulated that the closed conformation of the eIF4A protein bound by the ATP and RNA substrates is coupled to RNA duplex unwinding to promote protein translation initiation, rather than an open conformation in the absence of ATP and RNA substrates. However, the allosteric process of eIF4A from the open to closed state induced by the ATP and RNA substrates are not yet fully understood. Methodology: In the present work, we constructed a series of diplex and ternary models of the eIF4A protein bound by the ATP and RNA substrates to carry out molecular dynamics simulations, free energy calculations and conformation analysis and explore the allosteric properties of eIF4A. Results: The results showed that the eIF4A protein completes the conformational transition from the open to closed state via two allosteric processes of ATP binding followed by RNA and vice versa. Based on cooperative allosteric network analysis, the ATP binding to the eIF4A protein mainly caused the relative rotation of two domains, while the RNA binding caused the proximity of two domains via the migration of RNA bases in the presence of ATP. The cooperative binding of ATP and RNA for the eIF4A protein plays a key role in the allosteric transition.	[Meng, Hongqing; Li, Chaoqun; Wang, Yan; Chen, Guangju] Beijing Normal Univ, Coll Chem, Minist Educ, Key Lab Theoret & Computat Photochem, Beijing 100875, Peoples R China	Beijing Normal University	Wang, Y (corresponding author), Beijing Normal Univ, Coll Chem, Minist Educ, Key Lab Theoret & Computat Photochem, Beijing 100875, Peoples R China.	wangy@bnu.edu.cn; gjchen@bnu.edu.cn			National Science Foundation of China [20973024, 21073015, 21131003, 21271029]; Major State Basic Research Development Programs [2011CB808500]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Programs(National Basic Research Program of China)	The authors acknowledge research support from the National Science Foundation of China (No. 20973024, 21073015, 21131003 and 21271029), the Major State Basic Research Development Programs (grant No. 2011CB808500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Andreou AZ, 2013, RNA BIOL, V10, P19, DOI 10.4161/rna.21966; Andreou AZ, 2012, METHOD ENZYMOL, V511, P75, DOI 10.1016/B978-0-12-396546-2.00004-8; Aregger R, 2009, BIOCHEMISTRY-US, V48, P10679, DOI 10.1021/bi901278p; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; BROCKLEHURST SM, 1993, PROTEIN SCI, V2, P626; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Cheatham TE, 1998, J BIOMOL STRUCT DYN, V16, P265, DOI 10.1080/07391102.1998.10508245; CHUPRINA VP, 1993, J MOL BIOL, V234, P446, DOI 10.1006/jmbi.1993.1598; Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hilbert M, 2011, NUCLEIC ACIDS RES, V39, P2260, DOI 10.1093/nar/gkq1127; Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135; Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Jaya Herlambang S, 2012, J BIOL CHEM, V03, P183; Jayaram B, 1998, J AM CHEM SOC, V120, P10629, DOI 10.1021/ja981307p; Jensen F, 2017, INTRO COMPUTATIONAL; Johnson ER, 1999, RNA, V5, P1526, DOI 10.1017/S1355838299991410; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Karow AR, 2010, J MOL BIOL, V402, P629, DOI 10.1016/j.jmb.2010.07.049; Sadiq SK, 2010, PROTEINS, V78, P2873, DOI 10.1002/prot.22806; Klostermeier D, 2011, BIOCHEM SOC T, V39, P611, DOI 10.1042/BST0390611; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KOTTALAM J, 1990, BIOPOLYMERS, V29, P1409, DOI 10.1002/bip.360291008; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; Li QY, 1999, MOL CELL BIOL, V19, P7336; Linder P, 2000, YEAST, V16, P507, DOI 10.1002/(SICI)1097-0061(200004)16:6<507::AID-YEA549>3.0.CO;2-N; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; McQuarrie D. A, 2000, STAT MECH; Nielsen KH, 2009, RNA, V15, P67, DOI 10.1261/rna.1283109; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; Peck ML, 2003, RNA, V9, P1180, DOI 10.1261/rna.2103703; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spirin AS, 2009, BIOCHEMISTRY-US, V48, P10688, DOI 10.1021/bi901379a; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Svitkin YV, 2001, RNA, V7, P1743; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Venema J, 1995, YEAST, V11, P1629, DOI 10.1002/yea.320111607; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yap KL, 2001, METHOD MOL BIOL, V173, P1	58	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86104	10.1371/journal.pone.0086104	http://dx.doi.org/10.1371/journal.pone.0086104			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465900	gold, Green Submitted, Green Published			2022-12-25	WOS:000330288000053
J	Yamashita, A; Zhao, Y; Matsuura, Y; Yamasaki, K; Moriguchi-Goto, S; Sugita, C; Iwakiri, T; Okuyama, N; Koshimoto, C; Kawai, K; Tamaki, N; Zhao, SJ; Kuge, Y; Asada, Y				Yamashita, Atsushi; Zhao, Yan; Matsuura, Yunosuke; Yamasaki, Kazuaki; Moriguchi-Goto, Sayaka; Sugita, Chihiro; Iwakiri, Takashi; Okuyama, Nozomi; Koshimoto, Chihiro; Kawai, Keiichi; Tamaki, Nagara; Zhao, Songji; Kuge, Yuji; Asada, Yujiro			Increased Metabolite Levels of Glycolysis and Pentose Phosphate Pathway in Rabbit Atherosclerotic Arteries and Hypoxic Macrophage	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; GENE-EXPRESSION; SMOOTH-MUSCLE; KETONE-BODIES; FATTY-ACIDS; GLUCOSE; GLUTAMINE; PLAQUES; INFLAMMATION; MARKERS	Aims: Inflammation and possibly hypoxia largely affect glucose utilization in atherosclerotic arteries, which could alter many metabolic systems. However, metabolic changes in atherosclerotic plaques remain unknown. The present study aims to identify changes in metabolic systems relative to glucose uptake and hypoxia in rabbit atherosclerotic arteries and cultured macrophages. Methods: Macrophage-rich or smooth muscle cell (SMC)-rich neointima was created by balloon injury in the iliac-femoral arteries of rabbits fed with a 0.5% cholesterol diet or a conventional diet. THP-1 macrophages stimulated with lipopolysaccharides (LPS) and interferon-c (INF gamma) were cultured under normoxic and hypoxic conditions. We evaluated comprehensive arterial and macrophage metabolism by performing metabolomic analyses using capillary electrophoresis-time of flight mass spectrometry. We evaluated glucose uptake and its relationship to vascular hypoxia using F-18-fluorodeoxyglucose (F-18-FDG) and pimonidazole, a marker of hypoxia. Results: The levels of many metabolites increased in the iliac-femoral arteries with macrophage-rich neointima, compared with those that were not injured and those with SMC-rich neointima (glycolysis, 4 of 9; pentose phosphate pathway, 4 of 6; tricarboxylic acid cycle, 4 of 6; nucleotides, 10 of 20). The uptake of F-18-FDG in arterial walls measured by autoradiography positively correlated with macrophage-and pimonidazole-immunopositive areas (r = 0.76, and r = 0.59 respectively; n = 69 for both; p<0.0001). Pimonidazole immunoreactivity was closely localized with the nuclear translocation of hypoxia inducible factor-1 alpha and hexokinase II expression in macrophage-rich neointima. The levels of glycolytic (8 of 8) and pentose phosphate pathway (4 of 6) metabolites increased in LPS and INF gamma stimulated macrophages under hypoxic but not normoxic condition. Plasminogen activator inhibitor-1 protein levels in the supernatant were closely associated with metabolic pathways in the macrophages. Conclusion: Infiltrative macrophages in atherosclerotic arteries might affect metabolic systems, and hypoxia but not classical activation might augment glycolytic and pentose phosphate pathways in macrophages.	[Yamashita, Atsushi; Matsuura, Yunosuke; Moriguchi-Goto, Sayaka; Sugita, Chihiro; Iwakiri, Takashi; Okuyama, Nozomi; Asada, Yujiro] Miyazaki Univ, Dept Pathol, Miyazaki, Japan; [Zhao, Yan; Yamasaki, Kazuaki; Zhao, Songji] Hokkaido Univ, Dept Tracer Kinet & Bioanal, Sapporo, Hokkaido, Japan; [Matsuura, Yunosuke; Iwakiri, Takashi] Miyazaki Univ, Fac Med, Dept Internal Med, Miyazaki, Japan; [Koshimoto, Chihiro] Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan; [Kawai, Keiichi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Hlth Sci, Kanazawa, Ishikawa 9201192, Japan; [Kawai, Keiichi] Univ Fukui, Biomed Imaging Res Ctr, Fukui 910, Japan; [Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido, Japan; [Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan	University of Miyazaki; Hokkaido University; University of Miyazaki; University of Miyazaki; Kanazawa University; University of Fukui; Hokkaido University; Hokkaido University	Asada, Y (corresponding author), Miyazaki Univ, Dept Pathol, Miyazaki, Japan.	yasada@med.miyazaki-u.ac.jp			Mitsubishi Pharma Research Foundation [23790410, 25460440, 23659573, 23390084]; Integrated Research Project for Human and Veterinary Medicine, University of Miyazaki; Ministry of Education, Culture, Sports, Science and Technology; Japanese Government; Grants-in-Aid for Scientific Research [24659558] Funding Source: KAKEN	Mitsubishi Pharma Research Foundation; Integrated Research Project for Human and Veterinary Medicine, University of Miyazaki; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported in part by Grants-in-Aid for Scientific Research in Japan (Nos. 23790410, 25460440 AY, 23659573 YK, 23390084 YA), Mitsubishi Pharma Research Foundation (AY), and Integrated Research Project for Human and Veterinary Medicine, University of Miyazaki (AY, YA), and Project for Developing Innovation Systems from the Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government (NT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; Deguchi JO, 2009, ARTERIOSCL THROM VAS, V29, P1664, DOI 10.1161/ATVBAHA.109.194043; Derlin T, 2011, J NUCL MED, V52, P1848, DOI 10.2967/jnumed.111.095869; Folco EJ, 2011, J AM COLL CARDIOL, V58, P603, DOI 10.1016/j.jacc.2011.03.044; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Hiari Nadine, 2011, Curr Cardiol Rep, V13, P43, DOI 10.1007/s11886-010-0150-5; Kawamoto R, 2006, PATHOL RES PRACT, V202, P447, DOI 10.1016/j.prp.2005.12.011; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; KUROO M, 1991, J BIOL CHEM, V266, P3768; Leppanen O, 2006, ATHEROSCLEROSIS, V188, P323, DOI 10.1016/j.atherosclerosis.2005.11.017; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LOFLAND HB, 1965, ARCH PATHOL, V80, P291; Lord RS, 2008, ALTERN MED REV, V13, P205; Matsui R, 2006, ARTERIOSCL THROM VAS, V26, P910, DOI 10.1161/01.ATV.0000205850.49390.3b; MORRISON ES, 1972, ATHEROSCLEROSIS, V16, P175, DOI 10.1016/0021-9150(72)90051-2; NEWSHOLME P, 1987, BIOCHEM J, V242, P631, DOI 10.1042/bj2420631; NEWSHOLME P, 1989, BIOCHEM J, V261, P211, DOI 10.1042/bj2610211; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; Ogawa M, 2004, J NUCL MED, V45, P1245; Parathath S, 2011, CIRC RES, V109, P1141, DOI 10.1161/CIRCRESAHA.111.246363; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; RANDALL HM, 1966, AM J PHYSIOL, V211, P493, DOI 10.1152/ajplegacy.1966.211.2.493; RUNEBERG L, 1967, ANN MED EXP BIOL FEN, V45, P428; Saluk-Juszczak J, 2010, PLATELETS, V21, P632, DOI 10.3109/09537104.2010.512210; Satomi T, 2013, J NUCL MED, V54, P999, DOI 10.2967/jnumed.112.110551; Semenza GL, 2004, J APPL PHYSIOL, V96, P1173, DOI 10.1152/japplphysiol.00770.2003; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Sugimoto M, 2010, METABOLOMICS, V6, P27, DOI 10.1007/s11306-009-0175-1; Tawakol A, 2012, J NUCL MED, V53, P141; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; WHEREAT AF, 1967, EXP MOL PATHOL, V7, P233, DOI 10.1016/0014-4800(67)90032-9; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yamashita A, 2008, HISTOL HISTOPATHOL, V23, P127, DOI 10.14670/HH-23.127; Yamashita A, 2013, CIRC J, V77, P2626, DOI 10.1253/circj.CJ-12-1463; Yamashita A, 2009, ATHEROSCLEROSIS, V206, P418, DOI 10.1016/j.atherosclerosis.2009.03.014; Yun MJ, 2001, CLIN NUCL MED, V26, P314, DOI 10.1097/00003072-200104000-00007; Zhao S, 2011, EUR J NUCL MED MOL I, V38, P1876, DOI 10.1007/s00259-011-1865-2; Zhao Y, 2011, MOL IMAGING BIOL, V13, P712, DOI 10.1007/s11307-010-0389-7	42	41	43	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86426	10.1371/journal.pone.0086426	http://dx.doi.org/10.1371/journal.pone.0086426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466087	Green Submitted, gold, Green Published			2022-12-25	WOS:000330288000095
J	Gudur, MSR; Rao, RR; Peterson, AW; Caldwell, DJ; Stegemann, JP; Deng, CX				Gudur, Madhu Sudhan Reddy; Rao, Rameshwar R.; Peterson, Alexis W.; Caldwell, David J.; Stegemann, Jan P.; Deng, Cheri X.			Noninvasive Quantification of In Vitro Osteoblastic Differentiation in 3D Engineered Tissue Constructs Using Spectral Ultrasound Imaging	PLOS ONE			English	Article							MICRO-COMPUTED TOMOGRAPHY; MESENCHYMAL STEM-CELLS; NONDESTRUCTIVE EVALUATION; BIOMATERIALS; PARAMETERS; MATRIX; LESION	Non-destructive monitoring of engineered tissues is needed for translation of these products from the lab to the clinic. In this study, non-invasive, high resolution spectral ultrasound imaging (SUSI) was used to monitor the differentiation of MC3T3 pre-osteoblasts seeded within collagen hydrogels. SUSI was used to measure the diameter, concentration and acoustic attenuation of scatterers within such constructs cultured in either control or osteogenic medium over 21 days. Conventional biochemical assays were used on parallel samples to determine DNA content and calcium deposition. Construct volume and morphology were accurately imaged using ultrasound. Cell diameter was estimated to be approximately 12.5-15.5 mm using SUSI, which corresponded well to measurements of fluorescently stained cells. The total number of cells per construct assessed by quantitation of DNA content decreased from 5.662.4610 4 at day 1 to 0.960.2610 4 at day 21. SUSI estimation of the equivalent number of acoustic scatters showed a similar decreasing trend, except at day 21 in the osteogenic samples, which showed a marked increase in both scatterer number and acoustic impedance, suggestive of mineral deposition by the differentiating MC3T3 cells. Estimation of calcium content by SUSI was 41.7611.4 mg/ml, which agreed well with the biochemical measurement of 38.7616.7 mg/ml. Color coded maps of parameter values were overlaid on B-mode images to show spatiotemporal changes in cell diameter and calcium deposition. This study demonstrates the use of non-destructive ultrasound imaging to provide quantitative information on the number and differentiated state of cells embedded within 3D engineered constructs, and therefore presents a valuable tool for longitudinal monitoring of engineered tissue development.	[Gudur, Madhu Sudhan Reddy; Rao, Rameshwar R.; Peterson, Alexis W.; Caldwell, David J.; Stegemann, Jan P.; Deng, Cheri X.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Stegemann, JP (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	jpsteg@umich.edu; cxdeng@umich.edu		Caldwell, David/0000-0002-3179-5171	National Science Foundation Graduate Research Fellowship [DGE 1256260]; National Institutes of Health [R21-AR064041]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR064041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a National Science Foundation Graduate Research Fellowship, Grant # DGE 1256260 (to RRR) http://www.nsfgrfp.org/, and by the National Institutes of Health through R21-AR064041 (to CXD and JPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320; BUTLER WB, 1984, ANAL BIOCHEM, V141, P70, DOI 10.1016/0003-2697(84)90426-3; Czarnota GJ, 1999, BRIT J CANCER, V81, P520, DOI 10.1038/sj.bjc.6690724; Czekanska EM, 2012, EUR CELLS MATER, V24, P1; Declerq HA, 2005, BIOMATERIALS, V26, P4964, DOI 10.1016/j.biomaterials.2005.01.025; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Feleppa EJ, 2008, CANCER BIOMARK, V4, P201, DOI 10.3233/CBM-2008-44-504; Fite BZ, 2011, TISSUE ENG PART C-ME, V17, P495, DOI 10.1089/ten.tec.2010.0368; Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114; Gudur M, 2012, TISSUE ENG PART C-ME, V18, P935, DOI [10.1089/ten.tec.2012.0180, 10.1089/ten.TEC.2012.0180]; Gudur MSR, 2012, IEEE T ULTRASON FERR, V59, P1687, DOI 10.1109/TUFFC.2012.2374; Han JW, 2012, MACH VISION APPL, V23, P15, DOI 10.1007/s00138-010-0275-y; Ho KY, 2013, J MAGN RESON IMAGING, V37, P237, DOI 10.1002/jmri.23749; INSANA MF, 1990, J ACOUST SOC AM, V87, P179, DOI 10.1121/1.399283; Jones AC, 2004, BIOMATERIALS, V25, P4947, DOI [10.1016/j.biomaterials.2004.01.047, 10.1016/j.biomatcrials.2004.01.047]; Kolios MC, 2002, ULTRASOUND MED BIOL, V28, P589, DOI 10.1016/S0301-5629(02)00492-1; Kreitz S, 2011, TISSUE ENG PART C-ME, V17, P1021, DOI [10.1089/ten.tec.2010.0669, 10.1089/ten.TEC.2010.0669]; Kumon RE, 2012, GASTROINTEST ENDOSC, V75, P1175, DOI 10.1016/j.gie.2012.01.039; Kumon RE, 2012, ULTRASOUND MED BIOL, V38, P626, DOI 10.1016/j.ultrasmedbio.2012.01.004; Kumon RE, 2011, ULTRASOUND MED BIOL, V37, P834, DOI 10.1016/j.ultrasmedbio.2011.01.012; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lizzi FL, 2003, PATTERN RECOGN LETT, V24, P637, DOI 10.1016/S0167-8655(02)00172-1; Lizzi FL, 1997, INT J IMAG SYST TECH, V8, P3, DOI 10.1002/(SICI)1098-1098(1997)8:1<3::AID-IMA2>3.0.CO;2-E; Lizzi FL, 1997, 1997 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1 & 2, P1109, DOI 10.1109/ULTSYM.1997.661774; LIZZI FL, 1987, IEEE T ULTRASON FERR, V34, P319, DOI 10.1109/T-UFFC.1987.26950; Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E; Nazarian A, 2008, BONE, V43, P302, DOI 10.1016/j.bone.2008.04.009; Oe K, 2010, TISSUE ENG PART C-ME, V16, P347, DOI [10.1089/ten.tec.2008.0564, 10.1089/ten.TEC.2008.0564]; Oelze ML, 2004, IEEE T MED IMAGING, V23, P764, DOI 10.1109/TMI.2004.826953; OLIVER MH, 1989, J CELL SCI, V92, P513; Qian J, 2009, AM J CARDIOL, V103, P1210, DOI 10.1016/j.amjcard.2009.01.031; Rao RR, 2013, J BIOMED MATER RES A, V101, P1531, DOI 10.1002/jbm.a.34611; Rao RR, 2012, ANGIOGENESIS, V15, P253, DOI 10.1007/s10456-012-9257-1; Siebers S, 2004, ULTRASON, P1804; Tunis AS, 2005, ULTRASOUND MED BIOL, V31, P1041, DOI 10.1016/j.ultrasmedbio.2005.04.020; Vlad RM, 2008, INT J RADIAT ONCOL, V72, P1236, DOI 10.1016/j.ijrobp.2008.07.027; Wakatsuki T, 2003, BIOPHYS CHEM, V100, P593, DOI 10.1016/S0301-4622(02)00308-3; Walker JM, 2011, ANN BIOMED ENG, V39, P2521, DOI 10.1007/s10439-011-0351-0; Yang SY, 2006, MEAS SCI TECHNOL, V17, P2001, DOI 10.1088/0957-0233/17/7/045; Zscharnack M, 2010, AM J SPORT MED, V38, P1857, DOI 10.1177/0363546510365296	40	28	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85749	10.1371/journal.pone.0085749	http://dx.doi.org/10.1371/journal.pone.0085749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465680	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100069
J	Matthijs, S; Ye, LM; Stijlemans, B; Cornelis, P; Bossuyt, F; Roelants, K				Matthijs, Severine; Ye, Lumeng; Stijlemans, Benoit; Cornelis, Pierre; Bossuyt, Franky; Roelants, Kim			Low Structural Variation in the Host-Defense Peptide Repertoire of the Dwarf Clawed Frog Hymenochirus boettgeri (Pipidae)	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; SKIN SECRETIONS; PHYLOGENETIC-RELATIONSHIPS; GLOBAL PATTERNS; XENOPUS-LAEVIS; PICKEREL FROG; EVOLUTION; DIVERSIFICATION; SILURANA; FAMILY	The skin secretion of many amphibians contains peptides that are able to kill a broad range of microorganisms (antimicrobial peptides: AMPs) and potentially play a role in innate immune defense. Similar to the toxin arsenals of various animals, amphibian AMP repertoires typically show major structural variation, and previous studies have suggested that this may be the result of diversifying selection in adaptation to a diverse spectrum of pathogens. Here we report on transcriptome analyses that indicate a very different pattern in the dwarf clawed frog H. boettgeri. Our analyses reveal a diverse set of transcripts containing two to six tandem repeats, together encoding 14 distinct peptides. Five of these have recently been identified as AMPs, while three more are shown here to potently inhibit the growth of gram-negative bacteria, including multi-drug resistant strains of the medically important Pseudomonas aeruginosa. Although the number of predicted peptides is similar to the numbers of related AMPs in Xenopus and Silurana frog species, they show significantly lower structural variation. Selection analyses confirm that, in contrast to the AMPs of other amphibians, the H. boettgeri peptides did not evolve under diversifying selection. Instead, the low sequence variation among tandem repeats resulted from purifying selection, recent duplication and/or concerted gene evolution. Our study demonstrates that defense peptide repertoires of closely related taxa, after diverging from each other, may evolve under differential selective regimes, leading to contrasting patterns of structural diversity.	[Matthijs, Severine; Bossuyt, Franky; Roelants, Kim] Vrije Univ Brussel, Dept Biol, Amphibian Evolut Lab, Brussels, Belgium; [Ye, Lumeng; Cornelis, Pierre] Vrije Univ Brussel, Dept Bioengn Sci, Microbiol Res Grp, Brussels, Belgium; [Ye, Lumeng; Cornelis, Pierre] Vrije Univ Brussel, Vlaams Inst Biotechnol, Brussels, Belgium; [Stijlemans, Benoit] Vrije Univ Brussel, Unit Cellular & Mol Immunol, Brussels, Belgium; [Stijlemans, Benoit] Vlaams Inst Biotechnol, Lab Myeloid Cell Immunol, Brussels, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Roelants, K (corresponding author), Vrije Univ Brussel, Dept Biol, Amphibian Evolut Lab, Brussels, Belgium.	kroelant@vub.ac.be	Cornelis, Pierre/H-3058-2019; Stijlemans, Benoit/AAD-9122-2021	Stijlemans, Benoit/0000-0003-0082-9751; Roelants, Kim/0000-0001-5367-5958; Ye, Lumeng/0000-0001-8337-7118; Bossuyt, Franky/0000-0001-6804-9271	Fonds voor Wetenschappelijk Onderzoek - Vlaanderen (FWO-Vlaanderen) [G.0133.08]; Vrije Universiteit Brussel [OZR1621]; European Research Council [204509]	Fonds voor Wetenschappelijk Onderzoek - Vlaanderen (FWO-Vlaanderen)(FWO); Vrije Universiteit Brussel; European Research Council(European Research Council (ERC)European Commission)	Fonds voor Wetenschappelijk Onderzoek - Vlaanderen (FWO-Vlaanderen) granted postdoctoral fellowships and research grant G.0133.08 to KR and FB. FB is supported by grant OZR1621 from Vrije Universiteit Brussel and grant 204509 (project TAPAS) from the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MF, 2001, BBA-PROTEIN STRUCT M, V1550, P81, DOI 10.1016/S0167-4838(01)00272-2; ANASTASI A, 1970, BRIT J PHARMACOL, V38, P221, DOI 10.1111/j.1476-5381.1970.tb10351.x; ARAKI K, 1973, CHEM PHARM BULL, V21, P2801; Baez AM, 2003, ZOOL J LINN SOC-LOND, V139, P439, DOI 10.1046/j.1096-3642.2003.00085.x; Basir YJ, 2000, BBA-PROTEIN STRUCT M, V1543, P95, DOI 10.1016/S0167-4838(00)00191-6; BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; Bewick AJ, 2012, SYST BIOL, V61, P913, DOI 10.1093/sysbio/sys039; Bowie JH, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P283, DOI 10.1016/B978-012369442-3/50046-5; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; CANNATELLA DC, 1993, SYST BIOL, V42, P476, DOI 10.2307/2992485; Chuang TJ, 2012, P NATL ACAD SCI USA, V109, P15841, DOI 10.1073/pnas.1208214109; Conlon JM, 2008, PEPTIDES, V29, P1815, DOI 10.1016/j.peptides.2008.05.029; Conlon JM, 2008, PEPTIDES, V29, P1631, DOI 10.1016/j.peptides.2008.04.016; Conlon JM, 2013, COMP BIOCHEM PHYS D, V8, P352, DOI 10.1016/j.cbd.2013.10.002; Conlon JM, 2012, PEPTIDES, V37, P113, DOI 10.1016/j.peptides.2012.07.005; Conlon JM, 2012, GEN COMP ENDOCR, V176, P513, DOI 10.1016/j.ygcen.2011.10.010; Conlon JM, 2011, CELL MOL LIFE SCI, V68, P2303, DOI 10.1007/s00018-011-0720-8; Conlon JM, 2011, COMP BIOCHEM PHYS C, V153, P350, DOI 10.1016/j.cbpc.2010.12.007; Conlon JM, 2010, PEPTIDES, V31, P989, DOI 10.1016/j.peptides.2010.03.002; Conlon JM, 2009, ANN NY ACAD SCI, V1163, P75, DOI 10.1111/j.1749-6632.2008.03618.x; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DESA RO, 1990, MOL BIOL EVOL, V7, P365; Duda TF, 2002, MOL BIOL EVOL, V19, P858, DOI 10.1093/oxfordjournals.molbev.a004143; Ezawa K, 2010, MOL BIOL EVOL, V27, P2152, DOI 10.1093/molbev/msq109; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Hirakata Y, 2002, J EXP MED, V196, P109, DOI 10.1084/jem.20020005; HOFFMANN W, 1983, EMBO J, V2, P711, DOI 10.1002/j.1460-2075.1983.tb01489.x; Irisarri I, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-114; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Konig E, 2012, TOXICON, V60, P967, DOI 10.1016/j.toxicon.2012.06.015; Kozminsky-Atias A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-333; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Li L, 2003, PEPTIDES, V24, P863, DOI 10.1016/S0196-9781(03)00166-9; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Maglia AM, 2001, AM ZOOL, V41, P538, DOI 10.1668/0003-1569(2001)041[0538:CDOAUP]2.0.CO;2; McCrudden CM, 2007, PEPTIDES, V28, P1275, DOI 10.1016/j.peptides.2007.03.019; Mechkarska M, 2012, PEPTIDES, V35, P269, DOI 10.1016/j.peptides.2012.03.029; Mechkarska M, 2011, PEPTIDES, V32, P1502, DOI 10.1016/j.peptides.2011.05.025; Mechkarska M, 2011, COMP BIOCHEM PHYS D, V6, P206, DOI 10.1016/j.cbd.2011.03.003; Mechkarska M, 2010, COMP BIOCHEM PHYS C, V152, P467, DOI 10.1016/j.cbpc.2010.07.007; Moran Y, 2008, MOL BIOL EVOL, V25, P737, DOI 10.1093/molbev/msn021; Morita Y, 2012, MICROBIOL-SGM, V158, P1071, DOI 10.1099/mic.0.054320-0; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pugener LA, 2003, ZOOL J LINN SOC-LOND, V139, P129, DOI 10.1046/j.1096-3642.2003.00075.x; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rambaut A., 2007, TRACER V1 5; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Roelants K, 2005, SYST BIOL, V54, P111, DOI 10.1080/10635150590905894; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Roelants K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003662; Roelants K, 2010, CURR BIOL, V20, P125, DOI 10.1016/j.cub.2009.11.015; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roy PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008842; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; THOMAS EO, 1993, COPEIA, P133, DOI 10.2307/1446304; Tossi A, 2002, PEPTIDES 2002, P416; Vanhoye D, 2003, EUR J BIOCHEM, V270, P2068, DOI 10.1046/j.1432-1033.2003.03584.x; Warnecke T, 2007, MOL BIOL EVOL, V24, P2755, DOI 10.1093/molbev/msm210; Warnecke T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000250; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wiens JJ, 2007, AM NAT, V170, pS86, DOI 10.1086/519396; Wiens JJ, 2011, EVOLUTION, V65, P1283, DOI 10.1111/j.1558-5646.2011.01221.x; Yang XW, 2012, J PROTEOME RES, V11, P306, DOI 10.1021/pr200782u; Zahid OK, 2011, GEN COMP ENDOCR, V172, P314, DOI 10.1016/j.ygcen.2011.03.022; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhou T, 2010, MOL BIOL EVOL, V27, P1912, DOI 10.1093/molbev/msq077	70	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86339	10.1371/journal.pone.0086339	http://dx.doi.org/10.1371/journal.pone.0086339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466037	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100141
J	Ogawa, D; Eguchi, J; Wada, J; Terami, N; Hatanaka, T; Tachibana, H; Nakatsuka, A; Horiguchi, CS; Nishii, N; Makino, H				Ogawa, Daisuke; Eguchi, Jun; Wada, Jun; Terami, Naoto; Hatanaka, Takashi; Tachibana, Hiromi; Nakatsuka, Atsuko; Horiguchi, Chikage Sato; Nishii, Naoko; Makino, Hirofumi			Nuclear Hormone Receptor Expression in Mouse Kidney and Renal Cell Lines	PLOS ONE			English	Article							PPAR-ALPHA AGONIST; DIABETIC-NEPHROPATHY; ERR-ALPHA; INFLAMMATION; ACTIVATION; MICE; FENOFIBRATE; PROTEINURIA; METABOLISM; FIBROSIS	Nuclear hormone receptors (NHRs) are transcription factors that regulate carbohydrate and lipid metabolism, immune responses, and inflammation. Although several NHRs, including peroxisome proliferator-activated receptor-gamma (PPAR gamma) and PPAR alpha, demonstrate a renoprotective effect in the context of diabetic nephropathy (DN), the expression and role of other NHRs in the kidney are still unrecognized. To investigate potential roles of NHRs in the biology of the kidney, we used quantitative real-time polymerase chain reaction to profile the expression of all 49 members of the mouse NHR superfamily in mouse kidney tissue (C57BL/6 and db/m), and cell lines of mesangial (MES13), podocyte (MPC), proximal tubular epithelial (mProx24) and collecting duct (mIMCD3) origins in both normal and high-glucose conditions. In C57BL/6 mouse kidney cells, hepatocyte nuclear factor 4 alpha, chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) and COUP-TFIII were highly expressed. During hyperglycemia, the expression of the NHR 4A subgroup including neuron-derived clone 77 (Nur77), nuclear receptor-related factor 1, and neuron-derived orphan receptor 1 significantly increased in diabetic C57BL/6 and db/db mice. In renal cell lines, PPAR delta was highly expressed in mesangial and proximal tubular epithelial cells, while COUP-TFs were highly expressed in podocytes, proximal tubular epithelial cells, and collecting duct cells. High-glucose conditions increased the expression of Nur77 in mesangial and collecting duct cells, and liver x receptor alpha in podocytes. These data demonstrate NHR expression in mouse kidney cells and cultured renal cell lines and suggest potential therapeutic targets in the kidney for the treatment of DN.	[Ogawa, Daisuke; Eguchi, Jun; Wada, Jun; Terami, Naoto; Hatanaka, Takashi; Tachibana, Hiromi; Nakatsuka, Atsuko; Horiguchi, Chikage Sato; Nishii, Naoko; Makino, Hirofumi] Okayama Univ Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama, Japan; [Ogawa, Daisuke; Nakatsuka, Atsuko] Okayama Univ Grad Sch Med Dent & Pharmaceut Sci, Dept Diabet Nephropathy, Okayama, Japan	Okayama University; Okayama University	Ogawa, D (corresponding author), Okayama Univ Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama, Japan.	daiogawa@md.okayama-u.ac.jp	Wada, Jun/B-2023-2011	Wada, Jun/0000-0003-1468-5170	Ministry of Education, Culture, Sports, Science and Technology, Japan [25461223, 24790927]; Ministry of Health, Labour and Welfare of Japan; Takeda Science Foundation; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation)	This study was supported in part by Grants-in-Aid for Scientific Research (C) to Dr. Ogawa (25461223) and for Young Scientists (B) to Horiguchi (24790927) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by a Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis from the Ministry of Health, Labour and Welfare of Japan. This work also received support from the Takeda Science Foundation and the Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2010, MOL ENDOCRINOL, V24, P299, DOI 10.1210/me.2009-0114; Ansquer JC, 2009, CURR PHARM DESIGN, V15, P537, DOI 10.2174/138161209787315701; Auwerx J, 1999, CELL, V97, P161; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Catanuto P, 2009, KIDNEY INT, V75, P1194, DOI 10.1038/ki.2009.69; Chuang JC, 2008, MOL ENDOCRINOL, V22, P2353, DOI 10.1210/me.2007-0568; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Dwyer MA, 2011, MOL ENDOCRINOL, V25, P360, DOI 10.1210/me.2010-0392; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Ji R, 2012, BRIT J PHARMACOL, V166, P1033, DOI 10.1111/j.1476-5381.2011.01817.x; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kitamura S, 2003, NEPHRON EXP NEPHROL, V95, pE79, DOI 10.1159/000073675; Levi M, 2011, BBA-MOL BASIS DIS, V1812, P1061, DOI 10.1016/j.bbadis.2011.04.003; Libby P, 2007, AM J CARDIOL, V99, p27B, DOI 10.1016/j.amjcard.2006.11.004; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matsushita Y, 2011, DIABETES, V60, P960, DOI 10.2337/db10-1361; Niehof M, 2008, DIABETES, V57, P1069, DOI 10.2337/db07-1065; Ogawa D, 2011, EXP DIABETES RES, DOI 10.1155/2011/534872; Okada T, 2006, DIABETES, V55, P1666, DOI 10.2337/db05-1285; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; Park CW, 2006, KIDNEY INT, V69, P1511, DOI 10.1038/sj.ki.5000209; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pirih FQ, 2005, BIOCHEM BIOPH RES CO, V332, P494, DOI 10.1016/j.bbrc.2005.04.132; Pistrosch F, 2012, HORM METAB RES, V44, P914, DOI 10.1055/s-0032-1314836; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Sanchez-Nino MD, 2012, AM J PHYSIOL-RENAL, V302, pF647, DOI 10.1152/ajprenal.00090.2011; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Suh JM, 2006, MOL ENDOCRINOL, V20, P3412, DOI 10.1210/me.2006-0312; Susztak K, 2006, J AM SOC NEPHROL, V17, P361, DOI 10.1681/ASN.2005101109; Tachibana H, 2012, J AM SOC NEPHROL, V23, P1835, DOI 10.1681/ASN.2012010022; Tanaka Y, 2011, KIDNEY INT, V79, P871, DOI 10.1038/ki.2010.530; Teng CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026961; Tremblay AM, 2010, MOL ENDOCRINOL, V24, P22, DOI 10.1210/me.2009-0254; Wang LL, 2008, BIOCHEM J, V416, P407, DOI 10.1042/BJ20081085; Wang XXX, 2011, AM J PHYSIOL-RENAL, V300, pF801, DOI 10.1152/ajprenal.00338.2010; Wang XXX, 2010, NAT REV NEPHROL, V6, P342, DOI 10.1038/nrneph.2010.56; Wang XX, 2009, AM J PHYSIOL-RENAL, V297, pF1587, DOI 10.1152/ajprenal.00404.2009; Wang YL, 2012, J AM SOC NEPHROL, V23, P1977, DOI 10.1681/ASN.2012040383; Wu J, 2004, AM J PHYSIOL-RENAL, V287, pF886, DOI 10.1152/ajprenal.00123.2004; Yang JC, 2012, CURR OPIN NEPHROL HY, V21, P97, DOI 10.1097/MNH.0b013e32834de526; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yasuhara A, 2008, CIRCULATION, V118, P2146, DOI 10.1161/CIRCULATIONAHA.108.787259; Yu CT, 2012, DEVELOPMENT, V139, P2330, DOI 10.1242/dev.076299	45	11	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85594	10.1371/journal.pone.0085594	http://dx.doi.org/10.1371/journal.pone.0085594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465611	Green Published, gold			2022-12-25	WOS:000330283100050
J	Radhakrishnan, VM; Kojs, P; Young, G; Ramalingam, R; Jagadish, B; Mash, EA; Martinez, JD; Ghishan, FK; Kiela, PR				Radhakrishnan, Vijayababu M.; Kojs, Pawel; Young, Gavin; Ramalingam, Rajalakshmy; Jagadish, Bhumasamudram; Mash, Eugene A.; Martinez, Jesse D.; Ghishan, Fayez K.; Kiela, Pawel R.			pTyr(421) Cortactin Is Overexpressed in Colon Cancer and Is Dephosphorylated by Curcumin: Involvement of Non-Receptor Type 1 Protein Tyrosine Phosphatase (PTPN1)	PLOS ONE			English	Article							CHROMOSOME 11Q13 AMPLIFICATION; TANDEM MASS-SPECTROMETRY; RHO-FAMILY GTPASES; HEPATOCELLULAR-CARCINOMA; PHOSPHORYLATION SITES; ACTIN CYTOSKELETON; CLINICAL-TRIALS; CELL-ADHESION; INVASION; GROWTH	Cortactin (CTTN), first identified as a major substrate of the Src tyrosine kinase, actively participates in branching F-actin assembly and in cell motility and invasion. CTTN gene is amplified and its protein is overexpressed in several types of cancer. The phosphorylated form of cortactin (pTyr(421)) is required for cancer cell motility and invasion. In this study, we demonstrate that a majority of the tested primary colorectal tumor specimens show greatly enhanced expression of pTyr(421)-CTTN, but no change at the mRNA level as compared to healthy subjects, thus suggesting post-translational activation rather than gene amplification in these tumors. Curcumin (diferulolylmethane), a natural compound with promising chemopreventive and chemosensitizing effects, reduced the indirect association of cortactin with the plasma membrane protein fraction in colon adenocarcinoma cells as measured by surface biotinylation, mass spectrometry, and Western blotting. Curcumin significantly decreased the pTyr(421)-CTTN in HCT116 cells and SW480 cells, but was ineffective in HT-29 cells. Curcumin physically interacted with PTPN1 tyrosine phosphatases to increase its activity and lead to dephosphorylation of pTyr(421)-CTTN. PTPN1 inhibition eliminated the effects of curcumin on pTyr(421)-CTTN. Transduction with adenovirally-encoded CTTN increased migration of HCT116, SW480, and HT-29. Curcumin decreased migration of HCT116 and SW480 cells which highly express PTPN1, but not of HT-29 cells with significantly reduced endogenous expression of PTPN1. Curcumin significantly reduced the physical interaction of CTTN and pTyr(421)-CTTN with p120 catenin (CTNND1). Collectively, these data suggest that curcumin is an activator of PTPN1 and can reduce cell motility in colon cancer via dephosphorylation of pTyr(421)-CTTN which could be exploited for novel therapeutic approaches in colon cancer therapy based on tumor pTyr(421)-CTTN expression.	[Radhakrishnan, Vijayababu M.; Ramalingam, Rajalakshmy; Ghishan, Fayez K.; Kiela, Pawel R.] Univ Arizona, Hlth Sci Ctr, Dept Pediat, Steele Childrens Res Ctr, Tucson, AZ 85721 USA; [Kojs, Pawel] Dept Nutr Sci, Tucson, AZ USA; [Young, Gavin; Jagadish, Bhumasamudram; Mash, Eugene A.; Martinez, Jesse D.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; [Kiela, Pawel R.] Univ Arizona, Hlth Sci Ctr, Dept Immunobiol, Tucson, AZ USA; [Jagadish, Bhumasamudram; Mash, Eugene A.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA	University of Arizona; University of Arizona Health Sciences; Arizona Center Cancer Care; University of Arizona; University of Arizona; University of Arizona Health Sciences; University of Arizona	Kiela, PR (corresponding author), Univ Arizona, Hlth Sci Ctr, Dept Pediat, Steele Childrens Res Ctr, Tucson, AZ 85721 USA.	pkiela@peds.arizona.edu	Kiela, Pawel/AAF-5320-2020	Kiela, Pawel/0000-0002-0014-3517	National Institutes of Health [5 R01 DK067286]; NIH [P30 CA 23074]; NIEHS [ES006694]; NIH/NCI [CA023074]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Institutes of Health [5 R01 DK067286 to PRK and FKG]. NIH grant, P30 CA 23074 [EAM] NIEHS grant ES006694 to the Southwest Environmental Health Sciences Center (SWEHSC), NIH/NCI grant CA023074 to the Arizona Cancer Center and by the BIO5 Institute of the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Andon NL, 2002, PROTEOMICS, V2, P1156, DOI 10.1002/1615-9861(200209)2:9<1156::AID-PROT1156>3.0.CO;2-4; Angelo LS, 2013, BIOORGAN MED CHEM, V21, P932, DOI 10.1016/j.bmc.2012.12.008; Basile V, 2009, BIOCHEM PHARMACOL, V78, P1305, DOI 10.1016/j.bcp.2009.06.105; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Bringuier PP, 1996, ONCOGENE, V12, P1747; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Cheng TS, 2013, CANCER PREV RES, V6, P495, DOI 10.1158/1940-6207.CAPR-12-0293-T; Chuma M, 2004, J HEPATOL, V41, P629, DOI 10.1016/j.jhep.2004.06.018; Cooper B, 2003, J AM SOC MASS SPECTR, V14, P736, DOI 10.1016/S1044-0305(03)00125-9; Crostella L, 2001, ONCOGENE, V20, P3735, DOI 10.1038/sj.onc.1204474; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Donato RP, METHODS MOL BIOL, V763, P115; Grosheva I, 2001, J CELL SCI, V114, P695; Gupta SC, 2012, CLIN EXP PHARMACOL P, V39, P283, DOI 10.1111/j.1440-1681.2011.05648.x; Hashimoto A, PLOS ONE, V6; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Hofman P, 2008, BRIT J CANCER, V98, P956, DOI 10.1038/sj.bjc.6604245; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Ji JL, 2012, ANTI-CANCER AGENT ME, V12, P210, DOI 10.2174/187152012800228733; Kim JM, 2012, PHYTOMEDICINE, V19, P1085, DOI 10.1016/j.phymed.2012.07.002; Kim SY, 2005, BIOCHEM BIOPH RES CO, V337, P510, DOI 10.1016/j.bbrc.2005.09.079; Kuttan G, 2007, ADV EXP MED BIOL, V595, P173; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Larmonier CB, 2011, INFLAMM BOWEL DIS, V17, P503, DOI 10.1002/ibd.21391; Li YS, 2001, CANCER RES, V61, P6906; Liu J, 2005, P NATL ACAD SCI USA, V102, P1927, DOI 10.1073/pnas.0409472102; MacGrath SM, J CELL SCI, V125, P1621; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; Midura-Kiela MT, AM J PHYSL GASTROINT, V302, pG85; Mizushima H, 1997, CELL GROWTH DIFFER, V8, P979; Mo N, 2012, ASIAN PAC J CANCER P, V13, P5709, DOI 10.7314/APJCP.2012.13.11.5709; MURAKAMI H, 1980, P NATL ACAD SCI-BIOL, V77, P3464, DOI 10.1073/pnas.77.6.3464; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; OKAMURA H, 1995, J BIOL CHEM, V270, P26613, DOI 10.1074/jbc.270.44.26613; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Patel AS, 1998, ONCOGENE, V16, P3227, DOI 10.1038/sj.onc.1201850; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; SCHUURING E, 1992, ONCOGENE, V7, P355; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Shehzad A, 2013, BIOFACTORS, V39, P69, DOI 10.1002/biof.1066; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Stuible M, 2008, J BIOL CHEM, V283, P15740, DOI 10.1074/jbc.M710534200; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tsang RKY, 2012, CANCER INVEST, V30, P503, DOI 10.3109/07357907.2012.691192; vanDamme H, 1997, J BIOL CHEM, V272, P7374, DOI 10.1074/jbc.272.11.7374; Wang GC, 2009, WORLD J UROL, V27, P557, DOI 10.1007/s00345-009-0376-2; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wilbur DS, 1996, BIOCONJUGATE CHEM, V7, P689, DOI 10.1021/bc9600628; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yang CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037960; Yuan BZ, 2003, J MOL DIAGN, V5, P48, DOI 10.1016/S1525-1578(10)60451-5; ZHAN X, 1993, J BIOL CHEM, V268, P24427; ZHAN X, 1994, J BIOL CHEM, V269, P20221; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	63	24	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85796	10.1371/journal.pone.0085796	http://dx.doi.org/10.1371/journal.pone.0085796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465712	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100074
J	Tamim, S; Vo, DT; Uren, PJ; Qiao, M; Bindewald, E; Kasprzak, WK; Shapiro, BA; Nakaya, HI; Burns, SC; Araujo, PR; Nakano, I; Radek, AJ; Kuersten, S; Smith, AD; Penalva, LOF				Tamim, Saleh; Vo, Dat T.; Uren, Philip J.; Qiao, Mei; Bindewald, Eckart; Kasprzak, Wojciech K.; Shapiro, Bruce A.; Nakaya, Helder I.; Burns, Suzanne C.; Araujo, Patricia R.; Nakano, Ichiro; Radek, Agnes J.; Kuersten, Scott; Smith, Andrew D.; Penalva, Luiz O. F.			Genomic Analyses Reveal Broad Impact of miR-137 on Genes Associated with Malignant Transformation and Neuronal Differentiation in Glioblastoma Cells	PLOS ONE			English	Article							RNA-BINDING PROTEIN; MICRORNA REPLACEMENT THERAPY; EMBRYONIC STEM-CELLS; MIB1 LABELING INDEX; DOUBLECORTIN-LIKE; GLIOMA-CELLS; MESSENGER-RNAS; INTEGRATIVE ANALYSIS; TUMOR-SUPPRESSOR; UBIQUITIN LIGASE	miR-137 plays critical roles in the nervous system and tumor development; an increase in its expression is required for neuronal differentiation while its reduction is implicated in gliomagenesis. To evaluate the potential of miR-137 in glioblastoma therapy, we conducted genome-wide target mapping in glioblastoma cells by measuring the level of association between PABP and mRNAs in cells transfected with miR-137 mimics vs. controls via RIPSeq. Impact on mRNA levels was also measured by RNASeq. By combining the results of both experimental approaches, 1468 genes were found to be negatively impacted by miR-137 - among them, 595 (40%) contain miR-137 predicted sites. The most relevant targets include oncogenic proteins and key players in neurogenesis like c-KIT, YBX1, AKT2, CDC42, CDK6 and TGF beta 2. Interestingly, we observed that several identified miR-137 targets are also predicted to be regulated by miR-124, miR-128 and miR-7, which are equally implicated in neuronal differentiation and gliomagenesis. We suggest that the concomitant increase of these four miRNAs in neuronal stem cells or their repression in tumor cells could produce a robust regulatory effect with major consequences to neuronal differentiation and tumorigenesis.	[Tamim, Saleh; Vo, Dat T.; Qiao, Mei; Burns, Suzanne C.; Araujo, Patricia R.; Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Uren, Philip J.; Smith, Andrew D.] Univ So Calif, Div Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA USA; [Bindewald, Eckart; Kasprzak, Wojciech K.] SAIC Frederick Inc, Basic Sci Program, Ctr Canc Res Nanobiol Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Shapiro, Bruce A.] NCI, Ctr Canc Res, Nanobiol Program, Frederick, MD 21701 USA; [Nakaya, Helder I.] Univ Sao Paulo, Inst Pharmaceut Sci, Dept Clin Anal & Toxicol, Sao Paulo, Brazil; [Nakano, Ichiro] Ohio State Univ, Dept Neurol Surg, James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Radek, Agnes J.; Kuersten, Scott] Epicentre, Madison, WI USA; [Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade de Sao Paulo; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; University of Texas Health San Antonio	Penalva, LOF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Childrens Canc Res Inst, San Antonio, TX 78229 USA.	penalva@uthscsa.edu	Nakaya, Helder/AAF-1738-2020; Nakano, Ichiro/AAR-9562-2020; Tamim, Saleh/ABH-1777-2020; Nakano, Ichiro/F-2076-2014; Nakaya, Helder I/A-1397-2010; Smith, Andrew D./G-4104-2013	Nakaya, Helder/0000-0001-5297-9108; Nakano, Ichiro/0000-0002-0916-3207; Nakano, Ichiro/0000-0002-6734-3468; Nakaya, Helder I/0000-0001-5297-9108; Smith, Andrew D./0000-0002-3337-1970; Penalva, Luiz/0000-0003-4491-6769	National Institutes of Health [HG006015]; IIMS; CTSA (UTHSCSA); Center for Biomedical Neuroscience (CBN) (UTHSCSA); Max and Minnie Tomerlin Voelcker Fund; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of NIH, Frederick National Laboratory for Cancer Research, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC008382, P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120, KL2TR001118, UL1TR000149] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IIMS; CTSA (UTHSCSA); Center for Biomedical Neuroscience (CBN) (UTHSCSA); Max and Minnie Tomerlin Voelcker Fund; Frederick National Laboratory for Cancer Research, National Institutes of Health; Intramural Research Program of NIH, Frederick National Laboratory for Cancer Research, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health [HG006015 to A.D.S. and L.O.F.P.], IIMS and CTSA (UTHSCSA) [to L.O.F.P.], Center for Biomedical Neuroscience (CBN) (UTHSCSA) [to L.O.F.P.], and the Max and Minnie Tomerlin Voelcker Fund [to L.O.F.P.]. This project has been funded in whole or in part with Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government. This research was supported [in part] by the Intramural Research Program of NIH, Frederick National Laboratory for Cancer Research, Center for Cancer Research. Funding for open access charge: National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Ahluwalia MS, 2010, CANCER LETT, V298, P139, DOI 10.1016/j.canlet.2010.08.014; Aleskandarany MA, 2011, BREAST CANCER RES TR, V127, P591, DOI 10.1007/s10549-010-1028-3; Althoff K, 2013, INT J CANCER, V133, P1064, DOI 10.1002/ijc.28091; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt JD, 2011, J CELL BIOL, V194, P737, DOI 10.1083/jcb.201107021; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bier A, 2013, ONCOTARGET, V4, P665, DOI 10.18632/oncotarget.928; Boutz DR, 2011, J BIOL CHEM, V286, P18066, DOI 10.1074/jbc.M110.196451; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Ch'ng ES, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-251; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Chen LC, 2012, EUR J CANCER, V48, P3104, DOI 10.1016/j.ejca.2012.02.007; Chen QJ, 2011, DIGEST DIS SCI, V56, P2009, DOI 10.1007/s10620-010-1536-3; Chen XY, 2011, INVEST OPHTH VIS SCI, V52, P1193, DOI 10.1167/iovs.10-5272; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Costello JF, 1997, CANCER RES, V57, P1250; Cui Y, 2012, BRAIN RES, V1469, P1, DOI 10.1016/j.brainres.2012.06.043; Deng JP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/517172; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Emdad L, 2010, MOL CANCER THER, V9, P79, DOI 10.1158/1535-7163.MCT-09-0752; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Featherstone DE, 2011, GLIA, V59, P1351, DOI 10.1002/glia.21085; Fitzsimons CP, 2008, MOL ENDOCRINOL, V22, P248, DOI 10.1210/me.2007-0233; Fortin SP, 2012, MOL CANCER RES, V10, P958, DOI 10.1158/1541-7786.MCR-11-0616; Fotovati A, 2011, CANCER RES, V71, P5569, DOI 10.1158/0008-5472.CAN-10-2805; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao YY, 2009, MOL CANCER THER, V8, P3276, DOI 10.1158/1535-7163.MCT-09-0478; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Glazer RI, 2012, FRONT BIOSCI-LANDMRK, V17, P54, DOI 10.2741/3915; Gomes AL, 2007, CELL ONCOL, V29, P399; Gonzalez-Gomez P, 2011, MOL NEUROBIOL, V44, P235, DOI 10.1007/s12035-011-8196-y; Hau P, 2011, CURR PHARM BIOTECHNO, V12, P2150, DOI 10.2174/138920111798808347; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Henry JC, 2011, PHARM RES-DORDR, V28, P3030, DOI 10.1007/s11095-011-0548-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huveldt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056505; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; Kanemura Y, 2001, DIFFERENTIATION, V68, P141, DOI 10.1046/j.1432-0436.2001.680208.x; Kang K, 2012, J BIOL CHEM; Kelleher FC, 2012, CANCER J, V18, P132, DOI 10.1097/PPO.0b013e31824ba4df; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Kwon E., 2011, MOL PSYCHIAT; Lam PYP, 2000, BRIT J NEUROSURG, V14, P28; Langevin SM, 2011, CANCER-AM CANCER SOC, V117, P1454, DOI 10.1002/cncr.25689; Langevin SM, 2010, CARCINOGENESIS, V31, P864, DOI 10.1093/carcin/bgq051; Lee SG, 2011, CANCER RES, V71, P6514, DOI 10.1158/0008-5472.CAN-11-0782; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li B, 2012, ONCOL REP, V28, P909, DOI 10.3892/or.2012.1884; Li K.K., 2012, BRAIN PATHOL; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Milano V, 2009, MOL CANCER THER, V8, P394, DOI 10.1158/1535-7163.MCT-08-0669; Moretti F, 2012, NAT STRUCT MOL BIOL, V19, P603, DOI 10.1038/nsmb.2309; Nagamine T, 2011, J BIOCHEM, V149, P619, DOI 10.1093/jb/mvr013; Nielsen S, 1997, J NEUROSCI, V17, P171; O'Neill CJ, 2005, AM J SURG PATHOL, V29, P1034; Penalva LOF, 2004, BIOTECHNIQUES, V37, P604, DOI 10.2144/04374ST05; Perruisseau-Carrier C, 2011, MOL NEUROBIOL, V43, P215, DOI 10.1007/s12035-011-8179-z; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Pittoni P, 2011, ONCOGENE, V30, P757, DOI 10.1038/onc.2010.494; Pu PY, 2004, TUMOR BIOL, V25, P172, DOI 10.1159/000081099; Quintero A, 2006, J CLIN PATHOL, V59, P83, DOI 10.1136/jcp.2004.022939; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saaltink DJ, 2012, J COMP NEUROL, V520, P2805, DOI 10.1002/cne.23144; Sanchez-Diaz PC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-280; Schmitt A, 2006, HISTOPATHOLOGY, V49, P298, DOI 10.1111/j.1365-2559.2006.02505.x; Schneider T, 2006, J NEURO-ONCOL, V79, P61, DOI 10.1007/s11060-005-9116-7; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Senner V, 1999, J NEUROPATH EXP NEUR, V58, P795, DOI 10.1097/00005072-199908000-00002; Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37; Sharma S, 2004, APPL IMMUNOHISTO M M, V12, P290, DOI 10.1097/00129039-200412000-00002; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Song R, 2008, J EXP MED, V205, P2525, DOI 10.1084/jem.20081344; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Toda M, 2001, GLIA, V34, P1, DOI 10.1002/glia.1034; Verissimo CS, 2010, ENDOCR-RELAT CANCER, V17, P399, DOI 10.1677/ERC-09-0301; Vo DT, 2012, AM J PATHOL, V181, P1762, DOI 10.1016/j.ajpath.2012.07.031; Vo DT, 2012, MOL CANCER RES, V10, P143, DOI 10.1158/1541-7786.MCR-11-0208; Vo DT, 2011, RNA BIOL, V8, P817, DOI 10.4161/rna.8.5.16041; Warth A, 2007, J NEUROSCI RES, V85, P1336, DOI 10.1002/jnr.21224; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Yiin JJ, 2009, NEURO-ONCOLOGY, V11, P779, DOI 10.1215/15228517-2008-017; Yoo BK, 2011, PHARMACOL THERAPEUT, V130, P1, DOI 10.1016/j.pharmthera.2011.01.008; Zhang BB, 2009, INT J CANCER, V125, P585, DOI 10.1002/ijc.24314; Zhang DY, 2011, ONCOL REP, V26, P901, DOI 10.3892/or.2011.1362; Zhang JX, 2010, ONCOL REP, V24, P65, DOI 10.3892/or_00000829; Zhao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039102; ZHU X, 2012, FEBS LETT	104	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85591	10.1371/journal.pone.0085591	http://dx.doi.org/10.1371/journal.pone.0085591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465609	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100048
J	Ferre, ER; Kaliuzhna, M; Herbelin, B; Haggard, P; Blanke, O				Ferre, Elisa Raffaella; Kaliuzhna, Mariia; Herbelin, Bruno; Haggard, Patrick; Blanke, Olaf			Vestibular-Somatosensory Interactions: Effects of Passive Whole-Body Rotation on Somatosensory Detection	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; PARIETAL CORTEX; STIMULATION; MACAQUE; PERCEPTION; MODULATION; RESPONSES; MONKEYS; SYSTEM	Vestibular signals are strongly integrated with information from several other sensory modalities. For example, vestibular stimulation was reported to improve tactile detection. However, this improvement could reflect either a multimodal interaction or an indirect interaction driven by vestibular effects on spatial attention and orienting. Here we investigate whether natural vestibular activation induced by passive whole-body rotation influences tactile detection. In particular, we assessed the ability to detect faint tactile stimuli to the fingertips of the left and right hand during spatially congruent or incongruent rotations. We found that passive whole-body rotations significantly enhanced sensitivity to faint shocks, without affecting response bias. Critically, this enhancement of somatosensory sensitivity did not depend on the spatial congruency between the direction of rotation and the hand stimulated. Thus, our results support a multimodal interaction, likely in brain areas receiving both vestibular and somatosensory signals.	[Ferre, Elisa Raffaella; Haggard, Patrick] UCL, Inst Cognit Neurosci, London, England; [Kaliuzhna, Mariia; Herbelin, Bruno; Blanke, Olaf] Ecole Polytech Fed Lausanne, Brain Mind Inst, Cognit Neurosci Lab, Lausanne, Switzerland	University of London; University College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Ferre, ER (corresponding author), UCL, Inst Cognit Neurosci, London, England.	e.ferre@ucl.ac.uk		Ferre, Elisa Raffaella/0000-0002-0643-848X; herbelin, bruno/0000-0003-4570-5146; Haggard, Patrick/0000-0001-7798-793X; Kaliuzhna, Mariia/0000-0002-0954-961X	EU [257695]	EU(European Commission)	This work has been supported by EU FP7 project VERE WP1, Grant Agreement Number 257695. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLUM JHJ, 1976, EXP BRAIN RES, V26, P463; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Blanke O, 2000, J NEUROL NEUROSUR PS, V69, P553, DOI 10.1136/jnnp.69.4.553; BOTTINI G, 1995, NATURE, V376, P778, DOI 10.1038/376778a0; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; BUTTNER U, 1978, BRAIN RES, V153, P392, DOI 10.1016/0006-8993(78)90421-3; Dieterich M, 2003, CEREB CORTEX, V13, P994, DOI 10.1093/cercor/13.9.994; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Eickhoff SB, 2010, J NEUROSCI, V30, P6409, DOI 10.1523/JNEUROSCI.5664-09.2010; Emri M, 2003, J NEUROPHYSIOL, V89, P2639, DOI 10.1152/jn.00599.2002; Eulenburg PZ, 2013, NEUROIMAGE, V83, P75, DOI 10.1016/j.neuroimage.2013.06.057; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Fasold O, 2002, NEUROIMAGE, V17, P1384, DOI 10.1006/nimg.2002.1241; Ferre ER, 2013, NEUROSCI LETT, V550, P35, DOI 10.1016/j.neulet.2013.06.046; Ferre ER, 2013, CORTEX, V49, P748, DOI 10.1016/j.cortex.2012.01.012; Ferre ER, 2011, EUR J NEUROSCI, V34, P1337, DOI 10.1111/j.1460-9568.2011.07859.x; Ferre ER, 2012, BRAIN STRUCT FUNCT, V217, P859, DOI 10.1007/s00429-012-0404-7; Figliozzi F, 2005, J COGNITIVE NEUROSCI, V17, P1638, DOI 10.1162/089892905774597272; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P537; Guldin WO, 1998, TRENDS NEUROSCI, V21, P254, DOI 10.1016/S0166-2236(97)01211-3; HENN V, 1974, BRAIN RES, V71, P144, DOI 10.1016/0006-8993(74)90198-X; Jung P, 2009, J NEUROPHYSIOL, V101, P3246, DOI 10.1152/jn.91264.2008; Kerkhoff G, 2011, NEUROPSYCHOLOGIA, V49, P186, DOI 10.1016/j.neuropsychologia.2010.11.014; Lopez C, 2012, NEUROSCIENCE, V212, P159, DOI 10.1016/j.neuroscience.2012.03.028; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Macmillan NA, 1991, SIGNAL DETECTION THE; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Schmidt L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00090; VALLAR G, 1993, BRAIN, V116, P71, DOI 10.1093/brain/116.1.71; VALLAR G, 1990, CORTEX, V26, P123, DOI 10.1016/S0010-9452(13)80078-0; van Elk M, 2012, EXP BRAIN RES, V222, P219, DOI 10.1007/s00221-012-3209-2	33	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86379	10.1371/journal.pone.0086379	http://dx.doi.org/10.1371/journal.pone.0086379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466064	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500240
J	Gubern-Merida, A; Kallenberg, M; Platel, B; Mann, RM; Marti, R; Karssemeijer, N				Gubern-Merida, Albert; Kallenberg, Michiel; Platel, Bram; Mann, Ritse M.; Marti, Robert; Karssemeijer, Nico			Volumetric Breast Density Estimation from Full-Field Digital Mammograms: A Validation Study	PLOS ONE			English	Article							CANCER RISK; PARENCHYMAL PATTERNS	Objectives: To objectively evaluate automatic volumetric breast density assessment in Full-Field Digital Mammograms (FFDM) using measurements obtained from breast Magnetic Resonance Imaging (MRI). Material and Methods: A commercially available method for volumetric breast density estimation on FFDM is evaluated by comparing volume estimates obtained from 186 FFDM exams including mediolateral oblique (MLO) and cranial-caudal (CC) views to objective reference standard measurements obtained from MRI. Results: Volumetric measurements obtained from FFDM show high correlation with MRI data. Pearson's correlation coefficients of 0.93, 0.97 and 0.85 were obtained for volumetric breast density, breast volume and fibroglandular tissue volume, respectively. Conclusions: Accurate volumetric breast density assessment is feasible in Full-Field Digital Mammograms and has potential to be used in objective breast cancer risk models and personalized screening.	[Gubern-Merida, Albert; Marti, Robert] Univ Girona, Dept Comp Architecture & Technol, Girona, Spain; [Gubern-Merida, Albert; Kallenberg, Michiel; Platel, Bram; Mann, Ritse M.; Karssemeijer, Nico] Radboud Univ Nijmegen Med Ctr, Dept Radiol, Nijmegen, Netherlands	Universitat de Girona; Radboud University Nijmegen	Gubern-Merida, A (corresponding author), Univ Girona, Dept Comp Architecture & Technol, Girona, Spain.	albert.gubern@udg.edu	Mann, R.M./L-4502-2015; Platel, Bram/D-2132-2009; Karssemeijer, N./H-8058-2014; Gubern Merida, Albert/H-9781-2015; Martí, Robert/H-7917-2015	Mann, R.M./0000-0001-8111-1930; Platel, Bram/0000-0002-1936-6825; Gubern Merida, Albert/0000-0003-1648-986X; Martí, Robert/0000-0002-8080-2710	European Union [306088]; Spanish Science and Innovation grant [TIN2012-37171-C02-01]; FPU grant [AP2009-2835]	European Union(European Commission); Spanish Science and Innovation grant; FPU grant(Spanish Government)	The research leading to these results has received funding from the European Union's Seventh Framework Programme FP7 under grant agreement no 306088 and has been supported by the Spanish Science and Innovation grant nb. TIN2012-37171-C02-01. Albert Gubern-Merida holds a FPU grant AP2009-2835. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo-Proulx O, 2012, PHYS MED BIOL, V57, P7443, DOI 10.1088/0031-9155/57/22/7443; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; BYNG JW, 1994, PHYS MED BIOL, V39, P1629, DOI 10.1088/0031-9155/39/10/008; Ciatto S, 2012, BREAST, V21, P503, DOI 10.1016/j.breast.2012.01.005; D'Orsi C, 2003, BREAST IMAGING REPOR; Gubern-Merida A, 2011, MICCAI WORKSH BREAST, P73, DOI [10.1007/978-3-642-31271-7_32, DOI 10.1007/978-3-642-31271-7_32]; Gubern-Merida A, 2012, LECT NOTES COMPUT SC, V7511, P371, DOI 10.1007/978-3-642-33418-4_46; Highnam Ralph, 2012, Breast Imaging. Proceedings 11th International Workshop, IWDM 2012, P466, DOI 10.1007/978-3-642-31271-7_60; Highnam R, 1999, MAMMOGRAPHIC IMAGE A; Highnam R, 2010, LECT NOTES COMPUT SC, V6136, P342, DOI 10.1007/978-3-642-13666-5_46; Jeffreys M, 2006, BRIT J RADIOL, V79, P378, DOI 10.1259/bjr/24769358; Jeffreys M, 2010, LECT NOTES COMPUT SC, V6136, P408, DOI 10.1007/978-3-642-13666-5_55; Kallenberg MGJ, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/16/5155; Kaufhold J, 2002, MED PHYS, V29, P1867, DOI 10.1118/1.1493215; Kontos D, 2010, LECT NOTES COMPUT SC, V6136, P378; Li H, 2007, ACAD RADIOL, V14, P513, DOI 10.1016/j.acra.2007.02.003; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Ng KH, 2012, LANCET ONCOL, V13, P334, DOI 10.1016/S1470-2045(12)70093-1; Nielsen M, 2011, CANCER EPIDEMIOL, V35, P381, DOI 10.1016/j.canep.2010.10.011; Oliver A, 2010, J DIGIT IMAGING, V23, P527, DOI 10.1007/s10278-009-9217-5; Pawluczyk O, 2003, MED PHYS, V30, P352, DOI 10.1118/1.1539038; Sauber N, 2013, EUR C RAD SCI EXH; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Shepherd JA, 2011, CANCER EPIDEM BIOMAR, V20, P1473, DOI 10.1158/1055-9965.EPI-10-1150; Torrent A, 2008, LECT NOTES COMPUT SC, V5116, P9, DOI 10.1007/978-3-540-70538-3_2; Vachon CM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1829; van Engeland S, 2006, IEEE T MED IMAGING, V25, P273, DOI 10.1109/TMI.2005.862741; van Gils CH, 1998, EUR J EPIDEMIOL, V14, P315, DOI 10.1023/A:1007423824675; Wang Jeff, 2012, Breast Imaging. Proceedings 11th International Workshop, IWDM 2012, P619, DOI 10.1007/978-3-642-31271-7_80	31	102	102	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85952	10.1371/journal.pone.0085952	http://dx.doi.org/10.1371/journal.pone.0085952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465808	Green Published, gold			2022-12-25	WOS:000330244500154
J	Khurelbaatar, N; Krueger, WS; Heil, GL; Darmaa, B; Ulziimaa, D; Tserennorov, D; Baterdene, A; Anderson, BD; Gray, GC				Khurelbaatar, Nyamdavaa; Krueger, Whitney S.; Heil, Gary L.; Darmaa, Badarchiin; Ulziimaa, Daramragchaa; Tserennorov, Damdindorj; Baterdene, Ariungerel; Anderson, Benjamin D.; Gray, Gregory C.			Little Evidence of Avian or Equine Influenza Virus Infection among a Cohort of Mongolian Adults with Animal Exposures, 2010-2011	PLOS ONE			English	Article							ANTIBODIES; WATERFOWL	Avian (AIV) and equine influenza virus (EIV) have been repeatedly shown to circulate among Mongolia's migrating birds or domestic horses. In 2009, 439 Mongolian adults, many with occupational exposure to animals, were enrolled in a prospective cohort study of zoonotic influenza transmission. Sera were drawn upon enrollment and again at 12 and 24 months. Participants were contacted monthly for 24 months and queried regarding episodes of acute influenza-like illnesses (ILI). Cohort members confirmed to have acute influenza A infections, permitted respiratory swab collections which were studied with rRT-PCR for influenza A. Serologic assays were performed against equine, avian, and human influenza viruses. Over the 2 yrs of follow-up, 100 ILI investigations in the cohort were conducted. Thirty-six ILI cases (36%) were identified as influenza A infections by rRT-PCR; none yielded evidence for AIV or EIV. Serological examination of 12 mo and 24 mo annual sera revealed 37 participants had detectable antibody titers (>= 1: 10) against studied viruses during the course of study follow-up: 21 against A/Equine/Mongolia/01/2008(H3N8);4 against an avian A/Teal/Hong Kong/w3129(H6N1), 11 against an avian-like A/Hong Kong/1073/1999(H9N2), and 1 against an avian A/Migrating duck/Hong Kong/MPD268/2007(H10N4) virus. However, all such titers were <1:80 and none were statistically associated with avian or horse exposures. A number of subjects had evidence of seroconversion to zoonotic viruses, but the 4-fold titer changes were again not associated with avian or horse exposures. As elevated antibodies against seasonal influenza viruses were high during the study period, it seems likely that cross-reacting antibodies against seasonal human influenza viruses were a cause of the low-level seroreactivity against AIV or EIV. Despite the presence of AIV and EIV circulating among wild birds and horses in Mongolia, there was little evidence of AIV or EIV infection in this prospective study of Mongolians with animal exposures.	[Khurelbaatar, Nyamdavaa] Mongolian Assoc Infect Dis Researchers, Ulaanbaatar, Mongolia; [Krueger, Whitney S.; Heil, Gary L.; Anderson, Benjamin D.; Gray, Gregory C.] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA; [Krueger, Whitney S.; Heil, Gary L.; Anderson, Benjamin D.; Gray, Gregory C.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Darmaa, Badarchiin; Ulziimaa, Daramragchaa; Baterdene, Ariungerel] Minist Hlth, Natl Ctr Communicable Dis, Natl Influenza Ctr, Ulaanbaatar, Mongolia; [Tserennorov, Damdindorj] Minist Hlth, Natl Ctr Zoonot Dis, Ulaanbaatar, Mongolia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Ministry of Health Mongolia; National Center for Communicable Diseases of Mongolia; Ministry of Health Mongolia	Gray, GC (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.	gcgray@phhp.ufl.edu	Gray, Gregory C./ABF-1298-2020	Gray, Gregory/0000-0002-4628-5908	US Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program; National Institute of Allergy and Infectious Diseases [R01 AI068803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068803] Funding Source: NIH RePORTER	US Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by multiple grants from the US Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program (Dr. Gray, principal investigator) and an ARRA supplement grant from the National Institute of Allergy and Infectious Diseases (R01 AI068803-Dr. Gray) (http://www.afhsc.mil/geis, http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RH, 1967, AM J EPIDEMIOL, V86, P185, DOI 10.1093/oxfordjournals.aje.a120723; Blair PJ, 2013, J INFECT PUBLIC HEAL, V6, P69, DOI 10.1016/j.jiph.2012.11.005; Buchy P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010864; Burmaa A, 2012, INFLUENZA OTHER RESP, V6, pe97, DOI 10.1111/j.1750-2659.2012.00334.x; Gilbert M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044097; Gill JS, 2006, EMERG INFECT DIS, V12, P1284, DOI 10.3201/eid1708.060492; Gray GC, 2008, INFLUENZA OTHER RESP, V2, P61, DOI 10.1111/j.1750-2659.2008.00041.x; Ishtiaq F, 2012, J WILDLIFE DIS, V48, P768, DOI 10.7589/0090-3558-48.3.768; Jernigan DB, 2011, CLIN INFECT DIS, V52, pS36, DOI 10.1093/cid/ciq020; Kang HM, 2011, POULTRY SCI, V90, P2229, DOI 10.3382/ps.2011-01524; Kayali G, 2008, J CLIN VIROL, V43, P73, DOI 10.1016/j.jcv.2008.04.013; Kendal AP, 1982, CONCEPTS PROCEDURES; Khuntirat BP, 2011, CLIN INFECT DIS, V53, pE107, DOI 10.1093/cid/cir525; Khurelbaatar N, 2013, INFLUENZA R IN PRESS; Myers KP, 2007, CLIN INFECT DIS, V45, P4, DOI 10.1086/518579; Nukiwa-Souma N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033046; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sakoda Y, 2010, VIROLOGY, V406, P88, DOI 10.1016/j.virol.2010.07.007; Yondon M, 2013, INFLUENZA OTHER RESP	20	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85616	10.1371/journal.pone.0085616	http://dx.doi.org/10.1371/journal.pone.0085616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465622	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500083
J	Marsot, M; Rautureau, S; Dufour, B; Durand, B				Marsot, Maud; Rautureau, Severine; Dufour, Barbara; Durand, Benoit			Impact of Stakeholders Influence, Geographic Level and Risk Perception on Strategic Decisions in Simulated Foot and Mouth Disease Epizootics in France	PLOS ONE			English	Article							UK FOOT; VACCINATION; OUTBREAK; SPREAD; TRANSMISSION; EPIDEMIC; MODEL; VIRUS	Comparison of control strategies against animal infectious diseases allows determining optimal strategies according to their epidemiological and/or economic impacts. However, in real life, the choice of a control strategy does not always obey a pure economic or epidemiological rationality. The objective of this study was to analyze the choice of a foot and mouth disease (FMD) control strategy as a decision-making process in which the decision-maker is influenced by several stakeholders (government, agro-food industries, public opinion). For each of these, an indicator of epizootic impact was quantified to compare seven control strategies. We then determined how, in France, the optimal control strategy varied according to the relative weights of stakeholders and to the perception of risk by the decision-maker (risk-neutral/risk-averse). When the scope of decision was national, whatever their perception of risk and the stakeholders' weights, decision-makers chose a strategy based on vaccination. This consensus concealed marked differences between regions, which were connected with the regional breeding characteristics. Vaccination-based strategies were predominant in regions with dense cattle and swine populations, and in regions with a dense population of small ruminants, combined with a medium density of cattle and swine. These differences between regions suggested that control strategies could be usefully adapted to local breeding conditions. We then analyzed the feasibility of adaptive decision-making processes depending on the date and place where the epizootic starts, or on the evolution of the epizootic over time. The initial conditions always explained at least half of the variance of impacts, the remaining variance being attributed to the variability of epizootics evolution. However, the first weeks of this evolution explained a large part of the impacts variability. Although the predictive value of the initial conditions for determining the optimal strategy was weak, adaptive strategies changing dynamically according to the evolution of the epizootic appeared feasible.	[Marsot, Maud; Durand, Benoit] Univ Paris Est, French Agcy Food Environm & Occupat Hlth & Safety, Lab Sante Anim, Epidemiol Unit, Maisons Alfort, France; [Rautureau, Severine] Minist Agr Food Fisheries & Rural Affairs, French Gen Directorate Food DGAL, Anim Hlth Unit, Paris, France; [Dufour, Barbara] USC Anses, EPIMAI, Alfort Natl Vet Sch ENVA, Maisons Alfort, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA); Ecole Nationale Veterinaire d'Alfort (ENVA)	Durand, B (corresponding author), Univ Paris Est, French Agcy Food Environm & Occupat Hlth & Safety, Lab Sante Anim, Epidemiol Unit, Maisons Alfort, France.	benoit.durand@anses.fr	Marsot, Maud/ABF-8575-2021; Durand, Benoit/GSE-2511-2022	Marsot, Maud/0000-0002-2307-8957; Durand, Benoit/0000-0003-0669-1394				Backer J, 2009, VACCINATION FOOT AND; Backer JA, 2012, PREV VET MED, V107, P27, DOI 10.1016/j.prevetmed.2012.05.012; Barnett P, 2002, COMP IMMUNOL MICROB, V25, P345, DOI 10.1016/S0147-9571(02)00031-0; Bates TW, 2003, AM J VET RES, V64, P805, DOI 10.2460/ajvr.2003.64.805; Bates TW, 2003, AM J VET RES, V64, P195, DOI 10.2460/ajvr.2003.64.195; Bouma A, 2004, VET MICROBIOL, V98, P29, DOI 10.1016/j.vetmic.2003.10.016; Eble P, 2006, VET RES, V37, P647, DOI 10.1051/vetres:2006026; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; GARNER MG, 1995, PREV VET MED, V23, P9, DOI 10.1016/0167-5877(94)00433-J; Green DM, 2006, P ROY SOC B-BIOL SCI, V273, P2729, DOI 10.1098/rspb.2006.3648; Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960; Honhold N, 2006, IMPACT FARM GATE BIO; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kitching RP, 2005, VET J, V169, P197, DOI 10.1016/j.tvjl.2004.06.001; Kobayashi M, 2007, PREV VET MED, V79, P257, DOI 10.1016/j.prevetmed.2007.01.002; Leforban Y, 2002, REV SCI TECH OIE, V21, P549; Mahul O, 2000, PREV VET MED, V47, P23, DOI 10.1016/S0167-5877(00)00166-5; Martinez-Lopez B, 2010, PREV VET MED, V96, P19, DOI 10.1016/j.prevetmed.2010.05.015; Orton RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035089; Rautureau S, 2012, TRANSBOUND EMERG DIS, V59, P311, DOI 10.1111/j.1865-1682.2011.01271.x; Rautureau S, 2012, ANIMAL, V6, P1152, DOI 10.1017/S1751731111002631; Rautureau S, 2011, TRANSBOUND EMERG DIS, V58, P110, DOI 10.1111/j.1865-1682.2010.01187.x; Schoenbaum MA, 2003, PREV VET MED, V58, P25, DOI 10.1016/S0167-5877(03)00004-7; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Tildesley MJ, 2012, PREV VET MED, V104, P224, DOI 10.1016/j.prevetmed.2011.11.007; Tildesley MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3239, DOI 10.1098/rspb.2009.0427; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Toma B, 2002, COMP IMMUNOL MICROB, V25, P365, DOI 10.1016/S0147-9571(02)00032-2; Tomassen FHM, 2002, PREV VET MED, V54, P301, DOI 10.1016/S0167-5877(02)00053-3	29	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86323	10.1371/journal.pone.0086323	http://dx.doi.org/10.1371/journal.pone.0086323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466024	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500225
J	Van Straaten, B; Schrijvers, CTM; Van der Laan, J; Boersma, SN; Rodenburg, G; Wolf, JRLM; Van de Mheen, D				Van Straaten, Barbara; Schrijvers, Carola T. M.; Van der Laan, Jorien; Boersma, Sandra N.; Rodenburg, Gerda; Wolf, Judith R. L. M.; Van de Mheen, Dike			Intellectual Disability among Dutch Homeless People: Prevalence and Related Psychosocial Problems	PLOS ONE			English	Article							PSYCHIATRIC-ILLNESS; ALCOHOL-CONSUMPTION; SUBSTANCE USE; HEALTH-STATUS; ADULTS; DISORDERS; CHALLENGES	Background: There is a higher prevalence of intellectual disability (ID) among homeless people than in the general population. However, little is known about the additional psychosocial problems faced by homeless people with ID. We describe the prevalence of ID in a cohort of homeless people in the Netherlands, and report relationships between ID and psychosocial problems in terms of psychological distress, substance (mis) use and dependence, as well as demographic characteristics in this cohort. Methods: This cross-sectional study is part of a cohort study among homeless people in the four major cities of the Netherlands. Data were derived from 387 homeless people who were interviewed and screened for ID six months after the baseline measurement. Multivariate logistic regression analyses and x 2 tests were performed to analyze relationships between ID, psychosocial problems and demographic characteristics. Findings: Of all cohort members, 29.5% had a suspected ID. Participants with a suspected ID had a higher mean age, were more likely to be male and to fall in the lowest category of education than participants without a suspected ID. Having a suspected ID was related to general psychological distress (OR = 1.56, p<0.05), somatization (OR = 1.84, p<0.01), depression (OR = 1.58, p<0.05) and substance dependence (OR = 1.88, p<0.05). No relationships were found between a suspected ID and anxiety, regular substance use, substance misuse and primary substance of use. Conclusion: The prevalence of ID among Dutch homeless people is higher than in the general population, and is related to more psychosocial problems than among homeless people without ID. Homeless people with a suspected ID appear to be a vulnerable subgroup within the homeless population. This endorses the importance of the extra attention required for this subgroup.	[Van Straaten, Barbara; Schrijvers, Carola T. M.; Rodenburg, Gerda; Van de Mheen, Dike] Erasmus MC, Rotterdam, Netherlands; [Van Straaten, Barbara; Schrijvers, Carola T. M.; Rodenburg, Gerda; Van de Mheen, Dike] IVO Addict Res Inst, Rotterdam, Netherlands; [Van der Laan, Jorien; Boersma, Sandra N.; Wolf, Judith R. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Netherlands Ctr Social Care Res, NL-6525 ED Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	Van Straaten, B (corresponding author), Erasmus MC, Rotterdam, Netherlands.	straaten@ivo.nl	Boersma, S.N./L-4208-2015; Wolf, Judith/H-8122-2014	Boersma, S.N./0000-0002-5348-8295; Wolf, Judith/0000-0001-7106-9142; van Straaten, Barbara/0000-0002-5281-2145	Ministry of Health, Welfare and Sport	Ministry of Health, Welfare and Sport	The study was funded by the Ministry of Health, Welfare and Sport. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association on Intellectual and Developmental Disabilities, 2013, DEF INT DIS; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; [Anonymous], 1997, COMP INT DIAGN INT C; Ball SA, 2005, COMPR PSYCHIAT, V46, P371, DOI 10.1016/j.comppsych.2004.11.003; Barendregt C, 2013, SCREENEN MIDDELENGEB; Bolla KI, 2002, NEUROLOGY, V59, P1337, DOI 10.1212/01.WNL.0000031422.66442.49; Cooper SA, 2007, BRIT J PSYCHIAT, V190, P27, DOI 10.1192/bjp.bp.106.022483; Copeland J, 2001, J SUBST ABUSE TREAT, V21, P55, DOI 10.1016/S0740-5472(01)00179-9; Davis JP, 1997, AUST NZ J PSYCHIAT, V31, P232, DOI 10.3109/00048679709073826; De Beurs E., 2011, BRIEF SYMPTOM INVENT; Deb S, 2001, J INTELL DISABIL RES, V45, P495, DOI 10.1046/j.1365-2788.2001.00374.x; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Derogatis, 2001, BRIEF SYMPTOM INVENT; Derogatis L., 1994, SCL 90 R SYMPTOM CHE; Didden R, 2009, RES DEV DISABIL, V30, P927, DOI 10.1016/j.ridd.2009.01.002; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Finlay WML, 2001, PSYCHOL ASSESSMENT, V13, P319, DOI 10.1037//1040-3590.13.3.319; Green A, 2010, ALCOHOL CLIN EXP RES, V34, P443, DOI 10.1111/j.1530-0277.2009.01108.x; Hayes SC., 2000, HAYES ABILITY SCREEN; Kashner TM, 2002, ARCH GEN PSYCHIAT, V59, P938, DOI 10.1001/archpsyc.59.10.938; Kellett SC, 1999, J APPL RES INTELLECT, V12, P323, DOI 10.1111/j.1468-3148.1999.tb00088.x; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; McCaskill PA, 1998, J CLIN CHILD PSYCHOL, V27, P306, DOI 10.1207/s15374424jccp2703_7; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McGillicuddy NB, 1999, ADDICT BEHAV, V24, P869, DOI 10.1016/S0306-4603(99)00055-6; McNally RJ, 1991, HDB MENTAL RETARDATI, P413; Mercier C, 2011, J INTELL DISABIL RES, V55, P441, DOI 10.1111/j.1365-2788.2010.01366.x; Morgan VA, 2008, BRIT J PSYCHIAT, V193, P364, DOI 10.1192/bjp.bp.107.044461; Oakes PM, 2008, J INTELLECT DISABILI, V12, P325, DOI 10.1177/1744629508100496; RachBeisel J, 1999, PSYCHIATR SERV, V50, P1427, DOI 10.1176/ps.50.11.1427; Schippers GM, 2010, ADDICTION, V105, P862, DOI 10.1111/j.1360-0443.2009.02889.x; Schippers GM, 2007, MATE 2 0 HANDLEIDING; Smiley E., 2005, ADV PSYCHIAT TREAT, V11, P214, DOI [DOI 10.1192/APT.11.3.214, 10.1192/apt.11.3.214]; Spence S, 2004, J ROY SOC MED, V97, P375, DOI 10.1258/jrsm.97.8.375; Toro PA, 2007, J SOC ISSUES, V63, P505, DOI 10.1111/j.1540-4560.2007.00521.x; Tsemberis S, 2012, AM J PUBLIC HEALTH, V102, P13, DOI 10.2105/AJPH.2011.300320; Weinreb LF, 2006, AM J PUBLIC HEALTH, V96, P1444, DOI 10.2105/AJPH.2005.069310; Wullink M, 2007, J INTELL DISABIL RES, V51, P511, DOI 10.1111/j.1365-2788.2006.00917.x	38	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86112	10.1371/journal.pone.0086112	http://dx.doi.org/10.1371/journal.pone.0086112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465905	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500185
J	LeBlanc, SE; Wu, Q; Barutcu, AR; Xiao, HY; Ohkawa, Y; Imbalzano, AN				LeBlanc, Scott E.; Wu, Qiong; Barutcu, A. Rasim; Xiao, Hengyi; Ohkawa, Yasuyuki; Imbalzano, Anthony N.			The PPAR gamma Locus Makes Long-Range Chromatin Interactions with Selected Tissue-Specific Gene Loci during Adipocyte Differentiation in a Protein Kinase A Dependent Manner	PLOS ONE			English	Article							CHROMOSOME CONFORMATION CAPTURE; NUCLEAR-ORGANIZATION; TRANSCRIPTIONAL REGULATION; C/EBP-ALPHA; BETA-GENE; CELL; ADIPOGENESIS; EXPRESSION; BINDING; PPAR-GAMMA-2	Differentiation signaling results in reprogramming of cellular gene expression that leads to morphological changes and functional specialization of a precursor cell. This global change in gene expression involves temporal regulation of differentiation-specific genes that are located throughout the genome, raising the idea that genome structure may also be re-organized during cell differentiation to facilitate regulated gene expression. Using in vitro adipocyte differentiation as a model, we explored whether gene organization within the nucleus is altered upon exposure of precursor cells to signaling molecules that induce adipogenesis. The peroxisome proliferator-activated receptor gamma (PPAR gamma) nuclear hormone receptor is a master determinant of adipogenesis and is required for adipose differentiation. We utilized the chromosome conformation capture (3C) assay to determine whether the position of the PPAR gamma locus relative to other adipogenic genes is changed during differentiation. We report that the PPAR gamma 2 promoter is transiently positioned in proximity to the promoters of genes encoding adipokines and lipid droplet associated proteins at 6 hours post-differentiation, a time that precedes expression of any of these genes. In contrast, the PPAR gamma 2 promoter was not in proximity to the EF1 alpha promoter, which drives expression of a constitutively active, housekeeping gene that encodes a translation elongation factor, nor was the PPAR gamma 2 promoter in proximity to the promoter driving the expression of the C/EBP alpha regulatory protein. The formation of the long-range, intergenic interactions involving the PPAR gamma 2 promoter required the regulatory factor C/EBP beta, elevated cyclic AMP (cAMP) levels, and protein kinase A (PKA) signaling. We conclude that genome organization is dynamically remodeled in response to adipogenic signaling, and we speculate that these transient inter-genic interactions may be formed for the purposes of selecting some of the transcriptionally silent tissue-specific loci for subsequent transcriptional activation.	[LeBlanc, Scott E.; Wu, Qiong; Barutcu, A. Rasim; Xiao, Hengyi; Ohkawa, Yasuyuki; Imbalzano, Anthony N.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA; [Xiao, Hengyi] Sichuan Univ, West China Med Sch, West China Hosp, Lab Aging Res,State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Ohkawa, Yasuyuki] Kyushu Univ, Fac Med, JST CREST, Dept Adv Med Initiat, Fukuoka 812, Japan	University of Massachusetts System; University of Massachusetts Worcester; Sichuan University; Japan Science & Technology Agency (JST); Kyushu University	Imbalzano, AN (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA.	Anthony.imbalzano@umassmed.edu	Barutcu, Rasim/O-5973-2019; Ohkawa, Yasuyuki/C-4087-2016; Ohkawa, Yasuyuki/ABG-1839-2021	Barutcu, Rasim/0000-0002-4838-8695; Ohkawa, Yasuyuki/0000-0001-6440-9954; Ohkawa, Yasuyuki/0000-0001-6440-9954	National Institutes of Health [DK079239, DK084278, GM56244, F32DK082263, DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK082263, P30DK032520, R01DK084278, R21DK079239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants DK079239, DK084278 and GM56244 to ANI and F32DK082263 to SEL. ANI is a member of the UMass Medical School Diabetes and Endocrine Research Center, supported by the National Institutes of Health grant DK32520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Billyard T, 2007, BEST PRACT RES CL EN, V21, P641, DOI 10.1016/j.beem.2007.07.006; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; CHENG HC, 1986, J BIOL CHEM, V261, P989; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Cho YC, 2004, J CELL BIOCHEM, V91, P336, DOI 10.1002/jcb.10743; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Cope NF, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-204; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Falcao-Pires I, 2012, DRUG DISCOV TODAY, V17, P880, DOI 10.1016/j.drudis.2012.04.007; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Geyer PK, 2011, CURR OPIN CELL BIOL, V23, P354, DOI 10.1016/j.ceb.2011.03.002; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Harada A, 2012, EMBO J, V31, P2994, DOI 10.1038/emboj.2012.136; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kashina AS, 2004, CURR BIOL, V14, P1877, DOI 10.1016/j.cub.2004.10.003; Kocanova S, 2007, APOPTOSIS, V12, P731, DOI 10.1007/s10495-006-0016-x; Kociucka B, 2012, CYTOGENET GENOME RES, V136, P295, DOI 10.1159/000338255; Kuroda M, 2004, J CELL SCI, V117, P5897, DOI 10.1242/jcs.01508; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lamond AI, 2011, COLD SPRING HARB PER, V3; LeBlanc SE, 2012, MOL ENDOCRINOL, V26, P583, DOI 10.1210/me.2011-1162; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Naito M, 2012, HISTOCHEM CELL BIOL, V137, P235, DOI 10.1007/s00418-011-0890-3; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Papantonis A, 2011, TRANSCR-AUSTIN, V2, P41, DOI 10.4161/trns.2.1.14275; Paul A, 2008, CURR HYPERTENS REP, V10, P461, DOI 10.1007/s11906-008-0086-y; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; RUSSELL TR, 1976, P NATL ACAD SCI USA, V73, P4516, DOI 10.1073/pnas.73.12.4516; Salma N, 2006, J MOL ENDOCRINOL, V36, P139, DOI 10.1677/jme.1.01918; Schmidt SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-152; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2012, NAT PROTOC, V7, P1335, DOI 10.1038/nprot.2012.071; SIDHU RS, 1979, J BIOL CHEM, V254, P1111; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; SPIEGELMAN BM, 1980, J BIOL CHEM, V255, P8811; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Sugiyama H, 1997, J IMMUNOL, V158, P171; Szczerbal I, 2009, CHROMOSOMA, V118, P647, DOI 10.1007/s00412-009-0225-5; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tilgner K, 2009, J CELL SCI, V122, P401, DOI 10.1242/jcs.026179; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Verstraeten VLRM, 2007, CURR MED CHEM, V14, P1231; Verstraeten VLRM, 2011, HISTOCHEM CELL BIOL, V135, P251, DOI 10.1007/s00418-011-0792-4; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Xiao HY, 2011, J CELL PHYSIOL, V226, P86, DOI 10.1002/jcp.22308; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	72	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86140	10.1371/journal.pone.0086140	http://dx.doi.org/10.1371/journal.pone.0086140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465921	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500115
J	McFarland, NR; Dimant, H; Kibuuka, L; Ebrahimi-Fakhari, D; Desjardins, CA; Danzer, KM; Danzer, M; Fan, ZY; Schwarzschild, MA; Hirst, W; McLean, PJ				McFarland, Nikolaus R.; Dimant, Hemi; Kibuuka, Laura; Ebrahimi-Fakhari, Darius; Desjardins, Cody A.; Danzer, Karin M.; Danzer, Michael; Fan, Zhanyun; Schwarzschild, Michael A.; Hirst, Warren; McLean, Pamela J.			Chronic Treatment with Novel Small Molecule Hsp90 Inhibitors Rescues Striatal Dopamine Levels but Not alpha-Synuclein-Induced Neuronal Cell Loss	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; UBIQUITIN-PROTEASOME SYSTEM; RAT SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; NIGROSTRIATAL DEGENERATION; INDUCED TOXICITY; AGGREGATION; MODEL; CHAPERONES; GELDANAMYCIN	Hsp90 inhibitors such as geldanamycin potently induce Hsp70 and reduce cytotoxicity due to alpha-synuclein expression, although their use has been limited due to toxicity, brain permeability, and drug design. We recently described the effects of a novel class of potent, small molecule Hsp90 inhibitors in cells overexpressing alpha-synuclein. Screening yielded several candidate compounds that significantly reduced alpha-synuclein oligomer formation and cytotoxicity associated with Hsp70 induction. In this study we examined whether chronic treatment with candidate Hsp90 inhibitors could protect against alpha-synuclein toxicity in a rat model of parkinsonism. Rats were injected unilaterally in the substantia nigra with AAV8 expressing human alpha-synuclein and then treated with drug for approximately 8 weeks by oral gavage. Chronic treatment with SNX-0723 or the more potent, SNX-9114 failed to reduce dopaminergic toxicity in the substantia nigra compared to vehicle. However, SNX-9114 significantly increased striatal dopamine content suggesting a positive neuromodulatory effect on striatal terminals. Treatment was generally well tolerated, but higher dose SNX-0723 (6-10 mg/kg) resulted in systemic toxicity, weight loss, and early death. Although still limited by potential toxicity, Hsp90 inhibitors tested herein demonstrate oral efficacy and possible beneficial effects on dopamine production in a vertebrate model of parkinsonism that warrant further study.	[McFarland, Nikolaus R.] Univ Florida, Dept Neurol, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Dimant, Hemi; Kibuuka, Laura; Desjardins, Cody A.; Danzer, Michael; Fan, Zhanyun; Schwarzschild, Michael A.] Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Charlestown, MA USA; [Ebrahimi-Fakhari, Darius] Heidelberg Univ, Childrens Hosp, Univ Heidelberg Hosp, Div Neurol & Inherited Metab Dis, Heidelberg, Germany; [Danzer, Karin M.] Univ Ulm Klinikum, Deparment Neurol, Ulm, Germany; [Hirst, Warren] Pfizer Neurosci Res Unit, Cambridge, MA USA; [McLean, Pamela J.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	State University System of Florida; University of Florida; Harvard University; Massachusetts General Hospital; Ruprecht Karls University Heidelberg; Ulm University; Pfizer; Mayo Clinic	McFarland, NR (corresponding author), Univ Florida, Dept Neurol, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA.	nikolaus.mcfarland@neurology.ufl.edu; mclean.pamela@mayo.edu	McFarland, Nikolaus R/I-4209-2017	McFarland, Nikolaus R/0000-0002-8699-8857; Danzer, Michael A./0000-0002-4135-7263; Ebrahimi-Fakhari, Darius/0000-0002-0026-4714; Hirst, Warren/0000-0003-0389-8891; McLean, Pamela/0000-0003-4870-5715	NIH [K08-NS067024, K24NS060991, NS063963]; Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants [T32]; German National Academic Foundation (Studienstiftung des deutschen Volkes e.V.); Parkinson's Disease Foundation; DOD [W81XWH-11-1-0150]; Michael J. Fox Target Validation grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063963, K08NS067024, R01NS073740, K24NS060991] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants; German National Academic Foundation (Studienstiftung des deutschen Volkes e.V.); Parkinson's Disease Foundation; DOD(United States Department of Defense); Michael J. Fox Target Validation grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	N.R.M. is supported by NIH K08-NS067024. H.D. is supported by Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32). D.E-F. received support from the German National Academic Foundation (Studienstiftung des deutschen Volkes e.V.) and from the Parkinson's Disease Foundation. C.A.D. and M.A.S. were supported by DOD W81XWH-11-1-0150 and NIH K24NS060991. P.J.M. received support from then Michael J. Fox 2008 Target Validation grant and NIH NS063963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Chandarlapaty S, 2008, CLIN CANCER RES, V14, P240, DOI 10.1158/1078-0432.CCR-07-1667; Chen XQ, 2013, P NATL ACAD SCI USA, V110, P300, DOI 10.1073/pnas.1217296110; Chiosis G, 2006, IDRUGS, V9, P778; Chiosis G, 2006, CURR OPIN INVEST DR, V7, P534; Daniele A, 1999, NEW ENGL J MED, V341, P543, DOI 10.1056/NEJM199908123410721; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Daturpalli S, 2013, J MOL BIOL; DeTure M, 2010, CURR ALZHEIMER RES, V7, P677, DOI 10.2174/156720510793611565; Dickey Chad A., 2005, Current Alzheimer Research, V2, P231, DOI 10.2174/1567205053585927; Dimant H, 2012, NEUROSCIENTIST, V18, P589, DOI 10.1177/1073858412441372; Dong ZZ, 2005, MOL THER, V11, P80, DOI 10.1016/j.ymthe.2004.09.007; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Finkelstein DI, 2000, NEUROSCIENCE, V97, P99, DOI 10.1016/S0306-4522(00)00009-9; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Gartner EM, 2012, BREAST CANCER RES TR, V131, P933, DOI 10.1007/s10549-011-1866-7; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HORNYKIEWICZ O, 1974, LIFE SCI, V15, P1249, DOI 10.1016/0024-3205(74)90306-3; Kalia SK, 2010, CNS NEUROL DISORD-DR, V9, P741; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kon M, 2010, FEBS LETT, V584, P1399, DOI 10.1016/j.febslet.2009.12.025; Koprich JB, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-43; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; London CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027018; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; McFarland NR, 2009, J NEUROPATH EXP NEUR, V68, P515, DOI 10.1097/NEN.0b013e3181a24b53; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Neckers L, 2003, NATURE, V425, P357, DOI 10.1038/425357a; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; Shimshek DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010014; Song DD, 2000, J NEUROSCI, V20, P5102; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Tetzlaff JE, 2008, J BIOL CHEM; Ulusoy Ayse, 2010, Prog Brain Res, V184, P89, DOI 10.1016/S0079-6123(10)84005-1; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Waza M, 2006, J MOL MED, V84, P635, DOI 10.1007/s00109-006-0066-0; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WHITESELL L, 1992, CANCER RES, V52, P1721; ZIGMOND MJ, 1992, ANN NY ACAD SCI, V648, P71, DOI 10.1111/j.1749-6632.1992.tb24525.x	47	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86048	10.1371/journal.pone.0086048	http://dx.doi.org/10.1371/journal.pone.0086048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465863	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500103
J	Cornetti, L; Menegon, M; Giovine, G; Heulin, B; Vernesi, C				Cornetti, Luca; Menegon, Michele; Giovine, Giovanni; Heulin, Benoit; Vernesi, Cristiano			Mitochondrial and Nuclear DNA Survey of Zootoca vivipara across the Eastern Italian Alps: Evolutionary Relationships, Historical Demography and Conservation Implications	PLOS ONE			English	Article							OVIPAROUS POPULATIONS; BAYESIAN METHODS; PHYLOGEOGRAPHY; LACERTIDAE; LIKELIHOOD; SELECTION; SOFTWARE; SEQUENCE; DIVERGENCE; STRATEGIES	The European common lizard Zootoca vivipara exhibits reproductive bimodality, with populations being either viviparous or oviparous. In the central-eastern Italian Alps oviparous populations (Z. v. carniolica) and viviparous populations (Z. v. vivipara) partly overlap geographically. Studying the evolutionary relationship between these taxa presents an interesting opportunity to gain insight into the evolution of this trait. We aim to: i) test whether Z. v. carniolica, which is endangered, constitutes an ESU (Evolutionary Significant Unity); ii) infer mtDNA divergence time between the Z. v. carniolica clade and all the other Z. vivipara subspecies with the aid of an external calibration point; and iii) describe the phylogeographical and demographic scenarios in the area. To do so we sequenced about 200 individuals for mitochondrial variation; 64 of them were also analysed for three nuclear genes. Furthermore, we analysed the same nuclear markers in 17 individuals from the other oviparous subspecies Z. v. louislantzi and 11 individuals of Z. v. vivipara from widespread geographical origins. The mtDNA and nDNA loci that we examined supported the monophyly of Z. v. carniolica. The mtDNA-based estimate of divergence time between Z. v. carniolica and all the other subspecies indicated a separation at 4.5 Mya (95% CI 6.1-2.6), with about 5% of sequence divergence. Considering that Z. v. carniolica harbours higher genetic diversity, while Z. v. vivipara from central-eastern Alps shows a signature of recent population and spatial expansion, we argue that Z. v. carniolica represents a distinct evolutionary unit, with a presumably long-term evolutionary history of separation. Z. v. carniolica populations, occurring at higher latitudes and altitudes than insofar supposed, live in peat bogs, a seriously threatened habitat: taking into account also its evolutionary distinctness, specific conservation measures should be considered.	[Cornetti, Luca; Vernesi, Cristiano] Fdn Edmund Mach, Ctr Res & Innovat, Dept Biodivers & Mol Ecol, San Michele All Adige, Italy; [Cornetti, Luca] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Menegon, Michele] Museo Sci, Trento, Italy; [Giovine, Giovanni] Stn Sperimentale Reg Studio & Conservaz Anfibi Lo, Bergamo, Italy; [Heulin, Benoit] CNRS, UMR 6553, Stn Biol, Paimpont, France	Fondazione Edmund Mach; University of Ferrara; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Vernesi, C (corresponding author), Fdn Edmund Mach, Ctr Res & Innovat, Dept Biodivers & Mol Ecol, San Michele All Adige, Italy.	cristiano.vernesi@fmach.it		Vernesi, Cristiano/0000-0001-7534-5669	Autonomous Province of Trento (Italy)	Autonomous Province of Trento (Italy)(Autonomous Province of Trento)	This research is part of the ACE-SAP (University and Scientific Research Service regulation number 23, June 12th 2008) project funded by Autonomous Province of Trento (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albach DC, 2006, MOL ECOL, V15, P3269, DOI 10.1111/j.1365-294X.2006.02980.x; Arribas Oscar J., 2009, HERPETOZOA, V21, P123; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barata M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-167; BAUM DA, 1995, MONOG SYST BOTAN, V53, P289; Beerli P, 1996, EVOLUTION, V50, P1676, DOI 10.1111/j.1558-5646.1996.tb03939.x; BLACKBURN DG, 1994, HERPETOL J, V4, P65; Bragazza L, 2008, GLOBAL CHANGE BIOL, V14, P2688, DOI 10.1111/j.1365-2486.2008.01699.x; BRANA F., 1987, B SOC HERPETOL FR, V44, P1; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dely OG, 1984, HDB REPTILIEN AMPHIB, P362; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R., 2002, INTRO CONSERVATION G; Fu YX, 1997, GENETICS, V147, P915; Gamble T, 2008, ZOOL SCR, V37, P355, DOI 10.1111/j.1463-6409.2008.00330.x; Ghielmi Samuele, 2006, Acta Herpetologica, V1, P29; Ghielmi Samuele, 2001, Bulletin de la Societe Herpetologique de France, V98, P19; Giovine G, 1989, B GRUPPO RANA, V1, P59; Hartl DL, 2006, PRINCIPLES POPULATIO; Haubrich K, 2007, MOL ECOL, V16, P3643, DOI 10.1111/j.1365-294X.2007.03424.x; Heulin B, 2000, CR ACAD SCI III-VIE, V323, P461, DOI 10.1016/S0764-4469(00)00155-4; HEULIN B, 1988, CR ACAD SCI III-VIE, V306, P63; Heulin B., 1993, BIOGEOGRAPHICA, V69, P1; Heulin B, 2011, ECOGRAPHY, V34, P436, DOI 10.1111/j.1600-0587.2010.06540.x; Kerner A., 1870, NATURLICHEN FLOREN G; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LAC J, 1968, Zoologicke Listy, V17, P157; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindtke D, 2010, SALAMANDRA, V46, P73; Lymberakis P, 2008, SYST BIODIVERS, V6, P307, DOI 10.1017/S1477200008002727; Mayer W, 2007, MOL PHYLOGENET EVOL, V44, P1155, DOI 10.1016/j.ympev.2007.05.015; Mayer Werner, 2000, Herpetozoa, V13, P59; Mazzotti Stefano, 1993, Quaderni della Stazione di Ecologia del Civico Museo di Storia Naturale di Ferrara, V5, P1; Moore PD, 2002, ENVIRON CONSERV, V29, P3, DOI 10.1017/S0376892902000024; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nei M., 1987, MOL EVOLUTIONARY GEN; Odierna G, 2001, ECOGRAPHY, V24, P332, DOI 10.1034/j.1600-0587.2001.240311.x; Pavlicev M, 2006, J EXP BIOL B, V360B, P539; Pinho C, 2010, CONSERV GENET RESOUR, V2, P181, DOI 10.1007/s12686-009-9126-4; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Rambaut A., 2007, TRACER V1 5; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Runemark A, 2012, MOL ECOL, V21, P117, DOI 10.1111/j.1365-294X.2011.05377.x; Schonswetter P, 2002, MOL ECOL, V11, P2637, DOI 10.1046/j.1365-294X.2002.01651.x; SLATKIN M, 1991, GENETICS, V129, P555; SMITH MF, 1991, MOL BIOL EVOL, V8, P85; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Surget-Groba Y, 2006, BIOL J LINN SOC, V87, P1, DOI 10.1111/j.1095-8312.2006.00552.x; Surget-Groba Y, 2002, BIOL CONSERV, V106, P365, DOI 10.1016/S0006-3207(01)00263-4; Surget-Groba Y, 2001, MOL PHYLOGENET EVOL, V18, P449, DOI 10.1006/mpev.2000.0896; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Thiel-Egenter C, 2007, THESIS U ZURICH ZURI; Thiel-Egenter C, 2009, MOL ECOL, V18, P4495, DOI 10.1111/j.1365-294X.2009.04360.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557	62	25	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85912	10.1371/journal.pone.0085912	http://dx.doi.org/10.1371/journal.pone.0085912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465784	Green Published, gold			2022-12-25	WOS:000330237000075
J	Bluml, S; Wisnowski, JL; Nelson, MD; Paquette, L; Panigrahy, A				Blueml, Stefan; Wisnowski, Jessica L.; Nelson, Marvin D., Jr.; Paquette, Lisa; Panigrahy, Ashok			Metabolic Maturation of White Matter Is Altered in Preterm Infants	PLOS ONE			English	Article							NERVOUS-SYSTEM MYELINATION; HUMAN BRAIN; PERIVENTRICULAR LEUKOMALACIA; NEURODEVELOPMENTAL OUTCOMES; ABSOLUTE QUANTITATION; WATER; TERM; INJURY; RELAXOMETRY; RELAXATION	Significant physiological switches occur at birth such as the transition from fetal parallel blood flow to a two-circuit serial system with increased arterial oxygenation of blood delivered to all organs including the brain. In addition, the extra-uterine environment exposes premature infants to a host of stimuli. These events could conceivably alter the trajectory of brain development in premature infants. We used in vivo magnetic resonance spectroscopy to measure absolute brain metabolite concentrations in term and premature-born infants without evidence of brain injury at equivalent post-conceptional age. Prematurity altered the developmental time courses of N-acetyl-aspartate, a marker for axonal and neuronal development, creatine, an energy metabolite, and choline, a membrane metabolite, in parietal white matter. Specifically, at term-equivalency, metabolic maturation in preterm infants preceded development in term infants, but then progressed at a slower pace and trajectories merged at approximate to 340-370 post-conceptional days. In parieto/occipital grey matter similar trends were noticed but statistical significance was not reached. The timing of white matter development and synchronization of white matter and grey matter maturation in premature-born infants is disturbed. This may contribute to the greater risk of long-term neurological problems of premature infants and to their higher risk for white matter injury.	[Blueml, Stefan; Wisnowski, Jessica L.; Nelson, Marvin D., Jr.; Panigrahy, Ashok] Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA; [Paquette, Lisa] Childrens Hosp Los Angeles, Div Neonatol, Los Angeles, CA 90027 USA; [Wisnowski, Jessica L.] USC, Dornsife Cognit Neurosci Imaging Ctr, Los Angeles, CA USA; [Blueml, Stefan] Rudi Schulte Res Inst, Santa Barbara, CA USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California	Bluml, S (corresponding author), Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA.	sbluml@chla.usc.edu		Bluml, Stefan/0000-0003-2124-797X	Rudi Schulte Research Institute; National Institutes of Health [K23NS063371, 1UL1RR031986, P50NS019632]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS063371, P50NS019632] Funding Source: NIH RePORTER	Rudi Schulte Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Rudi Schulte Research Institute (SB), National Institutes of Health (K23NS063371 to AP, 1UL1RR031986 to AP, JLW, LP, and P50NS019632 to JLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als H, 2004, PEDIATRICS, V113, P846, DOI 10.1542/peds.113.4.846; Ball G, 2013, P NATL ACAD SCI USA, V110, P9541, DOI 10.1073/pnas.1301652110; BANKER BQ, 1962, ARCH NEUROL-CHICAGO, V7, P386, DOI 10.1001/archneur.1962.04210050022004; Bluml S, 1999, MAGNET RESON MED, V42, P643, DOI 10.1002/(SICI)1522-2594(199910)42:4<643::AID-MRM5>3.0.CO;2-N; Bluml S, 2012, CEREB CORTEX; Boardman JP, 2007, ANN NEUROL, V62, P185, DOI 10.1002/ana.21171; BRODY BA, 1987, J NEUROPATH EXP NEUR, V46, P283, DOI 10.1097/00005072-198705000-00005; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Folkerth RD, 2004, J NEUROPATH EXP NEUR, V63, P990, DOI 10.1093/jnen/63.9.990; Gimenez M, 2008, NEUROIMAGE, V41, P728, DOI 10.1016/j.neuroimage.2008.02.029; Hintz SR, 2011, PEDIATRICS, V127, P62, DOI 10.1542/peds.2010-1150; Huppi PS, 1996, PEDIATR RES, V39, P895; Huppi PS, 1998, PEDIATR RES, V44, P584; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Kapellou O, 2006, PLOS MED, V3, P1382, DOI 10.1371/journal.pmed.0030265; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; KOENIG SH, 1990, MAGNET RESON MED, V14, P482, DOI 10.1002/mrm.1910140306; KREIS R, 1993, J MAGN RESON SER B, V102, P9, DOI 10.1006/jmrb.1993.1056; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Lentner C, 1981, GEIGY SCI TABLES, p[220, 222, 223]; Leppert IR, 2009, J MAGN RESON IMAGING, V29, P258, DOI 10.1002/jmri.21646; Matsumae M, 2001, MECH AGEING DEV, V122, P1281, DOI 10.1016/S0047-6374(01)00265-2; Mewes AUJ, 2006, PEDIATRICS, V118, P23, DOI 10.1542/peds.2005-2675; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019; Riddle A, 2012, STROKE, V43, P178, DOI 10.1161/STROKEAHA.111.632265; Ross BD, 1999, NEUROIMAGING, P727; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Shestov AA, 2007, J NEUROSCI RES, V85, P3294, DOI 10.1002/jnr.21269; Sulyok E, 2001, BIOL NEONATE, V79, P67, DOI 10.1159/000047068; Vinall J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004666; Viola A, 2011, AM J NEURORADIOL, V32, P1451, DOI 10.3174/ajnr.A2555; Walker J B, 1979, Adv Enzymol Relat Areas Mol Biol, V50, P177; Wisnowski JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056880; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	43	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85829	10.1371/journal.pone.0085829	http://dx.doi.org/10.1371/journal.pone.0085829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465731	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100079
J	Ebeling, S; Naumann, K; Pollok, S; Wardecki, T; Vidal-y-Sy, S; Nascimento, JM; Boerries, M; Schmidt, G; Brandner, JM; Merfort, I				Ebeling, Sandra; Naumann, Katrin; Pollok, Simone; Wardecki, Tina; Vidal-y-Sy, Sabine; Nascimento, Juliana M.; Boerries, Melanie; Schmidt, Gudula; Brandner, Johanna M.; Merfort, Irmgard			From a Traditional Medicinal Plant to a Rational Drug: Understanding the Clinically Proven Wound Healing Efficacy of Birch Bark Extract	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SELECTIVE CYCLOOXYGENASE-2 INHIBITION; MESSENGER-RNA; RHO-GTPASES; ACTIN CYTOSKELETON; COX-2 EXPRESSION; BINDING PROTEINS; CELL-MIGRATION; BETULINIC ACID; P38	Background: Birch bark has a long lasting history as a traditional medicinal remedy to accelerate wound healing. Recently, the efficacy of birch bark preparations has also been proven clinically. As active principle pentacyclic triterpenes are generally accepted. Here, we report a comprehensive study on the underlying molecular mechanisms of the wound healing properties of a well-defined birch bark preparation named as TE (triterpene extract) as well as the isolated single triterpenes in human primary keratinocytes and porcine ex-vivo wound healing models. Methodology/Principal Findings: We show positive wound healing effects of TE and betulin in scratch assay experiments with primary human keratinocytes and in a porcine ex-vivo wound healing model (WHM). Mechanistical studies elucidate that TE and betulin transiently upregulate pro-inflammatory cytokines, chemokines and cyclooxygenase-2 on gene and protein level. For COX-2 and IL-6 this increase of mRNA is due to an mRNA stabilizing effect of TE and betulin, a process in which p38 MAPK and HuR are involved. TE promotes keratinocyte migration, putatively by increasing the formation of actin filopodia, lamellipodia and stress fibers. Detailed analyses show that the TE components betulin, lupeol and erythrodiol exert this effect even in nanomolar concentrations. Targeting the actin cytoskeleton is dependent on the activation of Rho GTPases. Conclusion/Significance: Our results provide insights to understand the molecular mechanism of the clinically proven wound healing effect of birch bark. TE and betulin address the inflammatory phase of wound healing by transient up-regulation of several pro-inflammatory mediators. Further, they enhance migration of keratinocytes, which is essential in the second phase of wound healing. Our results, together with the clinically proven efficacy, identify birch bark as the first medical plant with a high potential to improve wound healing, a field which urgently needs effective remedies.	[Ebeling, Sandra; Naumann, Katrin; Wardecki, Tina; Merfort, Irmgard] Univ Freiburg, D-79106 Freiburg, Germany; [Pollok, Simone; Vidal-y-Sy, Sabine; Brandner, Johanna M.] Univ Hosp Hamburg Eppendorf, Dept Dermatol & Venerol, Hamburg, Germany; [Schmidt, Gudula] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79106 Freiburg, Germany; [Nascimento, Juliana M.; Boerries, Melanie] Univ Freiburg, Inst Mol Med & Cell Res, D-79106 Freiburg, Germany; [Nascimento, Juliana M.; Boerries, Melanie] German Canc Consortium DKTK, Heidelberg, Germany; [Boerries, Melanie] German Canc Res Ctr, Heidelberg, Germany	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Merfort, I (corresponding author), Univ Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany.	Irmgard.Merfort@pharmazie.uni-freiburg.de	Nascimento, Juliana M/B-8764-2009; Boerries, Melanie/AAM-2602-2021	Nascimento, Juliana M/0000-0003-3126-4984; 	Aif; Birken AG; Albert-Ludwigs-University Freiburg	Aif; Birken AG; Albert-Ludwigs-University Freiburg	This study was funded by Aif and Birken AG. The article processing charge was funded by the open access publication fund of the Albert-Ludwigs-University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ghouleh I, 2012, SHOCK, V37, P433, DOI 10.1097/SHK.0b013e31824582e6; Ashcroft GS, 1999, MICROBES INFECT, V1, P1275, DOI 10.1016/S1286-4579(99)00257-9; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Behm B, 2012, J EUR ACAD DERMATOL, V26, P812, DOI 10.1111/j.1468-3083.2011.04415.x; Biname F, 2010, MOL BIOSYST, V6, P648, DOI 10.1039/b915591k; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Blomme EAG, 2003, BRIT J DERMATOL, V148, P211, DOI 10.1046/j.1365-2133.2003.05065.x; Busch H, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.36; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Di Mari JF, 2007, AM J PHYSIOL-GASTR L, V293, pG719, DOI 10.1152/ajpgi.00117.2007; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; Fernandez MA, 2001, J PHARM PHARMACOL, V53, P1533, DOI 10.1211/0022357011777909; Fernau NS, 2010, J BIOL CHEM, V285, P3896, DOI 10.1074/jbc.M109.081430; FLECKENSTEIN A, 1977, ANNU REV PHARMACOL, V17, P149, DOI 10.1146/annurev.pa.17.040177.001053; Futagami A, 2002, LAB INVEST, V82, P1503, DOI 10.1097/01.LAB.0000035024.75914.39; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Geuijen CAW, 2002, MOL BIOL CELL, V13, P3845, DOI 10.1091/mbc.02-01-0601; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Goh WI, 2011, J BIOL CHEM, V286, P13681, DOI 10.1074/jbc.M110.182683; Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Hardy MM, 2003, J PHARMACOL EXP THER, V304, P959, DOI 10.1124/jpet.102.044545; Harper KA, 2008, BIOCHEM SOC T, V36, P543, DOI 10.1042/BST0360543; Hata K, 2005, J BIOCHEM, V138, P467, DOI 10.1093/jb/mvi151; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hiller K., 2010, LEXIKON ARZNEIPFLANZ; Hoffmann C, 2004, J BIOL CHEM, V279, P16026, DOI 10.1074/jbc.M313556200; Ianaro A, 2001, FEBS LETT, V508, P61, DOI 10.1016/S0014-5793(01)03035-6; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Knust Z, 2010, TOXINS, V2, P116, DOI 10.3390/toxins2010116; Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004; Kustermans G, 2008, BIOCHEM PHARMACOL, V76, P1310, DOI 10.1016/j.bcp.2008.05.028; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Laszczyk M, 2006, PLANTA MED, V72, P1389, DOI 10.1055/s-2006-951723; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Laulederkind SJF, 2002, LAB INVEST, V82, P919, DOI 10.1097/01.LAB.0000020407.98665.98; Lee JL, 2003, TOXICOL APPL PHARM, V192, P294, DOI 10.1016/S0041-008X(03)00301-6; Lee SH, 2010, MOL CELLS, V29, P311, DOI 10.1007/s10059-010-0053-8; Lerm M, 1999, INFECT IMMUN, V67, P496, DOI 10.1128/IAI.67.2.496-503.1999; Liao WL, 2011, J BIOL CHEM, V286, P35499, DOI 10.1074/jbc.M111.263582; Lin YC, 2009, AM J CHINESE MED, V37, P97, DOI 10.1142/S0192415X09006606; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; MANSBRIDGE JN, 1987, J INVEST DERMATOL, V89, P253, DOI 10.1111/1523-1747.ep12471216; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; Martin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005975; Masiero L, 1999, J CELL SCI, V112, P3205; Metelmann HR, 2011, J CRANIOMAXILLOFAC S, V40, P150; Mifflin RC, 2004, MOL PHARMACOL, V65, P470, DOI 10.1124/mol.65.2.470; Muller-Decker K, 2002, J INVEST DERMATOL, V119, P1189, DOI 10.1046/j.1523-1747.2002.19501.x; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nuutila K, 2012, WOUND REPAIR REGEN, V20, P830, DOI 10.1111/j.1524-475X.2012.00831.x; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pollok S, 2011, J CELL MOL MED, V15, P861, DOI 10.1111/j.1582-4934.2010.01057.x; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; RECIO MD, 1995, PLANTA MED, V61, P9, DOI 10.1055/s-2006-957988; Reipschlaeger S., 2012, J BIOL CHEM, V287, P11183; Remick DG, 2005, CRIT CARE MED, V33, pS466, DOI 10.1097/01.CCM.0000186783.34908.18; Rennekampff HO, 2000, J SURG RES, V93, P41, DOI 10.1006/jsre.2000.5892; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; Rys-Sikora KE, 2000, AM J PHYSIOL-CELL PH, V278, pC822, DOI 10.1152/ajpcell.2000.278.4.C822; Schafer C, 2009, EXP CELL RES, V315, P1212, DOI 10.1016/j.yexcr.2008.11.008; Schafer M, 2007, ANNU REV CELL DEV BI, V23, P69, DOI 10.1146/annurev.cellbio.23.090506.123609; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schempp C, 2005, MERKURSTAB, V5, P402; Schreml S, 2010, J AM ACAD DERMATOL, V63, P866, DOI 10.1016/j.jaad.2009.10.048; Singh A, 2012, BIOINFORMATICS, V28, pI495, DOI 10.1093/bioinformatics/bts410; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Tudor C, 2009, FEBS LETT, V583, P1933, DOI 10.1016/j.febslet.2009.04.039; Vandekerckhove J, 1990, CURR OPIN CELL BIOL, V2, P41, DOI 10.1016/S0955-0674(05)80029-8; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Vockel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019740; Wang XP, 2004, J INVEST DERMATOL, V123, P124, DOI 10.1111/j.0022-202X.2004.22736.x; Weckesser S, 2010, FORSCH KOMPLEMENTMED, V17, P271, DOI 10.1159/000320592; Widgerow AD, 2012, WOUND REPAIR REGEN, V20, P2, DOI 10.1111/j.1524-475X.2011.00754.x; Wiederholt T, 2009, EXP DERMATOL, V18, P969, DOI 10.1111/j.1600-0625.2009.00884.x; Woelfle U, 2010, J INVEST DERMATOL, V130, P113, DOI 10.1038/jid.2009.248; Wojciak-Kosior M, 2011, FOLIA HISTOCHEM CYTO, V49, P664, DOI 10.5603/FHC.2011.0050; Yun YH, 2003, ARCH PHARM RES, V26, P1087, DOI 10.1007/BF02994763; Zdzisinska B, 2003, POL J PHARMACOL, V55, P235; Zhao W, 2008, J BIOL CHEM, V283, P1778, DOI 10.1074/jbc.M707573200	95	56	58	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86147	10.1371/journal.pone.0086147	http://dx.doi.org/10.1371/journal.pone.0086147			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465925	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100113
J	Han, JE; Wui, SR; Kim, KS; Cho, YJ; Cho, WJ; Lee, NG				Han, Ji Eun; Wui, Seo Ri; Kim, Kwang Sung; Cho, Yang Je; Cho, Wan Je; Lee, Na Gyong			Characterization of the Structure and Immunostimulatory Activity of a Vaccine Adjuvant, De-O-Acylated Lipooligosaccharide	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; ANTHRACIS PROTECTIVE ANTIGEN; TOLL-LIKE RECEPTOR-4; COLI DNA FRAGMENTS; ESCHERICHIA-COLI; IMMUNE-RESPONSES; MODIFIED LIPOPOLYSACCHARIDES; HPV VACCINE; RECOGNITION; ACTIVATION	Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram-negative bacteria. LPS elicits strong immunopathological responses during bacterial infection, and the lipid A moiety of LPS is responsible for this immunostimulatory activity. Lipid A exerts its biological activity by sending signals via TLR4 present on immune cells, and TLR4 agonists have been a target for vaccine adjuvant. Previously, we demonstrated an adjuvant activity of deacylated lipooligosaccharide (dLOS) to viral and bacterial antigens. In this study, we characterized the chemical structure of dLOS and evaluated its immunostimulatory activity on mouse and human immune cells in comparison with monophosphoryl lipid A (MPL). dLOS consists of a core oligosaccharide lacking the terminal glucose residue, a glucosamine disaccharide with two phosphate groups, and two N-linked acyl groups. dLOS was similar to MPL in induction of cytokine production in mouse peritoneal macrophages, but was a more potent activator in human monocytes and dendritic cells (DCs). Results of an analysis of allogeneic T cell responses revealed that dLOS induces Th1, Th2, and Th17-type immune responses in a dose-dependent manner. The immunostimulatory activities of dLOS were completely abrogated in TLR4(-/-) mice, which confirms its TLR4-dependency. These results suggest that in the presence of the core oligosaccharide, O-linked acyl groups of LPS are dispensable for activating the TLR4 signaling pathway. dLOS did not cause any pathological effects or death at 0.25, 0.5, or 1 mg per kg body weight in mice in the acute toxicity tests. This result suggests that dLOS has a low toxicity. dLOS should be considered for further development as a safe and effective adjuvant for human vaccines.	[Han, Ji Eun; Wui, Seo Ri; Lee, Na Gyong] Sejong Univ, Coll Biosci, Dept Biosci & Biotechnol, Seoul, South Korea; [Kim, Kwang Sung; Cho, Yang Je] EyeGene, Ctr Res & Dev, Seoul, South Korea; [Cho, Wan Je] Yonsei Univ, Gangnam Severance Hosp, Seoul 120749, South Korea	Sejong University; Yonsei University; Yonsei University Health System	Lee, NG (corresponding author), Sejong Univ, Coll Biosci, Dept Biosci & Biotechnol, Seoul, South Korea.	nglee@sejong.ac.kr			Transgovernmental Enterprise for Pandemic Influenza of Korea (TEPIK) [A103001]; National Research Foundation; Ministry of Science, ICT & Future Planning of Korea [2009-0074568]; Korean Health Technology R&D Project, Ministry of Health Welfare [HI13C0826]	Transgovernmental Enterprise for Pandemic Influenza of Korea (TEPIK); National Research Foundation; Ministry of Science, ICT & Future Planning of Korea; Korean Health Technology R&D Project, Ministry of Health Welfare	This study was supported by the Transgovernmental Enterprise for Pandemic Influenza of Korea (TEPIK) (grant No. A103001), the National Research Foundation funded by the Ministry of Science, ICT & Future Planning of Korea (grant No. 2009-0074568), and the Korean Health Technology R&D Project, Ministry of Health & Welfare (grant No. HI13C0826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bhattacharjee AK, 1996, J INFECT DIS, V173, P1157, DOI 10.1093/infdis/173.5.1157; Brandenburg K, 2000, EUR J BIOCHEM, V267, P3370, DOI 10.1046/j.1432-1327.2000.01370.x; Cho YJ, 2006, VACCINE, V24, P5862, DOI 10.1016/j.vaccine.2006.04.048; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Fox CB, 2010, SUBCELL BIOCHEM, V53, P303, DOI 10.1007/978-90-481-9078-2_14; Gandhapudi SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056855; Gomery K, 2012, P NATL ACAD SCI USA, V109, P20877, DOI 10.1073/pnas.1209253109; Han JE, 2012, VACCINE, V30, P4127, DOI 10.1016/j.vaccine.2012.04.079; Han JE, 2010, INT IMMUNOPHARMACOL, V10, P169, DOI 10.1016/j.intimp.2009.10.012; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Ishizaka ST, 2007, EXPERT REV VACCINES, V6, P773, DOI 10.1586/14760584.6.5.773; Johnson DA, 1999, BIOORG MED CHEM LETT, V9, P2273, DOI 10.1016/S0960-894X(99)00374-1; Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039; Kaniuk NA, 2004, J BIOL CHEM, V279, P31237, DOI 10.1074/jbc.M401879200; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kundi M, 2007, EXPERT REV VACCINES, V6, P133, DOI 10.1586/14760584.6.2.133; Kusumoto S, 2003, J ENDOTOXIN RES, V9, P361, DOI 10.1179/096805103225002737; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Muller-Loennies S, 2007, INT J MED MICROBIOL, V297, P321, DOI 10.1016/j.ijmm.2007.04.002; Muller-Loennies S, 2003, J BIOL CHEM, V278, P25618, DOI 10.1074/jbc.M302904200; Muller-Loennies S, 2002, EUR J BIOCHEM, V269, P5982, DOI 10.1046/j.1432-1033.2002.03322.x; Muroi M, 2002, INFECT IMMUN, V70, P6043, DOI 10.1128/IAI.70.11.6043-6047.2002; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Orr MT, 2013, EUR J IMMUN IN PRESS, DOI [10.1002/eji.201243124, DOI 10.1002/EJI.201243124.PUBMED:23716300]; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; QURESHI N, 1985, J BIOL CHEM, V260, P5271; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Schromm AB, 1998, J IMMUNOL, V161, P5464; Seydel U, 2000, EUR J BIOCHEM, V267, P3032; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Song ES, 2007, FEMS IMMUNOL MED MIC, V51, P496, DOI 10.1111/j.1574-695X.2007.00325.x; Stover AG, 2004, J BIOL CHEM, V279, P4440, DOI 10.1074/jbc.M310760200; WILLIAMSON SI, 1984, J IMMUNOL, V133, P2294; Wui SR, 2013, ARCH PHARM RES, V36, P464, DOI 10.1007/s12272-013-0034-5; Wui SR, 2011, INT IMMUNOPHARMACOL, V11, P1195, DOI 10.1016/j.intimp.2011.03.020; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	48	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85838	10.1371/journal.pone.0085838	http://dx.doi.org/10.1371/journal.pone.0085838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465739	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100081
J	DiBonaventura, MD; Yuan, Y; Lescrauwaet, B; L'Italien, G; Liu, GG; Kamae, I; Mauskopf, JA				DiBonaventura, Marco daCosta; Yuan, Yong; Lescrauwaet, Benedicte; L'Italien, Gilbert; Liu, Gordon G.; Kamae, Isao; Mauskopf, Josephine A.			Multicountry Burden of Chronic Hepatitis C Viral Infection among Those Aware of Their Diagnosis: A Patient Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; VIRUS-INFECTION; UNITED-STATES; IMPACT; PRODUCTIVITY; EPIDEMIOLOGY; PREDICTORS; ABSENCE; DISEASE; EUROPE	Background: The World Health Organization has called for global and regional assessments of the burden of hepatitis C (HCV) along with country-specific patient profiles to better inform healthcare policy. The present investigated the characteristics and burden of patients reporting a diagnosis of HCV infection in the US, France, Germany, Italy, Spain, the UK, urban China, and Japan using a consistent methodology of patient-reported surveys. Methods: The 2010 5EU (N = 57,805), 2009 US (N = 75,000), 2008/2009 Japan (N = 37,683), and 2009/2010 urban China (N = 33,261) waves of the National Health and Wellness Survey were used as the data source. Within each country, patients with a self-reported diagnosis of HCV were compared with those who did not report a diagnosis of HCV on sociodemographics, health behaviors, comorbidities, and health outcomes (e.g., Short Form-12v2). The effect of HCV was examined using regression analysis applying sampling weights. Results: The prevalence of HCV ranged from 0.26% (China) to 1.42% (Italy). Patients in Japan and Italy (61.60 and 61.02 years, respectively) were the oldest, while patients in the US were the most likely to be obese (39.31%) and have concomitant anxiety (38.43%) and depression (46.05%) compared with other countries. Pooling countries and adjusting for sociodemographics, health behaviors, and comorbidities, HCV was associated with significantly lower physical component summary scores (b = -22.51) and health utilities (b = -20.04) and greater overall work impairment (b = 8.79), physician visits (b = 2.91), and emergency department visits (b = 0.30) (all p<.05). The effects on health status were strongest in the US and UK while the effects on healthcare resource use were strongest in Japan. Conclusions: HCV was associated with a significant humanistic and economic burden. These results suggest that the manifestation of the HCV burden, and the profile of the patients themselves, varied dramatically by country. Successful disease management should be cognizant of region-specific unmet needs.	[DiBonaventura, Marco daCosta] Kantar Hlth, Hlth Outcomes Practice, New York, NY USA; [Yuan, Yong; L'Italien, Gilbert] Bristol Myers Squibb Co, Global Hlth Econ & Outcomes Res, Princeton, NJ USA; [Lescrauwaet, Benedicte] Xintera Consulting, Brussels, Belgium; [L'Italien, Gilbert] Yale Univ, Sch Med, New Haven, CT USA; [Liu, Gordon G.] Peking Univ, Natl Sch Dev, Beijing 100871, Peoples R China; [Kamae, Isao] Univ Tokyo, Grad Sch Publ Policy, Tokyo, Japan; [Mauskopf, Josephine A.] RTI Int, Res Triangle Pk, NC USA	Bristol-Myers Squibb; Yale University; Peking University; University of Tokyo; Research Triangle Institute	DiBonaventura, MD (corresponding author), Kantar Hlth, Hlth Outcomes Practice, New York, NY USA.	marco.dibonaventura@kantarhealth.com		Mauskopf, Josephine/0000-0002-6098-5548	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Bristol-Myers Squibb funded the analysis and manuscript preparation. YY and GL are current employees of Bristol-Myers Squibb. YY and G. L'ITALIEN (employees of the funder, Bristol-Myers Squibb) were involved in the study design, analysis interpretation, decision to publish and preparation of the manuscript.	CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cillo U, 2011, BLOOD PURIFICAT, V32, P144, DOI 10.1159/000325222; Cordoba J, 2003, J HEPATOL, V39, P231, DOI 10.1016/S0168-8278(03)00189-2; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; DiBonaventura MD, 2012, EUR J GASTROEN HEPAT, V24, P869, DOI 10.1097/MEG.0b013e3283551dee; DiBonaventura Marco daCosta, 2011, J Med Econ, V14, P253, DOI 10.3111/13696998.2011.566294; DiBonaventura Marco DaCosta, 2010, J Med Econ, V13, P709, DOI 10.3111/13696998.2010.535576; Foster GR, 1998, HEPATOLOGY, V27, P209, DOI 10.1002/hep.510270132; Grant WC, 2005, HEPATOLOGY, V42, P1406, DOI 10.1002/hep.20941; Groessl E. J., 2007, Current Hepatitis Reports, V6, P169, DOI 10.1007/s11901-007-0020-9; Hauser W, 2004, PSYCHOSOM MED, V66, P954, DOI 10.1097/01.psy.0000145824.82125.a8; Heintges T, 1997, HEPATOLOGY, V26, P521, DOI 10.1002/hep.510260338; Kang SC, 2005, WORLD J GASTROENTERO, V11, P7494, DOI 10.3748/wjg.v11.i47.7494; Kimura Tomoaki, 2004, Tokai J Exp Clin Med, V29, P135; Langley Paul C, 2011, J Med Econ, V14, P709, DOI 10.3111/13696998.2011.611201; Li D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054815; Liu GG, 2012, VALUE HEALTH, V15, pS65, DOI 10.1016/j.jval.2011.11.012; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Meffre C, 2010, J MED VIROL, V82, P546, DOI 10.1002/jmv.21734; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Seeff LB, 2002, HEPATOLOGY, V36, pS1, DOI 10.1053/jhep.2002.36992; Spiegel BMR, 2005, HEPATOLOGY, V41, P790, DOI 10.1002/hep.20659; Strauss E, 2006, LIVER INT, V26, P755, DOI 10.1111/j.1478-3231.2006.01331.x; Su J, 2010, HEPATOLOGY, V52, P436, DOI 10.1002/hep.23726; United States Census Bureau website, INT DAT BAS POP EST; Ware JE, 2002, SCORE VERSION 2 SF S; World Health Organization, PREV CONTR VIR HEP I	28	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86070	10.1371/journal.pone.0086070	http://dx.doi.org/10.1371/journal.pone.0086070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465875	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500176
J	Huang, L; Kondo, F; Harato, M; Feng, GG; Ishikawa, N; Fujiwara, Y; Okada, S				Huang, Lei; Kondo, Fumio; Harato, Misako; Feng, Guo-Gang; Ishikawa, Naoshisa; Fujiwara, Yoshihiro; Okada, Shoshiro			Enhanced Expression of WD Repeat-Containing Protein 35 via Nuclear Factor-Kappa B Activation in Bupivacaine-Treated Neuro2a Cells	PLOS ONE			English	Article							PPAR-GAMMA; C-JUN; APOPTOSIS; KINASE; AP-1; PATHWAYS; INVOLVEMENT; STRESS; DEATH	The family of WD repeat proteins comprises a large number of proteins and is involved in a wide variety of cellular processes such as signal transduction, cell growth, proliferation, and apoptosis. Bupivacaine is a sodium channel blocker administered for local infiltration, nerve block, epidural, and intrathecal anesthesia. Recently, we reported that bupivacaine induces reactive oxygen species (ROS) generation and p38 mitogen-activated protein kinase (MAPK) activation, resulting in an increase in the expression of WD repeat-containing protein 35 (WDR35) in mouse neuroblastoma Neuro2a cells. It has been shown that ROS activate MAPK through phosphorylation, followed by activation of nuclear factor-kappa B (NF-kappa B) and activator protein 1 (AP-1). The present study was undertaken to test whether NF-kappa B and c-Jun/AP-1 are involved in bupivacaine-induced WDR35 expression in Neuro2a cells. Bupivacaine activated both NF-kappa B and c-Jun in Neuro2a cells. APDC, an NF-kappa B inhibitor, attenuated the increase in NF-kappa B activity and WDR35 protein expression in bupivacaine-treated Neuro2a cells. GW9662, a selective peroxisome proliferator-activated receptor-gamma antagonist, enhanced the increase in NF-kappa B activity and WDR35 protein expression in bupivacaine-treated Neuro2a cells. In contrast, c-Jun siRNA did not inhibit the bupivacaine-induced increase in WDR35 mRNA expression. These results indicate that bupivacaine induces the activation of transcription factors NF-kappa B and c-Jun/AP-1 in Neuro2a cells, while activation of NF-kappa B is involved in bupivacaine-induced increases in WDR35 expression.	[Huang, Lei; Kondo, Fumio; Feng, Guo-Gang; Ishikawa, Naoshisa; Okada, Shoshiro] Aichi Med Univ, Sch Med, Dept Pharmacol, Nagakute, Aichi 48011, Japan; [Harato, Misako; Fujiwara, Yoshihiro] Aichi Med Univ, Sch Med, Dept Anesthesiol, Nagakute, Aichi 48011, Japan	Aichi Medical University; Aichi Medical University	Huang, L (corresponding author), Aichi Med Univ, Sch Med, Dept Pharmacol, Nagakute, Aichi 48011, Japan.	huanglei@aichi-med-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [S1101027];  [23790885]; Grants-in-Aid for Scientific Research [23592689] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (No. 23790885) and by a Strategic Research Foundation Grant-aided Project for Private Universities grant (S1101027) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu M, 2013, J ORAL PATHOL MED, V42, P491, DOI 10.1111/jop.12040; Bacino CA, 2012, AM J MED GENET A, V158A, P2917, DOI 10.1002/ajmg.a.35608; Granado-Serrano AB, 2010, BRIT J NUTR, V103, P168, DOI 10.1017/S0007114509991747; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Chun KS, 2004, CARCINOGENESIS, V25, P713, DOI 10.1093/carcin/bgh076; DAcquisto F, 1997, FEBS LETT, V418, P175, DOI 10.1016/S0014-5793(97)01377-X; Fakhfouri G, 2012, NEUROPHARMACOLOGY, V63, P653, DOI 10.1016/j.neuropharm.2012.05.013; Fan JH, 2012, HEPATOL RES, V42, P696, DOI 10.1111/j.1872-034X.2012.00972.x; Feng GG, 2010, BIOCHEM BIOPH RES CO, V394, P153, DOI 10.1016/j.bbrc.2010.02.133; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Harato M, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-149; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; Hsu TC, 2000, FREE RADICAL BIO MED, V28, P1338, DOI 10.1016/S0891-5849(00)00220-3; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kundu JK, 2006, BIOCHEM PHARMACOL, V72, P1506, DOI 10.1016/j.bcp.2006.08.005; Lepsch LB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-3; Lirk P, 2008, ANESTH ANALG, V106, P1456, DOI 10.1213/ane.0b013e318168514b; Liu ZJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/470975; Lu J, 2011, EUR J PHARMACOL, V657, P51, DOI 10.1016/j.ejphar.2011.01.055; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Meng QH, 2011, PROTEIN CELL, V2, P889, DOI 10.1007/s13238-011-1113-3; Mill P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/j.ajhg.2011.03.015; Nakajima K, 2006, NEUROSCI LETT, V401, P199, DOI 10.1016/j.neulet.2006.03.014; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nordlund J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034513; Park CJ, 2005, J DENT RES, V84, P852, DOI 10.1177/154405910508400914; Perez-Castro R, 2009, ANESTH ANALG, V108, P997, DOI 10.1213/ane.0b013e31819385e1; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Sato Y, 2010, CLIN EXP NEPHROL, V14, P205, DOI 10.1007/s10157-010-0276-1; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sun ZZ, 2013, J BIOL CHEM, V288, P16715, DOI 10.1074/jbc.M113.462564; Teng YN, 2013, INT J MOL SCI, V14, P625, DOI 10.3390/ijms14010625; Tsunekawa K, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-4; Unami Akira, 2003, J Toxicol Sci, V28, P77, DOI 10.2131/jts.28.77; Wang YY, 2010, P NATL ACAD SCI USA, V107, P815, DOI 10.1073/pnas.0908967107	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86336	10.1371/journal.pone.0086336	http://dx.doi.org/10.1371/journal.pone.0086336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466034	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500231
J	Karamichos, D; Funderburgh, ML; Hutcheon, AEK; Zieske, JD; Du, YQ; Wu, J; Funderburgh, JL				Karamichos, Dimitrios; Funderburgh, Martha L.; Hutcheon, Audrey E. K.; Zieske, James D.; Du, Yiqin; Wu, Jian; Funderburgh, James L.			A Role for Topographic Cues in the Organization of Collagenous Matrix by Corneal Fibroblasts and Stem Cells	PLOS ONE			English	Article							KERATAN SULFATE PROTEOGLYCANS; KERATOCYTE PHENOTYPE; BOVINE KERATOCYTES; IN-VITRO; STROMAL FIBROBLASTS; DIFFERENTIATION; EXPRESSION; MYOFIBROBLAST; TISSUE; LOCALIZATION	Human corneal fibroblasts (HCF) and corneal stromal stem cells (CSSC) each secrete and organize a thick stroma-like extracellular matrix in response to different substrata, but neither cell type organizes matrix on tissue-culture polystyrene. This study compared cell differentiation and extracellular matrix secreted by these two cell types when they were cultured on identical substrata, polycarbonate Transwell filters. After 4 weeks in culture, both cell types upregulated expression of genes marking differentiated keratocytes (KERA, CHST6, AQP1, B3GNT7). Absolute expression levels of these genes and secretion of keratan sulfate proteoglycans were significantly greater in CSSC than HCF. Both cultures produced extensive extracellular matrix of aligned collagen fibrils types I and V, exhibiting cornea-like lamellar structure. Unlike HCF, CSSC produced little matrix in the presence of serum. Construct thickness and collagen organization was enhanced by TGF-beta 3. Scanning electron microscopic examination of the polycarbonate membrane revealed shallow parallel grooves with spacing of 200-300 nm, similar to the topography of aligned nanofiber substratum which we previously showed to induce matrix organization by CSSC. These results demonstrate that both corneal fibroblasts and stromal stem cells respond to a specific pattern of topographical cues by secreting highly organized extracellular matrix typical of corneal stroma. The data also suggest that the potential for matrix secretion and organization may not be directly related to the expression of molecular markers used to identify differentiated keratocytes.	[Karamichos, Dimitrios; Hutcheon, Audrey E. K.; Zieske, James D.] Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA USA; [Karamichos, Dimitrios; Hutcheon, Audrey E. K.; Zieske, James D.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Funderburgh, Martha L.; Du, Yiqin; Wu, Jian; Funderburgh, James L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Funderburgh, JL (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.	jlfunder@pitt.edu	DU, YIQIN/AAO-1566-2020; Du, Yiqin/A-7727-2018; Wu, Jian/A-4023-2012; karamichos, dimitrios/D-9651-2015	DU, YIQIN/0000-0002-4330-0957; Zieske, James/0000-0002-3730-6180	NIH/NEI [EY020886, EY005665, EY03790, EY016415, EY009368, P30-EY008098]; Research to Prevent Blindness; Eye and Ear Foundation of Pittsburgh; NATIONAL EYE INSTITUTE [R01EY020886, P30EY003790, P30EY008098, R01EY016415, R01EY005665, R01EY009368] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Eye and Ear Foundation of Pittsburgh; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH/NEI Grant No. EY020886 (DK and JDZ), EY005665 (JDZ), EY03790 (Core-JDZ), EY016415 (JLF), EY009368 (JLF), P30-EY008098 (JLF), Research to Prevent Blindness, and the Eye and Ear Foundation of Pittsburgh (JLF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsby T, 2013, TISSUE ENG PT A, V19, P2156, DOI [10.1089/ten.tea.2012.0372, 10.1089/ten.TEA.2012.0372]; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; Berryhill BL, 2002, INVEST OPHTH VIS SCI, V43, P3416; Berryhill BL, 2001, INVEST OPHTH VIS SCI, V42, P1201; Carrington LM, 2006, INVEST OPHTH VIS SCI, V47, P1886, DOI 10.1167/iovs.05-0635; Chan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056831; Chan LY, 2013, BIOMATERIALS, V34, P382, DOI 10.1016/j.biomaterials.2012.09.033; Di Iorio E, 2010, EXP EYE RES, V91, P293, DOI 10.1016/j.exer.2010.06.001; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Du YQ, 2007, INVEST OPHTH VIS SCI, V48, P5038, DOI 10.1167/iovs.07-0587; Du YQ, 2010, MOL VIS, V16, P2680; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Fagerholm P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001022; Fraser SA, 2008, J BIOMED MATER RES A, V86A, P725, DOI 10.1002/jbm.a.31519; Freegard TJ, 1997, EYE, V11, P465, DOI 10.1038/eye.1997.127; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; Funderburgh JL, 1996, J BIOL CHEM, V271, P31431, DOI 10.1074/jbc.271.49.31431; Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; GARANA RMR, 1992, INVEST OPHTH VIS SCI, V33, P3271; Guillemette MD, 2009, INTEGR BIOL, V1, P196, DOI 10.1039/b820208g; Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Huh MI, 2009, J CELL BIOCHEM, V108, P476, DOI 10.1002/jcb.22277; JENNINGS JC, 1988, J CELL PHYSIOL, V137, P167, DOI 10.1002/jcp.1041370120; Kao WWY, 2002, GLYCOCONJUGATE J, V19, P275, DOI 10.1023/A:1025396316169; Karamichos D, 2011, J TISSUE ENG REGEN M, V5, pE228, DOI 10.1002/term.429; Karamichos D, 2013, INVEST OPHTH VIS SCI, V54, P6612, DOI 10.1167/iovs.13-12861; Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860; Kim M, 2012, J MECH BEHAV BIOMED, V11, P92, DOI 10.1016/j.jmbbm.2012.03.006; Kitayama K, 2007, J BIOL CHEM, V282, P30085, DOI 10.1074/jbc.M703695200; Lee ST, 2013, FASEB J, V27, P2644, DOI 10.1096/fj.12-223065; Long CJ, 2000, J BIOL CHEM, V275, P13918, DOI 10.1074/jbc.275.18.13918; McLaughlin CR, 2009, FRONT BIOSCI-LANDMRK, V14, P3326, DOI 10.2741/3455; Moller-Pedersen T, 1998, INVEST OPHTH VIS SCI, V39, P487; Musselmann K, 2005, J BIOL CHEM, V280, P32634, DOI 10.1074/jbc.m504724200; Musselmann K, 2006, EXP EYE RES, V83, P707, DOI 10.1016/j.exer.2005.11.020; Myrna KE, 2012, INVEST OPHTH VIS SCI, V53, P811, DOI 10.1167/iovs.11-7982; Ohno S, 2011, LARYNGOSCOPE, V121, P1404, DOI 10.1002/lary.21759; Pei Y, 2006, EXP EYE RES, V83, P1063, DOI 10.1016/j.exer.2006.05.011; Pinnamaneni N, 2012, STEM CELLS, V30, P1059, DOI 10.1002/stem.1100; Pot SA, 2010, INVEST OPHTH VIS SCI, V51, P1373, DOI 10.1167/iovs.09-4074; Ren R, 2008, DEV DYNAM, V237, P2705, DOI 10.1002/dvdy.21606; Ren YJ, 2013, ACTA BIOMATER, V9, P7727, DOI 10.1016/j.actbio.2013.04.034; Ruggiero F, 1996, INVEST OPHTH VIS SCI, V37, P1749; Ruiz-Ederra J, 2009, EXP EYE RES, V89, P159, DOI 10.1016/j.exer.2009.03.002; Seras-Franzoso J, 2013, NANOMEDICINE LOND; SHAH M, 1995, J CELL SCI, V108, P985; Wang Ming-Ke, 2012, World J Stem Cells, V4, P28; Wang PY, 2012, J MATER SCI-MATER M, V23, P3015, DOI 10.1007/s10856-012-4748-6; Wu J, 2013, TISSUE ENG A; Wu J, 2012, BIOMATERIALS, V33, P1343, DOI 10.1016/j.biomaterials.2011.10.055; Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037; Young RD, 2007, HISTOCHEM CELL BIOL, V127, P115, DOI 10.1007/s00418-006-0228-8; Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229	55	52	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86260	10.1371/journal.pone.0086260	http://dx.doi.org/10.1371/journal.pone.0086260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465995	Green Published, gold, Green Accepted			2022-12-25	WOS:000330244500214
J	Kumar, A; Mamidi, P; Das, I; Nayak, TK; Kumar, S; Chhatai, J; Chattopadhyay, S; Suryawanshi, AR; Chattopadhyay, S				Kumar, Abhishek; Mamidi, Prabhudutta; Das, Indrani; Nayak, Tapas K.; Kumar, Sameer; Chhatai, Jagamohan; Chattopadhyay, Subhasis; Suryawanshi, Amol R.; Chattopadhyay, Soma			A Novel 2006 Indian Outbreak Strain of Chikungunya Virus Exhibits Different Pattern of Infection as Compared to Prototype Strain	PLOS ONE			English	Article							REEMERGENCE; GENOTYPE	Background: The recent re-emergence of Chikungunya virus (CHIKV) in India after 32 years and its worldwide epidemics with unprecedented magnitude raised a great public health concern. Methods and Findings: In this study, a biological comparison was carried out between a novel 2006 Indian CHIKV outbreak strain, DRDE-06 and the prototype strain S-27 in mammalian cells in order to understand their differential infection pattern. Results showed that S-27 produced maximum number of progenies (2.43E+06 PFU/ml) at 20 to 24 hours post infection whereas DRDE-06 produced more than double number of progenies around 8 hours post infection in mammalian cells. Moreover, the observation of cytopathic effect, detection of viral proteins and viral proliferation assay confirmed the remarkably faster and significantly higher replication efficiency of DRDE-06. Moreover, our mutational analysis of whole genome of DRDE-06 revealed the presence of nineteen mutations as compared to S-27, whereas the analysis of 273 global isolates showed the consistent presence of fifteen out of nineteen mutations in almost all outbreak isolates. Further analysis revealed that similar to 46% of recent outbreak strains including DRDE-06 do not contain the E1-A226V mutation which was earlier shown to be associated with the adaptation of CHIKV in a new vector species, Aedes albopictus. Conclusions: A novel 2006 Indian CHIKV outbreak strain, DRDE-06 exhibits different pattern of infection as compared to prototype strain, S-27. This might be associated to some specific mutations observed in genome wide mutational analysis in DRDE-06 which emphasizes the need of future experimental investigation.	[Kumar, Abhishek; Mamidi, Prabhudutta; Das, Indrani; Kumar, Sameer; Chhatai, Jagamohan; Suryawanshi, Amol R.; Chattopadhyay, Soma] Inst Life Sci, Dept Infect Dis Biol, Bhubaneswar, Odisha, India; [Nayak, Tapas K.; Chattopadhyay, Subhasis] Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar, Odisha, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); National Institute of Science Education & Research (NISER)	Chattopadhyay, S (corresponding author), Inst Life Sci, Dept Infect Dis Biol, Bhubaneswar, Odisha, India.	sochat.ils@gmail.com	Kumar, Abhishek/AAO-1910-2020; Mamidi, Prabhudutta/GNM-5436-2022; Suryawanshi, Amol Ratnakar/AAM-5853-2020	Kumar, Abhishek/0000-0001-5880-8123; Suryawanshi, Amol/0000-0001-8519-2467	Department of Biotechnology, Ministry of Science and Technology, Govt. of India [BT/PR13118/GBD/27/186/2009, BT/PR15173/GBD/27/356/2011]; Council of Scientific and Industrial Research (CSIR), Ministry of Science and Technology, Govt. of India [37(1542)/12/EMR-II]	Department of Biotechnology, Ministry of Science and Technology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Ministry of Science and Technology, Govt. of India	This work was supported by Department of Biotechnology, Ministry of Science and Technology, Govt. of India vide grant no BT/PR13118/GBD/27/186/2009 and BT/PR15173/GBD/27/356/2011 and by Council of Scientific and Industrial Research (CSIR), Ministry of Science and Technology, Govt. of India vide Project No. 37(1542)/12/EMR-II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2007, EMERG INFECT DIS, V13, P147, DOI 10.3201/eid1301.060617; Anderson BD, 2012, J CLIN VIROL, V54, P265, DOI 10.1016/j.jcv.2012.03.006; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Brooks G.F., 2004, MED MICROBIOLOGY, P514; Chattopadhyay S, 2006, J VIROL, V80, P4491, DOI 10.1128/JVI.80.9.4491-4500.2006; Das B, 2012, INFECT GENET EVOL, V12, P1094, DOI 10.1016/j.meegid.2012.03.012; Dash PK, 2007, VECTOR-BORNE ZOONOT, V7, P519, DOI 10.1089/vbz.2007.7272; Dash PK, 2008, BIOCHEM BIOPH RES CO, V376, P718, DOI 10.1016/j.bbrc.2008.09.040; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1023; Hatta Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001139; Horwood PF, 2013, EMERG INFECT DIS, V19, P1535, DOI 10.3201/eid1909.130130; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Ray P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030025; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROSS R. W., 1956, JOUR HYG, V54, P192; Santhosh SR, 2008, VIRUS RES, V135, P36, DOI 10.1016/j.virusres.2008.02.004; Schlesinger, 1986, TOGAVIRIDAE FLAVIVIR, P35, DOI 10.1007/978-1-4757-0785-4_3; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Singh RK, 2012, J VIROL METHODS; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Suryawanshi AR, 2011, J ANDROL, V32, P240, DOI 10.2164/jandrol.110.010967; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thaikruea Lakkana, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P359; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; Yang EX, 2012, SCI CHINA LIFE SCI, V55, P336, DOI 10.1007/s11427-012-4313-z; Yusof MA, 2011, J GEN MOL VIROLOGY, V3, P35; Zhang X, 2013, VIROL J, V10, DOI [10.1186/1743-422X-10-194, 10.1186/1743-422X-10-174]	32	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85714	10.1371/journal.pone.0085714	http://dx.doi.org/10.1371/journal.pone.0085714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465661	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500067
J	Fonseca, S; Fernandez-Calvo, P; Fernandez, GM; Diez-Diaz, M; Gimenez-Ibanez, S; Lopez-Vidriero, I; Godoy, M; Fernandez-Barbero, G; Van Leene, J; De Jaeger, G; Franco-Zorrilla, JM; Solano, R				Fonseca, Sandra; Fernandez-Calvo, Patricia; Fernandez, Guillermo M.; Diez-Diaz, Monica; Gimenez-Ibanez, Selena; Lopez-Vidriero, Irene; Godoy, Marta; Fernandez-Barbero, Gemma; Van Leene, Jelle; De Jaeger, Geert; Manuel Franco-Zorrilla, Jose; Solano, Roberto			bHLH003, bHLH013 and bHLH017 Are New Targets of JAZ Repressors Negatively Regulating JA Responses	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; PROTEIN-BINDING MICROARRAYS; TRANSCRIPTION FACTORS; JASMONIC ACID; SPLICE VARIANT; DEFENSE; BIOSYNTHESIS; ISOLEUCINE; GROWTH; MOTIF	Cell reprogramming in response to jasmonates requires a tight control of transcription that is achieved by the activity of JA related transcription factors (TFs). Among them, MYC2, MYC3 and MYC4 have been described as activators of JA responses. Here we characterized the function of bHLH003, bHLH013 and bHLH017 that conform a phylogenetic clade closely related to MYC2, MYC3 and MYC4. We found that these bHLHs form homo- and heterodimers and also interact with JAZ repressors in vitro and in vivo. Phenotypic analysis of JA-regulated processes, including root and rosette growth, anthocyanin accumulation, chlorophyll loss and resistance to Pseudomonas syringae, on mutants and overexpression lines, suggested that these bHLHs are repressors of JA responses. bHLH003, bHLH013 and bHLH017 are mainly nuclear proteins and bind DNA with similar specificity to that of MYC2, MYC3 and MYC4, but lack a conserved activation domain, suggesting that repression is achieved by competition for the same cis-regulatory elements. Moreover, expression of bHLH017 is induced by JA and depends on MYC2, suggesting a negative feed-back regulation of the activity of positive JA-related TFs. Our results suggest that the competition between positive and negative TFs determines the output of JA-dependent transcriptional activation.	[Fonseca, Sandra; Fernandez-Calvo, Patricia; Fernandez, Guillermo M.; Diez-Diaz, Monica; Gimenez-Ibanez, Selena; Fernandez-Barbero, Gemma; Solano, Roberto] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Madrid, Spain; [Lopez-Vidriero, Irene; Godoy, Marta; Manuel Franco-Zorrilla, Jose] CSIC, Ctr Nacl Biotecnol, Genom Unit, Madrid, Spain; [Van Leene, Jelle; De Jaeger, Geert] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Van Leene, Jelle; De Jaeger, Geert] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Solano, R (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Madrid, Spain.	rsolano@cnb.csic.es	Franco-Zorrilla, Jose Manuel/ABD-5092-2021; Gimenez-Ibanez, Selena/B-1172-2017; Solano, Roberto/O-5908-2017; Fonseca, Sandra/AAB-3639-2019; Van Leene, Jelle/ABE-6697-2020; Franco-Zorrilla, Jose/M-8361-2015; Fernandez Calvo, Patricia/A-6559-2015; Diez-Diaz, Monica/R-6011-2018	Franco-Zorrilla, Jose Manuel/0000-0001-6769-7349; Gimenez-Ibanez, Selena/0000-0002-5453-8565; Solano, Roberto/0000-0001-5459-2417; Fonseca, Sandra/0000-0002-2021-4482; Van Leene, Jelle/0000-0002-4932-8192; Franco-Zorrilla, Jose/0000-0001-6769-7349; De Jaeger, Geert/0000-0001-6558-5669; Fernandez Calvo, Patricia/0000-0002-1576-9651; Diez-Diaz, Monica/0000-0002-3066-7784	Spanish Ministry for Science and Innovation [BIO2010-21739, CSD2007-00057, EUI2008-03666]; "Juan de la Cierva" fellowship from Spanish Ministry for Science and Innovation	Spanish Ministry for Science and Innovation(Spanish Government); "Juan de la Cierva" fellowship from Spanish Ministry for Science and Innovation(Ministry of Science and Innovation, Spain (MICINN))	This work was funded by the Spanish Ministry for Science and Innovation grants BIO2010-21739, CSD2007-00057 and EUI2008-03666 to R. S. S. G-I was supported by a "Juan de la Cierva" fellowship from the Spanish Ministry for Science and Innovation. J.V.L. is a Postdoctoral Fellows of the Research Foundation-Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta IF, 2013, P NATL ACAD SCI USA, V110, P15473, DOI 10.1073/pnas.1307910110; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Blechert S, 1999, PLANTA, V207, P470, DOI 10.1007/s004250050506; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Browse J, 2008, PLANT PHYSIOL, V146, P832, DOI 10.1104/pp.107.115683; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; Cheng ZW, 2011, MOL PLANT, V4, P279, DOI 10.1093/mp/ssq073; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, PLANT J, V59, P77, DOI 10.1111/j.1365-313X.2009.03852.x; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fonseca Sandra, 2013, Methods Mol Biol, V1011, P159, DOI 10.1007/978-1-62703-414-2_13; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Gidda SK, 2003, J BIOL CHEM, V278, P17895, DOI 10.1074/jbc.M211943200; Godoy M, 2011, PLANT J, V66, P700, DOI 10.1111/j.1365-313X.2011.04519.x; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Hu YR, 2013, PLANT CELL, V25, P2907, DOI 10.1105/tpc.113.112631; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kitaoka N, 2011, PLANT CELL PHYSIOL, V52, P1757, DOI 10.1093/pcp/pcr110; Koo AJK, 2011, P NATL ACAD SCI USA, V108, P9298, DOI 10.1073/pnas.1103542108; Laurie-Berry N, 2006, MOL PLANT MICROBE IN, V19, P789, DOI 10.1094/MPMI-19-0789; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Miersch O, 2008, NEW PHYTOL, V177, P114, DOI 10.1111/j.1469-8137.2007.02252.x; Moreno JE, 2013, PLANT PHYSIOL, V162, P1006, DOI 10.1104/pp.113.218164; Nakata M, 2013, PLANT CELL, V25, P1641, DOI 10.1105/tpc.113.111112; Niu YJ, 2011, J EXP BOT, V62, P2143, DOI 10.1093/jxb/erq408; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Qi TC, 2011, PLANT CELL, V23, P1795, DOI 10.1105/tpc.111.083261; Reinbothe C, 2009, FEBS J, V276, P4666, DOI 10.1111/j.1742-4658.2009.07193.x; Sasaki-Sekimoto Y, 2013, PLANT PHYSIOL, V163, P291, DOI 10.1104/pp.113.220129; Schweizer F, 2013, PLANT CELL, V25, P3117, DOI 10.1105/tpc.113.115139; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shyu C, 2012, PLANT CELL, V24, P536, DOI 10.1105/tpc.111.093005; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; Song SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003653; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Swiatek A, 2004, PLANT PHYSIOL, V135, P161, DOI 10.1104/pp.104.040501; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Uppalapati SR, 2007, MOL PLANT MICROBE IN, V20, P955, DOI 10.1094/MPMI-20-8-0955; Van Leene J, 2008, TRENDS PLANT SCI, V13, P517, DOI 10.1016/j.tplants.2008.08.002; Van Leene J, 2007, MOL CELL PROTEOMICS, V6, P1226, DOI 10.1074/mcp.M700078-MCP200; Van Leene J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.53; Wang L, 2007, PLANTA, V226, P159, DOI 10.1007/s00425-007-0477-3; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Yoshida Y, 2009, DEVELOPMENT, V136, P1039, DOI 10.1242/dev.030585; Zhang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003699; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	64	80	85	9	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86182	10.1371/journal.pone.0086182	http://dx.doi.org/10.1371/journal.pone.0086182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465948	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000061
J	Pinzon, AM; Orkisz, M; Useche, CMR; Gonzalez, JST; Teillaud, S; Sanchez, JA; Hoyos, MH				Morales Pinzon, Alfredo; Orkisz, Maciej; Rodriguez Useche, Catalina Maria; Torres Gonzalez, Juan Sebastian; Teillaud, Stanislas; Armando Sanchez, Juan; Hernandez Hoyos, Marcela			A Semi-Automatic Method to Extract Canal Pathways in 3D Micro-CT Images of Octocorals	PLOS ONE			English	Article							GASTROVASCULAR SYSTEM; COLONIAL ORGANISMS; CORAL; CIRCULATION; NETWORKS; CNIDARIA	The long-term goal of our study is to understand the internal organization of the octocoral stem canals, as well as their physiological and functional role in the growth of the colonies, and finally to assess the influence of climatic changes on this species. Here we focus on imaging tools, namely acquisition and processing of three-dimensional high-resolution images, with emphasis on automated extraction of canal pathways. Our aim was to evaluate the feasibility of the whole process, to point out and solve - if possible - technical problems related to the specimen conditioning, to determine the best acquisition parameters and to develop necessary image-processing algorithms. The pathways extracted are expected to facilitate the structural analysis of the colonies, namely to help observing the distribution, formation and number of canals along the colony. Five volumetric images of Muricea muricata specimens were successfully acquired by X-ray computed tomography with spatial resolution ranging from 4.5 to 25 micrometers. The success mainly depended on specimen immobilization. More than 85% of the canals were successfully detected and tracked by the image-processing method developed. Thus obtained three-dimensional representation of the canal network was generated for the first time without the need of histological or other destructive methods. Several canal patterns were observed. Although most of them were simple, i.e. only followed the main branch or "turned" into a secondary branch, many others bifurcated or fused. A majority of bifurcations were observed at branching points. However, some canals appeared and/or ended anywhere along a branch. At the tip of a branch, all canals fused into a unique chamber. Three-dimensional high-resolution tomographic imaging gives a non-destructive insight to the coral ultrastructure and helps understanding the organization of the canal network. Advanced image-processing techniques greatly reduce human observer's effort and provide methods to both visualize and quantify the structures of interest.	[Morales Pinzon, Alfredo; Rodriguez Useche, Catalina Maria; Torres Gonzalez, Juan Sebastian; Hernandez Hoyos, Marcela] Univ Los Andes, Dept Ingn Sistemas & Computac, Grp Imagine, Bogota, Colombia; [Orkisz, Maciej] Univ Lyon 1, CNRS, UMR5220, CREATIS, F-69622 Villeurbanne, France; [Teillaud, Stanislas; Armando Sanchez, Juan] Univ Los Andes, Fac Ciencias, Dept Ciencias Biol, Lab Biol Mol Marina BIOMMAR, Bogota, Colombia	Universidad de los Andes (Colombia); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidad de los Andes (Colombia)	Pinzon, AM (corresponding author), Univ Los Andes, Dept Ingn Sistemas & Computac, Grp Imagine, Bogota, Colombia.	alf-mora@uniandes.edu.co	sanchez, juan/GSD-8167-2022; Orkisz, Maciej/H-3761-2013	Orkisz, Maciej/0000-0003-1709-5766; Sanchez, Juan Armando/0000-0001-7149-8369	French ANR Labex PRIMES [ANR-11-LABX-0063]; Colombian COLCIENCIAS doctoral grant; "Proyecto interfacultades" (Vicerrectoria de Investigaciones, Universidad de los Andes); COLCIENCIAS [1204-521-29002]	French ANR Labex PRIMES(French National Research Agency (ANR)); Colombian COLCIENCIAS doctoral grant; "Proyecto interfacultades" (Vicerrectoria de Investigaciones, Universidad de los Andes); COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was done in the framework of the French ANR Labex PRIMES (ANR-11-LABX-0063). Alfredo Morales was supported by a Colombian COLCIENCIAS doctoral grant. Support from "Proyecto interfacultades" (Vicerrectoria de Investigaciones, Universidad de los Andes) and COLCIENCIAS (Grant No. 1204-521-29002) is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer F.M., 1973, P69; Bayer FM, 1961, SHALLOW WATER OCTOCO, P31; Beuck L, 2007, FACIES, V53, P157, DOI 10.1007/s10347-006-0094-9; Brun F, 2010, NUCL INSTRUM METH A, V615, P326, DOI 10.1016/j.nima.2010.02.063; Gabay Y, 2013, ECOL EVOL, V3, P465, DOI 10.1002/ece3.351; Hameeteman K, 2011, MED IMAGE ANAL, V15, P477, DOI 10.1016/j.media.2011.02.004; Heim I, 2010, ZOOTAXA, P1; Hernandez-Hoyos M, 1999, INT CONGR SER, V1191, P189; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Inoue S, 2013, NAT CLIM CHANGE, V3, P683, DOI [10.1038/NCLIMATE1855, 10.1038/nclimate1855]; Cadena NJ, 2010, MAR BIOL, V157, P1003, DOI 10.1007/s00227-009-1380-1; Kaandorp JA, 2005, P ROY SOC B-BIOL SCI, V272, P127, DOI 10.1098/rspb.2004.2934; Kaandorp JA, 2001, VIRTUAL LAB, P1; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Knackstedt MA, 2006, BIOMATERIALS, V27, P2776, DOI 10.1016/j.biomaterials.2005.12.016; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kruszynski K.J., 2006, P EUR IEEE VGTC S VI, P283, DOI [DOI 10.2312/VISSYM/EUROVIS06/283-290, 10.2312/VisSym/EuroVis06/283-290]; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Lesage D, 2009, MED IMAGE ANAL, V13, P819, DOI 10.1016/j.media.2009.07.011; McFadden CS, 2006, MOL PHYLOGENET EVOL, V41, P513, DOI 10.1016/j.ympev.2006.06.010; Meszaros A, 1999, J INVERTEBR PATHOL, V73, P321, DOI 10.1006/jipa.1999.4851; MURDOCK GR, 1978, B MAR SCI, V28, P363; Nishikawa T., 2009, J ORAL TISSUE ENG, V7, P121; Orkisz M., 2000, Machine Graphics & Vision, V9, P463; Orkisz Maciej, 2008, Machine Graphics & Vision, V17, P5; Orkisz MM, 1997, MAGNET RESON MED, V37, P914, DOI 10.1002/mrm.1910370617; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parrin AP, 2010, BIOL BULL-US, V219, P112, DOI 10.1086/BBLv219n2p112; Puce S, 2011, ZOOMORPHOLOGY, V130, P85, DOI 10.1007/s00435-011-0120-5; Roche RC, 2010, J EXP MAR BIOL ECOL, V396, P1, DOI 10.1016/j.jembe.2010.10.006; Sanchez JA, 2004, HYDROBIOLOGIA, V530, P283, DOI 10.1007/s10750-004-2684-2; Sanchez JA, 2004, AM NAT, V163, pE24, DOI 10.1086/382139; Sanchez JA, 2004, P ROY SOC B-BIOL SCI, V271, pS117, DOI 10.1098/rsbl.2003.0108; Sarwar A, 2008, RADIOLOGY, V249, P301, DOI 10.1148/radiol.2483072003; Schaap M, 2009, MED IMAGE ANAL, V13, P701, DOI 10.1016/j.media.2009.06.003; Shahzad R, 2013, ACAD RADIOL, V20, P1, DOI 10.1016/j.acra.2012.07.018; Shinozaki K, 1964, JPN J ECOL, V14, P97, DOI DOI 10.18960/SEITAI.14.3_97; Turcotte DL, 1996, P NATL ACAD SCI USA, V93, P14295, DOI 10.1073/pnas.93.25.14295; Turcotte DL, 1998, J THEOR BIOL, V193, P577, DOI 10.1006/jtbi.1998.0723; Wu YC, 2009, J MATER SCI-MATER M, V20, P1273, DOI 10.1007/s10856-009-3695-3	41	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85557	10.1371/journal.pone.0085557	http://dx.doi.org/10.1371/journal.pone.0085557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465599	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000017
J	Szamborska-Gbur, A; Rymarczyk, G; Orlowski, M; Kuzynowski, T; Jakob, M; Dziedzic-Letka, A; Gorecki, A; Dobryszycki, P; Ozyhar, A				Szamborska-Gbur, Agnieszka; Rymarczyk, Grzegorz; Orlowski, Marek; Kuzynowski, Tomasz; Jakob, Michal; Dziedzic-Letka, Agnieszka; Gorecki, Andrzej; Dobryszycki, Piotr; Ozyhar, Andrzej			The Molecular Basis of Conformational Instability of the Ecdysone Receptor DNA Binding Domain Studied by In Silico and In Vitro Experiments	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; RETINOID-X-RECEPTOR; RESPONSE ELEMENT; ECDYSTEROID RECEPTOR; THERMOPHILIC PROTEINS; COMPLEX INTERACTION; NUCLEAR RECEPTORS; STABILITY; DESIGN	The heterodimer of the ecdysone receptor (EcR) and ultraspiracle (Usp), members of the nuclear receptors superfamily, regulates gene expression associated with molting and metamorphosis in insects. The DNA binding domains (DBDs) of the Usp and EcR play an important role in their DNA-dependent heterodimerization. Analysis of the crystal structure of the UspDBD/EcRDBD heterocomplex from Drosophila melanogaster on the hsp27 gene response element, suggested an appreciable similarity between both DBDs. However, the chemical denaturation experiments showed a categorically lower stability for the EcRDBD in contrast to the UspDBD. The aim of our study was an elucidation of the molecular basis of this intriguing instability. Toward this end, we mapped the EcRDBD amino acid sequence positions which have an impact on the stability of the EcRDBD. The computational protein design and in vitro analyses of the EcRDBD mutants indicate that non-conserved residues within the a-helix 2, forming the EcRDBD hydrophobic core, represent a specific structural element that contributes to instability. In particular, the L58 appears to be a key residue which differentiates the hydrophobic cores of UspDBD and EcRDBD and is the main reason for the low stability of the EcRDBD. Our results might serve as a benchmark for further studies of the intricate nature of the EcR molecule.	[Szamborska-Gbur, Agnieszka; Rymarczyk, Grzegorz; Orlowski, Marek; Kuzynowski, Tomasz; Jakob, Michal; Dziedzic-Letka, Agnieszka; Dobryszycki, Piotr; Ozyhar, Andrzej] Wroclaw Univ Technol, Dept Biochem, Fac Chem, PL-50370 Wroclaw, Poland; [Gorecki, Andrzej] Jagiellonian Univ, Dept Phys Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland	Wroclaw University of Science & Technology; Jagiellonian University	Ozyhar, A (corresponding author), Wroclaw Univ Technol, Dept Biochem, Fac Chem, PL-50370 Wroclaw, Poland.	andrzej.ozyhar@pwr.wroc.pl		Orlowski, Marek/0000-0003-1282-2282; OZYHAR, Andrzej/0000-0002-5874-784X; Gorecki, Andrzej/0000-0002-4159-447X	Polish Ministry of Science and Higher Education; National Science Centre [2012/05/B/NZ1/00659]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre(National Science Centre, Poland)	The work was financed by a statutory activity subsidy from the Polish Ministry of Science and Higher Education for the Faculty of Chemistry of Wroclaw University of Technology and by the National Science Centre grant 2012/05/B/NZ1/00659. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; BARIK S, 1995, MOL BIOTECHNOL, V3, P1, DOI 10.1007/BF02821329; Borgo B, 2012, P NATL ACAD SCI USA, V109, P1494, DOI 10.1073/pnas.1115172109; Calhoun S, 2011, BIOCHEMISTRY-US, V50, P5345, DOI 10.1021/bi200192j; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Dantas G, 2007, J MOL BIOL, V366, P1209, DOI 10.1016/j.jmb.2006.11.080; Devarakonda S, 2003, EMBO J, V22, P5827, DOI 10.1093/emboj/cdg569; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; Gordon DB, 1999, CURR OPIN STRUC BIOL, V9, P509, DOI 10.1016/S0959-440X(99)80072-4; Grad I, 2001, EUR J BIOCHEM, V268, P3751, DOI 10.1046/j.1432-1327.2001.02287.x; Grad I, 2002, ACTA BIOCHIM POL, V49, P747; Gromiha MM, 2013, PROTEINS, V81, P715, DOI 10.1002/prot.24232; Gronemeyer H, 1995, PROTEIN PROFILE, V2, P1173; Holmbeck SMA, 1998, J MOL BIOL, V281, P271, DOI 10.1006/jmbi.1998.1908; Jakob M, 2007, NUCLEIC ACIDS RES, V35, P2705, DOI 10.1093/nar/gkm162; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kumar R, 2004, ESSAYS BIOCHEM, V40, P27, DOI 10.1042/bse0400027; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Low LY, 2002, J MOL BIOL, V319, P87, DOI 10.1016/S0022-2836(02)00236-X; LUISI BF, 1994, VITAM HORM, V49, P1; Meinke G, 1999, NAT STRUCT BIOL, V6, P471; Munson M, 1996, PROTEIN SCI, V5, P1584, DOI 10.1002/pro.5560050813; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Niedziela-Majka A, 1998, PROTEIN EXPRES PURIF, V14, P208, DOI 10.1006/prep.1998.0932; Niedziela-Majka A, 2000, EUR J BIOCHEM, V267, P507, DOI 10.1046/j.1432-1327.2000.01027.x; Orlowski M, 2004, MOL ENDOCRINOL, V18, P2166, DOI 10.1210/me.2004-0154; ORO AE, 1990, NATURE, V347, P298, DOI 10.1038/347298a0; OZYHAR A, 1993, J STEROID BIOCHEM, V46, P135, DOI 10.1016/0960-0760(93)90288-8; Pakula S, 2012, J BIOMOL STRUCT DYN, V30, P379, DOI 10.1080/07391102.2012.682215; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; RIDDIHOUGH G, 1987, EMBO J, V6, P3729, DOI 10.1002/j.1460-2075.1987.tb02707.x; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; SIEMION IZ, 1994, INT J PEPT PROT RES, V44, P61; Sikorska M, 2012, J INORG BIOCHEM, V115, P28, DOI 10.1016/j.jinorgbio.2012.05.009; Simons KT, 1999, PROTEINS, V34, P82, DOI 10.1002/(SICI)1097-0134(19990101)34:1<82::AID-PROT7>3.0.CO;2-A; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Srinivasan J, 1999, THEOR CHEM ACC, V101, P426, DOI 10.1007/s002140050460; Sterpone F, 2012, CHEM SOC REV, V41, P1665, DOI 10.1039/c1cs15199a; Teilum K, 2011, BBA-PROTEINS PROTEOM, V1814, P969, DOI 10.1016/j.bbapap.2010.11.005; van Tilborg MAA, 2000, J MOL BIOL, V301, P947, DOI 10.1006/jmbi.2000.4001; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wilkins MR, 1999, METH MOL B, V112, P531; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2	60	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86052	10.1371/journal.pone.0086052	http://dx.doi.org/10.1371/journal.pone.0086052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465866	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000046
J	Marcondes, JPD; de Oliveira, MLCS; Gontijo, AM; de Camargo, JLV; Salvadori, DMF				de Castro Marcondes, Joao Paulo; Cotrim Sartor de Oliveira, Maria Luiza; Gontijo, Alisson M.; Viana de Camargo, Joao Lauro; Favero Salvadori, Daisy Maria			Genetic Instability Persists in Non-Neoplastic Urothelial Cells from Patients with a History of Urothelial Cell Carcinoma	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; BLADDER-CANCER; DNA-DAMAGE; SMOKING; SMOKERS; MICRONUCLEUS; TUMORS; EXPRESSION; MUTATIONS; ASSAY	Bladder cancer is one of the most common genitourinary neoplasms in industrialized countries. Multifocality and high recurrence rates are prominent clinical features of this disease and contribute to its high morbidity. Therefore, more sensitive and less invasive techniques could help identify individuals with asymptomatic disease. In this context, we used the micronucleus assay to evaluate whether cytogenetic alterations could be used as biomarkers for monitoring patients with a history of urothelial cell carcinoma (UCC). We determined the frequency of micronucleated urothelial cells (MNC) in exfoliated bladder cells from 105 patients with (n = 52) or without (n = 53) a history of UCC, all of whom tested negative for neoplasia by cytopathological and histopathological analyses. MNC frequencies were increased in patients with a history of UCC (non-smoker and smoker/ex-smoker patients vs non-smoker and smoker/ex-smoker controls; p<0.001), in non-smoker UCC patients (vs non-smoker controls; p<0.01), and in smoker/ex-smoker controls (vs non-smoker controls; p<0.001). Patients with a history of recurrent disease also demonstrated a higher MNC frequency compared to patients with non-recurrent neoplasia. However, logistic regression using smoking habits, age and gender as confounding factors did not confirm MNC frequency as a marker for UCC recurrence. Fluorescent in situ hybridization analysis (using a pan-centromeric probe) showed that micronuclei (MN) arose mainly from clastogenic events regardless of UCC and/or smoking histories. In conclusion, our results confirm previous indications that subjects with a history of UCC harbor genetically unstable cells in the bladder urothelium. Furthermore, these results support using the micronucleus assay as an important tool for monitoring patients with a history of UCC and tumor recurrence.	[de Castro Marcondes, Joao Paulo; Cotrim Sartor de Oliveira, Maria Luiza; Viana de Camargo, Joao Lauro; Favero Salvadori, Daisy Maria] UNESP Univ Estadual Paulista, Fac Med, Botucatu, SP, Brazil; [Gontijo, Alisson M.] Univ Nova Lisboa, Fac Ciencias Med FCM, Ctr Estudos Doencas Cronicas, P-1200 Lisbon, Portugal	Universidade Estadual Paulista; Universidade Nova de Lisboa	Marcondes, JPD (corresponding author), UNESP Univ Estadual Paulista, Fac Med, Botucatu, SP, Brazil.	jpcastromarcondes@uol.com.br	Camargo, Joao Lauro Viana de/GPC-9056-2022; Salvadori, Daisy M.F./E-7744-2012; Marcondes, JP/G-6980-2012; Gontijo, Alisson/G-6719-2011	Salvadori, Daisy M.F./0000-0001-9323-3134; Marcondes, JP/0000-0002-5116-2494; Cotrim Sartor de Oliveira, Maria Luiza/0000-0002-8830-1267; Gontijo, Alisson/0000-0002-2530-3708	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/55594-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301079/2009-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, #05/55594-6, to M. L. C. S. O.), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, #301079/2009-9, to D. M. F. S.) and Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES, fellowship to J. P. C. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora SK, 2010, DIAGN CYTOPATHOL, V38, P811, DOI 10.1002/dc.21297; Baciuchka-Palmaro A, 2002, MUTAT RES-GEN TOX EN, V520, P189, DOI 10.1016/S1383-5718(02)00206-1; Bonassi S, 2011, MUTAGENESIS, V26, P93, DOI 10.1093/mutage/geq075; BURGAZ S, 1995, MUTAT RES-ENVIR MUTA, V335, P163, DOI 10.1016/0165-1161(95)90052-7; Centers for Disease Control and Prevention, 2013, TOB CONTR STAT HIGHL; Daffaud F, 1999, MUTAT RES-GEN TOX EN, V439, P259, DOI 10.1016/S1383-5718(99)00003-0; del Rey J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-280; Denzinger S, 2006, HUM PATHOL, V37, P143, DOI 10.1016/j.humpath.2005.10.014; Eble JN, 2004, WHO TUMORS URINARY S; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Frau DV, 2006, CANCER GENET CYTOGEN, V169, P21, DOI 10.1016/j.cancergencyto.2006.03.004; Gabor P, 2011, CYTOM PART A, V79A, P375, DOI 10.1002/cyto.a.21065; Gabriel U, 2012, MOL CARCINOGEN, V51, P907, DOI 10.1002/mc.20860; Gontijo AMD, 2002, ENVIRON MOL MUTAGEN, V40, P190, DOI 10.1002/em.10109; Gontijo AMDC, 2001, CANCER EPIDEM BIOMAR, V10, P987; Iarmarcovai G, 2006, MUTAGENESIS, V21, P159, DOI 10.1093/mutage/gel010; Instituto Brasileiro de Geografia e Estatistica, 2008, CAR RAC POP EST CAT; Jefford CE, 2006, CRIT REV ONCOL HEMAT, V59, P1, DOI 10.1016/j.critrevonc.2006.02.005; LaRue H, 2000, CARCINOGENESIS, V21, P101, DOI 10.1093/carcin/21.1.101; LEHUCHERMICHEL MP, 1995, MUTAGENESIS, V10, P329, DOI 10.1093/mutage/10.4.329; Marsit CJ, 2006, CARCINOGENESIS, V27, P112, DOI 10.1093/carcin/bgi172; Mothersill C, 1997, CARCINOGENESIS, V18, P1241, DOI 10.1093/carcin/18.6.1241; Pontes MGNE, 2013, UROL ONCOL-SEMIN ORI, V31, P827, DOI 10.1016/j.urolonc.2011.05.015; Reznikoff CA, 2000, UROL ONCOL, V5, P191, DOI 10.1016/S1078-1439(00)00079-X; Wallerand H, 2005, CARCINOGENESIS, V26, P177, DOI 10.1093/carcin/bgh275; Youssef RF, 2011, THESCIENTIFICWORLDJO, V11, P369, DOI 10.1100/tsw.2011.28; Zeegers MPA, 2004, WORLD J UROL, V21, P392, DOI 10.1007/s00345-003-0382-8	27	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86162	10.1371/journal.pone.0086162	http://dx.doi.org/10.1371/journal.pone.0086162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465937	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100118
J	Fischer, FU; Wolf, D; Scheurich, A; Fellgiebel, A				Fischer, Florian U.; Wolf, Dominik; Scheurich, Armin; Fellgiebel, Andreas			Association of Structural Global Brain Network Properties with Intelligence in Normal Aging	PLOS ONE			English	Article							DIFFUSION TENSOR; WHITE-MATTER; ALZHEIMERS-DISEASE; GENERAL INTELLIGENCE; THEORETICAL-ANALYSIS; FIBER-ORIENTATION; RECONSTRUCTION; CONNECTIVITY; TRACTOGRAPHY; PREDICTION	Higher general intelligence attenuates age-associated cognitive decline and the risk of dementia. Thus, intelligence has been associated with cognitive reserve or resilience in normal aging. Neurophysiologically, intelligence is considered as a complex capacity that is dependent on a global cognitive network rather than isolated brain areas. An association of structural as well as functional brain network characteristics with intelligence has already been reported in young adults. We investigated the relationship between global structural brain network properties, general intelligence and age in a group of 43 cognitively healthy elderly, age 60-85 years. Individuals were assessed cross-sectionally using Wechsler Adult Intelligence Scale-Revised (WAIS-R) and diffusion-tensor imaging. Structural brain networks were reconstructed individually using deterministic tractography, global network properties (global efficiency, mean shortest path length, and clustering coefficient) were determined by graph theory and correlated to intelligence scores within both age groups. Network properties were significantly correlated to age, whereas no significant correlation to WAIS-R was observed. However, in a subgroup of 15 individuals aged 75 and above, the network properties were significantly correlated to WAIS-R. Our findings suggest that general intelligence and global properties of structural brain networks may not be generally associated in cognitively healthy elderly. However, we provide first evidence of an association between global structural brain network properties and general intelligence in advanced elderly. Intelligence might be affected by age-associated network deterioration only if a certain threshold of structural degeneration is exceeded. Thus, age-associated brain structural changes seem to be partially compensated by the network and the range of this compensation might be a surrogate of cognitive reserve or brain resilience.	[Fischer, Florian U.; Wolf, Dominik; Scheurich, Armin; Fellgiebel, Andreas] Univ Med Ctr Mainz, Dept Psychiat & Psychotherapy, Mainz, Germany	Johannes Gutenberg University of Mainz	Fischer, FU (corresponding author), Univ Med Ctr Mainz, Dept Psychiat & Psychotherapy, Mainz, Germany.	florian.fischer@unimedizin-mainz.de			Research Focus on Interdisciplinary Neuroscience (Interdisziplinarer Forschungsschwerpunkt Neurowissenschaften, IFSN) of the Johannes Gutenberg-University Mainz, Germany	Research Focus on Interdisciplinary Neuroscience (Interdisziplinarer Forschungsschwerpunkt Neurowissenschaften, IFSN) of the Johannes Gutenberg-University Mainz, Germany	The study was funded by the Research Focus on Interdisciplinary Neuroscience (Interdisziplinarer Forschungsschwerpunkt Neurowissenschaften, IFSN) of the Johannes Gutenberg-University Mainz, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2000, MAGNET RESON MED, V44, P283, DOI 10.1002/1522-2594(200008)44:2<283::AID-MRM16>3.0.CO;2-V; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Anderson AW, 2001, MAGNET RESON MED, V46, P1174, DOI 10.1002/mrm.1315; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Bartzokis G, 2012, BIOL PSYCHIAT, V72, P1026, DOI 10.1016/j.biopsych.2012.07.010; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Dauguet J, 2006, LECT NOTES COMPUT SC, V4190, P109; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Deary I, 2008, NATURE, V456, P175, DOI 10.1038/456175a; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischer FU, 2012, J MAGN RESON IMAGING, V36, P84, DOI 10.1002/jmri.23621; Glascher J, 2010, P NATL ACAD SCI USA, V107, P4705, DOI 10.1073/pnas.0910397107; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Hiller W., 1997, INT DIAGNOSEN CHECKL; Ivkovic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035029; Jensen A.R., 1998, G FACTOR SCI MENTAL; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Jones DK, 2003, MAGN RESON MED, V49, P7, DOI 10.1002/mrm.10331; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Miller LJ, 2009, ARCH CLIN NEUROPSYCH, V24, P681, DOI 10.1093/arclin/acp072; MISSAR CD, 1994, SCHIZOPHR RES, V12, P247, DOI 10.1016/0920-9964(94)90034-5; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Penke L, 2012, MOL PSYCHIATR, V17, P1026, DOI 10.1038/mp.2012.66; Pfefferbaum A, 2005, NEUROIMAGE, V26, P891, DOI 10.1016/j.neuroimage.2005.02.034; PLASSMAN BL, 1995, NEUROLOGY, V45, P1446, DOI 10.1212/WNL.45.8.1446; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; Shao JM, 2012, NEUROBIOL AGING, V33, P2756, DOI 10.1016/j.neurobiolaging.2012.01.017; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Sullivan EV, 2003, EUR J RADIOL, V45, P244, DOI 10.1016/S0720-048X(02)00313-3; Tabert MH, 2006, ARCH GEN PSYCHIAT, V63, P916, DOI 10.1001/archpsyc.63.8.916; Tewes U., 1994, HAMBURG WECHSLER INT; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wittchen HU, 1997, DIA 10 SCREENING VER; Yeo RA, 2011, CURR ALZHEIMER RES, V8, P345; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022	58	46	47	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86258	10.1371/journal.pone.0086258	http://dx.doi.org/10.1371/journal.pone.0086258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465994	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100133
J	Mas-Oliva, J; Navarro-Vidal, E; Tapia-Vieyra, JV				Mas-Oliva, Jaime; Navarro-Vidal, Enrique; Tapia-Vieyra, Juana Virginia			ARP2, a Novel Pro-Apoptotic Protein Expressed in Epithelial Prostate Cancer LNCaP Cells and Epithelial Ovary CHO Transformed Cells	PLOS ONE			English	Article							CA2+ HOMEOSTASIS; STORE DEPLETION; PRP8 PROTEIN; DEATH; MECHANISMS; CHANNELS; TRP; DIFFERENTIATION; IDENTIFICATION; PATHOGENESIS	Neoplastic epithelial cells generate the most aggressive types of cancers such as those located in the lung, breast, colon, prostate and ovary. During advanced stages of prostate cancer, epithelial cells are associated to the appearance of androgen-independent tumors, an apoptotic-resistant phenotype that ultimately overgrows and promotes metastatic events. We have previously identified and electrophysiologically characterized a novel Ca2+-permeable channel activated during apoptosis in the androgen-independent prostate epithelial cancer cell line, LNCaP. In addition, we reported for the first time the cloning and characterization of this channel-like molecule named apoptosis regulated protein 2 (ARP2) associated to a lethal influx of Ca2+ in Xenopus oocytes. In the present study, LNCaP cells and Chinese hamster ovary cells (CHO cell line) transfected with arp2-cDNA are induced to undergo apoptosis showing an important impact on cell viability and activation of caspases 3 and 7 when compared to serum deprived grown cells and ionomycin treated cells. The subcellular localization of ARP2 in CHO cells undergoing apoptosis was studied using confocal microscopy. While apoptosis progresses, ARP2 initially localized in the peri-nuclear region of cells migrates with time towards the plasma membrane region. Based on the present results and those of our previous studies, the fact that ARP2 constitutes a novel cation channel is supported. Therefore, ARP2 becomes a valuable target to modulate the influx and concentration of calcium in the cytoplasm of epithelial cancer cells showing an apoptotic-resistant phenotype during the onset of an apoptotic event.	[Mas-Oliva, Jaime; Navarro-Vidal, Enrique; Tapia-Vieyra, Juana Virginia] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Mas-Oliva, Jaime] Univ Nacl Autonoma Mexico, Fac Med, Div Invest, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Mas-Oliva, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	jmas@ifc.unam.mx			CONACyT [141588]; DGAPA-UNAM [IN-205711/2]; Consejo Nacional de Ciencia y Tecnologia, (CONACyT) [251040]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia, (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACyT (Grant 141588) and DGAPA-UNAM (Grant IN-205711/2) awarded to Jaime Mas-Oliva. Enrique Navarro-Vidal was supported by scholarships from Consejo Nacional de Ciencia y Tecnologia, (CONACyT) (251040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonarakis ES, 2010, CANCER LETT, V291, P1, DOI 10.1016/j.canlet.2009.08.012; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bruckheimer EM, 1999, SEMIN ONCOL, V26, P382; BURSCH W, 1992, TRENDS PHARMACOL SCI, V13, P245, DOI 10.1016/0165-6147(92)90077-J; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Chung LWK, 2003, UROLOGY, V62, P44, DOI 10.1016/S0090-4295(03)00796-9; Chung LWK, 1996, MOL BIOL REP, V23, P13, DOI 10.1007/BF00357069; COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dutta T, 2005, CANCER CHEMOTH PHARM, V56, P427, DOI 10.1007/s00280-004-0993-9; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Flourakis M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.52; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gutierrez AA, 1999, J PHYSIOL-LONDON, V517, P95, DOI 10.1111/j.1469-7793.1999.0095z.x; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hirst Robert A, 2006, Methods Mol Biol, V312, P37; HOFFMAN B, 1994, ONCOGENE, V9, P1807; Hoskins AA, 2012, TRENDS BIOCHEM SCI, V37, P179, DOI 10.1016/j.tibs.2012.02.009; Isaacs JT, 1999, UROL CLIN N AM, V26, P263, DOI 10.1016/S0094-0143(05)70066-5; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; LEPOR H, 1982, J UROLOGY, V128, P335, DOI 10.1016/S0022-5347(17)52915-8; Lopacznski W, 2001, UROLOGY, V57, P194, DOI 10.1016/S0090-4295(00)00973-0; Luo HBR, 1999, RNA, V5, P893, DOI 10.1017/S1355838299990520; MAJNO G, 1995, AM J PATHOL, V146, P3; MARTIKAINEN P, 1991, CANCER RES, V51, P4693; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; Negoescu A, 2000, HISTOL HISTOPATHOL, V15, P281, DOI 10.14670/HH-15.281; NICOTERA P, 1992, ANNU REV PHARMACOL, V32, P449, DOI 10.1146/annurev.pa.32.040192.002313; O'Connor L, 2000, CURR OPIN CELL BIOL, V12, P257, DOI 10.1016/S0955-0674(99)00084-8; Orfanelli U, 2008, CELL RES, V18, P1128, DOI 10.1038/cr.2008.296; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Peehl DM, 2005, ENDOCR-RELAT CANCER, V12, P19, DOI 10.1677/erc.1.00795; Pigozzi D, 2006, CELL CALCIUM, V39, P401, DOI 10.1016/j.ceca.2006.01.003; Prevarskaya N, 2004, BIOCHEM BIOPH RES CO, V322, P1326, DOI 10.1016/j.bbrc.2004.08.037; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; Skryma R, 2000, J PHYSIOL-LONDON, V527, P71, DOI 10.1111/j.1469-7793.2000.00071.x; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Sung SY, 2002, DIFFERENTIATION, V70, P506, DOI 10.1046/j.1432-0436.2002.700905.x; Tapia-Vieyra JV, 2005, MOL CELL BIOCHEM, V269, P189, DOI 10.1007/s11010-005-3084-2; Tapia-Vieyra JV, 2001, ARCH MED RES, V32, P175, DOI 10.1016/S0188-4409(01)00274-0; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Turner IA, 2006, RNA, V12, P375, DOI 10.1261/rna.2229706; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Vanoverberghe K, 2004, CELL DEATH DIFFER, V11, P321, DOI 10.1038/sj.cdd.4401375; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; WILLIAMS GT, 1991, CELL, V65, P1097, DOI 10.1016/0092-8674(91)90002-G; WILLIAMS GT, 1993, CELL, V74, P777, DOI 10.1016/0092-8674(93)90457-2; Wu XC, 2003, CANCER RES, V63, P4936; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	57	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86089	10.1371/journal.pone.0086089	http://dx.doi.org/10.1371/journal.pone.0086089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465888	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100105
J	Ongkeko, WM; Burton, D; Kiang, A; Abhold, E; Kuo, SZ; Rahimy, E; Yang, M; Hoffman, RM; Wang-Rodriguez, J; Deftos, LJ				Ongkeko, Weg M.; Burton, Doug; Kiang, Alan; Abhold, Eric; Kuo, Selena Z.; Rahimy, Elham; Yang, Meng; Hoffman, Robert M.; Wang-Rodriguez, Jessica; Deftos, Leonard J.			Parathyroid Hormone Related-Protein Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer	PLOS ONE			English	Article							SIGNALING PATHWAYS; BONE METASTASES; BREAST-CANCER; STEM-CELLS; FLUORESCENT PROTEIN; PTH/PTHRP RECEPTOR; TUMOR PROGRESSION; INDIAN HEDGEHOG; E-CADHERIN; TGF-BETA	Parathyroid hormone-related protein (PTHrP) possesses a variety of physiological and developmental functions and is also known to facilitate the progression of many common cancers, notably their skeletal invasion, primarily by increasing bone resorption. The purpose of this study was to determine whether PTHrP could promote epithelial-to-mesenchymal transition (EMT), a process implicated in cancer stem cells that is critically involved in cancer invasion and metastasis. EMT was observed in DU 145 prostate cancer cells stably overexpressing either the 1-141 or 1-173 isoform of PTHrP, where there was upregulation of Snail and vimentin and downregulation of E-cadherin relative to parental DU 145. By contrast, the opposite effect was observed in PC-3 prostate cancer cells where high levels of PTHrP were knocked-down via lentiviral siRNA transduction. Increased tumor progression was observed in PTHrP-overexpressing DU 145 cells while decreased progression was observed in PTHrP-knockdown PC-3 cells. PTHrP-overexpressing DU 145 formed larger tumors when implanted orthoptopically into nude mice and in one case resulted in spinal metastasis, an effect not observed among mice injected with parental DU 145 cells. PTHrP-overexpressing DU 145 cells also caused significant bone destruction when injected into the tibiae of nude mice, while parental DU 145 cells caused little to no destruction of bone. Together, these results suggest that PTHrP may work through EMT to promote an aggressive and metastatic phenotype in prostate cancer, a pathway of importance in cancer stem cells. Thus, continued efforts to elucidate the pathways involved in PTHrP-induced EMT as well as to develop ways to specifically target PTHrP signaling may lead to more effective therapies for prostate cancer.	[Ongkeko, Weg M.; Kiang, Alan; Abhold, Eric; Kuo, Selena Z.; Rahimy, Elham] Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA; [Burton, Doug; Deftos, Leonard J.] Univ Calif San Diego, Vet Adm San Diego Healthcare Syst, Dept Med, La Jolla, CA 92093 USA; [Yang, Meng; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Wang-Rodriguez, Jessica] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Wang-Rodriguez, Jessica] Vet Adm San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Anti Cancer Inc; University of California System; University of California San Diego	Ongkeko, WM (corresponding author), Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA.	wongkeko@ucsd.edu		Rahimy, Elham/0000-0001-7356-3996	Veterans Administration Merit Award	Veterans Administration Merit Award	Veterans Administration Merit Award (LJ Deftos) supported this project (http://www.research.va.gov/services/csrd/merit_review.cfm#.UcI2KPY-uCg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2007, CARCINOGENESIS, V28, P1893, DOI 10.1093/carcin/bgm106; Aguilera Abelardo, 2005, Curr Opin Investig Drugs, V6, P262; Aklilu F, 1996, AM J PHYSIOL-ENDOC M, V271, pE277, DOI 10.1152/ajpendo.1996.271.2.E277; Ardura JA, 2010, J AM SOC NEPHROL, V21, P237, DOI 10.1681/ASN.2009050462; Arato-Ohshima T, 1999, INT J CANCER, V83, P387, DOI 10.1002/(SICI)1097-0215(19991029)83:3<387::AID-IJC15>3.0.CO;2-O; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Beier F, 2001, MOL BIOL CELL, V12, P3852, DOI 10.1091/mbc.12.12.3852; Bryden AAG, 2002, BRIT J CANCER, V86, P322, DOI 10.1038/sj/bjc/6600115; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; BURTON DW, 1994, ENDOCRINOLOGY, V135, P253, DOI 10.1210/en.135.1.253; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chan GK, 2001, ENDOCRINOLOGY, V142, P4900, DOI 10.1210/en.142.11.4900; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Datta NS, 2007, J BONE MINER RES, V22, P951, DOI 10.1359/JBMR.070328; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Deftos Leonard J., 2000, Cancer, V88, P3002; Deftos LJ, 2005, BIOCHEM BIOPH RES CO, V327, P468, DOI 10.1016/j.bbrc.2004.11.162; DELAMATA J, 1995, J CLIN INVEST, V95, P2846, DOI 10.1172/JCI117990; Ditmer LS, 1996, ENDOCRINOLOGY, V137, P1608, DOI 10.1210/en.137.5.1608; Downs TM, 2011, CANCER LETT, V306, P52, DOI 10.1016/j.canlet.2011.02.027; Duband JL, 1995, ACTA ANAT, V154, P63; Fortino V, 2002, CELL MOL LIFE SCI, V59, P2165, DOI 10.1007/s000180200015; Gleave Martin E., 1997, P367; Goltzman D, 1999, J BONE MINER RES, V14, P173, DOI 10.1359/jbmr.1999.14.2.173; Gonzalez-Moreno O, 2010, EXP CELL RES, V316, P554, DOI 10.1016/j.yexcr.2009.11.020; Greaves M, 2011, NAT MED, V17, P1046, DOI 10.1038/nm.2458; Grille SJ, 2003, CANCER RES, V63, P2172; Gujral A, 2001, CANCER RES, V61, P2282; Hajra KM, 2002, CANCER RES, V62, P1613; Hastings RH, 2010, CANCER BIOL THER, V10, P1068, DOI 10.4161/cbt.10.10.13374; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Iddon J, 2000, J PATHOL, V191, P170; Ionescu AM, 2001, J BIOL CHEM, V276, P11639, DOI 10.1074/jbc.M006564200; Isohata N, 2009, INT J CANCER, V125, P1212, DOI 10.1002/ijc.24400; Isowa S, 2010, ANTICANCER RES, V30, P2755; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; KEMP BE, 1987, SCIENCE, V238, P1568, DOI 10.1126/science.3685995; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LI X, 1994, J BIOL CHEM, V269, P6263; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Milsom CC, 2008, CANCER RES, V68, P10068, DOI 10.1158/0008-5472.CAN-08-2067; Nemeth JA, 1999, CANCER RES, V59, P1987; Rabbani SA, 1999, INT J CANCER, V80, P257, DOI 10.1002/(SICI)1097-0215(19990118)80:2<257::AID-IJC15>3.3.CO;2-V; Sepulveda VAT, 2002, REGUL PEPTIDES, V105, P109, DOI 10.1016/S0167-0115(02)00007-1; Shen XL, 2007, REGUL PEPTIDES, V141, P61, DOI 10.1016/j.regpep.2006.12.017; Shimo T, 2006, J BONE MINER RES, V21, P1045, DOI 10.1359/JBMR.060416; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Veltmaat JM, 2000, INT J DEV BIOL, V44, P297; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Yamamoto T, 2007, BONE, V40, P354, DOI 10.1016/j.bone.2006.09.002; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang M, 2006, CLIN CANCER RES, V12, P2602, DOI 10.1158/1078-0432.CCR-05-2050; Yang M, 2005, PROSTATE, V62, P374, DOI 10.1002/pros.20125; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	61	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85803	10.1371/journal.pone.0085803	http://dx.doi.org/10.1371/journal.pone.0085803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465715	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100076
J	Tyne, JA; Pollock, KH; Johnston, DW; Bejder, L				Tyne, Julian A.; Pollock, Kenneth H.; Johnston, David W.; Bejder, Lars			Abundance and Survival Rates of the Hawai'i Island Associated Spinner Dolphin (Stenella longirostris) Stock	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; PHOTOGRAPHIC IDENTIFICATION; TURSIOPS-TRUNCATUS; HUMPBACK WHALES; BEHAVIOR; PATTERNS; OCEAN; SOUND; BAYS	Reliable population estimates are critical to implement effective management strategies. The Hawai'i Island spinner dolphin (Stenella longirostris) is a genetically distinct stock that displays a rigid daily behavioural pattern, foraging offshore at night and resting in sheltered bays during the day. Consequently, they are exposed to frequent human interactions and disturbance. We estimated population parameters of this spinner dolphin stock using a systematic sampling design and capture-recapture models. From September 2010 to August 2011, boat-based photo-identification surveys were undertaken monthly over 132 days (>1,150 hours of effort; >100,000 dorsal fin images) in the four main resting bays along the Kona Coast, Hawai'i Island. All images were graded according to photographic quality and distinctiveness. Over 32,000 images were included in the analyses, from which 607 distinctive individuals were catalogued and 214 were highly distinctive. Two independent estimates of the proportion of highly distinctive individuals in the population were not significantly different (p = 0.68). Individual heterogeneity and time variation in capture probabilities were strongly indicated for these data; therefore capture-recapture models allowing for these variations were used. The estimated annual apparent survival rate (product of true survival and permanent emigration) was 0.97 SE +/- 0.05. Open and closed capture-recapture models for the highly distinctive individuals photographed at least once each month produced similar abundance estimates. An estimate of 221 +/- 4.3 SE highly distinctive spinner dolphins, resulted in a total abundance of 631 +/- 60.1 SE, (95% CI 524-761) spinner dolphins in the Hawai'i Island stock, which is lower than previous estimates. When this abundance estimate is considered alongside the rigid daily behavioural pattern, genetic distinctiveness, and the ease of human access to spinner dolphins in their preferred resting habitats, this Hawai'i Island stock is likely more vulnerable to negative impacts from human disturbance than previously believed.	[Tyne, Julian A.; Pollock, Kenneth H.; Johnston, David W.; Bejder, Lars] Murdoch Univ, Murdoch Univ Cetacean Res Unit, Ctr Fish Fisheries & Aquat Ecosyst Res, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Pollock, Kenneth H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Johnston, David W.; Bejder, Lars] Duke Univ, Marine Lab, Nicholas Sch Environm, Div Marine Sci & Conservat, Beaufort, NC 28516 USA	Murdoch University; University of North Carolina; North Carolina State University; Duke University	Tyne, JA (corresponding author), Murdoch Univ, Murdoch Univ Cetacean Res Unit, Ctr Fish Fisheries & Aquat Ecosyst Res, Sch Vet & Life Sci, South St, Murdoch, WA 6150, Australia.	j.tyne@murdoch.edu.au	Johnston, David/AAJ-5013-2020; Bejder, Lars/D-1772-2017	Bejder, Lars/0000-0001-8138-8606; Tyne, Julian/0000-0002-0676-5659; Johnston, David/0000-0003-2424-036X	National Oceanic and Atmospheric Adminstration (NOAA); Marine Mammal Commission	National Oceanic and Atmospheric Adminstration (NOAA); Marine Mammal Commission	Funding was provided by the National Oceanic and Atmospheric Adminstration (NOAA) and The Marine Mammal Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; Andrews KR, 2010, MOL ECOL, V19, P732, DOI 10.1111/j.1365-294X.2010.04521.x; Andrews KR, 2009, THESIS U HAWAII HONO; Aschettino JM, 2012, MAR MAMMAL SCI, V28, P666, DOI 10.1111/j.1748-7692.2011.00517.x; Baird RW, 2008, MAR MAMMAL SCI, V24, P591, DOI 10.1111/j.1748-7692.2008.00200.x; Barlow J, 2006, MAR MAMMAL SCI, V22, P446, DOI 10.1111/j.1748-7692.2006.00032.x; Bearzi G, 1999, MAR MAMMAL SCI, V15, P1065, DOI 10.1111/j.1748-7692.1999.tb00878.x; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Benoit-Bird KJ, 2009, J ACOUST SOC AM, V125, P125, DOI 10.1121/1.2967480; Burnham KP, 1987, AM FISHERIES SOC MON; Cantor M, 2012, MAR MAMMAL SCI, V28, P63, DOI 10.1111/j.1748-7692.2010.00456.x; Carretta JV, 2011, US PACIFIC MARINE MA; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Courbis S, 2007, TOURISM MARINE ENV, V4, P1, DOI DOI 10.3727/154427307784835697; Courbis S, 2009, MAR MAMMAL SCI, V25, P430, DOI 10.1111/j.1748-7692.2008.00254.x; Delfour F, 2007, J MAR BIOL ASSOC UK, V87, P109, DOI 10.1017/S0025315407054148; DUKAS R, 1995, ANIM BEHAV, V49, P1259, DOI 10.1006/anbe.1995.0158; Friday N, 2000, MAR MAMMAL SCI, V16, P355, DOI 10.1111/j.1748-7692.2000.tb00930.x; Gero S, 2005, CAN J ZOOL, V83, P1566, DOI 10.1139/Z05-155; Gormley AM, 2005, MAR MAMMAL SCI, V21, P204, DOI 10.1111/j.1748-7692.2005.tb01224.x; Gowans S, 2001, MAR MAMMAL SCI, V17, P76, DOI 10.1111/j.1748-7692.2001.tb00981.x; Hammond P., 1986, REPORT INT WHALING C, V8, P252; Hammond PS, 1990, REPORT INT WHALING C, P440; Hu WY, 2009, MAR RESOUR ECON, V24, P61, DOI 10.1086/mre.24.1.42629645; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Lammers Marc O., 2004, Aquatic Mammals, V30, P237, DOI 10.1578/AM.30.2.2004.237; Larsen F, 2004, J ZOOL, V263, P343, DOI 10.1017/S095283690400531X; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lusseau D., 2006, Tourism in Marine Environments, V3, P173, DOI 10.3727/154427306779435184; Lusseau D, 2005, MAR ECOL PROG SER, V295, P265, DOI 10.3354/meps295265; Martien KK, 2012, MAR MAMMAL SCI, V28, pE208, DOI 10.1111/j.1748-7692.2011.00506.x; MOBLEY JR, 2000, LJ0014C SW FISH SCI; Nicholson K, 2012, MAR FRESHWATER RES, V63, P1059, DOI 10.1071/MF12210; NOAA, 2005, 051110296529601 NOAA; Norris K.S., 1994, HAWAIIAN SPINNER DOL; NORRIS KS, 1980, FISH B-NOAA, V77, P821; O'Connor S., 2009, WHALE WATCHING WORLD; Ostman J., 1994, SOCIAL ORG SOCIAL BE; Ostman-Lind J, 2008, IMPACTS HUMAN ACTIVI; OstmanLind J., 2004, LJ0402C SW FISH SCI; Perrin WF, 1999, MAR MAMMAL SCI, V15, P1029, DOI 10.1111/j.1748-7692.1999.tb00876.x; PERRIN WF, 1990, P BIOL SOC WASH, V103, P453; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Read AJ, 2003, MAR MAMMAL SCI, V19, P59, DOI 10.1111/j.1748-7692.2003.tb01092.x; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Silva MA, 2009, MAR ECOL PROG SER, V392, P263, DOI 10.3354/meps08233; Smith HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076574; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Thorne LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043167; Timmel Gregory, 2008, Aquatic Mammals, V34, P402, DOI 10.1578/AM.34.4.2008.402; Urian K.W., 1999, STATUS PHOTO IDENTIF; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wiener CS, 2009, CURR ISSUES TOUR, V12, P489, DOI 10.1080/13683500902736855; Williams B. K., 2002, ANAL MANAGEMENT ANIM; WILLIAMS JA, 1993, CAN J ZOOL, V71, P2080, DOI 10.1139/z93-293; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; WOLANSKI E, 1988, SCIENCE, V241, P177, DOI 10.1126/science.241.4862.177	60	46	47	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86132	10.1371/journal.pone.0086132	http://dx.doi.org/10.1371/journal.pone.0086132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465917	Green Published, gold			2022-12-25	WOS:000330283100111
J	Wang, TY; Lin, SM; Shie, SS; Chou, PC; Huang, CD; Chung, FT; Kuo, CH; Chang, PJ; Kuo, HP				Wang, Tsai-Yu; Lin, Shu-Min; Shie, Shian-Sen; Chou, Pai-Chien; Huang, Chien-Da; Chung, Fu-Tsai; Kuo, Chih-His; Chang, Po-Jui; Kuo, Han-Pin			Clinical Characteristics and Treatment Outcomes of Patients with Low- and High-Concentration Isoniazid-Monoresistant Tuberculosis	PLOS ONE			English	Article							SHORT-COURSE CHEMOTHERAPY; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; DRUG RESISTANCE	Background: Isoniazid (INH) resistance is now the most common type of tuberculosis (TB) infection resistance worldwide. The aim of this study was to evaluate the clinical characteristics and treatment outcomes of patients with low-and high-concentration INH-monoresistant TB. Methods: One hundred and thirty-four patients with culture-confirmed INH-monoresistant TB during 2006 January to 2007 December were retrospectively enrolled. INH resistance was classified as either low-concentration or high-concentration resistance according to the critical concentrations of 0.2 mu g/mL or 1 mu g/mL of INH, respectively. The patients' clinical outcomes, treatment regimens, and treatment duration were analyzed. Results: The treatment success rates between low-and high-concentration INH-resistant TB were similar (81.8% vs. 86.7%). The treatment regimens and treatment duration were similar between both groups. Only a minor percentage of the patients in both groups received 6-month treatment regimens (low vs. high concentration resistance, 9.1% vs. 13.3%; respectively, p = 0.447) The most common reason for treatment duration longer than 6 months was pyrazinamide given for less than 6 months, followed by a delay in clinical response to treatment. Multivariable analysis showed that prior tuberculosis treatment (Odds ratio, 2.82, 95% C. I., 1.02-7.77, p = 0.045) was the only independent risk factor for unsuccessful treatment outcome. Conclusion: Different levels of INH resistance did not affect the treatment outcomes of patients with INH-monoresistant tuberculosis. Prolonged Rifampin-containing regimens may achieve those good outcomes in patients with low-and high-concentration INH-monoresistant TB.	[Wang, Tsai-Yu; Lin, Shu-Min; Chou, Pai-Chien; Huang, Chien-Da; Chung, Fu-Tsai; Kuo, Chih-His; Chang, Po-Jui; Kuo, Han-Pin] Chang Gung Univ, Chang Gung Mem Hosp, Dept Thorac Med, Sch Med, Taipei, Taiwan; [Shie, Shian-Sen] Chang Gung Univ, Chang Gung Mem Hosp, Dept Med, Div Infect Dis,Sch Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lin, SM (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Thorac Med, Sch Med, Taipei, Taiwan.	smlin100@gmail.com	Huang, Chien-Da/AAY-3771-2021	Huang, Chien-Da/0000-0002-4999-6019				Ando H, 2010, ANTIMICROB AGENTS CH, V54, P1793, DOI 10.1128/AAC.01691-09; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; [Anonymous], 1987, Am Rev Respir Dis, V136, P1339; Bang D, 2010, J INFECTION, V60, P452, DOI 10.1016/j.jinf.2010.03.017; Bloss E, 2012, INT J TUBERC LUNG D, V16, P462, DOI 10.5588/ijtld.11.0121; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Chowdhury AMR, 1999, LANCET, V353, P1003, DOI 10.1016/S0140-6736(99)02119-4; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Gegia M, 2012, INT J TUBERC LUNG D, V16, P812, DOI 10.5588/ijtld.11.0637; Hoopes AJ, 2008, ARCH INTERN MED, V168, P1984, DOI 10.1001/archinte.168.18.1984; Huang WL, 2009, J CLIN MICROBIOL, V47, P2520, DOI 10.1128/JCM.02499-08; Infectious Diseases Society of the Republic of China, 2004, J Microbiol Immunol Infect, V37, P382; Kim YH, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-6; MITCHISON DA, 1986, AM REV RESPIR DIS, V133, P423; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; WEBER WW, 1979, CLIN PHARMACOKINET, V4, P401, DOI 10.2165/00003088-197904060-00001; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1	21	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86316	10.1371/journal.pone.0086316	http://dx.doi.org/10.1371/journal.pone.0086316			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466020	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100138
J	Wong, SSW; Kao, RYT; Yuen, KY; Wang, Y; Yang, D; Samaranayake, LP; Seneviratne, CJ				Wong, Sarah Sze Wah; Kao, Richard Yi Tsun; Yuen, Kwok Yong; Wang, Yu; Yang, Dan; Samaranayake, Lakshman Perera; Seneviratne, Chaminda Jayampath			In Vitro and In Vivo Activity of a Novel Antifungal Small Molecule against Candida Infections	PLOS ONE			English	Article							DRUG-RESISTANCE MECHANISMS; BIOFILM FORMATION; DENTURE STOMATITIS; ECHINOCANDIN RESISTANCE; ORAL CANDIDIASIS; ALBICANS HYPHAE; AMPHOTERICIN-B; MURINE MODEL; EPIDEMIOLOGY; SUSCEPTIBILITY	Candida is the most common fungal pathogen of humans worldwide and has become a major clinical problem because of the growing number of immunocompromised patients, who are susceptible to infection. Moreover, the number of available antifungals is limited, and antifungal-resistant Candida strains are emerging. New and effective antifungals are therefore urgently needed. Here, we discovered a small molecule with activity against Candida spp. both in vitro and in vivo. We screened a library of 50,240 small molecules for inhibitors of yeast-to-hypha transition, a major virulence attribute of Candida albicans. This screening identified 20 active compounds. Further examination of the in vitro antifungal and anti-biofilm properties of these compounds, using a range of Candida spp., led to the discovery of SM21, a highly potent antifungal molecule (minimum inhibitory concentration (MIC) 0.2 - 1.6 mu g/ml). In vitro, SM21 was toxic to fungi but not to various human cell lines or bacterial species and was active against Candida isolates that are resistant to existing antifungal agents. Moreover, SM21 was relatively more effective against biofilms of Candida spp. than the current antifungal agents. In vivo, SM21 prevented the death of mice in a systemic candidiasis model and was also more effective than the common antifungal nystatin at reducing the extent of tongue lesions in a mouse model of oral candidiasis. Propidium iodide uptake assay showed that SM21 affected the integrity of the cell membrane. Taken together, our results indicate that SM21 has the potential to be developed as a novel antifungal agent for clinical use.	[Wong, Sarah Sze Wah; Samaranayake, Lakshman Perera; Seneviratne, Chaminda Jayampath] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Kao, Richard Yi Tsun; Yuen, Kwok Yong] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Wang, Yu] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Yang, Dan] Univ Hong Kong, Fac Sci, Dept Chem, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Kao, RYT (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	rytkao@hku.hk; jaya@hku.hk	Samaranayake, Lakshman/K-4947-2018; Wong, Sarah/DOH-8455-2022; YANG, Dan/HHD-2733-2022; Wong, Sarah/AAX-5103-2020	Samaranayake, Lakshman/0000-0002-9122-336X; Wong, Sarah/0000-0002-9440-1774; /0000-0003-0816-538X; Yuen, Kwok-yung/0000-0002-2083-1552; wang, yu/0000-0001-8697-2940	Health and Medical Research Fund; HKU; Tah-Wah Endowed Professorship fund	Health and Medical Research Fund; HKU(University of Hong Kong); Tah-Wah Endowed Professorship fund	This study was funded by Health and Medical Research Fund, HKU Research Output Prize and HKU Small project funding to CJS and Tah-Wah Endowed Professorship fund to LPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpan A, 2002, POSTGRAD MED J, V78, P455, DOI 10.1136/pmj.78.922.455; Ali I, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-7; Andes D, 2002, INT J ANTIMICROB AG, V19, P261, DOI 10.1016/S0924-8579(02)00022-5; Ben-Ami R, 2011, J INFECT DIS, V204, P626, DOI 10.1093/infdis/jir351; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chandrasekar P, 2011, J ANTIMICROB CHEMOTH, V66, P457, DOI 10.1093/jac/dkq479; Clancy CJ, 2011, J INFECT DIS, V204, P499, DOI 10.1093/infdis/jir355; Silva Wander José da, 2008, Braz. Dent. J., V19, P364, DOI 10.1590/S0103-64402008000400014; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6; Ellepola ANB, 1998, ARCH ORAL BIOL, V43, P999, DOI 10.1016/S0003-9969(98)00075-2; Gendreau L, 2011, J PROSTHODONT, V20, P251, DOI 10.1111/j.1532-849X.2011.00698.x; Grald A, 2012, J MED MICROBIOL, V61, P109, DOI 10.1099/jmm.0.034124-0; Hakki M, 2006, ANTIMICROB AGENTS CH, V50, P2522, DOI 10.1128/AAC.00148-06; Hawser S, 1999, J ANTIMICROB CHEMOTH, V43, P411, DOI 10.1093/jac/43.3.411; Ikeda F, 2000, ANTIMICROB AGENTS CH, V44, P614, DOI 10.1128/AAC.44.3.614-618.2000; Jarosz LM, 2011, APPL ENVIRON MICROB, V77, P8193, DOI 10.1128/AEM.06227-11; Jin Y, 2004, ARCH ORAL BIOL, V49, P789, DOI 10.1016/j.archoralbio.2004.04.011; Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003; John H., 2008, M27A328 CLIN LAB STA; Kamagata-Kiyoura Yusuke, 2004, Journal of Infection and Chemotherapy, V10, P253; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Kao RY, 2004, CHEM BIOL, V11, P1293, DOI 10.1016/j.chembiol.2004.07.013; Krcmery Vladimir, 2007, Recent Pat Antiinfect Drug Discov, V2, P182, DOI 10.2174/157489107782497317; LaFleur MD, 2011, J ANTIMICROB CHEMOTH, V66, P820, DOI 10.1093/jac/dkq530; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Louie A, 1998, ANTIMICROB AGENTS CH, V42, P1105, DOI 10.1128/AAC.42.5.1105; Midkiff J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025395; Miyazaki M, 2011, ANTIMICROB AGENTS CH, V55, P4652, DOI 10.1128/AAC.00291-11; ODDS FC, 1985, J GEN MICROBIOL, V131, P2581; Odds FC, 1988, CANDIDA CANDIDOSIS R; Ortega M, 2011, J HOSP INFECT, V77, P157, DOI 10.1016/j.jhin.2010.09.026; Ostrosky-Zeichner L, 2003, CLIN INFECT DIS, V37, P415, DOI 10.1086/376634; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Persidis A, 1999, NAT BIOTECHNOL, V17, P1141, DOI 10.1038/15141; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10; Ramage G, 2004, ORAL SURG ORAL MED O, V98, P53, DOI 10.1016/j.tripleo.2003.04.002; Ramani R, 1997, J CLIN MICROBIOL, V35, P2320, DOI 10.1128/JCM.35.9.2320-2324.1997; REX JH, 1993, CLIN MICROBIOL REV, V6, P367, DOI 10.1128/CMR.6.4.367-381.1993; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Seneviratne CJ, 2008, ORAL DIS, V14, P582, DOI 10.1111/j.1601-0825.2007.01424.x; Seneviratne CJ, 2011, MYCOPATHOLOGIA, V172, P389, DOI 10.1007/s11046-011-9444-4; Siikala E, 2010, J ANTIMICROB CHEMOTH, V65, P2505, DOI 10.1093/jac/dkq354; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Takakura N, 2003, MICROBIOL IMMUNOL, V47, P321, DOI 10.1111/j.1348-0421.2003.tb03403.x; Toenjes KA, 2005, ANTIMICROB AGENTS CH, V49, P963, DOI 10.1128/AAC.49.3.963-972.2005; Toenjes KA, 2009, J MED MICROBIOL, V58, P779, DOI 10.1099/jmm.0.006841-0; VANTWOUT JW, 1989, ANTIMICROB AGENTS CH, V33, P147, DOI 10.1128/AAC.33.2.147; Webb BC, 1998, AUST DENT J, V43, P160, DOI 10.1111/j.1834-7819.1998.tb00157.x; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	58	72	75	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85836	10.1371/journal.pone.0085836	http://dx.doi.org/10.1371/journal.pone.0085836			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465737	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100080
J	Ye, L; Wei, SS; Zou, YF; Yang, XB; Abdullah, A; Zhong, XN; Ruan, YH; Lin, XQ; Li, MQ; Wu, DR; Jiang, JJ; Xie, PY; Huang, JG; Liang, BY; Zhou, B; Su, JM; Liang, H; Huang, AL				Ye, Li; Wei, Suosu; Zou, Yunfeng; Yang, Xiaobo; Abdullah, Abu S.; Zhong, Xiaoni; Ruan, Yuhua; Lin, Xinqin; Li, Mingqiang; Wu, Deren; Jiang, Junjun; Xie, Peiyan; Huang, Jiegang; Liang, Bingyu; Zhou, Bo; Su, Jinming; Liang, Hao; Huang, Ailong			HIV Pre-Exposure Prophylaxis Interest among Female Sex Workers in Guangxi, China	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; CONDOM USE; ANTIRETROVIRAL PROPHYLAXIS; LIMITED KNOWLEDGE; PREVENTION; RISK; WOMEN; INFECTION; INTERVENTIONS; TRANSMISSION	Objectives: Acceptability of pre-exposure prophylaxis (PrEP) and willingness to participate in a clinical trial for both safety and efficacy of PrEP were investigated among female sex workers (FSWs) in Guangxi, China. Methods: A cross-sectional study was performed in three cities in Guangxi. Structured, self-administered questionnaires were used to assess the acceptability of PrEP and the willingness to participate in a clinical trial. Multivariable logistic regression models were fitted to identify predictors. Results: Among 405 participants, 15.1% had heard of PrEP. If PrEP was deemed to be effective, safe and provided for free, 85.9% reported that they would accept it, and 54.3% of those who accepted PrEP said that they would participate in a clinical trial. The increased acceptability of PrEP was associated with working in male dominated venues, higher income, a poor family relationship, better HIV/AIDS knowledge, not realizing HIV risk from unfamiliar clients, not being forced to use condoms by the gatekeepers, consistent use of condoms, and use of drugs to prevent STD infection. The increased willingness to participate in a clinical trial was associated with a poor family relationship, better HIV/AIDS knowledge, not realizing HIV risk from unfamiliar clients, a willingness to adhere to daily PreP use, and not being concerned about discrimination by others. The main reason for rejecting PrEP or participating in a clinical trial was the concern about the side effects of PrEP. Conclusions: Acceptability of PrEP among Guangxi FSWs is relatively high, indicating that PrEP intervention programs may be feasible for Chinese FSWs. Given the fact that most of the participants had never heard of PrEP before, and that family, gatekeepers, and social discrimination could significantly affect its acceptability, a comprehensive mix of multiple interventions is necessary for the successful implementation of a PrEP program among this population in Guangxi.	[Ye, Li; Zou, Yunfeng; Yang, Xiaobo; Abdullah, Abu S.; Li, Mingqiang; Jiang, Junjun; Xie, Peiyan; Huang, Jiegang; Liang, Bingyu; Zhou, Bo; Su, Jinming; Liang, Hao] Guangxi Med Univ, Sch Publ Hlth, Guangxi Key Lab AIDS Prevent & Treatment, Nanning, Guangxi, Peoples R China; [Wei, Suosu] Peoples Hosp Guangxi Zhuang Autonomous Reg, Nanning, Guangxi, Peoples R China; [Abdullah, Abu S.] Boston Univ, Sch Med, Dept Med, Boston Med Ctr, Boston, MA 02118 USA; [Zhong, Xiaoni; Huang, Ailong] Chongqing Med Univ, Sch Publ Hlth, Chongqing, Peoples R China; [Ruan, Yuhua] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Lin, Xinqin] Nanning Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China; [Li, Mingqiang] Liuzhou Ctr Dis Control & Prevent, Liuzhou, Guangxi, Peoples R China; [Wu, Deren] Beihai Ctr Dis Control & Prevent, Beihai, Guangxi, Peoples R China	Guangxi Medical University; Boston Medical Center; Boston University; Chongqing Medical University; Chinese Center for Disease Control & Prevention	Liang, H (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Guangxi Key Lab AIDS Prevent & Treatment, Nanning, Guangxi, Peoples R China.	haolphd@163.com; ahuang1964@yahoo.com.cn	Jiang, Kui/Z-2573-2019; Jiang, Junjun/AAH-9095-2020; Yang, Xiaobo/G-3854-2016	Jiang, Kui/0000-0002-4055-7503; wei, suosu/0000-0002-2022-7347	National Major Science and Technology Projects of the Twelfth Five-year Plan (China) [2012ZX10004910, 2012ZX10001-09]; Project for building of Talent Highland Innovative Team in Guangxi universities [[2010]38]	National Major Science and Technology Projects of the Twelfth Five-year Plan (China); Project for building of Talent Highland Innovative Team in Guangxi universities	This study was supported by National Major Science and Technology Projects of the Twelfth Five-year Plan (China, 2012ZX10004910 and 2012ZX10001-09), and the Project for building of Talent Highland Innovative Team in Guangxi universities (Guijiaoren [2010]38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron E, 2013, AIDS, V27, pF1, DOI 10.1097/QAD.0b013e32835917b4; ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten J, 2013, ANNU REV MED, V64, P219, DOI 10.1146/annurev-med-050911-163701; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Brown H, 2004, LANCET, V363, P1042, DOI 10.1016/S0140-6736(04)15881-9; CDC_Guangxi, 2009, WORKSH NIAAA VEN BAS; CDC_USA, 2010, CDC STAT RES IPREX T; Celum C, 2012, ANTIVIR THER, V17, P1483, DOI 10.3851/IMP2492; Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef; Choi SYP, 2008, SEX TRANSM DIS, V35, P141, DOI 10.1097/OLQ.0b013e31815407c3; Choi SYP, 2007, CULT HEALTH SEX, V9, P489, DOI 10.1080/13691050701220446; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; FRANK ML, 1995, WOMEN HEALTH, V23, P31, DOI 10.1300/J013v23n02_03; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Galindo GR, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-116; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gupta GR, 2002, BRIT MED J, V324, P183, DOI 10.1136/bmj.324.7331.183; Gupta GR, 1993, WOMEN AIDS DEV NEW H; Hallett TB, 2006, SEX TRANSM INFECT, V82, pI1, DOI 10.1136/sti.2005.016014; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; Hayes RJ, 2000, STAT METHODS MED RES, V9, P95, DOI 10.1191/096228000670953670; Hesketh T, 2005, AIDS CARE, V17, P958, DOI 10.1080/09540120500100676; Hong Y, 2008, AIDS BEHAV, V12, P623, DOI 10.1007/s10461-007-9287-7; Hong Y, 2008, SEX TRANSM DIS, V35, P662, DOI 10.1097/OLQ.0b013e31816b322c; Hong Y, 2011, AIDS CARE, V23, P54, DOI 10.1080/09540121.2011.554526; Huang YY, 2004, SEX TRANSM DIS, V31, P695, DOI 10.1097/01.olq.0000143107.06988.ea; Jana S, 1998, AIDS, V12 Suppl B, pS101; Kar SB, 1999, SOC SCI MED, V49, P1431, DOI 10.1016/S0277-9536(99)00200-2; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Lau JTF, 2002, AIDS CARE, V14, P219, DOI 10.1080/09540120220104721; Li Q, 2010, SEX TRANSM DIS, V37, P700, DOI 10.1097/OLQ.0b013e3181e1a2b2; Liao SS, 2003, AIDS EDUC PREV, V15, P109, DOI 10.1521/aeap.15.3.109.23834; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Mascolini M, 2012, 19 C RETR OPP INF SE; Mijiti P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067392; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Ministry of Health of People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2012, EST HIV AIDS EP CHIN; Pirkle C, 2007, SEX TRANSM DIS, V34, P695, DOI 10.1097/01.olq.0000260989.70866.94; Rogers SJ, 2002, AIDS EDUC PREV, V14, P217, DOI 10.1521/aeap.14.3.217.23892; Schneider JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011922; Severy LJ, 2005, AIDS BEHAV, V9, P121, DOI 10.1007/s10461-005-1687-y; STEIN ZA, 1990, AM J PUBLIC HEALTH, V80, P460, DOI 10.2105/AJPH.80.4.460; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Swendeman D, 2009, SOC SCI MED, V69, P1157, DOI 10.1016/j.socscimed.2009.07.035; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Turmen T, 2003, INT J GYNECOL OBSTET, V82, P411, DOI 10.1016/S0020-7292(03)00202-9; Van Damme L, 2012, 19 C RETR OPP INF MA; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Van Rompay KKA, 2006, JAIDS-J ACQ IMM DEF, V43, P6, DOI 10.1097/01.qai.0000224972.60339.7c; Wang B, 2005, SEX TRANSM DIS, V32, P696, DOI 10.1097/01.olq.0000175403.68410.ec; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; Whiteside YO, 2011, AIDS PATIENT CARE ST, V25, P365, DOI 10.1089/apc.2010.0224; Wong WCW, 2003, AIDS PATIENT CARE ST, V17, P417, DOI 10.1089/108729103322277439; Xia GM, 2005, AIDS EDUC PREV, V17, P143, DOI 10.1521/aeap.17.3.143.62904; Yang HM, 2005, SEX TRANSM DIS, V32, P572, DOI 10.1097/01.olq.0000175418.48665.95; Zhao Zhen, 2011, Zhejiang Da Xue Xue Bao Yi Xue Ban, V40, P281; Zhou F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032329	62	35	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86200	10.1371/journal.pone.0086200	http://dx.doi.org/10.1371/journal.pone.0086200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465956	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100124
J	Byrne, MB; Kimura, Y; Kapoor, A; He, Y; Mattam, KS; Hasan, KM; Olson, LN; Wang, F; Kenis, PJA; Rao, CV				Byrne, Matthew B.; Kimura, Yuki; Kapoor, Ashish; He, Yuan; Mattam, Kewin S.; Hasan, Katherine M.; Olson, Luke N.; Wang, Fei; Kenis, Paul J. A.; Rao, Christopher V.			Oscillatory Behavior of Neutrophils under Opposing Chemoattractant Gradients Supports a Winner-Take-All Mechanism	PLOS ONE			English	Article							EUKARYOTIC CHEMOTAXIS; MULTISTEP NAVIGATION; LEUKOCYTE ADHESION; ORDERED EXTENSION; LOCAL-EXCITATION; STOCHASTIC-MODEL; IN-VITRO; CELLS; MIGRATION; RECEPTOR	Neutrophils constitute the largest class of white blood cells and are the first responders in the innate immune response. They are able to sense and migrate up concentration gradients of chemoattractants in search of primary sites of infection and inflammation through a process known as chemotaxis. These chemoattractants include formylated peptides and various chemokines. While much is known about chemotaxis to individual chemoattractants, far less is known about chemotaxis towards many. Previous studies have shown that in opposing gradients of intermediate chemoattractants (interleukin-8 and leukotriene B-4), neutrophils preferentially migrate toward the more distant source. In this work, we investigated neutrophil chemotaxis in opposing gradients of chemoattractants using a microfluidic platform. We found that primary neutrophils exhibit oscillatory motion in opposing gradients of intermediate chemoattractants. To understand this behavior, we constructed a mathematical model of neutrophil chemotaxis. Our results suggest that sensory adaptation alone cannot explain the observed oscillatory motion. Rather, our model suggests that neutrophils employ a winner-take-all mechanism that enables them to transiently lock onto sensed targets and continuously switch between the intermediate attractant sources as they are encountered. These findings uncover a previously unseen behavior of neutrophils in opposing gradients of chemoattractants that will further aid in our understanding of neutrophil chemotaxis and the innate immune response. In addition, we propose a winner-take-all mechanism allows the cells to avoid stagnation near local chemical maxima when migrating through a network of chemoattractant sources.	[Byrne, Matthew B.; Kimura, Yuki; Kapoor, Ashish; Mattam, Kewin S.; Hasan, Katherine M.; Kenis, Paul J. A.; Rao, Christopher V.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Wang, Fei] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL USA; [Olson, Luke N.] Univ Illinois, Dept Comp Sci, Urbana, IL USA; [He, Yuan] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Michigan System; University of Michigan	Rao, CV (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.	chris@scs.uiuc.edu	Kapoor, Ashish/ABE-8197-2021; Kenis, Paul J A/S-7229-2016	Kapoor, Ashish/0000-0002-4686-394X; Kenis, Paul J A/0000-0001-7348-0381	National Institutes of Health [GM083601]; University of Illinois at Urbana-Champaign; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083601, R01GM083812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Urbana-Champaign; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for this study was provided by National Institutes of Health Grant GM083601 and the University of Illinois at Urbana-Champaign. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 1997, LANCET, V349, P490, DOI 10.1016/S0140-6736(96)07524-1; Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; ALLAN RB, 1978, EXP CELL RES, V111, P191, DOI 10.1016/0014-4827(78)90249-5; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; [Anonymous], [No title captured]; BARNETT ML, 1993, BIOCHIM BIOPHYS ACTA, V1177, P275, DOI 10.1016/0167-4889(93)90123-7; Benard EL, 2012, JOVE-J VIS EXP, DOI 10.3791/3781; Beta C, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/8/083015; Billadeau DD, 2008, NAT IMMUNOL, V9, P716, DOI 10.1038/ni0708-716; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006842; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Campbell JJ, 1997, EUR J IMMUNOL, V27, P2571, DOI 10.1002/eji.1830271016; Cavicchioni G, 2009, EUR J MED CHEM, V44, P4926, DOI 10.1016/j.ejmech.2009.08.010; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Dimasi D, 2013, INT IMMUNOPHARMACOL; FERNANDEZ HN, 1978, J IMMUNOL, V120, P109; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; GALLIN JI, 1978, J CLIN INVEST, V62, P1364, DOI 10.1172/JCI109257; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kim DH, 2012, ANAL CHEM; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; KREISLE RA, 1983, J EXP MED, V157, P628, DOI 10.1084/jem.157.2.628; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Levine H, 2006, P NATL ACAD SCI USA, V103, P9761, DOI 10.1073/pnas.0601302103; LEWIS MS, 1988, J CLIN INVEST, V82, P2045, DOI 10.1172/JCI113825; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lin F, 2005, ANN BIOMED ENG, V33, P475, DOI 10.1007/s10439-005-2503-6; Lin F, 2004, BIOCHEM BIOPH RES CO, V319, P576, DOI 10.1016/j.bbrc.2004.05.029; Lin F, 2006, LAB CHIP, V6, P1462, DOI 10.1039/b607071j; Lin F, 2008, J IMMUNOL, V181, P8335, DOI 10.4049/jimmunol.181.12.8335; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Ma L, 2004, BIOPHYS J, V87, P3764, DOI 10.1529/biophysj.104.045484; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Maree AFM, 2006, B MATH BIOL, V68, P1169, DOI 10.1007/s11538-006-9131-7; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mathias JR, 2009, METHODS MOL BIOL, V571, P151, DOI 10.1007/978-1-60761-198-1_10; Mathis SP, 2010, J IMMUNOL, V185, P3049, DOI 10.4049/jimmunol.1001031; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Millius A, 2009, CURR BIOL, V19, P253, DOI 10.1016/j.cub.2008.12.044; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Oelz D, 2005, MATH MED BIOL, V22, P291, DOI 10.1093/imammb/dqi009; Onsum M, 2007, PLOS COMPUT BIOL, V3, P436, DOI 10.1371/journal.pcbi.0030036; Porter JR, 2012, INTEGR BIOL-UK, V4, P310, DOI [10.1039/c2ib00114d, 10.1039/C2IB90009B]; REILLY IAG, 1988, J CLIN PATHOL, V41, P1163, DOI 10.1136/jcp.41.11.1163; SAGER R, 1991, ADV EXP MED BIOL, V305, P73; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; Van Haastert PJM, 2010, BIOPHYS J, V99, P3345, DOI 10.1016/j.bpj.2010.09.042; Van Haastert PJM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000874; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042; Wu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018805; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107	68	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85726	10.1371/journal.pone.0085726	http://dx.doi.org/10.1371/journal.pone.0085726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465668	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500099
J	Fung, T; Keenan, K				Fung, Tak; Keenan, Kevin			Confidence Intervals for Population Allele Frequencies: The General Case of Sampling from a Finite Diploid Population of Any Size	PLOS ONE			English	Article							SELECTION; DISTRIBUTIONS; INDIVIDUALS; DIVERSITY; EVOLUTION; INSECT; POWER	The estimation of population allele frequencies using sample data forms a central component of studies in population genetics. These estimates can be used to test hypotheses on the evolutionary processes governing changes in genetic variation among populations. However, existing studies frequently do not account for sampling uncertainty in these estimates, thus compromising their utility. Incorporation of this uncertainty has been hindered by the lack of a method for constructing confidence intervals containing the population allele frequencies, for the general case of sampling from a finite diploid population of any size. In this study, we address this important knowledge gap by presenting a rigorous mathematical method to construct such confidence intervals. For a range of scenarios, the method is used to demonstrate that for a particular allele, in order to obtain accurate estimates within 0.05 of the population allele frequency with high probability (>= 95%), a sample size of >30 is often required. This analysis is augmented by an application of the method to empirical sample allele frequency data for two populations of the checkerspot butterfly (Melitaea cinxia L.), occupying meadows in Finland. For each population, the method is used to derive >= 98.3% confidence intervals for the population frequencies of three alleles. These intervals are then used to construct two joint >= 95% confidence regions, one for the set of three frequencies for each population. These regions are then used to derive a >= 95% confidence interval for Jost's D, a measure of genetic differentiation between the two populations. Overall, the results demonstrate the practical utility of the method with respect to informing sampling design and accounting for sampling uncertainty in studies of population genetics, important for scientific hypothesis-testing and also for risk-based natural resource management.	[Fung, Tak] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Fung, Tak] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Keenan, Kevin] Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast, Antrim, North Ireland	National University of Singapore; Queens University Belfast; Queens University Belfast	Fung, T (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	tfung01@qub.ac.uk			National University of Singapore [WBS R-154-000-551-133]; Beaufort Marine Research Award in Ecosystem Approach; Sea Change Strategy and the Strategy for Science Technology and Innovation; Marine Institute; Marine Research Sub-Programme of the Irish National Development Plan; Beaufort Marine Research Award in Fish Population Genetics; Irish Government under the Sea Change Strategy	National University of Singapore(National University of Singapore); Beaufort Marine Research Award in Ecosystem Approach; Sea Change Strategy and the Strategy for Science Technology and Innovation; Marine Institute; Marine Research Sub-Programme of the Irish National Development Plan; Beaufort Marine Research Award in Fish Population Genetics; Irish Government under the Sea Change Strategy	TF is being supported by the National University of Singapore start-up grant WBS R-154-000-551-133. In addition, TF acknowledges past funding support by a Ph.D. studentship from the Beaufort Marine Research Award in Ecosystem Approach to Fisheries Management, carried out under the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2013), with the support of the Marine Institute, funded under the Marine Research Sub-Programme of the Irish National Development Plan 2007-2013 (http://www.marine.ie/home/research/MIFunded/BeaufortAwards/). KK is being supported by a Ph.D. studentship from the Beaufort Marine Research Award in Fish Population Genetics, funded by the Irish Government under the Sea Change Strategy as above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; [Anonymous], 2012, MATLAB VERS 8 0; [Anonymous], 2010, R LANG ENV STAT COMP; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Cai Y, 2005, COMPUT STAT DATA AN, V48, P605, DOI 10.1016/j.csda.2004.03.008; CHAKRABORTY R, 1992, HUM BIOL, V64, P141; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cox DR, 1974, THEORETICAL STAT; De Kovel CGF, 2006, GENET SEL EVOL, V38, P3, DOI 10.1051/gse:2005024; DeGiorgio M, 2010, GENETICS, V186, P1367, DOI 10.1534/genetics.110.121756; DeGiorgio M, 2009, MOL BIOL EVOL, V26, P501, DOI 10.1093/molbev/msn254; EANES WF, 1978, EVOLUTION, V32, P784, DOI 10.1111/j.1558-5646.1978.tb04633.x; FORBES SH, 1995, MOL BIOL EVOL, V12, P1106; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Friedlander SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052282; Gillespie J. H., 2004, POPULATION GENETICS; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; GREGORIUS HR, 1980, BIOMETRICS, V36, P643, DOI 10.2307/2556116; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hugnet C, 2004, J VET PHARMACOL THER, V27, P227, DOI 10.1111/j.1365-2885.2004.00585.x; Johnson N., 1997, DISCRETE MULTIVARIAT; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Laplace PS., 1820, THEORIE ANAL PROBABI; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Palo J, 1995, HEREDITAS, V123, P295, DOI 10.1111/j.1601-5223.1995.00295.x; Petrejcikova E, 2011, FORENSIC SCI INT-GEN, V5, pE53, DOI 10.1016/j.fsigen.2010.08.003; Rank NE, 2002, EVOLUTION, V56, P2278, DOI 10.1111/j.0014-3820.2002.tb00151.x; Rice J., 1995, MATH STAT DATA ANAL; Seider T, 2010, FORENSIC SCI INT-GEN, V4, pE159, DOI 10.1016/j.fsigen.2010.03.009; SJOGREN P, 1994, CONSERV BIOL, V8, P267, DOI 10.1046/j.1523-1739.1994.08010267.x; Talens E, 2005, STAT AUDITING AOQL M; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weir BS., 1996, METHODS DISCRETE POP; Wolfram Research Inc, 2003, MATH ED VERS 5 0	39	24	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85925	10.1371/journal.pone.0085925	http://dx.doi.org/10.1371/journal.pone.0085925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465792	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500147
J	Gabhann, JN; Hams, E; Smith, S; Wynne, C; Byrne, JC; Brennan, K; Spence, S; Kissenpfennig, A; Johnston, JA; Fallon, PG; Jefferies, CA				Gabhann, Joan Ni; Hams, Emily; Smith, Siobhan; Wynne, Claire; Byrne, Jennifer C.; Brennan, Kiva; Spence, Shaun; Kissenpfennig, Adrien; Johnston, James A.; Fallon, Padraic G.; Jefferies, Caroline A.			Btk Regulates Macrophage Polarization in Response to Lipopolysaccharide	PLOS ONE			English	Article							BRUTONS TYROSINE KINASE; NF-KAPPA-B; X-LINKED AGAMMAGLOBULINEMIA; ALTERNATIVE ACTIVATION; CELL-DEVELOPMENT; GENE-EXPRESSION; DENDRITIC CELLS; PHOSPHORYLATION; SYSTEM; GAMMA	Bacterial Lipopolysaccharide (LPS) is a strong inducer of inflammation and does so by inducing polarization of macrophages to the classic inflammatory M1 population. Given the role of Btk as a critical signal transducer downstream of TLR4, we investigated its role in M1/M2 induction. In Btk deficient (Btk(-\-)) mice we observed markedly reduced recruitment of M1 macrophages following intraperitoneal administration of LPS. Ex vivo analysis demonstrated an impaired ability of Btk(-/-) macrophages to polarize into M1 macrophages, instead showing enhanced induction of immunosuppressive M2-associated markers in response to M1 polarizing stimuli, a finding accompanied by reduced phosphorylation of STAT1 and enhanced STAT6 phosphorylation. In addition to STAT activation, M1 and M2 polarizing signals modulate the expression of inflammatory genes via differential activation of transcription factors and regulatory proteins, including NF-kappa B and SHIP1. In keeping with a critical role for Btk in macrophage polarization, we observed reduced levels of NF-kappa B p65 and Akt phosphorylation, as well as reduced induction of the M1 associated marker iNOS in Btk(-/-) macrophages in response to M1 polarizing stimuli. Additionally enhanced expression of SHIP1, a key negative regulator of macrophage polarisation, was observed in Btk(-/-) macrophages in response to M2 polarizing stimuli. Employing classic models of allergic M2 inflammation, treatment of Btk(-/-) mice with either Schistosoma mansoni eggs or chitin resulted in increased recruitment of M2 macrophages and induction of M2-associated genes. This demonstrates an enhanced M2 skew in the absence of Btk, thus promoting the development of allergic inflammation.	[Gabhann, Joan Ni; Smith, Siobhan; Wynne, Claire; Byrne, Jennifer C.; Jefferies, Caroline A.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Gabhann, Joan Ni; Smith, Siobhan; Wynne, Claire; Byrne, Jennifer C.; Jefferies, Caroline A.] Royal Coll Surgeons Ireland, RCSI Res Inst, Dublin 2, Ireland; [Hams, Emily; Brennan, Kiva; Fallon, Padraic G.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Wynne, Claire] Dublin Inst Technol, Sch Biol Sci, Dublin, Ireland; [Johnston, James A.] Univ Dublin Trinity Coll, St Jamess Hosp, Inst Mol Med, Dublin 2, Ireland; [Fallon, Padraic G.] Our Ladys Childrens Hosp Crumlin, Natl Childrens Res Ctr, Dublin, Ireland; [Spence, Shaun; Kissenpfennig, Adrien] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Johnston, James A.] Amgen Inc, Thousand Oaks, CA 91320 USA	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Trinity College Dublin; Technological University Dublin; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Queens University Belfast; Amgen	Jefferies, CA (corresponding author), Royal Coll Surgeons Ireland, Dublin 2, Ireland.	cjefferies@rcsi.ie	Jefferies, Caroline/AAI-1543-2021; Fallon, Padraic/Y-2711-2019	Jefferies, Caroline/0000-0002-8879-6722; Fallon, Padraic/0000-0002-8401-7293; Wynne, Claire/0000-0002-0481-8366; Ni Gabhann-Dromgoole, Joan/0000-0002-4247-3952; Hams, Emily/0000-0002-9745-3246; Kissenpfennig, Adrien/0000-0002-9633-3111; Brennan, Kiva/0000-0003-4960-7076	Health Research Board, Ireland [RP/2004/79, P/2006/121]; Science Foundation Ireland [08/IN.1/B2091]	Health Research Board, Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by the Health Research Board, Ireland (RP/2004/79) and P/2006/121 www.hrb.ie) and Science Foundation Ireland (Grant 08/IN.1/B2091 www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Amoras ALB, 2007, CLIN EXP IMMUNOL, V150, P422, DOI 10.1111/j.1365-2249.2007.03512.x; An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Antignano F, 2010, J IMMUNOL, V184, P2805, DOI 10.4049/jimmunol.0903170; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Byrne JC, 2013, J IMMUNOL IN PRESS; Costa-Carvalho BT, 2011, ALLERGOL IMMUNOPATH, V39, P128, DOI 10.1016/j.aller.2010.12.003; D'Cruz OJ, 2013, ONCOTARGETS THER, V6, P161, DOI 10.2147/OTT.S33732; Dasgupta P, 2012, J INNATE IMMUN, V4, P478, DOI 10.1159/000336025; de Diego RP, 2006, J ALLERGY CLIN IMMUN, V117, P1462, DOI 10.1016/j.jaci.2006.01.037; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Gabhann JN, 2010, J IMMUNOL, V184, P2314, DOI 10.4049/jimmunol.0902589; Gagliardi MC, 2003, CLIN EXP IMMUNOL, V133, P115, DOI 10.1046/j.1365-2249.2003.t01-1-02178.x; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hams E, 2011, SHOCK, V36, P295, DOI 10.1097/SHK.0b013e318225ad7e; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hendriks RW, 1996, EMBO J, V15, P4862, DOI 10.1002/j.1460-2075.1996.tb00867.x; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Hu XY, 2003, J IMMUNOL, V170, P4833, DOI 10.4049/jimmunol.170.9.4833; Jyonouchi H, 2008, EUR J PEDIATR, V167, P317, DOI 10.1007/s00431-007-0493-0; Kawakami Y, 2006, P NATL ACAD SCI USA, V103, P153, DOI 10.1073/pnas.0509784103; Kitaura J, 2000, J EXP MED, V192, P729, DOI 10.1084/jem.192.5.729; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lee KG, 2012, P NATL ACAD SCI USA, V109, P5791, DOI 10.1073/pnas.1119238109; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangan NE, 2007, EUR J IMMUNOL, V37, P1302, DOI 10.1002/eji.200636520; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mohammad DK, 2013, MOL CELL BIOL, V33, P3214, DOI 10.1128/MCB.00247-13; Ni Gabhann J, 2011, CLIN IMMUNOL; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Orme J, 2012, DISCOV MED, V13, P151; Ostrand-Rosenberg S, 2000, J IMMUNOL, V165, P6015, DOI 10.4049/jimmunol.165.11.6015; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Ramalingam TR, 2005, CURR OPIN ALLERGY CL, V5, P392, DOI 10.1097/01.all.0000182542.30100.6f; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Shabestari MS, 2008, J INVEST ALLERG CLIN, V18, P300; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Smith Philip, 2009, V517, P401, DOI 10.1007/978-1-59745-541-1_24; Spence S, 2013, IMMUNITY, V38, P66, DOI 10.1016/j.immuni.2012.09.013; Taha RA, 1999, J ALLERGY CLIN IMMUN, V103, P476, DOI 10.1016/S0091-6749(99)70474-4; TakahashiTezuka M, 1997, ONCOGENE, V14, P2273, DOI 10.1038/sj.onc.1201071; Taneichi H, 2008, CLIN IMMUNOL, V126, P148, DOI 10.1016/j.clim.2007.10.005; Uckun F, 2007, BRIT J HAEMATOL, V136, P574, DOI 10.1111/j.1365-2141.2006.06468.x; Weisser SB, 2011, EUR J IMMUNOL, V41, P1742, DOI 10.1002/eji.201041105; Xu F, 2013, J INFECT DIS, V208, P528, DOI 10.1093/infdis/jit177; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	70	61	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85834	10.1371/journal.pone.0085834	http://dx.doi.org/10.1371/journal.pone.0085834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465735	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500126
J	Lei, Y; Lui, VWY; Grandis, JR; Egloff, AM				Lei, Yu; Lui, Vivian W. Y.; Grandis, Jennifer R.; Egloff, Ann Marie			Identification of Mutations in the PYRIN-Containing NLR Genes (NLRP) in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							COLON INFLAMMATION; I INTERFERON; INFLAMMASOMES; AUTOPHAGY; CYTOKINES; PROTEIN; DISEASE; TUFM	Head and Neck Squamous Cell Carcinoma (HNSCC) encompasses malignancies that arise in the mucosa of the upper aerodigestive tract. Recent high throughput DNA sequencing revealed HNSCC genes mutations that contribute to several cancer cell characteristics, including dysregulation of cell proliferation and death, intracellular proinflammatory signaling, and autophagy. The PYRIN-domain containing NLR (Nucleotide-binding domain, Leucine rich Repeats - containing) proteins have recently emerged as pivotal modulators of cell death, autophagy, inflammation, and metabolism. Their close physiologic association with cancer development prompted us to determine whether mutations within the NLRP (PYRIN-containing NLR) gene family were associated with HNSCC genome instability and their clinicopathologic correlations. Catastrophic mutational events underlie cancer cell genome instability and mark a point-of-no-return in cancer cell development and generation of heterogeneity. The mutation profiles of 62 patients with primary conventional type HNSCC excluding other histologic variants were analyzed. Associations were tested using Fisher's Exact test or Mann-Whitney U test. Mutations in NLRP were associated with elevated genome instability as characterized by higher mutation rates. Clinically, NLRP mutations were more frequently found in HNSCC arising in the floor of mouth (50.0%) in comparison with HNSCC at other head and neck locations (14.8%). These mutations were clustered at the leucine rich repeats region of NLRP proteins, and affected NLRP genes were mostly localized at chromosomes 11p15.4 and 19q13.42-19q13.43. Twenty novel NLRP mutations were identified in HNSCC, and mutations in this group of genes were correlated with increased cancer cell genome mutation rates, and such features could be a potential molecular biomarker of HNSCC genome instability.	[Lei, Yu] Univ Pittsburgh, Sch Dent Med, Dept Diagnost Sci, Pittsburgh, PA 15213 USA; [Lui, Vivian W. Y.; Grandis, Jennifer R.; Egloff, Ann Marie] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; [Lui, Vivian W. Y.; Grandis, Jennifer R.; Egloff, Ann Marie] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Grandis, Jennifer R.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Egloff, Ann Marie] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lei, Y (corresponding author), Univ Pittsburgh, Sch Dent Med, Dept Diagnost Sci, Pittsburgh, PA 15213 USA.	leiyuleo@gmail.com	Lui, Vivian W. Y./I-5458-2016; Lei, Yu Leo/ABF-1293-2020	Lui, Vivian W. Y./0000-0001-6918-1573; Lei, Yu Leo/0000-0002-9868-9824	Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer neoplasm of the University of Pittsburgh [P50CA097190];  [K07CA137140]; NATIONAL CANCER INSTITUTE [P50CA097190, K07CA137140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023685] Funding Source: NIH RePORTER	Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer neoplasm of the University of Pittsburgh; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by P50CA097190 (JRG) the Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer neoplasm of the University of Pittsburgh and K07CA137140 (AME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ahn J, 2012, CANCER CAUSE CONTROL, V23, P399, DOI 10.1007/s10552-011-9892-7; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Brailo V, 2011, MED ORAL PATOL ORAL; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Collisson EA, 2012, NAT REV CLIN ONCOL; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Davis BK, 2011, ANN REV IMMUNOL; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jounai N, 2011, J IMMUNOL, V186, P1646, DOI 10.4049/jimmunol.1001654; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Lei Y, 2013, AUTOPHAGY, V9, P432, DOI 10.4161/auto.23026; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; MASHBERG A, 1995, CA-CANCER J CLIN, V45, P328, DOI 10.3322/canjclin.45.6.328; Meurman JH, 2010, J ORAL MICROBIOL, V10, P2; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Meyer MS, 2008, CANCER CAUSE CONTROL, V19, P895, DOI 10.1007/s10552-008-9163-4; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; O'Rorke MA, 2012, ORAL ONCOL; Pries R, 2006, CYTOKINE GROWTH F R, V17, P141, DOI 10.1016/j.cytogfr.2006.02.001; Slim R, 2012, MOL HUM REPROD, V18, P52, DOI 10.1093/molehr/gar060; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; van Monsjou HS, 2010, ORAL ONCOL, V46, P780, DOI 10.1016/j.oraloncology.2010.08.011; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Woods KV, 1998, CANCER RES, V58, P3132; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zaki MH, 2011, TRENDS IMMUNOL, V32, P171, DOI 10.1016/j.it.2011.02.002; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046	40	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85619	10.1371/journal.pone.0085619	http://dx.doi.org/10.1371/journal.pone.0085619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465623	Green Accepted, Green Published, gold			2022-12-25	WOS:000330244500084
J	Littlejohn, MD; Tiplady, K; Lopdell, T; Law, TA; Scott, A; Harland, C; Sherlock, R; Henty, K; Obolonkin, V; Lehnert, K; MacGibbon, A; Spelman, RJ; Davis, SR; Snell, RG				Littlejohn, Mathew D.; Tiplady, Kathryn; Lopdell, Thomas; Law, Tania A.; Scott, Andrew; Harland, Chad; Sherlock, Ric; Henty, Kristen; Obolonkin, Vlad; Lehnert, Klaus; MacGibbon, Alistair; Spelman, Richard J.; Davis, Stephen R.; Snell, Russell G.			Expression Variants of the Lipogenic AGPAT6 Gene Affect Diverse Milk Composition Phenotypes in Bos taurus	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; DAIRY-CATTLE; FERTILITY TRAITS; DGAT1; CARCASS; HEALTH; SCAN; QTL; IDENTIFICATION	Milk is composed of a complex mixture of lipids, proteins, carbohydrates and various vitamins and minerals as a source of nutrition for young mammals. The composition of milk varies between individuals, with lipid composition in particular being highly heritable. Recent reports have highlighted a region of bovine chromosome 27 harbouring variants affecting milk fat percentage and fatty acid content. We aimed to further investigate this locus in two independent cattle populations, consisting of a Holstein-Friesian x Jersey crossbreed pedigree of 711 F2 cows, and a collection of 32,530 mixed ancestry Bos taurus cows. Bayesian genome-wide association mapping using markers imputed from the Illumina BovineHD chip revealed a large quantitative trait locus (QTL) for milk fat percentage on chromosome 27, present in both populations. We also investigated a range of other milk composition phenotypes, and report additional associations at this locus for fat yield, protein percentage and yield, lactose percentage and yield, milk volume, and the proportions of numerous milk fatty acids. We then used mammary RNA sequence data from 212 lactating cows to assess the transcript abundance of genes located in the milk fat percentage QTL interval. This analysis revealed a strong eQTL for AGPAT6, demonstrating that high milk fat percentage genotype is also additively associated with increased expression of the AGPAT6 gene. Finally, we used whole genome sequence data from six F1 sires to target a panel of novel AGPAT6 locus variants for genotyping in the F2 crossbreed population. Association analysis of 58 of these variants revealed highly significant association for polymorphisms mapping to the 5'UTR exons and intron 1 of AGPAT6. Taken together, these data suggest that variants affecting the expression of AGPAT6 are causally involved in differential milk fat synthesis, with pleiotropic consequences for a diverse range of other milk components.	[Littlejohn, Mathew D.; Tiplady, Kathryn; Lopdell, Thomas; Scott, Andrew; Harland, Chad; Sherlock, Ric; Henty, Kristen; Obolonkin, Vlad; Lehnert, Klaus; Spelman, Richard J.; Davis, Stephen R.] Livestock Improvement Corp, Res & Dev, Hamilton, New Zealand; [Law, Tania A.; Henty, Kristen; Lehnert, Klaus; Snell, Russell G.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [MacGibbon, Alistair] Fonterra Res Ctr, Palmerston North, New Zealand	Livestock Improvement Corporation; University of Auckland; Fonterra	Littlejohn, MD (corresponding author), Livestock Improvement Corp, Res & Dev, Hamilton, New Zealand.	mlittlejohn@lic.co.nz	MacGibbon, Alastair Kenneth Hugh/AAE-4692-2022; Lopdell, Thomas John/T-6661-2019	MacGibbon, Alastair Kenneth Hugh/0000-0002-1223-3501; Lopdell, Thomas John/0000-0002-7684-4870; Snell, Russell/0000-0002-8166-4014; Littlejohn, Mathew/0000-0001-9044-047X; Harland, Chad/0000-0002-6268-0107	Ministry for Primary Industries	Ministry for Primary Industries	This work was funded by the Ministry for Primary Industries through the Primary Growth Partnership. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2012, CURR OPIN LIPIDOL, V23, P290, DOI 10.1097/MOL.0b013e328354fcf4; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Berry SD, 2010, NEW ZEAL VET J, V58, P1, DOI 10.1080/00480169.2010.65053; Berry SD, 2009, GENETICS, V182, P923, DOI 10.1534/genetics.109.101741; Berry S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057219; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Casas E, 2000, J ANIM SCI, V78, P560; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fernando RL, 2010, GENSEL USER MANUAL P; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Gilmour AR, 2009, ASREML USER GUIDE RE; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Heyen DW, 1999, PHYSIOL GENOMICS, V1, P165, DOI 10.1152/physiolgenomics.1999.1.3.165; *INT DAIR FED, 1987, MILK DET FAT CONT RO; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li X, 2013, MEAT SCI, V94, P153, DOI 10.1016/j.meatsci.2013.01.010; Littlejohn MD, 2010, PHYSIOL GENOMICS, V41, P21, DOI 10.1152/physiolgenomics.00108.2009; Mansson H.L., 2008, FOOD NUTR RES, V52; McClure MC, 2010, ANIM GENET, V41, P597, DOI 10.1111/j.1365-2052.2010.02063.x; Meuwissen THE, 2001, GENETICS, V157, P1819; Nalaila SM, 2012, J ANIM BREED GENET, V129, P107, DOI 10.1111/j.1439-0388.2011.00954.x; Neville MC, 1997, ANNU REV NUTR, V17, P159, DOI 10.1146/annurev.nutr.17.1.159; Pryce JE, 2010, J DAIRY SCI, V93, P3331, DOI 10.3168/jds.2009-2893; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROOK JAF, 1979, P NUTR SOC, V38, P309, DOI 10.1079/PNS19790053; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schopen GCB, 2011, J DAIRY SCI, V94, P3148, DOI 10.3168/jds.2010-4030; Spelman R. J., 2001, Proceedings of the Fourteenth Conference of the Association for the Advancement of Animal Breeding and Genetics, Queenstown, New Zealand, 30 July-2 August 2001, P393; Strucken EM, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-108; Thaller G, 2003, ANIM GENET, V34, P354, DOI 10.1046/j.1365-2052.2003.01011.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Wang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036663, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0040084, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045380]; Zhang Q, 1998, GENETICS, V149, P1959	45	46	48	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85757	10.1371/journal.pone.0085757	http://dx.doi.org/10.1371/journal.pone.0085757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465687	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500106
J	Melaiu, O; Stebbing, J; Lombardo, Y; Bracci, E; Uehara, N; Bonotti, A; Cristaudo, A; Foddis, R; Mutti, L; Barale, R; Gemignani, F; Giamas, G; Landi, S				Melaiu, Ombretta; Stebbing, Justin; Lombardo, Ylenia; Bracci, Elisa; Uehara, Norihisa; Bonotti, Alessandra; Cristaudo, Alfonso; Foddis, Rudy; Mutti, Luciano; Barale, Roberto; Gemignani, Federica; Giamas, Georgios; Landi, Stefano			MSLN Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma	PLOS ONE			English	Article							OVARIAN-CANCER; ANTITUMOR-ACTIVITY; SERUM MESOTHELIN; IMMUNOTHERAPY; CA125/MUC16; ACTIVATION; DIAGNOSIS; INVASION; THERAPY; BINDING	Genes involved in the carcinogenetic mechanisms underlying malignant pleural mesothelioma (MPM) are still poorly characterized. So far, mesothelin (MSLN) has aroused the most interest. It encodes for a membrane glycoprotein, frequently over-expressed in various malignancies such as MPM, and ovarian and pancreatic cancers. It has been proposed as a diagnostic and immunotherapeutic target with promising results. However, an alternative therapeutic approach seems to rise, whereby synthetic molecules, such as antisense oligonucleotides, could be used to inhibit MSLN activity. To date, such a gene-level inhibition has been attempted in two studies only, both on pancreatic and ovarian carcinoma cell lines, with the use of silencing RNA approaches. With regard to MPM, only one cell line (H2373) has been employed to study the effects of MSLN depletion. Indeed, the knowledge on the role of MSLN in MPM needs expanding. Accordingly, we investigated the expression of MSLN in a panel of three MPM cell lines, i.e. NCI-H28, Mero-14, and IstMes2; one non-MPM cell line was used as reference (Met5A). MSLN knock-down experiments on MSLN-overexpressing cells were also performed through silencing RNA (siRNA) to verify whether previous findings could be generalized to a different set of cell cultures. In agreement with previous studies, transient MSLN-silencing caused decreased proliferation rate and reduced invasive capacity and sphere formation in MSLN-overexpressing Mero-14 cells. Moreover, MSLN-siRNA combined with cisplatin, triggered a marked increase in apoptosis and a decrease in proliferation as compared to cells treated with each agent alone, thereby suggesting a sensitizing effect of siRNA towards cisplatin. In summary, our findings confirm that MSLN should be considered a key molecular target for novel gene-based targeted therapies of cancer.	[Melaiu, Ombretta; Bracci, Elisa; Barale, Roberto; Gemignani, Federica; Landi, Stefano] Univ Pisa, Dept Biol, Pisa, Italy; [Stebbing, Justin; Lombardo, Ylenia; Giamas, Georgios] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Uehara, Norihisa] Kansai Med Univ, Dept Pathol 2, Moriguchi, Osaka 570, Japan; [Bonotti, Alessandra; Cristaudo, Alfonso; Foddis, Rudy] Univ Pisa, Dept Endocrinol & Metab Orthoped & Traumatol, Pisa, Italy; [Mutti, Luciano] Vercelli Natl Hlth Trust, Lab Clin Oncol, Vercelli, Italy	University of Pisa; Imperial College London; Kansai Medical University; University of Pisa	Landi, S (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	slandi@biologia.unipi.it	Melaiu, Ombretta/Z-3461-2019; Giamas, Georgios/AAP-3487-2021; Mutti, Luciano/A-3545-2011; Uehara, Norihisa/ABB-8106-2020	Melaiu, Ombretta/0000-0001-7118-5186; GEMIGNANI, Federica/0000-0003-1297-0701; Mutti, Luciano/0000-0002-1578-2637; Stebbing, Justin/0000-0002-1117-6947; Landi, Stefano/0000-0001-8364-6357; Giamas, Georgios/0000-0002-4417-2707; BARALE, Roberto/0000-0003-4161-2241	University of Pisa; Fondazione Buzzi Unicem; Cancer Research UK [14549] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish	University of Pisa; Fondazione Buzzi Unicem; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The work was funded by the University of Pisa (www.unipi.it) (regular badget, ex 60%), and by the Fondazione Buzzi Unicem (www.buzziunicem.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2001, CLIN CANCER RES, V7, P3862; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; Bharadwaj U, 2008, MOL CANCER RES, V6, P1755, DOI 10.1158/1541-7786.MCR-08-0095; Breidenbach M, 2005, GENE THER, V12, P187, DOI 10.1038/sj.gt.3302404; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chen SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01870; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Grigoriu BD, 2007, CLIN CANCER RES, V13, P2928, DOI 10.1158/1078-0432.CCR-06-2144; Hassan R, 2006, CLIN CANCER RES, V12, P447, DOI 10.1158/1078-0432.CCR-05-1477; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Hassan R, 2000, J IMMUNOTHER, V23, P473, DOI 10.1097/00002371-200007000-00011; Hassan Raffit, 2007, Cancer Immun, V7, P20; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hung CF, 2007, GENE THER, V14, P921, DOI 10.1038/sj.gt.3302913; Hung CF, 2007, VACCINE, V25, P127, DOI 10.1016/j.vaccine.2006.06.087; Imamura O, 2008, CANCER LETT, V268, P278, DOI 10.1016/j.canlet.2008.04.002; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Marshall J, 2011, METHODS MOL BIOL, V769, P97, DOI 10.1007/978-1-61779-207-6_8; Orengo AM, 1999, EUR RESPIR J, V13, P527, DOI 10.1183/09031936.99.13352799; Robinson BWS, 2003, LANCET, V362, P1612, DOI 10.1016/S0140-6736(03)14794-0; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Sapede C, 2008, CANCER SCI, V99, P590, DOI 10.1111/j.1349-7006.2007.00715.x; Tang ZW, 2013, MOL CANCER THER, V12, P416, DOI 10.1158/1535-7163.MCT-12-0731; Tang ZW, 2013, ANTI-CANCER AGENT ME, V13, P276, DOI 10.2174/1871520611313020014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERSNEL MA, 1989, CANCER GENET CYTOGEN, V42, P115, DOI 10.1016/0165-4608(89)90014-9; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033214; YAMAGUCHI N, 1994, J BIOL CHEM, V269, P805; Yu LP, 2010, J CANCER, V1, P141; Zheng CN, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-84	31	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85935	10.1371/journal.pone.0085935	http://dx.doi.org/10.1371/journal.pone.0085935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465798	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000330244500148
J	Simo, R; Hernandez, C; Saez-Lopez, C; Soldevila, B; Puig-Domingo, M; Selva, DM				Simo, Rafael; Hernandez, Cristina; Saez-Lopez, Cristina; Soldevila, Berta; Puig-Domingo, Manel; Selva, David M.			Thyroid Hormone Upregulates Zinc-alpha(2)-glycoprotein Production in the Liver but Not in Adipose Tissue	PLOS ONE			English	Article							LIPID-MOBILIZING FACTOR; NECROSIS-FACTOR-ALPHA; ZINC-ALPHA-2-GLYCOPROTEIN; EXPRESSION; ZAG; INDUCTION; LIPOLYSIS; WEIGHT; MICE	Overproduction of zinc-alpha(2)-glycoprotein by adipose tissue is crucial in accounting for the lipolysis occurring in cancer cachexia of certain malignant tumors. The main aim of this study was to explore whether thyroid hormone could enhance zinc-alpha(2)-glycoprotein production in adipose tissue. In addition, the regulation of zinc-alpha(2)-glycoprotein by thyroid hormone in the liver was investigated. We performed in vitro (HepG2 cells and primary human adipocytes) and in vivo (C57BL6/mice) experiments addressed to examine the effect of thyroid hormone on zinc-alpha(2)-glycoprotein production (mRNA and protein levels) in liver and visceral adipose tissue. We also measured the zinc-alpha(2)-glycoprotein serum levels in a cohort of patients before and after controlling their hyperthyroidism. Our results showed that thyroid hormone up-regulates zinc-alpha(2)-glycoprotein production in HepG2 cells in a dose-dependent manner. In addition, the zinc-alpha(2)-glycoprotein proximal promoter contains functional thyroid hormone receptor binding sites that respond to thyroid hormone treatment in luciferase reporter gene assays in HepG2 cells. Furthermore, zinc-alpha(2)-glycoprotein induced lipolysis in HepG2 in a dose-dependent manner. Our in vivo experiments in mice confirmed the up-regulation of zinc-alpha(2)-glycoprotein induced by thyroid hormone in the liver, thus leading to a significant increase in zinc-alpha(2)-glycoprotein circulating levels. However, thyroid hormone did not regulate zinc-alpha(2)-glycoprotein production in either human or mouse adipocytes. Finally, in patients with hyperthyroidism a significant reduction of zinc-alpha(2)-glycoprotein serum levels was detected after treatment but was unrelated to body weight changes. We conclude that thyroid hormone up-regulates the production of zinc-alpha(2)-glycoprotein in the liver but not in the adipose tissue. The neutral effect of thyroid hormones on zinc-alpha(2)-glycoprotein expression in adipose tissue could be the reason why zinc-alpha(2)-glycoprotein is not related to weight loss in hyperthyroidism.	[Simo, Rafael; Hernandez, Cristina; Saez-Lopez, Cristina; Selva, David M.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Inst Recerca, Diabet & Metab Res Unit, E-08193 Barcelona, Spain; [Simo, Rafael; Hernandez, Cristina; Saez-Lopez, Cristina; Selva, David M.] CIBERDEM ISCIII, Barcelona, Spain; [Soldevila, Berta; Puig-Domingo, Manel] Univ Autonoma Barcelona, Germans Trias & Pujol Hlth Sci Reseach Inst & Hos, Dept Med, Serv Endocrinol & Nutr, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Autonomous University of Barcelona	Selva, DM (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Inst Recerca, Diabet & Metab Res Unit, E-08193 Barcelona, Spain.	david.martinez.selva@vhir.org	Puig-Domingo, Manel/S-2169-2019; Selva, David Martínez/O-6444-2016; Soldevila, Berta/GXV-0551-2022	Puig-Domingo, Manel/0000-0002-6744-7195; Simo Canonge, Rafael/0000-0003-0475-3096; Hernandez, Cristina/0000-0002-3109-1721	Instituto de Salud Carlos III [CP08/00058, PI09/144]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by two grants from the Instituto de Salud Carlos III (DMS): CP08/00058 and PI09/144. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Bing C, 2006, BRIT J CANCER, V95, P1028, DOI 10.1038/sj.bjc.6603360; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Ceperuelo-Mallafre V, 2009, J CLIN ENDOCR METAB, V94, P5062, DOI 10.1210/jc.2009-0764; Chen CY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011270; Flik G, 2009, J CLIN ENDOCR METAB, V94, P4668, DOI 10.1210/jc.2009-2199; Gao D, 2010, MOL CELL ENDOCRINOL, V325, P135, DOI 10.1016/j.mce.2010.05.020; Gong FY, 2009, INT J OBESITY, V33, P1023, DOI 10.1038/ijo.2009.141; Grasselli E, 2011, J HEPATOL, V54, P1230, DOI 10.1016/j.jhep.2010.09.027; Hirai K, 1998, CANCER RES, V58, P2359; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ittermann T, 2012, THYROID, V22, P568, DOI 10.1089/thy.2011.0279; Moreno-Navarrete JM, 2013, INT J OBESITY; Mracek T, 2010, J ENDOCRINOL, V204, P165, DOI 10.1677/JOE-09-0299; Mracek T, 2011, BRIT J CANCER, V104, P441, DOI 10.1038/sj.bjc.6606083; Philipp A, 2011, METABOLISM, V60, P669, DOI 10.1016/j.metabol.2010.06.019; Rolli V, 2007, FEBS LETT, V581, P394, DOI 10.1016/j.febslet.2006.12.047; Russell ST, 2011, INT J OBESITY, V35, P658, DOI 10.1038/ijo.2010.193; Russell ST, 2005, PROSTAG LEUKOTR ESS, V72, P409, DOI 10.1016/j.plefa.2005.03.002; Russell ST, 2005, BRIT J CANCER, V92, P876, DOI 10.1038/sj.bjc.6602404; Russell ST, 2004, BBA-MOL CELL BIOL L, V1636, P59, DOI 10.1016/j.bbalip.2003.12.004; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; Selva DM, 2007, J CLIN INVEST, V117, P3979, DOI 10.1172/JCI32249; Selva DM, 2009, J CLIN ENDOCR METAB, V94, P4499, DOI 10.1210/jc.2009-0758; Todorov PT, 1998, CANCER RES, V58, P2353; Viguerie N, 2002, J CLIN ENDOCR METAB, V87, P630, DOI 10.1210/jc.87.2.630; Yeung DCY, 2009, J CLIN ENDOCR METAB, V94, P2531, DOI 10.1210/jc.2009-0058	29	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85753	10.1371/journal.pone.0085753	http://dx.doi.org/10.1371/journal.pone.0085753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465683	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500104
J	Tkacik, G; Ghosh, A; Schneidman, E; Segev, R				Tkacik, Gasper; Ghosh, Anandamohan; Schneidman, Elad; Segev, Ronen			Adaptation to Changes in Higher-Order Stimulus Statistics in the Salamander Retina	PLOS ONE			English	Article							CONTRAST GAIN-CONTROL; RECEPTIVE-FIELDS; NEURAL RESPONSES; NATURAL SCENES; INFORMATION; MODEL; SPIKE; NEURONS; MECHANISM; SIGNALS	Adaptation in the retina is thought to optimize the encoding of natural light signals into sequences of spikes sent to the brain. While adaptive changes in retinal processing to the variations of the mean luminance level and second-order stimulus statistics have been documented before, no such measurements have been performed when higher-order moments of the light distribution change. We therefore measured the ganglion cell responses in the tiger salamander retina to controlled changes in the second (contrast), third (skew) and fourth (kurtosis) moments of the light intensity distribution of spatially uniform temporally independent stimuli. The skew and kurtosis of the stimuli were chosen to cover the range observed in natural scenes. We quantified adaptation in ganglion cells by studying linear-nonlinear models that capture well the retinal encoding properties across all stimuli. We found that the encoding properties of retinal ganglion cells change only marginally when higher-order statistics change, compared to the changes observed in response to the variation in contrast. By analyzing optimal coding in LN-type models, we showed that neurons can maintain a high information rate without large dynamic adaptation to changes in skew or kurtosis. This is because, for uncorrelated stimuli, spatio-temporal summation within the receptive field averages away non-gaussian aspects of the light intensity distribution.	[Tkacik, Gasper] IST Austria, Klosterneuburg, Austria; [Ghosh, Anandamohan] Indian Inst Sci Educ & Res Kolkata, Mohanpur, Nadia, India; [Schneidman, Elad] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Segev, Ronen] Ben Gurion Univ Negev, Dept Life Sci, Fac Nat Sci, IL-84105 Beer Sheva, Israel; [Segev, Ronen] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel	Institute of Science & Technology - Austria; Indian Institute of Science Education & Research (IISER) - Kolkata; Weizmann Institute of Science; Ben Gurion University; Ben Gurion University	Tkacik, G (corresponding author), IST Austria, Klosterneuburg, Austria.	gtkacik@ist.ac.at		Tkacik, Gasper/0000-0002-6699-1455; Segev, Ronen/0000-0002-8109-1076; schneidman, elad/0000-0001-8653-9848	Israel Science Foundation; Human Frontiers Science Program	Israel Science Foundation(Israel Science Foundation); Human Frontiers Science Program(Human Frontier Science Program)	This work was supported by The Israel Science Foundation and The Human Frontiers Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Adrian E.D., 1928, BASIS SENSATION; Arcas BAY, 2003, NEURAL COMPUT, V15, P1789, DOI 10.1162/08997660360675044; Atick JJ, 1990, NEURAL COMPUT, V2, P308, DOI 10.1162/neco.1990.2.3.308; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Balasubramanian V, 2009, J PHYSIOL-LONDON, V587, P2753, DOI 10.1113/jphysiol.2009.170704; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Beaudoin DL, 2007, J NEUROSCI, V27, P2636, DOI 10.1523/JNEUROSCI.4610-06.2007; Bialek W, 2005, FEATURES DIMENSIONS; Bonin V, 2006, J NEUROSCI, V26, P6346, DOI 10.1523/JNEUROSCI.0284-06.2006; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chubb C, 2004, VISION RES, V44, P3223, DOI 10.1016/j.visres.2004.07.019; Cover TM, 1991, ELEMENTS INFORM THEO; Fairhall AL, 2006, J NEUROPHYSIOL, V96, P2724, DOI 10.1152/jn.00995.2005; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Gaudry KS, 2007, J NEUROSCI, V27, P8071, DOI 10.1523/JNEUROSCI.1093-07.2007; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lesica NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003060; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Olveczky BP, 2007, NEURON, V56, P689, DOI 10.1016/j.neuron.2007.09.030; PARTRIDGE LD, 1976, J PHYSIOL-LONDON, V256, P315, DOI 10.1113/jphysiol.1976.sp011327; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Rajan K, 2013, NEURAL COMPUT, V25, P1661, DOI 10.1162/NECO_a_00463; Ratliff CP, 2010, P NATL ACAD SCI USA, V107, P17368, DOI 10.1073/pnas.1005846107; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; Sadeghi KS, 2009, THESIS PRINCETON U P; Schwartz G, 2008, J NEUROPHYSIOL, V99, P1787, DOI 10.1152/jn.01025.2007; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; SHAPLEY R, 1979, VISION RES, V19, P431, DOI 10.1016/0042-6989(79)90109-3; Shapley R, 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Simmons K, 2009, FRONT SYST NEUR COS, DOI [10.3389/conf.neuro.06.2009.03.144, DOI 10.3389/C0NF.NEUR0.06.2009.03.144]; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Tkacik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020409; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P18149, DOI 10.1073/pnas.0914916107; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P14419, DOI 10.1073/pnas.1004906107; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Wallach A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040029; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019	56	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85841	10.1371/journal.pone.0085841	http://dx.doi.org/10.1371/journal.pone.0085841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465742	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500130
J	Wei, L; Ye, XS; Pei, XH; Wu, JQ; Zhao, WH				Wei, Lu; Ye, Xiaoshuang; Pei, Xiaohua; Wu, Jianqing; Zhao, Weihong			Reference Intervals for Serum Cystatin C and Factors Influencing Cystatin C Levels Other than Renal Function in the Elderly	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE	Objective: The present study aimed to establish reference intervals for serum cystatin C (Scys-C) stratified by stages of chronic kidney disease, explore factors influencing Scys-C and compare the performance of Scys-C with serum creatinine (Scr) in the young and elderly. Methods: A total of 800 participants, 516 young (<60 years) and 284 old (>= 60 years) subjects were included in this study. Scys-C and Scr were assayed by the partical-enhanced immunoturbidimetry method and enzymatic method respectively. 95% reference interval was adopted to evaluate reference intervals. Influencing factors were characterized by multivariate linear regression analysis. Relationship between reference glomerular filtration rate (rGFR) and Scys-C or Scr was determined by correlation coefficient. Results: Reference intervals for Scys-C were calculated to be 0.71-1.38 mg/L, 0.83-1.67 mg/L, 1.02-2.61 mg/L, 1.32-4.48 mg/L, 1.95-6.11 mg/L in the aged in CKD G1, G2, G3a, G3b and G4-5 stages, respectively. Body mass index(BMI), nephritis, kidney neoplasm and hypertension were demonstrated as factors affecting Scys-C in the elderly while gender, nephritis and kidney neoplasm were clarified as influencing factors in the young group. Scr levels were affected by more factors, such as body surface area and hematological disease. Correlation coefficient between rGFR and Scys-C or Scr showed that serum Scys-C was superior to Scr, especially in the subjects with mildly decreased renal function (-0.593 vs. -0.520). Conclusions: Factors other than renal function influenced Scys-C when applying to evaluate glomerular filtration rate (GFR), such as BMI, nephritis, kidney neoplasm and hypertension, and Scys-C had higher correlation with GFR than Scr in the elderly.	[Wei, Lu; Ye, Xiaoshuang; Pei, Xiaohua; Wu, Jianqing; Zhao, Weihong] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhao, WH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China.	zhaoweihong_1@medmail.com.cn			Innovation of Science and Technology Achievement Transformation Fund of Jiangsu Province [BL2012066]; National Natural Science Foundation of China [H0511-810705]; Major State Basic Research Development Program of China [2013CB530803]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]	Innovation of Science and Technology Achievement Transformation Fund of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Innovation of Science and Technology Achievement Transformation Fund of Jiangsu Province BL2012066, the National Natural Science Foundation of China H0511-810705, and the grants from the Major State Basic Research Development Program of China 2013CB530803, a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions JX10231801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, KDIGO CLIN IN PRESS; Cepeda J, 2010, REV ESP CARDIOL, V63, P415, DOI 10.1016/S1885-5857(10)70090-6; Choe JY, 2010, J KOREAN MED SCI, V25, P42, DOI 10.3346/jkms.2010.25.1.42; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Herget-Rosenthal S, 2000, TRANSPL INT, V13, P285, DOI 10.1007/s001470050703; Herget-Rosenthal S, 2007, CLIN BIOCHEM, V40, P153, DOI 10.1016/j.clinbiochem.2006.10.014; Horio M, 2011, CLIN EXP NEPHROL, V15, P868, DOI 10.1007/s10157-011-0525-y; Jeon YK, 2011, J KOREAN MED SCI, V26, P258, DOI 10.3346/jkms.2011.26.2.258; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Moye J, 2013, AM PSYCHOL, V68, P158, DOI 10.1037/a0032159; Okura T, 2010, CLIN EXP NEPHROL, V14, P584, DOI 10.1007/s10157-010-0334-8; Pei XH, 2012, SCAND J UROL NEPHROL, V46, P223, DOI 10.3109/00365599.2012.660985; Pei XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057852; Seronie-Vivien S, 2008, CLIN CHEM LAB MED, V46, P1664, DOI 10.1515/CCLM.2008.336; Shankar A, 2011, J AM SOC HYPERTENS, V5, P378, DOI 10.1016/j.jash.2011.03.003; Stevens LA, 2009, KIDNEY INT, V75, P652, DOI 10.1038/ki.2008.638; Vikas R, 2002, AM J KIDNEY DIS, V40, P221; Yashiro M, 2009, CLIN EXP NEPHROL, V13, P598, DOI 10.1007/s10157-009-0202-6; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang QL, 2008, BMC PUBLIC HEALTH, P8117	20	12	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86066	10.1371/journal.pone.0086066	http://dx.doi.org/10.1371/journal.pone.0086066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465871	Green Submitted, gold, Green Published			2022-12-25	WOS:000330244500172
J	Wijnands, KAP; Hoeksema, MA; Meesters, DM; van den Akker, NMS; Molin, DGM; Briede, JJ; Ghosh, M; Kohler, SE; van Zandvoort, MAMJ; de Winther, MPJ; Buurman, WA; Lamers, WH; Poeze, M				Wijnands, Karolina A. P.; Hoeksema, Marten A.; Meesters, Dennis M.; van den Akker, Nynke M. S.; Molin, Daniel G. M.; Briede, Jacob J.; Ghosh, Mitrajit; Kohler, S. Eleonore; van Zandvoort, Marc A. M. J.; de Winther, Menno P. J.; Buurman, Wim A.; Lamers, Wouter H.; Poeze, Martijn			Arginase-1 Deficiency Regulates Arginine Concentrations and NOS2-Mediated NO Production during Endotoxemia	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELLS; IN-VIVO; ACTIVATED MACROPHAGES; HEMATOPOIETIC-CELLS; MOUSE MACROPHAGES; MESSENGER-RNA; OLD RATS; SEPSIS; EXPRESSION	Rationale and objective: Arginase-1 is an important component of the intricate mechanism regulating arginine availability during immune responses and nitric oxide synthase (NOS) activity. In this study Arg1(fl/fl)/Tie2-Cre(tg/-) mice were developed to investigate the effect of arginase-1 related arginine depletion on NOS2- and NOS3-dependent NO production and jejunal microcirculation under resting and endotoxemic conditions, in mice lacking arginase-1 in endothelial and hematopoietic cells. Methods and Results: Arginase-1-deficient mice as compared with control mice exhibited higher plasma arginine concentration concomitant with enhanced NO production in endothelial cells and jejunal tissue during endotoxemia. In parallel, impaired jejunal microcirculation was observed in endotoxemic conditions. Cultured bone-marrow-derived macrophages of arginase-1 deficient animals also presented a higher inflammatory response to endotoxin than control littermates. Since NOS2 competes with arginase for their common substrate arginine during endotoxemia, Nos2 deficient mice were also studied under endotoxemic conditions. As Nos2(-/-) macrophages showed an impaired inflammatory response to endotoxin compared to wild-type macrophages, NOS2 is potentially involved. A strongly reduced NO production in Arg1(fl/fl)/Tie2-Cre(tg/-) mice following infusion of the NOS2 inhibitor 1400W further implicated NOS2 in the enhanced capacity to produce NO production Arg1(fl/fl)/Tie2-Cre(tg/-) mice. Conclusions: Reduced arginase-1 activity in Arg1(fl/fl)/Tie2-Cre(tg/-) mice resulted in increased inflammatory response and NO production by NOS2, accompanied by a depressed microcirculatory flow during endotoxemia. Thus, arginase-1 deficiency facilitates a NOS2-mediated pro-inflammatory activity at the expense of NOS3-mediated endothelial relaxation.	[Wijnands, Karolina A. P.; Meesters, Dennis M.; Buurman, Wim A.; Poeze, Martijn] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands; [Wijnands, Karolina A. P.; Meesters, Dennis M.; Kohler, S. Eleonore; Buurman, Wim A.; Lamers, Wouter H.; Poeze, Martijn] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Hoeksema, Marten A.; de Winther, Menno P. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [van den Akker, Nynke M. S.] Maastricht Univ, Med Ctr, Dept Cardiol, Maastricht, Netherlands; [van den Akker, Nynke M. S.; Molin, Daniel G. M.; Ghosh, Mitrajit; van Zandvoort, Marc A. M. J.] Maastricht Univ, Med Ctr, CARIM Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [van den Akker, Nynke M. S.; Molin, Daniel G. M.] Maastricht Univ, Med Ctr, Dept Physiol, Maastricht, Netherlands; [Briede, Jacob J.] Maastricht Univ, Med Ctr, Dept Toxicogen, Maastricht, Netherlands; [Briede, Jacob J.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Ghosh, Mitrajit; van Zandvoort, Marc A. M. J.] Maastricht Univ, Med Ctr, Sect Mol Cell Biol, Dept Genet & Cell Biol, Maastricht, Netherlands; [Kohler, S. Eleonore; Lamers, Wouter H.] Maastricht Univ, Med Ctr, Dept Anat & Embryol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University	Wijnands, KAP (corresponding author), Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands.	n.wijnands@maastrichtuniversity.nl	Meesters, Dennis/K-2704-2019; Köhler, Eleonore/D-2915-2012; Lamers, Wouter H./D-2965-2012	Meesters, Dennis/0000-0003-1781-1363; Köhler, Eleonore/0000-0003-1977-9977; Hoeksema, Marten/0000-0001-5981-121X; Briede, Jacco/0000-0003-1405-5232; de Winther, Menno/0000-0002-4038-6636	ZonMw Innovational Research Incentives [VENI 916.76.191]; European Society of Intensive Care Medicine Eli Lilly Sepsis Elite Award; Interreg Euregio Meuse-Rhine IVa grant BioMIMedics; Interreg IVa Flanders-The Netherlands grant VaRiA	ZonMw Innovational Research Incentives; European Society of Intensive Care Medicine Eli Lilly Sepsis Elite Award; Interreg Euregio Meuse-Rhine IVa grant BioMIMedics; Interreg IVa Flanders-The Netherlands grant VaRiA	This study was supported by grants from ZonMw Innovational Research Incentives (VENI 916.76.191) and the European Society of Intensive Care Medicine Eli Lilly Sepsis Elite Award 2008. The co-author D. Molin is supported by the Interreg Euregio Meuse-Rhine IVa grant BioMIMedics. The co-authors N. van den Akker and D. Molin are supported by the Interreg IVa Flanders-The Netherlands grant VaRiA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachetti T, 2004, J MOL CELL CARDIOL, V37, P515, DOI 10.1016/j.yjmcc.2004.05.004; Balestra GM, 2009, CURR OPIN ANESTHESIO, V22, P184, DOI 10.1097/ACO.0b013e328328d31a; Bansal V, 2003, CURR OPIN CLIN NUTR, V6, P223, DOI 10.1097/00075197-200303000-00012; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Bultinck J, 2006, FASEB J, V20, P2363, DOI 10.1096/fj.06-5798fje; BUNE AJ, 1995, FEBS LETT, V366, P127, DOI 10.1016/0014-5793(95)00495-U; CASTILLO L, 1993, P NATL ACAD SCI USA, V90, P7749, DOI 10.1073/pnas.90.16.7749; Cederbaum SD, 2004, MOL GENET METAB, V81, pS38, DOI 10.1016/j.ymgme.2003.10.012; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Chicoine LG, 2004, AM J PHYSIOL-LUNG C, V287, pL60, DOI 10.1152/ajplung.00194.2003; Cloots RHE, 2013, AM J PHYSIOL-LUNG C, V305, pL364, DOI 10.1152/ajplung.00341.2012; Deignan JL, 2007, AM J PHYSIOL-CELL PH, V293, pC1296, DOI 10.1152/ajpcell.00393.2006; Deignan JL, 2006, MOL GENET METAB, V89, P87, DOI 10.1016/j.ymgme.2006.04.007; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Dymecki SM, 1996, GENE, V171, P197, DOI 10.1016/0378-1119(96)00035-2; Galijasevic S, 2003, P NATL ACAD SCI USA, V100, P14766, DOI 10.1073/pnas.2435008100; Ghosh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075331; Hein TW, 2003, FASEB J, V17, P2328, DOI 10.1096/fj.03-0115fje; Hoeksema MA, 2012, CURR ATHEROSCLER REP, V14, P254, DOI 10.1007/s11883-012-0240-5; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Kepka-Lenhart D, 2000, AM J PHYSIOL-REG I, V279, pR2237; Kietadisorn R, 2012, AM J PHYSIOL-ENDOC M, V302, pE481, DOI 10.1152/ajpendo.00540.2011; Kim JH, 2009, J APPL PHYSIOL, V107, P1249, DOI 10.1152/japplphysiol.91393.2008; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Knotek M, 2001, KIDNEY INT, V59, P2243, DOI 10.1046/j.1523-1755.2001.00740.x; Kvietys PR, 2012, FREE RADICAL BIO MED, V52, P556, DOI 10.1016/j.freeradbiomed.2011.11.002; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Liu SF, 1996, CRIT CARE MED, V24, P1219, DOI 10.1097/00003246-199607000-00026; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; Lu JL, 1996, BIOCHEM BIOPH RES CO, V225, P1, DOI 10.1006/bbrc.1996.1121; Luiking YC, 2005, JPEN-PARENTER ENTER, V29, pS70, DOI 10.1177/01486071050290S1S70; Luiking YC, 2004, CRIT CARE MED, V32, P2135, DOI 10.1097/01.CCM.0000142939.81045.A0; Luiking YC, 2007, CRIT CARE MED, V35, pS557, DOI 10.1097/01.CCM.0000279191.44730.A2; Luiking YC, 2010, CURR OPIN CLIN NUTR, V13, P97, DOI 10.1097/MCO.0b013e328332f99d; Luiking YC, 2009, AM J CLIN NUTR, V89, P142, DOI 10.3945/ajcn.2007.25765; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Morris SM, 2005, VASC MED, V10, pS83, DOI 10.1191/1358863x05vm601oa; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Ochoa JB, 2000, SURGERY, V127, P419, DOI 10.1067/msy.2000.104745; Ochoa JB, 2001, ANN SURG, V233, P393, DOI 10.1097/00000658-200103000-00014; OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Ryoo S, 2008, CIRC RES, V102, P923, DOI 10.1161/CIRCRESAHA.107.169573; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Soeters PB, 2002, AM J SURG, V183, P480, DOI 10.1016/S0002-9610(02)00847-4; Van den Bossche J, 2012, J LEUKOCYTE BIOL, V91, P685, DOI 10.1189/jlb.0911453; Vanhoutte PM, 2008, CIRC RES, V102, P866, DOI 10.1161/CIRCRESAHA.108.175570; VODOVOTZ Y, 1993, J EXP MED, V178, P605, DOI 10.1084/jem.178.2.605; White AR, 2006, HYPERTENSION, V47, P245, DOI 10.1161/01.HYP.0000198543.34502.d7; Wijnands KAP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037439; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205; Zhang CH, 2001, FASEB J, V15, P1264, DOI 10.1096/fj.00-0681fje	57	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86135	10.1371/journal.pone.0086135	http://dx.doi.org/10.1371/journal.pone.0086135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465919	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500192
J	Hung, C; Marschall, J; Burnham, CAD; Byun, AS; Henderson, JP				Hung, Chia; Marschall, Jonas; Burnham, Carey-Ann D.; Byun, Albert S.; Henderson, Jeffrey P.			The Bacterial Amyloid Curli Is Associated with Urinary Source Bloodstream Infection	PLOS ONE			English	Article							FIBRONECTIN-BINDING; EXPRESSION; STRAINS; CSGA; BIOGENESIS; NUCLEATOR; SECRETION; FIMBRIAE; OPERONS; PROTEIN	Urinary tract infections are the most common cause of E. coli bloodstream infections (BSI) but the mechanism of bloodstream invasion is poorly understood. Some clinical isolates have been observed to shield themselves with extracellular amyloid fibers called curli at physiologic temperature. We hypothesize that curli fiber assembly at 37 degrees C promotes bacteremic progression by urinary E. coli strains. Curli expression by cultured E. coli isolates from bacteriuric patients in the presence and absence of bacteremia were compared using Western blotting following amyloid fiber disruption with hexafluoroisopropanol. At 37 degrees C, urinary isolates from bacteremic patients were more likely to express curli than those from non-bacteremic patients [16/22 (73%) vs. 7/21 (33%); p = 0.01]. No significant difference in curli expression was observed at 30 degrees C [86% (19/22) vs. 76% (16/21); p = 0.5]. Isolates were clonally diverse between patients, indicating that this phenotype is distributed across multiple lineages. Most same-patient urine and blood isolates were highly related, consistent with direct invasion of urinary bacteria into the bloodstream. 37 degrees C curli expression was associated with bacteremic progression of urinary E. coli isolates in this population. These findings suggest new future diagnostic and virulence-targeting therapeutic approaches.	[Hung, Chia; Marschall, Jonas; Byun, Albert S.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Hung, Chia; Marschall, Jonas; Byun, Albert S.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Marschall, Jonas] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland; [Burnham, Carey-Ann D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Burnham, Carey-Ann D.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); University of Bern; University Hospital of Bern; Washington University (WUSTL); Washington University (WUSTL)	Henderson, JP (corresponding author), Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA.	jhenderson@borcim.wustl.edu	Hung, Chia-Suei/G-6167-2010; Marschall, Jonas/AAF-6425-2019; Henderson, Jeffrey P/D-3337-2015	Marschall, Jonas/0000-0002-0052-3210; Hung, Chia-Suei/0000-0001-9844-9954	NIH CTSA [UL1RR024992]; CDC Prevention Epicenters Program grant [U54 CK000162]; KL2 Career Development Award [KL2RR024994]; Washington University Building Interdisciplinary Research Careers in Women's Health (BIRCWH) program [5K12HD001459-13]; Barnes-Jewish Hospital Patient Safety & Quality Fellowship Program; Barnes-Jewish Hospital Foundation & Washington University's Institute of Clinical and Translational Sciences; Burroughs-Wellcome Career Award for Medical Scientists; NIH [HD001459-09, DK064540-09]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992, KL2RR024994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064540] Funding Source: NIH RePORTER	NIH CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); CDC Prevention Epicenters Program grant; KL2 Career Development Award; Washington University Building Interdisciplinary Research Careers in Women's Health (BIRCWH) program; Barnes-Jewish Hospital Patient Safety & Quality Fellowship Program; Barnes-Jewish Hospital Foundation & Washington University's Institute of Clinical and Translational Sciences; Burroughs-Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	JM and JH were supported by the NIH CTSA (UL1RR024992). JM has received support from a CDC Prevention Epicenters Program grant (U54 CK000162; PI Fraser), a KL2 Career Development Award (KL2RR024994), the Washington University Building Interdisciplinary Research Careers in Women's Health (BIRCWH) program (5K12HD001459-13) and the Barnes-Jewish Hospital Patient Safety & Quality Fellowship Program. JM was also supported by a research grant from the Barnes-Jewish Hospital Foundation & Washington University's Institute of Clinical and Translational Sciences. JPH is the recipient of a Burroughs-Wellcome Career Award for Medical Scientists and was supported by NIH HD001459-09 and DK064540-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNQVIST A, 1992, MOL MICROBIOL, V6, P2443; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bian Z, 2000, J INFECT DIS, V181, P602, DOI 10.1086/315233; Bokranz W, 2005, J MED MICROBIOL, V54, P1171, DOI 10.1099/jmm.0.46064-0; Casarez EA, 2007, WATER RES, V41, P3643, DOI 10.1016/j.watres.2007.03.020; Cegelski L, 2009, NAT CHEM BIOL, V5, P913, DOI 10.1038/nchembio.242; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Dueholm MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051274; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Holden NJ, 2004, J MED MICROBIOL, V53, P585, DOI 10.1099/jmm.0.05491-0; Hung C, 2013, MBIO, V4, DOI 10.1128/mBio.00645-13; Jubelin G, 2005, J BACTERIOL, V187, P2038, DOI 10.1128/JB.187.6.2038-2049.2005; Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Kosek M, 2012, AM J TROP MED HYG, V86, P1018, DOI 10.4269/ajtmh.2012.11-0671; La Ragione RM, 2000, EPIDEMIOL INFECT, V124, P351, DOI 10.1017/S0950268899004045; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LIU PYF, 1995, J CLIN MICROBIOL, V33, P1779, DOI 10.1128/JCM.33.7.1779-1783.1995; Mahenthiralingam E, 1996, J CLIN MICROBIOL, V34, P1129, DOI 10.1128/JCM.34.5.1129-1135.1996; Marschall J, 2012, CLIN INFECT DIS, V54, P1692, DOI 10.1093/cid/cis252; MASLOW JN, 1993, CLIN INFECT DIS, V17, P153, DOI 10.1093/clinids/17.2.153; McCrate OA, 2013, CHEM COMMUN, V49, P4193, DOI 10.1039/c2cc37792f; Nenninger AA, 2011, MOL MICROBIOL, V81, P486, DOI 10.1111/j.1365-2958.2011.07706.x; Norinder BS, 2012, MICROB PATHOGENESIS, V52, P10, DOI 10.1016/j.micpath.2011.08.005; OLSEN A, 1993, MOL MICROBIOL, V7, P523, DOI 10.1111/j.1365-2958.1993.tb01143.x; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Shu Q, 2012, P NATL ACAD SCI USA, V109, P6502, DOI 10.1073/pnas.1204161109; Skjot-Rasmussen L, 2012, CLIN MICROBIOL INFEC; Torres AG, 2005, APPL ENVIRON MICROB, V71, P8008, DOI 10.1128/AEM.71.12.8008-8015.2005; Uhlich GA, 2001, APPL ENVIRON MICROB, V67, P2367, DOI 10.1128/AEM.67.5.2367-2370.2001; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998; Wang R, 2012, J FOOD PROTECT, V75, P1418, DOI 10.4315/0362-028X.JFP-11-427; Wei GF, 2004, J MICROBIOL METH, V59, P91, DOI 10.1016/j.mimet.2004.06.007	37	31	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86009	10.1371/journal.pone.0086009	http://dx.doi.org/10.1371/journal.pone.0086009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465838	Green Published, gold			2022-12-25	WOS:000330240500099
J	Martonfalvi, Z; Kellermayer, M				Martonfalvi, Zsolt; Kellermayer, Miklos			Individual Globular Domains and Domain Unfolding Visualized in Overstretched Titin Molecules with Atomic Force Microscopy	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE MODULES; M-BAND; ENTROPIC ELASTICITY; CARDIAC-MUSCLE; PROTEIN; EXTENSIBILITY; REGION; STABILITY; MYOMESIN; FLEXIBILITY	Titin is a giant elastomeric protein responsible for the generation of passive muscle force. Mechanical force unfolds titins globular domains, but the exact structure of the overstretched titin molecule is not known. Here we analyzed, by using high-resolution atomic force microscopy, the structure of titin molecules overstretched with receding meniscus. The axial contour of the molecules was interrupted by topographical gaps with a mean width of 27.7 nm that corresponds well to the length of an unfolded globular (immunoglobulin and fibronectin) domain. The wide gap-width distribution suggests, however, that additional mechanisms such as partial domain unfolding and the unfolding of neighboring domain multimers may also be present. In the folded regions we resolved globules with an average spacing of 5.9 nm, which is consistent with a titin chain composed globular domains with extended interdomain linker regions. Topographical analysis allowed us to allocate the most distal unfolded titin region to the kinase domain, suggesting that this domain systematically unfolds when the molecule is exposed to overstretching forces. The observations support the prediction that upon the action of stretching forces the N-terminal ss-sheet of the titin kinase unfolds, thus exposing the enzymes ATP-binding site and hence contributing to the molecules mechanosensory function.	[Martonfalvi, Zsolt; Kellermayer, Miklos] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary; [Kellermayer, Miklos] Semmelweis Univ, MTA SE Mol Biophys Res Grp, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University	Kellermayer, M (corresponding author), Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary.	kellermayer.miklos@med.semmelweis-univ.hu			Hungarian Science Foundation [OTKA K84133, OTKA K109480]; European Union [HEALTH-F2-2011-278850]	Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission)	This work was supported by grants from the Hungarian Science Foundation (OTKA K84133, OTKA K109480). The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no HEALTH-F2-2011-278850 (INMiND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkova I, 2005, TRENDS CELL BIOL, V15, P477, DOI 10.1016/j.tcb.2005.07.001; Anderson BR, 2013, J BIOL CHEM, V288, P5303, DOI 10.1074/jbc.M112.401372; Anderson BR, 2012, PROG BIOPHYS MOL BIO, V110, P204, DOI 10.1016/j.pbiomolbio.2012.08.003; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BENSIMON D, 1995, PHYS REV LETT, V74, P4754, DOI 10.1103/PhysRevLett.74.4754; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Freiburg A, 2000, CIRC RES, V86, P1114; FUNATSU T, 1990, J CELL BIOL, V110, P53, DOI 10.1083/jcb.110.1.53; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; HOROWITS R, 1986, NATURE, V323, P160, DOI 10.1038/323160a0; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Karsai A, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345102; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kiss B, 2011, J MOL RECOGNIT, V24, P1095, DOI 10.1002/jmr.1158; Kruger M, 2011, J BIOL CHEM, V286, P9905, DOI 10.1074/jbc.R110.173260; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lange S, 2005, J MOL BIOL, V345, P289, DOI 10.1016/j.jmb.2004.10.040; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Linke WA, 1998, J CELL SCI, V111, P1567; Linke WA, 1999, J CELL BIOL, V146, P631, DOI 10.1083/jcb.146.3.631; Linke WA, 1998, P NATL ACAD SCI USA, V95, P8052, DOI 10.1073/pnas.95.14.8052; Linke WA, 1996, J MOL BIOL, V261, P62, DOI 10.1006/jmbi.1996.0441; Lu H, 2000, ADV EXP MED BIOL, V481, P143; Maruyama K, 1997, FASEB J, V11, P341, DOI 10.1096/fasebj.11.5.9141500; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; NAVE R, 1989, J CELL BIOL, V109, P2177, DOI 10.1083/jcb.109.5.2177; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441; Pires RH, 2011, J MOL RECOGNIT, V24, P467, DOI 10.1002/jmr.1112; Politou AS, 1996, J MOL BIOL, V255, P604, DOI 10.1006/jmbi.1996.0050; POLITOU AS, 1994, BIOCHEMISTRY-US, V33, P4730, DOI 10.1021/bi00181a604; Politou AS, 1995, BIOPHYS J, V69, P2601, DOI 10.1016/S0006-3495(95)80131-1; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; SOTERIOU A, 1993, J CELL SCI, V104, P119; Trombitas K, 2000, BIOPHYS J, V79, P3226, DOI 10.1016/S0006-3495(00)76555-6; Trombitas K, 1998, J CELL BIOL, V140, P853, DOI 10.1083/jcb.140.4.853; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Tskhovrebova L, 1997, J MOL BIOL, V265, P100, DOI 10.1006/jmbi.1996.0717; Tskhovrebova L, 2001, J MOL BIOL, V310, P755, DOI 10.1006/jmbi.2001.4700; Von Castelmur E, 2008, P NATL ACAD SCI USA, V105, P1186, DOI 10.1073/pnas.0707163105; Wang K, 1996, ADV BIOPHYS, V33, P123	46	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85847	10.1371/journal.pone.0085847	http://dx.doi.org/10.1371/journal.pone.0085847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465745	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500077
J	Meimoun, P; Mordret, E; Langlade, NB; Balzergue, S; Arribat, S; Bailly, C; El-Maarouf-Bouteau, H				Meimoun, Patrice; Mordret, Ernest; Langlade, Nicolas B.; Balzergue, Sandrine; Arribat, Sandrine; Bailly, Christophe; El-Maarouf-Bouteau, Hayat			Is Gene Transcription Involved in Seed Dry After-Ripening?	PLOS ONE			English	Article							MESSENGER-RNA; RELATIVE QUANTIFICATION; DORMANCY ALLEVIATION; RELEASE; GERMINATION; HIGHLIGHTS; EXPRESSION; OXIDATION; TEMPERATURE; MECHANISM	Orthodox seeds are living organisms that survive anhydrobiosis and may display dormancy, an inability to germinate at harvest. Seed germination potential can be acquired during a prolonged period of dry storage called after-ripening. The aim of this work was to determine if gene transcription is an underlying regulatory mechanism for dormancy alleviation during after-ripening. To identify changes in gene transcription strictly associated with the acquisition of germination potential but not with storage, we used seed storage at low relative humidity that maintains dormancy as control. Transcriptome profiling was performed using DNA microarray to compare change in gene transcript abundance between dormant (D), after-ripened non-dormant (ND) and after-ripened dormant seeds (control, C). Quantitative real-time polymerase chain reaction (qPCR) was used to confirm gene expression. Comparison between D and ND showed the differential expression of 115 probesets at cut-off values of two-fold change (p<0.05). Comparisons between both D and C with ND in transcript abundance showed that only 13 transcripts, among 115, could be specific to dormancy alleviation. qPCR confirms the expression pattern of these transcripts but without significant variation between conditions. Here we show that sunflower seed dormancy alleviation in the dry state is not related to regulated changes in gene expression.	[Meimoun, Patrice; Mordret, Ernest; Bailly, Christophe; El-Maarouf-Bouteau, Hayat] Univ Paris 06, UPMC, CNRS, UMR 7622, F-75005 Paris, France; [Langlade, Nicolas B.] INRA, CNRS, Lab Interact Plantes Microorganismes, UMR 441,UMR 2594, F-31326 Castanet Tolosan, France; [Balzergue, Sandrine; Arribat, Sandrine] INRA, CNRS UEVE 8114, UMR 1165, URGV, F-91057 Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; INRAE; UDICE-French Research Universities; Universite Paris Saclay	El-Maarouf-Bouteau, H (corresponding author), Univ Paris 06, UPMC, CNRS, UMR 7622, Bat C 2 Eme Etage,4,Pl Jussieu, F-75005 Paris, France.	hayat.bouteau@upmc.fr	Langlade, Nicolas/C-6191-2008; Bailly, Christophe/B-8907-2011	Langlade, Nicolas/0000-0002-5651-1446; Bailly, Christophe/0000-0002-5878-9249; Mordret, Ernest/0000-0001-6641-8336; Meimoun, Patrice/0000-0002-7027-6075; El-Maarouf-Bouteau, Hayat/0000-0002-6796-298X	Ecoseed, KBBE project	Ecoseed, KBBE project	This work has been supported by Ecoseed, KBBE project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bazin J, 2011, J EXP BOT, V62, P627, DOI 10.1093/jxb/erq314; Bazin J, 2011, PLANT CELL, V23, P2196, DOI 10.1105/tpc.111.086694; Bewley JD, 2013, SEEDS PHYSL DEV GERM, P368; Bouteau HEM, 2007, PLANT SIGNAL BEHAV, V2, P362, DOI 10.4161/psb.2.5.4460; Bove J, 2005, PLANT MOL BIOL, V57, P593, DOI 10.1007/s11103-005-0953-8; Buitink J, 2004, CRYOBIOLOGY, V48, P215, DOI 10.1016/j.cryobiol.2004.02.011; COMAI L, 1990, P NATL ACAD SCI USA, V87, P2671, DOI 10.1073/pnas.87.7.2671; CORBINEAU F, 1990, ISRAEL J BOT, V39, P313; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; DARCY RL, 1970, T FARADAY SOC, V66, P1236, DOI 10.1039/tf9706601236; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Gao F, 2013, PLANT BIOTECHNOL J, V11, P921, DOI 10.1111/pbi.12083; Gao F, 2012, PLANT BIOTECHNOL J, V10, P465, DOI 10.1111/j.1467-7652.2012.00682.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim SH, 2012, MOL BIOL REP, V39, P11231, DOI 10.1007/s11033-012-2034-9; LEOPOLD AC, 1988, PHYSIOL PLANTARUM, V74, P659, DOI 10.1111/j.1399-3054.1988.tb02032.x; Leubner-Metzger G, 2005, PLANT J, V41, P133, DOI 10.1111/j.1365-313X.2004.02284.x; Leymarie J, 2007, J EXP BOT, V58, P425, DOI 10.1093/jxb/erl211; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Oracz K, 2008, J EXP BOT, V59, P2241, DOI 10.1093/jxb/ern089; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Probert R. J., 2000, Seeds: the ecology of regeneration in plant communities, P261, DOI 10.1079/9780851994321.0261; Rajjou L, 2004, PLANT PHYSIOL, V134, P1598, DOI 10.1104/pp.103.036293; Rengel D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045249; Sreekantan L, 2010, PLANT MOL BIOL, V73, P191, DOI 10.1007/s11103-010-9611-x; Vertucci Christina W., 1993, Seed Science Research, V3, P201; Vertucci CW, 1995, SEED DEV GERMINATION; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Xu J, 2009, PLANT CELL, V21, P3270, DOI 10.1105/tpc.109.070078	37	32	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86442	10.1371/journal.pone.0086442	http://dx.doi.org/10.1371/journal.pone.0086442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24466101	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500133
J	Vega, FE; Simpkins, A; Bauchan, G; Infante, F; Kramer, M; Land, MF				Vega, Fernando E.; Simpkins, Ann; Bauchan, Gary; Infante, Francisco; Kramer, Matthew; Land, Michael F.			On the Eyes of Male Coffee Berry Borers as Rudimentary Organs	PLOS ONE			English	Article							COLEOPTERA-CURCULIONIDAE SCOLYTINAE; XYLEBORUS-FERRUGINEUS; COMPOUND EYE; BEETLE; ULTRASTRUCTURE; INSECTS	The coffee berry borer, Hypothenemus hampei, is the most damaging insect pest of coffee worldwide. Like males in other species in the genus, male coffee berry borers have a lower number of facets in the compound eyes than females. The rudimentary eyes in male coffee berry borers could be an evolutionary response to their cryptic life habit, whereby they are born inside a coffee berry and never leave the berry. The main objective of the study was to determine if the differences in the number of facets translates into differences in visual acuity. We used low-temperature scanning electron microscopy to visualize and quantify the number of facets in the compound eyes. There was a significantly lower (p<0.0001) number of facets in males (19.1 +/- 4.10) than in females (127.5 +/- 3.88). To assess visual acuity, we conducted optomotor response experiments, which indicate that females respond to movement, while males did not respond under the conditions tested. The coffee berry borer is an example of an insect whereby disuse of an organ has led to a rudimentary compound eye. This is the first study that has experimentally tested responses to movement in bark beetles.	[Vega, Fernando E.; Simpkins, Ann] ARS, Sustainable Perennial Crops Lab, USDA, Beltsville, MD USA; [Bauchan, Gary] ARS, Electron & Confocal Microscopy Unit, USDA, Beltsville, MD USA; [Infante, Francisco] El Colegio Frontera Sur, Tapachula, Chiapas, Mexico; [Kramer, Matthew] ARS, Biometr Consulting Serv, USDA, Beltsville, MD USA; [Land, Michael F.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); El Colegio de la Frontera Sur (ECOSUR); United States Department of Agriculture (USDA); University of Sussex	Vega, FE (corresponding author), ARS, Sustainable Perennial Crops Lab, USDA, Beltsville, MD USA.	Fernando.Vega@ars.usda.gov	Bauchan, Gary/ABH-3800-2020; Vega, Fernando E./AAM-5536-2021	Vega, Fernando E./0000-0001-8103-5640; Infante, Francisco/0000-0002-7419-7606; Bauchan, Gary/0000-0003-3060-7666	U.S. Department of Agriculture	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by U.S. Department of Agriculture core funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW HB, 1952, J EXP BIOL, V29, P667; Bell G, 2008, SELECTION: THE MECHANISM OF EVOLUTION, 2ND EDITION, P1; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; BRIGHT D E, 1981, Coleopterists Bulletin, V35, P117; BROWNE F. G., 1961, MALAYAN FOREST REC, V22, P1; BYERS JA, 1989, J CHEM ECOL, V15, P749, DOI 10.1007/BF01014716; CHAPMAN JA, 1972, ANN ENTOMOL SOC AM, V65, P550, DOI 10.1093/aesa/65.3.550; CHU H, 1975, CELL TISSUE RES, V165, P23; CHU HM, 1976, CELL TISSUE RES, V168, P315; Constantino LM, 2011, REV COLOMB ENTOMOL, V37, P173; Darwin C., 1859, ORIGIN SPECIES MEANS; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Hopkins AD, 1909, USDA BUR ENTOMOL TEC, V17, P1; HOULE D, 1992, GENETICS, V130, P195; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Land MF, 2012, OXF ANIMAL BIOL SER, P1; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Oliveira CM, 2013, J APPL ENTOMOL, V137, P1, DOI 10.1111/jen.12018; RUSSO GIUSEPPE, 1926, BOLL LAB ZOOL GEN E AGRAR R SCUOLA SUP AGRIC PORTICI, V19, P103; SAS JMP, 2005, JMP STAT GRAPH GUID; Vega F.E., 2004, ENCY ENTOMOLOGY, V1, P575; Vega FE, 2011, J ECON ENTOMOL, V104, P87, DOI 10.1603/EC10353; Vega Fernando E., 2009, Terrestrial Arthropod Reviews, V2, P129; Wood S.L., 2007, BARK AMBROSIA BEETLE	24	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85860	10.1371/journal.pone.0085860	http://dx.doi.org/10.1371/journal.pone.0085860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465752	Green Published, gold			2022-12-25	WOS:000330240500081
J	Baar, Y; Rosen, J; Shashar, N				Baar, Yuval; Rosen, Joseph; Shashar, Nadav			Circular Polarization of Transmitted Light by Sapphirinidae Copepods	PLOS ONE			English	Article							IRIDESCENT COPEPODS; FAMILY SAPPHIRINIDAE	Circularly polarized light, rare in the animal kingdom, has thus far been documented in only a handful of animals. Using a rotating circular polarization (CP) analyzer we detected CP in linearly polarized light transmitted through epipelagic free living Sapphirina metallina copepods. Both left and right handedness of CP was detected, generated from specific organs of the animal's body, especially on the dorsal cephalosome and prosome. Such CP transmittance may be generated by phase retardance either in the muscle fibers or in the multilayer membrane structure found underneath the cuticle. Although the role, if any, played by circularly polarized light in Sapphirinidae has yet to be clarified, in other animals it was suggested to take part in mate choice, species recognition, and other forms of communication. Highlights: Planktonic Sapphirinidae copepods were found to circularly polarize the light passing through them. Circular polarization may be created by unique, multilayered features of the membrane structure found under their cuticle or by organized muscle fibers.	[Baar, Yuval; Shashar, Nadav] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Rosen, Joseph] Ben Gurion Univ Negev, Dept Elect & Comp Engn, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Shashar, N (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Eilat Campus, IL-84105 Beer Sheva, Israel.	nadavsh@bgu.ac.il	Rosen, Joseph/M-4275-2019; Rosen, Joseph/F-1889-2012; Shashar, Nadav/Y-8552-2019	Rosen, Joseph/0000-0002-9739-2180; Rosen, Joseph/0000-0002-9739-2180; 	Israeli Science Foundation [1081/10]; Halperin foundation; Shechter foundation	Israeli Science Foundation(Israel Science Foundation); Halperin foundation; Shechter foundation	Israeli Science Foundation Grant # 1081/10 to NS and by the Halperin and Shechter foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaho M, 2012, PHYSIOL BEHAV, V105, P1067, DOI 10.1016/j.physbeh.2011.11.020; Brady P, 2010, AM NAT, V175, P614, DOI 10.1086/651593; CHAE J, 1994, MAR BIOL, V119, P205, DOI 10.1007/BF00349558; CHAE J, 1995, MAR ECOL PROG SER, V119, P111, DOI 10.3354/meps119111; Chae J, 2004, J MAR BIOL ASSOC UK, V84, P727, DOI 10.1017/S0025315404009816h; Chiou TH, 2008, CURR BIOL, V18, P429, DOI 10.1016/j.cub.2008.02.066; Chiou TH, 2012, J EXP BIOL, V215, P584, DOI 10.1242/jeb.066019; Cronin TW, 2009, P SPIE, V7461; Engel A., 1994, MYOLOGY; Goldstein DH, 2006, APPL OPTICS, V45, P7944, DOI 10.1364/AO.45.007944; Hubble SK, 2007, CRUSTACEANA, V80, P739, DOI 10.1163/156854007781360658; IVANOFF A, 1958, J MAR RES, V16, P255; Jarry G, 2000, J OPT SOC AM A, V17, P149, DOI 10.1364/JOSAA.17.000149; Manor S, 2009, VISION RES, V49, P2371, DOI 10.1016/j.visres.2009.07.007; NEVILLE AC, 1969, BIOL REV, V44, P531, DOI 10.1111/j.1469-185X.1969.tb00611.x; NEVILLE AC, 1971, J INSECT PHYSIOL, V17, P519, DOI 10.1016/0022-1910(71)90030-8; Parker AR, 2000, J OPT A-PURE APPL OP, V2, pR15, DOI 10.1088/1464-4258/2/6/201; Sabbah S, 2006, VISION RES, V46, P444, DOI 10.1016/j.visres.2005.05.017; Sabbah S., 2005, RECENT RES DEV EXP T, V1, P1; Seago AE, 2009, J R SOC INTERFACE, V6, pS165, DOI 10.1098/rsif.2008.0354.focus; SHAPIRO DB, 1991, P SOC PHOTO-OPT INS, V1537, P30, DOI 10.1117/12.49258; Sharma V, 2009, SCIENCE, V325, P449, DOI 10.1126/science.1172051; Shashar N, 2011, PHILOS T R SOC B, V366, P649, DOI 10.1098/rstb.2010.0190; TRAN PT, 1994, BIOL BULL, V187, P244, DOI 10.1086/BBLv187n2p244; VAISSIERE R., 1961, ARCH ZOOL EXPTL ET GEN, V100, P1; WYNBERG H, 1980, NATURE, V286, P641, DOI 10.1038/286641a0	26	4	4	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86131	10.1371/journal.pone.0086131	http://dx.doi.org/10.1371/journal.pone.0086131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465916	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000087
J	Matouskova, P; Bartikova, H; Bousova, I; Hanusova, V; Szotakova, B; Skalova, L				Matouskova, Petra; Bartikova, Hana; Bousova, Iva; Hanusova, Veronika; Szotakova, Barbora; Skalova, Lenka			Reference Genes for Real-Time PCR Quantification of Messenger RNAs and MicroRNAs in Mouse Model of Obesity	PLOS ONE			English	Article							NORMALIZING GENES; GREEN TEA; EXPRESSION; IDENTIFICATION; INFLAMMATION; PREVENTION; ENZYMES; LIVER; MICE; MSG	Obesity and metabolic syndrome is increasing health problem worldwide. Among other ways, nutritional intervention using phytochemicals is important method for treatment and prevention of this disease. Recent studies have shown that certain phytochemicals could alter the expression of specific genes and microRNAs (miRNAs) that play a fundamental role in the pathogenesis of obesity. For study of the obesity and its treatment, monosodium glutamate (MSG)-injected mice with developed central obesity, insulin resistance and liver lipid accumulation are frequently used animal models. To understand the mechanism of phytochemicals action in obese animals, the study of selected genes expression together with miRNA quantification is extremely important. For this purpose, real-time quantitative PCR is a sensitive and reproducible method, but it depends on proper normalization entirely. The aim of present study was to identify the appropriate reference genes for mRNA and miRNA quantification in MSG mice treated with green tea catechins, potential anti-obesity phytochemicals. Two sets of reference genes were tested: first set contained seven commonly used genes for normalization of messenger RNA, the second set of candidate reference genes included ten small RNAs for normalization of miRNA. The expression stability of these reference genes were tested upon treatment of mice with catechins using geNorm, NormFinder and BestKeeper algorithms. Selected normalizers for mRNA quantification were tested and validated on expression of NAD(P)H: quinone oxidoreductase, biotransformation enzyme known to be modified by catechins. The effect of selected normalizers for miRNA quantification was tested on two obesity-and diabetes-related miRNAs, miR-221 and miR-29b, respectively. Finally, the combinations of B2M/18S/HPRT1 and miR-16/sno234 were validated as optimal reference genes for mRNA and miRNA quantification in liver and 18S/RPlP0/HPRT1 and sno234/miR-186 in small intestine of MSG mice. These reference genes will be used for mRNA and miRNA normalization in further study of green tea catechins action in obese mice.	[Matouskova, Petra; Bartikova, Hana; Bousova, Iva; Hanusova, Veronika; Szotakova, Barbora; Skalova, Lenka] Charles Univ Prague, Dept Biochem Sci, Fac Pharm, Hradec Kralove, Czech Republic; [Hanusova, Veronika] Charles Univ Prague, Dept Med Biol & Genet, Fac Med, Hradec Kralove, Czech Republic	Charles University Prague; Charles University Prague; University Hospital Hradec Kralove	Matouskova, P (corresponding author), Charles Univ Prague, Dept Biochem Sci, Fac Pharm, Hradec Kralove, Czech Republic.	matousp7@faf.cuni.cz	Matoušková, Petra/S-5687-2017; Matoušková, Petra/AAL-1360-2021; Hanušová, Veronika/B-5707-2017; Bousova, Iva/S-5572-2017; Szotakova, Barbora/S-8742-2017; Skálová, Lenka/S-9187-2017	Matoušková, Petra/0000-0002-9421-5744; Matoušková, Petra/0000-0002-9421-5744; Hanušová, Veronika/0000-0002-4244-799X; Bousova, Iva/0000-0003-2863-717X; Szotakova, Barbora/0000-0002-0377-0743; Skálová, Lenka/0000-0003-0741-3871	European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/30.0022]; Czech Sciences Foundation, Centre of Excelence [P303/12/G163]	European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Czech Sciences Foundation, Centre of Excelence	Publication is co-financed by the European Social Fund and the state budget of the Czech Republic (Project no. CZ.1.07/2.3.00/30.0022) and by the Czech Sciences Foundation, Centre of Excelence (P303/12/G163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Aguilar FJ, 2008, EUR J PHARMACOL, V599, P152, DOI 10.1016/j.ejphar.2008.09.047; Alponti RF, 2011, REGUL PEPTIDES, V166, P98, DOI 10.1016/j.regpep.2010.09.002; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Daskalopoulou SS, 2004, ANGIOLOGY, V55, P589, DOI 10.1177/00033197040550i601; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Liu SN, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-176; Makarova JA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P638, DOI 10.1134/S0006297913060096; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Nagata M, 2006, EXP ANIM TOKYO, V55, P109, DOI 10.1538/expanim.55.109; Nakanishi Y, 2008, J AUTOIMMUN, V30, P42, DOI 10.1016/j.jaut.2007.11.016; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pi-Sunyer X, 2003, SCIENCE, V299, P859, DOI 10.1126/science.1082319; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Roman-Ramos R, 2011, BASIC CLIN PHARMACOL, V108, P406, DOI 10.1111/j.1742-7843.2011.00671.x; Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013; Sasaki Y, 2011, EUR J PHARMACOL, V662, P1, DOI 10.1016/j.ejphar.2011.04.051; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen JZ, 2012, DIABETOLOGIA, V55, P1836, DOI 10.1007/s00125-012-2519-z; Sirakov M, 2013, MOL BIOTECHNOL, V54, P930, DOI 10.1007/s12033-012-9643-3; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Tan XL, 2010, J NUTR, V140, P1404, DOI 10.3945/jn.110.121905; Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang FC, 2010, ANAL BIOCHEM, V399, P211, DOI 10.1016/j.ab.2009.12.029; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Xie HM, 2009, EXPERT OPIN THER TAR, V13, P1227, DOI 10.1517/14728220903190707; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xu LY, 2011, MOL BIOTECHNOL, V48, P255, DOI 10.1007/s12033-010-9366-2; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008; Yang CS, 2007, TOXICOL APPL PHARM, V224, P265, DOI 10.1016/j.taap.2006.11.024; Yang CS, 2012, EXPERT OPIN DRUG MET, V8, P677, DOI 10.1517/17425255.2012.681375	49	41	42	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86033	10.1371/journal.pone.0086033	http://dx.doi.org/10.1371/journal.pone.0086033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465854	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000085
J	Murakami, K; Etoh, Y; Ichihara, S; Maeda, E; Takenaka, S; Horikawa, K; Narimatsu, H; Kawano, K; Kawamura, Y; Ito, K				Murakami, Koichi; Etoh, Yoshiki; Ichihara, Sachiko; Maeda, Eriko; Takenaka, Shigeyuki; Horikawa, Kazumi; Narimatsu, Hiroshi; Kawano, Kimiko; Kawamura, Yoshiaki; Ito, Kenitiro			Isolation and Characteristics of Shiga Toxin 2f-Producing Escherichia coli among Pigeons in Kyushu, Japan	PLOS ONE			English	Article							EVOLUTIONARY GENETICS; PREVALENCE; STRAINS; IDENTIFICATION; RESTRICTION; VARIANTS; PATTERNS; GENES; EPEC; VTEC	An increasing number of Shiga toxin 2f-producing Escherichia coli (STEC2f) infections in humans are being reported in Europe, and pigeons have been suggested as a reservoir for the pathogen. In Japan, there is very little information regarding carriage of STEC2f by pigeons, prompting the need for further investigation. We collected 549 samples of pigeon droppings from 14 locations in Kyushu, Japan, to isolate STEC2f and to investigate characteristics of the isolates. Shiga toxin stx(2f) gene fragments were detected by PCR in 16 (2.9%) of the 549 dropping samples across four of the 14 locations. We obtained 23 STEC2f-isolates from seven of the original samples and from three pigeon dropping samples collected in an additional sampling experiment (from a total of seven locations across both sampling periods). Genotypic and phenotypic characteristics were then examined for selected isolates from each of 10 samples with pulsed-field gel electrophoresis profiles. Eight of the stx(2f) gene fragments sequenced in this study were homologous to others that were identified in Europe. Some isolates also contained virulence-related genes, including lpfA(O26), irp(2), and fyuA, and all of the 10 selected isolates maintained the eae, astA, and cdt genes. Moreover, five of the 10 selected isolates contained sfpA, a gene that is restricted to Shiga toxin-producing E. coli O165:H2 and sorbitol-fermenting Shiga toxin-producing E. coli O157:NM. We document serotypes O152:HNM, O128:HNM, and O145:H34 as STEC2f, which agrees with previous studies on pigeons and humans. Interestingly, O119:H21 was newly described as STEC2f. O145: H34, with sequence type 722, was described in a German study in humans and was also isolated in the current study. These results revealed that Japanese zoonotic STEC2f strains harboring several virulence-related factors may be of the same clonal complexes as some European strains. These findings provide useful information for public health-related disease management strategies in Japan.	[Murakami, Koichi; Etoh, Yoshiki; Ichihara, Sachiko; Maeda, Eriko; Takenaka, Shigeyuki; Horikawa, Kazumi] Fukuoka Inst Hlth & Environm Sci, Dept Hlth Sci, Fukuoka, Japan; [Narimatsu, Hiroshi] Oita Prefectural Inst Hlth & Environm, Microbiol Lab, Oita, Japan; [Kawano, Kimiko] Miyazaki Prefectural Inst Publ Hlth & Environm, Miyazaki, Japan; [Kawamura, Yoshiaki] Aichi Gakuin Univ, Dept Microbiol, Sch Pharm, Chikusa Ku, Nagoya, Aichi 464, Japan; [Ito, Kenitiro] Natl Inst Infect Dis, Shinjuku Ku, Tokyo, Japan	Aichi Gakuin University; National Institute of Infectious Diseases (NIID)	Murakami, K (corresponding author), Fukuoka Inst Hlth & Environm Sci, Dept Hlth Sci, Fukuoka, Japan.	murakami@fihes.pref.fukuoka.jp			JSPS KAKENHI [24590846]; Daido Life Welfare Foundation, Osaka, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Daido Life Welfare Foundation, Osaka, Japan	This work was supported by the JSPS KAKENHI, Grant No. 24590846, to Murakami, and was also supported in part by a grant to Etoh from the Daido Life Welfare Foundation, Osaka, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL: JSPS, http://www.jsps.go.jp/english/index.html; Daido Life Welfare Foundation, http://www.daido-life-welfare.or.jp/.	Bardiau M, 2010, VET RES, V41, DOI 10.1051/vetres/2010029; Blanco M, 2006, J MED MICROBIOL, V55, P1165, DOI 10.1099/jmm.0.46518-0; Deacon V, 2010, MICROBIOL-SGM, V156, P2527, DOI 10.1099/mic.0.039685-0; Etoh Y, 2009, JPN J INFECT DIS, V62, P315; Farooq S, 2009, LETT APPL MICROBIOLO; Grossmann K, 2005, BERL MUNCH TIERARZTL, V118, P456; Hyma KE, 2005, J BACTERIOL, V187, P619, DOI 10.1128/JB.187.2.619-628.2005; Isobe Junko, 2004, Kansenshogaku Zasshi, V78, P1000; Ito K, 2007, J CLIN MICROBIOL, V45, P1038, DOI 10.1128/JCM.01103-06; Jenkins C, 2003, J MED MICROBIOL, V52, P941, DOI 10.1099/jmm.0.05160-0; Kobayashi H, 2002, J VET MED SCI, V64, P1071, DOI 10.1292/jvms.64.1071; Kobayashi H, 2009, APPL ENVIRON MICROB, V75, P292, DOI 10.1128/AEM.01534-08; Kobayashi Kazuhiro, 2002, Kansenshogaku Zasshi, V76, P911; KONOWALCHUK J, 1977, INFECT IMMUN, V18, P775, DOI 10.1128/IAI.18.3.775-779.1977; Machado J, 2000, RES MICROBIOL, V151, P535, DOI 10.1016/S0923-2508(00)00223-0; Morabito S, 2001, VET MICROBIOL, V82, P275, DOI 10.1016/S0378-1135(01)00393-5; Murakami K, 2007, NEW MICROBIOL, V30, P155; Nakao H, 2002, FEMS IMMUNOL MED MIC, V34, P289, DOI 10.1111/j.1574-695X.2002.tb00636.x; Noda T, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-38; Oaks JL, 2010, EMERG INFECT DIS, V16, P638, DOI 10.3201/eid1604.090695; Ooka T, 2012, EMERG INFECT DIS, V18, P488, DOI 10.3201/eid1803.111401; Pickett CL, 1996, INFECT IMMUN, V64, P2070, DOI 10.1128/IAI.64.6.2070-2078.1996; Prager R, 2005, INT J MED MICROBIOL, V295, P29, DOI 10.1016/j.ijmm.2004.12.009; Prager R, 2009, INT J MED MICROBIOL, V299, P343, DOI 10.1016/j.ijmm.2008.10.008; Romling U, 2000, J CLIN MICROBIOL, V38, P464; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128/AEM.66.3.1205-1208.2000; Seto K, 2007, J VET MED SCI, V69, P1215, DOI 10.1292/jvms.69.1215; Sonntag AK, 2005, BERL MUNCH TIERARZTL, V118, P464; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Duynhoven YTHP, 2008, CLIN MICROBIOL INFEC, V14, P437, DOI 10.1111/j.1469-0691.2008.01963.x; YAMAGUCHI Y, 2001, ANN REP NAGASAKI PRE, V47, P21	33	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86076	10.1371/journal.pone.0086076	http://dx.doi.org/10.1371/journal.pone.0086076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465879	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000047
J	Flachsbart, F; Caliebe, A; Heinsen, FA; Hemming-Karlsen, T; Schreiber, S; Franke, A; Nebel, A				Flachsbart, Friederike; Caliebe, Amke; Heinsen, Femke-Anouska; Hemming-Karlsen, Tom; Schreiber, Stefan; Franke, Andre; Nebel, Almut			Investigation of Complement Component C4 Copy Number Variation in Human Longevity	PLOS ONE			English	Article							RP-C4-CYP21-TNX RCCX MODULES; MAJOR HISTOCOMPATIBILITY COMPLEX; SYSTEMIC-LUPUS-ERYTHEMATOSUS; 4TH COMPONENT; NULL ALLELES; RISK-FACTOR; GENE; POLYMORPHISMS; SMOKING; MHC	Genetic factors have been estimated to account for about 25% of the variation in an adult's life span. The complement component C4 with the isotypes C4A and C4B is an effector protein of the immune system, and differences in the overall C4 copy number or gene size (long C4L; short C4S) may influence the strength of the immune response and disease susceptibilities. Previously, an association between C4B copy number and life span was reported for Hungarians and Icelanders, where the C4B*Q0 genotype, which is defined by C4B gene deficiency, showed a decrease in frequency with age. Additionally, one of the studies indicated that a low C4B copy number might be a genetic trait that is manifested only in the presence of the environmental risk factor "smoking". These observations prompted us to investigate the role of the C4 alleles in our large German longevity sample (similar to 700 cases; 94-110 years and similar to 900 younger controls). No significant differences in the number of C4A, C4B and C4S were detected. Besides, the C4B*Q0 carrier state did not decrease with age, irrespective of smoking as an interacting variable. However, for C4L*Q0 a significantly different carrier frequency was observed in the cases compared with controls (cases: 5.08%; controls: 9.12%; p = 0.003). In a replication sample of 714 German cases (91-108 years) and 890 controls this result was not replicated (p = 0.14) although a similar trend of decreased C4L*Q0 carrier frequency in cases was visible (cases: 7.84%; controls: 10.00%).	[Flachsbart, Friederike; Heinsen, Femke-Anouska; Schreiber, Stefan; Franke, Andre; Nebel, Almut] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Caliebe, Amke] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Hemming-Karlsen, Tom] Oslo Univ Hosp, Rikshosp, Norwegian PSC Res Ctr, Div Canc Surg & Transplantat, Oslo, Norway; [Hemming-Karlsen, Tom] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Hemming-Karlsen, Tom] Oslo Univ Hosp, Rikshosp, Div Canc Surg & Transplantat, Sect Gastroenterol,Dept Transplantat Med, Oslo, Norway; [Hemming-Karlsen, Tom] Univ Bergen, Inst Med, Div Gastroenterol, Bergen, Norway; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Gen Med, Kiel, Germany; [Schreiber, Stefan] Univ Kiel, Popgen Biobank, Kiel, Germany	University of Kiel; University of Kiel; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Bergen; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Nebel, A (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	a.nebel@mucosa.de	Nebel, Almut/E-4196-2010; Franke, Andre/B-2151-2010	Franke, Andre/0000-0003-1530-5811	RESOLVE project [FP7-HEALTH-F4-2008-202047]; Excellence Cluster 'Inflammation at Interfaces'; INTERREG 4 A programme Syddanmark-Schleswig-K.E.R.N (EU funds from the European Regional Development Fund)	RESOLVE project; Excellence Cluster 'Inflammation at Interfaces'; INTERREG 4 A programme Syddanmark-Schleswig-K.E.R.N (EU funds from the European Regional Development Fund)	This study was supported by the RESOLVE project (FP7-HEALTH-F4-2008-202047), the Excellence Cluster 'Inflammation at Interfaces' and the INTERREG 4 A programme Syddanmark-Schleswig-K.E.R.N (with EU funds from the European Regional Development Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arason GJ, 2007, CLIN EXP IMMUNOL, V149, P132, DOI 10.1111/j.1365-2249.2007.03391.x; Arason GJ, 2003, ANN NY ACAD SCI, V1010, P496, DOI 10.1196/annals.1299.091; Bellavia D, 1999, J GERONTOL A-BIOL, V54, pB150, DOI 10.1093/gerona/54.4.B150; Benowitz NL, 2005, CANCER EPIDEM BIOMAR, V14, P1376, DOI 10.1158/1055-9965.EPI-04-0667; BISHOF NA, 1990, J INFECT DIS, V162, P248, DOI 10.1093/infdis/162.1.248; Blanchong CA, 2001, INT IMMUNOPHARMACOL, V1, P365, DOI 10.1016/S1567-5769(01)00019-4; Blasko B, 2008, INT IMMUNOL, V20, P31, DOI 10.1093/intimm/dxm117; Caliebe A, 2010, AGEING RES REV, V9, P238, DOI 10.1016/j.arr.2010.03.003; Candore G, 2006, ANN NY ACAD SCI, V1089, P516, DOI 10.1196/annals.1386.051; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Chung EK, 2002, AM J HUM GENET, V71, P823, DOI 10.1086/342777; DANGEL AW, 1994, IMMUNOGENETICS, V40, P425; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; FIELDER AHL, 1983, BMJ-BRIT MED J, V286, P425, DOI 10.1136/bmj.286.6363.425; Flachsbart F, 2010, MUTAT RES-FUND MOL M, V694, P13, DOI 10.1016/j.mrfmmm.2010.08.006; Flachsbart F, 2010, EUR J HUM GENET, V18, P59, DOI 10.1038/ejhg.2009.136; Franceschi C, 2000, AGING-CLIN EXP RES, V12, P77, DOI 10.1007/BF03339894; Franceschi S, 1999, ANN ONCOL, V10, P3, DOI 10.1023/A:1008379532307; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hitt R, 1999, LANCET, V354, P652, DOI 10.1016/S0140-6736(99)01987-X; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Hui J, 2004, TISSUE ANTIGENS, V63, P263, DOI 10.1111/j.1399-0039.2004.0175.x; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; KRAMER J, 1989, IMMUNOL LETT, V20, P83, DOI 10.1016/0165-2478(89)90073-4; KRAMER J, 1991, HUM GENET, V86, P595; KRAMER J, 1994, BRIT MED J, V309, P313, DOI 10.1136/bmj.309.6950.313; Kramer J, 2000, STROKE, V31, P2648, DOI 10.1161/01.STR.31.11.2648; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Ljungquist B, 1998, J GERONTOL A-BIOL, V53, pM441, DOI 10.1093/gerona/53A.6.M441; Mack M, 2004, IMMUNOGENETICS, V56, P321, DOI 10.1007/s00251-004-0705-y; Mizuno H, 2006, ATHEROSCLEROSIS, V185, P400, DOI 10.1016/j.atherosclerosis.2005.06.020; Nebel A, 2005, P NATL ACAD SCI USA, V102, P7906, DOI 10.1073/pnas.0408670102; Perls T, 2002, J AM GERIATR SOC, V50, P359, DOI 10.1046/j.1532-5415.2002.49283.x; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; R Development Core Team, 2008, LANG ENV STAT COMP; Saxena K, 2009, MOL IMMUNOL, V46, P1289, DOI 10.1016/j.molimm.2008.11.018; Skytthe A, 2003, TWIN RES, V6, P448, DOI 10.1375/twin.6.5.448; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; Szalai C, 2002, J MED GENET, V39, P46, DOI 10.1136/jmg.39.1.46; Szilagyi A, 2008, CYTOGENET GENOME RES, V123, P118, DOI 10.1159/000184699; Wahrmann M, 2011, J AM SOC NEPHROL, V22, P367, DOI 10.1681/ASN.2010050513; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wu YL, 2007, J IMMUNOL, V179, P3012, DOI 10.4049/jimmunol.179.5.3012; Yang XB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002916; Yang Y, 2003, J IMMUNOL, V171, P2734, DOI 10.4049/jimmunol.171.5.2734; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yang ZY, 1999, J BIOL CHEM, V274, P12147, DOI 10.1074/jbc.274.17.12147; YU CY, 1987, IMMUNOGENETICS, V25, P383; Yu CY, 2004, TRENDS IMMUNOL, V25, P694, DOI 10.1016/j.it.2004.10.006; Yu CY, 2003, PROG NUCLEIC ACID RE, V75, P217; YU CY, 1991, J IMMUNOL, V146, P1057; Zaher C, 2004, INT J TUBERC LUNG D, V8, P1423; Zaslavsky AM, 2001, INT J QUAL HEALTH C, V13, P481, DOI 10.1093/intqhc/13.6.481	54	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86188	10.1371/journal.pone.0086188	http://dx.doi.org/10.1371/journal.pone.0086188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465950	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100122
J	Gore-Panter, SR; Hsu, J; Hanna, P; Gillinov, AM; Pettersson, G; Newton, DW; Moravec, CS; Van Wagoner, DR; Chung, MK; Barnard, J; Smith, JD				Gore-Panter, Shamone R.; Hsu, Jeffery; Hanna, Peter; Gillinov, A. Marc; Pettersson, Gosta; Newton, David W.; Moravec, Christine S.; Van Wagoner, David R.; Chung, Mina K.; Barnard, John; Smith, Jonathan D.			Atrial Fibrillation Associated Chromosome 4q25 Variants Are Not Associated with PITX2c Expression in Human Adult Left Atrial Appendages	PLOS ONE			English	Article							AMINOPEPTIDASE-A; COMMON VARIANTS; SUSCEPTIBILITY; HEART; IDENTIFICATION; METAANALYSIS; ASYMMETRY; RISK; LUNG	Atrial Fibrillation (AF), the most common sustained arrhythmia, has a strong genetic component, but the mechanism by which common genetic variants lead to increased AF susceptibility is unknown. Genome-wide association studies (GWAS) have identified that the single nucleotide polymorphisms (SNPs) most strongly associated with AF are located on chromosome 4q25 in an intergenic region distal to the PITX2 gene. Our objective was to determine whether the AF-associated SNPs on chromosome 4q25 were associated with PITX2c expression in adult human left atrial appendages. Analysis of a lone AF GWAS identified four independent AF risk SNPs at chromosome 4q25. Human adult left atrial appendage tissue was obtained from 239 subjects of European Ancestry and used for SNP analysis of genomic DNA and determination of PITX2c RNA expression levels by quantitative PCR. Subjects were divided into three groups based on their history of AF and pre-operative rhythm. AF rhythm subjects had higher PITX2c expression than those with history of AF but in sinus rhythm. PITX2c expression was not associated with the AF risk SNPs in human adult left atrial appendages in all subjects combined or in each of the three subgroups. However, we identified seven SNPs modestly associated with PITX2c expression located in the introns of the ENPEP gene, similar to 54 kb proximal to PITX2. PITX2c expression in human adult left atrial appendages is not associated with the chromosome 4q25 AF risk SNPs; thus, the mechanism by which these SNPs are associated with AF remains enigmatic.	[Gore-Panter, Shamone R.; Hsu, Jeffery; Smith, Jonathan D.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Gore-Panter, Shamone R.; Hsu, Jeffery; Smith, Jonathan D.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; [Hanna, Peter] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Gillinov, A. Marc; Pettersson, Gosta] Cleveland Clin, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44106 USA; [Moravec, Christine S.; Van Wagoner, David R.; Chung, Mina K.; Smith, Jonathan D.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Newton, David W.; Moravec, Christine S.; Van Wagoner, David R.; Chung, Mina K.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Barnard, John] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Van Wagoner, DR (corresponding author), Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44106 USA.	vanwagd@ccf.org; chungm@ccf.org; barnarj@ccf.org; smithj4@ccf.org	Van Wagoner, David R/C-6783-2008; Smith, Jonathan D./H-9723-2013	Van Wagoner, David R/0000-0001-8250-9828; Hanna, Peter/0000-0003-3092-5090; Smith, Jonathan D./0000-0002-0415-386X	National Institutes of Health (NIH) [R01 HL090620, R01 HL111314]; Kaufman Center for Heart Failure; National Heart, Lung, And Blood Institute of the NIH [F31 HL103088];  [T32 GM088088]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090620, F31HL103088, R01HL111314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088088] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kaufman Center for Heart Failure; National Heart, Lung, And Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants R01 HL090620 and R01 HL111314 to MKC, JB, DRVW, and JDS. The donor tissue bank was supported by the Kaufman Center for Heart Failure. SRGP was supported by the National Heart, Lung, And Blood Institute of the NIH under award number F31 HL103088. JH was supported by T32 GM088088 to the Molecular Medicine PhD Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Ausma J, 1998, MOL CELL BIOCHEM, V186, P159, DOI 10.1023/A:1006887803970; Barth AS, 2005, CIRC RES, V96, P1022, DOI 10.1161/01.RES.0000165480.82737.33; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Hsu J, 2012, CIRC-CARDIOVASC GENE, V5, P327, DOI 10.1161/CIRCGENETICS.111.961631; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu CY, 2001, DEVELOPMENT, V128, P2039; Liu H., 2012, PROC PES INNOV SMART, P1; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Lubitz SA, 2010, CIRCULATION, V122, P976, DOI 10.1161/CIRCULATIONAHA.109.886440; Mitsui T, 2003, MOL MED, V9, P57, DOI 10.1007/BF03402108; Postma AV, 2011, CARDIOVASC RES, V91, P243, DOI 10.1093/cvr/cvr134; Reaux A, 2000, BIOCHEM SOC T, V28, P435, DOI 10.1042/0300-5127:0280435; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Thijssen VLJL, 2001, CARDIOVASC RES, V52, P14, DOI 10.1016/S0008-6363(01)00367-4; Vazeux G, 1996, J BIOL CHEM, V271, P9069, DOI 10.1074/jbc.271.15.9069; Wang J, 2010, P NATL ACAD SCI USA, V107, P9753, DOI 10.1073/pnas.0912585107; Wright JW, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/124758	27	39	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86245	10.1371/journal.pone.0086245	http://dx.doi.org/10.1371/journal.pone.0086245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465984	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100130
J	Havik, G; Catenazzi, A; Holmgren, M				Havik, Gilles; Catenazzi, Alessandro; Holmgren, Milena			Seabird Nutrient Subsidies Benefit Non-Nitrogen Fixing Trees and Alter Species Composition in South American Coastal Dry Forests	PLOS ONE			English	Article							ALLOCHTHONOUS INPUT; MARINE SUBSIDIES; LIZARD; ISLAND; LAND; PRODUCTIVITY; DYNAMICS; ESTABLISHMENT; LIMITATION; ABUNDANCE	Marine-derived nutrients can increase primary productivity and change species composition of terrestrial plant communities in coastal and riverine ecosystems. We hypothesized that sea nutrient subsidies have a positive effect on nitrogen assimilation and seedling survival of non-nitrogen fixing species, increasing the relative abundance of non-nitrogen fixing species close to seashore. Moreover, we proposed that herbivores can alter the effects of nutrient supplementation by preferentially feeding on high nutrient plants. We studied the effects of nutrient fertilization by seabird guano on tree recruitment and how these effects can be modulated by herbivorous lizards in the coastal dry forests of northwestern Peru. We combined field studies, experiments and stable isotope analysis to study the response of the two most common tree species in these forests, the nitrogen-fixing Prosopis pallida and the non-nitrogen-fixing Capparis scabrida. We did not find differences in herbivore pressure along the sea-inland gradient. We found that the non-nitrogen fixing C. scabrida assimilates marine-derived nitrogen and is more abundant than P. pallida closer to guano-rich soil. We conclude that the input of marine-derived nitrogen through guano deposited by seabirds feeding in the Pacific Ocean affects the two dominant tree species of the coastal dry forests of northern Peru in contrasting ways. The non-nitrogen fixing species, C. scabrida may benefit from sea nutrient subsidies by incorporating guano-derived nitrogen into its foliar tissues, whereas P. pallida, capable of atmospheric fixation, does not.	[Havik, Gilles; Holmgren, Milena] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Catenazzi, Alessandro] Southern Illinois Univ Carbondale, Dept Zool, Carbondale, IL 62901 USA	Wageningen University & Research; Southern Illinois University System; Southern Illinois University	Catenazzi, A (corresponding author), Southern Illinois Univ Carbondale, Dept Zool, Carbondale, IL 62901 USA.	acatenazzi@siu.edu	Catenazzi, Alessandro/C-8615-2009	Catenazzi, Alessandro/0000-0002-3650-4783	Alberta Mennega Stichting grant; NWO Meervoud grant [836.05.021]; Swiss National Science Foundation [116305]	Alberta Mennega Stichting grant; NWO Meervoud grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was partially funded by an Alberta Mennega Stichting grant to GH, a NWO Meervoud grant to MH (836.05.021) and a Swiss National Science Foundation Postdoctoral fellowship to AC (116305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WB, 1999, OECOLOGIA, V118, P324, DOI 10.1007/s004420050733; Anderson WB, 2008, ECOLOGY, V89, P660, DOI 10.1890/07-0234.1; Barrett K, 2005, OIKOS, V109, P145, DOI 10.1111/j.0030-1299.2005.13728.x; Baumberger T, 2012, ECOL INDIC, V15, P76, DOI 10.1016/j.ecolind.2011.09.009; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; Burger AE, 2005, J TROP ECOL, V21, P263, DOI 10.1017/S0266467404002159; Catenazzi A, 2007, J ARID ENVIRON, V71, P330, DOI 10.1016/j.jaridenv.2007.05.003; Catenazzi A, 2008, MAR ECOL PROG SER, V360, P285, DOI 10.3354/meps07393; Catenazzi A, 2007, MAR ECOL PROG SER, V349, P33, DOI 10.3354/meps07106; Catenazzi A, 2007, OIKOS, V116, P75, DOI 10.1111/j.2006.0030-1299.15230.x; Caut S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039125; de Falen Bernex, 1988, ATLAS REGIONAL PIURA ATLAS REGIONAL PIURA, P38; Ellis JC, 2005, PLANT ECOL, V181, P227, DOI 10.1007/s11258-005-7147-y; Farina JM, 2008, J ANIM ECOL, V77, P458, DOI 10.1111/j.1365-2656.2008.01361.x; Havik G, 2010, THESIS WAGENINGEN U; Helfield JM, 2001, ECOLOGY, V82, P2403, DOI 10.1890/0012-9658(2001)082[2403:EOSDNO]2.0.CO;2; Hilderbrand GV, 1999, OECOLOGIA, V121, P546, DOI 10.1007/s004420050961; Holmgren M, 2006, GLOBAL CHANGE BIOL, V12, P2263, DOI 10.1111/j.1365-2486.2006.01261.x; Hopcraft JGC, 2010, TRENDS ECOL EVOL, V25, P119, DOI 10.1016/j.tree.2009.08.001; Illius AW, 2000, OIKOS, V89, P283, DOI 10.1034/j.1600-0706.2000.890209.x; INRENA, 1998, MAP BOSQ SEC DEP PIU; Isaac ME, 2011, J PLANT PHYSIOL, V168, P776, DOI 10.1016/j.jplph.2010.10.011; Isaac ME, 2011, FOREST ECOL MANAG, V261, P582, DOI 10.1016/j.foreco.2010.11.011; KOEPCKE H.-W, 1952, PUBL MUS HIST NAT JAVIER PRADO" SER A ZOOL, V8, P1; Kolb G.S., 2011, P212; Kurdali F, 2009, ISOT ENVIRON HEALT S, V45, P198, DOI 10.1080/10256010903084126; Mellbrand K, 2011, ECOSYSTEMS, V14, P732, DOI 10.1007/s10021-011-9442-x; MIZUTANI H, 1988, ECOLOGY, V69, P340, DOI 10.2307/1940432; Mohtadi M, 2005, MAR GEOL, V216, P107, DOI 10.1016/j.margeo.2005.01.008; Mulder CPH, 2011, SEABIRD ISLANDS ECOL; Murphy R. C., 1925, BIRD ISLANDS PERU; Nesbit J.C., 1856, AGR CHEM NATURE PROP; Pasiecznik NM, 2001, PROSOPIS JULIFLORA P; PEREVOLOTSKY A, 1991, SMALL RUMINANT RES, V6, P199, DOI 10.1016/0921-4488(91)90156-K; Piovia-Scott J, 2011, SCIENCE, V331, P461, DOI 10.1126/science.1200282; Polis GA, 1998, NATURE, V395, P744, DOI 10.1038/27323; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Polis GA, 1997, ECOLOGY, V78, P1884; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Polis GA, 1998, ECOLOGY, V79, P490, DOI 10.2307/176948; Rodriguez E.F., 2007, ARNALDOA, V14, P269; Rose MD, 1998, ECOLOGY, V79, P998, DOI 10.2307/176595; Sanchez-Pinero F, 2000, ECOLOGY, V81, P3117, DOI 10.1890/0012-9658(2000)081[3117:BUDOAI]2.0.CO;2; Scheffer M, 2008, ECOSYSTEMS, V11, P226, DOI 10.1007/s10021-007-9118-8; Schmidt S, 2004, FUNCT PLANT BIOL, V31, P517, DOI 10.1071/FP04024; SHEARER G, 1983, OECOLOGIA, V56, P365, DOI 10.1007/BF00379714; Sitters J, 2012, RESTOR ECOL, V20, P33, DOI 10.1111/j.1526-100X.2010.00761.x; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Squeo FA, 2007, J VEG SCI, V18, P195, DOI 10.1111/j.1654-1103.2007.tb02530.x; Stapp P, 1999, NATURE, V401, P467, DOI 10.1038/46769; Therneau T.M., 2012, PACKAGE SURVIVAL ANA; van Leeuwen JP, 2011, J HERPETOL, V45, P472; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; WADA E, 1975, Geochemical Journal, V9, P139; Wait DA, 2005, J ARID ENVIRON, V60, P681, DOI 10.1016/j.jaridenv.2004.07.001; Young HS, 2011, AM J BOT, V98, P207, DOI 10.3732/ajb.1000159; Young HS, 2010, P NATL ACAD SCI USA, V107, P2072, DOI 10.1073/pnas.0914169107	58	17	17	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86381	10.1371/journal.pone.0086381	http://dx.doi.org/10.1371/journal.pone.0086381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466065	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100151
J	Kikuchi, Y; Kunitoh-Asari, A; Hayakawa, K; Imai, S; Kasuya, K; Abe, K; Adachi, Y; Fukudome, SI; Takahashi, Y; Hachimura, S				Kikuchi, Yosuke; Kunitoh-Asari, Ayami; Hayakawa, Katsuyuki; Imai, Shinjiro; Kasuya, Kenji; Abe, Kimio; Adachi, Yu; Fukudome, Shin-ichi; Takahashi, Yoshimasa; Hachimura, Satoshi			Oral Administration of Lactobacillus plantarum Strain AYA Enhances IgA Secretion and Provides Survival Protection against Influenza Virus Infection in Mice	PLOS ONE			English	Article							LYMPHOID-TISSUE; CELLS; BACTERIA; INTERLEUKIN-6; IL-6	The mucosal immune system provides the first line of defense against inhaled and ingested pathogenic microbacteria and viruses. This defense system, to a large extent, is mediated by the actions of secretory IgA. In this study, we screened 140 strains of lactic acid bacteria for induction of IgA production by murine Peyer's patch cells. We selected one strain and named it Lactobacillus plantarum AYA. We found that L. plantarum AYA-induced production of IL-6 in Peyer's patch dendritic cells, with this production promoting IgA(+) B cells to differentiate into IgA-secreting plasma cells. We also observed that oral administration of L. plantarum AYA in mice caused an increase in IgA production in the small intestine and lung. This production of IgA correlated strongly with protective ability, with the treated mice surviving longer than the control mice after lethal influenza virus infection. Our data therefore reveals a novel immunoregulatory role of the L. plantarum AYA strain which enhances mucosal IgA production and provides protection against respiratory influenza virus infection.	[Kikuchi, Yosuke; Kunitoh-Asari, Ayami; Hayakawa, Katsuyuki; Imai, Shinjiro; Fukudome, Shin-ichi] Nisshin Seifun Grp Inc, Res Ctr Basic Sci Res & Dev, Qual Assurance Div, Fujimino City, Saitama, Japan; [Imai, Shinjiro] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Shizuoka 4228526, Japan; [Kasuya, Kenji] Oriental Yeast Co Ltd, Yeast Funct Dev Unit, Itabashi Ku, Tokyo, Japan; [Abe, Kimio] Oriental Yeast Co Ltd, Lab Yeast & Fermentat Food Div, Itabashi Ku, Tokyo, Japan; [Adachi, Yu; Takahashi, Yoshimasa] Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan; [Hachimura, Satoshi] Univ Tokyo, Res Ctr Food Safety, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Nisshin Seifun Group Inc.; University of Shizuoka; Oriental Yeast Co., Ltd.; Oriental Yeast Co., Ltd.; National Institute of Infectious Diseases (NIID); University of Tokyo	Hachimura, S (corresponding author), Univ Tokyo, Res Ctr Food Safety, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	ahachi@mail.ecc.u-tokyo.ac.jp		Takahashi, Yoshimasa/0000-0001-6342-4087				BEAGLEY KW, 1989, J EXP MED, V169, P2133, DOI 10.1084/jem.169.6.2133; Blum S, 2002, CLIN REV ALLERG IMMU, V22, P287, DOI 10.1007/s12016-002-0013-y; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; He F, 2005, MICROBIOL IMMUNOL, V49, P995; Heczko PB, 2006, J PHYSIOL PHARMACOL, V57, P5; Heritage PL, 1997, AM J RESP CRIT CARE, V156, P1256, DOI 10.1164/ajrccm.156.4.97-03017; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Inoue R, 2007, BRIT J DERMATOL, V156, P499, DOI 10.1111/j.1365-2133.2006.07695.x; Ishida Y, 2003, BIOSCI BIOTECH BIOCH, V67, P951, DOI 10.1271/bbb.67.951; Izumo T, 2010, INT IMMUNOPHARMACOL, V10, P1101, DOI 10.1016/j.intimp.2010.06.012; KIM PH, 1990, J IMMUNOL, V144, P3411; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; KUNIMOTO DY, 1989, J IMMUNOL, V143, P2230; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mbawuike IN, 1999, J IMMUNOL, V162, P2530; Mora JR, 2008, MUCOSAL IMMUNOL, V1, P96, DOI 10.1038/mi.2007.14; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Perdigon G, 2001, Curr Issues Intest Microbiol, V2, P27; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Shikina T, 2004, J IMMUNOL, V172, P6259, DOI 10.4049/jimmunol.172.10.6259; Shvartsman Y S, 1976, Adv Immunol, V22, P291, DOI 10.1016/S0065-2776(08)60551-9; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; VANDERHEIJDEN PJ, 1987, IMMUNOLOGY, V62, P551; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Yasui H, 2004, CLIN DIAGN LAB IMMUN, V11, P675, DOI 10.1128/CDLI.11.4.675-679.2004	32	72	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86416	10.1371/journal.pone.0086416	http://dx.doi.org/10.1371/journal.pone.0086416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466081	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100159
J	Danzl, NM; Jeong, S; Choi, Y; Alexandropoulos, K				Danzl, Nichole M.; Jeong, Seihwan; Choi, Yongwon; Alexandropoulos, Konstantina			Identification of Novel Thymic Epithelial Cell Subsets Whose Differentiation Is Regulated by RANKL and Traf6	PLOS ONE			English	Article							SELF-TOLERANCE; T-CELLS; GENE-EXPRESSION; AIRE CONTROL; APECED GENE; AUTOIMMUNITY; PROGENITOR; SELECTION; ANTIGEN; REPERTOIRE	Thymic epithelial cells (TECs) are critical for the normal development and function of the thymus. Here, we examined the developmental stages of TECs using quantitative assessment of the cortical and medullary markers Keratin 5 and Keratin 8 (K5 and K8) respectively, in normal and gain/loss of function mutant animals. Gain of function mice overexpressed RANKL in T cells, whereas loss of function animals lacked expression of Traf6 in TECs (Traf6 Delta TEC). Assessment of K5 and K8 expression in conjunction with other TEC markers in wild type mice identified novel cortical and medullary TEC populations, expressing different combinations of these markers. RANKL overexpression led to expansion of all medullary TECs (mTECs) and enlargement of the thymic medulla. This in turn associated with a block in thymocyte development and loss of CD4(+)CD8(+), CD4(+) and CD8(+) thymocytes. In contrast, Traf6 deletion inhibited the production of most TEC populations including cortical TECs (cTECs), defined by absence of UEA-1 binding and LY51 expression, but had no apparent effect on thymocyte development. These results reveal a large degree of heterogeneity within the TEC compartment and the existence of several populations exhibiting concomitant expression of cortical, medullary and epithelial markers and whose production is regulated by RANKL and Traf6.	[Danzl, Nichole M.] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY USA; [Jeong, Seihwan; Alexandropoulos, Konstantina] Icahn Sch Med Mt Sinai, Inst Immunol, Div Clin Immunol, Dept Med, New York, NY 10029 USA; [Choi, Yongwon] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA	Columbia University; Icahn School of Medicine at Mount Sinai; University of Pennsylvania	Alexandropoulos, K (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, Div Clin Immunol, Dept Med, New York, NY 10029 USA.	k.alexandropoulos@mssm.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [RO1 AI088106-01, RO1 AI068963-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088106, R01AI068963, R01AI064909] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) grants: RO1 AI088106-01 and RO1 AI068963-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen J, 1999, ANN MED, V31, P111, DOI 10.3109/07853899708998786; Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Alexandropoulos K, 2012, IMMUNOL RES, V54, P177, DOI 10.1007/s12026-012-8301-y; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Anderson G, 2009, EUR J IMMUNOL, V39, P1694, DOI 10.1002/eji.200939379; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Baik S, 2013, EUR J IMMUNOL, V43, P589, DOI 10.1002/eji.201243209; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bonito AJ, 2013, J CLIN INVE IN PRESS; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Danzl NM, 2010, J EXP MED, V207, P999, DOI 10.1084/jem.20092384; Derbinski J, 2005, TRENDS IMMUNOL, V26, P503, DOI 10.1016/j.it.2005.07.006; Dooley J, 2008, J IMMUNOL, V181, P5225, DOI 10.4049/jimmunol.181.8.5225; Dooley J, 2007, DEV DYNAM, V236, P3459, DOI 10.1002/dvdy.21364; Gabler J, 2007, EUR J IMMUNOL, V37, P3363, DOI 10.1002/eji.200737131; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Guerau-De-Arellano M, 2009, J EXP MED, V206, P1245, DOI 10.1084/jem.20090300; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Irla M, 2010, TRENDS IMMUNOL, V31, P71, DOI 10.1016/j.it.2009.11.002; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Muller-Hermelink HK, 1999, ANN MED, V31, P5; Murata S, 2008, CURR OPIN IMMUNOL, V20, P192, DOI 10.1016/j.coi.2008.03.002; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nishikawa Y, 2010, J EXP MED, V207, P963, DOI 10.1084/jem.20092144; Nitta T, 2008, ADV IMMUNOL, V99, P59, DOI 10.1016/S0065-2776(08)00603-2; Ohigashi I, 2013, P NATL ACAD SCI USA, V110, P9885, DOI 10.1073/pnas.1301799110; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Takahama Y, 2010, SEMIN IMMUNOL, V22, P287, DOI 10.1016/j.smim.2010.04.012; Thomas CR, 1999, J CLIN ONCOL, V17, P2280, DOI 10.1200/JCO.1999.17.7.2280; Tykocinski LO, 2008, ANN NY ACAD SCI, V1143, P105, DOI 10.1196/annals.1443.018; Wang XP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00019; White AJ, 2010, J IMMUNOL, V185, P4769, DOI 10.4049/jimmunol.1002151; Yang SJ, 2006, INT IMMUNOL, V18, P729, DOI 10.1093/intimm/dxl010	50	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86129	10.1371/journal.pone.0086129	http://dx.doi.org/10.1371/journal.pone.0086129			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465914	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500191
J	Gola, H; Engler, A; Morath, J; Adenauer, H; Elbert, T; Kolassa, IT; Engler, H				Gola, Hannah; Engler, Andrea; Morath, Julia; Adenauer, Hannah; Elbert, Thomas; Kolassa, Iris-Tatjana; Engler, Harald			Reduced Peripheral Expression of the Glucocorticoid Receptor alpha Isoform in Individuals with Posttraumatic Stress Disorder: A Cumulative Effect of Trauma Burden	PLOS ONE			English	Article							BETA-ISOFORM; MONONUCLEAR LEUKOCYTES; MECHANISMS; WAR; SENSITIVITY; NUMBER	Background: Posttraumatic stress disorder (PTSD) is a serious psychiatric condition that was found to be associated with altered functioning of the hypothalamic-pituitary-adrenal (HPA) axis and changes in glucocorticoid (GC) responsiveness. The physiological actions of GCs are primarily mediated through GC receptors (GR) of which isoforms with different biological activities exist. This study aimed to investigate whether trauma-experience and/or PTSD are associated with altered expression of GR splice variants. Methods: GR alpha and GR beta mRNA expression levels were determined by real-time quantitative PCR in whole blood samples of individuals with chronic and severe forms of PTSD (n=42) as well as in ethnically matched reference subjects (non-PTSD, n=35). Results: Individuals suffering from PTSD exhibited significantly lower expression of the predominant and functionally active GR alpha isoform compared to non-PTSD subjects. This effect remained significant when accounting for gender, smoking, psychotropic medication or comorbid depression. Moreover, the GR alpha expression level was significantly negatively correlated with the number of traumatic event types experienced, both in the whole sample and within the PTSD patient group. Expression of the less abundant and non-ligand binding GR beta isoform was comparable between patient and reference groups. Conclusions: Reduced expression of the functionally active GR alpha isoform in peripheral blood cells of individuals with PTSD seems to be a cumulative effect of trauma burden rather than a specific feature of PTSD since non-PTSD subjects with high trauma load showed an intermediate phenotype between PTSD patients and individuals with no or few traumatic experiences.	[Gola, Hannah; Kolassa, Iris-Tatjana] Univ Ulm, D-89069 Ulm, Germany; [Engler, Andrea; Engler, Harald] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany; [Morath, Julia; Adenauer, Hannah; Elbert, Thomas] Univ Konstanz, Constance, Germany	Ulm University; University of Duisburg Essen; University of Konstanz	Engler, H (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany.	harald.engler@uk-essen.de	Elbert, Thomas/C-8556-2009; Kolassa, Iris Tatjana/Y-3032-2018; Engler, Harald/H-8773-2017	Elbert, Thomas/0000-0003-1332-4939; Engler, Harald/0000-0001-6329-1990	German Research Foundation (DFG) Research Unit FOR751 [EN 814/1-2, KO 3895/1-1]; European Refugee Fund	German Research Foundation (DFG) Research Unit FOR751; European Refugee Fund	This work was funded by the German Research Foundation (DFG) Research Unit FOR751 (EN 814/1-2 and KO 3895/1-1) and the European Refugee Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt SR, 2010, PSYCHONEUROENDOCRINO, V35, P544, DOI 10.1016/j.psyneuen.2009.09.001; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Baker DG, 2012, NEUROPHARMACOLOGY, V62, P663, DOI 10.1016/j.neuropharm.2011.02.027; BAMBERGER CM, 1995, J CLIN INVEST, V95, P2435, DOI 10.1172/JCI117943; Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; de Kloet CS, 2007, MOL PSYCHIATR, V12, P443, DOI 10.1038/sj.mp.4001934; de Kloet CS, 2006, J PSYCHIATR RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; deCastro M, 1996, MOL MED, V2, P597, DOI 10.1007/BF03401643; Duma D, 2006, J STEROID BIOCHEM, V102, P11, DOI 10.1016/j.jsbmb.2006.09.009; ENCIO IJ, 1991, J BIOL CHEM, V266, P7182; Gola H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-40; Gola H, 2012, PSYCHONEUROENDOCRINO, V37, P213, DOI 10.1016/j.psyneuen.2011.06.005; Golier JA, 2006, PSYCHONEUROENDOCRINO, V31, P1181, DOI 10.1016/j.psyneuen.2006.08.005; Gotovac K, 2003, CLIN EXP IMMUNOL, V131, P335, DOI 10.1046/j.1365-2249.2003.02075.x; Hagendorf A, 2005, J CLIN ENDOCR METAB, V90, P6237, DOI 10.1210/jc.2005-1042; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; Kolassa IT, 2010, PSYCHOL TRAUMA-US, V2, P169, DOI 10.1037/a0019362; Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu; Li LB, 2006, J LEUKOCYTE BIOL, V79, P818, DOI 10.1189/jlb.0805466; Maes M, 1999, BIOL PSYCHIAT, V45, P833, DOI 10.1016/S0006-3223(98)00131-0; Matic G, 2013, PROG NEURO-PSYCHOPH, V43, P238, DOI 10.1016/j.pnpbp.2013.01.005; Matsubara T, 2006, BIOL PSYCHIAT, V59, P689, DOI 10.1016/j.biopsych.2005.09.026; Neuner F, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-34; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; Oakley RH, 1996, J BIOL CHEM, V271, P9550, DOI 10.1074/jbc.271.16.9550; Pace TWW, 2011, BRAIN BEHAV IMMUN, V25, P6, DOI 10.1016/j.bbi.2010.10.003; Pace TWW, 2012, BRAIN BEHAV IMMUN, V26, P13, DOI 10.1016/j.bbi.2011.07.232; Pujols L, 2002, AM J PHYSIOL-CELL PH, V283, pC1324, DOI 10.1152/ajpcell.00363.2001; Revollo JR, 2009, ANN NY ACAD SCI, V1179, P167, DOI 10.1111/j.1749-6632.2009.04986.x; Rief W, 2003, PSYCHOSOMATICS, V44, P492, DOI 10.1176/appi.psy.44.6.492; Rohleder N, 2010, NEUROSCI BIOBEHAV R, V35, P104, DOI 10.1016/j.neubiorev.2009.12.003; Rosen GM, 2008, CLIN PSYCHOL REV, V28, P837, DOI 10.1016/j.cpr.2007.12.002; Schauer M, 2011, SHORTTERM TREATMENT, P77; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sommershof A, 2009, BRAIN BEHAV IMMUN, V23, P1117, DOI 10.1016/j.bbi.2009.07.003; Spitzer C, 2010, J PSYCHIATR RES, V44, P15, DOI 10.1016/j.jpsychires.2009.06.002; Su TP, 2009, J PSYCHIATR RES, V43, P1078, DOI 10.1016/j.jpsychires.2009.03.010; van Zuiden M, 2011, AM J PSYCHIAT, V168, P89, DOI 10.1176/appi.ajp.2010.10050706; Vidovic A, 2011, NEUROIMMUNOMODULAT, V18, P199, DOI 10.1159/000322869; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; YEHUDA R, 1991, AM J PSYCHIAT, V148, P499; Yehuda R, 2004, BIOL PSYCHIAT, V55, P1110, DOI 10.1016/j.biopsych.2004.02.010; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x; Yudt MR, 2003, MOL CELL BIOL, V23, P4319, DOI 10.1128/MCB.23.12.4319-4330.2003	48	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86333	10.1371/journal.pone.0086333	http://dx.doi.org/10.1371/journal.pone.0086333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466032	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500229
J	Ramon, M; Salces-Ortiz, J; Gonzalez, C; Perez-Guzman, MD; Garde, JJ; Garcia-Alvarez, O; Maroto-Morales, A; Calvo, JH; Serrano, MM				Ramon, Manuel; Salces-Ortiz, Judit; Gonzalez, Carmen; Dolores Perez-Guzman, M.; Julian Garde, J.; Garcia-Alvarez, Olga; Maroto-Morales, Alejandro; Calvo, Jorge H.; Magdalena Serrano, M.			Influence of the Temperature and the Genotype of the HSP90AA1 Gene over Sperm Chromatin Stability in Manchega Rams	PLOS ONE			English	Article							SCROTAL HEAT-STRESS; GERM-CELL APOPTOSIS; DNA FRAGMENTATION; STRUCTURE ASSAY; 105-KDA PROTEIN; BINDING PROTEIN; EXPRESSION; FERTILITY; INTEGRITY; SUBFERTILITY	The present study addresses the effect of heat stress on males' reproduction ability. For that, we have evaluated the sperm DNA fragmentation (DFI) by SCSA of ejaculates incubated at 37 degrees C during 0, 24 and 48 hours after its collection, as a way to mimic the temperature circumstances to which spermatozoa will be subject to in the ewe uterus. The effects of temperature and temperature-humidity index (THI) from day 60 prior collection to the date of semen collection on DFI were examined. To better understand the causes determining the sensitivity of spermatozoa to heat, this study was conducted in 60 males with alternative genotypes for the SNP G/C-660 of the HSP90AA1 promoter, which encode for the Hsp90 alpha protein. The Hsp90 alpha protein predominates in the brain and testis, and its role in spermatogenesis has been described in several species. Ridge regression analyses showed that days 29 to 35 and 7 to 14 before sperm collection (bsc) were the most critical regarding the effect of heat stress over DFI values. Mixed model analyses revealed that DFI increases over a threshold of 30 degrees C for maximum temperature and 22 for THI at days 29 to 35 and 7 to 14 bsc only in animals carrying the GG(-660) genotype. The period 29-35 bsc coincide with the meiosis I process for which the effect of the Hsp90 alpha has been described in mice. The period 7-14 bsc may correspond with later stages of the meiosis II and early stages of epididymal maturation in which the replacement of histones by protamines occurs. Because of GG(-660) genotype has been associated to lower levels of HSP90AA1 expression, suboptimal amounts of HSP90AA1 mRNA in GG(-660) animals under heat stress conditions make spermatozoa DNA more susceptible to be fragmented. Thus, selecting against the GG(-660) genotype could decrease the DNA fragmentation and spermatozoa thermal susceptibility in the heat season, and its putative subsequent fertility gains.	[Ramon, Manuel; Dolores Perez-Guzman, M.] CERSYRA, Valdepenas, Spain; [Salces-Ortiz, Judit; Gonzalez, Carmen; Magdalena Serrano, M.] INIA, Madrid, Spain; [Julian Garde, J.; Garcia-Alvarez, Olga; Maroto-Morales, Alejandro] Univ Castile La Mancha, CSIC, Hlth & Biotechnol IREC, Junta Comunidades Castilla La Mancha, Albacete, Spain; [Calvo, Jorge H.] CITA, Unidad Tecnol Prod Anim, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha	Serrano, MM (corresponding author), INIA, Madrid, Spain.	malena@inia.es	garcia-alvarez, olga/L-4424-2014; Garde, Julian J/O-5607-2015; López-Brea, José Julián Garde/AAE-5894-2019; Calvo, Jorge H/E-5240-2016; Serrano, Magdalena M/R-5716-2017; Fernandez, Manuel Ramon/B-5755-2014; Serrano, Malena/GXH-8219-2022; garcia-alvarez, olga/AAM-5128-2020	garcia-alvarez, olga/0000-0003-4310-0557; Garde, Julian J/0000-0002-3667-6518; López-Brea, José Julián Garde/0000-0002-3667-6518; Calvo, Jorge H/0000-0001-9513-0219; Serrano, Magdalena M/0000-0002-1621-3102; Fernandez, Manuel Ramon/0000-0003-4179-9894; garcia-alvarez, olga/0000-0003-4310-0557; Salces-Ortiz, Judit/0000-0002-3572-4020; Gonzalez Verdejo, Carmen/0000-0001-8757-9147	Subprograma de Investigacion Fundamental orientada a los Recursos y Tecnologias Agrarias [RTA2009-00098-00-00 INIA]	Subprograma de Investigacion Fundamental orientada a los Recursos y Tecnologias Agrarias	This work was supported by RTA2009-00098-00-00 INIA project (Subprograma de Investigacion Fundamental orientada a los Recursos y Tecnologias Agrarias). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Alekseev OM, 2003, J BIOL CHEM, V278, P8846, DOI 10.1074/jbc.M210352200; Amann RP, 2012, THERIOGENOLOGY, V77, P795, DOI 10.1016/j.theriogenology.2011.09.002; AMIR D, 1968, ANN BIOL ANIM BIOCH, V8, P195, DOI 10.1051/rnd:19680202; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; BALLACHEY BE, 1987, BIOL REPROD, V36, P915, DOI 10.1095/biolreprod36.4.915; Banks S, 2005, REPRODUCTION, V129, P505, DOI 10.1530/rep.1.00531; Barratt CLR, 2010, HUM REPROD, V25, P824, DOI 10.1093/humrep/dep465; Biggiogera M, 1996, EXP CELL RES, V229, P77, DOI 10.1006/excr.1996.0345; Bradley AD, 2009, J ANDROL, V30, P1; Bungum M, 2004, HUM REPROD, V19, P1401, DOI 10.1093/humrep/deh280; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; CARDOSO FM, 1988, ANIM REPROD SCI, V17, P77, DOI 10.1016/0378-4320(88)90047-4; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; Delbes G, 2010, MOL HUM REPROD, V16, P14, DOI 10.1093/molehr/gap087; DEVITA R, 1990, INT J HYPERTHER, V6, P543, DOI 10.3109/02656739009140950; Drabent B, 1998, CELL TISSUE RES, V291, P127, DOI 10.1007/s004410050986; Evenson Donald, 2000, Methods in Cell Science, V22, P169, DOI 10.1023/A:1009844109023; Evenson DP, 2006, THERIOGENOLOGY, V65, P979, DOI 10.1016/j.theriogenology.2005.09.011; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Evenson DP, 2002, J ANDROL, V23, P25, DOI 10.1002/j.1939-4640.2002.tb02599.x; Fernandez-Gonzalez R, 2008, BIOL REPROD, V78, P761, DOI 10.1095/biolreprod.107.065623; Fleming JS, 2004, MOL REPROD DEV, V68, P103, DOI 10.1002/mrd.20049; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garcia-Alvarez O, 2010, THERIOGENOLOGY, V74, P979, DOI 10.1016/j.theriogenology.2010.04.027; Garcia-Macias V, 2006, J ANDROL, V27, P837, DOI 10.2164/jandrol.106.000315; Gonzalez-Marin C, 2012, INT J MOL SCI, V13, P14026, DOI 10.3390/ijms131114026; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; Grazer Vera M, 2012, Biology (Basel), V1, P411, DOI 10.3390/biology1020411; Grimes SR, 2003, GENE, V304, P13, DOI 10.1016/S0378-1119(02)01201-5; Groen AF, 1997, LIVEST PROD SCI, V49, P1, DOI 10.1016/S0301-6226(97)00041-9; Hales Barbara F, 2005, Toxicol Appl Pharmacol, V207, P514, DOI 10.1016/j.taap.2004.12.021; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Hecht NB, 2000, MOL REPROD DEV, V56, P252; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; ITOH H, 1990, EUR J BIOCHEM, V193, P429, DOI 10.1111/j.1432-1033.1990.tb19356.x; ITOH H, 1991, FEBS LETT, V289, P110, DOI 10.1016/0014-5793(91)80920-X; Jannes P, 1998, HUM REPROD, V13, P372, DOI 10.1093/humrep/13.2.372; Lackner DH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r25; Legarra A, 2007, ANIMAL, V1, P193, DOI 10.1017/S1751731107657814; Marai IFM, 2007, SMALL RUMINANT RES, V71, P1, DOI 10.1016/j.smallrumres.2006.10.003; Marcos-Carcavilla A, 2008, CELL STRESS CHAPERON, V13, P19, DOI 10.1007/s12192-007-0004-2; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P343, DOI 10.1007/s12192-009-0149-2; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P67, DOI 10.1007/s12192-009-0123-z; MEISTRICH ML, 1985, DEV BIOL, V112, P230, DOI 10.1016/0012-1606(85)90137-X; Nasr-Esfahani MH, 2005, REPROD BIOMED ONLINE, V9, P652; Nordstoga AB, 2013, REPROD DOMEST ANIM, V48, P207, DOI 10.1111/j.1439-0531.2012.02132.x; Oliva R, 2006, HUM REPROD UPDATE, V12, P417, DOI 10.1093/humupd/dml009; Oner Y, 2012, LIVEST SCI, V150, P381, DOI 10.1016/j.livsci.2012.07.028; Paul C, 2008, REPRODUCTION, V136, P73, DOI 10.1530/REP-08-0036; Perez-Crespo M, 2008, MOL REPROD DEV, V75, P40, DOI 10.1002/mrd.20759; Pinheiro JC, 2000, STAT COMPUTER SERIES; R Core Team, 2013, LANG ENV STAT COMP; Sailer BL, 1997, J ANDROL, V18, P294; Salces-Ortiz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066641; Setchell B. P., 2006, Animal Reproduction, V3, P81; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Sotolongo B, 2003, BIOL REPROD, V69, P2029, DOI 10.1095/biolreprod.103.020594; Spano M, 2000, FERTIL STERIL, V73, P43, DOI 10.1016/S0015-0282(99)00462-8; Sreedhar AS, 2004, FEBS LETT, V562, P11; Szczygiel MA, 2002, BIOL REPROD, V67, P1532, DOI 10.1095/biolreprod.101.002667; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; ULBERG L. C., 1958, JOUR HEREDITY, V49, P62; VAMVAKOPOULOS NO, 1993, MOL CELL ENDOCRINOL, V98, P49, DOI 10.1016/0303-7207(93)90235-C; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Yaeram J, 2006, REPROD FERT DEVELOP, V18, P647, DOI 10.1071/RD05022; Yin YZ, 1998, BIOL REPROD, V58, P492, DOI 10.1095/biolreprod58.2.492; Yue L, 1999, GENETICS, V151, P1065; Zhang XS, 2005, FRONT BIOSCI-LANDMRK, V10, P3110, DOI 10.2741/1767	71	7	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86107	10.1371/journal.pone.0086107	http://dx.doi.org/10.1371/journal.pone.0086107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465903	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500184
J	Saremi, B; Winand, S; Friedrichs, P; Kinoshita, A; Rehage, J; Danicke, S; Haussler, S; Breves, G; Mielenz, M; Sauerwein, H				Saremi, Behnam; Winand, Sarah; Friedrichs, Paula; Kinoshita, Asako; Rehage, Juergen; Daenicke, Sven; Haeussler, Susanne; Breves, Gerhard; Mielenz, Manfred; Sauerwein, Helga			Longitudinal Profiling of the Tissue-Specific Expression of Genes Related with Insulin Sensitivity in Dairy Cows during Lactation Focusing on Different Fat Depots	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; SUBCUTANEOUS ADIPOSE-TISSUE; TRANSITION PERIOD; GROWTH-HORMONE; FACTOR-ALPHA; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; SERUM CONCENTRATIONS	In dairy cows the milk associated energy output in early lactation exceeds the input via voluntary feed intake. To spare glucose for mammary lactose synthesis, peripheral insulin sensitivity (IS) is reduced and fat mobilization is stimulated. For these processes a link between IS and the endocrine functions of adipose tissue (AT) is likely; we thus aimed to characterise the mRNA expression from bovine AT derived proteins and receptors that are related to IS according to the literature in metabolically active tissues plus systemic IS throughout lactation. Conjugated linoleic acids (CLA) reduce milk fat thus decreasing the milk drain of energy and potentially dampening lipolysis, but may also affect IS. Subcutaneous (s.c.) AT and liver from pluriparous cows receiving either control fat or CLA supplement (100 g/day from 1 to 182 days in milk each) were biopsied covering week -3 to 36 relative to parturition. In an additional trial with primiparous cows treated analogously and slaughtered on days in milk 1, 42 or 105, samples from liver, udder, skeletal muscle and 3 visceral and 3 s.c. AT were obtained and assayed for mRNA abundance of adiponectin, its receptors, leptin, leptin receptor, PPAR gamma, PPAR gamma 2, IL-6, and TNF-alpha. In pluriparous animals, the mRNA abundance of most of the target genes decreased after parturition in s.c. AT but increased in liver. In primiparous cows, AT depot specific differences were mostly related to retroperitoneal AT; adiponectin receptor 1 and TNF-alpha were affected predominantly. CLA effects in primiparous cows were largely limited to decreased PPARc2 mRNA abundance in udder tissue. In pluriparous cows, insulin secretion was increased by CLA resulting in decreased systemic IS but without consistent changes in tissue target mRNA abundance. The temporal gene expression profiles from the adipokines and related receptors support their coactive function in adapting to the needs of lactation.	[Saremi, Behnam; Winand, Sarah; Friedrichs, Paula; Haeussler, Susanne; Mielenz, Manfred; Sauerwein, Helga] Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, Bonn, Germany; [Kinoshita, Asako; Rehage, Juergen] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany; [Daenicke, Sven] FLI, Fed Res Inst Anim Hlth, Inst Anim Nutr, Braunschweig, Germany; [Breves, Gerhard] Univ Vet Med Hannover, Dept Physiol, Hannover, Germany	University of Bonn; University of Veterinary Medicine Hannover, Foundation; Friedrich Loeffler Institute; University of Veterinary Medicine Hannover, Foundation	Mielenz, M (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany.	mielenz@fbn-dummerstorf.de	Mielenz, Manfred/ABB-2293-2021; Sauerwein, Helga/R-8242-2019; Breves, Gerhard/ABI-1315-2020		German Research Foundation (Deutsche Forschungsgemeinschaft: DFG) [PAK 286/1, SA 432/10-1]; German Academic Exchange Service (DAAD)	German Research Foundation (Deutsche Forschungsgemeinschaft: DFG)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This study was supported by funds of the German Research Foundation (Deutsche Forschungsgemeinschaft: DFG), PAK 286/1, SA 432/10-1 (URL: http://www.dfg.de). In addition, the donation of a scholarship by the German Academic Exchange Service (DAAD) to A. Al-Dawood who was involved in measuring the leptin serum concentrations is gratefully acknowledged (https://www.daad.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2008, FRONT HORM RES, V36, P182, DOI 10.1159/000115365; Alluwaimi AM, 2004, RES VET SCI, V77, P211, DOI 10.1016/j.rvsc.2004.04.006; Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Arevalo-Turrubiarte M, 2012, PPAR RES, V2012, DOI 10.1155/2012/891841; Bartha T, 2005, DOMEST ANIM ENDOCRIN, V29, P193, DOI 10.1016/j.domaniend.2005.03.010; Bauman DE, 2011, ANNU REV NUTR, V31, P299, DOI 10.1146/annurev.nutr.012809.104648; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bernabucci U, 2005, J DAIRY SCI, V88, P2017, DOI 10.3168/jds.S0022-0302(05)72878-2; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Boden Guenther, 2005, Curr Diab Rep, V5, P167, DOI 10.1007/s11892-005-0004-5; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Bruun JM, 2003, EUR J ENDOCRINOL, V148, P535, DOI 10.1530/eje.0.1480535; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Dagon Y, 2006, BIOCHEM BIOPH RES CO, V340, P43, DOI 10.1016/j.bbrc.2005.11.159; Daval M, 2005, J BIOL CHEM, V280, P25250, DOI 10.1074/jbc.M414222200; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Faraj A, 2008, DIABETES METAB, V34, P334, DOI 10.1016/j.diabet.2008.01.014; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Gauthier MS, 2011, BIOCHEM BIOPH RES CO, V404, P382, DOI 10.1016/j.bbrc.2010.11.127; GfE (Society for Nutrition Physiology), 2001, AUSS BED GES ERN 8 E; Giesy SL, 2012, ENDOCRINOLOGY, V153, P5834, DOI 10.1210/en.2012-1765; Hagiwara K, 2001, VET RES COMMUN, V25, P99, DOI 10.1023/A:1006400801305; Hammarstedt A, 2005, PROSTAG LEUKOTR ESS, V73, P65, DOI 10.1016/j.plefa.2005.04.008; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hotger K, 2013, J DAIRY SCI, V96, P2258, DOI 10.3168/jds.2012-6127; Holtenius P, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-29; Hosseini A, 2012, J ANIM PHYSIOL AN N, V96, P570, DOI 10.1111/j.1439-0396.2011.01180.x; Hotamisligil GS, 2000, INT J OBESITY, V24, pS23, DOI 10.1038/sj.ijo.0801497; Ji P, 2012, J DAIRY SCI, V95, P4333, DOI 10.3168/jds.2011-5079; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Kadegowda AKG, 2009, J DAIRY SCI, V92, P4276, DOI 10.3168/jds.2008-1932; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Karastergiou K, 2010, MOL CELL ENDOCRINOL, V318, P69, DOI 10.1016/j.mce.2009.11.011; Khan MJ, 2013, J DAIRY SCI, V96, P2171, DOI 10.3168/jds.2012-5794; Koltes DA, 2012, DOMEST ANIM ENDOCRIN, V43, P307, DOI 10.1016/j.domaniend.2012.05.004; Komatsu M, 2007, ENDOCR J, V54, P553, DOI 10.1507/endocrj.K07-032; Kusenda M, 2013, J VET INTERN MED, V27, P200, DOI 10.1111/jvim.12010; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Leblanc S, 2010, J REPROD DEVELOP, V56, pS29, DOI 10.1262/jrd.1056S29; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lemor A, 2009, DOMEST ANIM ENDOCRIN, V37, P37, DOI 10.1016/j.domaniend.2009.01.004; Leury BJ, 2003, AM J PHYSIOL-REG I, V285, pR1107, DOI 10.1152/ajpregu.00320.2003; Locher LF, 2012, J DAIRY SCI, V95, P2497, DOI 10.3168/jds.2011-4830; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Loor JJ, 2006, PHYSIOL GENOMICS, V27, P29, DOI 10.1152/physiolgenomics.00036.2006; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046300; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Mielenz M, 2013, DOMEST ANIM ENDOCRIN, V44, P121, DOI 10.1016/j.domaniend.2012.10.004; Mielenz M, 2013, J DAIRY SCI, V96, P278, DOI 10.3168/jds.2012-5816; Miller JR, 2008, J LIPID RES, V49, P550, DOI 10.1194/jlr.M700275-JLR200; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200; Nieto-Vazquez I, 2007, DIABETES, V56, P404, DOI 10.2337/db06-0989; Ohtsuka H, 2001, J VET MED SCI, V63, P1021, DOI 10.1292/jvms.63.1021; Pappritz J, 2011, ARCH ANIM NUTR, V65, P89, DOI 10.1080/1745039X.2011.552275; Perseghin G, 2001, J CLIN ENDOCR METAB, V86, P4776, DOI 10.1210/jc.86.10.4776; Poirier H, 2005, DIABETOLOGIA, V48, P1059, DOI 10.1007/s00125-005-1765-8; Qin Y, 2010, MOL MED REP, V3, P525, DOI 10.3892/mmr_00000292; Reynolds CM, 2010, PROSTAG LEUKOTR ESS, V82, P199, DOI 10.1016/j.plefa.2010.02.021; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rossmeis M, 2004, INT J OBESITY, V28, pS38, DOI 10.1038/sj.ijo.0802855; Sadri H, 2010, J ANIM PHYSIOL AN N, V94, pe194, DOI 10.1111/j.1439-0396.2010.01005.x; Salles J, 2012, J NUTR BIOCHEM, V23, P1685, DOI 10.1016/j.jnutbio.2011.12.001; Saremi B, 2012, J DAIRY SCI, V95, P3131, DOI 10.3168/jds.2011-4803; Saremi B, 2012, VET IMMUNOL IMMUNOP, V146, P201, DOI 10.1016/j.vetimm.2012.03.011; Sauerwein H, 2004, LIVEST PROD SCI, V87, P189, DOI 10.1016/j.livprodsci.2003.08.001; SCHAMS D, 1991, LIVEST PROD SCI, V27, P285, DOI 10.1016/0301-6226(91)90124-9; Schmidt J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.C110.200477; Schoenberg KM, 2011, J DAIRY SCI, V94, P6021, DOI 10.3168/jds.2011-4533; Schoenberg KM, 2011, J DAIRY SCI, V94, P5523, DOI 10.3168/jds.2011-4501; Sigl T, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-16; Soardo G, 2011, METAB SYNDR RELAT D, V9, P397, DOI 10.1089/met.2010.0140; Sundvold H, 1997, BIOCHEM BIOPH RES CO, V239, P857, DOI 10.1006/bbrc.1997.7564; Thorn SR, 2008, AM J PHYSIOL-REG I, V295, pR1455, DOI 10.1152/ajpregu.90546.2008; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Toyoshima Y, 2005, ENDOCRINOLOGY, V146, P4024, DOI 10.1210/en.2005-0087; van Doorn M, 2006, BRIT J CLIN PHARMACO, V62, P391, DOI 10.1111/j.1365-2125.2005.02532.x; van Dorland HA, 2012, J ANIM PHYSIOL AN N, V96, P137, DOI 10.1111/j.1439-0396.2011.01130.x; Vels L, 2009, J DAIRY SCI, V92, P922, DOI 10.3168/jds.2008-1209; von Soosten D, 2012, J DAIRY SCI, V95, P1222, DOI 10.3168/jds.2011-4548; von Soosten D, 2011, J DAIRY SCI, V94, P2859, DOI 10.3168/jds.2010-3851; Vyas D, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/932928; Wendel AA, 2006, LIPIDS, V41, P241, DOI 10.1007/s11745-006-5093-7; Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yamazaki T, 2011, J NUTR BIOCHEM, V22, P543, DOI 10.1016/j.jnutbio.2010.04.009; Yang YK, 2008, CELL PHYSIOL BIOCHEM, V22, P531, DOI 10.1159/000185527; Yuen BSJ, 1999, J ENDOCRINOL, V163, pR11, DOI 10.1677/joe.0.163R011	94	48	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86211	10.1371/journal.pone.0086211	http://dx.doi.org/10.1371/journal.pone.0086211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465964	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500206
J	Smitson, CC; Tenna, A; Tsegaye, M; Alemu, AS; Fekade, D; Aseffa, A; Blumberg, HM; Kempker, RR				Smitson, Christopher C.; Tenna, Admasu; Tsegaye, Mulugeta; Alemu, Abere S.; Fekade, Daniel; Aseffa, Abraham; Blumberg, Henry M.; Kempker, Russell R.			No Association of Cryptococcal Antigenemia with Poor Outcomes among Antiretroviral Therapy-Experienced HIV-Infected Patients in Addis Ababa, Ethiopia	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; SOUTH-AFRICA; MORTALITY; METAANALYSIS; INDIVIDUALS; GUIDELINES; MORBIDITY	Introduction: There are limited data on clinical outcomes of ART-experienced patients with cryptococcal antigenemia. We assessed clinical outcomes of a predominantly asymptomatic, ART-experienced cohort of HIV+ patients previously found to have a high (8.4%) prevalence of cryptococcal antigenemia. Methods: The study took place at All Africa Leprosy, Tuberculosis and Rehabilitative Training Centre and Black Lion Hospital HIV Clinics in Addis Ababa, Ethiopia. A retrospective study design was used to perform 12-month follow-up of 367 mostly asymptomatic HIV-infected patients (CD4<200 cells/mu l) with high levels of antiretroviral therapy use (74%) who were previously screened for cryptococcal antigenemia. Medical chart abstraction was performed approximately one year after initial screening to obtain data on clinic visit history, ART use, CD4 count, opportunistic infections, and patient outcome. We evaluated the association of cryptococcal antigenemia and a composite poor outcome of death and loss to follow-up using logistic regression. Results: Overall, 323 (88%) patients were alive, 8 (2%) dead, and 36 (10%) lost to follow-up. Among the 31 patients with a positive cryptococcal antigen test (titers >= 1:8) at baseline, 28 were alive (all titers <= 1:512), 1 dead and 2 lost to follow-up (titers >= 1:1024). In multivariate analysis, cryptococcal antigenemia was not predictive of a poor outcome (aOR = 1.3, 95% CI 0.3-4.8). A baseline CD4 count,100 cells/mu l was associated with an increased risk of a poor outcome (aOR 3.0, 95% CI 1.4-6.7) while an increasing CD4 count (aOR 0.1, 95% CI 0.1-0.3) and receiving antiretroviral therapy at last follow-up visit (aOR 0.1, 95% CI 0.02-0.2) were associated with a reduced risk of a poor outcome. Conclusions: Unlike prior ART-naive cohorts, we found that among persons receiving ART and with CD4 counts <200 cells/ml, asymptomatic cryptococcal antigenemia was not predictive of a poor outcome.	[Smitson, Christopher C.] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA; [Tenna, Admasu; Fekade, Daniel] Univ Addis Ababa, Dept Med, Div Infect Dis, Addis Ababa, Ethiopia; [Tsegaye, Mulugeta] All Africa Leprosy TB & Rehabil Training Ctr, Addis Ababa, Ethiopia; [Alemu, Abere S.] Haramya Univ, Harar, Ethiopia; [Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Blumberg, Henry M.; Kempker, Russell R.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA	University of California System; University of California San Francisco; Addis Ababa University; Haramaya University; Emory University	Smitson, CC (corresponding author), Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA.	chrissmitson@gmail.com; kadmasen@gmail.com	Kempker, Russell/F-5776-2017; Aseffa, Abraham/J-3248-2016; Blumberg, Henry/W-2156-2019; hlupeni, admire/M-1539-2018	Aseffa, Abraham/0000-0002-8028-1150; Blumberg, Henry/0000-0002-3110-2443; Mamuye, Admasu Tenna/0000-0002-9882-9989	NIH NIAID [K23AI103044]; NIH Fogarty International Center [D43TW009127-01A1]; Infectious Diseases Society of America Medical Scholars Program; Emory University Global Health Institute; FOGARTY INTERNATIONAL CENTER [D43TW009127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI103044] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Infectious Diseases Society of America Medical Scholars Program; Emory University Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this study was provided by NIH NIAID (K23AI103044), NIH Fogarty International Center (D43TW009127-01A1), Infectious Diseases Society of America Medical Scholars Program, and Emory University Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058377; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Beck EJ, 1999, AIDS, V13, P2157, DOI 10.1097/00002030-199910220-00020; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hosmer D. W., 2000, LOGISTIC REGRESSION; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Jordan R, 2002, BMJ-BRIT MED J, V324, P757, DOI 10.1136/bmj.324.7340.757; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Siegfried N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008272.pub2; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	22	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85698	10.1371/journal.pone.0085698	http://dx.doi.org/10.1371/journal.pone.0085698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465651	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500092
J	Cai, HH; Chen, YS; Cui, XH; Cai, SH; Chen, Z				Cai, Honghao; Chen, Yushan; Cui, Xiaohong; Cai, Shuhui; Chen, Zhong			High-Resolution H-1 NMR Spectroscopy of Fish Muscle, Eggs and Small Whole Fish via Hadamard-Encoded Intermolecular Multiple-Quantum Coherence	PLOS ONE			English	Article							SALMON SALMO-SALAR; SPINNING NMR-SPECTROSCOPY; INHOMOGENEOUS FIELDS; PATTERN-RECOGNITION; THYNNUS L.; EXTRACTS; LIVER; PROFILE; REGENERATION; TISSUE	Background and Purpose: Nuclear magnetic resonance (NMR) spectroscopy has become an important technique for tissue studies. Since tissues are in semisolid-state, their high-resolution (HR) spectra cannot be obtained by conventional NMR spectroscopy. Because of this restriction, extraction and high-resolution magic angle spinning (HR MAS) are widely applied for HR NMR spectra of tissues. However, both of the methods are subject to limitations. In this study, the feasibility of HR H-1 NMR spectroscopy based on intermolecular multiple-quantum coherence (iMQC) technique is explored using fish muscle, fish eggs, and a whole fish as examples. Materials and Methods: Intact salmon muscle tissues, intact eggs from shishamo smelt and a whole fish (Siamese algae eater) are studied by using conventional 1D one-pulse sequence, Hadamard-encoded iMQC sequence, and HR MAS. Results: When we use the conventional 1D one-pulse sequence, hardly any useful spectral information can be obtained due to the severe field inhomogeneity. By contrast, HR NMR spectra can be obtained in a short period of time by using the Hadamard-encoded iMQC method without shimming. Most signals from fatty acids and small metabolites can be observed. Compared to HR MAS, the iMQC method is non-invasive, but the resolution and the sensitivity of resulting spectra are not as high as those of HR MAS spectra. Conclusion: Due to the immunity to field inhomogeneity, the iMQC technique can be a proper supplement to HR MAS, and it provides an alternative for the investigation in cases with field distortions and with samples unsuitable for spinning. The acquisition time of the proposed method is greatly reduced by introduction of the Hadamard-encoded technique, in comparison with that of conventional iMQC method.	[Cai, Honghao; Chen, Yushan; Cui, Xiaohong; Cai, Shuhui; Chen, Zhong] Xiamen Univ, Dept Elect Sci, Fujian Prov Key Lab Plasma & Magnet Resonance, State Key Lab Phys Chem Solid Surfaces, Xiamen, Peoples R China	Xiamen University	Cui, XH (corresponding author), Xiamen Univ, Dept Elect Sci, Fujian Prov Key Lab Plasma & Magnet Resonance, State Key Lab Phys Chem Solid Surfaces, Xiamen, Peoples R China.	cuixh@xmu.edu.cn; chenz@xmu.edu.cn	Cai, SH/G-3334-2010; Chen, Zhong/G-4601-2010	Cai, SH/0000-0003-2767-9490; Cui, Xiaohong/0000-0002-3201-3952; chen, zhong/0000-0002-1473-2224	National Natural Science Foundation of China [11074209, 11174239, 21203155]; Fundamental Research Fund for the Central Universities [2010121008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Fund for the Central Universities	This work was supported by the National Natural Science Foundation of China (11074209, 11174239 and 21203155), (http://www.nsfc.gov.cn/), and the Fundamental Research Fund for the Central Universities (2010121008), (http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aursand M, 2009, J AGR FOOD CHEM, V57, P3444, DOI 10.1021/jf8039268; Balla D, 2004, CHEM PHYS LETT, V393, P464, DOI 10.1016/j.cplett.2004.06.087; Bankefors J, 2011, FOOD CHEM, V129, P1397, DOI 10.1016/j.foodchem.2011.05.081; Bhouri A. M., 2010, African Journal of Food Science, V4, P522; Branca RT, 2011, MAGN RESON MED, V65, P313, DOI 10.1002/mrm.22622; Cai CB, 2008, CR PHYS, V9, P119, DOI 10.1016/j.crhy.2007.11.007; Cai CB, 2011, J MAGN RESON, V211, P162, DOI 10.1016/j.jmr.2011.05.008; Chen YS, 2012, NMR BIOMED, V25, P1088, DOI 10.1002/nbm.2773; Chen Z, 2004, J AM CHEM SOC, V126, P446, DOI 10.1021/ja036491f; Chen Z, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3076046; Ernst R. R., 1989, PHYS TODAY, V42, P75, DOI DOI 10.1063/1.2811094; Falch E, 2006, CHEM PHYS LIPIDS, V144, P4, DOI 10.1016/j.chemphyslip.2006.05.001; Gribbestad IS, 2005, AQUACULTURE, V250, P445, DOI 10.1016/j.aquaculture.2005.02.031; Gu T, 2007, MAGN RESON MATER PHY, V20, P255, DOI 10.1007/s10334-007-0093-z; Jenista ER, 2009, J MAGN RESON, V196, P74, DOI 10.1016/j.jmr.2008.09.027; Jerschow A, 1999, J MAGN RESON, V137, P206, DOI 10.1006/jmre.1998.1652; Jiang B, 2008, CHEM PHYS, V351, P33, DOI 10.1016/j.chemphys.2008.03.027; Kozlova TA, 1998, FISH PHYSIOL BIOCHEM, V19, P211, DOI 10.1023/A:1007706831689; Kupce E, 2003, PROG NUCL MAG RES SP, V42, P95, DOI 10.1016/S0079-6565(03)00022-0; Li M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025563; Lin YL, 2011, J AM CHEM SOC, V133, P7632, DOI 10.1021/ja1113479; Lin YY, 2000, PHYS REV LETT, V85, P3732, DOI 10.1103/PhysRevLett.85.3732; Locci E, 2011, J AGR FOOD CHEM, V59, P9497, DOI 10.1021/jf2012979; Mannina L, 2008, TALANTA, V77, P433, DOI 10.1016/j.talanta.2008.07.006; Mishkovsky M, 2009, J MAGN RESON, V200, P142, DOI 10.1016/j.jmr.2009.06.002; Mourente G, 2001, FISH PHYSIOL BIOCHEM, V24, P351, DOI 10.1023/A:1015011609017; Nestor G, 2010, J AGR FOOD CHEM, V58, P10799, DOI 10.1021/jf103338j; Power WP, 2010, ANNU REP NMR SPECTRO, V72, P111, DOI 10.1016/B978-0-12-385857-3.00003-7; Samino S, 2013, BIOCHIMIE, V95, P808, DOI 10.1016/j.biochi.2012.11.015; Savorani F, 2010, FOOD CHEM, V120, P907, DOI 10.1016/j.foodchem.2009.10.071; Scano P, 2013, FOOD CHEM, V138, P2115, DOI 10.1016/j.foodchem.2012.11.095; Scano P, 2012, MAGN RESON CHEM, V50, P436, DOI 10.1002/mrc.3819; Scano P, 2009, EUR J LIPID SCI TECH, V111, P505, DOI 10.1002/ejlt.200800226; Shameem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041824; Sheikh-Eldin Melika, 1995, Aquaculture International, V3, P172, DOI 10.1007/BF00118099; Sigurgisladottir S., 1997, REV FISH SCI, V5, P223; van Asten JJA, 2008, MAGN RESON MATER PHY, V21, P435, DOI 10.1007/s10334-008-0156-9; Waters NJ, 2002, BIOCHEM PHARMACOL, V64, P67, DOI 10.1016/S0006-2952(02)01016-X; Wind RA, 2001, MAGNET RESON MED, V46, P213, DOI 10.1002/mrm.1181; Yang YX, 2013, ANAL BIOANAL CHEM, V405, P3381, DOI 10.1007/s00216-013-6774-8; Zhang L, 2011, ENVIRON TOXICOL PHAR, V32, P218, DOI 10.1016/j.etap.2011.05.006; Zira A, 2013, TOXICOLOGY, V303, P115, DOI 10.1016/j.tox.2012.10.015	42	14	14	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86422	10.1371/journal.pone.0086422	http://dx.doi.org/10.1371/journal.pone.0086422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24466083	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000098
J	Lorente, G; Syriani, E; Morales, M				Lorente, Gisela; Syriani, Emilio; Morales, Miguel			Actin Filaments at the Leading Edge of Cancer Cells Are Characterized by a High Mobile Fraction and Turnover Regulation by Profilin I	PLOS ONE			English	Article							ENA/VASP PROTEINS; BINDING-SITE; MOTILITY; RICH; OVEREXPRESSION; MIGRATION; MICROFILAMENTS; IDENTIFICATION; LAMELLIPODIN; ACTIVATION	Cellular motility is the basis for cancer cell invasion and metastasis. In the case of breast cancer, the most common type of cancer among women, metastasis represents the most devastating stage of the disease. The central role of cellular motility in cancer development emphasizes the importance of understanding the specific mechanisms involved in this process. In this context, tumor development and metastasis would be the consequence of a loss or defect of the mechanisms that control cytoskeletal remodeling. Profilin I belongs to a family of small actin binding proteins that are thought to assist in actin filament elongation at the leading edge of migrating cells. Traditionally, Profilin I has been considered to be an essential control element for actin polymerization and cell migration. Expression of Profilin I is down-regulated in breast and various other cancer cells. In MDA-MB-231 cells, a breast cancer cell line, further inhibition of Profilin I expression promotes hypermotility and metastatic spread, a finding that contrasts with the proposed role of Profilin in enhancing polymerization. In this report, we have taken advantage of the fluorescence recovery after photobleaching (FRAP) of GFP-actin to quantify and compare actin dynamics at the leading edge level in both cancer and non-cancer cell models. Our results suggest that (i) a high level of actin dynamics (i. e., a large mobile fraction of actin filaments and a fast turnover) is a common characteristic of some cancer cells; (ii) actin polymerization shows a high degree of independence from the presence of extracellular growth factors; and (iii) our results also corroborate the role of Profilin I in regulating actin polymerization, as raising the intracellular levels of Profilin I decreased the mobile fraction ratio of actin filaments and slowed their polymerization rate; furthermore, increased Profilin levels also led to reduced individual cell velocity and directionality.	[Lorente, Gisela] Univ Barcelona, Neurophysiol Lab, Deptartment Physiol Sci 1, Sch Med, Barcelona, Spain; [Syriani, Emilio; Morales, Miguel] CIBIR Piqueras 98, Struct Synapt Plast Lab, Dept Neurodegenerat Dis, Logrono, La Rioja, Spain	University of Barcelona	Morales, M (corresponding author), CIBIR Piqueras 98, Struct Synapt Plast Lab, Dept Neurodegenerat Dis, Logrono, La Rioja, Spain.	miguelmorales@spineup.es	Morales, Miguel/G-8995-2014	Morales, Miguel/0000-0002-8885-2333	Spanish Ministry of Research [SAF2010-16024, BFU 2012-17537]; Fundacion Rioja funds; Universidad de Barcelona	Spanish Ministry of Research(Spanish Government); Fundacion Rioja funds; Universidad de Barcelona	This work was supported by grants from the Spanish Ministry of Research (SAF2010-16024; BFU 2012-17537; ONCE 2010 and 2011) and Fundacion Rioja funds. GL was fellowship holder of the Universidad de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bollig-Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017959; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; BUSS F, 1992, CELL MOTIL CYTOSKEL, V22, P51, DOI 10.1002/cm.970220106; BUTTON E, 1995, CELL MOTIL CYTOSKEL, V30, P247, DOI 10.1002/cm.970300402; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; Das T, 2009, J CELL PHYSIOL, V218, P436, DOI 10.1002/jcp.21618; Ding ZJ, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3433; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; FEDOROV AA, 1994, P NATL ACAD SCI USA, V91, P8636, DOI 10.1073/pnas.91.18.8636; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; GEY GO, 1952, CANCER RES, V12, P264; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; Gomez-Cabrero A, 2005, MOL VIS, V11, P1071; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; Ho A, 2001, CANCER RES, V61, P474; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Kovar DR, 2006, CURR BIOL, V16, pR535, DOI 10.1016/j.cub.2006.06.039; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-12; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Loureiro JJ, 2002, MOL BIOL CELL, V13, P2533, DOI 10.1091/mbc.E01-10-0102; Mahoney NM, 1999, NAT STRUCT BIOL, V6, P666, DOI 10.1038/10722; Mayboroda O, 1997, CELL MOTIL CYTOSKEL, V37, P166, DOI 10.1002/(SICI)1097-0169(1997)37:2<166::AID-CM9>3.0.CO;2-6; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; METZLER WJ, 1994, J BIOL CHEM, V269, P4620; Miki H, 1999, J BIOL CHEM, V274, P27605, DOI 10.1074/jbc.274.39.27605; Mimuro H, 2000, J BIOL CHEM, V275, P28893, DOI 10.1074/jbc.M003882200; Moldovan NI, 1997, CURR BIOL, V7, P24, DOI 10.1016/S0960-9822(06)00024-8; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Neely MD, 1997, P ROY SOC B-BIOL SCI, V264, P1701, DOI 10.1098/rspb.1997.0236; Nodelman IM, 1999, J MOL BIOL, V294, P1271, DOI 10.1006/jmbi.1999.3318; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Roy P, 2004, CELL MOTIL CYTOSKEL, V57, P84, DOI 10.1002/cm.10160; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Skare P, 2002, FEBS LETT, V522, P119, DOI 10.1016/S0014-5793(02)02913-7; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Syriani E, 2008, FASEB J, V22, P1581, DOI 10.1096/fj.06-7654com; TANAKA M, 1985, EUR J BIOCHEM, V151, P291, DOI 10.1111/j.1432-1033.1985.tb09099.x; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Wittenmayer N, 2004, MOL BIOL CELL, V15, P1600, DOI 10.1091/mbc.E03-12-0873; Wu N, 2006, PROTEOMICS, V6, P6095, DOI 10.1002/pmic.200500321; Yao W, 2013, CURR MOL MED, V13, P417; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038; Zou L, 2009, CELL MOTIL CYTOSKEL, V66, P1048, DOI 10.1002/cm.20407	63	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85817	10.1371/journal.pone.0085817	http://dx.doi.org/10.1371/journal.pone.0085817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465723	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000065
J	Zhu, HG; Russell, RA; Saunders, LJ; Ceccon, S; Garway-Heath, DF; Crabb, DP				Zhu, Haogang; Russell, Richard A.; Saunders, Luke J.; Ceccon, Stefano; Garway-Heath, David F.; Crabb, David P.			Detecting Changes in Retinal Function: Analysis with Non-Stationary Weibull Error Regression and Spatial Enhancement (ANSWERS)	PLOS ONE			English	Article							VISUAL-FIELD PROGRESSION; GLAUCOMA; VARIABILITY; SENSITIVITY; PERIMETRY; DISEASE; SERIES; TIME	Visual fields measured with standard automated perimetry are a benchmark test for determining retinal function in ocular pathologies such as glaucoma. Their monitoring over time is crucial in detecting change in disease course and, therefore, in prompting clinical intervention and defining endpoints in clinical trials of new therapies. However, conventional change detection methods do not take into account non-stationary measurement variability or spatial correlation present in these measures. An inferential statistical model, denoted 'analysis with Non-Stationary Weibull Error Regression and Spatial enhancement' (ANSWERS), was proposed. In contrast to commonly used ordinary linear regression models, which assume normally distributed errors, ANSWERS incorporates non-stationary variability modelled as a mixture of Weibull distributions. Spatial correlation of measurements was also included into the model using a Bayesian framework. It was evaluated using a large dataset of visual field measurements acquired from electronic health records, and was compared with other widely used methods for detecting deterioration in retinal function. ANSWERS was able to detect deterioration significantly earlier than conventional methods, at matched false positive rates. Statistical sensitivity in detecting deterioration was also significantly better, especially in short time series. Furthermore, the spatial correlation utilised in ANSWERS was shown to improve the ability to detect deterioration, compared to equivalent models without spatial correlation, especially in short follow-up series. ANSWERS is a new efficient method for detecting changes in retinal function. It allows for better detection of change, more efficient endpoints and can potentially shorten the time in clinical trials for new therapies.	[Zhu, Haogang; Russell, Richard A.; Saunders, Luke J.; Ceccon, Stefano; Crabb, David P.] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Zhu, Haogang; Garway-Heath, David F.] UCL, Inst Ophthalmol, London, England; [Garway-Heath, David F.] Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res Biomed Res Ctr Ophthalmol, London, England; [Garway-Heath, David F.] UCL Inst Ophthalmol, London, England	City University London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Zhu, HG (corresponding author), City Univ London, Sch Hlth Sci, London EC1V 0HB, England.	haogangzhu@gmail.com		Crabb, David/0000-0001-8754-3902; Garway-Heath, David/0000-0003-2907-6992	National Institute for Health Research, National Health Service, United Kingdom; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [PDF-2011-04-081, 11/129/245] Funding Source: researchfish	National Institute for Health Research, National Health Service, United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This report is independent research arising from a Research Fellow Award supported by the National Institute for Health Research, National Health Service, United Kingdom. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Artes PH, 2008, OPTOMETRY VISION SCI, V85, P380, DOI 10.1097/OPX.0b013e31817882ee; Artes PH, 2002, INVEST OPHTH VIS SCI, V43, P2654; Asaoka R, 2012, INVEST OPHTH VIS SCI, V53, P8396, DOI 10.1167/iovs.12-9794; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BIRCH MK, 1995, OPHTHALMOLOGY, V102, P1227, DOI 10.1016/S0161-6420(95)30885-8; BISHOP CM, 1996, NEURAL NETWORK PATTE; Bogachev MI, 2009, PHYSIOL MEAS, V30, P631, DOI 10.1088/0967-3334/30/7/008; Chauhan BC, 2008, BRIT J OPHTHALMOL, V92, P569, DOI 10.1136/bjo.2007.135012; CHAUHAN BC, 1990, INVEST OPHTH VIS SCI, V31, P512; Crabb DP, 1997, OPHTHALMOLOGY, V104, P517, DOI 10.1016/S0161-6420(97)30281-4; Cramer AO, 2013, CURR GENE THER, V13, P139; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Frackowiak RS., 1997, HUMAN BRAIN FUNCTION; Gardiner SK, 2002, INVEST OPHTH VIS SCI, V43, P1400; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Guo L, 2010, CURR ALZHEIMER RES, V7, P3, DOI 10.2174/156720510790274491; Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242; HEIJL A, 1989, ARCH OPHTHALMOL-CHIC, V107, P81, DOI 10.1001/archopht.1989.01070010083032; Heijl A, 2003, ACTA OPHTHALMOL SCAN, V81, P286, DOI 10.1034/j.1600-0420.2003.00070.x; Henson DB, 2000, INVEST OPHTH VIS SCI, V41, P417; Katz J, 1997, OPHTHALMOLOGY, V104, P1017, DOI 10.1016/S0161-6420(97)30192-4; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Malik R, 2006, VISION RES, V46, P2956, DOI 10.1016/j.visres.2006.03.004; McNeill A, 2013, MOL GENET METAB, V109, P221, DOI 10.1016/j.ymgme.2013.04.001; Morgan JE, 2012, CLIN EXP OPHTHALMOL, V40, P364, DOI 10.1111/j.1442-9071.2012.02789.x; Oliveira C, 2012, SEMIN OPHTHALMOL, V27, P187, DOI 10.3109/08820538.2012.708808; Patel PJ, 2011, INVEST OPHTH VIS SCI, V52, P3089, DOI 10.1167/iovs.10-6208; Patterson AJ, 2005, INVEST OPHTH VIS SCI, V46, P1659, DOI 10.1167/iovs.04-0953; Pizzarello L, 2004, ARCH OPHTHALMOL-CHIC, V122, P615, DOI 10.1001/archopht.122.4.615; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Redmond T, 2010, INVEST OPHTH VIS SCI, V51, P6540, DOI 10.1167/iovs.10-5718; Russell RA, 2012, INVEST OPHTH VIS SCI, V53, P5985, DOI 10.1167/iovs.12-10428; Smith SD, 1996, INVEST OPHTH VIS SCI, V37, P1419; Strouthidis NG, 2007, INVEST OPHTH VIS SCI, V48, P251, DOI 10.1167/iovs.06-0576; Strouthidis NG, 2006, INVEST OPHTH VIS SCI, V47, P5356, DOI 10.1167/iovs.05-1660; Swanson WH, 2000, OPHTHALMOLOGY, V107, P1950, DOI 10.1016/S0161-6420(00)00356-0; Swift S, 2002, ARTIF INTELL MED, V24, P5, DOI 10.1016/S0933-3657(01)00095-1; Tanna AP, 2011, OPHTHALMOLOGY, V118, P60, DOI 10.1016/j.ophtha.2010.04.038; TIERNEY L, 1986, J AM STAT ASSOC, V81, P82, DOI 10.2307/2287970; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Tucker A, 2005, ARTIF INTELL MED, V34, P163, DOI 10.1016/j.artmed.2004.07.004; Turin TC, 2011, CLIN J AM SOC NEPHRO, V6, P1805, DOI 10.2215/CJN.05950611; Viswanathan AC, 2003, BRIT J OPHTHALMOL, V87, P726, DOI 10.1136/bjo.87.6.726; Westcott MC, 2002, BRIT J OPHTHALMOL, V86, P761, DOI 10.1136/bjo.86.7.761; WILD JM, 1989, ACTA OPHTHALMOL, V67, P537	46	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85654	10.1371/journal.pone.0085654	http://dx.doi.org/10.1371/journal.pone.0085654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465636	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000330237000049
J	Guo, RN; Lin, JY; Li, LH; Ke, CW; He, JF; Zhong, HJ; Zhou, HQ; Peng, ZQ; Yang, F; Liang, WJ				Guo, Ru-ning; Lin, Jin-yan; Li, Lin-hui; Ke, Chang-wen; He, Jian-feng; Zhong, Hao-jie; Zhou, Hui-qiong; Peng, Zhi-qiang; Yang, Fen; Liang, Wen-jia			The Prevalence and Endemic Nature of Dengue Infections in Guangdong, South China: An Epidemiological, Serological, and Etiological Study from 2005-2011	PLOS ONE			English	Article							VIRUS; SEROPREVALENCE; GUANGZHOU; FEVER; REEMERGENCE; CHILDREN	Objectives: Frequent outbreaks of dengue are considered to be associated with an increased risk for endemicity of the disease. The occurrence of a large number of indigenous dengue cases in consecutive years indicates the epidemic pattern in Guangdong, China. Methods: To have a clear understanding of the current dengue epidemic, a retrospective study of epidemiological profile, serological response, and virological features of dengue infections from 2005-2011 was conducted. Case data were collected from the National Notifiable Infectious Diseases Reporting Network. Serum samples were collected and prepared for serological verification and etiological confirmation. Incidence, temporal and spatial distribution, and the clinical manifestation of dengue infections were analyzed. Pearson's Chi-Square test was used to compare incidences between different age groups. A seroprevalence survey was implemented in local healthy inhabitants to obtain the overall positive rate for the specific immunoglobulin (Ig) G antibody against dengue virus (DENV). Results: The overall annual incidence rate was 1.87/100000. A significant difference was found in age-specific incidence (Pearson's Chi-Square value 498.008, P<0.001). Children under 5 years of age had the lowest incidence of 0.28/100000. The vast majority of cases presented with a mild manifestation typical to dengue fever. The overall seroprevalence of dengue IgG antibody in local populations was 2.43% (range 0.28%-5.42%). DENV-1 was the predominant serotype in circulation through the years, while all 4 serotypes were identified in indigenous patients from different outbreak localities since 2009. Conclusions: A gradual change in the epidemic pattern of dengue infection has been observed in recent years in Guangdong. With the endemic nature of dengue infections, the transition from a monotypic to a multitypic circulation of dengue virus in the last several years will have an important bearing on the prevention and control of dengue in the province and in the neighboring districts.	[Guo, Ru-ning; Li, Lin-hui] Ctr Dis Control & Prevent Guangdong Prov, Publ Hlth Emergency Management Off, Guangzhou, Guangdong, Peoples R China; [Lin, Jin-yan] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Ke, Chang-wen; Zhou, Hui-qiong] Ctr Dis Control & Prevent Guangdong Prov, Inst Pathogen Microorganisms, Guangzhou, Guangdong, Peoples R China; [He, Jian-feng; Zhong, Hao-jie; Peng, Zhi-qiang; Yang, Fen; Liang, Wen-jia] Ctr Dis Control & Prevent Guangdong Prov, Inst Infect Dis Prevent & Control, Guangzhou, Guangdong, Peoples R China		He, JF (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Inst Infect Dis Prevent & Control, Guangzhou, Guangdong, Peoples R China.	hjf_2003@163.com	Zhou, Huiqiong/S-1276-2016	Zhou, Huiqiong/0000-0003-2124-6563	Research Base of Key Laboratory of Surveillance and Early-warning on Infectious Disease in China CDC, Health department of Guangdong province [C2012017]; Public Health Emergency Management and Filed Epidemiology Training Program of key medical subjects of 'Twelfth Five Year Plan' in Guangdong, China	Research Base of Key Laboratory of Surveillance and Early-warning on Infectious Disease in China CDC, Health department of Guangdong province; Public Health Emergency Management and Filed Epidemiology Training Program of key medical subjects of 'Twelfth Five Year Plan' in Guangdong, China	The study was supported by Research Base of Key Laboratory of Surveillance and Early-warning on Infectious Disease in China CDC, Health department of Guangdong province (project number: C2012017), and also supported by Public Health Emergency Management and Filed Epidemiology Training Program of key medical subjects of 'Twelfth Five Year Plan' in Guangdong, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gupta E, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-92; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Huang MT, 1981, ACTA MICROBIOLOGICA, V21, P239; Iturrino-Monge R, 2006, REV PANAM SALUD PUBL, V20, P39, DOI 10.1590/S1020-49892006000700005; Jian-Feng H., 2007, DENGUE B, P31; Jiang T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-125; Jin Y, 2009, CHIN J MICROBIOL IMM, V29, P121; Jing QL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-87; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lo CL, 2013, TROP MED INT HLTH; Luo Huiming, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P427; LUO L, 2002, ZHONGHUA LIU XING BI, V29, P203; Luo L, 2012, J VECTOR ECOL, V37, P230, DOI 10.1111/j.1948-7134.2012.00221.x; McBride WJH, 2010, INTERN MED J, V40, P247, DOI 10.1111/j.1445-5994.2010.02196.x; Ocazionez Raquel E, 2007, Rev. salud pública, V9, P262, DOI 10.1590/S0124-00642007000200010; Ocazionez RE, 2006, MEM I OSWALDO CRUZ, V101, P725, DOI 10.1590/S0074-02762006000700004; Ong SH, 2008, INFECT GENET EVOL, V8, P191, DOI 10.1016/j.meegid.2007.12.005; Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064; Ratnam I, 2012, EUR J CLIN MICROBIOL, V31, P1203, DOI 10.1007/s10096-011-1429-1; Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935; Siddiqui FJ, 2009, J INFECT DEV COUNTR, V3, P306; Vairo F, 2012, INT J INFECT DIS, V16, pE44, DOI 10.1016/j.ijid.2011.09.018; Wilder-Smith A, 2012, PAEDIATR INT CHILD H, V32, P28, DOI 10.1179/2046904712Z.00000000050; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Yamashiro T, 2004, AM J TROP MED HYG, V71, P138, DOI 10.4269/ajtmh.2004.71.138; Yang F, 2007, 2006 S CHINA J PREVE, V33, P8; Zhang Fu-chun, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P421; Zhao H, 2012, J VIROL, V86, P7021, DOI 10.1128/JVI.00858-12; Zheng K, 2009, EPIDEMIOL INFECT, V137, P73, DOI 10.1017/S0950268808000617; Zheng Kui, 2002, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V16, P382; Zhou HuiQiong, 2006, Chinese Journal of Zoonoses, V22, P665	33	47	52	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85596	10.1371/journal.pone.0085596	http://dx.doi.org/10.1371/journal.pone.0085596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465613	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000018
J	Schermel, A; Mendoza, J; Henson, S; Dukeshire, S; Pasut, L; Emrich, TE; Lou, W; Qi, Y; L'Abbe, MR				Schermel, Alyssa; Mendoza, Julio; Henson, Spencer; Dukeshire, Steven; Pasut, Laura; Emrich, Teri E.; Lou, Wendy; Qi, Ying; L'Abbe, Mary R.			Canadians' Perceptions of Food, Diet, and Health - A National Survey	PLOS ONE			English	Article							CLAIMS	Background: Poor nutrition is harmful to one's health as it can lead to overweight and obesity and a number of chronic diseases. Understanding consumer perceptions toward diet and nutrition is critical to advancing nutrition-related population health interventions to address such issues. The purpose of this paper was to examine Canadians' perceived health and diet status, compared to their actual health status, and general concern about their own diet and beliefs about health. Also analyzed were some of the perceived barriers to eating "healthy" foods, with a focus on the availability of "healthy" processed foods. Methods: Two surveys were administered online to a group of Canadian panelists from all ten provinces during May 2010 to January 2011. Thirty thousand were invited; 6,665 completed the baseline survey and 5,494 completed the second survey. Panelists were selected to be nationally representative of the Canadian adult population by age, sex, province and education level, according to 2006 census data. Results: Approximately one third of Canadians perceived their health or diet to be very good while very few Canadians perceived their health or diet to be very poor. While the majority of Canadians believed food and nutrition to be very important for improving one's health, fewer Canadians were concerned about their own diets. The majority of Canadians reported difficulty finding "healthy" processed foods (low in salt and sugar and with sufficient vitamins and minerals). Many also reported difficulty finding healthy foods that are affordable. Conclusion: Although consumers believe that nutrition is one of the most important factors for maintaining health, there are still a number of attitudinal and perceived environmental barriers to healthy eating.	[Schermel, Alyssa; Pasut, Laura; Emrich, Teri E.; L'Abbe, Mary R.] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Mendoza, Julio; Henson, Spencer] Univ Guelph, Food Agr & Resource Econ Dept, Guelph, ON N1G 2W1, Canada; [Dukeshire, Steven] Dalhousie Univ, Dept Business & Social Sci, Truro, NS, Canada; [Lou, Wendy; Qi, Ying] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada	University of Toronto; University of Guelph; Dalhousie University; University of Toronto	L'Abbe, MR (corresponding author), Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada.	Mary.Labbe@utoronto.ca	labbe, mary/AAC-3392-2020	Dukeshire, Steven/0000-0001-9187-3453	Advanced Foods and Materials Network (AFMNet) under Networks of Centres of Excellence (NCE); University of Toronto McHenry Professor research Fund; CIHR Strategic Training Program in Public Health Policy	Advanced Foods and Materials Network (AFMNet) under Networks of Centres of Excellence (NCE); University of Toronto McHenry Professor research Fund; CIHR Strategic Training Program in Public Health Policy(Canadian Institutes of Health Research (CIHR))	This research received funding from the Advanced Foods and Materials Network (AFMNet) under the Networks of Centres of Excellence (NCE) to SH, MRL, and SD; the University of Toronto McHenry Professor research Fund to MRL; and stipend support to AS funded by the CIHR Strategic Training Program in Public Health Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AC NIELS GLOB SER, 2006, WHATS HOT GLOB INS G; *AGR AGR FOOD CA, 2009, AGR AGR CAN SCI CULT, P87558; Brandt MB, 2010, FOOD TECHNOL-CHICAGO, V64, P34; Burns A.C., 2000, GLOBALIZATION, V1, P76; *CAN COUNC FOOD NU, TRACK NUTR TRENDS SU; *CAN COUNC FOOD NU, 2008, TRACK NUTR TRENDS 7; *CAN I HLTH INF, 2011, HP5107 CAN I HLTH IN; DEVILLE JC, 1993, J AM STAT ASSOC, V88, P1013, DOI 10.2307/2290793; Garriguet Didier, 2007, Health Rep, V18, P17; *HLTH CAN, INF PROV NUTR SURV; International Food Information Council Foundation, 2010, 2010 FOOD HLTH SURV; Izrael D, 2000, P 25 ANN SAS US GROU; *PUBL HLTH AG CAN, 2009, HP3232009E PUBL HLTH; Schermel A, 2013, APPL PHYSIOL NUTR ME, V38, P666, DOI 10.1139/apnm-2012-0386; Sodium Working Group, 2010, SOD RED STRAT CAN RE; *STAT CAN, 2006, CENS CAN IND PUBL US; *STAT CAN, INF NAT POP HLTH SUR; Statistics Canada, 2010, DAILY; Statistics Canada, 2005, CAN COMM HLTH SURV C; TJEPKEMA M, 2004, 82620MWE STAT CAN; Wong CL, 2013, AM J CLIN NUTR, V97, P1288, DOI 10.3945/ajcn.112.052910; World Health Organization, 2010, GLOB STAT REP NONC D	22	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86000	10.1371/journal.pone.0086000	http://dx.doi.org/10.1371/journal.pone.0086000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465832	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000037
J	Cha, PH; Shin, W; Zahoor, M; Kim, HY; Min, DS; Choi, KY				Cha, Pu-Hyeon; Shin, Wookjin; Zahoor, Muhammad; Kim, Hyun-Yi; Min, Do Sik; Choi, Kang-Yell			Hovenia dulcis Thunb Extract and Its Ingredient Methyl Vanillate Activate Wnt/beta-Catenin Pathway and Increase Bone Mass in Growing or Ovariectomized Mice	PLOS ONE			English	Article							BETA-CATENIN; VERTEBRAL FRACTURES; OSTEOPOROSIS; CONSTITUENTS; TERIPARATIDE; GROWTH; BISPHOSPHONATES; DIFFERENTIATION; OSTEOSARCOMAS; ALENDRONATE	The Wnt/beta-catenin pathway is a potential target for development of anabolic agents to treat osteoporosis because of its role in osteoblast differentiation and bone formation. However, there is no clinically available anti-osteoporosis drug that targets this Wnt/beta-catenin pathway. In this study, we screened a library of aqueous extracts of 350 plants and identified Hovenia dulcis Thunb (HDT) extract as a Wnt/beta-catenin pathway activator. HDT extract induced osteogenic differentiation of calvarial osteoblasts without cytotoxicity. In addition, HDT extract increased femoral bone mass without inducing significant weight changes in normal mice. In addition, thickness and area of femoral cortical bone were also significantly increased by the HDT extract. Methyl vanillate (MV), one of the ingredients in HDT, also activated the Wnt/beta-catenin pathway and induced osteoblast differentiation in vitro. MV rescued trabecular or cortical femoral bone loss in the ovariectomized mice without inducing any significant weight changes or abnormality in liver tissue when administrated orally. Thus, natural HDT extract and its ingredient MV are potential anabolic agents for treating osteoporosis.	[Cha, Pu-Hyeon; Shin, Wookjin; Zahoor, Muhammad; Kim, Hyun-Yi; Min, Do Sik; Choi, Kang-Yell] Yonsei Univ, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea; [Cha, Pu-Hyeon; Shin, Wookjin; Zahoor, Muhammad; Kim, Hyun-Yi; Choi, Kang-Yell] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Min, Do Sik] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Pusan 609735, South Korea	Yonsei University; Yonsei University; Pusan National University	Choi, KY (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea.	kychoi@yonsei.ac.kr	cha, puhyeon/ABA-7719-2020		National Research Foundation (NRF); Ministry of Future Creation and Science (MFCS) of Korea; Mid-career Researcher Program [2012R1A2A1A01010285]; Translational Research Center for Protein Function Control; Stem Research Project [2010-0020235]; Ministry of Knowledge Economy through the Korea Research Institute of Chemical Technology [SI-095];  [2009-0083522]	National Research Foundation (NRF); Ministry of Future Creation and Science (MFCS) of Korea; Mid-career Researcher Program; Translational Research Center for Protein Function Control; Stem Research Project; Ministry of Knowledge Economy through the Korea Research Institute of Chemical Technology(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); 	This work was supported by grants from the National Research Foundation (NRF), funded by the Ministry of Future Creation and Science (MFCS) of Korea; Mid-career Researcher Program (2012R1A2A1A01010285), Translational Research Center for Protein Function Control; (2009-0083522), and Stem Research Project (2010-0020235). This work was also partly supported by a grant from the Ministry of Knowledge Economy through the Korea Research Institute of Chemical Technology (SI-095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arioka M, 2013, BIOCHEM BIOPH RES CO; Bilezikian JP, 2009, J BONE MINER RES, V24, P373, DOI [10.1359/JBMR.090105, 10.1359/jbmr.090105]; Bouxsein ML, 2009, J BONE JOINT SURG AM, V91A, P1329, DOI 10.2106/JBJS.H.01030; Cai YP, 2010, J PATHOL, V220, P24, DOI 10.1002/path.2628; Chen Shao-hong, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1094; Cheng MJ, 2008, J CHIL CHEM SOC, V53, P1631, DOI 10.4067/S0717-97072008000300019; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Ding L. S., 1997, Yaoxue Xuebao, V32, P600; Finan B, 2012, NAT MED, V18, P1847, DOI 10.1038/nm.3009; Gadelha APR, 2005, PARASITOL RES, V97, P399, DOI 10.1007/s00436-005-1476-6; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; HUSSAIN RA, 1990, J ETHNOPHARMACOL, V28, P103, DOI 10.1016/0378-8741(90)90067-4; Hyun TK, 2010, PLANTA MED, V76, P943, DOI 10.1055/s-0030-1249776; Iwaniec UT, 2007, J BONE MINER RES, V22, P394, DOI 10.1359/JBMR.061118; Jeong WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002242; Kennel KA, 2009, MAYO CLIN PROC, V84, P632, DOI 10.1016/S0025-6196(11)60752-0; Khan AW, 2006, J OBSTET GYNAECOL CA, V28, P136, DOI 10.1016/S1701-2163(16)32063-1; Khosla S, 2005, ENDOCRIN METAB CLIN, V34, P1015, DOI 10.1016/j.ecl.2005.07.009; Kloen P, 1997, CANCER, V80, P2230; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li G, 2005, ARCH PHARM RES, V28, P804, DOI 10.1007/BF02977346; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lories RJU, 2007, ARTHRITIS RHEUM-US, V56, P4095, DOI 10.1002/art.23137; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; McGrath H, 1996, NEW ENGL J MED, V334, P734; Pei SJ, 2001, PHARM BIOL, V39, P74, DOI [10.1076/phbi.39.s1.74.0005, 10.1076/phbi.39.7.74.5869]; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Rodan GA, 1998, P NATL ACAD SCI USA, V95, P13361, DOI 10.1073/pnas.95.23.13361; Saag KG, 2009, ARTHRITIS RHEUM-US, V60, P3346, DOI 10.1002/art.24879; Sawadogo WR, 2012, BIOCHEM PHARMACOL, V84, P1225, DOI 10.1016/j.bcp.2012.07.021; Seeman E, 2009, CRIT REV EUKAR GENE, V19, P219, DOI 10.1615/CritRevEukarGeneExpr.v19.i3.40; Sibai T, 2011, CLIN ORTHOP RELAT R, V469, P2215, DOI 10.1007/s11999-010-1722-9; Tai A, 2012, BIOSCI BIOTECH BIOCH, V76, P314, DOI 10.1271/bbb.110700; Tang DZ, 2010, J BONE MINER RES, V25, P1234, DOI 10.1002/jbmr.21; Tashjian AH, 2006, J BONE MINER RES, V21, P354, DOI 10.1359/JBMR.051023; Trivedi R, 2008, MOL CELL ENDOCRINOL, V289, P85, DOI 10.1016/j.mce.2008.02.027; Vasudeva N, 2012, CHIN J INTEGR MED, V18, P473, DOI 10.1007/s11655-012-1120-0; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098; Yang SP, 2012, ACTA PHARMACOL SIN, V33, P1147, DOI 10.1038/aps.2012.105; YOSHIKAWA K, 1993, PHYTOCHEMISTRY, V34, P1431, DOI 10.1016/0031-9422(91)80044-2; Yoshikawa M, 1997, YAKUGAKU ZASSHI, V117, P108, DOI 10.1248/yakushi1947.117.2_108; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; YUNCHOI HS, 1987, J NAT PROD, V50, P1059, DOI 10.1021/np50054a008; Zhang JH, 2012, COMPLEMENT THER MED, V20, P100, DOI 10.1016/j.ctim.2011.09.004	49	28	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85546	10.1371/journal.pone.0085546	http://dx.doi.org/10.1371/journal.pone.0085546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465596	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100046
J	Larsen, SB; Grove, EL; Hvas, AM; Kristensen, SD				Larsen, Sanne Bojet; Grove, Erik Lerkevang; Hvas, Anne-Mette; Kristensen, Steen Dalby			Platelet Turnover in Stable Coronary Artery Disease - Influence of Thrombopoietin and Low-Grade Inflammation	PLOS ONE			English	Article							DUAL ANTIPLATELET THERAPY; RETICULATED PLATELETS; MYOCARDIAL-INFARCTION; HEART-DISEASE; IMMATURE PLATELETS; SIZE HETEROGENEITY; WHOLE-BLOOD; VOLUME; INTERLEUKIN-6; ACTIVATION	Background: Newly formed platelets are associated with increased aggregation and adverse outcomes in patients with coronary artery disease (CAD). The mechanisms involved in the regulation of platelet turnover in patients with CAD are largely unknown. Aim: To investigate associations between platelet turnover parameters, thrombopoietin and markers of low-grade inflammation in patients with stable CAD. Furthermore, to explore the relationship between platelet turnover parameters and type 2 diabetes, prior myocardial infarction, smoking, age, gender and renal insufficiency. Methods: We studied 581 stable CAD patients. Platelet turnover parameters (immature platelet fraction, immature platelet count, mean platelet volume, platelet distribution width and platelet large cell-ratio) were determined using automated flow cytometry (Sysmex XE-2100). Furthermore, we measured thrombopoietin and evaluated low-grade inflammation by measurement of high-sensitive CRP and interleukin-6. Results: We found strong associations between the immature platelet fraction, immature platelet count, mean platelet volume, platelet distribution width and platelet large cell ratio (r = 0.61-0.99, p<0.0001). Thrombopoietin levels were inversely related to all of the platelet turnover parameters (r = -0.17--0.25, p<0.0001). Moreover, thrombopoietin levels were significantly increased in patients with diabetes (p = 0.03) and in smokers (p = 0.003). Low-grade inflammation evaluated by high-sensitive CRP correlated significantly, yet weakly, with immature platelet count (r = 0.10, p = 0.03) and thrombopoietin (r = 0.16, p<0.001). Also interleukin-6 correlated with thrombopoietin (r = 0.10, p = 0.02). Conclusion: In stable CAD patients, thrombopoietin was inversely associated with platelet turnover parameters. Furthermore, thrombopoietin levels were increased in patients with diabetes and in smokers. However, low-grade inflammation did not seem to have a substantial impact on platelet turnover parameters.	[Larsen, Sanne Bojet; Grove, Erik Lerkevang; Kristensen, Steen Dalby] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Hvas, Anne-Mette] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Hvas, Anne-Mette; Kristensen, Steen Dalby] Aarhus Univ, Fac Hlth Sci, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Kristensen, SD (corresponding author), Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark.	steendk@dadlnet.dk		Grove, Erik/0000-0002-1466-0865	Danish Agency for Science Technology and Innovation [2101-05-0052]; Danish Heart Foundation; A. P. Moller Foundation; Department of Clinical Medicine, Aarhus University, Denmark,; Eva and Henry Fraenkel Foundation; Aase and Ejnar Danielsen Foundation; Korning Foundation; Physician's assurance association anno; Sophus Jacobsen and Spouse Astrid Jacobsen Foundation	Danish Agency for Science Technology and Innovation; Danish Heart Foundation; A. P. Moller Foundation; Department of Clinical Medicine, Aarhus University, Denmark,; Eva and Henry Fraenkel Foundation; Aase and Ejnar Danielsen Foundation; Korning Foundation(National Research Foundation of Korea); Physician's assurance association anno; Sophus Jacobsen and Spouse Astrid Jacobsen Foundation	The study was financially supported be the Danish Agency for Science Technology and Innovation (grant no. 2101-05-0052), The Danish Heart Foundation, A. P. Moller Foundation, Department of Clinical Medicine, Aarhus University, Denmark, The Eva and Henry Fraenkel Foundation, The Aase and Ejnar Danielsen Foundation, The Korning Foundation, The Physician's assurance association anno 1891 and The Sophus Jacobsen and Spouse Astrid Jacobsen Foundation. Carl and Ellen Hertz's legate to Danish medical and natural science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULT KA, 1992, AM J CLIN PATHOL, V98, P637, DOI 10.1093/ajcp/98.6.637; Briggs C, 2004, BRIT J HAEMATOL, V126, P93, DOI 10.1111/j.1365-2141.2004.04987.x; BROWN AS, 1994, EUR J CLIN INVEST, V24, P9, DOI 10.1111/j.1365-2362.1994.tb02419.x; Butkiewicz A M, 2006, Adv Med Sci, V51, P123; Cesari F, 2008, THROMB HAEMOSTASIS, V99, P930, DOI [10.1160/THOS-01-0002, 10.1160/TH08-01-0002]; Cesari F, 2013, THROMB HAEMOSTASIS, V109, P846, DOI 10.1160/TH12-09-0709; Coban E, 2005, INT J CLIN PRACT, V59, P981, DOI 10.1111/j.1742-1241.2005.00500.x; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; De Luca G, 2010, PLATELETS, V21, P508, DOI 10.3109/09537104.2010.494743; Deutsch VR, 2013, BRIT J HAEMATOL, V161, P778, DOI 10.1111/bjh.12328; Emmons RVB, 1996, BLOOD, V87, P4068, DOI 10.1182/blood.V87.10.4068.bloodjournal87104068; Folman CC, 2000, THROMB HAEMOSTASIS, V83, P923, DOI 10.1055/s-0037-1613944; Freynhofer MK, 2011, THROMB HAEMOSTASIS, V106, P182, DOI 10.1160/TH11-01-0051; Grove EL, 2011, J THROMB HAEMOST, V9, P185, DOI 10.1111/j.1538-7836.2010.04115.x; Grove EL, 2009, THROMB HAEMOSTASIS, V101, P151, DOI 10.1160/TH08-03-0186; Guthikonda S, 2008, J AM COLL CARDIOL, V52, P743, DOI 10.1016/j.jacc.2008.05.031; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; KARIO K, 1992, CLIN LAB HAEMATOL, V14, P281; Keating FK, 2003, AM J CARDIOL, V92, P1362, DOI 10.1016/j.amjcard.2003.08.033; Khode Vitthal, 2012, J Cardiovasc Dis Res, V3, P272, DOI 10.4103/0975-3583.102694; Klovaite J, 2011, J THROMB HAEMOST, V9, P49, DOI 10.1111/j.1538-7836.2010.04110.x; Koike Y, 1998, THROMB HAEMOSTASIS, V79, P1106; Larsen SB, 2012, THROMB HAEMOST, P108; LATERVEER L, 1993, EXP HEMATOL, V21, P1621; Lordkipanidze M, 2012, CURR PHARM DESIGN, V18, P5328, DOI 10.2174/138161212803251952; Lupia E, 2006, J AM COLL CARDIOL, V48, P2195, DOI 10.1016/j.jacc.2006.04.106; Lupia E, 2010, ATHEROSCLEROSIS, V210, P314, DOI 10.1016/j.atherosclerosis.2009.11.019; MARTIN JF, 1991, LANCET, V338, P1409, DOI 10.1016/0140-6736(91)92719-I; MARTIN JF, 1983, BRIT MED J, V287, P456, DOI 10.1136/bmj.287.6390.456; MARTIN JF, 1983, THROMB RES, V32, P443, DOI 10.1016/0049-3848(83)90255-4; Martin JF, 2012, NAT REV CARDIOL, V9, P658, DOI 10.1038/nrcardio.2012.131; Panasiuk A, 2004, HEPATO-GASTROENTEROL, V51, P1124; Gonzalez-Porras JR, 2010, THROMB HAEMOSTASIS, V103, P247, DOI 10.1160/TH09-02-0124; Ranjith MP, 2009, J CLIN PATHOL, V62, P830, DOI 10.1136/jcp.2009.066787; RITCHIE JL, 1977, AM J CARDIOL, V39, P595, DOI 10.1016/S0002-9149(77)80171-9; Sahin DY, 2012, CLIN APPL THROMB HEM; Schmidt Morten, 2010, Clin Epidemiol, V2, P137; Senaran H, 2001, CLIN CARDIOL, V24, P405, DOI 10.1002/clc.4960240511; Senchenkova EY, 2013, AM J PATHOL, V183, P173, DOI 10.1016/j.ajpath.2013.03.014; Sosman JA, 1997, CLIN CANCER RES, V3, P39; Takajo Y, 2001, J AM COLL CARDIOL, V38, P1320, DOI 10.1016/S0735-1097(01)01583-2; Tavil Y, 2010, PLATELETS, V21, P368, DOI 10.3109/09537101003628421; THOMPSON CB, 1982, BRIT J HAEMATOL, V50, P509, DOI 10.1111/j.1365-2141.1982.tb01947.x; Ucar H, 2013, PLATELETS IN PRESS, DOI [10.3109/09537104.2013.805406, DOI 10.3109/09537104.2013.805406).IN]; Watala C, 1999, PLATELETS, V10, P52, DOI 10.1080/09537109976356; Wurtz M, 2010, JACC-CARDIOVASC INTE, V3, P828, DOI 10.1016/j.jcin.2010.05.014; Zhang L, 2013, ARTERIOSCL THROM VAS, V33, P1820, DOI 10.1161/ATVBAHA.113.301507	47	39	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85566	10.1371/journal.pone.0085566	http://dx.doi.org/10.1371/journal.pone.0085566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465602	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500076
J	Ricketts, T; McGoldrick, P; Fratta, P; de Oliveira, HM; Kent, R; Phatak, V; Brandner, S; Blanco, G; Greensmith, L; Acevedo-Arozena, A; Fisher, EMC				Ricketts, Thomas; McGoldrick, Philip; Fratta, Pietro; de Oliveira, Hugo M.; Kent, Rosie; Phatak, Vinaya; Brandner, Sebastian; Blanco, Gonzalo; Greensmith, Linda; Acevedo-Arozena, Abraham; Fisher, Elizabeth M. C.			A Nonsense Mutation in Mouse Tardbp Affects TDP43 Alternative Splicing Activity and Causes Limb-Clasping and Body Tone Defects	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DISEASE PROTEIN TDP-43; STRESS GRANULES; ENU MUTAGENESIS; HEXANUCLEOTIDE REPEAT; ALZHEIMERS-DISEASE; TRANSGENIC MOUSE; LINKED TDP-43; FUS MUTATIONS	Mutations in TARDBP, encoding Tar DNA binding protein-43 (TDP43), cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Attempts to model TDP43 dysfunction in mice have used knockouts or transgenic overexpressors, which have revealed the difficulties of manipulating TDP43, whose level is tightly controlled by autoregulation. In a complementary approach, to create useful mouse models for the dissection of TDP43 function and pathology, we have identified a nonsense mutation in the endogenous mouse Tardbp gene through screening an N-ethyl-N-nitrosourea (ENU) mutant mouse archive. The mutation is predicted to cause a Q101X truncation in TDP43. We have characterised Tardbp(Q101X) mice to investigate this mutation in perturbing TDP43 biology at endogenous expression levels. We found the Tardbp(Q101X) mutation is homozygous embryonic lethal, highlighting the importance of TDP43 in early development. Heterozygotes (Tardbp(+/Q101X)) have abnormal levels of mutant transcript, but we find no evidence of the truncated protein and mice have similar full-length TDP43 protein levels as wildtype littermates. Nevertheless, Tardbp(+/Q101X) mice have abnormal alternative splicing of downstream gene targets, and limb-clasp and body tone phenotypes. Thus the nonsense mutation in Tardbp causes a mild loss-of-function phenotype and behavioural assessment suggests underlying neurological abnormalities. Due to the role of TDP43 in ALS, we investigated potential interactions with another known causative gene, mutant superoxide dismutase 1 (SOD1). Tardbp(+/Q101X) mice were crossed with the SOD1(G93Adl) transgenic mouse model of ALS. Behavioural and physiological assessment did not reveal modifying effects on the progression of ALS-like symptoms in the double mutant progeny from this cross. In summary, the Tardbp(Q101X) mutant mice are a useful tool for the dissection of TDP43 protein regulation, effects on splicing, embryonic development and neuromuscular phenotypes. These mice are freely available to the community.	[Ricketts, Thomas; de Oliveira, Hugo M.; Kent, Rosie; Phatak, Vinaya; Acevedo-Arozena, Abraham; Fisher, Elizabeth M. C.] MRC Mammalian Genet Unit, Harwell, Oxon, England; [Ricketts, Thomas; Fratta, Pietro; Brandner, Sebastian; Fisher, Elizabeth M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Ricketts, Thomas; McGoldrick, Philip; Fratta, Pietro; Brandner, Sebastian; Greensmith, Linda; Fisher, Elizabeth M. C.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England; [McGoldrick, Philip; Greensmith, Linda] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Blanco, Gonzalo] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	MRC Harwell; University of London; University College London; University of London; University College London; University of London; University College London; University of York - UK	Greensmith, L (corresponding author), UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England.	l.greensmith@ucl.ac.uk; a.acevedo@har.mrc.ac.uk; e.fisher@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014; Fratta, Pietro/G-1296-2019; Fisher, Elizabeth MC/C-2168-2008; Blanco, Gonzalo/D-8735-2014; Arozena, Abraham Acevedo/L-6584-2018	Brandner, Sebastian/0000-0002-9821-0342; Fratta, Pietro/0000-0002-8762-8188; Fisher, Elizabeth MC/0000-0003-2850-9936; Blanco, Gonzalo/0000-0003-3827-3111; Arozena, Abraham Acevedo/0000-0001-6127-7116; fratta, pietro/0000-0002-7554-1632; Oliveira, Hugo/0000-0001-7010-5252	Motor Neurone Disease Association (MNDA); MRC; Medical Research Council/Motor Neurone Disease Association; Brain Research Trust; European Community; Thierry Latran Foundation; UK Medical Research Council; Motor Neurone Disease Association; Medical Research Council [MR/K018523/1, G0500288, G0801110, G1000287, MC_UP_A390_1106, MR/K000608/1, MC_U142684168] Funding Source: researchfish; MRC [MC_UP_A390_1106, MR/K018523/1, G0801110, G1000287, MR/K000608/1, G0500288] Funding Source: UKRI	Motor Neurone Disease Association (MNDA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council/Motor Neurone Disease Association(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Brain Research Trust; European Community(European Commission); Thierry Latran Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neurone Disease Association; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TR was a recipient of a PhD studentship from the Motor Neurone Disease Association (MNDA). PM was a PhD student of the MRC Centre for Neuromuscular Diseases and is in receipt of an MRC Centenary Award. PF is funded by a Medical Research Council/Motor Neurone Disease Association Lady Edith Wolfson Fellowship. LG is The Graham Watts Senior Research Fellow funded by the Brain Research Trust and the European Community's Seventh Framework Programme (FP7/2007-2013). EMCF, PF, LG, AAA are funded by the Thierry Latran Foundation and the UK Medical Research Council and the Motor Neurone Disease Association.	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Acevedo-Arozena A, 2011, DIS MODEL MECH, V4, P686, DOI 10.1242/dmm.007237; Aizawa-Abe M, 2013, PHYSIOL GENOMICS, DOI [10.1152/physiolge-nomics.00040.2013, DOI 10.1152/PHYSI0LGE-N0MICS.00040.2013]; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Belzil VV, 2011, ARCH NEUROL-CHICAGO, V68, P395, DOI 10.1001/archneurol.2011.1; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Borroni B, 2010, REJUV RES, V13, P509, DOI 10.1089/rej.2010.1017; Borroni B, 2009, HUM MUTAT, V30, pE974, DOI 10.1002/humu.21100; Budini M, 2011, CURR ALZHEIMER RES, V8, P237, DOI 10.2174/156720511795563719; Budini M, 2011, J MOL NEUROSCI, V45, P473, DOI 10.1007/s12031-011-9573-8; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Buratti E, 2011, FEBS J, V278, P3530, DOI 10.1111/j.1742-4658.2011.08257.x; Chen S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-28; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Chio A, 2012, NEUROLOGY, V79, P1983, DOI 10.1212/WNL.0b013e3182735d36; Chio A, 2010, ARCH NEUROL-CHICAGO, V67, P1002, DOI 10.1001/archneurol.2010.173; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; Cruts M, TRENDS NEUROSCI; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Duysen EG, 2007, TOXICOLOGY, V233, P60, DOI 10.1016/j.tox.2006.11.069; Fallini C, 2012, HUM MOL GENET, V21, P3703, DOI 10.1093/hmg/dds205; Fiesel FC, 2011, FEBS J, V278, P3550, DOI 10.1111/j.1742-4658.2011.08258.x; Fiesel FC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-64; Han JH, 2013, EXP CELL RES, V319, P1998, DOI 10.1016/j.yexcr.2013.05.025; Hasegawa M, 2007, BRAIN, V130, P1386, DOI 10.1093/brain/awm065; Higashi S, 2013, J NEUROCHEM, V126, P288, DOI 10.1111/jnc.12194; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Iguchi Y, 2013, BRAIN, V136, P1371, DOI 10.1093/brain/awt029; Ingman K, 2004, PHARMACOL BIOCHEM BE, V77, P847, DOI 10.1016/j.pbb.2004.02.015; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Joyce PI, 2011, MAMM GENOME, V22, P420, DOI 10.1007/s00335-011-9339-1; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kalmar B, 2008, J NEUROCHEM, V107, P339, DOI 10.1111/j.1471-4159.2008.05595.x; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Kuramoto T, 2011, EXP ANIM TOKYO, V60, P57, DOI 10.1538/expanim.60.57; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040998; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Malik B, 2011, HUM MOL GENET, V20, P1776, DOI 10.1093/hmg/ddr061; Mashimo T, 2010, J NEUROSCI, V30, P5744, DOI 10.1523/JNEUROSCI.3360-09.2010; McGoldrick P, 2013, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbadis.2013.03.012, DOI 10.1016/J.BBA-DIS.2013.03.012]; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Messaoudi M, 2005, BRIT J NUTR, V93, pS27, DOI 10.1079/BJN20041348; Millecamps S, 2010, J MED GENET, V47, P554, DOI 10.1136/jmg.2010.077180; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Parker SJ, 2012, NEUROCHEM INT, V60, P415, DOI 10.1016/j.neuint.2012.01.019; Pokrishevsky E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035050; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Rathkolb B, 2000, EXP PHYSIOL, V85, P635, DOI 10.1017/S0958067000020947; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Sephton CF, 2012, BIOL CHEM, V393, P589, DOI 10.1515/hsz-2012-0115; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Sharp PS, 2005, NEUROSCIENCE, V130, P897, DOI 10.1016/j.neuroscience.2004.09.069; Somalinga BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035818; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stack EC, 2007, J NEUROSCI, V27, P12908, DOI 10.1523/JNEUROSCI.4318-07.2007; Swarup V, 2012, J NEUROSCI, V32, P18186, DOI 10.1523/JNEUROSCI.2267-12.2012; Tsao W, 2012, BRAIN RES, V1462, P26, DOI 10.1016/j.brainres.2012.04.031; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu ZS, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-27	77	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85962	10.1371/journal.pone.0085962	http://dx.doi.org/10.1371/journal.pone.0085962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465814	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500155
J	Singh, A; Vaidya, B; Khatri, I; Srinivas, TNR; Subramanian, S; Korpole, S; Pinnaka, AK				Singh, Aditya; Vaidya, Bhumika; Khatri, Indu; Srinivas, T. N. R.; Subramanian, Srikrishna; Korpole, Suresh; Pinnaka, Anil Kumar			Grimontia indica AK16(T), sp nov., Isolated from a Seawater Sample Reports the Presence of Pathogenic Genes Similar to Vibrio Genus	PLOS ONE			English	Article							FINISHED GENOME SEQUENCE; IDENTIFICATION; HOLLISAE; KEGG	Grimontia indica strain AK16(T) sp. nov. is the type strain of G. indica sp. nov. a new species within the genus Grimontia. This strain, whose genome is described here, was isolated from seawater sample collected from southeast coast of Palk Bay, India. G. indica AK16(T) is a Gram-negative, facultative aerobic rod shaped bacterium. There are only two other strains in the genus Grimontia one of which, Grimontia hollisae CIP 101886(T), is a reported human pathogen isolated from human stool sample while the other, 'Grimontia marina IMCC5001(T)', was isolated from a seawater sample. As compared to the pathogenic strain Grimontia hollisae CIP 101886(T), the strain AK16(T) lacks some genes for pathogenesis like the accessory colonization factors AcfA and AcfD, which are required for the colonization of the bacterium in the host body. While it carries some pathogenesis genes like OmpU, which are related to pathogenesis of Vibrio strains. This suggests that the life cycle of AK16(T) may include some pathogenic interactions with marine animal(s), or it may be an opportunistic pathogen. Study of the Grimontia genus is important because of the severe pathogenic traits exhibited by a member of the genus with only three species reported in total. The study will provide some vital information which may be useful in future clinical studies on the genus.	[Singh, Aditya; Vaidya, Bhumika; Khatri, Indu; Subramanian, Srikrishna; Korpole, Suresh; Pinnaka, Anil Kumar] Inst Microbial Technol, Microbial Type Culture Collect & Gene Bank, Chandigarh, India; [Srinivas, T. N. R.] Natl Inst Oceanog, Visakhapatnam, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO)	Pinnaka, AK (corresponding author), Inst Microbial Technol, Microbial Type Culture Collect & Gene Bank, Chandigarh, India.	apinnaka@imtech.res.in	Singh, Aditya/AAC-4183-2020; subramanian, srikrishna/N-3018-2019; Khatri, Indu/Y-2429-2018; TANUKU, SRINIVAS N R/F-1029-2013; Pinnaka, Anil Kumar/G-5063-2011	Singh, Aditya/0000-0003-0827-7429; subramanian, srikrishna/0000-0002-3263-1048; Khatri, Indu/0000-0002-7993-1953; TANUKU, SRINIVAS N R/0000-0003-3434-6993; 	CSIR-IMTECH	CSIR-IMTECH	This work was funded by CSIR-IMTECH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baharoglu Z, 2012, J BACTERIOL, V194, P1659, DOI 10.1128/JB.05982-11; Chiavelli DA, 2001, APPL ENVIRON MICROB, V67, P3220, DOI 10.1128/AEM.67.7.3220-3225.2001; Choi A, 2012, J MICROBIOL, V50, P170, DOI 10.1007/s12275-012-1615-6; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; Hinestrosa F, 2007, J CLIN MICROBIOL, V45, P3462, DOI 10.1128/JCM.01205-07; Jean-Christophe L, 2012, STAND GENOMIC SCI, V7, P343; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kokcha S, 2012, STAND GENOMIC SCI, V6, P346, DOI 10.4056/sigs.2776064; Lagier JC, 2012, STAND GENOMIC SCI, V6, P116, DOI 10.4056/sigs.2415480; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mishra AK, 2012, STAND GENOMIC SCI, V6, P304, DOI 10.4056/sigs.2625821; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Srinivas TNR, 2013, SYST APPL MICROBIOL, V36, P160, DOI 10.1016/j.syapm.2012.12.002; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson FL, 2003, INT J SYST EVOL MICR, V53, P1615, DOI 10.1099/ijs.0.02660-0; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; van Kessel JC, 2013, J BACTERIOL, V195, P436, DOI 10.1128/JB.01998-12	24	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85590	10.1371/journal.pone.0085590	http://dx.doi.org/10.1371/journal.pone.0085590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465608	Green Submitted, gold, Green Published			2022-12-25	WOS:000330244500079
J	Wagner, KV; Hausl, AS; Pohlmann, ML; Hartmann, J; Labermaier, C; Muller, MB; Schmidt, MV				Wagner, Klaus V.; Haeusl, Alexander S.; Poehlmann, Max L.; Hartmann, Jakob; Labermaier, Christiana; Mueller, Marianne B.; Schmidt, Mathias V.			Hippocampal Homer1 Levels Influence Motivational Behavior in an Operant Conditioning Task	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PREFRONTAL CORTEX; KNOCKOUT MICE; IP3 RECEPTORS; MEMORY; COCAINE; STRESS; SCHIZOPHRENIA; ASSOCIATION; ACTIVATION	Loss of motivation and learning impairments are commonly accepted core symptoms of psychiatric disorders such as depression and schizophrenia. Reward-motivated learning is dependent on the hippocampal formation but the molecular mechanisms that lead to functional incentive motivation in this brain region are still largely unknown. Recent evidence implicates neurotransmission via metabotropic glutamate receptors and Homer1, their interaction partner in the postsynaptic density, in drug addiction and motivational learning. As previous reports mainly focused on the prefrontal cortex and the nucleus accumbens, we now investigated the role of hippocampal Homer1 in operant reward learning in the present study. We therefore tested either Homer1 knockout mice or mice that overexpress Homer1 in the hippocampus in an operant conditioning paradigm. Our results show that deletion of Homer1 leads to a diverging phenotype that either displays an inability to perform the task or outstanding hyperactivity in both learning and motivational sessions. Due to the apparent bimodal distribution of this phenotype, the overall effect of Homer1 deletion in this paradigm is not significantly altered. Overexpression of hippocampal Homer1 did not lead to a significantly altered learning performance in any stage of the testing paradigm, yet may subtly contribute to emerging motivational deficits. Our results indicate an involvement of Homer1-mediated signaling in the hippocampus in motivation-based learning tasks and encourage further investigations regarding the specific molecular underpinnings of the phenotypes observed in this study. We also suggest to cautiously interpret the results of this and other studies regarding the phenotype following Homer1 manipulations in animals, since their behavioral phenotype appears to be highly diverse. Future studies would benefit from larger group sizes that would allow splitting the experimental groups in responders and non-responders.	[Wagner, Klaus V.; Haeusl, Alexander S.; Poehlmann, Max L.; Hartmann, Jakob; Labermaier, Christiana; Mueller, Marianne B.; Schmidt, Mathias V.] Max Planck Inst Psychiat, Res Grp Neurobiol Stress, Munich, Bavaria, Germany	Max Planck Society	Wagner, KV (corresponding author), Max Planck Inst Psychiat, Res Grp Neurobiol Stress, Munich, Bavaria, Germany.	kwagner@mpipsykl.mpg.de	Müller, Marianne B./AAL-8911-2021; Hartmann, Jakob/GPF-5919-2022	Müller, Marianne B./0000-0002-0269-6131; Hartmann, Jakob/0000-0002-1960-8177; Schmidt, Mathias/0000-0002-3788-2268	NARSAD [17322]	NARSAD(NARSAD)	This study was partially supported by NARSAD Grant No. 17322. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding has been received for this study.	Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Delgado MR, 2012, BIOL PSYCHIAT, V72, P134, DOI 10.1016/j.biopsych.2012.01.023; Fairhall SL, 2010, BIOL PSYCHOL, V85, P499, DOI 10.1016/j.biopsycho.2010.09.002; Feng W, 2002, J BIOL CHEM, V277, P44722, DOI 10.1074/jbc.M207675200; Gerstein H, 2012, NEUROBIOL LEARN MEM, V97, P17, DOI 10.1016/j.nlm.2011.08.009; Grinevich V, 2011, HORM METAB RES, V43, P551, DOI 10.1055/s-0031-1280828; Hernandez PJ, 2006, LEARN MEMORY, V13, P599, DOI 10.1101/lm.335006; Inoue N, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-7; Ishikawa A, 2008, J NEUROSCI, V28, P5088, DOI 10.1523/JNEUROSCI.0253-08.2008; Jaubert PJ, 2007, GENES BRAIN BEHAV, V6, P141, DOI 10.1111/j.1601-183X.2006.00240.x; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lieberman JA, 2001, BIOL PSYCHIAT, V50, P884, DOI 10.1016/S0006-3223(01)01303-8; Lominac KD, 2005, J NEUROSCI, V25, P11586, DOI 10.1523/JNEUROSCI.3764-05.2005; Mahan AL, 2012, J NEUROSCI, V32, P4651, DOI 10.1523/JNEUROSCI.3308-11.2012; McFarland K, 2003, J NEUROSCI, V23, P3531; Morgado-Bernal I, 2011, NEUROSCIENCE, V176, P12, DOI 10.1016/j.neuroscience.2010.12.056; Murray EA, 2010, CURR OPIN NEUROBIOL, V20, P212, DOI 10.1016/j.conb.2010.02.001; Norton N, 2003, AM J MED GENET B, V120B, P18, DOI 10.1002/ajmg.b.20032; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Rietschel M, 2010, BIOL PSYCHIAT, V68, P578, DOI 10.1016/j.biopsych.2010.05.038; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; Schmidt MV, 2011, P NATL ACAD SCI USA, V108, P17213, DOI 10.1073/pnas.1103318108; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Szumlinski KK, 2005, GENES BRAIN BEHAV, V4, P273, DOI 10.1111/j.1601-183X.2005.00120.x; Szumlinski KK, 2004, NEURON, V43, P401, DOI 10.1016/j.neuron.2004.07.019; Tronson NC, 2010, BIOL PSYCHIAT, V68, P1007, DOI 10.1016/j.biopsych.2010.09.004; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Uys JD, 2008, CNS NEUROL DISORD-DR, V7, P482, DOI 10.2174/187152708786927868; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Wagner KV, 2013, J NEUROSCI, V33, P3857, DOI 10.1523/JNEUROSCI.4333-12.2013; Wang XD, 2011, NEUROBIOL DIS, V42, P300, DOI 10.1016/j.nbd.2011.01.020; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5	39	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85975	10.1371/journal.pone.0085975	http://dx.doi.org/10.1371/journal.pone.0085975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465821	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500160
J	Barone, C; Pinto, C; Normanno, N; Capussotti, L; Cognetti, F; Falcone, A; Mantovani, L				Barone, Carlo; Pinto, Carmine; Normanno, Nicola; Capussotti, Lorenzo; Cognetti, Francesco; Falcone, Alfredo; Mantovani, Lorenzo			KRAS Early Testing: Consensus Initiative and Cost-Effectiveness Evaluation for Metastatic Colorectal Patients in an Italian Setting	PLOS ONE			English	Article							QUALITY INDICATORS; 1ST-LINE TREATMENT; DELPHI SURVEY; CANCER; CETUXIMAB; ONCOLOGY; CHEMOTHERAPY; MANAGEMENT; SOCIETY; ISSUES	KRAS testing is relevant for the choice of the most appropriate first-line therapy of metastatic colorectal cancer (CRC). Strategies for preventing unequal access to the test should be implemented, but their relevance in the practice is related to economic sustainability. The study adopted the Delphi technique to reach a consensus on several topics. Issues related to execution of KRAS testing were identified by an experts board and proposed to 108 Italian oncologists and pathologists through two subsequent questionnaires. The emerging proposal was evaluated by decision analyses models employed by technology assessment agencies in order to assess cost-effectiveness. Alternative therapeutic strategies included most commonly used chemotherapy regimens alone or in combination with cetuximab or bevacizumab. The survey indicated that time interval for obtaining KRAS test should not exceed 15 days, 10 days being an optimal interval. To assure the access to proper treatment, a useful strategy should be to anticipate the test after radical resection in patients at high risk of relapse. Early KRAS testing in high risk CRC patients generates incremental cost-effectiveness ratios between 6,000 and 13,000 Euro per quality adjusted life year (QALY) gained. In extensive sensitivity analyses ICERs were always below 15,000 Euro per QALY gained, far within the threshold of 60,000 Euro/QALY gained accepted by regulatory institutions in Italy. In metastatic CRC a time interval higher than 15 days for result of KRAS testing limits access to therapeutic choices. Anticipating KRAS testing before the onset of metastatic disease in patients at high risk does not affect the sustainability and cost-effectiveness profile of cetuximab in first-line mCRC. Early KRAS testing may prevent this inequality in high-risk patients, whether they develop metastases, and is a cost-effective strategy. Based on these results, present joined recommendations of Italian societies of Oncology and Pathology should be updated including early KRAS testing.	[Barone, Carlo] Gemelli Hosp, Med Oncol Unit, Rome, Italy; [Pinto, Carmine] St Orsola Marcello Malpighi Hosp, Med Oncol Unit, Bologna, Italy; [Normanno, Nicola] Pascale Fdn, Cellular Biol & Biotherapies Unit, Naples, Italy; [Capussotti, Lorenzo] Umberto I Hosp, Turin, Italy; [Cognetti, Francesco] Regina Elena Hosp, Dept Med Oncol, Rome, Italy; [Falcone, Alfredo] Santa Chiara Hosp, Oncol Transplantat & New Med Technol Dept, Pisa, Italy; [Mantovani, Lorenzo] Univ Naples Federico II, Clin Med & Surg Unit, Naples, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Fondazione Pascale; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Santa Chiara Hospital; University of Naples Federico II	Barone, C (corresponding author), Gemelli Hosp, Med Oncol Unit, Rome, Italy.	carlobarone@rm.unicatt.it	Cognetti, Francesco/AAC-2637-2019; Normanno, Nicola/AAT-1107-2021; Pinto, Carmine/AAC-2184-2020; Falcone, Alfredo/G-5217-2013; Mantovani, Lorenzo Giovanni/AAC-4263-2021	Pinto, Carmine/0000-0002-3159-5268; Mantovani, Lorenzo Giovanni/0000-0003-3866-8199; Falcone, Alfredo/0000-0001-5840-2529; COGNETTI, FRANCESCO/0000-0003-2022-9446; Normanno, Nicola/0000-0002-7158-2605	Merck Serono S.p.A.	Merck Serono S.p.A.	Merck Serono S.p.A. (http://www.merckserono.com/it/index.html) has given support to the scientific committee to finance the development of field work for the Delphi survey part of the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; [Anonymous], 2012, NICE TECHN APPR GUID; Asseburg C, 2011, CLIN THER, V33, P482, DOI 10.1016/j.clinthera.2011.04.010; Barone C, 2012, FARMECONOMIA S1, V13, P1; Behl AS, 2012, JNCI-J NATL CANCER I, V104, P1785, DOI 10.1093/jnci/djs433; Bokemeyer C, 2012, EUR J CANCER, V48, P1466, DOI 10.1016/j.ejca.2012.02.057; Chan A, 2009, CLIN THER, V31, P2379, DOI 10.1016/j.clinthera.2009.11.008; Danielson B, 2011, RADIOTHER ONCOL, V99, P29, DOI 10.1016/j.radonc.2011.02.013; Delva F, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-5; Dempke WCM, 2010, ANTICANCER RES, V30, P4673; Exposito J, 2010, CLIN TRANSL ONCOL, V12, P493, DOI 10.1007/s12094-010-0542-4; Fehr A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-312; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Frank SJ, 2011, BRACHYTHERAPY, V10, P357, DOI 10.1016/j.brachy.2011.01.014; Gagliardi AR, 2005, CAN J SURG, V48, P441; Garcia-Foncillas J, 2012, J CLIN ONCOL S4, V30; Graham B, 2003, J CLIN EPIDEMIOL, V56, P1150, DOI 10.1016/S0895-4356(03)00211-7; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Lievre A, 2013, EUR J CANCER, V49, P2126, DOI 10.1016/j.ejca.2013.02.016; Linstone HA, 1975, DELPHI METHOD TECHNI, P1; Loblaw DA, 2012, J CLIN ONCOL, V30, P3136, DOI 10.1200/JCO.2012.42.0489; Marchetti A, 2011, J CLIN ONCOL S, V29; Maughan TS, 2011, LANCET, V377, P2103, DOI 10.1016/S0140-6736(11)60613-2; Mileshkin Linda, 2012, Chemother Res Pract, V2012, P838509, DOI 10.1155/2012/838509; Moss EL, 2010, INT J GYNECOL CANCER, V20, P488, DOI 10.1111/IGC.0b013e3181a835a3; Petrelli F, 2012, INT J COLORECTAL DIS, V27, P997, DOI 10.1007/s00384-012-1438-2; Raijmakers NJH, 2012, PALLIATIVE MED, V26, P947, DOI 10.1177/0269216311423794; Robson N, 2010, EJSO-EUR J SURG ONC, V36, P230, DOI 10.1016/j.ejso.2010.01.002; Rowe G, 1999, INT J FORECASTING, V15, P353, DOI 10.1016/S0169-2070(99)00018-7; Shankaran V, 2009, ASCO 2009 GASTR CANC; Speksnijder HT, 2011, INT J NURS TERMIN CL, V22, P77, DOI 10.1111/j.1744-618X.2011.01183.x; Tveit KM, 2012, J CLIN ONCOL, V30, P1755, DOI 10.1200/JCO.2011.38.0915; Uphoff EPMM, 2012, CANCER NURS, V35, P29, DOI 10.1097/NCC.0b013e318210e3a2; Vijayaraghavan A, 2012, INT J CANCER, V131, P438, DOI 10.1002/ijc.26400; Winder T, 2010, CANCER TREAT REV, V36, P550, DOI 10.1016/j.ctrv.2010.03.005	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85897	10.1371/journal.pone.0085897	http://dx.doi.org/10.1371/journal.pone.0085897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465771	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500085
J	Manzou, R; Schumacher, C; Gregson, S				Manzou, Rumbidzai; Schumacher, Christina; Gregson, Simon			Temporal Dynamics of Religion as a Determinant of HIV Infection in East Zimbabwe: A Serial Cross-Sectional Analysis	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RURAL ZIMBABWE; SOUTH-AFRICA; HIV/AIDS; INVOLVEMENT; PREVENTION; MOZAMBIQUE; BEHAVIOR; DECLINE; GENDER	Background: Religion is an important underlying determinant of HIV spread in sub-Saharan Africa. However, little is known about how religion influences changes in HIV prevalence and associated sexual behaviours over time. Objectives: To compare changes in HIV prevalence between major religious groups in eastern Zimbabwe during a period of substantial HIV risk reduction (1998-2005) and to investigate whether variations observed can be explained by differences in behaviour change. Methods: We analysed serial cross-sectional data from two rounds of a longitudinal population survey in eastern Zimbabwe. Univariate and multivariate logistic regression models were developed to compare differences in sexual behaviour and HIV prevalence between religious groups and to investigate changes over time controlling for potential confounders. Results: Christian churches were the most popular religious grouping. Over time, Spiritualist churches increased in popularity and, for men, Traditional religion and no religion became less and more common, respectively. At baseline (1998-2000), HIV prevalence was higher in Traditionalists and in those with no religion than in people in Christian churches (men 26.7% and 23.8% vs. 17.5%, women: 35.4% and 37.5% vs. 24.1%). These effects were explained by differences in socio-demographic characteristics (for Traditional and men with no religion) or sexual behaviour (women with no religion). Spiritualist men (but not women) had lower HIV prevalence than Christians, after adjusting for socio-demographic characteristics (14.4% vs. 17.5%, aOR = 0.8), due to safer behaviour. HIV prevalence had fallen in all religious groups at follow-up (2003-2005). Odds of infection in Christians reduced relative to those in other religious groups for both sexes, effects that were mediated largely by greater reductions in sexual-risk behaviour and, possibly, for women, by patterns of conversion between churches. Conclusion: Variation in behavioural responses to HIV between the major church groupings has contributed to a change in the religious pattern of infection in eastern Zimbabwe.	[Manzou, Rumbidzai; Gregson, Simon] Biomed Res & Training Inst, Manicaland HIV STI Prevent Project, Harare, Zimbabwe; [Manzou, Rumbidzai; Gregson, Simon] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Schumacher, Christina] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Biomedical Research Training Institute; Imperial College London; Johns Hopkins University	Manzou, R (corresponding author), Biomed Res & Training Inst, Manicaland HIV STI Prevent Project, Harare, Zimbabwe.	rmanzou@brti.co.zw		Gregson, Simon/0000-0003-2707-0714	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The Wellcome Trust funded the Manicaland HIV/STD Prevention project from which data was used for this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanian V, 2005, SOC SCI MED, V61, P1529, DOI 10.1016/j.socscimed.2005.03.012; Agadjanian V, 2011, GLOB PUBLIC HEALTH, V6, pS148, DOI 10.1080/17441692.2011.598869; Bourdillon M, 1991, SHONA PEOPLES; Bourdillon MFC, 1997, WHERE ARE ANCESTORS; Chitima K, 2006, LOCAL CHURCH RESPONS; Epstein H, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-13; Eriksson E, 2010, CULT HEALTH SEX, V12, P103, DOI 10.1080/13691050903141192; Garner RC, 2000, J MOD AFR STUD, V38, P41, DOI 10.1017/S0022278X99003249; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 1999, POP STUD-J DEMOG, V53, P179, DOI 10.1080/00324720308084; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; Gregson S, 2007, P NATL ACAD SCI USA, V104, P14586, DOI 10.1073/pnas.0611540104; Gregson S, 2011, POPUL DEV REV, V37, P333, DOI 10.1111/j.1728-4457.2011.00413.x; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; Hallfors DD, 2013, ETHNIC HEALTH, V18, P53, DOI 10.1080/13557858.2012.694068; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Lagarde E, 2000, AIDS, V14, P2027, DOI 10.1097/00002030-200009080-00019; Takyi BK, 2003, SOC SCI MED, V56, P1221, DOI 10.1016/S0277-9536(02)00122-3; Takyi BK, 2005, RELIG HIV AIDS BEHAV; Trinitapoli J, 2009, SOC SCI MED, V69, P199, DOI 10.1016/j.socscimed.2009.04.018; UNAIDS, 2011, GLOB HIV AIDS RESP E; Velayati AA, 2007, ARCH IRAN MED, V10, P486; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2	23	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86060	10.1371/journal.pone.0086060	http://dx.doi.org/10.1371/journal.pone.0086060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297FH	24465868	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500106
J	Bersten, DC; Bruning, JB; Peet, DJ; Whitelaw, ML				Bersten, David C.; Bruning, John B.; Peet, Daniel J.; Whitelaw, Murray L.			Human Variants in the Neuronal Basic Helix-Loop-Helix/Per-Arnt-Sim (bHLH/PAS) Transcription Factor Complex NPAS4/ARNT2 Disrupt Function	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; DE-NOVO MUTATIONS; AUTISM SPECTRUM DISORDERS; PAS DOMAIN; RESPONSE ELEMENT; GENE-EXPRESSION; DNA-BINDING; CROSS-TALK; PROTEIN; OBESITY	Neuronal Per-Arnt-Sim homology (PAS) Factor 4 (NPAS4) is a neuronal activity-dependent transcription factor which heterodimerises with ARNT2 to regulate genes involved in inhibitory synapse formation. NPAS4 functions to maintain excitatory/inhibitory balance in neurons, while mouse models have shown it to play roles in memory formation, social interaction and neurodegeneration. NPAS4 has therefore been implicated in a number of neuropsychiatric or neurodegenerative diseases which are underpinned by defects in excitatory/inhibitory balance. Here we have explored a broad set of non-synonymous human variants in NPAS4 and ARNT2 for disruption of NPAS4 function. We found two variants in NPAS4 (F147S and E257K) and two variants in ARNT2 (R46W and R107H) which significantly reduced transcriptional activity of the heterodimer on a luciferase reporter gene. Furthermore, we found that NPAS4. F147S was unable to activate expression of the NPAS4 target gene BDNF due to reduced dimerisation with ARNT2. Homology modelling predicts F147 in NPAS4 to lie at the dimer interface, where it appears to directly contribute to protein/protein interaction. We also found that reduced transcriptional activation by ARNT2 R46W was due to disruption of nuclear localisation. These results provide insight into the mechanisms of NPAS4/ARNT dimerisation and transcriptional activation and have potential implications for cognitive phenotypic variation and diseases such as autism, schizophrenia and dementia.	[Whitelaw, Murray L.] Univ Adelaide, Sch Mol & Biomed Sci Biochem, Adelaide, SA, Australia; Univ Adelaide, Australian Res Council Special Res Ctr Mol Genet, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Whitelaw, ML (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci Biochem, Adelaide, SA, Australia.	murray.whitelaw@adelaide.edu.au	Peet, Daniel/AAE-6698-2020; Bruning, John/AAW-8567-2020	Peet, Daniel/0000-0002-6085-8936; Bruning, John/0000-0002-6919-1824	Australian Research Council	Australian Research Council(Australian Research Council)	This research was supported by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagyan R, 1997, PROTEINS, P29; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnautova YA, 2011, PROTEINS, V79, P477, DOI 10.1002/prot.22896; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bonnefond A, 2013, J CLIN INVEST, V123, P3037, DOI 10.1172/JCI68035; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chapman-Smith A, 2006, J BIOL CHEM, V281, P12535, DOI 10.1074/jbc.M512145200; Clement JP, 2012, CELL, V151, P709, DOI 10.1016/j.cell.2012.08.045; Coutellier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046604; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eguchi H, 1997, J BIOL CHEM, V272, P17640, DOI 10.1074/jbc.272.28.17640; Farrall AL, 2009, ONCOGENE, V28, P3671, DOI 10.1038/onc.2009.228; Flood WD, 2004, EUR J NEUROSCI, V20, P1819, DOI 10.1111/j.1460-9568.2004.03646.x; Floor K, 2012, EUR J MED GENET, V55, P695, DOI 10.1016/j.ejmg.2012.08.002; Fu W, 2012, NATURE; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hao N, 2011, NUCLEIC ACIDS RES, V39, P3695, DOI 10.1093/nar/gkq1336; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Kehrer C, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02/006.2008; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; LINDEBRO MC, 1995, EMBO J, V14, P3528, DOI 10.1002/j.1460-2075.1995.tb07359.x; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; Moffett P, 2000, FEBS LETT, V466, P80, DOI 10.1016/S0014-5793(99)01750-0; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Olechnowicz SWZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044564; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Ooe N, 2009, BBA-GENE REGUL MECH, V1789, P192, DOI 10.1016/j.bbagrm.2009.01.003; Ooe N, 2009, J BIOL CHEM, V284, P1057, DOI 10.1074/jbc.M805196200; Probst MR, 1997, J BIOL CHEM, V272, P4451, DOI 10.1074/jbc.272.7.4451; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Ramachandrappa S, 2013, J CLIN INVEST, V123, P3042, DOI 10.1172/JCI68016; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; Skalamera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020057; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun WM, 1997, J BIOL CHEM, V272, P31845, DOI 10.1074/jbc.272.50.31845; Tolson KP, 2010, J NEUROSCI, V30, P3803, DOI 10.1523/JNEUROSCI.5444-09.2010; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Woods SL, 2002, J BIOL CHEM, V277, P10236, DOI 10.1074/jbc.M110752200; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	65	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85768	10.1371/journal.pone.0085768	http://dx.doi.org/10.1371/journal.pone.0085768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465693	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000062
J	Edgehouse, M; Latta, LC; Brodie, ED; Brodie, ED				Edgehouse, Michael; Latta, Leigh C.; Brodie, Edmund D., III; Brodie, Edmund D., Jr.			Interspecific Aggression and Habitat Partitioning in Garter Snakes	PLOS ONE			English	Article							COMPETITION; TERRITORIALITY; EVOLUTIONARY	Defense of a limited resource, such as space or food, has recently been discovered in snakes and has been widely documented in lizards. Garter snakes (Thamnophis spp.) are historically considered generalist predators such that food is not a limiting resource. However, in this study we show that the common garter snake (Thamnophis sirtalis) and the aquatic garter snake (Thamnophis atratus) show a strong preference for amphibians as their primary food source at the Santa Lucia Preserve (SLP), Monterey County, California. This food preference forces these snake species at SLP to exploit aquatic habitats. Our principle goal was to investigate the aggressive behavior of T. sirtalis and the potential that this aggression displaces T. atratus from its preferred habitat. We found that when individuals from either species are alone, a 100% preference for aquatic or near aquatic habitat is observed. In contrast, when these species are together, T. sirtalis occupy the aquatic habitat and T. atratus occupy an area far removed from water. Thamnophis sirtalis often physically force T. atratus from the aquatic habitat through repeated biting and other displays of aggression.	[Edgehouse, Michael] Lewis Clark State Coll, Dept Nat Sci & Math, Lewiston, ID 83501 USA; [Latta, Leigh C.] Reed Coll, Dept Biol, Portland, OR 97202 USA; [Brodie, Edmund D., III] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Brodie, Edmund D., III] Univ Virginia, Mt Lake Biol Stn, Charlottesville, VA USA; [Brodie, Edmund D., Jr.] Utah State Univ, Dept Biol, Logan, UT 84322 USA	Idaho; Lewis Clark State College; Reed College - Oregon; University of Virginia; University of Virginia; Utah System of Higher Education; Utah State University	Edgehouse, M (corresponding author), Lewis Clark State Coll, Dept Nat Sci & Math, Lewiston, ID 83501 USA.	mjedgehouse@lcsc.edu			National Science Foundation [DEB-0315172, DEB-0922251]; Direct For Biological Sciences [0922216] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation grants to EDB Jr and EDB III (DEB-0315172, DEB-0922251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARPENTER CC, 1952, ECOL MONOGR, V22, P235, DOI 10.2307/1948469; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; de Mendiburu F, 2010, AGRICOLAE STAT PROCE; Duvall David, 1993, P165; Feldman CR, 2010, P ROY SOC B-BIOL SCI, V277, P3317, DOI 10.1098/rspb.2010.0748; Firmage M., 1996, Amphibia-Reptilia, V17, P55, DOI 10.1163/156853896X00298; Greene H. W., 1997, SNAKES EVOLUTION MYS; GREGORY P T, 1987, P366; Griffis MR, 1998, ECOLOGY, V79, P2494, DOI 10.2307/176838; Hanifin CT, 2010, MAR DRUGS, V8, P577, DOI 10.3390/md8030577; HESS NE, 1991, J HERPETOL, V25, P256, DOI 10.2307/1564669; Huang WS, 2011, P NATL ACAD SCI USA, V108, P7455, DOI 10.1073/pnas.1101804108; KAO CY, 1966, PHARMACOL REV, V18, P997; Kjoss VA, 2001, BIOL CONSERV, V98, P285, DOI 10.1016/S0006-3207(00)00167-1; KLEEBERGER SR, 1984, ECOLOGY, V65, P1846, DOI 10.2307/1937782; LANCASTER DL, 1995, BEHAV ECOL SOCIOBIOL, V37, P25, DOI 10.1007/BF00173895; Luiselli L, 2006, OIKOS, V114, P193, DOI 10.1111/j.2006.0030-1299.14064.x; Maynard Smith J., 1982, pi; NARAHASH.T, 1967, SCIENCE, V156, P976, DOI 10.1126/science.156.3777.976; Olson Daniel J., 2001, Herpetological Review, V32, P186; Pinter-Wollman N, 2006, J MAMMAL, V87, P48, DOI 10.1644/04-MAMM-A-194R2.1; PLUMMER MV, 1981, J HERPETOL, V15, P425, DOI 10.2307/1563532; REICHENBACH NG, 1980, J HERPETOL, V14, P409, DOI 10.2307/1563698; ROSSI JV, 2003, SNAKES US CANADA; SIMPFENDORFER C, 1992, AUST J MAR FRESH RES, V43, P33, DOI 10.1071/MF9920033; Smyers SD, 2002, HERPETOLOGICA, V58, P422, DOI 10.1655/0018-0831(2002)058[0422:IAICOB]2.0.CO;2; TOFT CA, 1985, COPEIA, P1; VORIS HK, 1983, AM ZOOL, V23, P411; WOLFF JO, 1983, BEHAV ECOL SOCIOBIOL, V12, P237, DOI 10.1007/BF00290776	29	5	5	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86208	10.1371/journal.pone.0086208	http://dx.doi.org/10.1371/journal.pone.0086208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465962	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100126
J	Kamika, I; Momba, MNB				Kamika, Ilunga; Momba, Maggie N. B.			Microbial Diversity of Emalahleni Mine Water in South Africa and Tolerance Ability of the Predominant Organism to Vanadium and Nickel	PLOS ONE			English	Article							HEAVY-METALS; SP-NOV.; BACTERIAL; RESISTANCE; WASTE; ACCUMULATION; METAGENOMICS; CADMIUM; STRAINS; LEAD	The present study aims firstly at determining the microbial diversity of mine-water collected in Emalahleni, South Africa and secondly isolating and characterizing the most dominant bacterial species found in the mine water in terms of its resistance to both V5+ and Ni2+ in a modified wastewater liquid media. The results revealed a microbial diversity of 17 orders, 27 families and 33 genera were found in the mine-water samples with Marinobacteria (47.02%) and Anabaena (17.66%) being the most abundant genera. Considering their abundance in the mine-water samples, a species of the Marinobacter genera was isolated, identified, and characterised for metal tolerance and removal ability. The MWI-1 isolate (Marinobacter sp. MWI1 [AB793286]) was found to be closely related to Marinobacter goseongensis at 97% of similarity. The isolate was exposed to various concentrations of Ni2+ and V5+ in wastewater liquid media and its tolerance to metals was also assessed. The MWI-1 isolate could tolerate V5+ and Ni2+ separately at concentrations (in terms of MIC) up to 13.41 +/- 0.56 mM and 5.39 +/- 0.5 mM at pH 7, whereas at pH 3, the tolerance limit decrease to 11.45 +/- 0.57 mM and 2.67 +/- 0.1 mM, respectively. The removal of V5+ and Ni2+ in liquid media was noted to gradually decrease with a gradual increase of the test metals. A significant difference (p<0.05) between V5+ and Ni2+ removal was noted. Marinobacter sp. MWI-1 achieved the maximum permissible limit of 0.1 mg-V5+/L prescribed by UN-FAO at 100 mg/L, while at 200 mg/L only V5+ was removed at approximately 95% and Ni2+ at 47%. This study suggests that mine-water indigenous microorganisms are the best solution for the remediation of polluted mine water.	[Kamika, Ilunga; Momba, Maggie N. B.] Tshwane Univ Technol, Fac Sci, Dept Environm Water & Earth Sci, Pretoria, Gauteng, South Africa	Tshwane University of Technology	Momba, MNB (corresponding author), Tshwane Univ Technol, Fac Sci, Dept Environm Water & Earth Sci, Pretoria, Gauteng, South Africa.	mombamnb@tut.ac.za	Kamika, Ilunga/AAY-2838-2021; Kamika, Ilunga/AEP-6948-2022	Momba, Maggy/0000-0003-3537-0354; KAMIKA, ILUNGA/0000-0001-6350-2647	National Research Foundation (NRF) [M590]	National Research Foundation (NRF)	The authors are grateful to the National Research Foundation (NRF) for the funding of this project (Grant number: M590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RA, 2007, ECON PEACE SECUR J, V2, P33; Amin SA, 2012, BIOMETALS, V25, P135, DOI 10.1007/s10534-011-9491-9; [Anonymous], 1984, GOVT GAZETTE, V9225; APHA, 2001, STANDARD METHODS EXA; Aslam Z., 2010, CROP ENV, V1, P59; Ayers R. S., 1985, FAO Irrigation and Drainage Paper; Christensen B, 1996, WATER RES, V30, P1617, DOI 10.1016/0043-1354(96)00049-8; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; DUXBURY T, 1981, FEMS MICROBIOL LETT, V11, P217; Gray NF, 2007, WATER ENVIRON J, V10, P332; Guo B, 2007, INT J SYST EVOL MICR, V57, P1970, DOI 10.1099/ijs.0.65030-0; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; He ZG, 2007, J BASIC MICROB, V47, P485, DOI 10.1002/jobm.200700219; Huu NB, 1999, INT J SYST BACTERIOL, V49, P367, DOI 10.1099/00207713-49-2-367; Johnson DB, 2003, RES MICROBIOL, V154, P466, DOI 10.1016/S0923-2508(03)00114-1; Kamika I, 2011, SCI TOTAL ENVIRON, V410, P172, DOI 10.1016/j.scitotenv.2011.09.060; Kamika I, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-28; Kuang J-L, 2012, ISME J, V139, P1; Lameiras S, 2008, BIORESOURCE TECHNOL, V99, P801, DOI 10.1016/j.biortech.2007.01.040; Liao SJ, 2013, GEOMICROBIOL J, V30, P150, DOI 10.1080/01490451.2011.654379; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lyer A, 2004, MAR POLLUT B, V50, P340; Madoni P, 1996, WATER RES, V30, P135, DOI 10.1016/0043-1354(95)00124-4; Malik A, 2000, WORLD J MICROB BIOT, V16, P177, DOI 10.1023/A:1008905902282; Momba MNB, 1996, WATER RES, V30, P364, DOI 10.1016/0043-1354(95)00190-5; Naz N, 2005, APPL ENVIRON MICROB, V71, P4610, DOI 10.1128/AEM.71.8.4610-4618.2005; Oarga Andreea, 2009, Revista de Biologia e Ciencias da Terra, V9, P1; Oelofse S, 2009, MINING ENV HLTH CONC, P84; Raji AI, 2008, BIOKEMISTRI, V20, P53; Rantsiou K, 2005, APPL ENVIRON MICROB, V71, P1977, DOI 10.1128/AEM.71.4.1977-1986.2005; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Roh SW, 2008, INT J SYST EVOL MICR, V58, P2866, DOI 10.1099/ijs.0.65522-0; Shirdam Ravanbakhsh, 2006, Iranian Journal of Biotechnology, V4, P180; Singer E, 2011, APPL ENVIRON MICROB, V77, P2763, DOI 10.1128/AEM.01866-10; Tekere M, 2011, AFR J BIOTECHNOL, V10, P18005, DOI 10.5897/AJB11.899; Tuffin IM, 2006, APPL ENVIRON MICROB, V72, P2247, DOI 10.1128/AEM.72.3.2247-2253.2006; Tunali S, 2006, CHEM ENG J, V115, P203, DOI 10.1016/j.cej.2005.09.023; US-EPA, 2006, 402R06011 USEPA; Wang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027597; Zhou ZJ, 2010, T NONFERR METAL SOC, V20, P1097, DOI 10.1016/S1003-6326(09)60263-6; Zucconi L, 2003, BIOL FERT SOILS, V37, P17, DOI 10.1007/s00374-002-0555-4	41	24	25	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86189	10.1371/journal.pone.0086189	http://dx.doi.org/10.1371/journal.pone.0086189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465951	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100123
J	Kokten, T; Becavin, T; Keller, L; Weickert, JL; Kuchler-Bopp, S; Lesot, H				Koekten, Tunay; Becavin, Thibault; Keller, Laetitia; Weickert, Jean-Luc; Kuchler-Bopp, Sabine; Lesot, Herve			Immunomodulation Stimulates the Innervation of Engineered Tooth Organ	PLOS ONE			English	Article							CYCLOSPORINE-A; IN-VITRO; CALCINEURIN INHIBITORS; DENTAL MESENCHYME; GROWTH-FACTOR; NERVE-FIBERS; TEETH; EXPRESSION; MOUSE; PULP	The sensory innervation of the dental mesenchyme is essential for tooth function and protection. Sensory innervation of the dental pulp is mediated by axons originating from the trigeminal ganglia and is strictly regulated in time. Teeth can develop from cultured re-associations between dissociated dental epithelial and mesenchymal cells from Embryonic Day 14 mouse molars, after implantation under the skin of adult ICR mice. In these conditions however, the innervation of the dental mesenchyme did not occur spontaneously. In order to go further with this question, complementary experimental approaches were designed. Cultured cell re-associations were implanted together with trigeminal ganglia for one or two weeks. Although axonal growth was regularly observed extending from the trigeminal ganglia to all around the forming teeth, the presence of axons in the dental mesenchyme was detected in less than 2.5% of samples after two weeks, demonstrating a specific impairment of their entering the dental mesenchyme. In clinical context, immunosuppressive therapy using cyclosporin A was found to accelerate the innervation of transplanted tissues. Indeed, when cultured cell re-associations and trigeminal ganglia were co-implanted in cyclosporin A-treated ICR mice, nerve fibers were detected in the dental pulp, even reaching odontoblasts after one week. However, cyclosporin A shows multiple effects, including direct ones on nerve growth. To test whether there may be a direct functional relationship between immunomodulation and innervation, cell re-associations and trigeminal ganglia were co-implanted in immunocompromised Nude mice. In these conditions as well, the innervation of the dental mesenchyme was observed already after one week of implantation, but axons reached the odontoblast layer after two weeks only. This study demonstrated that immunodepression per se does stimulate the innervation of the dental mesenchyme.	[Koekten, Tunay; Becavin, Thibault; Keller, Laetitia; Kuchler-Bopp, Sabine; Lesot, Herve] Univ Strasbourg, Fac Med, Team Osteoarticular & Dent Regenerat NanoMed, Unite Mixte Rech UMR 1109,INSERM, Strasbourg, France; [Koekten, Tunay; Kuchler-Bopp, Sabine; Lesot, Herve] Univ Strasbourg, Fac Chirurg Dent, Strasbourg, France; [Weickert, Jean-Luc] Univ Strasbourg, IGBMC, INSERM, UniteU964,Serv Microscopie Elect,CNRS,UMR1704, Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lesot, H (corresponding author), Univ Strasbourg, Fac Med, Team Osteoarticular & Dent Regenerat NanoMed, Unite Mixte Rech UMR 1109,INSERM, Strasbourg, France.	lesot@unistra.fr	Kuchler-Bopp, Sabine/P-2060-2018; Lesot, Herve/AAM-4523-2021	Kuchler-Bopp, Sabine/0000-0002-7497-1200	Dental School from the Universite de Strasbourg; ANR	Dental School from the Universite de Strasbourg; ANR(French National Research Agency (ANR))	Tunay Kokten was funded by the Dental School from the Universite de Strasbourg. This work was partially supported by the project NanoOscar from the ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchabahian A, 1998, RESTOR NEUROL NEUROS, V13, P129; BRABLETZ T, 1993, MOL CELL BIOL, V13, P1155, DOI 10.1128/MCB.13.2.1155; Byers MR, 1999, CRIT REV ORAL BIOL M, V10, P4, DOI 10.1177/10454411990100010101; Byers MR, 2003, MICROSC RES TECHNIQ, V60, P503, DOI 10.1002/jemt.10291; Descazeaud V, 2012, J CELL MOL MED, V16, P218, DOI 10.1111/j.1582-4934.2011.01398.x; Farahani RM, 2011, J COMP NEUROL, V519, P3306, DOI 10.1002/cne.22701; Fried K, 2000, CRIT REV ORAL BIOL M, V11, P318, DOI 10.1177/10454411000110030301; FRIED K, 1992, BRAIN RES, V572, P19, DOI 10.1016/0006-8993(92)90445-F; Hu B, 2005, ARCH ORAL BIOL, V50, P131, DOI 10.1016/j.archoralbio.2004.09.007; Hu B, 2005, J DENT RES, V84, P521, DOI 10.1177/154405910508400607; Hu B, 2006, TISSUE ENG, V12, P2069, DOI 10.1089/ten.2006.12.2069; Ibarra A, 2007, BRAIN RES, V1149, P200, DOI 10.1016/j.brainres.2007.02.056; Iohara Koichiro, 2013, Stem Cells Transl Med, V2, P818, DOI 10.5966/sctm.2012-0132erratum; ISHIZUKA H, 1992, ARCH HISTOL CYTOL, V55, P167, DOI 10.1679/aohc.55.167; Keller L, 2013, STEM CELLS IN CRANIOFACIAL DEVELOPMENT AND REGENERATION, P431; Keller LV, 2012, INT J DEV BIOL, V56, P737, DOI 10.1387/ijdb.120076hl; Kettunen P, 2005, DEVELOPMENT, V132, P323, DOI 10.1242/dev.01541; Lautermilch NJ, 2000, J NEUROSCI, V20, P315, DOI 10.1523/JNEUROSCI.20-01-00315.2000; Lechguer AN, 2011, J DENT RES, V90, P583, DOI 10.1177/0022034510391796; Lechguer AN, 2008, J DENT RES, V87, P1138, DOI 10.1177/154405910808701216; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Lillesaar C, 2004, NEUROSCIENCE, V125, P149, DOI 10.1016/j.neuroscience.2004.01.008; Magloire H, 2010, J OROFAC PAIN, V24, P335; Miroux C, 2012, TRANSPLANTATION, V94, P123, DOI 10.1097/TP.0b013e3182590d8f; MOHAMED SS, 1983, J ANAT, V136, P735; Nakagawa E, 2009, J DENT RES, V88, P219, DOI 10.1177/0022034509333198; NAKAKURAOHSHIMA K, 1995, J COMP NEUROL, V362, P551, DOI 10.1002/cne.903620409; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Ohazama A, 2004, J DENT RES, V83, P518, DOI 10.1177/154405910408300702; Oshima M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021531; Oshima S, 2012, EUR J ORAL SCI, V120, P386, DOI 10.1111/j.1600-0722.2012.00987.x; Pool M, 2012, MOL CELL NEUROSCI, V49, P68, DOI 10.1016/j.mcn.2011.09.004; Qian XB, 1996, ARCH ORAL BIOL, V41, P359, DOI 10.1016/0003-9969(95)00128-X; Quispe-Salcedo A, 2012, BIOMED RES-TOKYO, V33, P119, DOI 10.2220/biomedres.33.119; Rush D, 2013, TRANSPLANT REV-ORLAN, V27, P93, DOI 10.1016/j.trre.2013.04.003; Shin GT, 1998, TRANSPLANTATION, V65, P313, DOI 10.1097/00007890-199802150-00003; Siemionow M, 2011, PLAST RECONSTR SURG, V127, P1875, DOI 10.1097/PRS.0b013e31820e90c3; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Takahashi C, 2010, IN VITRO CELL DEV-AN, V46, P457, DOI 10.1007/s11626-009-9265-7; Terling C, 1995, INT J DEV BIOL, V39, P947; Volponi AA, 2013, J DENT RES, V92, P329, DOI 10.1177/0022034513481041; Wang BM, 2010, DEV BIOL, V344, P795, DOI 10.1016/j.ydbio.2010.05.511; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Zor F, 2010, TRANSPL INT, V23, P649, DOI 10.1111/j.1432-2277.2009.01032.x	44	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86011	10.1371/journal.pone.0086011	http://dx.doi.org/10.1371/journal.pone.0086011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465840	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100095
J	Tang, PC; Watson, GM				Tang, Pei-Ciao; Watson, Glen M.			Cadherin-23 May Be Dynamic in Hair Bundles of the Model Sea Anemone Nematostella vectensis	PLOS ONE			English	Article							TIP-LINK; MECHANOELECTRICAL TRANSDUCTION; CELLS; CHANNELS; MECHANOTRANSDUCTION; LOCALIZATION; STEREOCILIA; MECHANORECEPTORS; ADAPTATION; MUTATIONS	Cadherin 23 (CDH23), a component of tip links in hair cells of vertebrate animals, is essential to mechanotransduction by hair cells in the inner ear. A homolog of CDH23 occurs in hair bundles of sea anemones. Anemone hair bundles are located on the tentacles where they detect the swimming movements of nearby prey. The anemone CDH23 is predicted to be a large polypeptide featuring a short exoplasmic C-terminal domain that is unique to sea anemones. Experimentally masking this domain with antibodies or mimicking this domain with free peptide rapidly disrupts mechanotransduction and morphology of anemone hair bundles. The loss of normal morphology is accompanied, or followed by a decrease in F-actin in stereocilia of the hair bundles. These effects were observed at very low concentrations of the reagents, 0.1-10 nM, and within minutes of exposure. The results presented herein suggest that: (1) the interaction between CDH23 and molecular partners on stereocilia of hair bundles is dynamic and; (2) the interaction is crucial for normal mechanotransduction and morphology of hair bundles.	[Tang, Pei-Ciao; Watson, Glen M.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA	University of Louisiana Lafayette	Watson, GM (corresponding author), Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA.	gmw5722@louisiana.edu						ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; Di Palma F, 2001, GENE, V281, P31, DOI 10.1016/S0378-1119(01)00761-2; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99; HUDSPETH AJ, 1985, SCIENCE, V230, P745, DOI 10.1126/science.2414845; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Mahoney JL, 2011, J COMP PHYSIOL A, V197, P729, DOI 10.1007/s00359-011-0636-7; Meyer J, 1998, J NEUROSCI, V18, P6748; Mire P, 2002, HEARING RES, V163, P111, DOI 10.1016/S0378-5955(01)00392-6; Mire P, 1997, HEARING RES, V113, P224, DOI 10.1016/S0378-5955(97)00145-7; MIRETHIBODEAUX P, 1994, J EXP ZOOL, V268, P282, DOI 10.1002/jez.1402680404; Muller U, 2008, CURR OPIN CELL BIOL, V20, P557, DOI 10.1016/j.ceb.2008.06.004; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; TILNEY LG, 1992, DEVELOPMENT, V116, P213; Tsuprun V, 2004, BIOPHYS J, V87, P4106, DOI 10.1529/biophysj.104.049031; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Watson GM, 2008, J COMP PHYSIOL A, V194, P811, DOI 10.1007/s00359-008-0352-0; Watson GM, 2009, MAR BIOL, V156, P2129, DOI 10.1007/s00227-009-1243-9; Watson GM, 2001, J NEUROCYTOL, V30, P895, DOI 10.1023/A:1020665116719; Watson GM, 1998, HEARING RES, V115, P119, DOI 10.1016/S0378-5955(97)00185-8; WATSON GM, 1995, CELL MOTIL CYTOSKEL, V30, P208, DOI 10.1002/cm.970300305; WATSON GM, 1989, SCIENCE, V243, P1589, DOI 10.1126/science.2564698; Watson GM, 1998, J EXP ZOOL, V281, P582; Watson GM, 1997, HEARING RES, V107, P53, DOI 10.1016/S0378-5955(97)00022-1	41	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86084	10.1371/journal.pone.0086084	http://dx.doi.org/10.1371/journal.pone.0086084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465885	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100104
J	Carstensen, M; Wiza, C; Rohrig, K; Fahlbusch, P; Roden, M; Herder, C; Ouwens, DM				Carstensen, Maren; Wiza, Claudia; Roehrig, Karin; Fahlbusch, Pia; Roden, Michael; Herder, Christian; Ouwens, D. Margriet			Effect of Sfrp5 on Cytokine Release and Insulin Action in Primary Human Adipocytes and Skeletal Muscle Cells	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; OBESITY; RESISTANCE; PHOSPHORYLATION; INHIBITION; PATHWAY; PRAS40; GENE; AKT	Secreted frizzled-related protein 5 (Sfrp5) is an adipokine with anti-inflammatory and insulin-sensitizing properties in mice. However, the mechanism of Sfrp5 action, especially in humans, is largely unknown. Therefore, cytokine release and insulin signaling were analyzed to investigate the impact of Sfrp5 on inflammation and insulin signaling in primary human adipocytes and skeletal muscle cells (hSkMC). Sfrp5 neither affected interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1) and adiponectin release from human adipocytes, nor IL-6 and IL-8 release from hSkMC. In tumor necrosis factor (TNF) alpha-treated adipocytes, Sfrp5 reduced IL-6 release by 49% (p, 0.05), but did not affect MCP-1 and adiponectin release. In MCP-1-treated hSkMC, Sfrp5 did not affect cytokine secretion. In untreated adipocytes, Sfrp5 decreased the insulin-mediated phosphorylation of Akt-Ser473, Akt-Thr308, GSK3 alpha-Ser21 and PRAS40-Thr246 by 34% (p<0.01), 31% (p<0.05), 37% (p<0.05) and 34% (p<0.01), respectively, and the stimulation of glucose uptake by 25% (p<0.05). Incubation with TNF alpha increased the phosphorylation of JNK and NF kappa B, and impaired insulin signaling. When Sfrp5 and TNF alpha were combined, there was no additional effect on insulin signaling and JNK phosphorylation, but phosphorylation of NF kappa B was reversed to basal levels. Sfrp5 had no effect on insulin signaling in untreated or in MCP-1 treated hSkMC. Thus, Sfrp5 lowered IL-6 release and NF kappa B phosphorylation in cytokine-treated human adipocytes, but not under normal conditions, and decreased insulin signaling in untreated human adipocytes. Sfrp5 did not act on hSkMC. Therefore, the cellular actions of Sfrp5 seem to depend on the type of tissue as well as its inflammatory and metabolic state.	[Carstensen, Maren; Roehrig, Karin; Roden, Michael; Herder, Christian] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Carstensen, Maren; Wiza, Claudia; Roehrig, Karin; Fahlbusch, Pia; Roden, Michael; Herder, Christian; Ouwens, D. Margriet] German Ctr Diabet Res DZD, Dusseldorf, Germany; [Wiza, Claudia; Fahlbusch, Pia; Ouwens, D. Margriet] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Dusseldorf, Germany; [Roden, Michael] Univ Hosp Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Ouwens, D. Margriet] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Ghent University; Ghent University Hospital	Herder, C (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.	christian.herder@ddz.uni-duesseldorf.de	Roden, Michael/AAD-3843-2019; Ouwens, Margriet/H-2442-2013	Fahlbusch, Pia/0000-0002-4912-1722; Ouwens, Margriet/0000-0001-6709-2702	German Diabetes Association (DDG Allgemeine Projektforderung); German Federal Ministry of Health; Ministry of Innovation, Science and Research of the state North Rhine-Westphalia; German Federal Ministry of Education and Research (BMBF)	German Diabetes Association (DDG Allgemeine Projektforderung); German Federal Ministry of Health; Ministry of Innovation, Science and Research of the state North Rhine-Westphalia; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by a grant of the German Diabetes Association (DDG Allgemeine Projektforderung 2012) to Maren Carstensen. The German Diabetes Center was supported by the German Federal Ministry of Health and the Ministry of Innovation, Science and Research of the state North Rhine-Westphalia. This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Carstensen M, 2013, EUR J CLIN INVEST, V43, P350, DOI 10.1111/eci.12052; Ehrlund A, 2013, J CLIN ENDOCR METAB, V98, pE503, DOI 10.1210/jc.2012-3416; Herder C, 2013, DIABETES OBES METAB, V15, P39, DOI 10.1111/dom.12155; Hu WJ, 2013, J CLIN ENDOCR METAB, V98, P290, DOI 10.1210/jc.2012-2466; Hu ZP, 2013, DIABETES RES CLIN PR, V99, P391, DOI 10.1016/j.diabres.2012.11.026; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Lagathu C, 2009, DIABETES, V58, P609, DOI 10.2337/db08-1180; Lappas M, 2005, ENDOCRINOLOGY, V146, P1491, DOI 10.1210/en.2004-0809; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Lu YC, 2013, DIABETES-METAB RES, V29, P551, DOI 10.1002/dmrr.2426; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Oh DY, 2010, SCIENCE, V329, P397, DOI 10.1126/science.1193404; Okada Yuko, 2009, Kobe J Med Sci, V54, pE241; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Stuckenholz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062470; Wiza C, 2013, DIABETOLOGIA, V56, P1118, DOI 10.1007/s00125-013-2861-9; Wiza C, 2012, AM J PHYSIOL-ENDOC M, V302, pE1453, DOI 10.1152/ajpendo.00660.2011	23	32	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85906	10.1371/journal.pone.0085906	http://dx.doi.org/10.1371/journal.pone.0085906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465779	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500139
J	Gorrasi, A; Santi, AL; Amodio, G; Alfano, D; Remondelli, P; Montuori, N; Ragno, P				Gorrasi, Anna; Santi, Anna Li; Amodio, Giuseppina; Alfano, Daniela; Remondelli, Paolo; Montuori, Nunzia; Ragno, Pia			The Urokinase Receptor Takes Control of Cell Migration by Recruiting Integrins and FPR1 on the Cell Surface	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; FORMYL-PEPTIDE RECEPTORS; GROWTH-FACTOR RECEPTORS; MONOCYTE CHEMOTAXIS; UPAR; ADHESION; MOLECULES; CLEAVAGE; BIOLOGY; LIGAND	The receptor (uPAR) of the urokinase-type plasminogen activator (uPA) is crucial in cell migration since it concentrates uPA proteolytic activity at the cell surface, binds vitronectin and associates to integrins. uPAR cross-talk with receptors for the formylated peptide fMLF (fMLF-Rs) has been reported; however, cell-surface uPAR association to fMLF-Rs on the cell membrane has never been explored in detail. We now show that uPAR co-localizes at the cell-surface and co-immunoprecipitates with the high-affinity fMLF-R, FPR1, in uPAR-transfected HEK-293 (uPAR-293) cells. uPAR/beta 1 integrin and FPR1/beta 1 integrin co-localization was also observed. Serum or the WKYMVm peptide (W Pep), a FPR1 ligand, strongly increased all observed co-localizations in uPAR-293 cells, including FPR1/beta 1 integrin co-localization. By contrast, a low FPR1/beta 1 integrin co-localization was observed in uPAR-negative vector-transfected HEK-293 (V-293) cells, that was not increased by serum or W Pep stimulations. The role of uPAR interactions in cell migration was then explored. Both uPAR-293 and V293 control cells efficiently migrated toward serum or purified EGF. However, cell treatments impairing uPAR interactions with fMLF-Rs or integrins, or inhibiting specific cell-signaling mediators abrogated uPAR-293 cell migration, without exerting any effect on V-293 control cells. Accordingly, uPAR depletion by a uPAR-targeting siRNA or uPAR blocking with an anti-uPAR polyclonal antibody in cells constitutively expressing high uPAR levels totally impaired their migration toward serum. Altogether, these results suggest that both uPAR-positive and uPAR-negative cells are able to migrate toward serum; however, uPAR expression renders cell migration totally and irreversibly uPAR-dependent, since it is completely inhibited by uPAR blocking. We propose that uPAR takes control of cell migration by recruiting fMLF-Rs and beta 1 integrins, thus promoting their co-localization at the cell-surface and driving pro-migratory signaling pathways.	[Gorrasi, Anna; Santi, Anna Li; Alfano, Daniela; Ragno, Pia] Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy; [Amodio, Giuseppina; Remondelli, Paolo] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy; [Montuori, Nunzia] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy	University of Salerno; University of Salerno; University of Naples Federico II	Ragno, P (corresponding author), Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy.	pragno@unisa.it	Remondelli, Paolo/X-7805-2019; Santi, Anna Li/AAS-9058-2020; Amodio, Giuseppina/J-8755-2018	Amodio, Giuseppina/0000-0001-8971-8964; Montuori, Nunzia/0000-0001-8697-986X; REMONDELLI, Paolo/0000-0002-3698-3497	Associazione Italiana per la Ricerca sul Cancro(AIRC) [IG 4714]; University of Salerno,FARB [ORSA113852]	Associazione Italiana per la Ricerca sul Cancro(AIRC)(Fondazione AIRC per la ricerca sul cancro); University of Salerno,FARB	Associazione Italiana per la Ricerca sul Cancro(AIRC, IG 4714) University of Salerno,FARB 2011 (ORSA113852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano D, 2012, J CELL SCI, V125, P2369, DOI 10.1242/jcs.091579; Bifulco K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044806; BOHUSLAV J, 1995, J EXP MED, V181, P1381, DOI 10.1084/jem.181.4.1381; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; Campbell JJ, 1996, J CELL BIOL, V134, P255, DOI 10.1083/jcb.134.1.255; Chaurasia P, 2006, J BIOL CHEM, V281, P14852, DOI 10.1074/jbc.M512311200; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Degryse B, 2005, J BIOL CHEM, V280, P24792, DOI 10.1074/jbc.M413954200; Eden G, 2011, CURR PHARM DESIGN, V17, P1874, DOI 10.2174/138161211796718215; El Zein N, 2010, CELL SIGNAL, V22, P1437, DOI 10.1016/j.cellsig.2010.05.012; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; Furlan F, 2004, J CELL SCI, V117, P2909, DOI 10.1242/jcs.01149; GYETKO MR, 1994, J CLIN INVEST, V93, P1380, DOI 10.1172/JCI117114; Hoyer-Hansen G, 2001, BIOCHEM J, V358, P673, DOI 10.1042/0264-6021:3580673; Huang J, 2007, CANCER RES, V67, P5906, DOI 10.1158/0008-5472.CAN-07-0691; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Li YS, 2013, J MOL MED, V91, P781, DOI 10.1007/s00109-013-1005-5; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Mazzieri R, 2006, MOL BIOL CELL, V17, P367, DOI 10.1091/mbc.E05-07-0635; Miettinen HM, 1998, J CELL SCI, V111, P1921; Montuori N, 2012, Infez Med, V20 Suppl 2, P13; Montuori N, 2005, THROMB HAEMOSTASIS, V93, P192, DOI 10.1160/TH04-09-0580; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Montuori N, 2013, THROMB HAEMOSTASIS, V109, P309, DOI 10.1160/TH12-08-0546; Montuori N, 2011, CELL MOL LIFE SCI, V68, P2453, DOI 10.1007/s00018-010-0564-7; Montuori N, 2009, FRONT BIOSCI-LANDMRK, V14, P2494, DOI 10.2741/3392; Ragno P, 2006, CELL MOL LIFE SCI, V63, P1028, DOI 10.1007/s00018-005-5428-1; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Sadhu C, 1998, J IMMUNOL, V160, P5622; Selleri C, 2005, BLOOD, V105, P2198, DOI 10.1182/blood-2004-06-2424; Selleri C, 2006, CANCER RES, V66, P10885, DOI 10.1158/0008-5472.CAN-06-1311; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Tang CH, 2008, CELL MOL LIFE SCI, V65, P1916, DOI 10.1007/s00018-008-7573-9; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75	40	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86352	10.1371/journal.pone.0086352	http://dx.doi.org/10.1371/journal.pone.0086352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466048	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500237
J	Herrera, VL; Decano, JL; Tan, GA; Moran, AM; Pasion, KA; Matsubara, Y; Ruiz-Opazo, N				Herrera, Victoria L.; Decano, Julius L.; Tan, Glaiza A.; Moran, Ann M.; Pasion, Khristine A.; Matsubara, Yuichi; Ruiz-Opazo, Nelson			DEspR Roles in Tumor Vasculo-Angiogenesis, Invasiveness, CSC-Survival and Anoikis Resistance: A 'Common Receptor Coordinator' Paradigm	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER STEM-CELLS; EMBRYONIC LETHALITY; UBIQUITIN LIGASE; HYPOXIA; TRANSCRIPTION; EXPRESSION; GENE; SRC; NICHE	A priori, a common receptor induced in tumor microvessels, cancer cells and cancer stem-like cells (CSCs) that is involved in tumor angiogenesis, invasiveness, and CSC anoikis resistance and survival, could underlie contemporaneous coordination of these events rather than assume stochasticity. Here we show that functional analysis of the dual endothelin1/VEGFsignal peptide receptor, DEspR, (formerly named Dear, Chr.4q31.2) supports the putative common receptor paradigm in pancreatic ductal adenocarcinoma (PDAC) and glioblastoma (GBM) selected for their invasiveness, CD133+CSCs, and polar angiogenic features. Unlike normal tissue, DEspR is detected in PDAC and GBM microvessels, tumor cells, and CSCs isolated from PDAC-Panc1 and GBM-U87 cells. DEspR-inhibition decreased angiogenesis, invasiveness, CSC-survival and anoikis resistance in vitro, and decreased Panc1-CSC and U87-CSC xenograft tumor growth, vasculo-angiogenesis and invasiveness in nude nu/nu rats, suggesting that DEspR activation would coordinate these tumor progression events. As an accessible, cell-surface 'common receptor coordinator', DEspR-inhibition defines a novel targeted-therapy paradigm for pancreatic cancer and glioblastoma.	[Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Boston University; Boston University	Ruiz-Opazo, N (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	nruizo@bu.edu			Boston University (BU) Office of Technology; BU Clinical and Translational Science Institute, National Institutes of Health (NIH) [UL1RR025771]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771] Funding Source: NIH RePORTER	Boston University (BU) Office of Technology; BU Clinical and Translational Science Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Phase-I and Phase-II Ignition Awards from the Boston University (BU) Office of Technology, and Phase-I and Phase-II Clinical and Translational Science Awards from BU Clinical and Translational Science Institute, National Institutes of Health (NIH) grant UL1RR025771. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Bao B, 2012, BBA-REV CANCER, V1826, P272, DOI 10.1016/j.bbcan.2012.04.008; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Basson MD, 2008, CANCER RES, V68, P2, DOI 10.1158/0008-5472.CAN-07-2992; Bolos V, 2010, ONCOTARGETS THER, V3, P83; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Bunger S, 2012, EUR SURG RES, V49, P88, DOI 10.1159/000341669; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Cheng YB, 2012, CANCER METAST REV, V31, P75, DOI 10.1007/s10555-011-9330-z; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Decano JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055222; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fox JC, 1998, BRIT J CANCER, V77, P1267, DOI 10.1038/bjc.1998.212; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Glorioso N, 2007, CIRC RES, V100, P1522, DOI 10.1161/01.RES.0000267716.96196.60; Glorioso N, 2011, PHYSIOL GENOMICS, V43, P1219, DOI 10.1152/physiolgenomics.00012.2011; Gou SM, 2007, PANCREAS, V34, P429, DOI 10.1097/MPA.0b013e318033f9f4; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He H, 2012, ONCOL REP, V27, P45, DOI 10.3892/or.2011.1484; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Herrera VLM, 2008, PHYSIOL GENOMICS, V35, P316, DOI 10.1152/physiolgenomics.00044.2008; Herrera VLM, 2005, PHYSIOL GENOMICS, V23, P257, DOI 10.1152/physiolgenomics.00144.2005; Hiscox S, 2008, EXPERT OPIN THER TAR, V12, P757, DOI [10.1517/14728222.12.6.757, 10.1517/14728222.12.6.757 ]; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; Jiang BH, 1997, CANCER RES, V57, P5328; Kang HJ, 2006, J BIOL CHEM, V281, P13047, DOI 10.1074/jbc.M513033200; Li Y, 2012, CANC LETT; Li ZZ, 2010, CURR TOP MICROBIOL, V345, P21, DOI 10.1007/82_2010_75; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Long BJ, 2004, JNCI-J NATL CANCER I, V96, P456, DOI 10.1093/jnci/djh076; Matsuo Y, 2009, INT J CANCER, V125, P1027, DOI 10.1002/ijc.24383; Monti DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029794; Narazaki M, 2006, JNCI-J NATL CANCER I, V98, P294, DOI 10.1093/jnci/djj099; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Pezzolo A, 2007, J CLIN ONCOL, V25, P376, DOI 10.1200/JCO.2006.09.0696; Rak Janusz, 1999, Neoplasia (New York), V1, P23, DOI 10.1038/sj.neo.7900001; RAK JW, 1995, ANTI-CANCER DRUG, V6, P3, DOI 10.1097/00001813-199502000-00001; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rowher N, 2008, CANCER RES, V68, P10113; Ruiz-Opazo N, 2002, MOL MED, V8, P24, DOI 10.1007/BF03402000; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Smalley M, 2013, CANCER LETT, V338, P57, DOI 10.1016/j.canlet.2012.04.023; Tan K, 2013, J CANCER RES CLIN, V139, P1795, DOI 10.1007/s00432-013-1482-5; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yin T, 2011, INT J MOL SCI, V12, P1595, DOI 10.3390/ijms12031595; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Zhang L, 2011, ACTA PHARMACOL SIN, V32, P361, DOI 10.1038/aps.2010.213; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhao Y, 2011, INT J DEV BIOL, V55, P477, DOI 10.1387/ijdb.103225yz; Zhao YG, 2010, AM J PATHOL, V176, P3032, DOI 10.2353/ajpath.2010.090571	62	12	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85821	10.1371/journal.pone.0085821	http://dx.doi.org/10.1371/journal.pone.0085821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465725	Green Submitted, gold, Green Published			2022-12-25	WOS:000330244500119
J	Klein, D; Mendes-Madeira, A; Schlegel, P; Rolling, F; Lorenz, B; Haverkamp, S; Stieger, K				Klein, Daniela; Mendes-Madeira, Alexandra; Schlegel, Patrice; Rolling, Fabienne; Lorenz, Birgit; Haverkamp, Silke; Stieger, Knut			Immuno-Histochemical Analysis of Rod and Cone Reaction to RPE65 Deficiency in the Inferior and Superior Canine Retina	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; HUMAN GENE-THERAPY; PIGMENT EPITHELIUM; BRIARD DOGS; BIPOLAR CELLS; DYSTROPHY; VISION; MODEL; DEGENERATION; MUTATIONS	Mutations in the RPE65 gene are associated with autosomal recessive early onset severe retinal dystrophy. Morphological and functional studies indicate early and dramatic loss of rod photoreceptors and early loss of S-cone function, while L and M cones remain initially functional. The Swedish Briard dog is a naturally occurring animal model for this disease. Detailed information about rod and cone reaction to RPE65 deficiency in this model with regard to their location within the retina remains limited. The aim of this study was to analyze morphological parameters of cone and rod viability in young adult RPE65 deficient dogs in different parts of the retina in order to shed light on local disparities in this disease. In retinae of affected dogs, sprouting of rod bipolar cell dendrites and horizontal cell processes was dramatically increased in the inferior peripheral part of affected retinae, while central inferior and both superior parts did not display significantly increased sprouting. This observation was correlated with photoreceptor cell layer thickness. Interestingly, while L/M cone opsin expression was uniformly reduced both in the superior and inferior part of the retina, S-cone opsin expression loss was less severe in the inferior part of the retina. In summary, in retinae of young adult RPE65 deficient dogs, the degree of rod bipolar and horizontal cell sprouting as well as of S-cone opsin expression depends on the location. As the human retinal pigment epithelium (RPE) is pigmented similar to the RPE in the inferior part of the canine retina, and the kinetics of photoreceptor degeneration in humans seems to be similar to what has been observed in the inferior peripheral retina in dogs, this area should be studied in future gene therapy experiments in this model.	[Klein, Daniela; Lorenz, Birgit; Stieger, Knut] Univ Giessen, Fac Med, Dept Ophthalmol, D-35390 Giessen, Germany; [Mendes-Madeira, Alexandra; Rolling, Fabienne] Univ Nantes, Inst Rech Therapeut 1, INSERM UMR 1089, Nantes, France; [Schlegel, Patrice] Univ Marburg, Fac Math & Comp Sci, Dept Computat Intelligence, Marburg, Germany; [Haverkamp, Silke] Max Planck Inst Brain Res, Frankfurt, Germany	Justus Liebig University Giessen; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Philipps University Marburg; Max Planck Society	Stieger, K (corresponding author), Univ Giessen, Fac Med, Dept Ophthalmol, D-35390 Giessen, Germany.	knut.stieger@augen.med.uni-giessen.de	Stieger, Knut/A-1600-2012	Stieger, Knut/0000-0002-8298-5629	University Medical Center Giessen and Marburg	University Medical Center Giessen and Marburg	This work was supported by a Grant from the University Medical Center Giessen and Marburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aguirre G D, 1998, Mol Vis, V4, P23; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Banin E, 2010, HUM GENE THER, V21, P1749, DOI 10.1089/hum.2010.047; Beltran WA, 2009, VET OPHTHALMOL, V12, P192, DOI 10.1111/j.1463-5224.2009.00694.x; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2010, PROG RETIN EYE RES, V29, P398, DOI 10.1016/j.preteyeres.2010.04.002; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; Eliasieh K, 2007, INVEST OPHTH VIS SCI, V48, P2824, DOI 10.1167/iovs.06-1228; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hernandez M, 2010, INVEST OPHTH VIS SCI, V51, P6793, DOI 10.1167/iovs.10-5213; Jacobson SG, 2008, INVEST OPHTH VIS SCI, V49, P4573, DOI 10.1167/iovs.08-2121; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P2368, DOI 10.1167/iovs.08-2696; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Komaromy AM, 2013, MOL THER, V21, P1131, DOI 10.1038/mt.2013.50; Le Meur G, 2007, GENE THER, V14, P292, DOI 10.1038/sj.gt.3302861; Liets LC, 2006, P NATL ACAD SCI USA, V103, P12156, DOI 10.1073/pnas.0605211103; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Lorenz B, 2004, OPHTHALMOLOGY, V111, P1585, DOI 10.1016/j.ophtha.2004.01.033; Lorenz B, 2008, INVEST OPHTH VIS SCI, V49, P5235, DOI 10.1167/iovs.07-1671; Lorenz B, 2012, INVEST OPHTH VIS SCI, V53, P5641, DOI 10.1167/iovs.12-9974; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Michalakis S, 2013, CELL MOL LIFE SCI, V70, P1831, DOI 10.1007/s00018-012-1230-z; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Mowat FM, 2013, GENE THER, V20, P545, DOI 10.1038/gt.2012.63; Mowat FM, 2008, MOL VIS, V14, P2518; Narfstrom K, 2003, INVEST OPHTH VIS SCI, V44, P1663, DOI 10.1167/iovs.02-0595; NARFSTROM K, 1989, BRIT J OPHTHALMOL, V73, P750, DOI 10.1136/bjo.73.9.750; Ollivier FJ, 2004, VET OPHTHALMOL, V7, P11, DOI 10.1111/j.1463-5224.2004.00318.x; Pang JJ, 2005, MOL VIS, V11, P152; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Samardzija M, 2008, HUM MOL GENET, V17, P281, DOI 10.1093/hmg/ddm304; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Takahashi Y, 2011, FEBS J, V278, P2913, DOI 10.1111/j.1742-4658.2011.08216.x; Tang PH, 2011, J NEUROSCI, V31, P18618, DOI 10.1523/JNEUROSCI.4265-11.2011; Tang PH, 2011, J NEUROSCI, V31, P10403, DOI 10.1523/JNEUROSCI.0182-11.2011; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; WRIGSTAD A, 1992, EXP EYE RES, V55, P805, DOI 10.1016/0014-4835(92)90007-F; WRIGSTAD A, 1994, DOC OPHTHALMOL, V87, P337, DOI 10.1007/BF01203343; Zhang T, 2011, P NATL ACAD SCI USA, V108, P8879, DOI 10.1073/pnas.1017127108	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86304	10.1371/journal.pone.0086304	http://dx.doi.org/10.1371/journal.pone.0086304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466015	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500221
J	Kuhnisch, J; Seto, J; Lange, C; Schrof, S; Stumpp, S; Kobus, K; Grohmann, J; Kossler, N; Varga, P; Osswald, M; Emmerich, D; Tinschert, S; Thielemann, F; Duda, G; Seifert, W; el Khassawna, T; Stevenson, DA; Elefteriou, F; Kornak, U; Raum, K; Fratzl, P; Mundlos, S; Kolanczyk, M				Kuehnisch, Jirko; Seto, Jong; Lange, Claudia; Schrof, Susanne; Stumpp, Sabine; Kobus, Karolina; Grohmann, Julia; Kossler, Nadine; Varga, Peter; Osswald, Monika; Emmerich, Denise; Tinschert, Sigrid; Thielemann, Falk; Duda, Georg; Seifert, Wenke; el Khassawna, Thaqif; Stevenson, David A.; Elefteriou, Florent; Kornak, Uwe; Raum, Kay; Fratzl, Peter; Mundlos, Stefan; Kolanczyk, Mateusz			Multiscale, Converging Defects of Macro-Porosity, Microstructure and Matrix Mineralization Impact Long Bone Fragility in NF1	PLOS ONE			English	Article							NEUROFIBROMATOSIS TYPE-1; CORTICAL BONE; SKELETAL DEVELOPMENT; COMPACT-BONE; I COLLAGEN; GROWTH; OSTEOBLASTS; STRENGTH; DENSITY; PATHWAY	Bone fragility due to osteopenia, osteoporosis or debilitating focal skeletal dysplasias is a frequent observation in the Mendelian disease Neurofibromatosis type 1 (NF1). To determine the mechanisms underlying bone fragility in NF1 we analyzed two conditional mouse models, Nf1Prx1 (limb knock-out) and Nf1Col1 (osteoblast specific knock-out), as well as cortical bone samples from individuals with NF1. We examined mouse bone tissue with micro-computed tomography, qualitative and quantitative histology, mechanical tensile analysis, small-angle X-ray scattering (SAXS), energy dispersive Xray spectroscopy (EDX), and scanning acoustic microscopy (SAM). In cortical bone of Nf1Prx1 mice we detected ectopic blood vessels that were associated with diaphyseal mineralization defects. Defective mineral binding in the proximity of blood vessels was most likely due to impaired bone collagen formation, as these areas were completely devoid of acidic matrix proteins and contained thin collagen fibers. Additionally, we found significantly reduced mechanical strength of the bone material, which was partially caused by increased osteocyte volume. Consistent with these observations, bone samples from individuals with NF1 and tibial dysplasia showed increased osteocyte lacuna volume. Reduced mechanical properties were associated with diminished matrix stiffness, as determined by SAM. In line with these observations, bone tissue from individuals with NF1 and tibial dysplasia showed heterogeneous mineralization and reduced collagen fiber thickness and packaging. Collectively, the data indicate that bone fragility in NF1 tibial dysplasia is partly due to an increased osteocyte-related micro-porosity, hypomineralization, a generalized defect of organic matrix formation, exacerbated in the regions of tensional and bending force integration, and finally persistence of ectopic blood vessels associated with localized macro-porotic bone lesions.	[Kuehnisch, Jirko; Stumpp, Sabine; Emmerich, Denise; Kornak, Uwe; Mundlos, Stefan; Kolanczyk, Mateusz] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Kuehnisch, Jirko; Kobus, Karolina; Grohmann, Julia; Kossler, Nadine; Osswald, Monika; Emmerich, Denise; Kornak, Uwe; Mundlos, Stefan; Kolanczyk, Mateusz] Max Planck Inst Mol Genet, FG Dev & Dis, D-14195 Berlin, Germany; [Seto, Jong; Lange, Claudia; Fratzl, Peter] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Seto, Jong] Univ Konstanz, Dept Chem, Constance, Germany; [Lange, Claudia] Tech Univ Dresden, Inst Physiol Chem, MTZ, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany; [Schrof, Susanne; Varga, Peter; Duda, Georg; Raum, Kay] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Schrof, Susanne; Varga, Peter; Duda, Georg; Raum, Kay] Charite, Brandenburg Sch Regenerat Therapies, D-13353 Berlin, Germany; [Tinschert, Sigrid] Med Univ Innsbruck, Div Humangenet, A-6020 Innsbruck, Austria; [Tinschert, Sigrid] Tech Univ Dresden, Inst Klin Genet, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany; [Thielemann, Falk] Tech Univ Dresden, Klin Orthopadie, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany; [Duda, Georg; Fratzl, Peter; Mundlos, Stefan] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Seifert, Wenke] Charite, Inst Vegetat Anat, D-13353 Berlin, Germany; [el Khassawna, Thaqif] Univ Giessen, Lab Expt Trauma Surg Giessen, D-35390 Giessen, Germany; [Stevenson, David A.] Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT USA; [Elefteriou, Florent] Vanderbilt Univ, Med Ctr, Ctr Bone Biol, Dept Med Pharmacol & Canc Biol, Nashville, TN USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Max Planck Society; University of Konstanz; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Innsbruck; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Justus Liebig University Giessen; Utah System of Higher Education; University of Utah; Vanderbilt University	Kuhnisch, J (corresponding author), Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany.	jirko.kuehnisch@gmx.de; kolanshy@molgen.mpg.de	Elefteriou, Florent/GMW-8429-2022; Fratzl, Peter/H-9095-2012; Duda, Georg N/H-2085-2016; Mundlos, Stefan/ABH-9585-2020; Kühnisch, Jirko/M-3744-2019; Elefteriou, Florent/P-2586-2017; Seifert, Wenke/B-8772-2011; Kühnisch, Jirko/L-7761-2013; khassawna, Thaqif El/J-9748-2013; Raum, Kay/A-5576-2013; Varga, Peter/H-6181-2012	Elefteriou, Florent/0000-0002-2972-5633; Fratzl, Peter/0000-0003-4437-7830; Duda, Georg N/0000-0001-7605-3908; Kühnisch, Jirko/0000-0003-4744-5421; Elefteriou, Florent/0000-0002-2972-5633; khassawna, Thaqif El/0000-0002-1187-8578; Raum, Kay/0000-0003-0573-1622; Varga, Peter/0000-0003-2738-6436; Jahn, Denise/0000-0001-8912-5851; Seifert, Wenke/0000-0003-1432-9862; Mundlos, Stefan/0000-0002-9788-3166	Children Tumour Fundation - New York [2007-01-038]; Bundesministerium fur Bildung und Forschung [NF1-01GM0844]; Sixth Framework of the European Commission, EuroGrow project [LSHM-CT-2007-037471]; Berlin-Brandenburg Center for Regenerative Therapies: ("Optimisation and application of a mouse cortical injury system for the survey of new bone anabolic therapies and delivery systems" - Platform A) [30]; Doris Duke Charitable Foundation Clinical Scientist Development Award; Thrasher Research Fund	Children Tumour Fundation - New York; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Sixth Framework of the European Commission, EuroGrow project; Berlin-Brandenburg Center for Regenerative Therapies: ("Optimisation and application of a mouse cortical injury system for the survey of new bone anabolic therapies and delivery systems" - Platform A); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Thrasher Research Fund	MK and NK were supported by the Young Investigator Award from Children Tumour Fundation - New York, Grant 2007-01-038 and by Bundesministerium fur Bildung und Forschung, Grant NF1-01GM0844 (MK, SM). This work was also supported by the Sixth Framework of the European Commission, EuroGrow project LSHM-CT-2007-037471, and by grant from Berlin-Brandenburg Center for Regenerative Therapies: ("Optimisation and application of a mouse cortical injury system for the survey of new bone anabolic therapies and delivery systems" - Platform A nr-30). DS was supported by a Doris Duke Charitable Foundation Clinical Scientist Development Award and the Thrasher Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan S, 2005, CLIN GENET, V67, P378, DOI 10.1111/j.1399-0004.2005.00410.x; Ascenzi MG, 2012, J BONE MINER RES, V27, P702, DOI 10.1002/jbmr.1497; Chappard D, 2011, OSTEOPOROSIS INT, V22, P2225, DOI 10.1007/s00198-011-1573-6; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Cully M, 2008, CELL, V133, P1292, DOI 10.1016/j.cell.2008.06.020; CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1; Dang I, 2011, NEUROCHEM RES, V36, P1697, DOI 10.1007/s11064-011-0433-2; DAYAN D, 1989, HISTOCHEMISTRY, V93, P27, DOI 10.1007/BF00266843; Dudley AC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006536; El-Hoss J, 2011, J BONE MINER RES; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Franceschi RT, 2009, CELLS TISSUES ORGANS, V189, P144, DOI 10.1159/000151747; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Granke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058043; Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103; Gupta HS, 2005, NANO LETT, V5, P2108, DOI 10.1021/nl051584b; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kawamoto T, 2000, HISTOCHEM CELL BIOL, V113, P331; Kolanczyk M, 2007, HUM MOL GENET, V16, P874, DOI 10.1093/hmg/ddm032; Kolanczyk M, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-21; Kono SJ, 2007, BONE, V40, P68, DOI 10.1016/j.bone.2006.07.024; Kornak U, 2011, JOINT BONE SPINE, V78, P561, DOI 10.1016/j.jbspin.2011.03.020; Kossler N, 2011, HUM MOL GENET, V20, P2697, DOI 10.1093/hmg/ddr149; Kyono A, 2012, J BONE MINER METAB, V30, P19, DOI 10.1007/s00774-011-0288-2; Lakshmanan S, 2007, IEEE T ULTRASON FERR, V54, P1560, DOI 10.1109/TUFFC.2007.426; Lammert M, 2005, OSTEOPOROSIS INT, V16, P1161, DOI 10.1007/s00198-005-1940-2; Lange C, 2011, J STRUCT BIOL, V176, P159, DOI 10.1016/j.jsb.2011.08.003; Larizza L, 2009, CURR MOL MED, V9, P634, DOI 10.2174/156652409788488801; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; McCubrey JA, 2012, ONCOTARGET, V3, P954, DOI 10.18632/oncotarget.652; Ono K, 2013, HUM MOL GENET; Ozawa T, 2005, J BIOL CHEM, V280, P39524, DOI 10.1074/jbc.M503707200; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pascaretti-Grizon F., 2007, Morphologie, V91, P180, DOI 10.1016/j.morpho.2007.10.015; Preininger B, 2011, ULTRASOUND MED BIOL, V37, P474, DOI 10.1016/j.ultrasmedbio.2010.12.007; Raum K, 2006, PHYS MED BIOL, V51, P747, DOI 10.1088/0031-9155/51/3/018; Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/NMAT3115, 10.1038/nmat3115]; SCHAFFLER MB, 1988, J BIOMECH, V21, P13, DOI 10.1016/0021-9290(88)90186-8; Schneider P, 2007, J BONE MINER RES, V22, P1557, DOI 10.1359/JBMR.070703; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Seitz S, 2010, OSTEOPOROSIS INT, V21, P119, DOI 10.1007/s00198-009-0933-y; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Starinsky-Elbaz S, 2009, MOL CELL NEUROSCI, V42, P278, DOI 10.1016/j.mcn.2009.07.014; Stevenson DA, 2009, J PEDIATR ORTHOPED, V29, P385, DOI 10.1097/BPO.0b013e3181a567e3; Tanck E, 2006, J ANAT, V208, P73, DOI 10.1111/j.1469-7580.2006.00503.x; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tucker T, 2009, J MED GENET, V46, P259, DOI 10.1136/jmg.2008.061895; Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WEINER S, 1992, FASEB J, V6, P879, DOI 10.1096/fasebj.6.3.1740237; Xiao LP, 2013, J BONE MINER RES, V28, P35, DOI 10.1002/jbmr.1721	54	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86115	10.1371/journal.pone.0086115	http://dx.doi.org/10.1371/journal.pone.0086115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465906	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500186
J	Liu, WJ; Shiung, HJ; Lo, CF; Leu, JH; Lai, YJ; Lee, TL; Huang, WT; Kou, GH; Chang, YS				Liu, Wang-Jing; Shiung, Hui-Jui; Lo, Chu-Fang; Leu, Jiann-Horng; Lai, Ying-Jang; Lee, Tai-Lin; Huang, Wei-Tung; Kou, Guang-Hsiung; Chang, Yun-Shiang			Characterization and Interactome Study of White Spot Syndrome Virus Envelope Protein VP11	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PENAEUS-MONODON; MAJOR ENVELOPE; STRUCTURAL PROTEINS; PROTEOMIC ANALYSIS; WSSV INFECTION; TIGER SHRIMP; VP26; IDENTIFICATION; ENTRY	White spot syndrome virus (WSSV) is a large enveloped virus. The WSSV viral particle consists of three structural layers that surround its core DNA: an outer envelope, a tegument and a nucleocapsid. Here we characterize the WSSV structural protein VP11 (WSSV394, GenBank accession number AF440570), and use an interactome approach to analyze the possible associations between this protein and an array of other WSSV and host proteins. Temporal transcription analysis showed that vp11 is an early gene. Western blot hybridization of the intact viral particles and fractionation of the viral components, and immunoelectron microscopy showed that VP11 is an envelope protein. Membrane topology software predicted VP11 to be a type of transmembrane protein with a highly hydrophobic transmembrane domain at its N-terminal. Based on an immunofluorescence assay performed on VP11-transfected Sf9 cells and a trypsin digestion analysis of the virion, we conclude that, contrary to topology software prediction, the C-terminal of this protein is in fact inside the virion. Yeast two-hybrid screening combined with co-immunoprecipitation assays found that VP11 directly interacted with at least 12 other WSSV structural proteins as well as itself. An oligomerization assay further showed that VP11 could form dimers. VP11 is also the first reported WSSV structural protein to interact with the major nucleocapsid protein VP664.	[Liu, Wang-Jing] Univ Taipei, Dept Earth & Life Sci, Taipei, Taiwan; [Shiung, Hui-Jui; Lee, Tai-Lin; Huang, Wei-Tung; Chang, Yun-Shiang] Da Yeh Univ, Dept Mol Biotechnol, Changhua, Taiwan; [Lo, Chu-Fang] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Leu, Jiann-Horng] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Leu, Jiann-Horng] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Lai, Ying-Jang] Natl Quemoy Univ, Dept Food Sci, Kinmen, Taiwan; [Kou, Guang-Hsiung] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan	University of Taipei; Da Yeh University; National Cheng Kung University; National Taiwan Ocean University; National Taiwan Ocean University; Academia Sinica - Taiwan; National Taiwan University	Chang, YS (corresponding author), Da Yeh Univ, Dept Mol Biotechnol, Changhua, Taiwan.	yschang@mail.dyu.edu.tw	Lo, Chu-Fang/G-3088-2014	Lo, Chu-Fang/0000-0001-5136-8129	National Science Council [NSC99-2321-B-845-001-MY3, NSC100-2313-B-212-006]	National Science Council(Ministry of Science and Technology, Taiwan)	This investigation was supported financially by National Science Council (http://web1.nsc.gov.tw/) grants under grant numbers NSC99-2321-B-845-001-MY3 and NSC100-2313-B-212-006. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campadelli-Fiume G, 2007, REV MED VIROL, V17, P313, DOI 10.1002/rmv.546; Chang YS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010718; Chang YS, 2008, J VIROL, V82, P12555, DOI 10.1128/JVI.01238-08; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chen J, 2007, VIROLOGY, V364, P208, DOI 10.1016/j.virol.2007.02.030; Chen LL, 2007, DIS AQUAT ORGAN, V74, P171, DOI 10.3354/dao074171; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Fadoulogiou VE, 2008, ANAL BIOCHEM, V373, P404, DOI 10.1016/j.ab.2007.10.027; Herr W, 1998, COLD SPRING HARB SYM, V63, P599, DOI 10.1101/sqb.1998.63.599; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Huang R, 2005, J GEN VIROL, V86, P1357, DOI 10.1099/vir.0.80923-0; Jie ZL, 2008, ARCH VIROL, V153, P2103, DOI 10.1007/s00705-008-0221-8; Kang ST, 2009, VIROLOGY, V387, P353, DOI 10.1016/j.virol.2009.02.012; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar SR, 2008, FISH SHELLFISH IMMUN, V24, P467, DOI 10.1016/j.fsi.2008.01.004; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leu JH, 2008, DEV COMP IMMUNOL, V32, P121, DOI 10.1016/j.dci.2007.05.005; Li LJ, 2006, ARCH VIROL, V151, P1309, DOI 10.1007/s00705-005-0719-2; Li Q, 2012, ACTA VIROL, V56, P57, DOI 10.4149/av_2012_01_57; Li ZJ, 2007, MOL CELL PROTEOMICS, V6, P1609, DOI 10.1074/mcp.M600327-MCP200; Liang Y, 2005, DIS AQUAT ORGAN, V66, P81, DOI 10.3354/dao066081; Liu QH, 2009, DIS AQUAT ORGAN, V85, P23, DOI 10.3354/dao02050; Liu WJ, 2007, J VIROL, V81, P1461, DOI 10.1128/JVI.01880-06; Liu WJ, 2005, VIROLOGY, V334, P327, DOI 10.1016/j.virol.2005.01.047; Liu WJ, 2001, VIROLOGY, V289, P362, DOI 10.1006/viro.2001.1091; Lo C-F, 2005, DIS ASIAN AQUACULTUR, P421; Mettenleiter TC, 2004, VIRUS RES, V106, P167, DOI 10.1016/j.virusres.2004.08.013; Mettenleiter TC, 2006, CURR OPIN MICROBIOL, V9, P423, DOI 10.1016/j.mib.2006.06.013; Patikoglou G, 1997, ANNU REV BIOPH BIOM, V26, P289, DOI 10.1146/annurev.biophys.26.1.289; Rajcani J., 2003, Acta Microbiologica et Immunologica Hungarica, V50, P407, DOI 10.1556/AMicr.50.2003.4.8; Reske A, 2007, REV MED VIROL, V17, P205, DOI 10.1002/rmv.531; Rout N, 2007, VACCINE, V25, P2778, DOI 10.1016/j.vaccine.2006.12.056; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Tang XH, 2007, J VIROL, V81, P6709, DOI 10.1128/JVI.02505-06; Tsai JM, 2004, J VIROL, V78, P11360, DOI 10.1128/JVI.78.20.11360-11370.2004; Tsai JM, 2006, J VIROL, V80, P3021, DOI 10.1128/JVI.80.6.3021-3029.2006; Tsai MF, 1999, DIS AQUAT ORGAN, V38, P107, DOI 10.3354/dao038107; van Hulten MCW, 2001, VIROLOGY, V285, P228, DOI 10.1006/viro.2001.0928; Vaseeharan B, 2006, LETT APPL MICROBIOL, V43, P137, DOI 10.1111/j.1472-765X.2006.01941.x; Vlak JM, 2005, 8 REP INT COMM TAX V, P187; Wan Q, 2008, J VIROL, V82, P12598, DOI 10.1128/JVI.01732-08; Wang CH, 1995, DIS AQUAT ORGAN, V23, P239, DOI 10.3354/dao023239; Witteveldt J, 2004, FISH SHELLFISH IMMUN, V16, P571, DOI 10.1016/j.fsi.2003.09.006; Wu WL, 2005, VIROLOGY, V332, P578, DOI 10.1016/j.virol.2004.12.011; Xie XX, 2006, J VIROL, V80, P10615, DOI 10.1128/JVI.01452-06; Xie XX, 2006, J GEN VIROL, V87, P1903, DOI 10.1099/vir.0.81570-0; Xie XX, 2005, VIROLOGY, V336, P93, DOI 10.1016/j.virol.2005.03.011; Ye T, 2012, GENE, V505, P254, DOI 10.1016/j.gene.2012.06.015; Ye T, 2012, FISH SHELLFISH IMMUN, V33, P350, DOI 10.1016/j.fsi.2012.05.017; Yi GH, 2004, J BIOCHEM MOL BIOL, V37, P726; Zhan WB, 2013, FISH SHELLFISH IMMUN, V34, P228, DOI 10.1016/j.fsi.2012.10.019; Zhang XB, 2004, PROTEINS, V55, P229, DOI 10.1002/prot.10640; Zhou Q, 2009, J VIROL, V83, P4709, DOI 10.1128/JVI.02360-08; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003	54	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85779	10.1371/journal.pone.0085779	http://dx.doi.org/10.1371/journal.pone.0085779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465701	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500110
J	Wang, ZZ; Gagne, JP; Poirier, GG; Xu, WQ				Wang, Zhizhi; Gagne, Jean-Philippe; Poirier, Guy G.; Xu, Wenqing			Crystallographic and Biochemical Analysis of the Mouse Poly(ADP-Ribose) Glycohydrolase	PLOS ONE			English	Article							MAMMALIAN-CELLS; PARG REVEALS; DNA-REPAIR; IDENTIFICATION; MECHANISM; PURIFICATION; DEGRADATION; SENSITIVITY; ISOFORMS; FEATURES	Protein poly(ADP-ribosyl)ation (PARylation) regulates a number of important cellular processes. Poly(ADP-ribose) glycohydrolase (PARG) is the primary enzyme responsible for hydrolyzing the poly(ADP-ribose) (PAR) polymer in vivo. Here we report crystal structures of the mouse PARG (mPARG) catalytic domain, its complexes with ADP-ribose (ADPr) and a PARG inhibitor ADP-HPD, as well as four PARG catalytic residues mutants. With these structures and biochemical analysis of 20 mPARG mutants, we provide a structural basis for understanding how the PAR polymer is recognized and hydrolyzed by mPARG. The structures and activity complementation experiment also suggest how the N-terminal flexible peptide preceding the PARG catalytic domain may regulate the enzymatic activity of PARG. This study contributes to our understanding of PARG catalytic and regulatory mechanisms as well as the rational design of PARG inhibitors.	[Wang, Zhizhi; Xu, Wenqing] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Gagne, Jean-Philippe; Poirier, Guy G.] Univ Laval, Fac Med, Ctr Hosp Univ Quebec, Ctr Rech,Axe Canc, Quebec City, PQ G1K 7P4, Canada	University of Washington; University of Washington Seattle; Laval University	Xu, WQ (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	wxu@uw.edu	Wang, Zhizhi/K-3271-2016	Wang, Zhizhi/0000-0003-4948-925X; Xu, Wenqing/0000-0002-2884-3101; Poirier, Guy/0000-0002-4869-1424	NIH [R01 GM099766]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099766] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant R01 GM099766 to WX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALVAREZGONZALEZ R, 1989, MUTAT RES, V218, P67, DOI 10.1016/0921-8777(89)90012-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barkauskaite E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3164; Blenn C, 2011, MOLECULES, V16, P1854, DOI 10.3390/molecules16021854; Botta D, 2010, BIOCHEMISTRY-US, V49, P7674, DOI 10.1021/bi100973m; BRAUN SA, 1994, EUR J BIOCHEM, V220, P369, DOI 10.1111/j.1432-1033.1994.tb18633.x; BROCHU G, 1994, BBA-GENE STRUCT EXPR, V1219, P342, DOI 10.1016/0167-4781(94)90058-2; Cortes U, 2004, MOL CELL BIOL, V24, P7163, DOI 10.1128/MCB.24.16.7163-7178.2004; Cuzzocrea S, 2005, FASEB J, V19, P558, DOI 10.1096/fj.04-3117com; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Dunstan MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1889; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gagne JP, 2009, J PROTEOME RES, V8, P1014, DOI 10.1021/pr800810n; Hanai S, 2004, P NATL ACAD SCI USA, V101, P82, DOI 10.1073/pnas.2237114100; HATAKEYAMA K, 1986, J BIOL CHEM, V261, P4902; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; IKEJIMA M, 1988, J BIOL CHEM, V263, P11037; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Kim IK, 2012, NAT STRUCT MOL BIOL, V19, P653, DOI 10.1038/nsmb.2305; Koh DW, 2005, CELL CYCLE, V4, P397, DOI 10.4161/cc.4.3.1559; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Koh DW, 2003, BIOCHEMISTRY-US, V42, P4855, DOI 10.1021/bi0272048; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; LAUTIER D, 1993, MOL CELL BIOCHEM, V122, P171, DOI 10.1007/BF01076101; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; MALANGA M, 1994, J BIOL CHEM, V269, P17691; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MENARD L, 1987, BIOCHEM CELL BIOL, V65, P668, DOI 10.1139/o87-088; Meyer RG, 2007, EXP CELL RES, V313, P2920, DOI 10.1016/j.yexcr.2007.03.043; Min W, 2010, CARCINOGENESIS, V31, P2058, DOI 10.1093/carcin/bgq205; Min W, 2009, FRONT BIOSCI-LANDMRK, V14, P1619, DOI 10.2741/3329; MIWA M, 1974, J BIOL CHEM, V249, P3475; Niere M, 2012, J BIOL CHEM, V287, P16088, DOI 10.1074/jbc.M112.349183; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel CN, 2005, BIOCHEM J, V388, P493, DOI 10.1042/BJ20040942; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; Tucker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050889; Wang ZZ, 2012, GENE DEV, V26, P235, DOI 10.1101/gad.182618.111; Winstall E, 1999, EXP CELL RES, V246, P395, DOI 10.1006/excr.1998.4321; ZAHRADKA P, 1984, EUR J BIOCHEM, V142, P503, DOI 10.1111/j.1432-1033.1984.tb08314.x	43	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86010	10.1371/journal.pone.0086010	http://dx.doi.org/10.1371/journal.pone.0086010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465839	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500165
J	Qiao, MY; Cheng, J; Bian, W; Tao, DC				Qiao, Maoying; Cheng, Jun; Bian, Wei; Tao, Dacheng			Biview Learning for Human Posture Segmentation from 3D Points Cloud	PLOS ONE			English	Article							POSE ESTIMATION; RECOGNITION; REGRESSION	Posture segmentation plays an essential role in human motion analysis. The state-of-the-art method extracts sufficiently high-dimensional features from 3D depth images for each 3D point and learns an efficient body part classifier. However, high-dimensional features are memory-consuming and difficult to handle on large-scale training dataset. In this paper, we propose an efficient two-stage dimension reduction scheme, termed biview learning, to encode two independent views which are depth-difference features (DDF) and relative position features (RPF). Biview learning explores the complementary property of DDF and RPF, and uses two stages to learn a compact yet comprehensive low-dimensional feature space for posture segmentation. In the first stage, discriminative locality alignment (DLA) is applied to the high-dimensional DDF to learn a discriminative low-dimensional representation. In the second stage, canonical correlation analysis (CCA) is used to explore the complementary property of RPF and the dimensionality reduced DDF. Finally, we train a support vector machine (SVM) over the output of CCA. We carefully validate the effectiveness of DLA and CCA utilized in the two-stage scheme on our 3D human points cloud dataset. Experimental results show that the proposed biview learning scheme significantly outperforms the state-of-the-art method for human posture segmentation.	[Qiao, Maoying; Bian, Wei; Tao, Dacheng] Univ Technol Sydney, Fac Engn & Informat Technol, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia; [Cheng, Jun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Guangdong Prov Key Lab Robot & Intelligent Syst, Shenzhen, Guangdong, Peoples R China; [Cheng, Jun] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	University of Technology Sydney; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese University of Hong Kong	Cheng, J (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Guangdong Prov Key Lab Robot & Intelligent Syst, Shenzhen, Guangdong, Peoples R China.	jun.cheng@siat.ac.cn			CAS and Locality Cooperation Projects [ZNGZ-2011-012]; Guangdong-CAS Strategic Cooperation Program [2012B090400044]; Guangdong-Hongkong Technology Cooperation Funding [2011A091200001]; Shenzhen Technology Project [ZD201111040087A]; Australian Research Council [FT-130101457]	CAS and Locality Cooperation Projects; Guangdong-CAS Strategic Cooperation Program; Guangdong-Hongkong Technology Cooperation Funding; Shenzhen Technology Project; Australian Research Council(Australian Research Council)	This work is supported by five departments: CAS and Locality Cooperation Projects (Grand No. ZNGZ-2011-012), Guangdong-CAS Strategic Cooperation Program (Grand No. 2012B090400044), Guangdong-Hongkong Technology Cooperation Funding (Grand No. 2011A091200001), Shenzhen Technology Project (Grand No. ZD201111040087A), Australian Research Council (Grand No. FT-130101457). 1. CAS and Locality Cooperation Projects (ZNGZ-2011-012), http://www.cas.ac.cn/ 2. Guangdong-CAS Strategic Cooperation Program (2012B090400044), http://www.gdstc.gov.cn/ 3. Shenzhen Technology Project (ZD201111040087A), http://www.szsti.gov.cn/ 4. Guangdong-Hongkong Technology Cooperation Funding (2011A091200001), http://www.gdstc.gov.cn/ 5. Australian Research Council (FT-130101457), http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit Y, 1997, NEURAL COMPUT, V9, P1545, DOI 10.1162/neco.1997.9.7.1545; Balla-Arabe S, 2012, NEUROCOMPUTING, V93, P106, DOI 10.1016/j.neucom.2012.04.019; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Bregler C, 1998, PROC CVPR IEEE, P8, DOI 10.1109/CVPR.1998.698581; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chaudhuri K., 2009, PROC INT C MACHINE L, P129, DOI DOI 10.1145/1553374.1553391; Cheng J, 2011, SIGNAL PROCESS, V91, P2204, DOI 10.1016/j.sigpro.2011.04.003; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Dijkstra T.K., 2010, HDB PARTIAL LEAST SQ, DOI [DOI 10.1007/978-3-540-32827-8, 10.1007/978-3-540-32827-8]; Felzenszwalb PF, 2005, INT J COMPUT VISION, V61, P55, DOI 10.1023/B:VISI.0000042934.15159.49; Foster D., 2008, TR20084 TTI; Gao XB, 2008, NEUROCOMPUTING, V71, P1921, DOI 10.1016/j.neucom.2007.10.025; Girshick R, 2011, IEEE I CONF COMP VIS, P415, DOI 10.1109/ICCV.2011.6126270; Grest D, 2005, LECT NOTES COMPUT SC, V3663, P285; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Liu WF, 2013, IEEE T IMAGE PROCESS, V22, P2676, DOI 10.1109/TIP.2013.2255302; Luo Y, 2013, 27 AAAI C ART INT; Luo Y, 2013, IEEE T NEUR NET LEAR, V24, P709, DOI 10.1109/TNNLS.2013.2238682; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Mori G., 2002, P EUR C COMP VIS, P150; Moschini D, 2008, P THEMIS, P61; Pishchulin L, 2012, PROC CVPR IEEE, P3178, DOI 10.1109/CVPR.2012.6248052; Poppe R, 2007, COMPUT VIS IMAGE UND, V108, P4, DOI 10.1016/j.cviu.2006.10.016; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Rupnik J, 2010, C DAT MIN DAT WARH L; Shotton J, 2011, PROC CVPR IEEE, P1297, DOI 10.1109/CVPR.2011.5995316; SIMON DA, 1994, IEEE INT CONF ROBOT, P2235, DOI 10.1109/ROBOT.1994.350953; Sun M, 2012, PROC CVPR IEEE, P3394, DOI 10.1109/CVPR.2012.6248079; Tao DP, 2014, PATTERN RECOGN LETT, V35, P186, DOI 10.1016/j.patrec.2012.06.014; Tao DP, 2013, IEEE T CIRC SYST VID, V23, P1675, DOI 10.1109/TCSVT.2013.2255413; Tao DP, 2013, IEEE T CYBERNETICS, V43, P1406, DOI 10.1109/TCYB.2013.2264285; Tao DP, 2013, IEEE T MULTIMEDIA, V15, P833, DOI 10.1109/TMM.2013.2238909; Tao DP, 2012, NEUROCOMPUTING, V91, P11, DOI 10.1016/j.neucom.2012.02.024; Tu ZW, 2008, PROC CVPR IEEE, P735; TURK MA, 1991, 1991 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, P586; Wang XC, 2013, IEEE T IMAGE PROCESS, V22, P2646, DOI 10.1109/TIP.2013.2255300; Wang XM, 2010, NEUROCOMPUTING, V73, P2186, DOI 10.1016/j.neucom.2010.01.021; Wen J, 2010, NEUROCOMPUTING, V73, P827, DOI 10.1016/j.neucom.2009.10.013; Xie B, 2011, IEEE T SYST MAN CY B, V41, P1088, DOI 10.1109/TSMCB.2011.2106208; Xu C, 2013, ARXIV13045634; Yu J, 2012, IEEE T IMAGE PROCESS, V21, P4636, DOI 10.1109/TIP.2012.2207395; Zhang TH, 2008, LECT NOTES COMPUT SC, V5302, P725, DOI 10.1007/978-3-540-88682-2_55	44	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85811	10.1371/journal.pone.0085811	http://dx.doi.org/10.1371/journal.pone.0085811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465721	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500076
J	Vincze, S; Stamm, I; Kopp, PA; Hermes, J; Adlhoch, C; Semmler, T; Wieler, LH; Lubke-Becker, A; Walther, B				Vincze, Szilvia; Stamm, Ivonne; Kopp, Peter A.; Hermes, Julia; Adlhoch, Cornelia; Semmler, Torsten; Wieler, Lothar H.; Luebke-Becker, Antina; Walther, Birgit			Alarming Proportions of Methicillin-Resistant Staphylococcus aureus (MRSA) in Wound Samples from Companion Animals, Germany 2010-2012	PLOS ONE			English	Article							SKIN INFECTIONS; TRANSMISSION; STRAINS; HUMANS; SPREAD; ST398	Staphylococcus (S.) aureus is an important cause of wound infections in companion animals, and infections with methicillin-resistant S. aureus (MRSA) are of particular concern due to limited treatment options and their zoonotic potential. However, comparable epidemiological data on MRSA infections in dogs, cats and horses is scarce, also limiting the knowledge about possible links to MRSA isolates from human populations. To gain more knowledge about the occurrence and genotypic variation of MRSA among wound swabs of companion animal origin in Germany we performed a survey (2010-2012) including 5,229 samples from 1,170 veterinary practices. S. aureus was identified in 201 (5.8%) canine, 140 (12.2%) feline and 138 (22.8%) equine swabs from a total of 3,479 canine, 1,146 feline and 604 equine wounds, respectively. High MRSA rates were identified with 62.7%, 46.4% and 41.3% in S. aureus of canine, feline and equine origin, respectively. Further genotyping including spa typing and multilocus sequence typing (MLST) revealed a comparable distribution of spa types among canine and feline MRSA with CC22 (47.6%; 49.2%) and CC5 (30.2%; 29.2%) as predominant lineages followed by CC398 (13.5%; 7.7%) and CC8 (4.0%; 9.2%). In contrast, the majority of equine MRSA belonged to CC398 (87.7%). Our data highlight the importance of S. aureus and MRSA as a cause of wound infections, particularly in cats and horses in Germany. While ;"human-associated" MRSA lineages were most common in dogs and cats, a remarkable number of CC398-MRSA was detected in horses, indicating a replacement of CC8-MRSA as the predominant lineage within horses in Germany. These data enforce further longitudinal epidemiological approaches to examine the diversity and temporal relatedness of MRSA populations in humans and animals to assess probable sources of MRSA infections. This would enable a sound risk assessment and establishment of intervention strategies to limit the additional spread of MRSA.	[Vincze, Szilvia; Semmler, Torsten; Wieler, Lothar H.; Luebke-Becker, Antina; Walther, Birgit] Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany; [Stamm, Ivonne; Kopp, Peter A.] Vet Med Lab GmbH, Div IDEXX Labs, Ludwigsburg, Germany; [Hermes, Julia; Adlhoch, Cornelia] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany	Free University of Berlin; Robert Koch Institute	Vincze, S (corresponding author), Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany.	szilvia.vincze@fu-berlin.de	Semmler, Torsten/O-9540-2019; Semmler, Torsten/Q-7716-2018; Adlhoch, Cornelia/AAH-5888-2021	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Adlhoch, Cornelia/0000-0002-8842-0469; Walther, Birgit/0000-0003-3112-5722; Wieler, Lothar H./0000-0003-4365-3717	Federal Ministry of Education and Research (BMBF); MedVet-Staph project [01KI1014A]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); MedVet-Staph project	This work was supported by the Federal Ministry of Education and Research (BMBF) and is part of the MedVet-Staph project (01KI1014A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axon JE, 2011, AUST VET J, V89, P221, DOI 10.1111/j.1751-0813.2011.00711.x; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Leonard FC, 2008, VET J, V175, P27, DOI 10.1016/j.tvjl.2006.11.008; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Loeffler A, 2010, EPIDEMIOL INFECT, V138, P595, DOI 10.1017/S0950268809991476; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Malik S, 2006, J ANTIMICROB CHEMOTH, V58, P428, DOI 10.1093/jac/dkl253; Manian FA, 2003, CLIN INFECT DIS, V36, pE26, DOI 10.1086/344772; McCarthy AJ, 2012, APPL ENVIRON MICROB, V78, P8845, DOI 10.1128/AEM.02398-12; McCarthy AJ, 2012, VET DERMATOL, V23, P267, DOI 10.1111/j.1365-3164.2012.01072.x; Merlino J, 2002, J ANTIMICROB CHEMOTH, V49, P793, DOI 10.1093/jac/dkf021; Moodley A, 2006, J ANTIMICROB CHEMOTH, V58, P1118, DOI 10.1093/jac/dkl394; Nienhoff U, 2009, J ANTIMICROB CHEMOTH, V64, P660, DOI 10.1093/jac/dkp243; Otto M, 2012, CELL MICROBIOL, V14, P1513, DOI 10.1111/j.1462-5822.2012.01832.x; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Price LB, 2012, HOST ADAPTATION EMER, VCC398, P3, DOI DOI 10.1128/MBI0.00305-11; Rankin S, 2005, VET MICROBIOL, V108, P145, DOI 10.1016/j.vetmic.2005.02.013; Robert-Koch-Institut, 2011, EP B, P12; Rohde SM, 2013, J ANTIMICROB CHEMOTH; Sing A, 2008, NEW ENGL J MED, V358, P1200, DOI 10.1056/NEJMc0706805; Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13; Strommenger B, 2006, J ANTIMICROB CHEMOTH, V57, P461, DOI 10.1093/jac/dki471; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Van den Eede A, 2009, VET MICROBIOL, V133, P138, DOI 10.1016/j.vetmic.2008.06.021; van Duijkeren E, 2010, VET MICROBIOL, V141, P96, DOI 10.1016/j.vetmic.2009.08.009; van Duijkeren E, 2004, EMERG INFECT DIS, V10, P2235, DOI 10.3201/eid1012.040387; Vincze S, 2013, APPL ENVIRON MICROB, V79, P655, DOI 10.1128/AEM.02704-12; Walther B, 2008, VET MICROBIOL, V127, P171, DOI 10.1016/j.vetmic.2007.07.018; Walther B, 2012, EMERG INFECT DIS, V18, P2017, DOI 10.3201/eid1812.120238; Wayne P., 2010, CLIN LAB STANDARDS I; Wayne P., 2008, M31A3 CLSI, V28; Weese JS, 2006, VET MICROBIOL, V115, P148, DOI 10.1016/j.vetmic.2006.01.004; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Weese JS, 2006, VET MICROBIOL, V114, P160, DOI 10.1016/j.vetmic.2005.11.054; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Zhang Wanjiang, 2011, Vet J, V190, pe125, DOI 10.1016/j.tvjl.2011.02.006	40	84	86	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85656	10.1371/journal.pone.0085656	http://dx.doi.org/10.1371/journal.pone.0085656			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465637	gold, Green Published			2022-12-25	WOS:000330240500065
J	Dong, R; Jia, DS; Xue, P; Cui, XM; Li, K; Zheng, S; He, XH; Dong, KR				Dong, Rui; Jia, Deshui; Xue, Ping; Cui, Ximao; Li, Kai; Zheng, Shan; He, Xianghuo; Dong, Kuiran			Genome-Wide Analysis of Long Noncoding RNA (lncRNA) Expression in Hepatoblastoma Tissues	PLOS ONE			English	Article							CELL-SPECIFIC MOLECULE-1; COLORECTAL-CANCER; GASTRIC-CANCER; RISK-FACTORS; MEG3; CARCINOMA; OVEREXPRESSION; PROFILE; ESM-1; PROLIFERATION	Long noncoding RNAs (lncRNAs) have crucial roles in cancer biology. We performed a genome-wide analysis of lncRNA expression in hepatoblastoma tissues to identify novel targets for further study of hepatoblastoma. Hepatoblastoma and normal liver tissue samples were obtained from hepatoblastoma patients. The genome-wide analysis of lncRNA expression in these tissues was performed using a 46180 K lncRNA microarray and Sureprint G3 Human lncRNA Chips. Quantitative RTPCR (qRT-PCR) was performed to confirm these results. The differential expressions of lncRNAs and mRNAs were identified through fold-change filtering. Gene Ontology (GO) and pathway analyses were performed using the standard enrichment computation method. Associations between lncRNAs and adjacent protein-coding genes were determined through complex transcriptional loci analysis. We found that 2736 lncRNAs were differentially expressed in hepatoblastoma tissues. Among these, 1757 lncRNAs were upregulated more than two-fold relative to normal tissues and 979 lncRNAs were downregulated. Moreover, in hepatoblastoma there were 420 matched lncRNA-mRNA pairs for 120 differentially expressed lncRNAs, and 167 differentially expressed mRNAs. The co-expression network analysis predicted 252 network nodes and 420 connections between 120 lncRNAs and 132 coding genes. Within this co-expression network, 369 pairs were positive, and 51 pairs were negative. Lastly, qRT-PCR data verified six upregulated and downregulated lncRNAs in hepatoblastoma, plus endothelial cell-specific molecule 1 (ESM1) mRNA. Our results demonstrated that expression of these aberrant lncRNAs could respond to hepatoblastoma development. Further study of these lncRNAs could provide useful insight into hepatoblastoma biology.	[Dong, Rui; Xue, Ping; Cui, Ximao; Li, Kai; Zheng, Shan; Dong, Kuiran] Fudan Univ, Dept Pediat Surg, Childrens Hosp, Shanghai 200433, Peoples R China; [Dong, Rui; Xue, Ping; Cui, Ximao; Li, Kai; Zheng, Shan; Dong, Kuiran] Chinese Minist Hlth, Key Lab Neonatal Dis, Shanghai, Peoples R China; [Jia, Deshui; He, Xianghuo] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Ren Ji Hosp,Sch Med, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University	Dong, KR (corresponding author), Fudan Univ, Dept Pediat Surg, Childrens Hosp, Shanghai 200433, Peoples R China.	kuirand@fudan.edu.cn	He, Xianghuo/I-1497-2014; Jia, Deshui/U-9732-2019	He, Xianghuo/0000-0001-8872-668X; Zheng, Shan/0000-0002-9712-4573	State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute [SKLORG 90-12-01]	State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute	This study received financial support from the grant from the State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute (SKLORG # 90-12-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balik V, 2013, J NEURO-ONCOL, V112, P1, DOI 10.1007/s11060-012-1038-6; BUCKLEY JD, 1989, CANCER, V64, P1169, DOI 10.1002/1097-0142(19890901)64:5<1169::AID-CNCR2820640534>3.0.CO;2-I; De Ioris M, 2008, EUR J CANCER, V44, P545, DOI 10.1016/j.ejca.2007.11.022; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Dinger ME, 2009, NUCLEIC ACIDS RES, V37, pD122, DOI 10.1093/nar/gkn617; Ge XS, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0588-6; Haas JE, 2001, CANCER-AM CANCER SOC, V92, P3130, DOI 10.1002/1097-0142(20011215)92:12<3130::AID-CNCR10115>3.0.CO;2-#; Han L, 2012, INT J ONCOL, V40, P2004, DOI 10.3892/ijo.2012.1413; Herzog C E, 2000, Oncologist, V5, P445, DOI 10.1634/theoncologist.5-6-445; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Ji NY, 2010, CANCER SCI, V101, P2248, DOI 10.1111/j.1349-7006.2010.01665.x; Kang YH, 2012, CELL SIGNAL, V24, P1940, DOI 10.1016/j.cellsig.2012.06.004; Khachane AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010316; Lee CT, 2013, HUM PATHOL, V44, P802, DOI 10.1016/j.humpath.2012.08.003; Leroy X, 2010, HISTOPATHOLOGY, V56, P180, DOI 10.1111/j.1365-2559.2009.03458.x; Li JP, 2013, BIOCHEM BIOPH RES CO, V433, P200, DOI 10.1016/j.bbrc.2013.02.083; Litten JB, 2008, ONCOLOGIST, V13, P812, DOI 10.1634/theoncologist.2008-0011; Liu N, 2010, ANN SURG ONCOL, V17, P2628, DOI 10.1245/s10434-010-1037-9; Magrelli A, 2009, TRANSL ONCOL, V2, P157, DOI 10.1593/tlo.09124; Massimi M, 2012, BBA-GEN SUBJECTS, V1820, P1, DOI 10.1016/j.bbagen.2011.10.005; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Pan YF, 2013, J HUAZHONG U SCI-MED, V33, P96, DOI 10.1007/s11596-013-1078-y; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Qiao HP, 2013, ASIAN PAC J CANCER P, V14, P1077, DOI 10.7314/APJCP.2013.14.2.1077; Qin R, 2013, NEOPLASMA, V60, P486, DOI 10.4149/neo_2013_063; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Spector LG, 2008, BRIT J CANCER, V98, P1570, DOI 10.1038/sj.bjc.6604335; Sun WL, 2013, TUMOR BIOL, V34, P2697, DOI 10.1007/s13277-013-0821-0; Tomlinson GE, 2012, PEDIATR BLOOD CANCER, V59, P785, DOI 10.1002/pbc.24213; von Frowein J, 2011, HEPATOLOGY, V53, P833, DOI 10.1002/hep.24125; von Schweinitz D, 2012, SEMIN PEDIATR SURG, V21, P21, DOI 10.1053/j.sempedsurg.2011.10.011; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang PJ, 2012, J CELL BIOCHEM, V113, P1868, DOI 10.1002/jcb.24055; Yamamoto H, 2007, GENES CELLS, V12, P461, DOI 10.1111/j.1365-2443.2007.01065.x; Zhang X, 2010, ENDOCRINOLOGY, V151, P939, DOI 10.1210/en.2009-0657; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	38	61	64	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85599	10.1371/journal.pone.0085599	http://dx.doi.org/10.1371/journal.pone.0085599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465615	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000046
J	Halter, D; Collart, MA; Panasenko, OO				Halter, David; Collart, Martine A.; Panasenko, Olesya O.			The Not4 E3 Ligase and CCR4 Deadenylase Play Distinct Roles in Protein Quality Control	PLOS ONE			English	Article							MESSENGER-RNA DEADENYLASE; CAF1 PROTEINS; GENE-EXPRESSION; RING-FINGER; DEGRADATION; COMPLEX; YEAST; PROTEASOME; SUBUNIT; TRANSLATION	Eukaryotic cells control their proteome by regulating protein production and protein clearance. Protein production is determined to a large extent by mRNA levels, whereas protein degradation depends mostly upon the proteasome. Dysfunction of the proteasome leads to the accumulation of non-functional proteins that can aggregate, be toxic for the cell, and, in extreme cases, lead to cell death. mRNA levels are controlled by their rates of synthesis and degradation. Recent evidence indicates that these rates have oppositely co-evolved to ensure appropriate mRNA levels. This opposite co-evolution has been correlated with the mutations in the Ccr4-Not complex. Consistently, the deadenylation enzymes responsible for the rate-limiting step in eukaryotic mRNA degradation, Caf1 and Ccr4, are subunits of the Ccr4-Not complex. Another subunit of this complex is a RING E3 ligase, Not4. It is essential for cellular protein solubility and has been proposed to be involved in co-translational quality control. An open question has been whether this role of Not4 resides strictly in the regulation of the deadenylation module of the Ccr4-Not complex. However, Not4 is important for proper assembly of the proteasome, and the Ccr4-Not complex may have multiple functional modules that participate in protein quality control in different ways. In this work we studied how the functions of the Caf1/Ccr4 and Not4 modules are connected. We concluded that Not4 plays a role in protein quality control independently of the Ccr4 deadenylase, and that it is involved in clearance of aberrant proteins at least in part via the proteasome.	[Halter, David; Collart, Martine A.; Panasenko, Olesya O.] Univ Geneva, Inst Genet & Genom Geneva, Fac Med, Dept Microbiol & Mol Med, Geneva, Switzerland	University of Geneva	Panasenko, OO (corresponding author), Univ Geneva, Inst Genet & Genom Geneva, Fac Med, Dept Microbiol & Mol Med, Geneva, Switzerland.	olesya.panasenko@unige.ch	Panasenko, Olesya/AAC-1194-2021	Panasenko, Olesya/0000-0002-0990-7472; Collart, Martine/0000-0001-6955-1773	Ernst and Lucie Schmidheiny Foundation; Pierre Mercier Foundation; Swiss National Science Foundation [31003A_135794]	Ernst and Lucie Schmidheiny Foundation; Pierre Mercier Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Ernst and Lucie Schmidheiny (http://www.fondation-schmidheiny.ch/lafondation.html) and Pierre Mercier (http://www.fondationmercier.ch/wb/) Foundations awarded to OOP and a grant 31003A_135794 from the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx) awarded to MAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Azzouz N, 2009, RNA, V15, P377, DOI 10.1261/rna.1348209; Bai YL, 1999, MOL CELL BIOL, V19, P6642; Bartlam M, 2010, PROTEIN CELL, V1, P443, DOI 10.1007/s13238-010-0060-8; Basquin J, 2012, MOL CELL, V48, P207, DOI 10.1016/j.molcel.2012.08.014; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Bhaskar V, 2013, NAT STRUCT MOL BIOL, V20, P1281, DOI 10.1038/nsmb.2686; Boland A, 2013, NAT STRUCT MOL BIOL, V20, P1289, DOI 10.1038/nsmb.2681; Brachmann CB, 1998, YEAST, V14, P115; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Caponigro G, 1996, MICROBIOL REV, V60, P233, DOI 10.1128/MMBR.60.1.233-249.1996; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Chhangani D, 2012, MOL NEUROBIOL, V45, P571, DOI 10.1007/s12035-012-8273-x; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; Collart MA, 2013, MOL BIOL; Collart MA, 2013, CELL SIGNAL, V25, P743, DOI 10.1016/j.cellsig.2012.12.018; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gerlinger UM, 1997, MOL BIOL CELL, V8, P2487, DOI 10.1091/mbc.8.12.2487; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOLDBERG AL, 1974, ANNU REV BIOCHEM, V43, P835, DOI 10.1146/annurev.bi.43.070174.004155; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanzawa H, 2001, J BIOL CHEM, V276, P10185, DOI 10.1074/jbc.M009298200; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jeske M, 2006, J BIOL CHEM, V281, P25124, DOI 10.1074/jbc.M604802200; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kohler A, 2001, BIOCHIMIE, V83, P325, DOI 10.1016/S0300-9084(01)01242-1; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lau NC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009864; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Lyumkis D, 2013, P NATL ACAD SCI USA, V110, P1702, DOI 10.1073/pnas.1210041110; Maillet L, 2000, J MOL BIOL, V303, P131, DOI 10.1006/jmbi.2000.4131; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Mulder KW, 2007, GENETICS, V176, P181, DOI 10.1534/genetics.106.060640; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Nousch M, 2013, J CELL SCI, V126, P4274, DOI 10.1242/jcs.132936; Panasenko O, 2006, J BIOL CHEM, V281, P31389, DOI 10.1074/jbc.M604986200; Panasenko OO, 2012, MOL MICROBIOL, V83, P640, DOI 10.1111/j.1365-2958.2011.07957.x; Panasenko OO, 2011, MOL CELL BIOL, V31, P1610, DOI 10.1128/MCB.01210-10; Panasenko OO, 2009, GENETICS, V181, P447, DOI 10.1534/genetics.108.095422; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Sommer T, 2005, CELL, V120, P734, DOI 10.1016/j.cell.2005.03.003; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Temme C, 2010, RNA, V16, P1356, DOI 10.1261/rna.2145110; Thore S, 2003, EMBO REP, V4, P1150, DOI 10.1038/sj.embor.7400020; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Wahle E, 2013, BBA-GENE REGUL MECH, V1829, P561, DOI 10.1016/j.bbagrm.2013.01.003; Wiederhold K, 2010, BIOCHEM SOC T, V38, P1531, DOI 10.1042/BST0381531; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016	85	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86218	10.1371/journal.pone.0086218	http://dx.doi.org/10.1371/journal.pone.0086218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465968	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000089
J	Sakamoto, T; Kobayashi, M; Tada, K; Shinohara, M; Io, K; Nagata, K; Iwai, F; Takiuchi, Y; Arai, Y; Yamashita, K; Shindo, K; Kadowaki, N; Koyanagi, Y; Takaori-Kondo, A				Sakamoto, Takashi; Kobayashi, Masayuki; Tada, Kohei; Shinohara, Masanobu; Io, Katsuhiro; Nagata, Kayoko; Iwai, Fumie; Takiuchi, Yoko; Arai, Yasuyuki; Yamashita, Kouhei; Shindo, Keisuke; Kadowaki, Norimitsu; Koyanagi, Yoshio; Takaori-Kondo, Akifumi			CKIP-1 Is an Intrinsic Negative Regulator of T-Cell Activation through an Interaction with CARMA1	PLOS ONE			English	Article							NF-KAPPA-B; DOMAIN-CONTAINING PROTEIN; KINASE PKC-THETA; ADAPTER PROTEIN; IMMUNOLOGICAL SYNAPSE; UBIQUITIN LIGASE; SIGNALING PATHWAYS; C-THETA; CARD11; PHOSPHORYLATION	The transcription factor NF-kappa B plays a key regulatory role in lymphocyte activation and generation of immune response. Stimulation of T cell receptor (TCR) induces phosphorylation of CARMA1 by PKC theta, resulting in formation of CARMA1-Bcl10-MALT1 (CBM) complex at lipid rafts and subsequently leading to NF-kappa B activation. While many molecular events leading to NF-kappa B activation have been reported, it is less understood how this activation is negatively regulated. We performed a cell-based screening for negative regulators of TCR-mediated NF-kappa B activation, using mutagenesis and complementation cloning strategies. Here we show that casein kinase-2 interacting protein-1 (CKIP-1) suppresses PKCh-CBM-NF-kappa B signaling. We found that CKIP-1 interacts with CARMA1 and competes with PKC theta for association. We further confirmed that a PH domain of CKIP-1 is required for association with CARMA1 and its inhibitory effect. CKIP-1 represses NF-kappa B activity in unstimulated cells, and inhibits NF-kappa B activation induced by stimulation with PMA or constitutively active PKC theta, but not by stimulation with TNFa. Interestingly, CKIP-1 does not inhibit NF-kappa B activation induced by CD3/CD28 costimulation, which caused dissociation of CKIP-1 from lipid rafts. These data suggest that CKIP-1 contributes maintenance of a resting state on NF-kappa B activity or prevents T cells from being activated by inadequate signaling. In conclusion, we demonstrate that CKIP-1 interacts with CARMA1 and has an inhibitory effect on PKCh-CBM-NF-kappa B signaling.	[Sakamoto, Takashi; Kobayashi, Masayuki; Tada, Kohei; Shinohara, Masanobu; Io, Katsuhiro; Nagata, Kayoko; Iwai, Fumie; Takiuchi, Yoko; Arai, Yasuyuki; Yamashita, Kouhei; Shindo, Keisuke; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi] Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto, Japan; [Koyanagi, Yoshio] Kyoto Univ, Inst Virus Res, Lab Viral Pathogenesis, Kyoto 606, Japan	Kyoto University; Kyoto University	Kobayashi, M (corresponding author), Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto, Japan.	mkobayas@kuhp.kyoto-u.ac.jp	Arai, Yasuyuki/AAF-6623-2020	Shindo, Keisuke/0000-0001-8793-8189; Arai, Yasuyuki/0000-0002-9662-5093	JSPS KAKENHI [23591383]; Grants-in-Aid for Scientific Research [24115004] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 23591383. The URL is http://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Bosc DG, 2000, J BIOL CHEM, V275, P14295, DOI 10.1074/jbc.275.19.14295; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Chuang HC, 2011, NAT IMMUNOL, V12, P1113, DOI 10.1038/ni.2121; Cvijic ME, 2003, J IMMUNOL METHODS, V278, P293, DOI 10.1016/S0022-1759(03)00191-1; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Kawano Y, 2004, J VIROL, V78, P11352, DOI 10.1128/JVI.78.20.11352-11359.2004; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Krishna S, 2012, J IMMUNOL, V189, P1209, DOI 10.4049/jimmunol.1102429; Lamason RL, 2010, MOL CELL, V40, P798, DOI 10.1016/j.molcel.2010.11.007; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lim KH, 2012, IMMUNOL REV, V246, P359, DOI 10.1111/j.1600-065X.2012.01105.x; Ling S, 2012, CIRCULATION; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Nie J, 2013, AGEING RES REV, V12, P276, DOI 10.1016/j.arr.2012.07.002; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Safi A, 2004, MOL CELL BIOL, V24, P1245, DOI 10.1128/MCB.24.3.1245-1255.2004; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Snow AL, 2012, J EXP MED, V209, P2247, DOI 10.1084/jem.20120831; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Tokuda E, 2007, CANCER RES, V67, P9666, DOI 10.1158/0008-5472.CAN-07-1050; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wang YF, 2012, EMBO REP, V13, P1004, DOI 10.1038/embor.2012.144; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005; Yoshida T, 2008, TRAFFIC, V9, P540, DOI [10.1111/j.1600-0854.2007.00700.x, 10.1111/j.1600-0854.2008.00700.x]; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017; Zhang LQ, 2005, EMBO J, V24, P766, DOI 10.1038/sj.emboj.7600532	48	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85762	10.1371/journal.pone.0085762	http://dx.doi.org/10.1371/journal.pone.0085762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465689	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000060
J	Sirovich, L				Sirovich, Lawrence			Genomic Data and Disease Forecasting: Application to Type 2 Diabetes (T2D)	PLOS ONE			English	Article							MELLITUS GENETICS FUSION; SUSCEPTIBILITY LOCI; WIDE ASSOCIATION; GENES; SCAN	A general approach is presented for the extraction of a classifier of disease risk that is latent in large scale disease/control databases. Novel features are the following: (1) a data reorganization into a regularized standard form that emphasizes individual alleles instead of the single nucleotide polymorphism (Snp) allele pair to which they belong; (2) from this a procedure that significantly enhances the discovery of high value genomic loci; (3) an investigative analysis based on the hypothesis that disease represents a very small signal (small signal-to-noise) that is latent in the data. The resulting analyses applied to the FUSION T2D database leads to the polling of thousands of genomic loci to classify disease. This large genomic kernel of loci is shared by non-diabetics at nearly the same high level; but a small well defined separation exists and it is speculated that this might be due to unconventional disease mechanisms. Another analysis demonstrates that the FUSION database size limits its disease predictability, and only one third of the resulting classifier loci are estimated to relate to T2D. The remainder is associated with hidden features that might contrast the disease and control populations and that more data would eliminate.	Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Rockefeller University	Sirovich, L (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	lsirovich@rockefeller.edu			Rockefeller University Committee for Clinical and Translational Science [UL1RR024143]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	Rockefeller University Committee for Clinical and Translational Science; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	There were no external funding sources for this study. The high quality Fusion database was acquired from NIH at the request of the Rockefeller University Committee for Clinical and Translational Science, grant # UL1RR024143, National Center for Research Resources, National Institutes of Health.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Brookes AJ, 2000, NUCLEIC ACIDS RES, V28, P356, DOI 10.1093/nar/28.1.356; Chakravarti A, 2011, SCIENCE, V334, P15, DOI 10.1126/science.1214458; Dirac PAM, 1942, PROC R SOC LON SER-A, V180, P0001, DOI 10.1098/rspa.1942.0023; Elgar G, 2008, TRENDS GENET, V24, P344, DOI 10.1016/j.tig.2008.04.005; Everson RM, 1998, P NATL ACAD SCI USA, V95, P8334, DOI 10.1073/pnas.95.14.8334; Feynman RP, 2000, MATH P CAMB PHIL SOC, V41, P71; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kolata G, 2012, NYTIMES         0402; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roberts NJ, 2012, SCI TRANSL MED, V4; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Silander K, 2004, DIABETES, V53, P821, DOI 10.2337/diabetes.53.3.821; Sirovich L, 1996, PHYSICA D, V96, P355, DOI 10.1016/0167-2789(96)00033-4; Sirovich L, 2002, METH NE FRO NEUROSCI, P43; SIROVICH L, 1987, Q APPL MATH, V45, P561, DOI 10.1090/qam/910462; Sirovich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009266; Sirovich L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007051; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; Wigner E, 1932, PHYS REV, V40, P0749, DOI 10.1103/PhysRev.40.749; Wolpert L, 2007, PRINCIPLES DEV; Wolpert L, 1969, THEOR BIOL, V25, P147; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	30	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85684	10.1371/journal.pone.0085684	http://dx.doi.org/10.1371/journal.pone.0085684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465649	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000051
J	Chakraborty, R; Bhullar, RP; Dakshinamurti, S; Hwa, J; Chelikani, P				Chakraborty, Raja; Bhullar, Rajinder P.; Dakshinamurti, Shyamala; Hwa, John; Chelikani, Prashen			Inverse Agonism of SQ 29,548 and Ramatroban on Thromboxane A2 Receptor	PLOS ONE			English	Article							CONSTITUTIVELY ACTIVE MUTANT; PROTEIN-COUPLED RECEPTORS; A(2) RECEPTOR; P-SELECTIN; ANTAGONISTS; ACTIVATION; INSIGHTS; DISEASE; POTENT; CELLS	G protein-coupled receptors (GPCRs) show some level of basal activity even in the absence of an agonist, a phenomenon referred to as constitutive activity. Such constitutive activity in GPCRs is known to have important pathophysiological roles in human disease. The thromboxane A2 receptor (TP) is a GPCR that promotes thrombosis in response to binding of the prostanoid, thromboxane A2. TP dysfunction is widely implicated in pathophysiological conditions such as bleeding disorders, hypertension and cardiovascular disease. Recently, we reported the characterization of a few constitutively active mutants (CAMs) in TP, including a genetic variant A160T. Using these CAMs as reporters, we now test the inverse agonist properties of known antagonists of TP, SQ 29,548, Ramatroban, L-670596 and Diclofenac, in HEK293T cells. Interestingly, SQ 29,548 reduced the basal activity of both, WT-TP and the CAMs while Ramatroban was able to reduce the basal activity of only the CAMs. Diclofenac and L-670596 showed no statistically significant reduction in basal activity of WT-TP or CAMs. To investigate the role of these compounds on human platelet function, we tested their effects on human megakaryocyte based system for platelet activation. Both SQ 29,548 and Ramatroban reduced the platelet hyperactivity of the A160T genetic variant. Taken together, our results suggest that SQ 29,548 and Ramatroban are inverse agonists for TP, whereas, L-670596 and Diclofenac are neutral antagonists. Our findings have important therapeutic applications in the treatment of TP mediated pathophysiological conditions.	[Chakraborty, Raja; Bhullar, Rajinder P.; Chelikani, Prashen] Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada; [Dakshinamurti, Shyamala; Chelikani, Prashen] Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; [Dakshinamurti, Shyamala; Chelikani, Prashen] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Dakshinamurti, Shyamala; Chelikani, Prashen] Manitoba Inst Child Hlth, Biol Breathing Grp, Winnipeg, MB, Canada; [Hwa, John] Yale Univ, Sch Med, Dept Internal Med Cardiol, Cardiovasc Res Ctr, New Haven, CT USA	University of Manitoba; University of Manitoba; University of Manitoba; Yale University	Chelikani, P (corresponding author), Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada.	chelikan@cc.umanitoba.ca	Mo, Xiulei/A-1616-2017; Chakraborty, Raja/L-6316-2017	Chelikani, Prashen/0000-0003-1129-7957	Natural Sciences and Engineering Research Council of Canada [RGPIN 356285]; MMSF Allen Rouse Career Award; Manitoba Health Research Council studentship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074190, R01HL115247] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MMSF Allen Rouse Career Award; Manitoba Health Research Council studentship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada ((RGPIN 356285); and the MMSF Allen Rouse Career Award to PC, and a Manitoba Health Research Council studentship to RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blann AD, 2003, EUR HEART J, V24, P2166, DOI 10.1016/j.ehj.2003.08.021; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Bylund DB, 2013, BIOCH PHARM IN PRESS; Cai GP, 1999, MOL PHARMACOL, V56, P989, DOI 10.1124/mol.56.5.989; Chakraborty R, 2013, MOL CELL BIOL, V33, P184, DOI 10.1128/MCB.00725-12; Chakraborty R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029996; CHIDIAC P, 1994, MOL PHARMACOL, V45, P490; COSTA T, 1992, MOL PHARMACOL, V41, P549; Davi Giovanni, 2012, Handb Exp Pharmacol, P261, DOI 10.1007/978-3-642-29423-5_11; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; Fontana P, 2011, J THROMB HAEMOST, V9, P2109, DOI 10.1111/j.1538-7836.2011.04446.x; FORDHUTCHINSON AW, 1989, CAN J PHYSIOL PHARM, V67, P989, DOI 10.1139/y89-155; Geller F, 2004, AM J HUM GENET, V74, P572, DOI 10.1086/382490; Gleim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067314; Gleim S, 2009, CURR ATHEROSCLER REP, V11, P227, DOI 10.1007/s11883-009-0035-5; HIRATA T, 1994, J CLIN INVEST, V94, P1662, DOI 10.1172/JCI117510; Jones RL, 2009, BRIT J PHARMACOL, V158, P104, DOI 10.1111/j.1476-5381.2009.00317.x; Labrecque P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065767; Lesault PF, 2011, BRIT J CLIN PHARMACO, V71, P844, DOI 10.1111/j.1365-2125.2010.03858.x; Leytin V, 2000, BIOCHEM BIOPH RES CO, V273, P565, DOI 10.1006/bbrc.2000.2977; Li QL, 2007, J PHARMACOL EXP THER, V320, P637, DOI 10.1124/jpet.106.111203; Miggin SM, 2001, BBA-MOL CELL RES, V1539, P147, DOI 10.1016/S0167-4889(01)00103-3; Milligan G, 1997, TRENDS PHARMACOL SCI, V18, P468, DOI 10.1016/S0165-6147(97)90685-4; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Mo XL, 2013, BBA-MOL BASIS DIS, V1832, P1939, DOI 10.1016/j.bbadis.2013.06.006; OGLETREE ML, 1985, J PHARMACOL EXP THER, V234, P435; Perzborn E, 1990, STROKE, V21, pIV143; Pydi SP, 2012, J NEUROCHEM, V122, P537, DOI 10.1111/j.1471-4159.2012.07808.x; Selg E, 2007, BRIT J PHARMACOL, V152, P1185, DOI 10.1038/sj.bjp.0707518; Shibata K, 1996, BRIT J PHARMACOL, V118, P1403, DOI 10.1111/j.1476-5381.1996.tb15552.x; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Tang WH, 2011, J CLIN INVEST, V121, P4462, DOI 10.1172/JCI59291; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Wieland K, 2001, J PHARMACOL EXP THER, V299, P908	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85937	10.1371/journal.pone.0085937	http://dx.doi.org/10.1371/journal.pone.0085937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465800	gold, Green Submitted, Green Published			2022-12-25	WOS:000330288000033
J	Chen, SS; Otero, YF; Mulligan, KX; Lundblad, TM; Williams, PE; McGuinness, OP				Chen, Sheng-Song; Otero, Yolanda F.; Mulligan, Kimberly X.; Lundblad, Tammy M.; Williams, Phillip E.; McGuinness, Owen P.			Liver, but Not Muscle, Has an Entrainable Metabolic Memory	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; GLUCOSE-UPTAKE; INSULIN SENSITIVITY; GLYCOGEN-CONTENT; EXPRESSION; PYRUVATE; TIME; RESPONSIVENESS; HEPATOCYTES	Hyperglycemia in the hospitalized setting is common, especially in patients that receive nutritional support either continuously or intermittently. As the liver and muscle are the major sites of glucose disposal, we hypothesized their metabolic adaptations are sensitive to the pattern of nutrient delivery. Chronically catheterized, well-controlled depancreatized dogs were placed on one of three isocaloric diets: regular chow diet once daily (Chow) or a simple nutrient diet (ND) that was given either once daily (ND-4) or infused continuously (ND-C). Intraportal insulin was infused to maintain euglycemia. After 5 days net hepatic (NHGU) and muscle (MGU) glucose uptake and oxidation were assessed at euglycemia (120 mg/dl) and hyperglycemia (200 mg/dl) in the presence of basal insulin. While hyperglycemia increased both NHGU and MGU in Chow, NHGU was amplified in both groups receiving ND. The increase was associated with enhanced activation of glycogen synthase, glucose oxidation and suppression of pyruvate dehydrogenase kinase-4 (PDK-4). Accelerated glucose-dependent muscle glucose uptake was only evident with ND-C. This was associated with a decrease in PDK-4 expression and an increase in AMP-activated protein kinase (AMPK) phosphorylation. Interestingly, ND-C markedly increased hepatic FGF-21 expression. Thus, augmentation of carbohydrate disposal in the liver, as opposed to the muscle, is not dependent on the pattern of nutrient delivery.	[Chen, Sheng-Song; Otero, Yolanda F.; Mulligan, Kimberly X.; Lundblad, Tammy M.; Williams, Phillip E.; McGuinness, Owen P.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University	McGuinness, OP (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	owen.mcguinness@vanderbilt.edu			NIH [DK043748]; Diabetes and Research and Training Centre [DK020593]; American Diabetes Association; Molecular Endocrinology Training Grant [DK07563]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, R01DK043748, R29DK043748, R01DK078188, U2CDK059637, P30DK020593, T32DK007563, R56DK043748, P60DK020593] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Research and Training Centre; American Diabetes Association(American Diabetes Association); Molecular Endocrinology Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge support from NIH (DK043748; PI: Owen McGuinness), Diabetes and Research and Training Centre (DK020593) and American Diabetes Association. KXM and TML received support from the Molecular Endocrinology Training Grant (DK07563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are indebted to the Institutional Hormone Assay and Analysis Services Core (DK020593 and DK059637) and Molecular Cell Biology Resource Core and the Metabolic Physiology Shared Resource Core (DK020593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON AD, 1995, J CLIN INVEST, V96, P786, DOI 10.1172/JCI118124; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Chen SS, 2007, AM J PHYSIOL-ENDOC M, V292, pE928, DOI 10.1152/ajpendo.00063.2006; Chen SS, 2000, JPEN-PARENTER ENTER, V24, P255, DOI 10.1177/0148607100024005255; Chen SS, 2005, AM J PHYSIOL-REG I, V289, pR1319, DOI 10.1152/ajpregu.00175.2005; Chen SS, 2005, AM J PHYSIOL-ENDOC M, V288, pE163, DOI 10.1152/ajpendo.00192.2004; DAVIS MA, 1984, AM J PHYSIOL, V247, pE362, DOI 10.1152/ajpendo.1984.247.3.E362; Derave W, 2000, AM J PHYSIOL-ENDOC M, V279, pE947, DOI 10.1152/ajpendo.2000.279.5.E947; Infantino CAG, 2013, NUTRITION, V29, P497, DOI 10.1016/j.nut.2012.07.019; Habegger KM, 2013, DIABETES; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Jensen J, 2006, AM J PHYSIOL-ENDOC M, V290, pE154, DOI 10.1152/ajpendo.00330.2005; Johnson PM, 2011, METABOLISM, V60, P867, DOI 10.1016/j.metabol.2010.08.006; Lee MS, 2012, METABOLISM, V61, P1142, DOI 10.1016/j.metabol.2012.01.012; Lee-Young RS, 2013, DIABETOLOGIA, V56, P608, DOI 10.1007/s00125-012-2787-7; Li K, 2012, MOL CELL ENDOCRINOL, V348, P21, DOI 10.1016/j.mce.2011.07.026; LLOYD B, 1978, CLIN CHEM, V24, P1724; Mashili FL, 2011, DIABETES-METAB RES, V27, P286, DOI 10.1002/dmrr.1177; McMahon MM, 1996, MAYO CLIN PROC, V71, P587, DOI 10.4065/71.6.587; Moore MC, 2000, AM J PHYSIOL-ENDOC M, V279, pE1271, DOI 10.1152/ajpendo.2000.279.6.E1271; Mulligan KX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030160; Orho M, 1998, J CLIN INVEST, V102, P507, DOI 10.1172/JCI2890; Sanchez J, 2009, ENDOCRINOLOGY, V150, P5341, DOI 10.1210/en.2009-0466; Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003; STEVENSON RW, 1987, DIABETES, V36, P382, DOI 10.2337/diabetes.36.3.382; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Uebanso T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022976; Vienberg SG, 2012, EUR J ENDOCRINOL, V167, P49, DOI 10.1530/EJE-12-0039; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Winnick JJ, 2011, DIABETES, V60, P398, DOI 10.2337/db10-0592; ZINKER BA, 1993, J APPL PHYSIOL, V74, P2915, DOI 10.1152/jappl.1993.74.6.2915	36	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86164	10.1371/journal.pone.0086164	http://dx.doi.org/10.1371/journal.pone.0086164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465939	Green Submitted, gold, Green Published			2022-12-25	WOS:000330288000059
J	Feray, C; Bouscaillou, J; Falissard, B; Mohamed, MK; Arafa, N; Bakr, I; El-Hoseiny, M; El Daly, M; El-Kafrawy, S; Plancoulaine, S; Abdel-Hamid, M; Thiers, V; Fontanet, A				Feray, Cyrille; Bouscaillou, Julie; Falissard, Bruno; Mohamed, Mostafa K.; Arafa, Naglaa; Bakr, Iman; El-Hoseiny, Mostafa; El Daly, Mai; El-Kafrawy, Sherif; Plancoulaine, Sabine; Abdel-Hamid, Mohamed; Thiers, Valerie; Fontanet, Arnaud			A Novel Method to Identify Routes of Hepatitis C Virus Transmission	PLOS ONE			English	Article							RISK-FACTORS; INTRAFAMILIAL TRANSMISSION; SEXUAL TRANSMISSION; PERIPHERAL-BLOOD; INFECTION; HCV; EGYPT; EVOLUTION; SPOUSES; SPREAD	Background: We propose a new approach based on genetic distances among viral strains to infer about risk exposures and location of transmission at population level. Methods: We re-analysed 133 viral sequences obtained during a cross-sectional survey of 4020 subjects living in a hepatitis C virus (HCV) endemic area in 2002. A permutation test was used to analyze the correlation between matrices of genetic distances in the NS5b region of all pairwise combinations of the 133 viral strains and exposure status (jointly exposed or not) to several potential HCV risk factors. Results: Compared to subjects who did not share the same characteristics or iatrogenic exposures, the median Kimura genetic distances of viral strains were significantly smaller between brothers and sisters (0.031 versus 0.102, P<0.001), mother and child (0.044 versus 0.102, P<0.001), father and child (0.045 versus 0.102, P<0.001), or subjects exposed to periodontal treatment (0.084 versus 0.102, P = 0.02). Conversely, viral strains were more divergent between subjects exposed to blood transfusions (0.216 versus 0.102, P = 0.04) or tooth filling or extraction (0.108, versus 0.097, P = 0.05), suggesting acquisition of the virus outside of the village. Conclusion: This method provided insights on where infection took place (household, village) for several socio-demographic characteristics or iatrogenic procedures, information of great relevance for targeting prevention interventions. This method may have interesting applications for virologists and epidemiologists studying transmission networks in health-care facilities or among intravenous drug users.	[Feray, Cyrille] Hop Henri Mondor, Inserm 955, F-94010 Creteil, France; [Bouscaillou, Julie; Fontanet, Arnaud] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Falissard, Bruno] INSERM, U669, Paris, France; [Mohamed, Mostafa K.; Arafa, Naglaa; Bakr, Iman; El-Hoseiny, Mostafa] Ain Shams Univ, Dept Commun Environm & Occupat Med, Fac Med, Cairo, Egypt; [El Daly, Mai; El-Kafrawy, Sherif] Menoufia Univ, Natl Liver Inst, Shibin Al Kawm, Menufia, Egypt; [El Daly, Mai; El-Kafrawy, Sherif; Abdel-Hamid, Mohamed] Natl Hepatol & Trop Med Res Inst, Viral Hepatitis Res Lab, Cairo, Egypt; [Plancoulaine, Sabine] INSERM, U550, Paris, France; [Abdel-Hamid, Mohamed] Menia Univ, Dept Microbiol, Fac Med, Al Minya, Egypt; [Thiers, Valerie] Ctr Hepatobiliaire, INSERM, U785, Villejuif, France; [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Chaire Sante & Dev, Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); National Hepatology & Tropical Medicine Research Institute (NHTMRI); Institut National de la Sante et de la Recherche Medicale (Inserm); Egyptian Knowledge Bank (EKB); Minia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Feray, C (corresponding author), Hop Henri Mondor, Inserm 955, F-94010 Creteil, France.	cyrille.feray@gmail.com	Feray, Cyrille/S-2559-2018; El-Kafrawy, Sherif A/C-8699-2012; mohamed, mostafa/AFE-7371-2022; PLANCOULAINE, Sabine/E-2824-2017; El-Daly, Mai/C-4704-2013	El-Kafrawy, Sherif A/0000-0002-3667-7529; mohamed, mostafa/0000-0002-1421-2667; PLANCOULAINE, Sabine/0000-0003-0725-8306; Arafa, Naglaa/0000-0001-7015-0846; El-Daly, Mai/0000-0002-3864-523X; cyrille, feray/0000-0002-8627-9676; , arnaud/0000-0002-5239-6110	French Agency for the research on HIV and hepatitis [ANRS 1211, ANRS 12107]	French Agency for the research on HIV and hepatitis	This work was supported by the French Agency for the research on HIV and hepatitis (ANRS 1211 and ANRS 12107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz F, 2000, HEPATOLOGY, V32, P111, DOI 10.1053/jhep.2000.8438; Ackerman Z, 2000, J VIRAL HEPATITIS, V7, P93; Afonso AMR, 1999, J VIROL, V73, P9213, DOI 10.1128/JVI.73.11.9213-9221.1999; Arafa N, 2005, J HEPATOL, V43, P418, DOI 10.1016/j.jhep.2005.03.021; Collins KR, 2002, J VIROL, V76, P1697, DOI 10.1128/JVI.76.4.1697-1706.2002; Delarocque-Astagneau E, 2002, INFECT CONT HOSP EP, V23, P328, DOI 10.1086/502060; Diago M, 1996, J HEPATOL, V25, P125, DOI 10.1016/S0168-8278(96)80063-8; Dienstag JL, 1997, HEPATOLOGY, V26, pS66, DOI 10.1002/hep.510260712; Ducoulombier D, 2004, HEPATOLOGY, V39, P817, DOI 10.1002/hep.20087; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gigou M, 2001, J VIROL, V75, P11292, DOI 10.1128/JVI.75.23.11292-11297.2001; Jimenez AP, 2010, GUT, V59, P1554, DOI 10.1136/gut.2009.194266; KAMEL MA, 1992, LANCET, V340, P427, DOI 10.1016/0140-6736(92)91508-6; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Laouenan C, 2009, HUM GENET, V126, P697, DOI 10.1007/s00439-009-0721-y; LEGENDRE P, 1995, BRAIN BEHAV EVOLUT, V45, P110, DOI 10.1159/000113544; Magder LS, 2005, INT J EPIDEMIOL, V34, P160, DOI 10.1093/ije/dyh370; MANTEL N, 1967, CANCER RES, V27, P209; McKeating JA, 2004, J VIROL, V78, P8496, DOI 10.1128/JVI.78.16.8496-8505.2004; MEISEL H, 1995, LANCET, V345, P1209, DOI 10.1016/S0140-6736(95)91992-9; Mohamed MK, 2005, HEPATOLOGY, V42, P683, DOI 10.1002/hep.20811; Mostafa A, 2010, LIVER INT, V30, P560, DOI 10.1111/j.1478-3231.2009.02204.x; Murphy EL, 2000, HEPATOLOGY, V31, P756, DOI 10.1002/hep.510310329; PIAZZA M, 1995, J MED VIROL, V45, P40, DOI 10.1002/jmv.1890450108; Plancoulaine S, 2008, GUT, V57, P1268, DOI 10.1136/gut.2007.140681; Poss M, 1998, J VIROL, V72, P8240, DOI 10.1128/JVI.72.10.8240-8251.1998; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; SOKAL RR, 1992, P NATL ACAD SCI USA, V89, P7669, DOI 10.1073/pnas.89.16.7669; Stroffolini T, 2001, AM J GASTROENTEROL, V96, P3138, DOI 10.1111/j.1572-0241.2001.05267.x; Tahan V, 2005, AM J GASTROENTEROL, V100, P821, DOI 10.1111/j.1572-0241.2005.40879.x; WADDLE DM, 1994, NATURE, V368, P452, DOI 10.1038/368452a0; Zeuzem S, 1996, J HEPATOL, V24, P3	32	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86098	10.1371/journal.pone.0086098	http://dx.doi.org/10.1371/journal.pone.0086098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465895	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000050
J	Abd-Alhaseeb, MM; Zaitone, SA; Abou-El-Ela, SH; Moustafa, YM				Abd-Alhaseeb, Mohammad M.; Zaitone, Sawsan A.; Abou-El-Ela, Soad H.; Moustafa, Yasser M.			Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7)	PLOS ONE			English	Article							TYPE-1 RECEPTOR ANTAGONIST; ENDOTHELIAL GROWTH-FACTOR; HUMAN PANCREATIC-CANCER; I-CONVERTING-ENZYME; MICROVESSEL DENSITY; TUMOR ANGIOGENESIS; PROSTATE-CANCER; INHIBITS GROWTH; LUNG-CANCER; EXPRESSION	Local renin-angiotensin systems exist in various malignant tumor tissues; this suggests that the main effector peptide, angiotensin II, could act as a key factor in tumor growth. The underlying mechanisms for the anti-angiogenic effect of angiotensin II type 1 receptor blockers need to be further evaluated. The present study was carried out to investigate the anti-angiogenic effect of olmesartan alone or in combination with sorafenib, an angiotensin (1-7) agonist or an angiotensin (1-7) antagonist in Ehrlich's ascites carcinoma-bearing mice. The tumor was induced by intradermal injection of Ehrlich's ascites carcinoma cells into mice. Tumor discs were used to evaluate the microvessel density; the serum levels of vascular endothelial growth factor (VEGF) and serum insulin-like growth factor I (IGF-I); and their intratumoral receptors, VEGF receptor-2 and IGF-I receptor, respectively. All parameters were determined following the treatment course, which lasted for 21 days post-inoculation. Monotherapy with olmesartan and its combination with sorafenib resulted in a significant reduction in microvessel density and serum levels of VEGF and IGF-I, as well as their intratumoral receptors. In addition, the combination of olmesartan (30 mg/kg) with an angiotensin (1-7) agonist reduced the microvessel density, IGF-I serum levels and the levels of its intratumoral receptor. In conclusion, olmesartan reduced the levels of the angiogenesis markers IGF-I and VEGF and down-regulated the intratumoral expression of their receptors in a dose-dependent manner, and these effects were dependent on the angiotensin (1-7) receptor. These results suggest that olmesartan is a promising adjuvant to sorafenib in the treatment of cancer.	[Abd-Alhaseeb, Mohammad M.] Sinai Univ, Fac Pharm & Pharmaceut Ind, Dept Pharmacol & Toxicol, Arish, Egypt; [Zaitone, Sawsan A.; Moustafa, Yasser M.] Suez Canal Univ, Fac Pharm, Dept Pharmacol & Toxicol, Ismailia, Egypt; [Abou-El-Ela, Soad H.] Sinai Univ, Fac Pharm & Pharmaceut Ind, Dept Biochem, Arish, Egypt	Egyptian Knowledge Bank (EKB); Sinai University; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Sinai University	Abd-Alhaseeb, MM (corresponding author), Sinai Univ, Fac Pharm & Pharmaceut Ind, Dept Pharmacol & Toxicol, Arish, Egypt.	m.abdelhasseb@su.edu.eg	Abd-Alhaseeb, Mohammad M/R-6176-2017; Zaitone, Sawsan A/G-8930-2017; Moustafa, Yasser/AAS-1212-2021	Abd-Alhaseeb, Mohammad M/0000-0001-5388-5250; Zaitone, Sawsan A/0000-0002-9688-7683; Moustafa, Yasser/0000-0001-5394-5559				Abali H, 2002, MED HYPOTHESES, V59, P344, DOI 10.1016/S0306-9877(02)00185-8; Ager EI, 2008, CARCINOGENESIS, V29, P1675, DOI 10.1093/carcin/bgn171; AL Abdan M, 2012, SCI WORLD J, DOI 10.1100/2012/509838; Chen M, 2001, HYPERTENS RES, V24, P323, DOI 10.1291/hypres.24.323; Choi WWL, 2005, MODERN PATHOL, V18, P143, DOI 10.1038/modpathol.3800253; El-Azab M, 2011, EUR J PHARMACOL, V652, P7, DOI 10.1016/j.ejphar.2010.11.008; Ferrario CM, 2005, KIDNEY INT, V68, P2189, DOI 10.1111/j.1523-1755.2005.00675.x; Ferrario CM, 1997, HYPERTENSION, V30, P535, DOI 10.1161/01.HYP.30.3.535; Ferreira E, 2007, PATHOL RES PRACT, V203, P39, DOI 10.1016/j.prp.2006.09.005; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fraga-Silva RA, 2011, CLINICS, V66, P837, DOI 10.1590/S1807-59322011000500021; Fujimoto Y, 2001, FEBS LETT, V495, P197, DOI 10.1016/S0014-5793(01)02377-8; Fujita M, 2002, BIOCHEM BIOPH RES CO, V294, P441, DOI 10.1016/S0006-291X(02)00496-5; Funao K, 2008, ONCOL REP, V20, P295, DOI 10.3892/or_00000006; Goldenberg I, 2001, J HYPERTENS, V19, P1681, DOI 10.1097/00004872-200109000-00022; Gong QK, 2010, PANCREAS, V39, P581, DOI 10.1097/MPA.0b013e3181c314cd; Grunstein J, 1999, CANCER RES, V59, P1592; Habib SA., 2012, NAT SCI, V4, P808, DOI [10.4236/NS.2012.411108, DOI 10.4236/NS.2012.411108]; Hoff PM, 2012, CANCER TREAT REV, V38, P825, DOI 10.1016/j.ctrv.2012.04.006; Hofmann F, 2005, DRUG DISCOV TODAY, V10, P1041, DOI 10.1016/S1359-6446(05)03512-9; Huang W, 2008, DIGEST DIS SCI, V53, P1206, DOI 10.1007/s10620-007-0009-9; Huynh H, 2009, MOL CANCER THER, V8, P152, DOI 10.1158/1535-7163.MCT-08-0553; Inwang ER, 1997, BRIT J CANCER, V75, P1279, DOI 10.1038/bjc.1997.217; Jawen J, 2012, J PHYSIOL PHARMACOL, V63, P77; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kim S, 2000, PHARMACOL REV, V52, P11; Kosaka T, 2007, PROSTATE, V67, P41, DOI 10.1002/pros.20486; Kosugi M, 2006, CLIN CANCER RES, V12, P2888, DOI 10.1158/1078-0432.CCR-05-2213; Koukourakis MI, 2000, CANCER RES, V60, P3088; LAZARUS H., 1966, CANCER CHEMOTHERAP REP, V50, P543; Liu CY, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3457; Menon J, 2007, CANCER RES, V67, P2809, DOI 10.1158/0008-5472.CAN-06-3614; Miyajima A, 2002, CANCER RES, V62, P4176; Munzenmaier DH, 1996, HYPERTENSION, V27, P760, DOI 10.1161/01.HYP.27.3.760; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Ozaslan M, 2011, AFR J BIOTECHNOL, V10, P2375; Passos-Silva DG, 2013, CLIN SCI, V124, P443, DOI 10.1042/CS20120461; Rahbari-Oskoui F, 2011, AM J KIDNEY DIS, V57, P7, DOI 10.1053/j.ajkd.2010.09.012; Rakusan K, 2007, AM J PHYSIOL-HEART C, V292, pH1237, DOI 10.1152/ajpheart.00965.2006; Ratain MJ, 2006, J CLIN ONCOL, V24, P2505, DOI 10.1200/JCO.2005.03.6723; Reinmuth N, 2002, CLIN CANCER RES, V8, P3259; Schult C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-560; Schutz FAB, 2011, CRIT REV ONCOL HEMAT, V80, P291, DOI 10.1016/j.critrevonc.2010.11.007; Sica DA, 2006, J CLIN ONCOL, V24, P1329, DOI 10.1200/JCO.2005.04.5740; Siegelin MD, 2010, NEUROSCI LETT, V478, P165, DOI 10.1016/j.neulet.2010.05.009; Silva Alessandra Estrela da, 2004, Arq Bras Endocrinol Metabol, V48, P867; Soto-Pantoja DR, 2009, MOL CANCER THER, V8, P1676, DOI 10.1158/1535-7163.MCT-09-0161; Tallant EA, 1999, HYPERTENSION, V34, P950, DOI 10.1161/01.HYP.34.4.950; Tallant EA, 2003, HYPERTENSION, V42, P574, DOI 10.1161/01.HYP.0000090322.55782.30; Tamarat R, 2002, LAB INVEST, V82, P747, DOI 10.1097/01.LAB.0000017372.76297.EB; Taskinen M, 2010, EUR J CANCER, V46, P2506, DOI 10.1016/j.ejca.2010.06.014; Toyz RM, 2002, BRAZ J MED BIOL RES, V35, P1001, DOI 10.1590/S0100-879X2002000900001; Tsuda M, 2005, HYPERTENSION, V45, P545, DOI 10.1161/01.HYP.0000157409.88971.fc; Uemura Hiroji, 2005, Int J Clin Oncol, V10, P405, DOI 10.1007/s10147-005-0520-y; Ullrich RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019592; Walsh DA, 1997, BRIT J PHARMACOL, V120, P1302, DOI 10.1038/sj.bjp.0701062; Wang W, 2009, J INT MED RES, V37, P417, DOI 10.1177/147323000903700217; Wang YL, 2002, CURR CANCER DRUG TAR, V2, P191, DOI 10.2174/1568009023333863; Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Zaitone SA, 2012, EUR J PHARMACOL, V691, P134, DOI 10.1016/j.ejphar.2012.06.022	61	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85891	10.1371/journal.pone.0085891	http://dx.doi.org/10.1371/journal.pone.0085891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465768	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100086
J	Iglesias, I; Lorenzo, MN; Taboada, JJ				Iglesias, Isabel; Lorenzo, Maria N.; Taboada, Juan J.			Seasonal Predictability of the East Atlantic Pattern from Sea Surface Temperatures	PLOS ONE			English	Article							EURASIAN SNOW COVER; NORTH-ATLANTIC; ATMOSPHERIC CIRCULATION; IBERIAN PENINSULA; EL-NINO; TELECONNECTION PATTERNS; PRECIPITATION; VARIABILITY; OSCILLATION; RAINFALL	This study analyzes the influence of sea surface temperatures (SSTs) on the second mode of atmospheric variability in the north Atlantic/European sector, namely the East-Atlantic (EA) pattern, for the period 1950-2012. For this purpose, lead-lag relationships between SSTs and the EA pattern, ranging from 0 to 3 seasons, were assessed. As a main result, anomalies of the EA pattern in boreal summer and autumn are significantly related to SST anomalies in the Indo-Pacific Ocean during the preceding seasons. A statistical forecasting scheme based on multiple linear regression was used to hindcast the EA-anomalies with a lead-time of 1 to 2 months. The results of a one-year-out cross-validation approach indicate that the phases of the EA in summer and autumn can be properly hindcast.	[Iglesias, Isabel; Lorenzo, Maria N.] Univ Vigo, Fac Ciencias, Grupo Fis Atmosfera Oceano, Orense, Spain; [Iglesias, Isabel] Univ Porto, Ctr Interdisciplinar Invest Marinha Ambiental, P-4100 Oporto, Portugal; [Taboada, Juan J.] Xunta Galicia, Meteogalicia, Santiago De Compostela, Spain	Universidade de Vigo; Universidade do Porto	Iglesias, I (corresponding author), Univ Vigo, Fac Ciencias, Grupo Fis Atmosfera Oceano, Orense, Spain.	iiglesias@fe.up.pt	de las Nieves Lorenzo, María/B-9924-2011; Iglesias, Isabel/G-8407-2015	de las Nieves Lorenzo, María/0000-0001-5302-8312; Iglesias, Isabel/0000-0002-4900-135X; Taboada, Juan/0000-0001-9023-473X	Xunta de Galicia [10PXIB383169PR]; European Regional Development Fund (FEDER); RAIA [0313-RAIA-1-E]; RAIA. co [0520-RAIA-CO-1-E]; Programa Operativo de Cooperacion Transfronteriza Espana-Portugal (POCTEP); Department of Environment of the Galician Government (Xunta de Galicia)	Xunta de Galicia(Xunta de GaliciaEuropean Commission); European Regional Development Fund (FEDER)(European Commission); RAIA; RAIA. co; Programa Operativo de Cooperacion Transfronteriza Espana-Portugal (POCTEP); Department of Environment of the Galician Government (Xunta de Galicia)(Xunta de Galicia)	This work was supported by the Xunta de Galicia under Research Grant No. 10PXIB383169PR and co-financing by European Regional Development Fund (FEDER). Isabel Iglesias was supported by postdoctoral funds from RAIA (0313-RAIA-1-E) and RAIA. co (0520-RAIA-CO-1-E) projects. The RAIA Coastal Observatory has been funded by the Programa Operativo de Cooperacion Transfronteriza Espana-Portugal (POCTEP 2007-2013). Juan J. Taboada acknowledges the financial support from the Department of Environment of the Galician Government (Xunta de Galicia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MA, 2002, J CLIMATE, V15, P2205, DOI 10.1175/1520-0442(2002)015<2205:TABTIO>2.0.CO;2; Baldwin MP, 2003, SCIENCE, V301, P636, DOI 10.1126/science.1087143; BARNETT TP, 1989, J ATMOS SCI, V46, P661, DOI 10.1175/1520-0469(1989)046<0661:TEOESC>2.0.CO;2; BARNSTON AG, 1987, MON WEATHER REV, V115, P1083, DOI 10.1175/1520-0493(1987)115<1083:CSAPOL>2.0.CO;2; Bell CJ, 2009, J CLIMATE, V22, P4083, DOI 10.1175/2009JCLI2717.1; Brands S, 2013, J APPL METEOROL CLIM, V52, P1297, DOI 10.1175/JAMC-D-12-0303.1; Brands S, 2012, J CLIMATE, V25, P4023, DOI 10.1175/JCLI-D-12-00083.1; Bretherton CS, 1999, J CLIMATE, V12, P1990, DOI 10.1175/1520-0442(1999)012<1990:TENOSD>2.0.CO;2; Bronnimann S, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000199; Budikova D, 2009, GLOBAL PLANET CHANGE, V68, P149, DOI 10.1016/j.gloplacha.2009.04.001; Cassou C, 2004, J CLIMATE, V17, P3349, DOI 10.1175/1520-0442(2004)017<3349:SSSTCI>2.0.CO;2; Cassou C, 2007, J CLIMATE, V20, P3510, DOI 10.1175/JCLI4202.1; Comas-Bru L, 2014, Q J ROY METEOR SOC, V140, P354, DOI 10.1002/qj.2158; Czaja A, 2002, J CLIMATE, V15, P606, DOI 10.1175/1520-0442(2002)015<0606:OIOASA>2.0.CO;2; deCastro M, 2008, CLIM RES, V36, P169, DOI 10.3354/cr00742; Decastro M, 2006, CLIM RES, V32, P63, DOI 10.3354/cr032063; Doblas-Reyes FJ, 2013, WIRES CLIM CHANGE, V4, P245, DOI 10.1002/wcc.217; Douville H, 2000, CLIM DYNAM, V16, P719, DOI 10.1007/s003820000080; Frias MD, 2010, J CLIMATE, V23, P209, DOI 10.1175/2009JCLI2824.1; Garcia-Morales MB, 2007, INT J CLIMATOL, V27, P1691, DOI 10.1002/joc.1608; HAHN DG, 1976, J ATMOS SCI, V33, P2461, DOI 10.1175/1520-0469(1976)033<2461:AARBES>2.0.CO;2; Hoerling MP, 2001, SCIENCE, V292, P90, DOI 10.1126/science.1058582; Hoerling MP, 2004, CLIM DYNAM, V23, P391, DOI 10.1007/s00382-004-0433-x; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Ineson S, 2009, NAT GEOSCI, V2, P32, DOI 10.1038/NGEO381; Jewson S., 2005, WEATHER DERIVATIVE V; Josey SA, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006685; Knippertz P, 2003, INT J CLIMATOL, V23, P1293, DOI 10.1002/joc.944; Lau NC, 2001, J CLIMATE, V14, P2846, DOI 10.1175/1520-0442(2001)014<2846:IOEOSV>2.0.CO;2; LIVEZEY RE, 1983, MON WEATHER REV, V111, P46, DOI 10.1175/1520-0493(1983)111<0046:SFSAID>2.0.CO;2; Lorenzo MN, 2008, INT J CLIMATOL, V28, P1493, DOI 10.1002/joc.1646; Lorenzo MN, 2010, INT J CLIMATOL, V30, P980, DOI 10.1002/joc.1959; Mariotti A, 2005, CLIM DYNAM, V24, P511, DOI 10.1007/s00382-004-0498-6; Marshall J, 2001, INT J CLIMATOL, V21, P1863, DOI 10.1002/joc.693; Meza FJ, 2008, J APPL METEOROL CLIM, V47, P1269, DOI 10.1175/2007JAMC1540.1; MICHAELSEN J, 1987, J CLIM APPL METEOROL, V26, P1589, DOI 10.1175/1520-0450(1987)026<1589:CVISCF>2.0.CO;2; MURPHY AH, 1987, MON WEATHER REV, V115, P1330, DOI 10.1175/1520-0493(1987)115<1330:AGFFFV>2.0.CO;2; Nurmi P, 2003, SERIES ECMWF TECHNIC; Paeth H, 2003, CLIM DYNAM, V21, P63, DOI 10.1007/s00382-003-0318-4; Phillips ID, 2006, INT J CLIMATOL, V26, P1201, DOI 10.1002/joc.1302; Phillips ID, 2002, INT J CLIMATOL, V22, P197, DOI 10.1002/joc.726; Pozo-Vazquez D, 2005, INT J CLIMATOL, V25, P17, DOI 10.1002/joc.1097; Rodriguez-Fonseca B, 2006, INT J CLIMATOL, V26, P179, DOI 10.1002/joc.1234; Rodriguez-Fonseca B, 2002, J CLIMATE, V15, P1309, DOI 10.1175/1520-0442(2002)015<1309:WDCPBG>2.0.CO;2; Rodriguez-Puebla C, 2010, CLIMATIC CHANGE, V100, P667, DOI 10.1007/s10584-009-9721-0; Rodwell MJ, 1999, NATURE, V398, P320, DOI 10.1038/18648; Saenz J, 2001, J GEOPHYS RES-ATMOS, V106, P20641, DOI 10.1029/2001JD900247; Salmaso N, 2012, CLIM RES, V51, P125, DOI 10.3354/cr01063; Serrano A, 1999, J CLIMATE, V12, P2894, DOI 10.1175/1520-0442(1999)012<2894:MMOVOP>2.0.CO;2; Smith DM, 2007, SCIENCE, V317, P796, DOI 10.1126/science.1139540; Taboada JJ, 2005, J ATMOS OCEAN SCI, V10, P377, DOI [10.1080/17417530601127472, DOI 10.1080/17417530601127472]; Thomson MC, 2008, SEASONAL FORECASTS C; Trenberth KE, 1998, J GEOPHYS RES-OCEANS, V103, P14291, DOI 10.1029/97JC01444; Van Oldenborgh GJ, 2000, INT J CLIMATOL, V20, P565, DOI [10.1002/(SICI)1097-0088(200004)20:5<565::AID-JOC488>3.0.CO;2-5, 10.1002/(SICI)1097-0088(200004)20:5&lt;565::AID-JOC488&gt;3.0.CO;2-5]; Vicente-Serrano SM, 2006, INT J CLIMATOL, V26, P1427, DOI 10.1002/joc.1387; Wilks DS, 2006, STAT METHODS ATMOSPH	56	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86439	10.1371/journal.pone.0086439	http://dx.doi.org/10.1371/journal.pone.0086439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466098	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100166
J	Ludlow, LE; Hasang, W; Umbers, AJ; Forbes, EK; Ome, M; Unger, HW; Mueller, I; Siba, PM; Jaworowski, A; Rogerson, SJ				Ludlow, Louise E.; Hasang, Wina; Umbers, Alexandra J.; Forbes, Emily K.; Ome, Maria; Unger, Holger W.; Mueller, Ivo; Siba, Peter M.; Jaworowski, Anthony; Rogerson, Stephen J.			Peripheral Blood Mononuclear Cells Derived from Grand Multigravidae Display a Distinct Cytokine Profile in Response to P. falciparum Infected Erythrocytes	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PLASMODIUM-FALCIPARUM; PLACENTAL MALARIA; INTERFERON-GAMMA; HUMAN SYNCYTIOTROPHOBLAST; DEPENDENT MANNER; PREGNANT-WOMEN; BIRTH-WEIGHT; IMMUNITY; TRANSMISSION	Immunopathology of placental malaria is most significant in women in their first pregnancy especially in endemic areas, due to a lack of protective immunity to Plasmodium falciparum, which is acquired in successive pregnancies. In some studies (but not all), grand multigravidae (defined as 5 or more pregnancies, G5-7) are more susceptible to poor birth outcomes associated with malaria compared to earlier gravidities. By comparing peripheral cellular responses in primigravidae (G1), women in their second to fourth pregnancy (G2-4) and grand multigravidae we sought to identify key components of the dysregulated immune response. PBMC were exposed to CS2-infected erythrocytes (IE) opsonised with autologous plasma or unopsonised IE, and cytokine and chemokine secretion was measured. Higher levels of opsonising antibody were present in plasma derived from multigravid compared to primigravid women. Significant differences in the levels of cytokines and chemokines secreted in response to IE were observed. Less IL-10, IL-1 beta, IL-6 and TNF but more CXCL8, CCL8, IFN gamma and CXCL10 were detected in G5-7 compared to G2-4 women. Our study provides fresh insight into the modulation of peripheral blood cell function and effects on the balance between host protection and immunopathology during placental malaria infection.	[Ludlow, Louise E.; Hasang, Wina; Umbers, Alexandra J.; Forbes, Emily K.; Unger, Holger W.; Rogerson, Stephen J.] Univ Melbourne, PO Royal Melbourne Hosp, Dept Med RMH, Melbourne, Vic, Australia; [Ludlow, Louise E.; Hasang, Wina; Umbers, Alexandra J.; Forbes, Emily K.; Unger, Holger W.; Rogerson, Stephen J.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia; [Umbers, Alexandra J.; Ome, Maria; Unger, Holger W.; Siba, Peter M.] Papua New Guinea Inst Med Res, Vector Borne Dis Unit, Madang, Papua N Guinea; [Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Mueller, Ivo] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Jaworowski, Anthony] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Jaworowski, Anthony] Monash Univ, Dept Infect Dis, Clayton, Vic 3800, Australia; [Jaworowski, Anthony] Monash Univ, Dept Immunol, Clayton, Vic 3800, Australia	Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; PNG Institute Of Medical Research; Walter & Eliza Hall Institute; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Burnet Institute; Monash University; Monash University	Ludlow, LE (corresponding author), Univ Melbourne, PO Royal Melbourne Hosp, Dept Med RMH, Melbourne, Vic, Australia.	lludlow@unimelb.edu.au		Hasang, Wina/0000-0001-8664-7558; jaworowski, anthony/0000-0002-3844-805X; Rogerson, Stephen/0000-0003-4287-1982	Australian NHMRC Project [628611]; MiP Consortium; Bill & Melinda Gates Foundation	Australian NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia); MiP Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Australian NHMRC Project Grant 628611 to AJ and SJR. This study was supported by the MiP Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Ataide R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022491; Ataide R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010807; Bayoumi NK, 2009, J TROP PEDIATRICS, V55, P233, DOI 10.1093/tropej/fmn062; BRAY RS, 1979, T ROY SOC TROP MED H, V73, P427, DOI 10.1016/0035-9203(79)90170-6; CELADA A, 1982, CLIN EXP IMMUNOL, V47, P635; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; D'Ombrain MC, 2008, CLIN INFECT DIS, V47, P1380, DOI 10.1086/592971; D'Ombrain MC, 2007, CELL HOST MICROBE, V2, P130, DOI 10.1016/j.chom.2007.06.012; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Fievet N, 2001, J INFECT DIS, V183, P1530, DOI 10.1086/320201; Fried M, 1998, J IMMUNOL, V160, P2523; GREENWOOD BM, 1989, T ROY SOC TROP MED H, V83, P589, DOI 10.1016/0035-9203(89)90362-3; Jaworowski A, 2009, CLIN VACCINE IMMUNOL, V16, P312, DOI 10.1128/CVI.00356-08; Kline K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001755; Lucchi NW, 2007, J REPROD IMMUNOL, V73, P20, DOI 10.1016/j.jri.2006.05.005; Lucchi NW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-42; Ludlow LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032102; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Marielle KB, 2004, EUR CYTOKINE NETW, V15, P120; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Moore JM, 1999, J INFECT DIS, V179, P1218, DOI 10.1086/314737; Moormann AM, 1999, J INFECT DIS, V180, P1987, DOI 10.1086/315135; MORLEY D, 1964, BRIT MED J, V1, P667, DOI 10.1136/bmj.1.5384.667; Murphy SP, 2009, BIOL REPROD, V80, P848, DOI 10.1095/biolreprod.108.073353; Nacher M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-259; Ordi J, 2001, J INFECT DIS, V183, P1100, DOI 10.1086/319295; Proost P, 1996, J LEUKOCYTE BIOL, V59, P67, DOI 10.1002/jlb.59.1.67; Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Robinson LJ, 2009, INFECT IMMUN, V77, P3033, DOI 10.1128/IAI.00211-09; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; SCHOFIELD L, 1993, J EXP MED, V177, P145, DOI 10.1084/jem.177.1.145; Senn N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001195; SHERRY BA, 1995, J INFLAMM, V45, P85; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Suguitan AL, 2003, AM J TROP MED HYG, V69, P574, DOI 10.4269/ajtmh.2003.69.574; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; WATKINSON M, 1983, BMJ-BRIT MED J, V287, P251, DOI 10.1136/bmj.287.6387.251; Wilson N. O., 2010, Infectious Diseases in Obstetrics and Gynecology, V2010, P317430, DOI 10.1155/2010/317430; Zhou JL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-343	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86160	10.1371/journal.pone.0086160	http://dx.doi.org/10.1371/journal.pone.0086160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465935	Green Published, gold			2022-12-25	WOS:000330283100116
J	Brodeur, MR; Bouvet, C; Bouchard, S; Moreau, S; Leblond, J; deBlois, D; Moreau, P				Brodeur, Mathieu R.; Bouvet, Celine; Bouchard, Sonia; Moreau, Simon; Leblond, Jeanne; deBlois, Denis; Moreau, Pierre			Reduction of Advanced-Glycation End Products Levels and Inhibition of RAGE Signaling Decreases Rat Vascular Calcification Induced by Diabetes	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ISOLATED SYSTOLIC HYPERTENSION; MEDIAL ARTERIAL CALCIFICATION; CROSS-LINK BREAKER; OXIDATIVE STRESS; IN-VITRO; SUPEROXIDE-PRODUCTION; GENE-EXPRESSION; AGE; ACTIVATION	Advanced-glycation end products (AGEs) were recently implicated in vascular calcification, through a process mediated by RAGE (receptor for AGEs). Although a correlation between AGEs levels and vascular calcification was established, there is no evidence that reducing in vivo AGEs deposition or inhibiting AGEs-RAGE signaling pathways can decrease medial calcification. We evaluated the impact of inhibiting AGEs formation by pyridoxamine or elimination of AGEs by alagebrium on diabetic medial calcification. We also evaluated if the inhibition of AGEs-RAGE signaling pathways can prevent calcification. Rats were fed a high fat diet during 2 months before receiving a low dose of streptozotocin. Then, calcification was induced with warfarin. Pyridoxamine was administered at the beginning of warfarin treatment while alagebrium was administered 3 weeks after the beginning of warfarin treatment. Results demonstrate that AGEs inhibitors prevent the time-dependent accumulation of AGEs in femoral arteries of diabetic rats. This effect was accompanied by a reduced diabetes-accelerated calcification. Ex vivo experiments showed that N-methylpyridinium, an agonist of RAGE, induced calcification of diabetic femoral arteries, a process inhibited by antioxidants and different inhibitors of signaling pathways associated to RAGE activation. The physiological importance of oxidative stress was demonstrated by the reduction of femoral artery calcification in diabetic rats treated with apocynin, an inhibitor of reactive oxygen species production. We demonstrated that AGE inhibitors prevent or limit medial calcification. We also showed that diabetes-accelerated calcification is prevented by antioxidants. Thus, inhibiting the association of AGE-RAGE or the downstream signaling reduced medial calcification in diabetes.	[Brodeur, Mathieu R.; Bouvet, Celine; Bouchard, Sonia; Moreau, Simon; Leblond, Jeanne; deBlois, Denis; Moreau, Pierre] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Moreau, P (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada.	Pierre.moreau@umontreal.ca	Leblond, Jeanne/T-3453-2019	Chain Leblond, Jeanne/0000-0001-8390-4811; Moreau, Pierre/0000-0002-3604-721X	Pfizer Canada; Canadian Institutes for Health Research (CIHR); Rx D/CIHR; Fonds de la recherche en sante du Quebec (FRSQ)	Pfizer Canada(Pfizer); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Rx D/CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This project was supported by grants from Pfizer Canada and the Canadian Institutes for Health Research (CIHR). CB received a studentship from the Rx & D/CIHR and SM from the Fonds de la recherche en sante du Quebec (FRSQ). MRB was a fellow from Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baidoshvili A, 2004, ATHEROSCLEROSIS, V174, P287, DOI 10.1016/j.atherosclerosis.2004.02.012; Basta G, 2005, ARTERIOSCL THROM VAS, V25, P1401, DOI 10.1161/01.ATV.0000167522.48370.5e; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Boettler U, 2011, MOL NUTR FOOD RES, V55, P798, DOI 10.1002/mnfr.201100115; Bouvet C, 2008, ARTERIOSCL THROM VAS, V28, P856, DOI 10.1161/ATVBAHA.107.153056; Bouvet C, 2007, CARDIOVASC RES, V73, P504, DOI 10.1016/j.cardiores.2006.11.001; Bowman MAH, 2011, ARTERIOSCL THROM VAS, V31, P337, DOI 10.1161/ATVBAHA.110.217745; Brodeur MR, 2013, J VASC RES, V50, P430, DOI 10.1159/000354235; Bruel A, 1996, ATHEROSCLEROSIS, V127, P155, DOI 10.1016/S0021-9150(96)05947-3; Cameron JD, 2003, DIABETES CARE, V26, P2133, DOI 10.2337/diacare.26.7.2133; CHANTELAU E, 1995, DIABETES RES CLIN PR, V29, P169, DOI 10.1016/0168-8227(95)01126-9; Conway B, 2010, DIABETES TECHNOL THE, V12, P339, DOI 10.1089/dia.2009.0152; CORBETT JA, 1992, DIABETES, V41, P552, DOI 10.2337/diabetes.41.4.552; Corman B, 1998, P NATL ACAD SCI USA, V95, P1301, DOI 10.1073/pnas.95.3.1301; Coughlan MT, 2007, KIDNEY INT, V72, pS54, DOI 10.1038/sj.ki.5002387; Dao HH, 2005, CARDIOVASC RES, V66, P307, DOI 10.1016/j.cardiores.2005.01.012; Edmonds ME, 2000, Z KARDIOL, V89, P101; EDMONDS ME, 1982, BRIT MED J, V284, P928, DOI 10.1136/bmj.284.6320.928; Essalihi R, 2003, AM J HYPERTENS, V16, P103, DOI 10.1016/S0895-7061(02)03204-1; EVERHART JE, 1988, DIABETOLOGIA, V31, P16; Farsang C, 2001, J HYPERTENS, V19, P2279, DOI 10.1097/00004872-200112000-00023; Gawdzik J, 2011, AM J NEPHROL, V33, P250, DOI 10.1159/000324693; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Gupte AA, 2009, J APPL PHYSIOL, V106, P1425, DOI 10.1152/japplphysiol.91210.2008; GYLLENHAMMAR H, 1987, J IMMUNOL METHODS, V97, P209, DOI 10.1016/0022-1759(87)90461-3; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Inoguchi T, 2003, J AM SOC NEPHROL, V14, pS227, DOI 10.1097/01.ASN.0000077407.90309.65; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Kass DA, 2001, CIRCULATION, V104, P1464, DOI 10.1161/hc3801.097806; Kim HJ, 2010, ARTERIOSCL THROM VAS, V30, P2164, DOI 10.1161/ATVBAHA.110.212308; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Konova E, 2004, EXP GERONTOL, V39, P249, DOI 10.1016/j.exger.2003.10.003; Lehto S, 1996, ARTERIOSCL THROM VAS, V16, P978, DOI 10.1161/01.ATV.16.8.978; Li YB, 1998, J BIOL CHEM, V273, P2015, DOI 10.1074/jbc.273.4.2015; Liberman M, 2008, ARTERIOSCL THROM VAS, V28, P463, DOI 10.1161/ATVBAHA.107.156745; MONNIER VM, 1986, NEW ENGL J MED, V314, P403, DOI 10.1056/NEJM198602133140702; Muteliefu G, 2009, NEPHROL DIAL TRANSPL, V24, P2051, DOI 10.1093/ndt/gfn757; Nitenberg A, 2007, CARDIOVASC RES, V73, P450, DOI 10.1016/j.cardiores.2006.12.004; NUGENT LJ, 1984, CANCER RES, V44, P238; Qian MW, 1998, BIOCHEM BIOPH RES CO, V250, P385, DOI 10.1006/bbrc.1998.9326; Ren X, 2009, J INT MED RES, V37, P847, DOI 10.1177/147323000903700329; Sakata N, 2003, J VASC RES, V40, P567, DOI 10.1159/000075807; Sakata N, 2003, NEPHROL DIAL TRANSPL, V18, P1601, DOI 10.1093/ndt/gfg200; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Skatchkov MP, 1999, BIOCHEM BIOPH RES CO, V254, P319, DOI 10.1006/bbrc.1998.9942; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Suga T, 2011, J ATHEROSCLER THROMB, V18, P670, DOI 10.5551/jat.7120; Sun M, 1998, INT J EXP PATHOL, V79, P207; Sutra T, 2008, FREE RADICAL RES, V42, P789, DOI 10.1080/10715760802400766; Taki K, 2006, KIDNEY INT, V70, P218, DOI 10.1038/sj.ki.5000330; Tang FT, 2006, CALCIFIED TISSUE INT, V79, P326, DOI 10.1007/s00223-006-0004-8; Tanikawa T, 2009, J VASC RES, V46, P572, DOI 10.1159/000226225; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; Vasan S, 2003, ARCH BIOCHEM BIOPHYS, V419, P89, DOI 10.1016/j.abb.2003.08.016; Voziyan PA, 2003, J BIOL CHEM, V278, P46616, DOI 10.1074/jbc.M307155200; Voziyan PA, 2005, ANN NY ACAD SCI, V1043, P807, DOI 10.1196/annals.1333.093; Wang XH, 2011, BBA-MOL CELL RES, V1813, P827, DOI 10.1016/j.bbamcr.2011.01.027; Wang ZQ, 2012, ATHEROSCLEROSIS, V221, P387, DOI 10.1016/j.atherosclerosis.2012.01.019; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; Winlove CP, 1996, DIABETOLOGIA, V39, P1131, DOI 10.1007/BF02658498; Wolffenbuttel BHR, 1998, P NATL ACAD SCI USA, V95, P4630, DOI 10.1073/pnas.95.8.4630; Zieman SJ, 2007, J HYPERTENS, V25, P577, DOI 10.1097/HJH.0b013e328013e7dd; Zill H, 2003, BIOCHEM BIOPH RES CO, V300, P311, DOI 10.1016/S0006-291X(02)02856-5	65	57	60	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85922	10.1371/journal.pone.0085922	http://dx.doi.org/10.1371/journal.pone.0085922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465790	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500145
J	French, AS; Meisner, S; Su, CY; Torkkeli, PH				French, Andrew S.; Meisner, Shannon; Su, Chih-Ying; Torkkeli, Paeivi H.			Carbon Dioxide and Fruit Odor Transduction in Drosophila Olfactory Neurons. What Controls their Dynamic Properties?	PLOS ONE			English	Article							RECEPTOR NEURONS; PHEROMONE; STIMULUS; CO2; STIMULATION; INFORMATION; MECHANISMS; RANGE	We measured frequency response functions between odorants and action potentials in two types of neurons in Drosophila antennal basiconic sensilla. CO2 was used to stimulate ab1C neurons, and the fruit odor ethyl butyrate was used to stimulate ab3A neurons. We also measured frequency response functions for light-induced action potential responses from transgenic flies expressing H134R-channelrhodopsin-2 (ChR2) in the ab1C and ab3A neurons. Frequency response functions for all stimulation methods were well-fitted by a band-pass filter function with two time constants that determined the lower and upper frequency limits of the response. Low frequency time constants were the same in each type of neuron, independent of stimulus method, but varied between neuron types. High frequency time constants were significantly slower with ethyl butyrate stimulation than light or CO2 stimulation. In spite of these quantitative differences, there were strong similarities in the form and frequency ranges of all responses. Since light-activated ChR2 depolarizes neurons directly, rather than through a chemoreceptor mechanism, these data suggest that low frequency dynamic properties of Drosophila olfactory sensilla are dominated by neuron-specific ionic processes during action potential production. In contrast, high frequency dynamics are limited by processes associated with earlier steps in odor transduction, and CO2 is detected more rapidly than fruit odor.	[French, Andrew S.; Meisner, Shannon; Torkkeli, Paeivi H.] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada; [Su, Chih-Ying] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA	Dalhousie University; University of California System; University of California San Diego	French, AS (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada.	andrew.french@dal.ca		French, Andrew/0000-0001-8190-4084; Torkkeli, Paivi/0000-0002-8205-7339	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Baker TC, 2012, CHEM SENSES, V37, P299, DOI 10.1093/chemse/bjr122; Barrozo RB, 2006, J COMP PHYSIOL A, V192, P827, DOI 10.1007/s00359-006-0120-y; Benton R, 2008, CURR OPIN NEUROBIOL, V18, P357, DOI 10.1016/j.conb.2008.08.012; Campagnola L, 2008, J NEUROSCI METH, V169, P27, DOI 10.1016/j.jneumeth.2007.11.012; COOLEY JW, 1965, MATH COMPUT, V19, P297, DOI 10.2307/2003354; Faucher CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056361; French AS, 2007, CHEM SENSES, V32, P681, DOI 10.1093/chemse/bjm035; French AS, 2011, J NEUROSCI, V31, P861, DOI 10.1523/JNEUROSCI.5243-10.2011; French AS, 2009, BIOL CYBERN, V100, P417, DOI 10.1007/s00422-008-0262-9; FRENCH AS, 1971, KYBERNETIK, V8, P165, DOI 10.1007/BF00291117; Geier M, 1999, J EXP BIOL, V202, P1639; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Justus KA, 2005, J NEUROPHYSIOL, V93, P2233, DOI 10.1152/jn.00888.2004; Justus KA, 2002, PHYSIOL ENTOMOL, V27, P58, DOI 10.1046/j.1365-3032.2002.00269.x; Juusola M, 2003, J NEUROPHYSIOL, V90, P2014, DOI 10.1152/jn.00395.2003; Kaissling KE, 1998, CHEM SENSES, V23, P99, DOI 10.1093/chemse/23.1.99; Karniel A, 1999, MODERN TECHNIQUES NE, P589; Kim AJ, 2011, J COMPUT NEUROSCI, V30, P143, DOI 10.1007/s10827-010-0265-0; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lewis E.B., 1960, DROS INFORM SERV, V34, P117, DOI DOI 10.1101/PDB.REC081414; LUCAS P, 1992, PESTIC BIOCHEM PHYS, V43, P103, DOI 10.1016/0048-3575(92)90024-T; Marmarelis P.Z., 1978, ANAL PHYSL SYSTEMS W; Martelli C, 2013, J NEUROSCI, V33, P6285, DOI 10.1523/JNEUROSCI.0426-12.2013; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Piersol AG., 1980, ENG APPL CORRELATION; RiesgoEscovar JR, 1997, J COMP PHYSIOL A, V180, P151, DOI 10.1007/s003590050036; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Schuckel J, 2008, J NEUROSCI METH, V171, P98, DOI 10.1016/j.jneumeth.2008.02.013; Schuckel J, 2008, J COMP PHYSIOL A, V194, P483, DOI 10.1007/s00359-008-0322-6; Schuckel J, 2009, J NEUROPHYSIOL, V102, P214, DOI 10.1152/jn.00162.2009; Shannon C., 1964, MATH THEORY COMMUNIC; Sharpee TO, 2013, ANNU REV NEUROSCI, V36, P103, DOI 10.1146/annurev-neuro-062012-170253; Stierle JS, 2013, J NEUROSCI, V33, P6060, DOI 10.1523/JNEUROSCI.5838-12.2013; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Torkkeli PH, 2002, J NEUROPHYSIOL, V87, P1363, DOI 10.1152/jn.00440.2001; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Vetter RS, 2006, CHEM SENSES, V31, P359, DOI 10.1093/chemse/bjj040; Wasserman S, 2013, CURR BIOL, V23, P301, DOI 10.1016/j.cub.2012.12.038	44	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86347	10.1371/journal.pone.0086347	http://dx.doi.org/10.1371/journal.pone.0086347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466044	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500235
J	Lv, ZZ; Chen, AL; Liu, JC; Guan, Z; Zhou, Y; Xu, SY; Yang, SM; Li, C				Lv, Zhenzhen; Chen, Ailiang; Liu, Jinchuan; Guan, Zheng; Zhou, Yu; Xu, Siyuan; Yang, Shuming; Li, Cheng			A Simple and Sensitive Approach for Ochratoxin A Detection Using a Label-Free Fluorescent Aptasensor	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; LINKED-IMMUNOSORBENT-ASSAY; GOLD NANOPARTICLE; GREEN COFFEE; CHEMILUMINESCENCE DETECTION; APTAMER; BIOSENSOR; LIGANDS; WINES	Ochratoxin A(OTA) is found to be one of the predominant contaminating mycotoxins in a wide variety of food commodities. To avoid the risk of OTA consumption, the detection and quantitation of OTA level are of great significance. Based on the fact that ssDNA aptamer has the ability to form a double-strand structure with its complementary sequence, a simple and rapid aptamer-based label-free approach for highly sensitive and selective fluorescence detection of OTA was developed by using ultra-sensitive double-strand DNA specific dyes PicoGreen. The results showed that as low as 1 ng/mL of OTA could be detected with a dynamic range of more than 5 orders of magnitude which satisfies the requirements for OTA maximum residue limit in various food regulated by European Commission. With the specificity of aptamer, the assay exhibited high selectivity for OTA against two other analogues (N-acetyl-l-phenylalanine and zearalenone). We also tested the aptasensor practicability using real sample of 1% beer spiked with a series of concentration of OTA and the results show good tolerance to matrix effect. All detections could be achieved in less than 30 min, which provides a simple, quick and sensitive detection method for OTA screening in food safety and could be easily extend to other small molecular chemical compounds detection which aptamer has been selected.	[Lv, Zhenzhen; Li, Cheng] Sichuan Agr Univ, Coll Food Sci, Yaan, Peoples R China; [Lv, Zhenzhen; Chen, Ailiang; Liu, Jinchuan; Guan, Zheng; Zhou, Yu; Xu, Siyuan; Yang, Shuming] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100193, Peoples R China; [Lv, Zhenzhen; Chen, Ailiang; Liu, Jinchuan; Guan, Zheng; Zhou, Yu; Xu, Siyuan; Yang, Shuming] Minist Agr, Key Lab Agrifood Qual & Safety, Beijing, Peoples R China	Sichuan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS; Ministry of Agriculture & Rural Affairs	Chen, AL (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100193, Peoples R China.	ailiang.chen@gmail.com; lichenglcp@163.com	Chen, Ailiang/AAA-6470-2022; Guan, Zheng/L-7701-2018	Guan, Zheng/0000-0001-8617-8114	 [2012DFA31140]		Funding was provided by 2012DFA31140, http://www.istcp.org.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blesa J, 2004, J CHROMATOGR A, V1046, P127, DOI 10.1016/j.chroma.2004.06.086; Bonel L, 2011, BIOSENS BIOELECTRON, V26, P3254, DOI 10.1016/j.bios.2010.12.036; Chen CK, 2010, BIOSENS BIOELECTRON, V25, P1922, DOI 10.1016/j.bios.2010.01.005; Chen JH, 2012, FOOD CONTROL, V25, P555, DOI 10.1016/j.foodcont.2011.11.039; Cruz-Aguado JA, 2008, J AGR FOOD CHEM, V56, P10456, DOI 10.1021/jf801957h; Dragan AI, 2010, BIOPHYS J, V99, P3010, DOI 10.1016/j.bpj.2010.09.012; Duan N, 2012, ANAL LETT, V45, P714, DOI 10.1080/00032719.2011.653899; el Khoury A, 2010, TOXINS, V2, P461, DOI 10.3390/toxins2040461; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Elmholt S, 1999, MYCOPATHOLOGIA, V147, P67, DOI 10.1023/A:1007003106343; Fernandez-Baldo MA, 2011, ANALYST, V136, P2756, DOI 10.1039/c1an15148g; Guo ZJ, 2011, TALANTA, V85, P2517, DOI 10.1016/j.talanta.2011.08.015; Hernandez MJ, 2006, ANAL CHIM ACTA, V566, P117, DOI 10.1016/j.aca.2006.02.002; Jarvis BB, 2005, APPL MICROBIOL BIOT, V66, P367, DOI 10.1007/s00253-004-1753-9; Jornet D, 2000, J CHROMATOGR A, V882, P29, DOI 10.1016/S0021-9673(00)00237-5; Kuang H, 2010, BIOSENS BIOELECTRON, V26, P710, DOI 10.1016/j.bios.2010.06.058; Liu BH, 2008, ANAL CHEM, V80, P7029, DOI 10.1021/ac800951p; Liu JC, 2014, BIOSENS BIOELECTRON, V52, P265, DOI 10.1016/j.bios.2013.08.059; Mayer G, 2009, ANGEW CHEM INT EDIT, V48, P2672, DOI 10.1002/anie.200804643; Mehta J, 2011, J BIOTECHNOL, V155, P361, DOI 10.1016/j.jbiotec.2011.06.043; O'Brien E, 2005, CRIT REV TOXICOL, V35, P33, DOI 10.1080/10408440590905948; Pfohl-Leszkowicz A, 2007, MOL NUTR FOOD RES, V51, P61, DOI 10.1002/mnfr.200600137; Pittet A, 2002, J AGR FOOD CHEM, V50, P243, DOI 10.1021/jf010867w; Perrotta PR, 2012, SENSOR ACTUAT B-CHEM, V162, P327, DOI 10.1016/j.snb.2011.12.089; Santos EA, 2002, FOOD ADDIT CONTAM A, V19, P447, DOI 10.1080/02652030110213717; Sauceda-Friebe JC, 2011, ANAL CHIM ACTA, V689, P234, DOI 10.1016/j.aca.2011.01.030; Sheng LF, 2011, BIOSENS BIOELECTRON, V26, P3494, DOI 10.1016/j.bios.2011.01.032; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang LB, 2011, BIOSENS BIOELECTRON, V26, P3059, DOI 10.1016/j.bios.2010.11.040; Wang ZP, 2010, ANAL BIOANAL CHEM, V398, P2125, DOI 10.1007/s00216-010-4146-1; Yan XL, 2009, TALANTA, V79, P383, DOI 10.1016/j.talanta.2009.03.063; Yang C, 2012, BIOSENS BIOELECTRON, V32, P208, DOI 10.1016/j.bios.2011.12.011; Yang C, 2011, BIOSENS BIOELECTRON, V26, P2724, DOI 10.1016/j.bios.2010.09.032; Yu FY, 2011, J AGR FOOD CHEM, V59, P809, DOI 10.1021/jf103261u; Yu FY, 2005, J AGR FOOD CHEM, V53, P6947, DOI 10.1021/jf0513922; Zezza F, 2009, ANAL BIOANAL CHEM, V395, P1317, DOI 10.1007/s00216-009-2994-3; Zhao M, 2013, ANALYST, V138, P6639, DOI 10.1039/c3an01567j	37	38	43	3	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85968	10.1371/journal.pone.0085968	http://dx.doi.org/10.1371/journal.pone.0085968			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465818	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500158
J	Malvindi, MA; De Matteis, V; Galeone, A; Brunetti, V; Anyfantis, GC; Athanassiou, A; Cingolani, R; Pompa, PP				Malvindi, Maria Ada; De Matteis, Valeria; Galeone, Antonio; Brunetti, Virgilio; Anyfantis, George C.; Athanassiou, Athanassia; Cingolani, Roberto; Pompa, Pier Paolo			Toxicity Assessment of Silica Coated Iron Oxide Nanoparticles and Biocompatibility Improvement by Surface Engineering	PLOS ONE			English	Article							IN-VIVO TOXICITY; CELLULAR UPTAKE; SIO2 NANOPARTICLES; CONTRAST AGENTS; CELLS; CYTOTOXICITY; VITRO; GENOTOXICITY; DELIVERY; DEXTRAN	We have studied in vitro toxicity of iron oxide nanoparticles (NPs) coated with a thin silica shell (Fe3O4/SiO2 NPs) on A549 and HeLa cells. We compared bare and surface passivated Fe3O4/SiO2 NPs to evaluate the effects of the coating on the particle stability and toxicity. NPs cytotoxicity was investigated by cell viability, membrane integrity, mitochondrial membrane potential (MMP), reactive oxygen species (ROS) assays, and their genotoxicity by comet assay. Our results show that NPs surface passivation reduces the oxidative stress and alteration of iron homeostasis and, consequently, the overall toxicity, despite bare and passivated NPs show similar cell internalization efficiency. We found that the higher toxicity of bare NPs is due to their stronger in-situ degradation, with larger intracellular release of iron ions, as compared to surface passivated NPs. Our results indicate that surface engineering of Fe3O4/SiO2 NPs plays a key role in improving particles stability in biological environments reducing both cytotoxic and genotoxic effects.	[Malvindi, Maria Ada; De Matteis, Valeria; Galeone, Antonio; Brunetti, Virgilio; Pompa, Pier Paolo] Ist Italiano Tecnol, UNILE, Ctr Biomol Nanotechnol, Arnesano, Italy; [Anyfantis, George C.; Athanassiou, Athanassia; Cingolani, Roberto] Ist Italiano Tecnol, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT	Pompa, PP (corresponding author), Ist Italiano Tecnol, UNILE, Ctr Biomol Nanotechnol, Arnesano, Italy.	pierpaolo.pompa@iit.it	Anyfantis, George C/K-9048-2017; ATHANASSIOU, ATHANASSIA/B-4197-2018; De Matteis, Valeria/J-4530-2019; Brunetti, Virgilio/AGZ-3500-2022	ATHANASSIOU, ATHANASSIA/0000-0002-6533-3231; De Matteis, Valeria/0000-0003-2204-8817; Galeone, Antonio/0000-0002-8678-7726; Brunetti, Virgilio/0000-0002-7615-1150				Apopa PL, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-1; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Bardi G, 2010, BIOMATERIALS, V31, P6555, DOI 10.1016/j.biomaterials.2010.04.063; Bartolozzi C, 1999, EUR RADIOL, V9, P1496, DOI 10.1007/s003300050876; Brunetti V, 2013, NANOSCALE, V5, P307, DOI 10.1039/c2nr33024e; Buyukhatipoglu K, 2011, J BIOMED MATER RES A, V96A, P186, DOI 10.1002/jbm.a.32972; Chen YC, 2010, TOXICOL APPL PHARM, V245, P272, DOI 10.1016/j.taap.2010.03.011; Davila-Ibanez AB, 2012, ACS NANO, V6, P747, DOI 10.1021/nn204231g; Dunford HB, 2002, COORDIN CHEM REV, V233, P311, DOI 10.1016/S0010-8545(02)00024-3; Gazeau F, 2008, NANOMEDICINE-UK, V3, P831, DOI 10.2217/17435889.3.6.831; Ge YQ, 2009, COLLOID SURFACE B, V73, P294, DOI 10.1016/j.colsurfb.2009.05.031; Gharagozloo M, 2008, EUR J PHARMACOL, V589, P1, DOI 10.1016/j.ejphar.2008.03.059; Hong SC, 2011, INT J NANOMED, V6, P3219, DOI 10.2147/IJN.S26355; Jarrett BR, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/3/035603; Juang JH, 2010, TRANSPL P, V42, P2104, DOI 10.1016/j.transproceed.2010.05.103; Kang K, 2009, J PHYS CHEM B, V113, P536, DOI 10.1021/jp807081b; Klostergaard J, 2012, NANOMED-NANOTECHNOL, V8, pS37, DOI 10.1016/j.nano.2012.05.010; Kunzmann A, 2011, TOXICOL APPL PHARM, V253, P81, DOI 10.1016/j.taap.2011.03.011; Laskar A, 2012, NANOMEDICINE-UK, V7, P705, DOI [10.2217/nnm.11.148, 10.2217/NNM.11.148]; Lesniak A, 2012, ACS NANO, V6, P5845, DOI 10.1021/nn300223w; Levy M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/39/395103; Lorenzo R, 2006, ATMOS ENVIRON, V40, P7831, DOI 10.1016/j.atmosenv.2006.07.026; Lunov O, 2010, BIOMATERIALS, V31, P9015, DOI 10.1016/j.biomaterials.2010.08.003; Mahmoudi M, 2012, CHEM REV, V112, P2323, DOI 10.1021/cr2002596; Mahmoudi M, 2011, ACS NANO, V5, P7263, DOI 10.1021/nn2021088; Mahon E, 2012, CHEM COMMUN, V48, P7970, DOI 10.1039/c2cc34023b; Maiorano G, 2010, ACS NANO, V4, P7481, DOI 10.1021/nn101557e; Malvindi MA, 2012, NANOSCALE, V4, P486, DOI 10.1039/c1nr11269d; Malvindi MA, 2011, ADV FUNCT MATER, V21, P2548, DOI 10.1002/adfm.201100031; Manning T, 2009, CURR MED CHEM, V16, P2416, DOI 10.2174/092986709788682128; Murruni LG, 2009, ATMOS ENVIRON, V43, P4577, DOI 10.1016/j.atmosenv.2009.06.025; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Plank C, 2011, ADV DRUG DELIVER REV, V63, P1300, DOI 10.1016/j.addr.2011.08.002; Qhobosheane M, 2001, ANALYST, V126, P1274, DOI 10.1039/b101489g; Qiao RR, 2009, J MATER CHEM, V19, P6274, DOI 10.1039/b902394a; Reimer P, 2003, EUR RADIOL, V13, P1266, DOI 10.1007/s00330-002-1721-7; Rivera-Gil P, 2013, ACCOUNTS CHEM RES, V46, P743, DOI 10.1021/ar300039j; Schroedter A, 2002, ANGEW CHEM INT EDIT, V41, P17; Singh N, 2012, BIOMATERIALS, V33, P163, DOI 10.1016/j.biomaterials.2011.09.087; Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358; Soenen SJH, 2011, BIOMATERIALS, V32, P195, DOI 10.1016/j.biomaterials.2010.08.075; Soenen SJH, 2010, SMALL, V6, P832, DOI 10.1002/smll.200902084; Sowards JW, 2008, WELD J, V87, p106S; Wang FJ, 2013, NANOMED-NANOTECHNOL, V9, P1159, DOI 10.1016/j.nano.2013.04.010; Wei K, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-480; Wu W, 2008, NANOSCALE RES LETT, V3, P397, DOI 10.1007/s11671-008-9174-9; Yu M, 2012, INT J MOL SCI, V13, P5554, DOI 10.3390/ijms13055554; Zhu XM, 2012, INT J NANOMED, V7, P953, DOI 10.2147/IJN.S28316	48	159	161	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85835	10.1371/journal.pone.0085835	http://dx.doi.org/10.1371/journal.pone.0085835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465736	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500127
J	Smith, S; Tripathi, R; Goodings, C; Cleveland, S; Mathias, E; Hardaway, JA; Elliott, N; Yi, YJ; Chen, X; Downing, J; Mullighan, C; Swing, DA; Tessarollo, L; Li, LQ; Love, P; Jenkins, NA; Copeland, NG; Thompson, MA; Du, Y; Dave, UP				Smith, Stephen; Tripathi, Rati; Goodings, Charnise; Cleveland, Susan; Mathias, Elizabeth; Hardaway, J. Andrew; Elliott, Natalina; Yi, Yajun; Chen, Xi; Downing, James; Mullighan, Charles; Swing, Deborah A.; Tessarollo, Lino; Li, Liqi; Love, Paul; Jenkins, Nancy A.; Copeland, Neal G.; Thompson, Mary Ann; Du, Yang; Dave, Utpal P.			LIM Domain Only-2 (LMO2) Induces T-Cell Leukemia by Two Distinct Pathways	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GENOME-WIDE ANALYSIS; LIM-PROTEIN LMO2; TRANSCRIPTION FACTOR; GENE-THERAPY; HEMATOPOIETIC STEM; ONLY PROTEINS; MOUSE MODEL; FORMS PART; EXPRESSION	The LMO2 oncogene is deregulated in the majority of human T-cell leukemia cases and in most gene therapy-induced T-cell leukemias. We made transgenic mice with enforced expression of Lmo2 in T-cells by the CD2 promoter/enhancer. These transgenic mice developed highly penetrant T-ALL by two distinct patterns of gene expression: one in which there was concordant activation of Lyl1, Hhex, and Mycn or alternatively, with Notch1 target gene activation. Most strikingly, this gene expression clustering was conserved in human Early T-cell Precursor ALL (ETP-ALL), where LMO2, HHEX, LYL1, and MYCN were most highly expressed. We discovered that HHEX is a direct transcriptional target of LMO2 consistent with its concordant gene expression. Furthermore, conditional inactivation of Hhex in CD2-Lmo2 transgenic mice markedly attenuated T-ALL development, demonstrating that Hhex is a crucial mediator of Lmo2's oncogenic function. The CD2-Lmo2 transgenic mice offer mechanistic insight into concordant oncogene expression and provide a model for the highly treatment-resistant ETP-ALL subtype.	[Smith, Stephen; Tripathi, Rati; Goodings, Charnise; Cleveland, Susan; Mathias, Elizabeth; Elliott, Natalina; Dave, Utpal P.] Vanderbilt Univ, Med Ctr, Div Hematol Oncol, Nashville, TN 37212 USA; [Smith, Stephen; Tripathi, Rati; Goodings, Charnise; Cleveland, Susan; Mathias, Elizabeth; Elliott, Natalina; Dave, Utpal P.] Tennessee Valley Healthcare Syst, Nashville, TN USA; [Hardaway, J. Andrew] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Yi, Yajun] Vanderbilt Univ, Med Ctr, Div Med Genet, Nashville, TN USA; [Chen, Xi] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Downing, James; Mullighan, Charles] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Swing, Deborah A.; Tessarollo, Lino] NCI, Mouse Canc Genet Program, Frederick, MD 21701 USA; [Li, Liqi; Love, Paul] NICHHD, NIH, Bethesda, MD 20892 USA; [Jenkins, Nancy A.; Copeland, Neal G.] Methodist Hosp, Res Inst, Houston, TX 77030 USA; [Thompson, Mary Ann] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Du, Yang] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); The Methodist Hospital System; The Methodist Hospital - Houston; Vanderbilt University; Uniformed Services University of the Health Sciences - USA	Dave, UP (corresponding author), Vanderbilt Univ, Med Ctr, Div Hematol Oncol, Nashville, TN 37212 USA.	utpal.dave@vanderbilt.edu	Goodings, Charnise/S-7372-2019; Mullighan, Charles/H-3253-2011	Mullighan, Charles/0000-0002-1871-1850; Goodings, Charnise/0000-0001-8189-0989; Elliott, Natalina/0000-0002-6713-7349	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development [BX001799-01A1]; National Institutes of Health (NIH) [K08HL089403]; Leukemia & Lymphoma Society; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; Cancer Prevention Research Institute of Texas (CPRIT); American Society of Hematology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009592, ZICBC011265, P30CA021765, ZICBC010903, P30CA068485, R01CA143193] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001799] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; Cancer Prevention Research Institute of Texas (CPRIT); American Society of Hematology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a VA Merit award, BX001799-01A1 (UPD), by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development and the National Institutes of Health (NIH) grant K08HL089403, the Leukemia & Lymphoma Society, and the Vanderbilt Ingram Cancer Center (P30 CA68485) (UPD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the NIH. The VMC Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404). NGC and NAJ are supported in part by the Cancer Prevention Research Institute of Texas (CPRIT). They are also both CPRIT Scholars in Cancer Research. This work was also supported by a Bridge Grant from the American Society of Hematology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnafi V, 2004, BLOOD, V104, P4173, DOI 10.1182/blood-2003-11-3944; Berquam-Vrieze KE, 2011, BLOOD, V118, P4646, DOI 10.1182/blood-2011-03-343947; Bogue CW, 2003, P NATL ACAD SCI USA, V100, P556, DOI 10.1073/pnas.0236979100; Cai Y, 2009, BIOCHEM BIOPH RES CO, V390, P295, DOI 10.1016/j.bbrc.2009.09.111; Calero-Nieto FJ, 2013, ONCOGENE; Cleveland SM, 2013, STEM CELLS, V31, P882, DOI 10.1002/stem.1345; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Dave UP, 2004, SCIENCE, V303, P333, DOI 10.1126/science.1091667; Dave UP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000491; Deleuze V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040484; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drynan LF, 2001, ONCOGENE, V20, P4412, DOI 10.1038/sj.onc.1204538; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; George A, 2003, ONCOGENE, V22, P6764, DOI 10.1038/sj.onc.1206822; Giroux S, 2007, GENE EXPR PATTERNS, V7, P215, DOI 10.1016/j.modgep.2006.10.004; Grutz GG, 1998, EMBO J, V17, P4594, DOI 10.1093/emboj/17.16.4594; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; LARSON RC, 1994, ONCOGENE, V9, P3675; Li LQ, 2011, NAT IMMUNOL, V12, P129, DOI 10.1038/ni.1978; Lin YW, 2005, CANCER RES, V65, P7151, DOI 10.1158/0008-5472.CAN-05-1400; LOVE PE, 1994, J EXP MED, V179, P1485, DOI 10.1084/jem.179.5.1485; Matthews JM, 2013, NAT REV CANCER, V13, P111, DOI 10.1038/nrc3418; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; McCormack MP, 2003, MOL CELL BIOL, V23, P9003, DOI 10.1128/MCB.23.24.9003-9013.2003; McCormack MP, SCIENCE NEW YORK NY, V327, P879; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nam CH, 2006, MOL THER, V13, P15, DOI 10.1016/j.ymthe.2005.09.010; Neumann M, 2013, BLOOD; O'Neil J, 2005, BLOOD; Ono Y, 1998, MOL CELL BIOL, V18, P6939, DOI 10.1128/MCB.18.12.6939; Oram SH, 2010, ONCOGENE, V29, P5796, DOI 10.1038/onc.2010.320; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Rodriguez TA, 2001, DEV BIOL, V234, P304, DOI 10.1006/dbio.2001.0265; Soufi A, 2008, BIOCHEM J, V412, P399, DOI 10.1042/BJ20080035; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Tatarek J, 2011, BLOOD, V118, P1579, DOI 10.1182/blood-2010-08-300343; Treanor LM, 2011, BLOOD, V117, P5453, DOI 10.1182/blood-2010-09-309831; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Van Vlierberghe P, 2006, BLOOD, V108, P3520, DOI 10.1182/blood-2006-04-019927; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Watanabe H, 2013, GENE DEV, V27, P197, DOI 10.1101/gad.203208.112; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wu Chuanfeng, 2011, Front Med, V5, P356, DOI 10.1007/s11684-011-0159-1; Xu ZX, 2007, GENE DEV, V21, P942, DOI 10.1101/gad.1528507; Xu ZX, 2003, MOL CELL BIOL, V23, P7585, DOI 10.1128/MCB.23.21.7585-7599.2003; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zohren F, 2012, NAT IMMUNOL, V13, P761, DOI 10.1038/ni.2365	56	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85883	10.1371/journal.pone.0085883	http://dx.doi.org/10.1371/journal.pone.0085883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465765	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500135
J	Yague, P; Rodriguez-Garcia, A; Lopez-Garcia, MT; Rioseras, B; Martin, JF; Sanchez, J; Manteca, A				Yaguee, Paula; Rodriguez-Garcia, Antonio; Teresa Lopez-Garcia, Maria; Rioseras, Beatriz; Francisco Martin, Juan; Sanchez, Jesus; Manteca, Angel			Transcriptomic Analysis of Liquid Non-Sporulating Streptomyces coelicolor Cultures Demonstrates the Existence of a Complex Differentiation Comparable to That Occurring in Solid Sporulating Cultures	PLOS ONE			English	Article							ANTIBIOTIC PRODUCTION; MORPHOLOGICAL-DIFFERENTIATION; SECONDARY METABOLISM; SUBMERGED CULTURE; A3(2); LIVIDANS; FAMILY; GENE; IDENTIFICATION; ACTINORHODIN	Streptomyces species produce many clinically relevant secondary metabolites and exhibit a complex development that includes hyphal differentiation and sporulation in solid cultures. Industrial fermentations are usually performed in liquid cultures, conditions in which Streptomyces strains generally do not sporulate, and it was traditionally assumed that no differentiation took place. The aim of this work was to compare the transcriptomes of S. coelicolor growing in liquid and solid cultures, deepening the knowledge of Streptomyces differentiation. Microarrays demonstrated that gene expression in liquid and solid cultures were comparable and data indicated that physiological differentiation was similar for both conditions. Eighty-six percent of all transcripts showed similar abundances in liquid and solid cultures, such as those involved in the biosynthesis of actinorhodin (actVA, actII-4) and undecylprodigiosin (redF); activation of secondary metabolism (absR1, ndsA); genes regulating hydrophobic cover formation (aerial mycelium) (bldB, bldC, bldM, bldN, sapA, chpC, chpD, chpE, chpH, ramA, ramC, ramS); and even some genes regulating early stages of sporulation (wblA, whiG, whiH, whiJ). The two most important differences between transcriptomes from liquid and solid cultures were: first, genes related to secondary metabolite biosynthesis (CDA, CPK, coelichelin, desferrioxamine clusters) were highly up-regulated in liquid but not in solid cultures; and second, genes involved in the final stages of hydrophobic cover/spore maturation (chpF, rdlA, whiE, sfr) were up-regulated in solid but not in liquid cultures. New information was also provided for several non-characterized genes differentially expressed in liquid and solid cultures which might be regulating, at least in part, the metabolic and developmental differences observed between liquid and solid cultures.	[Yaguee, Paula; Teresa Lopez-Garcia, Maria; Rioseras, Beatriz; Sanchez, Jesus; Manteca, Angel] Univ Oviedo, Fac Med, Dept Biol Func, Area Microbiol, Oviedo, Spain; [Yaguee, Paula; Teresa Lopez-Garcia, Maria; Rioseras, Beatriz; Sanchez, Jesus; Manteca, Angel] Univ Oviedo, Fac Med, IUOPA, Oviedo, Spain; [Rodriguez-Garcia, Antonio; Francisco Martin, Juan] INBIOTEC, Inst Biotecnol Leon, Leon, Spain	University of Oviedo; University of Oviedo	Manteca, A (corresponding author), Univ Oviedo, Fac Med, Dept Biol Func, Area Microbiol, Oviedo, Spain.	mantecaangel@uniovi.es	Rodríguez-García, Antonio/A-9461-2011; Yagüe, Paula/AAT-3011-2020; Rioseras de Bustos, Beatriz/H-1522-2015; Manteca-Fernandez, Angel/L-9699-2018; López, Maite/G-9944-2015; Menéndez, Paula Yagüe/H-1496-2015	Rodríguez-García, Antonio/0000-0001-8118-9762; Yagüe, Paula/0000-0003-1526-3121; Manteca-Fernandez, Angel/0000-0001-8001-8988; López, Maite/0000-0001-8170-1316; Menéndez, Paula Yagüe/0000-0003-1526-3121	ERC [Strp-differentiation 280304];  [BIO2010-16303]	ERC(European Research Council (ERC)European Commission); 	This research was funded by an ERC Starting Grant (Strp-differentiation 280304). Jesus Sanchez was funded by project BIO2010-16303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BE, 2006, MOL MICROBIOL, V59, P1848, DOI 10.1111/j.1365-2958.2006.05065.x; Ainsa JA, 2010, ANTON LEEUW INT J G, V98, P225, DOI 10.1007/s10482-010-9443-3; Amin R, 2012, MICROBIOL-SGM, V158, P1172, DOI 10.1099/mic.0.054817-0; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Champness W. C., 2000, ACTINOMYCETE DEV ANT, P11; Chandra G, 2008, ANTON LEEUW INT J G, V94, P111, DOI 10.1007/s10482-008-9231-5; Cho YH, 2003, J BACTERIOL, V185, P6756, DOI 10.1128/JB.185.23.6756-6763.2003; Chouayekh H, 2002, MOL MICROBIOL, V43, P919, DOI 10.1046/j.1365-2958.2002.02557.x; Claessen D, 2002, MOL MICROBIOL, V44, P1483, DOI 10.1046/j.1365-2958.2002.02980.x; Claessen D, 2006, TRENDS MICROBIOL, V14, P313, DOI 10.1016/j.tim.2006.05.008; Darbon E, 2012, APPL MICROBIOL BIOT, V95, P1553, DOI 10.1007/s00253-012-3995-2; de Jong W, 2009, MOL MICROBIOL, V71, P1591, DOI 10.1111/j.1365-2958.2009.06633.x; Duong CTP, 2009, J MICROBIOL BIOTECHN, V19, P136, DOI 10.4014/jmb.0806.387; Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x; Fowler-Goldsworthy K, 2011, MICROBIOL-SGM, V157, P1312, DOI 10.1099/mic.0.047555-0; Gatewood ML, 2012, J BACTERIOL, V194, P2228, DOI 10.1128/JB.06541-11; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; Hesketh A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-261; Jayapal KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002097; KIESER HM, 1989, MOL GEN GENET, V220, P60, DOI 10.1007/BF00260856; Komatsu M, 2006, MOL MICROBIOL, V62, P1534, DOI 10.1111/j.1365-2958.2006.05461.x; Lee MY, 2012, BIOCHEMISTRY-US, V51, P3079, DOI 10.1021/bi201705q; Majka J, 2001, J BIOL CHEM, V276, P6243, DOI 10.1074/jbc.M007876200; Manteca A, 2006, RES MICROBIOL, V157, P143, DOI 10.1016/j.resmic.2005.07.003; Manteca A, 2008, APPL ENVIRON MICROB, V74, P3877, DOI 10.1128/AEM.02715-07; Manteca A, 2010, J PROTEOME RES, V9, P4801, DOI 10.1021/pr100513p; Nieselt K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-10; OMURA S, 1992, GENE, V115, P141, DOI 10.1016/0378-1119(92)90552-Z; Ou XJ, 2008, ACTA BIOCH BIOPH SIN, V40, P877, DOI 10.1111/j.1745-7270.2008.00466.x; Ou XJ, 2009, APPL ENVIRON MICROB, V75, P2158, DOI 10.1128/AEM.02209-08; Paget MSB, 2001, MOL MICROBIOL, V42, P1007, DOI 10.1046/j.1365-2958.2001.02675.x; Pamboukian CRD, 2002, BRAZ J MICROBIOL, V33, P17, DOI 10.1590/S1517-83822002000100003; Park U, 2000, J MICROBIOL BIOTECHN, V10, P169; Penyige A, 2009, J MICROBIOL, V47, P549, DOI 10.1007/s12275-009-0032-y; Rozas D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031760; Rueda B, 2001, CAN J MICROBIOL, V47, P1042, DOI 10.1139/cjm-47-11-1042; Sawai R, 2004, GENE, V334, P53, DOI 10.1016/j.gene.2004.02.046; Shima J, 1996, J BACTERIOL, V178, P7276, DOI 10.1128/jb.178.24.7276-7284.1996; Shin JH, 2011, J BACTERIOL, V193, P75, DOI 10.1128/JB.00965-10; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stocks SM, 2001, BIOTECHNOL BIOENG, V75, P702, DOI 10.1002/bit.10017; Tahlan K, 2008, J MOL BIOL, V383, P753, DOI 10.1016/j.jmb.2008.08.081; TAMAOKI T, 1990, BIO-TECHNOL, V8, P732, DOI 10.1038/nbt0890-732; Temuujin U, 2012, J BACTERIOL, V194, P142, DOI 10.1128/JB.05978-11; Umezawa K, 1997, ADV ENZYME REGUL, V37, P393, DOI 10.1016/S0065-2571(96)00022-2; vanWezel GP, 1997, MOL MICROBIOL, V23, P537, DOI 10.1046/j.1365-2958.1997.d01-1878.x; Wang XJ, 2009, J ANTIBIOT, V62, P309, DOI 10.1038/ja.2009.33; Xu GM, 2010, J BIOL CHEM, V285, P27440, DOI 10.1074/jbc.M110.143081; Yague P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060665; Yague P, 2013, FEMS MICROBIOL LETT, V342, P79, DOI 10.1111/1574-6968.12128; Yague P, 2010, APPL ENVIRON MICROB, V76, P3401, DOI 10.1128/AEM.00120-10	52	25	26	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86296	10.1371/journal.pone.0086296	http://dx.doi.org/10.1371/journal.pone.0086296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466012	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500220
J	Tamburic, B; Guruprasad, S; Radford, DT; Szabo, M; Lilley, RM; Larkum, AWD; Franklin, JB; Kramer, DM; Blackburn, SI; Raven, JA; Schliep, M; Ralph, PJ				Tamburic, Bojan; Guruprasad, Supriya; Radford, Dale T.; Szabo, Milan; Lilley, Ross McC; Larkum, Anthony W. D.; Franklin, Jim B.; Kramer, David M.; Blackburn, Susan I.; Raven, John A.; Schliep, Martin; Ralph, Peter J.			The Effect of Diel Temperature and Light Cycles on the Growth of Nannochloropsis oculata in a Photobioreactor Matrix	PLOS ONE			English	Article							OUTDOOR MASS CULTIVATION; CHLOROPHYLL FLUORESCENCE; MICROALGAE; DESIGN; AVAILABILITY; EFFICIENCY; BIODIESEL; PROSPECTS; CULTURES; REGIME	A matrix of photobioreactors integrated with metabolic sensors was used to examine the combined impact of light and temperature variations on the growth and physiology of the biofuel candidate microalgal species Nannochloropsis oculata. The experiments were performed with algal cultures maintained at a constant 20 degrees C versus a 15 degrees C to 25 degrees C diel temperature cycle, where light intensity also followed a diel cycle with a maximum irradiance of 1920 mu mol photons m(-2) s(-1). No differences in algal growth (Chlorophyll a) were found between the two environmental regimes; however, the metabolic processes responded differently throughout the day to the change in environmental conditions. The variable temperature treatment resulted in greater damage to photosystem II due to the combined effect of strong light and high temperature. Cellular functions responded differently to conditions before midday as opposed to the afternoon, leading to strong hysteresis in dissolved oxygen concentration, quantum yield of photosystem II and net photosynthesis. Overnight metabolism performed differently, probably as a result of the temperature impact on respiration. Our photobioreactor matrix has produced novel insights into the physiological response of Nannochloropsis oculata to simulated environmental conditions. This information can be used to predict the effectiveness of deploying Nannochloropsis oculata in similar field conditions for commercial biofuel production.	[Tamburic, Bojan; Guruprasad, Supriya; Radford, Dale T.; Szabo, Milan; Lilley, Ross McC; Larkum, Anthony W. D.; Franklin, Jim B.; Raven, John A.; Schliep, Martin; Ralph, Peter J.] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia; [Kramer, David M.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Blackburn, Susan I.] Commonwealth Sci & Ind Res Org, Marine & Atmospher Res, Hobart, Tas, Australia; [Raven, John A.] Univ Dundee, James Hutton Inst, Div Plant Sci, Invergowrie, Scotland	University of Technology Sydney; Michigan State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Hutton Institute; University of Dundee	Tamburic, B (corresponding author), Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia.	bojan.tamburic@uts.edu.au	Ralph, Peter/L-1527-2019; Kramer, David M/B-9588-2016; Szabo, Milan/L-9942-2014; Ralph, Peter J/C-5029-2009; Tamburic, Bojan/G-8484-2013	Ralph, Peter/0000-0002-3103-7346; Kramer, David M/0000-0003-2181-6888; Szabo, Milan/0000-0001-6235-2894; Ralph, Peter J/0000-0002-3103-7346; Tamburic, Bojan/0000-0001-5720-9380	C3 start-up grant; UTS Faculty of Science; UTS Strategic research support	C3 start-up grant; UTS Faculty of Science; UTS Strategic research support	Funds were provided by a C3 start-up grant, UTS Faculty of Science and UTS Strategic research support; The University of Dundee is a registered Scottish charity, No. SC015096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rezq TS, 1999, HYDROBIOLOGIA, V403, P97, DOI 10.1023/A:1003725626504; ANACC, 2013, AUSAUSTR NAT ALG CUL; [Anonymous], 2012, INT RENEW ENERGY, DOI DOI 10.5402/2012/631574; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; BEARDALL J, 1994, J PLANKTON RES, V16, P1401, DOI 10.1093/plankt/16.10.1401; Borowitzka MA, 1999, J BIOTECHNOL, V70, P313, DOI 10.1016/S0168-1656(99)00083-8; BOUSSIBA S, 1987, BIOMASS, V12, P37, DOI 10.1016/0144-4565(87)90006-0; BREWER PG, 1976, LIMNOL OCEANOGR, V21, P108, DOI 10.4319/lo.1976.21.1.0108; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Davison I, 1991, J PHYCOL, V8, P82; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; Flameling IA, 1998, LIMNOL OCEANOGR, V43, P284, DOI 10.4319/lo.1998.43.2.0284; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Georgianna DR, 2012, NATURE, V488, P329, DOI 10.1038/nature11479; GOLDMAN JC, 1980, LIMNOL OCEANOGR, V25, P352, DOI 10.4319/lo.1980.25.2.0352; Gouveia L, 2009, J IND MICROBIOL BIOT, V36, P269, DOI 10.1007/s10295-008-0495-6; Greenwell HC, 2010, J R SOC INTERFACE, V7, P703, DOI 10.1098/rsif.2009.0322; Gregor J, 2004, WATER RES, V38, P517, DOI 10.1016/j.watres.2003.10.033; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Hill R, 2011, LIMNOL OCEANOGR, V56, P139, DOI 10.4319/lo.2011.56.1.0139; HODGSON PA, 1991, J APPL PHYCOL, V3, P169, DOI 10.1007/BF00003699; Huertas E, 2000, AQUACULT ENG, V22, P181, DOI 10.1016/S0144-8609(99)00038-2; Janssen M, 2003, BIOTECHNOL BIOENG, V81, P193, DOI 10.1002/bit.10468; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; Kromkamp JC, 2009, AQUAT MICROB ECOL, V56, P309, DOI 10.3354/ame01318; Larkum AWD, 2010, CURR OPIN BIOTECH, V21, P271, DOI 10.1016/j.copbio.2010.03.004; Lehr F, 2009, CURR OPIN BIOTECH, V20, P280, DOI 10.1016/j.copbio.2009.04.004; Losh JL, 2013, NEW PHYTOL, V198, P52, DOI 10.1111/nph.12143; Pal D, 2011, APPL MICROBIOL BIOT, V90, P1429, DOI 10.1007/s00253-011-3170-1; Pawlowicz R., 2013, NAT ED KNOWL, V4, P13; Puri M, 2012, RENEW SUST ENERG REV, V16, P6022, DOI 10.1016/j.rser.2012.06.025; Ramsing N, 2013, SEAW GASS TAB PHYS P; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; Raven JA, 2011, PHYSIOL PLANTARUM, V142, P87, DOI 10.1111/j.1399-3054.2011.01465.x; Richmond A., 1986, HDB MICROALGAL MASS; Ritchie RJ, 2008, PHOTOSYNTHETICA, V46, P115, DOI 10.1007/s11099-008-0019-7; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Sandnes JM, 2005, J APPL PHYCOL, V17, P515, DOI 10.1007/s10811-005-9002-x; Sforza E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038975; Simionato D, 2011, BIORESOURCE TECHNOL, V102, P6026, DOI 10.1016/j.biortech.2011.02.100; Stephens E, 2010, TRENDS PLANT SCI, V15, P554, DOI 10.1016/j.tplants.2010.06.003; Sukenik A, 2009, AQUAT MICROB ECOL, V56, P297, DOI 10.3354/ame01309; Tamburic B, 2013, PHYS CHEM CHEM PHYS, V15, P10783, DOI 10.1039/c3cp51866c; Tamburic B, 2012, ENRGY PROCED, V29, P710, DOI 10.1016/j.egypro.2012.09.083; Tamburic B, 2012, INT J HYDROGEN ENERG, V37, P8988, DOI 10.1016/j.ijhydene.2012.02.043; Tamburic B, 2011, INT J HYDROGEN ENERG, V36, P6578, DOI 10.1016/j.ijhydene.2011.02.091; Vieler A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003064; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; YAMASAKI S, 1995, AQUACULT ENG, V14, P357, DOI 10.1016/0144-8609(94)00010-X; Zijffers JWF, 2008, MAR BIOTECHNOL, V10, P404, DOI 10.1007/s10126-007-9077-2	54	37	39	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86047	10.1371/journal.pone.0086047	http://dx.doi.org/10.1371/journal.pone.0086047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465862	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500102
J	Tang, XQ; Li, X; Li, PW; Zhang, Q; Li, R; Zhang, W; Ding, XX; Lei, JW; Zhang, ZW				Tang, Xiaoqian; Li, Xin; Li, Peiwu; Zhang, Qi; Li, Ran; Zhang, Wen; Ding, Xiaoxia; Lei, Jiawen; Zhang, Zhaowei			Development and Application of an Immunoaffinity Column Enzyme Immunoassay for Mycotoxin Zearalenone in Complicated Samples	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; PERFORMANCE LIQUID-CHROMATOGRAPHY; MONOCLONAL-ANTIBODY; T-2 TOXIN; CEREALS; CORN; OCHRATOXIN; CHINA; ELISA; CONTAMINATION	The zearalenone (ZEA) monoclonal antibody (mAb) 2D3, one of the highest sensitivity antibodies, was developed. Based on this mAb, it was established of an immunoaffinity column (IAC) coupled with an indirect competitive enzyme-linked immunosorbent assay (icELISA). After optimization, the icELISA allowed an IC50 against ZEA of 0.02 mu g L-1. The mAb 2D3 exhibited a high recognition of ZEA (100%) and beta-zearalenol (beta-ZOL, 88.2%). Its cross-reactivity with a-zearalenol (alpha-ZOL) and beta-zearalanol (beta-ZAL) were found to be 4.4% and 4.6%, respectively. The IAC-icELISA method was employed to analyze ZEA contamination in food samples, compared with high-performance liquid chromatography (HPLC). The spiked assay for ZEA demonstrated the considerable recoveries for IAC-icELISA (83-93%) and HPLC (94-108%) methods. Results showed that the mAb 2D3 and IAC-icELISA method posed potential applications in sensitively determination of ZEA in maize.	[Tang, Xiaoqian; Li, Xin; Li, Peiwu; Zhang, Qi; Li, Ran; Zhang, Wen; Ding, Xiaoxia; Lei, Jiawen; Zhang, Zhaowei] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China; [Tang, Xiaoqian; Li, Xin; Li, Peiwu; Zhang, Qi; Li, Ran; Zhang, Wen; Lei, Jiawen; Zhang, Zhaowei] Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Peoples R China; [Tang, Xiaoqian; Li, Xin; Li, Peiwu; Zhang, Qi; Li, Ran; Zhang, Wen; Lei, Jiawen; Zhang, Zhaowei] Minist Agr, Key Lab Detect Mycotoxins, Wuhan, Peoples R China; [Tang, Xiaoqian; Li, Xin; Li, Peiwu; Lei, Jiawen; Zhang, Zhaowei] Minist Agr, Lab Risk Assessment Oilseeds Prod Wuhan, Wuhan, Peoples R China; [Ding, Xiaoxia] Minist Agr, Qual Inspect & Test Ctr Oilseeds Prod, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs	Li, PW (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China.	peiwuli@oilcrops.cn; zhangqi521x@yahoo.cn	li, ran/GPW-6786-2022	, Zhaowei/0000-0002-6686-2995	Project of National Science and Technology Pillar Plan [2012BAB19B09]; Special Fund for Agro-scientific Research in the Public Interest [201203094]; National Natural Science Foundation of China [21205133]; Key Project of the Ministry of Agriculture [2011-G5]	Project of National Science and Technology Pillar Plan; Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Ministry of Agriculture	This work was supported by the Project of National Science and Technology Pillar Plan (2012BAB19B09), the Special Fund for Agro-scientific Research in the Public Interest (201203094), The National Natural Science Foundation of China (21205133) and the Key Project of the Ministry of Agriculture (2011-G5). We state the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayed-Boussema I, 2007, J BIOCHEM MOL TOXIC, V21, P136, DOI 10.1002/jbt.20171; Basova EY, 2010, ANAL BIOANAL CHEM, V397, P55, DOI 10.1007/s00216-009-3328-1; Bittencourt ABF, 2005, FOOD CONTROL, V16, P117, DOI 10.1016/j.foodcont.2003.12.005; Burkin AA, 2002, APPL BIOCHEM MICRO+, V38, P263, DOI 10.1023/A:1015479626475; Burmistrova NA, 2009, ANAL BIOANAL CHEM, V395, P1301, DOI 10.1007/s00216-009-2913-7; Cha SH, 2012, J VET SCI, V13, P119, DOI 10.4142/jvs.2012.13.2.119; Chilaka CA, 2012, J FOOD AGRIC ENVIRON, V10, P296; Chun HS, 2009, ANAL CHIM ACTA, V639, P83, DOI 10.1016/j.aca.2009.02.048; Dawlatana M, 1998, CHROMATOGRAPHIA, V47, P215, DOI 10.1007/BF02466584; Guan D, 2011, FOOD CHEM, V125, P1359, DOI 10.1016/j.foodchem.2010.10.006; Hamide Z, 2010, J CHROMATOGR B, V878, P115; Hervas M, 2009, ANALYST, V134, P2405, DOI 10.1039/b911839j; Hervas M, 2010, BIOSENS BIOELECTRON, V25, P1755, DOI 10.1016/j.bios.2009.12.031; Ibanez-Vea M, 2011, FOOD CONTROL, V22, P1949, DOI 10.1016/j.foodcont.2011.05.008; Liu G, 2012, FOOD CONTROL, V27, P200, DOI 10.1016/j.foodcont.2012.03.023; LIU MT, 1985, APPL ENVIRON MICROB, V50, P332, DOI 10.1128/AEM.50.2.332-336.1985; Park JW, 2003, FOOD AGR IMMUNOL, V15, P159, DOI 10.1080/09540100400013393; Pei SC, 2009, FOOD CONTROL, V20, P1080, DOI 10.1016/j.foodcont.2009.02.004; Pei SC, 2013, FOOD CONTROL, V31, P65, DOI 10.1016/j.foodcont.2012.09.006; RUSSO C, 1983, J IMMUNOL METHODS, V65, P269, DOI 10.1016/0022-1759(83)90324-1; Soleimany F, 2012, FOOD CONTROL, V25, P647, DOI 10.1016/j.foodcont.2011.11.012; Thongrussamee T, 2008, FOOD ADDIT CONTAM A, V25, P997, DOI 10.1080/02652030701823159; Visconti A, 1998, J CHROMATOGR A, V815, P133, DOI 10.1016/S0021-9673(98)00296-9; Wang YR, 2011, J CHROMATOGR B, V879, P3531, DOI 10.1016/j.jchromb.2011.09.037; Zeng HY, 2006, CHINESE J ANAL CHEM, V34, P351; Zhang AH, 2011, FOOD CONTROL, V22, P1723, DOI 10.1016/j.foodcont.2011.04.004; Zhang DH, 2009, ANAL CHIM ACTA, V636, P63, DOI 10.1016/j.aca.2009.01.010; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030	28	25	25	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85606	10.1371/journal.pone.0085606	http://dx.doi.org/10.1371/journal.pone.0085606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465616	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000047
J	Kanda, R; Sutoh, Y; Kasamatsu, J; Maenaka, K; Kasahara, M; Ose, T				Kanda, Ryo; Sutoh, Yoichi; Kasamatsu, Jun; Maenaka, Katsumi; Kasahara, Masanori; Ose, Toyoyuki			Crystal Structure of the Lamprey Variable Lymphocyte Receptor C Reveals an Unusual Feature in Its N-Terminal Capping Module	PLOS ONE			English	Article							SOMATIC DIVERSIFICATION; ANTIGEN RECOGNITION; COMPLEX; GLYCOPROTEIN; DIVERSITY; EVOLUTION; ALIGNMENT	Jawless vertebrates represented by lampreys and hagfish use variable lymphocyte receptors (VLRs) as antigen receptors to mount adaptive immune responses. VLRs generate diversity that is comparable to immunoglobulins and T-cell receptors by a gene conversion-like mechanism, which is mediated by cytosine deaminases. Currently, three types of VLRs, VLRA, VLRB, and VLRC, have been identified in lampreys. Crystal structures of VLRA and VLRB in complex with antigens have been reported recently, but no structural information is available for VLRC. Here, we present the first crystal structure of VLRC from the Japanese lamprey (Lethenteron japonicum). Similar to VLRA and VLRB, VLRC forms a typical horseshoe-like solenoid structure with a variable concave surface. Strikingly, its N-terminal cap has a long loop with limited sequence variability that protrudes toward the concave surface, which is the putative antigen-binding surface. Furthermore, as predicted previously, its C-terminal cap lacks a highly variable protruding loop that plays an important role in antigen recognition by lamprey VLRA and VLRB. Recent work suggests that VLRC+ lymphocytes in jawless vertebrates might be akin to gamma delta T cells in jawed vertebrates. Structural features of lamprey VLRC described here suggest that it may recognize antigens in a unique manner.	[Kanda, Ryo] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Sutoh, Yoichi; Kasamatsu, Jun; Kasahara, Masanori] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Maenaka, Katsumi; Ose, Toyoyuki] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Kasahara, M (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan.	mkasaha@med.hokudai.ac.jp; ose@pharm.hokudai.ac.jp	Sutoh, Yoichi/AAA-5516-2020; Ose, Toyoyuki/AAW-7821-2020; Kasahara, Masanori/G-7651-2011	Sutoh, Yoichi/0000-0002-1607-9759; Ose, Toyoyuki/0000-0002-2001-9388; Sutoh, Yoichi/0000-0002-3470-0465	Japan Society for the Promotion of Science [JSPS: 22021001]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS: 22021001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Boehm T, 2011, NAT REV IMMUNOL, V11, P307, DOI 10.1038/nri2944; Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Das S, 2013, P NATL ACAD SCI USA, V110, P6043, DOI 10.1073/pnas.1302500110; Das S, 2011, ADV IMMUNOL, V111, P143, DOI 10.1016/B978-0-12-385991-4.00004-0; Deng L, 2010, P NATL ACAD SCI USA, V107, P13408, DOI 10.1073/pnas.1005475107; Durbin R, 1988, BIOL SEQUENCE ANAL P; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Han BW, 2008, SCIENCE, V321, P1834, DOI 10.1126/science.1162484; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; Hirano M, 2013, NATURE IN PRESS; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kasamatsu J, 2010, P NATL ACAD SCI USA, V107, P14304, DOI 10.1073/pnas.1001910107; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kirchdoerfer RN, 2012, STRUCTURE, V20, P479, DOI 10.1016/j.str.2012.01.009; Kishishita N, 2010, EMBO REP, V11, P126, DOI 10.1038/embor.2009.274; Konigshofer Y, 2006, CURR OPIN IMMUNOL, V18, P527, DOI 10.1016/j.coi.2006.07.008; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li J, 2013, P NATL ACAD IN PRESS; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Sprengart ML, 1996, EMBO J, V15, P665, DOI 10.1002/j.1460-2075.1996.tb00399.x; Takaba H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01716; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tasumi S, 2009, P NATL ACAD SCI USA, V106, P12891, DOI 10.1073/pnas.0904443106; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Velikovsky CA, 2009, NAT STRUCT MOL BIOL, V16, P725, DOI 10.1038/nsmb.1619	42	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85875	10.1371/journal.pone.0085875	http://dx.doi.org/10.1371/journal.pone.0085875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465760	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000029
J	Shamblin, BM; Bolten, AB; Abreu-Grobois, FA; Bjorndal, KA; Cardona, L; Carreras, C; Clusa, M; Monzon-Arguello, C; Nairn, CJ; Nielsen, JT; Nel, R; Soares, LS; Stewart, KR; Vilaca, ST; Turkozan, O; Yilmaz, C; Dutton, PH				Shamblin, Brian M.; Bolten, Alan B.; Alberto Abreu-Grobois, F.; Bjorndal, Karen A.; Cardona, Luis; Carreras, Carlos; Clusa, Marcel; Monzon-Argueello, Catalina; Nairn, Campbell J.; Nielsen, Janne T.; Nel, Ronel; Soares, Luciano S.; Stewart, Kelly R.; Vilaca, Sibelle T.; Turkozan, Oguz; Yilmaz, Can; Dutton, Peter H.			Geographic Patterns of Genetic Variation in a Broadly Distributed Marine Vertebrate: New Insights into Loggerhead Turtle Stock Structure from Expanded Mitochondrial DNA Sequences	PLOS ONE			English	Article							CHELONIA-MYDAS POPULATIONS; CARETTA-CARETTA; GREEN TURTLE; SEA-TURTLES; GLOBAL PHYLOGEOGRAPHY; NESTING COLONIES; ATLANTIC; PACIFIC; MIGRATIONS; DIFFERENTIATION	Previous genetic studies have demonstrated that natal homing shapes the stock structure of marine turtle nesting populations. However, widespread sharing of common haplotypes based on short segments of the mitochondrial control region often limits resolution of the demographic connectivity of populations. Recent studies employing longer control region sequences to resolve haplotype sharing have focused on regional assessments of genetic structure and phylogeography. Here we synthesize available control region sequences for loggerhead turtles from the Mediterranean Sea, Atlantic, and western Indian Ocean basins. These data represent six of the nine globally significant regional management units (RMUs) for the species and include novel sequence data from Brazil, Cape Verde, South Africa and Oman. Genetic tests of differentiation among 42 rookeries represented by short sequences (380 bp haplotypes from 3,486 samples) and 40 rookeries represented by long sequences (similar to 800 bp haplotypes from 3,434 samples) supported the distinction of the six RMUs analyzed as well as recognition of at least 18 demographically independent management units (MUs) with respect to female natal homing. A total of 59 haplotypes were resolved. These haplotypes belonged to two highly divergent global lineages, with haplogroup I represented primarily by CC-A1, CC-A4, and CC-A11 variants and haplogroup II represented by CC-A2 and derived variants. Geographic distribution patterns of haplogroup II haplotypes and the nested position of CC-A11.6 from Oman among the Atlantic haplotypes invoke recent colonization of the Indian Ocean from the Atlantic for both global lineages. The haplotypes we confirmed for western Indian Ocean RMUs allow reinterpretation of previous mixed stock analysis and further suggest that contemporary migratory connectivity between the Indian and Atlantic Oceans occurs on a broader scale than previously hypothesized. This study represents a valuable model for conducting comprehensive international cooperative data management and research in marine ecology.	[Shamblin, Brian M.] Natl Res Council Res Associateship Program, Washington, DC USA; [Shamblin, Brian M.; Stewart, Kelly R.; Dutton, Peter H.] Natl Atmospher & Ocean Adm Fisheries, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Silver Spring, MD USA; [Bolten, Alan B.; Bjorndal, Karen A.; Soares, Luciano S.] Univ Florida, Archie Carr Ctr Sea Turtle Res, Gainesville, FL USA; [Bolten, Alan B.; Bjorndal, Karen A.; Soares, Luciano S.] Univ Florida, Dept Biol, Gainesville, FL USA; [Alberto Abreu-Grobois, F.] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Mazatlan, Mazatlan, Sinaloa, Mexico; [Cardona, Luis; Carreras, Carlos; Clusa, Marcel] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; [Cardona, Luis; Carreras, Carlos; Clusa, Marcel] Univ Barcelona, Fac Biol, IRBio, Barcelona, Spain; [Carreras, Carlos] Univ Exeter, Marine Turtle Res Grp, Coll Life & Environm Sci, Peryn, Cornwall, England; [Monzon-Argueello, Catalina] Univ Las Palmas Gran Canaria, Dept Biol, Las Palmas Gran Canaria, Spain; [Nairn, Campbell J.] Univ Georgia, Daniel B Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Nielsen, Janne T.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Nel, Ronel] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa; [Soares, Luciano S.] Projeto TAMAR ICMBio, Salvador, BA, Brazil; [Stewart, Kelly R.] Ocean Fdn, Washington, DC USA; [Vilaca, Sibelle T.] Univ Fed Minas Gerais, Lab Biodiversidade & Evolucao Mol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Turkozan, Oguz; Yilmaz, Can] Adnan Menderes Univ, Fac Sci & Arts, Dept Biol, Aydin, Turkey	National Academies of Sciences, Engineering & Medicine; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidad Nacional Autonoma de Mexico; University of Barcelona; University of Barcelona; University of Exeter; Universidad de Las Palmas de Gran Canaria; University System of Georgia; University of Georgia; University of Miami; Nelson Mandela University; Universidade Federal de Minas Gerais; Adnan Menderes University	Dutton, PH (corresponding author), Natl Atmospher & Ocean Adm Fisheries, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Silver Spring, MD USA.	Peter.Dutton@noaa.gov	Vilaça, Sibelle Torres/K-1965-2012; Grobois, Alberto Abreu/A-3560-2017; Vilaca, Sibelle/AAA-4573-2020; Carreras, Carlos/B-6772-2012; Nairn, Campbell J/B-6547-2018; Cardona, Luis/AAL-1354-2021; Turkozan, Oguz/V-8509-2019; Cardona, Luis/L-1680-2014	Vilaça, Sibelle Torres/0000-0002-6887-4703; Grobois, Alberto Abreu/0000-0002-7350-757X; Vilaca, Sibelle/0000-0002-6887-4703; Carreras, Carlos/0000-0002-2478-6445; Nairn, Campbell J/0000-0002-1690-1730; Cardona, Luis/0000-0002-7892-1323; Turkozan, Oguz/0000-0001-6889-7908; Cardona, Luis/0000-0002-7892-1323; Bolten, Alan/0000-0002-4834-2742; Bjorndal, Karen/0000-0002-6286-1901	NOAA-Fisheries Service; Ocean Foundation; National Research Foundation Thuthuka Grant; Nelson Mandela Metropolitan University; National Research Council; National Research Council at the Southwest Fisheries Science Center; Lenfest Ocean Program	NOAA-Fisheries Service(National Oceanic Atmospheric Admin (NOAA) - USA); Ocean Foundation; National Research Foundation Thuthuka Grant; Nelson Mandela Metropolitan University; National Research Council; National Research Council at the Southwest Fisheries Science Center; Lenfest Ocean Program	The NOAA-Fisheries Service and The Ocean Foundation funded travel for convening the Atlantic-Mediterranean Loggerhead Genetics Working Group meetings and laboratory analysis. The National Research Foundation Thuthuka Grant and Nelson Mandela Metropolitan University funded fieldwork in South Africa. Stipend support was provided to Brian Shamblin was by the National Research Council to lead data analysis and manuscript preparation at the NOAA-Southwest Fisheries Science Center. Funding support for Kelly Stewart was partially provided by the National Research Council at the Southwest Fisheries Science Center and also by the Lenfest Ocean Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Grobois FA, 2006, P 26 ANN S SEA TURTL, P179; Alekseyenko AV, 2008, SYST BIOL, V57, P772, DOI 10.1080/10635150802434394; Bagda E, 2012, BIOCHEM SYST ECOL, V43, P192, DOI 10.1016/j.bse.2012.03.015; Baldwin R, 2003, LOGGERHEAD SEA TURTL, P218; Benjamini Y, 2001, ANN STAT, V29, P1165; Bjorndal KA, 2006, CHELONIAN CONSERV BI, V5, P262, DOI 10.2744/1071-8443(2006)5[262:PSADOB]2.0.CO;2; Bolten AB, 1998, ECOL APPL, V8, P1; Bourjea J, 2007, MOL ECOL, V16, P175, DOI 10.1111/j.1365-294X.2006.03122.x; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; BOWEN B.W., 2003, LOGGERHEAD SEA TURTL, P7; Bowen BW, 2005, MOL ECOL, V14, P2389, DOI 10.1111/j.1365-294X.2005.02598.x; BOWEN BW, 1995, P NATL ACAD SCI USA, V92, P3731, DOI 10.1073/pnas.92.9.3731; Bowen BW, 1997, GENETICA, V101, P179, DOI 10.1023/A:1018382415005; BOWEN BW, 1994, EVOLUTION, V48, P1820, DOI 10.1111/j.1558-5646.1994.tb02217.x; Bowen BW, 2004, MOL ECOL, V13, P3797, DOI 10.1111/j.1365-294X.2004.02356.x; Boyle MC, 2009, P R SOC B, V276, P1993, DOI 10.1098/rspb.2008.1931; Carr A. F., 1942, PROC NEW ENGLAND ZOOL CLUB, V20, P95; Carreras C, 2007, CONSERV GENET, V8, P761, DOI 10.1007/s10592-006-9224-8; Carreras C, 2011, J HERED, V102, P666, DOI 10.1093/jhered/esr089; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clusa M, 2013, J EXP MAR BIOL ECOL, V439, P15, DOI 10.1016/j.jembe.2012.10.011; Dittman AH, 1996, J EXP BIOL, V199, P83; DODD CK, 1992, J HERPETOL, V26, P1, DOI 10.2307/1565014; Drosopoulou E, 2012, MITOCHONDR DNA, V23, P1, DOI 10.3109/19401736.2011.637109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duchene S, 2012, MOL PHYLOGENET EVOL, V65, P241, DOI 10.1016/j.ympev.2012.06.010; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; Dutton PH, 2013, CONSERV GENET, V14, P625, DOI 10.1007/s10592-013-0456-0; Dutton PH, 1999, J ZOOL, V248, P397, DOI 10.1111/j.1469-7998.1999.tb01038.x; Eder E, 2012, MAR ECOL PROG SER, V470, P113, DOI 10.3354/meps10018; Encalada SE, 1998, MAR BIOL, V130, P567, DOI 10.1007/s002270050278; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fang FX, 2003, DEEP-SEA RES PT II, V50, P2245, DOI 10.1016/S0967-0645(03)00055-9; Fitzsimmons N.N., 1996, P INT S SEA TURTL CO, P25; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Formia A, 2006, CONSERV GENET, V7, P353, DOI 10.1007/s10592-005-9047-z; Garofalo L, 2009, MAR BIOL, V156, P2085, DOI 10.1007/s00227-009-1239-5; Hatase H, 2002, MAR ECOL PROG SER, V233, P273, DOI 10.3354/meps233273; Hatase H, 2002, MAR BIOL, V141, P299, DOI 10.1007/s00227-002-0819-4; Hawkes LA, 2006, CURR BIOL, V16, P990, DOI 10.1016/j.cub.2006.03.063; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; HENDRICKSON JR, 1980, AM ZOOL, V20, P597; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Jensen MP, 2013, CRC MAR BIOL SER, P135; Laurent L, 1998, MOL ECOL, V7, P1529, DOI 10.1046/j.1365-294x.1998.00471.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Mansfield KL, 2013, CRC MAR BIOL SER, P189; MANTEL N, 1967, CANCER RES, V27, P209; Monzon-Arguello C, 2010, CONSERV GENET, V11, P1871, DOI 10.1007/s10592-010-0079-7; Monzon-Arguello C, 2009, J EXP MAR BIOL ECOL, V373, P79, DOI 10.1016/j.jembe.2009.03.007; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; National Marine Fisheries Services (NMFS) United States Fish and Wildlife Service (USFWS), 2011, FED REGISTER, P58868; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Prince Robert I.T., 1994, Marine Turtle Newsletter, V67, P5; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Rees AF, 2010, MAR ECOL PROG SER, V418, P201, DOI 10.3354/meps08767; Reis EC, 2010, CONSERV GENET, V11, P1467, DOI 10.1007/s10592-009-9975-0; Roden SE, 2013, ENDANGER SPECIES RES, V20, P227, DOI 10.3354/esr00500; Rousset F, 1997, GENETICS, V145, P1219; Ruiz U Ariel, 2008, Revista de Investigaciones Marinas, V29, P151; Saied A, 2012, MAR ECOL PROG SER, V450, P207, DOI 10.3354/meps09548; Schiller A, 2008, PROG OCEANOGR, V76, P334, DOI 10.1016/j.pocean.2008.01.003; Shamblin BM, 2012, MAR ECOL PROG SER, V469, P145, DOI 10.3354/meps09980; Shamblin BM, 2012, MOL ECOL, V21, P2330, DOI 10.1111/j.1365-294X.2012.05530.x; Shamblin BM, 2011, MAR BIOL, V158, P571, DOI 10.1007/s00227-010-1582-6; Shanker K, 2004, MOL ECOL, V13, P1899, DOI 10.1111/j.1365-294X.2004.02195.x; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Stewart KR, 2013, J ANIM ECOL, V82, P791, DOI 10.1111/1365-2656.12056; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tikochinski Y, 2012, MAR GENOM, V6, P17, DOI 10.1016/j.margen.2012.01.002; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Yilmaz C, 2011, BIOCHEM SYST ECOL, V39, P266, DOI 10.1016/j.bse.2011.08.018; ZANGERL R, 1980, AM ZOOL, V20, P585	75	66	70	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85956	10.1371/journal.pone.0085956	http://dx.doi.org/10.1371/journal.pone.0085956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465810	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000034
J	Bruce, A; Rybak, AP				Bruce, Anthony; Rybak, Adrian P.			CYB5D2 Requires Heme-Binding to Regulate HeLa Cell Growth and Confer Survival from Chemotherapeutic Agents	PLOS ONE			English	Article							ANCHORAGE-INDEPENDENT GROWTH; MEMBRANE COMPONENT 1; PROGESTERONE-RECEPTOR; SACCHAROMYCES-CEREVISIAE; CYTOCHROMES P450; CANCER-CELLS; NUDE MICE; PROTEIN; TUMORIGENICITY; DOMAIN	The cytochrome b5 domain containing 2 (CYB5D2; Neuferricin) protein has been reported to bind heme, however, the critical residues responsible for heme-binding are undefined. Furthermore, the relationship between heme-binding and CYB5D2-mediated intracellular functions remains unknown. Previous studies examining heme-binding in two cytochrome b5 heme-binding domain-containing proteins, damage-associated protein 1 (Dap1; Saccharomyces cerevisiae) and human progesterone receptor membrane component 1 (PGRMC1), have revealed that conserved tyrosine (Y) 73, Y79, aspartic acid (D) 86, and Y127 residues present in human CYB5D2 may be involved in heme-binding. CYB5D2 binds to type b heme, however, only the substitution of glycine (G) at D86 (D86G) within its cytochrome b5 heme-binding (cyt-b5) domain abolished its heme-binding ability. Both CYB5D2 and CYB5D2(D86G) localize to the endoplasmic reticulum. Ectopic CYB5D2 expression inhibited cell proliferation and anchorage-independent colony growth of HeLa cells. Conversely, CYB5D2 knockdown and ectopic CYB5D2(D86G) expression increased cell proliferation and colony growth. As PGRMC1 has been reported to regulate the expression and activities of cytochrome P450 proteins (CYPs), we examined the role of CYB5D2 in regulating the activities of CYPs involved in sterol synthesis (CYP51A1) and drug metabolism (CYP3A4). CYB5D2 co-localizes with cytochrome P450 reductase (CYPOR), while CYB5D2 knockdown reduced lanosterol demethylase (CYP51A1) levels and rendered HeLa cells sensitive to mevalonate. Additionally, knockdown of CYB5D2 reduced CYP3A4 activity. Lastly, CYB5D2 expression conferred HeLa cell survival from chemotherapeutic agents (paclitaxel, cisplatin and doxorubicin), with its ability to promote survival being dependent on its heme-binding ability. Taken together, this study provides evidence that heme-binding is critical for CYB5D2 in regulating HeLa cell growth and survival, with endogenous CYB5D2 being required to modulate CYP activities.	[Bruce, Anthony; Rybak, Adrian P.] McMaster Univ, Fac Hlth Sci, Med Sci Program, Hamilton, ON, Canada; [Bruce, Anthony; Rybak, Adrian P.] Father Sean OSullivan Res Inst, Hamilton, ON, Canada; [Bruce, Anthony; Rybak, Adrian P.] St Josephs Hosp, HCKR, Hamilton, ON, Canada	McMaster University; McGill University; McMaster University	Bruce, A (corresponding author), McMaster Univ, Fac Hlth Sci, Med Sci Program, Hamilton, ON, Canada.	brucea@mcmaster.ca; rybaka@mcmaster.ca		Rybak, Adrian/0000-0002-4933-0946	St. Joseph's HealthCare Hamilton (Division of Nephrology); Hamilton Centre for Kidney Research (HCKR); McMaster University in Hamilton, Ontario, Canada	St. Joseph's HealthCare Hamilton (Division of Nephrology); Hamilton Centre for Kidney Research (HCKR); McMaster University in Hamilton, Ontario, Canada	This work was supported by research funding from St. Joseph's HealthCare Hamilton (Division of Nephrology), the Hamilton Centre for Kidney Research (HCKR) and McMaster University in Hamilton, Ontario, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; COLBURN NH, 1978, CANCER RES, V38, P624; Craven RJ, 2007, J BIOL CHEM, V282, P36543, DOI 10.1074/jbc.M706770200; Crudden G, 2006, J PHARMACOL EXP THER, V316, P448, DOI 10.1124/jpet.105.094631; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Ghosh K, 2005, BIOCHEMISTRY-US, V44, P16729, DOI 10.1021/bi0511585; Hand RA, 2003, EUKARYOT CELL, V2, P306, DOI 10.1128/EC.2.2.306-317.2003; Harmsen S, 2007, CANCER TREAT REV, V33, P369, DOI 10.1016/j.ctrv.2007.02.003; HARRIS JW, 1994, CANCER RES, V54, P4026; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; KIM YK, 1987, J CELL PHYSIOL, V133, P553, DOI 10.1002/jcp.1041330317; Kimura I, 2008, J BIOL CHEM, V283, P4323, DOI 10.1074/jbc.M706679200; Kimura I, 2012, CURR PROTEIN PEPT SC, V13, P687, DOI 10.2174/138920312804142110; Kimura I, 2010, J NEUROCHEM, V112, P1156, DOI 10.1111/j.1471-4159.2009.06522.x; Klein Kathrin, 2013, Frontiers in Genetics, V4, P12, DOI 10.3389/fgene.2013.00012; Lee KH, 2005, GYNECOL ONCOL, V98, P45, DOI 10.1016/j.ygyno.2005.04.010; Losel RM, 2008, STEROIDS, V73, P929, DOI 10.1016/j.steroids.2007.12.017; Mallory JC, 2005, MOL CELL BIOL, V25, P1669, DOI 10.1128/MCB.25.5.1669-1679.2005; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Min L, 2005, FEBS J, V272, P5832, DOI 10.1111/j.1742-4658.2005.04977.x; Nakamoto SS, 2000, BIOCHIMIE, V82, P603, DOI 10.1016/S0300-9084(00)00605-2; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; Olczak T, 2001, J BACTERIOL, V183, P5599, DOI 10.1128/JB.183.19.5599-5608.2001; OSMAK M, 1993, RES EXP MED, V193, P389, DOI 10.1007/BF02576247; Pandey AV, 2013, PHARMACOL THERAPEUT, V138, P229, DOI 10.1016/j.pharmthera.2013.01.010; Pinto N, 2011, CURR DRUG METAB, V12, P487, DOI 10.2174/138920011795495321; Rodriguez-Antona C, 2007, BLOOD, V110, P3345, DOI 10.1182/blood-2007-02-075036; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Rybak AP, 2011, BBA-MOL CELL RES, V1813, P683, DOI 10.1016/j.bbamcr.2011.01.018; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Song J, 2004, J BIOMOL NMR, V30, P215, DOI 10.1023/B:JNMR.0000048943.34504.29; Szczesna-Skorupa E, 2011, MOL PHARMACOL, V79, P340, DOI 10.1124/mol.110.068478; Tang DM, 1997, J BIOL CHEM, V272, P12318, DOI 10.1074/jbc.272.19.12318; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Wojtowicz H, 2009, BIOCHEM BIOPH RES CO, V383, P178, DOI 10.1016/j.bbrc.2009.03.148; Xie YY, 2011, BIOCHEM CELL BIOL, V89, P341, DOI 10.1139/O11-004; Yoshitani N, 2005, PROTEOMICS, V5, P1472, DOI 10.1002/pmic.200401032; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6; Zhang Q, 2006, J PHARM SCI-US, V95, P2266, DOI 10.1002/jps.20714	45	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86435	10.1371/journal.pone.0086435	http://dx.doi.org/10.1371/journal.pone.0086435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466094	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100164
J	Cousins, FL; Murray, A; Esnal, A; Gibson, DA; Critchley, HOD; Saunders, PTK				Cousins, Fiona L.; Murray, Alison; Esnal, Arantza; Gibson, Douglas A.; Critchley, Hilary O. D.; Saunders, Philippa T. K.			Evidence from a Mouse Model That Epithelial Cell Migration and Mesenchymal-Epithelial Transition Contribute to Rapid Restoration of Uterine Tissue Integrity during Menstruation	PLOS ONE			English	Article							ENDOMETRIAL BREAKDOWN; MATRIX METALLOPROTEINASES; BONE-MARROW; STEM-CELLS; EXPRESSION; REGENERATION; ESTROGEN; RECEPTOR; HYPOXIA; REPAIR	Background: In women dynamic changes in uterine tissue architecture occur during each menstrual cycle. Menses, characterised by the shedding of the upper functional layer of the endometrium, is the culmination of a cascade of irreversible changes in tissue function including stromal decidualisation, inflammation and production of degradative enzymes. The molecular mechanisms that contribute to the rapid restoration of tissue homeostasis at time of menses are poorly understood. Methodology: A modified mouse model of menses was developed to focus on the events occurring within the uterine lining during endometrial shedding/repair. Decidualisation, vaginal bleeding, tissue architecture and cell proliferation were evaluated at 4, 8, 12, and 24 hours after progesterone (P4) withdrawal; mice received a single injection of bromodeoxyuridine (BrdU) 90 mins before culling. Expression of genes implicated in the regulation of mesenchymal to epithelial transition (MET) was determined using a RT2 PCR profiler array, qRTPCR and bioinformatic analysis. Principal Findings: Mice exhibited vaginal bleeding between 4 and 12 hours after P4 withdrawal, concomitant with detachment of the decidualised cell mass from the basal portion of the endometrial lining. Immunostaining for BrdU and pan cytokeratin revealed evidence of epithelial cell proliferation and migration. Cells that appeared to be in transition from a mesenchymal to an epithelial cell identity were identified within the stromal compartment. Analysis of mRNAs encoding genes expressed exclusively in the epithelial or stromal compartments, or implicated in MET, revealed dynamic changes in expression, consistent with a role for reprogramming of mesenchymal cells so that they could contribute to reepithelialisation. Conclusions/Significance: These studies have provided novel insights into the cellular processes that contribute to reepithelialisation post-menses implicating both epithelial cell migration and mesenchymal cell differentiation in restoration of an intact epithelial cell layer. These insights may inform development of new therapies to induce rapid healing in the endometrium and other tissues and offer hope to women who suffer from heavy menstrual bleeding.	[Cousins, Fiona L.; Murray, Alison; Esnal, Arantza; Gibson, Douglas A.; Critchley, Hilary O. D.; Saunders, Philippa T. K.] Univ Edinburgh, Med Res Council, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh	Saunders, PTK (corresponding author), Univ Edinburgh, Med Res Council, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	p.saunders@ed.ac.uk	Cousins, Fiona L/K-3790-2016; Saunders, Philippa TK/C-7489-2013	Cousins, Fiona L/0000-0002-7064-8596; Saunders, Philippa TK/0000-0001-9051-9380; CRITCHLEY, HILARY/0000-0003-1913-4044; Gibson, Douglas/0000-0002-9949-1983	MRC Programme [G1100356/1]; MRC; Medical Research Council [G1100356, G1002033] Funding Source: researchfish; MRC [G1002033, G1100356] Funding Source: UKRI	MRC Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	These studies were supported by MRC Programme Grant G1100356/1 and a MRC funded PhD studentship to FLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bombail V, 2008, HUM REPROD, V23, P2782, DOI 10.1093/humrep/den298; Brasted M, 2003, BIOL REPROD, V69, P1273, DOI 10.1095/biolreprod.103.016550; Brenner RM, 1996, HUM REPROD, V11, P150, DOI 10.1093/humrep/11.suppl_2.150; Cervello I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021221; Charlieu JP, 1995, J CELL SCI, P95; Chevronnay HPG, 2009, ENDOCRINOLOGY, V150, P5094, DOI 10.1210/en.2009-0750; Colas E, 2012, CLIN TRANSL ONCOL, V14, P715, DOI 10.1007/s12094-012-0866-3; Collins F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-330; Critchley HOD, 2006, ENDOCRINOLOGY, V147, P744, DOI 10.1210/en.2005-1153; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; Emera D, 2012, BIOESSAYS, V34, P26, DOI 10.1002/bies.201100099; Evans J, 2011, BIOL REPROD, V85, P511, DOI 10.1095/biolreprod.111.090993; FERENCZY A, 1976, AM J OBSTET GYNECOL, V124, P582, DOI 10.1016/0002-9378(76)90059-4; FINN CA, 1984, J ENDOCRINOL, V100, P295, DOI 10.1677/joe.0.1000295; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Garry R, 2010, BJOG-INT J OBSTET GY, V117, P1175, DOI 10.1111/j.1471-0528.2010.02630.x; Garry R, 2009, HUM REPROD, V24, P1393, DOI 10.1093/humrep/dep036; Gonzalez MLA, 2009, HUM REPROD, V24, P2217, DOI 10.1093/humrep/dep203; Huang CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044285; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Kaitu'u TJ, 2005, BIOL REPROD, V73, P672, DOI 10.1095/biolreprod.105.042473; Kaitu'u-Lino TJ, 2007, ENDOCRINOLOGY, V148, P5105, DOI 10.1210/en.2007-0716; Kane N, 2008, MOL ENDOCRINOL, V22, P716, DOI 10.1210/me.2007-0316; Marbaix E, 1996, HUM REPROD, V11, P134, DOI 10.1093/humrep/11.suppl_2.134; Maybin JA, 2011, J CLIN ENDOCR METAB, V96, P2475, DOI 10.1210/jc.2010-2971; Menning A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041800; Miller-Hodges E, 2012, J PATHOL, V226, P229, DOI 10.1002/path.2977; Morelli SS, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.107987; NOVAK E, 1946, Obstet Gynecol Surv, V1, P682; Patterson AL, 2013, STEM CELLS DEV, V22, P964, DOI 10.1089/scd.2012.0435; Pioli PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069216; Reardon SN, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.098871; Rudolph M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032922; TABIBZADEH S, 1995, HUM REPROD, V10, P776, DOI 10.1093/oxfordjournals.humrep.a136037; Taylor HS, 1997, BIOL REPROD, V57, P1338, DOI 10.1095/biolreprod57.6.1338; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tranguch S, 2005, CELL MOL LIFE SCI, V62, P1964, DOI 10.1007/s00018-005-5230-0; Wang QX, 2013, HUM REPROD, V28, P1670, DOI 10.1093/humrep/det052; Xu XB, 2013, ENDOCRINOLOGY, V154, P2900, DOI 10.1210/en.2012-1993	39	68	73	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86378	10.1371/journal.pone.0086378	http://dx.doi.org/10.1371/journal.pone.0086378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466063	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100150
J	Escobar, A; Aguirre, A; Guzman, MA; Gonzalez, R; Catalan, D; Acuna-Castillo, C; Larrondo, M; Lopez, M; Pesce, B; Rolland, J; O'Hehir, R; Aguillon, JC				Escobar, Alejandro; Aguirre, Adam; Guzman, Maria Antonieta; Gonzalez, Rodrigo; Catalan, Diego; Acuna-Castillo, Claudio; Larrondo, Milton; Lopez, Mercedes; Pesce, Barbara; Rolland, Jennifer; O'Hehir, Robyn; Aguillon, Juan Carlos			Tolerogenic Dendritic Cells Derived from Donors with Natural Rubber Latex Allergy Modulate Allergen-Specific T-Cell Responses and IgE Production	PLOS ONE			English	Article							HEALTH-CARE WORKERS; GRASS-POLLEN IMMUNOTHERAPY; HEV B 5; INTERLEUKIN-10 PRODUCTION; VENOM IMMUNOTHERAPY; IMMUNE-RESPONSES; REGULATORY CELLS; IN-VIVO; ANTIGEN; DIFFERENTIATION	Natural rubber latex (NRL; Hevea brasiliensis) allergy is an IgE-mediated reaction to latex proteins. When latex glove exposure is the main sensitizing agent, Hev b 5 is one of the major allergens. Dendritic cells (DC), the main antigen presenting cells, modulated with pharmacological agents can restore tolerance in several experimental models, including allergy. In the current study, we aimed to generate DC with tolerogenic properties from NRL-allergic patients and evaluate their ability to modulate allergen-specific T and B cell responses. Here we show that dexamethasone-treated DC (dxDC) differentiated into a subset of DC, characterized by low expression of MHC class II, CD40, CD80, CD86 and CD83 molecules. Compared with LPS-matured DC, dxDC secreted lower IL-12 and higher IL-10 after CD40L activation, and induced lower alloantigenic T cell proliferation. We also show that dxDC pulsed with the dominant Hev b 5 T-cell epitope peptide, Hev b 5(46-65), inhibited both proliferation of Hev b 5-specific T-cell lines and the production of Hev b 5-specific IgE. Additionally, dxDC induced a subpopulation of IL-10-producing regulatory T cells that suppressed proliferation of Hev b 5-primed T cells. In conclusion, dxDC generated from NRL-allergic patients can modulate allergen-specific T-cell responses and IgE production, supporting their potential use in allergen-specific immunotherapy.	[Escobar, Alejandro] Univ Chile, Fac Dent, Res Inst Dent Sci, Santiago, Chile; [Aguirre, Adam] Catholic Univ Chile, Fac Chem, Dept Pharm, Santiago, Chile; [Guzman, Maria Antonieta] Univ Chile, Clin Hosp Univ Chile, Allergy Ctr, Santiago, Chile; [Gonzalez, Rodrigo; Larrondo, Milton] Univ Chile, Blood Bank Clin Hosp Univ Chile, Santiago, Chile; [Catalan, Diego; Lopez, Mercedes; Pesce, Barbara; Aguillon, Juan Carlos] Univ Chile, Millennium Inst Immunol & Immunotherapy, Fac Med, Program Immunol, Santiago, Chile; [Acuna-Castillo, Claudio] Univ Santiago, Fac Chem & Biol, Dept Biol, Santiago, Chile; [Rolland, Jennifer; O'Hehir, Robyn] Monash Univ, AMREP, Dept Immunol, Melbourne, Vic 3004, Australia	Universidad de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Santiago de Chile; Monash University	Escobar, A (corresponding author), Univ Chile, Fac Dent, Res Inst Dent Sci, Santiago, Chile.	jano@med.uchile.cl; jaguillo@med.uchile.cl	Aguirre, Adam/GQQ-3265-2022; Lopez, Mercedes/CAF-4801-2022; O'Hehir, Robyn E/H-3627-2011; Catalán, Diego/AAN-3241-2020; Aguillon, Juan C/H-9234-2013; Catalán, Diego F/H-7983-2013; Acuña-Castillo, Claudio/AAI-7090-2021	O'Hehir, Robyn E/0000-0002-3489-7595; Catalán, Diego/0000-0002-4353-1229; Aguillon, Juan C/0000-0003-3148-6843; Catalán, Diego F/0000-0002-4353-1229; Acuña-Castillo, Claudio/0000-0003-3607-6077	Millennium Institute on Immunology and Immunotherapy [P09-016-F]; Research Support Office, Clinical Hospital of the University of Chile, Santiago; National Fund for Scientific and Technological Development, Chile [FONDECYT 1100102]	Millennium Institute on Immunology and Immunotherapy; Research Support Office, Clinical Hospital of the University of Chile, Santiago; National Fund for Scientific and Technological Development, Chile	This work was supported by grants from the Millennium Institute on Immunology and Immunotherapy P09-016-F, Research Support Office, Clinical Hospital of the University of Chile, Santiago and the National Fund for Scientific and Technological Development, Chile (FONDECYT 1100102). All authors have no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, TRANSPL IMMUNOL, V11, P357, DOI 10.1016/S0966-3274(03)00050-9; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Akdis CA, 2001, IMMUNOLOGY, V103, P131, DOI 10.1046/j.1365-2567.2001.01235.x; Akdis CA, 2001, MICROBES INFECT, V3, P891, DOI 10.1016/S1286-4579(01)01449-6; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Allan SE, 2008, IMMUNOL REV, V223, P391, DOI 10.1111/j.1600-065X.2008.00634.x; Beezhold DH, 2004, INT ARCH ALLERGY IMM, V134, P334, DOI 10.1159/000079537; Bellinghausen I, 1997, EUR J IMMUNOL, V27, P1131, DOI 10.1002/eji.1830270513; Bernstein DI, 2003, J ALLERGY CLIN IMMUN, V111, P610, DOI 10.1067/mai.2003.164; Bosma BM, 2008, IMMUNOLOGY, V125, P91, DOI 10.1111/j.1365-2567.2008.02824.x; Charous BL, 2002, J ALLERGY CLIN IMMUN, V109, P31, DOI 10.1067/mai.2002.120953; Ciesek S, 2005, TRANSPL P, V37, P20, DOI 10.1016/j.transproceed.2004.11.055; de Jong EC, 1999, J LEUKOCYTE BIOL, V66, P201, DOI 10.1002/jlb.66.2.201; de Silva HD, 2000, J ALLERGY CLIN IMMUN, V105, P1017, DOI 10.1067/mai.2000.105806; Delgado M, 2006, ANN NY ACAD SCI, V1070, P226, DOI 10.1196/annals.1317.019; Drew AC, 2004, J IMMUNOL, V173, P5872, DOI 10.4049/jimmunol.173.9.5872; Escobar A, 2005, CLIN EXP IMMUNOL, V142, P555, DOI 10.1111/1365-2249.2005.02938.x; Francis JN, 2003, J ALLERGY CLIN IMMUN, V111, P1255, DOI 10.1067/mai.2003.1570; Gardner LM, 2004, CLIN EXP ALLERGY, V34, P1209, DOI 10.1111/j.1365-2222.2004.02009.x; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Henry E, 2008, J IMMUNOL, V181, P7230, DOI 10.4049/jimmunol.181.10.7230; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jugde F, 2005, TOXICOLOGY, V212, P227, DOI 10.1016/j.tox.2005.04.019; Kalinski P, 1999, J IMMUNOL, V162, P3231; Kanjarawi R, 2011, INT ARCH ALLERGY IMM, V156, P387, DOI 10.1159/000323940; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Lyakh LA, 2005, J IMMUNOL, V174, P2061, DOI 10.4049/jimmunol.174.4.2061; Mahnke Karsten, 2008, V94, P29, DOI 10.1159/000154854; Morelli AE, 2001, BLOOD, V98, P1512, DOI 10.1182/blood.V98.5.1512; MOSER M, 1995, EUR J IMMUNOL, V25, P2818, DOI 10.1002/eji.1830251016; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Nasser SMS, 2001, EUR J IMMUNOL, V31, P3704, DOI 10.1002/1521-4141(200112)31:12<3704::AID-IMMU3704>3.0.CO;2-3; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Oh JW, 2002, J ALLERGY CLIN IMMUN, V110, P460, DOI 10.1067/mai.2002.127512; Pacciani V, 2010, J ALLERGY CLIN IMMUN, V125, P727, DOI 10.1016/j.jaci.2009.12.004; Piemonti L, 1999, J IMMUNOL, V162, P6473; Ranta PM, 2004, CLIN INFECT DIS, V38, P252, DOI 10.1086/380789; Reunala T, 2004, CURR OPIN ALLERGY CL, V4, P397, DOI 10.1097/00130832-200410000-00011; Rihs HP, 2002, J ALLERGY CLIN IMMUN, V110, P507, DOI 10.1067/mai.2002.127282; Rolland JM, 2009, PHARMACOL THERAPEUT, V121, P273, DOI 10.1016/j.pharmthera.2008.11.007; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Slater JE, 1996, J BIOL CHEM, V271, P25394, DOI 10.1074/jbc.271.41.25394; Steinbrink K, 2002, BLOOD, V99, P2468, DOI 10.1182/blood.V99.7.2468; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sutherland MF, 2002, CLIN EXP ALLERGY, V32, P583, DOI 10.1046/j.0954-7894.2002.01355.x; van der Merwe PA, 2000, NAT IMMUNOL, V1, P194, DOI 10.1038/79729; Xia CQ, 2005, SCAND J IMMUNOL, V62, P45, DOI 10.1111/j.1365-3083.2005.01640.x; Xia CQ, 2003, SCAND J IMMUNOL, V58, P23, DOI 10.1046/j.1365-3083.2003.01268.x	52	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85930	10.1371/journal.pone.0085930	http://dx.doi.org/10.1371/journal.pone.0085930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465795	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100089
J	Garrett, SH; Somji, S; Sens, DA; Zhang, KK				Garrett, Scott H.; Somji, Seema; Sens, Donald A.; Zhang, Ke K.			Prediction of the Number of Activated Genes in Multiple Independent Cd+2- and As+3-Induced Malignant Transformations of Human Urothelial Cells (UROtsa)	PLOS ONE			English	Article							GENOMIC ANALYSES; BLADDER-CANCER; EXPRESSION; CADMIUM; CARCINOGENESIS; HETEROGENEITY; MUTATIONS; ALGORITHM; CARCINOMA; PATTERNS	Background: Many toxic environmental agents such as cadmium and arsenic are found to be epidemiologically linked to increasing rates of cancers. In vitro studies show that these toxic agents induced malignant transformation in human cells. It is not clear whether such malignant transformation induced by a single toxic agent is driven by a common set of genes. Although the advancement of high-throughput technology has facilitated the profiling of global gene expression, it remains a question whether the sample size is sufficient to identify this common driver gene set. Results: We have developed a statistical method, SOFLR, to predict the number of common activated genes using a limited number of microarray samples. We conducted two case studies, cadmium and arsenic transformed human urothelial cells. Our method is able to precisely predict the number of stably induced and repressed genes and the number of samples to identify the common activated genes. The number of independent transformed isolates required for identifying the common activated genes is also estimated. The simulation study further validated our method and identified the important parameters in this analysis. Conclusions: Our method predicts the degree of similarity and diversity during cell malignant transformation by a single toxic agent. The results of our case studies imply the existence of common driver and passenger gene sets in toxin-induced transformation. Using a pilot study with small sample size, this method also helps microarray experimental design by determining the number of samples required to identify the common activated gene	[Garrett, Scott H.; Somji, Seema; Sens, Donald A.; Zhang, Ke K.] Univ N Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Zhang, KK (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58201 USA.	ke.zhang@med.und.edu			National Center for Research Resources [5P20RR016471-12]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103442-12]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Center for Research Resources (5P20RR016471-12) and the National Institute of General Medical Sciences (8 P20 GM103442-12) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, J ENV HLTH, V64, p[36, 44]; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benbrahim-Tallaa L, 2009, ENVIRON HEALTH PERSP, V117, P1847, DOI 10.1289/ehp.0900999; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cao L, 2010, J APPL TOXICOL, V30, P416, DOI 10.1002/jat.1513; CHEN CJ, 1992, BRIT J CANCER, V66, P888, DOI 10.1038/bjc.1992.380; Fujiwara K, 2004, CARCINOGENESIS, V25, P1495, DOI 10.1093/carcin/bgh155; Garrett SH, 2011, J TOXICOL ENV HEAL A, V74, P24, DOI 10.1080/15287394.2010.514230; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kellen E, 2007, CANCER DETECT PREV, V31, P77, DOI 10.1016/j.cdp.2006.12.001; Kitchin KT, 2010, CHEM RES TOXICOL, V23, P327, DOI 10.1021/tx900343d; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Li SYS, 2005, STAT MED, V24, P2267, DOI 10.1002/sim.2119; Lu X, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-23; Medeiros M, 2012, TOXICOLOGY, V291, P102, DOI 10.1016/j.tox.2011.11.002; Natsoulis G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.9; Petzoldt JL, 1995, UROL RES, V23, P337; Platanias LC, 2009, J BIOL CHEM, V284, P18583, DOI 10.1074/jbc.R900003200; Posey T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-115; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Sens DA, 2004, TOXICOL SCI, V79, P56, DOI 10.1093/toxsci/kfh086; Sjoblom T, 2008, CURR OPIN ONCOL, V20, P66; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Somji S, 2010, CHEM RES TOXICOL, V23, P348, DOI 10.1021/tx900346q; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Takahashi S, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-36; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Verma R, 2004, MOL CELL BIOCHEM, V255, P203, DOI 10.1023/B:MCBI.0000007276.94488.3d; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Zhang K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S10; 1993, IARC MON EV CARC RIS, V58, P1	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85614	10.1371/journal.pone.0085614	http://dx.doi.org/10.1371/journal.pone.0085614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465620	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100053
J	Huang, QY; Li, WH; Fan, RF; Chang, Y				Huang, Qingyang; Li, Wenhua; Fan, Ruifeng; Chang, Ying			New MADS-Box Gene in Fern: Cloning and Expression Analysis of DfMADS1 from Dryopteris fragrans	PLOS ONE			English	Article							CERATOPTERIS-RICHARDII; HOMEOTIC GENES; LAND PLANTS; EVOLUTION; ARABIDOPSIS; PROTEINS; FAMILY; GROWTH	MADS genes encode a family of transcription factors, some of which control the identities of floral organs in flowering plants. Most of the MADS-box genes in fern have been cloned and analyzed in model plants, such as Ceratopteris richardii and Ceratopteris pteridoides. In this study, a new MADS-box gene, DfMADS1(GU385475), was cloned from Dryopteris fragrans (L.) Schott to better understand the role of MADS genes in the evolution of floral organs. The full-length DfMADS1 cDNA was 973 bp in length with a 75bp 5'-UTR and a 169bp 3'-UTR. The DfMADS1 protein was predicted to contain a typical MIKC-type domain structure consisting of a MADS domain, a short I region, a K domain, and a C-terminal region. The DfMADS1 protein showed high homology with MADS box proteins from other ferns. Phylogenetic analysis revealed that DfMADS1 belongs to the CRM1-like subfamily. RT-PCR analysis indicated that DfMADS1 is expressed in both the gametophytes and the sporophytes of D. fragrans.	[Huang, Qingyang; Li, Wenhua; Chang, Ying] Northeast Agr Univ, Coll Life Sci, Plant Res Lab, Harbin, Heilongjiang Pr, Peoples R China; [Huang, Qingyang] Heilongjiang Acad Sci, Inst Nat Resources & Ecol, Harbin, Heilongjiang Pr, Peoples R China; [Fan, Ruifeng] Heilongjiang Univ Chinese Med, Minist Educ, Key Lab Chinese Mat Med, Harbin, Heilongjiang Pr, Peoples R China	Northeast Agricultural University - China; Heilongjiang University of Chinese Medicine	Chang, Y (corresponding author), Northeast Agr Univ, Coll Life Sci, Plant Res Lab, Harbin, Heilongjiang Pr, Peoples R China.	neau_changying@163.com			National Natural Science Foundation of China [31070291]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31070291). No additional external funding received for this study. (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk BJ, 2009, PLANT PHYSIOL, V149, P1713, DOI 10.1104/pp.109.135806; Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Banks JA, 1997, GENETICS, V147, P1885; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Davies B, 1994, Results Probl Cell Differ, V20, P235; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Hasebe M, 1998, P NATL ACAD SCI USA, V95, P6222, DOI 10.1073/pnas.95.11.6222; Henschel K, 2002, MOL BIOL EVOL, V19, P801, DOI 10.1093/oxfordjournals.molbev.a004137; Kater MM, 2006, J EXP BOT, V57, P3433, DOI 10.1093/jxb/erl097; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Kofuji, 1997, J PHYTOGEOGR TAXON, V45, P83; Kwantes M, 2012, MOL BIOL EVOL, V29, P293, DOI 10.1093/molbev/msr200; Mehrabi R, 2008, EUKARYOT CELL, V7, P791, DOI 10.1128/EC.00009-08; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Munster T, 1997, P NATL ACAD SCI USA, V94, P2415, DOI 10.1073/pnas.94.6.2415; PURUGGANAN MD, 1995, GENETICS, V140, P345; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Salmi ML, 2005, PLANT PHYSIOL, V138, P1734, DOI 10.1104/pp.105.062851; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Svensson ME, 2000, GENE, V253, P31, DOI 10.1016/S0378-1119(00)00243-2; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verelst W, 2007, PLANT PHYSIOL, V143, P447, DOI 10.1104/pp.106.089805; WIDEN CJ, 1971, CAN J BOTANY, V49, P989, DOI 10.1139/b71-138; Zhang LB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-180; Zobell O, 2010, MOL BIOL EVOL, V27, P1201, DOI 10.1093/molbev/msq005; 黄庆阳, 2007, [中草药, Chinese Traditional and Herbal Drugs], V38, P1573	27	12	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86349	10.1371/journal.pone.0086349	http://dx.doi.org/10.1371/journal.pone.0086349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466046	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100146
J	Piombino, P; Genovese, A; Esposito, S; Moio, L; Cutolo, PP; Chambery, A; Severino, V; Moneta, E; Smith, DP; Owens, SM; Gilbert, JA; Ercolini, D				Piombino, Paola; Genovese, Alessandro; Esposito, Silvia; Moio, Luigi; Cutolo, Pier Paolo; Chambery, Angela; Severino, Valeria; Moneta, Elisabetta; Smith, Daniel P.; Owens, Sarah M.; Gilbert, Jack A.; Ercolini, Danilo			Saliva from Obese Individuals Suppresses the Release of Aroma Compounds from Wine	PLOS ONE			English	Article							VITIS-VINIFERA L.; VOLATILE COMPOUNDS; OXIDATIVE STRESS; RETRONASAL AROMA; FLAVOR COMPOUNDS; FOOD; HABITUATION; PERCEPTION; VARIABILITY; MASTICATION	Background: Recent evidence suggests that a lower extent of the retronasal aroma release correspond to a higher amount of ad libitum food intake. This has been regarded as one of the bases of behavioral choices towards food consumption in obese people. In this pilot study we investigated the hypothesis that saliva from obese individuals could be responsible for an alteration of the retro-nasal aroma release. We tested this hypothesis in vitro, by comparing the release of volatiles from a liquid food matrix (wine) after its interaction with saliva from 28 obese (O) and 28 normal-weight (N) individuals. Methods and Findings: Amplicon sequencing of the 16S rRNA V4 region indicated that Firmicutes and Actinobacteria were more abundant in O, while Proteobacteria and Fusobacteria dominated in N. Streptococcaceae were significantly more abundant in the O subjects and constituted 34% and 19% on average of the saliva microbiota of O and N subjects, respectively. The Total Antioxidant Capacity was higher in O vs N saliva samples. A model mouth system was used to test whether the in-mouth wine aroma release differs after the interaction with O or N saliva. In O samples, a 18% to 60% significant decrease in the mean concentration of wine volatiles was detected as a result of interaction with saliva, compared with N. This suppression was linked to biochemical differences in O and N saliva composition, which include protein content. Conclusion: Microbiological and biochemical differences were found in O vs N saliva samples. An impaired retronasal aroma release from white wine was detected in vitro and linked to compositional differences between saliva from obese and normal-weight subjects. Additional in vivo investigations on diverse food matrices could contribute to understanding whether a lower olfactory stimulation due to saliva composition can be a co-factor in the development/maintenance of obesity.	[Piombino, Paola; Genovese, Alessandro; Esposito, Silvia; Moio, Luigi; Ercolini, Danilo] Univ Naples Federico II, Dept Agr Sci, Portici, Italy; [Cutolo, Pier Paolo] S Giovanni Bosco Hosp, Gen & Laparoscop Surg Unit, Naples, Italy; [Chambery, Angela; Severino, Valeria] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Chambery, Angela] IRCCS, Milan, Italy; [Moneta, Elisabetta] Agr Res Council, Res Ctr Food & Nutr, Rome, Italy; [Smith, Daniel P.; Owens, Sarah M.; Gilbert, Jack A.] Argonne Natl Lab, Argonne, IL 60439 USA; [Owens, Sarah M.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Naples Federico II; Universita della Campania Vanvitelli; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of Chicago	Piombino, P (corresponding author), Univ Naples Federico II, Dept Agr Sci, Portici, Italy.	paola.piombino@unina.it	Genovese, Alessandro/AAG-5396-2021; Smith, Daniel/L-6827-2019; Gilbert, Jack/AAF-3270-2019; Ercolini, Danilo/B-2431-2009	Genovese, Alessandro/0000-0002-9202-6122; Smith, Daniel/0000-0002-2479-2044; Ercolini, Danilo/0000-0003-3061-9560; Moneta, Elisabetta/0000-0002-7179-1570; Piombino, Paola/0000-0001-8705-9846; Chambery, Angela/0000-0002-5136-0941	"Premio Montana alla Ricerca Alimentare 2010''; Italian Ministry of University and Research (MIUR)	"Premio Montana alla Ricerca Alimentare 2010''; Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by "Premio Montana alla Ricerca Alimentare 2010'' awarded to P. Piombino and D. Ercolini by Montana Alimentari S. p. A, Italy (www.montanafood.it). Microbiological investigations were partially supported by the Italian Ministry of University and Research (MIUR, programme PRIN 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bausenwein J, 2010, MOL HUM REPROD, V16, P117, DOI 10.1093/molehr/gap078; Bond DS, 2010, INT J OBESITY, V34, P593, DOI 10.1038/ijo.2009.267; Bond DS, 2009, OBES SURG, V19, P873, DOI 10.1007/s11695-009-9861-3; Buettner A, 2001, CHEM SENSES, V26, P1211, DOI 10.1093/chemse/26.9.1211; Burgen ASV, 1961, PHYSIOLOGY SALIVARY, P140; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castagnola M, 2011, TRENDS BIOTECHNOL, V29, P409, DOI 10.1016/j.tibtech.2011.04.002; de Wijk RA, 2004, PHYSIOL BEHAV, V83, P81, DOI 10.1016/j.physbeh.2004.07.014; de Wijk RA, 2004, PHYSIOL BEHAV, V82, P397, DOI 10.1016/j.physbeh.2004.04.053; De Wijk RA, 2012, FLAVOUR, V1; Del Barrio-Galan R, 2012, EUR FOOD RES TECHNOL, V234, P231, DOI 10.1007/s00217-011-1633-3; del Caro A, 2012, S AFR J ENOL VITIC, V33, P115; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; EPSTEIN LH, 1992, PHYSIOL BEHAV, V51, P945, DOI 10.1016/0031-9384(92)90075-D; Escudero A, 2007, J AGR FOOD CHEM, V55, P4501, DOI 10.1021/jf0636418; Fernandez-Real JM, 2010, OBESITY, V18, P482, DOI 10.1038/oby.2009.266; Ferreira V, 2002, J AGR FOOD CHEM, V50, P4048, DOI 10.1021/jf0115645; Ferreira V, 2002, MOL METHODS PLANT AN, P88; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Genovese A, 2009, FOOD CHEM, V114, P100, DOI 10.1016/j.foodchem.2008.09.022; Genovese A, 2007, FOOD CHEM, V103, P1228, DOI 10.1016/j.foodchem.2006.10.027; Gierczynski I, 2011, FLAVOUR FRAG J, V26, P141, DOI 10.1002/ffj.2036; Gillespie KM, 2007, NAT PROTOC, V2, P867, DOI 10.1038/nprot.2007.100; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; Guichard E, 2002, FOOD REV INT, V18, P49, DOI 10.1081/FRI-120003417; Harthoorn LF, 2008, FOOD QUAL PREFER, V19, P644, DOI 10.1016/j.foodqual.2008.05.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHMANN EL, 1975, NONPARAMETRICS; LUBBERS S, 1994, AM J ENOL VITICULT, V45, P29; Ly MH, 2008, FOOD HYDROCOLLOID, V22, P211, DOI 10.1016/j.foodhyd.2006.11.001; Mandel AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013352; Maukonen J, 2008, J MED MICROBIOL, V57, P1560, DOI 10.1099/jmm.0.47352-0; MELA D, 2005, FOOD DIET OBESITY; Mishellany-Dutour A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041276; Moio L, 2004, AM J ENOL VITICULT, V55, P7; Moio L, 2004, J AGR FOOD CHEM, V52, P891, DOI 10.1021/jf034869n; Motoki M., 2000, FSTR, V6, P151, DOI [10.3136/fstr.6.151, DOI 10.3136/FSTR.6.151]; Neyraud E, 2012, ARCH ORAL BIOL, V57, P556, DOI 10.1016/j.archoralbio.2011.09.016; Palouzier-Paulignan B, 2012, CHEM SENSES, V37, P769, DOI 10.1093/chemse/bjs059; Pedersen AM, 2002, ORAL DIS, V8, P117, DOI 10.1034/j.1601-0825.2002.02851.x; Pepino MY, 2012, APPETITE, V58, P800, DOI 10.1016/j.appet.2012.01.026; Piombino P, 2010, INT J FOOD SCI TECH, V45, P234, DOI 10.1111/j.1365-2621.2009.02126.x; Repoux M, 2012, FLAVOUR FRAG J, V27, P40, DOI 10.1002/ffj.2077; Rocco M, 2011, J PROTEOME RES, V10, P4703, DOI 10.1021/pr200511f; Ruijschop RMAJ, 2009, J AGR FOOD CHEM, V57, P9888, DOI 10.1021/jf901445z; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salles C, 2011, CRIT REV FOOD SCI, V51, P67, DOI 10.1080/10408390903044693; Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009; Severino V, 2011, J PROTEOME RES, V10, P3212, DOI 10.1021/pr200244f; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Sorensen LB, 2003, INT J OBESITY, V27, P1152, DOI 10.1038/sj.ijo.0802391; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Tan Y, 2008, J FOOD SCI, V73, pS56, DOI 10.1111/j.1750-3841.2007.00591.x; Tehrani AB, 2012, NEUROGASTROENT MOTIL, V24, P305, DOI 10.1111/j.1365-2982.2012.01895.x; Temple JL, 2007, PHYSIOL BEHAV, V91, P250, DOI 10.1016/j.physbeh.2007.03.009; van Ruth SM, 2001, J AGR FOOD CHEM, V49, P2409, DOI 10.1021/jf001510f; van Ruth SM, 2000, FOOD CHEM, V71, P339, DOI 10.1016/S0308-8146(00)00186-2; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wisse BE, 2007, SCIENCE, V318, P928, DOI 10.1126/science.1148032; Wold S., 2006, MULTI MEGAVARIATE DA; Zeigler CC, 2012, OBESITY, V20, P157, DOI 10.1038/oby.2011.305	63	69	74	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85611	10.1371/journal.pone.0085611	http://dx.doi.org/10.1371/journal.pone.0085611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465618	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100052
J	Pocock, MJO; Evans, DM				Pocock, Michael J. O.; Evans, Darren M.			The Success of the Horse-Chestnut Leaf-Miner, Cameraria ohridella, in the UK Revealed with Hypothesis-Led Citizen Science	PLOS ONE			English	Article							NATIVE PARASITOIDS; ECOLOGICAL RESEARCH; INVASIVE LEAFMINER; GRACILLARIIDAE; HOST; LEPIDOPTERA; SPREAD; RECRUITMENT; VALIDATION; PREDICTION	Citizen science is an increasingly popular way of undertaking research and simultaneously engaging people with science. However, most emphasis of citizen science in environmental science is on long-term monitoring. Here, we demonstrate the opportunities provided by short-term hypothesis-led citizen science. In 2010, we ran the 'Conker Tree Science' project, in which over 3500 people in Great Britain provided data at a national scale of an insect (horse-chestnut leaf-mining moth, Cameraria ohridella) undergoing rapid range-expansion. We addressed two hypotheses, and found that (1) the levels of damage caused to leaves of the horse-chestnut tree, Aesculus hippocastanum, and (2) the level of attack by parasitoids of C. ohridella larvae were both greatest where C. ohridella had been present the longest. Specifically there was a rapid rise in leaf damage during the first three years that C. ohridella was present and only a slight rise thereafter, while estimated rates of parasitism (an index of true rates of parasitism) increased from 1.6 to 5.9% when the time C. ohridella had been present in a location increased from 3 to 6 years. We suggest that this increase is due to recruitment of native generalist parasitoids, rather than the adaptation or host-tracking of more specialized parasitoids, as appears to have occurred elsewhere in Europe. Most data collected by participants were accurate, but the counts of parasitoids from participants showed lower concordance with the counts from experts. We statistically modeled this bias and propagated this through our analyses. Bias-corrected estimates of parasitism were lower than those from the raw data, but the trends were similar in magnitude and significance. With appropriate checks for data quality, and statistically correcting for biases where necessary, hypothesis-led citizen science is a potentially powerful tool for carrying out scientific research across large spatial scales while simultaneously engaging many people with science.	[Pocock, Michael J. O.] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Evans, Darren M.] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	UK Centre for Ecology & Hydrology (UKCEH); University of Hull	Pocock, MJO (corresponding author), Ctr Ecol & Hydrol, Wallingford, Oxon, England.	michael.pocock@ceh.ac.uk	Evans, Darren Mark/J-9782-2012; Pocock, Michael/A-5632-2012	Pocock, Michael/0000-0003-4375-0445; Evans, Darren/0000-0003-4061-6726	Natural Environment Research Council (NERC); British Ecological Society; University of Bristol; NERC postdoctoral fellowship [NE/F014546/1]; NERC [NE/F014546/1] Funding Source: UKRI; Natural Environment Research Council [CEH010021, NE/F014546/1] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Ecological Society; University of Bristol; NERC postdoctoral fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Conker Tree Science project (www.conkertreescience.org.uk) was funded by the Natural Environment Research Council (NERC), with funding for a pilot project from the British Ecological Society and the University of Bristol. MJOP was partly supported by a NERC postdoctoral fellowship (grant number NE/F014546/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGASSIZ DJL, 1994, GLOBAL ECOL BIOGEOGR, V4, P1, DOI 10.2307/2997719; Alaback P, 2012, FRONT ECOL ENVIRON, V10, P284, DOI 10.1890/1540-9295-10.6.284a; Augustin S, 2009, J APPL ENTOMOL, V133, P58, DOI 10.1111/j.1439-0418.2008.01333.x; Augustin S, 2004, ENVIRON ENTOMOL, V33, P1584, DOI 10.1603/0046-225X-33.6.1584; Bonter DN, 2012, FRONT ECOL ENVIRON, V10, P305, DOI 10.1890/110273; Burnham K. P., 1998, MODEL SELECTION INFE; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Deguines N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045822; Dickinson J.L., 2012, CITIZEN SCI PUBLIC P; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Ferracini C, 2007, ENVIRON ENTOMOL, V36, P1147, DOI 10.1603/0046-225X(2007)36[1147:EOTCON]2.0.CO;2; Forest Research, 2013, DISTR MAPS HORS CHES; Gardiner MM, 2012, FRONT ECOL ENVIRON, V10, P471, DOI 10.1890/110185; Gelman A., 2007, DATA ANAL USING REGR; Gilbert M, 2005, J APPL ECOL, V42, P805, DOI 10.1111/j.1365-2664.2005.01074.x; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Gilbert M, 2003, J APPL ENTOMOL, V127, P354, DOI 10.1046/j.1439-0418.2003.00757.x; Girardoz S, 2007, J APPL ENTOMOL, V131, P603, DOI 10.1111/j.1439-0418.2007.01146.x; Girardoz S, 2006, AGR FOREST ENTOMOL, V8, P49, DOI 10.1111/j.1461-9555.2006.00281.x; Girardoz S, 2007, AGR FOREST ENTOMOL, V9, P141, DOI 10.1111/j.1461-9563.2007.00327.x; GODFRAY HCJ, 1995, J ANIM ECOL, V64, P393, DOI 10.2307/5899; Grabenweger G, 2010, BIOL INVASIONS, V12, P2797, DOI 10.1007/s10530-009-9685-z; Grobler BC, 2008, ECOL ENTOMOL, V33, P453, DOI 10.1111/j.1365-2311.2008.00990.x; Hellmann JJ, 2012, ANN NY ACAD SCI, V1249, P18, DOI 10.1111/j.1749-6632.2011.06410.x; Hernandez-Lopez A, 2012, EVOL APPL, V5, P256, DOI 10.1111/j.1752-4571.2011.00220.x; Klug T, 2008, B ENTOMOL RES, V98, P379, DOI 10.1017/S0007485308005695; Miller-Rushing A, 2012, FRONT ECOL ENVIRON, V10, P285, DOI 10.1890/110278; Nakagawa S, 2011, BEHAV ECOL SOCIOBIOL, V65, P103, DOI 10.1007/s00265-010-1044-7; NASH DR, 1995, J ANIM ECOL, V64, P225, DOI 10.2307/5757; POCOCK M, 2011, BRIT WILDLIFE, V22, P305; Ramert B, 2011, ACTA AGR SCAND B-S P, V61, P480, DOI 10.1080/09064710.2010.501341; Roy HE, UNDERSTANDING CITIZE; Schonrogge K, 2012, INSECT CONSERV DIVER, V5, P298, DOI 10.1111/j.1752-4598.2011.00161.x; Silvertown J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018927; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Straw N. A., 2006, Arboricultural Journal, V29, P83; Straw NA, 2013, AGR FOREST ENTOMOL, V15, P321, DOI 10.1111/afe.12020; Tomiczek C., 1998, Journal of Arboriculture, V24, P144; Tweddle JC, 2012, GUIDE CITIZEN SCI DE; Volter L, 2006, EUR J ENTOMOL, V103, P365, DOI 10.14411/eje.2006.049; Worthington JP, 2012, METHODS ECOL EVOL, V3, P303, DOI 10.1111/j.2041-210X.2011.00164.x	42	41	41	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86226	10.1371/journal.pone.0086226	http://dx.doi.org/10.1371/journal.pone.0086226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465973	Green Published, Green Accepted, gold			2022-12-25	WOS:000330283100128
J	Wang, XD; Huang, JL; Yang, L; Wei, DQ; Qi, YX; Jiang, ZL				Wang, Xiao-Dong; Huang, Jia-Liang; Yang, Lun; Wei, Dong-Qing; Qi, Ying-Xin; Jiang, Zong-Lai			Identification of Human Disease Genes from Interactome Network Using Graphlet Interaction	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; BREAST-CANCER; PRIORITIZATION; EXPRESSION; COMPLEXES	Identifying genes related to human diseases, such as cancer and cardiovascular disease, etc., is an important task in biomedical research because of its applications in disease diagnosis and treatment. Interactome networks, especially protein-protein interaction networks, had been used to disease genes identification based on the hypothesis that strong candidate genes tend to closely relate to each other in some kinds of measure on the network. We proposed a new measure to analyze the relationship between network nodes which was called graphlet interaction. The graphlet interaction contained 28 different isomers. The results showed that the numbers of the graphlet interaction isomers between disease genes in interactome networks were significantly larger than random picked genes, while graphlet signatures were not. Then, we designed a new type of score, based on the network properties, to identify disease genes using graphlet interaction. The genes with higher scores were more likely to be disease genes, and all candidate genes were ranked according to their scores. Then the approach was evaluated by leave-one-out cross-validation. The precision of the current approach achieved 90% at about 10% recall, which was apparently higher than the previous three predominant algorithms, random walk, Endeavour and neighborhood based method. Finally, the approach was applied to predict new disease genes related to 4 common diseases, most of which were identified by other independent experimental researches. In conclusion, we demonstrate that the graphlet interaction is an effective tool to analyze the network properties of disease genes, and the scores calculated by graphlet interaction is more precise in identifying disease genes.	[Wang, Xiao-Dong; Qi, Ying-Xin; Jiang, Zong-Lai] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, Shanghai 200030, Peoples R China; [Huang, Jia-Liang] GlaxoSmithKline Res & Dev China, Bioinformat Integrated Platform Sci, Shanghai, Peoples R China; [Yang, Lun] Shanghai Jiao Tong Univ, BioX Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Wei, Dong-Qing] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; GlaxoSmithKline; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Qi, YX (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, Shanghai 200030, Peoples R China.	qiyx@sjtu.edu.cn			National Natural Science Foundation of China [11232010, 11222223]; Shanghai Rising-Star Program [11QA1403200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	National Natural Science Foundation of China (Nos. 11232010 and 11222223) and Shanghai Rising-Star Program (No. 11QA1403200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Cong L, 2007, BIOCHEM J, V403, P519, DOI 10.1042/BJ20061478; De Wever O, 2004, FASEB J, V18, P1016, DOI 10.1096/fj.03-1110fje; del Rio G, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-102; Fraser HI, 2010, J IMMUNOL, V184, P5075, DOI 10.4049/jimmunol.0903734; Glunde K, 2006, NEOPLASIA, V8, P758, DOI 10.1593/neo.06187; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Ho HA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-84; Hu PZ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S64; Hu ZJ, 2005, NUCLEIC ACIDS RES, V33, pW352, DOI 10.1093/nar/gki431; Jacquemier J, 2005, CANCER RES, V65, P767; Jung SH, 2010, BIOINFORMATICS, V26, P385, DOI 10.1093/bioinformatics/btp668; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karni S, 2009, J COMPUT BIOL, V16, P181, DOI 10.1089/cmb.2008.05TT; Kim MS, 2010, APMIS, V118, P308, DOI 10.1111/j.1600-0463.2010.02592.x; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kumper S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011801; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Li XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S3; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Mahapatra S, 2011, AAPS J, V13, P365, DOI 10.1208/s12248-011-9279-4; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Milenkovic T, 2008, CANCER INFORM, V6, P257; Milenkovic T, 2010, J R SOC INTERFACE, V7, P423, DOI 10.1098/rsif.2009.0192; Misra UK, 2011, J CELL BIOCHEM, V112, P1685, DOI 10.1002/jcb.23083; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Sahu SN, 2007, AM J PHYSIOL-CELL PH, V292, pC2288, DOI 10.1152/ajpcell.00503.2006; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yu YJ, 2001, CANCER RES, V61, P1820; Zhao XM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn145	43	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86142	10.1371/journal.pone.0086142	http://dx.doi.org/10.1371/journal.pone.0086142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465923	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100112
J	Alrifai, M; Marsh, LM; Dicke, T; Kilic, A; Conrad, ML; Renz, H; Garn, H				Alrifai, Mohammed; Marsh, Leigh M.; Dicke, Tanja; Kilic, Ayse; Conrad, Melanie L.; Renz, Harald; Garn, Holger			Compartmental and Temporal Dynamics of Chronic Inflammation and Airway Remodelling in a Chronic Asthma Mouse Model	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ALLERGEN CHALLENGE; INHALED BUDESONIDE; CYCLOSPORINE-A; ANIMAL-MODELS; MURINE MODEL; MICE; RESOLUTION; CORTICOSTEROIDS; DEXAMETHASONE	Background: Allergic asthma is associated with chronic airway inflammation and progressive airway remodelling. However, the dynamics of the development of these features and their spontaneous and pharmacological reversibility are still poorly understood. We have therefore investigated the dynamics of airway remodelling and repair in an experimental asthma model and studied how pharmacological intervention affects these processes. Methods: Using BALB/c mice, the kinetics of chronic asthma progression and resolution were characterised in absence and presence of inhaled corticosteroid (ICS) treatment. Airway inflammation and remodelling was assessed by the analysis of bronchoalveolar and peribronichal inflammatory cell infiltrate, goblet cell hyperplasia, collagen deposition and smooth muscle thickening. Results: Chronic allergen exposure resulted in early (goblet cell hyperplasia) and late remodelling (collagen deposition and smooth muscle thickening). After four weeks of allergen cessation eosinophilic inflammation, goblet cell hyperplasia and collagen deposition were resolved, full resolution of lymphocyte inflammation and smooth muscle thickening was only observed after eight weeks. ICS therapy when started before the full establishment of chronic asthma reduced the development of lung inflammation, decreased goblet cell hyperplasia and collagen deposition, but did not affect smooth muscle thickening. These effects of ICS on airway remodelling were maintained for a further four weeks even when therapy was discontinued. Conclusions: Utilising a chronic model of experimental asthma we have shown that repeated allergen exposure induces reversible airway remodelling and inflammation in mice. Therapeutic intervention with ICS was partially effective in inhibiting the transition from acute to chronic asthma by reducing airway inflammation and remodelling but was ineffective in preventing smooth muscle hypertrophy.	[Alrifai, Mohammed; Marsh, Leigh M.; Dicke, Tanja; Kilic, Ayse; Conrad, Melanie L.; Renz, Harald; Garn, Holger] Univ Marburg, Fac Med, Inst Lab Med & Pathobiochem Mol Diagnost, UGMLC, Marburg, Germany; [Marsh, Leigh M.] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria	Philipps University Marburg; Ludwig Boltzmann Institute	Garn, H (corresponding author), Univ Marburg, Fac Med, Inst Lab Med & Pathobiochem Mol Diagnost, UGMLC, Marburg, Germany.	garn@staff.uni-marburg.de	Marsh, Leigh/AAB-5125-2021; Conrad, Melanie/AAH-8431-2019	Marsh, Leigh/0000-0002-1754-9249; Conrad, Melanie Lynn/0000-0002-8811-5536; Garn, Holger/0000-0002-5178-4023	Deutsche Forschungsgemeinschaft (DFG) [SFB/TR22 Z2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) grant SFB/TR22 Z2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAN D, 1987, BRIT J DIS CHEST, V81, P170, DOI 10.1016/0007-0971(87)90135-5; Bates JHT, 2009, AM J PHYSIOL-LUNG C, V297, pL401, DOI 10.1152/ajplung.00027.2009; Blyth DI, 2000, AM J RESP CELL MOL, V23, P241, DOI 10.1165/ajrcmb.23.2.3999; Bos IST, 2007, EUR RESPIR J, V30, P653, DOI 10.1183/09031936.00004907; Caramori Gaetano, 2008, J Occup Med Toxicol, V3 Suppl 1, pS6, DOI 10.1186/1745-6673-3-S1-S6; Chian CF, 2011, PULM PHARMACOL THER, V24, P256, DOI 10.1016/j.pupt.2010.07.001; Chu HW, 2006, MICROBES INFECT, V8, P1764, DOI 10.1016/j.micinf.2006.02.014; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Eickelberg O, 2001, FASEB J, V15, P797, DOI 10.1096/fj.00-0233com; Gauvreau GM, 2000, CLIN EXP ALLERGY, V30, P1235; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Henderson WR, 2006, AM J RESP CRIT CARE, V173, P718, DOI 10.1164/rccm.200501-088OC; Herbert C, 2008, CLIN EXP ALLERGY, V38, P847, DOI 10.1111/j.1365-2222.2008.02950.x; Hogan MB, 2008, ANN ALLERG ASTHMA IM, V101, P619, DOI 10.1016/S1081-1206(10)60225-6; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Karras JG, 2007, AM J RESP CELL MOL, V36, P276, DOI 10.1165/rcmb.2005-0456OC; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kelly MM, 2010, J ALLERGY CLIN IMMUN, V125, P349, DOI 10.1016/j.jaci.2009.09.011; KHALIL N, 1991, AM J RESP CELL MOL, V5, P155, DOI 10.1165/ajrcmb/5.2.155; Kumar RK, 2004, CLIN EXP ALLERGY, V34, P1796, DOI 10.1111/j.1365-2222.2004.02097.x; Kumar RK, 2003, J PHARMACOL EXP THER, V307, P349, DOI 10.1124/jpet.103.053819; Lederlin M, 2010, EUR RADIOL, V20, P128, DOI 10.1007/s00330-009-1541-0; Leigh R, 2002, AM J RESP CELL MOL, V27, P526, DOI 10.1165/rcmb.2002-0048OC; Leung SY, 2004, CLIN EXP ALLERGY, V34, P213, DOI 10.1111/j.1365-2222.2004.01870.x; Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x; Miller M, 2006, AM J PHYSIOL-LUNG C, V290, pL162, DOI 10.1152/ajplung.00252.2005; Murdoch JR, 2010, MUTAT RES-FUND MOL M, V690, P24, DOI 10.1016/j.mrfmmm.2009.09.005; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Nygaard UC, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-11; Persson C, 2010, THORAX, V65, P1111, DOI 10.1136/thx.2009.133363; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; Sakai K, 2001, INT ARCH ALLERGY IMM, V126, P126, DOI 10.1159/000049503; SCHMIDT J, 1994, EUR J PHARMACOL, V260, P247, DOI 10.1016/0014-2999(94)90345-X; Shen HH, 2002, AM J RESP CRIT CARE, V166, P146, DOI 10.1164/rccm.2008161; Southam DS, 2008, EUR RESPIR J, V32, P970, DOI 10.1183/09031936.00125307; Southam DS, 2008, AM J RESP CRIT CARE, V178, P1115, DOI 10.1164/rccm.200801-084OC; Suissa S, 2002, THORAX, V57, P880, DOI 10.1136/thorax.57.10.880; Temelkovski J, 1998, THORAX, V53, P849, DOI 10.1136/thx.53.10.849; Van Hove CL, 2007, AM J RESP CELL MOL, V36, P573, DOI 10.1165/rcmb.2006-0385OC; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Wegmann M, 2005, CLIN EXP ALLERGY, V35, P1263, DOI 10.1111/j.1365-2222.2005.02306.x; WEIBEL ER, 1997, LUNG SCI FDN, P333; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x	45	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85839	10.1371/journal.pone.0085839	http://dx.doi.org/10.1371/journal.pone.0085839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465740	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500128
J	Bayer, ML; Schjerling, P; Herchenhan, A; Zeltz, C; Heinemeier, KM; Christensen, L; Krogsgaard, M; Gullberg, D; Kjaer, M				Bayer, Monika L.; Schjerling, Peter; Herchenhan, Andreas; Zeltz, Cedric; Heinemeier, Katja M.; Christensen, Lise; Krogsgaard, Michael; Gullberg, Donald; Kjaer, Michael			Release of Tensile Strain on Engineered Human Tendon Tissue Disturbs Cell Adhesions, Changes Matrix Architecture, and Induces an Inflammatory Phenotype	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; 3-DIMENSIONAL COLLAGEN LATTICES; GENE-EXPRESSION; ALPHA-11-BETA-1 INTEGRIN; FIBROBLASTS; ALPHA-2-BETA-1; CONTRACTION; SCLERAXIS; BINDING; REPAIR	Mechanical loading of tendon cells results in an upregulation of mechanotransduction signaling pathways, cell-matrix adhesion and collagen synthesis, but whether unloading removes these responses is unclear. We investigated the response to tension release, with regard to matrix proteins, pro-inflammatory mediators and tendon phenotypic specific molecules, in an in vitro model where tendon-like tissue was engineered from human tendon cells. Tissue sampling was performed 1, 2, 4 and 6 days after surgical de-tensioning of the tendon construct. When tensile stimulus was removed, integrin type collagen receptors showed a contrasting response with a clear drop in integrin subunit alpha(11) mRNA and protein expression, and an increase in alpha(2) integrin mRNA and protein levels. Further, specific markers for tendon cell differentiation declined and normal tendon architecture was disturbed, whereas pro-inflammatory molecules were upregulated. Stimulation with the cytokine TGF-beta 1 had distinct effects on some tendon-related genes in both tensioned and de-tensioned tissue. These findings indicate an important role of mechanical loading for cellular and matrix responses in tendon, including that loss of tension leads to a decrease in phenotypical markers for tendon, while expression of pro-inflammatory mediators is induced.	[Bayer, Monika L.; Schjerling, Peter; Herchenhan, Andreas; Heinemeier, Katja M.; Kjaer, Michael] Univ Copenhagen, Inst Sports Med, Dept Orthoped Surg M, Bispebjerg Hosp, Copenhagen, Denmark; [Bayer, Monika L.; Schjerling, Peter; Herchenhan, Andreas; Heinemeier, Katja M.; Kjaer, Michael] Univ Copenhagen, Ctr Hlth Aging, Fac Hlth & Med Sci, Copenhagen, Denmark; [Zeltz, Cedric; Gullberg, Donald] Univ Bergen, Dept Biomed, Bergen, Norway; [Christensen, Lise] Univ Copenhagen, Dept Pathol, Bispebjerg Hosp, Copenhagen, Denmark; [Krogsgaard, Michael] Univ Copenhagen, Bispebjerg Hosp, Dept Orthoped Surg M, Sect Sports Traumatol, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Bergen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital	Bayer, ML (corresponding author), Univ Copenhagen, Inst Sports Med, Dept Orthoped Surg M, Bispebjerg Hosp, Copenhagen, Denmark.	Monika.Lucia.Bayer@regionh.dk	Schjerling, Peter/F-6194-2011; Kjaer, Michael/W-6842-2019; Gullberg, Donald/H-2495-2016; Bayer, Monika/ABE-4909-2020; krogsgaard, michael/ABF-4102-2020; Krogsgaard, Michael Rindom/ABC-6014-2020	Schjerling, Peter/0000-0001-7138-3211; Kjaer, Michael/0000-0002-4582-8755; Gullberg, Donald/0000-0002-7245-4437; Zeltz, Cedric/0000-0002-7828-6868	Nordea Foundation (Healthy Aging grant); Danish Agency for Science Technology and Innovation (Medical Research Council); Danish Rheumatism Association; Lundbeck Foundation; Danish Medical Research Council [271 07-0742]; Novo Nordisk Foundation	Nordea Foundation (Healthy Aging grant); Danish Agency for Science Technology and Innovation (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Rheumatism Association; Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Funding is gratefully acknowledged from the Nordea Foundation (Healthy Aging grant), the Danish Agency for Science Technology and Innovation (Medical Research Council), the Danish Rheumatism Association, the Lundbeck Foundation, the Danish Medical Research Council (no. 271 07-0742) and Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge HL, 2012, J BIOMECH, V45, P1288, DOI 10.1016/j.jbiomech.2012.01.030; Arnoczky SP, 2008, CLIN ORTHOP RELAT R, V466, P1583, DOI 10.1007/s11999-008-0264-x; Arnoczky SP, 2007, INT J EXP PATHOL, V88, P217, DOI 10.1111/j.1365-2613.2007.00548.x; Barczyk MM, 2013, J CELL PHYSIOL, V228, P1108, DOI 10.1002/jcp.24261; Bayer ML, 2010, BIOMATERIALS, V31, P4889, DOI 10.1016/j.biomaterials.2010.02.062; Berglund ME, 2010, J HAND SURG-AM, V35A, P1842, DOI 10.1016/j.jhsa.2010.06.031; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Carracedo S, 2010, J BIOL CHEM, V285, P10434, DOI 10.1074/jbc.M109.078766; Chang J, 2000, PLAST RECONSTR SURG, V105, P148, DOI 10.1097/00006534-200001000-00025; Chen LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040202; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Couppe C, 2008, J APPL PHYSIOL, V105, P805, DOI 10.1152/japplphysiol.90361.2008; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; da Rocha-Azevedo B, 2012, EXP CELL RES; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; Eliasson P, 2012, J ORTHOP RES, V30, P274, DOI 10.1002/jor.21511; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; Gardner K, 2012, J ORTHOP RES, V30, P1695, DOI 10.1002/jor.22131; Geiger B., 2011, COLD SPRING HARB PER, V3; Gelberman R H, 1985, Hand Clin, V1, P35; Giddings VL, 2000, MED SCI SPORT EXER, V32, P627, DOI 10.1097/00005768-200003000-00012; Heinemeier KM, 2013, SCAND J MED SCI SPOR, V23, pe150, DOI 10.1111/j.1600-0838.2011.01414.x; Heinemeier KM, 2009, J APPL PHYSIOL, V106, P178, DOI 10.1152/japplphysiol.91092.2008; Herchenhan A, 2013, DEV DYNAM, V242, P2, DOI 10.1002/dvdy.23896; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Jarvinen Tero A H, 2005, Foot Ankle Clin, V10, P255, DOI 10.1016/j.fcl.2005.01.013; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Juneja SC, 2013, CONNECT TISSUE RES, V54, P218, DOI 10.3109/03008207.2013.787418; Kapacce Z, 2008, MATRIX BIOL, V27, P371, DOI 10.1016/j.matbio.2007.11.006; Kessler-Becker D, 2004, BIOCHEM J, V379, P351, DOI 10.1042/BJ20031371; Klass BR, 2009, POSTGRAD MED J, V85, P9, DOI 10.1136/pgmj.2008.069831; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Leask Andrew, 2009, Front Biosci (Elite Ed), V1, P115; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Lu N, 2010, MATRIX BIOL, V29, P166, DOI 10.1016/j.matbio.2009.11.003; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Mendias CL, 2011, J ORTHOP RES; Meyer DC, 2006, J BONE JOINT SURG BR, V88B, P1533, DOI 10.1302/0301-620X.88B11.17791; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Olsson N, 2011, KNEE SURG SPORT TR A, V19, P1385, DOI 10.1007/s00167-011-1511-3; Peters MA, 2012, ARTHRITIS RHEUM-US, V64, P1359, DOI 10.1002/art.33487; Popov C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.71; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Robertson CM, 2012, AM J SPORT MED, V40, P1993, DOI 10.1177/0363546512456519; Roca-Cusachs P, 2012, J CELL SCI, V125, P3025, DOI 10.1242/jcs.095794; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; SCHIRO JA, 1991, CELL, V67, P403, DOI 10.1016/0092-8674(91)90191-Z; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Stanley RL, 2007, J ANAT, V211, P325, DOI 10.1111/j.1469-7580.2007.00781.x; Sun HB, 2008, CLIN ORTHOP RELAT R, V466, P1555, DOI 10.1007/s11999-008-0278-4; Talior-Volodarsky I, 2012, CARDIOVASC RES, V96, P265, DOI 10.1093/cvr/cvs259; Taylor SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016337; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; TOMASEK JJ, 1992, ANAT REC, V234, P153, DOI 10.1002/ar.1092340202; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; Zhu J, 2010, BIOMATERIALS, V31, P6952, DOI 10.1016/j.biomaterials.2010.05.058	70	48	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86078	10.1371/journal.pone.0086078	http://dx.doi.org/10.1371/journal.pone.0086078			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465881	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500178
J	He, Q; Yang, QC; Zhou, Q; Zhu, H; Niu, WY; Feng, J; Wang, Y; Cao, J; Chen, BY				He, Qing; Yang, Qing-chan; Zhou, Qin; Zhu, Hui; Niu, Wen-yan; Feng, Jing; Wang, Yan; Cao, Jie; Chen, Bao-yuan			Effects of Varying Degrees of Intermittent Hypoxia on Proinflammatory Cytokines and Adipokines in Rats and 3T3-L1 Adipocytes	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; NF-KAPPA-B; INSULIN-RESISTANCE; DOWN-REGULATION; TNF-ALPHA; ADIPONECTIN; EXPRESSION; INFLAMMATION; METABOLISM; ACTIVATION	Objectives: Intermittent hypoxia (IH), resulted from recurring episodes of upper airway obstruction, is the hallmark feature and the most important pathophysiologic pathway of obstructive sleep apnea (OSA). IH is believed to be the most important factor causing systemic inflammation. Studies suggest that insulin resistance (IR) is positively associated with OSA. In this study, we hypothesized that the recurrence of IH might result in cellular and systemic inflammation, which was manifested through the levels of proinflammatory cytokines and adipokines after IH exposure, and because IR is linked with inflammation tightly, this inflammatory situation may implicate an IR status. Methods: We developed an IH 3T3-L1 adipocyte and rat model respectively, recapitulating the nocturnal oxygen profile in OSA. In IH cells, nuclear factor kappa B (NF-kappa B) DNA binding reactions, hypoxia-inducible factor-1 alpha (HIF-1 alpha), glucose transporter-1 (Glut-1), necrosis factor alpha (TNF-alpha), interleukin (IL) -6, leptin, adiponectin mRNA transcriptional activities and protein expressions were measured. In IH rats, blood glucose, insulin, TNF-alpha, IL-6, leptin and adiponectin levels were analyzed. Results: The insulin and blood glucose levels in rats and NF-kappa B DNA binding activities in cells had significantly statistical results described as severe IH > moderate IH > mild IH > sustained hypoxia > control. The mRNA and protein levels of HIF-1 alpha and Glut-1 in severe IH group were the highest. In cellular and animal models, both the mRNA and protein levels of TNF-alpha, IL-6 and leptin were the highest in severe IH group, when the lowest in severe IH group for adiponectin. Conclusions: Oxidative stress and the release of pro-inflammatory cytokines/adipokines, which are the systemic inflammatory markers, are associated with IH closely and are proportional to the severity of IH. Because IR and glucose intolerance are linked with inflammation tightly, our results may implicate the clinical relationships between OSA and IR.	[He, Qing; Zhou, Qin; Zhu, Hui] Tianjin Med Univ, Gen Hosp, Dept Endocrinol, Tianjin, Peoples R China; [Yang, Qing-chan; Feng, Jing; Wang, Yan; Cao, Jie; Chen, Bao-yuan] Tianjin Med Univ, Gen Hosp, Resp Dept, Tianjin, Peoples R China; [Niu, Wen-yan] Tianjin Med Univ, Dept Immunol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Feng, J (corresponding author), Tianjin Med Univ, Gen Hosp, Resp Dept, Tianjin, Peoples R China.	zyyhxkfj@126.com			National Natural Science Foundation of China [81270144, 30800507, 81170071]; Natural Science Foundation of Tianjin City [13JCYBJC22400, 13JCYBJC40000]; Tianjin Municipal Science and Technology Commission [09ZCZDSF04500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin City(Natural Science Foundation of Tianjin); Tianjin Municipal Science and Technology Commission	This study was supported by grants from the National Natural Science Foundation of China (81270144, 30800507, 81170071), by grants from the Natural Science Foundation of Tianjin City (13JCYBJC22400, 13JCYBJC40000) and by grants from Tianjin Municipal Science and Technology Commission grant (# 09ZCZDSF04500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnardottir ES, 2009, SLEEP, V32, P447, DOI 10.1093/sleep/32.4.447; Bonsignore MR, 2009, EUR RESPIR REV, V18, P113, DOI 10.1183/09059180.00000109; Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196; Bruckbauer A, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-77; Carter Robert 3rd, 2008, Pathophysiology, V15, P71, DOI 10.1016/j.pathophys.2008.04.009; Chaska B, 1996, AM FAM PHYSICIAN, V53, P247; Chen L, 2010, CHINESE MED J-PEKING, V123, P463, DOI 10.3760/cma.j.issn.0366-6999.2010.04.015; Cooper C, 2004, CLIN CANCER RES, V10, P8720, DOI 10.1158/1078-0432.CCR-04-1235; Coughlin SR, 2004, EUR HEART J, V25, P735, DOI 10.1016/j.ehj.2004.02.021; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Drager LF, 2010, BEST PRACT RES CL EN, V24, P843, DOI 10.1016/j.beem.2010.08.011; Feng J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013201; Feng J, 2010, CHINESE MED J-PEKING, V123, P2392, DOI 10.3760/cma.j.issn.0366-6999.2010.17.020; Feng J, 2009, SLEEP BREATH, V13, P277, DOI 10.1007/s11325-009-0246-6; Feng J, 2009, CHINESE MED J-PEKING, V122, P1464, DOI 10.3760/cma.j.issn.0366-6999.2009.12.021; Feng Jing, 2007, Zhonghua Yi Xue Za Zhi, V87, P774; Feng Jing, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P202; Fouillioux C, 2008, AM J THER, V15, P389, DOI 10.1097/MJT.0b013e318169bca8; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gilmartin GS, 2010, AM J PHYSIOL-HEART C, V299, pH925, DOI 10.1152/ajpheart.00253.2009; Grisouard J, 2010, BIOCHEM PHARMACOL, V80, P1736, DOI 10.1016/j.bcp.2010.08.021; Han Q, 2013, CELL BIOCHEM BIOPHYS, V66, P431, DOI 10.1007/s12013-012-9491-6; Hargens TA, 2013, SLEEP BREATH, V17, P403, DOI 10.1007/s11325-012-0708-0; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; de Lima AMJ, 2010, RESPIRATION, V79, P370, DOI 10.1159/000227800; Jun J, 2007, SLEEP MED CLIN, V2, P263, DOI 10.1016/j.jsmc.2007.03.009; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; Kilkenny C, 2010, J GENE MED, V12, P561, DOI 10.1002/jgm.1473; Lam JCM, 2008, SLEEP, V31, P1721, DOI 10.1093/sleep/31.12.1721; Lam JCM, 2012, RESPIROLOGY, V17, P223, DOI 10.1111/j.1440-1843.2011.02081.x; Lavie L, 2009, RESPIRATION, V78, P361, DOI 10.1159/000243552; Lavie L, 2009, PROG CARDIOVASC DIS, V51, P303, DOI 10.1016/j.pcad.2008.08.003; Lesser DJ, 2012, PEDIATR RES, V72, P293, DOI 10.1038/pr.2012.73; Levy P, 2009, EUR RESPIR J, V34, P243, DOI 10.1183/09031936.00166808; Li JG, 2005, CIRC RES, V97, P698, DOI 10.1161/01.RES.0000183879.60089.a9; Li JG, 2006, PHYSIOL GENOMICS, V25, P450, DOI 10.1152/physiolgenomics.00293.2005; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li S, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13309; Louis M, 2009, J APPL PHYSIOL, V106, P1538, DOI 10.1152/japplphysiol.91523.2008; Lumeng Julie C, 2008, Proc Am Thorac Soc, V5, P242, DOI 10.1513/pats.200708-135MG; Magalang UJ, 2009, EXP CLIN ENDOCR DIAB, V117, P129, DOI 10.1055/s-2008-1078738; Marx N, 2004, CIRC RES, V94, P1168, DOI 10.1161/01.RES.0000127122.22685.0A; McNicholas WT, 2009, PROG CARDIOVASC DIS, V51, P392, DOI 10.1016/j.pcad.2008.10.005; Morton NM, 2010, MOL CELL ENDOCRINOL, V316, P154, DOI 10.1016/j.mce.2009.09.024; Ota H, 2012, LIFE SCI, V90, P206, DOI 10.1016/j.lfs.2011.11.011; Pallayova M, 2011, MED HYPOTHESES, V77, P930, DOI 10.1016/j.mehy.2011.08.016; Pittas AG, 2004, J CLIN ENDOCR METAB, V89, P447, DOI 10.1210/jc.2003-031005; Polotsky VY, 2003, J PHYSIOL-LONDON, V552, P253, DOI 10.1113/jphysiol.2003.048173; Punjabi NM, 2009, AM J RESP CRIT CARE, V179, P235, DOI 10.1164/rccm.200809-1392OC; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Reinke C, 2011, J APPL PHYSIOL, V111, P881, DOI 10.1152/japplphysiol.00492.2011; Neto JCR, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-125; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Snyder EM, 2008, APPL PHYSIOL NUTR ME, V33, P929, DOI 10.1139/H08-079; Toffoli S, 2009, ANGIOGENESIS, V12, P47, DOI 10.1007/s10456-009-9131-y; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Wang B, 2007, PFLUG ARCH EUR J PHY, V455, P479, DOI 10.1007/s00424-007-0301-8; Wolk R, 2005, OBES RES, V13, P186, DOI 10.1038/oby.2005.24; Yamauchi M, 2006, SLEEP BREATH, V10, P189, DOI 10.1007/s11325-006-0074-x; Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008; Yang RH, 2011, AM J PHYSIOL-HEART C, V300, pH1467, DOI 10.1152/ajpheart.00604.2009; Yokoe T, 2008, J PHYSIOL-LONDON, V586, P899, DOI 10.1113/jphysiol.2007.143586; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Yuan GX, 2011, J CELL PHYSIOL, V226, P2925, DOI 10.1002/jcp.22640; Zhang XF, 2010, CHINESE MED J-PEKING, V123, P2249, DOI 10.3760/cma.j.issn.0366-6999.2010.16.017	70	59	64	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86326	10.1371/journal.pone.0086326	http://dx.doi.org/10.1371/journal.pone.0086326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466027	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500227
J	Pouliekova, A; Mazalova, P; Vasut, RJ; Sarhanova, P; Neustupa, J; Skaloud, P				Pouliekova, Aloisie; Mazalova, Petra; Vasut, Radim J.; Sarhanova, Petra; Neustupa, Jioi; Skaloud, Pavel			DNA Content Variation and Its Significance in the Evolution of the Genus Micrasterias (Desmidiales, Streptophyta)	PLOS ONE			English	Article							NUCLEAR-DNA; GENOME SIZE; FLOW-CYTOMETRY; SEXUAL REPRODUCTION; MOLECULAR PHYLOGENY; CHROMOSOME-NUMBER; C-VALUE; GREEN; ALGAE; CHLOROPHYTA	It is now clear that whole genome duplications have occurred in all eukaryotic evolutionary lineages, and that the vast majority of flowering plants have experienced polyploidisation in their evolutionary history. However, study of genome size variation in microalgae lags behind that of higher plants and seaweeds. In this study, we have addressed the question whether microalgal phylogeny is associated with DNA content variation in order to evaluate the evolutionary significance of polyploidy in the model genus Micrasterias. We applied flow-cytometric techniques of DNA quantification to microalgae and mapped the estimated DNA content along the phylogenetic tree. Correlations between DNA content and cell morphometric parameters were also tested using geometric morphometrics. In total, DNA content was successfully determined for 34 strains of the genus Micrasterias. The estimated absolute 2C nuclear DNA amount ranged from 2.1 to 64.7 pg; intraspecific variation being 17.4-30.7 pg in M. truncata and 32.0-64.7 pg in M. rotata. There were significant differences between DNA contents of related species. We found strong correlation between the absolute nuclear DNA content and chromosome numbers and significant positive correlation between the DNA content and both cell size and number of terminal lobes. Moreover, the results showed the importance of cell/life cycle studies for interpretation of DNA content measurements in microalgae.	[Pouliekova, Aloisie; Mazalova, Petra; Vasut, Radim J.; Sarhanova, Petra] Palacky Univ, Fac Sci, Dept Bot, CR-77147 Olomouc, Czech Republic; [Neustupa, Jioi; Skaloud, Pavel] Charles Univ Prague, Dept Bot, Prague, Czech Republic; [Mazalova, Petra] Univ Hradec Kralove, Fac Sci, Dept Biol, Hradec Kralove, Czech Republic	Palacky University Olomouc; Charles University Prague; University of Hradec Kralove	Pouliekova, A (corresponding author), Palacky Univ, Fac Sci, Dept Bot, CR-77147 Olomouc, Czech Republic.	aloisie.poulickova@upol.cz	Sarhanova, Petra/B-2597-2019; Vasut, Radim/J-8983-2012; Neustupa, Jiri/J-1610-2015; Skaloud, Pavel/F-3103-2011	Sarhanova, Petra/0000-0002-1006-4003; Vasut, Radim/0000-0001-6882-5509; Neustupa, Jiri/0000-0003-3610-8120; Skaloud, Pavel/0000-0003-1201-3290	Czech science foundation [206/09/0906]; Internal Grant Agency of the Palacky University [Prf-2013-003]	Czech science foundation(Grant Agency of the Czech Republic); Internal Grant Agency of the Palacky University	This work was supported by the Czech science foundation [grant number 206/09/0906] and the Internal Grant Agency of the Palacky University [grant number Prf-2013-003]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacic T, 2007, TAXON, V56, P129; Becker B, 2009, ANN BOT-LONDON, V103, P999, DOI 10.1093/aob/mcp044; Bennett MD, 2011, ANN BOT-LONDON, V107, P467, DOI 10.1093/aob/mcq258; Bennett M.D., 2010, PLANT DNA C VALUES D, DOI DOI 10.1371/journal.pcbi.1003537; Bennett MD, 2005, ANN BOT-LONDON, V95, P1, DOI 10.1093/aob/mci001; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; BENNETT MD, 1987, NEW PHYTOL, V106, P177, DOI 10.1111/j.1469-8137.1987.tb04689.x; Bennett MD, 2005, ANN BOT-LONDON, V95, P45, DOI 10.1093/aob/mci003; Bennett MD, 2012, PLANT DNA C VALUES D; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BLACKBURN SI, 1981, BRIT PHYCOL J, V16, P217, DOI 10.1080/00071618100650231; BLACKBURN SI, 1987, BRIT PHYCOL J, V22, P277, DOI 10.1080/00071618700650341; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; BRANDHAM PE, 1965, J PHYCOL, V1, P55, DOI 10.1111/j.1529-8817.1965.tb04556.x; BRANDHAM PE, 1964, THESIS U LONDON UK; BROOK AJ, 1981, BOT MONOGRAPHS, V16; Buggs RJA, 2012, AM J BOT, V99, P372, DOI 10.3732/ajb.1100395; Cerna K, 2010, AQUAT ECOL, V44, P409, DOI 10.1007/s10452-009-9296-x; Chung KS, 2012, EVOLUTION, V66, P2708, DOI 10.1111/j.1558-5646.2012.01624.x; Chung KS, 2011, AM J BOT, V98, P122, DOI 10.3732/ajb.1000046; COESEL PFM, 1974, ACTA BOT NEERL, V23, P603, DOI 10.1111/j.1438-8677.1974.tb00972.x; Denboh T, 2001, J PHYCOL, V37, P1063, DOI 10.1046/j.1529-8817.2001.00146.x; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; DOLEZEL J, 1992, PHYSIOL PLANTARUM, V85, P625, DOI 10.1111/j.1399-3054.1992.tb04764.x; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Duchoslav M, 2010, ANN BOT-LONDON, V105, P719, DOI 10.1093/aob/mcq035; Gontcharov AA, 2003, J MOL EVOL, V56, P89, DOI 10.1007/s00239-002-2383-4; Gontcharov AA, 2008, AM J BOT, V95, P1079, DOI 10.3732/ajb.0800046; Gontcharov AA, 2011, PROTIST, V162, P253, DOI 10.1016/j.protis.2010.08.003; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; Greilhuber J, 2006, PLANT BIOLOGY, V8, P770, DOI 10.1055/s-2006-924101; Greilhuber J, 2005, ANN BOT-LONDON, V95, P255, DOI 10.1093/aob/mci019; Greilhuber J, 2010, J BOT, V2010, DOI [10.1155/2010/946138, DOI 10.1155/2010/946138]; Greilhuber J, 2009, CHROMOSOMA, V118, P391, DOI 10.1007/s00412-009-0205-9; Grif VG, 2000, INT REV CYTOL, V196, P131; Guerra M, 2010, CYTOGENET GENOME RES, V129, P82, DOI 10.1159/000314289; HALKKA O, 1964, HEREDITAS-GENETISK A, V52, P81; Hall JD, 2008, J PHYCOL, V44, P467, DOI 10.1111/j.1529-8817.2008.00485.x; HAMADA J, 1987, J PHYCOL, V23, P541; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Handke Kurt, 1996, Mitteilungen aus dem Institut fuer Allgemeine Botanik Hamburg, V26, P5; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Herben T, 2012, ANN BOT-LONDON, V110, P1357, DOI 10.1093/aob/mcs099; HOSHAW RW, 1988, PHYCOLOGIA, V27, P511, DOI 10.2216/i0031-8884-27-4-511.1; Kapraun DF, 2005, ANN BOT-LONDON, V95, P7, DOI 10.1093/aob/mci002; Kapraun DF, 2007, ANN BOT-LONDON, V99, P677, DOI 10.1093/aob/mcl294; Kasprik W., 1973, NOVA HEDWIGIA S, V42, P115; Kaur N, 2012, BOT J LINN SOC, V169, P555, DOI 10.1111/j.1095-8339.2012.01238.x; KING G. C., 1960, NEW PHYTOL, V59, P65, DOI 10.1111/j.1469-8137.1960.tb06203.x; KING GC, 1953, NATURE, V172, P592, DOI 10.1038/172592a0; Kolar F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039988; LEGALL Y, 1993, PROTOPLASMA, V173, P123; Lemaire SD, 1999, EUR J PHYCOL, V34, P279, DOI 10.1080/09670269910001736332; LENZENWEGER R, 1973, NOVA HEDVIG S, V42, P155; Mann DG, 2010, PHYCOLOGIA, V49, P183, DOI 10.2216/PH09-08.1; Mazalova P, 2011, FOTTEA, V11, P317, DOI 10.5507/fot.2011.030; McCourt RM, 2004, TRENDS ECOL EVOL, V19, P661, DOI 10.1016/j.tree.2004.09.013; MIDGLEY JJ, 1991, BIOL J LINN SOC, V44, P81, DOI 10.1111/j.1095-8312.1991.tb00608.x; Nemjova K, 2011, PHYCOL RES, V59, P208, DOI 10.1111/j.1440-1835.2011.00619.x; Neustupa J, 2008, AQUAT MICROB ECOL, V51, P77, DOI 10.3354/ame01184; Neustupa J, 2013, FOTTEA, V13, P53, DOI 10.5507/fot.2013.005; Neustupa J, 2011, HYDROBIOLOGIA, V667, P223, DOI 10.1007/s10750-011-0650-3; Neustupa J, 2010, J PHYCOL, V46, P703, DOI 10.1111/j.1529-8817.2010.00863.x; NISHIKAWA K, 1984, JPN J GENET, V59, P465, DOI 10.1266/jjg.59.465; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Poulickova A, 2010, PROTIST, V161, P353, DOI 10.1016/j.protis.2009.12.003; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rotreklova O, 2011, PRESLIA, V83, P25; Schnable JC, 2012, GENOME BIOL EVOL, V4, P265, DOI 10.1093/gbe/evs009; SIMON N, 1994, J PHYCOL, V30, P922, DOI 10.1111/j.0022-3646.1994.00922.x; Skaloud P, 2011, MOL PHYLOGENET EVOL, V61, P933, DOI 10.1016/j.ympev.2011.08.018; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Sonnleitner M, 2010, ANN BOT-LONDON, V106, P967, DOI 10.1093/aob/mcq192; STARR RC, 1958, AM J BOT, V45, P243, DOI 10.2307/2446456; Veldhuis MJW, 1997, J PHYCOL, V33, P527, DOI 10.1111/j.0022-3646.1997.00527.x; VERBRUGGEN H, 2009, TREEGRADIENTS V 1 02; Voglmayr H, 2000, ANN BOT-LONDON, V85, P531, DOI 10.1006/anbo.1999.1103; Wang WM, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-10; WARIS H, 1957, ANN ACAD SCI FENN A, V37, P1; Weiss TL, 2011, J APPL PHYCOL, V23, P833, DOI 10.1007/s10811-010-9586-7; Weiss TL, 2010, J PHYCOL, V46, P534, DOI 10.1111/j.1529-8817.2010.00820.x; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5	88	9	11	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86247	10.1371/journal.pone.0086247	http://dx.doi.org/10.1371/journal.pone.0086247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465986	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500212
J	Spronck, B; Merken, JJ; Reesink, KD; Kroon, W; Delhaas, T				Spronck, Bart; Merken, Jort J.; Reesink, Koen D.; Kroon, Wilco; Delhaas, Tammo			Ureter Smooth Muscle Cell Orientation in Rat Is Predominantly Longitudinal	PLOS ONE			English	Article							2-PHOTON MICROSCOPY; PERISTALSIS; TISSUE	In ureter peristalsis, the orientation of the contracting smooth muscle cells is essential, yet current descriptions of orientation and composition of the smooth muscle layer in human as well as in rat ureter are inconsistent. The present study aims to improve quantification of smooth muscle orientation in rat ureters as a basis for mechanistic understanding of peristalsis. A crucial step in our approach is to use two-photon laser scanning microscopy and image analysis providing objective, quantitative data on smooth muscle cell orientation in intact ureters, avoiding the usual sectioning artifacts. In 36 rat ureter segments, originating from a proximal, middle or distal site and from a left or right ureter, we found close to the adventitia a well-defined longitudinal smooth muscle orientation. Towards the lamina propria, the orientation gradually became slightly more disperse, yet the main orientation remained longitudinal. We conclude that smooth muscle cell orientation in rat ureter is predominantly longitudinal, though the orientation gradually becomes more disperse towards the proprial side. These findings do not support identification of separate layers. The observed longitudinal orientation suggests that smooth muscle contraction would rather cause local shortening of the ureter, than cause luminal constriction. However, the net-like connective tissue of the ureter wall may translate local longitudinal shortening into co-local luminal constriction, facilitating peristalsis. Our quantitative, minimally invasive approach is a crucial step towards more mechanistic insight into ureter peristalsis, and may also be used to study smooth muscle cell orientation in other tube-like structures like gut and blood vessels.	[Spronck, Bart; Merken, Jort J.; Reesink, Koen D.; Kroon, Wilco; Delhaas, Tammo] Maastricht Univ, CARIM Sch Cardiovasc Dis, Dept Biomed Engn, Maastricht, Netherlands; [Kroon, Wilco] Univ Lugano, Inst Computat Sci, Lugano, Switzerland	Maastricht University; Universita della Svizzera Italiana	Spronck, B (corresponding author), Maastricht Univ, CARIM Sch Cardiovasc Dis, Dept Biomed Engn, Maastricht, Netherlands.	b.spronck@maastrichtuniversity.nl	Spronck, Bart/AAE-9386-2019	Spronck, Bart/0000-0003-1076-1922; Reesink, Koen/0000-0003-2354-883X; Delhaas, Tammo/0000-0001-6897-9700	Maastricht University, Maastricht, The Netherlands	Maastricht University, Maastricht, The Netherlands(Netherlands Government)	This study was supported by a Kootstra talent fellowship awarded to BS by Maastricht University, Maastricht, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAGONA F, 1988, International Urology and Nephrology, V20, P239, DOI 10.1007/BF02549510; Bouvin MJ, 1869, THESIS HOOGESCHOOL U; Brasseur JG, 2007, WORLD J GASTROENTERO, V13, P1335, DOI 10.3748/wjg.v13.i9.1335; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Disse J, 1896, HDB ANATOMIE MENSC 1, V7; Disselhorst R., 1894, Anatomische Hefte, Viv, P127; DODDS WJ, 1973, J CLIN INVEST, V52, P1, DOI 10.1172/JCI107152; Ebner VW, 1902, KOELLIKER HDB GEWEBE; FAY FS, 1973, P NATL ACAD SCI USA, V70, P641, DOI 10.1073/pnas.70.3.641; Floyd RV, 2008, J UROLOGY, V180, P398, DOI 10.1016/j.juro.2008.02.045; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Goeppert-Mayer M., 1931, ANN PHYS, V401, P273, DOI DOI 10.1002/ANDP.19314010303; Gosling JA, 1983, FUNCTIONAL ANATOMY U; Hayes SC, 1999, ACCEPTANCE COMMITMEN; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Henle J., 1866, HDB EINGEWEIDELEHRE; HICKS RM, 1965, J CELL BIOL, V26, P25, DOI 10.1083/jcb.26.1.25; Holzapfel GA, 2002, EUR J MECH A-SOLID, V21, P441, DOI 10.1016/S0997-7538(01)01206-2; HOYES AD, 1976, INVEST UROL, V14, P38; Jahne B., 1993, SPATIOTEMPORAL IMAGE; Kollilker A, 1859, HDB GEWEBELEHRE MENS; Lang RJ, 2001, J UROLOGY, V166, P329, DOI 10.1016/S0022-5347(05)66154-X; Maier R, 1881, VIRCHOWS ARCH, V85, P49; Megens RTA, 2006, J VASC RES, V43, P39; MURNAGHAN G F, 1957, Br J Urol, V29, P403, DOI 10.1111/j.1464-410X.1957.tb09373.x; O'Connell MK, 2008, MATRIX BIOL, V27, P171, DOI 10.1016/j.matbio.2007.10.008; Obersteiner H, 1871, HDB LEHRE GEWEBEN ME, P521; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Protopopow SA, 1897, PFLUGERS ARCH GES PH, V66, P1; RHODIN JAG, 1967, J ULTRA MOL STRUCT R, V18, P181, DOI 10.1016/S0022-5320(67)80239-9; Sappey PC, 1873, TRAITE ANATOMIE DESC; Satani Y, 1919, J UROLOGY, V3, P247, DOI 10.1016/S0022-5347(17)74176-6; Schneider W, 1938, ANAT EMBRYOL, V109, P187; SHOTTON DM, 1989, J CELL SCI, V94, P175; Silverman B.W., 1986, DENSITY ESTIMATION S; Stevens A, 1992, HISTOLOGY; TODD ME, 1983, CIRC RES, V53, P319, DOI 10.1161/01.RES.53.3.319; Toldt C, 1877, LEHRBUCH GEWEBELEHRE; van Zandvoort M, 2004, J VASC RES, V41, P54, DOI 10.1159/000076246; von Mollendorff W., 1930, HDB MIKROSKOPISCHEN; WALMSLEY JG, 1979, BLOOD VESSELS, V16, P43; Wolf JS, 1996, J ENDOUROL, V10, P527, DOI 10.1089/end.1996.10.527; WOODBURN.RT, 1965, ANAT REC, V151, P243, DOI 10.1002/ar.1091510305	44	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86207	10.1371/journal.pone.0086207	http://dx.doi.org/10.1371/journal.pone.0086207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465961	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500204
J	Zhou, ZJ; Shi, FM; Zhao, L				Zhou, Zhijun; Shi, Fuming; Zhao, Ling			The First Mitochondrial Genome for the Superfamily Hagloidea and Implications for Its Systematic Status in Ensifera	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; NUCLEOTIDE-SEQUENCE; GENE ORGANIZATION; ORTHOPTERA; EVOLUTION; TETTIGONIIDAE; KATYDIDS; INSECTA; CRICKET; REGION	Hagloidea Handlirsch, 1906 was an ancient group of Ensifera, that was much more diverse in the past extending at least into the Triassic, apparently diminishing in diversity through the Cretaceous, and now only represented by a few extant species. In this paper, we report the complete mitochondrial genome (mitogenome) of Tarragoilus diuturnus Gorochov, 2001, representing the first mitogenome of the superfamily Hagloidea. The size of the entire mitogenome of T. diuturnus is 16144 bp, containing 13 protein-coding genes (PCGs), 2 ribosomal RNA (rRNA) genes, 22 transfer RNA (tRNA) genes and one control region. The order and orientation of the gene arrangement pattern is identical to that of D. yakuba and most ensiferans species. A phylogenomic analysis was carried out based on the concatenated dataset of 13 PCGs and 2 rRNA genes from mitogenome sequences of 15 ensiferan species, comprising four superfamilies Grylloidea, Tettigonioidae, Rhaphidophoroidea and Hagloidea. Both maximum likelihood and Bayesian inference analyses strongly support Hagloidea T. diuturnus and Rhaphidophoroidea Troglophilus neglectus as forming a monophyletic group, sister to the Tettigonioidea. The relationships among four superfamilies of Ensifera were (Grylloidea, (Tettigonioidea, (Hagloidea, Rhaphidophoroidea))).	[Zhou, Zhijun; Shi, Fuming] Hebei Univ, Coll Life Sci, Baoding, Hebei Province, Peoples R China; [Zhao, Ling] Mianyang Normal Univ, Coll Life Sci & Biotechnol, Mianyang, Sichuan Provinc, Peoples R China	Hebei University; Mianyang Teachers' College	Zhou, ZJ (corresponding author), Hebei Univ, Coll Life Sci, Baoding, Hebei Province, Peoples R China.	zhijunzhou@163.com; shif_m@126.com			National Natural Science Foundation of PR China [31101632, 31071955, 31372232]	National Natural Science Foundation of PR China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of PR China (No. 31101632, 31071955 and 31372232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ander K, 1939, VERGLEICHEND ANATOMI; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Cranston P.S., 2009, ENCY INSECTS, P780; Desutter-Grandcolas L, 2003, ZOOL SCR, V32, P525, DOI 10.1046/j.1463-6409.2003.00142.x; Ding Fang-mei, 2007, Zoological Research, V28, P580; Eades DC, 2013, ORTHOPTERA SPECIES F; Fenn JD, 2007, INSECT MOL BIOL, V16, P239, DOI 10.1111/j.1365-2583.2006.00721.x; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Flook PK, 1999, SYST BIOL, V48, P233, DOI 10.1080/106351599260274; Flook PK, 1995, J MOL EVOL, V41, P928, DOI 10.1007/BF00173173; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gorochov Andrei V., 2003, Acta Zoologica Cracoviensia, V46, P117; Grimaldi David, 2005, pi; Gu Jun-Jie, 2010, Journal of Orthoptera Research, V19, P41, DOI 10.1665/034.019.0110; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gwynne Darryl T., 1995, Journal of Orthoptera Research, V4, P203; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jost MC, 2006, MOL PHYLOGENET EVOL, V38, P510, DOI 10.1016/j.ympev.2005.10.004; Kim I, 2005, GENE, V353, P155, DOI 10.1016/j.gene.2005.04.019; Liu CX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-114; Liu Nian, 2006, Chinese Journal of Zoology, V41, P61; Mugleston JD, 2013, MOL PHYLOGENET EVOL, V69, P1120, DOI 10.1016/j.ympev.2013.07.014; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Sheffield NC, 2010, MITOCHONDR DNA, V21, P87, DOI 10.3109/19401736.2010.500812; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Staden R, 2000, Methods Mol Biol, V132, P115; Steinberg S, 1997, J MOL BIOL, V266, P269, DOI 10.1006/jmbi.1996.0803; Stewart JB, 2006, GENOME, V49, P815, DOI 10.1139/G06-037; Stewart JB, 2005, GENOME, V48, P46, DOI 10.1139/G04-090; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yang MR, 2012, J GENET, V91, P141, DOI 10.1007/s12041-012-0157-3; Zhang C, 2008, ACTA BIOCH BIOPH SIN, V40, P7, DOI 10.1111/j.1745-7270.2008.00375.x; Zhou Zhi-Jun, 2011, Acta Entomologica Sinica, V54, P548; Zhou ZJ, 2008, J GENET GENOMICS, V35, P341, DOI 10.1016/S1673-8527(08)60050-8; Zhou ZJ, 2007, GENOME, V50, P855, DOI 10.1139/G07-057; Zhou ZhiJun, 2013, Acta Entomologica Sinica, V56, P408; Zhou ZJ, 2010, J GENET GENOMICS, V37, P315, DOI 10.1016/S1673-8527(09)60049-7; Zhou ZJ, 2009, MOL BIOL REP, V36, P7, DOI 10.1007/s11033-007-9145-8	41	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86027	10.1371/journal.pone.0086027	http://dx.doi.org/10.1371/journal.pone.0086027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465850	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500168
J	Chen, L; Hao, LG; Condon, AG; Hu, YG				Chen, Liang; Hao, Liugen; Condon, Anthony G.; Hu, Yin-Gang			Exogenous GA3 Application Can Compensate the Morphogenetic Effects of the GA-Responsive Dwarfing Gene Rht12 in Bread Wheat	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; GREEN-REVOLUTION; SPRING-WHEAT; GIBBERELLIN BIOSYNTHESIS; AGRONOMIC PERFORMANCE; FLORET DEVELOPMENT; COLEOPTILE LENGTH; PLANT HEIGHT; WINTER-WHEAT; EARLY GROWTH	The most common dwarfing genes in wheat, Rht-B1b and Rht-D1b, classified as gibberellin-insensitive (GAI) dwarfing genes due to their reduced response to exogenous GA, have been verified as encoding negative regulators of gibberellin signaling. In contrast, the response of gibberellin-responsive (GAR) dwarfing genes, such as Rht12, to exogenous GA is still unclear and the role of them, if any, in GA biosynthesis or signaling is unknown. The responses of Rht12 to exogenous GA(3) were investigated on seedling vigour, spike phenological development, plant height and other agronomic traits, using F-2:3 and F-3:4 lines derived from a cross between Ningchun45 and Karcagi-12 in three experiments. The application of exogenous GA(3) significantly increased coleoptile length and seedling leaf 1 length and area. While there was no significant difference between the dwarf and the tall lines at the seedling stage in the responsiveness to GA(3), plant height was significantly increased, by 41 cm (53%) averaged across the three experiments, in the GA(3)-treated Rht12 dwarf lines. Plant height of the tall lines was not affected significantly by GA(3) treatment (<10 cm increased). Plant biomass and seed size of the GA(3)-treated dwarf lines was significantly increased compared with untreated dwarf plants while there was no such difference in the tall lines. GA(3)-treated Rht12 dwarf plants with the dominant Vrn-B1 developed faster than untreated plants and reached double ridge stage 57 days, 11 days and 50 days earlier and finally flowered earlier by almost 7 days while the GA(3)-treated tall lines flowering only 1-2 days earlier than the untreated tall lines. Thus, it is clear that exogenous GA(3) can break the masking effect of Rht12 on Vrn-B1 and also restore other characters of Rht12 to normal. It suggested that Rht12 mutants may be deficient in GA biosynthesis rather than in GA signal transduction like the GA-insensitive dwarfs.	[Chen, Liang; Hao, Liugen; Hu, Yin-Gang] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Chen, Liang; Hao, Liugen; Hu, Yin-Gang] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Condon, Anthony G.] CSIRO Plant Ind, Canberra, ACT, Australia; [Hu, Yin-Gang] Northwest A&F Univ, Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Northwest A&F University - China	Hu, YG (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	huyingang@nwsuaf.edu.cn	Condon, Anthony G/F-3255-2011		863 Program of the Ministry of Science and Technology [2011AA100504, 2013AA102902]; key project of Chinese Universities Scientific Fund, Northwest AF University [ZD2012002]; China 111 Project, P. R. China [B12007]; ACIAR Project of Australia [CIM/2005/111]	863 Program of the Ministry of Science and Technology; key project of Chinese Universities Scientific Fund, Northwest AF University; China 111 Project, P. R. China; ACIAR Project of Australia(Australian Ctr Intl Agr Res)	This work was supported by the sub-project of the 863 Program (2011AA100504, 2013AA102902) of the Ministry of Science and Technology, the key project of Chinese Universities Scientific Fund, Northwest A&F University (ZD2012002), the China 111 Project (B12007), P. R. China, and the ACIAR Project (CIM/2005/111) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addisu M, 2009, EUPHYTICA, V166, P249, DOI 10.1007/s10681-008-9838-7; ALLAN RE, 1989, CROP SCI, V29, P1103, DOI 10.2135/cropsci1989.0011183X002900050001x; Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Appleford NEJ, 2007, J EXP BOT, V58, P3213, DOI 10.1093/jxb/erm166; Berry PM, 2000, FIELD CROP RES, V67, P59, DOI 10.1016/S0378-4290(00)00084-8; Botwright TL, 2005, ANN BOT-LONDON, V95, P631, DOI 10.1093/aob/mci069; Botwright TL, 2001, EUPHYTICA, V119, P349, DOI 10.1023/A:1017527911084; Busov VB, 2008, NEW PHYTOL, V177, P589, DOI 10.1111/j.1469-8137.2007.02324.x; Butler JD, 2005, CROP SCI, V45, P939, DOI 10.2135/cropsci2004.0323; Chandler PM, 2013, J EXP BOT, V64, P1603, DOI 10.1093/jxb/ert022; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Chapman SC, 2007, EUPHYTICA, V157, P391, DOI 10.1007/s10681-006-9304-3; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062285; Davies P.J., 2004, PLANT HORMONES BIOSY; Ellis MH, 2004, FUNCT PLANT BIOL, V31, P583, DOI 10.1071/FP03207; EVANS MMS, 1995, PLANT PHYSIOL, V108, P475, DOI 10.1104/pp.108.2.475; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; FLINTHAM JE, 1983, THEOR APPL GENET, V66, P249, DOI 10.1007/BF00251155; GARDNER JS, 1985, AM J BOT, V72, P548, DOI 10.2307/2443587; Gasperini D, 2012, J EXP BOT, V63, P4419, DOI 10.1093/jxb/ers138; HAUN JR, 1973, AGRON J, V65, P116, DOI 10.2134/agronj1973.00021962006500010035x; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Hu JH, 2008, PLANT CELL, V20, P320, DOI 10.1105/tpc.107.057752; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; KEYES GJ, 1989, ANN BOT-LONDON, V64, P683, DOI 10.1093/oxfordjournals.aob.a087894; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Konzak CF, 1985, RES COORD M INT AT E, P39; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Miralles DJ, 1995, PLANT BREEDING, V114, P392, DOI 10.1111/j.1439-0523.1995.tb00818.x; Miralles DJ, 1998, FIELD CROP RES, V59, P21, DOI 10.1016/S0378-4290(98)00103-8; Monna L, 2002, DNA RES, V9, P11, DOI 10.1093/dnares/9.1.11; Ogawa M, 2000, GENE, V245, P21, DOI 10.1016/S0378-1119(00)00018-4; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Rebetzke GJ, 2012, FIELD CROP RES, V126, P87, DOI 10.1016/j.fcr.2011.09.022; Rebetzke GJ, 2004, AUST J AGR RES, V55, P733, DOI 10.1071/AR04037; Rebetzke GJ, 1999, EUPHYTICA, V106, P159, DOI 10.1023/A:1003518920119; Rebetzke GJ, 2000, AUST J AGR RES, V51, P235, DOI 10.1071/AR99043; RICHARDS RA, 1992, AUST J AGR RES, V43, P529, DOI 10.1071/AR9920529; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Sun TP, 2000, CURR OPIN PLANT BIOL, V3, P374, DOI 10.1016/S1369-5266(00)00099-6; Swain SM, 2005, TRENDS PLANT SCI, V10, P123, DOI 10.1016/j.tplants.2005.01.007; VIGLASI P, 1968, ACTA AGRON HUNG, V17, P205; WADDINGTON SR, 1983, ANN BOT-LONDON, V51, P119, DOI 10.1093/oxfordjournals.aob.a086434; Wang ZL, 2001, PLANT GROWTH REGUL, V35, P225, DOI 10.1023/A:1014442006862; Wen CK, 2002, PLANT CELL, V14, P87, DOI 10.1105/tpc.010325; Wilhelm EP, 2013, THEOR APPL GENET, V126, P1733, DOI 10.1007/s00122-013-2088-7; Wojciechowski T, 2009, J EXP BOT, V60, P2565, DOI 10.1093/jxb/erp107; WORLAND AJ, 1994, PLANT BREEDING, V113, P187, DOI 10.1111/j.1439-0523.1994.tb00722.x; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	55	24	27	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86431	10.1371/journal.pone.0086431	http://dx.doi.org/10.1371/journal.pone.0086431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24466090	Green Submitted, gold, Green Published			2022-12-25	WOS:000330240500132
J	Steemson, JD; Baake, M; Rakonjac, J; Arcus, VL; Liddament, MT				Steemson, John D.; Baake, Matthias; Rakonjac, Jasna; Arcus, Vickery L.; Liddament, Mark T.			Tracking Molecular Recognition at the Atomic Level with a New Protein Scaffold Based on the OB-Fold	PLOS ONE			English	Article							BINDING-PROTEINS; PHAGE DISPLAY; DOMAIN; COMPLEMENTARITY; PREDICTION; INHIBITOR; LIBRARIES; SELECTION; BRIDGES; BONDS	The OB-fold is a small, versatile single-domain protein binding module that occurs in all forms of life, where it binds protein, carbohydrate, nucleic acid and small-molecule ligands. We have exploited this natural plasticity to engineer a new class of non-immunoglobulin alternatives to antibodies with unique structural and biophysical characteristics. We present here the engineering of the OB-fold anticodon recognition domain from aspartyl tRNA synthetase taken from the thermophile Pyrobaculum aerophilum. For this single-domain scaffold we have coined the term OBody. Starting from a naive combinatorial library, we engineered an OBody with 3 nM affinity for hen egg-white lysozyme, by optimising the affinity of a naive OBody 11,700-fold over several affinity maturation steps, using phage display. At each maturation step a crystal structure of the engineered OBody in complex with hen egg-white lysozyme was determined, showing binding elements in atomic detail. These structures have given us an unprecedented insight into the directed evolution of affinity for a single antigen on the molecular scale. The engineered OBodies retain the high thermal stability of the parental OB-fold despite mutation of up to 22% of their residues. They can be expressed in soluble form and also purified from bacteria at high yields. They also lack disulfide bonds. These data demonstrate the potential of OBodies as a new scaffold for the engineering of specific binding reagents and provide a platform for further development of future OBody-based applications.	[Steemson, John D.; Baake, Matthias; Arcus, Vickery L.] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Rakonjac, Jasna] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand; [Liddament, Mark T.] OBodies Ltd, Hamilton, New Zealand	University of Waikato; Massey University	Liddament, MT (corresponding author), OBodies Ltd, Hamilton, New Zealand.	mliddament@obodies.co.nz	Rakonjac, Jasna V/E-6836-2011	Rakonjac, Jasna V/0000-0002-6756-4682; Liddament, Mark/0000-0002-8130-3972	Marsden Fund of New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery; New Enterprise Research Fund; AgResearch Limited; University of Waikato; OBodies Ltd	Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); Maurice Wilkins Centre for Molecular Biodiscovery; New Enterprise Research Fund; AgResearch Limited; University of Waikato; OBodies Ltd	This project was funded by a grant from the Marsden Fund of New Zealand with additional funds from the Maurice Wilkins Centre for Molecular Biodiscovery, New Enterprise Research Fund, AgResearch Limited, The University of Waikato and OBodies Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beekwilder J, 1999, GENE, V228, P23, DOI 10.1016/S0378-1119(99)00013-X; Beste G, 1999, P NATL ACAD SCI USA, V96, P1898, DOI 10.1073/pnas.96.5.1898; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2005, CURR OPIN BIOTECH, V16, P459, DOI 10.1016/j.copbio.2005.06.005; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Cinier M, 2012, J BIOL INORG CHEM, V17, P399, DOI 10.1007/s00775-011-0863-y; Cobaugh CW, 2008, J MOL BIOL, V378, P622, DOI 10.1016/j.jmb.2008.02.037; Dufner P, 2006, TRENDS BIOTECHNOL, V24, P523, DOI 10.1016/j.tibtech.2006.09.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gallicchio E, 2010, J CHEM THEORY COMPUT, V6, P2961, DOI 10.1021/ct1002913; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3191, DOI 10.1073/pnas.0436100100; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lee SC, 2012, P NATL ACAD SCI USA, V109, P3299, DOI 10.1073/pnas.1113193109; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; LIN SL, 1995, J MOL BIOL, V248, P151, DOI 10.1006/jmbi.1995.0208; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lorenzen S, 2005, PROTEINS, V58, P589, DOI 10.1002/prot.20342; LOWMAN HB, 1991, BIOCHEMISTRY-US, V30, P10832, DOI 10.1021/bi00109a004; Malm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062791; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monchois V, 2001, J BIOL CHEM, V276, P18437, DOI 10.1074/jbc.M010297200; Mouratou B, 2007, P NATL ACAD SCI USA, V104, P17983, DOI 10.1073/pnas.0702963104; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nord K, 1997, NAT BIOTECHNOL, V15, P772, DOI 10.1038/nbt0897-772; Norel R, 1999, PROTEINS, V36, P307, DOI 10.1002/(SICI)1097-0134(19990815)36:3<307::AID-PROT5>3.3.CO;2-I; NOREL R, 1995, J MOL BIOL, V252, P263, DOI 10.1006/jmbi.1995.0493; Nygren PA, 2004, J IMMUNOL METHODS, V290, P3, DOI 10.1016/j.jim.2004.04.006; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rakonjac J, 1997, GENE, V198, P99, DOI 10.1016/S0378-1119(97)00298-9; Schonfeld D, 2009, P NATL ACAD SCI USA, V106, P8198, DOI 10.1073/pnas.0813399106; Schrodinger L., 2020, PYMOL; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Srivastava AK, 2010, BIOCHEMISTRY-US, V49, P9746, DOI 10.1021/bi101000m; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Xu D, 1997, J MOL BIOL, V265, P68, DOI 10.1006/jmbi.1996.0712; Zhu XL, 2011, PROTEINS, V79, P2671, DOI 10.1002/prot.23094	52	12	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86050	10.1371/journal.pone.0086050	http://dx.doi.org/10.1371/journal.pone.0086050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465865	Green Submitted, gold, Green Published			2022-12-25	WOS:000330240500105
J	Yin, GH; Gu, J; Zhang, FS; Hao, L; Cong, PF; Liu, ZX				Yin, Guanghua; Gu, Jian; Zhang, Fasheng; Hao, Liang; Cong, Peifei; Liu, Zuoxin			Maize Yield Response to Water Supply and Fertilizer Input in a Semi-Arid Environment of Northeast China	PLOS ONE			English	Article							USE EFFICIENCY; MANAGEMENT-PRACTICES; LOESS PLATEAU; WHEAT; AGRICULTURE; PHOSPHORUS; DRYLAND; RICE	Maize grain yield varies highly with water availability as well as with fertilization and relevant agricultural management practices. With a 311-A optimized saturation design, field experiments were conducted between 2006 and 2009 to examine the yield response of spring maize (Zhengdan 958, Zea mays L) to irrigation (I), nitrogen fertilization (total nitrogen, urea-46% nitrogen,) and phosphorus fertilization (P2O5, calcium superphosphate-13% P2O5) in a semi-arid area environment of Northeast China. According to our estimated yield function, the results showed that N is the dominant factor in determining maize grain yield followed by I, while P plays a relatively minor role. The strength of interaction effects among I, N and P on maize grain yield follows the sequence N+I > P+I > N+P. Individually, the interaction effects of N+I and N+P on maize grain yield are positive, whereas that of P+I is negative. To achieve maximum grain yield (10506.0 kg.ha(-1)) for spring maize in the study area, the optimum application rates of I, N and P are 930.4 m(3).ha(-1), 304.9 kg.ha(-1) and 133.2 kg.ha(-1) respectively that leads to a possible economic profit (EP) of 10548.4 CNY.ha(-1) (CNY, Chinese Yuan). Alternately, to obtain the best EP (10827.3 CNY.ha(-1)), the optimum application rates of I, N and P are 682.4 m(3).ha(-1), 241.0 kg.ha(-1) and 111.7 kg.ha(-1) respectively that produces a potential grain yield of 10289.5 kg.ha(-1)	[Yin, Guanghua; Gu, Jian; Zhang, Fasheng; Hao, Liang; Cong, Peifei; Liu, Zuoxin] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Hao, Liang; Cong, Peifei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, FS (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China.	fasheng.zhang@yahoo.com	gu, jian/B-1743-2013	gu, jian/0000-0001-7931-1220	Special Fund for Agro-scientific Research in the Public Interest [201303125-9]; National Major Technology Program [2011BAD16B12, 2012BAD09B02, 2013BAD05B07]	Special Fund for Agro-scientific Research in the Public Interest; National Major Technology Program	This work was funded by the Special Fund for Agro-scientific Research in the Public Interest (201303125-9) and National Major Technology Program (2011BAD16B12, 2012BAD09B02, 2013BAD05B07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernacchi CJ, 2005, GLOBAL CHANGE BIOL, V11, P1867, DOI 10.1111/j.1365-2486.01050.x; Ci X, 2012, EUPHYTICA, V183, P1; Cui ZL, 2013, GLOBAL CHANGE BIOL, V19, P2467, DOI 10.1111/gcb.12213; Dang TH, 2006, PEDOSPHERE, V16, P495, DOI 10.1016/S1002-0160(06)60080-5; Ding XQ, 1986, APPL REGRESSION DESI, P199; El-Hendawy SE, 2010, AGR WATER MANAGE, V97, P439, DOI 10.1016/j.agwat.2009.11.002; Fan TL, 2005, AGR ECOSYST ENVIRON, V106, P313, DOI 10.1016/j.agee.2004.09.003; Fang Q, 2010, AGR WATER MANAGE, V97, P1165, DOI 10.1016/j.agwat.2009.02.012; Grassini P, 2012, P NATL ACAD SCI USA, V109, P1074, DOI 10.1073/pnas.1116364109; Guo RP, 2010, AGR WATER MANAGE, V97, P1185, DOI 10.1016/j.agwat.2009.07.006; Hou P, 2012, FIELD CROP RES, V129, P1, DOI 10.1016/j.fcr.2012.01.006; Hu HY, 2013, FIELD CROP RES, V142, P85, DOI 10.1016/j.fcr.2012.12.001; Jin LB, 2012, FIELD CROP RES, V134, P30, DOI 10.1016/j.fcr.2012.04.008; Jin XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059353; JOKELA WE, 1992, SOIL SCI SOC AM J, V56, P148, DOI 10.2136/sssaj1992.03615995005600010023x; Ju XT, 2011, FIELD CROP RES, V124, P450, DOI 10.1016/j.fcr.2011.08.002; Koledoye, 2012, J AGR BIODIVERS RES, V1, P25; Lawlor DW, 2001, PLANT NITROGEN, P343; Li Jiansheng, 2009, P563, DOI 10.1007/978-0-387-79418-1_28; Li X, 2011, AGR SYST, V104, P348, DOI 10.1016/j.agsy.2010.12.006; Liu WZ, 2007, FIELD CROP RES, V100, P302, DOI 10.1016/j.fcr.2006.08.005; Liu Z, 2009, APPL BASIS TECHNOLOG, P314; Ma WQ, 2011, CHEMOSPHERE, V84, P814, DOI 10.1016/j.chemosphere.2011.04.055; Meng QF, 2013, FIELD CROP RES, V143, P91, DOI 10.1016/j.fcr.2012.09.023; Mulwa Richard, 2009, International Journal of Operational Research, V4, P250, DOI 10.1504/IJOR.2009.023284; Peng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037726; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Rahman S, 2012, J ASIA PAC ECON, V17, P138, DOI 10.1080/13547860.2012.640016; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Sharma AR, 2011, J CROP IMPROV, V25, P392, DOI 10.1080/15427528.2011.574498; Tao FL, 2011, CLIMATIC CHANGE, V105, P409, DOI 10.1007/s10584-010-9883-9; Tong CL, 2003, AGR ECOSYST ENVIRON, V95, P523, DOI 10.1016/S0167-8809(02)00182-2; Wang ChongTao, 2010, Scientia Agricultura Sinica, V43, P1136; Wang HX, 2009, ADV AGRON, V103, P101, DOI 10.1016/S0065-2113(09)03003-X; Wang TY, 2011, CROP SCI, V51, P512, DOI 10.2135/cropsci2010.06.0383; Wang XB, 2011, FIELD CROP RES, V120, P47, DOI 10.1016/j.fcr.2010.08.010; Wang XY, 2012, FIELD CROP RES, V134, P130, DOI 10.1016/j.fcr.2012.06.002; Wang XY, 2010, SOIL SCI SOC AM J, V74, P1348, DOI 10.2136/sssaj2009.0366; Wang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044334; Wortmann CS, 2009, AGRON J, V101, P546, DOI 10.2134/agronj2008.0103x; Xiong W, 2010, AGR ECOSYST ENVIRON, V135, P58, DOI 10.1016/j.agee.2009.08.015; Zhang FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069326; ZOU C, 2008, MICRONUTRIENT DEFICI	43	26	30	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86099	10.1371/journal.pone.0086099	http://dx.doi.org/10.1371/journal.pone.0086099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465896	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500112
J	Molina, LA; Skelin, I; Gruber, AJ				Molina, Leonardo A.; Skelin, Ivan; Gruber, Aaron J.			Acute NMDA Receptor Antagonism Disrupts Synchronization of Action Potential Firing in Rat Prefrontal Cortex	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; GAMMA-OSCILLATIONS; WORKING-MEMORY; HEALTHY-VOLUNTEERS; PYRAMIDAL NEURONS; SCHIZOPHRENIA; INTERNEURONS; KETAMINE; PHENCYCLIDINE; PARVALBUMIN	Antagonists of N-methyl-D-aspartate receptors (NMDAR) have psychotomimetic effects in humans and are used to model schizophrenia in animals. We used high-density electrophysiological recordings to assess the effects of acute systemic injection of an NMDAR antagonist (MK-801) on ensemble neural processing in the medial prefrontal cortex of freely moving rats. Although MK-801 increased neuron firing rates and the amplitude of gamma-frequency oscillations in field potentials, the synchronization of action potential firing decreased and spike trains became more Poisson-like. This disorganization of action potential firing following MK-801 administration is consistent with changes in simulated cortical networks as the functional connections among pyramidal neurons become less clustered. Such loss of functional heterogeneity of the cortical microcircuit may disrupt information processing dependent on spike timing or the activation of discrete cortical neural ensembles, and thereby contribute to hallucinations and other features of psychosis induced by NMDAR antagonists.	[Molina, Leonardo A.; Skelin, Ivan; Gruber, Aaron J.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Gruber, AJ (corresponding author), Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada.	aaron.gruber@uleth.ca		Gruber, Aaron/0000-0003-2700-5429	Canadian Natural Sciences and Engineering Research Council; Alberta Heritage Foundation for Medical Research; Alberta Innovates-Health Solutions	Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Alberta Innovates-Health Solutions	This work has been supported by funding from the Canadian Natural Sciences and Engineering Research Council (AJG), Alberta Heritage Foundation for Medical Research (AJG), and Alberta Innovates-Health Solutions (AJG, IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 1998, BIOL PSYCHIAT, V43, P811, DOI 10.1016/S0006-3223(97)00556-8; Ahn S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016201; Andine P, 1999, J PHARMACOL EXP THER, V290, P1393; Anticevic A, 2012, P NATL ACAD SCI USA, V109, P16720, DOI 10.1073/pnas.1208494109; Arvanov VL, 1997, BRAIN RES, V768, P361, DOI 10.1016/S0006-8993(97)00842-1; Barr MS, 2010, SCHIZOPHR RES, V121, P146, DOI 10.1016/j.schres.2010.05.023; Bauer EP, 2007, J NEUROSCI, V27, P9369, DOI 10.1523/JNEUROSCI.2153-07.2007; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Gallinat J, 2004, CLIN NEUROPHYSIOL, V115, P1863, DOI 10.1016/j.clinph.2004.03.013; Gandal MJ, 2012, NEUROPHARMACOLOGY, V62, P1504, DOI 10.1016/j.neuropharm.2011.02.007; Gruber AJ, 2010, J NEUROSCI, V30, P17102, DOI 10.1523/JNEUROSCI.4623-10.2010; Haig AR, 2000, CLIN NEUROPHYSIOL, V111, P1461, DOI 10.1016/S1388-2457(00)00347-3; Hakami T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006755; Harris K, 2002, KLUSTAKWIK AUTOMATIC; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Hong LE, 2010, NEUROPSYCHOPHARMACOL, V35, P632, DOI 10.1038/npp.2009.168; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Insel N, 2012, J NEUROSCI, V32, P16331, DOI 10.1523/JNEUROSCI.1577-12.2012; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Kikuchi M, 2011, SCHIZOPHR RES, V130, P187, DOI 10.1016/j.schres.2011.06.003; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kloosterman F, 2009, J VISUALIZED EXPT JO; KOEK W, 1988, J PHARMACOL EXP THER, V245, P969; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Kulikova SP, 2012, EUR J NEUROSCI, V36, P3407, DOI 10.1111/j.1460-9568.2012.08263.x; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Lazarewicz MT, 2010, J COGNITIVE NEUROSCI, V22, P1452, DOI 10.1162/jocn.2009.21305; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Ma JY, 2007, PSYCHOPHARMACOLOGY, V191, P961, DOI 10.1007/s00213-006-0667-x; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Malhotra AK, 1996, NEUROPSYCHOPHARMACOL, V14, P301, DOI 10.1016/0893-133X(95)00137-3; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Pinault D, 2008, BIOL PSYCHIAT, V63, P730, DOI 10.1016/j.biopsych.2007.10.006; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Povysheva NV, 2006, CEREB CORTEX, V16, P541, DOI 10.1093/cercor/bhj002; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Redish A, 2002, MCLUST SPIKE SORTING; Rotaru DC, 2011, J NEUROSCI, V31, P142, DOI 10.1523/JNEUROSCI.1970-10.2011; Rung JP, 2005, PROG NEURO-PSYCHOPH, V29, P833, DOI 10.1016/j.pnpbp.2005.03.003; Slewa-Younan S, 2001, INT J NEUROSCI, V107, P131, DOI 10.3109/00207450109149762; Spencer KM, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00190; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; STURGEON RD, 1979, EUR J PHARMACOL, V59, P169; STURGEON RD, 1981, EUR J PHARMACOL, V76, P37, DOI 10.1016/0014-2999(81)90007-8; TIEDTKE PI, 1990, J NEURAL TRANSM-GEN, V81, P173, DOI 10.1007/BF01245040; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; VANEDEN CG, 1992, EUR J NEUROSCI, V4, P77; Verma A, 1996, J NEUROSCI, V16, P373; Wang XJ, 1996, J NEUROSCI, V16, P6402; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Winterer G, 2004, AM J PSYCHIAT, V161, P490, DOI 10.1176/appi.ajp.161.3.490; Wood J, 2012, J NEUROSCI, V32, P3022, DOI 10.1523/JNEUROSCI.6377-11.2012; Xi D, 2009, INT J NEUROPSYCHOPH, V12, P1395, DOI 10.1017/S146114570900042X	75	39	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85842	10.1371/journal.pone.0085842	http://dx.doi.org/10.1371/journal.pone.0085842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465743	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000067
J	Vindas, MA; Sorensen, C; Johansen, IB; Folkedal, O; Hoglund, E; Khan, UW; Stien, LH; Kristiansen, TS; Braastad, BO; Overli, O				Vindas, Marco A.; Sorensen, Christina; Johansen, Ida B.; Folkedal, Ole; Hoglund, Erik; Khan, Uniza W.; Stien, Lars H.; Kristiansen, Tore S.; Braastad, Bjarne O.; Overli, Oyvind			Coping with Unpredictability: Dopaminergic and Neurotrophic Responses to Omission of Expected Reward in Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							CHARR SALVELINUS-ALPINUS; SPATIAL WORKING-MEMORY; CELL-PROLIFERATION; ARCTIC-CHARR; AGONISTIC BEHAVIOR; PREFRONTAL CORTEX; NEURAL PLASTICITY; FACTOR EXPRESSION; SOCIAL-DOMINANCE; BRAIN MONOAMINES	Comparative studies are imperative for understanding the evolution of adaptive neurobiological processes such as neural plasticity, cognition, and emotion. Previously we have reported that prolonged omission of expected rewards (OER, or `frustrative nonreward') causes increased aggression in Atlantic salmon (Salmo salar). Here we report changes in brain monoaminergic activity and relative abundance of brain derived neurotrophic factor (BDNF) and dopamine receptor mRNA transcripts in the same paradigm. Groups of fish were initially conditioned to associate a flashing light with feeding. Subsequently, the expected food reward was delayed for 30 minutes during two out of three meals per day in the OER treatment, while the previously established routine was maintained in control groups. After 8 days there was no effect of OER on baseline brain stem serotonin (5-HT) or dopamine (DA) activity. Subsequent exposure to acute confinement stress led to increased plasma cortisol and elevated turnover of brain stem DA and 5-HT in all animals. The DA response was potentiated and DA receptor 1 (D1) mRNA abundance was reduced in the OER-exposed fish, indicating a sensitization of the DA system. In addition OER suppressed abundance of BDNF in the telencephalon of non-stressed fish. Regardless of OER treatment, a strong positive correlation between BDNF and D1 mRNA abundance was seen in non-stressed fish. This correlation was disrupted by acute stress, and replaced by a negative correlation between BDNF abundance and plasma cortisol concentration. These observations indicate a conserved link between DA, neurotrophin regulation, and corticosteroid-signaling pathways. The results also emphasize how fish models can be important tools in the study of neural plasticity and responsiveness to environmental unpredictability.	[Vindas, Marco A.; Khan, Uniza W.; Braastad, Bjarne O.; Overli, Oyvind] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway; [Sorensen, Christina; Johansen, Ida B.] Univ Oslo, Dept Biosci, Oslo, Norway; [Folkedal, Ole; Stien, Lars H.; Kristiansen, Tore S.] Inst Marine Res, Dept Anim Welf, Matredal, Norway; [Hoglund, Erik] Danish Inst Fisheries Res, Dept Marine Ecol & Aquaculture, Hirtshals, Denmark	Norwegian University of Life Sciences; University of Oslo; Institute of Marine Research - Norway; Technical University of Denmark	Vindas, MA (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway.	marco.vindas@umb.no	Johansen, Ida Beitnes/W-3766-2019; Sørensen, Christina/E-7933-2012; Kristiansen, Tore/ABC-7142-2020	Sørensen, Christina/0000-0003-4009-1608; Kristiansen, Tore S/0000-0001-5904-0224	Research Council of Norway [119728]	Research Council of Norway(Research Council of Norway)	This study has been carried out with financial support from the Research Council of Norway, Project 119728 SALMOWA (www.imr.no/salmowa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2005, NEUROREPORT, V16, P669, DOI 10.1097/00001756-200505120-00003; Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014; AMSEL A, 1992, PSYCHOL BULL, V112, P396, DOI 10.1037/0033-2909.112.3.396; Bratland S, 2010, AQUACULT INT, V18, P991, DOI 10.1007/s10499-009-9317-8; Brezun JM, 2000, EUR J NEUROSCI, V12, P391, DOI 10.1046/j.1460-9568.2000.00932.x; Butler A. B., 2005, COMP VERTEBRATE NEUR; Calabrese F., 2009, PSYCHONEUROENDOCRINO, V34, pS208, DOI DOI 10.1016/J.PSYNEUEN.2009.05.014; Calu DJ, 2010, NEURON, V68, P991, DOI 10.1016/j.neuron.2010.11.019; CARLSTEAD K, 1986, APPL ANIM BEHAV SCI, V16, P25, DOI 10.1016/0168-1591(86)90037-7; Chorley P, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00021; DANTZER R, 1980, PHYSIOL BEHAV, V24, P1, DOI 10.1016/0031-9384(80)90005-0; DUNCAN IJH, 1971, ANIM BEHAV, V19, P500, DOI 10.1016/S0003-3472(71)80104-5; Eisch AJ, 2007, CURR PHARM BIOTECHNO, V8, P147; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gray JD, 2013, NEUROSCIENCE, V239, P214, DOI 10.1016/j.neuroscience.2012.08.034; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Hess U, 2009, AM PSYCHOL, V64, P120, DOI 10.1037/a0013386; Hoglund E, 2000, J EXP BIOL, V203, P1711; Huntingford FA, 2006, J FISH BIOL, V68, P332, DOI 10.1111/j.0022-1112.2006.001046.x; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Izquierdo A, 2012, BEHAV BRAIN RES, V233, P494, DOI 10.1016/j.bbr.2012.05.032; Johansen IB, 2012, COMP BIOCHEM PHYS D, V7, P161, DOI 10.1016/j.cbd.2012.01.002; Johansen IB, 2011, COMP BIOCHEM PHYS D, V6, P126, DOI 10.1016/j.cbd.2010.11.002; Johnson AW, 2008, EUR J NEUROSCI, V28, P997, DOI 10.1111/j.1460-9568.2008.06383.x; Kalueff AV, 2012, BEHAVIOUR, V149, P1019, DOI 10.1163/1568539X-00003030; Karakatsouli N, 2012, AQUACULTURE, V364, P48, DOI 10.1016/j.aquaculture.2012.07.033; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; KEENLEYSIDE MILES H. A., 1962, BEHAVIOUR, V19, P139, DOI 10.1163/156853961X00231; Kino T, 2010, MOL ENDOCRINOL, V24, P941, DOI 10.1210/me.2009-0395; Kittilsen S, 2009, AQUACULTURE, V298, P146, DOI 10.1016/j.aquaculture.2009.10.009; Kohler T, 2005, HISTOCHEM CELL BIOL, V123, P315, DOI 10.1007/s00418-004-0730-9; Krause J., 2011, FISH COGNITION BEHAV, P10; Kuppers E, 2001, NEUROREPORT, V12, P1175; Li BJ, 2010, EUR J PHARMACOL, V628, P104, DOI 10.1016/j.ejphar.2009.11.036; Lillesaar C, 2011, J CHEM NEUROANAT, V41, P294, DOI 10.1016/j.jchemneu.2011.05.009; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Maximino C, 2010, ZEBRAFISH, V7, P359, DOI 10.1089/zeb.2010.0669; MAYER I, 1990, CAN J ZOOL, V68, P1360, DOI 10.1139/z90-203; MCINTYRE DC, 1979, BEHAV NEURAL BIOL, V25, P90, DOI 10.1016/S0163-1047(79)90807-0; MICZEK KA, 1994, NEUROSCI BIOBEHAV R, V18, P97, DOI 10.1016/0149-7634(94)90040-X; Neeley EW, 2011, NEUROSCIENCE, V187, P24, DOI 10.1016/j.neuroscience.2011.03.065; Numakawa T, 2013, NEUROSCIENCE, V239, P157, DOI 10.1016/j.neuroscience.2012.09.073; O'Connell LA, 2013, J CHEM NEUROANAT, V47, P106, DOI 10.1016/j.jchemneu.2012.12.007; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; O'Connell LA, 2011, J COMP NEUROL, V519, P75, DOI 10.1002/cne.22506; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; Overli O, 1999, BRAIN BEHAV EVOLUT, V54, P263, DOI 10.1159/000006627; Papini M.R., 1997, REV GEN PSYCHOL, V1, P175, DOI [10.1037/1089-2680.1.2.175, DOI 10.1037/1089-2680.1.2.175]; Prunet P, 2012, FISH PHYSIOL BIOCHEM, V38, P43, DOI 10.1007/s10695-011-9522-z; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Rose JD, 2007, DIS AQUAT ORGAN, V75, P139, DOI 10.3354/dao075139; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; SHANNON NJ, 1986, J NEUROCHEM, V47, P958; SMITH MA, 1995, ENDOCRINOLOGY, V136, P3743, DOI 10.1210/en.136.9.3743; Sorensen C, 2013, GEN COMP ENDOCR, V181, P25, DOI 10.1016/j.ygcen.2012.12.003; Sorensen C, 2012, BEHAV BRAIN RES, V227, P311, DOI 10.1016/j.bbr.2011.01.041; Sorensen C, 2011, PHYSIOL BEHAV, V102, P518, DOI 10.1016/j.physbeh.2010.12.023; Stien LH, 2013, REV AQUACULT, V5, P33, DOI 10.1111/j.1753-5131.2012.01083.x; Suri D, 2013, NEUROSCIENCE, V239, P196, DOI 10.1016/j.neuroscience.2012.08.065; Taylor SL, 2011, BEHAV NEUROSCI, V125, P911, DOI 10.1037/a0026172; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; Vindas MA, 2012, ANIM COGN, V15, P903, DOI 10.1007/s10071-012-0517-7; von Krogh K, 2010, PHYSIOL BEHAV, V101, P32, DOI 10.1016/j.physbeh.2010.04.003; Williams SN, 2009, NEUROREPORT, V20, P606, DOI 10.1097/WNR.0b013e32832a0a98; WINBERG S, 1992, J COMP PHYSIOL A, V170, P93; WINBERG S, 1991, J COMP PHYSIOL A, V168, P241; WINBERG S, 1993, COMP BIOCHEM PHYS C, V106, P597, DOI 10.1016/0742-8413(93)90216-8; WINBERG S, 1992, NEUROREPORT, V3, P243, DOI 10.1097/00001756-199203000-00006; Xing B, 2012, BEHAV BRAIN RES, V235, P36, DOI 10.1016/j.bbr.2012.06.035; Zimmerman PH, 1998, BEHAV PROCESS, V44, P73, DOI 10.1016/S0376-6357(98)00035-7; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571; Zupanc GKH, 2000, ETHOLOGY, V106, P467, DOI 10.1046/j.1439-0310.2000.00546.x	76	21	21	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85543	10.1371/journal.pone.0085543	http://dx.doi.org/10.1371/journal.pone.0085543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297EA	24465595	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000330237000043
J	Du, BM; Liu, CJ; Kang, HZ; Zhu, PH; Yin, S; Shen, GR; Hou, JL; Ilvesniemi, H				Du, Baoming; Liu, Chunjiang; Kang, Hongzhang; Zhu, Penghua; Yin, Shan; Shen, Guangrong; Hou, Jingli; Ilvesniemi, Hannu			Climatic Control on Plant and Soil delta C-13 along an Altitudinal Transect of Lushan Mountain in Subtropical China: Characteristics and Interpretation of Soil Carbon Dynamics	PLOS ONE			English	Article							ORGANIC-MATTER; ISOTOPE COMPOSITION; TERRESTRIAL BIOSPHERE; FOREST SOILS; RAIN-FOREST; C-13 NMR; LITTER; DECOMPOSITION; RATIOS; LEAF	Decreasing temperature and increasing precipitation along altitude gradients are typical mountain climate in subtropical China. In such a climate regime, identifying the patterns of the C stable isotope composition (delta C-13) in plants and soils and their relations to the context of climate change is essential. In this study, the patterns of delta C-13 variation were investigated for tree leaves, litters, and soils in the natural secondary forests at four altitudes (219, 405, 780, and 1268 m a.s.l.) in Lushan Mountain, central subtropical China. For the dominant trees, both leaf and leaf-litter delta C-13 decreased as altitude increased from low to high altitude, whereas surface soil delta C-13 increased. The lower leaf delta C-13 at high altitudes was associated with the high moisture-related discrimination, while the high soil delta C-13 is attributed to the low temperature-induced decay. At each altitude, soil delta C-13 became enriched with soil depth. Soil delta C-13 increased with soil C concentrations and altitude, but decreased with soil depth. A negative relationship was also found between O-alkyl C and delta C-13 in litter and soil, whereas a positive relationship was observed between aromatic C and delta C-13. Lower temperature and higher moisture at high altitudes are the predominant control factors of delta C-13 variation in plants and soils. These results help understand C dynamics in the context of global warming.	[Du, Baoming; Liu, Chunjiang; Kang, Hongzhang; Yin, Shan; Shen, Guangrong] Shanghai Jiao Tong Univ, Sch Agr, Shanghai 200030, Peoples R China; [Du, Baoming; Liu, Chunjiang; Kang, Hongzhang; Yin, Shan; Shen, Guangrong] Shanghai Jiao Tong Univ, Res Ctr Low Carbon Agr, Shanghai 200030, Peoples R China; [Liu, Chunjiang; Kang, Hongzhang; Zhu, Penghua; Yin, Shan; Shen, Guangrong] Minist Agr, Key Lab Urban Agr South, Shanghai, Peoples R China; [Hou, Jingli] Shanghai Jiao Tong Univ, Instrumental Anal Ctr SJTU, Shanghai 200030, Peoples R China; [Ilvesniemi, Hannu] Finnish Forest Res Inst, Vantaa, Finland	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Ministry of Agriculture & Rural Affairs; Shanghai Jiao Tong University; Natural Resources Institute Finland (Luke)	Liu, CJ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr, Shanghai 200030, Peoples R China.	chjliu@sjtu.edu.cn		Kang, Hongzhang/0000-0003-4026-3588	State Key Basic Research and Development Plan of China [2011CB403201]; CFERN&GENE Award Funds	State Key Basic Research and Development Plan of China(National Basic Research Program of China); CFERN&GENE Award Funds	This work was supported by the State Key Basic Research and Development Plan of China (2011CB403201) and the CFERN&GENE Award Funds on ecological paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1991, SCIENCE, V253, P1402, DOI 10.1126/science.253.5026.1402; Baldock JA, 1997, AUST J SOIL RES, V35, P1061, DOI 10.1071/S97004; BALESDENT J, 1987, SOIL BIOL BIOCHEM, V19, P25, DOI 10.1016/0038-0717(87)90120-9; BALESDENT J, 1993, ECOLOGY, V74, P1713, DOI 10.2307/1939930; BENNER R, 1987, NATURE, V329, P708, DOI 10.1038/329708a0; BIRD MI, 1994, GLOBAL BIOGEOCHEM CY, V8, P13, DOI 10.1029/93GB03487; Bird MI, 1996, NATURE, V381, P143, DOI 10.1038/381143a0; Bostrom B, 2007, OECOLOGIA, V153, P89, DOI 10.1007/s00442-007-0700-8; Bowling DR, 2008, NEW PHYTOL, V178, P24, DOI 10.1111/j.1469-8137.2007.02342.x; Chen PN, 2010, CHINESE SCI BULL, V55, P55, DOI 10.1007/s11434-009-0405-y; Cotrufo MF, 2005, SOIL BIOL BIOCHEM, V37, P1105, DOI 10.1016/j.soilbio.2004.11.009; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; DZUREC RS, 1985, OECOLOGIA, V66, P17, DOI 10.1007/BF00378547; Ehleringer JR, 2000, ECOL APPL, V10, P412, DOI 10.1890/1051-0761(2000)010[0412:CIRIBC]2.0.CO;2; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Garten CT, 2000, ECOLOGY, V81, P1108, DOI 10.1890/0012-9658(2000)081[1108:CCOFSC]2.0.CO;2; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/NCLIMATE1329, 10.1038/nclimate1329]; Gouveia AC, 2009, TREES-STRUCT FUNCT, V23, P267, DOI 10.1007/s00468-008-0274-z; Hartman G, 2010, OECOLOGIA, V162, P837, DOI 10.1007/s00442-009-1514-7; Ito A, 2003, TELLUS B, V55, P596, DOI 10.1034/j.1600-0889.2003.01423.x; Jien SH, 2011, J FOREST RES-JPN, V16, P275, DOI 10.1007/s10310-010-0231-8; KALEMBASA SJ, 1973, J SCI FOOD AGR, V24, P1085, DOI 10.1002/jsfa.2740240910; Kaplan JO, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001403; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; KORNER C, 1988, OECOLOGIA, V74, P623, DOI 10.1007/BF00380063; Kramer MG, 2003, ECOLOGY, V84, P2021, DOI 10.1890/02-3097; Li JW, 2013, SOIL BIOL BIOCHEM, V66, P204, DOI 10.1016/j.soilbio.2013.07.018; Li JW, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001769; Loffler J, 2011, ERDKUNDE, V65, P189, DOI 10.3112/erdkunde.2011.02.06; MELILLO JM, 1989, PLANT SOIL, V115, P189, DOI 10.1007/BF02202587; Garcia MAM, 2012, CATENA, V94, P26, DOI 10.1016/j.catena.2011.06.007; NADELHOFFER KF, 1988, SOIL SCI SOC AM J, V52, P1633, DOI 10.2136/sssaj1988.03615995005200060024x; Peri PL, 2012, GLOBAL CHANGE BIOL, V18, P311, DOI 10.1111/j.1365-2486.2011.02494.x; Powers JS, 2006, BIOL FERT SOILS, V42, P580, DOI 10.1007/s00374-005-0054-5; Powers JS, 2002, GEODERMA, V109, P141, DOI 10.1016/S0016-7061(02)00148-9; Quideau SA, 2000, FOREST ECOL MANAG, V138, P19, DOI 10.1016/S0378-1127(00)00409-6; Rumpel C, 2002, ORG GEOCHEM, V33, P1131, DOI 10.1016/S0146-6380(02)00088-8; Schmidt MWI, 1997, EUR J SOIL SCI, V48, P319, DOI 10.1111/j.1365-2389.1997.tb00552.x; Skjemstad JO, 2008, GEODERMA, V143, P231, DOI 10.1016/j.geoderma.2007.11.006; TOWNSEND AR, 1995, ECOLOGY, V76, P721, DOI 10.2307/1939339; Tu CL, 2011, ENVIRON EARTH SCI, V63, P723, DOI 10.1007/s12665-010-0741-x; Wang H, 2010, ECOL RES, V25, P1071, DOI 10.1007/s11284-010-0730-2; Wei K, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038294; Ziegler SE, 2013, SOIL BIOL BIOCHEM, V60, P23, DOI 10.1016/j.soilbio.2013.01.001; Zimmermann M, 2012, BIOGEOCHEMISTRY, V107, P423, DOI 10.1007/s10533-010-9562-y	46	9	10	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86440	10.1371/journal.pone.0086440	http://dx.doi.org/10.1371/journal.pone.0086440			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466099	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000096
J	Pal, HC; Sharma, S; Strickland, LR; Katiyar, SK; Ballestas, ME; Athar, M; Elmets, CA; Afaq, F				Pal, Harish Chandra; Sharma, Samriti; Strickland, Leah Ray; Katiyar, Santosh K.; Ballestas, Mary E.; Athar, Mohammad; Elmets, Craig A.; Afaq, Farrukh			Fisetin Inhibits Human Melanoma Cell Invasion through Promotion of Mesenchymal to Epithelial Transition and by Targeting MAPK and NF kappa B Signaling Pathways	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; DIETARY FLAVONOID FISETIN; BREAST-CANCER; TRANSCRIPTIONAL REPRESSOR; INVERSE CORRELATION; THYROID-CANCER; CYCLE ARREST; IN-VITRO; KINASE; SNAIL	Malignant melanoma is responsible for approximately 75% of skin cancer-related deaths. BRAF plays an important role in regulating the mitogen-activated protein kinase (MAPK) signaling cascade in melanoma with activating mutations in the serine/threonine kinase BRAF occurring in 60-70% of malignant melanomas. The BRAF-MEK-ERK (MAPK) pathway is a key regulator of melanoma cell invasion. In addition, activation of NF kappa B via the MAPK pathway is regulated through MEK-induced activation of IKK. These pathways are potential targets for prevention and treatment of melanoma. In this study, we investigated the effect of fisetin, a phytochemical present in fruits and vegetables, on melanoma cell invasion and epithelialmesenchymal transition, and delineated the underlying molecular mechanism. Treatment of multiple human malignant melanoma cell lines with fisetin (5-20 mu M) resulted in inhibition of cell invasion. BRAF mutated melanoma cells were more sensitive to fisetin treatment, and this was associated with a decrease in the phosphorylation of MEK1/2 and ERK1/2. In addition, fisetin inhibited the activation of IKK leading to a reduction in the activation of the NF kappa B signaling pathway. Treatment of cells with an inhibitor of MEK1/2 (PD98059) or of NF kappa B (caffeic acid phenethyl ester) also reduced melanoma cell invasion. Furthermore, treatment of fisetin promoted mesenchymal to epithelial transition in melanoma cells, which was associated with a decrease in mesenchymal markers (N-cadherin, vimentin, snail and fibronectin) and an increase in epithelial markers (E-cadherin and desmoglein). Employing three dimensional skin equivalents consisting of A375 cells admixed with normal human keratinocytes embedded onto a collagen-constricted fibroblast matrix, we found that treatment of fisetin reduced the invasive potential of melanoma cells into the dermis and increased the expression of E-cadherin with a concomitant decrease in vimentin. These results indicate that fisetin inhibits melanoma cell invasion through promotion of mesenchymal to epithelial transition and by targeting MAPK and NF kappa B signaling pathways.	[Pal, Harish Chandra; Sharma, Samriti; Strickland, Leah Ray; Katiyar, Santosh K.; Athar, Mohammad; Elmets, Craig A.; Afaq, Farrukh] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Katiyar, Santosh K.; Athar, Mohammad; Elmets, Craig A.; Afaq, Farrukh] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Ballestas, Mary E.] Univ Alabama Birmingham, Sch Med, Childrens Alabama, Dept Pediat Infect Dis, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Afaq, F (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	fafaq@uab.edu	Pal, Harish C./AAH-9604-2020	Pal, Harish C./0000-0003-3079-7439; Ballestas, Mary/0000-0003-0660-9477	NIH [1R21CA173043-01A1, R01CA138998]; UAB Skin Disease Research Center Pilot and Feasibility [P30AR50948]; NATIONAL CANCER INSTITUTE [R01CA138998, R21CA173043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Skin Disease Research Center Pilot and Feasibility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH Grant 1R21CA173043-01A1, R01CA138998 and UAB Skin Disease Research Center Pilot and Feasibility Grant (P30AR50948). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013; Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7; Amschler K, 2010, J INVEST DERMATOL, V130, P1073, DOI 10.1038/jid.2009.365; Arai Y, 2000, J NUTR, V130, P2243; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Behrens J, 1999, CANCER METAST REV, V18, P15, DOI 10.1023/A:1006200102166; Boyd SC, 2013, J INVEST DERMATOL, V133, P1269, DOI 10.1038/jid.2012.421; Broekaert SMC, 2010, PIGM CELL MELANOMA R, V23, P763, DOI 10.1111/j.1755-148X.2010.00778.x; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen YC, 2002, ARCH TOXICOL, V76, P351, DOI 10.1007/s00204-002-0346-6; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Cohen C, 2002, CLIN CANCER RES, V8, P3728; Criswell TL, 2007, J BIOL CHEM, V282, P32491, DOI 10.1074/jbc.M704434200; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; DOMAGALA W, 1990, AM J PATHOL, V136, P219; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; Goh FY, 2012, EUR J PHARMACOL, V679, P109, DOI 10.1016/j.ejphar.2012.01.002; Gowrishankar K, 2012, J INVEST DERMATOL, V132, P1850, DOI 10.1038/jid.2012.63; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Haddad AQ, 2006, PROSTATE CANCER P D, V9, P68, DOI 10.1038/sj.pcan.4500845; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Hou DX, 2001, INT J ONCOL, V18, P1175; Huber MA, 2004, CELL CYCLE, V3, P1477, DOI 10.4161/cc.3.12.1280; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ikenoue T, 2004, CANCER RES, V64, P3428, DOI 10.1158/0008-5472.CAN-03-3591; Ikoma N, 2005, ONCOL REP, V14, P633; Jiao W, 2002, BRIT J CANCER, V86, P98, DOI 10.1038/sj.bjc.6600017; Kaufmann WK, 2008, J INVEST DERMATOL, V128, P175, DOI 10.1038/sj.jid.5700935; Khan N, 2008, CANCER RES, V68, P8555, DOI 10.1158/0008-5472.CAN-08-0240; Khan N, 2008, CARCINOGENESIS, V29, P1049, DOI 10.1093/carcin/bgn078; Kim SC, 2012, IMMUNOPHARM IMMUNOT, V34, P645, DOI 10.3109/08923973.2011.648270; Knauf JA, 2011, ONCOGENE, V30, P3153, DOI 10.1038/onc.2011.44; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Kreizenbeck GM, 2008, CANCER EPIDEM BIOMAR, V17, P949, DOI 10.1158/1055-9965.EPI-07-2729; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Leotoing L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068388; Lin Kimberly, 2010, Genes Cancer, V1, P409; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Maurer G, 2011, ONCOGENE, V30, P3477, DOI 10.1038/onc.2011.160; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; Mohapatra S, 2007, MOL CANCER RES, V5, P145, DOI 10.1158/1541-7786.MCR-06-0300; Murtaza I, 2009, INT J CANCER, V125, P2465, DOI 10.1002/ijc.24628; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Nucera C, 2010, P NATL ACAD SCI USA, V107, P10649, DOI 10.1073/pnas.1004934107; Pal HC, 2013, EXP DERMATOL, V22, P470, DOI 10.1111/exd.12181; Pizzimenti S, 2013, FREE RADICAL BIO MED, V65, P765, DOI 10.1016/j.freeradbiomed.2013.06.035; Poser I, 2001, J BIOL CHEM, V276, P24661, DOI 10.1074/jbc.M011224200; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; SEGER R, 1992, J BIOL CHEM, V267, P25628; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025224; Suh Y, 2010, CARCINOGENESIS, V31, P1424, DOI 10.1093/carcin/bgq115; Suh Y, 2009, CARCINOGENESIS, V30, P300, DOI 10.1093/carcin/bgn269; Sung B, 2007, MOL PHARMACOL, V71, P1703, DOI 10.1124/mol.107.034512; Syed DN, 2011, J INVEST DERMATOL, V131, P1291, DOI 10.1038/jid.2011.6; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tucci MG, 2007, BRIT J DERMATOL, V157, P1212, DOI 10.1111/j.1365-2133.2007.08246.x; Usami Y, 2008, J PATHOL, V215, P330, DOI 10.1002/path.2365; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021539; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Weiss MB, 2012, CANCER RES, V72, P6382, DOI 10.1158/0008-5472.CAN-12-1033; Yang JM, 2001, CANCER RES, V61, P4901; Yao K, 2008, MOL VIS, V14, P1865	67	69	71	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86338	10.1371/journal.pone.0086338	http://dx.doi.org/10.1371/journal.pone.0086338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466036	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000086
J	Hu, J; Zhang, YH; Wang, JF; Zhou, YM				Hu, Jun; Zhang, Yonghong; Wang, Jinfang; Zhou, Yongming			Glycerol Affects Root Development through Regulation of Multiple Pathways in Arabidopsis	PLOS ONE			English	Article							MITOCHONDRIAL GLYCEROL-3-PHOSPHATE SHUTTLE; DEPENDENT AUXIN GRADIENTS; BRASSICA-NAPUS L.; BOX PROTEIN TIR1; SYSTEM ARCHITECTURE; HYDROGEN-PEROXIDE; GENE FAMILY; PLANT; DEHYDROGENASE; THALIANA	Glycerol metabolism has been well studied biochemically. However, the means by which glycerol functions in plant development is not well understood. This study aimed to investigate the mechanism underlying the effects of glycerol on root development in Arabidopsis thaliana. Exogenous glycerol inhibited primary root growth and altered lateral root development in wild-type plants. These phenotypes appeared concurrently with increased endogenous glycerol-3-phosphate (G3P) and H2O2 contents in seedlings, and decreased phosphate levels in roots. Upon glycerol treatment, G3P level and root development did not change in glycerol kinase mutant gli1, but G3P level increased in gpdhc1 and fad-gpdh mutants, which resulted in more severely impaired root development. Overexpression of the FAD-GPDH gene attenuated the alterations in G3P, phosphate and H2O2 levels, leading to increased tolerance to exogenous glycerol, which suggested that FAD-GPDH plays an important role in modulating this response. Free indole-3-acetic acid (IAA) content increased by 46%, and DR5pro::GUS staining increased in the stele cells of the root meristem under glycerol treatment, suggesting that glycerol likely alters normal auxin distribution. Decreases in PIN1 and PIN7 expression, b-glucuronidase (GUS) staining in plants expressing PIN7pro::GUS and green fluorescent protein (GFP) fluorescence in plants expressing PIN7pro::PIN7-GFP were observed, indicating that polar auxin transport in the root was downregulated under glycerol treatment. Analyses with auxin-related mutants showed that TIR1 and ARF7 were involved in regulating root growth under glycerol treatment. Glycerol-treated plants showed significant reductions in root meristem size and cell number as revealed by CYCB1; 1pro::GUS staining. Furthermore, the expression of CDKA and CYCB1 decreased significantly in treated plants compared with control plants, implying possible alterations in cell cycle progression. Our data demonstrated that glycerol treatment altered endogenous levels of G3P, phosphate and ROS, affected auxin distribution and cell division in the root meristem, and eventually resulted in modifications of root development.	[Hu, Jun; Zhang, Yonghong; Wang, Jinfang; Zhou, Yongming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Hu, Jun; Wang, Jinfang; Zhou, Yongming] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Zhou, YM (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	ymzhou@mail.hzau.edu.cn			Ministry of Science and Technology of China [2006CB101604]; National Natural Science Foundation of China [30471097]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the funding from the Ministry of Science and Technology of China (Grant no. 2006CB101604) and the National Natural Science Foundation of China (30471097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; AUBERT S, 1994, J BIOL CHEM, V269, P21420; Bellettre A, 2001, PLANT PHYSIOL BIOCH, V39, P503, DOI 10.1016/S0981-9428(01)01263-3; BENAMOTZ A, 1973, PLANT PHYSIOL, V51, P875, DOI 10.1104/pp.51.5.875; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Caparros-Martin JA, 2007, PLANT MOL BIOL, V63, P505, DOI 10.1007/s11103-006-9104-0; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Chanda B, 2008, PLANT PHYSIOL, V147, P2017, DOI 10.1104/pp.108.121335; Chanda B, 2011, NAT GENET, V43, P421, DOI 10.1038/ng.798; CHITLARU E, 1991, PLANT PHYSIOL, V96, P50, DOI 10.1104/pp.96.1.50; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; Dubrovsky JG, 2008, P NATL ACAD SCI USA, V105, P8790, DOI 10.1073/pnas.0712307105; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Eastmond PJ, 2004, PLANT J, V37, P617, DOI 10.1111/j.1365-313X.2003.01989.x; ELVIN CM, 1985, J BACTERIOL, V161, P1054, DOI 10.1128/JB.161.3.1054-1058.1985; Fernandez-Marcos M, 2011, P NATL ACAD SCI USA, V108, P18506, DOI 10.1073/pnas.1108644108; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; GERBER DW, 1988, PLANT SCI, V56, P31, DOI 10.1016/0168-9452(88)90182-3; Gibson SW, 2012, J PLANT BIOL, V55, P361, DOI 10.1007/s12374-011-0328-4; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Hausler RE, 2000, ANAL BIOCHEM, V281, P1, DOI 10.1006/abio.2000.4556; HIPPMANN H, 1976, Z PFLANZENPHYSIOL, V79, P408, DOI 10.1016/S0044-328X(76)80160-2; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Inoue Y, 2006, PLANT CELL PHYSIOL, V47, P471, DOI 10.1093/pcp/pcj013; Jain A, 2007, PLANT PHYSIOL, V144, P232, DOI 10.1104/pp.106.092130; Kachroo A, 2004, P NATL ACAD SCI USA, V101, P5152, DOI 10.1073/pnas.0401315101; Kachroo P, 2005, PLANT PHYSIOL, V139, P1717, DOI 10.1104/pp.105.071662; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; KUNST L, 1988, P NATL ACAD SCI USA, V85, P4143, DOI 10.1073/pnas.85.12.4143; Lariguet P, 2013, PLANTA, V238, P381, DOI 10.1007/s00425-013-1901-5; LEEGOOD RC, 1988, PLANTA, V176, P117, DOI 10.1007/BF00392487; Lewis DR, 2011, DEVELOPMENT, V138, P3485, DOI 10.1242/dev.065102; Li BH, 2011, PLANT CELL ENVIRON, V34, P933, DOI 10.1111/j.1365-3040.2011.02295.x; Lima JE, 2010, PLANT CELL, V22, P3621, DOI 10.1105/tpc.110.076216; LIN ECC, 1976, ANNU REV MICROBIOL, V30, P535, DOI 10.1146/annurev.mi.30.100176.002535; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; Liu HB, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-2; Malamy JE, 1997, DEVELOPMENT, V124, P33; Mandal MK, 2012, PLANT CELL, V24, P1654, DOI 10.1105/tpc.112.096768; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Min L, 2013, PLANT J, V75, P823, DOI 10.1111/tpj.12245; Mishra BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004502; Nissen TL, 2000, YEAST, V16, P463, DOI 10.1002/(SICI)1097-0061(20000330)16:5<463::AID-YEA535>3.0.CO;2-3; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Petricka JJ, 2012, ANNU REV PLANT BIOL, V63, P563, DOI 10.1146/annurev-arplant-042811-105501; Quettier AL, 2008, PLANT PHYSIOL, V148, P519, DOI 10.1104/pp.108.123703; Ramaiah M, 2011, PLANT PHYSIOL, V157, P279, DOI 10.1104/pp.111.178541; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Shen WY, 2010, J BIOL CHEM, V285, P22955, DOI 10.1074/jbc.M109.097758; Shen WY, 2006, PLANT CELL, V18, P422, DOI 10.1105/tpc.105.039750; Shen WY, 2003, FEBS LETT, V536, P92, DOI 10.1016/S0014-5793(03)00033-4; Siderius M, 2000, MOL MICROBIOL, V36, P1381, DOI 10.1046/j.1365-2958.2000.01955.x; Sukumar P, 2013, PLANT CELL ENVIRON, V36, P909, DOI 10.1111/pce.12036; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Vigeolas H, 2004, PLANTA, V219, P827, DOI 10.1007/s00425-004-1273-y; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Wei YD, 2004, J BIOL CHEM, V279, P429, DOI 10.1074/jbc.M308363200; Wieland OH, 1974, METHOD ENZYMAT AN, P504; Williamson LC, 2001, PLANT PHYSIOL, V126, P875, DOI 10.1104/pp.126.2.875; Xu CC, 2006, PLANT J, V47, P296, DOI 10.1111/j.1365-313X.2006.02790.x; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081756; Yu KS, 2013, CELL REP, V3, P1266, DOI 10.1016/j.celrep.2013.03.030; Zhang HM, 1999, P NATL ACAD SCI USA, V96, P6529, DOI 10.1073/pnas.96.11.6529; Zhao YK, 2011, NEW PHYTOL, V189, P1122, DOI 10.1111/j.1469-8137.2010.03545.x; Zhuge J, 2001, APPL MICROBIOL BIOT, V55, P686, DOI 10.1007/s002530100596	80	7	7	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86269	10.1371/journal.pone.0086269	http://dx.doi.org/10.1371/journal.pone.0086269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465999	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100136
J	Kottler, VA; Koch, I; Flotenmeyer, M; Hashimoto, H; Weigel, D; Dreyer, C				Kottler, Verena A.; Koch, Iris; Floetenmeyer, Matthias; Hashimoto, Hisashi; Weigel, Detlef; Dreyer, Christine			Multiple Pigment Cell Types Contribute to the Black, Blue, and Orange Ornaments of Male Guppies (Poecilia reticulata)	PLOS ONE			English	Article							FEMALE MATE PREFERENCE; LEBISTES-RETICULATUS; SEXUAL SELECTION; DICHROMATIC CHROMATOPHORES; COUNTERGRADIENT VARIATION; FISH CHROMATOPHORES; PATTERN-FORMATION; ORYZIAS-LATIPES; COLOR PATTERNS; PETERS PISCES	The fitness of male guppies (Poecilia reticulata) highly depends on the size and number of their black, blue, and orange ornaments. Recently, progress has been made regarding the genetic mechanisms underlying male guppy pigment pattern formation, but we still know little about the pigment cell organization within these ornaments. Here, we investigate the pigment cell distribution within the black, blue, and orange trunk spots and selected fin color patterns of guppy males from three genetically divergent strains using transmission electron microscopy. We identified three types of pigment cells and found that at least two of these contribute to each color trait. Further, two pigment cell layers, one in the dermis and the other in the hypodermis, contribute to each trunk spot. The pigment cell organization within the black and orange trunk spots was similar between strains. The presence of iridophores in each of the investigated color traits is consistent with a key role for this pigment cell type in guppy color pattern formation.	[Kottler, Verena A.; Weigel, Detlef; Dreyer, Christine] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Koch, Iris; Floetenmeyer, Matthias] Max Planck Inst Dev Biol, Tubingen, Germany; [Hashimoto, Hisashi] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan	Max Planck Society; Max Planck Society; Nagoya University	Kottler, VA (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany.	verena.kottler@tuebingen.mpg.de; christine.dreyer@tuebingen.mpg.de	Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Floetenmeyer, Matthias/0000-0002-0133-1632	Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft; Max Planck Society; Grants-in-Aid for Scientific Research [26440121] Funding Source: KAKEN	Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft; Max Planck Society(Max Planck Society); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft and funds from the Max Planck Society to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HJ, 2004, J EVOLUTION BIOL, V17, P1238, DOI 10.1111/j.1420-9101.2004.00788.x; Braasch I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-74; Brooks R, 1996, NATURWISSENSCHAFTEN, V83, P39, DOI 10.1007/BF01139310; Deere KA, 2012, P ROY SOC B-BIOL SCI, V279, P1684, DOI 10.1098/rspb.2011.2132; Eakley AL, 2004, P ROY SOC B-BIOL SCI, V271, pS299, DOI 10.1098/rsbl.2004.0165; ENDLER JA, 1983, ENVIRON BIOL FISH, V9, P173, DOI 10.1007/BF00690861; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1987, ANIM BEHAV, V35, P1376, DOI 10.1016/S0003-3472(87)80010-6; FARR JA, 1977, EVOLUTION, V31, P162, DOI 10.1111/j.1558-5646.1977.tb00993.x; FARR JA, 1980, BEHAVIOUR, V74, P38, DOI 10.1163/156853980X00311; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; FUJII R, 1989, ZOOL SCI, V6, P477; FUJII R, 1993, INT REV CYTOL, V143, P191; Fujii R., 1966, Annotationes Zoologicae Japonenses, V39, P185; FUJII R, 1970, Annotationes Zoologicae Japonenses, V43, P123; Fujii Ryozo, 1993, P535; GODA M, 1994, ZOOL SCI, V11, P527; Goda M, 2001, ZOOL SCI, V18, P165, DOI 10.2108/zsj.18.165; Goda M, 2013, BIOL BULL-US, V224, P14, DOI 10.1086/BBLv224n1p14; Goda M, 2011, PIGM CELL MELANOMA R, V24, P614, DOI 10.1111/j.1755-148X.2011.00861.x; Goodrich HB, 1944, GENETICS, V29, P584; Goodrich HB, 1941, GENETICS, V26, P573; Grether GF, 2005, EVOLUTION, V59, P175, DOI 10.1111/j.0014-3820.2005.tb00904.x; Grether GF, 2001, P ROY SOC B-BIOL SCI, V268, P1245, DOI 10.1098/rspb.2001.1624; GUNDERSEN RE, 1982, J MORPHOL, V172, P349, DOI 10.1002/jmor.1051720309; HAMA T, 1970, CHEM BIOL PTERIDINES, P391; Hama T., 1975, MEDAKA KILLIFISH BIO, P138; Harris MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000206; Haskins CP, 1938, AM NAT, V72, P571, DOI 10.1086/280808; HAWKES JW, 1974, CELL TISSUE RES, V149, P159, DOI 10.1007/BF00222271; Hirata M, 2005, DEV DYNAM, V234, P293, DOI 10.1002/dvdy.20513; Hirata M, 2003, DEV DYNAM, V227, P497, DOI 10.1002/dvdy.10334; Houde AE, 1987, EVOLUTION, P1; Hughes KA, 1999, ANIM BEHAV, V58, P907, DOI 10.1006/anbe.1999.1225; Hughes KA, 2013, NATURE, V503, P108, DOI 10.1038/nature12717; IGA T, 1978, J EXP ZOOL, V205, P413, DOI 10.1002/jez.1402050310; Inaba M, 2012, SCIENCE, V335, P677, DOI 10.1126/science.1212821; Kelsh RN, 2009, SEMIN CELL DEV BIOL, V20, P90, DOI 10.1016/j.semcdb.2008.10.001; KODRICBROWN A, 1985, BEHAV ECOL SOCIOBIOL, V17, P199, DOI 10.1007/BF00300137; Kottler VA, 2013, GENETICS, V194, P631, DOI 10.1534/genetics.113.151738; Kuriyama T, 2006, ZOOL SCI, V23, P793, DOI 10.2108/zsj.23.793; Maderspacher F, 2003, DEVELOPMENT, V130, P3447, DOI 10.1242/dev.00519; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; MATSUMOTO J, 1965, J CELL BIOL, V27, P493, DOI 10.1083/jcb.27.3.493; MENTER DG, 1979, J MORPHOL, V160, P103, DOI 10.1002/jmor.1051600107; MORRISON RL, 1995, PIGM CELL RES, V8, P28, DOI 10.1111/j.1600-0749.1995.tb00771.x; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; OBIKA M, 1990, PIGM CELL RES, V3, P33, DOI 10.1111/j.1600-0749.1990.tb00259.x; OBIKA M, 1993, CELL TISSUE RES, V271, P81, DOI 10.1007/BF00297544; OLIPHANT LW, 1993, PIGM CELL RES, V6, P205, DOI 10.1111/j.1600-0749.1993.tb00603.x; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Patterson LB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003561; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schmidt J, 1920, C R TRAV LABOR CARLS, V14; Sheets L, 2007, CURR BIOL, V17, P1721, DOI 10.1016/j.cub.2007.09.028; TAKEUCHI I K, 1975, Annotationes Zoologicae Japonenses, V48, P242; TAKEUCHI IK, 1976, CELL TISSUE RES, V173, P17; Tripathi N, 2009, GENETICS, V182, P365, DOI 10.1534/genetics.108.098541; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Tripathi N, 2008, ZEBRAFISH, V5, P265, DOI 10.1089/zeb.2008.0548; WINGE O, 1947, HEREDITY, V1, P65, DOI 10.1038/hdy.1947.4; Winge O, 1927, J GENET, V18, P1, DOI 10.1007/BF03052599; Winge O, 1922, J GENET, V12, P145, DOI 10.1007/BF02983078	66	27	30	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85647	10.1371/journal.pone.0085647	http://dx.doi.org/10.1371/journal.pone.0085647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465632	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100055
J	Hakim, Y; Yaniv, SP; Schuldiner, O				Hakim, Yaniv; Yaniv, Shiri P.; Schuldiner, Oren			Astrocytes Play a Key Role in Drosophila Mushroom Body Axon Pruning	PLOS ONE			English	Article							METAMORPHOSIS; RECEPTOR; DEGENERATION; EXPRESSION; DISEASE; PROTEIN; DRAPER; SYSTEM; BRAIN	Axon pruning is an evolutionarily conserved strategy used to remodel neuronal connections during development. The Drosophila mushroom body (MB) undergoes neuronal remodeling in a highly stereotypical and tightly regulated manner, however many open questions remain. Although it has been previously shown that glia instruct pruning by secreting a TGF-beta ligand, myoglianin, which primes MB neurons for fragmentation and also later engulf the axonal debris once fragmentation has been completed, which glia subtypes participate in these processes as well as the molecular details are unknown. Here we show that, unexpectedly, astrocytes are the major glial subtype that is responsible for the clearance of MB axon debris following fragmentation, even though they represent only a minority of glia in the MB area during remodeling. Furthermore, we show that astrocytes both promote fragmentation of MB axons as well as clear axonal debris and that this process is mediated by ecdysone signaling in the astrocytes themselves. In addition, we found that blocking the expression of the cell engulfment receptor Draper in astrocytes only affects axonal debris clearance. Thereby we uncoupled the function of astrocytes in promoting axon fragmentation to that of clearing axonal debris after fragmentation has been completed. Our study finds a novel role for astrocytes in the MB and suggests two separate pathways in which they affect developmental axon pruning.	[Hakim, Yaniv; Yaniv, Shiri P.; Schuldiner, Oren] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Schuldiner, O (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	oren.schuldiner@weizmann.ac.il	Schuldiner, Oren/K-1353-2012	Schuldiner, Oren/0000-0002-7350-9380; Yaniv, Shiri/0000-0003-1334-5836	Israel Science Foundation grants (ISF) [1864/08, 683/11]; Yeda-Sela Foundation	Israel Science Foundation grants (ISF); Yeda-Sela Foundation	This work was funded by the Israel Science Foundation grants (ISF) 1864/08 and 683/11 (Bio-med Legacy program) and the Yeda-Sela Foundation. All the images were obtained using a Zeiss LSM710 confocal microscope that was purchased with the help of the Adelis Foundation. O.S. is incumbent of the Aser Rothstein Career Development Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; Boulanger A, 2010, NAT NEUROSCI; Cao FJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-223; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Corty Megan M, 2013, J Cell Biol, V203, P395, DOI 10.1083/jcb.201306099; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; HANTAZAMBROISE D, 1994, J NEUROCYTOL, V23, P179, DOI 10.1007/BF01181559; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Kirilly D, 2009, NAT NEUROSCI, V12, P1497, DOI 10.1038/nn.2415; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Liu ZW, 2010, J NEUROSCI, V30, P11624, DOI 10.1523/JNEUROSCI.0410-10.2010; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Pignoni F, 1997, P NATL ACAD SCI USA, V94, P9220, DOI 10.1073/pnas.94.17.9220; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Tasdemir-Yilmaz OE, 2013, GENES DEV IN PRESS; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Yu XMM, 2013, NEURON, V78, P456, DOI 10.1016/j.neuron.2013.03.004; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	29	50	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86178	10.1371/journal.pone.0086178	http://dx.doi.org/10.1371/journal.pone.0086178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465945	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500199
J	Lin, H; Yang, YN; Wang, Y; Wang, LH; Zhou, X; Liu, J; Peng, DZ				Lin, Heng; Yang, Yanni; Wang, Yong; Wang, Lihua; Zhou, Xin; Liu, Jing; Peng, Daizhi			Effect of Mixed Transplantation of Autologous and Allogeneic Microskin Grafts on Wound Healing in a Rat Model of Acute Skin Defect	PLOS ONE			English	Article							EPIDERMAL STEM-CELLS; SYNGENEIC KERATINOCYTES; INTEGRIN FUNCTION; CRUCIAL ROLE; IN-VITRO; ADHESION; DEDIFFERENTIATION; BETA-1-INTEGRIN; FIBROBLASTS; EXPRESSION	The treatment of extensive thermal injuries with insufficient autologous skin remains a great challenge to burn surgeons. In this study, we investigated the influence of the ratio of autologous and allogeneic tissue in mixed microskin grafts on wound healing in order to develop an effective method for using limited donor skin to cover a large open wound. Four different mixtures were tested: autologous microskin at an area expansion ratio of 10:1 with allogeneic microskin at an area expansion ratio of 10:1 or 10:3 and autologous microskin at an expansion ratio of 20:1 with allogeneic microskin at an expansion ratio of 20:3 or 20:6. Wound healing, wound contraction, and integrin beta 1 expression were measured. Mixed microskin grafting facilitated wound healing substantially. The mixture of autologous microskin at an expansion ratio of 10:1 with the same amount of allogeneic microskin achieved the most satisfactory wound healing among the 4 tested mixtures. Histological examination revealed the presence of obviously thickened epidermis and ectopic integrin beta 1 expression. Keratinocytes expressing integrin beta 1 were scattered in the suprabasal layer. Higher levels of integrin beta 1 expression were associated with faster wound healing, implying that ectopic expression of integrin beta 1 in keratinocytes may play a pivotal role in wound healing. In conclusion, this study proves that this new skin grafting technique may improve wound healing.	[Lin, Heng; Yang, Yanni; Wang, Yong; Wang, Lihua; Zhou, Xin; Liu, Jing; Peng, Daizhi] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, Chongqing, Peoples R China; [Lin, Heng; Peng, Daizhi] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Tissue Engn Res Unit, Chongqing, Peoples R China	Army Medical University; Army Medical University	Peng, DZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, Chongqing, Peoples R China.	dzpengpub@126.com			National Key Basic Research and Development Project of China (973 Project) [2005CB522605]; National High Technology Research and Development Project of China (863 Project) [2006AA02A121]; Independent Research Subject Project Type I of State Key Laboratory of Trauma, Burns and Combined Injury [SKLZZ200904]	National Key Basic Research and Development Project of China (973 Project)(National Basic Research Program of China); National High Technology Research and Development Project of China (863 Project); Independent Research Subject Project Type I of State Key Laboratory of Trauma, Burns and Combined Injury	This study was supported in part by grants from National Key Basic Research and Development Project of China (973 Project) (No. 2005CB522605), National High Technology Research and Development Project of China (863 Project) (No. 2006AA02A121) and Independent Research Subject Project Type I of State Key Laboratory of Trauma, Burns and Combined Injury (No. SKLZZ200904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottcher-Haberzeth S, 2010, BURNS, V36, P450, DOI 10.1016/j.burns.2009.08.016; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Brakebusch C, 1997, J CELL SCI, V110, P2895; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Cao YP, 2003, TRANSPLANTATION, V75, P1390, DOI 10.1097/01.TP.0000061599.24682.EC; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Chen MK, 1999, J SURG RES, V84, P82, DOI 10.1006/jsre.1999.5614; El Ghalbzouri A, 2002, CELL TISSUE RES, V310, P189, DOI 10.1007/s00441-002-0621-0; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; Fu XB, 2001, LANCET, V358, P1067, DOI 10.1016/S0140-6736(01)06202-X; Grose R, 2002, DEVELOPMENT, V129, P2303; HOTCHIN NA, 1995, J CELL BIOL, V128, P1209, DOI 10.1083/jcb.128.6.1209; JOHNSONWINT B, 1988, ANN NY ACAD SCI, V548, P167, DOI 10.1111/j.1749-6632.1988.tb18803.x; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kato A, 1997, CRIT REV ONCOL HEMAT, V26, P1, DOI 10.1016/S1040-8428(97)00011-5; KIM ZW, 1970, SURG GYNECOL OBSTETR, V131, P495; Larochelle F, 1998, LAB INVEST, V78, P1089; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li HH, 2007, CELL BIOL INT, V31, P1436, DOI 10.1016/j.cellbi.2007.05.016; Mai A, 2011, J CELL BIOL, V194, P291, DOI 10.1083/jcb.201012126; McCarty JH, 2009, CELL ADHES MIGR, V3, P211, DOI 10.4161/cam.3.2.7767; Nowinski D, 2004, J INVEST DERMATOL, V122, P216, DOI 10.1046/j.0022-202X.2003.22112.x; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rouabhia M, 1996, TRANSPLANTATION, V61, P1290, DOI 10.1097/00007890-199605150-00002; Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023; Weis SM, 2007, METHOD ENZYMOL, V426, P505, DOI 10.1016/S0076-6879(07)26021-5; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; YAMADA KM, 1996, MOL CELLULAR BIOL WO, P311; YANG CC, 1980, BURNS, V6, P141; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Zhang CP, 2010, J CELL MOL MED, V14, P1135, DOI 10.1111/j.1582-4934.2009.00765.x; Zhang M, 2001, Zhonghua Wai Ke Za Zhi, V39, P708; Zhang M L, 1986, Burns Incl Therm Inj, V12, P540; Zuo HB, 2012, J MATER SCI-MATER M, V23, P2933, DOI 10.1007/s10856-012-4745-9	37	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85672	10.1371/journal.pone.0085672	http://dx.doi.org/10.1371/journal.pone.0085672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465646	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500090
J	Marnewick, K; Ferreira, SM; Grange, S; Watermeyer, J; Maputla, N; Davies-Mostert, HT				Marnewick, Kelly; Ferreira, Sam M.; Grange, Sophie; Watermeyer, Jessica; Maputla, Nakedi; Davies-Mostert, Harriet T.			Evaluating the Status of and African Wild Dogs Lycaon pictus and Cheetahs Acinonyx jubatus through Tourist-based Photographic Surveys in the Kruger National Park	PLOS ONE			English	Article							SOUTH-AFRICA; POPULATION; COMPETITION; CARNIVORES; EXTINCTION; SERENGETI; AREAS	The Kruger National Park is a stronghold for African wild dog Lycaon pictus and cheetah Acinonyx jubatus conservation in South Africa. Tourist photographic surveys have been used to evaluate the minimum number of wild dogs and cheetahs alive over the last two decades. Photographic-based capture-recapture techniques for open populations were used on data collected during a survey done in 2008/9. Models were run for the park as a whole and per region (northern, central, southern). A total of 412 (329-495; SE 41.95) cheetahs and 151 (144-157; SE 3.21) wild dogs occur in the Kruger National Park. Cheetah capture probabilities were affected by time (number of entries) and sex, whereas wild dog capture probabilities were affected by the region of the park. When plotting the number of new individuals identified against the number of entries received, the addition of new wild dogs to the survey reached an asymptote at 210 entries, but cheetahs did not reach an asymptote. The cheetah population of Kruger appears to be acceptable, while the wild dog population size and density are of concern. The effectiveness of tourist-based surveys for estimating population sizes through capture-recapture analyses is shown.	[Marnewick, Kelly; Grange, Sophie; Watermeyer, Jessica; Davies-Mostert, Harriet T.] Endangered Wildlife Trust, Johannesburg, South Africa; [Marnewick, Kelly] Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa; [Ferreira, Sam M.] SANParks, Sci Serv, Skukuza, South Africa; [Watermeyer, Jessica] Rhodes Univ, Dept Zool & Entomol, Wildlife & Reserve Management Res Grp, ZA-6140 Grahamstown, South Africa; [Maputla, Nakedi] African Wildlife Fdn, Nairobi, Kenya; [Davies-Mostert, Harriet T.] Univ Oxford, Recanati Kaplan Ctr, Wildlife Conservat Res Unit, Dept Zool, Oxford, England	University of Pretoria; Rhodes University; University of Oxford	Marnewick, K (corresponding author), Endangered Wildlife Trust, Johannesburg, South Africa.	kellym@ewt.org.za		Davies-Mostert, Harriet/0000-0001-7824-4863	Howard G Buffett Foundation; Tinga Lodge; Esor	Howard G Buffett Foundation; Tinga Lodge; Esor	Howard G Buffett Foundation (www.thehowardgbuffettfoundation.org), Tinga Lodge (www.tinga.co.za) and Esor (www.esorfranki.co.za). Jaguar Land Rover South Africa (http://www.landrover.com/za/en/lr/about-land-rover/sponsorship/conservation/) provided a vehicle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowland A, 1994, 1990 1991 CHEETAH PH; Broomhall LS, 2003, J ZOOL, V261, P119, DOI 10.1017/S0952836903004059; Burnham KP, 2002, MULTIMODEL INFERENCE; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; CARO TM, 1987, ETHOLOGY, V74, P52; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Creel S, 1996, CONSERV BIOL, V10, P526, DOI 10.1046/j.1523-1739.1996.10020526.x; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; Davies HT, 2000, 1999 2000 WILD UNPUB; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Ferreira SM, 2010, WILDLIFE RES, V37, P194, DOI 10.1071/WR09030; Ferreira SM, 2009, S AFR J WILDL RES, V39, P181, DOI 10.3957/056.039.0205; GINSBERG JR, 1995, P ROY SOC B-BIOL SCI, V262, P221, DOI 10.1098/rspb.1995.0199; Gros PM, 2002, BIOL CONSERV, V106, P177, DOI 10.1016/S0006-3207(01)00244-0; Gros PM, 1998, BIOL CONSERV, V85, P137, DOI 10.1016/S0006-3207(97)00135-3; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Lindsey P, 2004, S AFR J WILDL RES, V34, P143; MADDOCK AH, 1994, BIOL CONSERV, V67, P57, DOI 10.1016/0006-3207(94)90009-4; Marnewick K, 2008, S AFR J WILDL RES, V38, P59, DOI 10.3957/0379-4369-38.1.59; Mills M.G.L., 2005, 4 WILD DOG 2 C UNPUB; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Ransom JI, 2012, J WILDLIFE MANAGE, V76, P299, DOI 10.1002/jwmg.204; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilkinson I, 1995, 1994 1995 WILD UNPUB; Woodroffe R, 2004, AFRICAN WILD DOG LYC, P174	25	25	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86265	10.1371/journal.pone.0086265	http://dx.doi.org/10.1371/journal.pone.0086265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465998	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500215
J	Rodriguez-Carrio, J; de Paz, B; Lopez, P; Prado, C; Alperi-Lopez, M; Ballina-Garcia, FJ; Suarez, A				Rodriguez-Carrio, Javier; de Paz, Banesa; Lopez, Patricia; Prado, Catuxa; Alperi-Lopez, Mercedes; Javier Ballina-Garcia, Francisco; Suarez, Ana			IFN alpha Serum Levels Are Associated with Endothelial Progenitor Cells Imbalance and Disease Features in Rheumatoid Arthritis Patients	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PERIPHERAL-BLOOD CELLS; TUMOR-NECROSIS-FACTOR; INTERFERON-ALPHA; I INTERFERON; CARDIOVASCULAR RISK; AUTOIMMUNE-DISEASES; CROSS-REGULATION; ATHEROSCLEROSIS; DYSFUNCTION	Introduction: IFN alpha has been largely implicated in the ethiopathogenesis of autoimmune diseases but only recently it has been linked to endothelial damage and accelerated atherosclerosis in autoimmunity. In addition, proinflammatory conditions are supposed to be implicated in the cardiovascular status of these patients. Since a role for IFN alpha in endothelial damage and impaired Endothelial Progenitor Cell (EPC) number and function has been reported in other diseases, we aimed to evaluate the potential associations of IFN alpha serum levels on EPC populations and cytokine profiles in Rheumatoid Arthritis (RA) patients. Methods: pre-EPC, EPC and mature EPC (mEPC) populations were quantified by flow cytometry analyzing their differential CD34, CD133 and VEGFR2 expression in blood samples from 120 RA patients, 52 healthy controls (HC), and 83 systemic lupus erythematosus (SLE) patients as disease control. Cytokine serum levels were measured by immunoassays and clinical and immunological data, including cardiovascular (CV) events and CV risk factors, were retrospectively obtained by reviewing clinical records. Results: Long-standing, but not recent onset RA patients displayed a significant depletion of all endothelial progenitor populations, unless high IFN alpha levels were present. In fact, the IFNhigh RA patient group (n = 40, 33%), showed increased EPC levels, comparable to SLE patients. In addition, high IFN alpha serum levels were associated with higher disease activity (DAS28), presence of autoantibodies, higher levels of IL-1 beta, IL-6, IL-10 and MIP-1 alpha, lower amounts of TGF-beta, and increased mEPC/EPC ratio, thus suggesting higher rates of endothelial damage and an endothelial repair failure. Finally, the relationship between high IFN alpha levels and occurrence of CV events observed in RA patients seems to support this hypothesis. Conclusions: IFN alpha serum marker could be used to identify a group of RA patients with increased disease activity, EPC imbalance, enhanced proinflammatory profile and higher cardiovascular risk, probably due, at least in part, to an impaired endothelial repair.	[Rodriguez-Carrio, Javier; de Paz, Banesa; Lopez, Patricia; Prado, Catuxa; Suarez, Ana] Univ Oviedo, Fac Med, Dept Funct Biol, Area Immunol, Oviedo, Spain; [Alperi-Lopez, Mercedes; Javier Ballina-Garcia, Francisco] Hosp Univ Cent Asturias, Dept Rheumatol, Oviedo, Spain	University of Oviedo; Central University Hospital Asturias	Suarez, A (corresponding author), Univ Oviedo, Fac Med, Dept Funct Biol, Area Immunol, Oviedo, Spain.	Anasua@Uniovi.Es	López, Patricia/B-8603-2018; Suarez, Ana/F-4492-2015	López, Patricia/0000-0002-1843-0653; Suarez, Ana/0000-0002-4452-7539; Alperi-Lopez, Mercedes/0000-0002-8727-0876; Rodriguez-Carrio, Javier/0000-0002-0011-5102; Prado, Catuxa/0000-0002-6630-4395	European Union FEDER funds; Fondo de Investigacion Sanitaria (FIS) [PI08/0570, PI12/0053]; FPU grant from the Ministerio de Educacion; FIS; FICYT	European Union FEDER funds(European Commission); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); FPU grant from the Ministerio de Educacion(German Research Foundation (DFG)); FIS(Instituto de Salud Carlos III); FICYT	This work was supported by European Union FEDER funds and the Fondo de Investigacion Sanitaria (FIS, PI08/0570 and PI12/0053). JRC is a recipient of a FPU grant from the Ministerio de Educacion. CP was supported by a fellowship from FIS and BdP was supported by a fellowship from FICYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allanore Y, 2007, CLIN EXP RHEUMATOL, V25, P60; Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Bauer JW, 2006, PLOS MED, V3, P2274, DOI 10.1371/journal.pmed.0030491; Cantaert T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3150; Cantaert T, 2010, RHEUMATOLOGY, V49, P156, DOI 10.1093/rheumatology/kep345; CUSH JJ, 1995, ARTHRITIS RHEUM-US, V38, P96, DOI 10.1002/art.1780380115; Deng XL, 2010, RHEUMATOL INT, V30, P1429, DOI 10.1007/s00296-009-1156-4; Denny MF, 2007, BLOOD, V110, P2907, DOI 10.1182/blood-2007-05-089086; Dessein PH, 2005, ARTHRITIS RES THER, V7, pR634, DOI 10.1186/ar1717; Distler JHW, 2009, ANN RHEUM DIS, V68, P163, DOI 10.1136/ard.2008.091918; Egan CG, 2008, RHEUMATOLOGY, V47, P1484, DOI 10.1093/rheumatology/ken299; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Friedrich EB, 2006, CIRC RES, V98, pE20, DOI 10.1161/01.RES.0000205765.28940.93; Full LE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2631; Gehling UM, 2000, BLOOD, V95, P3106; Grisar J, 2008, RHEUMATOLOGY, V47, P1476, DOI 10.1093/rheumatology/ken286; Grisar J, 2005, CIRCULATION, V111, P204, DOI 10.1161/01.CIR.0000151875.21836.AE; Hansel S, 2003, ATHEROSCLEROSIS, V170, P177, DOI 10.1016/S0021-9150(03)00281-8; Herbrig K, 2006, ANN RHEUM DIS, V65, P157, DOI 10.1136/ard.2005.035378; Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; HO KKL, 1993, J AM COLL CARDIOL  S, V22, P6; Jodon dV V, 2010, ARTHRITIS RES THER, V12, pR27, DOI [10.1186/ar2934, DOI 10.1186/AR2934]; Kaplan MJ, 2011, ARTHRITIS RHEUM-US, V63, P334, DOI 10.1002/art.30161; Kariuki SN, 2008, ARTHRITIS RHEUM, V58, P2818, DOI 10.1002/art.23728; Kerola AM, 2012, ANN RHEUM DIS, V71, P1606, DOI 10.1136/annrheumdis-2012-201334; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Kirou KA, 2013, ARTHRITIS RHEUM S, V54, P5807; KOBAYASHI T, 1992, INTERNAL MED, V31, P936, DOI 10.2169/internalmedicine.31.936; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Kuwata A, 2002, AM J MED SCI, V324, P331, DOI 10.1097/00000441-200212000-00008; Lacki JK, 1997, CLIN RHEUMATOL, V16, P275, DOI 10.1007/BF02238963; Lee PY, 2007, ARTHRITIS RHEUM-US, V56, P3759, DOI 10.1002/art.23035; Lopez P, 2008, J RHEUMATOL, V35, P1559; Malarstig A, 2008, HEART, V94, P724, DOI 10.1136/hrt.2007.119271; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Pompilio G, 2009, INT J CARDIOL, V131, P156, DOI 10.1016/j.ijcard.2008.08.033; Reynier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024828; Rodriguez-Carrio J, 2012, RHEUMATOLOGY, V51, P1775, DOI 10.1093/rheumatology/kes152; Rodriguez-Rodriguez L, 2011, ATHEROSCLEROSIS, V216, P125, DOI 10.1016/j.atherosclerosis.2010.10.052; Ronnblom L, 2011, UPSALA J MED SCI, V116, P227, DOI 10.3109/03009734.2011.624649; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Somers EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037000; Tan FK, 2006, RHEUMATOLOGY, V45, P694, DOI 10.1093/rheumatology/kei244; Thacker SG, 2012, ARTHRITIS RHEUM-US, V64, P2975, DOI 10.1002/art.34504; Thacker SG, 2010, J IMMUNOL, V185, P4457, DOI 10.4049/jimmunol.1001782; van Baarsen LGM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2912; van Gestel AM, 1999, J RHEUMATOL, V26, P705; Weckerle CE, 2012, ARTHRITIS RHEUM-US, V64, P2947, DOI 10.1002/art.34483; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; Yao YH, 2009, ARTHRITIS RHEUM, V60, P1785, DOI 10.1002/art.24557; Yiu KH, 2010, J RHEUMATOL, V37, P529, DOI 10.3899/jrheum.090782; Zhao W, 2009, ARTHRITIS RHEUM S10, V60, P582	55	32	33	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86069	10.1371/journal.pone.0086069	http://dx.doi.org/10.1371/journal.pone.0086069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465874	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500175
J	Thorolfsdottir, RB; Aspelund, T; Capewell, S; Critchley, J; Gudnason, V; Andersen, K				Thorolfsdottir, Rosa Bjoerk; Aspelund, Thor; Capewell, Simon; Critchley, Julia; Gudnason, Vilmundur; Andersen, Karl			Population Assessment of Future Trajectories in Coronary Heart Disease Mortality	PLOS ONE			English	Article							RISK-FACTORS; LIFE EXPECTANCY; YOUNG-ADULTS; DECLINE; ENGLAND; WALES; DECREASE; PROFILE; DEATHS; IMPACT	Background: Coronary heart disease (CHD) mortality rates have been decreasing in Iceland since the 1980s, largely reflecting improvements in cardiovascular risk factors. The purpose of this study was to predict future CHD mortality in Iceland based on potential risk factor trends. Methods and findings: The previously validated IMPACT model was used to predict changes in CHD mortality between 2010 and 2040 among the projected population of Iceland aged 25-74. Calculations were based on combining: i) data on population numbers and projections (Statistics Iceland), ii) population risk factor levels and projections (Refine Reykjavik study), and iii) effectiveness of specific risk factor reductions (published meta-analyses). Projections for three contrasting scenarios were compared: 1) If the historical risk factor trends of past 30 years were to continue, the declining death rates of past decades would level off, reflecting population ageing. 2) If recent trends in risk factors (past 5 years) continue, this would result in a death rate increasing from 49 to 70 per 100,000. This would reflect a recent plateau in previously falling cholesterol levels and recent rapid increases in obesity and diabetes prevalence. 3) Assuming that in 2040 the entire population enjoys optimal risk factor levels observed in low risk cohorts, this would prevent almost all premature CHD deaths before 2040. Conclusions: The potential increase in CHD deaths with recent trends in risk factor levels is alarming both for Iceland and probably for comparable Western populations. However, our results show considerable room for reducing CHD mortality. Achieving the best case scenario could eradicate premature CHD deaths by 2040. Public health policy interventions based on these predictions may provide a cost effective means of reducing CHD mortality in the future.	[Thorolfsdottir, Rosa Bjoerk; Aspelund, Thor; Gudnason, Vilmundur; Andersen, Karl] Iceland Heart Assoc, Kopavogur, Iceland; [Thorolfsdottir, Rosa Bjoerk; Aspelund, Thor; Gudnason, Vilmundur; Andersen, Karl] Univ Iceland, Reykjavik, Iceland; [Capewell, Simon] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England; [Critchley, Julia] Univ London, Dept Populat Hlth Sci & Educ, London, England	Icelandic Heart Association; University of Iceland; University of Liverpool; University of London	Andersen, K (corresponding author), Iceland Heart Assoc, Kopavogur, Iceland.	andersen@landspitali.is	Shao, Ruitai/AAU-7642-2021; Gudnason, Vilmundur/AAE-7126-2019; Aspelund, Thor/C-5983-2008	Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Critchley, Julia/0000-0002-5248-4188; Thorolfsdottir, Rosa B/0000-0001-7475-0398				Allender S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-148; Aspelund A, 2007, EUROPEAN SOC CARDIOL, V14, P761; Aspelund T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013957; Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136; Bennett K, 2006, J EPIDEMIOL COMMUN H, V60, P322, DOI 10.1136/jech.2005.038638; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Bruthans J, 2014, EUR J PREV CARDIOL, V21, P829, DOI 10.1177/2047487312469476; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2006, HEART, V92, P521, DOI 10.1136/hrt.2004.053645; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Critchley JA, 2003, J EPIDEMIOL COMMUN H, V57, P243, DOI 10.1136/jech.57.4.243; Critchley JA, 2002, EUR HEART J, V23, P110, DOI 10.1053/euhj.2001.2681; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P1588, DOI 10.1001/jama.292.13.1588; Emberson J, 2004, EUR HEART J, V25, P484, DOI 10.1016/j.ehj.2003.11.012; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Hughes J, 2013, EUR J PREV CARDIOL, V20, P310, DOI 10.1177/2047487312441725; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; O'Flaherty M, 2012, INT J CARDIOL, V158, P193, DOI 10.1016/j.ijcard.2011.01.016; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Statistics-Iceland, 2011, BIRTHS DEATHS; Thorsson B, 2013, EUR HEART J, V34, P1778, DOI 10.1093/eurheartj/ehs395; Unal B, 2005, J CLIN EPIDEMIOL, V58, P733, DOI 10.1016/j.jclinepi.2004.09.015; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; World Health Organization, 2012, REV WHO DISC PAP DEV; World Health Organization, 2011, LEAD CAUS DEATHS 200; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	34	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85800	10.1371/journal.pone.0085800	http://dx.doi.org/10.1371/journal.pone.0085800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465713	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500115
J	Kojima, R; Ohno, T; Iikura, M; Niki, T; Hirashima, M; Iwaya, K; Tsuda, H; Nonoyama, S; Matsuda, A; Saito, H; Matsumoto, K; Nakae, S				Kojima, Reiji; Ohno, Tatsukuni; Iikura, Motoyasu; Niki, Toshiro; Hirashima, Mitsuomi; Iwaya, Keichi; Tsuda, Hitoshi; Nonoyama, Shigeaki; Matsuda, Akio; Saito, Hirohisa; Matsumoto, Kenji; Nakae, Susumu			Galectin-9 Enhances Cytokine Secretion, but Suppresses Survival and Degranulation, in Human Mast Cell Line	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; DENDRITIC CELLS; MELANOMA-CELLS; BINDING LECTIN; MURINE MODEL; T-CELLS; TIM-3; APOPTOSIS; DISEASE; IL-33	Galectin-9 (Gal-9), a lectin having a beta-galactoside-binding domain, can induce apoptosis of Th1 cells by binding to TIM-3. In addition, Gal-9 inhibits IgE/Ag-mediated degranulation of mast cell/basophilic cell lines by binding to IgE, thus blocking IgE/ Ag complex formation. However, the role of Gal-9 in mast cell function in the absence of IgE is not fully understood. Here, we found that recombinant Gal-9 directly induced phosphorylation of Erk1/2 but not p38 MAPK in a human mast cell line, HMC-1, which does not express Fc epsilon RI. Gal-9 induced apoptosis and inhibited PMA/ionomycin-mediated degranulation of HMC-1 cells. On the other hand, Gal-9 induced cytokine and/or chemokine production by HMC-1 cells, dependent on activation of ERK1/2 but not p38 MAPK. In addition, the lectin activity of Gal-9 was required for Gal-9-mediated cytokine secretion by HMC-1 cells. These observations suggest that Gal-9 has dual properties as both a regulator and an activator of mast cells.	[Kojima, Reiji; Iwaya, Keichi; Tsuda, Hitoshi] Natl Def Med Coll, Dept Basic Pathol, Saitama, Japan; [Kojima, Reiji; Nonoyama, Shigeaki] Natl Def Med Coll, Dept Pediat, Saitama, Japan; [Kojima, Reiji; Ohno, Tatsukuni; Matsuda, Akio; Saito, Hirohisa; Matsumoto, Kenji; Nakae, Susumu] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Iikura, Motoyasu] Natl Ctr Global Hlth & Med, Dept Resp Med, Tokyo, Japan; [Niki, Toshiro; Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunol, Takamatsu, Kagawa 760, Japan; [Niki, Toshiro; Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunopathol, Takamatsu, Kagawa 760, Japan; [Niki, Toshiro; Hirashima, Mitsuomi] GalPharma Co, Res Ctr, Takamatsu, Kagawa, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo, Japan; [Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan; National Center for Child Health & Development - Japan; National Center for Global Health & Medicine - Japan; Kagawa University; Kagawa University; University of Tokyo; Japan Science & Technology Agency (JST)	Nakae, S (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan.	snakae@ims.u-tokyo.ac.jp		Saito, Hirohisa/0000-0002-6630-8337	Ministry of Education, Culture, Sports, Science and Technology, Japan; Program for Improvement of Research Environments for Young Researchers; Special Coordination Funds for Promoting Science and Technology; PRESTO from the Japan Science and Technology Agency; Japanese Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research [23390262] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Improvement of Research Environments for Young Researchers; Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO from the Japan Science and Technology Agency; Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Young Scientists (B) (T.O.), Scientific Research (C) (M.I.) and Scientific Research (B) (H.S. and K.M.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, by the Program for Improvement of Research Environments for Young Researchers, The Special Coordination Funds for Promoting Science and Technology (S.N.), PRESTO from the Japan Science and Technology Agency, (S.N.), and by Grants-in-Aid from the Japanese Ministry of Health, Labour and Welfare (H.S. and K.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Barlow JL, 2011, CLIN EXP ALLERGY, V41, P1012, DOI 10.1111/j.1365-2222.2011.03728.x; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Dai SY, 2005, J IMMUNOL, V175, P2974, DOI 10.4049/jimmunol.175.5.2974; Hirashima M, 2002, GLYCOCONJUGATE J, V19, P593, DOI 10.1023/B:GLYC.0000014090.63206.2f; Hirofumi A, 2002, J IMMUNOL, V169, P5912, DOI 10.4049/jimmunol.169.10.5912; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Irie A, 2005, CLIN CANCER RES, V11, P2962, DOI 10.1158/1078-0432.CCR-04-0861; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Kearley J, 2007, J EXP MED, V204, P1289, DOI 10.1084/jem.20062093; Liu Y, 2010, CLIN IMMUNOL, V137, P288, DOI 10.1016/j.clim.2010.07.012; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Matsumoto R, 2002, J IMMUNOL, V168, P1961, DOI 10.4049/jimmunol.168.4.1961; Matsushita N, 2000, J BIOL CHEM, V275, P8355, DOI 10.1074/jbc.275.12.8355; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Nakae S, 2007, BLOOD, V110, P2565, DOI 10.1182/blood-2006-11-058800; Nakae S, 2007, J LEUKOCYTE BIOL, V81, P1258, DOI 10.1189/jlb.1006610; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Niki T, 2009, J BIOL CHEM, V284, P32344, DOI 10.1074/jbc.M109.035196; Nobumoto A, 2009, CLIN IMMUNOL, V130, P322, DOI 10.1016/j.clim.2008.09.014; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Sziksz E, 2010, INT ARCH ALLERGY IMM, V151, P308, DOI 10.1159/000250439; Tang ZH, 2013, J IMMUNOL, V190, P1788, DOI 10.4049/jimmunol.1202814; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wiener Z, 2007, J INVEST DERMATOL, V127, P906, DOI 10.1038/sj.jid.5700616; Wiersma VR, 2012, J INVEST DERMATOL, V132, P2302, DOI 10.1038/jid.2012.133; XIA HZ, 1995, J IMMUNOL, V154, P5472; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818; Yamamoto H, 2007, INT ARCH ALLERGY IMM, V143, P95, DOI 10.1159/000101414; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	37	20	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86106	10.1371/journal.pone.0086106	http://dx.doi.org/10.1371/journal.pone.0086106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465902	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500113
J	Paluzzi, JP; Vanderveken, M; O'Donnell, MJ				Paluzzi, Jean-Paul; Vanderveken, Mark; O'Donnell, Michael J.			The Heterodimeric Glycoprotein Hormone, GPA2/GPB5, Regulates Ion Transport across the Hindgut of the Adult Mosquito, Aedes aegypti	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; GENOMIC ORGANIZATION; MOLECULAR-CLONING; SWISS-MODEL; FUNCTIONAL-CHARACTERIZATION; DEVELOPMENTAL REGULATION; CHORIONIC-GONADOTROPIN; EXPRESSION ANALYSIS; RECEPTOR; PROTEIN	A family of evolutionarily old hormones is the glycoprotein cysteine knot-forming heterodimers consisting of alpha- (GPA) and beta-subunits (GPB), which assemble by noncovalent bonds. In mammals, a common glycoprotein hormone alpha-subunit (GPA1) pairs with unique beta-subunits that establish receptor specificity, forming thyroid stimulating hormone (GPA1/TSH beta) and the gonadotropins luteinizing hormone (GPA1/LH beta), follicle stimulating hormone (GPA1/FSH beta), choriogonadotropin (GPA1/CG beta). A novel glycoprotein heterodimer was identified in vertebrates by genome analysis, called thyrostimulin, composed of two novel subunits, GPA2 and GPB5, and homologs occur in arthropods, nematodes and cnidarians, implying that this neurohormone system existed prior to the emergence of bilateral metazoans. In order to discern possible physiological roles of this hormonal signaling system in mosquitoes, we have isolated the glycoprotein hormone genes producing the alpha-and beta-subunits (AedaeGPA2 and AedaeGPB5) and assessed their temporal expression profiles in the yellow and dengue-fever vector, Aedes aegypti. We have also isolated a putative receptor for this novel mosquito hormone, AedaeLGR1, which contains features conserved with other glycoprotein leucine-rich repeating containing G protein-coupled receptors. AedaeLGR1 is expressed in tissues of the alimentary canal such as the midgut, Malpighian tubules and hindgut, suggesting that this novel mosquito glycoprotein hormone may regulate ionic and osmotic balance. Focusing on the hindgut in adult stage A. aegypti, where AedaeLGR1 was highly enriched, we utilized the Scanning Ion-selective Electrode Technique (SIET) to determine if AedaeGPA2/GPB5 modulated cation transport across this epithelial tissue. Our results suggest that AedaeGPA2/GPB5 does indeed participate in ionic and osmotic balance, since it appears to inhibit natriuresis and promote kaliuresis. Taken together, our findings imply this hormone may play an important role in ionic balance when levels of Na+ are limited and levels of K+ are in excess - such as during the digestion and assimilation of erythrocytes following vertebrate blood-feeding by females.	[Paluzzi, Jean-Paul] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Paluzzi, Jean-Paul; Vanderveken, Mark; O'Donnell, Michael J.] McMaster Univ, Dept Biol, Hamilton, ON, Canada	York University - Canada; McMaster University	Paluzzi, JP (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	paluzzi@yorku.ca		Paluzzi, Jean-Paul/0000-0002-7761-0590	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported through an NSERC postdoctoral fellowship to J.P.P. and an NSERC Discovery Grant and Discovery Accelerator Supplement to MJO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMANN D, 1987, NEUROSCI LETT, V74, P221, DOI 10.1016/0304-3940(87)90153-4; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruysters M, 2008, J BIOL CHEM, V283, P25821, DOI 10.1074/jbc.M804395200; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Eriksen KK, 2000, GENOME RES, V10, P924, DOI 10.1101/gr.10.7.924; Fan QR, 2007, MOL CELL ENDOCRINOL, V260, P73, DOI 10.1016/j.mce.2005.12.055; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FRAENKEL G, 1963, SCIENCE, V141, P1057, DOI 10.1126/science.141.3585.1057; FRAENKEL G, 1962, SCIENCE, V138, P27, DOI 10.1126/science.138.3536.27; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hauser F, 1997, J BIOL CHEM, V272, P1002, DOI 10.1074/jbc.272.2.1002; Hsu SY, 2002, MOL ENDOCRINOL, V16, P1538, DOI 10.1210/me.16.7.1538; Jayakannan M, 2011, J PLANT PHYSIOL, V168, P1045, DOI 10.1016/j.jplph.2010.12.006; JIA XC, 1991, MOL ENDOCRINOL, V5, P759, DOI 10.1210/mend-5-6-759; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Lide D. R., 2002, HDB CHEM PHYS; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Mendive FM, 2005, FEBS LETT, V579, P2171, DOI 10.1016/j.febslet.2005.03.006; Messerli MA, 2008, ANAL BIOANAL CHEM, V390, P1355, DOI 10.1007/s00216-007-1804-z; MISRAHI M, 1990, BIOCHEM BIOPH RES CO, V166, P394, DOI 10.1016/0006-291X(90)91958-U; Mueller S, 2010, TRENDS ENDOCRIN MET, V21, P111, DOI 10.1016/j.tem.2009.09.001; NAGAYAMA Y, 1989, BIOCHEM BIOPH RES CO, V165, P1184, DOI 10.1016/0006-291X(89)92727-7; Naikkhwah W, 2012, J EXP BIOL, V215, P461, DOI 10.1242/jeb.064048; Nakabayashi K, 2003, MOL CELL ENDOCRINOL, V202, P139, DOI 10.1016/S0303-7207(03)00075-3; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Nishi S, 2000, ENDOCRINOLOGY, V141, P4081, DOI 10.1210/en.141.11.4081; Oishi A, 2009, GENES CELLS, V14, P1141, DOI 10.1111/j.1365-2443.2009.01341.x; Paluzzi JP, 2012, MOL CELL ENDOCRINOL, V363, P36, DOI 10.1016/j.mce.2012.07.007; Paluzzi JP, 2010, P NATL ACAD SCI USA, V107, P10290, DOI 10.1073/pnas.1003666107; Paluzzi JPV, 2012, PEPTIDES, V34, P127, DOI 10.1016/j.peptides.2011.10.025; Patrick ML, 2006, J EXP BIOL, V209, P4638, DOI 10.1242/jeb.02551; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Phillips JE, 1995, AM ZOOL, V35, P503; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Royer J, 2008, ENDOCRINOLOGY, V149, P5088, DOI 10.1210/en.2008-0423; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sellami A, 2011, GEN COMP ENDOCR, V170, P582, DOI 10.1016/j.ygcen.2010.11.015; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; SPRING JH, 1980, J EXP BIOL, V86, P225; Sudo S, 2005, ENDOCRINOLOGY, V146, P3596, DOI 10.1210/en.2005-0317; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas RC, 1978, ION SENSITIVE INTRAC; TILLY JL, 1992, ENDOCRINOLOGY, V131, P799, DOI 10.1210/en.131.2.799; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vibede N, 1998, BIOCHEM BIOPH RES CO, V252, P497, DOI 10.1006/bbrc.1998.9661; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; WILLIAMS JC, 1983, J COMP PHYSIOL, V153, P257, DOI 10.1007/BF00689629; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906	56	47	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86386	10.1371/journal.pone.0086386	http://dx.doi.org/10.1371/journal.pone.0086386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24466069	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500131
J	Sepulveda, MA; Singer, RS; Silva-Rodriguez, E; Stowhas, P; Pelican, K				Sepulveda, Maximiliano A.; Singer, Randall S.; Silva-Rodriguez, Eduardo; Stowhas, Paulina; Pelican, Katharine			Domestic Dogs in Rural Communities around Protected Areas: Conservation Problem or Conflict Solution?	PLOS ONE			English	Article							LIVESTOCK; PREDATION; WILDLIFE; POPULATION; RABIES; SHEEP; CARNIVORES; DEMOGRAPHY; LANDSCAPE; ECOLOGY	Although domestic dogs play many important roles in rural households, they can also be an important threat to the conservation of wild vertebrates due to predation, competition and transmission of infectious diseases. An increasing number of studies have addressed the impact of dogs on wildlife but have tended to ignore the motivations and attitudes of the humans who keep these dogs and how the function of dogs might influence dog-wildlife interactions. To determine whether the function of domestic dogs in rural communities influences their interactions with wildlife, we conducted surveys in rural areas surrounding protected lands in the Valdivian Temperate Forests of Chile. Sixty percent of farm animal owners reported the use of dogs as one of the primary means of protecting livestock from predators. The probability of dog-wild carnivore interactions was significantly associated with the raising of poultry. In contrast, dog-wild prey interactions were not associated with livestock presence but had a significant association with poor quality diet as observed in previous studies. Dog owners reported that they actively encouraged the dogs to chase off predators, accounting for 25-75% of the dog-wild carnivore interactions observed, depending on the predator species. Humans controlled the dog population by killing pups and unwanted individuals resulting in few additions to the dog population through breeding; the importation of predominantly male dogs from urban areas resulted in a sex ratios highly dominated by males. These results indicate that dog interactions with wildlife are related to the role of the dog in the household and are directly influenced by their owners. To avoid conflict with local communities in conservation areas, it is important to develop strategies for managing dogs that balance conservation needs with the roles that dogs play in these rural households.	[Sepulveda, Maximiliano A.; Singer, Randall S.; Pelican, Katharine] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Singer, Randall S.] Univ Austral Chile, Fac Ciencias Vet, Inst Med Prevent Vet, Valdivia, Chile; [Silva-Rodriguez, Eduardo] Univ Andres Bello, Fac Ecol & Recursos Nat, Dept Ecol & Biodiversidad, Santiago, Chile; [Stowhas, Paulina] Univ Mayor, Fac Ciencias Vet & Pecuarias, Santiago, Chile	University of Minnesota System; University of Minnesota Twin Cities; Universidad Austral de Chile; Universidad Andres Bello; Universidad Mayor	Sepulveda, MA (corresponding author), Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA.	maximiliano.sepulveda@gmail.com	Silva-Rodriguez, Eduardo A./B-1854-2010	Silva-Rodriguez, Eduardo A./0000-0001-9416-8653; Sepulveda, Maximiliano/0000-0003-4295-7890	Morris Animal Foundation [D10ZO-057]; Panthera Foundation; University of Minnesota	Morris Animal Foundation; Panthera Foundation; University of Minnesota(University of Minnesota System)	Funding for this study was provided by the Morris Animal Foundation (award number D10ZO-057; www.morrisanimalfoundation.org), Panthera Foundation (www.panthera.org) and the University of Minnesota Grant-in-Aid program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Jamett G, 2010, PREV VET MED, V94, P272, DOI 10.1016/j.prevetmed.2010.01.002; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Alexander KA, 2010, FRONT ECOL ENVIRON, V8, P522, DOI 10.1890/090057; Andelt WF, 2000, J RANGE MANAGE, V53, P259, DOI 10.2307/4003429; ANDELT WF, 1992, WILDLIFE SOC B, V20, P55; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Ciucci P, 1998, WILDLIFE SOC B, V26, P504; CODEFF, 2002, PLAN MAN AR SILV PRI; Davlin SL, 2012, VACCINE, V30, P3492, DOI 10.1016/j.vaccine.2012.03.069; Delgado C., 2010, PLAN MANEJO RESERVA; Farias AA, 2014, REV CHIL HIST NAT, V87, DOI 10.1186/0717-6317-87-3; Fiorello C. V, 2004, THESIS; Flores-Ibarra M, 2004, PREV VET MED, V62, P79, DOI 10.1016/j.prevetmed.2003.10.002; Gehring TM, 2010, WILDLIFE RES, V37, P715, DOI 10.1071/WR10023; Gehring TM, 2010, BIOSCIENCE, V60, P299, DOI 10.1525/bio.2010.60.4.8; GONZALEZ A, 2012, HUMAN WILDLIFE INTER, V6, P134; Grimes DA, 2008, OBSTET GYNECOL, V111, P423, DOI 10.1097/01.AOG.0000297304.32187.5d; Hart Benjamin L., 1995, P65; Hosmer DW, 1997, STAT MED, V16, P965; Hughes J, 2013, BIOL CONSERV, V157, P341, DOI 10.1016/j.biocon.2012.07.005; Instituto Nacional de Estadisticas, 2011, ENC GAN OV; IUCN, 2013, IUCN RES LIST THREAT, DOI [10.2305/IUCN.UK.2013-2. RLTS.T56270A18388729.en, DOI 10.2305/IUCN.UK.2013-2.RLTS.T56270A18388729.EN]; Koster J, 2008, ENVIRON CONSERV, V35, P211, DOI 10.1017/S0376892908005055; Luebert F, 2005, HIST BIODIVERSIDAD E, P61; Matter HC, 2000, ACTA TROP, V75, P95, DOI 10.1016/S0001-706X(99)00085-6; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ratsitorahina M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-21; Rigg R., 2001, 1 IUCNSSC CAN SPEC G; SCHAEFER JM, 1981, J WILDLIFE MANAGE, V45, P883, DOI 10.2307/3808097; Sepulveda M, 2013, THESIS U MINNESOTA; Silva-Rodriguez EA, 2012, BIOL CONSERV, V150, P103, DOI 10.1016/j.biocon.2012.03.008; Silva-Rodriguez EA, 2011, CONSERV BIOL, V25, P808, DOI 10.1111/j.1523-1739.2011.01690.x; Silva-Rodriguez EA, 2010, AUSTRAL ECOL, V35, P765, DOI 10.1111/j.1442-9993.2009.02083.x; Stowhas P, 2012, THESIS U MAYOR SANTI; Sundqvist AK, 2008, CONSERV GENET, V9, P1275, DOI 10.1007/s10592-007-9454-4; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Taborsky M., 1988, Notornis, V35, P197; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; Vila C, 1999, J HERED, V90, P71, DOI 10.1093/jhered/90.1.71; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Woodroffe R, 2011, J APPL ECOL, V48, P1345, DOI 10.1111/j.1365-2664.2011.02059.x; Young JK, 2011, BIOSCIENCE, V61, P125, DOI 10.1525/bio.2011.61.2.7	43	52	55	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86152	10.1371/journal.pone.0086152	http://dx.doi.org/10.1371/journal.pone.0086152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465930	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500117
J	Chen, T; Zhou, T; He, B; Yu, HY; Guo, XJ; Song, XF; Sha, JH				Chen, Tong; Zhou, Tao; He, Bing; Yu, Haiyan; Guo, Xuejiang; Song, Xiaofeng; Sha, Jiahao			mUbiSiDa: A Comprehensive Database for Protein Ubiquitination Sites in Mammals	PLOS ONE			English	Article							PROTEOMICS APPROACH; IDENTIFICATION; SYSTEM; CELLS; DEGRADATION; CROSSTALK	Motivation: Protein ubiquitination is one of the important post-translational modifications by attaching ubiquitin to specific lysine (K) residues in target proteins, and plays important regulatory roles in many cell processes. Recent studies indicated that abnormal protein ubiquitination have been implicated in many diseases by degradation of many key regulatory proteins including tumor suppressor, oncoprotein, and cell cycle regulator. The detailed information of protein ubiquitination sites is useful for scientists to investigate the mechanism of many cell activities and related diseases. Results: In this study we established mUbiSida for mammalian Ubiquitination Site Database, which provides a scientific community with a comprehensive, freely and high-quality accessible resource of mammalian protein ubiquitination sites. In mUbiSida, we deposited about 35,494 experimentally validated ubiquitinated proteins with 110,976 ubiquitination sites from five species. The mUbiSiDa can also provide blast function to predict novel protein ubiquitination sites in other species by blast the query sequence in the deposit sequences in mUbiSiDa. The mUbiSiDa was designed to be a widely used tool for biologists and biomedical researchers with a user-friendly interface, and facilitate the further research of protein ubiquitination, biological networks and functional proteomics. The mUbiSiDa database is freely available at http://reprod.njmu.edu.cn/mUbiSiDa.	[Chen, Tong; He, Bing; Yu, Haiyan; Song, Xiaofeng] Nanjing Univ Aeronaut & Astronaut, Dept Biomed Engn, Nanjing, Jiangsu, Peoples R China; [Zhou, Tao; Guo, Xuejiang; Sha, Jiahao] Nanjing Med Univ, State Key Lab Reprod Med, Dept Histol & Embryol, Nanjing, Jiangsu, Peoples R China	Nanjing University of Aeronautics & Astronautics; Nanjing Medical University	Guo, XJ (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Dept Histol & Embryol, Nanjing, Jiangsu, Peoples R China.	guo_xuejiang@njmu.edu.cn; xfsong@nuaa.edu.cn	Zhou, Tao/H-1094-2013; Guo, Xuejiang/J-9600-2014	Zhou, Tao/0000-0003-2219-6385; Guo, Xuejiang/0000-0002-0475-5705	National Key Basic Research Program Grant [2011CB944304]; National Natural Science Foundation of China [81222006, 61171191]; Natural Science Foundation of Jiangsu Province in China [BK2010500]	National Key Basic Research Program Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province in China(Natural Science Foundation of Jiangsu Province)	The study was supported by grants from National Key Basic Research Program Grant (2011CB944304), National Natural Science Foundation of China (81222006, 61171191) and Natural Science Foundation of Jiangsu Province in China (BK2010500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chernorudskiy AL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-126; Ciechanover A, 2000, J CELL BIOCHEM, P40; Denis NJ, 2007, PROTEOMICS, V7, P868, DOI 10.1002/pmic.200600410; Du YP, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar055; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Hagai T, 2012, MOL BIOSYST, V8, P1865, DOI 10.1039/c2mb25052g; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jeon HB, 2007, BIOCHEM BIOPH RES CO, V357, P731, DOI 10.1016/j.bbrc.2007.04.015; Kirkpatrick DS, 2005, PROTEOMICS, V5, P2104, DOI 10.1002/pmic.200401089; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Na CH, 2012, J PROTEOME RES, V11, P4722, DOI 10.1021/pr300536k; Oshikawa K, 2012, J PROTEOME RES, V11, P796, DOI 10.1021/pr200668y; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Sorokin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1411, DOI 10.1134/S000629790913001X; Tan FW, 2008, PROTEOMICS, V8, P2885, DOI 10.1002/pmic.200700887; Vasilescu J, 2005, J PROTEOME RES, V4, P2192, DOI 10.1021/pr050265i; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002	27	47	48	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85744	10.1371/journal.pone.0085744	http://dx.doi.org/10.1371/journal.pone.0085744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465676	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000058
J	Do, JS; Weigel, KM; Meschke, JS; Cangelosi, GA				Do, Julie S.; Weigel, Kris M.; Meschke, John S.; Cangelosi, Gerard A.			Biosynthetic Enhancement of the Detection of Bacteria by the Polymerase Chain Reaction	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; ESCHERICHIA-COLI; WASTE-WATER; MYCOBACTERIUM-TUBERCULOSIS; RAPID DETECTION; CELLS; PCR; ACINETOBACTER; VIABILITY	Molecular viability testing (MVT) was previously reported to specifically detect viable bacterial cells in complex samples. In MVT, brief nutritional stimulation induces viable cells, but not non-viable cells, to produce abundant amounts of species-specific ribosomal RNA precursors (pre-rRNA). Quantitative polymerase chain reaction (qPCR) is used to quantify specific pre-rRNAs in a stimulated aliquot relative to a non-stimulated control. In addition to excluding background signal from nonviable cells and from free DNA, we report here that MVT increases the analytical sensitivity of qPCR when detecting viable cells. Side-by-side limit-of-detection comparisons showed that MVT is 5-fold to >10-fold more sensitive than standard (static) DNA-targeted qPCR when detecting diverse bacterial pathogens (Aeromonas hydrophila, Acinetobacter baumannii, Listeria monocytogenes, Mycobacterium avium, and Staphylococcus aureus) in serum, milk, and tap water. Sensitivity enhancement may come from the elevated copy number of pre-rRNA relative to genomic DNA, and also from the ratiometric measurement which reduces ambiguity associated with weak or borderline signals. We also report that MVT eliminates false positive signals from bacteria that have been inactivated by moderately elevated temperatures (pasteurization), a condition that can confound widely-used cellular integrity tests that utilize membrane-impermeant compounds such as propidium iodide (PI) or propidium monoazide (PMA) to differentiate viable from inactivated bacteria. MVT enables the sensitive and specific detection of very small numbers of viable bacteria in complex matrices.	[Do, Julie S.] AttoDx Inc, Seattle, WA USA; [Weigel, Kris M.; Meschke, John S.; Cangelosi, Gerard A.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Cangelosi, GA (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	gcang@uw.edu		Weigel, Kris/0000-0003-3199-2148	NIDCR from the National Institutes of Health [R21DE021510]; Life Sciences Discovery Fund [7205249]; AttoDx, Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021510] Funding Source: NIH RePORTER	NIDCR from the National Institutes of Health; Life Sciences Discovery Fund; AttoDx, Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded in part by NIDCR grant #R21DE021510 from the National Institutes of Health, grant #7205249 from the Life Sciences Discovery Fund, and by AttoDx, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, with one exception: AttoDx, Inc., supported work done by its employee, Julie Do.	Cangelosi GA, 1997, J BACTERIOL, V179, P4457, DOI 10.1128/jb.179.14.4457-4463.1997; Cangelosi GA, 1997, APPL ENVIRON MICROB, V63, P4859, DOI 10.1128/AEM.63.12.4859-4865.1997; Cangelosi GA, 2010, APPL ENVIRON MICROB, V76, P960, DOI 10.1128/AEM.01810-09; Davey HM, 2011, APPL ENVIRON MICROB, V77, P5571, DOI 10.1128/AEM.00744-11; Gyorke CE, 2013, J CLIN MICROBIOL, V51, P278, DOI 10.1128/JCM.02120-12; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Lisle JT, 1999, LETT APPL MICROBIOL, V29, P42, DOI 10.1046/j.1365-2672.1999.00572.x; Lovdal T, 2011, J MICROBIOL METH, V85, P164, DOI 10.1016/j.mimet.2011.01.027; MACKOW ER, 1985, FEBS LETT, V182, P407, DOI 10.1016/0014-5793(85)80343-4; Nanassy OZ, 2011, J CLIN MICROBIOL, V49, P1010, DOI 10.1128/JCM.01132-10; Nkuipou-Kenfack E, 2013, J MICROBIOL METH, V93, P20, DOI 10.1016/j.mimet.2013.01.018; Nocker A, 2009, FEMS MICROBIOL LETT, V291, P137, DOI 10.1111/j.1574-6968.2008.01429.x; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Oerther DB, 2002, WATER SCI TECHNOL, V46, P443, DOI 10.2166/wst.2002.0514; Oerther DB, 2000, APPL ENVIRON MICROB, V66, P2154, DOI 10.1128/AEM.66.5.2154-2165.2000; Rossney AS, 2008, J CLIN MICROBIOL, V46, P3285, DOI 10.1128/JCM.02487-07; Shu ZQ, 2012, J CLIN MICROBIOL, V50, P3575, DOI 10.1128/JCM.00896-12; SRIVASTAVA AK, 1990, ANNU REV MICROBIOL, V44, P105, DOI 10.1146/annurev.mi.44.100190.000541; Stroot PG, 2003, WATER SCI TECHNOL, V47, P241, DOI 10.2166/wst.2003.0611; Van Kessel JS, 2004, J DAIRY SCI, V87, P2822, DOI 10.3168/jds.S0022-0302(04)73410-4; Weigel KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054886; Yang XQ, 2011, FOOD MICROBIOL, V28, P1478, DOI 10.1016/j.fm.2011.08.013	22	5	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86433	10.1371/journal.pone.0086433	http://dx.doi.org/10.1371/journal.pone.0086433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24466092	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000100
J	Huang, GY; Xu, JJ; Xu, L; Wang, SF; Li, RP; Liu, K; Zheng, J; Cai, ZY; Zhang, K; Luo, YD; Xu, WG				Huang, Guoyang; Xu, Jiajun; Xu, Li; Wang, Shifeng; Li, Runping; Liu, Kan; Zheng, Juan; Cai, Zhiyu; Zhang, Kun; Luo, Yuandeng; Xu, Weigang			Hyperbaric Oxygen Preconditioning Induces Tolerance against Oxidative Injury and Oxygen-Glucose Deprivation by Up-Regulating Heat Shock Protein 32 in Rat Spinal Neurons	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; CORD-INJURY; INCREASED EXPRESSION; HEME OXYGENASE-1; HEAT-SHOCK-PROTEIN-70; ANTIOXIDANT; REPAIR	Objective: Hyperbaric oxygen (HBO) preconditioning (HBO-PC) has been testified to have protective effects on spinal cord injury (SCI). However, the mechanisms remain enigmatic. The present study aimed to explore the effects of HBO-PC on primary rat spinal neurons against oxidative injury and oxygen-glucose deprivation (OGD) and the relationship with heat shock proteins (HSPs). Methods: Primary rat spinal neurons after 7 days of culture were used in this study. HSPs were detected in rat spinal neurons following a single exposure to HBO at different time points by Western blot. Using lactate dehydrogenase release assay and cell counting kit-8 assay, the injuries induced by hydrogen peroxide (H2O2) insult or OGD were determined and compared among neurons treated with HBO-PC with or without HSP inhibitors. Results: The results of Western blot showed that HSP27, HSP70 and HSP90 have a slight but not significant increase in primary neurons following HBO exposure. However, HSP32 expression significantly increased and reached highest at 12 h following HBO exposure. HBO-PC significantly increased the cell viability and decreased the medium lactate dehydrogenase content in cultures treated with H2O2 or OGD. Pretreatment with zinc protoporphyrin IX, a specific inhibitor of HSP32, significantly blocked the protective effects of HBO-PC. Conclusions: These results suggest that HBO-PC could protect rat spinal neurons in vitro against oxidative injury and OGD mostly by up-regulating of HSP32 expression.	[Huang, Guoyang; Xu, Jiajun; Xu, Li; Li, Runping; Liu, Kan; Zheng, Juan; Cai, Zhiyu; Zhang, Kun; Luo, Yuandeng; Xu, Weigang] Second Mil Med Univ, Fac Naval Med, Dept Diving & Hyperbar Med, Shanghai, Peoples R China; [Wang, Shifeng] Inst Naval Med, Shanghai, Peoples R China	Naval Medical University	Xu, WG (corresponding author), Second Mil Med Univ, Fac Naval Med, Dept Diving & Hyperbar Med, Shanghai, Peoples R China.	wgxu@hotmail.com	xu, wei/HHD-2891-2022		National Natural Science Foundation of China [81171873]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, No. 81171873. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Waili NS, 2005, ADV THER, V22, P659, DOI 10.1007/BF02849960; Baranano DE, 2000, J BIOL CHEM, V275, P15166, DOI 10.1074/jbc.275.20.15166; Blatteau JE, 2011, NEUROCRIT CARE, V15, P120, DOI 10.1007/s12028-010-9370-1; Chow AM, 2013, CELL STRESS CHAPERON, V18, P155, DOI 10.1007/s12192-012-0364-0; Coselli JS, 2007, ANN THORAC SURG, V83, pS862, DOI 10.1016/j.athoracsur.2006.10.088; Dong HL, 2002, ANESTHESIOLOGY, V96, P907, DOI 10.1097/00000542-200204000-00018; GRIM PS, 1990, JAMA-J AM MED ASSOC, V263, P2216; He XZ, 2011, J SURG RES, V170, pE271, DOI 10.1016/j.jss.2011.06.008; Jiang XY, 2006, J NEUROSCI METH, V158, P13, DOI 10.1016/j.jneumeth.2006.05.014; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Latchman DS, 2001, CARDIOVASC RES, V51, P637, DOI 10.1016/S0008-6363(01)00354-6; Li QB, 2007, LIFE SCI, V80, P1087, DOI 10.1016/j.lfs.2006.11.043; Liu Y, 2011, CLIN EXP PHARMACOL P, V38, P675, DOI 10.1111/j.1440-1681.2011.05560.x; Lu PG, 2012, NEUROL RES, V34, P944, DOI 10.1179/1743132812Y.0000000096; Macario AJL, 2007, FRONT BIOSCI-LANDMRK, V12, P2588, DOI 10.2741/2257; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1981, BIOCHIM BIOPHYS ACTA, V673, P339, DOI 10.1016/0304-4165(81)90465-7; Ni XX, 2013, EXP BIOL MED, V238, P12, DOI 10.1258/ebm.2012.012101; Nie H, 2006, J CEREBR BLOOD F MET, V26, P666, DOI 10.1038/sj.jcbfm.9600221; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Redaelli CA, 2001, TRANSPL INT, V14, P351, DOI 10.1007/s001470100000; Reddy SJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E4; Robinson MB, 2005, J NEUROSCI, V25, P9735, DOI 10.1523/JNEUROSCI.1912-05.2005; Shyu WC, 2004, CELL MOL NEUROBIOL, V24, P257, DOI 10.1023/B:CEMN.0000018620.41913.d2; Soejima Y, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-9; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tai PA, 2010, J NEUROTRAUM, V27, P1121, DOI 10.1089/neu.2009.1162; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Topuz K, 2010, ARCH MED RES, V41, P506, DOI 10.1016/j.arcmed.2010.10.004; Tsuchihashi Sei-ichiro, 2004, Ann Transplant, V9, P84; Verhoeven EL, 2009, EUR J VASC ENDOVASC, V38, P155, DOI 10.1016/j.ejvs.2009.05.002; Wang LP, 2009, J NEUROTRAUM, V26, P55, DOI 10.1089/neu.2008.0538; Zhang Q, 2010, NEUROL RES, V32, P852, DOI 10.1179/016164110X12556180206112	33	27	32	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85967	10.1371/journal.pone.0085967	http://dx.doi.org/10.1371/journal.pone.0085967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465817	gold, Green Submitted, Green Published			2022-12-25	WOS:000330237000080
J	Delgado-Silva, Y; Vaz, C; Carvalho-Pereira, J; Carneiro, C; Nogueira, E; Correia, A; Carreto, L; Silva, S; Faustino, A; Pais, C; Oliveira, R; Sampaio, P				Delgado-Silva, Yolanda; Vaz, Catarina; Carvalho-Pereira, Joana; Carneiro, Catarina; Nogueira, Eugenia; Correia, Alexandra; Carreto, Laura; Silva, Sonia; Faustino, Augusto; Pais, Celia; Oliveira, Rui; Sampaio, Paula			Participation of Candida albicans Transcription Factor RLM1 in Cell Wall Biogenesis and Virulence	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INTEGRITY SIGNALING PATHWAY; GENOME-WIDE ANALYSIS; SACCHAROMYCES-CEREVISIAE; CHITIN-SYNTHASE; C HOMOLOG; YEAST; GENE; STRAINS; MORPHOGENESIS	Candida albicans cell wall is important for growth and interaction with the environment. RLM1 is one of the putative transcription factors involved in the cell wall integrity pathway, which plays an important role in the maintenance of the cell wall integrity. In this work we investigated the involvement of RLM1 in the cell wall biogenesis and in virulence. Newly constructed C. albicans Delta/Delta rlm1 mutants showed typical cell wall weakening phenotypes, such as hypersensitivity to Congo Red, Calcofluor White, and caspofungin (phenotype reverted in the presence of sorbitol), confirming the involvement of RLM1 in the cell wall integrity. Additionally, the cell wall of C. albicans Delta/Delta rlm1 showed a significant increase in chitin (213%) and reduction in mannans (60%), in comparison with the wild-type, results that are consistent with cell wall remodelling. Microarray analysis in the absence of any stress showed that deletion of RLM1 in C. albicans significantly down-regulated genes involved in carbohydrate catabolism such as DAK2, GLK4, NHT1 and TPS1, up-regulated genes involved in the utilization of alternative carbon sources, like AGP2, SOU1, SAP6, CIT1 or GAL4, and genes involved in cell adhesion like ECE1, ALS1, ALS3, HWP1 or RBT1. In agreement with the microarray results adhesion assays showed an increased amount of adhering cells and total biomass in the mutant strain, in comparison with the wild-type. C. albicans mutant Delta/Delta rlm1 strain was also found to be less virulent than the wild-type and complemented strains in the murine model of disseminated candidiasis. Overall, we showed that in the absence of RLM1 the modifications in the cell wall composition alter yeast interaction with the environment, with consequences in adhesion ability and virulence. The gene expression findings suggest that this gene participates in the cell wall biogenesis, with the mutant rearranging its metabolic pathways to allow the use of alternative carbon sources.	[Delgado-Silva, Yolanda; Vaz, Catarina; Carvalho-Pereira, Joana; Carneiro, Catarina; Nogueira, Eugenia; Correia, Alexandra; Pais, Celia; Oliveira, Rui; Sampaio, Paula] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal; [Correia, Alexandra; Faustino, Augusto] Univ Porto, ICBAS UP Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Carreto, Laura] Univ Aveiro, Dept Biol, RNA Biol Lab, Aveiro, Portugal; [Carreto, Laura] Univ Aveiro, CESAM, Aveiro, Portugal; [Silva, Sonia] Univ Minho, Ctr Biol Engn, Inst Biotechnol & Bioengn, Braga, Portugal; [Faustino, Augusto] Univ Porto, ICBAS UP, Inst Ciencias Biomed Abel Salazar, Dept Patol & Imunol Mol, P-4100 Oporto, Portugal	Universidade do Minho; Universidade do Porto; Universidade de Aveiro; Universidade de Aveiro; Universidade do Minho; Universidade do Porto	Sampaio, P (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal.	psampaio@bio.uminho.pt	Correia, Alexandra/AID-6313-2022; Sampaio, Paula/I-7566-2015; Oliveira, Rui/K-7898-2013; Silva, Sónia/F-1190-2013; Pais, Célia/A-9186-2010; Nogueira, Eugénia/AAE-1766-2020; Nogueira, Eugénia/B-6052-2016; Correia, Alexandra/J-7926-2013	Correia, Alexandra/0000-0003-0408-6262; Sampaio, Paula/0000-0002-1415-4428; Oliveira, Rui/0000-0002-3989-8925; Silva, Sónia/0000-0003-0000-7387; Pais, Célia/0000-0001-5959-290X; Nogueira, Eugénia/0000-0001-8211-245X; Nogueira, Eugénia/0000-0001-8211-245X; Correia, Alexandra/0000-0003-0408-6262; Pereira, Joana/0000-0001-7813-8382; Vaz, Catarina/0000-0002-0174-9748	CBMA (Centre of Molecular and Environmental Biology) through FCT (Fundacao para a Ciencia e Tecnologia) [PEst-C/BIA/UI4050/2011]; ALbAN scholarship [E07D400922PE];  [SFRH/BD/31354/2006]	CBMA (Centre of Molecular and Environmental Biology) through FCT (Fundacao para a Ciencia e Tecnologia); ALbAN scholarship; 	This work was supported by CBMA (Centre of Molecular and Environmental Biology) through the FCT (Fundacao para a Ciencia e Tecnologia) project PEst-C/BIA/UI4050/2011. Yolanda Delgado-Silva was supported by an ALbAN scholarship (No E07D400922PE), and Alexandra Correia by SFRH/BD/31354/2006 fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2012, MICROBIOL-SGM, V158, P1258, DOI 10.1099/mic.0.057075-0; Askew C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000612; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Becerra M, 2011, GENOME, V54, P99, DOI 10.1139/G10-101; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Blankenship JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000752; Boorsma A, 2004, YEAST, V21, P413, DOI 10.1002/yea.1109; Bruno VM, 2006, PLOS PATHOG, V2, P204, DOI 10.1371/journal.ppat.0020021; Cantero PD, 2007, MOL MICROBIOL, V64, P1115, DOI 10.1111/j.1365-2958.2007.05723.x; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Castillo L, 2006, FUNGAL GENET BIOL, V43, P124, DOI 10.1016/j.fgb.2005.12.002; Correia A, 2010, INFECT IMMUN, V78, P4839, DOI 10.1128/IAI.00248-10; COSTIGAN C, 1994, MOL GEN GENET, V243, P286, DOI 10.1007/BF00301064; DiezOrejas R, 1997, INFECT IMMUN, V65, P833, DOI 10.1128/IAI.65.2.833-837.1997; Dodou E, 1997, MOL CELL BIOL, V17, P1848, DOI 10.1128/MCB.17.4.1848; Ernst JF, 2000, MICROBIOL-SGM, V146, P1763, DOI 10.1099/00221287-146-8-1763; Francois JM, 2006, NAT PROTOC, V1, P2995, DOI 10.1038/nprot.2006.457; Galan-Diez M, 2010, INFECT IMMUN, V78, P1426, DOI 10.1128/IAI.00989-09; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Gelis S, 2012, FUNGAL GENET BIOL, V49, P322, DOI 10.1016/j.fgb.2012.01.010; Herrero AB, 2004, EUKARYOT CELL, V3, P1423, DOI 10.1128/EC.3.6.1423-1432.2004; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kohler GA, 1997, J BACTERIOL, V179, P2331; Kusch H, 2008, INT J MED MICROBIOL, V298, P291, DOI 10.1016/j.ijmm.2007.03.020; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; LEE KS, 1992, MOL CELL BIOL, V12, P172, DOI 10.1128/MCB.12.1.172; Lenardon MD, 2009, MOL GENET GENOMICS, V281, P459, DOI 10.1007/s00438-009-0423-0; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; MARTIN H, 1993, MOL GEN GENET, V241, P177, DOI 10.1007/BF00280215; Martinez P, 2005, MOL CELL BIOL, V25, P9435, DOI 10.1128/MCB.25.21.9435-9446.2005; Martinez-Lopez R, 2004, MICROBIOL-SGM, V150, P3341, DOI 10.1099/mic.0.27320-0; MILLON L, 1994, J CLIN MICROBIOL, V32, P1115, DOI 10.1128/JCM.32.4.1115-1118.1994; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Navarro-Garcia F, 2005, MICROBIOL-SGM, V151, P2737, DOI 10.1099/mic.0.28038-0; Navarro-Garcia F, 1998, MICROBIOL-UK, V144, P411, DOI 10.1099/00221287-144-2-411; NAVARROGARCIA F, 1995, MOL CELL BIOL, V15, P2197; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Nett JE, 2011, EUKARYOT CELL, V10, P1660, DOI 10.1128/EC.05126-11; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Paravicini G, 1996, YEAST, V12, P741, DOI 10.1002/(SICI)1097-0061(19960630)12:8<741::AID-YEA967>3.0.CO;2-G; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; Reinoso-Martin C, 2003, EUKARYOT CELL, V2, P1200, DOI 10.1128/EC.2.6.1200-1210.2003; Reuss O, 2006, MOL MICROBIOL, V60, P795, DOI 10.1111/j.1365-2958.2006.05136.x; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Sampaio P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010155; Sanz M, 2005, MICROBIOL-SGM, V151, P2623, DOI 10.1099/mic.0.28093-0; Sasse C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025623; Selvaggini S, 2004, MICROBIOL-SGM, V150, P921, DOI 10.1099/mic.0.26661-0; Sen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002384; Silva S, 2009, MED MYCOL, V47, P681, DOI 10.3109/13693780802549594; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Tavares D, 2003, MICROBIOL-SGM, V149, P333, DOI 10.1099/mic.0.25915-0; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; Warenda AJ, 2003, INFECT IMMUN, V71, P4045, DOI 10.1128/IAI.71.7.4045-4051.2003; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615; Wolf JM, 2010, EUKARYOT CELL, V9, P1203, DOI 10.1128/EC.00056-10	62	47	50	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86270	10.1371/journal.pone.0086270	http://dx.doi.org/10.1371/journal.pone.0086270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466000	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000075
J	Card, RM; Warburton, PJ; MacLaren, N; Mullany, P; Allan, E; Anjum, MF				Card, Roderick M.; Warburton, Philip J.; MacLaren, Nikki; Mullany, Peter; Allan, Elaine; Anjum, Muna F.			Application of Microarray and Functional-Based Screening Methods for the Detection of Antimicrobial Resistance Genes in the Microbiomes of Healthy Humans	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; DIHYDROPTEROATE SYNTHASE; SULFONAMIDE RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; NEISSERIA-MENINGITIDIS; SEQUENCE; DNA; BACTERIA; SUSCEPTIBILITY	The aim of this study was to screen for the presence of antimicrobial resistance genes within the saliva and faecal microbiomes of healthy adult human volunteers from five European countries. Two non-culture based approaches were employed to obviate potential bias associated with difficult to culture members of the microbiota. In a gene target-based approach, a microarray was employed to screen for the presence of over 70 clinically important resistance genes in the saliva and faecal microbiomes. A total of 14 different resistance genes were detected encoding resistances to six antibiotic classes (aminoglycosides, beta-lactams, macrolides, sulphonamides, tetracyclines and trimethoprim). The most commonly detected genes were erm(B), bla(TEM), and sul2. In a functional-based approach, DNA prepared from pooled saliva samples was cloned into Escherichia coli and screened for expression of resistance to ampicillin or sulphonamide, two of the most common resistances found by array. The functional ampicillin resistance screen recovered genes encoding components of a predicted AcrRAB efflux pump. In the functional sulphonamide resistance screen, folP genes were recovered encoding mutant dihydropteroate synthase, the target of sulphonamide action. The genes recovered from the functional screens were from the chromosomes of commensal species that are opportunistically pathogenic and capable of exchanging DNA with related pathogenic species. Genes identified by microarray were not recovered in the activity-based screen, indicating that these two methods can be complementary in facilitating the identification of a range of resistance mechanisms present within the human microbiome. It also provides further evidence of the diverse reservoir of resistance mechanisms present in bacterial populations in the human gut and saliva. In future the methods described in this study can be used to monitor changes in the resistome in response to antibiotic therapy.	[Card, Roderick M.; MacLaren, Nikki; Anjum, Muna F.] Anim Hlth & Vet Labs Agcy, Dept Bacteriol, Addlestone, Surrey, England; [Warburton, Philip J.; Mullany, Peter; Allan, Elaine] UCL, Dept Microbial Dis, Eastman Dent Inst, London, England	Veterinary Laboratories Agency; University of London; University College London	Anjum, MF (corresponding author), Anim Hlth & Vet Labs Agcy, Dept Bacteriol, Addlestone, Surrey, England.	Muna.Anjum@ahvla.gsi.gov.uk	anjum, muna/C-5213-2011; Warburton, Philip/AAV-1606-2021	Warburton, Philip/0000-0002-5810-0296	European Community [241446]	European Community(European Commission)	This study has been carried out with financial support from the Commission of the European Communities, specifically the Infectious Diseases research domain of the Health theme of the 7th Framework Programme, contract 241446, "The effects of antibiotic administration on the emergence and persistence of antibiotic-resistant bacteria in humans and on the composition of the indigenous microbiotas at various body sites". Part of the work undertaken at AHVLA was funded by the Department for Innovation, University and Skills. Public Sector Research Exploitation Fund: fourth round, MicroArray (Capacity Building). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; Anjum MF, 2011, J ANTIMICROB CHEMOTH, V66, P550, DOI 10.1093/jac/dkq498; [Anonymous], 2012, BSAC METHODS ANTIMIC; ARTHUR M, 1987, ANTIMICROB AGENTS CH, V31, P404, DOI 10.1128/AAC.31.3.404; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bailey JK, 2010, J MED MICROBIOL, V59, P1331, DOI 10.1099/jmm.0.022475-0; Batchelor M, 2008, INT J ANTIMICROB AG, V31, P440, DOI 10.1016/j.ijantimicag.2007.11.017; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Card R, 2013, ANTIMICROB AGENTS CH, V57, P458, DOI 10.1128/AAC.01223-12; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; DANNER DB, 1982, P NATL ACAD SCI-BIOL, V79, P2393, DOI 10.1073/pnas.79.7.2393; Dastidar V, 2007, J BACTERIOL, V189, P5550, DOI 10.1128/JB.00471-07; Dean CR, 2005, ANTIMICROB AGENTS CH, V49, P3129, DOI 10.1128/AAC.49.8.3129-3135.2005; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diaz-Torres ML, 2003, ANTIMICROB AGENTS CH, V47, P1430, DOI 10.1128/AAC.47.4.1430-1432.2003; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Donato JJ, 2010, APPL ENVIRON MICROB, V76, P4396, DOI 10.1128/AEM.01763-09; Duffin PM, 2010, J BACTERIOL, V192, P4436, DOI 10.1128/JB.00442-10; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ellis RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054783; Fiebelkorn KR, 2005, ANTIMICROB AGENTS CH, V49, P536, DOI 10.1128/AAC.49.2.536-540.2005; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; Glad T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-10; Gronow S, 2010, STAND GENOMIC SCI, V2, P57, DOI 10.4056/sigs.521107; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Haasum Y, 2001, ANTIMICROB AGENTS CH, V45, P805, DOI 10.1128/AAC.45.3.805-809.2001; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jones YE, 2002, VET REC, V150, P649, DOI 10.1136/vr.150.21.649; Kaczmarek FS, 2004, ANTIMICROB AGENTS CH, V48, P1630, DOI 10.1128/AAC.48.5.1630-1639.2004; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kirchner M, 2013, ANAEROBE, V23, P20, DOI 10.1016/j.anaerobe.2013.07.011; LOPEZ P, 1987, J BACTERIOL, V169, P4320, DOI 10.1128/jb.169.9.4320-4326.1987; Pallecchi L, 2007, ANTIMICROB AGENTS CH, V51, P1179, DOI 10.1128/AAC.01101-06; Parsley LC, 2010, APPL ENVIRON MICROB, V76, P3753, DOI 10.1128/AEM.03080-09; Pehrsson EC, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00145; Penders J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00087; RADSTROM P, 1992, J BACTERIOL, V174, P6386; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Schmieder R, 2012, FUTURE MICROBIOL, V7, P73, DOI [10.2217/fmb.11.135, 10.2217/FMB.11.135]; Seville LA, 2009, MICROB DRUG RESIST, V15, P159, DOI 10.1089/mdr.2009.0916; Skold O, 2001, VET RES, V32, P261, DOI 10.1051/vetres:2001123; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Swedberg G, 1998, ANTIMICROB AGENTS CH, V42, P1062, DOI 10.1128/AAC.42.5.1062; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warburton P, 2009, ANTIMICROB AGENTS CH, V53, P273, DOI 10.1128/AAC.00788-08; Wright GD, 2010, EXPERT OPIN DRUG DIS, V5, P779, DOI 10.1517/17460441.2010.497535; WUST J, 1978, ANTIMICROB AGENTS CH, V14, P384, DOI 10.1128/AAC.14.3.384; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Zhang L, 2011, APPL ENVIRON MICROB, V77, P7134, DOI 10.1128/AEM.05087-11	55	39	39	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86428	10.1371/journal.pone.0086428	http://dx.doi.org/10.1371/journal.pone.0086428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466089	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000330283100162
J	Dray, MW; Crowther, TW; Thomas, SM; A'Bear, AD; Godbold, DL; Ormerod, SJ; Hartley, SE; Jones, TH				Dray, Matthew W.; Crowther, Thomas W.; Thomas, Stephen M.; A'Bear, A. Donald; Godbold, Douglas L.; Ormerod, Steve J.; Hartley, Susan E.; Jones, T. Hefin			Effects of Elevated CO2 on Litter Chemistry and Subsequent Invertebrate Detritivore Feeding Responses	PLOS ONE			English	Article							INCREASED ATMOSPHERIC CO2; LEAF-LITTER; DECOMPOSITION; QUALITY; DYNAMICS; TEMPERATURE; NITROGEN; GROWTH	Elevated atmospheric CO2 can change foliar tissue chemistry. This alters leaf litter palatability to macroinvertebrate detritivores with consequences for decomposition, nutrient turnover, and food-web structure. Currently there is no consensus on the link between CO2 enrichment, litter chemistry, and macroinvertebrate-mediated leaf decomposition. To identify any unifying mechanisms, we presented eight invertebrate species from aquatic and terrestrial ecosystems with litter from Alnus glutinosa (common alder) or Betula pendula (silver birch) trees propagated under ambient (380 ppm) or elevated (ambient + 200 ppm) CO2 concentrations. Alder litter was largely unaffected by CO2 enrichment, but birch litter from leaves grown under elevated CO2 had reduced nitrogen concentrations and greater C/N ratios. Invertebrates were provided individually with either (i) two litter discs, one of each CO2 treatment ('choice'), or (ii) one litter disc of each CO2 treatment alone ('no-choice'). Consumption was recorded. Only Odontocerum albicorne showed a feeding preference in the choice test, consuming more ambient-than elevated-CO2 birch litter. Species' responses to alder were highly idiosyncratic in the no-choice test: Gammarus pulex and O. albicorne consumed more elevated-CO2 than ambient-CO2 litter, indicating compensatory feeding, while Oniscus asellus consumed more of the ambient-CO2 litter. No species responded to CO2 treatment when fed birch litter. Overall, these results show how elevated atmospheric CO2 can alter litter chemistry, affecting invertebrate feeding behaviour in species-specific ways. The data highlight the need for greater species-level information when predicting changes to detrital processing-a key ecosystem function-under atmospheric change.	[Dray, Matthew W.; Crowther, Thomas W.; Thomas, Stephen M.; A'Bear, A. Donald; Ormerod, Steve J.; Jones, T. Hefin] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Crowther, Thomas W.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT USA; [Godbold, Douglas L.] Univ Nat Resources & Life Sci BOKU, Inst Forest Ecol, Vienna, Austria; [Hartley, Susan E.] Univ York, York Environm Sustainabil Inst, York YO10 5DD, N Yorkshire, England	Cardiff University; Yale University; University of Natural Resources & Life Sciences, Vienna; University of York - UK	Dray, MW (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	draymw@cardiff.ac.uk	Ormerod, Steve J/A-4326-2010	Ormerod, Steve J/0000-0002-8174-302X; Hartley, Sue/0000-0002-5117-687X; Jones, T Hefin/0000-0002-7874-3627; Crowther, Thomas/0000-0001-5674-8913	Cardiff University; Yale Climate and Energy Institute Fellowship; Knowledge Economy Skills Scholarship (KESS) studentship; Science Research Investment Fund (SRIF); Forestry Commission Wales; Centre for Integrated Research in the Rural Environment (CIRRE);  [NERC/I527861]	Cardiff University; Yale Climate and Energy Institute Fellowship; Knowledge Economy Skills Scholarship (KESS) studentship; Science Research Investment Fund (SRIF); Forestry Commission Wales; Centre for Integrated Research in the Rural Environment (CIRRE); 	Funding by Postgraduate Research Studentships to MWD (Cardiff University President's Research Scholarship) and ADA (NERC/I527861); a Yale Climate and Energy Institute Fellowship to TWC; and a Knowledge Economy Skills Scholarship (KESS) studentship to SMT. Bangor FACE facility development funded by the Science Research Investment Fund (SRIF), with Forestry Commission Wales and the Centre for Integrated Research in the Rural Environment (CIRRE) supporting running costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Websites for funding bodies as follows: Cardiff University President's Scholarship, http://www.cardiff.ac.uk/presidents/; NERC, http://www.nerc.ac.uk. Yale Climate and Energy Institute Fellowship, http://climate.yale.edu/grants-fellowships/postdoctoral-fellowships; KESS, http://www.higherskillswales.co.uk/kess/; SRIF, http://www.delni.gov.uk/index/further-and-higher-education/higher-education/role-structure-he-division/he-research-policy/research-capital-funding-srif. htm; Forestry Commission Wales, http://naturalresourceswales.gov.uk/splash?orig=/; and CIRRE, http://www.cirre.ac.uk/.	[Anonymous], CLIMATE CHANGE 2007; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; COTRUFO MF, 1994, PLANT SOIL, V163, P121, DOI 10.1007/BF00033948; Cotrufo MF, 1998, SOIL BIOL BIOCHEM, V30, P1565, DOI 10.1016/S0038-0717(98)00032-7; Couteaux MM, 1999, TREE PHYSIOL, V19, P301; Crawley MJ., 2007, R BOOK; Curtis PS, 1998, OECOLOGIA, V113, P219; Daniel O, 1997, PEDOBIOLOGIA, V41, P397; Ferreira V, 2010, GLOBAL CHANGE BIOL, V16, P3284, DOI 10.1111/j.1365-2486.2009.02153.x; Foster C.F., 2010, J VIS EXP, V37, DOI [10.3791/1837, DOI 10.3791/1837]; Fox J., 2011, CAR COMPANION APPL R; Friberg N, 1999, FRESHWATER BIOL, V32, P133; Frost PC, 2005, ARCH HYDROBIOL, V163, P463, DOI 10.1127/0003-9136/2005/0163-0463; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Graca MAS, 2001, FRESHWATER BIOL, V46, P947, DOI 10.1046/j.1365-2427.2001.00729.x; Hattenschwiler S, 2001, GLOBAL CHANGE BIOL, V7, P565, DOI 10.1046/j.1365-2486.2001.00402.x; Hattenschwiler S, 1999, OIKOS, V85, P271, DOI 10.2307/3546493; Hladyz S, 2009, FRESHWATER BIOL, V54, P957, DOI 10.1111/j.1365-2427.2008.02138.x; Kuhn M., 2011, CONTRAST COLLECTION; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; Lenth R. V., 2013, LSMEANS LEAST SQUARE; Lindroth RL, 2012, ECOL REV, P120; Liu LL, 2007, PLANT SOIL, V299, P65, DOI 10.1007/s11104-007-9361-y; MacNeil C, 1997, BIOL REV, V72, P349, DOI 10.1017/S0006323196005038; Martinson HM, 2008, ECOL RES, V23, P487, DOI 10.1007/s11284-008-0471-7; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Miglietta F, 2001, NEW PHYTOL, V150, P465, DOI 10.1046/j.1469-8137.2001.00115.x; Moog O, 2002, FAUNA AQUATICA AUSTR; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; Ott D, 2012, PHILOS T R SOC B, V367, P3025, DOI 10.1098/rstb.2012.0240; Parsons WFJ, 2004, GLOBAL CHANGE BIOL, V10, P1666, DOI 10.1111/j.1365-2486.2004.00851.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; Prather CM, 2013, BIOL REV, V88, P327, DOI 10.1111/brv.12002; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reidinger S, 2012, NEW PHYTOL, V195, P699, DOI 10.1111/j.1469-8137.2012.04179.x; Robinson EA, 2012, NEW PHYTOL, V194, P321, DOI 10.1111/j.1469-8137.2012.04074.x; Shurin JB, 2006, P ROY SOC B-BIOL SCI, V273, P1, DOI 10.1098/rspb.2005.3377; Smith AR, 2013, NEW PHYTOL, V198, P156, DOI 10.1111/nph.12136; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Swan CM, 2006, OECOLOGIA, V149, P107, DOI 10.1007/s00442-006-0436-x; Temperton VM, 2003, TREE PHYSIOL, V23, P1051, DOI 10.1093/treephys/23.15.1051; Treplin M, 2012, ECOSYSTEMS, V15, P477, DOI 10.1007/s10021-012-9523-5; Tuchman NC, 2003, HYDROBIOLOGIA, V495, P203, DOI 10.1023/A:1025493018012; Tuchman NC, 2002, GLOBAL CHANGE BIOL, V8, P163, DOI 10.1046/j.1365-2486.2002.00460.x; Wallace JB, 1996, ANNU REV ENTOMOL, V41, P115, DOI 10.1146/annurev.en.41.010196.000555; Warnes GR, 2012, GMODELS VARIOUS R PR; Wurst S, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P28	49	19	20	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86246	10.1371/journal.pone.0086246	http://dx.doi.org/10.1371/journal.pone.0086246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465985	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000330283100131
J	Hall, JS; Iype, R; Senra, J; Taylor, J; Armenoult, L; Oguejiofor, K; Li, YY; Stratford, I; Stern, PL; O'Connor, MJ; Miller, CJ; West, CML				Hall, John S.; Iype, Rohan; Senra, Joana; Taylor, Janet; Armenoult, Lucile; Oguejiofor, Kenneth; Li, Yaoyong; Stratford, Ian; Stern, Peter L.; O'Connor, Mark J.; Miller, Crispin J.; West, Catharine M. L.			Investigation of Radiosensitivity Gene Signatures in Cancer Cell Lines	PLOS ONE			English	Article							CERVICAL-CANCER; INTRINSIC RADIOSENSITIVITY; RADIATION-RESISTANCE; PROGNOSTIC-FACTOR; MICROARRAY DATA; UP-REGULATION; EXPRESSION; CARCINOMA; RADIOTHERAPY; SENSITIVITY	Intrinsic radiosensitivity is an important factor underlying radiotherapy response, but there is no method for its routine assessment in human tumours. Gene signatures are currently being derived and some were previously generated by expression profiling the NCI-60 cell line panel. It was hypothesised that focusing on more homogeneous tumour types would be a better approach. Two cell line cohorts were used derived from cervix [n = 16] and head and neck [n = 11] cancers. Radiosensitivity was measured as surviving fraction following irradiation with 2 Gy (SF2) by clonogenic assay. Differential gene expression between radiosensitive and radioresistant cell lines (SF2 </> median) was investigated using Affymetrix GeneChip Exon 1.0ST (cervix) or U133A Plus2 (head and neck) arrays. There were differences within cell line cohorts relating to tissue of origin reflected by expression of the stratified epithelial marker p63. Of 138 genes identified as being associated with SF2, only 2 (1.4%) were congruent between the cervix and head and neck carcinoma cell lines (MGST1 and TFPI), and these did not partition the published NCI-60 cell lines based on SF2. There was variable success in applying three published radiosensitivity signatures to our cohorts. One gene signature, originally trained on the NCI-60 cell lines, did partially separate sensitive and resistant cell lines in all three cell line datasets. The findings do not confirm our hypothesis but suggest that a common transcriptional signature can reflect the radiosensitivity of tumours of heterogeneous origins.	[Hall, John S.; Iype, Rohan; Taylor, Janet; Armenoult, Lucile; Oguejiofor, Kenneth; West, Catharine M. L.] Univ Manchester, Translat Radiobiol Grp, Manchester, Lancs, England; [Senra, Joana; Stratford, Ian] Univ Manchester, Expt Oncol Grp, Manchester, Lancs, England; [Senra, Joana] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England; [Taylor, Janet; Li, Yaoyong; Miller, Crispin J.] CRUK Manchester Inst, Appl Computat Biol & Bioinformat Grp, Manchester, Lancs, England; [Stern, Peter L.] CRUK Manchester Inst, Immunol Group, Manchester, Lancs, England; [O'Connor, Mark J.] Astra Zeneca, Canc Biosci, Macclesfield, Cheshire, England	University of Manchester; University of Manchester; University of Oxford; AstraZeneca	West, CML (corresponding author), Univ Manchester, Translat Radiobiol Grp, Manchester, Lancs, England.	Catharine.West@manchester.ac.uk	West, Catharine/J-4152-2012	West, Catharine/0000-0002-0839-3449; Miller, Crispin/0000-0003-4341-1283; stratford, ian/0000-0002-5222-4765	Cancer Research UK [C1094/A9437, C1467/A7286, C147/A6058]; Medical Research Council UK [GO801525]; ECMC [C1467/A7286]; Cancer Research UK [15675] Funding Source: researchfish; Medical Research Council [G0500366, G0801525] Funding Source: researchfish; MRC [G0500366, G0801525] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ECMC; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Cancer Research UK (C1094/A9437, C1467/A7286, and C147/A6058), the Medical Research Council UK (GO801525), and ECMC (C1467/A7286) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Pavon MA, 2008, INT J CANCER, V123, P1068, DOI 10.1002/ijc.23635; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjork-Eriksson T, 2000, INT J RADIAT ONCOL, V46, P13, DOI 10.1016/S0360-3016(99)00373-9; Brady CS, 2000, TISSUE ANTIGENS, V55, P401, DOI 10.1034/j.1399-0039.2000.550502.x; BRISTOW RG, 1990, INT J RADIAT ONCOL, V18, P331, DOI 10.1016/0360-3016(90)90098-5; Choudhury A, 2010, CANCER RES, V70, P7017, DOI 10.1158/0008-5472.CAN-10-1202; Chung YM, 2005, INT J CANCER, V117, P194, DOI 10.1002/ijc.21180; CROOK T, 1991, ONCOGENE, V6, P873; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Dobbin E, 2008, LEUKEMIA RES, V32, P1554, DOI 10.1016/j.leukres.2008.02.007; Dobbin KK, 2008, CLIN CANCER RES, V14, P108, DOI 10.1158/1078-0432.CCR-07-0443; Eschrich S, 2009, INT J RADIAT ONCOL, V75, P497, DOI 10.1016/j.ijrobp.2009.05.056; Eschrich SA, 2012, CLIN CANCER RES, V18, P5134, DOI 10.1158/1078-0432.CCR-12-0891; Eschrich SA, 2009, INT J RADIAT ONCOL, V75, P489, DOI 10.1016/j.ijrobp.2009.06.014; FERTIL B, 1985, INT J RADIAT ONCOL, V11, P1699, DOI 10.1016/0360-3016(85)90223-8; Hall JS, 2011, BRIT J CANCER, V104, P971, DOI 10.1038/bjc.2011.66; Hall JS, 2013, INT J RADIAT ONCOL, V85, pE223, DOI 10.1016/j.ijrobp.2012.11.030; Hampson L, 2001, FASEB J, V15, P1445, DOI 10.1096/fj.00-0728fje; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim HS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-348; Kim MK, 2010, J GYNECOL ONCOL, V21, P181, DOI 10.3802/jgo.2010.21.3.181; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Marples B, 1998, BRIT J CANCER, V77, P1108, DOI 10.1038/bjc.1998.184; Moeller BJ, 2011, CLIN CANCER RES, V17, P2035, DOI 10.1158/1078-0432.CCR-10-2641; Otomo T, 2004, J RADIAT RES, V45, P53, DOI 10.1269/jrr.45.53; Pawlak M, 2002, PROTEOMICS, V2, P383, DOI 10.1002/1615-9861(200204)2:4<383::AID-PROT383>3.0.CO;2-E; Pedersen N, 2003, CANCER RES, V63, P1943; ROBERTS SA, 1990, INT J RADIAT BIOL, V57, P1243, DOI 10.1080/09553009014551321; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tewari D, 2005, GYNECOL ONCOL, V99, P84, DOI 10.1016/j.ygyno.2005.05.043; Torres-Roca JF, 2005, CANCER RES, V65, P7169, DOI 10.1158/0008-5472.CAN-05-0656; Toustrup K, 2012, SEMIN RADIAT ONCOL, V22, P119, DOI 10.1016/j.semradonc.2011.12.006; West C M, 1992, BJR Suppl, V24, P146; West CML, 1997, BRIT J CANCER, V76, P1184, DOI 10.1038/bjc.1997.531; Williams MV, 2009, CLIN ONCOL-UK, V21, P575, DOI 10.1016/j.clon.2009.07.003; Yates T, 2008, NUCLEIC ACIDS RES, V36, pD780, DOI 10.1093/nar/gkm779	41	40	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86329	10.1371/journal.pone.0086329	http://dx.doi.org/10.1371/journal.pone.0086329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466029	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000330283100139
J	Inoue, S; Becker, AL; Kim, JH; Shu, ZQ; Soelberg, SD; Weigel, KM; Hiraiwa, M; Cairns, A; Lee, HB; Furlong, CE; Oh, K; Lee, KH; Gao, DY; Chung, JH; Cangelosi, GA				Inoue, Shinnosuke; Becker, Annie L.; Kim, Jong-Hoon; Shu, Zhiquan; Soelberg, Scott D.; Weigel, Kris M.; Hiraiwa, Morgan; Cairns, Andrew; Lee, Hyun-Boo; Furlong, Clement E.; Oh, Kieseok; Lee, Kyong-Hoon; Gao, Dayong; Chung, Jae-Hyun; Cangelosi, Gerard A.			Semi-Automated, Occupationally Safe Immunofluorescence Microtip Sensor for Rapid Detection of Mycobacterium Cells in Sputum	PLOS ONE			English	Article							LABORATORY DIAGNOSIS; XPERT MTB/RIF; TUBERCULOSIS; OPPORTUNITIES; MICROSCOPY	An occupationally safe (biosafe) sputum liquefaction protocol was developed for use with a semi-automated antibody-based microtip immunofluorescence sensor. The protocol effectively liquefied sputum and inactivated microorganisms including Mycobacterium tuberculosis, while preserving the antibody-binding activity of Mycobacterium cell surface antigens. Sputum was treated with a synergistic chemical-thermal protocol that included moderate concentrations of NaOH and detergent at 60 degrees C for 5 to 10 min. Samples spiked with M. tuberculosis complex cells showed approximately 10(6)-fold inactivation of the pathogen after treatment. Antibody binding was retained post-treatment, as determined by analysis with a microtip immunosensor. The sensor correctly distinguished between Mycobacterium species and other cell types naturally present in biosafe-treated sputum, with a detection limit of 100 CFU/mL for M. tuberculosis, in a 30-minute sample-to-result process. The microtip device was also semi-automated and shown to be compatible with low-cost, LED-powered fluorescence microscopy. The device and biosafe sputum liquefaction method opens the door to rapid detection of tuberculosis in settings with limited laboratory infrastructure.	[Inoue, Shinnosuke; Kim, Jong-Hoon; Shu, Zhiquan; Hiraiwa, Morgan; Cairns, Andrew; Lee, Hyun-Boo; Gao, Dayong; Chung, Jae-Hyun] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Becker, Annie L.; Weigel, Kris M.; Cangelosi, Gerard A.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Soelberg, Scott D.; Furlong, Clement E.] Univ Washington, Dept Med, Div Med Genet & Genome Sci, Seattle, WA USA; [Oh, Kieseok; Lee, Kyong-Hoon] NanoFacture Inc, Bellevue, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chung, JH (corresponding author), Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.	jae71@uw.edu; gcang@uw.edu		Kim, Jong-Hoon/0000-0001-6088-7676; Shu, Zhiquan/0000-0002-9261-5832; Weigel, Kris/0000-0003-3199-2148	Catalysis Foundation for Health; NSF Career Award [ECCS-0846454]; National Institute of Allergy and Infectious Disease [R01 AI093418]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093418] Funding Source: NIH RePORTER	Catalysis Foundation for Health; NSF Career Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Catalysis Foundation for Health, NSF Career Award (ECCS-0846454), and National Institute of Allergy and Infectious Disease (R01 AI093418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Bemer-Melchior P, 1999, J CLIN MICROBIOL, V37, P2350, DOI 10.1128/JCM.37.7.2350-2351.1999; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chun AL, 2009, NAT NANOTECHNOL, V4, P698, DOI 10.1038/nnano.2009.322; Clouse K, 2012, SAMJ S AFR MED J, V102, P805, DOI [10.7196/SAMJ.5851, 10.7196/samj.5851]; Doig C, 2002, J CLIN PATHOL, V55, P778, DOI 10.1136/jcp.55.10.778; Drobniewski FA, 2003, LANCET INFECT DIS, V3, P141, DOI 10.1016/S1473-3099(03)00544-9; Fukushima M, 2003, J CLIN MICROBIOL, V41, P2605, DOI 10.1128/JCM.41.6.2605-2615.2003; Gaster RS, 2011, LAB CHIP, V11, P950, DOI [10.1039/c0lc00534g, 10.1039/c01c00534g]; Horan KL, 2006, J CLIN MICROBIOL, V44, P783, DOI 10.1128/JCM.44.3.783-789.2006; Kim JH, 2012, LAB CHIP, V12, P1437, DOI [10.1039/c2lc21131a, 10.1039/c2lc21131]; LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; McNerney R, 2011, NAT REV MICROBIOL, V9, P204, DOI 10.1038/nrmicro2521; Minion J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022495; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Pfyffer GE, 2003, MANUAL CLIN MICROBIO, P532; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Smithwich RW, 1976, LAB MANUAL ACID FAST; Trusov A, 2009, INT J TUBERC LUNG D, V13, P836; WHO, 2011, WHO GLOBAL TUBERCULO; Yassi A, 2013, AIDS CARE, V25, P525, DOI 10.1080/09540121.2012.712668; ZWADYK P, 1994, J CLIN MICROBIOL, V32, P2140, DOI 10.1128/JCM.32.9.2140-2146.1994	25	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86018	10.1371/journal.pone.0086018	http://dx.doi.org/10.1371/journal.pone.0086018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465845	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100097
J	Reynolds, HT; Barton, HA				Reynolds, Hannah T.; Barton, Hazel A.			Comparison of the White-Nose Syndrome Agent Pseudogymnoascus destructans to Cave-Dwelling Relatives Suggests Reduced Saprotrophic Enzyme Activity	PLOS ONE			English	Article							GEOMYCES-DESTRUCTANS; BATRACHOCHYTRIUM-DENDROBATIDIS; MAXIMUM-LIKELIHOOD; CANDIDA-ALBICANS; BAT HIBERNACULA; ACID REAGENT; LEAF-LITTER; SP-NOV; FUNGI; PATHOGEN	White-nose Syndrome (WNS) is an emerging infectious mycosis that has impacted multiple species of North American bats since its initial discovery in 2006, yet the physiology of the causal agent, the psychrophilic fungus Pseudogymnoascus destructans (=Geomyces destructans), is not well understood. We investigated the ability of P. destructans to secrete enzymes that could permit environmental growth or affect pathogenesis and compared enzyme activity across several Pseudogymnoascus species isolated from both hibernating bats and cave sediments. We found that P. destructans produced enzymes that could be beneficial in either a pathogenic or saprotrophic context, such as lipases, hemolysins, and urease, as well as chitinase and cellulases, which could aid in saprotrophic growth. The WNS pathogen showed significantly lower activity for urease and endoglucanase compared to con-generic species (Pseudogymnoascus), which may indicate a shift in selective pressure to the detriment of P. destructans' saprotrophic ability. Based on the positive function of multiple saprotrophic enzymes, the causal agent of White-nose Syndrome shows potential for environmental growth on a variety of substrates found in caves, albeit at a reduced level compared to environmental strains. Our data suggest that if P. destructans emerged as an opportunistic infection from an environmental source, co-evolution with its host may have led to a reduced capacity for saprotrophic growth.	[Reynolds, Hannah T.; Barton, Hazel A.] Univ Akron, Dept Biol, Akron, OH 44325 USA	University System of Ohio; University of Akron	Reynolds, HT (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	hannah.t.reynolds@gmail.com		Barton, Hazel/0000-0001-8585-9997	US Fish and Wildlife Services	US Fish and Wildlife Services(US Fish & Wildlife Service)	US Fish and Wildlife Services (www.fws.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbu P, 2004, MYCOPATHOLOGIA, V158, P303, DOI 10.1007/s11046-004-3465-1; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; BOWER VE, 1955, J RES NAT BUR STAND, V55, P197, DOI 10.6028/jres.055.021; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Christen-Zaech S, 2008, J AM ACAD DERMATOL, V58, pS112, DOI 10.1016/j.jaad.2007.04.019; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Chronakova A, 2009, FOLIA MICROBIOL, V54, P436, DOI 10.1007/s12223-009-0061-2; Cole GT, 1997, HOST-FUNGUS INTERPLAY, P247; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; CURRAH RS, 1985, MYCOTAXON, V24, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dilly O, 2001, SOIL BIOL BIOCHEM, V33, P921, DOI 10.1016/S0038-0717(00)00239-X; Duncan SM, 2008, ANTARCTIC SCI, V20, P5; Dzal Y, 2011, BIOL LETTERS, V7, P392, DOI 10.1098/rsbl.2010.0859; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emmons C., 1977, MED MYCOLOGY; Fenice M, 1997, POLAR BIOL, V17, P275, DOI 10.1007/s003000050132; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Geiser DM, 2006, MYCOLOGIA, V98, P1053, DOI 10.3852/mycologia.98.6.1053; Ghosh S, 2009, INFECT IMMUN, V77, P1596, DOI 10.1128/IAI.01452-08; Gianni C, 2003, MYCOSES, V46, P430, DOI 10.1046/j.1439-0507.2003.00897.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hayes MHB, 2001, SOIL SCI, V166, P723, DOI 10.1097/00010694-200111000-00002; HSU SC, 1975, APPL MICROBIOL, V29, P422, DOI 10.1128/AEM.29.3.422-426.1975; Johnson LJ, 2013, APPL ENV MI IN PRESS; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Kelley RH, 2002, HYDROBIOLOGIA, V482, P41, DOI 10.1023/A:1021209906661; Kochkina GA, 2007, MICROBIOLOGY+, V76, P31, DOI 10.1134/s0026261707010055; Lee IR, 2013, FEMS MICROBIOL LETT, V345, P77, DOI 10.1111/1574-6968.12181; Lorch JM, 2013, APPL ENVIRON MICROB, V79, P1293, DOI 10.1128/AEM.02939-12; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Lorch JM, 2013, MYCOLOGIA; Maddison WP, 2011, MESQUITE MODULAR SYS; Marshall WA, 1998, MICROBIAL ECOL, V36, P212, DOI 10.1007/s002489900108; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; Mirbod-Donovan F, 2006, INFECT IMMUN, V74, P504, DOI 10.1128/IAI.74.1.504-515.2006; Mitchell KM, 2008, P ROY SOC B-BIOL SCI, V275, P329, DOI 10.1098/rspb.2007.1356; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Mudarra M, 2011, SCI TOTAL ENVIRON, V409, P3448, DOI 10.1016/j.scitotenv.2011.05.026; Navarathna DHMLP, 2010, FEMS YEAST RES, V10, P209, DOI 10.1111/j.1567-1364.2010.00602.x; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Perotto S, 2002, PLANT SOIL, V244, P41, DOI 10.1023/A:1020289401610; Pikula J, 2012, J WILDLIFE DIS, V48, P207, DOI 10.7589/0090-3558-48.1.207; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Polseela R, 2011, SE ASIAN J TROP MED, V42, P1395; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Reynolds HT, 2013, MICROBIOLOG IN PRESS; Rice AV, 2006, MYCOLOGIA, V98, P307, DOI 10.3852/mycologia.98.2.307; Rice AV, 2006, MICROBIAL ROOT ENDOP, P227; Rosa LH, 2010, FEMS MICROBIOL ECOL, V73, P178, DOI 10.1111/j.1574-6941.2010.00872.x; Saiz-Jiminez C, 1999, J ANAL APPL PYROLYSI, V49; SAZCI A, 1986, J APPL BACTERIOL, V61, P559, DOI 10.1111/j.1365-2672.1986.tb01729.x; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shelley V, 2013, J CAVE KARST STUD, V75, P1, DOI 10.4311/2011LSC0249; Simon KS, 2007, J CAVE KARST STUD, V69, P279; Sogonov MV, 2005, MYCOLOGIA, V97, P695, DOI 10.3852/mycologia.97.3.695; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stehr F, 2004, FEMS YEAST RES, V4, P401, DOI 10.1016/S1567-1356(03)00205-8; Taylor JP, 2002, SOIL BIOL BIOCHEM, V34, P387, DOI 10.1016/S0038-0717(01)00199-7; Team RC, 2012, R LANG ENV STAT COMP; UDAGAWA S, 1993, MYCOTAXON, V48, P157; Vanderwolf KJ, 2013, NORTHEAST NAT, V20, P115, DOI 10.1656/045.020.0109; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Vohnik M, 2007, FOLIA MICROBIOL, V52, P407, DOI 10.1007/BF02932096; Wang Z, 2006, MOL PHYLOGENETICS EV, V41; Wang Z, 2006, MYCOLOGIA, V98; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Weckerly FW, 2012, J CAVE KARST STUD, V74, P1, DOI 10.4311/2011LSC0223; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Yoon Ji Hwan, 2007, Mycobiology, V35, P21, DOI 10.4489/MYCO.2007.35.1.021	79	40	40	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86437	10.1371/journal.pone.0086437	http://dx.doi.org/10.1371/journal.pone.0086437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466096	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100165
J	Thomas, B; van Pelt, M; Mehrotra, R; Robinson-Cohen, C; LoGerfo, J				Thomas, Bernadette; van Pelt, Maurits; Mehrotra, Rajnish; Robinson-Cohen, Cassianne; LoGerfo, James			An Estimation of the Prevalence and Progression of Chronic Kidney Disease in a Rural Diabetic Cambodian Population	PLOS ONE			English	Article							RENAL-DISEASE; HELP-SEEKING; RISK-FACTORS; BURDEN; INDIA; MEN; CKD; MORTALITY; IMPACT	Background: To date, there are no known estimates of the prevalence of chronic kidney disease within Cambodia, the vast majority of whose citizens live in rural areas with limited access to renal replacement therapy. Methods: Observational analysis of patients from the Takeo province in Cambodia who presented to MoPoTsyo, a non-governmental organization, for screening and management of diabetes mellitus between 2010 and 2012 (n = 402; 75% females). Estimated glomerular filtration rate (eGFR) was calculated using the CKD-Epi equation. Results: On average, women were younger, with a higher percentage of hypercholesterolemia but also high-density lipoprotein level. Men had a higher serum creatinine level (1.31 mg/dl) than that of women (1.13 mg/dl) at 95% CI. More than half of all screened patients had a reduced eGFR; 60% (95% CI 55%, 65%) had an eGFR <60 ml/min/1.73 m(2); 54% (49%, 59%) had an eGFR 30-60 ml/min/1.73 m(2), and 5.7% (3.4%, 8.0%) with eGFR 15-30 ml/min/1.73 m(2). Women had a greater prevalence of stage 3 CKD (57% women vs. 47% men) and stage 4 CKD (7.0% vs. 2.0%). The adjusted odds ratio for females compared to males having an eGFR,60 ml/min/1.73 m(2) was 3.19 (95% CI 1.78, 5.43; p value <0.001). Thirty-two percent of patients lost >= 5 ml/min/1.73 m(2) eGFR during median follow-up time of 433 days (IQR 462 days) days. Conclusions: Over one-half of Cambodians with diabetes mellitus had reduced eGFR, implying a point-prevalence of chronic kidney disease of 1.2% in among adult Cambodians within the country. This high burden of kidney disease in a society that lacks universal access to renal replacement therapy underscores the importance of early diagnosis - a largely unmet need in Cambodia.	[Thomas, Bernadette; Mehrotra, Rajnish] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [van Pelt, Maurits] MoPoTsyo Patient Informat Ctr, Phnom Penh, Cambodia; [Robinson-Cohen, Cassianne] Univ Washington, Kidney Res Inst, Seattle, WA 98195 USA; [LoGerfo, James] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Thomas, B (corresponding author), Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA.	bathomas@uw.edu	Robinson-Cohen, Cassianne/ABB-4985-2021	Robinson-Cohen, Cassianne/0000-0003-4783-7046	 [5F32DK093167-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK093167] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Bernadette Thomas was supported by grant #5F32DK093167-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; Agarwal SK, 2009, NEPHRON CLIN PRACT, V111, pC197, DOI 10.1159/000199460; Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; [Anonymous], 2010, PREV NONC DIS RISK F; Barsoum RS, 2002, ARTIF ORGANS, V26, P737, DOI 10.1046/j.1525-1594.2002.07061.x; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Ito J, 2008, NEPHRON CLIN PRACT, V109, pC25, DOI 10.1159/000134379; Jha V., 2009, ETHN DIS, V19; Jha V, 2012, NEPHROL DIAL TRANSPL, V27, P32, DOI 10.1093/ndt/gfs113; Kapur N, 2005, BRIT J GEN PRACT, V55, P108; King H, 2005, LANCET, V366, P1633, DOI 10.1016/S0140-6736(05)67662-3; Kirby T, 2010, LANCET, V375, P1240, DOI 10.1016/S0140-6736(10)60527-2; Moller-Leimkuhler AM, 2002, J AFFECT DISORDERS, V71, P1, DOI 10.1016/S0165-0327(01)00379-2; Naicker S, 2009, ETHNIC DIS, P19; National Institute of Statistics, 2011, CAMB DEM HLTH SURV 2; Rajapurkar M, 2010, CLIN NEPHROL, V74, pS9; Rajapurkar MM, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-10; Shan Y, 2010, NEPHROLOGY, V15, P354, DOI 10.1111/j.1440-1797.2009.01249.x; Stevens LA, 2011, AM J KIDNEY DIS, V57, pS9, DOI 10.1053/j.ajkd.2010.11.007; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; van Pelt M, 2013, YES THEY CAN PEER ED, Vxvii; World Health Organization, 2010, NCD COUNTR PROF	23	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86123	10.1371/journal.pone.0086123	http://dx.doi.org/10.1371/journal.pone.0086123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465909	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100108
J	Misailidi, M; Tzatzarakis, MN; Kavvalakis, MP; Koutedakis, Y; Tsatsakis, AM; Flouris, AD				Misailidi, Maria; Tzatzarakis, Manolis N.; Kavvalakis, Mathaios P.; Koutedakis, Yiannis; Tsatsakis, Aristidis M.; Flouris, Andreas D.			Instruments to Assess Secondhand Smoke Exposure in Large Cohorts of Never Smokers: The Smoke Scales	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; HAIR NICOTINE; SEGMENTAL ANALYSIS; CIGARETTE-SMOKING; COTININE LEVELS; PREGNANT-WOMEN; SERUM COTININE; SELF-REPORT; CHILDREN; HEALTH	The objectives of this study were to: (i) to develop questionnaires that can identify never-smoking children and adults experiencing increased exposure to secondhand smoke (SHS+), (ii) to determine their validity against hair nicotine, and (iii) assess their reliability. A sample of 191 children (85 males; 106 females; 7-18 years) and 95 adult (23 males; 72 females; 1862 years) never-smokers consented to hair nicotine analysis and answered a large number of questions assessing all sources of SHS. A randomly-selected 30% answered the questions again after 20-30 days. Prevalence of SHS+ in children and adults was 0.52 +/- 0.07 and 0.67 +/- 0.10, respectively (p<0.05). The Smoke Scale for Children (SS-C) and the Smoke Scale for Adults (SS-A) were developed via factor analysis and included nine questions each. Positivity criteria for SS-C and SS-A via receiver operating characteristics curve analysis were identified at >16.5 and >16, respectively. Significant Kappa agreement (p<0.05) was confirmed when comparing the SS-C and SS-A to hair nicotine concentration. Reliability analyses demonstrated that the SS-C and SS-A scores obtained on two different days are highly correlated (p<0.001) and not significantly different (p>0.05). Area under the curve and McNemar's Chi-square showed no pair-wise differences in sensitivity and specificity at the cutoff point between the two different days for SS-C and SS-A (p>0.05). We conclude that the SS-C and the SS-A represent valid, reliable, practical, and inexpensive instruments to identify children and adult never-smokers exposed to increased SHS. Future research should aim to further increase the validity of the two questionnaires.	[Misailidi, Maria; Flouris, Andreas D.] Ctr Res & Technol Hellas, FAME Lab, Trikala, Greece; [Misailidi, Maria; Koutedakis, Yiannis] Univ Thessaly, Dept Exercise Sci, Trikala, Greece; [Misailidi, Maria] Reg Directorate Primary & Secondary Educ Western, Patras, Greece; [Tzatzarakis, Manolis N.; Kavvalakis, Mathaios P.; Tsatsakis, Aristidis M.] Univ Crete, Sch Med, Ctr Toxicol Sci & Res, Iraklion, Greece; [Koutedakis, Yiannis] Wolverhampton Univ, Sch Sports Performing Arts & Leisure, Walsall, W Midlands, England	Centre for Research & Technology Hellas; University of Thessaly; University of Crete; University of Wolverhampton	Flouris, AD (corresponding author), Ctr Res & Technol Hellas, FAME Lab, Trikala, Greece.	aflouris@ireteth.certh.gr	Tsatsakis, Aristidis M./H-2890-2013; Flouris, Andreas/GXG-4893-2022; Flouris, Andreas/I-5930-2014	Tsatsakis, Aristidis M./0000-0003-3824-2462; Flouris, Andreas/0000-0002-9823-3915; Koutedakis, Yiannis/0000-0002-7065-9447; Kavvalakis, Matthaios/0000-0003-3033-6165				Al-Delaimy W. K., 2002, Journal of Epidemiology and Community Health, V56, P66, DOI 10.1136/jech.56.1.66; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Bernert JT, 2000, J ANAL TOXICOL, V24, P333, DOI 10.1093/jat/24.5.333; Boyd N R, 1998, Matern Child Health J, V2, P77, DOI 10.1023/A:1022936705438; Brajenovic N, 2013, ARCH ENVIRON OCCUP H, V68, P117, DOI 10.1080/19338244.2012.658121; Britton GRA, 2004, JOGNN-J OBST GYN NEO, V33, P306, DOI 10.1177/0884217504264866; Callais F, 2003, PREV MED, V36, P108, DOI 10.1006/pmed.2002.1132; Caraballo RS, 2001, AM J EPIDEMIOL, V153, P807, DOI 10.1093/aje/153.8.807; Carrillo Andres E., 2009, Inflammation & Allergy Drug Targets, V8, P359; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dinas PC, 2011, INT J CARDIOL; Directorate General Health and Consumers, 2010, SPEC EUR 332 WAV 72; DWYER AJ, 1991, RADIOLOGY, V178, P328, DOI 10.1148/radiology.178.2.1987587; Eisner Mark D, 2005, Environ Health, V4, P7, DOI 10.1186/1476-069X-4-7; Eisner MD, 2001, ENVIRON HEALTH PERSP, V109, P809, DOI 10.2307/3454823; EMMONS KM, 1994, PREV MED, V23, P35, DOI 10.1006/pmed.1994.1005; Faught Brent E., 2009, Inflammation & Allergy Drug Targets, V8, P321; Florescu A, 2007, THER DRUG MONIT, V29, P437, DOI 10.1097/FTD.0b013e318074df6e; Florescu A, 2009, THER DRUG MONIT, V31, P14, DOI 10.1097/FTD.0b013e3181957a3b; Flouris AD, 2008, INT J OBESITY, V32, P1506, DOI 10.1038/ijo.2008.142; Flouris AD, 2005, BRIT J SPORT MED, V39, P166, DOI 10.1136/bjsm.2004.012500; Flouris AD, 2004, J SCI MED SPORT, V7, P197, DOI 10.1016/S1440-2440(04)80009-4; Flouris AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031880; Flouris AD, 2010, HEART, V96, P860, DOI 10.1136/hrt.2009.190744; Flouris Andreas D., 2009, Inflammation & Allergy Drug Targets, V8, P319; Flouris AD, 2010, AM J PHYSIOL-LUNG C, V298, pL3, DOI 10.1152/ajplung.00215.2009; Flouris AD, 2008, J CHILD HEALTH CARE, V12, P221, DOI 10.1177/1367493508092509; Flouris AD, 2009, AM J RESP CRIT CARE, V179, P1029, DOI 10.1164/rccm.200812-1920OC; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Gorsuch R., 1983, FACTOR ANAL; Jaakkola MS, 1997, EUR RESPIR J, V10, P2384, DOI 10.1183/09031936.97.10102384; JARVIS MJ, 1988, AM J PUBLIC HEALTH, V78, P696, DOI 10.2105/AJPH.78.6.696; Kidwell DA, 1995, NIDA RES MONOGRAPH H, P19; Kim SR, 2009, BIOMED CHROMATOGR, V23, P273, DOI 10.1002/bmc.1110; Koren G, 2008, THER DRUG MONIT, V30, P246, DOI 10.1097/FTD.0b013e318167d05b; Llaquet H, 2010, ANAL BIOANAL CHEM, V396, P379, DOI 10.1007/s00216-009-2831-8; Metsios GS, 2007, J CLIN ENDOCR METAB, V92, P208, DOI 10.1210/jc.2006-0762; Metsios GS, 2009, INFLAMM ALLERGY DRUG, V8; Misailidi M, 2012, ARCH HELL MED, V29, P174; NAFSTAD P, 1995, INT J EPIDEMIOL, V24, P88, DOI 10.1093/ije/24.1.88; Nondahl DM, 2005, ENVIRON RES, V97, P76, DOI 10.1016/j.envres.2004.02.005; Oberg M, 2010, GLOBAL ESTIMATE BURD; OConnor TZ, 1995, AM J EPIDEMIOL, V142, P1315, DOI 10.1093/oxfordjournals.aje.a117599; Olivieri M, 2002, ARCH ENVIRON HEALTH, V57, P355, DOI 10.1080/00039890209601421; Pichini S, 2003, J EXPO ANAL ENV EPID, V13, P144, DOI 10.1038/sj.jea.7500264; Pitsavos C, 2002, TOB CONTROL, V11, P220, DOI 10.1136/tc.11.3.220; Preacher K. J., 2003, UNDERSTANDING STAT, V2, P13, DOI DOI 10.1207/S15328031US0201_02; Sandhu S, 2004, ORAL ONCOL, V40, P576, DOI 10.1016/j.oraloncology.2003.11.006; Tzatzarakis MN, 2012, HUM EXP TOXICOL, V31, P258, DOI 10.1177/0960327111422401; U.S. Environmental Protection Agency, 1992, US EPA MON, V4, p[44, 270, 232]; Warren Charles W., 2008, Morbidity and Mortality Weekly Report, V57, P1; Webb David A, 2003, J Public Health Manag Pract, V9, P322; Woodruff SI, 2007, AM J HEALTH PROMOT, V22, P93, DOI 10.4278/0890-1171-22.2.93; World Health Organization, 2011, REP GLOB TOB EP WARN; Zhou X, 2002, STAT METHODS DIAGNOS, P185	56	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85809	10.1371/journal.pone.0085809	http://dx.doi.org/10.1371/journal.pone.0085809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465719	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500117
J	Potter, CS; Wang, Z; Silva, KA; Kennedy, VE; Stearns, TM; Burzenski, L; Shultz, LD; HogenEsch, H; Sundberg, JP				Potter, Christopher S.; Wang, Zhe; Silva, Kathleen A.; Kennedy, Victoria E.; Stearns, Timothy M.; Burzenski, Lisa; Shultz, Leonard D.; HogenEsch, Harm; Sundberg, John P.			Chronic Proliferative Dermatitis in Sharpin Null Mice: Development of an Autoinflammatory Disease in the Absence of B and T Lymphocytes and IL4/IL13 Signaling	PLOS ONE			English	Article							ATOPIC-DERMATITIS; INCREASED EXPRESSION; SKIN-DISEASE; IL-4; INFLAMMATION; CPDM/CPDM; APOPTOSIS; PHENOTYPE; COMPONENT; CYTOKINES	SHARPIN is a key regulator of NFKB and integrin signaling. Mice lacking Sharpin develop a phenotype known as chronic proliferative dermatitis (CPDM), typified by progressive epidermal hyperplasia, apoptosis of keratinocytes, cutaneous and systemic eosinophilic inflammation, and hypoplasia of secondary lymphoid organs. Rag1(-/-) mice, which lack mature B and T cells, were crossed with Sharpin(-/-) mice to examine the role of lymphocytes in CDPM. Although inflammation in the lungs, liver, and joints was reduced in these double mutant mice, dermatitis was not reduced in the absence of functional lymphocytes, suggesting that lymphocytes are not primary drivers of the inflammation in the skin. Type 2 cytokine expression is increased in CPDM. In an attempt to reduce this aspect of the phenotype, Il4ra(-/-) mice, unresponsive to both IL4 and IL13, were crossed with Sharpin(-/-) mice. Double homozygous Sharpin(-/-), Il4ra(-/-) mice developed an exacerbated granulocytic dermatitis, acute system inflammation, as well as hepatic necrosis and mineralization. High expression of CHI3L4, normally seen in CPDM skin, was abolished in Sharpin(-/-), Il4ra(-/-) double mutant mice indicating the crucial role of IL4 and IL13 in the expression of this protein. Cutaneous eosinophilia persisted in Sharpin(-/-), Il4ra(-/-) mice, although expression of Il5 mRNA was reduced and the expression of Ccl11 and Ccl24 was completely abolished. TSLP and IL33 were both increased in the skin of Sharpin(-/-) mice and this was maintained in Sharpin(-/-), Il4ra(-/-) mice suggesting a role for TSLP and IL33 in the eosinophilic dermatitis in SHARPIN-deficient mice. These studies indicate that cutaneous inflammation in SHARPIN-deficient mice is autoinflammatory in nature developing independently of B and T lymphocytes, while the systemic inflammation seen in CPDM has a strong lymphocyte-dependent component. Both the cutaneous and systemic inflammation is enhanced by loss of IL4 and IL13 signaling indicating that these cytokines normally play an anti-inflammatory role in SHARPIN-deficient mice.	[Potter, Christopher S.; Silva, Kathleen A.; Kennedy, Victoria E.; Stearns, Timothy M.; Burzenski, Lisa; Shultz, Leonard D.; Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA; [Wang, Zhe; HogenEsch, Harm; Sundberg, John P.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Jackson Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Sundberg, JP (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	john.sundberg@jax.org	Wang, Zhe/O-6663-2016; Wang, Zhe/N-6846-2015	Stearns, Timothy/0000-0002-5533-6076; HogenEsch, Harm/0000-0002-2738-9189	National Institutes of Health [AR49288]; National Cancer Institute [CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant from the National Institutes of Health (AR49288)(http://www.nih.gov/). Core facilities at The Jackson Laboratory were supported by the National Cancer Institute (CA034196)(http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Carey GB, 2007, CELL RES, V17, P942, DOI 10.1038/sj.cr.2007.90; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; GAUTAM S, 1992, J IMMUNOL, V148, P1725; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; GIJBELS MJJ, 1995, J INVEST DERMATOL, V105, P769, DOI 10.1111/1523-1747.ep12325599; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; HOGENESCH H, 1993, AM J PATHOL, V143, P972; HogenEsch H, 1999, J IMMUNOL, V162, P3890; HogenEsch H, 2001, EUR J IMMUNOL, V31, P734, DOI 10.1002/1521-4141(200103)31:3<734::AID-IMMU734>3.0.CO;2-9; HogenEsch H, 2006, EXP DERMATOL, V15, P808, DOI 10.1111/j.1600-0625.2006.00483.x; Hwang H, 2007, J BIOCHEM MOL BIOL, V40, P36; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Leyva-Castillo JM, 2013, J INVEST DERMATOL, V133, P154, DOI 10.1038/jid.2012.239; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Mikaelian I, 2004, TOXICOL PATHOL, V32, P181, DOI 10.1080/01926230490274335; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Park H, 2012, NAT REV IMMUNOL, V12, P570, DOI 10.1038/nri3261; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Renninger ML, 2010, EXP DERMATOL, V19, P252, DOI 10.1111/j.1600-0625.2009.00944.x; Renninger ML, 2005, EXP DERMATOL, V14, P906, DOI 10.1111/j.1600-0625.2005.00378.x; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Savinko T, 2012, J INVEST DERMATOL, V132, P1392, DOI 10.1038/jid.2011.446; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Seymour R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055224; Sieber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029993; Silva K, 2012, LAB MOUSE, P779; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Sundberg JP, 2008, MAMM GENOME, V19, P413, DOI 10.1007/s00335-008-9123-z; TEVELDE AA, 1990, BLOOD, V76, P1392; Todaro M, 2008, CELL DEATH DIFFER, V15, P762, DOI 10.1038/sj.cdd.4402305; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Wang Z, 2012, J CELL MOL MED, V16, P2271, DOI 10.1111/j.1582-4934.2012.01574.x; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031809; Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Yagi R, 2002, J IMMUNOL, V168, P2020, DOI 10.4049/jimmunol.168.4.2020; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503	49	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85666	10.1371/journal.pone.0085666	http://dx.doi.org/10.1371/journal.pone.0085666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465642	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500088
J	Seki, T; Yuasa, S; Kusumoto, D; Kunitomi, A; Saito, Y; Tohyama, S; Yae, K; Kishino, Y; Okada, M; Hashimoto, H; Takei, M; Egashira, T; Kodaira, M; Kuroda, Y; Tanaka, A; Okata, S; Suzuki, T; Murata, M; Fujita, J; Fukuda, K				Seki, Tomohisa; Yuasa, Shinsuke; Kusumoto, Dai; Kunitomi, Akira; Saito, Yuki; Tohyama, Shugo; Yae, Kojiro; Kishino, Yoshikazu; Okada, Marina; Hashimoto, Hisayuki; Takei, Makoto; Egashira, Toru; Kodaira, Masaki; Kuroda, Yusuke; Tanaka, Atsushi; Okata, Shinichiro; Suzuki, Tomoyuki; Murata, Mitsushige; Fujita, Jun; Fukuda, Keiichi			Generation and Characterization of Functional Cardiomyocytes Derived from Human T Cell-Derived Induced Pluripotent Stem Cells	PLOS ONE			English	Article							DIFFERENTIATION; CALCIUM; MODELS	Induced pluripotent stem cells (iPSCs) have been proposed as novel cell sources for genetic disease models and revolutionary clinical therapies. Accordingly, human iPSC-derived cardiomyocytes are potential cell sources for cardiomyocyte transplantation therapy. We previously developed a novel generation method for human peripheral T cell-derived iPSCs (TiPSCs) that uses a minimally invasive approach to obtain patient cells. However, it remained unknown whether TiPSCs with genomic rearrangements in the T cell receptor (TCR) gene could differentiate into functional cardiomyocyte in vitro. To address this issue, we investigated the morphology, gene expression pattern, and electrophysiological properties of TiPSC-derived cardiomyocytes differentiated by floating culture. RT-PCR analysis and immunohistochemistry showed that the TiPSC-derived cardiomyocytes properly express cardiomyocyte markers and ion channels, and show the typical cardiomyocyte morphology. Multiple electrode arrays with application of ion channel inhibitors also revealed normal electrophysiological responses in the TiPSC-derived cardiomyocytes in terms of beating rate and the field potential waveform. In this report, we showed that TiPSCs successfully differentiated into cardiomyocytes with morphology, gene expression patterns, and electrophysiological features typical of native cardiomyocytes. TiPSCs-derived cardiomyocytes obtained from patients by a minimally invasive technique could therefore become disease models for understanding the mechanisms of cardiac disease and cell sources for revolutionary cardiomyocyte therapies.	[Seki, Tomohisa; Yuasa, Shinsuke; Kusumoto, Dai; Kunitomi, Akira; Saito, Yuki; Tohyama, Shugo; Yae, Kojiro; Kishino, Yoshikazu; Okada, Marina; Hashimoto, Hisayuki; Takei, Makoto; Egashira, Toru; Kodaira, Masaki; Kuroda, Yusuke; Tanaka, Atsushi; Okata, Shinichiro; Suzuki, Tomoyuki; Murata, Mitsushige; Fujita, Jun; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan; [Seki, Tomohisa; Tohyama, Shugo] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Keio University; Japan Society for the Promotion of Science	Fukuda, K (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan.	kfukuda@a2.keio.jp	Seki, Tomohisa/L-3524-2013; Fukuda, Keiichi/L-3777-2013; Hashimoto, Hisayuki/AAS-1938-2020	Hashimoto, Hisayuki/0000-0001-7367-4805; Yuasa, Shinsuke/0000-0001-5593-7552; Kishino, Yoshikazu/0000-0003-3291-2795; Saito, Yuki/0000-0003-2686-9604; Kodaira, Masaki/0000-0002-7293-617X; Seki, Tomohisa/0000-0002-4281-135X	Support Program to break the bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome; Highway Program for the Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research [25461117] Funding Source: KAKEN	Support Program to break the bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome; Highway Program for the Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the Support Program to break the bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome, the Highway Program for the Realization of Regenerative Medicine, and a Grant-in-Aid for JSPS Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Choi SH, 2012, CIRC J, V76, P1307, DOI 10.1253/circj.CJ-11-1479; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI [10.1002/0471142727.mb2303s51, 10.1002/0471142727.mb2302s51]; Egashira T, 2013, BIOL PHARM BULL, V36, P182, DOI 10.1248/bpb.b12-00960; Egashira T, 2012, CARDIOVASC RES, V95, P419, DOI 10.1093/cvr/cvs206; Germanguz I, 2011, J CELL MOL MED, V15, P38, DOI 10.1111/j.1582-4934.2009.00996.x; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Knollmann BC, 2013, CIRC RES, V112, P969, DOI 10.1161/CIRCRESAHA.112.300567; Kunisato A, 2011, STEM CELLS DEV, V20, P159, DOI 10.1089/scd.2010.0063; Lan F, 2013, CELL STEM CELL, V12, P101, DOI 10.1016/j.stem.2012.10.010; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Ma DR, 2013, EUR HEART J, V34, P1122, DOI 10.1093/eurheartj/ehs226; Malan D, 2011, CIRC RES, V109, P841, DOI 10.1161/CIRCRESAHA.111.243139; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Mummery C, 2002, J ANAT, V200, P233, DOI 10.1046/j.1469-7580.2002.00031.x; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Novak A, 2012, J CELL MOL MED, V16, P468, DOI 10.1111/j.1582-4934.2011.01476.x; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schaub MC, 2006, J MOL CELL CARDIOL, V41, P183, DOI 10.1016/j.yjmcc.2006.04.005; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Sinnecker D, 2013, CIRC RES, V112, P961, DOI 10.1161/CIRCRESAHA.112.268623; Smyth JW, 2012, HEART RHYTHM, V9, P151, DOI 10.1016/j.hrthm.2011.07.028; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka T, 2009, BIOCHEM BIOPH RES CO, V385, P497, DOI 10.1016/j.bbrc.2009.05.073; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Yamanaka S, 2010, CELL STEM CELL, V7, P1, DOI 10.1016/j.stem.2010.06.009; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yuasa Shinsuke, 2008, Expert Rev Cardiovasc Ther, V6, P803, DOI 10.1586/14779072.6.6.803; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885; Zwi-Dantsis L, 2013, EUR HEART J, V34, P1575, DOI 10.1093/eurheartj/ehs096	40	13	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85645	10.1371/journal.pone.0085645	http://dx.doi.org/10.1371/journal.pone.0085645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465630	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500087
J	Jin, B; Bai, XJ; Han, LL; Liu, J; Zhang, WG; Chen, XM				Jin, Bo; Bai, Xiaojuan; Han, Lulu; Liu, Jing; Zhang, Weiguang; Chen, Xiangmei			Association between Kidney Function and Framingham Global Cardiovascular Disease Risk Score: A Chinese Longitudinal Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; AMBULATORY BLOOD-PRESSURE; RENAL-INSUFFICIENCY; SERUM CREATININE; ALL-CAUSE; MORTALITY; ALBUMINURIA; OUTCOMES; OLDER; PREDICTOR	Background: Chronic kidney disease (CKD) is generally considered an independent risk factor for cardiovascular disease (CVD) development, but rates in individuals with estimated glomerular filtration rate (eGFR) >60 ml/min/1.73 m(2) are uncertain. The Framingham global CVD risk score (FRS) equation is a widely accepted tool used to predict CVD risk in the general population. The purpose of the present study was to examine whether an association exists between eGFR and FRS in a Chinese population with no CKD or CVD. Methods: A total of 333 participants were divided into three groups based on FRS. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation and CKD-EPI equation for Asians (CKD-EPI-ASIA) were used to measure eGFR. Results: A significant inverse association between eGFR and FRS was confirmed with Pearson correlation coefficients of -0.669, -0.698 (eGFR(CKD-EPI), P<0.01) and -0.658, -0.690 (eGFR(CKD-EPI-ASIA), P<0.01). This association gradually diminished with progression from the low-to high-risk groups (eGFR(CKD-EPI), r = -0.615, -0.282, -0.197, P<0.01, P<0.01, P>0.05; similar results according to the CKD-EPI-ASIA equation). In the low-or moderate-risk new-groups, this association became stronger with increased FRS (eGFR(CKD-EPI-ASIA), r = -0557, -0.622 or -0.326, -0.329, P<0.01). In contrast to the results from 2008, eGFR was independently associated with FRS following adjustment for traditional cardiovascular risk factors (P<0.05). Conclusion: Renal function has multiple influences on predicting CVD risk in various populations. With increasing FRS and decreasing eGFR, it is also independently associated with CVD, even in individuals with eGFR>60 ml/min/1.73 m2.	[Jin, Bo; Bai, Xiaojuan; Han, Lulu] China Med Univ, Shengjing Hosp, Dept Gerontol & Geriatr, Shenyang, Peoples R China; [Liu, Jing] Asia Heart Hosp, Dept Circulat, Wuhan, Peoples R China; [Zhang, Weiguang; Chen, Xiangmei] Chinese Peoples Liberat Army, Gen Hosp, Dept Kidney, Beijing, Peoples R China	China Medical University; Chinese People's Liberation Army General Hospital	Bai, XJ (corresponding author), China Med Univ, Shengjing Hosp, Dept Gerontol & Geriatr, Shenyang, Peoples R China.	xjuanbai@hotmail.com			National Basic Research Program of China (973-Program) [G2000057006, 2007CB507405, 2013CB530804]	National Basic Research Program of China (973-Program)(National Basic Research Program of China)	This work was supported by grants from the National Basic Research Program of China (973-Program #G2000057006, #2007CB507405, and #2013CB530804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astor BC, 2012, AM J KIDNEY DIS, V59, P653, DOI 10.1053/j.ajkd.2011.11.042; Barzouhi A, 2011, PLOS ONE, V6; Bowling CB, 2012, J GERONTOL A-BIOL, V67, P1379, DOI 10.1093/gerona/gls173; Burl VL, 1992, HYPERTENSION, V25, P305; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7; Dukkipati R, 2008, DRUG AGING, V25, P241, DOI 10.2165/00002512-200825030-00006; DUNNE FP, 1991, CLIN SCI, V81, P515, DOI 10.1042/cs0810515; Eyster KM, 2011, MENOPAUSE, V18, P1087, DOI 10.1097/gme.0b013e3182163fea; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Joosen IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047267; KHOURY S, 1992, AM J HYPERTENS, V5, P616, DOI 10.1093/ajh/5.9.616; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Rao M, 2007, KIDNEY INT, V72, P549, DOI 10.1038/sj.ki.5002391; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; Schillaci G, 2001, ARCH INTERN MED, V161, P886, DOI 10.1001/archinte.161.6.886; Shlipak MG, 2002, KIDNEY INT, V62, P997, DOI 10.1046/j.1523-1755.2002.00522.x; Shlipar MG, 2011, J AM COLL CARDIOL, V38, P705; STAESSEN J, 1990, J HYPERTENS, V8, pS57; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038218; Wang XJ, 2011, CLIN CHIM ACTA, V412, P1793, DOI 10.1016/j.cca.2011.05.033; WIINBERG N, 1995, AM J HYPERTENS, V8, P978, DOI 10.1016/0895-7061(95)00216-2	36	8	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86082	10.1371/journal.pone.0086082	http://dx.doi.org/10.1371/journal.pone.0086082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465883	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500108
J	Tomaru, A; Sasaki, R; Miyahara, H; Okino, A; Ogawa, N; Hamasaki, K				Tomaru, Akiko; Sasaki, Ryota; Miyahara, Hidekazu; Okino, Akitoshi; Ogawa, Nobuhiro; Hamasaki, Koji			Settlement of Planulae of the Moon Jellyfish Aurelia aurita onto Hydrophilic Polycarbonate Plates Modified by Atmospheric Plasma Treatment	PLOS ONE			English	Article							SURFACE MODIFICATION; PELAGIC CNIDARIANS; COMMON JELLYFISH; POLYIMIDE FILMS; WESTERN SWEDEN; GULLMAR FJORD; LIFE-HISTORY; SCYPHOZOA; LARVAE; PREFERENCES	It has been reported that planula larvae of some jellyfish prefer artificial substrates for settlement. This research focused on the relationship between the settlement of planulae and the wettability of artificial substrate surfaces. We used atmospheric plasmas to change the wettability of the surfaces of polycarbonate (PC) plates because plasma treatment has no chemical side effects. The treatment made the surfaces hydrophilic, as evidenced by the decrease of contact angle from 85 degrees to 35 degrees. X-ray photoelectron spectroscopy revealed that the change of wettability of the PC plates could be attributed to N-2, which was probably ionized in the air above the plates. Scanning electron microscopy revealed no difference in the surface morphology of the plates before and after plasma treatment. Results of bioassays using treated PC plates showed that planulae tended to preferentially settle on hydrophobic surfaces.	[Tomaru, Akiko; Ogawa, Nobuhiro; Hamasaki, Koji] Univ Tokyo, Dept Marine Ecosyst Dynam, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Sasaki, Ryota; Miyahara, Hidekazu; Okino, Akitoshi] Tokyo Inst Technol, Dept Energy Sci, Yokohama, Kanagawa 227, Japan	University of Tokyo; Tokyo Institute of Technology	Tomaru, A (corresponding author), Fukushima Univ, Dept Environm Management, Fukushima, Japan.	akotoma@gmail.com	Okino, Akitoshi/O-1804-2013	Okino, Akitoshi/0000-0002-8949-294X; Hamasaki, Koji/0000-0002-8514-506X	Agriculture, Forestry and Fisheries Research Council	Agriculture, Forestry and Fisheries Research Council(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by the Agriculture, Forestry and Fisheries Research Council (POMAL-STOPJELLY Project) (http://www.s.affrc.go.jp/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M.N., 1997, FUNCTIONAL BIOL SCYP; ARAI MN, 1988, CAN J ZOOL, V66, P1913, DOI 10.1139/z88-280; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; BREWER RH, 1984, BIOL BULL, V166, P11, DOI 10.2307/1541426; BREWER RH, 1978, ESTUARIES, V1, P120, DOI 10.2307/1351601; CARPENTER EJ, 1972, SCIENCE, V175, P1240, DOI 10.1126/science.175.4027.1240; Cui NY, 2002, APPL SURF SCI, V189, P31, DOI 10.1016/S0169-4332(01)01035-2; GRONDAHL F, 1989, MAR ECOL PROG SER, V56, P119, DOI 10.3354/meps056119; GROSBERG RK, 1981, NATURE, V290, P700, DOI 10.1038/290700a0; HERNROTH L, 1985, B MAR SCI, V37, P567; HERNROTH L, 1985, OPHELIA, V24, P37, DOI 10.1080/00785236.1985.10426617; Holst S, 2007, MAR BIOL, V151, P863, DOI 10.1007/s00227-006-0530-y; Hoover RA, 2009, HYDROBIOLOGIA, V616, P259, DOI 10.1007/s10750-008-9595-6; Japanese Industrial Standards Committee (JIS), 1999, R3257 JIS COMM; KANAZAWA S, 1988, J PHYS D APPL PHYS, V21, P838, DOI 10.1088/0022-3727/21/5/028; Kang SM, 2008, THIN SOLID FILMS, V516, P1405, DOI 10.1016/j.tsf.2007.07.176; KEEN SL, 1987, MAR ECOL PROG SER, V38, P151, DOI 10.3354/meps038151; Kim MC, 2003, SURF COAT TECH, V171, P312, DOI 10.1016/S0257-8972(03)00292-5; Kramp P. L., 1968, Vidensk. Meddr dansk. naturh. Foren, V131, P67; Lai JN, 2006, APPL SURF SCI, V252, P3375, DOI 10.1016/j.apsusc.2005.05.038; Lin YS, 2006, SURF COAT TECH, V200, P3775, DOI 10.1016/j.surfcoat.2004.11.031; Lo WT, 2008, ICES J MAR SCI, V65, P453, DOI 10.1093/icesjms/fsm185; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; MAYER AG, 1910, MEDUSAE WORLD; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Miyake H, 2002, J OCEANOGR, V58, P451, DOI 10.1023/A:1021628314041; Miyake H., 2004, MAR BIOTECHNOL, V6, pS174, DOI 10.1007/s10126-004-8366-2; Miyake Hiroshi, 1997, South Pacific Study, V17, P273; MOLLER H, 1980, MEERESFORSCHUNG, V28, P90; Noeske M, 2004, INT J ADHES ADHES, V24, P171, DOI 10.1016/j.ijadhadh.2003.09.006; Pitt KA, 2000, MAR BIOL, V136, P269, DOI 10.1007/s002270050685; PURCELL JE, 1985, B MAR SCI, V37, P739; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2007, MAR ECOL PROG SER, V348, P183, DOI 10.3354/meps07056; Rasmussen E., 1973, OPHELIA, V11, P41; Russell F. S., 1970, MEDUSAE BRIT ISLES 2; Takamatsu T, 2013, IEEE T PLASMA SCI, V41, P119, DOI 10.1109/TPS.2012.2227459; Tanford C, 1973, CELLULAR MENBRANES D, P321; UNEP (United Nations Environmental Programme), 1991, MED ACT PLAN TECHN R, V47; Uye Shin-ichi, 2004, Bulletin of the Japanese Society of Fisheries Oceanography, V68, P9; WINSTON JE, 1982, MAR POLLUT BULL, V13, P348, DOI 10.1016/0025-326X(82)90038-8; Yaghoubi H, 2011, APPL SURF SCI, V257, P9836, DOI 10.1016/j.apsusc.2011.06.034; Yaghoubi H, 2010, SURF COAT TECH, V204, P1562, DOI 10.1016/j.surfcoat.2009.09.085; Zar JH, 2010, BIOSTAT ANAL, P286	45	4	4	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85569	10.1371/journal.pone.0085569	http://dx.doi.org/10.1371/journal.pone.0085569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465603	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500059
J	Mustafi, N; Grunberger, A; Mahr, R; Helfrich, S; Noh, K; Blombach, B; Kohlheyer, D; Frunzke, J				Mustafi, Nurije; Gruenberger, Alexander; Mahr, Regina; Helfrich, Stefan; Noeh, Katharina; Blombach, Bastian; Kohlheyer, Dietrich; Frunzke, Julia			Application of a Genetically Encoded Biosensor for Live Cell Imaging of L-Valine Production in Pyruvate Dehydrogenase Complex-Deficient Corynebacterium glutamicum Strains	PLOS ONE			English	Article							MOLECULAR ANALYSIS; MICROBIAL-POPULATIONS; EXPORT SYSTEM; L-METHIONINE; L-ISOLEUCINE; GENE; ENZYME; CHAIN; HETEROGENEITIES; INFORMATION	The majority of biotechnologically relevant metabolites do not impart a conspicuous phenotype to the producing cell. Consequently, the analysis of microbial metabolite production is still dominated by bulk techniques, which may obscure significant variation at the single-cell level. In this study, we have applied the recently developed Lrp-biosensor for monitoring of amino acid production in single cells of gradually engineered L-valine producing Corynebacterium glutamicum strains based on the pyruvate dehydrogenase complex-deficient (PDHC) strain C. glutamicum Delta aceE. Online monitoring of the sensor output (eYFP fluorescence) during batch cultivation proved the sensor's suitability for visualizing different production levels. In the following, we conducted live cell imaging studies on C. glutamicum sensor strains using microfluidic chip devices. As expected, the sensor output was higher in microcolonies of high-yield producers in comparison to the basic strain C. glutamicum Delta aceE. Microfluidic cultivation in minimal medium revealed a typical Gaussian distribution of single cell fluorescence during the production phase. Remarkably, low amounts of complex nutrients completely changed the observed phenotypic pattern of all strains, resulting in a phenotypic split of the population. Whereas some cells stopped growing and initiated L-valine production, others continued to grow or showed a delayed transition to production. Depending on the cultivation conditions, a considerable fraction of non-fluorescent cells was observed, suggesting a loss of metabolic activity. These studies demonstrate that genetically encoded biosensors are a valuable tool for monitoring single cell productivity and to study the phenotypic pattern of microbial production strains.	[Mustafi, Nurije; Gruenberger, Alexander; Mahr, Regina; Helfrich, Stefan; Noeh, Katharina; Kohlheyer, Dietrich; Frunzke, Julia] Forschungszentrum Julich, IBG Biotechnol 1, D-52425 Julich, Germany; [Blombach, Bastian] Univ Stuttgart, Inst Biochem Engn, D-70174 Stuttgart, Germany	Helmholtz Association; Research Center Julich; University of Stuttgart	Frunzke, J (corresponding author), Forschungszentrum Julich, IBG Biotechnol 1, D-52425 Julich, Germany.	j.frunzke@fz-juelich.de	Frunzke, Julia/A-9918-2012; Kohlheyer, Dietrich/A-9645-2012	Frunzke, Julia/0000-0001-6209-7950; Kohlheyer, Dietrich/0000-0001-6215-1857; Helfrich, Stefan/0000-0003-3549-8649; Blombach, Bastian/0000-0002-2996-2049; Grunberger, Alexander/0000-0002-7564-4957; Noh, Katharina/0000-0002-5407-2275	Helmholtz association [VH-NG-716]; German ministry of education and research [0315589A]; Deutsche Forschungsgemeinschaft [SPP1617]	Helmholtz association(Helmholtz Association); German ministry of education and research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by grants of the Helmholtz association (VH-NG-716), the German ministry of education and research (0315589A) and the Deutsche Forschungsgemeinschaft (SPP1617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Bartek T, 2011, APPL ENVIRON MICROB, V77, P6644, DOI 10.1128/AEM.00575-11; Binder S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r40; Blombach B, 2008, APPL MICROBIOL BIOT, V79, P471, DOI 10.1007/s00253-008-1444-z; Blombach B, 2007, APPL ENVIRON MICROB, V73, P2079, DOI 10.1128/AEM.02826-06; Buchholz J, 2013, APPL ENVIRON MICROB, V79, P5566, DOI 10.1128/AEM.01741-13; Carlquist M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-94; Delvigne F, 2011, BIOTECHNOL J, V6, P968, DOI 10.1002/biot.201000410; Dietrich JA, 2010, ANNU REV BIOCHEM, V79, P563, DOI 10.1146/annurev-biochem-062608-095938; Enfors SO, 2001, J BIOTECHNOL, V85, P175, DOI 10.1016/S0168-1656(00)00365-5; Eriksen DT, 2014, J STRUCT BIOL, V185, P234, DOI 10.1016/j.jsb.2013.03.011; Fernandes RL, 2011, BIOTECHNOL ADV, V29, P575, DOI 10.1016/j.biotechadv.2011.03.007; Gruenberger A, 2013, JOVE-J VIS EXP, DOI 10.3791/50560; Grunberger A, 2013, BIOTECHNOL BIOENG, V110, P220, DOI 10.1002/bit.24616; Grunberger A, 2012, LAB CHIP, V12, P2060, DOI [10.1039/c2lc40156h, 10.1039/c21c40156h]; Hasegawa S, 2013, APPL ENVIRON MICROB, V79, P1250, DOI 10.1128/AEM.02806-12; Haussmann U, 2012, J PROTEOMICS, V75, P2649, DOI 10.1016/j.jprot.2012.03.005; Heinemann M, 2011, CURR OPIN BIOTECH, V22, P26, DOI 10.1016/j.copbio.2010.09.008; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; Kensy F, 2009, MICROB CELL FACT, V8, DOI [10.1186/1475-2859-1188-1131, DOI 10.1186/1475-2859-1188-1131]; Kinoshita S., 1957, J GEN APPL MICROBIOL, V3, P193, DOI [10.2323/jgam.3.193, DOI 10.2323/JGAM.3.193]; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lange C, 2012, J BIOTECHNOL, V158, P231, DOI 10.1016/j.jbiotec.2011.06.003; Lara AR, 2006, MOL BIOTECHNOL, V34, P355, DOI 10.1385/MB:34:3:355; Liden G, 2002, BIOPROC BIOSYST ENG, V24, P273, DOI 10.1007/s004490100263; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/NCHEMBIO.436, 10.1038/nchembio.436]; Litsanov B, 2012, MICROB BIOTECHNOL, V5, P116, DOI [10.1111/j.1751-7915.2011.00310.x, 10.1111/j.1751-7915.2012.00347.x]; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Michener JK, 2012, METAB ENG, V14, P212, DOI 10.1016/j.ymben.2011.09.004; Muller S, 2010, FEMS MICROBIOL REV, V34, P554, DOI 10.1111/j.1574-6976.2010.00214.x; Muller S, 2010, CURR OPIN BIOTECH, V21, P100, DOI 10.1016/j.copbio.2010.01.002; Mustafi N, 2012, METAB ENG, V14, P449, DOI 10.1016/j.ymben.2012.02.002; Neumeyer A, 2013, MICROB BIOTECHNOL, V6, P157, DOI 10.1111/1751-7915.12018; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Radmacher E, 2002, APPL ENVIRON MICROB, V68, P2246, DOI 10.1128/AEM.68.5.2246-2250.2002; Sambrook J, 2001, MOL CLONING LAB MANU; Schafer A, 1997, GENE, V203, P95, DOI 10.1016/S0378-1119(97)00519-2; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schreiner ME, 2006, J BACTERIOL, V188, P1341, DOI 10.1128/JB.188.4.1341-1350.2006; Schreiner ME, 2005, J BACTERIOL, V187, P6005, DOI 10.1128/JB.187.17.6005-6018.2005; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Strack RL, 2009, BIOCHEMISTRY-US, V48, P9704, DOI 10.1021/bi901587v; Takors R, 2012, J BIOTECHNOL, V160, P3, DOI 10.1016/j.jbiotec.2011.12.010; Trotschel C, 2005, J BACTERIOL, V187, P3786, DOI 10.1128/JB.187.11.3786-3794.2005; Unthan S, 2014, BIOTECHNOL BIOENG, V111, P359, DOI 10.1002/bit.25103; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Wendisch V. F., 2007, AMINO ACID BIOSYNTHE; Yin L, 2013, J APPL MICROBIOL, V114, P1369, DOI 10.1111/jam.12141; Zhang FZ, 2011, TRENDS MICROBIOL, V19, P323, DOI 10.1016/j.tim.2011.05.003	52	78	83	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85731	10.1371/journal.pone.0085731	http://dx.doi.org/10.1371/journal.pone.0085731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465669	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000056
J	Sun, Y; Yang, YX; Zeng, SC; Tan, YQ; Lu, GX; Lin, G				Sun, Yi; Yang, Yixuan; Zeng, Sicong; Tan, Yueqiu; Lu, Guangxiu; Lin, Ge			Identification of Proteins Related to Epigenetic Regulation in the Malignant Transformation of Aberrant Karyotypic Human Embryonic Stem Cells by Quantitative Proteomics	PLOS ONE			English	Article							CARCINOMA-CELLS; COPY NUMBER; DNA METHYLTRANSFERASES; PROMYELOCYTIC LEUKEMIA; HISTONE DEACETYLASES; GENOMIC INSTABILITY; EXPRESSED PROTEINS; GASTRIC-CANCER; SELF-RENEWAL; BETA-CATENIN	Previous reports have demonstrated that human embryonic stem cells (hESCs) tend to develop genomic alterations and progress to a malignant state during long-term in vitro culture. This raises concerns of the clinical safety in using cultured hESCs. However, transformed hESCs might serve as an excellent model to determine the process of embryonic stem cell transition. In this study, ITRAQ-based tandem mass spectrometry was used to quantify normal and aberrant karyotypic hESCs proteins from simple to more complex karyotypic abnormalities. We identified and quantified 2583 proteins, and found that the expression levels of 316 proteins that represented at least 23 functional molecular groups were significantly different in both normal and abnormal hESCs. Dysregulated protein expression in epigenetic regulation was further verified in six pairs of hESC lines in early and late passage. In summary, this study is the first large-scale quantitative proteomic analysis of the malignant transformation of aberrant karyotypic hESCs. The data generated should serve as a useful reference of stem cell-derived tumor progression. Increased expression of both HDAC2 and CTNNB1 are detected as early as the pre-neoplastic stage, and might serve as prognostic markers in the malignant transformation of hESCs.	[Sun, Yi; Zeng, Sicong; Tan, Yueqiu; Lu, Guangxiu; Lin, Ge] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China; [Sun, Yi; Tan, Yueqiu; Lu, Guangxiu; Lin, Ge] Natl Engn & Res Ctr Human Stem Cells, Changsha, Hunan, Peoples R China; [Sun, Yi; Tan, Yueqiu; Lin, Ge] Minist Hlth, Key Lab Stem Cells & Reprod Engn, Changsha, Hunan, Peoples R China; [Yang, Yixuan] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ China, Affiliated Hosp 2, Chongqing, Peoples R China	Central South University; Chongqing Medical University; Ministry of Education, China	Lu, GX (corresponding author), Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China.	lugxdirector@aliyun.com; linggf@hotmail.com	yang, yx/GZM-0464-2022	Sun, Yi/0000-0001-9238-976X	National Basic Research Program of China (973 program) [2011CB964900]; National Natural Science Foundation of China [81101510]; Natural Science Foundation of Hunan Province [14JJ2004, 09JJ4009]; Research Fund for the Doctoral Program of Higher Education of China [200805331133]; National High Technology Research and Development Program of China (863 program) [2006AA02A102]; Fundamental Research Funds for the Central Universities [201012200219]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (973 program 2011CB964900), the National Natural Science Foundation of China (81101510), the Natural Science Foundation of Hunan Province (14JJ2004 and 09JJ4009), the Research Fund for the Doctoral Program of Higher Education of China (200805331133), National High Technology Research and Development Program of China (863 program 2006AA02A102), and the Fundamental Research Funds for the Central Universities (201012200219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; ANDREWS PW, 1984, LAB INVEST, V50, P147; Aranda P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007809; Asplund A, 2012, PROTEOMICS, V12, P2067, DOI 10.1002/pmic.201100504; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Chaerkady R, 2010, PROTEOMICS, V10, P1359, DOI 10.1002/pmic.200900483; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Fathi A, 2009, PROTEOMICS, V9, P4859, DOI 10.1002/pmic.200900003; Geiman TM, 2004, BIOCHEM BIOPH RES CO, V318, P544, DOI 10.1016/j.bbrc.2004.04.058; Gerwe BA, 2011, PROTEOMICS, V11, P2515, DOI 10.1002/pmic.201000032; Giudice FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058672; Gu YF, 2013, ONCOL LETT, V5, P452, DOI 10.3892/ol.2012.1057; Guo T, 2008, J PROTEOME RES, V7, P4831, DOI 10.1021/pr800403z; Hack Catherine Jane, 2004, Briefings in Functional Genomics & Proteomics, V3, P212, DOI 10.1093/bfgp/3.3.212; Hatzimichael E, 2013, J DRUG DELIV, V2013, DOI 10.1155/2013/529312; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Rodriguez-Jimenez FJ, 2008, STEM CELLS, V26, P2052, DOI 10.1634/stemcells.2007-1016; Kim JK, 2013, MOL CANCER RES, V11, P62, DOI 10.1158/1541-7786.MCR-12-0332; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Lin G, 2009, CELL STEM CELL, V5, P461, DOI 10.1016/j.stem.2009.10.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz P, 2003, PROTEOMICS, V3, P991, DOI 10.1002/pmic.200300412; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Macia A, 2011, MOL CELL BIOL, V31, P300, DOI 10.1128/MCB.00561-10; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mantel C, 2007, BLOOD, V109, P4518, DOI 10.1182/blood-2006-10-054247; Martens-de Kemp SR, 2013, CLIN CANCER RES, V19, P1994, DOI 10.1158/1078-0432.CCR-12-2539; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Nishimura Y, 2013, BRIT J CANCER, V108, P1324, DOI 10.1038/bjc.2013.65; Noh JH, 2013, CANCER LETT, V335, P455, DOI 10.1016/j.canlet.2013.03.003; O'Brien RN, 2010, MOL CELL PROTEOMICS, V9, P2238, DOI 10.1074/mcp.M110.000281; Papachristou EK, 2013, J PROTEOME RES, V12, P2078, DOI 10.1021/pr301067r; Pierce A, 2008, MOL CELL PROTEOMICS, V7, P853, DOI 10.1074/mcp.M700251-MCP200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SHAFFER LG, 2013, ISCN 2013 INT SYSTEM, P140; Sun Y, 2007, FEBS LETT, V581, P131, DOI 10.1016/j.febslet.2006.12.008; Thakur R, 2013, J CELL MOL MED, V17, P449, DOI 10.1111/jcmm.12033; Turner-Ivey B, 2013, ONCOGENE, DOI [10.1038/onc.2012.624, DOI 10.1038/0NC.2012.624]; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wang DJ, 2004, J PROTEOME RES, V3, P627, DOI 10.1021/pr049976r; Xie CQ, 2004, BIOCHEM BIOPH RES CO, V315, P581, DOI 10.1016/j.bbrc.2004.01.089; Yang S, 2010, CELL PROLIFERAT, V43, P195, DOI 10.1111/j.1365-2184.2010.00669.x; Yang S, 2008, GENE CHROMOSOME CANC, V47, P665, DOI 10.1002/gcc.20574; Yang YX, 2012, J PROTEOME RES, V11, P5736, DOI 10.1021/pr300555y; Yang YX, 2010, J PROTEOME RES, V9, P4767, DOI 10.1021/pr100492x; Zhang XY, 2013, CELL CYCLE, V12, P1279, DOI 10.4161/cc.24364; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102; Zhou D, 2009, CELL BIOL INT, V33, P796, DOI 10.1016/j.cellbi.2009.04.008	60	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85823	10.1371/journal.pone.0085823	http://dx.doi.org/10.1371/journal.pone.0085823			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465727	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000066
J	Mi, Y; Wang, LJ; Zong, L; Pei, ML; Lu, QY; Huang, P				Mi, Yang; Wang, Lijuan; Zong, Lu; Pei, Meili; Lu, Qingyang; Huang, Pu			Genetic Variants in microRNA Target Sites of 37 Selected Cancer-Related Genes and the Risk of Cervical Cancer	PLOS ONE			English	Article							REGULATORY T-CELLS; BREAST-CANCER; BINDING SITES; EXPRESSION; TUMOR; INTERLEUKIN-16; POLYMORPHISMS; ASSOCIATION; INFLAMMATION; PROGRESSION	Objectives: Single nucleotide polymorphisms (SNPs) in putative microRNA binding sites (miRSNPs) modulate cancer susceptibility via affecting miRNA binding. Here, we sought to investigate the association between miRSNPs and cervical cancer risk. Methods: We first genotyped 41 miRSNPs of 37 cancer-related genes in 338 patients and 334 controls (Study 1), and replicated the significant associations in 502 patients and 600 controls (Study 2). We tested the effects of miRSNPs on microRNA-mRNA interaction by luciferase reporter assay. Results: Five SNPs displayed notable association with cervical cancer risk in Study 1. Only IL-16 rs1131445 maintained a significant association with cervical cancer (CT/CC vs. TT, adjusted OR = 1.51, P = 0.001) in Study 2. This association was more evident in the combined data of two studies (adjusted OR = 1.49, P = 0.00007). We also found that miR-135b mimics interacted with IL-16 3'-UTR to reduce gene expression and that the rs1131445 T to C substitution within the putative binding site impaired the interaction of miR-135b with IL-16 3'-UTR. An ELISA indicated that the serum IL-16 of patients with cervical cancer was elevated (vs. controls, P = 0.001) and correlated with the rs1131445 genotype. Patients who carried the rs1131445 C allele had higher serum IL-16 than non-carriers (P, 0.001). Conclusions: These results support our hypothesis that miRSNPs constitute a susceptibility factor for cervical cancers. rs1131445 affects IL-16 expression by interfering with the suppressive function of miR135b and this variant is significantly associated with cervical cancer risk.	[Mi, Yang] Maternal & Child Hlth Hosp Shaanxi Prov, Obstet Dept, Xian, Shaanxi, Peoples R China; [Mi, Yang; Wang, Lijuan; Zong, Lu; Huang, Pu] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian 710049, Shaanxi, Peoples R China; [Lu, Qingyang] Liaocheng Peoples Hosp, Dept Pathol, Liaocheng, Shandong, Peoples R China	Xi'an Jiaotong University	Wang, LJ (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian 710049, Shaanxi, Peoples R China.	ljwangdr@gmail.com; pu_huang_xjtu@163.com			Xi'an Science and Technology Research Program [XASTR1125]; Scientific Research Foundation for the Returned Overseas Chinese Scholars(State Education Ministry)	Xi'an Science and Technology Research Program; Scientific Research Foundation for the Returned Overseas Chinese Scholars(State Education Ministry)(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by Xi'an Science and Technology Research Program (Grants XASTR1125), the Scientific Research Foundation for the Returned Overseas Chinese Scholars(State Education Ministry)'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	BELLINI A, 1993, J ALLERGY CLIN IMMUN, V92, P412, DOI 10.1016/0091-6749(93)90120-5; Boccardo E, 2010, CARCINOGENESIS, V31, P1905, DOI 10.1093/carcin/bgq176; Brendle A, 2008, CARCINOGENESIS, V29, P1394, DOI 10.1093/carcin/bgn126; Carlsson A, 2011, P NATL ACAD SCI USA, V108, P14252, DOI 10.1073/pnas.1103125108; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Compagni A, 2000, BRIT J CANCER, V83, P1; Comperat E, 2010, PROSTATE, V70, P1622, DOI 10.1002/pros.21197; CRUIKSHANK W, 1982, J IMMUNOL, V128, P2569; Cruikshank W, 2008, CRIT REV IMMUNOL, V28, P467; Deftereos G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028423; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Ferguson R, 2012, INT J CANCER, V131, pE312, DOI 10.1002/ijc.27356; FRIEDL F, 1970, P SOC EXP BIOL MED, V135, P543; Fukuda Koji, 2012, Front Biosci (Schol Ed), V4, P787; Gardiner Jr WCM, 2010, INFECT AGENTS CANCER, V5, pA55, DOI DOI 10.1186/1750-9378-5-S1-A55; Guan XX, 2013, FASEB J, V27, P1404, DOI 10.1096/fj.12-223420; Hammes LS, 2007, GYNECOL ONCOL, V105, P157, DOI 10.1016/j.ygyno.2006.11.023; Hiura T, 2005, J IMMUNOL, V175, P5058, DOI 10.4049/jimmunol.175.8.5058; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kovacs E, 2001, BIOMED PHARMACOTHER, V55, P111, DOI 10.1016/S0753-3322(00)00023-8; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Liebrich M, 2007, ARCH IMMUNOL THER EX, V55, P41, DOI 10.1007/s00005-007-0003-0; Lu Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001149; Magnusson PKE, 1999, NATURE, V400, P29, DOI 10.1038/21801; Mathy NL, 2000, IMMUNOLOGY, V100, P63, DOI 10.1046/j.1365-2567.2000.00997.x; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Milke L, 2013, CARCINOGENESIS, V34, P850, DOI 10.1093/carcin/bgs387; Naccarati A, 2012, CARCINOGENESIS, V33, P1346, DOI 10.1093/carcin/bgs172; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Safaeian M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033619; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Shi TY, 2013, CARCINOGENESIS, V34, P770, DOI 10.1093/carcin/bgt001; van der Burg SH, 2007, P NATL ACAD SCI USA, V104, P12087, DOI 10.1073/pnas.0704672104; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang SS, 2009, CANCER EPIDEM BIOMAR, V18, P113, DOI 10.1158/1055-9965.EPI-08-0591; WANG SS, 2003, J NATL CANC I MONOGR, V31, P35, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003480; Xie H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046990; Yellapa A, 2012, INT J GYNECOL CANCER, V22, P199, DOI 10.1097/IGC.0b013e318236a27b; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026	42	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86061	10.1371/journal.pone.0086061	http://dx.doi.org/10.1371/journal.pone.0086061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465869	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100101
J	Zhang, YC; Lu, L; Jia, JP; Jia, LF; Geula, C; Pei, JJ; Xu, ZQ; Qin, W; Liu, RQ; Li, D; Pan, N				Zhang, Yichi; Lu, Lu; Jia, Jianping; Jia, Longfei; Geula, Changiz; Pei, Jinjing; Xu, Zhiqing; Qin, Wei; Liu, Ruiqin; Li, Dan; Pan, Na			A Lifespan Observation of a Novel Mouse Model: In Vivo Evidence Supports A beta Oligomer Hypothesis	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; TRANSGENIC MICE; TAU-HYPERPHOSPHORYLATION; SYNAPSE LOSS; NEURON LOSS; MUTANT PRESENILIN-1; NATURAL OLIGOMERS; MEMORY DEFICITS; BRAINS	Transgenic mouse models are powerful tools in exploring the mechanisms of AD. Most current transgenic models of AD mimic the memory impairment and the main pathologic features, among which the formation of beta-amyloid (A beta) plaques is considered a dominant pathologic event. Recently, A beta oligomers have been identified as more neurotoxic than A beta plaques. However, no ideal transgenic mouse model directly support A beta oligomers as a neurotoxic species due to the puzzling effects of amyloid plaques in the more widely-used models. Here, we constructed a single-mutant transgenic (Tg) model harboring the PS1(V97L) mutation and used Non-Tg littermates as a control group. Employing the Morris water maze, electrophysiology, immunohistochemistry, biochemistry, and electron microscopy, we investigated behavioral changes and pathology progression in our single-mutant transgenic model. We discovered the pathological alteration of intraneuronal accumulation of A beta oligomers without A beta plaques in the PS1(V97L)-Tg mouse model, which might be the result of PS1 gene mutation. Following A beta oligomers, we detected synaptic alteration, tau hyperphosphorylation and glial activation. This model supports an initial role for A beta oligomers in the onset of AD and suggests that A beta plaques may not be the only prerequisite. This model provides a useful tool for studying the role of A beta oligomers in AD pathogenesis.	[Zhang, Yichi; Lu, Lu; Jia, Jianping; Qin, Wei; Liu, Ruiqin; Li, Dan] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China; [Jia, Jianping; Qin, Wei; Liu, Ruiqin; Li, Dan] Beijing Key Lab Geriatr Cognit Disorders, Beijing, Peoples R China; [Jia, Jianping; Qin, Wei; Liu, Ruiqin; Li, Dan] Minist Educ Peoples Republ China, Key Neurodegenerat Lab, Beijing, Peoples R China; [Jia, Longfei] Capital Med Univ, Beijing Tong Ren Hosp, Dept Neurol, Beijing, Peoples R China; [Pei, Jinjing] Karolinska Inst, Dept Neurobiol, Stockholm, Sweden; [Geula, Changiz] Northwestern Univ, Lab Cognit & Mol Morphometry, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA; [Xu, Zhiqing; Pan, Na] Capital Med Univ, Dept Neurobiol, Beijing, Peoples R China	Capital Medical University; Ministry of Education, China; Capital Medical University; Karolinska Institutet; Northwestern University; Capital Medical University	Jia, JP (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China.	jiajp@vip.126.com	Xu, Zhi-Qing David/H-9757-2013	Xu, Zhi-Qing David/0000-0002-0387-7559	CHINA-CANADA Joint Initiative on Alzheimer's Disease and Related Disorders [812111340]; National Science and Technology Major Projects for "Major New Drug Innovation and Development" of the Twelfth 5-year Plan Period [2011ZX09307-001-02]; Science and Technology Plan of the Beijing Municipal Science & Technology Commission [SCW 2011-10]	CHINA-CANADA Joint Initiative on Alzheimer's Disease and Related Disorders; National Science and Technology Major Projects for "Major New Drug Innovation and Development" of the Twelfth 5-year Plan Period; Science and Technology Plan of the Beijing Municipal Science & Technology Commission	This work was supported by CHINA-CANADA Joint Initiative on Alzheimer's Disease and Related Disorders (812111340), the National Science and Technology Major Projects for "Major New Drug Innovation and Development" of the Twelfth 5-year Plan Period (2011ZX09307-001-02), and the major project of the Science and Technology Plan of the Beijing Municipal Science & Technology Commission (SCW 2011-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alafuzoff I, 2006, J NEUROPATH EXP NEUR, V65, P740, DOI 10.1097/01.jnen.0000229986.17548.27; ALLSOP D, 1988, P NATL ACAD SCI USA, V85, P2790, DOI 10.1073/pnas.85.8.2790; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Bussiere T, 2004, AM J PATHOL, V165, P987, DOI 10.1016/S0002-9440(10)63360-3; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Ferretti MT, 2012, NEUROBIOL AGING, V33, P1329, DOI 10.1016/j.neurobiolaging.2011.01.007; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jankowsky JL, 2007, J BIOL CHEM, V282, P22707, DOI 10.1074/jbc.M611050200; Jia JP, 2005, J ALZHEIMERS DIS, V7, P119; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Leon WC, 2010, J ALZHEIMERS DIS, V20, P113, DOI 10.3233/JAD-2010-1349; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Mathis DM, 2011, JOVE-J VIS EXP, DOI 10.3791/2330; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PIKE CJ, 1991, EUR J PHARM-MOLEC PH, V207, P367, DOI 10.1016/0922-4106(91)90014-9; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; SELKOE DJ, 1989, CELL, V58, P611, DOI 10.1016/0092-8674(89)90093-7; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang Y, 2012, J NEUROCHEM, V121, P135, DOI 10.1111/j.1471-4159.2011.07489.x; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhang B, 2004, J NEUROSCI, V24, P4657, DOI 10.1523/JNEUROSCI.0797-04.2004; Zheng K, 2005, NEUROPEPTIDES, V39, P259, DOI 10.1016/j.npep.2005.02.005	64	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85885	10.1371/journal.pone.0085885	http://dx.doi.org/10.1371/journal.pone.0085885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465766	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500136
J	Zawaski, C; Busov, VB				Zawaski, Christine; Busov, Victor B.			Roles of Gibberellin Catabolism and Signaling in Growth and Physiological Response to Drought and Short-Day Photoperiods in Populus Trees	PLOS ONE			English	Article							SHOOT ELONGATION; SALIX PENTANDRA; DELLA PROTEINS; ABIOTIC STRESS; CHLOROPHYLL-A; ROOT-GROWTH; ARABIDOPSIS; BIOSYNTHESIS; POPLAR; PLANTS	Survival and productivity of perennial plants in temperate zones are dependent on robust responses to prolonged and seasonal cycles of unfavorable conditions. Here we report whole-genome microarray, expression, physiological, and transgenic evidence in hybrid poplar (Populus tremula x Populus alba) showing that gibberellin (GA) catabolism and repressive signaling mediates shoot growth inhibition and physiological adaptation in response to drought and short-day (SD) induced bud dormancy. Both water deprivation and SDs elicited activation of a suite of poplar GA2ox and DELLA encoding genes. Poplar transgenics with up-regulated GA 2-oxidase (GA2ox) and DELLA domain proteins showed hypersensitive growth inhibition in response to both drought and SDs. In addition, the transgenic plants displayed greater drought resistance as evidenced by increased pigment concentrations (chlorophyll and carotenoid) and reductions in electrolyte leakage (EL). Comparative transcriptome analysis using whole-genome microarray showed that the GA-deficiency and GA-insensitivity, SD-induced dormancy, and drought response in poplar share a common regulon of 684 differentially-expressed genes, which suggest GA metabolism and signaling plays a role in plant physiological adaptations in response to alterations in environmental factors. Our results demonstrate that GA catabolism and repressive signaling represents a major route for control of growth and physiological adaptation in response to immediate or imminent adverse conditions.	[Zawaski, Christine; Busov, Victor B.] Michigan Technol Univ, Sch Forest Res & Environm Sci, Houghton, MI 49931 USA	Michigan Technological University	Busov, VB (corresponding author), Michigan Technol Univ, Sch Forest Res & Environm Sci, Houghton, MI 49931 USA.	vbusov@mtu.edu			US Department of Energy (DOE); Poplar Genome Based Research for Carbon Sequestration in Terrestrial Ecosystems [DE-FG02-06ER64185, DE-FG02-05ER64113]; Consortium for Plant Biotechnology Research, Inc. [GO12026-203A]; United States Department of Agriculture (USDA) CSREES; USDA-NRI Plant Genome program [2003-04345]; USDA CSREES; Biotechnology Risk Assessment Research Grants Program [2004-35300-14687]; Plant Feedstock Genomics for Bioenergy: A Joint Research Program of USDA and DOE [2009-65504-05767, ER65454-1040591-0018445]	US Department of Energy (DOE)(United States Department of Energy (DOE)); Poplar Genome Based Research for Carbon Sequestration in Terrestrial Ecosystems; Consortium for Plant Biotechnology Research, Inc.; United States Department of Agriculture (USDA) CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA-NRI Plant Genome program; USDA CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Biotechnology Risk Assessment Research Grants Program; Plant Feedstock Genomics for Bioenergy: A Joint Research Program of USDA and DOE	This work was supported in part by grants from the US Department of Energy (DOE), Poplar Genome Based Research for Carbon Sequestration in Terrestrial Ecosystems (DE-FG02-06ER64185, DE-FG02-05ER64113), the Consortium for Plant Biotechnology Research, Inc. (GO12026-203A), the United States Department of Agriculture (USDA) CSREES, the USDA-NRI Plant Genome program (2003-04345) and USDA CSREES, the Biotechnology Risk Assessment Research Grants Program (2004-35300-14687), Plant Feedstock Genomics for Bioenergy: A Joint Research Program of USDA and DOE (2009-65504-05767, ER65454-1040591-0018445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2009, J EXP BOT, V60, P1085, DOI 10.1093/jxb/ern301; Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Achard P, 2007, PLANT PHYSIOL, V143, P1163, DOI 10.1104/pp.106.092254; Achard P, 2009, CURR BIOL, V19, P1188, DOI 10.1016/j.cub.2009.05.059; Alabadi D, 2004, PLANT PHYSIOL, V134, P1050, DOI 10.1104/pp.103.035451; Arrigoni O, 2000, J PLANT PHYSIOL, V157, P481, DOI 10.1016/S0176-1617(00)80102-9; ASHRAF M, 1994, CRIT REV PLANT SCI, V13, P17, DOI 10.1080/713608051; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Biemelt S, 2004, PLANT PHYSIOL, V135, P254, DOI 10.1104/pp.103.036988; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouvier-Nave P, 2010, PLANT PHYSIOL, V152, P107, DOI 10.1104/pp.109.145672; Burke EJ, 2006, J HYDROMETEOROL, V7, P1113, DOI 10.1175/JHM544.1; Busov V, 2006, PLANTA, V224, P288, DOI 10.1007/s00425-005-0213-9; Busov VB, 2003, PLANT PHYSIOL, V132, P1283, DOI 10.1104/pp.103.020354; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; Claeys H, 2012, PLANT PHYSIOL, V159, P739, DOI 10.1104/pp.112.195032; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Elias AA, 2012, PLANT PHYSIOL, V160, P1130, DOI 10.1104/pp.112.200741; Fang J, 2008, PLANT J, V54, P177, DOI 10.1111/j.1365-313X.2008.03411.x; Faver KL, 1996, CROP SCI, V36, P922, DOI 10.2135/cropsci1996.0011183X003600040018x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Gou JQ, 2011, NEW PHYTOL, V192, P626, DOI 10.1111/j.1469-8137.2011.03837.x; Gou JQ, 2010, PLANT CELL, V22, P623, DOI 10.1105/tpc.109.073239; Hedden P, 2012, BIOCHEM J, V444, P11, DOI 10.1042/BJ20120245; Hoffman A. A., 1993, EVOLUTIONARY GENETIC; Itoh H, 2005, PLANT J, V44, P669, DOI 10.1111/j.1365-313X.2005.02562.x; JUNTTILA O, 1988, PHYSIOL PLANTARUM, V74, P371, DOI 10.1111/j.1399-3054.1988.tb00645.x; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; MATHIS JN, 1989, PLANT PHYSIOL, V91, P19, DOI 10.1104/pp.91.1.19; Mauriat M, 2011, PLANT J, V67, P805, DOI 10.1111/j.1365-313X.2011.04635.x; Oerke EC, 2004, CROP PROT, V23, P275, DOI 10.1016/j.cropro.2003.10.001; Olsen JE, 1995, PHYSIOL PLANTARUM, V95, P627, DOI 10.1111/j.1399-3054.1995.tb05532.x; OLSEN JE, 1995, PHYSIOL PLANTARUM, V93, P639, DOI 10.1111/j.1399-3054.1995.tb05111.x; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Ortiz R, 2008, ANN ARID ZONE, V47, P1; Percival Glynn C., 2001, Journal of Arboriculture, V27, P233; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Ren J, 2006, TREE PHYSIOL, V26, P665, DOI 10.1093/treephys/26.5.665; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Rohde A, 2002, PLANT CELL, V14, P1885, DOI 10.1105/tpc.003186; Rohde A, 2007, TRENDS PLANT SCI, V12, P217, DOI 10.1016/j.tplants.2007.03.012; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Tanimoto E, 2012, ANN BOT-LONDON, V110, P373, DOI 10.1093/aob/mcs049; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Vasil IK, 1998, NAT BIOTECHNOL, V16, P399, DOI 10.1038/nbt0598-399; Vaughton G, 2001, AM J BOT, V88, P1223, DOI 10.2307/3558333; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wen CK, 2002, PLANT CELL, V14, P87, DOI 10.1105/tpc.010325; Wilkins O, 2009, PLANT J, V60, P703, DOI 10.1111/j.1365-313X.2009.03993.x; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Zawaski C, 2011, PLANTA, V234, P1285, DOI 10.1007/s00425-011-1485-x; Zawaski C, 2011, NEW PHYTOL, V191, P678, DOI 10.1111/j.1469-8137.2011.03742.x; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	66	64	74	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86217	10.1371/journal.pone.0086217	http://dx.doi.org/10.1371/journal.pone.0086217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465967	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500120
J	Brunamonti, E; Chiricozzi, FR; Clausi, S; Olivito, G; Giusti, MA; Molinari, M; Ferraina, S; Leggio, M				Brunamonti, Emiliano; Chiricozzi, Francesca R.; Clausi, Silvia; Olivito, Giusy; Giusti, Maria Assunta; Molinari, Marco; Ferraina, Stefano; Leggio, Maria			Cerebellar Damage Impairs Executive Control and Monitoring of Movement Generation	PLOS ONE			English	Article							RESPONSE-INHIBITION; BASAL GANGLIA; COGNITIVE CONTROL; SUBCORTICAL CONTRIBUTIONS; FUNCTIONAL-SIGNIFICANCE; GENDER-DIFFERENCES; PREMOTOR CORTEX; ERROR-DETECTION; NORMALIZATION; PERFORMANCE	Executive control of motor responses is a psychological construct of the executive system. Several studies have demonstrated the involvement of the cerebral cortex, basal ganglia, and thalamus in the inhibition of actions and monitoring of performance. The involvement of the cerebellum in cognitive function and its functional interaction with basal ganglia have recently been reported. Based on these findings, we examined the hypothesis of cerebellar involvement in executive control by administering a countermanding task in patients with focal cerebellar damage. The countermanding task requires one to make a movement in response to a 'go' signal and to halt it when a 'stop' signal is presented. The duration of the go process (reaction time; RT), the duration of the stop process (stop signal reaction time; SSRT), and their relationship, expressed by a psychometric function, are recorded as measures of executive control. All patients had longer go process duration in general and in particular, as a proactive control, as demonstrated by the increase in RT after erroneously performed stop trials. Further, they were defective in the slope of the psychometric function indicating a difficulty on triggering the stop process, although the SSRT did not differ from controls. Notably, their performance was worse when lesions affected deep cerebellar nuclei. Our results support the hypothesis that the cerebellum regulates the executive control of voluntary actions. We speculate that its activity is attributed to specific cerebellar influence over the cortico-striatal loop.	[Brunamonti, Emiliano; Giusti, Maria Assunta; Ferraina, Stefano] Univ Roma La Sapienza, Dept Physiol & Pharmacol, I-00185 Rome, Italy; [Chiricozzi, Francesca R.; Clausi, Silvia; Olivito, Giusy; Leggio, Maria] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Chiricozzi, Francesca R.; Clausi, Silvia; Olivito, Giusy; Molinari, Marco; Leggio, Maria] IRCCS Santa Lucia Fdn, Ataxia Res Lab, Rome, Italy	Sapienza University Rome; Sapienza University Rome; IRCCS Santa Lucia	Ferraina, S (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	stefano.ferraina@uniroma1.it; maria.leggio@uniroma1.it	Olivito, Giusy/J-8733-2018; Leggio, Maria G/D-1269-2010; Clausi, Silvia/T-8443-2017; Molinari, Marco/A-9624-2010; ferraina, stefano/M-5230-2018	Olivito, Giusy/0000-0001-5832-8402; Leggio, Maria G/0000-0003-3750-2760; Clausi, Silvia/0000-0001-8721-1799; Molinari, Marco/0000-0001-9808-9688; ferraina, stefano/0000-0001-6100-2438; Brunamonti, Emiliano/0000-0002-5119-6950	Italian Ministry of Health [RC08G-]; Italian National Institute of Health (ISS) [11US/38A]	Italian Ministry of Health(Ministry of Health, Italy); Italian National Institute of Health (ISS)	This study was supported by Italian Ministry of Health grants (RC08G- to MM, and ML, in part) and by the Italian National Institute of Health (ISS; project BRUCOS grant agreement 11US/38A to SF, in part). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; APPOLLONIO IM, 1993, NEUROLOGY, V43, P1536, DOI 10.1212/WNL.43.8.1536; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aron AR, 2009, ENCY NEUROSCIENCE, V2, P1069; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Beste C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000086; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bostan AC, 2010, NEUROPSYCHOL REV, V20, P261, DOI 10.1007/s11065-010-9143-9; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Brunamonti E, 2012, NEUROSCIENCE, V215, P69, DOI 10.1016/j.neuroscience.2012.04.051; Brunamonti E, 2011, RES DEV DISABIL, V32, P1792, DOI 10.1016/j.ridd.2011.03.008; Brunia CHM, 2003, ERRORS CONFLICTS BRA; Carlesimo GA, 1996, NEUROPSYCHOLOGIA, V34, P785, DOI 10.1016/0028-3932(95)00162-X; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Clausi S, 2009, NEUROSCIENCE, V162, P827, DOI 10.1016/j.neuroscience.2009.02.001; Corsi P.M., 1972, THESIS MCGILL U MONT; Courchesne E, 1997, LEARN MEMORY, V4, P1, DOI 10.1101/lm.4.1.1; Diedrichsen J, 2011, NEUROIMAGE, V54, P1786, DOI 10.1016/j.neuroimage.2010.10.035; Dimitrova A, 2006, NEUROIMAGE, V30, P12, DOI 10.1016/j.neuroimage.2005.09.020; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Duque J, 2003, BRAIN, V126, P732, DOI 10.1093/brain/awg069; Ebner T, 2008, CEREBELLUM, V7, P583, DOI 10.1007/s12311-008-0059-3; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; GAINOTTI G, 1977, CORTEX, V13, P109, DOI 10.1016/S0010-9452(77)80002-6; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Habas C, 2010, CEREBELLUM, V9, P22, DOI 10.1007/s12311-009-0119-3; Holmes G, 1939, BRAIN, V62, P1, DOI 10.1093/brain/62.1.1; Ide JS, 2011, NEUROIMAGE, V54, P455, DOI 10.1016/j.neuroimage.2010.07.042; Ilg W, 2008, BRAIN, V131, P2913, DOI 10.1093/brain/awn246; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Ito M, 1984, CEREBELLUM NEURAL CO; Justus T, 2004, J COGNITIVE NEUROSCI, V16, P1115, DOI 10.1162/0898929041920513; Leggio MG, 2008, BRAIN, V131, P1332, DOI 10.1093/brain/awn040; Leggio MG, 2000, J NEUROL NEUROSUR PS, V69, P102, DOI 10.1136/jnnp.69.1.102; Li CSR, 2008, NEUROIMAGE, V41, P1352, DOI 10.1016/j.neuroimage.2008.04.023; Li CSR, 2006, NEUROIMAGE, V32, P1918, DOI 10.1016/j.neuroimage.2006.05.017; Li CSR, 2009, BRAIN IMAGING BEHAV, V3, P262, DOI 10.1007/s11682-009-9068-1; Logan GD, 1984, INHIBITORY PROCESSES, P189; Luciani L, 1891, CERVELLETTO NUOVE ST; Marcos E, 2013, NEURON, V78, P249, DOI 10.1016/j.neuron.2013.02.006; Miall RC, 1998, NOVART FDN SYMP, V218, P272; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mirabella G, 2011, J NEUROPHYSIOL, V106, P1454, DOI 10.1152/jn.00995.2010; Mirabella G, 2009, EXP BRAIN RES, V192, P199, DOI 10.1007/s00221-008-1570-y; Molinari M, 2004, J NEUROL NEUROSUR PS, V75, P235; Molinari M, 2005, BRAIN RES BULL, V67, P448, DOI 10.1016/j.brainresbull.2005.07.014; Molinari M, 1997, BRAIN, V120, P1753, DOI 10.1093/brain/120.10.1753; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Nambu A, 1996, J NEUROSCI, V16, P2671; Neau JP, 2000, ACTA NEUROL SCAND, V102, P363, DOI 10.1034/j.1600-0404.2000.102006363.x; Raven JC, 1949, SETS A AB B BOARD BO; Reichenberg Abraham, 2010, Dialogues Clin Neurosci, V12, P383; Restuccia D, 2007, BRAIN, V130, P276, DOI 10.1093/brain/awl236; Rey A., 1958, LEXAMEN CLINIQUE PSY; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; Schall JD, 2012, CURR OPIN NEUROBIOL, V22, P1012, DOI 10.1016/j.conb.2012.06.002; Schlerf J, 2012, J NEUROSCI, V32, P4913, DOI 10.1523/JNEUROSCI.4504-11.2012; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Silveri MC, 1998, BRAIN, V121, P2175, DOI 10.1093/brain/121.11.2175; Tanaka H, 2003, NEUROPSYCHOBIOLOGY, V47, P206, DOI 10.1159/000071216; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; Thoma P, 2008, BEHAV BRAIN RES, V194, P214, DOI 10.1016/j.bbr.2008.07.016; Tu PC, 2006, J PSYCHIATR RES, V40, P606, DOI 10.1016/j.jpsychires.2006.05.012; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; van Mier H, 1998, J NEUROPHYSIOL, V80, P2177, DOI 10.1152/jn.1998.80.4.2177; Van Mier HI, 2002, ANN NY ACAD SCI, V978, P334; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; VILLA G, 1990, CORTEX, V26, P399, DOI 10.1016/S0010-9452(13)80089-5; Willemssen R, 2008, J NEURAL TRANSM, V115, P461, DOI 10.1007/s00702-007-0842-1; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Zar J.H., 2009, BIOSTATISTICAL ANAL	80	49	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85997	10.1371/journal.pone.0085997	http://dx.doi.org/10.1371/journal.pone.0085997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465830	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000081
J	Comstock, SS; Hortos, K; Kovan, B; McCaskey, S; Pathak, DR; Fenton, JI				Comstock, Sarah S.; Hortos, Kari; Kovan, Bruce; McCaskey, Sarah; Pathak, Dorothy R.; Fenton, Jenifer I.			Adipokines and Obesity Are Associated with Colorectal Polyps in Adult Males: A Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; VISCERAL FAT ACCUMULATION; C-REACTIVE PROTEIN; LIFE-STYLE FACTORS; CANCER-RISK; ADIPONECTIN LEVELS; SERUM INTERLEUKIN-6; PLASMA ADIPONECTIN; SERRATED POLYPS; LEPTIN RECEPTOR	Background: Obesity increases the risk of colon cancer. It is also known that most colorectal cancers develop from adenomatous polyps. However, the effects of obesity and adipokines on colonic polyp formation are unknown. Methods: To determine if BMI, waist circumference or adipokines are associated with colon polyps in males, 126 asymptomatic men (48-65 yr) were recruited at time of colonoscopy, and anthropometric measures as well as blood were collected. Odds ratios were determined using polytomous logistic regression for polyp number (0 or >= 3) and polyp type (no polyp, hyperplastic polyp, tubular adenoma). Results: 41% of the men in our study were obese (BMI >= 30). The odds of an obese individual having >= 3 polyps was 6.5 (CI: 1.3-33.0) times greater than those of a lean (BMI <25) individual. Additionally, relative to lean individuals, obese individuals were 7.8 (CI: 2.0-30.8) times more likely to have a tubular adenoma than no polyp. As BMI category increased, participants were 2.9 (CI: 1.5-5.4) times more likely to have a tubular adenoma than no polyps. Serum leptin, IP-10 and TNF-alpha were significantly associated with tubular adenoma presence. Serum leptin and IP-10 were significantly associated with increased likelihood of >= 3 polyps, and TNF-alpha showed a trend (p = 0.09). Conclusions: Obese men are more likely to have at least three polyps and adenomas. This cross-sectional study provides evidence that colonoscopy should be recommended for obese, white males.	[Comstock, Sarah S.; Fenton, Jenifer I.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Hortos, Kari; Kovan, Bruce; McCaskey, Sarah; Fenton, Jenifer I.] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; [Kovan, Bruce] Profess Corp, Tricty Gastroenterol, Clinton Township, MI USA; [Pathak, Dorothy R.] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University College of Osteopathic Medicine; Michigan State University	Fenton, JI (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	imigjeni@msu.edu			National Cancer Institute [1R03CA142000]; Clinical and Translational Sciences Institute at Michigan State University; NATIONAL CANCER INSTITUTE [R03CA142000] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clinical and Translational Sciences Institute at Michigan State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding came from the National Cancer Institute 1R03CA142000 and Clinical and Translational Sciences Institute at Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Ben QW, 2012, GASTROENTEROLOGY, V142, P762, DOI 10.1053/j.gastro.2011.12.050; Birmingham JM, 2009, CARCINOGENESIS; Bobe G, 2010, CANCER EPIDEM BIOMAR, V19, P1441, DOI 10.1158/1055-9965.EPI-09-1082; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; Chia VM, 2007, CANCER EPIDEM BIOMAR, V16, P2697, DOI 10.1158/1055-9965.EPI-07-0467; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Endo H, 2011, GUT, V60, P1363, DOI 10.1136/gut.2010.235754; Erarslan E, 2009, DIGEST DIS SCI, V54, P862, DOI 10.1007/s10620-008-0440-6; Fenton JI, 2008, MOL CARCINOGEN, V47, P9, DOI 10.1002/mc.20357; Fenton JI, 2006, CARCINOGENESIS, V27, P1507, DOI 10.1093/carcin/bgl018; Fenton JI, 2005, CANCER EPIDEM BIOMAR, V14, P1646, DOI 10.1158/1055-9965.EPI-04-0916; Fenton JI, 2010, OPEN OBESITY J, V2, P23; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fu ZM, 2012, AM J EPIDEMIOL, V176, P766, DOI 10.1093/aje/kws157; Fukumoto J, 2008, CANCER SCI, V99, P781, DOI 10.1111/j.1349-7006.2008.00745.x; Groblewska M, 2008, CLIN CHEM LAB MED, V46, P1423, DOI 10.1515/CCLM.2008.278; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardwick JCH, 2001, GASTROENTEROLOGY, V121, P79, DOI 10.1053/gast.2001.25490; Harriss DJ, 2009, COLORECTAL DIS, V11, P547, DOI 10.1111/j.1463-1318.2009.01766.x; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; Herder C, 2007, INT J OBESITY, V31, P403, DOI 10.1038/sj.ijo.0803432; Herder C, 2007, J CLIN ENDOCR METAB, V92, P4569, DOI 10.1210/jc.2007-0955; Huang XF, 2009, OBES REV, V10, P610, DOI 10.1111/j.1467-789X.2009.00607.x; Il'yasova D, 2005, CANCER EPIDEM BIOMAR, V14, P2413, DOI 10.1158/1055-9965.EPI-05-0316; Jiang Z, 2010, MOL BIOL REP, V37, P3029, DOI 10.1007/s11033-009-9873-z; Kahi CJ, 2013, GASTROINTEST ENDOSC, V77, P335, DOI 10.1016/j.gie.2013.01.002; Kang M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-91; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Kumor A, 2009, INT J COLORECTAL DIS, V24, P275, DOI 10.1007/s00384-008-0605-y; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Lieberman DA, 2003, JAMA-J AM MED ASSOC, V290, P2959, DOI 10.1001/jama.290.22.2959; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Ma YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053916; Makkar R, 2012, CLEV CLIN J MED, V79, P865, DOI 10.3949/ccjm.79a.12034; Mlecnik B, 2010, GASTROENTEROLOGY, V138, P1429, DOI 10.1053/j.gastro.2009.10.057; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Morimoto LM, 2002, CANCER EPIDEM BIOMAR, V11, P1012; Murashima M, 2012, J NUTR EDUC BEHAV, V44, P556, DOI 10.1016/j.jneb.2011.05.008; Nakajima TE, 2010, CANCER SCI, V101, P1286, DOI 10.1111/j.1349-7006.2010.01518.x; Noffsinger AE, 2009, ANNU REV PATHOL-MECH, V4, P343, DOI 10.1146/annurev.pathol.4.110807.092317; Odze RD, 2010, ARCH PATHOL LAB MED, V134, P896, DOI 10.1043/1543-2165-134.6.896; Okabayashi K, 2012, AM J GASTROENTEROL, V107, P1175, DOI 10.1038/ajg.2012.180; Omata F, 2013, SCAND J GASTROENTERO, V48, P136, DOI 10.3109/00365521.2012.737364; Otake S, 2005, CLIN CANCER RES, V11, P3642, DOI 10.1158/1078-0432.CCR-04-1868; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Sandhofer A, 2003, OBES RES, V11, P760, DOI 10.1038/oby.2003.106; Sasaki Y, 2012, CLIN CANCER RES, V18, P392, DOI 10.1158/1078-0432.CCR-11-0896; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Tilg H, 2005, EXPERT OPIN THER TAR, V9, P245, DOI 10.1517/14728222.9.2.245; Toiyama Y, 2012, INT J ONCOL, V40, P560, DOI 10.3892/ijo.2011.1247; Wan MF, 2006, J SURG RES, V136, P53, DOI 10.1016/j.jss.2006.07.004; Wang W, 2013, CELL RES; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Wernli KJ, 2010, GROWTH HORM IGF RES, V20, P305, DOI 10.1016/j.ghir.2010.04.001; WHO, 2013, WHO GLOB DAT BMI; Yamaji T, 2010, CANCER RES, V70, P5430, DOI 10.1158/0008-5472.CAN-10-0178; Yang XL, 2006, J LEUKOCYTE BIOL, V80, P1434, DOI 10.1189/jlb.0306212; Yuan Y, 2011, J STAT SOFTWARE, V45; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Zhang J, 2011, GASTROENTEROLOGY, V141, P50, DOI 10.1053/j.gastro.2011.05.010; Zhang Y, 2003, J INVEST DERMATOL, V121, P713, DOI 10.1046/j.1523-1747.2003.12517.x	70	37	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85939	10.1371/journal.pone.0085939	http://dx.doi.org/10.1371/journal.pone.0085939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465801	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000078
J	Nakamura, T; Okada, T; Endo, M; Kadomatsu, T; Taniwaki, T; Sei, A; Odagiri, H; Masuda, T; Fujimoto, T; Nakamura, T; Oike, Y; Mizuta, H				Nakamura, Takayuki; Okada, Tatsuya; Endo, Motoyoshi; Kadomatsu, Tsuyoshi; Taniwaki, Takuya; Sei, Akira; Odagiri, Haruki; Masuda, Tetsuro; Fujimoto, Toru; Nakamura, Takafumi; Oike, Yuichi; Mizuta, Hiroshi			Angiopoietin-Like Protein 2 Induced by Mechanical Stress Accelerates Degeneration and Hypertrophy of the Ligamentum Flavum in Lumbar Spinal Canal Stenosis	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; TISSUE FIBROSIS; TGF-BETA; MATRIX METALLOPROTEINASES; ENDOTHELIAL-CELLS; GENE-EXPRESSION; GROWTH-FACTOR; CALCINEURIN; INFLAMMATION; PATHOMECHANISM	Chronic inflammation and subsequent fibrosis induced by mechanical stress play an important role in ligamentum flavum (LF) hypertrophy and degeneration in patients with lumbar spinal canal stenosis (LSCS). Angiopoietin-like protein 2 (Angptl2) is a chronic inflammatory mediator induced under various pathological conditions and increases the expression of TGF-beta 1, which is a well-characterized mediator in LF hypertrophy. We investigated whether Angptl2 is induced by mechanical stress, and whether it contributes to LF hypertrophy and degeneration by activating the TGF-beta 1 signaling cascade. In this study, we investigated human LF tissue and LF fibroblasts isolated from patients who underwent lumbar surgery. We found that Angptl2 was abundantly expressed in fibroblasts of hypertrophied LF tissues at both the mRNA and protein levels. This expression was not only positively correlated with LF thickness and degeneration but also positively correlated with lumbar segmental motion. Our in vitro experiments with fibroblasts from hypertrophied LF tissue revealed that mechanical stretching stress increases the expression and secretion of Angptl2 via activation of calcineurin/NFAT pathways. In hypertrophied LF tissue, expression of TGF-beta 1 mRNA was also increased and TGF-beta 1/Smad signaling was activated. Angptl2 expression in LF tissue was positively correlated with the expression of TGF-beta 1 mRNA, suggesting cooperation between Angptl2 and TGF-beta 1 in the pathogenesis of LF hypertrophy. In vitro experiments revealed that Angptl2 increased levels of TGF-b1 and its receptors, and also activated TGF-beta 1/Smad signaling. Mechanical stretching stress increased TGF-beta 1 mRNA expression, which was partially attenuated by treatment with a calcineurin/NFAT inhibitor or Angptl2 siRNA, indicating that induction of TGF-beta 1 expression by mechanical stretching stress is partially mediated by Angptl2. We conclude that expression of Angptl2 induced by mechanical stress in LF fibroblasts promotes LF tissue degeneration by activation of TGF-beta 1/Smad signaling, which results in LF hypertrophy in patients with LSCS.	[Nakamura, Takayuki; Okada, Tatsuya; Taniwaki, Takuya; Sei, Akira; Odagiri, Haruki; Masuda, Tetsuro; Fujimoto, Toru; Mizuta, Hiroshi] Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Chuo Ku, Kumamoto, Japan; [Nakamura, Takayuki; Endo, Motoyoshi; Kadomatsu, Tsuyoshi; Odagiri, Haruki; Masuda, Tetsuro; Oike, Yuichi] Kumamoto Univ, Dept Mol Genet, Grad Sch Med Sci, Chuo Ku, Kumamoto, Japan; [Nakamura, Takafumi] Nakamura Orthopaed Clin, Kita Ku, Kumamoto, Japan; [Oike, Yuichi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Kumamoto University; Kumamoto University; Japan Science & Technology Agency (JST)	Okada, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Chuo Ku, Kumamoto, Japan.	tatsuya-okada@fc.kuh.kumamoto-u.ac.jp	Endo, Motoyoshi/T-5840-2019		Grants-in-Aid for Scientific Research [25461192] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alam WCA, 2002, INDIAN J AEROSPACE M, V46, P48; Alameddine HS, 2012, NEUROBIOL DIS, V48, P508, DOI 10.1016/j.nbd.2012.07.023; Aoi J, 2011, CANCER RES, V71, P7502, DOI 10.1158/0008-5472.CAN-11-1758; Ariel A, 2013, J PATHOL, V229, P250, DOI 10.1002/path.4108; Aydemir ABC, 2007, ANN NY ACAD SCI, V1117, P138, DOI 10.1196/annals.1402.004; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YT, 2011, SPINE, V36, pE1193, DOI 10.1097/BRS.0b013e3182053f58; Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; Cutroneo KR, 2007, WOUND REPAIR REGEN, V15, pS54, DOI 10.1111/j.1524-475X.2007.00226.x; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; FUKUYAMA S, 1995, J SPINAL DISORD, V8, P126; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Iwano M, 2001, MOL THER, V3, P149, DOI 10.1006/mthe.2000.0251; Kong MH, 2009, SPINE, V34, P2537, DOI 10.1097/BRS.0b013e3181b353ea; Kosaka H, 2007, SPINE, V32, P2805, DOI 10.1097/BRS.0b013e31815b650f; Kubota Y, 2005, GENE EXPR PATTERNS, V5, P679, DOI 10.1016/j.modgep.2005.02.006; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lohr M, 2011, ACTA NEUROCHIR, V153, P134, DOI 10.1007/s00701-010-0839-7; Moon HJ, 2012, SPINE, V37, pE147, DOI 10.1097/BRS.0b013e3182269b19; Nakatani T, 2002, J ORTHOP RES, V20, P1380, DOI 10.1016/S0736-0266(02)00046-3; Naruse K, 1998, AM J PHYSIOL-HEART C, V274, pH1532; NARUSE K, 1993, AM J PHYSIOL, V264, pC1037, DOI 10.1152/ajpcell.1993.264.4.C1037; Nishida M, 2008, N-S ARCH PHARMACOL, V378, P395, DOI 10.1007/s00210-008-0321-8; Ogata A, 2012, BIOCHEM BIOPH RES CO, V418, P494, DOI 10.1016/j.bbrc.2012.01.052; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; Park J B, 2001, Spine (Phila Pa 1976), V26, pE492, DOI 10.1097/00007632-200111010-00007; Park JO, 2013, J SPINAL DISORD TECH, V26, pE6, DOI 10.1097/BSD.0b013e3182698501; Rana OR, 2009, J MOL CELL CARDIOL, V46, P568, DOI 10.1016/j.yjmcc.2008.12.006; Sairyo K, 2005, SPINE, V30, P2649, DOI 10.1097/01.brs.0000188117.77657.ee; Sairyo K, 2007, SPINE, V32, pE340, DOI 10.1097/01.brs.0000263407.25009.6e; Saito T, 2003, J MOL CELL CARDIOL, V35, P1153, DOI 10.1016/S0022-2828(03)00234-7; Schiller M, 2004, J DERMATOL SCI, V35, P83, DOI 10.1016/j.jdermsci.2003.12.006; Schrader PK, 1999, EUR SPINE J, V8, P323, DOI 10.1007/s005860050181; Shimoyama M, 2000, CIRCULATION, V102, P1996, DOI 10.1161/01.CIR.102.16.1996; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Takahashi K, 2013, J CELL MOL MED, V17, P225, DOI 10.1111/jcmm.12027; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Tian Z, 2013, J MOL CELL CARDIOL, V57, P1, DOI 10.1016/j.yjmcc.2013.01.004; Wang JP, 2011, BIOCHEM BIOPH RES CO, V408, P269, DOI 10.1016/j.bbrc.2011.04.011; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	46	39	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85542	10.1371/journal.pone.0085542	http://dx.doi.org/10.1371/journal.pone.0085542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465594	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000042
J	Fedecostante, M; Spannella, F; Cola, G; Espinosa, E; Dessi-Fulgheri, P; Sarzani, R				Fedecostante, Massimiliano; Spannella, Francesco; Cola, Giovanna; Espinosa, Emma; Dessi-Fulgheri, Paolo; Sarzani, Riccardo			Chronic Kidney Disease Is Characterized by "Double Trouble" Higher Pulse Pressure plus Night-Time Systolic Blood Pressure and More Severe Cardiac Damage	PLOS ONE			English	Article							SODIUM SENSITIVITY; GENERAL-POPULATION; CIRCADIAN-RHYTHM; HYPERTENSION; NATRIURESIS; PREVALENCE; NONDIPPER; PREDICTOR	Background: Hypertension plays a key role in chronic kidney disease (CKD), but CKD itself affects the blood pressure (BP) profile. The aim of this study was to assess the association of BP profile with CKD and the presence of cardiac organ damage. Methods: We studied 1805 patients, referred to our Hypertension Centre, in whom ABPM, blood tests, and echocardiography were clinically indicated. The glomerular filtration rate was estimated (eGFR) using the MDRD equation and CKD was defined as eGFR, 60 mL/min/1.73 m(2). Cardiac organ damage was evaluated by echocardiography. Results: Among patients with CKD there were higher systolic blood pressure (SBP) during the night-time, greater prevalence of non-dippers (OR: 1.8) and increased pulse pressure (PP) during 24-hour period, daytime and night-time (all p<0.001). Patients with CKD had a greater LVM/h(2.7) index, and a higher prevalence of left ventricular hypertrophy and diastolic dysfunction (all p<0.001). Nocturnal SBP and PP correlated more strongly with cardiac organ damage (p<0.001). Patients with CKD had a greater Treatment Intensity Score (p<0.001) in the absence of a significantly greater BP control. Conclusions: CKD patients have an altered night-time pressure profile and higher PP that translate into a more severe cardiac organ damage. In spite of a greater intensity of treatment in most patients with CKD, BP control was similar to patients without CKD. Our findings indicate the need of a better antihypertensive therapy in CKD, better selected drugs, dosages and posology to provide optimal coverage of 24 hours and night-time BP.	[Fedecostante, Massimiliano; Spannella, Francesco; Espinosa, Emma; Dessi-Fulgheri, Paolo; Sarzani, Riccardo] Univ Politecn Marche, Italian Natl Res Ctr Aging U Sestilli, IRCCS INRCA, Ancona, Italy; [Fedecostante, Massimiliano; Spannella, Francesco; Espinosa, Emma; Dessi-Fulgheri, Paolo; Sarzani, Riccardo] Univ Politecn Marche, Italian Natl Res Ctr Aging U Sestilli, IRCCS INRCA,Dept Clin & Mol Sci, Hypertens Excellence Ctr,European Soc Hypertens, Ancona, Italy; [Cola, Giovanna] Univ Politecn Marche, Osped Riuniti, Dept Cardiovasc Sci, Cardiol Clin, Ancona, Italy	IRCCS INRCA; Marche Polytechnic University; IRCCS INRCA; Marche Polytechnic University; Marche Polytechnic University	Fedecostante, M (corresponding author), Univ Politecn Marche, Italian Natl Res Ctr Aging U Sestilli, IRCCS INRCA, Ancona, Italy.	mfedek@gmail.com	Spannella, Francesco/AAB-2960-2021; Fedecostante, Massimiliano/K-1789-2018; Sarzani, Riccardo/AAB-3110-2021	Spannella, Francesco/0000-0002-1846-7819; Fedecostante, Massimiliano/0000-0002-0130-5805; Sarzani, Riccardo/0000-0002-5159-0181				Agarwal R, 2009, HYPERTENSION, V54, P646, DOI 10.1161/HYPERTENSIONAHA.109.135822; Andersen MJ, 2005, MED CLIN N AM, V89, P525, DOI 10.1016/j.mcna.2004.12.001; Bailey KR, 2008, HYPERTENSION, V51, P841, DOI 10.1161/HYPERTENSIONAHA.107.101659; Buckalew VM, 1996, AM J KIDNEY DIS, V28, P811, DOI 10.1016/S0272-6386(96)90380-7; Coresh J, 2001, ARCH INTERN MED, V161, P1207, DOI 10.1001/archinte.161.9.1207; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; De Nicola Luca, 2011, G Ital Nefrol, V28, P401; DENTONS, 2019, 2019 CHIN DAT PROT C, P17; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Fagard RH, 2009, J HUM HYPERTENS, V23, P645, DOI 10.1038/jhh.2009.9; Franklin SS, 2001, CIRCULATION, V103, P1245; Fujii T, 1999, AM J KIDNEY DIS, V33, P29, DOI 10.1016/S0272-6386(99)70254-4; Fukuda M, 2004, KIDNEY INT, V65, P621, DOI 10.1111/j.1523-1755.2004.00419.x; Hansen TW, 2011, HYPERTENSION, V57, P3, DOI 10.1161/HYPERTENSIONAHA.109.133900; Head GA, 2012, J HYPERTENS, V30, P253, DOI 10.1097/HJH.0b013e32834de621; Hering D, 2012, J AM SOC NEPHROL, V23, P1250, DOI 10.1681/ASN.2011111062; Kanno A, 2012, NEPHROL DIAL TRANSPL, V27, P3218, DOI 10.1093/ndt/gfs054; Khattar R S, 2001, J Clin Hypertens (Greenwich), V3, P90, DOI 10.1111/j.1524-6175.2001.00445.x; Kimura G, 1997, J HYPERTENS, V15, P1055, DOI 10.1097/00004872-199715100-00002; Kimura Genjiro, 1995, P1569; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Nichols W, 1998, MCDONALDS BLOOD FLOW; OBRIEN E, 1988, LANCET, V2, P397; Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; Staessen JA, 1997, HYPERTENSION, V29, P30, DOI 10.1161/01.HYP.29.1.30; Toussain ND, 2008, NEPHROL DIAL TRANSPL, V23, P586, DOI 10.1093/ndt/gfm660; US Renal Data System, 2020, USRDS 2020 ANN DAT R; Uzu T, 1997, CIRCULATION, V96, P1859, DOI 10.1161/01.CIR.96.6.1859; Uzu T, 1996, HYPERTENSION, V28, P139, DOI 10.1161/01.HYP.28.1.139; VERDECCHIA P, 1994, HYPERTENSION, V24, P793, DOI 10.1161/01.HYP.24.6.793; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865	33	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86155	10.1371/journal.pone.0086155	http://dx.doi.org/10.1371/journal.pone.0086155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465931	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000058
J	Randi, E; Hulva, P; Fabbri, E; Galaverni, M; Galov, A; Kusak, J; Bigi, D; Bolfikova, BC; Smetanova, M; Caniglia, R				Randi, Ettore; Hulva, Pavel; Fabbri, Elena; Galaverni, Marco; Galov, Ana; Kusak, Josip; Bigi, Daniele; Bolfikova, Barbora Cerna; Smetanova, Milena; Caniglia, Romolo			Multilocus Detection of Wolf x Dog Hybridization in Italy, and Guidelines for Marker Selection	PLOS ONE			English	Article							WOLVES CANIS-LUPUS; DOMESTIC DOGS; POPULATION ASSIGNMENT; EVOLUTIONARY HISTORY; GENETIC-VARIABILITY; GENOTYPING ERRORS; COAT COLOR; MITOCHONDRIAL; ADMIXTURE; SOFTWARE	Hybridization and introgression can impact the evolution of natural populations. Several wild canid species hybridize in nature, sometimes originating new taxa. However, hybridization with free-ranging dogs is threatening the genetic integrity of grey wolf populations (Canis lupus), or even the survival of endangered species (e. g., the Ethiopian wolf C. simensis). Efficient molecular tools to assess hybridization rates are essential in wolf conservation strategies. We evaluated the power of biparental and uniparental markers (39 autosomal and 4 Y-linked microsatellites, a melanistic deletion at the beta-defensin CBD103 gene, the hypervariable domain of the mtDNA control-region) to identify the multilocus admixture patterns in wolf x dog hybrids. We used empirical data from 2 hybrid groups with different histories: 30 presumptive natural hybrids from Italy and 73 Czechoslovakian wolfdogs of known hybrid origin, as well as simulated data. We assessed the efficiency of various marker combinations and reference samples in admixture analyses using 69 dogs of different breeds and 99 wolves from Italy, Balkans and Carpathian Mountains. Results confirmed the occurrence of hybrids in Italy, some of them showing anomalous phenotypic traits and exogenous mtDNA or Y-chromosome introgression. Hybridization was mostly attributable to village dogs and not strictly patrilineal. The melanistic b-defensin deletion was found only in Italian dogs and in putative hybrids. The 24 most divergent microsatellites (largest wolf-dog FST values) were equally or more informative than the entire panel of 39 loci. A smaller panel of 12 microsatellites increased risks to identify false admixed individuals. The frequency of F1 and F2 was lower than backcrosses or introgressed individuals, suggesting hybridization already occurred some generations in the past, during early phases of wolf expansion from their historical core areas. Empirical and simulated data indicated the identification of the past generation backcrosses is always uncertain, and a larger number of ancestry-informative markers is needed.	[Randi, Ettore; Fabbri, Elena; Galaverni, Marco; Caniglia, Romolo] Ist Super Protez Ric Ambientale, Genet Lab, Bologna, Italy; [Randi, Ettore] Aalborg Univ, Dept 18, Sect Environm Engn, Aalborg, Denmark; [Hulva, Pavel] Charles Univ Prague, Dept Zool, Prague, Czech Republic; [Hulva, Pavel] Univ Ostrava, Life Sci Res Ctr, CZ-70103 Ostrava, Czech Republic; [Galov, Ana] Univ Zagreb, Fac Sci, Dept Biol, Zagreb 41000, Croatia; [Kusak, Josip] Univ Zagreb, Dept Biol, Fac Vet Med, Zagreb 41000, Croatia; [Bigi, Daniele] Univ Bologna, Dept Agr & Food Sci & Technol, Bologna, Italy; [Bolfikova, Barbora Cerna; Smetanova, Milena] Czech Univ Life Sci, Fac Trop AgriSci, Prague, Czech Republic	Aalborg University; Charles University Prague; University of Ostrava; University of Zagreb; University of Zagreb; University of Bologna; Czech University of Life Sciences Prague	Caniglia, R (corresponding author), Ist Super Protez Ric Ambientale, Genet Lab, Bologna, Italy.	romolo.caniglia@isprambiente.it	Galov, Ana/AAC-4557-2020; Bolfikova, Barbora Cerna/I-6620-2019; Kusak, Josip/T-8344-2019	Galov, Ana/0000-0002-3709-7286; Bolfikova, Barbora Cerna/0000-0001-8059-4889; Galaverni, Marco/0000-0002-2648-1506; Kusak, Josip/0000-0002-5544-6486; CANIGLIA, Romolo/0000-0002-3641-9490	Italian Ministry of Environment; Italian Institute for Environmental Protection and Research; Czech University of Life Sciences Prague [IGA CZU 51120/1312/3107]; International Visegrad Fund	Italian Ministry of Environment; Italian Institute for Environmental Protection and Research; Czech University of Life Sciences Prague; International Visegrad Fund	This project was supported by grants from the Italian Ministry of Environment, the Italian Institute for Environmental Protection and Research, the Czech University of Life Sciences Prague (IGA CZU 51120/1312/3107) and the International Visegrad Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2003, MOL ECOL, V12, P541, DOI 10.1046/j.1365-294X.2003.01708.x; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Almudevar A, 2000, CAN J STAT, V28, P81; Anderson EC, 2002, GENETICS, V160, P1217; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Andersone Z, 2002, MAMM BIOL, V67, P79, DOI 10.1078/1616-5047-00012; [Anonymous], 1996, 5000 CNRS UMR; Aspi J, 2006, MOL ECOL, V15, P1561, DOI 10.1111/j.1365-294X.2006.02877.x; Aspi J, 2009, CONSERV GENET, V10, P815, DOI 10.1007/s10592-008-9642-x; Banks MA, 2003, BIOINFORMATICS, V19, P1436, DOI 10.1093/bioinformatics/btg172; Banks MA, 2000, J HERED, V91, P87, DOI 10.1093/jhered/91.1.87; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Breitenmoser U, 1998, BIOL CONSERV, V83, P279, DOI 10.1016/S0006-3207(97)00084-0; Broseth H, 2010, BIOL CONSERV, V143, P113, DOI 10.1016/j.biocon.2009.09.012; Brumfield RT, 2010, MOL ECOL, V19, P5079, DOI 10.1111/j.1365-294X.2010.04896.x; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Caniglia R, 2013, EUR J WILDLIFE RES, V59, P543, DOI 10.1007/s10344-013-0703-1; Caniglia R, 2012, CONSERV GENET, V13, P53, DOI 10.1007/s10592-011-0266-1; Ciucci P, 2007, J ZOOL, V273, P125, DOI 10.1111/j.1469-7998.2007.00379.x; Ciucci P, 2003, CAN J ZOOL, V81, P2077, DOI 10.1139/Z03-183; Ciucci P, 2009, J WILDLIFE MANAGE, V73, P1300, DOI 10.2193/2008-510; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Coulson T, 2011, SCIENCE, V334, P1275, DOI 10.1126/science.1209441; Czarnomska SD, 2013, CONSERV GENET, V14, P573, DOI 10.1007/s10592-013-0446-2; Duchesne P, 2009, MOL ECOL RESOUR, V9, P1333, DOI 10.1111/j.1755-0998.2009.02571.x; Echegaray J, 2010, ANIM CONSERV, V13, P157, DOI 10.1111/j.1469-1795.2009.00315.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fabbri E, 2007, MOL ECOL, V16, P1661, DOI 10.1111/j.1365-294X.2007.03262.x; Falush D, 2003, GENETICS, V164, P1567; Feulner PGD, 2013, MOL ECOL, V22, P635, DOI 10.1111/j.1365-294X.2012.05680.x; Flagstad O, 2003, MOL ECOL, V12, P869, DOI 10.1046/j.1365-294X.2003.01784.x; Fraser DJ, 2011, HEREDITY, V106, P404, DOI 10.1038/hdy.2010.167; Gaubert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042740; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Godinho R, 2011, MOL ECOL, V20, P5154, DOI 10.1111/j.1365-294X.2011.05345.x; Gomercic T, 2010, ZOOL STUD, V49, P816; GOTTELLI D, 1994, MOL ECOL, V3, P301, DOI 10.1111/j.1365-294X.1994.tb00070.x; Grant PR, 2005, AM NAT, V166, P56, DOI 10.1086/430331; Hailer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003333; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465; HOPE J, 1994, SMITHSONIAN, V25, P34; Iacolina L, 2010, MAMM BIOL, V75, P341, DOI 10.1016/j.mambio.2010.02.004; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Kaelin CB, 2013, ANNU REV ANIM BIOSCI, V1, P125, DOI 10.1146/annurev-animal-031412-103659; Kays R, 2010, BIOL LETTERS, V6, P89, DOI 10.1098/rsbl.2009.0575; Kennedy LJ, 2011, TISSUE ANTIGENS, V77, P118, DOI 10.1111/j.1399-0039.2010.01591.x; Kerns JA, 2004, MAMM GENOME, V15, P798, DOI 10.1007/s00335-004-2377-1; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; Laurenson K, 1998, ANIM CONSERV, V1, P273, DOI 10.1111/j.1469-1795.1998.tb00038.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linnell JDC, 2012, HYSTRIX, V23, P80, DOI 10.4404/hystrix-23.1-4676; Lucchini V, 2004, MOL ECOL, V13, P523, DOI 10.1046/j.1365-294X.2004.02077.x; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Michalakis Y, 1996, GENETICS, V142, P1061; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Munoz-Fuentes V, 2010, CONSERV GENET, V11, P547, DOI 10.1007/s10592-009-9974-1; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Ollivier M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075110; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pilot M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-104; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Randi E, 2000, CONSERV BIOL, V14, P464, DOI 10.1046/j.1523-1739.2000.98280.x; Randi E, 2002, CONSERV GENET, V3, P31; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Scandura M, 2011, EUR J WILDLIFE RES, V57, P949, DOI 10.1007/s10344-011-0509-y; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Shriver MD, 1997, AM J HUM GENET, V60, P957; Stronen AV, 2012, ECOL EVOL, V2, P2128, DOI 10.1002/ece3.335; Sundqvist AK, 2001, MOL ECOL, V10, P1959, DOI 10.1046/j.1365-294X.2001.01326.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Verardi A, 2006, MOL ECOL, V15, P2845, DOI 10.1111/j.1365-294X.2006.02995.x; Vila C, 2003, HEREDITY, V90, P17, DOI 10.1038/sj.hdy.6800175; Vila C, 1999, CONSERV BIOL, V13, P195, DOI 10.1046/j.1523-1739.1999.97425.x; vonHoldt BM, 2013, MAMM GENOME, V24, P80, DOI 10.1007/s00335-012-9432-0; vonHoldt BM, 2011, GENOME RES, V21, P1294, DOI 10.1101/gr.116301.110; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wayne RK, 2012, MAMM GENOME, V23, P3, DOI 10.1007/s00335-011-9386-7; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	96	71	71	1	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86409	10.1371/journal.pone.0086409	http://dx.doi.org/10.1371/journal.pone.0086409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466077	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100156
J	Sharbanee, JM; Hu, L; Stritzke, WGK; Wiers, RW; Rinck, M; MacLeod, C				Sharbanee, Jason M.; Hu, Litje; Stritzke, Werner G. K.; Wiers, Reinout W.; Rinck, Mike; MacLeod, Colin			The Effect of Approach/Avoidance Training on Alcohol Consumption Is Mediated by Change in Alcohol Action Tendency	PLOS ONE			English	Article							AUTOMATIC ACTION-TENDENCIES; BIAS MODIFICATION; ATTENTIONAL BIAS; FREQUENCY; VALIDITY; CHILD	Training people to respond to alcohol images by making avoidance joystick movements can affect subsequent alcohol consumption, and has shown initial efficacy as a treatment adjunct. However, the mechanisms that underlie the training's efficacy are unknown. The present study aimed to determine 1) whether the training's effect is mediated by a change in action tendency or a change in selective attention, and 2) whether the training's effect is moderated by individual differences in working memory capacity (WMC). Three groups of social drinkers (total N = 74) completed either approach-alcohol training, avoid-alcohol training or a sham-training on the Approach-Avoidance Task (AAT). Participants' WMC was assessed prior to training, while their alcohol-related action tendency and selective attention were assessed before and after the training on the recently developed Selective-Attention/Action Tendency Task (SA/ATT), before finally completing an alcohol taste-test. There was no significant main effect of approach/avoidance training on alcohol consumption during the taste-test. However, there was a significant indirect effect of training on alcohol consumption mediated by a change in action tendency, but no indirect effect mediated by a change in selective attention. There was inconsistent evidence of WMC moderating training efficacy, with moderation found only for the effect of approach-alcohol training on the AAT but not on the SA/ATT. Thus approach/avoidance training affects alcohol consumption specifically by changing the underlying action tendency. Multiple training sessions may be required in order to observe more substantive changes in drinking behaviour.	[Sharbanee, Jason M.; Stritzke, Werner G. K.; MacLeod, Colin] Univ Western Australia, Sch Psychol, Ctr Adv Res Emot, Crawley, Australia; [Hu, Litje; Rinck, Mike] Radboud Univ Nijmegen, Inst Behav Sci, Dept Clin Psychol, NL-6525 ED Nijmegen, Netherlands; [Wiers, Reinout W.] Univ Amsterdam, Dept Psychol, Addict Dev & Psychopathol Adapt Lab, Amsterdam, Netherlands	University of Western Australia; Radboud University Nijmegen; University of Amsterdam	Sharbanee, JM (corresponding author), Univ Western Australia, Sch Psychol, Ctr Adv Res Emot, Crawley, Australia.	jason.sharbanee@grs.uwa.edu.au	Wiers, Reinout/AAB-4008-2021; Sharbanee, Jason Mark/AFO-5659-2022; Sharbanee, Jason/L-5579-2013; Rinck, Mike/A-6944-2010	Wiers, Reinout/0000-0002-4312-9766; Sharbanee, Jason Mark/0000-0003-1822-9092; Sharbanee, Jason/0000-0003-1822-9092; MacLeod, Colin/0000-0003-2407-7339				Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; [Anonymous], 1969, MONOGRAPHS RUTGERS C; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; BOLLEN KA, 1985, SOCIOL METHOD RES, V13, P510, DOI 10.1177/0049124185013004004; Carey KB, 2001, J STUD ALCOHOL, V62, P79, DOI 10.15288/jsa.2001.62.79; Cohen J., 2003, APPL MULTIPLE REGRES; Eberl C, 2013, DEV COGN NEUROS-NETH, V4, P38, DOI 10.1016/j.dcn.2012.11.002; Fadardi JS, 2009, DRUG ALCOHOL DEPEN, V101, P137, DOI 10.1016/j.drugalcdep.2008.11.015; Field M, 2009, PSYCHOL BULL, V135, P589, DOI 10.1037/a0015843; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Hayes A. F., 2013, STAT MEDIATION ANAL; HOMMEL B, 1994, PSYCHOL RES-PSYCH FO, V56, P261, DOI 10.1007/BF00419656; Kane MJ, 2008, VARIATION WORKING ME, P21; Kazdin AE, 2003, J CHILD PSYCHOL PSYC, V44, P1116, DOI 10.1111/1469-7610.00195; Kokotailo PK, 2004, ALCOHOL CLIN EXP RES, V28, P914, DOI 10.1097/01.ALC.0000128239.87611.F5; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Lewandowsky S, 2010, BEHAV RES METHODS, V42, P571, DOI 10.3758/BRM.42.2.571; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; MacKinnon D.P., 2012, INTRO STAT MEDIATION; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maric M, 2012, CLIN CHILD FAM PSYCH, V15, P177, DOI 10.1007/s10567-012-0114-y; McEvoy PM, 2004, ADDICTION, V99, P482, DOI 10.1111/j.1360-0443.2004.00714.x; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; R Core Team, 2012, R LANG ENV STAT COMP; Rinck M, 2007, J BEHAV THER EXP PSY, V38, P105, DOI 10.1016/j.jbtep.2006.10.001; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Salemink E, 2012, BEHAV RES THER, V50, P40, DOI 10.1016/j.brat.2011.10.006; Schoenmakers TM, 2010, DRUG ALCOHOL DEPEN, V109, P30, DOI 10.1016/j.drugalcdep.2009.11.022; Sharbanee JM, 2013, PSYCHOL ADDICT BEHAV, V27, P649, DOI 10.1037/a0029982; Sharbanee JM, 2013, ADDICTION, V108, P1758, DOI 10.1111/add.12256; Sharbanee JM, 2013, PSYCHOPHARMACOLOGY, DOI DOI 10.1007/S00213-013-3318-Z.ACCESSED; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Shipstead Z, 2010, PSYCHOL BELG, V50, P245, DOI 10.5334/pb-50-3-4-245; Stritzke W.G., 2007, MOTIVATION HLTH BEHA, P31; Van der Meer T, 2010, AM SOCIOL REV, V75, P173, DOI 10.1177/0003122409359166; Watson P, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00440; Wendt M, 2009, EXP PSYCHOL, V56, P206, DOI 10.1027/1618-3169.56.3.206; Wiers RW, 2009, GENES BRAIN BEHAV, V8, P101, DOI 10.1111/j.1601-183X.2008.00454.x; Wiers RW, 2007, PHARMACOL BIOCHEM BE, V86, P263, DOI 10.1016/j.pbb.2006.09.021; Wiers RW, 2011, PSYCHOL SCI, V22, P490, DOI 10.1177/0956797611400615; Wiers RW, 2010, ADDICTION, V105, P279, DOI 10.1111/j.1360-0443.2009.02775.x; Wiers RW, 2013, CLIN PSYCHOL SCI; Wiers RW, 2008, IDENTIFICATION TREAT, P187; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257	48	29	29	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85855	10.1371/journal.pone.0085855	http://dx.doi.org/10.1371/journal.pone.0085855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465750	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100083
J	Szalinski, CM; Labilloy, A; Bruns, JR; Weisz, OA				Szalinski, Christina M.; Labilloy, Anatalia; Bruns, Jennifer R.; Weisz, Ora A.			VAMP7 Modulates Ciliary Biogenesis in Kidney Cells	PLOS ONE			English	Article							APICAL PLASMA-MEMBRANE; SNARE COMPLEXES; PRIMARY CILIUM; SYNTAXIN 3; PROTEIN; TRANSPORT; TRAFFICKING; EXPRESSION; IDENTIFICATION; DELIVERY	Epithelial cells elaborate specialized domains that have distinct protein and lipid compositions, including the apical and basolateral surfaces and primary cilia. Maintaining the identity of these domains is required for proper cell function, and requires the efficient and selective SNARE-mediated fusion of vesicles containing newly synthesized and recycling proteins with the proper target membrane. Multiple pathways exist to deliver newly synthesized proteins to the apical surface of kidney cells, and the post-Golgi SNAREs, or VAMPs, involved in these distinct pathways have not been identified. VAMP7 has been implicated in apical protein delivery in other cell types, and we hypothesized that this SNARE would have differential effects on the trafficking of apical proteins known to take distinct routes to the apical surface in kidney cells. VAMP7 expressed in polarized Madin Darby canine kidney cells colocalized primarily with LAMP2-positive compartments, and siRNA-mediated knockdown modulated lysosome size, consistent with the known function of VAMP7 in lysosomal delivery. Surprisingly, VAMP7 knockdown had no effect on apical delivery of numerous cargoes tested, but did decrease the length and frequency of primary cilia. Additionally, VAMP7 knockdown disrupted cystogenesis in cells grown in a three-dimensional basement membrane matrix. The effects of VAMP7 depletion on ciliogenesis and cystogenesis are not directly linked to the disruption of lysosomal function, as cilia lengths and cyst morphology were unaffected in an MDCK lysosomal storage disorder model. Together, our data suggest that VAMP7 plays an essential role in ciliogenesis and lumen formation. To our knowledge, this is the first study implicating an R-SNARE in ciliogenesis and cystogenesis.	[Szalinski, Christina M.; Labilloy, Anatalia; Bruns, Jennifer R.; Weisz, Ora A.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Pittsburgh, PA 15260 USA; [Weisz, Ora A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA; [Labilloy, Anatalia] CNPq, Brasilia, DF, Brazil	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weisz, OA (corresponding author), Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Pittsburgh, PA 15260 USA.	weisz@pitt.edu		Szalinski, Christina/0000-0002-5991-5606	NIH [R01 DK54407, T32 DK061296]; Core C of the Pittsburgh Center for Kidney Research [P30 DK079307]; Brazilian National Council for Scientific and Technological Development (CNPq); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R01DK054407, T32DK061296] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core C of the Pittsburgh Center for Kidney Research; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH R01 DK54407 (to OAW) and by Core C of the Pittsburgh Center for Kidney Research (P30 DK079307). CMS was supported in part by NIH T32 DK061296. AL was supported in part by the Brazilian National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Baust T, 2008, MOL BIOL CELL, V19, P1942, DOI 10.1091/mbc.E08-02-0110; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Breton S, 2002, AM J PHYSIOL-RENAL, V282, pF523, DOI 10.1152/ajprenal.00128.2001; Breuza L, 2000, AM J PHYSIOL-CELL PH, V279, pC1239, DOI 10.1152/ajpcell.2000.279.4.C1239; Chaineau M, 2008, J BIOL CHEM, V283, P34365, DOI 10.1074/jbc.M804587200; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Coco S, 1999, J NEUROSCI, V19, P9803; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cresawn KO, 2007, EMBO J, V26, P3737, DOI 10.1038/sj.emboj.7601813; Danglot L, 2012, J NEUROSCI, V32, P1962, DOI 10.1523/JNEUROSCI.4436-11.2012; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Galvez-Santisteban M, 2012, NAT CELL BIOL, V14, P838, DOI 10.1038/ncb2541; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hager HA, 2010, EMBO J, V29, P532, DOI 10.1038/emboj.2009.379; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Henkel JR, 1998, MOL BIOL CELL, V9, P2477, DOI 10.1091/mbc.9.9.2477; Henkel JR, 1998, J BIOL CHEM, V273, P6518, DOI 10.1074/jbc.273.11.6518; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; Hsiao Yi-Chun, 2012, Cilia, V1, P4, DOI 10.1186/2046-2530-1-4; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Ihrke G, 2001, EMBO J, V20, P6256, DOI 10.1093/emboj/20.22.6256; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jones LC, 2012, J PHYSIOL-LONDON, V590, P545, DOI 10.1113/jphysiol.2011.222091; Kent HM, 2012, DEV CELL, V22, P979, DOI 10.1016/j.devcel.2012.01.018; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Kotsis F, 2013, NEPHROL DIAL TRANSPL, V28, P518, DOI 10.1093/ndt/gfs524; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; LEBIVIC A, 1990, J CELL BIOL, V111, P1351, DOI 10.1083/jcb.111.4.1351; Leung SM, 1998, J BIOL CHEM, V273, P17732, DOI 10.1074/jbc.273.28.17732; Li X, 2002, AM J PHYSIOL-RENAL, V283, pF1111, DOI 10.1152/ajprenal.00185.2002; Low SH, 1998, J BIOL CHEM, V273, P3422, DOI 10.1074/jbc.273.6.3422; Mandon B, 1996, J CLIN INVEST, V98, P906, DOI 10.1172/JCI118873; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; MATTER K, 1990, J BIOL CHEM, V265, P3503; Mattila PE, 2012, TRAFFIC, V13, P433, DOI 10.1111/j.1600-0854.2011.01315.x; Mazelova J, 2009, J CELL SCI, V122, P2003, DOI 10.1242/jcs.039982; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nishimura N, 2002, P NATL ACAD SCI USA, V99, P6755, DOI 10.1073/pnas.092150699; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Pocard T, 2007, J CELL SCI, V120, P3309, DOI 10.1242/jcs.007948; Pols MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2360; Potter BA, 2004, MOL BIOL CELL, V15, P1407, DOI 10.1091/mbc.E03-08-0550; Proux-Gillardeaux V, 2007, BIOL CELL, V99, P261, DOI 10.1042/BC20060097; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Rbaibi Y, 2012, TRAFFIC, V13, P1295, DOI 10.1111/j.1600-0854.2012.01387.x; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Saito T, 2000, AM J MED GENET, V96, P317, DOI 10.1002/1096-8628(20000612)96:3<317::AID-AJMG17>3.0.CO;2-R; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Steegmaier M, 2000, TRAFFIC, V1, P553, DOI 10.1034/j.1600-0854.2000.010705.x; Szalinski CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053790; Takeda T, 2003, AM J PHYSIOL-CELL PH, V284, pC1105, DOI 10.1152/ajpcell.00514.2002; Torkko JM, 2008, J CELL SCI, V121, P1193, DOI 10.1242/jcs.015495; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; Vieira OV, 2006, P NATL ACAD SCI USA, V103, P18556, DOI 10.1073/pnas.0608291103; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615; Zeng Q, 1998, MOL BIOL CELL, V9, P2423, DOI 10.1091/mbc.9.9.2423; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	73	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86425	10.1371/journal.pone.0086425	http://dx.doi.org/10.1371/journal.pone.0086425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466086	Green Published, Green Accepted, gold			2022-12-25	WOS:000330283100160
J	Alkon, A; Boyce, WT; Tran, L; Harley, KG; Neuhaus, J; Eskenazi, B				Alkon, Abbey; Boyce, W. Thomas; Linh Tran; Harley, Kim G.; Neuhaus, John; Eskenazi, Brenda			Prenatal Adversities and Latino Children's Autonomic Nervous System Reactivity Trajectories from 6 Months to 5 Years of Age	PLOS ONE			English	Article							STRESS REACTIVITY; BIOLOGICAL SENSITIVITY; INDIVIDUAL-DIFFERENCES; HEMODYNAMIC-RESPONSES; DEVELOPMENTAL-CHANGES; EARLY EXPERIENCE; CUMULATIVE RISK; MATERNAL STRESS; SOCIAL SUPPORT; CORTISOL	The purpose of the study was to determine whether mothers' adversities experienced during early pregnancy are associated with offspring's autonomic nervous system (ANS) reactivity trajectories from 6 months to 5 years of age. This cohort study of primarily Latino families included maternal interviews at 13-14 weeks gestation about their experience of a range of adversities: father's absence, general social support, poverty level, and household density. ANS measures of heart rate, respiratory sinus arrhythmia (parasympathetic nervous system) and preejection period (sympathetic nervous system) were collected during resting and challenging conditions on children at 6 months and 1, 3.5 and 5 years of age. Reactivity measures were calculated as the mean of the responses to challenging conditions minus a resting condition. Fixed effects models were conducted for the 212 children with two or more timepoints of ANS measures. Interactions between maternal prenatal adversity levels and child age at time of ANS protocol were included in the models, allowing the calculation of separate trajectories or slopes for each level of adversity. Results showed no significant relations between mothers' prenatal socioeconomic or social support adversity and offspring's parasympathetic nervous system trajectories, but there was a statistically significant relationship between social support adversity and offspring's heart rate trajectories (p,. 05) and a borderline significant relationship between socioeconomic adversity and offspring's sympathetic nervous system trajectories (p = .05). Children whose mothers experienced one, not two, social support adversity had the smallest increases in heart rate reactivity compared to children whose mothers experienced no adversity. The children whose mothers experienced no social support and no socioeconomic adversity had the largest increases in heart rate and preejection period respectively from 6 months to 5 years showing the most plasticity. Mothers' prenatal adverse experiences may program their children's physiologic trajectory to dampen their heart rate or sympathetic responsivity to challenging conditions.	[Alkon, Abbey] Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA; [Boyce, W. Thomas] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Linh Tran] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Harley, Kim G.] CERCH, Berkeley, CA USA; [Neuhaus, John] Univ Calif San Francisco, UCSF Epidemiol & Biostat, San Francisco, CA 94143 USA; [Eskenazi, Brenda] Univ Calif Berkeley, Sch Publ Hlth, CERCH, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of British Columbia; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Alkon, A (corresponding author), Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA.	abbey.alkon@nursing.ucsf.edu			National Institute of Environmental Health Sciences (NIEHS) [ES009605]; Environmental Protection Agency (EPA) [R826709011, RD-83171001]; National Institute of Child Health and Development (NICHD) [ARRA 445211-33252-01 HD058091]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009605] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Environmental Protection Agency (EPA)(United States Environmental Protection Agency); National Institute of Child Health and Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by the National Institute of Environmental Health Sciences (NIEHS) ES009605, Environmental Protection Agency (EPA) R826709011 and RD-83171001 and the data analysis for this paper was funded by the National Institute of Child Health and Development (NICHD) ARRA 445211-33252-01 HD058091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkon A, 2006, DEV PSYCHOBIOL, V48, P197, DOI 10.1002/dev.20129; Alkon A, 2003, DEV PSYCHOBIOL, V42, P64, DOI 10.1002/dev.10082; Alkon A, 2011, J DEV BEHAV PEDIATR, V32, P668, DOI 10.1097/DBP.0b013e3182331fa6; Allen MT, 1997, PSYCHOPHYSIOLOGY, V34, P329, DOI 10.1111/j.1469-8986.1997.tb02403.x; Bar-Haim Y, 2000, DEV PSYCHOBIOL, V37, P44, DOI 10.1002/1098-2302(200007)37:1<44::AID-DEV6>3.0.CO;2-7; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; BORNSTEIN MH, 1989, PSYCHOL BULL, V105, P179, DOI 10.1037/0033-2909.105.2.179; Bosch NM, 2012, PSYCHONEUROENDOCRINO, V37, P1439, DOI 10.1016/j.psyneuen.2012.01.013; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; BOYCE WT, 1995, PSYCHOSOM MED, V57, P411, DOI 10.1097/00006842-199509000-00001; Brennan PA, 2008, J CHILD PSYCHOL PSYC, V49, P1099, DOI 10.1111/j.1469-7610.2008.01914.x; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; Bureau USC, 2000, POV THRESH 2000 CURR; Bush NR, 2011, DEV PSYCHOPATHOL, V23, P1089, DOI 10.1017/S0954579411000514; Cacioppo JT, 1998, ANN NY ACAD SCI, V840, P664, DOI 10.1111/j.1749-6632.1998.tb09605.x; Chen E, 2012, PERSPECT PSYCHOL SCI, V7, P135, DOI 10.1177/1745691612436694; Crowell SE, 2006, J ABNORM PSYCHOL, V115, P174, DOI 10.1037/0021-843X.115.1.174; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Davis EP, 2011, J CHILD PSYCHOL PSYC, V52, P119, DOI 10.1111/j.1469-7610.2010.02314.x; DiPietro JA, 2012, J ADOLESCENT HEALTH, V51, pS3, DOI 10.1016/j.jadohealth.2012.04.008; DiPietro JA, 2010, CHILD DEV, V81, P115, DOI 10.1111/j.1467-8624.2009.01384.x; Ellis BJ, 2005, DEV PSYCHOPATHOL, V17, P303, DOI 10.1017/S0954579405050157; Eskenazi B., 2003, J CHILD HLTH, V1, P3, DOI [DOI 10.3109/713610244, 10.3109/713610244]; Essex M, 2011, CHILD DEV, P1; Evans GW, 2007, DEV PSYCHOL, V43, P341, DOI 10.1037/0012-1649.43.2.341; Evans GW, 2007, PSYCHOL SCI, V18, P953, DOI 10.1111/j.1467-9280.2007.02008.x; Grant KA, 2009, DEV PSYCHOBIOL, V51, P625, DOI 10.1002/dev.20397; Graziano P, 2013, BIOL PSYCHOL, V94, P22, DOI 10.1016/j.biopsycho.2013.04.011; Graziano PA, 2011, OBESITY, V19, P1818, DOI 10.1038/oby.2011.98; Gunnar MR, 2001, DEV PSYCHOPATHOL, V13, P515, DOI 10.1017/S0954579401003066; Gutteling BM, 2005, PSYCHONEUROENDOCRINO, V30, P541, DOI 10.1016/j.psyneuen.2005.01.002; Haller J, 2004, PSYCHOPHARMACOLOGY, V174, P197, DOI 10.1007/s00213-003-1746-x; Harley K, 2006, SOC SCI MED, V62, P3048, DOI 10.1016/j.socscimed.2005.11.036; Hertzman C, 1999, ANN NY ACAD SCI, V896, P85, DOI 10.1111/j.1749-6632.1999.tb08107.x; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Hinnant JB, 2011, DEV PSYCHOBIOL, V53, P59, DOI 10.1002/dev.20487; Igosheva N, 2004, J PHYSIOL-LONDON, V557, P273, DOI 10.1113/jphysiol.2003.056911; Jacob S, 2009, INFANT MENT HEALTH J, V30, P82, DOI 10.1002/imhj.20204; Keenan K, 2007, INFANT BEHAV DEV, V30, P134, DOI 10.1016/j.infbeh.2006.08.001; Kraemer HC, 2000, AM J PSYCHIAT, V157, P163, DOI 10.1176/appi.ajp.157.2.163; Lamme, 2012, PLOS ONE, V7, P1; Leung E, 2010, CLIN PEDIATR, V49, P158, DOI 10.1177/0009922809346570; Little R.J.A., 2002, STAT ANAL MISSING DA; Loman MM, 2010, NEUROSCI BIOBEHAV R, V34, P867, DOI 10.1016/j.neubiorev.2009.05.007; Matthews KA, 2002, PSYCHOPHYSIOLOGY, V39, P826, DOI 10.1111/1469-8986.3960826; McCulloch C. E., 2008, GEN LINEAR MIXED MOD; Obradovic J, 2010, CHILD DEV, V81, P270, DOI 10.1111/j.1467-8624.2009.01394.x; Obradovic J, 2009, DEV NEUROSCI-BASEL, V31, P300, DOI 10.1159/000216541; Oosterman M, 2010, DEV PSYCHOPATHOL, V22, P109, DOI 10.1017/S0954579409990290; Ouellet-Morin I, 2009, BIOL PSYCHIAT, V65, P409, DOI 10.1016/j.biopsych.2008.10.003; Porges SW, 2001, INT J PSYCHOPHYSIOL, V42, P123, DOI 10.1016/S0167-8760(01)00162-3; Propper C, 2008, CHILD DEV, V79, P1377, DOI 10.1111/j.1467-8624.2008.01194.x; Quiros-Alcala L, 2011, NEUROTOXICOLOGY, V32, P646, DOI 10.1016/j.neuro.2011.05.017; SAMEROFF A, 1987, SCHIZOPHRENIA BULL, V13, P383, DOI 10.1093/schbul/13.3.383; Sandman Curt A, 2011, Int J Pept, V2011, P837596, DOI 10.1155/2011/837596; Schneider ML, 1999, CHILD DEV, V70, P263, DOI 10.1111/1467-8624.00020; Selye H, 1956, J BONE JOINT SURG; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Tegethoff M, 2011, ENVIRON HEALTH PERSP, V119, P1647, DOI 10.1289/ehp.1003253; US Census Bureau, 2011, HISP POP US 2011; Wolff BC, 2012, DEV PSYCHOPATHOL, V24, P677, DOI 10.1017/S0954579412000247	62	35	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86283	10.1371/journal.pone.0086283	http://dx.doi.org/10.1371/journal.pone.0086283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24466003	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500217
J	Emu, B; Moretto, WJ; Hoh, R; Krone, M; Martin, JN; Nixon, DF; Deeks, SG; McCune, JM				Emu, Brinda; Moretto, Walter J.; Hoh, Rebecca; Krone, Melissa; Martin, Jeffrey N.; Nixon, Douglas F.; Deeks, Steven G.; McCune, Joseph M.			Composition and Function of T Cell Subpopulations Are Slow to Change Despite Effective Antiretroviral Treatment of HIV Disease	PLOS ONE			English	Article							IMMUNE ACTIVATION; LYMPHOCYTE SUBSETS; INFECTED SUBJECTS; THERAPY; CD8; IMMUNODEFICIENCY; NAIVE; INTENSIFICATION; REPLICATION; RALTEGRAVIR	The ability to reconstitute a normal immune system with antiretroviral therapy in the setting of HIV infection remains uncertain. This study aimed to characterize quantitative and qualitative aspects of various T cell subpopulations that do not improve despite effective ART. CD4:CD8 ratio was evaluated in HIV-infected subjects with viral loads >10,000 copies/mu l ("non-controllers", n = 42), those with undetectable viral loads on ART ("ART-suppressed", n = 53), and HIV-uninfected subjects (n = 22). In addition, T cell phenotype and function were examined in 25 non-controllers, 18 ART-suppressed, and 7 HIV-uninfected subjects. CD4:CD8 ratio in non-controllers, ART-suppressed, and HIV-uninfected subjects was 0.25, 0.48, and 1.95 respectively (P<0.0001 for all comparisons). The increased ratio in ART-suppressed compared to non-controllers was driven by an increase of CD4+ T cells, with no change in the expanded CD8+ T cell population. Expansion of differentiated (CD28-CD27-CD45RA+/-CCR7-) T cell subpopulations persisted despite ART and minimal changes were noted in naive T cell frequencies over time. Increased number of CD8+CD28- T cells and increased CD8+ CMV-specific T cell responses were associated with a decreased CD4: CD8 ratio. Measures of T cell function demonstrated persistence of high frequencies of CD8+ T cells producing IFN-gamma. Lastly, though all CD8+ subpopulations demonstrated significantly lower Ki67 expression in ART-suppressed subjects, CD4+ T cell subpopulations did not consistently show this decrease, thus demonstrating different proliferative responses in the setting of T cell depletion. In summary, this study demonstrated that CD4:CD8 ratios remained significantly decreased and naive T cell numbers were slow to increase despite long-term viral suppression on ART. In addition, there is a evidence of differential regulation of the CD4+ and CD8+ T cell subpopulations, suggesting independent homeostatic regulation of the two compartments.	[Emu, Brinda] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Moretto, Walter J.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Hoh, Rebecca; Martin, Jeffrey N.; Deeks, Steven G.; McCune, Joseph M.] Univ Calif San Francisco, Posit Hlth Program, San Francisco, CA 94143 USA; [Krone, Melissa; Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Nixon, Douglas F.; McCune, Joseph M.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA	Yale University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Emu, B (corresponding author), Yale Univ, Dept Med, New Haven, CT 06520 USA.	brinda.emu@yale.edu	Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786; Deeks, Steven/0000-0001-6371-747X	National Institute of Allergy and Infectious Diseases [AI052745, AI47062, AI43864, AI055273, AI44595, P30 AI027763, R24 AI067039]; amfAR [106710-40-RGRL]; California AIDS Research Center [CC99-SF, ID01-SF-049]; Center for AIDS Prevention Studies [P30 MH62246]; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; National Institutes of Health (NIH) Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research [DPI OD00329]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI067039, R01AI044595, R01AI052745, U01AI043864, R01AI047062, R01AI043864, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); amfAR; California AIDS Research Center; Center for AIDS Prevention Studies; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); National Institutes of Health (NIH) Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by grants from the National Institute of Allergy and Infectious Diseases (AI052745 to BE; AI47062 and AI43864 to JMM; and AI055273 and AI44595 to SGD; P30 AI027763 and R24 AI067039 to JNM), amfAR (106710-40-RGRL), the California AIDS Research Center (CC99-SF, ID01-SF-049), and the Center for AIDS Prevention Studies (P30 MH62246). JMM is a recipient of the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research and the National Institutes of Health (NIH) Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research, funded through grant number DPI OD00329. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Appay V, 2007, EXP GERONTOL, V42, P432, DOI 10.1016/j.exger.2006.12.003; Appay V, 2011, AIDS, V25, P1813, DOI 10.1097/QAD.0b013e32834640e6; BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; BRINCHMANN JE, 1994, J INFECT DIS, V169, P730, DOI 10.1093/infdis/169.4.730; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Caggiari L, 2001, CYTOMETRY, V46, P233, DOI 10.1002/cyto.1132; Catalfamo M, 2008, P NATL ACAD SCI USA, V105, P19851, DOI 10.1073/pnas.0810032105; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; CHOREMIPAPADOPOULOU H, 1994, J ACQ IMMUN DEF SYND, V7, P245; d'Ettorre G, 2011, CURR HIV RES, V9, P148, DOI 10.2174/157016211795945296; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fagnoni FF, 2002, IMMUNOLOGY, V106, P27, DOI 10.1046/j.1365-2567.2002.01400.x; Fagnoni FF, 1996, IMMUNOLOGY, V88, P501, DOI 10.1046/j.1365-2567.1996.d01-689.x; Fagnoni FF, 2000, BLOOD, V95, P2860, DOI 10.1182/blood.V95.9.2860.009k35_2860_2868; Fleury S, 2000, P NATL ACAD SCI USA, V97, P5393, DOI 10.1073/pnas.97.10.5393; FRAZER IH, 1986, Q J MED, V61, P921; Haas A, 2010, EMBO MOL MED, V2, P231, DOI 10.1002/emmm.201000075; Harari A, 2004, EUR J IMMUNOL, V34, P3525, DOI 10.1002/eji.200425324; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Howard RR, 1996, CYTOMETRY, V26, P231, DOI 10.1002/(SICI)1097-0320(19960915)26:3<231::AID-CYTO9>3.3.CO;2-3; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Khanna N, 2008, CLIN INFECT DIS, V47, P1093, DOI 10.1086/592113; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Li TS, 2011, CLIN INFECT DIS, V53, P944, DOI 10.1093/cid/cir552; Llibre JM, 2012, ANTIVIR THER, V17, P355, DOI 10.3851/IMP1917; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; RABIN RL, 1995, J CLIN INVEST, V95, P2054, DOI 10.1172/JCI117891; RIEDY MC, 1991, CYTOMETRY, V12, P133, DOI 10.1002/cyto.990120206; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SANSONI P, 1993, BLOOD, V82, P2767; Sauce D, 2011, BLOOD, V117, P5142, DOI 10.1182/blood-2011-01-331306; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; Young J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001194; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb	43	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85613	10.1371/journal.pone.0085613	http://dx.doi.org/10.1371/journal.pone.0085613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465619	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500082
J	Feldman, N; Kosolapov, L; Ben-Zvi, A				Feldman, Naama; Kosolapov, Libby; Ben-Zvi, Anat			Fluorodeoxyuridine Improves Caenorhabditis elegans Proteostasis Independent of Reproduction Onset	PLOS ONE			English	Article							LIFE-SPAN; DNA-DAMAGE; STEM-CELLS; LONGEVITY; ACTIVATION; COLLAPSE; NUCLEAR; SIGNALS; SYSTEM; GROWTH	Protein homeostasis (proteostasis) networks are dynamic throughout the lifespan of an organism. During Caenorhabditis elegans adulthood, the maintenance of metastable proteins and the activation of stress responses are inversely associated with germline stem cell proliferation. Here, we employed the thymidylate synthase inhibitor 5-fluoro-2'-deoxyuridine (FUdR) to chemically inhibit reproduction, thus allowing for examination of the interplay between reproduction and somatic proteostasis. We found that treatment with FUdR modulates proteostasis decline both before and after reproduction onset, such that effective induction of the heat shock response was maintained during adulthood and that metastable temperature-sensitive mutant phenotypes were rescued under restrictive conditions. However, FUdR treatment also improved the folding capacity of germline-and gonadogenesis-defective mutants, suggesting that proteostasis modulation by FUdR is independent of germline stem cell proliferation or inhibition of reproduction. Our data, therefore, indicate that FUdR converges on alternative regulatory signals that modulate C. elegans proteostasis capacity during development and adulthood.	[Ben-Zvi, Anat] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Ben-Zvi, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	anatbz@bgu.ac.il	BEN-ZVI, ANAT/F-1674-2012	BEN-ZVI, ANAT/0000-0003-2477-6519	Binational Science Foundation [2009187]; FP7-People-Marie Curie international reintegration grants (IRG) [268285]	Binational Science Foundation(US-Israel Binational Science Foundation); FP7-People-Marie Curie international reintegration grants (IRG)	This work was supported by the Binational Science Foundation grant # 2009187 (http://www.bsf.org.il/BSFPublic/Default.aspx) and FP7-People-Marie Curie international reintegration grants (IRG) grant # 268285 (http://cordis.europa.eu/fp7/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitlhadj L, 2010, MECH AGEING DEV, V131, P364, DOI 10.1016/j.mad.2010.03.002; Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Antebi A, 2013, EXP GERONTOL, V48, P596, DOI 10.1016/j.exger.2012.09.009; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Bar-Lavan Y, 2012, FEBS J, V279, P526, DOI 10.1111/j.1742-4658.2011.08455.x; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Clark DA, 2007, J NEUROSCI, V27, P6083, DOI 10.1523/JNEUROSCI.1032-07.2007; Cohen E, 2010, AGING CELL, V9, P126, DOI 10.1111/j.1474-9726.2009.00541.x; Crawford D, 2007, AGING CELL, V6, P715, DOI 10.1111/j.1474-9726.2007.00327.x; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Davies SK, 2012, MECH AGEING DEV, V133, P46, DOI 10.1016/j.mad.2011.11.002; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; Ermolaeva MA, 2013, NATURE, V501, P416, DOI 10.1038/nature12452; GANDHI S, 1980, MECH AGEING DEV, V12, P137, DOI 10.1016/0047-6374(80)90090-1; Garigan D, 2002, GENETICS, V161, P1101; Gerisch B, 2007, P NATL ACAD SCI USA, V104, P5014, DOI 10.1073/pnas.0700847104; Ghazi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000639; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Golden TR, 2007, AGING CELL, V6, P179, DOI 10.1111/j.1474-9726.2007.00273.x; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Haldimann P, 2011, J BIOL CHEM, V286, P18784, DOI 10.1074/jbc.M111.234773; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; HOSONO R, 1978, EXP GERONTOL, V13, P369, DOI 10.1016/0531-5565(78)90047-5; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Ito S, 2010, CURR BIOL, V20, P333, DOI 10.1016/j.cub.2009.12.032; Judy ME, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003714; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Liu G, 2011, EMBO J, V30, P2990, DOI 10.1038/emboj.2011.195; McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x; MILLER DM, 1983, CELL, V34, P477, DOI 10.1016/0092-8674(83)90381-1; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; O'Rourke EJ, 2013, GENE DEV, V27, P429, DOI 10.1101/gad.205294.112; Olsen A, 2006, SCIENCE, V312, P1381, DOI 10.1126/science.1124981; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; SANTI DV, 1972, P NATL ACAD SCI USA, V69, P1855, DOI 10.1073/pnas.69.7.1855; Shemesh N, 2013, AGING CELL, V12, P814, DOI 10.1111/acel.12110; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; van Oosten-Hawle P, 2013, CELL, V153, P1366, DOI 10.1016/j.cell.2013.05.015; Van Raamsdonk JM, 2011, MECH AGEING DEV, V132, P519, DOI 10.1016/j.mad.2011.08.006; Vermezovic J, 2012, CELL DEATH DIFFER, V19, P1847, DOI 10.1038/cdd.2012.69; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wollam J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001305; Yamawaki TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000468; YOSHIOKA A, 1987, J BIOL CHEM, V262, P8235	48	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85964	10.1371/journal.pone.0085964	http://dx.doi.org/10.1371/journal.pone.0085964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465816	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500157
J	McDonald, AA; Kunz, MD; McLoon, LK				McDonald, Abby A.; Kunz, Matthew D.; McLoon, Linda K.			Dystrophic Changes in Extraocular Muscles after Gamma Irradiation in mdx:utrophin(+/-) Mice	PLOS ONE			English	Article							MDX MOUSE MUSCLE; MYOGENIC STEM-CELL; GROWTH-FACTOR-I; SKELETAL-MUSCLE; SATELLITE CELL; BOTULINUM TOXIN; EXTRACELLULAR-MATRIX; REGENERATION; EXPRESSION; UTROPHIN	Extraocular muscles (EOM) have a strikingly different disease profile than limb skeletal muscles. It has long been known that they are spared in Duchenne (DMD) and other forms of muscular dystrophy. Despite many studies, the cause for this sparing is not understood. We have proposed that differences in myogenic precursor cell properties in EOM maintain normal morphology over the lifetime of individuals with DMD due to either greater proliferative potential or greater resistance to injury. This hypothesis was tested by exposing wild type and mdx:utrophin(+/-) (het) mouse EOM and limb skeletal muscles to 18 Gy gamma irradiation, a dose known to inhibit satellite cell proliferation in limb muscles. As expected, over time het limb skeletal muscles displayed reduced central nucleation mirrored by a reduction in Pax7-positive cells, demonstrating a significant loss in regenerative potential. In contrast, in the first month post-irradiation in the het EOM, myofiber cross-sectional areas first decreased, then increased, but ultimately returned to normal compared to non-irradiated het EOM. Central nucleation significantly increased in the first post-irradiation month, resembling the dystrophic limb phenotype. This correlated with decreased EECD34 stem cells and a concomitant increase and subsequent return to normalcy of both Pax7 and Pitx2-positive cell density. By two months, normal het EOM morphology returned. It appears that irradiation disrupts the normal method of EOM remodeling, which react paradoxically to produce increased numbers of myogenic precursor cells. This suggests that the EOM contain myogenic precursor cell types resistant to 18 Gy gamma irradiation, allowing return to normal morphology 2 months post-irradiation. This supports our hypothesis that ongoing proliferation of specialized regenerative populations in the het EOM actively maintains normal EOM morphology in DMD. Ongoing studies are working to define the differences in the myogenic precursor cells in EOM as well as the cellular milieu in which they reside.	[McLoon, Linda K.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Grad Program Mol Cellular Dev Biol & Genet, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	McLoon, LK (corresponding author), Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA.	mcloo001@umn.edu		McLoon, LInda/0000-0001-9714-4681	NIH [EY55137]; National Eye Institute [EY11375]; NIAMS [P30-AR0507220]; 3M Science & Technology Fellowship; Minnesota Medical Foundation; Minnesota Lions and Lionesses; Department of Ophthalmology from Research to Prevent Blindness, Inc.;  [T32EY007133]; NATIONAL EYE INSTITUTE [P30EY011374, T32EY007133] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); 3M Science & Technology Fellowship(3M); Minnesota Medical Foundation; Minnesota Lions and Lionesses; Department of Ophthalmology from Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by NIH EY55137 (LKM) and EY11375 from the National Eye Institute, T32EY007133 (AAM), NIAMS P30-AR0507220, the 3M Science & Technology Fellowship (AAM), the Minnesota Medical Foundation, the Minnesota Lions and Lionesses, and an unrestricted grant to the Department of Ophthalmology from Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi M, 2010, INVEST OPHTH VIS SCI, V51, P3494, DOI 10.1167/iovs.09-5030; Anderson BC, 2006, INVEST OPHTH VIS SCI, V47, P2461, DOI 10.1167/iovs.05-1416; Becher UM, 2009, EXP CELL RES, V315, P2741, DOI 10.1016/j.yexcr.2009.07.005; Brack AS, 2007, STEM CELL REV, V3, P226, DOI 10.1007/s12015-007-9000-2; CARLSON BM, 1983, MED SCI SPORT EXER, V15, P187; Christiansen SP, 2006, INVEST OPHTH VIS SCI, V47, P605, DOI 10.1167/iovs.05-1069; Christiansen SP, 2010, INVEST OPHTH VIS SCI, V51, P5646, DOI 10.1167/iovs.10-5523; Deconinck N, 1997, NAT MED, V3, P1216, DOI 10.1038/nm1197-1216; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; DUCHEN LW, 1970, J NEUROL NEUROSUR PS, V33, P40, DOI 10.1136/jnnp.33.1.40; Fischer MD, 2002, PHYSIOL GENOMICS, V9, P71, DOI 10.1152/physiolgenomics.00115.2001; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Granata AL, 1998, ACTA NEUROPATHOL, V96, P564, DOI 10.1007/s004010050936; Gross JG, 1999, MUSCLE NERVE, V22, P174, DOI 10.1002/(SICI)1097-4598(199902)22:2<174::AID-MUS5>3.0.CO;2-S; HASSAN SM, 1995, BRAIN, V118, P533, DOI 10.1093/brain/118.2.533; Hebert SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058405; Heslop L, 2000, J CELL SCI, V113, P2299; Huang P, 2011, MUSCLE NERVE, V43, P263, DOI 10.1002/mus.21848; Jackson JR, 2012, AM J PHYSIOL-CELL PH, V303, pC854, DOI 10.1152/ajpcell.00207.2012; Kallestad KM, 2011, EXP CELL RES, V317, P873, DOI 10.1016/j.yexcr.2011.01.018; Kallestad KM, 2010, J CELL PHYSIOL, V222, P676, DOI 10.1002/jcp.21989; KAMINSKI HJ, 1992, ANN NEUROL, V32, P586, DOI 10.1002/ana.410320418; KARPATI G, 1986, AM J MED GENET, V25, P653, DOI 10.1002/ajmg.1320250407; KHURANA TS, 1995, J EXP MED, V182, P467, DOI 10.1084/jem.182.2.467; Kovanen V, 2002, EXERC SPORT SCI REV, V30, P20, DOI 10.1097/00003677-200201000-00005; Lowe DA, 1999, CELL TISSUE RES, V296, P531, DOI 10.1007/s004410051314; Lucas CA, 1997, INVEST OPHTH VIS SCI, V38, P2817; Marques MJ, 2007, MUSCLE NERVE, V35, P349, DOI 10.1002/mus.20697; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; MCGEACHIE JK, 1993, J NEUROL SCI, V119, P169, DOI 10.1016/0022-510X(93)90130-Q; McGeachie JK, 1999, J ANAT, V194, P287, DOI 10.1046/j.1469-7580.1999.19420287.x; McLoon Linda K, 2002, Trans Am Ophthalmol Soc, V100, P119; McLoon LK, 2004, MUSCLE NERVE, V29, P707, DOI 10.1002/mus.20012; McLoon LK, 2003, INVEST OPHTH VIS SCI, V44, P1927, DOI 10.1167/iovs.02-0673; McLoon LK, 2002, MUSCLE NERVE, V25, P348, DOI 10.1002/mus.10056; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; MORGAN JE, 1990, J CELL BIOL, V111, P2437, DOI 10.1083/jcb.111.6.2437; Mouly V, 2005, ACTA PHYSIOL SCAND, V184, P3, DOI 10.1111/j.1365-201X.2005.01417.x; Mu XD, 2013, FASEB J, V27, P3619, DOI 10.1096/fj.13-233460; Pagel CN, 1999, J NEUROL SCI, V164, P103, DOI 10.1016/S0022-510X(99)00061-1; Phelan JN, 1997, ANAT REC, V247, P179, DOI 10.1002/(SICI)1097-0185(199702)247:2<179::AID-AR4>3.0.CO;2-T; Porter JD, 2003, FASEB J, V17, P893, DOI 10.1096/fj.02-0810fje; QUINLAN JG, 1995, MUSCLE NERVE, V18, P201, DOI 10.1002/mus.880180209; Ragusa RJ, 1997, NEUROMUSCULAR DISORD, V7, P379, DOI 10.1016/S0960-8966(97)00096-5; Renault V, 2000, EXP GERONTOL, V35, P711, DOI 10.1016/S0531-5565(00)00151-0; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; ROSENBLATT JD, 1992, J APPL PHYSIOL, V73, P2538, DOI 10.1152/jappl.1992.73.6.2538; Sakurai T, 2009, INT J RADIAT BIOL, V85, P153, DOI 10.1080/09553000802641177; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; SPENCER RF, 1987, ARCH OPHTHALMOL-CHIC, V105, P1703, DOI 10.1001/archopht.1987.01060120101035; Stager Jr D, 2013, T AM OPHTHAL SOC, V111, P70; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Taylor-Jones JM, 2002, MECH AGEING DEV, V123, P649, DOI 10.1016/S0047-6374(01)00411-0; Ugalde I, 2005, INVEST OPHTH VIS SCI, V46, P4114, DOI 10.1167/iovs.05-0549; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; van Putten M, 2012, NEUROMUSCULAR DISORD, V22, P406, DOI 10.1016/j.nmd.2011.10.011; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Wehling M, 1998, NEUROMUSCULAR DISORD, V8, P22, DOI 10.1016/S0960-8966(97)00136-3; WELLER B, 1991, J NEUROPATH EXP NEUR, V50, P419, DOI 10.1097/00005072-199107000-00003; Yang SY, 2010, LAB INVEST, V90, P391, DOI 10.1038/labinvest.2009.139; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029; Zhou YF, 2011, J PHYSIOL-LONDON, V589, P4601, DOI 10.1113/jphysiol.2011.207076; Zhou YF, 2009, INVEST OPHTH VIS SCI, V50, P4531, DOI 10.1167/iovs.08-2950	66	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86424	10.1371/journal.pone.0086424	http://dx.doi.org/10.1371/journal.pone.0086424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466085	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500243
J	Organ, SL; Hai, J; Radulovich, N; Marshall, CB; Leung, L; Sasazuki, T; Shirasawa, S; Zhu, CQ; Navab, R; Ikura, M; Tsao, MS				Organ, Shawna L.; Hai, Josephine; Radulovich, Nikolina; Marshall, Christopher B.; Leung, Lisa; Sasazuki, Takehiko; Shirasawa, Senji; Zhu, Chang-Qi; Navab, Roya; Ikura, Mitsuhiko; Tsao, Ming-Sound			p120RasGAP Is a Mediator of Rho Pathway Activation and Tumorigenicity in the DLD1 Colorectal Cancer Cell Line	PLOS ONE			English	Article							KIRSTEN RAS MUTATIONS; REAL-TIME NMR; TYROSINE PHOSPHORYLATION; CAPILLARY MALFORMATION; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; CATALYTIC DOMAIN; WEBER-SYNDROME; LUNG-CANCER; C-SRC	KRAS is mutated in similar to 40% of colorectal cancer (CRC), and there are limited effective treatments for advanced KRAS mutant CRC. Therefore, it is crucial that downstream mediators of oncogenic KRAS continue to be studied. We identified p190RhoGAP as being phosphorylated in the DLD1 CRC cell line, which expresses a heterozygous KRAS G13D allele, and not in DKO4 in which the mutant allele has been deleted by somatic recombination. We found that a ubiquitous binding partner of p190RhoGAP, p120RasGAP (RasGAP), is expressed in much lower levels in DKO4 cells compared to DLD1, and this expression is regulated by KRAS. Rescue of RasGAP expression in DKO4 rescued Rho pathway activation and partially rescued tumorigenicity in DKO4 cells, indicating that the combination of mutant KRAS and RasGAP expression is crucial to these phenotypes. We conclude that RasGAP is an important effector of mutant KRAS in CRC.	[Organ, Shawna L.; Hai, Josephine; Radulovich, Nikolina; Marshall, Christopher B.; Leung, Lisa; Zhu, Chang-Qi; Navab, Roya; Ikura, Mitsuhiko; Tsao, Ming-Sound] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Organ, Shawna L.; Radulovich, Nikolina; Tsao, Ming-Sound] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hai, Josephine; Leung, Lisa; Ikura, Mitsuhiko; Tsao, Ming-Sound] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Sasazuki, Takehiko] Int Med Ctr Japan, Res Inst, Dept Pathol, Tokyo, Japan; [Shirasawa, Senji] Fukuoka Univ, Sch Med, Dept Cell Biol, Fukuoka 81401, Japan	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; National Center for Global Health & Medicine - Japan; Fukuoka University	Tsao, MS (corresponding author), Princess Margaret Canc Ctr, Toronto, ON, Canada.	ming.tsao@uhn.on.ca	Navab, Roya/AGD-7380-2022; Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017; Marshall, Christopher/K-8943-2019; Hai, Josephine/AAO-9919-2020	Tsao, Ming Sound/0000-0002-9160-5405; Marshall, Christopher/0000-0002-7571-5700; Hai, Josephine/0000-0002-5842-7686; Zhu, ChangQi/0000-0002-9992-0258; Ikura, Mitsuhiko/0000-0002-9524-1303	Canadian Institutes of Health Research [MOP-64345]; Cancer Research Society of Canada; Ontario Ministry of Health and Long Term Care; CIHR Banting and Best Doctoral Research Award; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society of Canada; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); CIHR Banting and Best Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work is supported in parts by grants from the Canadian Institutes of Health Research MOP-64345 (MST), Cancer Research Society of Canada (MI), and the Ontario Ministry of Health and Long Term Care. SLO is supported by the CIHR Banting and Best Doctoral Research Award. MI holds the Canada Research Chair in Cancer Structural Biology. MST is the M. Qasim Choksi Chair in Lung Cancer Translational Research. The UHN NMR facility is supported by the Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Andreyev HJN, 2001, BRIT J CANCER, V85, P692, DOI 10.1054/bjoc.2001.1964; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barshack I, 1998, MODERN PATHOL, V11, P271; Boon LM, 2005, CURR OPIN GENET DEV, V15, P265, DOI 10.1016/j.gde.2005.03.004; Cailliau K, 2001, FEBS LETT, V496, P161, DOI 10.1016/S0014-5793(01)02410-3; Calvisi DF, 2011, J HEPATOL, V54, P311, DOI 10.1016/j.jhep.2010.06.036; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Davidson B, 1998, PATHOL RES PRACT, V194, P399, DOI 10.1016/S0344-0338(98)80030-7; de Wijn RS, 2012, EUR J MED GENET, V55, P191, DOI 10.1016/j.ejmg.2012.01.009; DRUKER B, 1992, BLOOD, V79, P2215; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Habets GG, 2001, METHOD ENZYMOL, V332, P245; Hai J, 2012, CLIN CANCER RES, V18, P1914, DOI 10.1158/1078-0432.CCR-11-2893; Hecker TP, 2004, ONCOGENE, V23, P3962, DOI 10.1038/sj.onc.1207541; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; Hershkovitz D, 2008, ARCH DERMATOL RES, V300, P385, DOI 10.1007/s00403-008-0842-5; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jiang W, 2008, J BIOL CHEM, V283, P20978, DOI 10.1074/jbc.M802588200; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kadam SD, 2012, ARCH DERMATOL RES, V304, P229, DOI 10.1007/s00403-012-1210-z; Keller JW, 2007, J CELL PHYSIOL, V210, P740, DOI 10.1002/jcp.20898; Koehler JA, 2001, CELL GROWTH DIFFER, V12, P551; Konopke R, 2012, J GASTROINTEST LIVER, V21, P83; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Makrodouli E, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-118; Marshall CB, 2012, METHODS, V57, P473, DOI 10.1016/j.ymeth.2012.06.014; Marshall CB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000029; MITSUDOMI T, 1994, HUM GENET, V93, P27; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; Organ SL, 2011, J PROTEOME RES, V10, P3200, DOI 10.1021/pr200238t; Plattner R, 1999, ONCOGENE, V18, P1807, DOI 10.1038/sj.onc.1202482; Radutovich N, 2008, METHOD ENZYMOL, V439, P1, DOI 10.1016/S0076-6879(07)00401-6; Revencu N, 2008, HUM MUTAT, V29, P959, DOI 10.1002/humu.20746; Rieske P, 2001, J BIOL CHEM, V276, P8460, DOI 10.1074/jbc.M007482200; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; SCHEIDIG AJ, 1995, J MOL BIOL, V253, P132, DOI 10.1006/jmbi.1995.0541; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; Sharma SV, 1998, ONCOGENE, V17, P271, DOI 10.1038/sj.onc.1201921; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sinclair P, 2012, GASTROINTEST ENDOSC, V75, P1072, DOI 10.1016/j.gie.2012.01.004; SKORSKI T, 1994, J EXP MED, V179, P1855, DOI 10.1084/jem.179.6.1855; Smith MJ, 2013, P NATL ACAD SCI USA, V110, P4574, DOI 10.1073/pnas.1218173110; STAHLEBACKDHAL M, 1995, AM J PATHOL, V146, P1073; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Tocque B, 1997, CELL SIGNAL, V9, P153, DOI 10.1016/S0898-6568(96)00135-0; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; vanderGeer P, 1997, MOL CELL BIOL, V17, P1840, DOI 10.1128/MCB.17.4.1840; Vartanian S, 2013, J BIOL CHEM, V288, P2403, DOI 10.1074/jbc.M112.394130; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Yue YZ, 2004, J BIOL CHEM, V279, P12883, DOI 10.1074/jbc.M312308200; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	63	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86103	10.1371/journal.pone.0086103	http://dx.doi.org/10.1371/journal.pone.0086103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465899	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500182
J	Shao, SH; Li, ZL; Gao, W; Yu, GH; Liu, DX; Pan, F				Shao, Shuhong; Li, Zunling; Gao, Wei; Yu, Guohua; Liu, Dexiang; Pan, Fang			ADAM-12 as a Diagnostic Marker for the Proliferation, Migration and Invasion in Patients with Small Cell Lung Cancer	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HUMAN BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC-SIGNIFICANCE; EXTRACELLULAR-MATRIX; HUMAN GLIOBLASTOMAS; TUMOR-PROGRESSION; FAMILY-MEMBERS; MESSENGER-RNA; EXPRESSION	Small cell lung cancer (SCLC) is highly aggressive and is characterized by malignant metastasis. Approximately 90% of patients die due to extensive metastasis. The extracellular matrix (ECM) is a natural barrier that can prevent cellular invasion and metastasis. Therefore, degradation of the ECM must take place in order for extensive metastasis to occur. A disintegrin and metalloprotease (ADAM) is a multi-domain protease that plays an important role in tumorigenesis, as well as tumor development, invasion and metastasis. However, there have been few reports on the expression and role of ADAMs in SCLC. In the current study, the expression and role of ADAMs in SCLC proliferation, invasion and metastasis was investigated. A total of 150 SCLC tissue samples were examined by immunohistochemistry for ADAMs expression. ADAM-12 was found to be abundantly expressed in 72.67% samples and other ADAMs were found to be expressed in 10% to 40% of samples. ADAM-12 levels in serum and urine, from 70 SCLC patients and 40 normal controls, were also measured using ELISA. ADAM-12 expression was significantly higher in SCLC patients than in healthy controls and in patients with extensive disease compared to those with more limited disease. Silencing the expression of ADAM-12 in H1688 cells through the use of specific siRNA significantly reduced cellular proliferation, invasion and metastasis. Supplementing the expression of ADAM-12-L or -S in H345 cells, significantly enhanced cellular proliferation, invasion and metastasis. Animal models with metastatic SCLC also exhibited increased expression of ADAM-12 along with enhanced invasion and metastasis. In brief, ADAM-12 is an independent prognostic factor and diagnostic marker, and is involved in the proliferation, invasion and metastasis of SCLC.	[Shao, Shuhong; Liu, Dexiang; Pan, Fang] Shandong Univ, Sch Med, Inst Med Psychol, Jinan 250100, Peoples R China; [Shao, Shuhong] Binzhou Med Univ, Dept Med Psychol, Yantai, Peoples R China; [Li, Zunling] Binzhou Med Univ, Dept Biochem & Mol Biol, Yantai, Peoples R China; [Gao, Wei] Jinan Cent Hosp, Dept Pathol, Jinan, Shandong, Peoples R China; [Yu, Guohua] Yuhuangding Hosp, Dept Pathol, Yantai, Shandong, Peoples R China	Shandong University; Binzhou Medical University; Binzhou Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences	Pan, F (corresponding author), Shandong Univ, Sch Med, Inst Med Psychol, Jinan 250100, Peoples R China.	panfang2003@hotmail.com			National Natural Science Foundation of China [81302017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81302017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Buttery RC, 2004, INT J BIOCHEM CELL B, V36, P1154, DOI 10.1016/S1357-2725(03)00261-9; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; Chang MH, 2012, APMIS, V120, P28, DOI 10.1111/j.1600-0463.2011.02788.x; Costa FF, 2004, ONCOGENE, V23, P1481, DOI 10.1038/sj.onc.1207263; Ding X, 2004, WORLD J GASTROENTERO, V10, P2735, DOI 10.3748/wjg.v10.i18.2735; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Frohlich C, 2013, BIOCHEM J, V452, P97, DOI 10.1042/BJ20121558; Hu ZY, 2012, CARCINOGENESIS, V33, P1178, DOI 10.1093/carcin/bgs141; Huang J, 2005, MOL BIOL CELL, V16, P4982, DOI 10.1091/mbc.E05-03-0258; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Ishikawa N, 2004, CLIN CANCER RES, V10, P8363, DOI 10.1158/1078-0432.CCR-04-1436; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lei YH, 2012, ONCOL REP, V27, P151, DOI 10.3892/or.2011.1489; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Michael M, 1999, J CLIN ONCOL, V17, P1802, DOI 10.1200/JCO.1999.17.6.1802; Mino N, 2009, J SURG ONCOL, V100, P267, DOI 10.1002/jso.21313; Mori S, 2003, J BIOL CHEM, V278, P46029, DOI 10.1074/jbc.M306393200; Moss LAS, 2012, AM J PATHOL, V181, P1895, DOI 10.1016/j.ajpath.2012.08.044; Nakada M, 2005, ACTA NEUROPATHOL, V110, P239, DOI 10.1007/s00401-005-1032-6; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; O'Shea C, 2003, INT J CANCER, V105, P754, DOI 10.1002/ijc.11161; Ohtsuka T, 2006, INT J CANCER, V118, P263, DOI 10.1002/ijc.21324; Rocks N, 2006, BRIT J CANCER, V94, P724, DOI 10.1038/sj.bjc.6602990; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Roy R, 2011, J BIOL CHEM, V286, P20758, DOI 10.1074/jbc.M110.216036; Schutz A, 2005, VIRCHOWS ARCH, V446, P421, DOI 10.1007/s00428-004-1193-z; Tanaka M, 2004, J BIOL CHEM, V279, P41950, DOI 10.1074/jbc.M400086200; Thodeti CK, 2003, J BIOL CHEM, V278, P9576, DOI 10.1074/jbc.M208937200; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129; Zhang YL, 2013, J THORAC DIS, V5, P538, DOI 10.3978/j.issn.2072-1439.2013.07.04	35	47	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85936	10.1371/journal.pone.0085936	http://dx.doi.org/10.1371/journal.pone.0085936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465799	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500149
J	Zhang, HJ; Liu, X; Liu, YB; Wu, Y; Li, HX; Zhao, CB; Li, HZ; Meng, QG; Li, W				Zhang, Hanjun; Liu, Xing; Liu, Youbin; Wu, Yin; Li, Hongxi; Zhao, Chengbin; Li, Huazhe; Meng, Qinggang; Li, Wei			Effect of Hematoporphyrin Monomethyl Ether-Sonodynamic Therapy (HMME-SDT) on Hypertrophic Scarring	PLOS ONE			English	Article							CELLS	Objective: The aim of the present study was to explore the potential for hematoporphyrin monomethyl ether-Sonodynamic Therapy (HMME-SDT) treatment of hypertrophic scars within rabbit ears. Methods: 60 white rabbits were randomly divided into five groups: 1) untreated controls, 2) lesioned, 3) lesioned + HMME, 4) lesioned + US (Ultrasound), and 5) lesioned + HMME-SDT. After induction of a lesion upon the ears of the rabbits, hypertrophic scars were assessed at 14, 28, 42 and 56 days post-lesion +/- treatment. Assessments consisted of visual inspection in the change of the skin, scar formation pathological morphology by hematoxylin and eosin (HE) staining technique with optical microscopy, calculation of a hypertrophic index, fibroblastic density measures, and observation of collagen changes in the scar tissue by Van Gieson's (VG) Stain along with calculation of collagen area density. Results: With continued HMME-SDT treatment there was a gradual improvement in all parameters over the duration of the experiment. The lesion-induced scars of rabbits receiving HMME-SDT treatment were soft, the size was reduced, hyperplasia was flat and the color pale. The fibroblasts and collagens were reduced and the collagens were light red, sparse and orderly. The hypertrophic index was reduced, since the fibroblastic density was lowered and collagen area density was decreased. Conclusion: HMME is an effective sonosensitizer and the combination of HMME-SDT treatment can exert significant benefits in reducing the formation of hypertrophic scars.	[Zhang, Hanjun; Liu, Xing; Liu, Youbin; Wu, Yin; Li, Hongxi; Zhao, Chengbin; Li, Huazhe; Li, Wei] Harbin Med Univ, Dept Orthopaed Surg, Harbin, Peoples R China; [Meng, Qinggang] First Hosp Harbin City, Dept Orthopaed Surg, Harbin, Peoples R China	Harbin Medical University	Zhao, CB (corresponding author), Harbin Med Univ, Dept Orthopaed Surg, Harbin, Peoples R China.	Zhaochengbin9129@126.com; mengqinggang2009@126.com; liwei9129@126.com			Heilongjiang Provincial Health Bureau [2012-690, 2012-726]; Heilongjiang Province traditional Chinese medical science Bureau [zh1112-z177]; Heilongjiang province science and technology plan and technological project [GC10C303-4]; Harbin technological innovative personnel and special fund project [2012RFXXS066]	Heilongjiang Provincial Health Bureau; Heilongjiang Province traditional Chinese medical science Bureau; Heilongjiang province science and technology plan and technological project; Harbin technological innovative personnel and special fund project	This work is supported in part by funding from Heilongjiang Provincial Health Bureau funding: (2012-690, 2012-726), Heilongjiang Province traditional Chinese medical science Bureau (zh1112-z177), Heilongjiang province science and technology plan and technological project (GC10C303-4), Harbin technological innovative personnel and special fund project (2012RFXXS066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branski LK, 2012, CHIRURG, V83, P831, DOI 10.1007/s00104-011-2243-0; Furusawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029012; Lee JH, 2012, PHYTOMEDICINE, V19, P1223, DOI 10.1016/j.phymed.2012.08.002; Li W, 2014, ZHONGHUA SH IN PRESS; Li YX, 2012, ULTRASONICS, V52, P490, DOI 10.1016/j.ultras.2011.10.013; Liu H, 2012, Biomed Opt Express, V3, P3278, DOI 10.1364/BOE.3.003278; Lv Y, 2012, CELLULAR PHYSL BIOCH, V30, DOI [10.1159/000339067, DOI 10.1159/000339067.PMID:22739213]; Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021; Nomikou N, 2012, CHEMMEDCHEM, V7, P1465, DOI 10.1002/cmdc.201200233; Stewart TL, 2012, J BURN CARE RES, V33, P764, DOI 10.1097/BCR.0b013e318257db36; Tang W, 2011, ULTRASONICS, V51, P777, DOI 10.1016/j.ultras.2011.02.008; Yang JY, 2012, ANN PLASTIC SURG, V69, DOI [10.1097/SAP.0b013e318274d876, DOI 10.1097/SAP.0B013E318274D876.PMID:23154335]	12	8	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86003	10.1371/journal.pone.0086003	http://dx.doi.org/10.1371/journal.pone.0086003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465834	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500163
J	Havixbeck, JJ; Rieger, AM; Wong, ME; Wilkie, MP; Barreda, DR				Havixbeck, Jeffrey J.; Rieger, Aja M.; Wong, Michael E.; Wilkie, Michael P.; Barreda, Daniel R.			Evolutionary Conservation of Divergent Pro-Inflammatory and Homeostatic Responses in Lamprey Phagocytes	PLOS ONE			English	Article							ZYMOSAN-INDUCED PERITONITIS; APOPTOTIC CELLS; IMMUNE-SYSTEM; RESOLUTION; ENGULFMENT; EXPRESSION; INNATE; LYMPHOCYTES; MACROPHAGES; NEUTROPHILS	In higher vertebrates, phagocytosis plays a critical role in development and immunity, based on the internalization and removal of apoptotic cells and invading pathogens, respectively. Previous studies describe the effective uptake of these particles by lower vertebrate and invertebrate phagocytes, and identify important molecular players that contribute to this internalization. However, it remains unclear if individual phagocytes mediate internalization processes in these ancient organisms, and how this impacts the balance of pro-inflammatory and homeostatic events within their infection sites. Herein we show that individual phagocytes of the jawless vertebrate Petromyzon marinus (sea lamprey), like those of teleost fish and mice, display the capacity for divergent pro-inflammatory and homeostatic responses following internalization of zymosan and apoptotic cells, respectively. Professional phagocytes (macrophages, monocytes, neutrophils) were the primary contributors to the internalization of pro-inflammatory particles among goldfish (C. auratus) and lamprey (P. marinus) hematopoietic leukocytes. However, goldfish showed a greater ability for zymosan phagocytosis when compared to their jawless counterparts. Coupled to this increase was a significantly lower sensitivity of goldfish phagocytes to homeostatic signals derived from apoptotic cell internalization. Together, this translated into a significantly greater capacity for induction of antimicrobial respiratory burst responses compared to lamprey phagocytes, but also a decreased efficacy in apoptotic cell-driven leukocyte homeostatic mechanisms that attenuate this pro-inflammatory process. Overall, our results show the long-standing evolutionary contribution of intrinsic phagocyte mechanisms for the control of inflammation, and illustrate one effective evolutionary strategy for increased responsiveness against invading pathogens. In addition, they highlight the need for development of complementary regulatory mechanisms of inflammation to ensure continued maintenance of host integrity amidst increasing challenges from invading pathogens.	[Havixbeck, Jeffrey J.; Rieger, Aja M.; Wong, Michael E.; Barreda, Daniel R.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Barreda, Daniel R.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Wilkie, Michael P.] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada	University of Alberta; University of Alberta; Wilfrid Laurier University	Barreda, DR (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	dan.barreda@ualberta.ca	Barreda, Daniel/A-2613-2014	Barreda, Daniel/0000-0003-4630-2840	Natural Sciences and Engineering Council of Canada (NSERC) Discovery Grants; NSERC CGS-M scholarship; NSERC Vanier doctoral scholarship	Natural Sciences and Engineering Council of Canada (NSERC) Discovery Grants; NSERC CGS-M scholarship; NSERC Vanier doctoral scholarship	This work was supported by Natural Sciences and Engineering Council of Canada (NSERC) Discovery Grants to DRB and MPW. JJH was supported by an NSERC CGS-M scholarship and AMR was supported by NSERC Vanier doctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bianchi SM, 2008, AM J RESP CRIT CARE, V177, P35, DOI 10.1164/rccm.200612-1804OC; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Chadzinska M, 2008, DEV COMP IMMUNOL, V32, P509, DOI 10.1016/j.dci.2007.08.008; Cooper MD, 2010, NAT REV IMMUNOL, V10, P2, DOI 10.1038/nri2686; Devitt A, 2011, J LEUKOCYTE BIOL, V90, P447, DOI 10.1189/jlb.0211095; Dupre-Crochet S, 2013, J LEUKOCYTE BIOL, V94, P657, DOI 10.1189/jlb.1012544; Erwig LP, 2007, AM J PATHOL, V171, P2, DOI 10.2353/ajpath.2007.070135; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Franc NC, 1999, CURR OPIN IMMUNOL, V11, P47, DOI 10.1016/S0952-7915(99)80009-0; FRISTROM D, 1969, MOL GEN GENET, V103, P363, DOI 10.1007/BF00383486; Fullard JF, 2009, APOPTOSIS, V14, P1029, DOI 10.1007/s10495-009-0335-9; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jordan HE, 1930, AM J ANAT, V46, P355, DOI 10.1002/aja.1000460302; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Kolaczkowska E, 2008, INFLAMM RES, V57, P272, DOI 10.1007/s00011-007-7131-1; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Maderna P, 2003, BBA-MOL BASIS DIS, V1639, P141, DOI 10.1016/j.bbadis.2003.09.004; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mayer WE, 2002, P NATL ACAD SCI USA, V99, P14350, DOI 10.1073/pnas.212527499; Morkert Sidney B., 1998, North American Journal of Fisheries Management, V18, P966, DOI 10.1577/1548-8675(1998)018<0966:EFEMOS>2.0.CO;2; Noga EJ, 2009, COMP BIOCHEM PHYS B, V152, P299, DOI 10.1016/j.cbpb.2008.12.018; Overland HS, 2010, FISH SHELLFISH IMMUN, V28, P193, DOI 10.1016/j.fsi.2009.10.021; PERCY R, 1976, J ZOOL, V178, P319; PIAVIS GW, 1971, COPEIA, P722; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Rieger AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047070; Rieger AM, 2011, DEV COMP IMMUNOL, V35, P1238, DOI 10.1016/j.dci.2011.03.009; Rieger AM, 2010, DEV COMP IMMUNOL, V34, P1144, DOI 10.1016/j.dci.2010.06.006; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Stafford JL, 2001, DEV COMP IMMUNOL, V25, P447, DOI 10.1016/S0145-305X(01)00015-5; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Youson JH, 2003, J GREAT LAKES RES, V29, P26, DOI 10.1016/S0380-1330(03)70476-6; ZAPATA A, 1979, DEV COMP IMMUNOL, V3, P55, DOI 10.1016/S0145-305X(79)80006-3; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	41	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86255	10.1371/journal.pone.0086255	http://dx.doi.org/10.1371/journal.pone.0086255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465992	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500124
J	Lin, CS; Ku, HL; Chao, HT; Tu, PC; Li, CT; Cheng, CM; Su, TP; Lee, YC; Hsieh, JC				Lin, Chia-Shu; Ku, Hsiao-Lun; Chao, Hsiang-Tai; Tu, Pei-Chi; Li, Cheng-Ta; Cheng, Chou-Ming; Su, Tung-Ping; Lee, Ying-Chiao; Hsieh, Jen-Chuen			Neural Network of Body Representation Differs between Transsexuals and Cissexuals	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; PRIMARY SOMATOSENSORY CORTEX; DEFAULT MODE; PREFRONTAL CORTEX; COGNITIVE CONTROL; BRAIN-FUNCTION; ORGANIZATION; DISORDER; EMOTION; SELF	Body image is the internal representation of an individual's own physical appearance. Individuals with gender identity disorder (GID), commonly referred to as transsexuals (TXs), are unable to form a satisfactory body image due to the dissonance between their biological sex and gender identity. We reasoned that changes in the resting-state functional connectivity (rsFC) network would neurologically reflect such experiential incongruence in TXs. Using graph theory-based network analysis, we investigated the regional changes of the degree centrality of the rsFC network. The degree centrality is an index of the functional importance of a node in a neural network. We hypothesized that three key regions of the body representation network, i.e., the primary somatosensory cortex, the superior parietal lobule and the insula, would show a higher degree centrality in TXs. Twenty-three pre-treatment TXs (11 male-to-female and 12 female-to-male TXs) as one psychosocial group and 23 age-matched healthy cissexual control subjects (CISs, 11 males and 12 females) were recruited. Resting-state functional magnetic resonance imaging was performed, and binarized rsFC networks were constructed. The TXs demonstrated a significantly higher degree centrality in the bilateral superior parietal lobule and the primary somatosensory cortex. In addition, the connectivity between the right insula and the bilateral primary somatosensory cortices was negatively correlated with the selfness rating of their desired genders. These data indicate that the key components of body representation manifest in TXs as critical function hubs in the rsFC network. The negative association may imply a coping mechanism that dissociates bodily emotion from body image. The changes in the functional connectome may serve as representational markers for the dysphoric bodily self of TXs.	[Lin, Chia-Shu] Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei 112, Taiwan; [Lin, Chia-Shu; Ku, Hsiao-Lun; Cheng, Chou-Ming; Hsieh, Jen-Chuen] Taipei Vet Gen Hosp, Dept Med Res, Integrated Brain Res Unit, Taipei, Taiwan; [Ku, Hsiao-Lun; Tu, Pei-Chi; Li, Cheng-Ta; Su, Tung-Ping; Lee, Ying-Chiao] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Ku, Hsiao-Lun] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, Taipei, Taiwan; [Chao, Hsiang-Tai] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chao, Hsiang-Tai] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Obstet & Gynecol, Taipei 112, Taiwan; [Tu, Pei-Chi] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Li, Cheng-Ta; Su, Tung-Ping; Lee, Ying-Chiao] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Psychiat, Taipei 112, Taiwan; [Hsieh, Jen-Chuen] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lee, YC (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	yclee@vghtpe.gov.tw; jchsieh@ym.edu.tw	Li, Cheng-Ta/AAI-5759-2021; Lin, Chia-Shu/HGD-7267-2022; Ku, Hsiao-Lun/G-6053-2016; Lin, Chia-shu/AAA-5143-2019	Li, Cheng-Ta/0000-0002-0670-1153; Lin, Chia-Shu/0000-0002-6575-0887; Ku, Hsiao-Lun/0000-0002-5640-5256; 	National Science Council [99-2314-B-075-018]; Taipei Veterans General Hospital [V100E3-002, V101C-201, V101E3-002]; Brain Research Center of National Yang-Ming University [98A-C-B501_23]; Ministry of Education for National Yang-Ming University	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Brain Research Center of National Yang-Ming University; Ministry of Education for National Yang-Ming University	This work was supported by the National Science Council (99-2314-B-075-018), the Taipei Veterans General Hospital (V100E3-002, V101C-201 and V101E3-002), the Brain Research Center of National Yang-Ming University (98A-C-B501_23) and the Aim for the Top University Plan of the Ministry of Education for National Yang-Ming University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Alexopoulos GS, 2013, J AFFECT DISORDERS, V149, P398, DOI 10.1016/j.jad.2012.11.023; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arienzo D, 2013, NEUROPSYCHOPHARMACOL, V38, P1130, DOI 10.1038/npp.2013.18; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bond M, 1986, EMPIRICAL STUDIES EG, P127; Cisler JM, 2013, PSYCHOL MED, V43, P507, DOI 10.1017/S0033291712001390; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Daniels JK, 2011, J PSYCHIATR NEUROSCI, V36, P56, DOI 10.1503/jpn.100050; Deen B, 2011, CEREB CORTEX, V21, P1498, DOI 10.1093/cercor/bhq186; Favaro A, 2012, BIOL PSYCHIAT, V72, P864, DOI 10.1016/j.biopsych.2012.04.025; Ferri F, 2012, J COGNITIVE NEUROSCI, V24, P1584, DOI 10.1162/jocn_a_00230; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hanggi J, 2011, J NEUROSCI, V31, P5816, DOI 10.1523/JNEUROSCI.0964-10.2011; Haggard P, 2013, CURR BIOL, V23, pR164, DOI 10.1016/j.cub.2013.01.047; Ham T, 2013, J NEUROSCI, V33, P7091, DOI 10.1523/JNEUROSCI.4692-12.2013; Harsay HA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00246; Hepp U, 2005, J PSYCHOSOM RES, V58, P259, DOI 10.1016/j.jpsychores.2004.08.010; KLEIN F, 1985, J HOMOSEXUAL, V11, P35, DOI 10.1300/J082v11n01_04; Ku HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070808; Lee YC, 2000, DEV DEFENSE STYLE QU; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; LINDGREN TW, 1975, ARCH SEX BEHAV, V4, P639, DOI 10.1007/BF01544272; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Manoliu A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00216; Michel A, 2002, EUR PSYCHIAT, V17, P353, DOI 10.1016/S0924-9338(02)00703-4; Morin A, 2007, BRAIN RES BULL, V74, P387, DOI 10.1016/j.brainresbull.2007.06.013; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ramachandran VS, 2007, MED HYPOTHESES, V69, P1001, DOI 10.1016/j.mehy.2007.02.024; Romanski L.M., 2012, NEURAL BASEMULTISE; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Savic I, 2011, CEREB CORTEX, V21, P2525, DOI 10.1093/cercor/bhr032; Schurmann M, 2011, HUM BRAIN MAPP, V32, P612, DOI 10.1002/hbm.21049; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sehm B, 2012, J NEUROPHYSIOL, V108, P3253, DOI 10.1152/jn.00606.2012; Simmons WK, 2012, HUM BRAIN MAPP; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Straube T, 2011, NEUROIMAGE, V54, P2534, DOI 10.1016/j.neuroimage.2010.10.010; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vanden Bulcke C, 2013, PAIN, V154, P1464, DOI 10.1016/j.pain.2013.05.009; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Weyers S, 2009, J SEX MED, V6, P752, DOI 10.1111/j.1743-6109.2008.01082.x; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Yan CG, 2013, NEUROIMAGE; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zhang S, 2012, CEREB CORTEX, V22, P99, DOI 10.1093/cercor/bhr088; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	57	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85914	10.1371/journal.pone.0085914	http://dx.doi.org/10.1371/journal.pone.0085914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465785	Green Published, gold			2022-12-25	WOS:000330240500087
J	Osabe, K; Clement, JD; Bedon, F; Pettolino, FA; Ziolkowski, L; Llewellyn, DJ; Finnegan, EJ; Wilson, IW				Osabe, Kenji; Clement, Jenny D.; Bedon, Frank; Pettolino, Filomena A.; Ziolkowski, Lisa; Llewellyn, Danny J.; Finnegan, E. Jean; Wilson, Iain W.			Genetic and DNA Methylation Changes in Cotton (Gossypium) Genotypes and Tissues	PLOS ONE			English	Article							CYTOSINE METHYLATION; EPIGENETIC INHERITANCE; FIBER INITIATION; HIRSUTUM; HYPOMETHYLATION; GENOME; RICE; POLYMORPHISM; EXPRESSION; DIVERSITY	In plants, epigenetic regulation is important in normal development and in modulating some agronomic traits. The potential contribution of DNA methylation mediated gene regulation to phenotypic diversity and development in cotton was investigated between cotton genotypes and various tissues. DNA methylation diversity, genetic diversity, and changes in methylation context were investigated using methylation-sensitive amplified polymorphism (MSAP) assays including a methylation insensitive enzyme (BsiSI), and the total DNA methylation level was measured by high-performance liquid chromatography (HPLC). DNA methylation diversity was greater than the genetic diversity in the selected cotton genotypes and significantly different levels of DNA methylation were identified between tissues, including fibre. The higher DNA methylation diversity (CHG methylation being more diverse than CG methylation) in cotton genotypes suggest epigenetic regulation may be important for cotton, and the change in DNA methylation between fibre and other tissues hints that some genes may be epigenetically regulated for fibre development. The novel approach using BsiSI allowed direct comparison between genetic and epigenetic diversity, and also measured CC methylation level that cannot be detected by conventional MSAP.	[Osabe, Kenji; Clement, Jenny D.; Bedon, Frank; Pettolino, Filomena A.; Ziolkowski, Lisa; Llewellyn, Danny J.; Finnegan, E. Jean; Wilson, Iain W.] CSIRO, Plant Ind, Campbell, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Wilson, IW (corresponding author), CSIRO, Plant Ind, Campbell, ACT, Australia.	Iain.Wilson@csiro.au	Wilson, Iain/D-4839-2009; Bedon, Frank/B-5497-2011; Clement, Jenny/C-7510-2011; Pettolino, Filomena A/I-1493-2012; Llewellyn, Danny J/D-5230-2009; Finnegan, Elizabeth J/A-1183-2010	Wilson, Iain/0000-0002-4626-8059; Bedon, Frank/0000-0002-9940-5926; Clement, Jenny/0000-0001-6329-2977; Pettolino, Filomena A/0000-0002-9077-1532; Llewellyn, Danny J/0000-0001-9535-8707; Finnegan, Elizabeth J/0000-0002-2724-9311	CSIRO, Plant Industry, Australia	CSIRO, Plant Industry, Australia	This study was supported by CSIRO, Plant Industry, Australia. The funder has permitted to publish the manuscript.	Abdalla AM, 2001, THEOR APPL GENET, V102, P222, DOI 10.1007/s001220051639; Amoah S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-193; Applequist WL, 2001, EVOL DEV, V3, P3, DOI 10.1046/j.1525-142x.2001.00079.x; Ashikawa I, 2001, PLANT MOL BIOL, V45, P31, DOI 10.1023/A:1006457321781; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bedon F, 2013, BIOTECHNIQUES, V54, P44, DOI 10.2144/000113969; Bossdorf O, 2010, EVOL ECOL, V24, P541, DOI 10.1007/s10682-010-9372-7; Brubaker C.L., 1999, COTTON ORIGIN HIST T, P3; Campbell BT, 2009, EUPHYTICA, V169, P285, DOI 10.1007/s10681-009-9917-4; Cao DH, 2011, AFR J BIOTECHNOL, V10, P18971, DOI 10.5897/AJB11.2989; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fang J, 2008, J HORTIC SCI BIOTECH, V83, P833, DOI 10.1080/14620316.2008.11512469; Fang JG, 2010, ACTA PHYSIOL PLANT, V32, P1023, DOI 10.1007/s11738-010-0491-0; Finnegan EJ, 1998, P NATL ACAD SCI USA, V95, P5824, DOI 10.1073/pnas.95.10.5824; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Fojtova M, 2001, PLANT SCI, V160, P585, DOI 10.1016/S0168-9452(00)00411-8; Garcia-Vallve S, 1999, MOL BIOL EVOL, V16, P1125, DOI 10.1093/oxfordjournals.molbev.a026203; Gore UR, 1932, AM J BOT, V19, P795, DOI 10.2307/2436228; HALLDEN C, 1994, THEOR APPL GENET, V88, P123, DOI 10.1007/BF00222404; Hauben M, 2009, P NATL ACAD SCI USA, V106, P20109, DOI 10.1073/pnas.0908755106; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; HEDGES SB, 1992, MOL BIOL EVOL, V9, P366; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Hsieh T-f, 2011, SCIENCE, V1451; Iqbal MJ, 1997, THEOR APPL GENET, V94, P139, DOI 10.1007/s001220050392; Isbell R. F., 1996, The Australian soil classification.; Jaccard P., 1901, B SOCIT VAUDOISE SCI, V37, P547, DOI DOI 10.5169/SEALS-266450; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jia F, 2011, AFR J AGR RES, V6, P1545; Jin X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060547; Johnston JW, 2005, PLANT PHYSIOL BIOCH, V43, P844, DOI 10.1016/j.plaphy.2005.07.015; Kakutani T, 2004, COLD SPRING HARB SYM, V69, P139, DOI 10.1101/sqb.2004.69.139; KAKUTANI T, 1995, NUCLEIC ACIDS RES, V23, P130, DOI 10.1093/nar/23.1.130; Kashkush K, 2002, GENETICS, V160, P1651; Kazmierczak J, 1998, FOLIA HISTOCHEM CYTO, V36, P45; Keyte AL, 2006, J HERED, V97, P444, DOI 10.1093/jhered/esl023; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Laurentin H, 2009, GENET RESOUR CROP EV, V56, P277, DOI 10.1007/s10722-008-9397-8; Lauria M, 2004, PLANT CELL, V16, P510, DOI 10.1105/tpc.017780; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li Q, 2012, J GENET GENOMICS, V39, P351, DOI 10.1016/j.jgg.2012.04.008; Li XueLin, 2009, Acta Agronomica Sinica, V35, P588, DOI 10.3724/SP.J.1006.2009.00588; LINTILHAC PM, 1974, AM J BOT, V61, P129, DOI 10.2307/2441181; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lovell D, 2007, AUST J BOT, V55, P608, DOI 10.1071/BT07003; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Mansoor S, 2012, TRENDS BIOTECHNOL, V30, P521, DOI 10.1016/j.tibtech.2012.06.003; MARANO MR, 1991, PLANT MOL BIOL, V16, P11, DOI 10.1007/BF00017913; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; MESSEGUER R, 1991, PLANT MOL BIOL, V16, P753, DOI 10.1007/BF00015069; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Miura K, 2009, P NATL ACAD SCI USA, V106, P11218, DOI 10.1073/pnas.0901942106; Nelson R, 1995, IRRI DISCUSSION PAPE, V14; PALMGREN G, 1991, PLANT PHYSIOL, V95, P174, DOI 10.1104/pp.95.1.174; Pang MX, 2011, J PLANT PHYSIOL, V168, P824, DOI 10.1016/j.jplph.2010.10.006; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Rohlf FJ, 2008, NTSYSPC NUMERICAL TA; Romanel E, 2012, PLANT MOL BIOL, V80, P443, DOI 10.1007/s11103-012-9959-1; Ruiz-Garcia L, 2005, PLANTA, V222, P301, DOI 10.1007/s00425-005-1524-6; Sakowicz T, 1998, ACTA SOC BOT POL, V67, P175, DOI 10.5586/asbp.1998.020; Salmon A, 2008, PLANT SCI, V174, P61, DOI 10.1016/j.plantsci.2007.09.012; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schob H, 2006, CELL, V126, P1025, DOI 10.1016/j.cell.2006.09.002; SCHULZ P, 1977, AM J BOT, V64, P384, DOI 10.2307/2441767; SCOTT NS, 1984, PLANTA, V161, P12, DOI 10.1007/BF00951454; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Stricker D, 2008, COMPUT METH PROG BIO, V92, P135, DOI 10.1016/j.cmpb.2008.06.010; Takata M, 2005, BREEDING SCI, V55, P57, DOI 10.1270/jsbbs.55.57; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wang ZM, 2012, MOL PLANT, V5, P889, DOI 10.1093/mp/ssr094; WENDEL JF, 1992, AM J BOT, V79, P1291, DOI 10.2307/2445058; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu YH, 2009, PLANTA, V229, P471, DOI 10.1007/s00425-008-0844-8; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107; Zhang M, 2011, PLANT PHYSL; Zhang MS, 2007, THEOR APPL GENET, V115, P195, DOI 10.1007/s00122-007-0555-8; Zhang MS, 2010, J GENET GENOMICS, V37, P1, DOI 10.1016/S1673-8527(09)60020-5; Zhao Y, 2008, MOL BIOL+, V42, P169, DOI 10.1134/S0026893308020015; Zhao YL, 2010, AGR SCI CHINA, V9, P783, DOI 10.1016/S1671-2927(09)60155-3; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462	90	44	46	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86049	10.1371/journal.pone.0086049	http://dx.doi.org/10.1371/journal.pone.0086049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465864	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500104
J	Ishtiaque, I; Shafique, K; Ul-Haq, Z; Shaikh, AR; Khan, NA; Memon, AR; Mirza, SS; Ishtiaque, A				Ishtiaque, Iqra; Shafique, Kashif; Ul-Haq, Zia; Shaikh, Abdul Rauf; Khan, Naveed Ali; Memon, Abdul Rauf; Mirza, Saira Saeed; Ishtiaque, Afra			Water-Pipe Smoking and Albuminuria: New Dog with Old Tricks	PLOS ONE			English	Article							RENAL-FUNCTION; UNIVERSITY-STUDENTS; CIGARETTE-SMOKING; TOXICANT EXPOSURE; NICOTINE EXPOSURE; TOBACCO SMOKING; DISEASE; VASOPRESSIN; PROGRESSION; INCREASES	Water-pipe (WP) smoking is on rise worldwide for the past few years, particularly among younger individuals. Growing evidence indicates that WP smoking is as harmful as cigarette smoking. To date, most of the research has focused on acute health effects of WP smoking, and evidence remains limited when it comes to chronic health effects in relation to long-term WP smoking. Therefore, the aim of this study was to examine the association between WP smoking and albuminuria in apparently healthy individuals. This analysis was conducted on data of a population-based cross-sectional study-the Urban Rural Chronic Diseases Study (URCDS). The study sample was recruited from three sites in Pakistan. Trained nurses carried out individual interviews and obtained the information on demographics, lifestyle factors, and past and current medical history. Measurements of complete blood count, lipid profile, fasting glucose level, and 24-hour albuminuria were also made by using blood and urine samples. Albumin excretion was classified into three categories using standard cut-offs: normal excretion, high-normal excretion and microalbuminuria. Multiple logistic regression models were used to examine the relationship between WP smoking and albuminuria. The final analysis included data from 1,626 health individuals, of which 829 (51.0%) were males and 797 (49.0%) females. Of 1,626 individuals, 267 (16.4%) were current WP smokers and 1,359 (83.6%) were non-WP smokers. WP smoking was significantly associated with high-normal albuminuria (OR = 2.33, 95% CI 1.68-3.22, p-value < 0.001) and microalbuminuria (OR = 1.75, 95% CI 1.18-2.58, p-value 0.005) after adjustment for age, sex, BMI, social class, hypertension, and diabetes mellitus. WP smoking was significantly associated with high-normal albuminuria and microalbuminuria when analysis was stratified on hypertension and diabetes mellitus categories. WP smoking has a strong association with albuminuria in apparently healthy individuals. More research is warranted to evaluate the temporality of this association between WP smoking and albuminuria.	[Ishtiaque, Iqra] Univ Med & Dent Coll, Faisalabad, Pakistan; [Shafique, Kashif] Dow Univ Hlth Sci, Sch Publ Hlth, Karachi, Pakistan; [Shafique, Kashif; Ul-Haq, Zia] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Ul-Haq, Zia] Khyber Med Univ, Inst Publ Hlth & Social Sci, Peshawar, Kpk, Pakistan; [Shaikh, Abdul Rauf] Dow Univ Hlth Sci, Dept Community Med, Karachi, Pakistan; [Khan, Naveed Ali] Dow Univ Hlth Sci, Dept Surg, Karachi, Pakistan; [Memon, Abdul Rauf] Dow Univ Hlth Sci, Dept Med, Karachi, Pakistan; [Mirza, Saira Saeed] Univ Rotterdam, Dept Epidemiol, Rotterdam, Netherlands; [Ishtiaque, Afra] King Edward Med Univ, Lahore, Pakistan	Dow University of Health Sciences; University of Glasgow; Khyber Medical University; Dow University of Health Sciences; Dow University of Health Sciences; Dow University of Health Sciences; Erasmus University Rotterdam	Shafique, K (corresponding author), Dow Univ Hlth Sci, Sch Publ Hlth, Karachi, Pakistan.	k.shafique@duhs.edu.pk	Ul Haq, Zia/GZM-0053-2022	Shafique, Kashif/0000-0001-7151-5122; ul haq, zia/0000-0001-5124-2171				Akl EA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-244; Al Ali R, 2013, TOB CONTROL, DOI [10.1136/tobaccocontrol-2013-051206, DOI 10.1136/T0BACC0C0NTR0L-2013-051206]; ANDERSSON K, 1983, ACTA PHYSIOL SCAND, V118, P35, DOI 10.1111/j.1748-1716.1983.tb07237.x; Cobb CO, 2011, NICOTINE TOB RES, V13, P78, DOI 10.1093/ntr/ntq212; Cooper RG, 2008, RENAL FAILURE, V30, P107, DOI 10.1080/08860220701742179; Daher N, 2010, ATMOS ENVIRON, V44, P8, DOI 10.1016/j.atmosenv.2009.10.004; Doggen K, 2013, J DIABETES COMPLICAT, V27, P370, DOI 10.1016/j.jdiacomp.2013.02.008; Eissenberg T, 2009, AM J PREV MED, V37, P518, DOI 10.1016/j.amepre.2009.07.014; HOSTETTER TH, 1995, ANNU REV PHYSIOL, V57, P263, DOI 10.1146/annurev.ph.57.030195.001403; Jacob P, 2011, CANCER EPIDEM BIOMAR, V20, P2345, DOI 10.1158/1055-9965.EPI-11-0545; Jawaid A, 2008, INT J TUBERC LUNG D, V12, P1077; Khabour OF, 2012, INHAL TOXICOL, V24, P667, DOI 10.3109/08958378.2012.710918; LIGHTMAN S, 1982, CLIN ENDOCRINOL, V16, P353, DOI 10.1111/j.1365-2265.1982.tb00727.x; Maziak W, 2004, ANN EPIDEMIOL, V14, P646, DOI 10.1016/j.annepidem.2003.11.003; Maziak W, 2004, PREV MED, V39, P330, DOI 10.1016/j.ypmed.2004.01.024; Maziak W, 2011, ADDICT BEHAV, V36, P1, DOI 10.1016/j.addbeh.2010.08.030; Neergaard J, 2007, NICOTINE TOB RES, V9, P987, DOI 10.1080/14622200701591591; NEURINGER JR, 1993, AM J KIDNEY DIS, V22, P98, DOI 10.1016/S0272-6386(12)70174-9; Orth SR, 2002, CURR OPIN NEPHROL HY, V11, P483, DOI 10.1097/00041552-200209000-00002; Orth SR, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018401.82863.FD; Orth SR, 2008, CLIN J AM SOC NEPHRO, V3, P226, DOI 10.2215/CJN.03740907; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; Roskin J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-10; Shafagoj YA, 2002, INT J CLIN PHARM TH, V40, P249; Shafique K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039734; Shaikh R B, 2008, J Prev Med Hyg, V49, P101; Smith JR, 2011, AM J PUBLIC HEALTH, V101, P1876, DOI 10.2105/AJPH.2011.300196; Svensson MK, 2013, DIABETES VASC DIS RE, V10, P520, DOI 10.1177/1479164113500798; Tamaoki L, 2009, AM J NEPHROL, V30, P377, DOI 10.1159/000235622; Warnakulasuriya Saman, 2011, Evid Based Dent, V12, P44, DOI 10.1038/sj.ebd.6400790; WONG LTY, 1992, J PHARMACOL EXP THER, V261, P21	31	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85652	10.1371/journal.pone.0085652	http://dx.doi.org/10.1371/journal.pone.0085652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465635	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000330237000048
J	Shi, Y; Pinto, M				Shi, Yun; Pinto, Mario			Human Lactate Dehydrogenase A Inhibitors: A Molecular Dynamics Investigation	PLOS ONE			English	Article							PARTICLE MESH EWALD; LACTIC-DEHYDROGENASE; ATOMIC CHARGES; CANCER; FORCE; RESP; IDENTIFICATION; ASSOCIATION; EXPRESSION; EFFICIENT	Lactate dehydrogenase A (LDHA) is an important enzyme in fermentative glycolysis, generating most energy for cancer cells that rely on anaerobic respiration even under normal oxygen concentrations. This renders LDHA a promising molecular target for the treatment of various cancers. Several efforts have been made recently to develop LDHA inhibitors with nanomolar inhibition and cellular activity, some of which have been studied in complex with the enzyme by X-ray crystallography. In this work, we present a molecular dynamics (MD) study of the binding interactions of selected ligands with human LDHA. Conventional MD simulations demonstrate different binding dynamics of inhibitors with similar binding affinities, whereas steered MD simulations yield discrimination of selected LDHA inhibitors with qualitative correlation between the in silico unbinding difficulty and the experimental binding strength. Further, our results have been used to clarify ambiguities in the binding modes of two well-known LDHA inhibitors.	[Shi, Yun; Pinto, Mario] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Pinto, M (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	bpinto@sfu.ca	Shi, Yun/AAG-3890-2020	Shi, Yun/0000-0003-3365-4679	Natural Sciences and Engineering Research Council of Canada [EGP/434441-2012]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserccrsng. gc.ca/index_eng.asp) in the form of an Engage Grant (grant ID: EGP/434441-2012) to BMP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banga I, 1932, H-S Z PHYSIOL CHEM, V210, P228, DOI 10.1515/bchm2.1932.210.5-6.228; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Mai BK, 2010, J CHEM INF MODEL, V50, P2236, DOI 10.1021/ci100346s; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Colizzi F, 2010, J AM CHEM SOC, V132, P7361, DOI 10.1021/ja100259r; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deck LM, 1998, J MED CHEM, V41, P3879, DOI 10.1021/jm980334n; Dragovich PS, 2013, BIOORG MED CHEM LETT, V23, P3186, DOI 10.1016/j.bmcl.2013.04.001; DUNN CR, 1991, PHILOS T ROY SOC B, V332, P177, DOI 10.1098/rstb.1991.0047; Dupradeau FY, 2008, NUCLEIC ACIDS RES, V36, pD360, DOI 10.1093/nar/gkm887; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Eszes CM, 1996, FEBS LETT, V399, P193, DOI 10.1016/S0014-5793(96)01317-8; Fauber BP, 2013, BIOORG MED CHEM LETT, V23, P5533, DOI 10.1016/j.bmcl.2013.08.060; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GOLDMAN RD, 1964, CANCER RES, V24, P389; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; Granchi C, 2011, J MED CHEM, V54, P1599, DOI 10.1021/jm101007q; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; KANNO T, 1988, CLIN CHIM ACTA, V173, P89, DOI 10.1016/0009-8981(88)90359-2; Kohlmann A, 2013, J MED CHEM, V56, P1023, DOI 10.1021/jm3014844; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Koukourakis MI, 2006, J CLIN ONCOL, V24, P4301, DOI 10.1200/JCO.2006.05.9501; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; McClendon S, 2005, BIOPHYS J, V89, P2024, DOI 10.1529/biophysj.105.062604; Nicolini P, 2013, J COMPUT CHEM, V34, P1561, DOI 10.1002/jcc.23286; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Read JA, 2001, PROTEINS, V43, P175, DOI 10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#; Schmidt RK, 1999, J MOL MODEL, V5, P153, DOI 10.1007/s008940050115; Straub FB, 1940, BIOCHEM J, V34, P483, DOI 10.1042/bj0340483; Swiderek K, 2012, PHYS CHEM CHEM PHYS, V14, P12614, DOI 10.1039/c2cp40953d; Swiderek K, 2010, J PHYS CHEM B, V114, P3393, DOI 10.1021/jp100026z; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WARBURG O, 1956, SCIENCE, V124, P269; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Ward RA, 2012, J MED CHEM, V55, P3285, DOI 10.1021/jm201734r; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Zhuang LQ, 2010, MODERN PATHOL, V23, P45, DOI 10.1038/modpathol.2009.129	53	180	185	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86365	10.1371/journal.pone.0086365	http://dx.doi.org/10.1371/journal.pone.0086365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24466056	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000093
J	Moser, KA; Agrawal, S; Smith, GD; Ebrahim, S				Moser, Kath A.; Agrawal, Sutapa; Smith, George Davey; Ebrahim, Shah			Socio-Demographic Inequalities in the Prevalence, Diagnosis and Management of Hypertension in India: Analysis of Nationally-Representative Survey Data	PLOS ONE			English	Article							BLOOD-PRESSURE; EPIDEMIOLOGY; AWARENESS; URBAN; POPULATIONS; POSITION; DISEASE; ADULTS; HEALTH; TRENDS	Background: Hypertension is a major contributing factor to the current epidemic of cardiovascular disease in India. Small studies suggest high, and increasing, prevalence especially in urban areas, with poor detection and management, but national data has been lacking. The aim of the current study was to use nationally-representative survey data to examine socio-demographic inequalities in the prevalence, diagnosis and management of hypertension in Indian adults. Methods: Using data on self-reported diagnosis and treatment, and blood pressure measurement, collected from 12,198 respondents aged 18+ in the 2007 WHO Study on Global Ageing and Adult Health in India, factors associated with prevalence, diagnosis and treatment of hypertension were investigated. Results: 22% men and 26% women had hypertension; prevalence increased steeply with body mass index (<18.5 kg/m(2) : 18% men, 21% women; 25-29.9 kg/m(2) : 35% men, 35% women), was higher in the least poor vs. poorest (men: odds ratio (95% CI) 1.82 (1.20 to 2.76); women: 1.40 (1.08 to 1.81)), urban vs. rural men (1.64 (1.19 to 2.25)), and men recently vs. never using alcohol (1.96 (1.40 to 2.76)). Over half the hypertension in women, and 70% in men, was undetected with particularly poor detection rates in young urban men, and in poorer households. Two-thirds of men and women with detected hypertension were treated. Two-thirds of women treated had their hypertension controlled, irrespective of urban/rural setting or wealth. Adequate blood pressure control was sub-optimal in urban men. Conclusion: Hypertension is very common in India, even among underweight adults and those of lower socioeconomic position. Improved detection is needed to reduce the burden of disease attributable to hypertension. Levels of treatment and control are relatively good, particularly in women, although urban men require more careful attention.	[Moser, Kath A.; Ebrahim, Shah] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Agrawal, Sutapa; Ebrahim, Shah] Publ Hlth Fdn India, South Asia Network Chron Dis, New Delhi, India; [Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of Bristol	Moser, KA (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	kath.moser@lshtm.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	Wellcome Trust [084674]; MRC [MC_UU_12013/1] Funding Source: UKRI; Cancer Research UK [16491] Funding Source: researchfish; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by a Wellcome Trust (http://www.wellcome.ac.uk/) Strategic Award Grant No. 084674 to establish the South Asia Network for Chronic Disease. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo J, 2009, J EPIDEMIOL COMMUN H, V63, P646, DOI 10.1136/jech.2008.081828; Altunkan S, 2006, BLOOD PRESS MONIT, V11, P79; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; *BOS BOSCH SOHN GE, BLOOD PRESS INSTR BR; Bovet P, 2003, J HYPERTENS, V21, P509, DOI 10.1097/00004872-200303000-00016; Chaturvedi S, 2007, TROP DOCT, V37, P142, DOI 10.1258/004947507781524593; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Colhoun HM, 1998, J HUM HYPERTENS, V12, P91, DOI 10.1038/sj.jhh.1000558; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dobe Madhumita, 2013, Indian J Public Health, V57, P1, DOI 10.4103/0019-557X.111354; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ferguson B., 2003, HLTH SYSTEMS PERFORM, P747; Gupta R, 2004, J HUM HYPERTENS, V18, P73, DOI 10.1038/sj.jhh.1001633; HART JT, 1992, BRIT J GEN PRACT, V42, P116; *IIPS MACR INT, 2007, NAT FAM HLTH SURV NF, V1, pCH8; Joshi Shashank R, 2003, J Assoc Physicians India, V51, P151; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mohan V, 2007, J Assoc Physicians India, V55, P326; OLSHANSKY SJ, 1986, MILBANK Q, V64, P355, DOI 10.2307/3350025; Patel R, 2006, J HUM HYPERTENS, V20, P733, DOI 10.1038/sj.jhh.1002064; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Reddy KS, 1998, CIRCULATION, V97, P596; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Society of Actuaries, 1959, BUILD BLOOD PRESS ST; Tian HY, 2010, BLOOD PRESS MONIT, V15, P326, DOI 10.1097/MBP.0b013e32833f56fb; UN Population Division, 2009, WORLD POP PROSP 2008; WHO, 2004, LANCET, V363, P902; WHO, 2002, RED RISKS PROM HLTH; WILBER JA, 1972, AM J MED, V52, P653, DOI 10.1016/0002-9343(72)90055-1; Yadav K, 2008, OBES REV, V9, P400, DOI 10.1111/j.1467-789X.2008.00505.x; [No title captured]	37	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86043	10.1371/journal.pone.0086043	http://dx.doi.org/10.1371/journal.pone.0086043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465859	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000330288000044
J	Ahn, HJ; Kim, KI; Hoan, NN; Kim, CH; Moon, E; Choi, KS; Yang, SS; Lee, JS				Ahn, Hak Jun; Kim, Kang Il; Nguyen Ngoc Hoan; Kim, Churl Ho; Moon, Eunpyo; Choi, Kyeong Sook; Yang, Sang Sik; Lee, Jong-Soo			Targeting Cancer Cells with Reactive Oxygen and Nitrogen Species Generated by Atmospheric-Pressure Air Plasma	PLOS ONE			English	Article							BARRIER DISCHARGE PLASMA; SIGNAL-TRANSDUCTION; NITRIC-OXIDE; ACTIVATION; APOPTOSIS; PATHWAYS; STRESS; KINASE; JNK	The plasma jet has been proposed as a novel therapeutic method for cancer. Anticancer activity of plasma has been reported to involve mitochondrial dysfunction. However, what constituents generated by plasma is linked to this anticancer process and its mechanism of action remain unclear. Here, we report that the therapeutic effects of air plasma result from generation of reactive oxygen/nitrogen species (ROS/RNS) including H2O2, Ox, OH- center dot O-2, NOx, leading to depolarization of mitochondrial membrane potential and mitochondrial ROS accumulation. Simultaneously, ROS/RNS activate c-Jun NH2-terminal kinase (JNK) and p38 kinase. As a consequence, treatment with air plasma jets induces apoptotic death in human cervical cancer HeLa cells. Pretreatment of the cells with antioxidants, JNK and p38 inhibitors, or JNK and p38 siRNA abrogates the depolarization of mitochondrial membrane potential and impairs the air plasma-induced apoptotic cell death, suggesting that the ROS/RNS generated by plasma trigger signaling pathways involving JNK and p38 and promote mitochondrial perturbation, leading to apoptosis. Therefore, administration of air plasma may be a feasible strategy to eliminate cancer cells.	[Ahn, Hak Jun; Nguyen Ngoc Hoan; Moon, Eunpyo; Lee, Jong-Soo] Ajou Univ, Dept Life Sci, Suwon 441749, South Korea; [Kim, Kang Il; Yang, Sang Sik] Ajou Univ, Dept Elect & Comp Engn, Suwon 441749, South Korea; [Kim, Churl Ho; Choi, Kyeong Sook] Ajou Univ, Sch Med, Suwon 441749, South Korea	Ajou University; Ajou University; Ajou University	Lee, JS (corresponding author), Ajou Univ, Dept Life Sci, Suwon 441749, South Korea.	jsjlee@ajou.ac.kr		Choi, Kyeong Sook/0000-0003-2331-0856	National Research Foundation of Korea; Korea government (MSIP) [2012M3A9B2052871, 2010-018546, 2011-0030043]	National Research Foundation of Korea(National Research Foundation of Korea); Korea government (MSIP)	This work was supported by the National Research Foundation of Korea grants funded by the Korea government (MSIP) (2012M3A9B2052871, 2010-018546, 2011-0030043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Arjunan KP, 2012, J R SOC INTERFACE, V9, P147, DOI 10.1098/rsif.2011.0220; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Chalah A, 2008, ADV EXP MED BIOL, V615, P25, DOI 10.1007/978-1-4020-6554-5_3; Cook SA, 1999, CIRC RES, V85, P940; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dobrynin D, 2012, IEEE T PLASMA SCI, V40, P2163, DOI 10.1109/TPS.2012.2204780; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Franco R, 2007, J BIOL CHEM, V282, P30452, DOI 10.1074/jbc.M703091200; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Hong YF, 2009, LETT APPL MICROBIOL, V48, P33, DOI 10.1111/j.1472-765X.2008.02480.x; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Kim GC, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/3/032005; Kim GJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292206; Kim K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FL15; Kim K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3555434; Kim K, 2010, MICROELECTRON ENG, V87, P1177, DOI 10.1016/j.mee.2009.12.045; Kim SY, 2006, EXP MOL MED, V38, P535, DOI 10.1038/emm.2006.63; Koritzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064498; Kong ANT, 2000, ARCH PHARM RES, V23, P1, DOI 10.1007/BF02976458; Laurent A, 2005, CANCER RES, V65, P948; Lee HJ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115026; Lindsay J, 2011, BBA-MOL CELL RES, V1813, P532, DOI 10.1016/j.bbamcr.2010.10.017; MARLETTA MA, 1989, TRENDS BIOCHEM SCI, V14, P488, DOI 10.1016/0968-0004(89)90181-3; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Rupf S, 2010, J MED MICROBIOL, V59, P206, DOI 10.1099/jmm.0.013714-0; Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9; Sun J, 2003, SENSORS-BASEL, V3, P276, DOI 10.3390/s30800276; Torres M, 2003, FRONT BIOSCI, V8, pD369, DOI 10.2741/999; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Zhang XH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959735; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	40	153	155	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86173	10.1371/journal.pone.0086173	http://dx.doi.org/10.1371/journal.pone.0086173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465942	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500198
J	Coffey, R; Nam, H; Knutson, MD				Coffey, Richard; Nam, Hyeyoung; Knutson, Mitchell D.			Microarray Analysis of Rat Pancreas Reveals Altered Expression of Alox15 and Regenerating Islet-Derived Genes in Response to Iron Deficiency and Overload	PLOS ONE			English	Article							INSULIN SECRETORY CAPACITY; HEREDITARY HEMOCHROMATOSIS; BETA-CELLS; GLUCOSE-HOMEOSTASIS; DIABETES-MELLITUS; OXIDATIVE STRESS; KNOCKOUT MICE; MOUSE MODEL; 12-LIPOXYGENASE; PROTEIN	It is well known that iron overload can result in pancreatic iron deposition, beta-cell destruction, and diabetes in humans. Recent studies in animals have extended the link between iron status and pancreatic function by showing that iron depletion confers protection against beta-cell dysfunction and diabetes. The aim of the present study was to identify genes in the pancreas that are differentially expressed in response to iron deficiency or overload. Weanling male Sprague-Dawley rats (n = 6/group) were fed iron-deficient, iron-adequate, or iron-overloaded diets for 3 weeks to alter their iron status. Total RNA was isolated from the pancreases and pooled within each group for microarray analyses in which gene expression levels were compared to those in iron-adequate controls. In iron-deficient pancreas, a total of 66 genes were found to be differentially regulated (10 up, 56 down), whereas in iron-overloaded pancreas, 164 genes were affected (82 up, 82 down). The most up-regulated transcript in iron-deficient pancreas was arachidonate 15-lipoxygenase (Alox15), which has been implicated in the development of diabetes. In iron-overloaded pancreas, the most upregulated transcripts were Reg1a, Reg3a, and Reg3b belonging to the regenerating islet-derived gene (Reg) family. Reg expression has been observed in response to pancreatic stress and is thought to facilitate pancreatic regeneration. Subsequent qRT-PCR validation indicated that Alox15 mRNA levels were 4 times higher in iron-deficient than in iron-adequate pancreas and that Reg1a, Reg3a, and Reg3b mRNA levels were 17-36 times higher in iron-overloaded pancreas. The elevated Alox15 mRNA levels in iron-deficient pancreas were associated with 8-fold higher levels of Alox15 protein as indicated by Western blotting. Overall, these data raise the possibility that Reg expression may serve as a biomarker for iron-related pancreatic stress, and that iron deficiency may adversely affect the risk of developing diabetes through up-regulation of Alox15.	[Coffey, Richard; Nam, Hyeyoung; Knutson, Mitchell D.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Knutson, MD (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA.	mknutson@ufl.edu			National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) [R01 DK-080706]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080706] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research funding from grant R01 DK-080706 from the National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) to M.D.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2006, DIABETOLOGIA, V49, P2546, DOI 10.1007/s00125-006-0445-7; Aggarwal NT, 2009, AM J PHYSIOL-HEART C, V296, pH678, DOI 10.1152/ajpheart.00777.2008; Al-Abdullah IH, 2000, PANCREAS, V21, P63, DOI 10.1097/00006676-200007000-00053; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bleich D, 1999, J CLIN INVEST, V103, P1431, DOI 10.1172/JCI5241; Bleich D, 1998, INT J MOL MED, V1, P265; Bogan RL, 2010, REPRODUCTION, V139, P163, DOI 10.1530/REP-09-0005; BOREL MJ, 1991, J NUTR, V121, P729, DOI 10.1093/jn/121.5.729; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Chen M, 2005, DIABETOLOGIA, V48, P486, DOI 10.1007/s00125-005-1673-y; Choi JH, 2010, BIOL CHEM, V391, P1019, DOI 10.1515/BC.2010.101; Clardy SL, 2006, J NEURAL TRANSM-SUPP, P173; Closa D, 2007, WORLD J GASTROENTERO, V13, P170, DOI 10.3748/wjg.v13.i2.170; Collins JF, 2008, AM J PHYSIOL-GASTR L, V294, pG948, DOI 10.1152/ajpgi.00274.2007; Cooksey RC, 2004, ENDOCRINOLOGY, V145, P5305, DOI 10.1210/en.2004-0392; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; GORDON JI, 1985, J BIOL CHEM, V260, P1995; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JH, 2007, J BIOL CHEM, V282, P37501, DOI 10.1074/jbc.M703625200; Huang JY, 2011, DIABETES, V60, P80, DOI 10.2337/db10-0593; Kamei A, 2010, PHYSIOL GENOMICS, V42, P149, DOI 10.1152/physiolgenomics.00150.2009; Lee YW, 2001, J LIPID RES, V42, P783; Lim JW, 2009, ANN NY ACAD SCI, V1171, P545, DOI 10.1111/j.1749-6632.2009.04702.x; Ma K, 2010, J CLIN ENDOCR METAB, V95, P887, DOI 10.1210/jc.2009-1102; McClain DA, 2006, DIABETOLOGIA, V49, P1661, DOI 10.1007/s00125-006-0200-0; McDuffie M, 2008, DIABETES, V57, P199, DOI 10.2337/db07-0830; Minamiyama Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1140, DOI 10.1152/ajpendo.00620.2009; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Nam H, 2012, BIOMETALS, V25, P115, DOI 10.1007/s10534-011-9487-5; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Ramey G, 2007, FEBS LETT, V581, P1053, DOI 10.1016/j.febslet.2007.02.002; Riaz S, 2010, J PHARMACEUT BIOMED, V51, P1103, DOI 10.1016/j.jpba.2009.11.016; Simpson RJ, 1997, CLIN SCI, V93, P453, DOI 10.1042/cs0930453; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Tosh D, 2007, BIOL CELL, V99, P37, DOI 10.1042/BC20060050; Unno M, 2002, DIABETES, V51, pS478, DOI 10.2337/diabetes.51.2007.S478; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; WATANABE T, 1994, P NATL ACAD SCI USA, V91, P3589, DOI 10.1073/pnas.91.9.3589; WATANABE T, 1993, EUR J BIOCHEM, V212, P605, DOI 10.1111/j.1432-1033.1993.tb17699.x; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Webb GC, 2000, P NATL ACAD SCI USA, V97, P5773, DOI 10.1073/pnas.100126597; Weiss EP, 2002, PHYSIOL GENOMICS, V10, P145, DOI 10.1152/physiolgenomics.00070.2001; Whittaker P, 1997, TOXICOL PATHOL, V25, P556, DOI 10.1177/019262339702500604; Xiong XQ, 2011, AM J PHYSIOL-ENDOC M, V300, pE669, DOI 10.1152/ajpendo.00600.2010; Xue Y, 2010, ENDOCRINE, V37, P83, DOI 10.1007/s12020-009-9273-0; Yao L, 2012, PROSTAG OTH LIPID M, V99, P96, DOI 10.1016/j.prostaglandins.2012.09.001; Zenilman ME, 2000, ANN SURG, V232, P646, DOI 10.1097/00000658-200011000-00005	49	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86019	10.1371/journal.pone.0086019	http://dx.doi.org/10.1371/journal.pone.0086019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465846	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500167
J	Nishiya, AS; de Almeida-Neto, C; Ferreira, SC; Alencar, CS; Di-Lorenzo-Oliveira, C; Levi, JE; Salles, NA; Mendrone, A; Sabino, EC				Nishiya, Anna S.; de Almeida-Neto, Cesar; Ferreira, Suzete C.; Alencar, Cecilia S.; Di-Lorenzo-Oliveira, Claudia; Levi, Jose E.; Salles, Nanci A.; Mendrone, Alfredo, Jr.; Sabino, Ester C.			HCV Genotypes, Characterization of Mutations Conferring Drug Resistance to Protease Inhibitors, and Risk Factors among Blood Donors in Sao Paulo, Brazil	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SPONTANEOUS VIRAL CLEARANCE; NS3 PROTEASE; DECREASED SENSITIVITY; SEROLOGIC MARKERS; GENETIC DIVERSITY; PLUS RIBAVIRIN; PREVALENCE; INFECTION; TELAPREVIR	Background: Hepatitis C virus (HCV) infection is a global health problem estimated to affect almost 200 million people worldwide. The aim of this study is to analyze the subtypes and existence of variants resistant to protease inhibitors and their association with potential HCV risk factors among blood donors in Brazil. Methods: Repeat anti-HCV reactive blood donors are systematically asked to return for retest, notification, and counseling in which they are interviewed for risk factors for transfusion-transmitted diseases. We analyzed 202 donors who returned for counseling from 2007 to 2010 and presented enzyme immunoassay-and immunoblot-reactive results. The HCV genotypes and resistance mutation analyses were determined by the direct sequencing of the NS5b and NS3 regions, respectively. The HCV viral load was determined using an in-house real-time PCR assay targeting the 5'-NCR. Results: HCV subtypes 1b, 1a, and 3a were found in 45.5%, 32.0%, and 18.0% of the donors, respectively. The mean viral load of genotype 1 was significantly higher than that of the genotype 3 isolates. Subtype 1a was more frequent among young donors and 3a was more frequent among older donors. Protease inhibitor-resistant variants were detected in 12.8% of the sequenced samples belonging to genotype 1, and a higher frequency was observed among subtype 1a (20%) in comparison to 1b (8%). There was no difference in the prevalence of HCV risk factors among the genotypes or drug-resistant variants. Conclusions: We found a predominance of subtype 1b, with an increase in the frequency of subtype 1a, in young subjects. Mutations conferring resistance to NS3 inhibitors were frequent in treatment-naive blood donors, particularly those infected with subtype 1a. These variants were detected in the major viral population of HCV quasispecies, have replicative capacities comparable to nonresistant strains, and could be important for predicting the response to antiviral triple therapy.	[Nishiya, Anna S.; de Almeida-Neto, Cesar; Ferreira, Suzete C.; Levi, Jose E.; Salles, Nanci A.; Mendrone, Alfredo, Jr.] Fundacao Prosangue Hemoctr Sao Paulo, Sao Paulo, Brazil; [Nishiya, Anna S.; Ferreira, Suzete C.; Alencar, Cecilia S.; Sabino, Ester C.] Univ Fed Sao Paulo, Infect Dis Div DIPA, Sao Paulo, Brazil; [de Almeida-Neto, Cesar] Univ Sao Paulo, Fac Med, Discipline Med Sci, Sao Paulo, Brazil; [Alencar, Cecilia S.] HCFMUSP, Dept Pathol, LIM Lab Medice Lab 03, Sao Paulo, Brazil; [Di-Lorenzo-Oliveira, Claudia] Univ Sao Joao del Rei, Divinopolis, MG, Brazil; [Sabino, Ester C.] Univ Sao Paulo, Fac Med, Dept Infect Dis, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Nishiya, AS (corresponding author), Fundacao Prosangue Hemoctr Sao Paulo, Sao Paulo, Brazil.	a_nishiya@hotmail.com	Sabino, Ester C/F-7750-2010; de Almeida-Neto, Cesar/O-9224-2014; Ferreira, Suzete Cleusa/K-1626-2016; Nishiya, Anna/Q-8156-2016	Sabino, Ester C/0000-0003-2623-5126; de Almeida-Neto, Cesar/0000-0002-8490-4634; Ferreira, Suzete Cleusa/0000-0002-4190-0238; 	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) of Brazilian Ministry of Education; Fundacao Pro-Sangue/Hemocentro de Sao Paulo	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) of Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Pro-Sangue/Hemocentro de Sao Paulo	This study was supported by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) of Brazilian Ministry of Education and by Fundacao Pro-Sangue/Hemocentro de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Oliveira MDA, 2009, J CLIN VIROL, V44, P200, DOI 10.1016/j.jcv.2008.12.008; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bartels DJ, 2008, J INFECT DIS, V198, P800, DOI 10.1086/591141; Bartels DJ, 2013, J VIROL, V87, P1544, DOI 10.1128/JVI.02294-12; Berger A, 1996, J MED VIROL, V48, P339, DOI 10.1002/(SICI)1096-9071(199604)48:4&lt;339::AID-JMV7&gt;3.0.CO;2-8; Besse B, 2012, J VIROL METHODS, V185, P94, DOI 10.1016/j.jviromet.2012.06.011; Brandao Ajacio B M, 2002, BMC Gastroenterol, V2, P18, DOI 10.1186/1471-230X-2-18; Calado RA, 2011, J MED VIROL, V83, P608, DOI 10.1002/jmv.21955; Campiotto S, 2005, BRAZ J MED BIOL RES, V38, P41, DOI 10.1590/S0100-879X2005000100007; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Curry S, 2008, J VIROL METHODS, V153, P156, DOI 10.1016/j.jviromet.2008.07.020; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; de Almeida-Neto C, 2013, TRANSFUSION, V53, P827, DOI 10.1111/j.1537-2995.2012.03840.x; Dias PT, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-208; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P231, DOI 10.1053/j.gastro.2005.11.010; DONAHUE JG, 1992, NEW ENGL J MED, V327, P369, DOI 10.1056/NEJM199208063270601; Duggal P, 2013, ANN INTERN MED, V158, P235, DOI 10.7326/0003-4819-158-4-201302190-00003; ENOMOTO N, 1990, BIOCHEM BIOPH RES CO, V170, P1021, DOI 10.1016/0006-291X(90)90494-8; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Focaccia, 1998, Braz J Infect Dis, V2, P269; Focaccia R., 2004, Braz J Infect Dis, V8, P348, DOI 10.1590/S1413-86702004000500003; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hoffmann L, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-57; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jensen DM, 2011, NEW ENGL J MED, V364, P1272, DOI 10.1056/NEJMe1100829; Kieffer TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034372; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lampe E, 2010, INFECT GENET EVOL, V10, P886, DOI 10.1016/j.meegid.2010.05.010; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lopes Carmen L R, 2009, Rev. Saúde Pública, V43, P43, DOI 10.1590/S0034-89102009000800008; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606; Nakano T, 2012, LIVER INT, V32, P339, DOI 10.1111/j.1478-3231.2011.02684.x; Nascimento MC, 2008, J MED VIROL, V80, P53, DOI 10.1002/jmv.21046; Oliveira Maria de Lourdes Aguiar, 2006, Cad. Saúde Pública, V22, P861, DOI 10.1590/S0102-311X2006000400024; Oliveira MLA, 1999, BRAZ J MED BIOL RES, V32, P279, DOI 10.1590/S0100-879X1999000300005; Organization WH, 2012, N 164 FS; Paolucci S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-245; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pereira LMMB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-60; Peres-da-Silva A, 2012, MEM I OSWALDO CRUZ, V107, P254, DOI 10.1590/S0074-02762012000200016; Peres-da-Silva A, 2010, ARCH VIROL, V155, P807, DOI 10.1007/s00705-010-0642-z; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011170; Rong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052467; Rosini Nilton, 2003, Braz J Infect Dis, V7, P262, DOI 10.1590/S1413-86702003000400006; Salles Nanci A., 2003, Rev Panam Salud Publica, V13, P111, DOI 10.1590/S1020-49892003000200011; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1270, DOI 10.1053/j.gastro.2007.01.041; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Schroter M, 2002, J CLIN MICROBIOL, V40, P1866, DOI 10.1128/JCM.40.5.1866-1868.2002; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Shindo H, 2011, HEPATOL INT; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SIMMONDS P, 1993, J GEN VIROL, V74, P661, DOI 10.1099/0022-1317-74-4-661; Simmonds P, 1996, J GEN VIROL, V77, P3013, DOI 10.1099/0022-1317-77-12-3013; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Suzuki F, 2012, J CLIN VIROL, V54, P352, DOI 10.1016/j.jcv.2012.04.024; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Torres KL, 2009, EMERG INFECT DIS, V15, P676, DOI 10.3201/eid1504.081288; Valente VB, 2005, REV SOC BRAS MED TRO, V38, P488, DOI 10.1590/S0037-86822005000600008; Vermehren J, 2012, J VIRAL HEPATITIS, V19, P120, DOI 10.1111/j.1365-2893.2011.01449.x; Vicenti I, 2012, J ANTIMICROB CHEMOTH, V67, P984, DOI 10.1093/jac/dkr581; Vigani AG, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-164; Wasley Annemarie, 2007, MMWR Surveill Summ, V56, P1; Welsch C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r16; Wyles David L, 2012, Top Antivir Med, V20, P139; Zarife MAS, 2006, T ROY SOC TROP MED H, V100, P663, DOI 10.1016/j.trstmh.2005.09.009; Zeminian LB, 2013, MEM I OSWALDO CRUZ, V108, P13, DOI 10.1590/S0074-02762013000100002; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	79	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86413	10.1371/journal.pone.0086413	http://dx.doi.org/10.1371/journal.pone.0086413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466079	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500242
J	Rocha, CS; Gomes-Santos, AC; Moreira, TG; de Azevedo, M; Luerce, TD; Mariadassou, M; Delamare, APL; Langella, P; Maguin, E; Azevedo, V; de Faria, AMC; Miyoshi, A; van de Guchte, M				Rocha, Clarissa Santos; Gomes-Santos, Ana Cristina; Moreira, Thais Garcias; de Azevedo, Marcela; Luerce, Tessalia Diniz; Mariadassou, Mahendra; Longaray Delamare, Ana Paula; Langella, Philippe; Maguin, Emmanuelle; Azevedo, Vasco; Caetano de Faria, Ana Maria; Miyoshi, Anderson; van de Guchte, Maarten			Local and Systemic Immune Mechanisms Underlying the Anti-Colitis Effects of the Dairy Bacterium Lactobacillus delbrueckii	PLOS ONE			English	Article							T-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; CROHNS-DISEASE; KAPPA-B; STRAINS; MICROFLORA; PROBIOTICS; INDUCTION; RESPONSES; PREVENTS	Several probiotic bacteria have been proposed for treatment or prevention of inflammatory bowel diseases (IBD), showing a protective effect in animal models of experimental colitis and for some of them also in human clinical trials. While most of these probiotic bacteria are isolated from the digestive tract, we recently reported that a Lactobacillus strain isolated from cheese, L. delbrueckii subsp. lactis CNRZ327 (Lb CNRZ327), also possesses anti-inflammatory effects in vitro and in vivo, demonstrating that common dairy bacteria may be useful in the treatment or prevention of IBD. Here, we studied the mechanisms underlying the protective effects of Lb CNRZ327 in vivo, in a mouse dextran sodium sulfate (DSS) colitis model. During colitis, Lb CNRZ327 modulated the production of TGF-beta, IL-6, and IL-12 in colonic tissue and of TGF-beta and IL-6 in the spleen, and caused an expansion of CD4+Foxp3+ regulatory T cells in the cecal lymph nodes. Moreover, a strong tendency to CD4+Foxp3+ expansion was also observed in the spleen. The results of this study for the first time show that orally administered dairy lactobacilli can not only modulate mucosal but also systemic immune responses and constitute an effective treatment of IBD.	[Rocha, Clarissa Santos; de Azevedo, Marcela; Luerce, Tessalia Diniz; Azevedo, Vasco; Miyoshi, Anderson] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Gen Biol, Belo Horizonte, MG, Brazil; [Gomes-Santos, Ana Cristina; Moreira, Thais Garcias; Caetano de Faria, Ana Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Rocha, Clarissa Santos; Langella, Philippe; Maguin, Emmanuelle; van de Guchte, Maarten] INRA, Micalis UMR1319, Jouy En Josas, France; [Rocha, Clarissa Santos; Langella, Philippe; Maguin, Emmanuelle; van de Guchte, Maarten] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Mariadassou, Mahendra] INRA, UR1077, Jouy En Josas, France; [Longaray Delamare, Ana Paula] Univ Caxias do Sul, Inst Biotechnol, Caxias Do Sul, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universidade de Caxias do Sul	van de Guchte, M (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	maarten.vandeguchte@jouy.inra.fr	Langella, Philippe/N-8368-2017; Longaray Delamare, Ana Paula/AGZ-4312-2022; Azevedo, Vasco A.C/F-4315-2011; Delamare, Ana Paula Longaray/AHE-9445-2022; de Azevedo, Marcela Santiago Pacheco/AAO-2859-2020; Azevedo, Vasco/B-1556-2019	Langella, Philippe/0000-0001-5960-4341; Azevedo, Vasco A.C/0000-0002-4775-2280; Delamare, Ana Paula Longaray/0000-0001-9638-5483; de Azevedo, Marcela Santiago Pacheco/0000-0001-5694-4578; Azevedo, Vasco/0000-0002-4775-2280; Faria, Ana Maria/0000-0002-0604-8510	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brasil (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES); EC EST project "LABHEALTH" [MEST-2-CT-2004-514428]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brasil (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES); EC EST project "LABHEALTH"	This study received financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brasil (FAPEMIG), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES), and the EC EST project "LABHEALTH" (Marie Curie Contract MEST-2-CT-2004-514428). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Chung YW, 2008, CLIN EXP IMMUNOL, V151, P182, DOI 10.1111/j.1365-2249.2007.03549.x; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; de Moreno de Leblanc Alejandra, 2011, ISRN Gastroenterol, V2011, P892971, DOI 10.5402/2011/892971; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Diaz-Ropero MP, 2007, J APPL MICROBIOL, V102, P337, DOI 10.1111/j.1365-2672.2006.03102.x; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Fichtner-Feigl S, 2007, J IMMUNOL, V178, P5859, DOI 10.4049/jimmunol.178.9.5859; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kim SW, 2010, INFLAMM BOWEL DIS, V16, P1514, DOI 10.1002/ibd.21262; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Lievin V, 2000, GUT, V47, P646, DOI 10.1136/gut.47.5.646; Fernandez EM, 2011, GUT, V60, P1444, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Makita S, 2004, J IMMUNOL, V173, P3119, DOI 10.4049/jimmunol.173.5.3119; Malin M, 1996, ANN NUTR METAB, V40, P137, DOI 10.1159/000177907; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Maron R, 1999, INT IMMUNOL, V11, P1573, DOI 10.1093/intimm/11.9.1573; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; McCafferty DM, 2000, AM J PHYSIOL-GASTR L, V279, pG90, DOI 10.1152/ajpgi.2000.279.1.G90; Meijer BJ, 2011, J CLIN GASTROENTEROL, V45, pS139, DOI 10.1097/MCG.0b013e31822103f7; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Nishitani Y, 2009, INT IMMUNOPHARMACOL, V9, P1444, DOI 10.1016/j.intimp.2009.08.018; O'Sullivan DJ, 2001, J AGR FOOD CHEM, V49, P1751, DOI 10.1021/jf0012244; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pallone F, 1998, GUT, V43, P735, DOI 10.1136/gut.43.6.735; Philippe D, 2011, INT J FOOD MICROBIOL, V149, P45, DOI 10.1016/j.ijfoodmicro.2010.12.020; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rocha CS, 2012, INFLAMM BOWEL DIS, V18, P657, DOI 10.1002/ibd.21834; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Smelt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047244; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Solomon L., 2010, COMP CLIN PATHOL, V19, DOI [10.1007/s00580-010-0979-4, DOI 10.1007/S00580-010-0979-4]; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712	47	30	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85923	10.1371/journal.pone.0085923	http://dx.doi.org/10.1371/journal.pone.0085923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465791	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500146
J	Rock, CA; Han, L; Doehring, TC				Rock, Christopher A.; Han, Lin; Doehring, Todd C.			Complex Collagen Fiber and Membrane Morphologies of the Whole Porcine Aortic Valve	PLOS ONE			English	Article							HEART-VALVES	Objectives: Replacement aortic valves endeavor to mimic native valve function at the organ, tissue, and in the case of bioprosthetic valves, the cellular levels. There is a wealth of information about valve macro and micro structure; however, there presently is limited information on the morphology of the whole valve fiber architecture. The objective of this study was to provide qualitative and quantitative analyses of whole valve and leaflet fiber bundle branching patterns using a novel imaging system. Methods: We developed a custom automated microscope system with motor and imaging control. Whole leaflets (n = 25) were imaged at high resolution (e.g. 30,000620,000 pixels) using elliptically polarized light to enhance contrast between structures without the need for staining or other methods. Key morphologies such as fiber bundle size and branching were measured for analyses. Results: The left coronary leaflet displayed large asymmetry in fiber bundle organization relative to the right coronary and non-coronary leaflets. We observed and analyzed three main patterns of fiber branching; tree-like, fan-like, and pinnate structures. High resolution images and quantitative metrics are presented such as fiber bundle sizes, positions, and branching morphological parameters. Significance: To our knowledge there are currently no high resolution images of whole fresh leaflets available in the literature. The images of fiber/membrane structures and analyses presented here could be highly valuable for improving the design and development of more advanced bioprosthetic and/or bio-mimetic synthetic valve replacements.	[Rock, Christopher A.; Han, Lin; Doehring, Todd C.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Drexel University	Rock, CA (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	car55@drexel.edu	Han, Lin/D-2602-2014	Han, Lin/0000-0003-4180-1288	National Institutes of Health [5R03EB10224]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB010224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by a grant from the National Institutes of Health (5R03EB10224). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balguid A, 2008, J BIOMECH, V41, P2612, DOI 10.1016/j.jbiomech.2008.06.031; Butcher JT, 2011, ADV DRUG DELIVER REV, V63, P242, DOI 10.1016/j.addr.2011.01.008; Doehring TC, 2005, J HEART VALVE DIS, V14, P679; Dohmen P., 2012, HSR P INT CAR CARD A, P89; Grande KJ, 1998, ANN BIOMED ENG, V26, P534, DOI 10.1114/1.122; Gross L, 1931, AM J PATHOL, V7, P0445; Gundiah N, 2008, ANN THORAC SURG, V85, P1631, DOI 10.1016/j.athoracsur.2008.01.035; HILBERT SL, 1986, J BIOMED MATER RES, V20, P1411, DOI 10.1002/jbm.820200914; Khan Z, 2008, ULTRASOUND MED BIOL, V34, P1504, DOI 10.1016/j.ultrasmedbio.2008.02.001; PESKIN CS, 1994, AM J PHYSIOL, V266, pH319, DOI 10.1152/ajpheart.1994.266.1.H319; Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005; Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122; Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015; Sauren A.A.H.J, 1981, MECH BEHAV AORTIC VA; Sim EKW, 2003, CLIN ANAT, V16, P193, DOI 10.1002/ca.10149; Writing Group M, 2012, CIRCULATION, V125, pe2; Zimmermann WH, 2003, CARDIOVASC RES, V60, P460, DOI 10.1016/j.cardiores.2003.10.007	17	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86087	10.1371/journal.pone.0086087	http://dx.doi.org/10.1371/journal.pone.0086087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465887	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500180
J	Sarmiento-Ramirez, JM; Abella-Perez, E; Phillott, AD; Sim, J; van West, P; Martin, MP; Marco, A; Dieguez-Uribeondo, J				Sarmiento-Ramirez, Jullie M.; Abella-Perez, Elena; Phillott, Andrea D.; Sim, Jolene; van West, Pieter; Martin, Maria P.; Marco, Adolfo; Dieguez-Uribeondo, Javier			Global Distribution of Two Fungal Pathogens Threatening Endangered Sea Turtles	PLOS ONE			English	Article							SOLANI SPECIES COMPLEX; FUSARIUM-SOLANI; CARETTA-CARETTA; PHYLOGENETIC-RELATIONSHIPS; APHANOMYCES-ASTACI; RIBOSOMAL DNA; SP-NOV; INFECTIONS; SAPROLEGNIA; EVOLUTION	Nascent fungal infections are currently considered as one of the main threats for biodiversity and ecosystem health, and have driven several animal species into critical risk of extinction. Sea turtles are one of the most endangered groups of animals and only seven species have survived to date. Here, we described two pathogenic species, i.e., Fusarium falciforme and Fusarium keratoplasticum, that are globally distributed in major turtle nesting areas for six sea turtle species and that are implicated in low hatch success. These two fungi possess key biological features that are similar to emerging pathogens leading to host extinction, e. g., high virulence, and a broad host range style of life. Their optimal growth temperature overlap with the optimal incubation temperature for eggs, and they are able to kill up to 90% of the embryos. Environmental forcing, e. g., tidal inundation and clay/silt content of nests, were correlated to disease development. Thus, these Fusarium species constitute a major threat to sea turtle nests, especially to those experiencing environmental stressors. These findings have serious implications for the survival of endangered sea turtle populations and the success of conservation programs worldwide.	[Sarmiento-Ramirez, Jullie M.; Martin, Maria P.; Dieguez-Uribeondo, Javier] Real Jardin Bot CSIC, Dept Micol, Madrid, Spain; [Abella-Perez, Elena; Marco, Adolfo] CSIC, Estn Biol Donana, Dept Biol Conservac, E-41080 Seville, Spain; [Phillott, Andrea D.] Asian Univ Women, Fac Sci, Chittagong, Bangladesh; [Phillott, Andrea D.] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia; [Sim, Jolene] Ascens Isl Govt, Conservat Off, George Town, Ascension Islan, Malaysia; [van West, Pieter] Univ Aberdeen, Coll Life Sci & Med, Aberdeen Oomycete Lab, Aberdeen AB9 1FX, Scotland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Asian University for Women; James Cook University; University of Aberdeen	Dieguez-Uribeondo, J (corresponding author), Real Jardin Bot CSIC, Dept Micol, Madrid, Spain.	dieguez@rjb.csic.es	Martín, María/HDL-9512-2022; Marco, Adolfo/B-7118-2009; Diéguez-Uribeondo, Javier/ABF-1130-2021; Martín, María/H-8069-2012; dieguez-uribeondo, javier/I-2178-2015	Marco, Adolfo/0000-0002-6523-9704; Diéguez-Uribeondo, Javier/0000-0002-4488-0658; Martín, María/0000-0002-1235-4418; dieguez-uribeondo, javier/0000-0002-4488-0658; van West, Pieter/0000-0002-0767-6017	Ministerio de Ciencia e Innovacion, Spain [CGL2009-10032, CGL2012-32934]; CSIC [JAEPre 0901804]; Natural Environment Research Council; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/J018333/1, BB/G012075/1] Funding Source: researchfish; BBSRC [BB/G012075/1, BB/J018333/1] Funding Source: UKRI	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants of Ministerio de Ciencia e Innovacion, Spain (CGL2009-10032, CGL2012-32934). J.M.S.R was supported by PhD fellowship of the CSIC (JAEPre 0901804). The Natural Environment Research Council and the Biotechnology and Biological Sciences Research Council supported P. V. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Mesen Rafael Arturo, 1992, Brenesia, V38, P159; Adaskaveg JE, 1997, PHYTOPATHOLOGY, V87, P979, DOI 10.1094/PHYTO.1997.87.9.979; Aoki T, 2003, MYCOLOGIA, V95, P660, DOI 10.2307/3761942; Aoki Takayuki, 2005, Mycoscience, V46, P162, DOI 10.1007/s10267-005-0235-y; BLANCK CE, 1981, J EXP MAR BIOL ECOL, V49, P163, DOI 10.1016/0022-0981(81)90068-X; Booth C, 1977, FUSARIUM LAB GUIDE I; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Davenport J, 1997, J THERM BIOL, V22, P479, DOI 10.1016/S0306-4565(97)00066-1; Davidson OG, 2001, FIRE TURTLE HOUSE GR; Dieguez-Uribeondo J, 2003, PHYTOPATHOLOGY, V93, P923, DOI 10.1094/PHYTO.2003.93.8.923; DIEGUEZURIBEONDO J, 1995, MYCOL RES, V99, P574, DOI 10.1016/S0953-7562(09)80716-8; ECKERT KL, 1990, BIOL CONSERV, V53, P37, DOI 10.1016/0006-3207(90)90061-S; Eckert KL, 1999, RES MANAGEMENT TECHN; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Beneitez MJ, 2008, FEMS MICROBIOL LETT, V279, P23, DOI 10.1111/j.1574-6968.2007.01002.x; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Guclu O, 2010, AFR J MICROBIOL RES, V4, P408; Hube B, 2009, CURR OPIN MICROBIOL, V12, P347, DOI 10.1016/j.mib.2009.06.009; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2004, IUCN RED LIST THREAT; Kim K, 2004, AM NAT, V164, pS52, DOI 10.1086/424609; Kitancharoen N, 1996, FISH PATHOL, V31, P49, DOI 10.3147/jsfp.31.49; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kornerup A, 1978, MATHUEN HDB COLOR; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Miller J.D., 1985, Biology of Reptilia, V14, P269; Mo CL, 1990, 10 ANN WORKSH SEA TU, P249; MROSOVSKY N, 1994, J EXP ZOOL, V270, P16, DOI 10.1002/jez.1402700104; MROSOVSKY N, 1992, CAN J ZOOL, V70, P1920, DOI 10.1139/z92-261; Nelson EP, 1983, FUSARIUM SPECIES ILL; Nirenberg HI, 1998, MYCOLOGIA, V90, P434, DOI 10.2307/3761403; Nylander J.A.A., 2008, MRMODELTEST; O'Donnell K, 2000, MYCOLOGIA, V92, P919, DOI 10.2307/3761588; O'Donnell K, 2008, J CLIN MICROBIOL, V46, P2477, DOI 10.1128/JCM.02371-07; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Perez Elena Abella, 2011, Zoologia Caboverdiana, V2, P40; PETERS A, 1994, HERPETOLOGICA, V50, P369; Phillott A. D., 2004, Memoirs of the Queensland Museum, V49, P701; Phillott AD, 2001, AUST J ZOOL, V49, P713, DOI 10.1071/ZO00051; Phillott AD, 2001, J EXP ZOOL, V289, P317, DOI 10.1002/1097-010X(20010415/30)289:5<317::AID-JEZ5>3.0.CO;2-0; Phillott AD, 2003, FUNGAL COLONISATION; Phillott Andrea D., 2001, Chelonian Conservation and Biology, V4, P170; Rambaut A, 2002, SE AL SEQUENCE ALIGN; Ray H, 1998, PHYSIOL MOL PLANT P, V53, P81, DOI 10.1006/pmpp.1998.0165; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Sarmiento-Ramirez JM, 2010, FEMS MICROBIOL LETT, V312, P192, DOI 10.1111/j.1574-6968.2010.02116.x; Short DPG, 2013, FUNGAL GENET BIOL, V53, P59, DOI 10.1016/j.fgb.2013.01.004; Short DPG, 2011, J CLIN MICROBIOL, V49, P4264, DOI 10.1128/JCM.05468-11; SODERHALL K, 1978, MYCOPATHOLOGIA, V64, P9, DOI 10.1007/BF00443081; Solomon SE, 1980, 7 EUR C EL MICR FDN, P434; Spotila James R., 1997, P297; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Summerbell RC, 2002, J CLIN MICROBIOL, V40, P2866, DOI 10.1128/JCM.40.8.2866-2875.2002; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Vandersea MW, 2006, APPL ENVIRON MICROB, V72, P1551, DOI 10.1128/AEM.72.2.1551-1557.2006; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wharton P, 2007, MICHIGAN POTATO DIS; White T., 1990, PCR PROTOCOLS GUIDE, P315; WYNEKEN J, 1988, J HERPETOL, V22, P88, DOI 10.2307/1564360; Zhang N, 2006, J CLIN MICROBIOL, V44, P2186, DOI 10.1128/JCM.00120-06	67	55	59	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85853	10.1371/journal.pone.0085853	http://dx.doi.org/10.1371/journal.pone.0085853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465748	Green Published, Green Accepted, gold			2022-12-25	WOS:000330244500131
J	Sharma, VK; Casey, TA				Sharma, Vijay K.; Casey, Thomas A.			Determining the Relative Contribution and Hierarchy of hha and qseBC in the Regulation of Flagellar Motility of Escherichia coli O157:H7	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ENTEROCYTE EFFACEMENT; H-NS; VIRULENCE FACTORS; TRANSCRIPTIONAL REGULATION; PATHOGENICITY ISLAND; TERMINAL RECTUM; SENSOR KINASE; WEANED CALVES; III SECRETION	In recent studies, we demonstrated that a deletion of hha caused increased secretion of locus of enterocyte encoded adherence proteins and reduced motility of enterohemorrhagic Escherichia coli (EHEC) O157:H7. In addition to the importance of hha in positive regulation of motility, a two-component quorum sensing pathway encoded by the qseBC genes has been shown to activate bacterial motility in response to mammalian stress hormones epinephrine and norepinephrine as well as bacterially produced autoinducer-3. In this study, we compared regulatory contribution and hierarchy of hha, a member of the Hha/YmoA family of nucleoid-associated proteins, to that of qseBC in the expression of EHEC O157:H7 motility. Since norepinephrine affects motility of EHEC O157:H7 through a qseBC-encoded two-component quorum sensing signaling, we also determined whether the hha-mediated regulation of motility is affected by norepinephrine and whether this effect is qseBC dependent. We used single (Delta hha or Delta qseC) and double (Delta hha Delta qseC) deletion mutants to show that hha exerts a greater positive regulatory effect in comparison to qseBC on the expression of motility by EHEC O157:H7. We also show that Hha is hierarchically superior in transcriptional regulation of motility than QseBC because transcription of qseC was significantly reduced in the hha deletion mutant compared to that in the parental and the hha-complemented mutant strains. These results suggest that hha regulates motility of EHEC O157:H7 directly as well as indirectly by controlling the transcription of qseBC.	[Sharma, Vijay K.; Casey, Thomas A.] ARS, Food Safety & Enter Pathogens Res Unit, USDA, Natl Anim Dis Ctr, Ames, IA 50011 USA	United States Department of Agriculture (USDA)	Sharma, VK (corresponding author), ARS, Food Safety & Enter Pathogens Res Unit, USDA, Natl Anim Dis Ctr, Ames, IA 50011 USA.	vijay.sharma@ars.usda.gov			USDA-ARS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	USDA-ARS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Bearson BL, 2008, MICROB PATHOGENESIS, V44, P271, DOI 10.1016/j.micpath.2007.10.001; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Clarke MB, 2005, MOL MICROBIOL, V58, P441, DOI 10.1111/j.1365-2958.2005.04819.x; Clarke MB, 2005, MOL MICROBIOL, V57, P1734, DOI 10.1111/j.1365-2958.2005.04792.x; Dean-Nystrom EA, 2008, APPL ENVIRON MICROB, V74, P6378, DOI 10.1128/AEM.00636-08; DeanNystrom EA, 1997, INFECT IMMUN, V65, P1842, DOI 10.1128/IAI.65.5.1842-1848.1997; Dobbin HS, 2006, INFECT IMMUN, V74, P2894, DOI 10.1128/IAI.74.5.2894-2905.2006; Duan QD, 2013, J BASIC MICROB, V53, P1, DOI [10.1002/jobm.201370001, 10.1002/jobm.201100335]; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Elliott SJ, 1999, INFECT IMMUN, V67, P4260, DOI 10.1128/IAI.67.8.4260-4263.1999; Fahlen TF, 2001, J BACTERIOL, V183, P6620, DOI 10.1128/JB.183.22.6620-6629.2001; Friedberg D, 1999, MOL MICROBIOL, V34, P941, DOI 10.1046/j.1365-2958.1999.01655.x; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Hansen AM, 2009, MOL MICROBIOL, V73, P446, DOI 10.1111/j.1365-2958.2009.06781.x; Honda N, 2009, MOL MICROBIOL, V74, P1393, DOI 10.1111/j.1365-2958.2009.06937.x; Hughes DT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000553; Iyoda S, 2006, J BACTERIOL, V188, P5682, DOI 10.1128/JB.00352-06; Jarvis KG, 1996, INFECT IMMUN, V64, P4826, DOI 10.1128/IAI.64.11.4826-4829.1996; Kanamaru K, 2000, MOL MICROBIOL, V38, P805, DOI 10.1046/j.1365-2958.2000.02171.x; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; Kendall MM, 2011, J BACTERIOL, V193, P6843, DOI 10.1128/JB.06141-11; Ko M, 2000, J BACTERIOL, V182, P4670, DOI 10.1128/JB.182.16.4670-4672.2000; Laaberki MH, 2006, INT J MED MICROBIOL, V296, P197, DOI 10.1016/j.ijmm.2006.02.017; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; Madrid C, 2007, MOL MICROBIOL, V63, P7, DOI 10.1111/j.1365-2958.2006.05497.x; Mahajan A, 2009, CELL MICROBIOL, V11, P121, DOI 10.1111/j.1462-5822.2008.01244.x; MCKEE ML, 1995, INFECT IMMUN, V63, P3739, DOI 10.1128/IAI.63.9.3739-3744.1995; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Mourino M, 1996, INFECT IMMUN, V64, P2881; Nart P, 2008, INFECT IMMUN, V76, P5366, DOI 10.1128/IAI.01223-07; Naylor SW, 2005, MICROBIOL-SGM, V151, P2773, DOI 10.1099/mic.0.28060-0; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Porter ME, 2005, J BACTERIOL, V187, P458, DOI 10.1128/JB.187.2.458-472.2005; Pruss BM, 1997, J BACTERIOL, V179, P5602; Reading NC, 2007, J BACTERIOL, V189, P2468, DOI 10.1128/JB.01848-06; Rosser T, 2008, INFECT IMMUN, V76, P5598, DOI 10.1128/IAI.01180-08; Sharma VK, 2013, MICROB PATHOGENESIS, V57, P21, DOI 10.1016/j.micpath.2013.02.002; Sharma VK, 2012, INFECT IMMUN, V80, P1333, DOI 10.1128/IAI.05869-11; Sharma VK, 2013, APPL ENVIRON MICROB, V79, P2384, DOI 10.1128/AEM.02998-12; Sharma VK, 2010, MICROBIOL-SGM, V156, P1303, DOI 10.1099/mic.0.034330-0; Sharma VK, 2005, FEMS MICROBIOL LETT, V243, P189, DOI 10.1016/j.femsle.2004.12.003; Sharma VK, 2004, J BACTERIOL, V186, P7290, DOI 10.1128/JB.186.21.7290-7301.2004; SHIN S, 1995, J BACTERIOL, V177, P4696, DOI 10.1128/jb.177.16.4696-4702.1995; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Sperandio V, 2002, INFECT IMMUN, V70, P3085, DOI 10.1128/IAI.70.6.3085-3093.2002; Sperandio V, 2010, GUT MICROBES, V1, P432, DOI 10.4161/gmic.1.6.14177; Tree JJ, 2011, MOL MICROBIOL, V80, P1349, DOI 10.1111/j.1365-2958.2011.07650.x; Ueda T, 2013, DNA RES, V20, P263, DOI 10.1093/dnares/dst008; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005	57	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85866	10.1371/journal.pone.0085866	http://dx.doi.org/10.1371/journal.pone.0085866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465756	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500134
J	Trautmann, T; Kozik, JH; Carambia, A; Richter, K; Lischke, T; Schwinge, D; Mittrucker, HW; Lohse, AW; Oxenius, A; Wiegard, C; Herkel, J				Trautmann, Tanja; Kozik, Jan-Hendrik; Carambia, Antonella; Richter, Kirsten; Lischke, Timo; Schwinge, Dorothee; Mittruecker, Hans-Willi; Lohse, Ansgar W.; Oxenius, Annette; Wiegard, Christiane; Herkel, Johannes			CD4+T-Cell Help Is Required for Effective CD8+T Cell-Mediated Resolution of Acute Viral Hepatitis in Mice	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CD4(+) T-CELLS; B-VIRUS; DISEASE; LIVER; RESPONSES; QUANTIFICATION; MECHANISMS; LACKING; MODEL	Cytotoxic CD8+ T cells are essential for the control of viral liver infections, such as those caused by HBV or HCV. It is not entirely clear whether CD4+ T-cell help is necessary for establishing anti-viral CD8+ T cell responses that successfully control liver infection. To address the role of CD4+ T cells in acute viral hepatitis, we infected mice with Lymphocytic Choriomeningitis Virus (LCMV) of the strain WE; LCMV-WE causes acute hepatitis in mice and is cleared from the liver by CD8+ T cells within about two weeks. The role of CD4+ T-cell help was studied in CD4+ T cell-lymphopenic mice, which were either induced by genetic deficiency of the major histocompatibility (MHC) class II transactivator (CIITA) in CIITA-/- mice, or by antibody-mediated CD4+ cell depletion. We found that CD4+ T cell-lymphopenic mice developed protracted viral liver infection, which seemed to be a consequence of reduced virus-specific CD8+ T-cell numbers in the liver. Moreover, the antiviral effector functions of the liver-infiltrating CD8+ T cells in response to stimulation with LCMV peptide, notably the IFN-gamma production and degranulation capacity were impaired in CIITA-/- mice. The impaired CD8+ T-cell function in CIITA-/- mice was not associated with increased expression of the exhaustion marker PD-1. Our findings indicate that CD4+ T-cell help is required to establish an effective antiviral CD8+ T-cell response in the liver during acute viral infection. Insufficient virus control and protracted viral hepatitis may be consequences of impaired initial CD4+ T-cell help.	[Trautmann, Tanja; Kozik, Jan-Hendrik; Carambia, Antonella; Schwinge, Dorothee; Lohse, Ansgar W.; Wiegard, Christiane; Herkel, Johannes] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Richter, Kirsten; Oxenius, Annette] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Lischke, Timo; Mittruecker, Hans-Willi] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Herkel, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany.	jherkel@uke.de	Oxenius, Annette/G-7794-2015	Herkel, Johannes/0000-0001-9055-9999; Lischke, Timo/0000-0003-0413-4252	Deutsche Forschungsgemeinschaft [SFB 841]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (SFB 841) (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Bergthaler A, 2007, J GEN VIROL, V88, P592, DOI 10.1099/vir.0.82428-0; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Carambia A, 2012, J HEPATOL, V57, P943, DOI 10.1016/j.jhep.2012.08.010; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Hokeness KL, 2007, J VIROL, V81, P1241, DOI 10.1128/JVI.01937-06; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Lang KS, 2010, DIGEST DIS, V28, P25, DOI 10.1159/000282061; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sant AJ, 2012, J EXP MED, V209, P1391, DOI 10.1084/jem.20121517; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wiesel M, 2012, EUR J IMMUNOL, V42, P1080, DOI 10.1002/eji.201142205; Wiesel M, 2011, J IMMUNOL, V186, P754, DOI 10.4049/jimmunol.1003166; Zinkernagel RM, 2002, CURR TOP MICROBIOL, V263, P1; ZINKERNAGEL RM, 1985, NATURE, V316, P814, DOI 10.1038/316814a0; zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388	35	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86348	10.1371/journal.pone.0086348	http://dx.doi.org/10.1371/journal.pone.0086348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466045	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500236
J	Yi, L; Zhao, YL; Wang, XJ; Dai, M; Hellstrom, KE; Hellstrom, I; Zhang, H				Yi, Ling; Zhao, Yanlin; Wang, Xiaojue; Dai, Min; Hellstroem, Karl Erik; Hellstroem, Ingegerd; Zhang, Hongtao			Human and Mouse CD137 Have Predominantly Different Binding CRDs to Their Respective Ligands	PLOS ONE			English	Article							T-CELL-ACTIVATION; HUMAN 4-1BB; CRYSTAL-STRUCTURE; FAMILY-MEMBERS; RECEPTOR; TNF; CANCER; COMPLEX; IMMUNOTHERAPY; STIMULATION	Monoclonal antibodies (mAbs) to CD137 (a.k.a. 4-1BB) have anti-tumor efficacy in several animal models and have entered clinical trials in patients with advanced cancer. Importantly, anti-CD137 mAbs can also ameliorate autoimmunity in preclinical models. As an approach to better understand the action of agonistic and antagonistic anti-CD137 mAbs we have mapped the binding region of the CD137 ligand (CD137L) to human and mouse CD137. By investigating the binding of CD137L to cysteine rich domain II (CRDII) and CRDIII of CD137, we found that the binding interface was limited and differed between the two species in that mouse CD137L mainly combined with CRDII and human CD137L mainly combined with CRDIII.	[Yi, Ling; Wang, Xiaojue; Zhang, Hongtao] Capital Med Univ, Dept Cent Lab, Beijing Chest Hosp, Beijing, Peoples R China; [Yi, Ling; Wang, Xiaojue; Zhang, Hongtao] Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China; [Zhao, Yanlin] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Dai, Min; Hellstroem, Karl Erik; Hellstroem, Ingegerd] Univ Washington, Harborview Med Ctr, Dept Pathol, Seattle, WA 98104 USA	Capital Medical University; Chinese Center for Disease Control & Prevention; Harborview Medical Center; University of Washington; University of Washington Seattle	Zhang, H (corresponding author), Capital Med Univ, Dept Cent Lab, Beijing Chest Hosp, Beijing, Peoples R China.	zhtbeijing@163.com	DAI, M/GPS-8291-2022		National Natural Science Foundation of China [81273209, 30572123]; National Basic Research Program of China (the "973'' Program) [2014CB744403]; Beijing Science and Technology Foundation of China [Z121107001012146]; National 12.5 grant [2013ZX10003003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (the "973'' Program)(National Basic Research Program of China); Beijing Science and Technology Foundation of China; National 12.5 grant	This work was supported by the National Natural Science Foundation of China (grant numbers 81273209 and 30572123), National Basic Research Program of China (the "973'' Program, No. 2014CB744403), Beijing Science and Technology Foundation of China (grant number Z121107001012146), and supported in part by National 12.5 grant (2013ZX10003003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON MR, 1994, EUR J IMMUNOL, V24, P2219, DOI 10.1002/eji.1830240943; An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Ascierto PA, 2010, SEMIN ONCOL, V37, P508, DOI 10.1053/j.seminoncol.2010.09.008; Baessler T, 2010, BLOOD, V115, P3058, DOI 10.1182/blood-2009-06-227934; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; Compaan DM, 2006, STRUCTURE, V14, P1321, DOI 10.1016/j.str.2006.06.015; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Fisher TS, 2012, CANCER IMMUNOL IMMUN, V61, P1721, DOI 10.1007/s00262-012-1237-1; HUCK S, 1986, NUCLEIC ACIDS RES, V14, P1779, DOI 10.1093/nar/14.4.1779; Hunig T, 2012, NAT REV IMMUNOL, V12, P317, DOI 10.1038/nri3192; Kachapati K, 2012, J IMMUNOL, V189, P5001, DOI 10.4049/jimmunol.1101013; Kim J, 2005, BLOOD, V105, P2206, DOI 10.1182/blood-2004-06-2080; Kohrt HE, 2012, J CLIN INVEST, V122, P1066, DOI 10.1172/JCI61226; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Liu CZ, 2010, J IMMUNOL, V184, P6910, DOI 10.4049/jimmunol.0904033; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lynch DH, 2008, IMMUNOL REV, V222, P277, DOI 10.1111/j.1600-065X.2008.00621.x; Magis C, 2012, TRENDS BIOCHEM SCI, V37, P353, DOI 10.1016/j.tibs.2012.06.002; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 2008, TRENDS PHARMACOL SCI, V29, P383, DOI 10.1016/j.tips.2008.05.005; Muller N, 2008, J CLIN INVEST, V118, P1405, DOI 10.1172/JCI32698; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Nishimoto H, 2005, BLOOD, V106, P4241, DOI 10.1182/blood-2005-04-1358; Niu LG, 2007, J IMMUNOL, V178, P4194, DOI 10.4049/jimmunol.178.7.4194; SCHWARZ H, 1995, BLOOD, V85, P1043, DOI 10.1182/blood.V85.4.1043.bloodjournal8541043; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; SIKORAV JL, 1980, NUCLEIC ACIDS RES, V8, P3143, DOI 10.1093/nar/8.14.3143; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Vinay DS, 2006, J MOL MED, V84, P726, DOI 10.1007/s00109-006-0072-2; Vinay DS, 2012, MOL CANCER THER, V11, P1062, DOI 10.1158/1535-7163.MCT-11-0677; Wang J, 2010, J IMMUNOL, V185, P7654, DOI 10.4049/jimmunol.1000927; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Won EY, 2010, J BIOL CHEM, V285, P9202, DOI 10.1074/jbc.M109.084442; Ye ZM, 2002, NAT MED, V8, P343, DOI 10.1038/nm0402-343; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004; Zhang GY, 2004, CURR OPIN STRUC BIOL, V14, P154, DOI 10.1016/j.sbi.2004.03.003; Zhang XY, 2010, J IMMUNOL, V184, P787, DOI 10.4049/jimmunol.0901619; Zhu YW, 2007, BLOOD, V109, P4882, DOI 10.1182/blood-2006-10-043463	42	7	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86337	10.1371/journal.pone.0086337	http://dx.doi.org/10.1371/journal.pone.0086337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466035	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500232
J	Zhou, YJ; Zhu, JP; Zhou, T; Cheng, Q; Yu, LX; Wang, YX; Yang, S; Jiang, YF; Tong, W; Gao, F; Yu, H; Li, GX; Tong, GZ				Zhou, Yan-Jun; Zhu, Jian-Ping; Zhou, Tao; Cheng, Qun; Yu, Ling-Xue; Wang, Ya-Xin; Yang, Shen; Jiang, Yi-Feng; Tong, Wu; Gao, Fei; Yu, Hai; Li, Guo-Xin; Tong, Guang-Zhi			Identification of Differentially Expressed Proteins in Porcine Alveolar Macrophages Infected with Virulent/Attenuated Strains of Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							CELLULAR-PROTEINS; PROTEOMIC ALTERATION; CELLS; REPLICATION; INHIBITION; GLYCOLYSIS; ANNOTATION; BLAST2GO; REQUIRES; DISEASE	The highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) is still a serious threat to the swine industry. However, the pathogenic mechanism of HP-PRRSV remains unclear. We infected host porcine alveolar macrophages (PAMs) with the virulent HuN4 strain and the attenuated HuN4-F112 strain and then utilized fluorescent two-dimensional difference gel electrophoresis (2D-DIGE) to screen for intracellular proteins that were differentially expressed in host cells infected with the two strains. There were 153 proteins with significant different expression (P<0.01) observed, 42 of which were subjected to mass spectrometry, and 24 proteins were identified. PAM cells infected with the virulent strain showed upregulated expression of pyruvate kinase M2 (PKM2), heat shock protein beta-1 (HSPB1), and proteasome subunit alpha type 6 (PSMA6), which were downregulated in cells infected with the attenuated strain. The upregulation of PKM2 provides sufficient energy for viral replication, and the upregulation of HSPB1 inhibits host cell apoptosis and therefore facilitates mass replication of the virulent strain, while the upregulation of PSMA6 facilitates the evasion of immune surveillance by the virus. Studying on those molecules mentioned above may be able to help us to understand some unrevealed details of HP-PRRSV infection, and then help us to decrease its threat to the swine industry in the future.	[Zhou, Yan-Jun; Zhu, Jian-Ping; Cheng, Qun; Yu, Ling-Xue; Wang, Ya-Xin; Yang, Shen; Jiang, Yi-Feng; Tong, Wu; Gao, Fei; Yu, Hai; Li, Guo-Xin; Tong, Guang-Zhi] CAAS, Shanghai Vet Res Inst, Div Swine Infect Dis, Shanghai, Peoples R China; [Zhou, Tao] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Michigan State University	Tong, GZ (corresponding author), CAAS, Shanghai Vet Res Inst, Div Swine Infect Dis, Shanghai, Peoples R China.	gztong@shvri.ac.cn	jiang, yifeng/GWM-9104-2022; Zhou, Tao/B-5757-2017	Zhou, Tao/0000-0002-3648-9923	Natural Science Foundation of China [31100121]; National High Tech Plan (863 plan) [2011AA10A208]; National Basic Research Program of China [2014CB542702]; International Sci & Tech Cooperation Program [2010DFB33920]; Shanghai Sci & Tech Committee Program [11JC1415200]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Plan (863 plan); National Basic Research Program of China(National Basic Research Program of China); International Sci & Tech Cooperation Program; Shanghai Sci & Tech Committee Program	The study was supported by Natural Science Foundation of China (No. 31100121), National High Tech Plan (863 plan) (2011AA10A208), National Basic Research Program of China (No. 2014CB542702), International Sci & Tech Cooperation Program (2010DFB33920), Shanghai Sci & Tech Committee Program(11JC1415200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso P, 2004, PROTEOMICS, V4, P2037, DOI 10.1002/pmic.200300742; BARDELL D, 1974, INFECT IMMUN, V9, P824, DOI 10.1128/IAI.9.5.824-827.1974; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chen IT, 2011, J VIROL, V85, P12919, DOI 10.1128/JVI.05385-11; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Delboy MG, 2008, J VIROL, V82, P3381, DOI 10.1128/JVI.02296-07; Delgado T, 2010, P NATL ACAD SCI USA, V107, P10696, DOI 10.1073/pnas.1004882107; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Ding Z, 2012, VET IMMUNOL IMMUNOP, V145, P206, DOI 10.1016/j.vetimm.2011.11.005; Duan X, 1997, VET MICROBIOL, V56, P9, DOI 10.1016/S0378-1135(96)01347-8; Fukagawa Y, 2008, ELECTROPHORESIS, V29, P3192, DOI 10.1002/elps.200800086; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Jiang Yong, 2012, Protistology, V7, P34; Karpe YA, 2012, J VIROL, V86, P5948, DOI 10.1128/JVI.07039-11; Liu N, 2008, PROTEOMICS, V8, P1851, DOI 10.1002/pmic.200700757; Lopez T, 2011, J VIROL, V85, P11964, DOI 10.1128/JVI.05286-11; McArdle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002502; Miller LC, 2008, DEV BIOLOGICALS, V132, P169, DOI 10.1159/000317157; Molitor TW, 1997, VET MICROBIOL, V55, P265, DOI 10.1016/S0378-1135(96)01327-2; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Pejsak Z, 1997, VET MICROBIOL, V55, P317, DOI 10.1016/S0378-1135(96)01326-0; Petiot E, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-84; Pol JMA, 1997, VET MICROBIOL, V55, P203, DOI 10.1016/S0378-1135(96)01329-6; Rodgers MA, 2009, J AM CHEM SOC, V131, P5030, DOI 10.1021/ja809949r; Rollin R, 2009, RHEUMATOL INT, V29, P969, DOI 10.1007/s00296-009-0891-x; Rossow KD, 1996, VET PATHOL, V33, P551, DOI 10.1177/030098589603300510; Satheshkumar PS, 2009, J VIROL, V83, P2469, DOI 10.1128/JVI.01986-08; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; STECK TL, 1968, CANCER RES, V28, P1611; Sun JF, 2008, J PROTEOME RES, V7, P5263, DOI 10.1021/pr800546m; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tian ZJ, 2009, VET MICROBIOL, V138, P34, DOI 10.1016/j.vetmic.2009.03.003; Tong GZ, 2007, EMERG INFECT DIS, V13, P1434, DOI 10.3201/eid1309.070399; Vastag L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002124; Wang ZK, 2011, J VIROL, V85, P11457, DOI 10.1128/JVI.00879-11; WARBURG O, 1956, SCIENCE, V124, P269; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Widjaja I, 2010, J VIROL, V84, P9625, DOI 10.1128/JVI.01048-10; Xiao SQ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-107; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Zhang HM, 2009, J PROTEOME RES, V8, P3091, DOI 10.1021/pr900002f; Zhang ZS, 2000, J BIOL CHEM, V275, P15157, DOI 10.1074/jbc.M910378199; Zheng XJ, 2008, MOL CELL PROTEOMICS, V7, P612, DOI 10.1074/mcp.M700396-MCP200; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08; Zhou P, 2011, INT J BIOL SCI, V7, P947, DOI 10.7150/ijbs.7.947; Zhou YJ, 2008, TRANSBOUND EMERG DIS, V55, P152, DOI 10.1111/j.1865-1682.2008.01020.x; Zhou YJ, 2011, CHINESE J ANIMAL INF, V19, P1	52	8	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85767	10.1371/journal.pone.0085767	http://dx.doi.org/10.1371/journal.pone.0085767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465692	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500107
J	Ansar, S; Chatzikonstantinou, E; Thiagarajah, R; Tritschler, L; Fatar, M; Hennerici, MG; Meairs, S				Ansar, Saema; Chatzikonstantinou, Eva; Thiagarajah, Rushani; Tritschler, Laurent; Fatar, Marc; Hennerici, Michael G.; Meairs, Stephen			Pro-Inflammatory Mediators and Apoptosis Correlate to rt-PA Response in a Novel Mouse Model of Thromboembolic Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; TISSUE-PLASMINOGEN-ACTIVATOR; MATRIX METALLOPROTEINASES; BRAIN-INJURY; REPERFUSION; TRANSIENT; MATRIX-METALLOPROTEINASE-9; HISTOPATHOLOGY; THROMBOLYSIS; MECHANISMS	Background: A recent study suggests that patients with persistent occlusion of the middle cerebral artery (MCA) following treatment with recombinant tissue plasminogen activator (rt-PA) have better outcomes than patients with MCA occlusion not receiving rt-PA. We performed a study to elucidate possible mechanisms of this finding in a new model of thromboembolic stroke closely mimicking human pathophysiology. Methods: Thromboembolic stroke was induced by local injection of thrombin directly into the right MCA of C57 black/6J mice. Rt-PA was administered 20 and 40 min after clot formation. The efficiency of rt-PA to induce thrombolysis was measured by laser Doppler. After 24 h, all animals were euthanized and interleukin (IL)-6, tumor necrosis factor-alpha (TNF-alpha), matrix metalloproteinase (MMP)-9, Caspase-3, hsp 32 and hsp 70 protein levels were investigated by immunofluorescence. Presence of hemorrhage was verified and infarct volume was measured using histology. Results: Thrombin injection resulted in clot formation giving rise to cortical brain infarction. Early rt-PA treatment starting at 20 min after the clot formation resulted in 100% recanalization. However, rt-PA-induced thrombolysis dissolved the clot in only 38% of the animals when administered 40 min after clot formation. Protein levels of IL-6, TNF-alpha, MMP-9, Caspase-3, hsp 32 and hsp 70 were increased after MCAO, whereas treatment with rt-PA attenuated the expressions of inflammatory markers in those animals where the thrombolysis was successful. In addition, the infarct size was significantly reduced with rt-PA treatment compared to non-treated MCAO, regardless of whether MCA thrombolysis was successful. Conclusions: The present study demonstrates a clear correlation of the protein expression of inflammatory mediators, apoptosis and stress genes with the recanalization data after rt-PA treatment. In this model rt-PA treatment decreases the infarct size regardless of whether vessel recanalization is successful.	[Ansar, Saema; Chatzikonstantinou, Eva; Thiagarajah, Rushani; Tritschler, Laurent; Fatar, Marc; Hennerici, Michael G.; Meairs, Stephen] Heidelberg Univ, Univ Med Mannheim, Dept Neurol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Meairs, S (corresponding author), Heidelberg Univ, Univ Med Mannheim, Dept Neurol, Heidelberg, Germany.	meairs@neuro.ma.uni-heidelberg.de	Tritschler, Laurent/G-9278-2018; Fatar, Marc/E-6892-2015	Tritschler, Laurent/0000-0002-7041-0764; 	European Union [201024, 202213]	European Union(European Commission)	This work was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreements no. 201024 and no. 202213 (European Stroke Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AV, 2002, NEUROLOGY, V59, P862, DOI 10.1212/WNL.59.6.862; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Dawson DA, 1997, BRAIN RES, V749, P200, DOI 10.1016/S0006-8993(96)01166-3; DELZOPPO GJ, 1992, ANN NEUROL, V32, P78, DOI 10.1002/ana.410320113; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Garcia-Yebenes I, 2011, STROKE, V42, P196, DOI 10.1161/STROKEAHA.110.600452; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kablau M, 2012, TREATMENT TPA PREDIC; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Langhauser Friederike L, 2012, Exp Transl Stroke Med, V4, P18, DOI 10.1186/2040-7378-4-18; Langheinrich AC, 2007, ATHEROSCLEROSIS, V191, P73, DOI 10.1016/j.atherosclerosis.2006.05.021; Li FH, 2000, STROKE, V31, P946, DOI 10.1161/01.STR.31.4.946; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; Minami M, 2003, LIFE SCI, V74, P321, DOI 10.1016/j.lfs.2003.09.019; Muir KW, 2007, CURR OPIN NEUROL, V20, P334, DOI 10.1097/WCO.0b013e32813ba151; Nedelmann M, 2010, J CEREBR BLOOD F MET, V30, P1712, DOI 10.1038/jcbfm.2010.82; OKADA Y, 1994, STROKE, V25, P1847, DOI 10.1161/01.STR.25.9.1847; Orset C, 2007, STROKE, V38, P2771, DOI 10.1161/STROKEAHA.107.487520; Pfeuffer J, 2002, MAGNET RESON MED, V47, P903, DOI 10.1002/mrm.10154; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Saver JL, 2011, J THROMB HAEMOST, V9, P333, DOI 10.1111/j.1538-7836.2011.04371.x; Sicard KM, 2006, STROKE, V37, P2593, DOI 10.1161/01.STR.0000239667.15532.c1; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Vivien D, 2011, J CEREBR BLOOD F MET, V31, P2119, DOI 10.1038/jcbfm.2011.127; Vogel J, 1999, STROKE, V30, P1134, DOI 10.1161/01.STR.30.5.1134; Wahlgren N, 2008, LANCET, V372, P1303, DOI 10.1016/S0140-6736(08)61339-2; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006	31	10	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85849	10.1371/journal.pone.0085849	http://dx.doi.org/10.1371/journal.pone.0085849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465746	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500078
J	Benaglia, L; Cardellicchio, L; Filippi, F; Paffoni, A; Vercellini, P; Somigliana, E; Fedele, L				Benaglia, Laura; Cardellicchio, Lucia; Filippi, Francesca; Paffoni, Alessio; Vercellini, Paolo; Somigliana, Edgardo; Fedele, Luigi			The Rapid Growth of Fibroids during Early Pregnancy	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; SMOOTH-MUSCLE-CELLS; UTERINE LEIOMYOMAS; LUTEINIZING-HORMONE; ULIPRISTAL ACETATE; IN-VITRO; MYOMAS; MANAGEMENT; PROLACTIN; WOMEN	Several studies aimed to disentangle whether pregnancy influences the growth of uterine fibroids but results were inconsistent. In this study, we speculated that fibroid enlargement during pregnancy may not be linear and we hypothesized that this phenomenon may mainly occur during initial pregnancy. To test this hypothesis, we set up a prospective cohort study of women with fibroids undergoing IVF. Cases were women achieving a viable pregnancy. Controls were the subsequent women with fibroids but failing to become pregnant. Twenty-five cases and 25 controls were recruited. The total number of fibroids in the two groups was 46 and 41, respectively. The mean +/- SD diameter of the fibroids was 17 +/- 10 and 20 +/- 11 mm, respectively (p = 0.18). A statistically significant enlargement emerged exclusively in pregnant women. The median (Interquartile Range) modification of the diameter of the lesions in cases and controls was +34% (+6%/+65%) and +2% (-6%/+12%), respectively (p<0.001). The median (Interquartile Range) modification of the volume of the lesions was +140% (+23%/+357%) and 0% (-18%/+37%), respectively (p<0.001). In pregnant women, we failed to document any significant correlation between the magnitude of the growth and ovarian responsiveness to hyper-stimulation, suggesting that steroids hormones are not the unique factors involved. In conclusion, fibroids undergo a rapid and remarkable growth during initial pregnancy. Reasons behind this phenomenon remain to be clarified. The early rise in steroids hormones during early pregnancy may not be sufficient to explain the process. Other pregnancy-related hormones and proteins may play also key roles.	[Benaglia, Laura; Cardellicchio, Lucia; Filippi, Francesca; Paffoni, Alessio; Vercellini, Paolo; Somigliana, Edgardo; Fedele, Luigi] Osped Maggiore Policlin, Fdn Ca Granda, Dept Obstet Gynecol, Milan, Italy; [Cardellicchio, Lucia; Filippi, Francesca; Vercellini, Paolo; Fedele, Luigi] Univ Milan, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Benaglia, L (corresponding author), Osped Maggiore Policlin, Fdn Ca Granda, Dept Obstet Gynecol, Milan, Italy.	laurabenaglia@hotmail.it	Somigliana, Edgardo/Z-3749-2019; Benaglia, Laura/ABC-7961-2020; Paffoni, Alessio/I-7404-2015; Vercellini, Paolo/K-5295-2016	Somigliana, Edgardo/0000-0002-0223-0032; Paffoni, Alessio/0000-0003-3112-3161; Vercellini, Paolo/0000-0003-4195-0996; fedele, luigi/0000-0001-6297-7165; Benaglia, Laura/0000-0002-7404-9830				AHARONI A, 1988, BRIT J OBSTET GYNAEC, V95, P510, DOI 10.1111/j.1471-0528.1988.tb12807.x; Baird DD, 2006, J SOC GYNECOL INVEST, V13, P130, DOI 10.1016/j.jsgi.2005.12.001; Benaglia L, 2011, FERTIL STERIL, V95, P2489, DOI 10.1016/j.fertnstert.2010.12.051; De Vivo A, 2011, ULTRASOUND OBST GYN, V37, P361, DOI 10.1002/uog.8826; Donnez J, 2012, NEW ENGL J MED, V366, P421, DOI 10.1056/NEJMoa1103180; Donnez J, 2012, NEW ENGL J MED, V366, P409, DOI 10.1056/NEJMoa1103182; Fritz MA, 2011, CLIN GYNECOLOGIC END, P269; Hammoud AO, 2006, J MINIM INVAS GYN, V13, P386, DOI 10.1016/j.jmig.2006.04.003; Horiuchi A, 2000, MOL HUM REPROD, V6, P523, DOI 10.1093/molehr/6.6.523; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; KORNYEI JL, 1993, BIOL REPROD, V49, P1149, DOI 10.1095/biolreprod49.6.1149; La Marca A, 2005, HUM REPROD, V20, P1569, DOI 10.1093/humrep/deh819; LEVTOAFF AS, 1987, RADIOLOGY, V164, P375, DOI 10.1148/radiology.164.2.3299488; Neiger R, 2006, J REPROD MED, V51, P671; Nohara A, 1997, BIOCHEM BIOPH RES CO, V238, P473, DOI 10.1006/bbrc.1997.7322; Ozturk E, 2009, CLIN EXP OBSTET GYN, V36, P182; Parker WH, 2007, FERTIL STERIL, V88, P255, DOI 10.1016/j.fertnstert.2007.06.044; ROSATI P, 1992, J ULTRAS MED, V11, P511; SINGH M, 1995, BIOL REPROD, V53, P591, DOI 10.1095/biolreprod53.3.591; Somigliana E, 2011, HUM REPROD, V26, P834, DOI 10.1093/humrep/der015; STEWART EA, 1995, FERTIL STERIL, V64, P972, DOI 10.1016/S0015-0282(16)57912-6; Wallach EE, 2004, OBSTET GYNECOL, V104, P393, DOI 10.1097/01.AOG.0000136079.62513.39	22	28	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85933	10.1371/journal.pone.0085933	http://dx.doi.org/10.1371/journal.pone.0085933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465797	gold, Green Submitted, Green Published			2022-12-25	WOS:000330240500091
J	Estany, J; Ros-Freixedes, R; Tor, M; Pena, RN				Estany, Joan; Ros-Freixedes, Roger; Tor, Marc; Pena, Ramona N.			A Functional Variant in the Stearoyl-CoA Desaturase Gene Promoter Enhances Fatty Acid Desaturation in Pork	PLOS ONE			English	Article							COENZYME-A DESATURASE; ADIPOSE-TISSUE; BINDING PROTEIN; MESSENGER-RNA; MEAT QUALITY; MUSCLE; EXPRESSION; PIGS; METABOLISM; DEPOSITION	There is growing public concern about reducing saturated fat intake. Stearoyl-CoA desaturase (SCD) is the lipogenic enzyme responsible for the biosynthesis of oleic acid (18:1) by desaturating stearic acid (18:0). Here we describe a total of 18 mutations in the promoter and 3' non-coding region of the pig SCD gene and provide evidence that allele T at AY487830:g.2228T>C in the promoter region enhances fat desaturation (the ratio 18:1/18:0 in muscle increases from 3.78 to 4.43 in opposite homozygotes) without affecting fat content (18:0+18:1, intramuscular fat content, and backfat thickness). No mutations that could affect the functionality of the protein were found in the coding region. First, we proved in a purebred Duroc line that the C-T-A haplotype of the 3 single nucleotide polymorphisms (SNPs) (g.2108C>T; g.2228T>C; g.2281A>G) of the promoter region was additively associated to enhanced 18:1/18:0 both in muscle and subcutaneous fat, but not in liver. We show that this association was consistent over a 10-year period of overlapping generations and, in line with these results, that the C-T-A haplotype displayed greater SCD mRNA expression in muscle. The effect of this haplotype was validated both internally, by comparing opposite homozygote siblings, and externally, by using experimental Duroc-based crossbreds. Second, the g.2281A>G and the g.2108C>T SNPs were excluded as causative mutations using new and previously published data, restricting the causality to g.2228T>C SNP, the last source of genetic variation within the haplotype. This mutation is positioned in the core sequence of several putative transcription factor binding sites, so that there are several plausible mechanisms by which allele T enhances 18:1/18:0 and, consequently, the proportion of monounsaturated to saturated fat.	[Estany, Joan; Ros-Freixedes, Roger; Tor, Marc; Pena, Ramona N.] Univ Lleida, Agrotecnio Ctr, Dept Prod Anim, Lleida, Catalonia, Spain	Centre de Recerca en Agrotecnologia (Agrotecnio); Universitat de Lleida	Estany, J (corresponding author), Univ Lleida, Agrotecnio Ctr, Dept Prod Anim, Lleida, Catalonia, Spain.	jestany@prodan.udl.cat	Estany, Joan/D-3228-2013; Ros-Freixedes, Roger/M-5247-2013; Tor, Marc/L-7820-2013; Pena, Romi/C-7756-2011	Estany, Joan/0000-0002-5660-5709; Ros-Freixedes, Roger/0000-0002-3745-6736; Tor, Marc/0000-0002-2572-9274; Pena, Romi/0000-0002-3558-7302	Spanish Ministry of Science and Innovation [AGL2009-09779, AGL2012-33529, BES-2010-034607]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by grants from the Spanish Ministry of Science and Innovation (AGL2009-09779 and AGL2012-33529). RRF is recipient of a PhD scholarship from the Spanish Ministry of Science and Innovation (BES-2010-034607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bartz M, 2013, J ANIM SCI, V91, P10, DOI 10.2527/jas.2012-5380; Bene H, 2001, BIOCHEM BIOPH RES CO, V284, P1194, DOI 10.1006/bbrc.2001.5102; Bosch L, 2012, MEAT SCI, V91, P358, DOI 10.1016/j.meatsci.2012.02.019; Bosch L, 2009, MEAT SCI, V82, P432, DOI 10.1016/j.meatsci.2009.02.013; Brandebourg TD, 2005, J ANIM SCI, V83, P98; Canovas A, 2009, J ANIM SCI, V87, P3905, DOI 10.2527/jas.2009-2091; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cho ES, 2011, AFR J AGR RES, V6, P6425, DOI 10.5897/AJAR11.720; Christophersen OA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-16; de Lorgeril M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-50; Dodson MV, 2010, INT J BIOL SCI, V6, P691; Doran O, 2006, BRIT J NUTR, V95, P609, DOI 10.1079/BJN20051526; Duran-Montge P, 2009, ANIMAL, V3, P1580, DOI 10.1017/S1751731109990450; Enderlin V, 1997, NEUROSCI LETT, V229, P125, DOI 10.1016/S0304-3940(97)00424-2; Falconer D. S, 1996, INTRO QUANTITATIVE G; FAO, 2008, 91 FAO; Hulbert AJ, 2010, INTEGR COMP BIOL, V50, P808, DOI 10.1093/icb/icq007; Kloareg M, 2007, BRIT J NUTR, V97, P35, DOI 10.1017/S0007114507205793; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Maharani D, 2013, MOL BIOL REP, V40, P73, DOI 10.1007/s11033-012-2014-0; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001; McAfee AJ, 2010, MEAT SCI, V84, P1, DOI 10.1016/j.meatsci.2009.08.029; Merino DM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-63; Miyazaki M, 2003, PROSTAG LEUKOTR ESS, V68, P113, DOI 10.1016/S0952-3278(02)00261-2; Munoz R, 2013, MEAT SCI, V93, P746, DOI 10.1016/j.meatsci.2012.11.045; Ntambi JM, 1999, J LIPID RES, V40, P1549; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Nurnberg K, 1998, LIVEST PROD SCI, V56, P145, DOI 10.1016/S0301-6226(98)00188-2; Ohsaki H, 2007, COMP BIOCHEM PHYS A, V148, P629, DOI 10.1016/j.cbpa.2007.08.004; Olivares A, 2009, MEAT SCI, V81, P295, DOI 10.1016/j.meatsci.2008.07.029; Olivares A, 2009, MEAT SCI, V82, P6, DOI 10.1016/j.meatsci.2008.11.006; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Perez E, 2012, BBA-MOL CELL BIOL L, V1821, P57, DOI 10.1016/j.bbalip.2011.04.003; Quintanilla R, 2011, J ANIM SCI, V89, P2963, DOI 10.2527/jas.2011-3974; Ren J, 2004, GENE, V340, P19, DOI 10.1016/j.gene.2004.06.017; Ren J, 2004, ANIM GENET, V35, P255, DOI 10.1111/j.1365-2052.2004.01129.x; Ren J, 2003, ANIM GENET, V34, P471, DOI 10.1046/j.0268-9146.2003.01058.x; Renaville B, 2013, MEAT SCI, V93, P495, DOI 10.1016/j.meatsci.2012.11.019; Ros-Freixedes R, 2012, J ANIM SCI, V90, P4230, DOI 10.2527/jas.2011-5063; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez MP, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-55; Smith J. W., 2010, Adapting animal production to changes for a growing human population, International Conference, Lleida, Spain, 19-21 May, 2010, P25; Uemoto Y, 2012, ANIM GENET, V43, P225, DOI 10.1111/j.1365-2052.2011.02236.x; Uemoto Y, 2012, ANIM GENET, V43, P27, DOI 10.1111/j.1365-2052.2011.02218.x; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Waters KM, 1997, BIOCHEM BIOPH RES CO, V233, P838, DOI 10.1006/bbrc.1997.6550; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Wood JD, 2004, MEAT SCI, V66, P21, DOI 10.1016/S0309-1740(03)00022-6; Zulkifli RM, 2010, J ANIM SCI, V88, P2565, DOI 10.2527/jas.2009-2603	51	47	49	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86177	10.1371/journal.pone.0086177	http://dx.doi.org/10.1371/journal.pone.0086177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465944	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500118
J	Fischer, K; Beatty, WL; Weil, GJ; Fischer, PU				Fischer, Kerstin; Beatty, Wandy L.; Weil, Gary J.; Fischer, Peter U.			High Pressure Freezing/Freeze Substitution Fixation Improves the Ultrastructural Assessment of Wolbachia Endosymbiont - Filarial Nematode Host Interaction	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; BRUGIA-MALAYI; INTRACELLULAR BACTERIA; FREEZE-SUBSTITUTION; GENE-EXPRESSION; PROTEINS; TISSUE; MICROORGANISMS; BIOGENESIS; PHYLOGENY	Background: Wolbachia alpha-proteobacteria are essential for growth, reproduction and survival for many filarial nematode parasites of medical and veterinary importance. Endobacteria were discovered in filarial parasites by transmission electron microscopy in the 1970's using chemically fixed specimens. Despite improvements of fixation and electron microscopy techniques during the last decades, methods to study the Wolbachia/filaria interaction on the ultrastructural level remained unchanged and the mechanisms for exchange of materials and for motility of endobacteria are not known. Methodology/Principal Finding: We used high pressure freezing/freeze substitution to improve fixation of Brugia malayi and its endosymbiont, and this led to improved visualization of different morphological forms of Wolbachia. The three concentric, bilayer membranes that surround the endobacterial cytoplasm were well preserved. Vesicles with identical membrane structures were identified close to the endobacteria, and multiple bacteria were sometimes enclosed within a single outer membrane. Immunogold electron microscopy using a monoclonal antibody directed against Wolbachia surface protein-1 labeled the membranes that enclose Wolbachia and Wolbachi alpha-associated vesicles. High densities of Wolbachia were observed in the lateral chords of L4 larvae, immature, and mature adult worms. Extracellular Wolbachia were sometimes present in the pseudocoelomic cavity near the developing female reproductive organs. Wolbachi alpha-associated actin tails were not observed. Wolbachia motility may be explained by their residence within vacuoles, as they may co-opt the host cell's secretory pathway to move within and between cells. Conclusions/Significance: High pressure freezing/freeze substitution significantly improved the preservation of filarial tissues for electron microscopy to reveal membranes and sub cellular structures that could be crucial for exchange of materials between Wolbachia and its host.	[Fischer, Kerstin; Weil, Gary J.; Fischer, Peter U.] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; [Beatty, Wandy L.] Washington Univ, Sch Med, Dept Mol Microbiol, Imaging Facil, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Fischer, PU (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA.	Pufische@DOM.wustl.edu		Fischer, Peter/0000-0003-4558-3417	Barnes Jewish Hospital Foundation; National Center for Research Resources, National Institutes of Health [S10RR031552]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031552] Funding Source: NIH RePORTER	Barnes Jewish Hospital Foundation; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the Barnes Jewish Hospital Foundation and by Award Number S10RR031552 from the National Center for Research Resources, National Institutes of Health. The funding organizations had no influence on study design or data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson R, 2009, J CELL SCI, V122, P4570, DOI 10.1242/jcs.054981; Amano A, 2010, MICROBES INFECT, V12, P791, DOI 10.1016/j.micinf.2010.05.008; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Bazzocchi C, 2008, INT J PARASITOL, V38, P1401, DOI 10.1016/j.ijpara.2008.03.002; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Canton J, 2012, CELL MICROBIOL, V14, P1676, DOI 10.1111/cmi.12000; Cho KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022703; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; Fischer K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001174; Fischer P, 2002, EXP PARASITOL, V102, P201, DOI 10.1016/S0014-4894(03)00058-4; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; FRANZ M, 1988, TROP MED PARASITOL, V39, P74; FRANZ M, 1987, PARASITOL RES, V74, P73, DOI 10.1007/BF00534936; FRANZ M, 1983, TROPENMED PARASITOL, V34, P122; Frohlich K, 2012, J MICROBIOL METH, V91, P222, DOI 10.1016/j.mimet.2012.08.012; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Ghedin E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000525; Hawes P, 2007, J MICROSC-OXFORD, V226, P182, DOI 10.1111/j.1365-2818.2007.01767.x; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; Hughes GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036277; Kawafune K, 2013, PROTOPLASMA, V250, P949, DOI 10.1007/s00709-012-0469-4; KOZEK WJ, 1977, J PARASITOL, V63, P992, DOI 10.2307/3279832; KOZEK WJ, 1977, AM J TROP MED HYG, V26, P663, DOI 10.4269/ajtmh.1977.26.663; KOZEK WJ, 1983, TROPENMED PARASITOL, V34, P38; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Landmann F, 2012, BIOL OPEN, V1, P536, DOI 10.1242/bio.2012737; MCLAREN DJ, 1975, T ROY SOC TROP MED H, V69, P509, DOI 10.1016/0035-9203(75)90110-8; McMahon KJ, 2012, J BACTERIOL, V194, P3241, DOI 10.1128/JB.00016-12; Melnikow E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002151; Melnikow E, 2011, INT J PARASITOL, V41, P1053, DOI 10.1016/j.ijpara.2011.05.008; Muller-Reichert T, 2010, METHOD CELL BIOL, V96, P331, DOI 10.1016/S0091-679X(10)96015-9; Sacchi L., 2003, Parassitologia (Rome), V45, P89; Salvenmoser W, 2010, METHOD CELL BIOL, V96, P307, DOI 10.1016/S0091-679X(10)96014-7; Serio AW, 2010, CELL HOST MICROBE, V7, P388, DOI 10.1016/j.chom.2010.04.008; Sironi M, 1995, MOL BIOCHEM PARASIT, V74, P223, DOI 10.1016/0166-6851(95)02494-8; Taylor MJ, 1999, EXP PARASITOL, V91, P356, DOI 10.1006/expr.1998.4383; Van Kirk LS, 2000, INFECT IMMUN, V68, P4706, DOI 10.1128/IAI.68.8.4706-4713.2000; Voronin D A, 2004, Dokl Biol Sci, V396, P227, DOI 10.1023/B:DOBS.0000033284.76770.c1; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Weimer Robby M., 2006, V351, P203	42	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86383	10.1371/journal.pone.0086383	http://dx.doi.org/10.1371/journal.pone.0086383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24466066	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000094
J	Heydari, H; Siow, CC; Tan, MF; Jakubovics, NS; Wee, WY; Mutha, NVR; Wong, GJ; Ang, MY; Yazdi, AH; Choo, SW				Heydari, Hamed; Siow, Cheuk Chuen; Tan, Mui Fern; Jakubovics, Nick S.; Wee, Wei Yee; Mutha, Naresh V. R.; Wong, Guat Jah; Ang, Mia Yang; Yazdi, Amir Hessam; Choo, Siew Woh			CoryneBase: Corynebacterium Genomic Resources and Analysis Tools at Your Fingertips	PLOS ONE			English	Article							DIPHTHERIA-TOXIN; GENETIC DIVERSITY; VIRULENCE FACTORS; DATABASE; ULCERANS; GENERATION; VFDB; EMERGENCE; INFECTION; STRAINS	Corynebacteria are used for a wide variety of industrial purposes but some species are associated with human diseases. With increasing number of corynebacterial genomes having been sequenced, comparative analysis of these strains may provide better understanding of their biology, phylogeny, virulence and taxonomy that may lead to the discoveries of beneficial industrial strains or contribute to better management of diseases. To facilitate the ongoing research of corynebacteria, a specialized central repository and analysis platform for the corynebacterial research community is needed to host the fast-growing amount of genomic data and facilitate the analysis of these data. Here we present CoryneBase, a genomic database for Corynebacterium with diverse functionality for the analysis of genomes aimed to provide: (1) annotated genome sequences of Corynebacterium where 165,918 coding sequences and 4,180 RNAs can be found in 27 species; (2) access to comprehensive Corynebacterium data through the use of advanced web technologies for interactive web interfaces; and (3) advanced bioinformatic analysis tools consisting of standard BLAST for homology search, VFDB BLAST for sequence homology search against the Virulence Factor Database (VFDB), Pairwise Genome Comparison (PGC) tool for comparative genomic analysis, and a newly designed Pathogenomics Profiling Tool (PathoProT) for comparative pathogenomic analysis. CoryneBase offers the access of a range of Corynebacterium genomic resources as well as analysis tools for comparative genomics and pathogenomics. It is publicly available at http://corynebacterium.um.edu.my/.	[Heydari, Hamed; Siow, Cheuk Chuen; Tan, Mui Fern; Wee, Wei Yee; Mutha, Naresh V. R.; Wong, Guat Jah; Ang, Mia Yang; Yazdi, Amir Hessam; Choo, Siew Woh] Univ Malaya, Genome Informat Res Lab, Kuala Lumpur, Malaysia; [Jakubovics, Nick S.] Newcastle Univ, Sch Dent Sci, Ctr Oral Hlth Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wee, Wei Yee; Wong, Guat Jah; Ang, Mia Yang; Choo, Siew Woh] Univ Malaya, Dept Oral Biol & Biomed Sci, Fac Dent, Kuala Lumpur, Malaysia; [Heydari, Hamed] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Software Engn, Kuala Lumpur, Malaysia; [Yazdi, Amir Hessam] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Comp Syst & Technol, Kuala Lumpur, Malaysia	Universiti Malaya; Newcastle University - UK; Universiti Malaya; Universiti Malaya; Universiti Malaya	Choo, SW (corresponding author), Univ Malaya, Genome Informat Res Lab, HIR Bldg, Kuala Lumpur, Malaysia.	lchoo@um.edu.my	Choo, Siew Woh/E-3406-2010; Jakubovics, Nicholas S/B-1938-2010	Jakubovics, Nicholas S/0000-0001-6667-0515; Siow, Cheuk Chuen/0000-0001-8336-7059	Ministry of Higher Education Malaysia [UM-MOHE UM.C/HIR/MOHE/08]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	This work was supported by UM High Impact Research Grant UM-MOHE UM.C/HIR/MOHE/08 from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bernard K, 2012, J CLIN MICROBIOL, V50, P3152, DOI 10.1128/JCM.00796-12; Birney E, 2004, BRIEF BIOINFORM, V5, P31, DOI 10.1093/bib/5.1.31; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Burkovski Andreas, 2013, ISRN Microbiol, V2013, P935736, DOI 10.1155/2013/935736; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Clinton LK, 2013, J CLIN MICROBIOL; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; De Zoysa A, 2005, J CLIN MICROBIOL, V43, P223, DOI 10.1128/JCM.43.1.223-228.2005; Funke G, 1999, EMERG INFECT DIS, V5, P477, DOI 10.3201/eid0503.990326; Gubler J, 1998, CLIN INFECT DIS, V27, P1295, DOI 10.1086/514997; Heydari H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062443; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Meyer F, 2009, NUCLEIC ACIDS RES, V37, P6643, DOI 10.1093/nar/gkp698; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Peterson J.W., 1996, MED MICROBIOLOGY; Pettigrew MM, 2012, APPL ENVIRON MICROB, V78, P6262, DOI 10.1128/AEM.01051-12; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Reacher M, 2000, EMERG INFECT DIS, V6, P640; Rogers EA, 2011, ADV EXP MED BIOL, V715, P91, DOI 10.1007/978-94-007-0940-9_6; Romney MG, 2006, J CLIN MICROBIOL, V44, P1625, DOI 10.1128/JCM.44.5.1625-1629.2006; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Sekizuka T, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-72; Shashikala P, 2011, J CLIN MICROBIOL, V49, P763, DOI 10.1128/JCM.01543-10; Shields RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055339; Sing A, 2005, CLIN INFECT DIS, V40, P325, DOI 10.1086/426687; Sing A, 2003, J CLIN MICROBIOL, V41, P4848, DOI 10.1128/JCM.41.10.4848-4851.2003; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094; Trost E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-383; Uchiyama I, 2013, NUCLEIC ACIDS RES, V41, pD631, DOI 10.1093/nar/gks1006; Weinstein JN, 2008, SCIENCE, V319, P1772, DOI 10.1126/science.1151888; Westesson O, 2013, BRIEF BIOINFORM, V14, P172, DOI 10.1093/bib/bbr078; Wilkinson L, 2009, AM STAT, V63, P179, DOI 10.1198/tas.2009.0033; Wojewoda CM, 2012, J CLIN MICROBIOL, V50, P2170, DOI 10.1128/JCM.00237-12; Wu XY, 2007, APPL ENVIRON MICROB, V73, P83, DOI 10.1128/AEM.00990-06; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang R, 2006, MICROBES INFECT, V8, P1613, DOI 10.1016/j.micinf.2005.11.019; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	46	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86318	10.1371/journal.pone.0086318	http://dx.doi.org/10.1371/journal.pone.0086318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24466021	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000091
J	Meisner, MH; Rosenheim, JA				Meisner, Matthew H.; Rosenheim, Jay A.			Ecoinformatics Reveals Effects of Crop Rotational Histories on Cotton Yield	PLOS ONE			English	Article							PEST-MANAGEMENT; LYGUS-HESPERUS; INSECT; TILLAGE; PLANT	Crop rotation has been practiced for centuries in an effort to improve agricultural yield. However, the directions, magnitudes, and mechanisms of the yield effects of various crop rotations remain poorly understood in many systems. In order to better understand how crop rotation influences cotton yield, we used hierarchical Bayesian models to analyze a large ecoinformatics database consisting of records of commercial cotton crops grown in California's San Joaquin Valley. We identified several crops that, when grown in a field the year before a cotton crop, were associated with increased or decreased cotton yield. Furthermore, there was a negative association between the effect of the prior year's crop on June densities of the pest Lygus hesperus and the effect of the prior year's crop on cotton yield. This suggested that some crops may enhance L. hesperus densities in the surrounding agricultural landscape, because residual L. hesperus populations from the previous year cannot continuously inhabit a focal field and attack a subsequent cotton crop. In addition, we found that cotton yield declined approximately 2.4% for each additional year in which cotton was grown consecutively in a field prior to the focal cotton crop. Because L. hesperus is quite mobile, the effects of crop rotation on L. hesperus would likely not be revealed by small plot experimentation. These results provide an example of how ecoinformatics datasets, which capture the true spatial scale of commercial agriculture, can be used to enhance agricultural productivity.	[Meisner, Matthew H.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Meisner, Matthew H.] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Rosenheim, Jay A.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Meisner, MH (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	mhmeisner@ucdavis.edu			California State Support Committee of Cotton Incorporated; University of California Statewide IPM Program; USDA-NRICGP [2006-01761]; California Department of Pesticide Regulation; National Science Foundation GRFP [DGE-1148897]	California State Support Committee of Cotton Incorporated; University of California Statewide IPM Program; USDA-NRICGP(United States Department of Agriculture (USDA)); California Department of Pesticide Regulation; National Science Foundation GRFP(National Science Foundation (NSF))	Funding Sources: 1. California State Support Committee of Cotton Incorporated. URL: http://www.ccgga.org/cotton_research/cssc.htm. 2. University of California Statewide IPM Program. URL: http://www.ipm.ucdavis.edu. 3. USDA-NRICGP (Grant 2006-01761). URL: http://www.csrees.usda.gov/funding/rfas/nri_rfa.html. 4. California Department of Pesticide Regulation. URL: http://www.cdpr.ca.gov. 5. National Science Foundation GRFP (Grant DGE-1148897). URL: http://www.nsfgrfp.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson GO, 1985, P CORN SORGH RES C C, P161; Bordovsky JP, 2011, APPL ENG AGRIC, V27, P359; BORDOVSKY JP, 1994, AGRON J, V86, P1, DOI 10.2134/agronj1994.00021962008600010001x; Carriere Y, 2006, ENTOMOL EXP APPL, V118, P203, DOI 10.1111/j.1570-7458.2006.00384.x; Carriere Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039862; CONSTABLE GA, 1992, SOIL TILL RES, V23, P41, DOI 10.1016/0167-1987(92)90004-U; Cook RJ, 1984, ORGANIC FARMING CURR, P111; Crookston R. K., 1984, Crops and Soils Magazine, V36, P12; EDWARDS JH, 1988, AGRON J, V80, P76, DOI 10.2134/agronj1988.00021962008000010018x; Forbes AA, 2011, ENTOMOL EXP APPL, V139, P242, DOI 10.1111/j.1570-7458.2011.01125.x; Gelman A, 2009, DATA ANAL USING REGR; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; GOBBLE MM, 2013, RES TECHNOL MANAGE, V56, P64; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Godfrey LD, 2013, UC IPM PEST MANAGEME; Hoffman MD, 2013, J MACH LEAR IN PRESS; JOHNSON T. C., 1927, JOUR AMER SOC AGRON, V19, P518; KARLEN DL, 1994, ADV AGRON, V53, P1, DOI 10.1016/S0065-2113(08)60611-2; LIEBMAN M, 1993, ECOL APPL, V3, P92, DOI 10.2307/1941795; MITCHELL CC, 1991, AGRON J, V83, P24, DOI 10.2134/agronj1991.00021962008300010010x; Mitchell CC, 2008, AGRON J, V100, P1493, DOI 10.2134/agronj2007.0395; MUELLER AJ, 1974, J ECON ENTOMOL, V67, P77, DOI 10.1093/jee/67.1.77; O'Rourke ME, 2011, ECOL APPL, V21, P1782, DOI 10.1890/10-0241.1; Peairs FB, 2013, W CORN ROOTWORM; Rosenheim JA, 2006, ENVIRON ENTOMOL, V35, P1141, DOI 10.1603/0046-225X(2006)35[1141:ETIOLH]2.0.CO;2; Rosenheim JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080518; Rosenheim JA, 2011, J ECON ENTOMOL, V104, P331, DOI 10.1603/EC10380; Rosner D, 2013, ENVIRON RES, V120, P126, DOI 10.1016/j.envres.2012.08.011; Rothamsted Research Center, 2006, TECHNICAL REPORT; Russelle MP, 1987, SOIL CONS SOC AM, P41; Sevacherian B, 1975, ENVIRON ENTOMOL, V4, P163; Sivakoff FS, 2012, BIOL CONTROL, V63, P296, DOI 10.1016/j.biocontrol.2012.09.008; Stan Development Team, 2013, STAN MOD LANG US GUI; Stan Development Team, 2019, STAN C LIB PROBABILI; Streibich Karl-Heinz, 2013, Database and Network Journal, V43, P12; Wheeler TA, 2012, PLANT DIS, V96, P985, DOI 10.1094/PDIS-02-11-0111-RE; White K. D., 1970, AGR HIST, V44, P281; White K.D., 1970, ROMAN FARMING	38	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85710	10.1371/journal.pone.0085710	http://dx.doi.org/10.1371/journal.pone.0085710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465657	Green Published, gold			2022-12-25	WOS:000330237000053
J	Anstey, KJ; Cherbuin, N; Herath, PM; Qiu, CX; Kuller, LH; Lopez, OL; Wilson, RS; Fratiglioni, L				Anstey, Kaarin J.; Cherbuin, Nicolas; Herath, Pushpani M.; Qiu, Chengxuan; Kuller, Lewis H.; Lopez, Oscar L.; Wilson, Robert S.; Fratiglioni, Laura			A Self-Report Risk Index to Predict Occurrence of Dementia in Three Independent Cohorts of Older Adults: The ANU-ADRI	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; COGNITIVE DECLINE; KUNGSHOLMEN PROJECT; LATE-LIFE; METAANALYSIS; PREVENTION	Background and Aims: The Australian National University AD Risk Index (ANU-ADRI, http://anuadri.anu.edu.au) is a self-report risk index developed using an evidence-based medicine approach to measure risk of Alzheimer's disease (AD). We aimed to evaluate the extent to which the ANU-ADRI can predict the risk of AD in older adults and to compare the ANU-ADRI to the dementia risk index developed from the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study for middle-aged cohorts. Methods: This study included three validation cohorts, i.e., the Rush Memory and Aging Study (MAP) (n = 903, age >= 53 years), the Kungsholmen Project (KP) (n = 905, age >= 75 years), and the Cardiovascular Health Cognition Study (CVHS) (n = 2496, age >= 65 years) that were each followed for dementia. Baseline data were collected on exposure to the 15 risk factors included in the ANU-ADRI of which MAP had 10, KP had 8 and CVHS had 9. Risk scores and C-statistics were computed for individual participants for the ANU-ADRI and the CAIDE index. Results: For the ANU-ADRI using available data, the MAP study c-statistic was 0.637 (95% CI 0.596-0.678), for the KP study it was 0.740 (0.712-0.768) and for the CVHS it was 0.733 (0.691-0.776) for predicting AD. When a common set of risk and protective factors were used c-statistics were 0.689 (95% CI 0.650-0.727), 0.666 (0.628-0.704) and 0.734 (0.707-0.761) for MAP, KP and CVHS respectively. Results for CAIDE ranged from c-statistics of 0.488 (0.427-0.554) to 0.595 (0.565-0.625). Conclusion: A composite risk score derived from the ANU-ADRI weights including 8-10 risk or protective factors is a valid, self-report tool to identify those at risk of AD and dementia. The accuracy can be further improved in studies including more risk factors and younger cohorts with long-term follow-up.	[Anstey, Kaarin J.; Cherbuin, Nicolas; Herath, Pushpani M.] Australian Natl Univ, Ctr Res Ageing Hlth & Wellbeing, Canberra, ACT, Australia; [Qiu, Chengxuan; Fratiglioni, Laura] Stockholm Univ, Karolinska Inst, Aging Res Ctr, S-10691 Stockholm, Sweden; [Kuller, Lewis H.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Lopez, Oscar L.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Wilson, Robert S.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Fratiglioni, Laura] Stockholm Gerontol Res Ctr, Stockholm, Sweden	Australian National University; Karolinska Institutet; Stockholm University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rush University; Karolinska Institutet	Anstey, KJ (corresponding author), Australian Natl Univ, Ctr Res Ageing Hlth & Wellbeing, Canberra, ACT, Australia.	kaarin.anstey@anu.edu.au	Anstey, Kaarin/A-3852-2008; Cherbuin, Nicolas/A-8515-2008	Anstey, Kaarin/0000-0002-9706-9316; Cherbuin, Nicolas/0000-0001-6481-0748; Qiu, Chengxuan/0000-0003-1922-4912	Swedish Research Council, Stockholm, Sweden; NATIONAL INSTITUTE ON AGING [R01AG017917] Funding Source: NIH RePORTER	Swedish Research Council, Stockholm, Sweden(Swedish Research Council); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr C Qiu is supported by the Swedish Research Council, Stockholm, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Anstey KJ, 2008, AM J GERIAT PSYCHIAT, V16, P343, DOI 10.1097/JGP.0b013e31816b72d4; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Anstey KJ, 2013, PREV SCI, V14, P411, DOI 10.1007/s11121-012-0313-2; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Barnes DE, 2009, NEUROLOGY, V73, P173, DOI 10.1212/WNL.0b013e3181a81636; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Barnes DE, 2010, ALZHEIMERS DEMENT, V6, P138, DOI 10.1016/j.jalz.2010.01.005; Bennett DA, 2005, NEUROEPIDEMIOLOGY, V25, P163, DOI 10.1159/000087446; Calderon-Garciduenas L, 2012, J ALZHEIMERS DIS, V28, P93, DOI 10.3233/JAD-2011-110722; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Fratiglioni L, 2007, PHYSIOL BEHAV, V92, P98, DOI 10.1016/j.physbeh.2007.05.059; Fratiglioni L, 2011, LANCET NEUROL, V10, P778, DOI 10.1016/S1474-4422(11)70145-4; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Lopez OL, 2003, NEUROEPIDEMIOLOGY, V22, P1, DOI 10.1159/000067110; Palmer K, 2003, BRIT MED J, V326, P245, DOI 10.1136/bmj.326.7383.245; Power MC, 2011, EPIDEMIOLOGY, V22, P646, DOI 10.1097/EDE.0b013e31822708b5; SHAFER JL, 1997, ANAL INCOMPLETE MULT; Williams John W, 2010, Evid Rep Technol Assess (Full Rep), P1; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Zammit S, 2010, BRIT J PSYCHIAT, V197, P207, DOI 10.1192/bjp.bp.109.070904	24	75	78	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86141	10.1371/journal.pone.0086141	http://dx.doi.org/10.1371/journal.pone.0086141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465922	Green Published, gold, Green Accepted			2022-12-25	WOS:000330288000056
J	Li, M; Wang, J; Yang, L; Gao, P; Tian, QB; Liu, DW				Li, Man; Wang, Jian; Yang, Lei; Gao, Ping; Tian, Qing-bao; Liu, Dian-wu			eRF3b, a Biomarker for Hepatocellular Carcinoma, Influences Cell Cycle and Phosphoralation Status of 4E-BP1	PLOS ONE			English	Article							CHAIN RELEASE FACTORS; TRANSLATION TERMINATION; CANCER; MTOR; EXPRESSION; DEPLETION; UPSTREAM; HOMOLOG; PROTEIN	Background: Hepatitis B virus (HBV) infection and its sequelae are now recognized as serious problems globally. Our aime is to screen hepatocellular carcinoma (HCC) from chronic hepatitis B (CHB) and identify the characteristics of proteins involved. Methodology/Principal Findings: We affinity-purified sample serum with weak cation-exchange (WCX) magnetic beads and matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) analysis to search for potential markers. The 4210 Da protein, which differed substantially between HCC and CHB isolates, was later identified to be eukaryotic peptide chain release factor GTP-binding subunit eRF3b. Further research showed that eRF3b/GSPT2 was positively expressed in liver tissues. GSPT2 mRNA was, however differentially expressed in blood. Compared with normal controls, the relative expression of GSPT2/18s rRNA was higher in CHB patients than in patients with either LC or HCC (P = 0.035 for CHB vs. LC; P = 0.020 for CHB vs. HCC). The data of further research showed that eRF3b/GSPT2 promoted the entrance of the HepG2 cells into the S-phase and that one of the substrates of the mTOR kinase, 4E-BP1, was hyperphosphorylated in eRF3b-overexpressing HepG2 cells. Conclusions: Overall, the differentially expressed protein eRF3b, which was discovered as a biomarker for HCC, could change the cell cycle and influence the phosphorylation status of 4E-BP1 on Ser65 in HepG2.	[Li, Man; Wang, Jian; Yang, Lei; Gao, Ping; Tian, Qing-bao; Liu, Dian-wu] Hebei Med Univ, Dept Epidemiol & Stat, Shijiazhuang, Hebei Province, Peoples R China; [Wang, Jian] Hebei North Univ, Dept Epidemiol, Zhangjiakou, Hebei Province, Peoples R China	Hebei Medical University; Hebei North University	Liu, DW (corresponding author), Hebei Med Univ, Dept Epidemiol & Stat, Shijiazhuang, Hebei Province, Peoples R China.	dwliu1956@hotmail.com		Liu, Dian-Wu/0000-0003-2087-6299; Li, Man/0000-0002-6907-250X	National Natural Science Foundation of China [30972516]; Hebei Province Natural Science Fund of China [C2010000481]; Hebei Key Medical Guidence Topics of Health Department [20130457]; Fostering talents project of Hebei Medical University [0620970001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Province Natural Science Fund of China; Hebei Key Medical Guidence Topics of Health Department; Fostering talents project of Hebei Medical University	This work was supported by grant from the National Natural Science Foundation of China (30972516); Hebei Province Natural Science Fund of China (C2010000481), Hebei Key Medical Guidence Topics of Health Department (20130457) and the Fostering talents project of Hebei Medical University (0620970001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Basu J, 1998, CELL MOTIL CYTOSKEL, V39, P286, DOI 10.1002/(SICI)1097-0169(1998)39:4<286::AID-CM4>3.0.CO;2-1; Chang JTC, 2006, CLIN BIOCHEM, V39, P1144, DOI 10.1016/j.clinbiochem.2006.08.010; Chauvin C, 2005, MOL CELL BIOL, V25, P5801, DOI 10.1128/MCB.25.14.5801-5811.2005; Chauvin C, 2007, MOL CELL BIOL, V27, P5619, DOI 10.1128/MCB.00035-07; Cheng AJ, 2005, CLIN CHEM, V51, P2236, DOI 10.1373/clinchem.2005.052324; COLOMBO M, 1992, J HEPATOL, V15, P225, DOI 10.1016/0168-8278(92)90041-M; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoshino S, 1998, J BIOL CHEM, V273, P22254, DOI 10.1074/jbc.273.35.22254; HOSHINO S, 1989, EMBO J, V8, P3807, DOI 10.1002/j.1460-2075.1989.tb08558.x; Jakobsen CG, 2001, MOL BIOL+, V35, P575, DOI 10.1023/A:1010527127440; Leal MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042255; Li Man, 2011, Wei Sheng Yan Jiu, V40, P315; Liu CB, 2012, EXP THER MED, V3, P1005, DOI 10.3892/etm.2012.515; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malta-Vacas J, 2005, J CLIN PATHOL, V58, P621, DOI 10.1136/jcp.2004.021774; Petricoin EF, 2002, J NATL CANCER I, V94, P1576; Pons B, 2012, ONCOL REP, V27, P225, DOI 10.3892/or.2011.1462; Srinivas PR, 2002, CLIN CHEM, V48, P1160; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Valouev IA, 2002, CELL MOTIL CYTOSKEL, V52, P161, DOI 10.1002/cm.10040; Wagner PD, 2004, ANN NY ACAD SCI, V1022, P9, DOI 10.1196/annals.1318.003; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	26	8	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86371	10.1371/journal.pone.0086371	http://dx.doi.org/10.1371/journal.pone.0086371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466059	Green Submitted, gold, Green Published			2022-12-25	WOS:000330288000091
J	Manikandan, K; Sabareesh, V; Singh, N; Saigal, K; Mechold, U; Sinha, KM				Manikandan, Kasi; Sabareesh, Varatharajan; Singh, Nirpendra; Saigal, Kashyap; Mechold, Undine; Sinha, Krishna Murari			Two-Step Synthesis and Hydrolysis of Cyclic di-AMP in Mycobacterium tuberculosis	PLOS ONE			English	Article							BACILLUS-SUBTILIS; MYCOPLASMA-PNEUMONIAE; STRINGENT RESPONSE; ESCHERICHIA-COLI; GENE-EXPRESSION; DNA INTEGRITY; IN-VIVO; PROTEIN; GROWTH; MECHANISM	Cyclic di-AMP is a recently discovered signaling molecule which regulates various aspects of bacterial physiology and virulence. Here we report the characterization of c-di-AMP synthesizing and hydrolyzing proteins from Mycobacterium tuberculosis. Recombinant Rv3586 (MtbDisA) can synthesize c-di-AMP from ATP through the diadenylate cyclase activity. Detailed biochemical characterization of the protein revealed that the diadenylate cyclase (DAC) activity is allosterically regulated by ATP. We have identified the intermediates of the DAC reaction and propose a two-step synthesis of c-di-AMP from ATP/ADP. MtbDisA also possesses ATPase activity which is suppressed in the presence of the DAC activity. Investigations by liquid chromatography -electrospray ionization mass spectrometry have detected multimeric forms of c-di-AMP which have implications for the regulation of c-di-AMP cellular concentration and various pathways regulated by the dinucleotide. We have identified Rv2837c (MtbPDE) to have c-di-AMP specific phosphodiesterase activity. It hydrolyzes c-di-AMP to 59-AMP in two steps. First, it linearizes c-di-AMP into pApA which is further hydrolyzed to 59-AMP. MtbPDE is novel compared to c-di-AMP specific phosphodiesterase, YybT (or GdpP) in being a soluble protein and hydrolyzing c-di-AMP to 59-AMP. Our results suggest that the cellular concentration of c-di-AMP can be regulated by ATP concentration as well as the hydrolysis by MtbPDE.	[Manikandan, Kasi; Saigal, Kashyap; Sinha, Krishna Murari] Inst Mol Med, New Delhi, India; [Sabareesh, Varatharajan] Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi, India; [Sabareesh, Varatharajan] IGIB Extens Ctr Naraina, New Delhi, India; [Singh, Nirpendra] Univ Delhi, Cent Instrument Facil, New Delhi, India; [Mechold, Undine] Inst Pasteur, CNRS, UMR 3528, Unite Biochim Interact Macromol, Paris, France	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sinha, KM (corresponding author), Inst Mol Med, New Delhi, India.	krishna@immindia.org	Mechold, Undine/GYV-3918-2022; Sabareesh, Varatharajan/C-3922-2019	Mechold, Undine/0000-0002-6019-0972; Singh, Nirpendra/0000-0003-4141-2936; K, Dr. MANIKANDAN/0000-0003-1567-1264	Department of Biotechnology, Govt. of India; Council of Scientific and Industrial Research [MLP6201, FAC002, NWP036, NWP004]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by a grant from Department of Biotechnology, Govt. of India to K. M. S. The projects MLP6201, FAC002, NWP036 and NWP004 of Council of Scientific and Industrial Research are gratefully acknowledged for generous funding to IGIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Bai Y., 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Beam CE, 2002, J BACTERIOL, V184, P6836, DOI 10.1128/JB.184.24.6836-6844.2002; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Chin KH, 2012, ACTA CRYSTALLOGR D, V68, P1380, DOI 10.1107/S0907444912030594; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; DATTA AK, 1975, J BIOL CHEM, V250, P7313; Fang M, 2009, NUCLEIC ACIDS RES, V37, P5114, DOI 10.1093/nar/gkp527; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Gamulin V, 2004, FEMS MICROBIOL LETT, V238, P57, DOI 10.1016/j.femsle.2004.07.017; Goldman SR, 2011, MOL CELL, V42, P817, DOI 10.1016/j.molcel.2011.06.005; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Jain V, 2006, J MICROBIOL, V44, P1; James BW, 2000, J APPL MICROBIOL, V88, P669, DOI 10.1046/j.1365-2672.2000.01020.x; Keppetipola N, 2006, RNA, V12, P73, DOI 10.1261/rna.2196406; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Krause DC, 1996, MOL MICROBIOL, V20, P247, DOI 10.1111/j.1365-2958.1996.tb02613.x; Lovett S, 2006, DNA REPAIR, V5, P1421, DOI 10.1016/j.dnarep.2006.06.008; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Postic G, 2012, RNA, V18, P155, DOI 10.1261/rna.029132.111; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Rand L, 2003, MOL MICROBIOL, V50, P1031, DOI 10.1046/j.1365-2958.2003.03765.x; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Sinha KM, 2009, GENE DEV, V23, P1423, DOI 10.1101/gad.1805709; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Vvedenskaya IO, 2012, GENE DEV, V26, P1498, DOI 10.1101/gad.192732.112; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Zhang L, 2013, J BIOL CHEM, V288, P22426, DOI 10.1074/jbc.M113.464883	41	40	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86096	10.1371/journal.pone.0086096	http://dx.doi.org/10.1371/journal.pone.0086096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465894	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000049
J	Usami, M; Iwadare, Y; Kodaira, M; Watanabe, K; Saito, K				Usami, Masahide; Iwadare, Yoshitaka; Kodaira, Masaki; Watanabe, Kyota; Saito, Kazuhiko			Near Infrared Spectroscopy Study of the Frontopolar Hemodynamic Response and Depressive Mood in Children with Major Depressive Disorder: A Pilot Study	PLOS ONE			English	Article							VERBAL FLUENCY TASK; ACTIVATION; ANTIDEPRESSANTS; SCHIZOPHRENIA; QUESTIONNAIRE; MEDICATION; CHILDHOOD; ALGORITHM; VALIDITY; SUICIDE	AIM: The aim of this study was to evaluate the frontopolar hemodynamic response and depressive mood in children with mild or moderate major depressive disorder during six weeks treatment without medication. METHODS: The subjects were 10 patients with mild or moderate depression. They were depressive drug-naive children and adolescents. The scores of Depression Self Rating Scale (DSRS), the results of the Verbal Fluency Test (VFT), and the concentrations of oxy-hemoglobin (Oxy-Hb) of frontal pole brain assessed by two-channel near infrared spectroscopy (NIRS) after six weeks of treatment was compared with those of initial treatment. RESULTS: The score of DSRS was significantly reduced after six weeks of initial treatment (p<0.001, t-test). The word number of VFT was not significantly changed after six weeks of treatment. The oxy-Hb concentration significantly increased after six weeks of treatment (p<0.001, t-test). CONCLUSIONS: This study demonstrated that the concentration of oxy-Hb of frontopolar cortex in children with mild and moderate depression improved along with their depressive mood. These results suggested that concentration of oxy-Hb using NIRS may be used as the state maker for change in depressive mood of children having depression, similar to that in adults.	[Usami, Masahide; Iwadare, Yoshitaka; Watanabe, Kyota] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Ichikawa, Japan; [Kodaira, Masaki; Saito, Kazuhiko] Aiiku Hosp, Imperial Gift Fdn, Dept Child Mental Hlth, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Saiseikai Imperial Gift Foundation, Inc.	Usami, M (corresponding author), Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Ichikawa, Japan.	usami.masahide@hospk.ncgm.go.jp	Usami, Masahide/G-1404-2015	Usami, Masahide/0000-0002-1145-9971	National Center for Global Health and Medicine [21-130]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported by the grant of National Center for Global Health and Medicine (21-130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beats BC, 1996, PSYCHOL MED, V26, P591, DOI 10.1017/S0033291700035662; BIRLESON P, 1981, J CHILD PSYCHOL PSYC, V22, P73, DOI 10.1111/j.1469-7610.1981.tb00533.x; Cyranoski D, 2011, NATURE, V469, P148, DOI 10.1038/469148a; Dean AJ, 2009, J CHILD ADOL PSYCHOP, V19, P179, DOI 10.1089/cap.2008.075; Goren JL, 2008, EXPERT OPIN DRUG SAF, V7, P223, DOI [10.1517/14740338.7.3.223 , 10.1517/14740330802049468]; Haddad PM, 2001, DRUG SAFETY, V24, P183, DOI 10.2165/00002018-200124030-00003; Hetrick S, 2008, AUSTRALAS PSYCHIATRY, V16, P354, DOI 10.1080/10398560802189888; Holtkamp K, 2008, NERVENARZT, V79, P1237, DOI 10.1007/s00115-008-2555-6; Hughes CW, 2007, J AM ACAD CHILD PSY, V46, P667, DOI 10.1097/chi.0b013e31804a859b; Inoue Y, 2012, NEUROREPORT, V23, P55, DOI 10.1097/WNR.0b013e32834e664c; Kanbayashi Y, 2003, ATTENTION DEFICIET H; Kuwabara H, 2006, BEHAV BRAIN RES, V172, P272, DOI 10.1016/j.bbr.2006.05.020; Libby AM, 2007, AM J PSYCHIAT, V164, P884, DOI 10.1176/appi.ajp.164.6.884; Loeber R, 2000, J AM ACAD CHILD PSY, V39, P1468, DOI 10.1097/00004583-200012000-00007; Maki A, 1995, MED PHYS, V22, P1997, DOI 10.1118/1.597496; Matsuishi T, 2008, BRAIN; Moritz S, 2002, ARCH CLIN NEUROPSYCH, V17, P477, DOI 10.1016/S0887-6177(01)00130-5; Murata T, 2006, SAISHIN SEISHIN IGAK, V1, P131; Nakadoi Y, 2012, PSYCHIAT CLIN NEUROS, V66, P26, DOI 10.1111/j.1440-1819.2011.02290.x; Noda T, 2012, J PSYCHIATR RES, V46, P905, DOI 10.1016/j.jpsychires.2012.04.001; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; Prager LM, 2009, PEDIATR REV, V30, P199, DOI 10.1542/pir.30-6-199; Pu SH, 2008, PSYCHIAT CLIN NEUROS, V62, P728, DOI 10.1111/j.1440-1819.2008.01882.x; Sawada M, 2010, PSYCHIAT CLIN NEUROS, V64, P491, DOI 10.1111/j.1440-1819.2010.02134.x; society TBP, 2005, DEPR CHILDR YOUNG PE; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Takizawa R, 2008, SCHIZOPHR RES, V99, P250, DOI 10.1016/j.schres.2007.10.025; Tandt H, 2009, Tijdschr Psychiatr, V51, P387; Tsapakis EM, 2008, BRIT J PSYCHIAT, V193, P10, DOI 10.1192/bjp.bp.106.031088; Usami M, 2013, PLOS ONE, DOI [10.1371/journal.pone.0079806, DOI 10.1371/J0URNAL.P0NE.0079806]; Usami M, 2012, JPN J CHILD ADOLES S, V52, P25; Usami M, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-11; Warnick EM, 2008, CHILD ADOL MENT H-UK, V13, P140, DOI 10.1111/j.1475-3588.2007.00461.x; Yanagata B, 2008, PSYCHOGERIATRICS, V8, P79, DOI 10.1111/j.1479-8301.2008.00232.x	34	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86290	10.1371/journal.pone.0086290	http://dx.doi.org/10.1371/journal.pone.0086290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466008	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000079
J	Borkin, KM; Parsons, S				Borkin, Kerry M.; Parsons, Stuart			Effects of Clear-Fell Harvest on Bat Home Range	PLOS ONE			English	Article							LONG-TAILED BATS; RAIN-FOREST BAT; CHALINOLOBUS-TUBERCULATUS; ACTIVITY PATTERNS; ROOST SELECTION; CONSERVATION STATUS; HABITAT SELECTION; PLANTATION FOREST; SOUTH CANTERBURY; LANDSCAPE	We investigated effects of roost loss due to clear-fell harvest on bat home range. The study took place in plantation forest, inhabited by the New Zealand long-tailed bat (Chalinolobus tuberculatus), in which trees are harvested between the ages 26-32 years. We determined home ranges by radiotracking different bats in areas that had and had not been recently clear-fell harvested. Home ranges were smaller in areas that had been harvested. Adult male bats selected 20-25 year old stands within home ranges before and after harvest. Males selected edges with open unplanted areas when harvest had not occurred but no longer selected these at proportions greater than their availability post harvest, probably because they were then readily available. This is the first radiotracking study to demonstrate a change in home range size and selection concomitant with felling of large areas of plantation forest, and thus quantify negative effects of forestry operations on this speciose group. The use of smaller home ranges post-harvest may reflect smaller colony sizes and lower roost availability, both of which may increase isolation of colonies and vulnerability to local extinction.	[Borkin, Kerry M.; Parsons, Stuart] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland	Parsons, S (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	s.parsons@auckland.ac.nz		Parsons, Stuart/0000-0003-1025-5616	Enterprise Scholarship; Tertiary Education Commission; Hancock Forest Management; Carter Holt Harvey Forests; Blakely Pacific Limited; Pan Pacific; P.F. Olsen Ltd; Kaingaroa Timberlands	Enterprise Scholarship; Tertiary Education Commission; Hancock Forest Management; Carter Holt Harvey Forests; Blakely Pacific Limited; Pan Pacific; P.F. Olsen Ltd; Kaingaroa Timberlands	KMB was supported by an Enterprise Scholarship funded by the Tertiary Education Commission, Hancock Forest Management, Carter Holt Harvey Forests, Blakely Pacific Limited, Pan Pacific, P.F. Olsen Ltd, and Kaingaroa Timberlands. Research was funded by Environment Waikato, Bat Conservation International, J.S. Watson Trust, E. B. Firth Charitable Trust, O.T. P. P. New Zealand Forest Investments Ltd., and the Valder Award. C. H. H. Kinleith Pulp and Paper, A.D.T. Security, and Forest Protech provided logistical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Bernard E, 2007, BIOL CONSERV, V134, P332, DOI 10.1016/j.biocon.2006.07.021; Bohr YEMB, 2011, INT J PRIMATOL, V32, P901, DOI 10.1007/s10764-011-9509-8; Borkin KM, 2011, ACTA CHIROPTEROL, V13, P373, DOI 10.3161/150811011X624848; Borkin KM, 2011, BIODIVERS CONSERV, V20, P3537, DOI 10.1007/s10531-011-0144-7; Borkin KM, 2011, FOREST ECOL MANAG, V262, P845, DOI 10.1016/j.foreco.2011.05.018; Borkin KM, 2010, NEW ZEAL J ZOOL, V37, P35, DOI 10.1080/03014221003602190; Borkin Kerry M., 2009, New Zealand Journal of Forestry, V53, P38; Borkin KM, 2010, ECOLOGY NZ LONG TAIL; Brunet-Rossinni Anja K., 2009, P315; Chaverri G, 2007, J MAMMAL, V88, P477, DOI 10.1644/05-MAMM-A-260R2.1; Chaverri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028821; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; Cleugh HA, 2002, AUST J EXP AGR, V42, P665, DOI 10.1071/EA02004; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Crampton LH, 1996, BC MIN FOR RES PROGR, V23, P238; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Daniel S, 2008, CAN J ZOOL, V86, P623, DOI 10.1139/Z08-041; Dekrout A, 2009, MONITORING NZ LONG T; Field A., 2009, DISCOVERING STAT USI; Griffiths RW, 2007, NEW ZEAL J ZOOL, V34, P247, DOI 10.1080/03014220709510083; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hillen J, 2010, ACTA CHIROPTEROL, V12, P187, DOI 10.3161/150811010X504680; Jenkins RKB, 2007, ORYX, V41, P263, DOI 10.1017/S0030605307001883; Kalcounis-Ruppell MC, 2005, WILDLIFE SOC B, V33, P1123, DOI 10.2193/0091-7648(2005)33[1123:TRSBBA]2.0.CO;2; Kerth G, 2009, BIOL CONSERV, V142, P270, DOI 10.1016/j.biocon.2008.10.022; Law Bradley S., 1996, Pacific Conservation Biology, V2, P363; Lindenmayer DB, 2009, ANN NY ACAD SCI, V1162, P284, DOI 10.1111/j.1749-6632.2009.04148.x; Manly B.F.J., 2002, RESOURCE SELECTION A; Menzel MA, 2002, FOREST ECOL MANAG, V162, P209, DOI 10.1016/S0378-1127(01)00516-3; Miller DA, 2003, WILDLIFE SOC B, V31, P30; Mills LS, 1991, CANADIAN J ZOOLOGY, V69; Ministry of Agriculture and Fisheries, 2007, NAT EX FOR DESCR 1 A; N. S. Foundation, 2018, S BIG DAT INN HUB; NEU CW, 1974, J WILDLIFE MANAGE, V38, P541, DOI 10.2307/3800887; O'Donnell CFJ, 2010, NEW ZEAL J ZOOL, V37, P297, DOI 10.1080/03014223.2010.513395; O'Donnell CFJ, 2000, MAMMAL REV, V30, P89, DOI 10.1046/j.1365-2907.2000.00059.x; O'Donnell CFJ, 2000, ANIM CONSERV, V3, P287, DOI 10.1017/S1367943000001013; O'Donnell CFJ, 2001, J ZOOL, V253, P253, DOI 10.1017/S095283690100022X; O'Donnell CFJ, 2003, POWER DETECT TRENDS, V224, P224; ODONNELL CFJ, 2005, HDB NZ MAMMALS, P98; Owen SF, 2004, NORTH J APPL FOR, V21, P154, DOI 10.1093/njaf/21.3.154; Patriquin KJ, 2003, J APPL ECOL, V40, P646, DOI 10.1046/j.1365-2664.2003.00831.x; Pawson SM, 2008, BIODIVERS CONSERV, V17, P1127, DOI 10.1007/s10531-008-9363-y; Popa-Lisseanu AG, 2009, J ZOOL, V278, P126, DOI 10.1111/j.1469-7998.2009.00556.x; Pryde MA, 2005, BIOL CONSERV, V126, P175, DOI 10.1016/j.biocon.2005.05.006; Pryde MA, 2006, NEW ZEAL J ZOOL, V33, P85, DOI 10.1080/03014223.2006.9518433; Racey Paul A., 2009, P249; Rhodes M, 2007, J MAMMAL, V88, P1252, DOI 10.1644/06-MAMM-A-374R1.1; Rooney SM, 1998, MAMMAL REV, V28, P89, DOI 10.1046/j.1365-2907.1998.00028.x; Rothenwohrer C, 2011, J ZOOL, V283, P108, DOI 10.1111/j.1469-7998.2010.00748.x; Sedgeley JA, 1999, BIOL CONSERV, V88, P261, DOI 10.1016/S0006-3207(98)00069-X; Sedgeley JA, 2004, NEW ZEAL J ECOL, V28, P1; South Waikato Economic Development Trust South Waikato District Council, 2006, EC SPIR S WAIK DISTR; Watt, 1970, ANNU REV ECOL SYST, V1, P263	55	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86163	10.1371/journal.pone.0086163	http://dx.doi.org/10.1371/journal.pone.0086163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465938	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100119
J	de Boer, MN; Simmonds, MP; Reijnders, PJH; Aarts, G				de Boer, Marijke N.; Simmonds, Mark P.; Reijnders, Peter J. H.; Aarts, Geert			The Influence of Topographic and Dynamic Cyclic Variables on the Distribution of Small Cetaceans in a Shallow Coastal System	PLOS ONE			English	Article							PORPOISE PHOCOENA-PHOCOENA; WHALES BALAENOPTERA-ACUTOROSTRATA; HARBOR PORPOISE; HABITAT PREFERENCES; GRAMPUS-GRISEUS; SEASONAL DISTRIBUTION; RISSOS DOLPHINS; TIDAL CYCLE; FIN WHALES; WATERS	The influence of topographic and temporal variables on cetacean distribution at a fine-scale is still poorly understood. To study the spatial and temporal distribution of harbour porpoise Phocoena phocoena and the poorly known Risso's dolphin Grampus griseus we carried out land-based observations from Bardsey Island (Wales, UK) in summer (2001-2007). Using Kernel analysis and Generalized Additive Models it was shown that porpoises and Risso's appeared to be linked to topographic and dynamic cyclic variables with both species using different core areas (dolphins to the West and porpoises to the East off Bardsey). Depth, slope and aspect and a low variation in current speed (for Risso's) were important in explaining the patchy distributions for both species. The prime temporal conditions in these shallow coastal systems were related to the tidal cycle (Low Water Slack and the flood phase), lunar cycle (a few days following the neap tidal phase), diel cycle (afternoons) and seasonal cycle (peaking in August) but differed between species on a temporary but predictable basis. The measure of tidal stratification was shown to be important. Coastal waters generally show a stronger stratification particularly during neap tides upon which the phytoplankton biomass at the surface rises reaching its maximum about 2-3 days after neap tide. It appeared that porpoises occurred in those areas where stratification is maximised and Risso's preferred more mixed waters. This fine-scale study provided a temporal insight into spatial distribution of two species that single studies conducted over broader scales (tens or hundreds of kilometers) do not achieve. Understanding which topographic and cyclic variables drive the patchy distribution of porpoises and Risso's in a Headland/Island system may form the initial basis for identifying potentially critical habitats for these species.	[de Boer, Marijke N.; Reijnders, Peter J. H.; Aarts, Geert] Wageningen UR, Inst Marine Resources & Ecosyst Studies, Dept Ecosyst, Den Burg, Netherlands; [de Boer, Marijke N.; Reijnders, Peter J. H.; Aarts, Geert] Wageningen Univ, Dept Aquat Ecol Waterqual Management, NL-6700 AP Wageningen, Netherlands; [Simmonds, Mark P.] Whale & Dolphin Conservat, Dept Sci, Chippenham, Wilts, England	Wageningen University & Research; Wageningen University & Research	de Boer, MN (corresponding author), Wageningen UR, Inst Marine Resources & Ecosyst Studies, Dept Ecosyst, Den Burg, Netherlands.	marijke.deboer@wur.nl		reijnders, peter/0000-0002-3783-8283	BBC Wildlife Fund; Countryside Council for Wales; NWO-ZKO grant Effects of underwater noise on fish and marine mammals in the North Sea	BBC Wildlife Fund; Countryside Council for Wales; NWO-ZKO grant Effects of underwater noise on fish and marine mammals in the North Sea	This work is funded by the BBC Wildlife Fund and the Countryside Council for Wales. G. Aarts is funded by the NWO-ZKO grant Effects of underwater noise on fish and marine mammals in the North Sea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2012, METHODS ECOL EVOL, V3, P177, DOI 10.1111/j.2041-210X.2011.00141.x; Atkinson T, 1996, RISSOS DOLPHINS GRAM; Bailey H, 2010, MAR ECOL PROG SER, V418, P223, DOI 10.3354/meps08789; Bearzi G, 2010, MAMM BIOL, DOI [10.1016/j.mambio.2010.06.003, DOI 10.1016/j.mambio.2010.06.003]; Booth CG, 2013, MAR ECOL PROG SER, V478, P273, DOI 10.3354/meps10239; BOYLE PR, 1986, J MAR BIOL ASSOC UK, V66, P855, DOI 10.1017/S0025315400048487; Buckland S.T., 2001, pi; Calderan S.V., 2003, THESIS U WALES BANGO; Canadas A, 2002, DEEP-SEA RES PT I, V49, P2053, DOI 10.1016/S0967-0637(02)00123-1; Chenoweth EM, 2011, MAR ECOL PROG SER, V423, P279, DOI 10.3354/meps08891; CLARKE MR, 1985, J MAR BIOL ASSOC UK, V65, P663, DOI 10.1017/S0025315400052504; de Boer Marijke, 2002, British Wildlife, V13, P246; de Boer Marijke N., 2013, Open Journal of Marine Science, V3, P66; Dohl TP, 1981, CETACEA SO CALIFOR 2; Elliott A, 1995, HYDROGRAPHIC J, V78, P13; Embling CB, 2007, THESIS U ST ANDREWS; Embling CB, 2012, J APPL ECOL, V49, P481, DOI 10.1111/j.1365-2664.2012.02114.x; Embling CB, 2010, BIOL CONSERV, V143, P267, DOI 10.1016/j.biocon.2009.09.005; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Evans PGH, 2003, UK CETACEAN STATUS R; Fithian W, ANN APPL ST IN PRESS; Fury CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052987; GASKIN DE, 1985, FISH B-NOAA, V83, P427; Gill A, 1997, EUROPEAN RES CETACEA, V11, P109; Gilles Anita, 2011, Endangered Species Research, V14, P157, DOI 10.3354/esr00344; Hall, 2011, THESIS U BRIT COLUMB; Hammond PS, 2013, BIOL CONSERV, V164, P107, DOI 10.1016/j.biocon.2013.04.010; Hastie GD, 2005, ICES J MAR SCI, V62, P760, DOI 10.1016/j.icesjms.2005.02.004; Hope Jones P, 1990, REPORT BARDSEY BIRD, V33, P57; Horne JS, 2006, J WILDLIFE MANAGE, V70, P641, DOI 10.2193/0022-541X(2006)70[641:LCVLSC]2.0.CO;2; Hoyt E., 2011, MARINE PROTECTED ARE; Isojunno S, 2012, MAR ECOL PROG SER, V448, P155, DOI 10.3354/meps09415; Jefferson TA, 2014, MAMMAL REV, V44, P56, DOI 10.1111/mam.12008; Johnston DW, 2005, MAR ECOL PROG SER, V305, P287, DOI 10.3354/meps305287; Johnston DW, 2005, MAR ECOL PROG SER, V295, P279, DOI 10.3354/meps295279; Jones AR, 2012, THESIS U SOUTHAMPTON; Kruse S., 1999, HDB MARINE MAMMALS, P183; MacLeod CD, 2014, HYDROBIOLOGIA, V725, P125, DOI 10.1007/s10750-013-1555-0; MacLeod CD, 2005, MAR BIOL, V147, P1, DOI 10.1007/s00227-004-1546-9; MacLeod CD, 2007, J MAR BIOL ASSOC UK, V87, P157, DOI 10.1017/S0025315407055270; Macleod K, 2004, MAR ECOL PROG SER, V277, P263, DOI 10.3354/meps277263; Mann KH, 1996, DYNAMICS MARINE ECOS, P480, DOI 10.2307/2960585; Marubini F, 2009, MAR ECOL PROG SER, V381, P297, DOI 10.3354/meps07893; Matthiopoulos J, 2003, OIKOS, V102, P367, DOI 10.1034/j.1600-0706.2003.12528.x; Matthiopoulos Jason, 2010, P68; Mendes S, 2002, MAR ECOL PROG SER, V239, P221, DOI 10.3354/meps239221; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Neill SP, 2008, ESTUAR COAST SHELF S, V79, P419, DOI 10.1016/j.ecss.2008.04.015; Neill SP, 2007, CONT SHELF RES, V27, P82, DOI 10.1016/j.csr.2006.09.002; NORTHRIDGE SP, 1995, ICES J MAR SCI, V52, P55, DOI 10.1016/1054-3139(95)80015-8; Panigada S, 2008, REMOTE SENS ENVIRON, V112, P3400, DOI 10.1016/j.rse.2007.11.017; Pereira Jose Nuno D. S. G., 2008, Aquatic Mammals, V34, P426, DOI 10.1578/AM.34.4.2008.426; Pierpoint C, 2008, J MAR BIOL ASSOC UK, V88, P1167, DOI 10.1017/S0025315408000507; PINGREE RD, 1978, J GEOPHYS RES-OCEANS, V83, P4615, DOI 10.1029/JC083iC09p04615; Powell RA, 2000, METH C CONS, P65; PRACA E, 2007, OCEAN SCI, V0004, P00785, DOI DOI 10.5194/0SD-4-785-2007; Redfern JV, 2008, MAR ECOL PROG SER, V363, P1, DOI 10.3354/meps07495; Reid J.B., 2003, ATLAS CETACEAN DISTR; Santos MB, 2004, MAR MAMMAL SCI, V20, P1, DOI 10.1111/j.1748-7692.2004.tb01138.x; Scott BE, 2010, MAR ECOL PROG SER, V408, P207, DOI 10.3354/meps08552; SHANE SH, 1995, MAR ECOL PROG SER, V123, P5, DOI 10.3354/meps123005; Sharples J, 2008, J PLANKTON RES, V30, P183, DOI 10.1093/plankt/fbm088; Siebert U, 2006, J SEA RES, V56, P65, DOI 10.1016/j.seares.2006.01.003; Silverman B.W., 1986, DENSITY ESTIMATION S; Simard Y, 2002, CAN J FISH AQUAT SCI, V59, P197, DOI 10.1139/f01-210; Simmonds MP, 2010, WILDLIFE RES, V37, P688, DOI 10.1071/WR10020; SIMPSON JH, 1974, NATURE, V250, P404, DOI 10.1038/250404a0; SIMPSON JH, 1981, DEEP-SEA RES, V28, P727, DOI 10.1016/0198-0149(81)90132-1; Skov H, 2008, MAR ECOL PROG SER, V373, P173, DOI 10.3354/meps07666; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Sveegaard S, 2012, MAR ECOL PROG SER, V468, P245, DOI 10.3354/meps09959; Sveegaard S, 2012, MAR BIOL, V159, P1029, DOI 10.1007/s00227-012-1883-z; Sveegaard S, 2011, ICES J MAR SCI, V68, P929, DOI 10.1093/icesjms/fsr025; Trimmer M, 2003, ESTUAR COAST SHELF S, V56, P1011, DOI 10.1016/S0272-7714(02)00312-8; Verfuss UK, 2007, J MAR BIOL ASSOC UK, V87, P165, DOI 10.1017/S0025315407054938; Visser F, 2011, MAR MAMMAL SCI, V27, P366, DOI 10.1111/j.1748-7692.2010.00398.x; Warton DI, 2010, ANN APPL STAT, V4, P1383, DOI 10.1214/10-AOAS331; Weir CR, 2001, CONT SHELF RES, V21, P1047, DOI 10.1016/S0278-4343(00)00124-2; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zamon JE, 2003, MAR ECOL PROG SER, V261, P243, DOI 10.3354/meps261243	80	20	20	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86331	10.1371/journal.pone.0086331	http://dx.doi.org/10.1371/journal.pone.0086331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466031	Green Published, gold			2022-12-25	WOS:000330283100140
J	Hamilton, CD; Lydersen, C; Ims, RA; Kovacs, KM				Hamilton, Charmain D.; Lydersen, Christian; Ims, Rolf A.; Kovacs, Kit M.			Haul-Out Behaviour of the World's Northernmost Population of Harbour Seals (Phoca vitulina) throughout the Year	PLOS ONE			English	Article							PRINS KARLS FORLAND; SAN-MIGUEL-ISLAND; DIVING BEHAVIOR; COMMON SEALS; MATERNAL INVESTMENT; HALICHOERUS-GRYPUS; MARINE MAMMALS; SITE FIDELITY; SVALBARD; PATTERNS	The harbour seal population in Svalbard occurs at the northernmost limit of the species' range. It experiences environmental extremes far beyond the norm for this species, including an extended period of polar night and extensive sea ice cover. In 2009 and 2010, 60 harbour seals (30 pups + 30 immature/mature seals) from this population were equipped with Satellite-Relay Data Loggers (SRDLs) to study their haul-out behaviour, with a special focus on the winter period. Using a combination of Generalized Additive Mixed Models and Cox Proportional Hazard models, the influences of sex, maturity, temporal, spatial and environmental factors on haul-out behaviour were explored. All of the seals continued to haul out even through the coldest periods during the polar night, though clear seasonality in the time spent hauled out daily was displayed by both immature and mature seals. Time spent hauled out daily decreased from similar to 5.2 hrs in September to similar to 1.2 hrs in February in these age groups, while pups displayed less seasonality (similar to 2.4 hrs/day throughout most of the year). The average at-sea period also exhibited seasonality, increasing to a maximum of similar to 1.6 days in February (monthly maxima for individual animals ranged from 7 to 19 days). The seals showed a strong preference to haul out at low tide when hauling out on land but not when using sea ice as a haul-out platform. A diel rhythm in haul-out behaviour was present during the months with day-night cycling and midnight sun but not during the polar night. Haul-out behaviour was impacted to a greater extent by air pressure, through its effect on wind speed, than by absolute temperature values. The extreme environment in Svalbard likely causes some physiological challenges that might impact survival rates negatively, particularly among pups. Climate warming is likely to have positive effects on Svalbard's harbour seal population.	[Hamilton, Charmain D.; Lydersen, Christian; Kovacs, Kit M.] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Hamilton, Charmain D.; Ims, Rolf A.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway	Norwegian Polar Institute; UiT The Arctic University of Tromso	Hamilton, CD (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	charmain.hamilton@npolar.no			Norwegian Research Council [184644]; Norwegian Polar Institute	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Polar Institute	This research was funded by the Norwegian Research Council (Sea and Coastal Programme, grant no 184644; http://www.forskningsradet.no/) and the Norwegian Polar Institute (http://www.npolar.no/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen LW, 2011, BIOL J LINN SOC, V102, P420, DOI 10.1111/j.1095-8312.2010.01577.x; Andrews-Goff Virginia, 2010, Endangered Species Research, V10, P83, DOI 10.3354/esr00257; Bajzak CE, 2013, POLAR BIOL, V36, P477, DOI 10.1007/s00300-012-1274-4; Barry R. G., 1992, ATMOSPHERE WEATHER C; BARTHOLOMEW GA, 1970, EVOLUTION, V24, P546, DOI 10.1111/j.1558-5646.1970.tb01790.x; Barton K., 2013, MUMIN MULTIMODAL INF; Bernt KE, 1996, MAR MAMMAL SCI, V12, P476, DOI 10.1111/j.1748-7692.1996.tb00602.x; Bigg MA, 1969, B FISH RES BD CAN, V172; Bjorge A, 2002, MAR MAMMAL SCI, V18, P963, DOI 10.1111/j.1748-7692.2002.tb01085.x; Bjorge A, 1995, DEV MAR BIO, V4, P211; Blix AS, 2007, POLAR BIOL, V30, P1449, DOI 10.1007/s00300-007-0306-y; Blundell GM, 2011, MAR ECOL PROG SER, V429, P277, DOI 10.3354/meps09073; Boulva J, 1979, B FISH RES BD CAN, V200; Boveng PL, 2003, MAR MAMMAL SCI, V19, P111, DOI 10.1111/j.1748-7692.2003.tb01096.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CALAMBOKIDIS J, 1987, CAN J ZOOL, V65, P1391, DOI 10.1139/z87-219; Canty A, 2012, BOOT BOOTSTRAP R S P; CLS (Collecte Localisation Satellites), 2011, COLLECTE LOCALISATIO; COX DR, 1972, J R STAT SOC B, V34, P187; Cronin M. A., 2010, Endangered Species Research, V10, P255, DOI 10.3354/esr00170; Cunningham L, 2009, AQUAT CONSERV, V19, P398, DOI 10.1002/aqc.983; Drescher HE, 1980, CAN TRANSL FISH AQUA, V4635, P1; Fedak M, 2002, INTEGR COMP BIOL, V42, P3, DOI 10.1093/icb/42.1.3; FELTZ ET, 1966, CRYOBIOLOGY, V3, P261, DOI 10.1016/S0011-2240(66)80020-2; Folkow LP, 2010, POLAR BIOL, V33, P433, DOI 10.1007/s00300-009-0718-y; Fox J, 2011, COX PROPORTIONAL HAZ; Gales NJ, 2009, MAR MAMMAL SCI, V25, P725, DOI 10.1111/j.1748-7692.2008.00279.x; Gerland S, 2006, ANN GLACIOL-SER, V44, P231, DOI 10.3189/172756406781811367; Gjertz I, 2001, POLAR BIOL, V24, P209, DOI 10.1007/s003000000197; GODSELL J, 1988, J ZOOL, V215, P83, DOI 10.1111/j.1469-7998.1988.tb04886.x; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HANSEN S, 1995, PHYSIOL ZOOL, V68, P290, DOI 10.1086/physzool.68.2.30166505; Hansen S, 1997, PHYSIOL ZOOL, V70, P85, DOI 10.1086/639549; Hastings KK, 2012, J MAMMAL, V93, P1368, DOI 10.1644/11-MAMM-A-291.1; Hastings KK, 2004, CAN J ZOOL, V82, P1755, DOI 10.1139/Z04-145; Henriksen G, 1997, MAR MAMMAL SCI, V13, P157, DOI 10.1111/j.1748-7692.1997.tb00622.x; Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753; Ingvaldsen R, 2009, ECOSYSTEM BARENTS SE, P33; IRVING LAURENCE, 1957, CANADIAN JOUR ZOOL, V35, P497, DOI 10.1139/z57-041; Jorgensen C, 2001, J EXP BIOL, V204, P3993; Kovacs Kit M., 2008, Science Progress, V91, P117, DOI 10.3184/003685008X324010; KOVACS KM, 1992, CAN J ZOOL, V70, P1953, DOI 10.1139/z92-265; KOVACS KM, 1986, J ANIM ECOL, V55, P1035, DOI 10.2307/4432; Krafft BA, 2002, POLAR BIOL, V25, P230, DOI 10.1007/s00300-001-0330-2; Leclerc LME, 2012, POLAR BIOL, V35, P1197, DOI 10.1007/s00300-012-1166-7; Lesage W, 2004, CAN J ZOOL, V82, P1070, DOI 10.1139/Z04-084; LING JK, 1970, Q REV BIOL, V45, P16, DOI 10.1086/406361; London JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038180; Lydersen C, 2005, POLAR BIOL, V28, P156, DOI 10.1007/s00300-004-0656-7; Lydersen C, 2006, NAMMCO SCI PUBL, V8, P47; MANSFIELD AW, 1967, J MAMMAL, V48, P249, DOI 10.2307/1378028; MCCONNELL BJ, 1992, J ZOOL, V226, P271, DOI 10.1111/j.1469-7998.1992.tb03839.x; McIlveen R, 1992, FUNDAMENTALS WEATHER; MCLAREN IA, 1993, BIOL REV, V68, P1, DOI 10.1111/j.1469-185X.1993.tb00731.x; Merkel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067576; MILLER K, 1975, AM J PHYSIOL, V229, P506, DOI 10.1152/ajplegacy.1975.229.2.506; OIEN N, 1988, Rit Fiskideildar, V11, P65; PITCHER KW, 1986, J WILDLIFE MANAGE, V50, P463, DOI 10.2307/3801106; PRESTRUD P, 1990, MAR MAMMAL SCI, V6, P215, DOI 10.1111/j.1748-7692.1990.tb00245.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Reder S, 2003, POLAR BIOL, V27, P6, DOI 10.1007/s00300-003-0557-1; Reierth E, 1998, CAN J ZOOL, V76, P2031, DOI 10.1139/cjz-76-11-2031; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Roen R, 1995, DEV MAR BIO, V4, P61; SCHEFFER VB, 1967, J MAMMAL, V48, P459; Sharples RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037216; Sharples RJ, 2009, MAR ECOL PROG SER, V378, P289, DOI 10.3354/meps07827; Simpkins MA, 2003, MAR MAMMAL SCI, V19, P791, DOI 10.1111/j.1748-7692.2003.tb01130.x; STEWART BS, 1984, J WILDLIFE MANAGE, V48, P1459, DOI 10.2307/3801821; Therneau T.M., 2012, PACKAGE SURVIVAL ANA; Therneau TM, 2000, MODELING SURVIVAL DA; THOMPSON P, 1987, J ZOOL, V212, P597, DOI 10.1111/j.1469-7998.1987.tb05958.x; Thompson Paul M., 1993, Symposia of the Zoological Society of London, V66, P225; THOMPSON PM, 1991, J ANIM ECOL, V60, P283, DOI 10.2307/5460; THOMPSON PM, 1989, J APPL ECOL, V26, P521, DOI 10.2307/2404078; van Oort BEH, 2005, NATURE, V438, P1095, DOI 10.1038/4381095a; Van Parijs SM, 2000, CAN J ZOOL, V78, P2209, DOI 10.1139/cjz-78-12-2209; Vincent Cecile, 2010, NAMMCO Scientific Publications, V8, P285; VINJE T, 1991, POLAR RES, V10, P59, DOI 10.1111/j.1751-8369.1991.tb00635.x; WADHAMS P, 1981, REV GEOPHYS, V19, P345, DOI 10.1029/RG019i003p00345; WATTS P, 1993, J THEOR BIOL, V163, P505, DOI 10.1006/jtbi.1993.1135; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; WIIG O, 1989, MAR MAMMAL SCI, V5, P149, DOI 10.1111/j.1748-7692.1989.tb00329.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood S, 2012, GAMM4 GEN ADDITIVE M; YOCHEM PK, 1987, MAR MAMMAL SCI, V3, P323, DOI 10.1111/j.1748-7692.1987.tb00319.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	88	18	18	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86055	10.1371/journal.pone.0086055	http://dx.doi.org/10.1371/journal.pone.0086055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465867	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100100
J	Pereira, NL; Redfield, MM; Scott, C; Tosakulwong, N; Olson, TM; Bailey, KR; Rodeheffer, RJ; Burnett, JC				Pereira, Naveen L.; Redfield, Margaret M.; Scott, Christopher; Tosakulwong, Nirubol; Olson, Timothy M.; Bailey, Kent R.; Rodeheffer, Richard J.; Burnett, John C., Jr.			A Functional Genetic Variant (N521D) in Natriuretic Peptide Receptor 3 Is Associated with Diastolic Dysfunction: The Prevalence of Asymptomatic Ventricular Dysfunction Study	PLOS ONE			English	Article							BLOOD-PRESSURE; HEART-FAILURE; GENERAL COMMUNITY; HYPERTENSION; POPULATION; ECHOCARDIOGRAPHY; HYPERTROPHY; ACTIVATION; SYSTEM; IMPACT	Objectives: To evaluate the impact of a functional genetic variant in the natriuretic peptide clearance receptor, NPR3, on circulating natriuretic peptides (NPs) and myocardial structure and function in the general community. Background: NPR3 plays an important role in the clearance of NPs and through direct signaling mechanisms modulates smooth muscle cell function and cardiac fibroblast proliferation. A NPR3 nonsynonymous single nucleotide polymorphism (SNP) rs2270915, resulting in a N521D substitution in the intracellular catalytic domain that interacts with Gi could affect receptor function. Whether this SNP is associated with alterations in NPs levels and altered cardiac structure and function is unknown. Methods: DNA samples of 1931 randomly selected residents of Olmsted County, Minnesota were genotyped. Plasma NT-proANP(1-98), ANP(1-28), proBNP(1-108), NT-proBNP(1-76), BNP1-32 and BNP3-32 levels were measured. All subjects underwent comprehensive echocardiography. Results: Genotype frequencies for rs2270915 were as follows: (A/A 60%, A/G 36%, G/G 4%). All analyses performed were for homozygotes G/G versus wild type A/A plus the heterozygotes A/G. Diastolic dysfunction was significantly more common (p = 0.007) in the homozygotes G/G (43%) than the A/A+A/G (28%) group. Multivariate regression adjusted for age, sex, body mass index and hypertension demonstrated rs2270915 to be independently associated with diastolic dysfunction (odds ratio 1.94, p = 0.03). There was no significant difference in NPs levels between the 2 groups suggesting that the clearance function of the receptor was not affected. Conclusions: A nonsynonymous NPR3 SNP is independently associated with diastolic dysfunction and this association does not appear to be related to alterations in circulating levels of natriuretic peptides.	[Pereira, Naveen L.; Redfield, Margaret M.; Olson, Timothy M.; Rodeheffer, Richard J.; Burnett, John C., Jr.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Pereira, Naveen L.; Redfield, Margaret M.; Olson, Timothy M.; Rodeheffer, Richard J.; Burnett, John C., Jr.] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Scott, Christopher; Bailey, Kent R.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA; [Tosakulwong, Nirubol] Mayo Clin, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Pereira, NL (corresponding author), Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA.	pereira.naveen@mayo.edu		Olson, Timothy/0000-0003-2716-9423	CTSA from the National Center for Advancing Translational Sciences [UL1 TR000135]; Pharmacogenomics Research Network [U19 GM61388];  [RO1 HL36634];  [PO1 HL76611]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036634, U10HL110262, P01HL076611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061388] Funding Source: NIH RePORTER	CTSA from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Pharmacogenomics Research Network; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was made possible by CTSA Grant Number UL1 TR000135 (NLP) from the National Center for Advancing Translational Sciences, U19 GM61388 (The Pharmacogenomics Research Network) and RO1 HL36634 (JCB) and PO1 HL76611 (JCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURNETT JC, 1986, SCIENCE, V231, P1145, DOI 10.1126/science.2935937; Cannone V, 2011, J AM COLL CARDIOL, V58, P629, DOI 10.1016/j.jacc.2011.05.011; Cataliotti A, 2005, CIRCULATION, V112, P836, DOI 10.1161/CIRCULATIONAHA.105.538520; Charles CJ, 1996, AM J PHYSIOL-REG I, V271, pR373, DOI 10.1152/ajpregu.1996.271.2.R373; Chauhan SD, 2003, P NATL ACAD SCI USA, V100, P1426, DOI 10.1073/pnas.0336365100; Cheung BMY, 1997, CLIN EXP PHARMACOL P, V24, P966, DOI 10.1111/j.1440-1681.1997.tb02729.x; Costello-Boerrigter LC, 2006, J AM COLL CARDIOL, V47, P345, DOI 10.1016/j.jacc.2005.09.025; Giuliani I, 2006, CLIN CHEM, V52, P1054, DOI 10.1373/clinchem.2005.061770; Hashim S, 2006, AM J PHYSIOL-HEART C, V291, pH3144, DOI 10.1152/ajpheart.00327.2006; Huntley BK, 2006, J CELL PHYSIOL, V209, P943, DOI 10.1002/jcp.20793; KOHNO M, 1992, AM J MED, V92, P29, DOI 10.1016/0002-9343(92)90011-Y; LEVY D, 1987, AM J CARDIOL, V59, P956, DOI 10.1016/0002-9149(87)91133-7; Liu Y, 2012, CLIN EXP HYPERTENS, V34, P504, DOI 10.3109/10641963.2012.681719; Lynch AI, 2008, JAMA-J AM MED ASSOC, V299, P296, DOI 10.1001/jama.299.3.296; Macheret F, 2012, J AM COLL CARDIOL, V60, P1558, DOI 10.1016/j.jacc.2012.05.049; Maisel AS, 2001, AM HEART J, V141, P367, DOI 10.1067/mhj.2001.113215; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; McKie PM, 2010, J AM COLL CARDIOL, V55, P2140, DOI 10.1016/j.jacc.2010.01.031; Mouawad R, 2004, MOL PHARMACOL, V65, P917, DOI 10.1124/mol.65.4.917; Munagala VK, 2004, CURR PROB CARDIOLOGY, V29, P707, DOI 10.1016/j.cpcardiol.2004.07.002; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Pereira NL, 2013, CIRC-CARDIOVASC GENE, V6, P201, DOI 10.1161/CIRCGENETICS.112.964742; Pereira NL, 2010, J MOL CELL CARDIOL, V49, P864, DOI 10.1016/j.yjmcc.2010.07.020; Prins B A, 1996, Curr Opin Nephrol Hypertens, V5, P170, DOI 10.1097/00041552-199603000-00013; Pritchett AM, 2003, J AM COLL CARDIOL, V41, P1036, DOI 10.1016/S0735-1097(02)02981-9; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Sangaralingham SJ, 2011, HYPERTENSION, V57, P201, DOI 10.1161/HYPERTENSIONAHA.110.160796; Sarzani R, 1999, J HYPERTENS, V17, P1301, DOI 10.1097/00004872-199917090-00010; Saulnier PJ, 2011, DIABETES CARE, V34, P1199, DOI 10.2337/dc10-2057; SHUB C, 1994, MAYO CLIN PROC, V69, P205, DOI 10.1016/S0025-6196(12)61058-1; Yamamoto K, 1997, AM J PHYSIOL-HEART C, V273, pH2406, DOI 10.1152/ajpheart.1997.273.5.H2406	33	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85708	10.1371/journal.pone.0085708	http://dx.doi.org/10.1371/journal.pone.0085708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465655	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100063
J	Sharma, M; Singh, SB; Sarkar, S				Sharma, Manish; Singh, Shashi Bala; Sarkar, Soma			Genome Wide Expression Analysis Suggests Perturbation of Vascular Homeostasis during High Altitude Pulmonary Edema	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; EXHALED NITRIC-OXIDE; GENE-EXPRESSION; STRESS FAILURE; BRONCHOALVEOLAR LAVAGE; MODERATE ALTITUDE; RECEPTOR; LUNG; RATS; HYPERTENSION	Background: High altitude pulmonary edema (HAPE) is a life-threatening form of non-cardiogenic edema which occurs in unacclimatized but otherwise normal individuals within two to four days after rapid ascent to altitude beyond 3000 m. The precise pathoetiology and inciting mechanisms regulating HAPE remain unclear. Methodology/Principle findings: We performed global gene expression profiling in individuals with established HAPE compared to acclimatized individuals. Our data suggests concurrent modulation of multiple pathways which regulate vascular homeostasis and consequently lung fluid dynamics. These pathways included those which regulate vasoconstriction through smooth muscle contraction, cellular actin cytoskeleton rearrangements and endothelial permeability/dysfunction. Some notable genes within these pathways included MYLK; rho family members ARGEF11, ARHGAP24; cell adhesion molecules such as CLDN6, CLDN23, PXN and VCAM1 besides other signaling intermediates. Further, several important regulators of systemic/pulmonary hypertension including ADRA1D, ECE1, and EDNRA were upregulated in HAPE. We also observed significant upregulation of genes involved in paracrine signaling through chemokines and lymphocyte activation pathways during HAPE represented by transcripts of TNF, JAK2, MAP2K2, MAP2K7, MAPK10, PLCB1, ARAF, SOS1, PAK3 and RELA amongst others. Perturbation of such pathways can potentially skew vascular homeostatic equilibrium towards altered vascular permeability. Additionally, differential regulation of hypoxia-sensing, hypoxia-response and OXPHOS pathway genes in individuals with HAPE were also observed. Conclusions/Significance: Our data reveals specific components of the complex molecular circuitry underlying HAPE. We show concurrent perturbation of multiple pathways regulating vascular homeostasis and suggest multi-genic nature of regulation of HAPE.	[Sharma, Manish; Singh, Shashi Bala; Sarkar, Soma] DRDO, Def Inst Physiol & Allied Sci DIPAS, Div Mol Biol, Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Sarkar, S (corresponding author), DRDO, Def Inst Physiol & Allied Sci DIPAS, Div Mol Biol, Delhi, India.	soma_sarkar2000@yahoo.com	Singh, Shashi Bala/AAS-9889-2021		Defence Research and Development Organization, India [ST-PI-05/DIP-247]	Defence Research and Development Organization, India(Defence Research & Development Organisation (DRDO))	Defence Research and Development Organization, India financially supported under the institutional project: Grant No. ST-PI-05/DIP-247 to Soma Sarkar. The funding agency had no role in study design, data collection, analysis, decision to publish or preparation of manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bartsch P, 2005, J APPL PHYSIOL, V98, P1101, DOI 10.1152/japplphysiol.01167.2004; BARTSCH P, 1991, NEW ENGL J MED, V325, P1284, DOI 10.1056/NEJM199110313251805; Bartsch P, 1997, RESPIRATION, V64, P435; Bartsch P, 1999, MED SCI SPORT EXER, V31, pS23; BONVALLET ST, 1994, AM J PHYSIOL, V266, pH1327, DOI 10.1152/ajpheart.1994.266.4.H1327; Busch T, 2001, AM J RESP CRIT CARE, V163, P368, DOI 10.1164/ajrccm.163.2.2001134; Carpenter TC, 2000, AM J PHYSIOL-LUNG C, V279, pL547, DOI 10.1152/ajplung.2000.279.3.L547; Charu R, 2006, THORAX, V61, P1011, DOI 10.1136/thx.2006.066019; Chen SJ, 1997, J CARDIOVASC PHARM, V29, P713, DOI 10.1097/00005344-199706000-00003; Dehnert C, 2006, AM J RESP CRIT CARE, V174, P1132, DOI 10.1164/rccm.200606-780OC; Duplain H, 2000, AM J RESP CRIT CARE, V162, P221, DOI 10.1164/ajrccm.162.1.9908039; Durmowicz AG, 1997, J PEDIATR-US, V130, P838, DOI 10.1016/S0022-3476(97)80033-9; Faber JE, 2006, AM J PHYSIOL-HEART C, V291, pH2272, DOI 10.1152/ajpheart.00404.2006; Gabri AL, 2003, CHEST, V123, P49, DOI 10.1378/chest.123.1.49; Ganfornina MD, 2005, J PHYSIOL-LONDON, V566, P491, DOI 10.1113/jphysiol.2005.088815; GRISSOM C, 2006, RESP EMERGENCIES, P253; Grocott M, 2008, HIGH ALT MED BIOL, V9, P123, DOI 10.1089/ham.2008.1012; Grunig E, 2000, CIRCULATION, V102, P1145, DOI 10.1161/01.CIR.102.10.1145; Hackett P, 2002, JAMA-J AM MED ASSOC, V287, P2275, DOI 10.1001/jama.287.17.2275; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hopkins SR, 2010, EUR RESPIR J, V35, P470, DOI 10.1183/09031936.00178709; Hopkins SR, 2005, AM J RESP CRIT CARE, V171, P83, DOI 10.1164/rccm.200406-707OC; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ji Y, 2007, P NATL ACAD SCI USA, V104, P8839, DOI 10.1073/pnas.0611416104; Katoh M, 2004, INT J MOL MED, V14, P333; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kubo K, 1998, RESP PHYSIOL, V111, P301, DOI 10.1016/S0034-5687(98)00006-1; Kubo K, 1996, THORAX, V51, P739, DOI 10.1136/thx.51.7.739; LI H, 1994, AM J PHYSIOL, V266, pL553, DOI 10.1152/ajplung.1994.266.5.L553; Maggiorini M, 2001, CIRCULATION, V103, P2078; Pandey R, 2004, BIOINFORMATICS, V20, P2156, DOI 10.1093/bioinformatics/bth215; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ran Yu-Hua, 2011, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V27, P201; Ricci A, 1999, HYPERTENSION, V33, P708, DOI 10.1161/01.HYP.33.2.708; Sarkar S, 2012, IND J AEROSPACE MED, V56, P1; Sartori C, 1999, CIRCULATION, V99, P2665, DOI 10.1161/01.CIR.99.20.2665; Sartori C, 2010, PROG CARDIOVASC DIS, V52, P493, DOI 10.1016/j.pcad.2010.02.005; SCHMITZ JM, 1981, J PHARMACOL EXP THER, V219, P400; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; SCHOENE RB, 1988, J APPL PHYSIOL, V64, P2605, DOI 10.1152/jappl.1988.64.6.2605; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Shimoda LA, 2002, RESP PHYSIOL NEUROBI, V132, P93, DOI 10.1016/S1569-9048(02)00052-6; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Srivastava S, 2011, J RENIN-ANGIO-ALDO S, V13, P155; Stream JO, 2008, WILD ENVIRON MED, V19, P293, DOI 10.1580/07-WEME-REV-173.1; Swenson ER, 2002, JAMA-J AM MED ASSOC, V287, P2228, DOI 10.1001/jama.287.17.2228; Vernon SD, 2002, DIS MARKERS, V18, P193, DOI 10.1155/2002/892374; West JB, 2000, J APPL PHYSIOL, V89, P2483, DOI 10.1152/jappl.2000.89.6.2483; WEST JB, 1995, EUR RESPIR J, V8, P523; WEST JB, 1992, INT J SPORTS MED, V13, pS54, DOI 10.1055/s-2007-1024594; WHAYNE TF, 1968, J APPL PHYSIOL, V25, P729, DOI 10.1152/jappl.1968.25.6.729; WOODMAN OL, 1987, AM J PHYSIOL, V253, pH388, DOI 10.1152/ajpheart.1987.253.2.H388; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; ZHAO Y, 1993, AM J PHYSIOL, V265, pL87	55	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85902	10.1371/journal.pone.0085902	http://dx.doi.org/10.1371/journal.pone.0085902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465776	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100088
J	Tosser-Klopp, G; Bardou, P; Bouchez, O; Cabau, C; Crooijmans, R; Dong, Y; Donnadieu-Tonon, C; Eggen, A; Heuven, HCM; Jamli, S; Jiken, AJ; Klopp, C; Lawley, CT; McEwan, J; Martin, P; Moreno, CR; Mulsant, P; Nabihoudine, I; Pailhoux, E; Palhiere, I; Rupp, R; Sarry, J; Sayre, BL; Tircazes, A; Wang, J; Wang, W; Zhang, WG				Tosser-Klopp, Gwenola; Bardou, Philippe; Bouchez, Olivier; Cabau, Cedric; Crooijmans, Richard; Dong, Yang; Donnadieu-Tonon, Cecile; Eggen, Andre; Heuven, Henri C. M.; Jamli, Saadiah; Jiken, Abdullah Johari; Klopp, Christophe; Lawley, Cynthia T.; McEwan, John; Martin, Patrice; Moreno, Carole R.; Mulsant, Philippe; Nabihoudine, Ibouniyamine; Pailhoux, Eric; Palhiere, Isabelle; Rupp, Rachel; Sarry, Julien; Sayre, Brian L.; Tircazes, Aurelie; Wang, Jun; Wang, Wen; Zhang, Wenguang		Int Goat Genome Consortium	Design and Characterization of a 52K SNP Chip for Goats	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CLASSICAL SCRAPIE; GENOTYPING ASSAY; CAPRA-HIRCUS; PRP GENE; GENOME; ASSOCIATION; POLLEDNESS; GENERATION; DISCOVERY	The success of Genome Wide Association Studies in the discovery of sequence variation linked to complex traits in humans has increased interest in high throughput SNP genotyping assays in livestock species. Primary goals are QTL detection and genomic selection. The purpose here was design of a 50-60,000 SNP chip for goats. The success of a moderate density SNP assay depends on reliable bioinformatic SNP detection procedures, the technological success rate of the SNP design, even spacing of SNPs on the genome and selection of Minor Allele Frequencies (MAF) suitable to use in diverse breeds. Through the federation of three SNP discovery projects consolidated as the International Goat Genome Consortium, we have identified approximately twelve million high quality SNP variants in the goat genome stored in a database together with their biological and technical characteristics. These SNPs were identified within and between six breeds (meat, milk and mixed): Alpine, Boer, Creole, Katjang, Saanen and Savanna, comprising a total of 97 animals. Whole genome and Reduced Representation Library sequences were aligned on >10 kb scaffolds of the de novo goat genome assembly. The 60,000 selected SNPs, evenly spaced on the goat genome, were submitted for oligo manufacturing (Illumina, Inc) and published in dbSNP along with flanking sequences and map position on goat assemblies (i.e. scaffolds and pseudo-chromosomes), sheep genome V2 and cattle UMD3.1 assembly. Ten breeds were then used to validate the SNP content and 52,295 loci could be successfully genotyped and used to generate a final cluster file. The combined strategy of using mainly whole genome Next Generation Sequencing and mapping on a contig genome assembly, complemented with Illumina design tools proved to be efficient in producing this GoatSNP50 chip. Advances in use of molecular markers are expected to accelerate goat genomic studies in coming years.	[Tosser-Klopp, Gwenola; Bardou, Philippe; Bouchez, Olivier; Cabau, Cedric; Donnadieu-Tonon, Cecile; Mulsant, Philippe; Nabihoudine, Ibouniyamine; Sarry, Julien] INRA, UMR444, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France; [Tosser-Klopp, Gwenola; Bardou, Philippe; Bouchez, Olivier; Cabau, Cedric; Donnadieu-Tonon, Cecile; Mulsant, Philippe; Nabihoudine, Ibouniyamine; Sarry, Julien] ENVT, UMR444, Lab Genet Cellulaire, Castanet Tolosan, France; [Bardou, Philippe; Cabau, Cedric; Klopp, Christophe; Nabihoudine, Ibouniyamine] INRA, Sigenae, F-31326 Castanet Tolosan, France; [Bouchez, Olivier; Donnadieu-Tonon, Cecile] INRA, GeT PlaGe, F-31326 Castanet Tolosan, France; [Crooijmans, Richard] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands; [Dong, Yang; Wang, Wen; Zhang, Wenguang] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Eggen, Andre; Lawley, Cynthia T.] Illumina Inc, Hayward, CA USA; [Heuven, Henri C. M.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [Jamli, Saadiah; Jiken, Abdullah Johari] Strateg Livestock Res Ctr, Malaysian Agr Res & Dev Inst, Kuala Lumpur, Malaysia; [Klopp, Christophe] INRA, UR Math & Informat Appl Toulouse 0875, F-31326 Castanet Tolosan, France; [McEwan, John] AgResearch, Invermay Agr Ctr, Mosgiel, New Zealand; [Martin, Patrice] INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France; [Martin, Patrice] AgroParisTech, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France; [Moreno, Carole R.; Palhiere, Isabelle; Rupp, Rachel; Tircazes, Aurelie] INRA, UPR0631, Stn Ameliorat Genet Anim, F-31326 Castanet Tolosan, France; [Pailhoux, Eric] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Pailhoux, Eric] ENVA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Sayre, Brian L.] Virginia State Univ, Dept Biol, Petersburg, VA 23806 USA; [Wang, Jun; Wang, Wen] BGI Shenzhen, Bejing Genome Inst, Shenzhen, Peoples R China; [Zhang, Wenguang] Inner Mongolia Agr Univ, Inner Mongolia Key Lab Anim Genet Breeding & Repr, Hohhot, Inner Mongolia, Peoples R China	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; INRAE; INRAE; Wageningen University & Research; Chinese Academy of Sciences; Kunming Institute of Zoology; Illumina; Utrecht University; Institute Penyelidikan Dan Kemajuan Pertanian; INRAE; AgResearch - New Zealand; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); Virginia State University; Beijing Genomics Institute (BGI); Inner Mongolia Agricultural University	Tosser-Klopp, G (corresponding author), INRA, UMR444, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France.	Gwenola.Tosser@toulouse.inra.fr; atcgnmbi@aliyun.com	Wang, Wen/AAP-9873-2020; Amills, Marcel/D-4908-2019; Wang, Jun/A-7261-2013; Klopp, Christophe/J-3164-2019; Stella, Alessandra/AAY-7322-2020; McEwan, John/A-1143-2008; Xu, Xun/AAI-6763-2020; Crooijmans, Richard PMA/E-2492-2012; Sayre, Brian/V-7889-2019; AJMONE MARSAN, Paolo/M-2466-2018; Wang, Jun/C-8434-2016; valentini, alessio/L-3970-2013; Wang, Jun/B-9503-2016	Amills, Marcel/0000-0002-8999-0770; Klopp, Christophe/0000-0001-7126-5477; McEwan, John/0000-0003-4801-6207; Xu, Xun/0000-0002-5338-5173; Ajmone, Paola Francesca/0000-0002-0624-4634; Bardou, Philippe/0000-0002-0004-0251; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Lawley, Cynthia/0000-0001-7001-4705; Wang, Jun/0000-0002-8540-8931; TOSSER-KLOPP, GWENOLA/0000-0003-0550-4673; valentini, alessio/0000-0003-4733-7519; Wang, Jun/0000-0002-2113-5874; Rupp, Rachel/0000-0003-3375-5816	ANR [ANR-09-GENM-009-03 GENIDOV, CHEST-454]; APIS-GENE; CAPRISNIP programme: UNCEIA; CAPGENES; EC's Seventh Framework Programme, 3SR Integrated Project	ANR(French National Research Agency (ANR)); APIS-GENE; CAPRISNIP programme: UNCEIA; CAPGENES; EC's Seventh Framework Programme, 3SR Integrated Project	Grants were funded by ANR (http://www.agence-nationale-recherche.fr/), ANR-09-GENM-009-03 GENIDOV, CHEST-454, funded by APIS-GENE; CAPRISNIP programme: UNCEIA, CAPGENES and APIS-GENE French Breeding organizations; and EC's Seventh Framework Programme, 3SR Integrated Project(Sustainable Solutions for Small Ruminants) http://www.3srbreeding.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barillet F, 2009, J GEN VIROL, V90, P769, DOI 10.1099/vir.0.006114-0; Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Boussaha M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-238; Bouzalas IG, 2010, J GEN VIROL, V91, P1629, DOI 10.1099/vir.0.017350-0; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Du XY, 2012, SMALL RUMINANT RES, V105, P114, DOI 10.1016/j.smallrumres.2011.11.023; Fan B, 2010, ASIAN AUSTRAL J ANIM, V23, P833, DOI 10.5713/ajas.2010.r.03; Fontanesi L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-639; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; Gunderson Kevin L., 2009, V529, P197, DOI 10.1007/978-1-59745-538-1_13; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Illumina, 2006, BIOTECHNIQUES PROTOC, V12-29; Kijas JW, 2013, ANIM GENET, V44, P325, DOI 10.1111/age.12011; Kraus RHS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-150; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin P, 2013, ADV DAIRY CHEM PROTE; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Papasavva-Stylianou P, 2011, VET J, V187, P245, DOI 10.1016/j.tvjl.2009.10.015; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Schibler L, 2009, CYTOGENET GENOME RES, V126, P77, DOI 10.1159/000245908; Schibler L, 1998, GENOME RES, V8, P901, DOI 10.1101/gr.8.9.901; Schibler L, 1998, MAMM GENOME, V9, P119, DOI 10.1007/s003359900701; Taberlet P, 2011, CR BIOL, V334, P247, DOI 10.1016/j.crvi.2010.12.007; Vaiman D, 1996, MAMM GENOME, V7, P133, DOI 10.1007/s003359900033	29	113	124	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86227	10.1371/journal.pone.0086227	http://dx.doi.org/10.1371/journal.pone.0086227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465974	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100129
J	Albanese, E; Strand, BH; Guralnik, JM; Patel, KV; Kuh, D; Hardy, R				Albanese, Emiliano; Strand, Bjorn Heine; Guralnik, Jack M.; Patel, Kushang V.; Kuh, Diana; Hardy, Rebecca			Weight Loss and Premature Death: The 1946 British Birth Cohort Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; OLDER-ADULTS; ASSOCIATION; AGE; DISEASE; RISK; OVERWEIGHT; WOMEN; MEN	Objective: The relationship between weight loss and mortality has important clinical and public health significance but has proved to be complex. Evidence is mixed and particularly limited on the association between weight loss in mid-life and premature death (i.e. before 65 years of age), a small albeit important segment of total mortality. We aimed to study the association between midlife weight change and mortality accounting for health and lifestyle characteristics, and also considering potential bias due to preexisting chronic diseases and smoking status. Design: Longitudinal, population-based, 'the 1946 British' birth cohort study. Subjects and Measures: In 2750 men and women, mortality from age 53 through 65 years was analyzed according to categories of measured 10 year weight change between 43 and 53 years. Cox's hazard ratios (HR) were progressively adjusted for socio-demographic, lifestyle and health characteristics. Results: Nearly 20% of participants lost weight and over 50% gained 5 kg or more in midlife. There were 164 deaths. Compared to those who gained between 2 and 5 kg, those who lost 5 kg or more had an increased risk of premature death independently of midlife physical activity, socio-economic circumstances and educational attainment. This association was unaltered when highest weight loss (lost more than 15 Kg) (p = 0.04) and early deaths were excluded (p<0.001), but was no longer significant after adjustment for cardiovascular risk factors and health status (HR = 1.8; 95% CI: 0.9 to 3.5). Conclusion: The inverse association between weight loss in midlife and higher risk of premature death may be explained by vascular risk factors and ill health. In consideration of the burden of premature death, closer monitoring of weight loss in mid-life is warranted.	[Albanese, Emiliano] NIA, Lab Populat Sci, Bethesda, MD 20892 USA; [Strand, Bjorn Heine] Norwegian Inst Publ Hlth, Oslo, Norway; [Guralnik, Jack M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Patel, Kushang V.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Kuh, Diana; Hardy, Rebecca] UCL, MRC Unit Lifelong Hlth & Ageing, London, England	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Norwegian Institute of Public Health (NIPH); University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle; University of London; University College London	Albanese, E (corresponding author), NIA, Lab Populat Sci, Bethesda, MD 20892 USA.	emiliano.albanese@gmail.com	Kuh, Diana/L-6019-2014; Hardy, Rebecca/AFR-1989-2022; Strand, Bjørn/AAV-7948-2021	Kuh, Diana/0000-0001-7386-2857; Strand, Bjørn/0000-0003-4385-8886; Hardy, Rebecca/0000-0001-9949-0799	MRC Unit for Lifelong Health and Ageing, UK; National Institute on Aging, National Institutes of Health; MRC [MC_UU_12019/2, MC_UU_12019/1] Funding Source: UKRI; Medical Research Council [MC_UU_12019/1, MC_UU_12019/2] Funding Source: researchfish	MRC Unit for Lifelong Health and Ageing, UK; National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The NSHD study is funded by the MRC Unit for Lifelong Health and Ageing, UK and was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875; Arnold AM, 2010, J GERONTOL A-BIOL, V65, P63, DOI 10.1093/gerona/glp050; Breeze E, 2006, INT J EPIDEMIOL, V35, P169, DOI 10.1093/ije/dyi212; Committee E, 1972, BURNH FURTH ED COMM; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Diehr P, 1998, AM J PUBLIC HEALTH, V88, P623, DOI 10.2105/AJPH.88.4.623; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2010, AM J EPIDEMIOLOGY; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; Harris TB, 1997, BMJ-BRIT MED J, V314, P1791, DOI 10.1136/bmj.314.7097.1791; HMSO, 1970, SURV OOPCA CLASS OCC; IRIBARREN C, 1995, NEW ENGL J MED, V333, P686, DOI 10.1056/NEJM199509143331102; Kalantar-Zadeh K, 2007, CURR OPIN CLIN NUTR, V10, P433, DOI 10.1097/MCO.0b013e3281a30594; Knudtson MD, 2005, ANN EPIDEMIOL, V15, P483, DOI 10.1016/j.annepidem.2004.12.003; Kolata G., 2007, NY TIMES; Kuh D, 2009, SOC SCI MED, V68, P1565, DOI 10.1016/j.socscimed.2009.02.006; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; LOSONCZY KG, 1995, AM J EPIDEMIOL, V141, P312, DOI 10.1093/aje/141.4.312; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Maru S, 2004, AM J CLIN NUTR, V80, P231; Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325; Miller SL, 2008, J NUTR HEALTH AGING, V12, P487, DOI 10.1007/BF02982710; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; Nilsson G, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000012; Nilsson PM, 2002, J INTERN MED, V252, P70, DOI 10.1046/j.1365-2796.2002.01010.x; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Sorensen T I A, 2003, Obes Rev, V4, P3, DOI 10.1046/j.1467-789X.2003.00090.x; Stampfer M, 2005, PLOS MED, V2, P476, DOI 10.1371/journal.pmed.0020181; Wadsworth MEJ, 2003, SOC SCI MED, V57, P2193, DOI 10.1016/S0277-9536(03)00083-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Wannamethee SG, 2005, ARCH INTERN MED, V165, P1035, DOI 10.1001/archinte.165.9.1035; Wedick NM, 2002, J AM GERIATR SOC, V50, P1810, DOI 10.1046/j.1532-5415.2002.50509.x; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wilsgaard T, 2009, GENDER MED, V6, P575, DOI 10.1016/j.genm.2009.12.003; Yaari S, 1998, AM J EPIDEMIOL, V148, P546, DOI 10.1093/oxfordjournals.aje.a009680	35	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86282	10.1371/journal.pone.0086282	http://dx.doi.org/10.1371/journal.pone.0086282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24466002	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500216
J	Chen, L; Ye, HL; Zhang, G; Yao, WM; Chen, XZ; Zhang, FC; Liang, G				Chen, Li; Ye, Hui-Lan; Zhang, Guo; Yao, Wen-Min; Chen, Xing-Zhou; Zhang, Fa-Can; Liang, Gang			Autophagy Inhibition Contributes to the Synergistic Interaction between EGCG and Doxorubicin to Kill the Hepatoma Hep3B Cells	PLOS ONE			English	Article							INDUCED DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA; INDUCED APOPTOSIS; CANCER; KINASE; DEATH; RESISTANCE; RISK; SORAFENIB; GALLATE	(-)-Epigallocatechin-3-O-gallate(EGCG), the highest catechins from green tea, has promisingly been found to sensitize the efficacy of several chemotherapy agents like doxorubicin (DOX) in hepatocellular carcinoma (HCC) treatment. However, the detailed mechanisms by which EGCG augments the chemotherapeutic efficacy remain unclear. Herein, this study was designed to determine the synergistic impacts of EGCG and DOX on hepatoma cells and particularly to reveal whether the autophagic flux is involved in this combination strategy for the HCC. Electron microscopy and fluorescent microscopy confirmed that DOX significantly increased autophagic vesicles in hepatoma Hep3B cells. Western blot and trypan blue assay showed that the increasing autophagy flux by DOX impaired about 45% of DOX-induced cell death in these cells. Conversely, both qRT-PCR and western blotting showed that EGCG played dose-dependently inhibitory role in autophagy signaling, and that markedly promoted cellular growth inhibition. Amazingly, the combined treatment caused a synergistic effect with 40 to 60% increment on cell death and about 45% augmentation on apoptosis versus monotherapy pattern. The DOX-induced autophagy was abolished by this combination therapy. Rapamycin, an autophagic agonist, substantially impaired the anticancer effect of either DOX or combination with EGCG treatment. On the other hand, using small interference RNA targeting chloroquine autophagy-related gene Atg5 and beclin1 to inhibit autophagy signal, hepatoma cell death was dramatically enhanced. Furthermore, in the established subcutaneous Hep3B cells xenograft tumor model, about 25% reduction in tumor growth as well as 50% increment of apoptotic cells were found in combination therapy compared with DOX alone. In addition, immunohistochemistry analysis indicated that the suppressed tendency of autophagic hallmark microtubule-associated protein light chain 3 (LC3) expressions was consistent with thus combined usage in vitro. Taken together, the current study suggested that EGCG emerges as a chemotherapeutic augmenter and synergistically enhances DOX anticancer effects involving autophagy inhibition in HCC.	[Chen, Li] Guangxi Med Univ, Affiliated Hosp 1, New Drug Res & Dev Ctr, Nanning, Guangxi, Peoples R China; [Chen, Li; Ye, Hui-Lan; Zhang, Guo; Yao, Wen-Min; Chen, Xing-Zhou; Zhang, Fa-Can] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Gastroenterol, Nanning, Guangxi, Peoples R China; [Chen, Li; Liang, Gang] Guangxi Med Univ, Sch Pharm, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Zhang, G (corresponding author), Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Gastroenterol, Nanning, Guangxi, Peoples R China.	zhangguogx@hotmail.com	Zhang, Guo/AAG-4155-2020; ZHANG, GUO/D-2556-2014		National Natural Science Foundation of China [81172260, 30960145, 81102495]; Guangxi Natural Science Foundation [2010GXNSFC013020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was supported by grants from the National Natural Science Foundation of China (no. 81172260; 30960145 to GZ and no. 81102495 to LC) and Guangxi Natural Science Foundation (2010GXNSFC013020 to GZ). The URL of website is http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, PHYTOMEDICINE, V17, P902, DOI 10.1016/j.phymed.2010.03.008; Bhutia SK, 2013, ADV CANCER RES, V118, P61, DOI 10.1016/B978-0-12-407173-5.00003-0; Carew Jennifer S, 2012, Cancer Manag Res, V4, P357, DOI 10.2147/CMAR.S26133; Chen TC, 2011, CANCER LETT, V302, P100, DOI 10.1016/j.canlet.2010.11.008; Choi JH, 2012, APMIS, V120, P597, DOI 10.1111/j.1600-0463.2012.02876.x; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; Escalante AM, 2013, CANCER CHEMOTH PHARM, V71, P1567, DOI 10.1007/s00280-013-2156-3; Gluer AM, 2012, HPB, V14, P285, DOI 10.1111/j.1477-2574.2012.00446.x; Gong H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054198; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Hashimoto K, 2008, ANTICANCER RES, V28, P1713; He W, 2013, ONCOGENE; Humbert M, 2013, BIOCHEM BIOPH RES CO, V431, P264, DOI 10.1016/j.bbrc.2012.12.120; Ca H, 2012, ANTICANCER RES, V32, P1379; Kang R, 2012, AM J CANCER RES, V2, P383; Kuo PL, 2003, J BIOMED SCI, V10, P219, DOI 10.1159/000068711; Kurahashi N, 2008, AM J EPIDEMIOL, V167, P71, DOI 10.1093/aje/kwm249; Lee AJX, 2012, J PATHOL, V226, P482, DOI 10.1002/path.2998; Li W, 2011, BIOCHEM PHARMACOL, V81, P1152, DOI 10.1016/j.bcp.2011.02.015; Liang G, 2010, INT J ONCOL, V37, P111, DOI 10.3892/ijo_00000659; Lin SB, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-3; Liu FF, 2013, ONCOL LETT, V5, P1261, DOI 10.3892/ol.2013.1154; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Manov I, 2011, FEBS J, V278, P3494, DOI 10.1111/j.1742-4658.2011.08271.x; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nobili S, 2006, CURR DRUG TARGETS, V7, P861, DOI 10.2174/138945006777709593; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Pan YZ, 2011, CLIN CANCER RES, V17, P3248, DOI 10.1158/1078-0432.CCR-10-0890; Schramm Laura, 2013, J Carcinog Mutagen, V4, P1000142; Selvakumaran M, 2013, CLIN CANCER RES, V19, P2995, DOI 10.1158/1078-0432.CCR-12-1542; Shan K, 1996, ANN INTERN MED, V125, P47, DOI 10.7326/0003-4819-125-1-199607010-00008; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Shimizu M, 2008, CANCER EPIDEM BIOMAR, V17, P3020, DOI 10.1158/1055-9965.EPI-08-0528; Shimizu S, 2012, INT J CANCER, V131, P548, DOI 10.1002/ijc.26374; Stelton CR, 2013, CLIN RHEUMATOL, V32, P895, DOI 10.1007/s10067-013-2226-2; Sul YH, 2013, BIOL PHARM BULL, V36, P158, DOI 10.1248/bpb.b12-00873; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Tsao AS, 2009, CANCER PREV RES, V2, P931, DOI 10.1158/1940-6207.CAPR-09-0121; Tu SH, 2011, MOL NUTR FOOD RES, V55, P455, DOI 10.1002/mnfr.201000254; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Wang DG, 2008, INT J UROL, V15, P435, DOI 10.1111/j.1442-2042.2008.02025.x; Xie BS, 2011, INT J MOL MED, V27, P599, DOI 10.3892/ijmm.2011.607; Xu N, 2012, BIOCHEM BIOPH RES CO, V423, P826, DOI 10.1016/j.bbrc.2012.06.048; Xu XM, 2012, J PHARMACOL EXP THER, V341, P183, DOI 10.1124/jpet.111.189589; Yan J, 2012, J NUTR BIOCHEM, V23, P716, DOI 10.1016/j.jnutbio.2011.03.014; Zhang G, 2008, J BIOL CHEM, V283, P24343, DOI 10.1074/jbc.M803444200; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046749; Zheng J, 2011, EUR J PHARMACOL, V652, P82, DOI 10.1016/j.ejphar.2010.10.082; Zhu L, 2013, B CANC	49	82	85	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85771	10.1371/journal.pone.0085771	http://dx.doi.org/10.1371/journal.pone.0085771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465696	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500108
J	D'Adamo, S; Jinkerson, RE; Boyd, ES; Brown, SL; Baxter, BK; Peters, JW; Posewitz, MC				D'Adamo, Sarah; Jinkerson, Robert E.; Boyd, Eric S.; Brown, Susan L.; Baxter, Bonnie K.; Peters, John W.; Posewitz, Matthew C.			Evolutionary and Biotechnological Implications of Robust Hydrogenase Activity in Halophilic Strains of Tetraselmis	PLOS ONE			English	Article							ANAEROBIC ENERGY-METABOLISM; CHLAMYDOMONAS-REINHARDTII; GREEN-ALGA; MICROBIAL MATS; H-2 PRODUCTION; DUNALIELLA; EXPRESSION; DIVERSITY; PROTEIN; MICROORGANISMS	Although significant advances in H-2 photoproduction have recently been realized in fresh water algae (e.g. Chlamydomonas reinhardtii), relatively few studies have focused on H-2 production and hydrogenase adaptations in marine or halophilic algae. Salt water organisms likely offer several advantages for biotechnological H-2 production due to the global abundance of salt water, decreased H-2 and O-2 solubility in saline and hypersaline systems, and the ability of extracellular NaCl levels to influence metabolism. We screened unialgal isolates obtained from hypersaline ecosystems in the southwest United States and identified two distinct halophilic strains of the genus Tetraselmis (GSL1 and QNM1) that exhibit both robust fermentative and photo H-2-production activities. The influence of salinity (3.5%, 5.5% and 7.0% w/v NaCl) on H-2 production was examined during anoxic acclimation, with the greatest in vivo H-2-production rates observed at 7.0% NaCl. These Tetraselmis strains maintain robust hydrogenase activity even after 24 h of anoxic acclimation and show increased hydrogenase activity relative to C. reinhardtii after extended anoxia. Transcriptional analysis of Tetraselmis GSL1 enabled sequencing of the cDNA encoding the FeFe-hydrogenase structural enzyme (HYDA) and its maturation proteins (HYDE, HYDEF and HYDG). In contrast to freshwater Chlorophyceae, the halophilic Tetraselmis GSL1 strain likely encodes a single HYDA and two copies of HYDE, one of which is fused to HYDF. Phylogenetic analyses of HYDA and concatenated HYDA, HYDE, HYDF and HYDG in Tetraselmis GSL1 fill existing knowledge gaps in the evolution of algal hydrogenases and indicate that the algal hydrogenases sequenced to date are derived from a common ancestor. This is consistent with recent hypotheses that suggest fermentative metabolism in the majority of eukaryotes is derived from a common base set of enzymes that emerged early in eukaryotic evolution with subsequent losses in some organisms.	[D'Adamo, Sarah; Jinkerson, Robert E.; Posewitz, Matthew C.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA; [Boyd, Eric S.; Peters, John W.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Boyd, Eric S.; Peters, John W.] Montana State Univ, Thermal Biol Inst, Bozeman, MT 59717 USA; [Brown, Susan L.] Univ Hawaii, Ctr Marine Microbial Ecol & Divers, Honolulu, HI 96822 USA; [Baxter, Bonnie K.] Westminster Coll, Dept Biol, Salt Lake City, UT USA; [Baxter, Bonnie K.] Westminster Coll, Great Salt Lake Inst, Salt Lake City, UT USA; [Peters, John W.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Colorado School of Mines; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University of Hawaii System; Montana State University System; Montana State University Bozeman	Posewitz, MC (corresponding author), Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA.	mposewit@mines.edu		Jinkerson, Robert/0000-0001-9399-1613; D'Adamo, Sarah/0000-0001-7654-941X; Peters, John/0000-0001-9117-9568	United States Air Force Office of Scientific Research [FA9550-11-1-0211, FA9550-11-1-0218]; Gordon and Betty Moore Foundation [2637]	United States Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research is part of the United States Air Force Office of Scientific Research under Grant FA9550-11-1-0211 and FA9550-11-1-0218. For the transcriptome part this research was funded in part by the Gordon and Betty Moore Foundation through Grant #2637 to the National Center for Genome Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Narvaez-Zapata JA, 2011, BIOTECHNOL LETT, V33, P1021, DOI 10.1007/s10529-011-0523-x; Alkayal F, 2010, PLANT SCI, V179, P437, DOI 10.1016/j.plantsci.2010.07.001; Allakhverdiev SI, 2010, J PHOTOCH PHOTOBIO C, V11, P87; Ananyev G, 2008, APPL ENVIRON MICROB, V74, P6102, DOI 10.1128/AEM.01078-08; Antal TK, 2011, APPL MICROBIOL BIOT, V89, P3, DOI 10.1007/s00253-010-2879-6; Arakaki A, 2013, PHYTOCHEMISTRY, V85, P107, DOI 10.1016/j.phytochem.2012.09.006; Araujo GS, 2011, BIORESOURCE TECHNOL, V102, P5248, DOI 10.1016/j.biortech.2011.01.089; Arora M, 2013, EUR J PHYCOL, V48, P61, DOI 10.1080/09670262.2013.768357; Atteia A, 2013, BBA-BIOENERGETICS, V1827, P210, DOI 10.1016/j.bbabio.2012.08.002; Barz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013846; Beer LL, 2009, CURR OPIN BIOTECH, V20, P264, DOI 10.1016/j.copbio.2009.06.002; Bhosale SH, 2009, MICROBIOL RES, V164, P131, DOI 10.1016/j.micres.2006.11.006; Bondioli P, 2012, BIORESOURCE TECHNOL, V114, P567, DOI 10.1016/j.biortech.2012.02.123; Boyd ES, 2010, ISME J, V4, P1485, DOI 10.1038/ismej.2010.76; Boyd ES, 2009, APPL ENVIRON MICROB, V75, P4620, DOI 10.1128/AEM.00582-09; Brazelton WJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00268; Burow LC, 2012, ISME J, V6, P863, DOI 10.1038/ismej.2011.142; Cai GQ, 2011, BIOTECHNOL ADV, V29, P375, DOI 10.1016/j.biotechadv.2011.02.001; Carballo-Cardenas EC, 2003, BIOMOL ENG, V20, P139, DOI 10.1016/S1389-0344(03)00040-6; Carrieri D, 2010, APPL ENVIRON MICROB, V76, P6455, DOI 10.1128/AEM.00975-10; Catalanotti C, 2012, PLANT CELL, V24, P692, DOI 10.1105/tpc.111.093146; Chen H, 2011, SCI TOTAL ENVIRON, V409, P1291, DOI 10.1016/j.scitotenv.2010.12.038; Chen H, 2009, J CELL PHYSIOL, V219, P251, DOI 10.1002/jcp.21715; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chou CJ, 2008, METAB ENG, V10, P394, DOI 10.1016/j.ymben.2008.06.007; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; Elliott LG, 2012, ALGAL RES, V1, P102, DOI 10.1016/j.algal.2012.05.002; Eroglu E, 2011, BIORESOURCE TECHNOL, V102, P8403, DOI 10.1016/j.biortech.2011.03.026; Esquivel MG, 2011, TRENDS BIOTECHNOL, V29, P595, DOI 10.1016/j.tibtech.2011.06.008; Fan F, 2011, PROCESS BIOCHEM, V46, P1212, DOI 10.1016/j.procbio.2011.02.005; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Ghirardi ML, 2009, CHEM SOC REV, V38, P52, DOI 10.1039/b718939g; Greenbaum E, 1999, BIOHYDROGEN, V31, P235; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hoehler TM, 2002, ANTON LEEUW INT J G, V81, P575, DOI 10.1023/A:1020517924466; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; Jahnke LS, 2003, J PLANT PHYSIOL, V160, P1193, DOI 10.1078/0176-1617-01068; Jenney Jr FE, 2008, ANN NY ACAD SCI, V1125, P1; Jinkerson RE, 2013, BIOENGINEERED, V4, P37, DOI 10.4161/bioe.21880; Jinkerson RE, 2011, BIOFUELS-UK, V2, P125, DOI [10.4155/BFS.11.7, 10.4155/bfs.11.7]; Kosourov SN, 2009, BIOTECHNOL BIOENG, V102, P50, DOI 10.1002/bit.22050; Kruse O, 2010, CURR OPIN BIOTECH, V21, P238, DOI 10.1016/j.copbio.2010.03.012; Lambertz C, 2011, J BIOL CHEM, V286, P40614, DOI 10.1074/jbc.M111.283648; Lim DKY, 2012, PLOS ONE, P7; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; Melis A, 2004, PHOTOSYNTH RES, V80, P401, DOI 10.1023/B:PRES.0000030421.31730.cb; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Meuser JE, 2013, MICROB ECOL; Meuser JE, 2012, BIOCHEM BIOPH RES CO, V417, P704, DOI 10.1016/j.bbrc.2011.12.002; Meuser JE, 2011, PLANTA, V234, P829, DOI 10.1007/s00425-011-1431-y; Meuser JE, 2009, J BIOTECHNOL, V142, P21, DOI 10.1016/j.jbiotec.2009.01.015; Montoya H., 2009, NATURAL RESOURCES EN, V15, P127; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; NEWMAN SM, 1990, GENETICS, V126, P875; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Peters J.W., 2013, ALGAE BIOFUELS ENERG, P37; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Posewitz MC, 2005, BIOCHEM SOC T, V33, P102, DOI 10.1042/BST0330102; Posewitz MC, 2009, CHLAMYDOMONAS SOURCE, P217, DOI [10.1016/B978-0-12-370873, DOI 10.1016/B978-0-12-370873]; Prince RC, 2005, CRIT REV MICROBIOL, V31, P19, DOI 10.1080/10408410590912961; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; REED RH, 1986, FEMS MICROBIOL LETT, V39, P51; ROESSLER PG, 1984, PLANT PHYSIOL, V75, P705, DOI 10.1104/pp.75.3.705; Schwarz C, 2010, ADV EXP MED BIOL, V675, P305, DOI 10.1007/978-1-4419-1528-3_18; Shepard EM, 2011, CURR OPIN CHEM BIOL, V15, P319, DOI 10.1016/j.cbpa.2011.02.012; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Skjanes K, 2008, INT J HYDROGEN ENERG, V33, P511, DOI 10.1016/j.ijhydene.2007.09.040; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Srirangan K, 2011, BIORESOURCE TECHNOL, V102, P8589, DOI 10.1016/j.biortech.2011.03.087; Stern D. B., 2009, CHLAMYDOMONAS SOURCE, V2; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Vieler A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003064; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9; Whitney LAS, 2011, NEW PHYTOL, V190, P488, DOI 10.1111/j.1469-8137.2010.03503.x; Work VH, 2013, ENVIRON PROG SUSTAIN, V32, P989, DOI 10.1002/ep.11849; Xu D, 2013, BIORESOURCE TECHNOL, V127, P386, DOI 10.1016/j.biortech.2012.09.068; Yao CH, 2012, BIORESOURCE TECHNOL, V118, P438, DOI 10.1016/j.biortech.2012.05.030; ZINN T, 1994, Z NATURFORSCH C, V49, P33	88	14	14	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85812	10.1371/journal.pone.0085812	http://dx.doi.org/10.1371/journal.pone.0085812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465722	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500118
J	Nash, WJ; Chapman, T				Nash, William J.; Chapman, Tracey			Effect of Dietary Components on Larval Life History Characteristics in the Medfly (Ceratitis capitata: Diptera, Tephritidae)	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLY; BODY-SIZE; MOLECULAR-STRUCTURE; FEEDING-BEHAVIOR; SELECTION; HOST; RESTRICTION; INSECT; FLIES; METAMORPHOSIS	Background: The ability to respond to heterogenous nutritional resources is an important factor in the adaptive radiation of insects such as the highly polyphagous Medfly. Here we examined the breadth of the Medfly's capacity to respond to different developmental conditions, by experimentally altering diet components as a proxy for host quality and novelty. Methodology/Principal Findings: We tested responses of larval life history to diets containing protein and carbohydrate components found in and outside the natural host range of this species. A 40% reduction in the quantity of protein caused a significant increase in egg to adult mortality by 26.5% +/- 6% in comparison to the standard baseline diet. Proteins and carbohydrates had differential effects on larval versus pupal development and survival. Addition of a novel protein source, casein (i.e. milk protein), to the diet increased larval mortality by 19.4% +/- 3% and also lengthened the duration of larval development by 1.93 +/- 0.5 days in comparison to the standard diet. Alteration of dietary carbohydrate, by replacing the baseline starch with simple sugars, increased mortality specifically within the pupal stage (by 28.2% +/- 8% and 26.2% +/- 9% for glucose and maltose diets, respectively). Development in the presence of the novel carbohydrate lactose (milk sugar) was successful, though on this diet there was a decrease of 29.8 +/- 1.6 mu g in mean pupal weight in comparison to pupae reared on the baseline diet. Conclusions: The results confirm that laboratory reared Medfly retain the ability to survive development through a wide range of fluctuations in the nutritional environment. We highlight new facets of the responses of different stages of holometabolous life histories to key dietary components. The results are relevant to colonisation scenarios and key to the biology of this highly invasive species.	[Nash, William J.; Chapman, Tracey] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Nash, WJ (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	w.nash@uea.ac.uk	Chapman, Tracey/E-5100-2011	Nash, Will/0000-0002-6790-1167	Natural Environment Research Council; BBSRC [BB/K000489/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K000489/1] Funding Source: researchfish; Natural Environment Research Council [1092992] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded as part of a Natural Environment Research Council quota PhD studentship, www.nerc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila JR, 2013, J EXP BIOL, V216, P399, DOI 10.1242/jeb.078311; Andersson Malte, 1994; Anjos-Duarte CS, 2011, J APPL ENTOMOL, V135, P367, DOI 10.1111/j.1439-0418.2010.01552.x; CANATO CM, 1993, J INSECT PHYSIOL, V39, P981, DOI 10.1016/0022-1910(93)90007-E; CANGUSSU JA, 1995, J INSECT PHYSIOL, V41, P223, DOI 10.1016/0022-1910(94)00099-3; Cangussu Jomara Alves, 1993, Revista Brasileira de Biologia, V53, P155; Cangussu Jomara Alves, 1997, Revista Brasileira de Biologia, V57, P611; Carey JR, 2005, AGING CELL, V4, P31, DOI 10.1111/j.1474-9728.2004.00140.x; CAREY JR, 1984, ECOL ENTOMOL, V9, P261, DOI 10.1111/j.1365-2311.1984.tb00850.x; Chang CL, 2004, ANN ENTOMOL SOC AM, V97, P529, DOI 10.1603/0013-8746(2004)097[0529:EOAAOL]2.0.CO;2; Chang CL, 2001, ANN ENTOMOL SOC AM, V94, P702, DOI 10.1603/0013-8746(2001)094[0702:ARCOCC]2.0.CO;2; Chapman RF, 2013, J CHEM INF MODEL, V5th; Davidowitz G, 2005, INTEGR COMP BIOL, V45, P525, DOI 10.1093/icb/45.3.525; Davidowitz G, 2004, INTEGR COMP BIOL, V44, P443, DOI 10.1093/icb/44.6.443; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Placido-Silva MD, 2006, NEOTROP ENTOMOL, V35, P747, DOI 10.1590/S1519-566X2006000600004; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; FernandesDaSilva PG, 1997, J INSECT PHYSIOL, V43, P939, DOI 10.1016/S0022-1910(97)00059-0; FERNANDESDASILVA PG, 1993, J INSECT PHYSIOL, V39, P883, DOI 10.1016/0022-1910(93)90121-7; Forister ML, 2012, ECOLOGY, V93, P981, DOI 10.1890/11-0650.1; FRIES DC, 1971, ACTA CRYSTALL B-STRU, VB 27, P994, DOI 10.1107/S0567740871003364; Gasperi G, 2002, GENETICA, V116, P125, DOI 10.1023/A:1020971911612; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jurkevitch E, 2011, INSECT SYMBIOLOGY IS, P27; Kaspi R, 2002, PHYSIOL ENTOMOL, V27, P29, DOI 10.1046/j.1365-3032.2001.00264.x; Kaspi R, 2000, ECOL ENTOMOL, V25, P279, DOI 10.1046/j.1365-2311.2000.00266.x; Katsoyannos B.I., 1989, World Crop Pests, V3A, P307; Katsoyannos BI, 1997, ENTOMOL EXP APPL, V82, P181, DOI 10.1023/A:1002940012328; KATSOYANNOS BI, 1986, ENTOMOL EXP APPL, V42, P187, DOI 10.1007/BF00343546; KRAINACKER DA, 1987, OECOLOGIA, V73, P583, DOI 10.1007/BF00379420; Liquido N.J., 1991, MISCELLANEOUS PUBLIC, V77, P1; Morrison NI, 2009, ENTOMOL EXP APPL, V133, P146, DOI 10.1111/j.1570-7458.2009.00909.x; Navarro-Campos C, 2011, ENVIRON ENTOMOL, V40, P931, DOI 10.1603/EN10302; Nestel D, 2004, ARCH INSECT BIOCHEM, V56, P97, DOI 10.1002/arch.20000; Nestel D, 2003, ANN ENTOMOL SOC AM, V96, P237, DOI 10.1603/0013-8746(2003)096[0237:LCAPPD]2.0.CO;2; Nestel D, 2008, ENTOMOL EXP APPL, V126, P53, DOI 10.1111/j.1570-7458.2007.00639.x; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Papachristos DP, 2009, ANN APPL BIOL, V155, P381, DOI 10.1111/j.1744-7348.2009.00350.x; Papachristos DP, 2008, J ECON ENTOMOL, V101, P866, DOI 10.1603/0022-0493(2008)101[866:SADOIS]2.0.CO;2; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; PROKOPY RJ, 1984, ENTOMOL EXP APPL, V35, P65, DOI 10.1007/BF00343460; Public Health England, 2019, MCCANCE WIDDOWSONS C; QUIGLEY GJ, 1970, J AM CHEM SOC, V92, P5834, DOI 10.1021/ja00723a003; R Core Team, 2016, R FDN STAT COMP; Robinson AS, 2002, FLA ENTOMOL, V85, P171, DOI 10.1653/0015-4040(2002)085[0171:RFOMSB]2.0.CO;2; Roff Derek A., 1992; Salvatore A, 2004, J CHEM ECOL, V30, P323, DOI 10.1023/B:JOEC.0000017980.66124.d1; SIMPSON SJ, 1993, PHILOS T R SOC B, V342, P381, DOI 10.1098/rstb.1993.0166; Simpson SJ, 2007, J GERONTOL A-BIOL, V62, P707, DOI 10.1093/gerona/62.7.707; Stearns S.C., 1992, pi; Taylor PW, 1999, ANIM BEHAV, V58, P247, DOI 10.1006/anbe.1999.1137; Thibert-Plante X, 2011, J EVOLUTION BIOL, V24, P326, DOI 10.1111/j.1420-9101.2010.02169.x; Tolmasky DS, 2001, ARCH BIOCHEM BIOPHYS, V392, P38, DOI 10.1006/abbi.2001.2394; Zucoloto F. S., 1993, Revista Brasileira de Biologia, V53, P611; ZUCOLOTO FS, 1993, ENTOMOL EXP APPL, V67, P119, DOI 10.1007/BF02386516	59	42	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86029	10.1371/journal.pone.0086029	http://dx.doi.org/10.1371/journal.pone.0086029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465851	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000330244500169
J	Nombela, C; Rittman, T; Robbins, TW; Rowe, JB				Nombela, Cristina; Rittman, Timothy; Robbins, Trevor W.; Rowe, James B.			Multiple Modes of Impulsivity in Parkinson's Disease	PLOS ONE			English	Article							ADDENBROOKES COGNITIVE EXAMINATION; PLATELET SEROTONIN TRANSPORTER; OBSESSIVE-COMPULSIVE DISORDER; INFERIOR FRONTAL GYRUS; DEEP BRAIN-STIMULATION; STOP-SIGNAL TASK; PREFRONTAL CORTEX; DECISION-MAKING; DOPAMINERGIC MODULATION; BEHAVIORAL-INHIBITION	Cognitive problems are a major factor determining quality of life of patients with Parkinson's disease. These include deficits in inhibitory control, ranging from subclinical alterations in decision-making to severe impulse control disorders. Based on preclinical studies, we proposed that Parkinson's disease does not cause a unified disorder of inhibitory control, but rather a set of impulsivity factors with distinct psychological profiles, anatomy and pharmacology. We assessed a broad set of measures of the cognitive, behavioural and temperamental/trait aspects of impulsivity. Sixty adults, including 30 idiopathic Parkinson's disease patients (Hoehn and Yahr stage I-III) and 30 healthy controls, completed a neuropsychological battery, objective behavioural measures and self-report questionnaires. Univariate analyses of variance confirmed group differences in nine out of eleven metrics. We then used factor analysis (principal components method) to identify the structure of impulsivity in Parkinson's disease. Four principal factors were identified, consistent with four different mechanisms of impulsivity, explaining 60% of variance. The factors were related to (1) tests of response conflict, interference and self assessment of impulsive behaviours on the Barrett Impulsivity Scale, (2) tests of motor inhibitory control, and the self-report behavioural approach system, (3) time estimation and delay aversion, and (4) reflection in hypothetical scenarios including temporal discounting. The different test profiles of these four factors were consistent with human and comparative studies of the pharmacology and functional anatomy of impulsivity. Relationships between each factor and clinical and demographic features were examined by regression against factor loadings. Levodopa dose equivalent was associated only with factors (2) and (3). The results confirm that impulsivity is common in Parkinson's disease, even in the absence of impulse control disorders, and that it is not a unitary phenomenon. A better understanding of the structure of impulsivity in Parkinson's disease will support more evidence-based and effective strategies to treat impulsivity.	[Nombela, Cristina; Rittman, Timothy; Rowe, James B.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Robbins, Trevor W.] Univ Cambridge, Dept Psychol, Cambridge, England; [Robbins, Trevor W.; Rowe, James B.] Behav & Clin Neurosci Inst, Cambridge, England; [Rowe, James B.] MRC, Cognit & Brain Sci Unit, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Nombela, C (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.	cn331@cam.ac.uk	Tick, Beata/ABA-1728-2020; Otero, Cristina Nombela/AAA-1463-2019; Rittman, Timothy/K-7572-2019; Robbins, Trevor W/A-7551-2008; Rowe, James/C-3661-2013	Rittman, Timothy/0000-0003-1063-6937; Robbins, Trevor/0000-0003-0642-5977; Rowe, James/0000-0001-7216-8679; Nombela Otero, Cristina/0000-0002-9806-2351	Wellcome Trust [088324]; Medical Research Council [MC-A060-5PQ30, G1100464]; Parkinson's UK [RES/0211-7258]; NIHR Cambridge Biomedical Research Centre; MRC; Wellcome Trust; MRC [G1100464, MC_U105597119] Funding Source: UKRI; Medical Research Council [G0001354B, G0001354, MC_U105597119, G1000183B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson's UK(Parkinson's UK); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (088324 to JBR); the Medical Research Council (MC-A060-5PQ30 and G1100464 Clinical training fellowship to TR); Parkinson's UK (RES/0211-7258 to CNO); and the NIHR Cambridge Biomedical Research Centre. The BCNI is co-funded by a grant from the MRC and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Altmann LJP, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/238956; Antonelli F, 2011, J NEUROL SCI, V310, P202, DOI 10.1016/j.jns.2011.06.006; Antonini A, 2011, MOVEMENT DISORD, V26, P464, DOI 10.1002/mds.23501; Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ballanger B, 2009, ANN NEUROL, V66, P817, DOI 10.1002/ana.21795; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Bari A, 2013, PSYCHOPHARMACOLOGY, V230, P89, DOI 10.1007/s00213-013-3141-6; Bari A, 2011, J NEUROSCI, V31, P9254, DOI 10.1523/JNEUROSCI.1543-11.2011; Bari A, 2009, PSYCHOPHARMACOLOGY, V205, P273, DOI 10.1007/s00213-009-1537-0; Barker RA, 2009, EXP NEUROL, V219, P382, DOI 10.1016/j.expneurol.2009.07.015; BARRATT E. S., 1959, PERCEPT MOTOR SKILLS, V9, P191; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Biundo R, 2011, J NEUROL SCI, V310, P64, DOI 10.1016/j.jns.2011.08.001; Boggio PS, 2005, MOVEMENT DISORD, V20, P1178, DOI 10.1002/mds.20508; Bouvard M, 2012, ENCEPHALE, V38, P418, DOI 10.1016/j.encep.2012.01.004; Brambilla F, 2010, PSYCHONEUROENDOCRINO, V35, P729, DOI 10.1016/j.psyneuen.2009.10.014; Brodsky MA, 2003, MOVEMENT DISORD, V18, P668, DOI 10.1002/mds.10429; Broos N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036781; Buhusi CV, 2007, BEHAV PROCESS, V74, P159, DOI 10.1016/j.beproc.2006.10.004; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burrell JR, 2012, NEUROLOGY, V78, P1816, DOI 10.1212/WNL.0b013e318258f75c; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Carver CSW, 1994, VIOLENCE MENTAL DISO, P61; Ceravolo R, 2009, PARKINSONISM RELAT D, V15, pS111, DOI 10.1016/S1353-8020(09)70847-8; Chamberlain SR, 2007, NEUROPSYCHOLOGIA, V45, P654, DOI 10.1016/j.neuropsychologia.2006.07.016; Chamberlain SR, 2006, AM J PSYCHIAT, V163, P1282, DOI 10.1176/appi.ajp.163.7.1282; Chamberlain SR, 2009, BIOL PSYCHIAT, V65, P550, DOI 10.1016/j.biopsych.2008.10.014; Cherbuin N, 2008, SOC COGN AFFECT NEUR, V3, P262, DOI 10.1093/scan/nsn018; Cilia R, 2008, ARCH NEUROL-CHICAGO, V65, P1604, DOI 10.1001/archneur.65.12.1604; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Clark L, 2010, PHILOS T R SOC B, V365, P319, DOI 10.1098/rstb.2009.0147; Cools R, 2005, NEUROPSYCHOPHARMACOL, V30, P1362, DOI 10.1038/sj.npp.1300704; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Cumming Paul, 2012, Curr Top Behav Neurosci, V11, P117, DOI 10.1007/7854_2011_165; Czernecki V, 2002, NEUROPSYCHOLOGIA, V40, P2257, DOI 10.1016/S0028-3932(02)00108-2; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Del-Ben CM, 2005, NEUROPSYCHOPHARMACOL, V30, P1724, DOI 10.1038/sj.npp.1300728; Di Giovanni G, 2008, PROG BRAIN RES, V172, P45, DOI 10.1016/S0079-6123(08)00903-5; Djamshidian A, 2011, NEUROPSYCHOLOGIA, V49, P2483, DOI 10.1016/j.neuropsychologia.2011.04.026; Djamshidian A, 2011, PARKINSONISM RELAT D, V17, P212, DOI 10.1016/j.parkreldis.2010.12.014; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Durana J, 1993, IMPULSIVE CLIENT THE; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Eagle DM, 2011, J NEUROSCI, V31, P7349, DOI 10.1523/JNEUROSCI.6182-10.2011; Eagle DM, 2009, NEUROPSYCHOPHARMACOL, V34, P1311, DOI 10.1038/npp.2008.202; Evans AH, 2005, NEUROLOGY, V65, P1570, DOI 10.1212/01.wnl.0000184487.72289.f0; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Fera F, 2007, BRAIN RES BULL, V74, P75, DOI 10.1016/j.brainresbull.2007.05.009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gauggel S, 2004, J NEUROL NEUROSUR PS, V75, P539; Ghahremani DG, 2012, J NEUROSCI, V32, P7316, DOI 10.1523/JNEUROSCI.4284-11.2012; Ghosh BCP, 2012, BRAIN, V135, P2089, DOI 10.1093/brain/aws128; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goldstein DS, 2011, EUR J NEUROL, V18, P703, DOI 10.1111/j.1468-1331.2010.03246.x; Grant JE., 2008, IMPULSE CONTROL DISO; Halbig TD, 2009, EUR J NEUROL, V16, P493, DOI 10.1111/j.1468-1331.2008.02509.x; HALLIDAY GM, 1990, BRAIN RES, V510, P104, DOI 10.1016/0006-8993(90)90733-R; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Housden CR, 2010, NEUROPSYCHOPHARMACOL, V35, P2155, DOI 10.1038/npp.2010.84; Isaias IU, 2008, MOVEMENT DISORD, V23, P411, DOI 10.1002/mds.21872; Jones CRG, 2004, EXP BRAIN RES, V158, P366, DOI 10.1007/s00221-004-1912-3; Karalunas SL, 2011, J CLIN CHILD ADOLESC, V40, P837, DOI 10.1080/15374416.2011.614578; Kim J.-O., 1978, INTRO FACTOR ANAL WH; Kirby KN, 1996, PSYCHON B REV, V3, P100, DOI 10.3758/BF03210748; Klein-Flugge MC, 2011, NEURON, V72, P654, DOI 10.1016/j.neuron.2011.08.024; Kobayakawa M, 2008, MOVEMENT DISORD, V23, P547, DOI 10.1002/mds.21865; Koch G, 2008, NEUROPSYCHOLOGIA, V46, P1305, DOI 10.1016/j.neuropsychologia.2007.12.005; Krack P, 2010, TRENDS NEUROSCI, V33, P474, DOI 10.1016/j.tins.2010.07.002; Lee MS, 2011, ACTA NEUROL SCAND, V124, P196, DOI 10.1111/j.1600-0404.2010.01446.x; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Lord S, 2011, J NEUROL, V258, P566, DOI 10.1007/s00415-010-5789-8; Macoveanu J, 2012, EUR NEUROPSYCHOPHARM; Marazziti D, 2008, NEUROPSYCHOBIOLOGY, V57, P38, DOI 10.1159/000129665; Marazziti D, 2010, PHYSIOL BEHAV, V100, P364, DOI 10.1016/j.physbeh.2010.03.013; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Milenkova M, 2011, MOVEMENT DISORD, V26, P2004, DOI 10.1002/mds.23756; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mobini S, 2000, PSYCHOPHARMACOLOGY, V149, P313, DOI 10.1007/s002130000385; Nakahara H, 2010, NEURAL COMPUT, V22, P3062, DOI 10.1162/NECO_a_00049; NathanielJames DA, 1997, NEUROPSYCHOLOGIA, V35, P559, DOI 10.1016/S0028-3932(96)00104-2; O'Callaghan C, 2012, CORTEX; Obeso I, 2011, EXP BRAIN RES, V212, P371, DOI 10.1007/s00221-011-2736-6; Obeso VT, 2005, ACAD MED, V80, pS71, DOI 10.1097/00001888-200510001-00020; Olijslagers JE, 2006, CURR NEUROPHARMACOL, V4, P59, DOI 10.2174/157015906775203020; Overtoom CCE, 2009, BIOL PSYCHIAT, V65, P614, DOI 10.1016/j.biopsych.2008.10.048; Penney TB, 2000, J EXP PSYCHOL HUMAN, V26, P1770, DOI 10.1037//0096-1523.26.6.1770; Penny WD, 2000, IEEE T REHABIL ENG, V8, P214, DOI 10.1109/86.847820; Perbal S, 2005, BRAIN COGNITION, V58, P35, DOI 10.1016/j.bandc.2005.02.003; Perneczky R, 2011, NEUROBIOL DIS, V43, P79, DOI 10.1016/j.nbd.2011.01.032; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Politis M, 2010, NEUROBIOL DIS, V40, P216, DOI 10.1016/j.nbd.2010.05.028; Potenza MN, 2007, NAT CLIN PRACT NEURO, V3, P664, DOI 10.1038/ncpneuro0680; Rae CL, 2012, NEUROIMAGE, V62, P1675, DOI 10.1016/j.neuroimage.2012.06.012; Rahman S, 2006, NEUROPSYCHOPHARMACOL, V31, P651, DOI 10.1038/sj.npp.1300886; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; Rakshi JS, 1999, BRAIN, V122, P1637, DOI 10.1093/brain/122.9.1637; Raust A, 2007, PSYCHOL MED, V37, P411, DOI 10.1017/S0033291706009111; Rittman T, 2013, J NEUROL NEUROSUR PS, V84, P544, DOI 10.1136/jnnp-2012-303618; Rivaud-Pechoux S, 2007, BRAIN, V130, P256, DOI 10.1093/brain/awl315; Robinson ESJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1028, DOI 10.1038/sj.npp.1301487; Rotondo A, 2010, MOVEMENT DISORD, V25, P1994, DOI 10.1002/mds.23177; Rowe JB, 2010, NEUROBIOL AGING, V31, P1064, DOI 10.1016/j.neurobiolaging.2008.07.009; Rowe JB, 2008, BRAIN, V131, P2094, DOI 10.1093/brain/awn112; SCATTON B, 1983, BRAIN RES, V275, P321, DOI 10.1016/0006-8993(83)90993-9; Schirmbeck F, 2011, PSYCHOL MED, V41, P2361, DOI 10.1017/S0033291711000419; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Spencer TJ, 2006, J CLIN PSYCHIAT, V67, P415, DOI 10.4088/JCP.v67n0312; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sugden C, 2012, ANN SURG, V255, P222, DOI 10.1097/SLA.0b013e3182306c99; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Takeuchi H, 2012, NEUROIMAGE, V59, P2899, DOI 10.1016/j.neuroimage.2011.09.064; Temel Y, 2009, EXP NEUROL, V216, P481, DOI 10.1016/j.expneurol.2009.01.007; Voon V, 2011, CURR OPIN NEUROL, V24, P324, DOI 10.1097/WCO.0b013e3283489687; Voon V, 2010, NEURON, V65, P135, DOI 10.1016/j.neuron.2009.12.027; Voon V, 2010, PSYCHOPHARMACOLOGY, V207, P645, DOI 10.1007/s00213-009-1697-y; Voon V, 2009, LANCET NEUROL, V8, P1140, DOI 10.1016/S1474-4422(09)70287-X; Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969; Weintraub D, 2010, ANN NEUROL, V68, P963, DOI 10.1002/ana.22164; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092; Williams-Gray CH, 2007, J NEUROSCI, V27, P4832, DOI 10.1523/JNEUROSCI.0774-07.2007; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Wolters EC, 2008, J NEUROL, V255, P48, DOI 10.1007/s00415-008-5010-5; Zapata MA, 2011, ADICCIONES, V23, P17, DOI 10.20882/adicciones.163	136	75	75	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85747	10.1371/journal.pone.0085747	http://dx.doi.org/10.1371/journal.pone.0085747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465678	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500103
J	Javle, M; Li, YN; Tan, DF; Dong, XQ; Chang, P; Kar, S; Li, DH				Javle, Milind; Li, Yanan; Tan, Dongfeng; Dong, Xiaoqun; Chang, Ping; Kar, Siddhartha; Li, Donghui			Biomarkers of TGF-beta Signaling Pathway and Prognosis of Pancreatic Cancer	PLOS ONE			English	Article							PREOPERATIVE PLASMA-LEVELS; REPAIR GENE POLYMORPHISMS; TUMOR MICROENVIRONMENT; ENHANCED EXPRESSION; DISEASE PROGRESSION; BREAST-CANCER; DPC4 GENE; CARCINOMA; TGF-BETA(1); SURVIVAL	Background: Transforming growth factor (TGF)-beta signaling pathway, may act both as a tumor suppressor and as a tumor promoter in pancreatic cancer, depending on tumor stage and cellular context. TGF-beta pathway has been under intensive investigation as a potential therapeutic target in the treatment of cancer. We hypothesized a correlation between TGF-beta R2/SMAD4 expression in the tumor, plasma TGF-beta 1 ligand level, genetic variation in TGF-B pathway and prognosis of pancreatic cancer. Method: We examined TGF-beta R2 and SMAD4 protein expression in biopsy or surgical samples from 91 patients with pancreatic ductal adenocarcinoma (PDAC) using immunohistochemistry. Plasma level of TGF-beta 1 was measured in 644 patients with PDAC using ELISA. Twenty-eight single nucleotide polymorphisms (SNP) of the TGF-beta 1, TGF-beta 2, TGF-beta 3, TGF-beta R1, TGF-beta R2, and SMAD4 genes were determined in 1636 patients with PDAC using the Sequenom method. Correlation between protein expression in the tumor, plasma TGF-beta 1 level, and genotypes with overall survival (OS) was evaluated with Cox proportional regression models. Results: The expression level of TGF-beta R2 and SMAD4 as an independent marker was not associated with OS. However, patients with both low nuclear staining of TGF-beta R2 and high nuclear staining of SMAD4 may have better survival (P = 0.06). The mean and median level of TGF-beta 1 was 15.44 (SD: 10.99) and 12.61 (interquartile range: 8.31 to 19.04) ng/ml respectively. Patients with advanced disease and in the upper quartile range of TGF-beta 1 level had significantly reduced survival than those with low levels (P = 0.02). A significant association of SMAD4 SNP rs113545983 with overall survival was observed (P<0.0001). Conclusion: Our data provides valuable baseline information regarding the TGF-beta pathway in pancreatic cancer, which can be utilized in targeted therapy clinical trials. High TGF-beta 1 plasma level, SMAD4 SNP or TGF-beta R2/SMAD4 tumor protein expression may suggest a dependence on this pathway in patients with advanced pancreatic cancer.	[Javle, Milind; Li, Yanan; Dong, Xiaoqun; Chang, Ping; Kar, Siddhartha; Li, Donghui] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Tan, Dongfeng] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Javle, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA.	mjavle@mdanderson.org; dli@mdanderson.org		Kar, Siddhartha P./0000-0002-2314-1426	Imclone Corporation/Eli Lilly; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA130821] Funding Source: NIH RePORTER	Imclone Corporation/Eli Lilly; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from Imclone Corporation/Eli Lilly and by Donor Funds, a collection of funds from patients with pancreatic cancer or from their families. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Bhayal AC, 2011, TUMOR BIOL, V32, P1049, DOI 10.1007/s13277-011-0208-z; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Crane CH, 2011, J CLIN ONCOL, V29, P3037, DOI 10.1200/JCO.2010.33.8038; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dong XQ, 2009, J CLIN ONCOL, V27, P1592, DOI 10.1200/JCO.2008.20.1111; Fang F, 2010, MED ONCOL, V27, P1324, DOI 10.1007/s12032-009-9383-9; FRIESS H, 1993, CANCER RES, V53, P2704; FRIESS H, 1993, GASTROENTEROLOGY, V105, P1846, DOI 10.1016/0016-5085(93)91084-U; Fukuchi M, 2004, CLIN CANCER RES, V10, P2738, DOI 10.1158/1078-0432.CCR-1096-03; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hua Z, 2003, WORLD J GASTROENTERO, V9, P2764; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Ijichi H, 2001, BIOCHEM BIOPH RES CO, V289, P350, DOI 10.1006/bbrc.2001.5988; Ivanovic V, 2003, EUR J CANCER, V39, P454, DOI 10.1016/S0959-8049(02)00502-6; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Joshi A, 2010, FRONT BIOSCI-LANDMRK, V15, P180, DOI 10.2741/3614; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Li DH, 2009, CLIN CANCER RES, V15, P740, DOI 10.1158/1078-0432.CCR-08-1607; Lin MB, 2011, CARCINOGENESIS, V32, P1050, DOI 10.1093/carcin/bgr067; Schutte M, 1996, CANCER RES, V56, P2527; Scollen S, 2011, CANCER EPIDEM BIOMAR, V20, P1112, DOI 10.1158/1055-9965.EPI-11-0062; Shariat SF, 2001, J CLIN ONCOL, V19, P2856, DOI 10.1200/JCO.2001.19.11.2856; Shariat SF, 2001, CANCER-AM CANCER SOC, V92, P2985, DOI 10.1002/1097-0142(20011215)92:12<2985::AID-CNCR10175>3.0.CO;2-5; Smith RA, 2011, BRIT J CANCER, V104, P1440, DOI 10.1038/bjc.2011.110; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wang Y, 2013, DIGEST DIS SCI, V58, P1644, DOI 10.1007/s10620-012-2550-4; Yin JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025559	31	85	88	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85942	10.1371/journal.pone.0085942	http://dx.doi.org/10.1371/journal.pone.0085942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465802	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500092
J	Rengarajan, C; Matzke, A; Reiner, L; Orian-Rousseau, V; Scholpp, S				Rengarajan, Charanya; Matzke, Alexandra; Reiner, Luisa; Orian-Rousseau, Veronique; Scholpp, Steffen			Endocytosis of Fgf8 Is a Double-Stage Process and Regulates Spreading and Signaling	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MIDBRAIN-HINDBRAIN BOUNDARY; CLATHRIN-COATED VESICLES; FACTOR RECEPTOR; DOWN-REGULATION; MEDIATED ENDOCYTOSIS; MORPHOGEN GRADIENT; ZEBRAFISH; INTERNALIZATION; PROTEIN	Tightly controlled concentration gradients of morphogens provide positional information and thus regulate tissue differentiation and morphogenesis in multicellular organisms. However, how such morphogenetic fields are formed and maintained remains debated. Here we show that fibroblast growth factor 8 (Fgf8) morphogen gradients in zebrafish embryos are established and maintained by two essential mechanisms. Firstly, Fgf8 is taken up into the cell by clathrin-mediated endocytosis. The speed of the uptake rate defines the range of the morphogenetic gradient of Fgf8. Secondly, our data demonstrate that after endocytosis the routing of Fgf8 from the early endosome to the late endosome shuts down signaling. Therefore, intracellular endocytic transport regulates the intensity and duration of Fgf8 signaling. We show that internalization of Fgf8 into the early endosome and subsequent transport towards the late endosome are two independent processes. Therefore, we hypothesize that Fgf8 receiving cells control both, the propagation width and the signal strength of the morphogen.	[Rengarajan, Charanya; Matzke, Alexandra; Reiner, Luisa; Orian-Rousseau, Veronique; Scholpp, Steffen] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Scholpp, S (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany.	steffen.scholpp@kit.edu	Scholpp, Steffen/H-2060-2013; Scholpp, Steffen/E-4472-2018; Orian-Rousseau, Véronique/H-5735-2013	Scholpp, Steffen/0000-0002-4903-9657; Scholpp, Steffen/0000-0002-4903-9657; Orian-Rousseau, Véronique/0000-0003-2939-9257	DFG Emmy Noether fellowship [847/2]	DFG Emmy Noether fellowship(German Research Foundation (DFG))	CR, LR and SS were supported by the DFG Emmy Noether fellowship 847/2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auciello G, 2013, J CELL SCI, V126, P613, DOI 10.1242/jcs.116228; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; Belleudi F, 2002, HISTOCHEM CELL BIOL, V118, P1, DOI 10.1007/S00418-002-0424-0; BIKFALVI A, 1989, EXP CELL RES, V181, P75, DOI 10.1016/0014-4827(89)90183-3; Blader P, 1997, SCIENCE, V278, P1937, DOI 10.1126/science.278.5345.1937; Bokel C, 2013, CURR OPIN GENET DEV, V23, P415, DOI 10.1016/j.gde.2013.03.002; Boilly B, 2000, CYTOKINE GROWTH F R, V11, P295, DOI 10.1016/S1359-6101(00)00014-9; BRAND M, 2002, ZEBRAFISH KEEPING RA; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; Citores L, 1999, MOL BIOL CELL, V10, P3835, DOI 10.1091/mbc.10.11.3835; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Esain V, 2010, DEVELOPMENT, V137, P33, DOI 10.1242/dev.038026; Gleizes PE, 1996, EUR J CELL BIOL, V71, P144; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Haugsten EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021708; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Kataoka A, 2008, DEVELOPMENT, V135, P2873, DOI 10.1242/dev.021618; Kim GY, 2012, MOL CELL BIOL, V32, P4482, DOI 10.1128/MCB.00872-12; Kirchhausen T, 2012, NAT CELL BIOL, V14, P906, DOI 10.1038/ncb2570; Kural C, 2012, METHOD ENZYMOL, V505, P59, DOI 10.1016/B978-0-12-388448-0.00012-7; Marchese C, 1998, J CELL SCI, V111, P3517; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Miraoui H, 2011, MOL CELL ENDOCRINOL, V346, P37, DOI 10.1016/j.mce.2011.05.042; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Molina GA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-62; Monsonego-Ornan E, 2002, FEBS LETT, V528, P83, DOI 10.1016/S0014-5793(02)03255-6; MORI S, 1995, BIOCHEM BIOPH RES CO, V213, P32, DOI 10.1006/bbrc.1995.2094; Moscatelli D, 1990, GROWTH FACTORS, V3, DOI 10.3109/08977199009037499; Mott NN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010143; Muller P, 2013, DEVELOPMENT, V140, P1621, DOI 10.1242/dev.083519; Muller P, 2011, DEV CELL, V21, P145, DOI 10.1016/j.devcel.2011.06.001; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Nowak M, 2011, NAT CELL BIOL, V13, P153, DOI 10.1038/ncb2155; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; Reifers F, 1998, DEVELOPMENT, V125, P2381; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; Scholpp S, 2004, DEV GENES EVOL, V214, P285, DOI 10.1007/s00427-004-0409-1; Scholpp S, 2003, DEV DYNAM, V228, P313, DOI 10.1002/dvdy.10384; Scholpp S, 2004, CURR BIOL, V14, P1834, DOI 10.1016/j.cub.2004.09.084; SOROKIN A, 1994, J BIOL CHEM, V269, P17056; Steinberg F, 2010, J BIOL CHEM, V285, P2193, DOI 10.1074/jbc.M109.058248; STOSCHECK CM, 1984, J CELL BIOL, V98, P1048, DOI 10.1083/jcb.98.3.1048; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; Vecchione A, 2007, PROTEOMICS, V7, P4565, DOI 10.1002/pmic.200700615; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wiedlocha A, 2004, CURR TOP MICROBIOL, V286, P45; Wong A, 2002, P NATL ACAD SCI USA, V99, P6684, DOI 10.1073/pnas.052138899; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	61	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86373	10.1371/journal.pone.0086373	http://dx.doi.org/10.1371/journal.pone.0086373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24466061	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500129
J	Rodrigues, JHD; Ueda-Nakamura, T; Correa, AG; Sangi, DP; Nakamura, CV				da Silva Rodrigues, Jean Henrique; Ueda-Nakamura, Tania; Correa, Arlene Goncalves; Sangi, Diego Pereira; Nakamura, Celso Vataru			A Quinoxaline Derivative as a Potent Chemotherapeutic Agent, Alone or in Combination with Benznidazole, against Trypanosoma cruzi	PLOS ONE			English	Article							IN-VITRO; SYNERGISTIC ACTIVITY; CELL-DEATH; AUTOPHAGY; DRUGS; EPIMASTIGOTE; PARTHENOLIDE; PATHOGENESIS; ECHINOMYCIN; TOXICITY	Background: Chagas' disease is a condition caused by the protozoan Trypanosoma cruzi that affects millions of people, mainly in Latin America where it is considered endemic. The chemotherapy for Chagas disease remains a problem; the standard treatment currently relies on a single drug, benznidazole, which unfortunately induces several side effects and it is not successful in the cure of most of the chronic patients. In order to improve the drug armamentarium against Chagas' disease, in the present study we describe the synthesis of the compound 3-chloro-7-methoxy-2-(methylsulfonyl) quinoxaline (quinoxaline 4) and its activity, alone or in combination with benznidazole, against Trypanosoma cruzi in vitro. Methodology/Principal Findings: Quinoxaline 4 was found to be strongly active against Trypanosoma cruzi Y strain and more effective against the proliferative forms. The cytotoxicity against LLCMK2 cells provided selective indices above one for all of the parasite forms. The drug induced very low hemolysis, but its anti-protozoan activity was partially inhibited when mouse blood was added in the experiment against trypomastigotes, an effect that was specifically related to blood cells. A synergistic effect between quinoxaline 4 and benznidazole was observed against epimastigotes and trypomastigotes, accompanied by an antagonistic interaction against LLCMK2 cells. Quinoxaline 4 induced several ultrastructural alterations, including formations of vesicular bodies, profiles of reticulum endoplasmic surrounding organelles and disorganization of Golgi complex. These alterations were also companied by cell volume reduction and maintenance of cell membrane integrity of treated-parasites. Conclusion/Significance: Our results demonstrated that quinoxaline 4, alone or in combination with benznidazole, has promising effects against all the main forms of T. cruzi. The compound at low concentrations induced several ultrastructural alterations and led the parasite to an autophagic-like cell death. Taken together these results may support the further development of a combination therapy as an alternative more effective in Chagas' disease treatment.	[da Silva Rodrigues, Jean Henrique] Univ Estadual Maringa, Programa Posgrad Ciencias Biol Biol Celular & Mol, Maringa, Parana, Brazil; [Ueda-Nakamura, Tania; Nakamura, Celso Vataru] Univ Estadual Maringa, Dept Ciencias Basicas Saude, Lab Inovacao Tecnol Desenvolvimento Farmacos & Co, Maringa, Parana, Brazil; [Correa, Arlene Goncalves; Sangi, Diego Pereira] Univ Fed Sao Carlos, Dept Quim, Lab Sintese Prod Nat, Sao Paulo, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Federal de Sao Carlos	Nakamura, CV (corresponding author), Univ Estadual Maringa, Dept Ciencias Basicas Saude, Lab Inovacao Tecnol Desenvolvimento Farmacos & Co, Maringa, Parana, Brazil.	cvnakamura@uem.br	Sangi, Diego/D-4056-2016; Nogal-Ruiz, Juan Jose/H-1908-2017; Ueda-Nakamura, Tania/P-8250-2015; Rodrigues, Jean Henrique/G-6277-2017; Correa, Arlene/C-1926-2012; Nakamura, Celso Vataru/AAA-5620-2019; ESCARIO, JOSE ANTONIO/AAD-5497-2022; Gómez-Barrio, Alicia/K-1810-2014	Nogal-Ruiz, Juan Jose/0000-0002-8714-049X; Ueda-Nakamura, Tania/0000-0001-5057-3518; Rodrigues, Jean Henrique/0000-0003-2902-4578; Correa, Arlene/0000-0003-4247-2228; ESCARIO, JOSE ANTONIO/0000-0002-4742-2783; Gómez-Barrio, Alicia/0000-0002-0347-758X; Sangi, Diego/0000-0003-0388-5409	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (FINEP); Fundacao de Auxilio a Pesquisa do Estado de Sao Paulo (FAPESP); Trust in Science Project - GlaxoSmithKline (GSK); Programa de Pos-Graduacao em Ciencias Biologicas; Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM) da Universidade Estadual de Maringa	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Auxilio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Trust in Science Project - GlaxoSmithKline (GSK); Programa de Pos-Graduacao em Ciencias Biologicas; Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM) da Universidade Estadual de Maringa	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Financiadora de Estudos e Projetos (FINEP), Fundacao de Auxilio a Pesquisa do Estado de Sao Paulo (FAPESP), Trust in Science Project - GlaxoSmithKline (GSK), Programa de Pos-Graduacao em Ciencias Biologicas and Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM) da Universidade Estadual de Maringa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS NW, 1982, J PROTOZOOL, V29, P264, DOI 10.1111/j.1550-7408.1982.tb04024.x; [Anonymous], 2012, C PART WHO FRAM CONV, P1; Barea C, 2012, MOLECULES, V17, P9451, DOI 10.3390/molecules17089451; Barrett MP, 2012, BRIT MED BULL, V104, P175, DOI 10.1093/bmb/lds031; Becerra MC, 2012, EXP PARASITOL, V131, P57, DOI 10.1016/j.exppara.2012.02.028; Benaim G, 2006, J MED CHEM, V49, P892, DOI 10.1021/jm050691f; Silva CMBL, 2012, CHEM PHARM BULL, V60, P1372, DOI 10.1248/cpb.c12-00356; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; Burscha W, 2008, TOXICOLOGY, V254, P147, DOI 10.1016/j.tox.2008.07.048; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Cencig S, 2012, INT J ANTIMICROB AG, V40, P527, DOI 10.1016/j.ijantimicag.2012.08.002; Chaabane W, 2013, ARCH IMMUNOL THER EX, V61, P43, DOI 10.1007/s00005-012-0205-y; Chen LL, 2011, ANTIVIR RES, V91, P314, DOI 10.1016/j.antiviral.2011.07.008; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P549, DOI 10.1590/S0074-02762009000400002; Espinosa A, 2012, PARASITOL RES, V111, P2473, DOI 10.1007/s00436-012-3019-2; Estevez Y, 2011, EXP PARASITOL, V127, P745, DOI 10.1016/j.exppara.2011.01.009; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Fernandes MC, 2012, PARASITOLOGY, V139, P26, DOI 10.1017/S0031182011001612; Font M, 1997, Drug Des Discov, V14, P305; Ishikawa H, 2012, BIOORG CHEM, V41-42, P1, DOI 10.1016/j.bioorg.2011.12.002; Izumi E, 2008, EXP PARASITOL, V118, P324, DOI 10.1016/j.exppara.2007.08.015; Izumi E, 2012, J MED CHEM, V55, P2994, DOI 10.1021/jm201451h; Izumi E, 2011, NAT PROD REP, V28, P809, DOI 10.1039/c0np00069h; Jeon YW, 2013, ONCOL REP, V29, P819, DOI 10.3892/or.2012.2158; Kim YB, 2004, BIOORG MED CHEM LETT, V14, P541, DOI 10.1016/j.bmcl.2003.09.086; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Krantz A, 1997, BLOOD CELL MOL DIS, V23, P58, DOI 10.1006/bcmd.1997.0119; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; LOPES JN, 1978, ANN TROP MED PARASIT, V72, P523, DOI 10.1080/00034983.1978.11719356; Loyse A, 2012, CLIN INFECT DIS, V54, P121, DOI 10.1093/cid/cir745; Macedo AM, 2004, MEM I OSWALDO CRUZ, V99, P1, DOI 10.1590/S0074-02762004000100001; MALDONADO RA, 1993, ANTIMICROB AGENTS CH, V37, P1353, DOI 10.1128/AAC.37.6.1353; Maya JD, 2007, COMP BIOCHEM PHYS A, V146, P601, DOI 10.1016/j.cbpa.2006.03.004; Menna-Barreto RFS, 2009, FREE RADICAL BIO MED, V47, P644, DOI 10.1016/j.freeradbiomed.2009.06.004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nahid Payam, 2006, Proc Am Thorac Soc, V3, P103, DOI 10.1513/pats.200511-119JH; Park KS, 2012, CLIN RHEUMATOL, V31, P317, DOI 10.1007/s10067-011-1818-y; Pelizzaro-Rocha KJ, 2010, PHYTOMEDICINE, V18, P36, DOI 10.1016/j.phymed.2010.09.005; Perez-Mazliah DE, 2012, J ANTIMICROB CHEMOTH, V1, P1; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Reiners JJ, 2009, J PHARMACOL EXP THER, V328, P796, DOI 10.1124/jpet.108.144808; Sangi DP, 2010, J BRAZIL CHEM SOC, V21, P795, DOI 10.1590/S0103-50532010000500005; Schrijvers D, 2003, CLIN PHARMACOKINET, V42, P779, DOI 10.2165/00003088-200342090-00001; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Urbina JA, 2010, ACTA TROP, V115, P55, DOI 10.1016/j.actatropica.2009.10.023; Valdez RH, 2012, ANTIMICROB AGENTS CH, V56, P507, DOI 10.1128/AAC.05575-11; van der Vaart A, 2010, AUTOPHAGY, V6, P800, DOI 10.1091/mbc.E09-04-0345; Veiga-Santos P, 2010, PARASITOLOGY, V137, P1661, DOI 10.1017/S003118201000034X; Venkatesh C, 2005, ORG LETT, V7, P2169, DOI 10.1021/ol0505095; Larrea SCV, 2011, INT J PARASITOL, V41, P405, DOI 10.1016/j.ijpara.2010.11.008; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Zhao Liang, 2010, Front Biosci (Elite Ed), V2, P241, DOI 10.2741/e86	56	47	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85706	10.1371/journal.pone.0085706	http://dx.doi.org/10.1371/journal.pone.0085706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465654	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000052
J	Guo, WW; Yan, LC; Yang, L; Liu, XY; E, QK; Gao, PY; Ye, XF; Liu, W; Zuo, J				Guo, Weiwei; Yan, Lichong; Yang, Ling; Liu, Xiaoyu; E, Qiukai; Gao, Peiye; Ye, Xiaofei; Liu, Wen; Zuo, Ji			Targeting GRP75 Improves HSP90 Inhibitor Efficacy by Enhancing p53-Mediated Apoptosis in Hepatocellular Carcinoma	PLOS ONE			English	Article							CANCER-CELLS; MOLECULAR CHAPERONE; ELEVATED LEVELS; MORTALIN; EXPRESSION; BINDING; HSP70; ACTIVATION; MUTATIONS; PROTEINS	Heat shock protein 90 (HSP90) inhibitors are potential drugs for cancer therapy. The inhibition of HSP90 on cancer cell growth largely through degrading client proteins, like Akt and p53, therefore, triggering cancer cell apoptosis. Here, we show that the HSP90 inhibitor 17-AAG can induce the expression of GRP75, a member of heat shock protein 70 (HSP70) family, which, in turn, attenuates the anti-growth effect of HSP90 inhibition on cancer cells. Additionally, 17-AAG enhanced binding of GRP75 and p53, resulting in the retention of p53 in the cytoplasm. Blocking GRP75 with its inhibitor MKT-077 potentiated the anti-tumor effects of 17-AAG by disrupting the formation of GRP75-p53 complexes, thereby facilitating translocation of p53 into the nuclei and leading to the induction of apoptosis-related genes. Finally, dual inhibition of HSP90 and GRP75 was found to significantly inhibit tumor growth in a liver cancer xenograft model. In conclusion, the GRP75 inhibitor MKT-077 enhances 17-AAG-induced apoptosis in HCCs and increases p53-mediated inhibition of tumor growth in vivo. Dual targeting of GRP75 and HSP90 may be a useful strategy for the treatment of HCCs.	[Guo, Weiwei; Yan, Lichong; Yang, Ling; Liu, Xiaoyu; E, Qiukai; Gao, Peiye; Ye, Xiaofei; Liu, Wen; Zuo, Ji] Fudan Univ, Sch Basic Med Sci, Dept Cellular & Genet Med, Shanghai 200433, Peoples R China	Fudan University	Liu, W (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Cellular & Genet Med, Shanghai 200433, Peoples R China.	liuwen@shmu.edu.cn; jzuo@shmu.edu.cn			National Natural Science Foundation of China [81000978]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81000978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Ayrault O, 2009, P NATL ACAD SCI USA, V106, P17037, DOI 10.1073/pnas.0902880106; Beliveau A, 2007, CELL CYCLE, V6, P1284, DOI 10.4161/cc.6.11.4298; Breinig M, 2009, HEPATOLOGY, V50, P102, DOI 10.1002/hep.22912; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Deocaris CC, 2007, CANCER LETT, V252, P259, DOI 10.1016/j.canlet.2006.12.038; Dimopoulos MA, 2011, CL LYMPH MYELOM LEUK, V11, P17, DOI 10.3816/CLML.2011.n.002; Drakos E, 2009, LEUKEMIA, V23, P784, DOI 10.1038/leu.2008.348; Ferenci P, 2010, J CLIN GASTROENTEROL, V44, P239, DOI 10.1097/MCG.0b013e3181d46ef2; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gooljarsingh LT, 2006, P NATL ACAD SCI USA, V103, P7625, DOI 10.1073/pnas.0602650103; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kaul SC, 2001, NEOPLASIA, V3, P110, DOI 10.1038/sj.neo.7900139; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Langer CJ, 2013, CANCER TREAT REV, V39, P252, DOI 10.1016/j.ctrv.2012.05.003; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Maloney A, 2007, CANCER RES, V67, P3239, DOI 10.1158/0008-5472.CAN-06-2968; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; ORNATSKY OI, 1995, BIOCHEM J, V311, P119, DOI 10.1042/bj3110119; Pascale RM, 2005, HEPATOLOGY, V42, P1310, DOI 10.1002/hep.20962; Pimienta G, 2011, MOL PHARMACEUT, V8, P2252, DOI 10.1021/mp200346y; Pizzatti L, 2006, BBA-PROTEINS PROTEOM, V1764, P929, DOI 10.1016/j.bbapap.2006.02.004; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Propper DJ, 1999, ANN ONCOL, V10, P923, DOI 10.1023/A:1008336904585; Rozenberg P, 2013, INT J CANCER, V133, P514, DOI 10.1002/ijc.28029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCORSONE KA, 1992, CANCER RES, V52, P1635; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Sharp SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044642; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Takano S, 1997, EXP CELL RES, V237, P38, DOI 10.1006/excr.1997.3754; Teufel A, 2007, WORLD J GASTROENTERO, V13, P2271, DOI 10.3748/wjg.v13.i16.2271; Vadlakonda L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00165; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wadhwa R, 2004, J GENE MED, V6, P439, DOI 10.1002/jgm.530; Wadhwa R, 2002, EXP CELL RES, V274, P246, DOI 10.1006/excr.2002.5468; Wadhwa R, 2000, CANCER RES, V60, P6818; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Xu J, 1999, ONCOL RES, V11, P429; Yang L, 2008, ACTA BIOCH BIOPH SIN, V40, P339, DOI 10.1111/j.1745-7270.2008.00409.x; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200	48	21	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85766	10.1371/journal.pone.0085766	http://dx.doi.org/10.1371/journal.pone.0085766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465691	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000061
J	Samuel, ER; Beloki, L; Newton, K; Mackinnon, S; Lowdell, MW				Samuel, Edward R.; Beloki, Lorea; Newton, Katy; Mackinnon, Stephen; Lowdell, Mark W.			Isolation of Highly Suppressive CD25+FoxP3+T Regulatory Cells from G-CSF-Mobilized Donors with Retention of Cytotoxic Anti-Viral CTLs: Application for Multi-Functional Immunotherapy Post Stem Cell Transplantation	PLOS ONE			English	Article							CD8(+) T-CELLS; IMMUNOLOGICAL SELF-TOLERANCE; ALLOGENEIC BONE-MARROW; CYTOMEGALOVIRUS-INFECTION; ADOPTIVE TRANSFER; REACTIVE CD4(+); EX-VIVO; ANTIGEN; LYMPHOCYTES; EXPANSION	Previous studies have demonstrated the effective control of cytomegalovirus (CMV) infections post haematopoietic stem cell transplant through the adoptive transfer of donor derived CMV-specific T cells (CMV-T). Strategies for manufacturing CMV immunotherapies has involved a second leukapheresis or blood draw from the donor, which in the unrelated donor setting is not always possible. We have investigated the feasibility of using an aliquot of the original G-CSF-mobilized graft as a starting material for manufacture of CMV-T and examined the activation marker CD25 as a targeted approach for identification and isolation following CMVpp65 peptide stimulation. CD25+ cells isolated from G-CSF-mobilized apheresis revealed a significant increase in the proportion of FoxP3 expression when compared with conventional non-mobilized CD25+ cells and showed a superior suppressive capacity in a T cell proliferation assay, demonstrating the emergence of a population of Tregs not present in non-mobilized apheresis collections. The expansion of CD25+ CMV-T in short-term culture resulted in a mixed population of CD4+ and CD8+ T cells with CMV-specificity that secreted cytotoxic effector molecules and lysed CMVpp65 peptide-loaded phytohaemagglutinin-stimulated blasts. Furthermore CD25 expanded cells retained their suppressive capacity but did not maintain FoxP3 expression or secrete IL-10. In summary our data indicates that CD25 enrichment post CMV stimulation in G-CSF-mobilized PBMCs results in the simultaneous generation of both a functional population of anti-viral T cells and Tregs thus illustrating a potential single therapeutic strategy for the treatment of both GvHD and CMV reactivation following allogeneic haematopoietic stem cell transplantation. The use of G-CSF-mobilized cells as a starting material for cell therapy manufacture represents a feasible approach to alleviating the many problems incurred with successive donations and procurement of cells from unrelated donors. This approach may therefore simplify the clinical application of adoptive immunotherapy and broaden the approach for manufacturing multi-functional T cells.	[Samuel, Edward R.; Mackinnon, Stephen; Lowdell, Mark W.] UCL, Dept Haematol, London, England; [Beloki, Lorea] Navarrabiomed Miguel Servet Fdn, Oncohematol Res Grp, Pamplona, Spain; [Newton, Katy] Cell Med Ltd, London, England; [Newton, Katy] UCL, London, England; [Lowdell, Mark W.] Royal Free London NHS Fdn Trust, London, England	University of London; University College London; Navarrabiomed; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust	Samuel, ER (corresponding author), UCL, Dept Haematol, Royal Free Campus, London, England.	edward.samuel@ucl.ac.uk	Mackinnon, Stephen/C-5559-2008		UK Government Technology Strategy Board translational award	UK Government Technology Strategy Board translational award	The study was supported by a UK Government Technology Strategy Board translational award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbi KKS, 2013, BONE MARROW TRANSPL, V48, P357, DOI 10.1038/bmt.2012.144; Adeegbe DO, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00190; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Arpinati M, 2000, BLOOD, V95, P2484, DOI 10.1182/blood.V95.8.2484; Brincks EL, 2013, J IMMUNOL, V190, P3438, DOI 10.4049/jimmunol.1203140; Chakrabarti S, 2002, BLOOD, V99, P4357, DOI 10.1182/blood.V99.12.4357; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Clancy LE, 2013, BIOL BLOOD MARROW TR, V19, P725, DOI 10.1016/j.bbmt.2013.01.021; Cobbold M, 2005, J EXP MED, V202, P379, DOI 10.1084/jem.20040613; Di Ianni M, 2011, BLOOD, V117, P3921, DOI 10.1182/blood-2010-10-311894; Einsele H, 2002, BLOOD, V99, P3916, DOI 10.1182/blood.V99.11.3916; Feuchtinger T, 2004, EXP HEMATOL, V32, P282, DOI 10.1016/j.exphem.2003.12.009; Feuchtinger T, 2010, BLOOD, V116, P4360, DOI 10.1182/blood-2010-01-262089; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gallot G, 2001, J IMMUNOL, V167, P4196, DOI 10.4049/jimmunol.167.8.4196; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; KITABAYASHI A, 1995, BLOOD, V86, P2220, DOI 10.1182/blood.V86.6.2220.bloodjournal8662220; Leen AM, 2006, NAT MED, V12, P1160, DOI 10.1038/nm1475; Levine JE, 2002, J CLIN ONCOL, V20, P405, DOI 10.1200/JCO.20.2.405; Litjens NHR, 2012, J IMMUNOL, V188, P1083, DOI 10.4049/jimmunol.1101974; Lugthart G, 2012, J IMMUNOTHER, V35, P42, DOI 10.1097/CJI.0b013e31823569e2; Melenhorst JJ, 2008, CYTOTHERAPY, V10, P152, DOI 10.1080/14653240701853536; Micklethwaite K, 2007, BIOL BLOOD MARROW TR, V13, P707, DOI 10.1016/j.bbmt.2007.02.004; Moosmann A, 2010, BLOOD, V115, P2960, DOI 10.1182/blood-2009-08-236356; Nguyen VH, 2008, BLOOD, V111, P945, DOI 10.1182/blood-2007-07-103895; Pan LP, 1999, BLOOD, V93, P4071, DOI 10.1182/blood.V93.12.4071.412k41_4071_4078; Peggs KS, 2011, CLIN INFECT DIS, V52, P49, DOI 10.1093/cid/ciq042; Peggs KS, 2003, LANCET, V362, P1375, DOI 10.1016/S0140-6736(03)14634-X; Powell DJ, 2005, J IMMUNOTHER, V28, P403, DOI 10.1097/01.cji.0000170363.22585.5a; REUSSER P, 1991, BLOOD, V78, P1373; RIDDELL SR, 1992, SCIENCE, V257, P238; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Samuel ER, 2013, BRIT J HAEMATOL, V160, P87, DOI 10.1111/bjh.12082; Sloand EM, 2000, BLOOD, V95, P2269, DOI 10.1182/blood.V95.7.2269.007k37_2269_2274; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Tayebi H, 2001, EXP HEMATOL, V29, P458, DOI 10.1016/S0301-472X(01)00613-0; Toh HC, 2009, CLIN IMMUNOL, V132, P83, DOI 10.1016/j.clim.2009.03.509; Tovar-Salazar A, 2010, VIROLOGY, V398, P158, DOI 10.1016/j.virol.2009.11.038; Ukena SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051644; Walker MR, 2005, P NATL ACAD SCI USA, V102, P4103, DOI 10.1073/pnas.0407691102; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Watanabe K, 2008, INT J HEMATOL, V88, P311, DOI 10.1007/s12185-008-0134-z; Wehler TC, 2008, J IMMUNOL METHODS, V339, P23, DOI 10.1016/j.jim.2008.07.017; Wolfl M, 2007, BLOOD, V110, P201, DOI 10.1182/blood-2006-11-056168	48	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85911	10.1371/journal.pone.0085911	http://dx.doi.org/10.1371/journal.pone.0085911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465783	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000074
J	Bar-Kochva, I; Breznitz, Z				Bar-Kochva, Irit; Breznitz, Zvia			Reading Proficiency and Adaptability in Orthographic Processing: An Examination of the Effect of Type of Orthography Read on Brain Activity in Regular and Dyslexic Readers	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; DEVELOPMENTAL DYSLEXIA; TIME-COURSE; PHONEME CONVERSION; LEXICAL DECISION; ERP; HEBREW; IDENTIFICATION; TRANSLATION; PERCEPTION	Regular readers were found to adjust the routine of reading to the demands of processing imposed by different orthographies. Dyslexic readers may lack such adaptability in reading. This hypothesis was tested among readers of Hebrew, as Hebrew has two forms of script differing in phonological transparency. Event-related potentials were recorded from 24 regular and 24 dyslexic readers while they carried out a lexical decision task in these two forms of script. The two forms of script elicited distinct amplitudes and latencies at similar to 165 ms after target onset, and these effects were larger in regular than in dyslexic readers. These early effects appeared not to be merely a result of the visual difference between the two forms of script (the presence of diacritics). The next effect of form of script was obtained on amplitudes elicited at latencies associated with orthographic-lexical processing and the categorization of stimuli, and these appeared earlier in regular readers (similar to 340 ms) than in dyslexic readers (similar to 400 ms). The behavioral measures showed inferior reading skills of dyslexic readers compared to regular readers in reading of both forms of script. Taken together, the results suggest that although dyslexic readers are not indifferent to the type of orthography read, they fail to adjust the routine of reading to the demands of processing imposed by both a transparent and an opaque orthography.	[Bar-Kochva, Irit; Breznitz, Zvia] Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel	University of Haifa	Bar-Kochva, I (corresponding author), Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel.	iritbarkochva@gmail.com		Bar-Kochva, Irit/0000-0003-4895-3225	Edmond J. Safra Philanthropic Foundation	Edmond J. Safra Philanthropic Foundation	This study was supported by the Edmond J. Safra Philanthropic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhadi S., 2011, WRITING SYST RES, V3, P117, DOI [10.1093/wsr/wsr014, DOI 10.1093/WSR/WSR014]; APA (American Psychiatric Association), 1994, DIAQN STAT MAN OLM D; Balgur R., 1968, BASIC WORD LIST ELEM; Bar-Kochva I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036030; BENTIN S, 1989, J EXP PSYCHOL LEARN, V15, P61; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Brem S, 2005, NEUROREPORT, V16, P45, DOI 10.1097/00001756-200501190-00011; Breznitz Z, 2003, BRAIN LANG, V85, P486, DOI 10.1016/S0093-934X(03)00071-3; Breznitz Z., 2006, FLUENCY READING SYNC; BRUCK M, 1990, DEV PSYCHOL, V26, P439, DOI 10.1037/0012-1649.26.3.439; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Deutsch A, 1999, LANG COGNITIVE PROC, V14, P393, DOI 10.1080/016909699386284; FROST R, 1995, J EXP PSYCHOL LEARN, V21, P398, DOI 10.1037/0278-7393.21.2.398; Frost R, 2005, J EXP PSYCHOL LEARN, V31, P1293, DOI 10.1037/0278-7393.31.6.1293; Frost R, 1997, J EXP PSYCHOL LEARN, V23, P829, DOI 10.1037/0278-7393.23.4.829; Frost R, 1998, PSYCHOL BULL, V123, P71, DOI 10.1037/0033-2909.123.1.71; Frost R, 1994, EXP PSYCHOL LEARN ME, V20, P116; Frost R, 2009, WORD FREQUENCY DATAB; Frost R, 2005, BL HBK DEV PSYCHOL, P272, DOI 10.1002/9780470757642.ch15; Gratton G., 1983, ELECTROENCEPHALOGRAP, V5, P468, DOI DOI 10.1016/0013-4694(83)90135-9; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hu W, 2010, BRAIN, V133, P1694, DOI 10.1093/brain/awq106; Kast M, 2010, INT J PSYCHOPHYSIOL, V77, P59, DOI 10.1016/j.ijpsycho.2010.04.003; Katz L., 1992, ADV PSYCHOL, V94, P67, DOI [10.1016/S0166-4115(08)62789-2, DOI 10.1016/S0166-4115(08)62789-2]; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KORIAT A, 1984, ATTENTION PERFORM, V10, P227; KORIAT A, 1985, MEM COGNITION, V13, P37, DOI 10.3758/BF03198441; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; Maurer U, 2005, J COGNITIVE NEUROSCI, V17, P1532, DOI 10.1162/089892905774597218; Maurer U, 2007, BRAIN, V130, P3200, DOI 10.1093/brain/awm193; Maurer U, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-13; Mayseless N, 2011, CLIN NEUROPHYSIOL, V122, P284, DOI 10.1016/j.clinph.2010.06.029; NAVON D, 1981, J VERB LEARN VERB BE, V20, P97, DOI 10.1016/S0022-5371(81)90334-0; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; Proverbio AM, 2004, J COGNITIVE NEUROSCI, V16, P301, DOI 10.1162/089892904322984580; Proverbio AM, 2003, BRAIN LANG, V87, P412, DOI 10.1016/S0093-934X(03)00139-1; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Schneider W., 2002, E PRIME USERS GUIDE; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Shani M., 2006, ALEF AD TAF A Z DIAG; Shatil E., 2001, DICTATION TEST UNPUB; Shatil E., 1997, ONE MINUTE TES UNPUB; Shatil E., 2001, PHONOLOGICAL T UNPUB; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; SHIMRON J, 1982, READ RES QUART, V17, P210, DOI 10.2307/747484; Shimron J., 2006, READING HEBREW LANGU; Simon GG, 2004, INT J NEUROSCI, V114, P1401, DOI 10.1080/00207450490476057; Simon G, 2006, BRAIN RES, V1104, P141, DOI 10.1016/j.brainres.2006.05.071; Smolka E, 2006, COGN NEUROPSYCHOL, V23, P972, DOI 10.1080/02643290600654855; Spinelli D, 2002, CORTEX, V38, P179, DOI 10.1016/S0010-9452(08)70649-X; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; Wechsler D., 1997, WAIS 3 ADULT INTELLI; WOLF M, 1986, CHILD DEV, V57, P988, DOI 10.2307/1130373; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3; Zorzi M, 2012, P NATL ACAD SCI USA, V109, P11455, DOI 10.1073/pnas.1205566109	61	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86016	10.1371/journal.pone.0086016	http://dx.doi.org/10.1371/journal.pone.0086016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465844	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100096
J	Bonaldo, RM; Hay, ME				Bonaldo, Roberta M.; Hay, Mark E.			Seaweed-Coral Interactions: Variance in Seaweed Allelopathy, Coral Susceptibility, and Potential Effects on Coral Resilience	PLOS ONE			English	Article							MARINE PROTECTED AREAS; REGION-WIDE DECLINES; SCLERACTINIAN CORALS; DISEASE PREVALENCE; BENTHIC ALGAE; PHASE-SHIFTS; BAND DISEASE; REEF; COMPETITION; BIODIVERSITY	Tropical reefs are in global decline with seaweeds commonly replacing corals. Negative associations between macroalgae and corals are well documented, but the mechanisms involved, the dynamics of the interactions, and variance in effects of different macroalgal-coral pairings are poorly investigated. We assessed the frequency, magnitude, and dynamics of macroalgal-coral competition involving allelopathic and non-allelopathic macroalgae on three, spatially grouped pairs of no-take Marine Protected Areas (MPAs) and non-MPAs in Fiji. In non-MPAs, biomass of herbivorous fishes was 70-80% lower, macroalgal cover 4-9 fold higher, macroalgal-coral contacts 5-15 fold more frequent and 23-67 fold more extensive (measured as % of colony margin contacted by macroalgae), and coral cover 51-68% lower than in MPAs. Coral contacts with allelopathic macroalgae occurred less frequently than expected by chance across all sites, while contact with non-allelopathic macroalgae tended to occur more frequently than expected. Transplants of allelopathic macroalgae (Chlorodesmis fastigiata and Galaxaura filamentosa) against coral edges inflicted damage to Acropora aspera and Pocillopora damicornis more rapidly and extensively than to Porites cylindrica and Porites lobata, which appeared more resistant to these macroalgae. Montipora digitata experienced intermediate damage. Extent of damage from macroalgal contact was independent of coral colony size for each of the 10 macroalgal-coral pairings we established. When natural contacts with Galaxaura filamentosa were removed in the field, recovery was rapid for Porites lobata, but Pocillopora damicornis did not recover and damage continued to expand. As macroalgae increase on overfished tropical reefs, allelopathy could produce feedbacks that suppress coral resilience, prevent coral recovery, and promote the stability of algal beds in habitats previously available to corals.	[Bonaldo, Roberta M.; Hay, Mark E.] Georgia Tech, Sch Biol, Atlanta, GA 30332 USA; [Bonaldo, Roberta M.] Univ Sao Paulo, Dept Ecol, IB, Sao Paulo, Brazil	University System of Georgia; Georgia Institute of Technology; Universidade de Sao Paulo	Hay, ME (corresponding author), Georgia Tech, Sch Biol, Atlanta, GA 30332 USA.	mark.hay@biology.gatech.edu	Hay, Mark E/D-9752-2011	Hay, Mark E/0000-0002-6130-9349	National Science Foundation [OCE-0929119]; National Institutes of Health ICBG [U01-TW007401]; Teasley Endowment to Georgia Tech; FOGARTY INTERNATIONAL CENTER [U01TW007401, U19TW007401] Funding Source: NIH RePORTER; Directorate For Geosciences [0929119] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health ICBG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Teasley Endowment to Georgia Tech; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support was provided by National Science Foundation grant OCE-0929119, National Institutes of Health ICBG grant U01-TW007401, and the Teasley Endowment to Georgia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Andras TD, 2012, J CHEM ECOL, V38, P1203, DOI 10.1007/s10886-012-0204-9; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Barott KL, 2012, MAR ECOL PROG SER, V460, P1, DOI 10.3354/meps09874; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bender D, 2012, J EXP MAR BIOL ECOL, V429, P15, DOI 10.1016/j.jembe.2012.06.014; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Coral Cay Conservation L, 2005, FISH RES ASS REP KOR; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Edwards KF, 2011, ECOLOGY, V92, P2085, DOI 10.1890/11-0395.1; Fong P, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P241, DOI 10.1007/978-94-007-0114-4_17; FROESE R., 2012, FISHBASE; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Haapkyla J, 2007, J MAR BIOL ASSOC UK, V87, P403, DOI 10.1017/S0025315407055828; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; HAY ME, 1986, AM NAT, V128, P617, DOI 10.1086/284593; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; LANG J, 1973, B MAR SCI, V23, P260; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Littler MM, 2006, HARMFUL ALGAE, V4, P1092; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mantyka CS, 2007, MARINE ECOLOGY PROGR, V352, P117; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; McCook, 1998, REEF RES, V8, P5; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Morrow KM, 2013, MAR ECOL PROG SER, V488, P103, DOI 10.3354/meps10394; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Page C, 2006, DIS AQUAT ORGAN, V69, P41, DOI 10.3354/dao069041; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Rasher DB, 2012, OECOLOGIA, V169, P187, DOI 10.1007/s00442-011-2174-y; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; STRAUSS RE, 1979, T AM FISH SOC, V108, P344, DOI 10.1577/1548-8659(1979)108<344:REFIEI>2.0.CO;2; Team RDC, 2019, R LANG ENV STAT COMP; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; Urban MC, 2011, J ANIM ECOL, V80, P505, DOI 10.1111/j.1365-2656.2011.01838.x	62	74	74	2	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85786	10.1371/journal.pone.0085786	http://dx.doi.org/10.1371/journal.pone.0085786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465707	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100073
J	Han, HW; Chou, CM; Chu, CY; Cheng, CH; Yang, CH; Hung, CC; Hwang, PP; Lee, SJ; Liao, YF; Huang, CJ				Han, Hao-Wei; Chou, Chih-Ming; Chu, Cheng-Ying; Cheng, Chia-Hsiung; Yang, Chung-Hsiang; Hung, Chin-Chun; Hwang, Pung-Pung; Lee, Shyh-Jye; Liao, Yung-Feng; Huang, Chang-Jen			The Nogo-C2/Nogo Receptor Complex Regulates the Morphogenesis of Zebrafish Lateral Line Primordium through Modulating the Expression of dkk1b, a Wnt Signal Inhibitor	PLOS ONE			English	Article							CELL-MIGRATION; FAMILY-MEMBER; INNER-EAR; EMBRYONIC-DEVELOPMENT; NEGATIVE REGULATOR; AXON REGENERATION; MYELIN INHIBITORS; WNT/BETA-CATENIN; HEAD INDUCTION; NOGO RECEPTOR	The fish lateral line (LL) is a mechanosensory system closely related to the hearing system of higher vertebrates, and it is composed of several neuromasts located on the surface of the fish. These neuromasts can detect changes in external water flow, to assist fish in maintaining a stationary position in a stream. In the present study, we identified a novel function of Nogo/Nogo receptor signaling in the formation of zebrafish neuromasts. Nogo signaling in zebrafish, like that in mammals, involves three ligands and four receptors, as well as three co-receptors (TROY, p75, and LINGO-1). We first demonstrated that Nogo-C2, NgRH1a, p75, and TROY are able to form a Nogo-C2 complex, and that disintegration of this complex causes defective neuromast formation in zebrafish. Time-lapse recording of the CldnB::lynEGFP transgenic line revealed that functional obstruction of the Nogo-C2 complex causes disordered morphogenesis, and reduces rosette formation in the posterior LL (PLL) primordium during migration. Consistent with these findings, hair-cell progenitors were lost from the PLL primordium in p75, TROY, and Nogo-C2/NgRH1a morphants. Notably, the expression levels of pea3, a downstream marker of Fgf signaling, and dkk1b, a Wnt signaling inhibitor, were both decreased in p75, TROY, and Nogo-C2/NgRH1a morphants; moreover, dkk1b mRNA injection could rescue the defects in neuromast formation resulting from knockdown of p75 or TROY. We thus suggest that a novel Nogo-C2 complex, consisting of Nogo-C2, NgRH1a, p75, and TROY, regulates Fgf signaling and dkk1b expression, thereby ensuring stable organization of the PLL primordium.	[Han, Hao-Wei; Huang, Chang-Jen] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Han, Hao-Wei; Chu, Cheng-Ying; Yang, Chung-Hsiang; Hung, Chin-Chun; Huang, Chang-Jen] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Chou, Chih-Ming; Cheng, Chia-Hsiung] Taipei Med Univ, Dept Biochem, Taipei, Taiwan; [Hwang, Pung-Pung; Liao, Yung-Feng] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Lee, Shyh-Jye] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Taipei Medical University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Liao, YF (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	yliao@sinica.edu.tw; cjibc@gate.sinica.edu.tw	Cheng, Chia-Hsiung/A-6044-2019; hwang, pp/A-3641-2011; Hwang, Pung-Pung/AAH-1538-2022; Lee, Shyh-Jye/C-6092-2008; Liao, Yung-Feng/A-9761-2011; Hwang, Pung-Pung/AEQ-4633-2022; Hung, Chin-Chun/G-8879-2019	Lee, Shyh-Jye/0000-0001-8452-9152; Cheng, Chia-Hsiung/0000-0003-0307-9650; Hung, Chin-Chun/0000-0003-4769-7194	Academia Sinica and one [AS-95-TP-B02]; National Science Council, Taipei, Taiwan [NSC97-2313-B-001-002-MY3]; NSC (National Science Council), Taiwan [100-2321-B-001-030]	Academia Sinica and one; National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); NSC (National Science Council), Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant (AS-95-TP-B02) from Academia Sinica and one (NSC97-2313-B-001-002-MY3) from the National Science Council, Taipei, Taiwan. The authors thank the Taiwan Zebrafish Core Facility at Academia Sinica (ZCAS), which is supported by the NSC (National Science Council, NSC 100-2321-B-001-030), Taiwan, for providing AB wild type zebrafish. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre D, 1999, P NATL ACAD SCI USA, V96, P7558, DOI 10.1073/pnas.96.13.7558; Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Brosamle C, 2009, MOL CELL NEUROSCI, V40, P401, DOI 10.1016/j.mcn.2008.10.009; Chen XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029515; Chen YC, 2010, NUCLEIC ACIDS RES, V38, P4635, DOI 10.1093/nar/gkq230; Chou CM, 2006, BIOCHEM BIOPH RES CO, V340, P767, DOI 10.1016/j.bbrc.2005.12.090; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Diekmann H, 2005, MOL BIOL EVOL, V22, P1635, DOI 10.1093/molbev/msi158; Dorsky RI, 1999, MECH DEVELOP, V86, P147, DOI 10.1016/S0925-4773(99)00101-X; Fafilek B, 2013, GASTROENTEROLOGY, V144, P381, DOI 10.1053/j.gastro.2012.10.048; Feng Y, 2010, DEV BIOL, V339, P507, DOI 10.1016/j.ydbio.2009.12.028; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klinger M, 2004, MOL BIOL EVOL, V21, P76, DOI 10.1093/molbev/msg241; Kozlowski DJ, 2005, DEV BIOL, V277, P27, DOI 10.1016/j.ydbio.2004.08.033; Laguerre L, 2005, DEV DYNAM, V233, P466, DOI 10.1002/dvdy.20343; Lecaudey V, 2008, DEVELOPMENT, V135, P2695, DOI 10.1242/dev.025981; Li Q, 2004, DEV BIOL, V269, P123, DOI 10.1016/j.ydbio.2004.01.020; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; Matsuda M, 2010, DEVELOPMENT, V137, P3477, DOI 10.1242/dev.052761; McGraw HF, 2011, DEVELOPMENT, V138, P3921, DOI 10.1242/dev.062554; Me Westerfield, 2007, ZEBRAFISH BOOK GUIDE; METCALFE WK, 1985, J COMP NEUROL, V238, P218, DOI 10.1002/cne.902380208; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Nixon SJ, 2007, J CELL SCI, V120, P2151, DOI 10.1242/jcs.003830; Oertle T, 2003, FASEB J, V17, P1238, DOI 10.1096/fj.02-1166hyp; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Popper AN, 2000, PHILOS T ROY SOC B, V355, P1277, DOI 10.1098/rstb.2000.0683; Ribeiro D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015786; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Sahly I, 1999, DEV GENES EVOL, V209, P399, DOI 10.1007/s004270050270; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shen YC, 2008, DEV DYNAM, V237, P941, DOI 10.1002/dvdy.21486; Shinya M, 2000, MECH DEVELOP, V98, P3, DOI 10.1016/S0925-4773(00)00433-0; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Ungos JM, 2003, DEVELOPMENT, V130, P5351, DOI 10.1242/dev.00722; Untergasser G, 2011, GENE EXPR PATTERNS, V11, P491, DOI 10.1016/j.gep.2011.08.005; Valdivia LE, 2011, DEVELOPMENT, V138, P3931, DOI 10.1242/dev.062695; Yiu G, 2003, CURR OPIN NEUROBIOL, V13, P545, DOI 10.1016/j.conb.2003.09.006; Zhao BF, 2010, BLOOD, V116, P5423, DOI 10.1182/blood-2010-02-271577	53	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86345	10.1371/journal.pone.0086345	http://dx.doi.org/10.1371/journal.pone.0086345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466042	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500234
J	Min, SY; Yan, F; Zhang, YL; Ye, XQ; Zhong, MQ; Cao, JS; Zou, HY; Chen, JH				Min, Shaoying; Yan, Fang; Zhang, Yueling; Ye, Xiangqun; Zhong, Mingqi; Cao, Jinsong; Zou, Haiying; Chen, Jiehui			Characterization of a Novel Hemolytic Activity of Human IgG Fractions Arising from Diversity in Protein and Oligosaccharide Components	PLOS ONE			English	Article							SHRIMP PENAEUS-VANNAMEI; IMMUNE-SYSTEM; ERYTHROCYTE-MEMBRANE; LITOPENAEUS-VANNAMEI; ALPHA-HEMOLYSIN; IDENTIFICATION; GLYCOSYLATION; HEMOCYANIN; BINDING; INVERTEBRATE	Human IgG is a well-established multifunctional antigen specific immunoglobulin molecule of the adaptive immune system. However, an antigen nonspecific immunological function of human IgG has never been reported. In this study, human IgG was isolated using ammonium sulfate fractional precipitation and diethylaminoethanol (DEAE) cellulose 52 ion exchange chromatography, from which h-IgG and hs-IgG fractions were purified on the basis of their differential binding to rabbit anti-shrimp hemocyanin antibody (h) and rabbit anti-shrimp hemocyanin's small subunit antibody (hs), respectively. We found that h-IgG had a higher hemolytic activity than hs-IgG against erythrocytes from humans, rabbits, mice and chickens, whereas the control IgG showed negligible activity. h-IgG could interact directly with erythrocyte membranes, and this interaction was suppressed by high molecular weight osmoprotectants, showing that it may follow a colloid-osmotic mechanism. In comparative proteomics and glycomics studies, h-IgG and hs-IgG yielded 20 and 5 significantly altered protein spots, respectively, on a 2-D gel. The mean carbohydrate content of h-IgG and hs-IgG was approximately 3.6- and 2-fold higher than that of IgG, respectively, and the alpha-D-mannose/alpha-D-glucose content was in the order of h-IgG. hs-IgG. IgG. In this study, a novel antigen nonspecific immune property of human IgG was investigated, and the diversity in the protein constituents and glycosylation levels may have functional signficance.	[Min, Shaoying; Yan, Fang; Zhang, Yueling; Zhong, Mingqi; Cao, Jinsong; Chen, Jiehui] Shantou Univ, Dept Biol, Shantou, Peoples R China; [Min, Shaoying; Yan, Fang; Zhang, Yueling; Zhong, Mingqi; Cao, Jinsong; Chen, Jiehui] Shantou Univ, Guangdong Prov Key Lab Marine Biotechnol, Shantou, Peoples R China; [Yan, Fang] Mariculture Inst Shandong Prov, Qingdao, Peoples R China; [Ye, Xiangqun; Zou, Haiying] Shantou Univ, Coll Med, Shantou, Peoples R China	Shantou University; Shantou University; Shantou University	Zhang, YL (corresponding author), Shantou Univ, Dept Biol, Shantou, Peoples R China.	zhangyl@stu.edu.cn			National Natural Science Foundation of China [31072237]; New Century Excellent Talents Program of Ministry of Education of China [NCET-11-0922]; Natural Science Foundation of Guangdong Province [10251503101000002]; Guangdong Province College Talent Introduction Project Special Funds; Key Innovation Project of Science and Technology of Guangdong Province College [2012CXZD0025]; Academic Innovation Team Construction Project of Shantou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents Program of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Province College Talent Introduction Project Special Funds; Key Innovation Project of Science and Technology of Guangdong Province College; Academic Innovation Team Construction Project of Shantou University	This work was sponsored by National Natural Science Foundation of China (No. 31072237), New Century Excellent Talents Program of Ministry of Education of China (No. NCET-11-0922), Natural Science Foundation of Guangdong Province (No. 10251503101000002), Guangdong Province College Talent Introduction Project Special Funds (2011), The Key Innovation Project of Science and Technology of Guangdong Province College (No. 2012CXZD0025) and Academic Innovation Team Construction Project of Shantou University (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda FJ, 2005, BBA-BIOMEMBRANES, V1713, P51, DOI 10.1016/j.bbamem.2005.05.003; Becker MI, 2009, INT IMMUNOPHARMACOL, V9, P330, DOI 10.1016/j.intimp.2008.12.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannon JP, 2002, NAT IMMUNOL, V3, P1200, DOI 10.1038/ni849; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Coelho V, 2010, P NATL ACAD SCI USA, V107, P18587, DOI 10.1073/pnas.1009388107; Danchaivijitr P, 2011, AM J HEMATOL, V86, P331, DOI 10.1002/ajh.21950; Dishaw LJ, 2011, P NATL ACAD SCI USA, V108, P16747, DOI 10.1073/pnas.1109687108; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; FigueroaSoto CG, 1997, COMP BIOCHEM PHYS B, V117, P203, DOI 10.1016/S0305-0491(96)00321-5; FLEISCHMAN JB, 1963, BIOCHEM J, V88, P220, DOI 10.1042/bj0880220; Gala FA, 2002, J BIOL CHEM, V277, P29005, DOI 10.1074/jbc.M203258200; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; Gu S, 2008, PROTEOMICS, V8, P3061, DOI 10.1002/pmic.200700715; HATAKEYAMA T, 1995, J BIOL CHEM, V270, P3560, DOI 10.1074/jbc.270.8.3560; Hoek RM, 1996, EUR J IMMUNOL, V26, P939, DOI 10.1002/eji.1830260433; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Hou SZ, 2011, CHEM-BIOL INTERACT, V192, P184, DOI 10.1016/j.cbi.2011.03.007; Hughes AL, 1997, BIOESSAYS, V19, P777, DOI 10.1002/bies.950190907; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Kang B, 2000, PROG BIOCHEM BIOPHYS, V27, P210; Kasahara M, 2004, TRENDS IMMUNOL, V25, P105, DOI 10.1016/j.it.2003.11.005; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; LanzMendoza H, 1996, CELL IMMUNOL, V169, P47, DOI 10.1006/cimm.1996.0089; LASER H, 1951, SCIENCE, V113, P609, DOI 10.1126/science.113.2943.609; LEDDY JP, 1993, J CLIN INVEST, V91, P1672, DOI 10.1172/JCI116376; LIN DC, 1979, BIOCHEM BIOPH RES CO, V91, P761, DOI 10.1016/0006-291X(79)91945-4; Mimura Y, 2001, J BIOL CHEM, V276, P45539, DOI 10.1074/jbc.M107478200; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; Nagai T, 2001, J BIOL CHEM, V276, P27166, DOI 10.1074/jbc.M102596200; OSMAND AP, 1977, P NATL ACAD SCI USA, V74, P1214, DOI 10.1073/pnas.74.3.1214; Promdonkoy B, 2003, BIOCHEM J, V374, P255, DOI 10.1042/BJ20030437; Qiao J, 2011, FISH SHELLFISH IMMUN, V31, P736, DOI 10.1016/j.fsi.2011.07.005; Raju TS, 2000, GLYCOBIOLOGY, V10, P477, DOI 10.1093/glycob/10.5.477; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; Schluter SF, 1999, DEV COMP IMMUNOL, V23, P107; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; STEFANINI M, 1961, AM J MED SCI, V242, P303, DOI 10.1097/00000441-196109000-00005; Thomas P, 2009, SCIENCE, V325, P393, DOI 10.1126/science.325_393a; TITANI K, 1965, SCIENCE, V149, P1090, DOI 10.1126/science.149.3688.1090; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069; Zhang XB, 2004, ANTIVIR RES, V61, P93, DOI 10.1016/j.antiviral.2003.08.019; Zhang YL, 2006, J PROTEOME RES, V5, P815, DOI 10.1021/pr0503984; Zhang YL, 2004, J EXP MAR BIOL ECOL, V301, P39, DOI 10.1016/j.jembe.2003.09.011; Zhang YL, 2009, FISH SHELLFISH IMMUN, V27, P330, DOI 10.1016/j.fsi.2009.05.017	48	3	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85711	10.1371/journal.pone.0085711	http://dx.doi.org/10.1371/journal.pone.0085711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465658	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500094
J	Pong, T; Scherrer-Crosbie, M; Atochin, DN; Bloch, KD; Huang, PL				Pong, Terrence; Scherrer-Crosbie, Marielle; Atochin, Dmitriy N.; Bloch, Kenneth D.; Huang, Paul L.			Phosphomimetic Modulation of eNOS Improves Myocardial Reperfusion and Mimics Cardiac Postconditioning in Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PERCUTANEOUS CORONARY INTERVENTION; BLOOD-FLOW; CONTRAST ECHOCARDIOGRAPHY; PARADIGM SHIFT; IN-VIVO; INJURY; INFARCTION; ISCHEMIA; HEART	Objective: Myocardial infarction resulting from ischemia-reperfusion injury can be reduced by cardiac postconditioning, in which blood flow is restored intermittently prior to full reperfusion. Although key molecular mechanisms and prosurvival pathways involved in postconditioning have been identified, a direct role for eNOS-derived NO in improving regional myocardial perfusion has not been shown. The objective of this study is to measure, with high temporal and spatial resolution, regional myocardial perfusion during ischemia-reperfusion and postconditioning, in order to determine the contribution of regional blood flow effects of NO to infarct size and protection. Methods and Results: We used myocardial contrast echocardiography to measure regional myocardial blood flow in mice over time. Reperfusion after myocardial ischemia-reperfusion injury is improved by postconditioning, as well as by phosphomimetic eNOS modulation. Knock-in mice expressing a phosphomimetic S1176D form of eNOS showed improved myocardial reperfusion and significantly reduced infarct size. eNOS knock-out mice failed to show cardioprotection from postconditioning. The size of the no-reflow zone following ischemia-reperfusion is substantially reduced by postconditioning and by the phosphomimetic eNOS mutation. Conclusions and Significance: Using myocardial contrast echocardiography, we show that temporal dynamics of regional myocardial perfusion restoration contribute to reduced infarct size after postconditioning. eNOS has direct effects on myocardial blood flow following ischemia-reperfusion, with reduction in the size of the no-reflow zone. These results have important implications for ongoing clinical trials on cardioprotection, because the degree of protective benefit may be significantly influenced by the regional hemodynamic effects of eNOS-derived NO.	[Pong, Terrence; Scherrer-Crosbie, Marielle; Atochin, Dmitriy N.; Bloch, Kenneth D.; Huang, Paul L.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Pong, Terrence; Huang, Paul L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Pong, Terrence; Huang, Paul L.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Scherrer-Crosbie, Marielle] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Cardiac Ultrasound Lab, Boston, MA 02114 USA; [Bloch, Kenneth D.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Anesthesia Ctr Crit Care Res, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Huang, PL (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Cardiol, Cardiovasc Res Ctr, Boston, MA 02114 USA.	phuang1@partners.org	Atochin, Dmitriy/Q-3150-2016; Atochin, Dmitriy/AAH-8843-2020	Huang, Paul/0000-0002-5436-8658; Atochin, Dmitriy/0000-0002-2405-2070	American Heart Association; NIH [R01 NS33335, HL57818]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033335] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by an American Heart Association predoctoral fellowship to T. Pong and by NIH R01 NS33335 and HL57818 to P. Huang. THe funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayata C, 2004, J CEREBR BLOOD F MET, V24, P744, DOI 10.1097/01.WCB.0000122745.72175.D5; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Costa ADT, 2008, CARDIOVASC RES, V77, P344, DOI 10.1093/cvr/cvm050; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054; Hausenloy DJ, 2011, NAT REV CARDIOL, V8, P619, DOI 10.1038/nrcardio.2011.85; Huang PL, 2005, CIRC RES, V96, P1129, DOI 10.1161/01.RES.0000170705.56583.45; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Jones SP, 1999, AM J PHYSIOL-HEART C, V276, pH1567, DOI 10.1152/ajpheart.1999.276.5.H1567; Kashiwagi S, 2013, BIOCHEM BIOPH RES CO, V431, P284, DOI 10.1016/j.bbrc.2012.12.110; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; KAUL S, 1989, J AM COLL CARDIOL, V13, P468, DOI 10.1016/0735-1097(89)90528-7; Kin H, 2004, CARDIOVASC RES, V62, P74, DOI 10.1016/j.cardiores.2004.01.006; Kitakaze M, 1998, HEART VESSELS, V13, P211, DOI 10.1007/BF03257244; Lacerda L, 2009, CARDIOVASC RES, V84, P201, DOI 10.1093/cvr/cvp274; Laskey WK, 2008, CATHETER CARDIO INTE, V72, P212, DOI 10.1002/ccd.21583; Lefer DJ, 2011, J CARDIOVASC PHARM T, V16, P332, DOI 10.1177/1074248411414155; LIU GS, 1991, CIRCULATION, V84, P350, DOI 10.1161/01.CIR.84.1.350; Lonborg J, 2010, CIRC-CARDIOVASC INTE, V3, P34, DOI 10.1161/CIRCINTERVENTIONS.109.905521; Looft-Wilson R, 2007, J CLIN INVEST, V117, P1961, DOI 10.1172/JCI29877; Ludman AJ, 2010, DIS MODEL MECH, V3, P35, DOI 10.1242/dmm.003855; Ma XJ, 2006, SCAND CARDIOVASC J, V40, P327, DOI 10.1080/14017430601047864; Mewton N, 2010, DIS MODEL MECH, V3, P39, DOI 10.1242/dmm.004309; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129; Raher MJ, 2007, CIRCULATION, V116, P1250, DOI 10.1161/CIRCULATIONAHA.107.707737; Reffelmann T, 2006, BASIC RES CARDIOL, V101, P359, DOI 10.1007/s00395-006-0615-2; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Scherrer-Crosbie M, 2000, J AM SOC ECHOCARDIOG, V13, P353, DOI 10.1016/S0894-7317(00)70004-6; Schleicher M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000343; Schwartz Longacre L, 2011, CIRCULATION, V124, P1172, DOI 10.1161/CIRCULATIONAHA.111.032698; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Thibault H, 2008, CIRCULATION, V117, P1037, DOI 10.1161/CIRCULATIONAHA.107.729780; Wei K, 1998, CIRCULATION, V97, P473; Yezzi A, 1997, IEEE T MED IMAGING, V16, P199, DOI 10.1109/42.563665; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	38	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85946	10.1371/journal.pone.0085946	http://dx.doi.org/10.1371/journal.pone.0085946			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465805	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500152
J	Udayashankar, AP; Kossl, M; Nowotny, M				Udayashankar, Arun Palghat; Koessl, Manfred; Nowotny, Manuela			Lateralization of Travelling Wave Response in the Hearing Organ of Bushcrickets	PLOS ONE			English	Article							ACOUSTIC TRACHEA; GAIN; REPRESENTATION; MEMBRANE; NEUROPIL; MOTION; EAR	Travelling waves are the physical basis of frequency discrimination in many vertebrate and invertebrate taxa, including mammals, birds, and some insects. In bushcrickets (Tettigoniidae), the crista acustica is the hearing organ that has been shown to use sound-induced travelling waves. Up to now, data on mechanical characteristics of sound-induced travelling waves were only available along the longitudinal (proximal-distal) direction. In this study, we use laser Doppler vibrometry to investigate in-vivo radial (anterior-posterior) features of travelling waves in the tropical bushcricket Mecopoda elongata. Our results demonstrate that the maximum of sound-induced travelling wave amplitude response is always shifted towards the anterior part of the crista acustica. This lateralization of the travelling wave response induces a tilt in the motion of the crista acustica, which presumably optimizes sensory transduction by exerting a shear motion on the sensory cilia in this hearing organ.	[Udayashankar, Arun Palghat; Koessl, Manfred; Nowotny, Manuela] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, AK Neurobiol & Biosensor, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Nowotny, M (corresponding author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, AK Neurobiol & Biosensor, D-60054 Frankfurt, Germany.	nowotny@bio.uni-frankfurt.de			German Research Foundation [NO 841/1-2]	German Research Foundation(German Research Foundation (DFG))	Financial support for this study was provided by a grant to MN 194 from the German Research Foundation (NO 841/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai HX, 2005, J R SOC INTERFACE, V2, P341, DOI 10.1098/rsif.2005.0049; Fisher JAN, 2012, NEURON, V76, P989, DOI 10.1016/j.neuron.2012.09.031; Fridberger A, 2003, NAT NEUROSCI, V6, P446, DOI 10.1038/nn1047; HEINRICH R, 1993, J ACOUST SOC AM, V93, P3481, DOI 10.1121/1.405678; HOFFMANN E, 1995, J ACOUST SOC AM, V98, P1845, DOI 10.1121/1.413371; Hummel J, 2011, J EXP BIOL, V214, P3596, DOI 10.1242/jeb.054445; Manoussaki D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088701; MICHELSEN A, 1994, J COMP PHYSIOL A, V175, P145, DOI 10.1007/BF00215110; Nilsen KE, 1999, NAT NEUROSCI, V2, P642, DOI 10.1038/10197; Ren TY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1226; ROMER H, 1983, NATURE, V306, P60, DOI 10.1038/306060a0; ROMER H, 1987, J COMP PHYSIOL A, V161, P33, DOI 10.1007/BF00609453; SEYMOUR C, 1978, J COMP PHYSIOL, V123, P205, DOI 10.1007/BF00656873; Udayashankar AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031008; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051	15	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86090	10.1371/journal.pone.0086090	http://dx.doi.org/10.1371/journal.pone.0086090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465889	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500181
J	Wei, LH; Shao, Y; Wan, JW; Feng, H; Zhu, H; Huang, HW; Zhou, YJ				Wei, Lihui; Shao, Ying; Wan, Jingwang; Feng, Hui; Zhu, Hua; Huang, Huiwen; Zhou, Yijun			Isolation and Characterization of a Rhizobacterial Antagonist of Root-Knot Nematodes	PLOS ONE			English	Article							MELOIDOGYNE-INCOGNITA; BIOCONTROL ACTIVITY; SOIL; COMMUNITY; BACTERIA; MANAGEMENT; PROTEASE; STRAINS; CHA0	The rhizobacterial strain Jdm2 was isolated from the rhizosphere of the traditional Chinese medicinal herb Trichosanthes kirilowii in Jiangsu province, China, and was identified as Bacillus subtilis. Exposure of cell-free filtrate of the strain to the root-knot nematode Meloidogyne incognita under in vitro conditions caused substantial mortality of the second stage juvenile (J2) and significantly reduced egg hatchability. A greenhouse trial demonstrated that 56 days after treatment with Jdm2, the number of galls associated with M. incognita infection in the tomato (Solanum lycopersicum) roots was significantly reduced compared to controls, and the disease severity of infected plants was lower in treated plants (36%) compared to water control (75%). Consistently, in the field trial, the biocontrol efficacy of Jdm2 reached 69%, 51% and 48% after 30, 60 and 90 days post-transplantation, respectively. As indicated by PCR-DGGE analysis, inoculation with Jdm2 strain had an effect on the bacterial community of the tomato rhizosphere at the first stage, but was not able to imperil the bacterial community stability for long time. The novel bacterial strain Jdm2 enhances plant growth and inhibits nematode activity, and has the potential to be a safe and effective microbial pesticide.	[Wei, Lihui; Shao, Ying; Wan, Jingwang; Feng, Hui; Zhu, Hua; Huang, Huiwen; Zhou, Yijun] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Wei, LH (corresponding author), Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China.	weilihui@jaas.ac.cn; yjzhou@jaas.ac.cn	黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022		Jiangsu Agricultural scientific self-innovation fund [CX(10)206]	Jiangsu Agricultural scientific self-innovation fund	This research was performed by the Jiangsu Agricultural scientific self-innovation fund, grant No. CX(10)206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali NI, 2002, SOIL BIOL BIOCHEM, V34, P1051, DOI 10.1016/S0038-0717(02)00029-9; BRIDGE J, 1980, TROP PEST MANAGE, V26, P296, DOI 10.1080/09670878009414416; Brimner TA, 2003, AGR ECOSYST ENVIRON, V100, P3, DOI 10.1016/S0167-8809(03)00200-7; Cayrol J., 1989, REV NEMATOLOGIE, V12, P331; El-Nagdi WM, 2004, J PEST SCI, V77, P75, DOI 10.1007/s10340-003-0029-y; Fliessbach A, 2009, MICROB ECOL, V57, P611, DOI 10.1007/s00248-009-9489-9; Gao GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031806; Garbeva P, 2003, MICROB ECOL, V45, P302, DOI 10.1007/s00248-002-2034-8; Glick B. R., 1999, BIOCH GENETIC MECH U, DOI DOI 10.1142/P130; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Huang XW, 2005, RES MICROBIOL, V156, P719, DOI 10.1016/j.resmic.2005.02.006; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Kloepper JW, 2006, MICROBIAL ROOT ENDOP, P33, DOI DOI 10.1007/3-540-33526-9_3; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Maniatis T., 1982, MOL CLONING LAB MANU; MCCLURE MA, 1973, J NEMATOL, V5, P230; Mendoza AR, 2008, BIOCONTROL SCI TECHN, V18, P377, DOI 10.1080/09583150801952143; Milling A, 2004, PLANT SOIL, V266, P23; Natsch A, 1998, FEMS MICROBIOL ECOL, V27, P365, DOI 10.1111/j.1574-6941.1998.tb00552.x; Neipp PW, 1999, J NEMATOL, V31, P54; Oka Y, 2000, PEST MANAG SCI, V56, P983, DOI 10.1002/1526-4998(200011)56:11<983::AID-PS233>3.0.CO;2-X; OKA Y, 1993, BIOCONTROL SCI TECHN, V3, P115, DOI 10.1080/09583159309355267; Prevost K, 2006, BIOCONTROL, V51, P533, DOI 10.1007/s10526-005-4240-z; PUTTER I, 1981, EXPERIENTIA, V37, P963, DOI 10.1007/BF01971780; Reddy P. P., 2012, RECENT ADV CROP PROT, V1st, P13, DOI DOI 10.1007/978-81-322-0723-8; ROMANOWSKI G, 1993, APPL ENVIRON MICROB, V59, P3438, DOI 10.1128/AEM.59.10.3438-3446.1993; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; SASSER JN, 1983, ANNU REV PHYTOPATHOL, V21, P271, DOI 10.1146/annurev.py.21.090183.001415; Siddiqui MA, 2003, SOIL BIOL BIOCHEM, V35, P1615, DOI 10.1016/j.soilbio.2003.08.006; Siddiqui Z. A., 2002, Thai Journal of Agricultural Science, V35, P1; Siddiqui ZA, 1999, BIORESOURCE TECHNOL, V69, P167, DOI 10.1016/S0960-8524(98)00122-9; SIKORA R A, 1988, Mededelingen van de Faculteit Landbouwwetenschappen Universiteit Gent, V53, P867; Tian HL, 2000, J NEMATOL, V32, P370; Upadhyay KD, 2007, TXB PLANT NEMATOLOGY; Vahjen W, 1995, FEMS MICROBIOL ECOL, V18, P317; Walia RK, 2003, DIRECTORATE INFORM P; Wang B, 2009, MICROBIOL RES, V164, P665, DOI 10.1016/j.micres.2009.01.003; Wei LH, 2010, BIOCONTROL SCI TECHN, V20, P739, DOI 10.1080/09583151003714109; Xia YF, 2011, FEMS MICROBIOL LETT, V322, P99, DOI 10.1111/j.1574-6968.2011.02336.x; Xue QY, 2009, BIOL CONTROL, V48, P252, DOI 10.1016/j.biocontrol.2008.11.004; Yang JH, 2008, J APPL MICROBIOL, V104, P91, DOI 10.1111/j.1365-2672.2007.03534.x; [赵鸿 Zhao Hong], 2003, [植物保护, Plant Protection], V29, P6; Zhao Lei, 2012, Southwest China Journal of Agricultural Sciences, V25, P517	43	23	28	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85988	10.1371/journal.pone.0085988	http://dx.doi.org/10.1371/journal.pone.0085988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465828	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500161
J	Styer, AM; Roesch, SL; Argyropoulos, G				Styer, Amanda M.; Roesch, Stephen L.; Argyropoulos, George			Modulation of Fibroblast Growth Factor 19 Expression by Bile Acids, Meal Replacement and Energy Drinks, Milk, and Coffee	PLOS ONE			English	Article							DECAFFEINATED COFFEE; METABOLIC-RATE; WEIGHT-LOSS; RISK; FIBROBLAST-GROWTH-FACTOR-19; FGF19; ACTIVATION; INDUCTION; CAFFEINE	Background: The enterohepatic pathway involving the fibroblast growth factor 19 (FGF19) and bile acids (BA) has been linked with the etiology and remission of type 2 diabetes (T2D) following Roux-en-Y gastric bypass (RYGB) surgery. Specifically, diabetic patients had lower FGF19 circulating levels but postoperative FGF19 and BA levels were higher in diabetic patients that experience remission of T2D, as compared to non-diabetic patients and diabetic patients that do not experience remission. It has been proposed that this may be due to the direct flow of digestate-free bile acids into the ileum benefiting mostly T2D patients without severe diabetes. Methods/Results: We used a human colorectal cell line (LS174T) that endogenously expresses FGF19, real time PCR, and Elisas for precise quantitation of FGF19 mRNA and secreted protein levels. We report here that BA and fractions of BA stimulated FGF19 in vitro but this effect was partially blocked when BA were pre-incubated with a lipoprotein mix which emulates digested food. In addition, we show that FGF19 mRNA was stimulated by meal replacement drinks (Ensure, Glucerna, SlimFast), non-fat milk, and coffee which has been linked with reduced risk for developing diabetes. Pure caffeine and the 5-hour Energy drink, on the other hand, decreased FGF19 mRNA. Conclusions: In summary, FGF19 expression in vitro is modifiable by popular drinks suggesting that such approaches could potentially be used for modulating FGF19 expression in humans.	[Styer, Amanda M.; Roesch, Stephen L.; Argyropoulos, George] Geisinger Hlth Syst, Weis Ctr Res, Danville, PA 17821 USA; [Argyropoulos, George] Geisinger Hlth Syst, Inst Obes, Danville, PA USA	Geisinger Health System; Geisinger Health System	Argyropoulos, G (corresponding author), Geisinger Hlth Syst, Weis Ctr Res, Danville, PA 17821 USA.	gargyropoulos1@geisinger.edu						Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603; Cheng BA, 2011, J AGR FOOD CHEM, V59, P13147, DOI 10.1021/jf201702h; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Foster GD, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.3; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Ge HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033603; Gerhard GS, 2013, DIABETES CARE, V36, P1859, DOI 10.2337/dc12-2255; Gerhard GS, 2013, INT J OBES; Gerhard GS, 2013, DIABETES CA IN PRESS; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Keogh JB, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/918571; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Miyata M, 2012, J STEROID BIOCHEM, V132, P41, DOI 10.1016/j.jsbmb.2012.04.008; Muley A, 2012, CURR DIABETES REV, V8, P162, DOI 10.2174/157339912800564016; Olthof MR, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-10; Pournaras DJ, 2012, ENDOCRINOLOGY, V153, P3613, DOI 10.1210/en.2011-2145; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512; Wadden TA, 2009, OBESITY, V17, P713, DOI 10.1038/oby.2008.637; Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93; Wistuba W, 2007, WORLD J GASTROENTERO, V13, P4230, DOI 10.3748/wjg.v13.i31.4230; Wu X, J BIOL CHEM, V285, P5165; Wu XL, 2010, P NATL ACAD SCI USA, V107, P14158, DOI 10.1073/pnas.1009427107; Wu XL, 2009, AGING-US, V1, P1023, DOI 10.18632/aging.100108; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zhang JH, 2013, AM J PHYSIOL-GASTR L, V304, pG940, DOI 10.1152/ajpgi.00398.2012; Zhang W, 2009, DIABETES CARE, V32, P1043, DOI 10.2337/dc08-2251	32	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85558	10.1371/journal.pone.0085558	http://dx.doi.org/10.1371/journal.pone.0085558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465600	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500058
J	Leong, M; Kremen, C; Roderick, GK				Leong, Misha; Kremen, Claire; Roderick, George K.			Pollinator Interactions with Yellow Starthistle (Centaurea solstitialis) across Urban, Agricultural, and Natural Landscapes	PLOS ONE			English	Article							CARABID BEETLE ASSEMBLAGES; POLLEN LIMITATION; CROP POLLINATION; INVASIVE PLANT; GLOBAL CHANGE; NATIVE BEES; BIODIVERSITY; SERVICES; URBANIZATION; CONSERVATION	Pollinator-plant relationships are found to be particularly vulnerable to land use change. Yet despite extensive research in agricultural and natural systems, less attention has focused on these interactions in neighboring urban areas and its impact on pollination services. We investigated pollinator-plant interactions in a peri-urban landscape on the outskirts of the San Francisco Bay Area, California, where urban, agricultural, and natural land use types interface. We made standardized observations of floral visitation and measured seed set of yellow starthistle (Centaurea solstitialis), a common grassland invasive, to test the hypotheses that increasing urbanization decreases 1) rates of bee visitation, 2) viable seed set, and 3) the efficiency of pollination (relationship between bee visitation and seed set). We unexpectedly found that bee visitation was highest in urban and agricultural land use contexts, but in contrast, seed set rates in these human-altered landscapes were lower than in natural sites. An explanation for the discrepancy between floral visitation and seed set is that higher plant diversity in urban and agricultural areas, as a result of more introduced species, decreases pollinator efficiency. If these patterns are consistent across other plant species, the novel plant communities created in these managed landscapes and the generalist bee species that are favored by human-altered environments will reduce pollination services.	[Leong, Misha; Kremen, Claire; Roderick, George K.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Leong, M (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	mishaleong@berkeley.edu		Roderick, George/0000-0001-7557-2415	Margaret C. Walker Fund; Department of Environmental Science Policy and Management; Essig Museum of Entomology; Berkeley Institute for Global Change Biology; Gordon and Betty Moore Foundation; UC Berkeley's Undergraduate Research Apprentice Program	Margaret C. Walker Fund; Department of Environmental Science Policy and Management; Essig Museum of Entomology; Berkeley Institute for Global Change Biology; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); UC Berkeley's Undergraduate Research Apprentice Program	This work was supported by The Margaret C. Walker Fund, Department of Environmental Science Policy and Management, Essig Museum of Entomology, the Berkeley Institute for Global Change Biology, the Gordon and Betty Moore Foundation, and UC Berkeley's Undergraduate Research Apprentice Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Ash C, 2008, SCIENCE, V319, P739, DOI 10.1126/science.319.5864.739; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barthell JF, 2001, ECOL APPL, V11, P1870, DOI 10.1890/1051-0761(2001)011[1870:POSSIY]2.0.CO;2; Bates D, 2011, LME4 LINEAR MIXED EF; Bjerknes AL, 2007, BIOL CONSERV, V138, P1, DOI 10.1016/j.biocon.2007.04.015; Boone CG, 2012, URBAN ECOSYST, V15, P795, DOI 10.1007/s11252-012-0240-9; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Deguines N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045822; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Engel EC, 2003, AM J BOT, V90, P1612, DOI 10.3732/ajb.90.11.1612; ERRINGTON A, 1994, J RURAL STUD, V10, P367, DOI 10.1016/0743-0167(94)90046-9; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gill S.E., 2007, BUILT ENV, V33, P115, DOI [10.2148/benv.33.1.115, 10.2148/benv.33.1.115., DOI 10.2148/BENV.33.1.115]; Grabas GP, 1999, ECOSCIENCE, V6, P230, DOI 10.1080/11956860.1999.11682524; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Guise V, 2011, 2011 ANN CROP LIVEST; Hennig EI, 2011, PERSPECT PLANT ECOL, V13, P137, DOI 10.1016/j.ppees.2011.03.003; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kearns C. A., 1993, TECHNIQUES POLLINATI; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Kollin C, 1991, BALANCE WEIGHING BEN; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kremen C, 2011, CONSERV BIOL, V25, P607, DOI 10.1111/j.1523-1739.2011.01657.x; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Leong M, 2013, DRYAD DIGITAL REPOSI; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; Magura T, 2004, LANDSCAPE ECOL, V19, P747, DOI 10.1007/s10980-005-1128-4; Mciver J, 2009, WEED BIOL MANAG, V9, P137, DOI 10.1111/j.1445-6664.2009.00331.x; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Morandin LA, 2013, ECOL APPL, V23, P829, DOI 10.1890/12-1051.1; Niemela J, 2002, LANDSCAPE ECOL, V17, P387, DOI 10.1023/A:1021270121630; Oksanen J., 2016, R PACKAG; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pauw A, 2007, ECOLOGY, V88, P1759, DOI 10.1890/06-1383.1; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Sampson BJ, 2000, J ECON ENTOMOL, V93, P1726, DOI 10.1603/0022-0493-93.6.1726; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; SCHEMSKE DW, 1984, SCIENCE, V225, P519, DOI 10.1126/science.225.4661.519; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; Stout JC, 2009, APIDOLOGIE; Swope SM, 2012, ECOL APPL, V22, P2122, DOI 10.1890/12-0131.1; Tscheulin T, 2013, BIOL INVASIONS, V15, P385, DOI 10.1007/s10530-012-0293-y; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Westerkamp C, 1991, PLANT SYSTEMATICS EV; Whittington R, 2004, J ECON ENTOMOL, V97, P1384, DOI 10.1603/0022-0493-97.4.1384; Williams NM, 2011, BASIC APPL ECOL, V12, P332, DOI 10.1016/j.baae.2010.11.008; Wilson L. M., 2003, BIOL BIOL CONTROL YE; Winfree R, 2009, P ROYAL SOC B, V276, P1; Winfree R, 2007, CONSERV BIOL, V21, P213, DOI 10.1111/j.1523-1739.2006.00574.x; Wojcik VA, 2012, URBAN ECOSYST, V15, P581, DOI 10.1007/s11252-011-0211-6; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	59	40	41	0	195	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86357	10.1371/journal.pone.0086357	http://dx.doi.org/10.1371/journal.pone.0086357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24466050	gold, Green Published			2022-12-25	WOS:000330237000092
J	van Welzen, PC; Strijk, JS; van Konijnenburg-van Cittert, JHA; Nucete, M; Merckx, VSFT				van Welzen, Peter C.; Strijk, Joeri S.; van Konijnenburg-van Cittert, Johanna H. A.; Nucete, Monica; Merckx, Vincent S. F. T.			Dated Phylogenies of the Sister Genera Macaranga and Mallotus (Euphorbiaceae): Congruence in Historical Biogeographic Patterns?	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; SPECIES EUPHORBIACEAE; CENOZOIC TECTONICS; DNA-SEQUENCE; DISTANCE; AFRICA; REGION; EAST; S.S.	Molecular phylogenies and estimates of divergence times within the sister genera Macaranga and Mallotus were estimated using Bayesian relaxed clock analyses of two generic data sets, one per genus. Both data sets were based on different molecular markers and largely different samples. Per genus three calibration points were utilised. The basal calibration point (crown node of all taxa used) was taken from literature and used for both taxa. The other three calibrations were based on fossils of which two were used per genus. We compared patterns of dispersal and diversification in Macaranga and Mallotus using ancestral area reconstruction in RASP (S-DIVA option) and contrasted our results with biogeographical and geological records to assess accuracy of inferred age estimates. A check of the fossil calibration point showed that the Japanese fossil, used for dating the divergence of Mallotus, probably had to be attached to a lower node, the stem node of all pioneer species, but even then the divergence time was still younger than the estimated age of the fossil. The African (only used in the Macaranga data set) and New Zealand fossils (used for both genera) seemed reliably placed. Our results are in line with existing geological data and the presence of stepping stones that provided dispersal pathways from Borneo to New Guinea-Australia, from Borneo to mainland Asia and additionally at least once to Africa and Madagascar via land and back to India via Indian Ocean island chains. The two genera show congruence in dispersal patterns, which corroborate divergence time estimates, although the overall mode and tempo of dispersal and diversification differ significantly as shown by distribution patterns of extant species.	[van Welzen, Peter C.; van Konijnenburg-van Cittert, Johanna H. A.; Nucete, Monica; Merckx, Vincent S. F. T.] Nat Biodivers Ctr, Sect Herbarium, Leiden, Netherlands; [van Welzen, Peter C.] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Strijk, Joeri S.] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan Province, Peoples R China	Naturalis Biodiversity Center; Leiden University; Leiden University - Excl LUMC; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	van Welzen, PC (corresponding author), Nat Biodivers Ctr, Sect Herbarium, Leiden, Netherlands.	peter.vanwelzen@naturalis.nl	Merckx, Vincent/C-6025-2011; Strijk, Joeri S./F-8220-2019; van Welzen, Peter/GYR-0640-2022	Merckx, Vincent/0000-0002-3959-8623; Strijk, Joeri S./0000-0003-1109-7015; 				Banfer G, 2006, MOL ECOL, V15, P4409, DOI 10.1111/j.1365-294X.2006.03064.x; Baldwin SL, 2012, ANNU REV EARTH PL SC, V40, P495, DOI 10.1146/annurev-earth-040809-152540; Blattner FR, 2001, MOL PHYLOGENET EVOL, V19, P331, DOI 10.1006/mpev.2001.0941; Conti E, 2002, EVOLUTION, V56, P1931; De Boer A. J., 1995, Tijdschrift voor Entomologie, V138, P169; Drummond A.J., 2012, BEAST V 1 7 5; Drummond AJ, 2013, MOL BIOL EVOL; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Govaerts R, 2000, WORLD CHECKLIST BIBL; Gradstein F.M., 2004, A; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Hall R, 2012, TECTONOPHYSICS, V570, P1, DOI 10.1016/j.tecto.2012.04.021; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Kubitzki K., 1996, FLORISTIC CHARACTERI, P65; Kulju KKM, 2007, BLUMEA, V52, P115, DOI 10.3767/000651907X612364; Kulju KKM, 2007, AM J BOT, V94, P1726, DOI 10.3732/ajb.94.10.1726; Lee DE, 2010, REV PALAEOBOT PALYNO, V163, P127, DOI 10.1016/j.revpalbo.2010.10.002; Li YQ, 2009, SYST BOT, V34, P521, DOI 10.1600/036364409789271263; Massini JLG, 2010, PALAEONTOL ELECTRON, V13; Metais G, 2009, J ASIAN EARTH SCI, V34, P154, DOI 10.1016/j.jseaes.2008.04.006; Michaux B, 2010, BIOL J LINN SOC, V101, P193, DOI 10.1111/j.1095-8312.2010.01473.x; Morley R. J., 2007, P1, DOI 10.1007/978-3-540-48842-2_1; Morley RJ, 2000, ORIGIN EVOLUTION TRO; Morley Robert J., 1998, P211; Nucete M, 2012, PALAEOGEOGR PALAEOCL, V353, P104, DOI 10.1016/j.palaeo.2012.07.016; Ogg J. G., 2008, CONCISE GEOLOGICAL T; Pybus OG, 2002, BIOINFORMATICS, V18, P1404, DOI 10.1093/bioinformatics/18.10.1404; Raes N, 2009, BLUMEA, V54, P6, DOI 10.3767/000651909X475888; Rambaut A., 2006, FIGTREE TREE FIGURE; Rambaut A, 2014, TRACER V1 6; Rambaut A., 2002, PHYLOGEN PHYLOGENETI, V1.1; Rogl F., 1999, EVOLUTION NEOGENE TE, V1, P8, DOI [10.1017/CBO9780511542329.002, DOI 10.1017/CBO9780511542329.002]; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; SCHMIDTKE EA, 1990, TECTONICS, V9, P123, DOI 10.1029/TC009i001p00123; Sierra SEC, 2007, BLUMEA, V52, P361, DOI 10.3767/000651907X609106; Sierra SEC, 2010, TAXON, V59, P101, DOI 10.1002/tax.591011; Slik JWF, 2003, ECOL INDIC, V2, P311; Slik JWF, 2001, SYST BOT, V26, P786; Strijk JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042932; TANAI T, 1990, Bulletin of the National Science Museum Series C (Geology and Paleontology), V16, P91; TANAI T, 1989, Bulletin of the National Science Museum Series C (Geology and Paleontology), V15, P121; Van Balgooy M. M. J., 1996, P191; van Ufford AQ, 2005, AAPG BULL, V89, P119, DOI 10.1306/08300403073; van Welzen PC, 2009, BLUMEA, V54, P25, DOI 10.3767/000651909X474078; Wakita K, 2005, J ASIAN EARTH SCI, V24, P679, DOI 10.1016/j.jseaes.2004.04.004; Warren BH, 2010, CLADISTICS, V26, P526, DOI 10.1111/j.1096-0031.2009.00300.x; Welzen P. C. van, 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P199; Whitmore TC, 2008, GENUS MACARANGA PROD; Wurdack KJ, 2005, AM J BOT, V92, P1397, DOI 10.3732/ajb.92.8.1397; Xi ZX, 2012, P NATL ACAD SCI USA, V109, P17519, DOI 10.1073/pnas.1205818109; Yu Y, 2011, SYSTEM BIOL IN PRESS; Yu Y., 2011, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhou LL, 2012, J BIOGEOGR, V39, P322, DOI 10.1111/j.1365-2699.2011.02598.x	58	17	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85713	10.1371/journal.pone.0085713	http://dx.doi.org/10.1371/journal.pone.0085713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465660	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000054
J	Bergmann, G; Bender, A; Graichen, F; Dymke, J; Rohlmann, A; Trepczynski, A; Heller, MO; Kutzner, I				Bergmann, Georg; Bender, Alwina; Graichen, Friedmar; Dymke, Joern; Rohlmann, Antonius; Trepczynski, Adam; Heller, Markus O.; Kutzner, Ines			Standardized Loads Acting in Knee Implants	PLOS ONE			English	Article							DEMANDING DAILY ACTIVITIES; JOINT-CONTACT FORCES; MEASURED IN-VIVO; WEAR SIMULATION; NORMAL WALKING; REPLACEMENT; MUSCLE; ARTHROPLASTY; PREDICTION; TELEMETRY	The loads acting in knee joints must be known for improving joint replacement, surgical procedures, physiotherapy, biomechanical computer simulations, and to advise patients with osteoarthritis or fractures about what activities to avoid. Such data would also allow verification of test standards for knee implants. This work analyzes data from 8 subjects with instrumented knee implants, which allowed measuring the contact forces and moments acting in the joint. The implants were powered inductively and the loads transmitted at radio frequency. The time courses of forces and moments during walking, stair climbing, and 6 more activities were averaged for subjects with I) average body weight and average load levels and II) high body weight and high load levels. During all investigated activities except jogging, the high force levels reached 3,372-4,218N. During slow jogging, they were up to 5,165N. The peak torque around the implant stem during walking was 10.5 Nm, which was higher than during all other activities including jogging. The transverse forces and the moments varied greatly between the subjects, especially during non-cyclic activities. The high load levels measured were mostly above those defined in the wear test ISO 14243. The loads defined in the ISO test standard should be adapted to the levels reported here. The new data will allow realistic investigations and improvements of joint replacement, surgical procedures for tendon repair, treatment of fractures, and others. Computer models of the load conditions in the lower extremities will become more realistic if the new data is used as a gold standard. However, due to the extreme individual variations of some load components, even the reported average load profiles can most likely not explain every failure of an implant or a surgical procedure.	[Bergmann, Georg; Bender, Alwina; Graichen, Friedmar; Dymke, Joern; Rohlmann, Antonius; Trepczynski, Adam; Kutzner, Ines] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Heller, Markus O.] Univ Southampton, Engn Sci Unit, Southampton, Hants, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Southampton	Bergmann, G (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	georg.bergmann@charite.de	Rohlmann, Antonius/E-4778-2011; Heller, Markus O/F-8437-2010	Rohlmann, Antonius/0000-0002-0083-2793; Heller, Markus O/0000-0002-7879-1135; Kutzner, Ines/0000-0002-2316-6017; Bender, Alwina/0000-0002-4444-6309	Deutsche Forschungsgemeinschaft [Be 804/18]; Deutsche Arthrose-Hilfe e.V.; Zimmer GmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Arthrose-Hilfe e.V.; Zimmer GmbH	This work was supported by Deutsche Forschungsgemeinschaft (Be 804/18) (http://www.dfg.de/en/index.jsp), Deutsche Arthrose-Hilfe e.V. (http://www.arthrose.de/), and Zimmer GmbH (http://www.zimmer.com/en-US/index.jspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 1997, J AIR WASTE MANAGE, V47, P682, DOI 10.1080/10473289.1997.10463923; [Anonymous], 2009, 142431 ISO; Bender A, 2012, COMPUT METHOD BIOMEC, V15, P761, DOI 10.1080/10255842.2011.560841; Bergmann G, 2010, BIO-MED MATER ENG, V20, P65, DOI 10.3233/BME-2010-0616; D'Lima DD, 2007, J BIOMECH, V40, pS11, DOI 10.1016/j.jbiomech.2007.03.004; D'Lima DD, 2006, J ARTHROPLASTY, V21, P255, DOI 10.1016/j.arth.2005.07.011; D'Lima DD, 2005, CLIN ORTHOP RELAT R, P45, DOI 10.1097/01.blo.0000186559.62942.8c; Franta L, 2011, WEAR, V271, P2687, DOI 10.1016/j.wear.2011.02.026; Fregly BJ, 2012, J ORTHOP RES, V30, P503, DOI 10.1002/jor.22023; Halder A, 2012, J BONE JOINT SURG AM, V94A, P1023, DOI 10.2106/JBJS.K.00927; Heinlein B, 2007, J BIOMECH, V40, pS4, DOI 10.1016/j.jbiomech.2007.02.014; Helmert U, 2004, GESUNDHEITSWESEN, V66, P409, DOI 10.1055/s-2004-813324; Johnson TS, 2001, WEAR, V250, P222, DOI 10.1016/S0043-1648(01)00650-0; Kaufman KR, 1996, J BIOMECH, V29, P667, DOI 10.1016/0021-9290(95)00124-7; Kirking B, 2006, J BIOMECH, V39, P1744, DOI 10.1016/j.jbiomech.2005.05.023; Kuster MS, 1997, J BONE JOINT SURG BR, V79B, P109, DOI 10.1302/0301-620X.79B1.6978; Kutzner I, 2010, J BIOMECH, V43, P2164, DOI 10.1016/j.jbiomech.2010.03.046; Kutzner I, 2011, J BIOMECH, V44, P1354, DOI 10.1016/j.jbiomech.2011.01.014; Lundberg HJ, 2012, P I MECH ENG H, V226, P227, DOI 10.1177/0954411911431650; MIKOSZ RP, 1988, J ORTHOPAED RES, V6, P205, DOI 10.1002/jor.1100060207; MORRISON JB, 1970, J BIOMECH, V3, P51, DOI 10.1016/0021-9290(70)90050-3; Mundermann A, 2008, J ORTHOP RES, V26, P1167, DOI 10.1002/jor.20655; Ngai V, 2009, P I MECH ENG H, V223, P889, DOI 10.1243/09544070JEIM549; Popoola OO, 2010, J ORTHOP RES, V28, P1120, DOI 10.1002/jor.21104; Portier K, 2007, RISK ANAL, V27, P11, DOI 10.1111/j.1539-6924.2006.00856.x; Sasaki K, 2010, J BIOMECH, V43, P2780, DOI 10.1016/j.jbiomech.2010.06.011; Schwiesau J, 2013, MED ENG PHYS, V35, P1204, DOI 10.1016/j.medengphy.2012.12.015; Schwiesau J, 2013, MED ENG PHYS, V35, P591, DOI 10.1016/j.medengphy.2012.07.003; SEIREG A, 1975, J BIOMECH, V8, P89, DOI 10.1016/0021-9290(75)90089-5; Shelburne KB, 2005, MED SCI SPORT EXER, V37, P1948, DOI 10.1249/01.mss.0000180404.86078.ff; Taylor SJG, 1998, J ARTHROPLASTY, V13, P428, DOI 10.1016/S0883-5403(98)90009-2; Taylor SJG, 1997, J BIOMECH, V30, P225, DOI 10.1016/S0021-9290(96)00141-8; Taylor WR, 2010, GAIT POSTURE, V32, P231, DOI 10.1016/j.gaitpost.2010.05.005; Taylor WR, 2004, J ORTHOP RES, V22, P625, DOI 10.1016/j.orthres.2003.09.003; Thambyah A, 2005, KNEE, V12, P383, DOI 10.1016/j.knee.2004.12.005; Trepczynski A, 2012, J ORTHOP RES, V30, P408, DOI 10.1002/jor.21540; Walker PS, 2000, CLIN ORTHOP RELAT R, P290	37	194	199	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86035	10.1371/journal.pone.0086035	http://dx.doi.org/10.1371/journal.pone.0086035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465856	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000330288000042
J	Kirchner, M; Schubert, P; Liebherr, M; Haas, CT				Kirchner, Marietta; Schubert, Patric; Liebherr, Magnus; Haas, Christian T.			Detrended Fluctuation Analysis and Adaptive Fractal Analysis of Stride Time Data in Parkinson's Disease: Stitching Together Short Gait Trials	PLOS ONE			English	Article							WALKING SPEED; OLDER-ADULTS; VARIABILITY; DYNAMICS; SERIES; QUANTIFICATION; RELIABILITY; COMPLEXITY; PARAMETERS; STABILITY	Variability indicates motor control disturbances and is suitable to identify gait pathologies. It can be quantified by linear parameters (amplitude estimators) and more sophisticated nonlinear methods (structural information). Detrended Fluctuation Analysis (DFA) is one method to measure structural information, e. g., from stride time series. Recently, an improved method, Adaptive Fractal Analysis (AFA), has been proposed. This method has not been applied to gait data before. Fractal scaling methods (FS) require long stride-to-stride data to obtain valid results. However, in clinical studies, it is not usual to measure a large number of strides (e. g., <100 strides). Amongst others, clinical gait analysis is limited due to short walkways, thus, FS seem to be inapplicable. The purpose of the present study was to evaluate FS under clinical conditions. Stride time data of five self-paced walking trials (25 strides each) of subjects with PD and a healthy control group (CG) was measured. To generate longer time series, stride time sequences were stitched together. The coefficient of variation (CV), fractal scaling exponents alpha (DFA) and H (AFA) were calculated. Two surrogate tests were performed: A) the whole time series was randomly shuffled; B) the single trials were randomly shuffled separately and afterwards stitched together. CV did not discriminate between PD and CG. However, significant differences between PD and CG were found concerning alpha and H. Surrogate version B yielded a higher mean squared error and empirical quantiles than version A. Hence, we conclude that the stitching procedure creates an artificial structure resulting in an overestimation of true alpha. The method of stitching together sections of gait seems to be appropriate in order to distinguish between PD and CG with FS. It provides an approach to integrate FS as standard in clinical gait analysis and to overcome limitations such as short walkways.	[Kirchner, Marietta; Schubert, Patric; Liebherr, Magnus; Haas, Christian T.] Univ Appl Sci, Hsch Fresenius, Fac Hlth & Social Sci, Idstein, Germany		Kirchner, M (corresponding author), Univ Appl Sci, Hsch Fresenius, Fac Hlth & Social Sci, Idstein, Germany.	marietta.kirchner@gmail.com			LOEWE focus PreBionics; Hilde-Ulrichs Foundation	LOEWE focus PreBionics; Hilde-Ulrichs Foundation	This research was supported by the LOEWE focus PreBionics and Hilde-Ulrichs Foundation for Parkinson's research. Please consult the website: http://praeventive-biomechanik.eu/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch R, 2007, PHYSICA A, V383, P455, DOI 10.1016/j.physa.2007.04.120; Beauchet O, 2003, J AM GERIATR SOC, V51, P1187, DOI 10.1046/j.1532-5415.2003.51385.x; Beauchet O, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-37; BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; Bloem BR, 2004, CLIN DISORDERS BALAN, V2, P173; Brach JS, 2008, ARCH PHYS MED REHAB, V89, P2293, DOI 10.1016/j.apmr.2008.06.010; Cavanaugh JT, 2010, J GERONTOL A-BIOL, V65, P197, DOI 10.1093/gerona/glp144; Chang MD, 2010, HUM MOVEMENT SCI, V29, P977, DOI 10.1016/j.humov.2010.04.009; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Damouras S, 2010, GAIT POSTURE, V31, P336, DOI 10.1016/j.gaitpost.2009.12.002; Delignieres D, 2011, COMPUT BIOL, V7; Delignieres D, 2006, J MATH PSYCHOL, V50, P525, DOI 10.1016/j.jmp.2006.07.004; Dingwell JB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000856; Diniz A, 2011, HUM MOVEMENT SCI, V30, P889, DOI 10.1016/j.humov.2010.07.006; Dutta S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00274; Eke A, 2000, PFLUG ARCH EUR J PHY, V439, P403, DOI 10.1007/s004249900135; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Frenkel-Toledo Silvi, 2005, J Neuroeng Rehabil, V2, P23, DOI 10.1186/1743-0003-2-23; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Hausdorff J. M., 2005, J NEUROENG REHABIL, V2, P2; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; Hausdorff JM, 2001, PHYSICA A, V302, P138, DOI 10.1016/S0378-4371(01)00460-5; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Hollman JH, 2007, GAIT POSTURE, V26, P113, DOI 10.1016/j.gaitpost.2006.08.005; Hollman JH, 2010, GAIT POSTURE, V32, P23, DOI 10.1016/j.gaitpost.2010.02.017; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kirchner M, 2012, PHYSICA A, V391, P4692, DOI 10.1016/j.physa.2012.05.034; Kressig RW, 2006, AGING CLIN EXP RES, V18, P174, DOI 10.1007/BF03327437; Kuznetsov N, 2013, ANN BIOMED ENG, V41, P1646, DOI 10.1007/s10439-012-0646-9; Lewis GN, 2000, BRAIN, V123, P2077, DOI 10.1093/brain/123.10.2077; Lindemann U, 2008, GAIT POSTURE, V27, P91, DOI 10.1016/j.gaitpost.2007.02.005; Lord S, 2011, GAIT POSTURE, V34, P443, DOI 10.1016/j.gaitpost.2011.07.010; Montero-Odasso M, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-35; Morris ME, 1999, HUM MOVEMENT SCI, V18, P461, DOI 10.1016/S0167-9457(99)00020-2; Ota L., 2012, Proceedings of the 2012 ICME International Conference on Complex Medical Engineering (CME), P521, DOI 10.1109/ICCME.2012.6275643; Owings TM, 2003, J BIOMECH, V36, P1215, DOI 10.1016/S0021-9290(03)00108-8; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Priest AW, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-29; Riley MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00371; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Schubert P, 2013, DEUT Z SPORTMED, V64, P132, DOI 10.5960/dzsm.2012.064; Simon SR, 2004, J BIOMECH, V37, P1869, DOI 10.1016/j.jbiomech.2004.02.047; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005; Weron R, 2002, PHYSICA A, V312, P285, DOI 10.1016/S0378-4371(02)00961-5; Winter DA, 1993, J MOTOR BEHAV, V15; Zheng BW, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019510, 10.1371/journal.pone.0019976]	57	41	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85787	10.1371/journal.pone.0085787	http://dx.doi.org/10.1371/journal.pone.0085787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465708	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000024
J	Kudapa, H; Azam, S; Sharpe, AG; Taran, B; Li, R; Deonovic, B; Cameron, C; Farmer, AD; Cannon, SB; Varshney, RK				Kudapa, Himabindu; Azam, Sarwar; Sharpe, Andrew G.; Taran, Bunyamin; Li, Rong; Deonovic, Benjamin; Cameron, Connor; Farmer, Andrew D.; Cannon, Steven B.; Varshney, Rajeev K.			Comprehensive Transcriptome Assembly of Chickpea (Cicer arietinum L.) Using Sanger and Next Generation Sequencing Platforms: Development and Applications	PLOS ONE			English	Article							DRAFT GENOME SEQUENCE; GENE DISCOVERY; EST DATABASES; SSR-MARKERS; DROUGHT; CROP; RESOURCE; DIVERSITY; PROVIDES; LEGUMES	A comprehensive transcriptome assembly of chickpea has been developed using 134.95 million Illumina single-end reads, 7.12 million single-end FLX/454 reads and 139,214 Sanger expressed sequence tags (ESTs) from >17 genotypes. This hybrid transcriptome assembly, referred to as Cicer arietinum Transcriptome Assembly version 2 (CaTA v2, available at http://data.comparative-legumes.org/transcriptomes/cicar/lista_cicar-201201), comprising 46,369 transcript assembly contigs (TACs) has an N50 length of 1,726 bp and a maximum contig size of 15,644 bp. Putative functions were determined for 32,869 (70.8%) of the TACs and gene ontology assignments were determined for 21,471 (46.3%). The new transcriptome assembly was compared with the previously available chickpea transcriptome assemblies as well as to the chickpea genome. Comparative analysis of CaTA v2 against transcriptomes of three legumes - Medicago, soybean and common bean, resulted in 27,771 TACs common to all three legumes indicating strong conservation of genes across legumes. CaTA v2 was also used for identification of simple sequence repeats (SSRs) and intron spanning regions (ISRs) for developing molecular markers. ISRs were identified by aligning TACs to the Medicago genome, and their putative mapping positions at chromosomal level were identified using transcript map of chickpea. Primer pairs were designed for 4,990 ISRs, each representing a single contig for which predicted positions are inferred and distributed across eight linkage groups. A subset of randomly selected ISRs representing all eight chickpea linkage groups were validated on five chickpea genotypes and showed 20% polymorphism with average polymorphic information content (PIC) of 0.27. In summary, the hybrid transcriptome assembly developed and novel markers identified can be used for a variety of applications such as gene discovery, marker-trait association, diversity analysis etc., to advance genetics research and breeding applications in chickpea and other related legumes.	[Kudapa, Himabindu; Azam, Sarwar; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Res Program Grain Legumes, Patancheru, Andhra Pradesh, India; [Sharpe, Andrew G.; Li, Rong] Natl Res Council Canada NRC CNRC, Saskatoon, SK, Canada; [Taran, Bunyamin] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [Deonovic, Benjamin; Cannon, Steven B.] Univ Iowa, Dept Agron, Ames, IA USA; [Cameron, Connor; Farmer, Andrew D.] NCGR, Santa Fe, NM USA; [Cannon, Steven B.] USDA ARS, Corn Insects & Crop Genet Res Unit USDA ARS CICGR, Ames, IA USA; [Varshney, Rajeev K.] CIMMYT, CGIAR Generat Challenge Programme GCP, Mexico City 06600, DF, Mexico	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); National Research Council Canada; University of Saskatchewan; University of Iowa; National Center for Genome Resources (NCGR); United States Department of Agriculture (USDA); CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Res Program Grain Legumes, Patancheru, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Varshney, Rajeev K/C-5295-2014	Varshney, Rajeev K/0000-0002-4562-9131; Tar'an, Bunyamin/0000-0003-3583-3910; Kudapa, Himabindu/0000-0003-0778-9959	DST-INSPIRE program by Department of Science and Technology, Government of India; Indo-German Science Technology Centre (IGSTC); CGIAR Generation Challenge Programme (GCP); Saskatchewan Agriculture Development Fund (ADF); ARS [ARS-0425040] Funding Source: Federal RePORTER	DST-INSPIRE program by Department of Science and Technology, Government of India; Indo-German Science Technology Centre (IGSTC); CGIAR Generation Challenge Programme (GCP); Saskatchewan Agriculture Development Fund (ADF); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors are thankful to the DST-INSPIRE program by Department of Science and Technology, Government of India, Indo-German Science Technology Centre (IGSTC), CGIAR Generation Challenge Programme (GCP) and the Saskatchewan Agriculture Development Fund (ADF) for financial support to undertake part of research presented in this study. This work has been undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of CGIAR Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052443; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Azam S, 2012, AM J BOT, V99, P186, DOI 10.3732/ajb.1100419; Bohra A, 2012, THEOR APPL GENET, V125, P1325, DOI 10.1007/s00122-012-1916-5; Bohra A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-56; BROCKWELL J, 1995, PLANT SOIL, V174, P143, DOI 10.1007/BF00032245; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Deokar AA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-70; Dubey A, 2011, DNA RES, V18, P153, DOI 10.1093/dnares/dsr007; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gaur PM, 2008, PLANT PROD SCI, V11, P3, DOI 10.1626/pps.11.3; Gaur R, 2012, DNA RES, V19, P357, DOI 10.1093/dnares/dss018; Gujaria N, 2011, THEOR APPL GENET, V122, P1577, DOI 10.1007/s00122-011-1556-1; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Kashiwagi J, 2006, FIELD CROP RES, V95, P171, DOI 10.1016/j.fcr.2005.02.012; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kudapa H, 2012, MOL PLANT, V5, P1020, DOI 10.1093/mp/ssr111; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Libault M, 2009, PLANT PHYSIOL, V151, P991, DOI 10.1104/pp.109.144105; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Rozen S, 2000, Methods Mol Biol, V132, P365; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schlueter JA, 2004, GENOME, V47, P868, DOI [10.1139/g04-047, 10.1139/G04-047]; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Thudi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027275; Thudi M, 2010, EUPHYTICA, V174, P253, DOI 10.1007/s10681-010-0148-5; van Kessel C, 2000, FIELD CROP RES, V65, P165, DOI 10.1016/S0378-4290(99)00085-4; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-523; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Varshney RK, 2005, TRENDS PLANT SCI, V10, P621, DOI 10.1016/j.tplants.2005.10.004; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Yang SY, 2006, THEOR APPL GENET, V113, P585, DOI 10.1007/s00122-006-0317-z; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zia-ul-Haq M., 2012, Journal of Medicinal Plants Research, V6, P2029	49	67	68	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86039	10.1371/journal.pone.0086039	http://dx.doi.org/10.1371/journal.pone.0086039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465857	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000043
J	Mondejar, R; Solano, F; Rubio, R; Delgado, M; Perez-Sempere, A; Gonzalez-Meneses, A; Vendrell, T; Izquierdo, G; Martinez-Mir, A; Lucas, M				Mondejar, Rufino; Solano, Francisca; Rubio, Rocio; Delgado, Mercedes; Perez-Sempere, Angel; Gonzalez-Meneses, Antonio; Vendrell, Teresa; Izquierdo, Guillermo; Martinez-Mir, Amalia; Lucas, Miguel			Mutation Prevalence of Cerebral Cavernous Malformation Genes in Spanish Patients	PLOS ONE			English	Article							EXPRESSION ANALYSIS; CCM2; KRIT1; PROTEIN; VARIANTS	Objective: To study the molecular genetic and clinical features of cerebral cavernous malformations (CCM) in a cohort of Spanish patients. Methods: We analyzed the CCM1, CCM2, and CCM3 genes by MLPA and direct sequencing of exons and intronic boundaries in 94 familial forms and 41 sporadic cases of CCM patients of Spanish extraction. When available, RNA studies were performed seeking for alternative or cryptic splicing. Results: A total of 26 pathogenic mutations, 22 of which predict truncated proteins, were identified in 29 familial forms and in three sporadic cases. The repertoire includes six novel non-sense and frameshift mutations in CCM1 and CCM3. We also found four missense mutations, one of them located at the third NPXY motif of CCM1 and another one that leads to cryptic splicing of CCM1 exon 6. We found four genomic deletions with the loss of the whole CCM2 gene in one patient and a partial loss of CCM1 and CCM2 genes in three other patients. Four families had mutations in CCM3. The results include a high frequency of intronic variants, although most of them localize out of consensus splicing sequences. The main symptoms associated to clinical debut consisted of cerebral haemorrhage, migraines and epileptic seizures. The rare co-occurrence of CCM with Noonan and Chiari syndromes and delayed menarche is reported. Conclusions: Analysis of CCM genes by sequencing and MLPA has detected mutations in almost 35% of a Spanish cohort (36% of familial cases and 10% of sporadic patients). The results include 13 new mutations of CCM genes and the main clinical symptoms that deserves consideration in molecular diagnosis and genetic counselling of cerebral cavernous malformations.	[Mondejar, Rufino; Solano, Francisca; Rubio, Rocio; Delgado, Mercedes; Lucas, Miguel] Hosp Univ Virgen Macarena, Fac Med, Serv Biol Mol, Seville, Spain; [Izquierdo, Guillermo] Hosp Univ Virgen Macarena, Fac Med, Serv Neurol, Seville, Spain; [Perez-Sempere, Angel] Hosp Univ Alicante, Serv Neurol, Alicante, Spain; [Gonzalez-Meneses, Antonio] Hosp Univ Virgen del Roci, Unidad Dismorfol, Seville, Spain; [Vendrell, Teresa] Hosp Univ Vall dHebron, Unidad Genet, Barcelona, Spain; [Martinez-Mir, Amalia] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain	Hospital Universitario Virgen Macarena; University of Sevilla; Hospital Universitario Virgen Macarena; University of Sevilla; General University Hospital of Alicante; Hospital Universitari Vall d'Hebron; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Lucas, M (corresponding author), Hosp Univ Virgen Macarena, Fac Med, Serv Biol Mol, Seville, Spain.	lucas@us.es	Sempere, Angel P/AAG-3860-2019; IBIS, NEUROGENETICA/P-2947-2015; Martinez-Mir, Amalia/K-7715-2018; Delgado-Garcia, Mercedes/D-2102-2015	Sempere, Angel P/0000-0002-0195-2834; Martinez-Mir, Amalia/0000-0002-1628-8972; Delgado-Garcia, Mercedes/0000-0002-8900-2357; Mondejar, Rufino/0000-0001-6641-2073	Instituto de Salud Carlos III, Spain [CP10/00526]; Junta de Andalucia, Spain [P07-CVI-02790]; Jose Luis Castano Foundation	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Junta de Andalucia, Spain(Junta de Andalucia); Jose Luis Castano Foundation	This work has been supported by grants CP10/00526 (Instituto de Salud Carlos III, Spain) and P07-CVI-02790 (Junta de Andalucia, Spain). RM received a fellowship of Jose Luis Castano Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Cave-Riant F, 2002, EUR J HUM GENET, V10, P733, DOI 10.1038/sj.ejhg.5200870; Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; D'Angelo R, 2012, INT J MOL MED, V29, P1113, DOI 10.3892/ijmm.2012.927; D'Angelo R, 2011, BRAIN PATHOL, V21, P215, DOI 10.1111/j.1750-3639.2010.00441.x; Dammann P, 2013, J NEUROL NEUROSUR PS, V84, P194, DOI 10.1136/jnnp-2012-302599; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Felbor U, 2007, NEUROGENETICS, V8, P149, DOI 10.1007/s10048-006-0076-7; Harel L, 2009, NEURON, V63, P585, DOI 10.1016/j.neuron.2009.08.020; Kehrer-Sawatzki H, 2002, ACTA NEUROPATHOL, V104, P231, DOI 10.1007/s00401-002-0552-6; Kim J, 2011, J CELL SCI, V124, P3929, DOI 10.1242/jcs.095471; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Liquori Christina L, 2006, Hum Mutat, V27, P118, DOI 10.1002/humu.9389; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Ortiz L, 2007, J NEUROL, V254, P322, DOI 10.1007/s00415-006-0359-9; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Riant F, 2013, NEUROGENETICS, V14, P133, DOI 10.1007/s10048-013-0362-0; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Verlaan DJ, 2004, ANN NEUROL, V55, P757, DOI 10.1002/ana.20112; Verlaan DJ, 2002, AM J HUM GENET, V70, P1564, DOI 10.1086/340604; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256	22	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86286	10.1371/journal.pone.0086286	http://dx.doi.org/10.1371/journal.pone.0086286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466005	Green Published, gold			2022-12-25	WOS:000330288000077
J	Gieseck, RL; Hannan, NRF; Bort, R; Hanley, NA; Drake, RAL; Cameron, GWW; Wynn, TA; Vallier, L				Gieseck, Richard L., III; Hannan, Nicholas R. F.; Bort, Roque; Hanley, Neil A.; Drake, Rosemary A. L.; Cameron, Grant W. W.; Wynn, Thomas A.; Vallier, Ludovic			Maturation of Induced Pluripotent Stem Cell Derived Hepatocytes by 3D-Culture	PLOS ONE			English	Article							COLLAGEN-SANDWICH CONFIGURATION; PLASTIC COMPRESSED COLLAGEN; EXTRACELLULAR-MATRIX; LIVER DEVELOPMENT; LONG-TERM; EXPRESSION; CULTURES	Induced pluripotent stem cell derived hepatocytes (IPSC-Heps) have the potential to reduce the demand for a dwindling number of primary cells used in applications ranging from therapeutic cell infusions to in vitro toxicology studies. However, current differentiation protocols and culture methods produce cells with reduced functionality and fetal-like properties compared to adult hepatocytes. We report a culture method for the maturation of IPSC-Heps using 3-Dimensional (3D) collagen matrices compatible with high throughput screening. This culture method significantly increases functional maturation of IPSC-Heps towards an adult phenotype when compared to conventional 2D systems. Additionally, this approach spontaneously results in the presence of polarized structures necessary for drug metabolism and improves functional longevity to over 75 days. Overall, this research reveals a method to shift the phenotype of existing IPSC-Heps towards primary adult hepatocytes allowing such cells to be a more relevant replacement for the current primary standard.	[Gieseck, Richard L., III; Hannan, Nicholas R. F.; Vallier, Ludovic] Univ Cambridge, Wellcome Trust Med Res Council, Stem Cell Inst, Anne McLaren Lab Regenerat Med,Dept Surg, Cambridge, England; [Gieseck, Richard L., III; Wynn, Thomas A.] NIAID, Immunopathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Bort, Roque] Inst Invest Sanitaria La Fe, Unidad Hepatol Expt, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Valencia, Spain; [Hanley, Neil A.] Univ Manchester, Fac Med & Human Sci, Ctr Endocrinol & Diabet, Inst Human Dev,Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Drake, Rosemary A. L.; Cameron, Grant W. W.] TAP Biosyst, Royston, England; [Vallier, Ludovic] Wellcome Trust Sanger Inst, Hinxton, England	University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Manchester; Wellcome Trust Sanger Institute	Vallier, L (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council, Stem Cell Inst, Anne McLaren Lab Regenerat Med,Dept Surg, Cambridge, England.	lv225@cam.ac.uk	vallier, ludovic/C-6368-2011; Bort, Roque/Y-5466-2019; Wynn, Thomas A/AAO-3523-2021; Hannan, Nicholas/ABG-6497-2020	Bort, Roque/0000-0002-7285-0536; Wynn, Thomas A/0000-0002-7244-8731; Gieseck, Richard/0000-0003-0200-581X; Hannan, Nicholas/0000-0002-9843-1559; Vallier, Ludovic/0000-0002-3848-2602; Hanley, Neil/0000-0003-3234-4038	ERC starting grant; Cambridge Hospitals National Institute for Health Research Biomedical Research Center; NIH-Oxford Cambridge Scholars Program Fellowship; Evelyn trust; EU grant InnovaLiv; EPSRC [DT/E005039/2] Funding Source: UKRI; MRC [G0701448] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1085978] Funding Source: researchfish; Engineering and Physical Sciences Research Council [DT/E005039/2] Funding Source: researchfish; Medical Research Council [G0701448] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001194, ZIAAI000829] Funding Source: NIH RePORTER	ERC starting grant; Cambridge Hospitals National Institute for Health Research Biomedical Research Center; NIH-Oxford Cambridge Scholars Program Fellowship; Evelyn trust; EU grant InnovaLiv; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by an ERC starting grant (L. V.), the Cambridge Hospitals National Institute for Health Research Biomedical Research Center (L. V., N.R.F.H.), the NIH-Oxford Cambridge Scholars Program Fellowship (R. L. G.), the Evelyn trust (N.R.F.H.), and the EU grant InnovaLiv (R. L. G, R. B., and L. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthiaume F, 1996, FASEB J, V10, P1471, DOI 10.1096/fasebj.10.13.8940293; Dhawan A, 2009, HEPATOCYTE TRANSPLAN, Vxvii; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Elaut G, 2006, CURR DRUG METAB, V7, P629, DOI 10.2174/138920006778017759; Fraczek J, 2013, ARCH TOXICOL, V87, P577, DOI 10.1007/s00204-012-0983-3; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; HONG WJ, 1989, EXP CELL RES, V182, P256, DOI 10.1016/0014-4827(89)90296-6; Kern A, 1997, BIOCHEM PHARMACOL, V54, P761, DOI 10.1016/S0006-2952(97)00204-9; KOMORI M, 1990, BIOCHEMISTRY-US, V29, P4430, DOI 10.1021/bi00470a024; LECLUYSE EL, 1994, AM J PHYSIOL, V266, pC1764, DOI 10.1152/ajpcell.1994.266.6.C1764; Levis HJ, 2013, CURR EYE RES, V38, P41, DOI 10.3109/02713683.2012.725799; Levis HJ, 2010, BIOMATERIALS, V31, P7726, DOI 10.1016/j.biomaterials.2010.07.012; Lora JM, 1998, HEPATOLOGY, V28, P1095, DOI 10.1002/hep.510280426; Nies AT, 2007, PFLUG ARCH EUR J PHY, V453, P643, DOI 10.1007/s00424-006-0109-y; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; SALATREPAT JM, 1979, BIOCHEMISTRY-US, V18, P2167, DOI 10.1021/bi00578a006; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Tuschl G, 2009, CHEM-BIOL INTERACT, V181, P124, DOI 10.1016/j.cbi.2009.05.015; Vinken M, 2006, CRIT REV TOXICOL, V36, P299, DOI 10.1080/10408440600599273; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	21	134	140	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86372	10.1371/journal.pone.0086372	http://dx.doi.org/10.1371/journal.pone.0086372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466060	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100149
J	Amiard, S; Da Ines, O; Gallego, ME; White, CI				Amiard, Simon; Da Ines, Olivier; Gallego, Maria Eugenia; White, Charles I.			Responses to Telomere Erosion in Plants	PLOS ONE			English	Article							LIPID TRANSFER PROTEINS; SINGLE-STRANDED-DNA; LENGTH REGULATION; STEM-CELLS; ARABIDOPSIS; ATR; DAMAGE; MAINTENANCE; REPAIR; ROLES	In striking contrast to animals, plants are able to develop and reproduce in the presence of significant levels of genome damage. This is seen clearly in both the viability of plants carrying knockouts for key recombination and DNA repair genes, which are lethal in vertebrates, and in the impact of telomere dysfunction. Telomerase knockout mice show accelerated ageing and severe developmental phenotypes, with effects on both highly proliferative and on more quiescent tissues, while cell death in Arabidopsis tert mutants is mostly restricted to actively dividing meristematic cells. Through phenotypic and whole-transcriptome RNAseq studies, we present here an analysis of the response of Arabidopsis plants to the continued presence of telomere damage. Comparison of second-generation and seventh-generation tert mutant plants has permitted separation of the effects of the absence of the telomerase enzyme and the ensuing chromosome damage. In addition to identifying a large number of genes affected by telomere damage, many of which are of unknown function, the striking conclusion of this study is the clear difference observed at both cellular and transcriptome levels between the ways in which mammals and plants respond to chronic telomeric damage.	[Amiard, Simon; Da Ines, Olivier; Gallego, Maria Eugenia; White, Charles I.] Clermont Univ, INSERM, CNRS, UMR 6293,U1103, Aubiere, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	White, CI (corresponding author), Clermont Univ, INSERM, CNRS, UMR 6293,U1103, Aubiere, France.	chwhite@univ-bpclermont.fr	amiard, simon/J-6951-2015; Gallego, Maria E/F-1044-2011; DA INES, Olivier/J-6901-2015; White, Charles I/F-1001-2011	amiard, simon/0000-0002-0427-1647; Gallego, Maria E/0000-0001-5588-9116; DA INES, Olivier/0000-0002-1868-3781; White, Charles I/0000-0001-8152-5797	European Union [LSHG-CT-2005-018785]; French Government ANR [ANR-07-BLAN- 0068]; Centre National de la Recherche Scientifique; Universite Blaise Pascal; Universite d'Auvergne; Institut National de la Sante et la Recherche Medicale	European Union(European Commission); French Government ANR(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Blaise Pascal; Universite d'Auvergne; Institut National de la Sante et la Recherche Medicale	This work was partly financed by a European Union research grant (LSHG-CT-2005-018785), a French Government ANR grant (ANR-07-BLAN- 0068), the Centre National de la Recherche Scientifique, the Universite Blaise Pascal, the Universite d'Auvergne, and the Institut National de la Sante et la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2011, P NATL ACAD SCI USA, V108, P10004, DOI 10.1073/pnas.1103584108; Amiard S, 2011, PLANT CELL, V23, P4254, DOI 10.1105/tpc.111.092387; Amiard S, 2011, CURR PROTEIN PEPT SC, V12, P84, DOI 10.2174/138920311795684931; Amiard S, 2010, PLANT CELL, V22, P3020, DOI 10.1105/tpc.110.078527; Aubert S, 1996, J CELL BIOL, V133, P1251, DOI 10.1083/jcb.133.6.1251; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Boltz KA, 2012, MOL BIOL CELL, V23, P1558, DOI 10.1091/mbc.E11-12-1002; Charbonnel C, 2011, DNA REPAIR, V10, P611, DOI 10.1016/j.dnarep.2011.04.002; Charbonnel C, 2010, PLANT J, V64, P280, DOI 10.1111/j.1365-313X.2010.04331.x; Chen IP, 2003, PLANT J, V35, P771, DOI 10.1046/j.1365-313X.2003.01847.x; Cifuentes-Rojas C, 2012, GENE DEV, V26, P2512, DOI 10.1101/gad.202960.112; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; De Veylder L, 2011, TRENDS PLANT SCI, V16, P624, DOI 10.1016/j.tplants.2011.07.001; Eklund DM, 2003, PLANT PHYSIOL, V132, P1249, DOI 10.1104/pp.103.020875; Fitzgerald MS, 1999, P NATL ACAD SCI USA, V96, P14813, DOI 10.1073/pnas.96.26.14813; Fulcher N, 2009, P NATL ACAD SCI USA, V106, P20984, DOI 10.1073/pnas.0909218106; Furukawa T, 2010, DNA REPAIR, V9, P940, DOI 10.1016/j.dnarep.2010.06.006; Garcia V, 2003, PLANT CELL, V15, P119, DOI 10.1105/tpc.006577; Garcia-Olmedo Francisco, 1995, Trends in Microbiology, V3, P72, DOI 10.1016/S0966-842X(00)88879-4; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Giraud-Panis MJ, 2010, MOL CELL, V39, P665, DOI 10.1016/j.molcel.2010.08.024; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Hashimura Y, 2011, PLANT J, V68, P657, DOI 10.1111/j.1365-313X.2011.04718.x; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Kevei Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020618; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Leehy KA, 2013, PLANT CELL, V25, P1343, DOI 10.1105/tpc.112.107425; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Molinier J, 2004, PLANT CELL, V16, P1633, DOI 10.1105/tpc.021378; Pacurar DI, 2011, PHYSIOL MOL PLANT P, V76, P76, DOI 10.1016/j.pmpp.2011.06.004; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Price CM, 2010, CELL CYCLE, V9, P3157, DOI 10.4161/cc.9.16.12547; Ricaud L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000430; Riha K, 2001, SCIENCE, V291, P1797, DOI 10.1126/science.1057110; Rozan LM, 2007, CELL DEATH DIFFER, V14, P3, DOI 10.1038/sj.cdd.4402058; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Shay JW, 2010, FEBS LETT, V584, P3819, DOI 10.1016/j.febslet.2010.05.026; Shore D, 2009, EMBO J, V28, P2309, DOI 10.1038/emboj.2009.195; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; STERK P, 1991, PLANT CELL, V3, P907, DOI 10.1105/tpc.3.9.907; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Templeton GW, 2005, EMBO REP, V6, P723, DOI 10.1038/sj.embor.7400479; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Yoshiyama K, 2009, P NATL ACAD SCI USA, V106, P12843, DOI 10.1073/pnas.0810304106	49	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86220	10.1371/journal.pone.0086220	http://dx.doi.org/10.1371/journal.pone.0086220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465970	Green Submitted, gold, Green Published			2022-12-25	WOS:000330244500208
J	Burghardt, KM; Avinashi, V; Kosar, C; Xu, W; Wales, PW; Avitzur, Y; Muise, A				Burghardt, Karolina Maria; Avinashi, Vishal; Kosar, Christina; Xu, Wei; Wales, Paul W.; Avitzur, Yaron; Muise, Aleixo			A CARD9 Polymorphism Is Associated with Decreased Likelihood of Persistent Conjugated Hyperbilirubinemia in Intestinal Failure	PLOS ONE			English	Article							COLITIS SUSCEPTIBILITY LOCI; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; INNATE IMMUNITY; CROHNS-DISEASE; PARENTERAL-NUTRITION; PROTEIN CARD9; GENE; ACTIVATION; RECEPTORS	Recently, genetic associations have been described in intestinal transplants. Namely, Crohn's disease susceptibility gene NOD2 polymorphisms have been reported to be more prevalent in patients with graft failure following intestinal transplantation (IT). Therefore, we sought to determine if polymorphisms in the NOD2 signaling cascade, including NOD2, CARD9, RAC1 and ATG16L1 are associated with intestinal failure (IF) or its complications. We carried out a cross-sectional study of 59 children with IF and 500 healthy Caucasian controls. Using the Taqman platform we determined the prevalence of NOD2 as well as ATG16L1, RAC1 and CARD9 SNPs. NOD2 pathway polymorphisms were evaluated in relation to outcomes of episodes of sepsis, ICU admissions, hyperbilirubinemia and need for IT. We found that the minor allele of a CARD9 SNP was associated with protection from developing IF when compared to healthy controls and was also associated with decreased odds of sustained conjugated hyperbilirubinemia. Therefore, IF patients with CARD9 polymorphism are less likely to develop progressive liver disease and suggests that host innate immunity may play a role in IF associated liver disease.	[Burghardt, Karolina Maria; Kosar, Christina; Wales, Paul W.; Avitzur, Yaron] Transplant Ctr, Grp Improvement Intestinal Funct & Treatment GIFT, Toronto, ON, Canada; [Burghardt, Karolina Maria; Avitzur, Yaron; Muise, Aleixo] Dept Pediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON, Canada; [Muise, Aleixo] Univ Toronto, Hosp Sick Children, Cell Biol Program, SickKids IBD Ctr, Toronto, ON M5G 1X8, Canada; [Avinashi, Vishal] BC Children Hosp, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Vancouver, BC, Canada; [Xu, Wei] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); BC Childrens Hospital; University of Toronto	Avitzur, Y (corresponding author), Transplant Ctr, Grp Improvement Intestinal Funct & Treatment GIFT, Toronto, ON, Canada.	Yaron.avitzur@sickkids.ca; Aleixo.muise@sickkids.ca		Avitzur, Yaron/0000-0002-8072-5727; Avinashi, Vishal/0000-0003-4507-3425; Belza, Christina/0000-0001-6917-295X	Ontario Ministry of Research and Innovation; Canadian Institute of Health Research [MOP119457]; Sick Kids Transplant Centre Astellas Research Competition Grant	Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Sick Kids Transplant Centre Astellas Research Competition Grant	AMM is supported by an Early Researcher Award from the Ontario Ministry of Research and Innovation and funded by a Canadian Institute of Health Research - Operating Grant (MOP119457). Partial funding was provided by a Sick Kids Transplant Centre Astellas Research Competition Grant to AMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	El Kasmi KC, 2012, HEPATOLOGY, V55, P1518, DOI 10.1002/hep.25500; Fishbein I, 2008, CIRCULATION, V117, P2096, DOI 10.1161/CIRCULATIONAHA.107.746412; Fishbein T, 2008, GUT, V57, DOI 10.1136/gut.2007.133322; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Janse M, 2009, ROLE GENETIC CROHNS; Janse M, 2011, HEPATOLOGY, V53, P1977, DOI 10.1002/hep.24307; Jensen SR, 2011, INFLAMM BOWEL DIS, V17, P2392, DOI 10.1002/ibd.21656; Lang R, 2011, IMMUNOBIOLOGY, V216, P1184, DOI 10.1016/j.imbio.2011.06.005; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Messlik A, 2009, J PROTEOME RES, V8, P4406, DOI 10.1021/pr9000465; Miyake Y, 2012, HEPATOL RES; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moran CJ, 2013, INFLAMM BOWEL DIS, V19, P115, DOI 10.1002/ibd.22974; Moran CJ, 2012, INFLAMM BOWEL DIS, DOI 10.1002/ibd.22974; Muise AM, 2009, GUT, V58, P1121, DOI 10.1136/gut.2008.175117; Muise AM, 2007, CURR BIOL, V17, P1212, DOI 10.1016/j.cub.2007.06.013; Muise AM, 2012, GASTROENTEROLOGY, V143, P285, DOI 10.1053/j.gastro.2012.06.025; Muise AM, 2012, GUT, V61, P1028, DOI 10.1136/gutjnl-2011-300078; Muise AM, 2011, GASTROENTEROLOGY, V141, P633, DOI 10.1053/j.gastro.2011.04.057; Nasr A, 2007, J PEDIATR SURG, V42, P359, DOI 10.1016/j.jpedsurg.2006.10.008; Ningappa M, 2011, AM J GASTROENTEROL, V106, P157, DOI 10.1038/ajg.2010.322; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quiros-Tejeira RE, 2004, J PEDIATR-US, V145, P157, DOI 10.1016/j.jpeds.2004.02.030; Ren JY, 2011, AM J HYPERTENS, V24, P701, DOI 10.1038/ajh.2011.42; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Roth S, 2013, TRENDS IMMUNOL, V34, P243, DOI 10.1016/j.it.2013.02.006; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sokol H, 2013, GASTROENTEROLOGY; Travassos LH, 2010, AUTOPHAGY, V6, P409, DOI 10.4161/auto.6.3.11305; Willis TC, 2010, JPEN-PARENTER ENTER, V34, P32, DOI 10.1177/0148607109332772; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85915	10.1371/journal.pone.0085915	http://dx.doi.org/10.1371/journal.pone.0085915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465786	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500143
J	Chan, MC; Chiu, SK; Hsueh, PR; Wang, NC; Wang, CC; Fang, CT				Chan, Ming-Chin; Chiu, Sheng-Kang; Hsueh, Po-Ren; Wang, Ning-Chi; Wang, Chih-Chien; Fang, Chi-Tai			Risk Factors for Healthcare-Associated Extensively Drug-Resistant Acinetobacter baumannii Infections: A Case-Control Study	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; MULTIDRUG-RESISTANT; CARBAPENEM RESISTANCE; DISSEMINATION; SURVEILLANCE; EMERGENCE; OUTBREAK; PATTERNS; CLASS-1; GENES	The emergence of extensively drug-resistant Acinetobacter baumannii (XDRAB) is a serious threat to hospitalized patients. From 2008 to 2010, surveillance detected 25 hospital-acquired infection (HAI) cases caused by XDRAB at a medical center in Taipei. The site of XDRAB infection was bloodstream (n = 8), urinary tract (n = 12), lower respiratory tract (n = 3), surgical site (n = 1), and cardiovascular (n = 1). The isolates were resistant to all currently available antibiotics except for colistin. The XDRAB isolates are genetically diverse, shown by pulsed-field gel electrophoresis, but 23 of 25 harbored class 1 integron with a 2.3-kb gene cassette. Most of these isolates carry OXA-23 (n = 21) and OXA-51-like carbapenemase genes (n = 25). To identify the risk factors, a case-control study was conducted. The 25 cases were compared with 100 controls randomly selected from hospitalized patients without XDRAB-HAIs, matched by the onset date, ward, and age, at a ratio of 1:4. Prior use of imipenem, meropenem, piperacillin/tazobactam or fourth-generation cephalosporins (adjusted OR: 3.2, 95% CI: 1.03-10.2, P = 0.04) and >30 days bed-ridden (adjusted OR: 6.0, 95% CI: 1.3-27.6, P = 0.02) were found to be the independent risk factors for XDRAB-HAIs. These findings highlight that, even in the absence of clonal dissemination, XDRAB can emerge under the selective pressure of broad-spectrum antibiotics and causes subsequent HAIs in compromised hosts. An appropriate response to the XDRAB threat therefore should include a component of prudent use of broad-spectrum antibiotics active against gram-negative bacteria.	[Chan, Ming-Chin; Wang, Ning-Chi] Natl Def Med Ctr, Triserv Gen Hosp, Infect Control Off, Taipei, Taiwan; [Chiu, Sheng-Kang; Wang, Ning-Chi] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Hsueh, Po-Ren; Fang, Chi-Tai] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 10764, Taiwan; [Wang, Chih-Chien] Natl Def Med Ctr, Triserv Gen Hosp, Dept Pediat, Taipei, Taiwan; [Fang, Chi-Tai] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University	Wang, CC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Pediat, Taipei, Taiwan.	ndmcccw@yahoo.com.tw; fangct@ntu.edu.tw	Fang, Chi-Tai/P-2908-2016; Wang, Ning-Chi/GLT-7544-2022; Chiu, Sheng-Kang/GQO-8638-2022; Hsueh, Po-Ren/ABE-1594-2021	Fang, Chi-Tai/0000-0002-7380-1699; HSUEH, PO-REN/0000-0002-7502-9225	Tri-Service General Hospital, Taipei, Taiwan	Tri-Service General Hospital, Taipei, Taiwan	This work was financially supported by Tri-Service General Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben RJ, 2011, INT J ANTIMICROB AG, V38, P403, DOI 10.1016/j.ijantimicag.2011.05.014; Brown S, 2006, J ANTIMICROB CHEMOTH, V57, P1, DOI 10.1093/jac/dki425; Carvalho KR, 2009, INT J ANTIMICROB AG, V34, P25, DOI 10.1016/j.ijantimicag.2008.12.009; Chiu CH, 2010, INT J ANTIMICROB AG, V35, P382, DOI 10.1016/j.ijantimicag.2009.12.009; Clinical and Laboratory Standards Institute, 2005, PERF STAND ANT SUS S; Gaur A, 2007, INT J ANTIMICROB AG, V29, P446, DOI 10.1016/j.ijantimicag.2006.11.014; Gur D, 2008, J MED MICROBIOL, V57, P1529, DOI 10.1099/jmm.0.2008/002469-0; Heritier C, 2005, ANTIMICROB AGENTS CH, V49, P3198, DOI 10.1128/AAC.49.8.3198-3202.2005; Hope R, 2007, J ANTIMICROB CHEMOTH, V60, P770, DOI 10.1093/jac/dkm297; HORAN TC, 2004, HOSP EPIDEMIOLOGY IN, P1659; Huang LY, 2008, CLIN MICROBIOL INFEC, V14, P1010, DOI 10.1111/j.1469-0691.2008.02077.x; Jean SS, 2011, J FORMOS MED ASSOC, V110, P4, DOI 10.1016/S0929-6646(11)60002-8; Jean SS, 2009, INT J ANTIMICROB AG, V33, P266, DOI 10.1016/j.ijantimicag.2008.08.026; Jones RN, 2007, J CLIN MICROBIOL, V45, P227, DOI 10.1128/JCM.01588-06; Kaufmann ME, 1994, METHODS PRACTICAL LA; Kraniotaki E, 2006, INT J ANTIMICROB AG, V28, P193, DOI 10.1016/j.ijantimicag.2006.04.016; Kuo HY, 2010, DIAGN MICR INFEC DIS, V66, P195, DOI 10.1016/j.diagmicrobio.2009.09.013; Kuo SC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-200; Lee NY, 2007, INFECT CONT HOSP EP, V28, P713, DOI 10.1086/517954; Lin MF, 2010, JPN J INFECT DIS, V63, P440; Lin WR, 2011, KAOHSIUNG J MED SCI, V27, P207, DOI 10.1016/j.kjms.2010.11.004; Park YS, 2010, INT J ANTIMICROB AG, V36, P430, DOI 10.1016/j.ijantimicag.2010.06.049; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2006, J ANTIMICROB CHEMOTH, V57, P794, DOI 10.1093/jac/dkl036; Roe MT, 2003, EMERG INFECT DIS, V9, P822, DOI 10.3201/eid0907.020529; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Zhou H, 2007, J MED MICROBIOL, V56, P1076, DOI 10.1099/jmm.0.47206-0	29	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85973	10.1371/journal.pone.0085973	http://dx.doi.org/10.1371/journal.pone.0085973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465819	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500159
J	Lai, B; Li, XJ; Hu, B; Qin, YH; Huang, XM; Wang, HC; Hu, GB				Lai, Biao; Li, Xiao-Jing; Hu, Bing; Qin, Yong-Hua; Huang, Xu-Ming; Wang, Hui-Cong; Hu, Gui-Bing			LcMYB1 Is a Key Determinant of Differential Anthocyanin Accumulation among Genotypes, Tissues, Developmental Phases and ABA and Light Stimuli in Litchi chinensis	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTORS; RED COLORATION; ABSCISIC-ACID; NEGATIVE REGULATOR; FRUIT COLORATION; VITIS-VINIFERA; PATHWAY GENES; FLOWER COLOR; APPLE FRUIT; BIOSYNTHESIS	The red coloration of litchi fruit depends on the accumulation of anthocyanins. The anthocyanins level in litchi fruit varies widely among cultivars, developmental stages and environmental stimuli. Previous studies on various plant species demonstrate that anthocyanin biosynthesis is controlled at the transcriptional level. Here, we describe a litchi R2R3-MYB transcription factor gene, LcMYB1, which demonstrates a similar sequence as other known anthocyanin regulators. The transcription levels of the LcMYB1 and anthocyanin biosynthetic genes were investigated in samples with different anthocyanin levels. The expression of LcMYB1 was strongly associated with tissue anthocyanin content. LcMYB1 transcripts were only detected in anthocyanin-accumulating tissues and were positively correlated with anthocyanin accumulation in the pericarps of 12 genotypes. ABA and sunlight exposure promoted, whereas CPPU and bagging inhibited the expression of LcMYB1 and anthocyanin accumulation in the pericarp. Cis-elements associated with light responsiveness and abscisic acid responsiveness were identified in the promoter region of LcMYB1. Among the 6 structural genes tested, only LcUFGT was highly correlated with LcMYB1. These results suggest that LcMYB1 controls anthocyanin biosynthesis in litchi and LcUFGT might be the structural gene that is targeted and regulated by LcMYB1. Furthermore, the overexpression of LcMYB1 induced anthocyanin accumulation in all tissues in tobacco, confirming the function of LcMYB1 in the regulation of anthocyanin biosynthesis. The upregulation of NtAn1b in response to LcMYB1 overexpression seems to be essential for anthocyanin accumulation in the leaf and pedicel. In the reproductive tissues of transgenic tobacco, however, increased anthocyanin accumulation is independent of tobacco's endogenous MYB and bHLH transcriptional factors, but associated with the upregulation of specific structural genes.	[Lai, Biao; Li, Xiao-Jing; Hu, Bing; Qin, Yong-Hua; Huang, Xu-Ming; Hu, Gui-Bing] South China Agr Univ, Coll Hort, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Wang, Hui-Cong] South China Agr Univ, Coll Hort, Physiol Lab South China Fruits, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Wang, HC (corresponding author), South China Agr Univ, Coll Hort, Physiol Lab South China Fruits, Guangzhou, Guangdong, Peoples R China.	wanghc1972@263.net; guibing@scau.edu.cn			China Litchi and Longan Industry Technology Research System [CARS-33]; National Natural Science Fund of China [30971985]; Key Laboratory of Innovation and Utilization for Germplasm Resources in Horticultural Crops in Southern China of Guangdong Higher Education Institutes, South China Agricultural University [KBL11008]	China Litchi and Longan Industry Technology Research System; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Innovation and Utilization for Germplasm Resources in Horticultural Crops in Southern China of Guangdong Higher Education Institutes, South China Agricultural University	The project was supported by the China Litchi and Longan Industry Technology Research System (Project No. CARS-33), the National Natural Science Fund of China (Project No. 30971985), and the Key Laboratory of Innovation and Utilization for Germplasm Resources in Horticultural Crops in Southern China of Guangdong Higher Education Institutes, South China Agricultural University (No. KBL11008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; Bai YH, 2011, PLANTA, V234, P363, DOI 10.1007/s00425-011-1407-y; Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; Butelli E, 2012, PLANT CELL, V24, P1242, DOI 10.1105/tpc.111.095232; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; Chiu LW, 2012, PLANTA, V236, P1153, DOI 10.1007/s00425-012-1665-3; Chiu LW, 2010, PLANT PHYSIOL, V154, P1470, DOI 10.1104/pp.110.164160; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; FULEKI T, 1968, J FOOD SCI, V33, P78, DOI 10.1111/j.1365-2621.1968.tb00888.x; Gagne S, 2011, J PLANT GROWTH REGUL, V30, P1, DOI 10.1007/s00344-010-9165-9; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Hiratsuka S, 2001, SCI HORTIC-AMSTERDAM, V90, P121, DOI 10.1016/S0304-4238(00)00264-8; Honda C, 2002, PLANT PHYSIOL BIOCH, V40, P955, DOI 10.1016/S0981-9428(02)01454-7; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huang YJ, 2013, PLANT CELL TISS ORG, V113, P491, DOI 10.1007/s11240-013-0291-5; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Jia HJ, 2005, POSTHARVEST BIOL TEC, V35, P61, DOI 10.1016/j.postharvbio.2004.06.004; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Kobayashi S, 2001, PLANT SCI, V160, P543, DOI 10.1016/S0168-9452(00)00425-8; Koyama K, 2010, FUNCT INTEGR GENOMIC, V10, P367, DOI 10.1007/s10142-009-0145-8; LEE HS, 1991, J FOOD SCI, V56, P466, DOI 10.1111/j.1365-2621.1991.tb05305.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li YY, 2012, PLANT PHYSIOL, V160, P1011, DOI 10.1104/pp.112.199703; Lin-Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI 10.1111/j.1365-3040.2011.02316.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier A, 2013, PLANT J, V74, P638, DOI 10.1111/tpj.12153; Malone LA, 2009, ENTOMOL EXP APPL, V133, P117, DOI 10.1111/j.1570-7458.2009.00910.x; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; Matsui K, 2008, PLANT J, V55, P954, DOI 10.1111/j.1365-313X.2008.03565.x; Niu SS, 2010, PLANTA, V231, P887, DOI 10.1007/s00425-009-1095-z; Paolocci F, 2011, J EXP BOT, V62, P1189, DOI 10.1093/jxb/erq344; Pattanaik S, 2010, PLANTA, V231, P1061, DOI 10.1007/s00425-010-1108-y; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Peppi MC, 2006, HORTSCIENCE, V41, P1440, DOI 10.21273/HORTSCI.41.6.1440; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Qi TC, 2011, PLANT CELL, V23, P1795, DOI 10.1105/tpc.111.083261; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Shimizu Y, 2010, PLANT BIOTECHNOL-NAR, V27, P481, DOI 10.5511/plantbiotechnology.10.0722b; Spelt C, 2002, PLANT CELL, V14, P2121, DOI 10.1105/tpc.003772; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Takahashi R, 2013, J HERED, V104, P149, DOI 10.1093/jhered/ess081; Takahashi R, 2011, J HERED, V102, P458, DOI 10.1093/jhered/esr028; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang HC, 2007, PLANT GROWTH REGUL, V52, P189, DOI 10.1007/s10725-007-9189-8; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xie XB, 2012, PLANT CELL ENVIRON, V35, P1884, DOI 10.1111/j.1365-3040.2012.02523.x; Yamagishi M, 2010, PLANT CELL PHYSIOL, V51, P463, DOI 10.1093/pcp/pcq011; Zhu HF, 2009, MOL PLANT, V2, P790, DOI 10.1093/mp/ssp030; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	63	91	117	5	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86293	10.1371/journal.pone.0086293	http://dx.doi.org/10.1371/journal.pone.0086293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466010	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500219
J	Li, CJ; Li, L; Lin, L; Jiang, HX; Zhong, ZY; Li, WM; Zhang, YJ; Zheng, P; Tan, XH; Zhou, L				Li, Chuan-Jiang; Li, Liang; Lin, Li; Jiang, Hai-Xia; Zhong, Ze-Yan; Li, Wei-Mo; Zhang, Yan-Jun; Zheng, Ping; Tan, Xu-Hui; Zhou, Lin			Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR Genetic Polymorphisms on Tacrolimus Metabolism in Chinese Renal Transplant Recipients	PLOS ONE			English	Article							CALCINEURIN INHIBITORS; DOSE REQUIREMENTS; INCREASED RISK; PHARMACOKINETICS; POPULATION; EXPOSURE	Tacrolimus is a widely used immunosuppressive drug for preventing the rejection of solid organ transplants. The efficacy of tacrolimus shows considerable variability, which might be related to genetic variation among recipients. We conducted a retrospective study of 240 Chinese renal transplant recipients receiving tacrolimus as immunosuppressive drug. The retrospective data of all patients were collected for 40 days after transplantation. Seventeen SNPs of CYP3A5, CYP3A4, COMT, IL-10 and POR were identified by the SNaPshot assay. Tacrolimus blood concentrations were obtained on days 1-3, days 6-8 and days 12-14 after transplantation, as well as during the period of the predefined therapeutic concentration range. Kruskal-Wallis test was used to examine the effect of genetic variation on the tacrolimus concentration/dose ratio (C-0/D) at different time points. Chi-square test was used to compare the proportions of patients who achieved the target C-0 range in the different genotypic groups at weeks 1, 2, 3 and 4 after transplantation. After correction for multiple testing, there was a significant association of C-0/D with CYP3A5*3, CYP3A4*1G and CYP3A4 rs4646437 T>C at different time points after transplantation. The proportion of patients in the IL-10 rs1800871-TT group who achieved the target C-0 range was greater (p = 0.004) compared to the IL-10 rs1800871-CT and IL-10 rs1800871-CC groups at week 3 after transplantation. CYP3A5*3, CYP3A4 *1G, CYP3A4 rs4646437 T>C and IL-10 rs1800871 C>T might be potential polymorphisms affecting the interindividual variability in tacrolimus metabolism among Chinese renal transplant recipients.	[Li, Chuan-Jiang; Li, Wei-Mo] Southern Med Univ, Nanfang Hosp, Dept Surg, Guangzhou, Guangdong, Peoples R China; [Li, Liang; Lin, Li; Zhong, Ze-Yan; Zhou, Lin] Southern Med Univ, Sch Basic Med Sci, Dept Med Genet, Guangzhou, Guangdong, Peoples R China; [Jiang, Hai-Xia] Southern Med Univ, Nanfang Hosp, Dept Clin Lab, Guangzhou, Guangdong, Peoples R China; [Zhang, Yan-Jun] Univ Cincinnati, Acad Hlth Ctr, Coll Pharm, Cincinnati, OH USA; [Zheng, Ping] Southern Med Univ, Nanfang Hosp, Dept Pharm, Guangzhou, Guangdong, Peoples R China; [Tan, Xu-Hui] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; University System of Ohio; University of Cincinnati; Southern Medical University - China; Southern Medical University - China	Li, L (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Med Genet, Guangzhou, Guangdong, Peoples R China.	liliang@smu.edu.cn	li, liang/F-2165-2011		National Natural Science Fund of China(NSFC) [81101328]; Pearl River Young Talents of Science and Technology in Guangzhou [2013J2200050]; Natural Science Fund of Guangdong [S2012040007745]; Nanfang Hospital	National Natural Science Fund of China(NSFC)(National Natural Science Foundation of China (NSFC)); Pearl River Young Talents of Science and Technology in Guangzhou; Natural Science Fund of Guangdong(National Natural Science Foundation of Guangdong Province); Nanfang Hospital	This work was funded by a programme grant from the National Natural Science Fund of China to Liang Li (NSFC, No. 81101328), the Pearl River Young Talents of Science and Technology in Guangzhou to Liang Li (No. 2013J2200050), the Natural Science Fund of Guangdong to Liang Li (No. S2012040007745), the Research Fund for the President of Nanfang Hospital to Chuan-Jiang Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SY, 2013, CLIN TRANSPLANT, V27, pE272, DOI 10.1111/ctr.12101; Crettol S, 2008, THER DRUG MONIT, V30, P689, DOI 10.1097/FTD.0b013e31818a2a60; Dai ZY, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-24; de Jonge H, 2012, CLIN PHARMACOL THER, V92, P366, DOI 10.1038/clpt.2012.109; de Jonge H, 2011, PHARMACOGENOMICS, V12, P1281, DOI [10.2217/PGS.11.77, 10.2217/pgs.11.77]; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Elens L, 2013, BRIT J CLIN PHARMACO, V75, P1545, DOI 10.1111/bcp.12038; Elens L, 2012, PHARMACOGENET GENOM, V22, P373, DOI 10.1097/FPC.0b013e328351f3c1; Elens L, 2011, CLIN CHEM, V57, P1574, DOI 10.1373/clinchem.2011.165613; Goto M, 2004, PHARMACOGENETICS, V14, P471, DOI 10.1097/01.fpc.0000114747.08559.49; Haufroid V, 2006, AM J TRANSPLANT, V6, P2706, DOI 10.1111/j.1600-6143.2006.01518.x; He BX, 2011, BASIC CLIN PHARMACOL, V108, P208, DOI 10.1111/j.1742-7843.2010.00657.x; Jacobson PA, 2011, TRANSPLANTATION, V91, P300, DOI 10.1097/TP.0b013e318200e991; Kuypers DRJ, 2004, CLIN PHARMACOL THER, V75, P434, DOI 10.1016/j.clpt.2003.12.009; Li L, 2011, EUR J CLIN PHARMACOL, V67, P787, DOI 10.1007/s00228-011-1010-y; Li LA, 2011, CLIN BIOCHEM, V44, P418, DOI 10.1016/j.clinbiochem.2010.12.018; MacPhee IAM, 2004, AM J TRANSPLANT, V4, P914, DOI 10.1111/j.1600-6143.2004.00435.x; Masuda S, 2006, PHARMACOL THERAPEUT, V112, P184, DOI 10.1016/j.pharmthera.2006.04.006; Miura M, 2011, PHARMACOGENOMICS, V12, P977, DOI [10.2217/pgs.11.33, 10.2217/PGS.11.33]; Roy JN, 2006, PHARMACOGENET GENOM, V16, P659, DOI 10.1097/01.fpc.0000220571.20961.dd; Schirmer M, 2007, PHARMACOGENOMICS, V8, P443, DOI 10.2217/14622416.8.5.443; Thervet E, 2010, CLIN PHARMACOL THER, V87, P721, DOI 10.1038/clpt.2010.17; Wallemacq P, 2009, THER DRUG MONIT, V31, P139, DOI 10.1097/FTD.0b013e318198d092; Wang D, 2011, PHARMACOGENOMICS J, V11, P274, DOI 10.1038/tpj.2010.28; Xie HG, 2004, PHARMACOGENOMICS, V5, P243, DOI 10.1517/phgs.5.3.243.29833; Zhang XQ, 2011, EUR J CLIN PHARMACOL, V67, P803, DOI 10.1007/s00228-011-0993-8; Zhang XL, 2011, DRUG METAB DISPOS, V39, P1433, DOI 10.1124/dmd.111.038836; Zheng HX, 2004, J CLIN PHARMACOL, V44, P135, DOI 10.1177/0091270003262108; Zheng HX, 2003, AM J TRANSPLANT, V3, P477, DOI 10.1034/j.1600-6143.2003.00077.x; Zuo XC, 2013, PHARMACOGENET GENOM, V23, P251, DOI 10.1097/FPC.0b013e32835fcbb6	30	73	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86206	10.1371/journal.pone.0086206	http://dx.doi.org/10.1371/journal.pone.0086206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465960	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500203
J	Nasholm, E; Rohlfing, S; Sauer, JD				Naesholm, Erika; Rohlfing, Sarah; Sauer, James D.			Pirate Stealth or Inattentional Blindness? The Effects of Target Relevance and Sustained Attention on Security Monitoring for Experienced and Naive Operators	PLOS ONE			English	Article							SELECTIVE LOOKING; VISUAL-SEARCH; CCTV; CAPTURE; EYE; CONTINGENT; COST	Closed Circuit Television (CCTV) operators are responsible for maintaining security in various applied settings. However, research has largely ignored human factors that may contribute to CCTV operator error. One important source of error is inattentional blindness - the failure to detect unexpected but clearly visible stimuli when attending to a scene. We compared inattentional blindness rates for experienced (84 infantry personnel) and naive (87 civilians) operators in a CCTV monitoring task. The task-relevance of the unexpected stimulus and the length of the monitoring period were manipulated between participants. Inattentional blindness rates were measured using typical post-event questionnaires, and participants' real-time descriptions of the monitored event. Based on the post-event measure, 66% of the participants failed to detect salient, ongoing stimuli appearing in the spatial field of their attentional focus. The unexpected task-irrelevant stimulus was significantly more likely to go undetected (79%) than the unexpected task-relevant stimulus (55%). Prior task experience did not inoculate operators against inattentional blindness effects. Participants' real-time descriptions revealed similar patterns, ruling out inattentional amnesia accounts.	[Naesholm, Erika; Rohlfing, Sarah; Sauer, James D.] Univ Portsmouth, Portsmouth, Hants, England	University of Portsmouth	Sauer, JD (corresponding author), Univ Portsmouth, Portsmouth, Hants, England.	James.Sauer@port.ac.uk		Sauer, James/0000-0002-0872-3647				Armitage Rachel, 2002, CCTV NOT CCTV REV CU; BECKLEN R, 1983, MEM COGNITION, V11, P601, DOI 10.3758/BF03198284; Braun J, 1998, NATURE, V393, P424, DOI 10.1038/30875; Braun J, 1998, PERCEPT PSYCHOPHYS, V60, P1, DOI 10.3758/BF03211915; Braun J, 2001, PSYCHE; Bressan P, 2008, COGNITION, V106, P370, DOI 10.1016/j.cognition.2007.03.001; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Cartwright-Finch U, 2007, COGNITION, V102, P321, DOI 10.1016/j.cognition.2006.01.002; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; Chabris CF, 2011, I-PERCEPTION, V2, P150, DOI 10.1068/i0436; Davis JP, 2009, APPL COGNITIVE PSYCH, V23, P482, DOI 10.1002/acp.1490; Donald F, 2008, P 1 AUSTR SEC INT C, P26; Drew T, 2013, PSYCHOL SCI, V24, P1848, DOI 10.1177/0956797613479386; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Durlach PJ, 2004, HUM-COMPUT INTERACT, V19, P423, DOI 10.1207/s15327051hci1904_10; Edkins GD, 1997, ACCIDENT ANAL PREV, V29, P533, DOI 10.1016/S0001-4575(97)00033-X; FOLK CL, 1994, J EXP PSYCHOL HUMAN, V20, P317, DOI 10.1037/0096-1523.20.2.317; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Fussey P, 2008, BRIT POLIT, V3, P120, DOI 10.1057/palgrave.bp.4200082; Gill M, 2005, 292 HOM OFF; Hillstrom A., 2008, APPL PSYCHOL SCI CCT; Howard CJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00441; Keval HU, 2006, P INT ERG ASS; Mack A., 1998, INATTENTIONAL BLINDN; Memmert D, 2006, CONSCIOUS COGN, V15, P620, DOI 10.1016/j.concog.2006.01.001; Most SB, 2005, PSYCHOL REV, V112, P217, DOI 10.1037/0033-295X.112.1.217; Most SB, 2001, PSYCHOL SCI, V12, P9, DOI 10.1111/1467-9280.00303; NEISSER U, 1975, COGNITIVE PSYCHOL, V7, P480, DOI 10.1016/0010-0285(75)90019-5; Neisser U., 1979, PERCEPTION ITS DEV T, P201; Parasuraman R, 2009, J EXP PSYCHOL-APPL, V15, P275, DOI 10.1037/a0017132; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; Rensink RA, 2000, PSYCHE; Rich AN, 2008, J VISION, V8, DOI 10.1167/8.15.15; Richards A, 2010, PSYCHOL RES-PSYCH FO, V74, P513, DOI 10.1007/s00426-009-0273-8; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Scott-Brown KC, 2008, POLICING, V31, P395, DOI 10.1108/13639510810895777; Scott-Brown KC, 2007, POLICE J, V80; Simons DJ, 2009, PSYCHON B REV, V16, P398, DOI 10.3758/PBR.16.2.398; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; Simons DJ, 2000, TRENDS COGN SCI, V4, P147, DOI 10.1016/S1364-6613(00)01455-8; Stedmon AW, 2011, SECUR J, V24, P344, DOI 10.1057/sj.2010.7; Surette R, 2005, POLICING, V28, P152, DOI 10.1108/13639510510581039; Tabachnick B. G., 2001, USING MULTIVARIATE S; Taylor E, 2010, CRIME PREV COMMUNITY, V12, P209, DOI 10.1057/cpcs.2010.13; Troscianko T, 2004, PERCEPTION, V33, P87, DOI 10.1068/p3402; Wolfe JM, 2007, J EXP PSYCHOL GEN, V136, P623, DOI 10.1037/0096-3445.136.4.623; Wolfe JM, 2005, NATURE, V435, P439, DOI 10.1038/435439a; Wolfe JM, 1999, MIT BRAD COGN PSYCH, P71	48	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86157	10.1371/journal.pone.0086157	http://dx.doi.org/10.1371/journal.pone.0086157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465932	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500196
J	Adams, CP; Walker, KA; Obare, SO; Docherty, KM				Adams, Clara P.; Walker, Katherine A.; Obare, Sherine O.; Docherty, Kathryn M.			Size-Dependent Antimicrobial Effects of Novel Palladium Nanoparticles	PLOS ONE			English	Article							OUTER-MEMBRANE PERMEABILITY; METAL-OXIDE NANOPARTICLES; SILVER NANOPARTICLES; ESCHERICHIA-COLI; TOXICOLOGICAL IMPACT; BACTERIAL TOXICITY; NANOMATERIALS; ZNO; SHAPE; CYTOTOXICITY	Investigating the interactions between nanoscale materials and microorganisms is crucial to provide a comprehensive, proactive understanding of nanomaterial toxicity and explore the potential for novel applications. It is well known that nanomaterial behavior is governed by the size and composition of the particles, though the effects of small differences in size toward biological cells have not been well investigated. Palladium nanoparticles (Pd NPs) have gained significant interest as catalysts for important carbon-carbon and carbon-heteroatom reactions and are increasingly used in the chemical industry, however, few other applications of Pd NPs have been investigated. In the present study, we examined the antimicrobial capacity of Pd NPs, which provides both an indication of their usefulness as target antimicrobial compounds, as well as their potency as potential environmental pollutants. We synthesized Pd NPs of three different well-constrained sizes, 2.0 +/- 0.1 nm, 2.5 +/- 0.2 nm and 3.1 +/- 0.2 nm. We examined the inhibitory effects of the Pd NPs and Pd2+ ions toward gram negative Escherichia coli (E. coli) and gram positive Staphylococcus aureus (S. aureus) bacterial cultures throughout a 24 hour period. Inhibitory growth effects of six concentrations of Pd NPs and Pd2+ ions (2.5 x 10(-4), 10(-5), 10(-6), 10(-7), 10(-8), and 10(-9) M) were examined. Our results indicate that Pd NPs are generally much more inhibitory toward S. aureus than toward E. coli, though all sizes are toxic at >= 10(-5) M to both organisms. We observed a significant difference in size-dependence of antimicrobial activity, which differed based on the microorganism tested. Our work shows that Pd NPs are highly antimicrobial, and that fine-scale (<1 nm) differences in size can alter antimicrobial activity.	[Adams, Clara P.; Obare, Sherine O.] Western Michigan Univ, Dept Chem, Kalamazoo, MI 49008 USA; [Walker, Katherine A.; Docherty, Kathryn M.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA	Western Michigan University; Western Michigan University	Docherty, KM (corresponding author), Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA.	kathryn.docherty@wmich.edu			National Science Foundation [0936768]; Western Michigan University; WMU Office of the Vice President for Research Faculty Research and Creative Activities Award [W2012-019]; WMU's Lee Honors College; Department of Education GAANN Program Award [P200A090217]; AGEP; Division Of Materials Research [0963678] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Western Michigan University; WMU Office of the Vice President for Research Faculty Research and Creative Activities Award; WMU's Lee Honors College; Department of Education GAANN Program Award; AGEP(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank the National Science Foundation under award DMR 0936768 for partial support of this work. Funds for KMD and KAW were provided by Western Michigan University start-up funds and the WMU Office of the Vice President for Research Faculty Research and Creative Activities Award (Project Number W2012-019) and WMU's Lee Honors College. CPA is thankful to the Department of Education GAANN Program Award P200A090217 and AGEP for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004; Ahmed JU, 2011, BIRDEM MED, V1, P30; Arnaout CL, 2012, ENVIRON SCI TECHNOL, V46, P5387, DOI 10.1021/es204540z; Astruc D, 2007, INORG CHEM, V46, P1884, DOI 10.1021/ic062183h; Auffan M, 2008, ENVIRON SCI TECHNOL, V42, P6730, DOI 10.1021/es800086f; Baccar H, 2013, INT J NANOTECHNOL, V10, P563, DOI 10.1504/IJNT.2013.053525; Balusamy B, 2012, J RARE EARTH, V30, P1298, DOI 10.1016/S1002-0721(12)60224-5; BEVERIDGE TJ, 1981, APPL ENVIRON MICROB, V42, P325, DOI 10.1128/AEM.42.2.325-335.1981; Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Chang Z, 2008, ELECTROANAL, V20, P131, DOI 10.1002/elan.200704023; Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071; Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021; Choi OY, 2010, WATER RES, V44, P6095, DOI 10.1016/j.watres.2010.06.069; Conti JA, 2008, ENVIRON SCI TECHNOL, V42, P3155, DOI 10.1021/es702158q; Dash A, 2012, NANO-MICRO LETT, V4, P158, DOI 10.1007/BF03353707; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Favier F, 2001, SCIENCE, V293, P2227, DOI 10.1126/science.1063189; Ganesan M, 2007, CHEM MATER, V19, P3464, DOI 10.1021/cm062655q; Grassian VH, 2007, ENVIRON HEALTH PERSP, V115, P397, DOI 10.1289/ehp.9469; HECK RF, 1968, J AM CHEM SOC, V90, P5531, DOI 10.1021/ja01022a036; HECK RF, 1968, J AM CHEM SOC, V90, P5535, DOI 10.1021/ja01022a037; HECK RF, 1972, J ORG CHEM, V37, P2320, DOI 10.1021/jo00979a024; HECK RF, 1968, J AM CHEM SOC, V90, P5542, DOI 10.1021/ja01022a039; HECK RF, 1968, J AM CHEM SOC, V90, P5526, DOI 10.1021/ja01022a035; Holsapple MP, 2005, TOXICOL SCI, V88, P12, DOI 10.1093/toxsci/kfi293; Huang ZB, 2008, LANGMUIR, V24, P4140, DOI 10.1021/la7035949; Hudlicky M, 1996, REDUCTIONS ORGANIC C, P429; Hudson LO, 2012, J CLIN MICROBIOL, V50, P573, DOI 10.1128/JCM.05336-11; Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002; Hutchings GJ, 2012, METAL NANOPARTICLES; Tran HD, 2012, J MED MICROBIOL, V61, P431, DOI 10.1099/jmm.0.034744-0; Jana R, 2011, CHEM REV, V111, P1417, DOI 10.1021/cr100327p; Jiang W, 2009, ENVIRON POLLUT, V157, P1619, DOI 10.1016/j.envpol.2008.12.025; Kamat PV, 2003, CR CHIM, V6, P999, DOI 10.1016/j.crci.2003.06.005; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim KJ, 2009, BIOMETALS, V22, P235, DOI 10.1007/s10534-008-9159-2; Kumar A, 2011, FREE RADICAL BIO MED, V51, P1872, DOI 10.1016/j.freeradbiomed.2011.08.025; Kumar VS, 2004, J MOL CATAL A-CHEM, V223, P313, DOI 10.1016/j.molcata.2003.09.047; Leeb M, 2004, NATURE, V431, P892, DOI 10.1038/431892a; Li M, 2011, ENVIRON SCI TECHNOL, V45, P1977, DOI 10.1021/es102624t; Li WJ, 2007, PHARM RES-DORDR, V24, P438, DOI 10.1007/s11095-006-9180-5; Li ZQ, 2010, ENVIRON SCI TECHNOL, V44, P3462, DOI 10.1021/es9031198; Liu J, 2009, ENVIRON SCI TECHNOL, V43, P8178, DOI 10.1021/es902121r; Liu J, 2008, GEOCHIM COSMOCHIM AC, V72, P5984, DOI 10.1016/j.gca.2008.10.010; LIU TZ, 1979, TOXICOL LETT, V4, P469, DOI 10.1016/0378-4274(79)90113-9; Lopes I, 2012, ECOTOXICOLOGY, V21, P637, DOI 10.1007/s10646-011-0808-9; Lu ZS, 2008, LANGMUIR, V24, P5445, DOI 10.1021/la704075r; Lyon DY, 2005, ENVIRON TOXICOL CHEM, V24, P2757, DOI 10.1897/04-649R.1; Macek T, 2011, MICROBIAL BIOSORPTIO; Malleron JL, 2000, HDB PALLADIUM CATALY; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; MARQUIS RE, 1976, CAN J MICROBIOL, V22, P975, DOI 10.1139/m76-142; MILSTEIN D, 1978, J AM CHEM SOC, V100, P3636, DOI 10.1021/ja00479a077; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Monnet D. L., 2005, International Journal of Risk & Safety in Medicine, V17, P133; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Moxham G, 2007, NAT NANOTECHNOL; Mudunkotuwa IA, 2011, J ENVIRON MONITOR, V13, P1135, DOI 10.1039/c1em00002k; Nair S, 2009, J MATER SCI-MATER M, V20, P235, DOI 10.1007/s10856-008-3548-5; National Science and technology Council on Committee on Technology; Subcommittee on Nanoscale Science Engineering and Technology, 2000, NAT NAN IN IN ITS IM; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Neuberger T, 2005, J MAGN MAGN MATER, V293, P483, DOI 10.1016/j.jmmm.2005.01.064; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nutt MO, 2005, ENVIRON SCI TECHNOL, V39, P1346, DOI 10.1021/es048560b; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Park H, 2010, ENVIRON TOXICOL CHEM, V29, P715, DOI 10.1002/etc.72; Pasquini LM, 2012, ENVIRON SCI TECHNOL, V46, P6297, DOI 10.1021/es300514s; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Raimondi F, 2005, ANGEW CHEM INT EDIT, V44, P2190, DOI 10.1002/anie.200460466; Rubasinghege G, 2010, LANGMUIR, V26, P1524, DOI 10.1021/la903950e; Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006; Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103; Shrivastava S, 2009, ACS NANO, V3, P1357, DOI 10.1021/nn900277t; Simon-Deckers A, 2009, ENVIRON SCI TECHNOL, V43, P8423, DOI 10.1021/es9016975; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sonogashira K, 2002, J ORGANOMET CHEM, V653, P46, DOI 10.1016/S0022-328X(02)01158-0; Stoimenov PK, 2002, LANGMUIR, V18, P6679, DOI 10.1021/la0202374; Su CC, 2011, PROTEIN SCI, V20, P6, DOI 10.1002/pro.532; Tirrell DA, 2012, BIOMATERIALS IMPORTA; Tratnyek PG, 2006, NANO TODAY, V1, P44, DOI 10.1016/S1748-0132(06)70048-2; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; VOORHEES PW, 1985, J STAT PHYS, V38, P231, DOI 10.1007/BF01017860; Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159; Widenhoefer RA, 1996, ORGANOMETALLICS, V15, P3534, DOI 10.1021/om9603169; Witham CA, 2010, NAT CHEM, V2, P36, DOI [10.1038/NCHEM.468, 10.1038/nchem.468]; Yoon KY, 2007, SCI TOTAL ENVIRON, V373, P572, DOI 10.1016/j.scitotenv.2006.11.007; Yu SF, 2005, CHEM MATER, V17, P3445, DOI 10.1021/cm048191i; Zeyons O, 2009, NANOTOXICOLOGY, V3, P284, DOI 10.3109/17435390903305260; Zhang D, 2010, NANOSCALE, V2, P917, DOI 10.1039/c0nr00065e	93	155	159	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85981	10.1371/journal.pone.0085981	http://dx.doi.org/10.1371/journal.pone.0085981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465824	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500096
J	Bagatini, IL; Eiler, A; Bertilsson, S; Klaveness, D; Tessarolli, LP; Vieira, AAH				Bagatini, Inessa Lacativa; Eiler, Alexander; Bertilsson, Stefan; Klaveness, Dag; Tessarolli, Leticia Piton; Henriques Vieira, Armando Augusto			Host-Specificity and Dynamics in Bacterial Communities Associated with Bloom-Forming Freshwater Phytoplankton	PLOS ONE			English	Article							MICROCYSTIS-AERUGINOSA; HETEROTROPHIC BACTERIA; CYLINDROSPERMOPSIS-RACIBORSKII; CYANOBACTERIAL BLOOMS; BACTERIOPLANKTON; DIVERSITY; FLAVOBACTERIA; POPULATIONS; HYDROLYSIS; PHOSPHORUS	Many freshwater phytoplankton species have the potential to form transient nuisance blooms that affect water quality and other aquatic biota. Heterotrophic bacteria can influence such blooms via nutrient regeneration but also via antagonism and other biotic interactions. We studied the composition of bacterial communities associated with three bloom-forming freshwater phytoplankton species, the diatom Aulacoseira granulata and the cyanobacteria Microcystis aeruginosa and Cylindrospermopsis raciborskii. Experimental cultures incubated with and without lake bacteria were sampled in three different growth phases and bacterial community composition was assessed by 454-Pyrosequencing of 16S rRNA gene amplicons. Betaproteobacteria were dominant in all cultures inoculated with lake bacteria, but decreased during the experiment. In contrast, Alphaproteobacteria, which made up the second most abundant class of bacteria, increased overall during the course of the experiment. Other bacterial classes responded in contrasting ways to the experimental incubations causing significantly different bacterial communities to develop in response to host phytoplankton species, growth phase and between attached and free-living fractions. Differences in bacterial community composition between cyanobacteria and diatom cultures were greater than between the two cyanobacteria. Despite the significance, major differences between phytoplankton cultures were in the proportion of the OTUs rather than in the absence or presence of specific taxa. Different phytoplankton species favoring different bacterial communities may have important consequences for the fate of organic matter in systems where these bloom forming species occur. The dynamics and development of transient blooms may also be affected as bacterial communities seem to influence phytoplankton species growth in contrasting ways.	[Bagatini, Inessa Lacativa; Tessarolli, Leticia Piton; Henriques Vieira, Armando Augusto] Univ Fed Sao Carlos, Dept Bot, Lab Ficol, BR-13560 Sao Carlos, SP, Brazil; [Eiler, Alexander; Bertilsson, Stefan] Uppsala Univ, Dept Ecol & Genet Limnol & Sci Life Labs, Uppsala, Sweden; [Klaveness, Dag] Univ Oslo, Dept Biosci, Oslo, Norway	Universidade Federal de Sao Carlos; Uppsala University; University of Oslo	Bagatini, IL (corresponding author), Univ Fed Sao Carlos, Dept Bot, Lab Ficol, BR-13560 Sao Carlos, SP, Brazil.	inessalacativa@gmail.com	Bagatini, I.L./H-9960-2017; Fapesp, Biota/F-8655-2017; Eiler, Alexander/V-9220-2017	Bagatini, I.L./0000-0002-5549-2255; Fapesp, Biota/0000-0002-9887-8449; Eiler, Alexander/0000-0001-9916-9567	Brazilian agencies CAPES [BEX: 1111-12-4]; FAPESP [2011/50054-4]; Swedish Research Council; Department of Biology of University of Oslo; K&A Wallenberg foundation; Science for Life Laboratories	Brazilian agencies CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Department of Biology of University of Oslo; K&A Wallenberg foundation(Knut & Alice Wallenberg Foundation); Science for Life Laboratories	The study was partially funded by the Brazilian agencies CAPES (grant #BEX: 1111-12-4 and a scholarship grant to ILB), by FAPESP (process 2011/50054-4), the Swedish Research Council (grant to SB), and by the Department of Biology of University of Oslo. The 454 pyrosequencing was enabled by an instrument grant from the K&A Wallenberg foundation and Science for Life Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Beier S, 2011, LIMNOL OCEANOGR, V56, P1179, DOI 10.4319/lo.2011.56.4.1179; Berg KA, 2009, ISME J, V3, P314, DOI 10.1038/ismej.2008.110; Bertilsson S., 2003, AQUATIC ECOSYSTEMS I, P3, DOI DOI 10.1016/B978-012256371-3/50002-0; Besemer K, 2009, ISME J, V3, P1318, DOI 10.1038/ismej.2009.73; Bruckner CG, 2011, ENVIRON MICROBIOL, V13, P1052, DOI 10.1111/j.1462-2920.2010.02411.x; Casamatta DA, 2000, MICROB ECOL, V40, P64, DOI 10.1007/s002480000035; Colombo V, 2006, THESIS U FEDERAL SAO; CYNAR FJ, 1985, MICROBIAL ECOL, V11, P281, DOI 10.1007/BF02016812; Dabney A, 2013, QVALUE Q VALUE ESTIM; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Dellamano-Oliveira MJ, 2008, FUND APPL LIMNOL, V171, P27, DOI 10.1127/1863-9135/2008/0171-0027; Doucette Gregory J., 1995, Natural Toxins, V3, P65, DOI 10.1002/nt.2620030202; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eigemann F, 2013, FEMS MICROBIOL ECOL, V83, P650, DOI 10.1111/1574-6941.12022; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Eiler A, 2007, APPL ENVIRON MICROB, V73, P3511, DOI 10.1128/AEM.02534-06; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Figueredo CC, 2007, J PHYCOL, V43, P256, DOI 10.1111/j.1529-8817.2007.00333.x; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Vieira AAH, 2008, LIMNOL OCEANOGR, V53, P1887, DOI 10.4319/lo.2008.53.5.1887; Vieira AAH, 2013, AQUAT MICROB ECOL, V69, P169, DOI 10.3354/ame01629; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Huisman J, 1999, ECOLOGY, V80, P211, DOI 10.2307/176991; Jiang LJ, 2007, HYDROBIOLOGIA, V581, P161, DOI 10.1007/s10750-006-0518-0; Karsten U, 2002, J PHYCOL, V35, P967; Kersters K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P3, DOI 10.1007/0-387-30745-1_1; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; KLAVENESS D, 1982, Nordic Journal of Botany, V2, P183, DOI 10.1111/j.1756-1051.1982.tb01179.x; KOGURE K, 1981, J EXP MAR BIOL ECOL, V56, P197, DOI 10.1016/0022-0981(81)90189-1; Kolmonen E, 2004, AQUAT MICROB ECOL, V36, P201, DOI 10.3354/ame036201; LEGENDRE P, 1998, NUMERICAL ECOLOGY DE, P20; Li HB, 2011, WATER RES, V45, P1702, DOI 10.1016/j.watres.2010.11.011; Li N, 2011, CHIN J OCEANOL LIMN, V29, P505, DOI 10.1007/s00343-011-0056-0; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Malfatti F, 2009, AQUAT MICROB ECOL, V58, P1, DOI 10.3354/ame01355; MARCHANT HJ, 1983, J MICROSC-OXFORD, V131, P127, DOI 10.1111/j.1365-2818.1983.tb04239.x; Marinho MM, 2007, AQUAT ECOL, V41, P525, DOI 10.1007/s10452-007-9118-y; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Mayali X, 2007, AQUAT MICROB ECOL, V50, P51, DOI 10.3354/ame01143; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mummey D, 2006, MICROB ECOL, V51, P404, DOI 10.1007/s00248-006-9020-5; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Nusch E.A., 1980, ARCH HYDROBIOLOGIE B, V14, P14; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Paerl HW, 1996, MICROSC RES TECHNIQ, V33, P47; Pope PB, 2008, FEMS MICROBIOL ECOL, V64, P9, DOI 10.1111/j.1574-6941.2008.00448.x; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Core Team, 2012, R LANG ENV STAT COMP; Rashidan KK, 2001, MICROBIAL ECOL, V41, P97; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Rooney-Varga JN, 2005, MICROB ECOL, V49, P163, DOI 10.1007/s00248-003-1057-0; Sapp M, 2007, MICROB ECOL, V53, P683, DOI 10.1007/s00248-006-9162-5; Schafer H, 2002, FEMS MICROBIOL ECOL, V42, P25, DOI 10.1111/j.1574-6941.2002.tb00992.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sher D, 2011, ISME J, V5, P1125, DOI 10.1038/ISMEJ.2011.1; Shi LM, 2012, ENV MICROBIOL REP, V4, P669, DOI 10.1111/1758-2229.12001; Shi LM, 2011, ANN LIMNOL-INT J LIM, V47, P355, DOI 10.1051/limn/2011047; Shi LM, 2010, J FRESHWATER ECOL, V25, P193; Shi LM, 2009, J ENVIRON SCI, V21, P1581, DOI 10.1016/S1001-0742(08)62459-6; Sinha R, 2012, WATER RES, V46, P1408, DOI 10.1016/j.watres.2011.12.019; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Worm J, 1998, AQUAT MICROB ECOL, V14, P19, DOI 10.3354/ame014019; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0	72	72	74	1	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85950	10.1371/journal.pone.0085950	http://dx.doi.org/10.1371/journal.pone.0085950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465807	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500093
J	Ray, M; Weeks, D; Welsh, TN				Ray, Matthew; Weeks, Daniel; Welsh, Timothy N.			Distractor Interference during a Choice Limb Reaching Task	PLOS ONE			English	Article							ACTION-CENTERED ATTENTION; MOVEMENT TRAJECTORIES; DEVIATIONS	According to action-centered models of attention, the patterns of distractor interference that emerge in selective reaching tasks are related to the time and effort required to resolve a race for activation between competing target and non-target response producing processes. Previous studies have only used unimanual aiming tasks and, as such, only examined the effects of competition that occurs within a limb. The results of studies using unimanual aiming movements often reveal an "ipsilateral effect" - distractors on the same side of space as the effector cause greater interference than distractors on the opposite side of space. The cost of the competition when response selection is between the limbs has yet to be addressed. Participants in the present study executed reaching movements to 1 of 4 (2 left, 2 right) possible target locations with and without a distractor. Participants made ipsilateral reaches (left hand to left targets, right hand to right targets). In contrast to studies using unimanual aiming movements, a "contralateral effect" was observed; distractors affording responses for the other hand (in contralateral space) caused more interference than distractors affording responses for the same hand. The findings from the present research demonstrate that when certain portions of response planning must be resolved prior to response initiation, distractors that code for that dimension cause the greatest interference.	[Ray, Matthew; Welsh, Timothy N.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Weeks, Daniel] Univ Lethbridge, Dept Psychol, Lethbridge, AB T1K 3M4, Canada; [Welsh, Timothy N.] Univ Toronto, Ctr Motor Control, Toronto, ON, Canada	University of Toronto; University of Lethbridge; University of Toronto	Ray, M (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.	matthew.ray@utoronto.ca			NSERC; Ontario Ministry of Research and Innovation; Alberta Ingenuity Fund	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Alberta Ingenuity Fund	Funding was provided by a Discovery Grant from NSERC (http://www.nserc-crsng.gc.ca/index_eng.asp); Early Research Award from the Ontario Ministry of Research and Innovation; and New Faculty Award from the Alberta Ingenuity Fund. The funders had no role in the study design, data collecting and analysis, decision to publish, or preparation of the manuscript.	Chapman CS, 2010, COGNITION, V116, P168, DOI 10.1016/j.cognition.2010.04.008; Hommel B, 2009, PSYCHOL RES-PSYCH FO, V73, P512, DOI 10.1007/s00426-009-0234-2; Keulen RF, 2002, J EXP PSYCHOL HUMAN, V28, P515, DOI 10.1037/0096-1523.28.3.515; Meegan DV, 1998, Q J EXP PSYCHOL-A, V51, P225, DOI 10.1080/02724989843000004; Meegan DV, 1999, J EXP PSYCHOL HUMAN, V25, P1347, DOI 10.1037/0096-1523.25.5.1347; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; ROSENBAUM DA, 1980, J EXP PSYCHOL GEN, V109, P444, DOI 10.1037/0096-3445.109.4.444; Sanders Andries, 1987, PERSPECTIVES PERCEPT, P395; TIPPER SP, 1992, J EXP PSYCHOL HUMAN, V18, P891, DOI 10.1037/0096-1523.18.4.891; Tremblay L, 2005, EXP BRAIN RES, V160, P79, DOI 10.1007/s00221-004-1987-x; Weeks D., 2010, VISION GOAL DIRECTED, P39; Welsh TN, 2011, ACTA PSYCHOL, V137, P300, DOI 10.1016/j.actpsy.2011.03.011; Welsh TN, 2009, MOTOR CONTROL, V13, P100, DOI 10.1123/mcj.13.1.100; Welsh TN, 2004, Q J EXP PSYCHOL-A, V57, P1031, DOI 10.1080/02724980343000666; Welsh TN, 1999, EXP BRAIN RES, V127, P207, DOI 10.1007/s002210050790	15	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85961	10.1371/journal.pone.0085961	http://dx.doi.org/10.1371/journal.pone.0085961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297EA	24465813	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000079
J	Astrand, E; Enel, P; Ibos, G; Dominey, PF; Baraduc, P; Ben Hamed, S				Astrand, Elaine; Enel, Pierre; Ibos, Guilhem; Dominey, Peter Ford; Baraduc, Pierre; Ben Hamed, Suliann			Comparison of Classifiers for Decoding Sensory and Cognitive Information from Prefrontal Neuronal Populations	PLOS ONE			English	Article							FRONTAL EYE FIELD; VISUAL RECEPTIVE-FIELDS; SPATIAL INFORMATION; WORKING-MEMORY; MACAQUE; ATTENTION; STATE; MICROSTIMULATION; CONNECTIONS; PERFORMANCE	Decoding neuronal information is important in neuroscience, both as a basic means to understand how neuronal activity is related to cerebral function and as a processing stage in driving neuroprosthetic effectors. Here, we compare the readout performance of six commonly used classifiers at decoding two different variables encoded by the spiking activity of the non-human primate frontal eye fields (FEF): the spatial position of a visual cue, and the instructed orientation of the animal's attention. While the first variable is exogenously driven by the environment, the second variable corresponds to the interpretation of the instruction conveyed by the cue; it is endogenously driven and corresponds to the output of internal cognitive operations performed on the visual attributes of the cue. These two variables were decoded using either a regularized optimal linear estimator in its explicit formulation, an optimal linear artificial neural network estimator, a non-linear artificial neural network estimator, a non-linear naive Bayesian estimator, a non-linear Reservoir recurrent network classifier or a non-linear Support Vector Machine classifier. Our results suggest that endogenous information such as the orientation of attention can be decoded from the FEF with the same accuracy as exogenous visual information. All classifiers did not behave equally in the face of population size and heterogeneity, the available training and testing trials, the subject's behavior and the temporal structure of the variable of interest. In most situations, the regularized optimal linear estimator and the non-linear Support Vector Machine classifiers outperformed the other tested decoders.	[Astrand, Elaine; Ibos, Guilhem; Baraduc, Pierre; Ben Hamed, Suliann] Univ Lyon 1, CNRS, UMR 5529, Ctr Neurosci Cognit, Bron, France; [Enel, Pierre; Dominey, Peter Ford] Univ Lyon 1, INSERM, U846, Stem Cell & Brain Res Inst, Bron, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Ben Hamed, S (corresponding author), Univ Lyon 1, CNRS, UMR 5529, Ctr Neurosci Cognit, Bron, France.	benhamed@isc.cnrs.fr	Ben Hamed, Suliann/O-6070-2014; Astrand, Elaine/AAL-3927-2021; Dominey, Peter/H-3832-2012	Ben Hamed, Suliann/0000-0003-1510-7284; Dominey, Peter/0000-0002-9318-179X; Enel, Pierre/0000-0001-8983-6223; Ibos, Guilhem/0000-0002-9280-1280	Centre national de la recherchescientifique; Direction generale des armees; CNRS multidisciplinary program; CNRS Biology-Maths-Computer science program;  [ANR-05-JCJC-0230-01]	Centre national de la recherchescientifique(Centre National de la Recherche Scientifique (CNRS)); Direction generale des armees; CNRS multidisciplinary program; CNRS Biology-Maths-Computer science program; 	EA was funded by the Centre national de la recherchescientifique and the Direction generale des armees. S. BH and the present study were funded by the ANR-05-JCJC-0230-01, a CNRS multidisciplinary program (2010) and a CNRS Biology-Maths-Computer science program (2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Aizerman A., 1964, AUTOMAT REM CONTR, V25, P821, DOI DOI 10.1234/12345678; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Armstrong KM, 2009, J NEUROSCI, V29, P15621, DOI 10.1523/JNEUROSCI.4465-09.2009; Barak O, 2010, J NEUROSCI, V30, P9424, DOI 10.1523/JNEUROSCI.1875-10.2010; Barone P, 2000, J NEUROSCI, V20, P3263, DOI 10.1523/JNEUROSCI.20-09-03263.2000; Ben Hamed S, 2007, J NEUROPHYSIOL, V98, P327, DOI 10.1152/jn.00760.2006; Ben Hamed S, 2003, J NEUROPHYSIOL, V90, P549, DOI 10.1152/jn.00639.2002; Bishop C. M., 2007, J ELECT IMAGING, V2nd, DOI 10.1117/1.2819119; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Bullier J, 1996, BEHAV BRAIN RES, V76, P89, DOI 10.1016/0166-4328(95)00182-4; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohen MR, 2011, NEURON, V70, P1192, DOI 10.1016/j.neuron.2011.04.029; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crowe DA, 2010, J NEUROSCI, V30, P11640, DOI 10.1523/JNEUROSCI.0954-10.2010; Duda R.O., 2000, PATTERN CLASSIFICATI; Ecker AS, 2011, J NEUROSCI, V31, P14272, DOI 10.1523/JNEUROSCI.2539-11.2011; Gregoriou GG, 2012, NEURON, V73, P581, DOI 10.1016/j.neuron.2011.12.019; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Gunduz A, 2012, NEUROIMAGE, V60, P2285, DOI 10.1016/j.neuroimage.2012.02.017; Hermans M, 2012, NEURAL COMPUT, V24, P104, DOI 10.1162/NECO_a_00200; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Ibos G, 2013, J NEUROSCI, V33, P8359, DOI 10.1523/JNEUROSCI.4058-12.2013; Ibos G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006716; Jaeger H., 2001, 148 GMD GERM NAT RES; Kadohisa M, 2013, NEURON, V80, P235, DOI 10.1016/j.neuron.2013.07.041; Kia SF, 2011, J PHYSIOL-PARIS, V105, P115, DOI 10.1016/j.jphysparis.2011.07.015; Lukosevicius M, 2009, COMPUT SCI REV, V3, P127, DOI 10.1016/j.cosrev.2009.03.005; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Markowitz DA, 2011, J NEUROSCI, V31, P18412, DOI 10.1523/JNEUROSCI.4165-11.2011; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Meyers EM, 2012, P NATL ACAD SCI USA, V109, P4651, DOI 10.1073/pnas.1201022109; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; MOHLER CW, 1973, BRAIN RES, V61, P385, DOI 10.1016/0006-8993(73)90543-X; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; POUGET A, 1994, CEREB CORTEX, V4, P314, DOI 10.1093/cercor/4.3.314; Pouget P, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.002.2009; REFREGIER P, 1989, EUROPHYS LETT, V10, P387, DOI 10.1209/0295-5075/10/4/018; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Rotermund D, 2013, J NEUROSCI, V33, P6001, DOI 10.1523/JNEUROSCI.4225-12.2013; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Schmichuber J, 2007, NEURAL COMPUT, V19, P757, DOI 10.1162/neco.2007.19.3.757; Seeger Matthias, 2004, Int J Neural Syst, V14, P69, DOI 10.1142/S0129065704001899; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shi ZW, 2007, IEEE T NEURAL NETWOR, V18, P359, DOI 10.1109/TNN.2006.885113; Standage D, 2011, NEURAL NETWORKS, V24, P1062, DOI 10.1016/j.neunet.2011.05.004; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Stokes MG, 2013, NEURON, V78, P364, DOI 10.1016/j.neuron.2013.01.039; Thompson KA, 2005, ABA J, V91, P25; Thomson EE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2497; TIKHONOV AN, 1963, DOKL AKAD NAUK SSSR+, V151, P501; Verstraeten D, 2007, NEURAL NETWORKS, V20, P391, DOI 10.1016/j.neunet.2007.04.003; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	64	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86314	10.1371/journal.pone.0086314	http://dx.doi.org/10.1371/journal.pone.0086314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466019	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000083
J	Du, S; Guan, ZZ; Hao, LH; Song, Y; Wang, L; Gong, LL; Liu, L; Qi, XY; Hou, ZY; Shao, SJ				Du, Sha; Guan, Zhuzhu; Hao, Lihong; Song, Yang; Wang, Lan; Gong, Linlin; Liu, Lu; Qi, Xiaoyu; Hou, Zhaoyuan; Shao, Shujuan			Fructose-Bisphosphate Aldolase A Is a Potential Metastasis-Associated Marker of Lung Squamous Cell Carcinoma and Promotes Lung Cell Tumorigenesis and Migration	PLOS ONE			English	Article							GLYCOLYTIC-ENZYMES; HEMOLYTIC-ANEMIA; IDENTIFICATION; PROTEINS; TUBULIN; CANCER; MUSCLE; GENE	Fructose-bisphosphate aldolase A (ALDOA) is a key enzyme in glycolysis and is responsible for catalyzing the reversible conversion of fructose-1,6-bisphosphate to glyceraldehydes-3-phosphate and dihydroxyacetone phosphate. ALDOA contributes to various cellular functions such as muscle maintenance, regulation of cell shape and mobility, striated muscle contraction, actin filament organization and ATP biosynthetic process. Here, we reported that ALDOA is a highly expressed in lung squamous cell carcinoma (LSCC) and its expression level is correlated with LSCC metastasis, grades, differentiation status and poor prognosis. Depletion of ALDOA expression in the lung squamous carcinoma NCI-H520 cells reduces the capabilities of cell motility and tumorigenesis. These data suggest that ALDOA could be a potential marker for LSCC metastasis and a therapeutic target for drug development.	[Du, Sha; Guan, Zhuzhu; Hao, Lihong; Song, Yang; Wang, Lan; Gong, Linlin; Liu, Lu; Qi, Xiaoyu; Shao, Shujuan] Dalian Med Univ, Dept Histol & Embryol, Liaoning, Peoples R China; [Du, Sha; Hou, Zhaoyuan] Dalian Med Univ, Inst Canc Stem Cell, Ctr Canc, Liaoning, Peoples R China; [Guan, Zhuzhu; Shao, Shujuan] Dalian Med Univ, Liaoning Key Lab Prote, Liaoning, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University	Hou, ZY (corresponding author), Dalian Med Univ, Inst Canc Stem Cell, Ctr Canc, Liaoning, Peoples R China.	houzy@sjtu.edu.cn; shaoshujuan2006@126.com			National Basic Research Program of China (973 Program) [2012CB967003]; Natural Science Foundation of China [20935004, 81071784, 81172028]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Basic Research Program of China (973 Program, No. 2012CB967003 to S. Shao), Natural Science Foundation of China (NO. 20935004, 81071784 to S. Shao, and 81172028 to Z. Hou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD H, 1968, EUR J BIOCHEM, V6, P163, DOI 10.1111/j.1432-1033.1968.tb00434.x; CARR D, 1993, BIOCHEM BIOPH RES CO, V195, P289, DOI 10.1006/bbrc.1993.2043; Chaerkady R, 2008, J PROTEOME RES, V7, P4289, DOI 10.1021/pr800197z; CLARKE FM, 1975, BIOCHIM BIOPHYS ACTA, V381, P37, DOI 10.1016/0304-4165(75)90187-7; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Heist RS, 2012, J THORAC ONCOL, V7, P924, DOI 10.1097/JTO.0b013e31824cc334; Kajita E, 2001, MECH DEVELOP, V102, P283, DOI 10.1016/S0925-4773(01)00324-0; KISHI H, 1987, P NATL ACAD SCI USA, V84, P8623, DOI 10.1073/pnas.84.23.8623; KNULL HR, 1992, CURR TOP CELL REGUL, V33, P15; Kusakabe T, 1997, ARCH BIOCHEM BIOPHYS, V344, P184, DOI 10.1006/abbi.1997.0204; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; May Caroline, 2012, Methods Mol Biol, V893, P75, DOI 10.1007/978-1-61779-885-6_6; MIWA S, 1981, AM J HEMATOL, V11, P425, DOI 10.1002/ajh.2830110412; PFLEIDERER G, 1975, BEITR PATHOL, V156, P266; Poschmann G, 2009, MOL CELL PROTEOMICS, V8, P1105, DOI 10.1074/mcp.M800422-MCP200; Rho JH, 2009, PROTEIN J, V28, P148, DOI 10.1007/s10930-009-9177-0; St-Jean M, 2007, J BIOL CHEM, V282, P14309, DOI 10.1074/jbc.M611505200; Tochio T, 2010, J DERMATOL SCI, V58, P123, DOI 10.1016/j.jdermsci.2010.02.012; WALSH JL, 1989, BIOCHIM BIOPHYS ACTA, V999, P64, DOI 10.1016/0167-4838(89)90031-9; WALSH JL, 1988, BIOCHIM BIOPHYS ACTA, V952, P83, DOI 10.1016/0167-4838(88)90104-5; Yao DC, 2004, BLOOD, V103, P2401, DOI 10.1182/blood-2003-09-3160	21	86	95	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85804	10.1371/journal.pone.0085804	http://dx.doi.org/10.1371/journal.pone.0085804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465716	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000026
J	Stoker, SD; Wildeman, MA; Fles, R; Indrasari, SR; Herdini, C; Wildeman, PL; van Diessen, JNA; Tjokronagoro, M; Tan, IB				Stoker, Sharon D.; Wildeman, Maarten A.; Fles, Renske; Indrasari, Sagung R.; Herdini, Camelia; Wildeman, Pieter L.; van Diessen, Judi N. A.; Tjokronagoro, Maesadji; Tan, I. Bing			A Prospective Study: Current Problems in Radiotherapy for Nasopharyngeal Carcinoma in Yogyakarta, Indonesia	PLOS ONE			English	Article							TREATMENT TIME; ESTRO-QUARTS; CANCER; COUNTRIES; CHEMORADIOTHERAPY; INFRASTRUCTURE; GUIDELINES; BURDEN	Introduction: Nasopharyngeal carcinoma (NPC) has a high incidence in Indonesia. Previous study in Yogyakarta revealed a complete response of 29% and a median overall survival of less than 2 years. These poor treatment outcome are influenced by the long diagnose-to-treatment interval to radiotherapy (DTI) and the extended overall treatment time of radiotherapy (OTT). This study reveals insight why the OTT and DTI are prolonged. Method: All patients treated with curative intent radiotherapy for NPC between July 2011 until October 2012 were included. During radiotherapy a daily diary was kept, containing information on DTI, missed radiotherapy days, the reason for missing and length of OTT. Results: Sixty-eight patients were included. The median DTI was 106 days (95% CI: 982170). Fifty-nine patients (87%) finished the treatment. The median OTT for radiotherapy was 57 days (95% CI: 57-65). The main reason for missing days was an inoperative radiotherapy machine (36%). Other reasons were patient's poor condition (21%), public holidays (14%), adjustment of the radiation field (7%), power blackout (3%), inoperative treatment planning system (2%) and patient related reasons (9%). Patient's insurance type was correlated to DTI in disadvantage for poor people. Conclusion: Yogyakarta has a lack of sufficient radiotherapy units which causes a delay of 3-4 months, besides the OTT is extended by 10-12 days. This influences treatment outcome to a great extend. The best solution would be creating sufficient radiotherapy units and better management in health care for poor patients. The growing economy in Indonesia will expectantly in time enable these solutions, but in the meantime solutions are needed. Solutions can consist of radiation outside office hours, better maintenance of the facilities and more effort from patient, doctor and nurse to finish treatment in time. These results are valuable when improving cancer care in low and middle income countries.	[Stoker, Sharon D.; Wildeman, Maarten A.; Fles, Renske; Tan, I. Bing] Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands; [Wildeman, Maarten A.; Tan, I. Bing] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1105 AZ Amsterdam, Netherlands; [Indrasari, Sagung R.; Herdini, Camelia] Univ Gadjah Mada, Dept Otorhinolaryngol, Dr Sardjito Gen Hosp, Fac Med, Yogyakarta, Indonesia; [Wildeman, Pieter L.] ValueCare BV, Utrecht, Netherlands; [van Diessen, Judi N. A.] Netherlands Canc Inst, Dept Radiat & Oncol, Amsterdam, Netherlands; [Tjokronagoro, Maesadji] Univ Gadjah Mada, Dept Radiotherapy, Dr Sardjito Gen Hosp, Fac Med, Yogyakarta, Indonesia; [Tan, I. Bing] Univ Amsterdam, Acad Med Ctr, Dept Oral & Maxillofacial Surg, NL-1105 AZ Amsterdam, Netherlands	Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Gadjah Mada University; Netherlands Cancer Institute; Gadjah Mada University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Tan, IB (corresponding author), Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands.	i.tan@nki.nl	van+Diessen, Judi/ABD-8703-2020		Dutch Cancer Foundation [2008-4233]; Dutch Cancer Foundation [2008-4233]	Dutch Cancer Foundation(KWF Kankerbestrijding); Dutch Cancer Foundation(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Foundation, project number 2008-4233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 1997, JPN J CLIN ONCOL, V27, P240, DOI 10.1093/jjco/27.4.240; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Anderson BO, 2011, LANCET ONCOL, V12, P387, DOI 10.1016/S1470-2045(11)70031-6; Barton MB, 2006, LANCET ONCOL, V7, P584, DOI 10.1016/S1470-2045(06)70759-8; Bentzen SM, 2005, RADIOTHER ONCOL, V75, P355, DOI 10.1016/j.radonc.2004.12.007; Boyle P, 2008, WORLD CANC REPORT 20; Chen Z, 2008, RADIOTHER ONCOL, V87, P3, DOI 10.1016/j.radonc.2007.11.016; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Gondhowiardjo Sa, 2008, Biomed Imaging Interv J, V4, pe42, DOI 10.2349/biij.4.3.e42; Ho ACW, 2011, ORAL ONCOL, V47, P742, DOI 10.1016/j.oraloncology.2011.06.001; Jakarta Globe, 2012, SBY TELLS IND STOP S; Kimman M, 2012, ASIAN PAC J CANCER P, V13, P411, DOI 10.7314/APJCP.2012.13.2.411; Kwong DLW, 1997, INT J RADIAT ONCOL, V39, P703, DOI 10.1016/S0360-3016(97)00339-8; MARKS LB, 1991, INT J RADIAT ONCOL, V21, P1377, DOI 10.1016/0360-3016(91)90301-J; Platek ME, 2012, HEAD NECK-J SCI SPEC, V35, P684; Rosenblatt E, 2013, LANCET ONCOL, V14, pE79, DOI 10.1016/S1470-2045(12)70556-9; Satriana S, 2012, SOCIAL PROTECTION AS; Slotman BJ, 2005, RADIOTHER ONCOL, V75, P349, DOI 10.1016/j.radonc.2004.12.005; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Waaijer A, 2003, RADIOTHER ONCOL, V66, P271, DOI 10.1016/S0167-8140(03)00036-7; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wildeman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063706	24	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85959	10.1371/journal.pone.0085959	http://dx.doi.org/10.1371/journal.pone.0085959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465811	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000035
J	Xiang, Y; Ma, L; Wu, WD; Liu, W; Li, YG; Zhu, X; Wang, Q; Ma, JF; Cao, MQ; Wang, Q; Yao, XM; Yang, L; Wubuli, A; Merle, C; Milligan, P; Mao, Y; Gu, JY; Xin, XM				Xiang, Yang; Ma, Long; Wu, Weidong; Liu, Wei; Li, Yongguang; Zhu, Xia; Wang, Qian; Ma, Jinfeng; Cao, Mingqin; Wang, Qian; Yao, Xuemei; Yang, Lei; Wubuli, Atikaimu; Merle, Corinne; Milligan, Paul; Mao, Ying; Gu, Jiayi; Xin, Xiumei			The Incidence of Liver Injury in Uyghur Patients Treated for TB in Xinjiang Uyghur Autonomous Region, China, and Its Association with Hepatic Enzyme Polymorphisms NAT2, CYP2E1, GSTM1 and GSTT1	PLOS ONE			English	Article							DRUG-INDUCED HEPATOTOXICITY; GLUTATHIONE-S-TRANSFERASE; CYTOCHROME-P450 2E1 GENOTYPE; GENETIC POLYMORPHISMS; ANTITUBERCULOSIS DRUGS; METABOLIZING-ENZYMES; NULL MUTATIONS; RISK-FACTORS; SUSCEPTIBILITY; M1	Background and Objective: Of three first-line anti-tuberculosis (anti-TB) drugs, isoniazid is most commonly associated with hepatotoxicity. Differences in INH-induced toxicity have been attributed to genetic variability at several loci, NAT2, CYP2E1, GSTM1and GSTT1, that code for drug-metabolizing enzymes. This study evaluated whether the polymorphisms in these enzymes were associated with an increased risk of anti-TB drug-induced hepatitis in patients and could potentially be used to identify patients at risk of liver injury. Methods and Design: In a cross-sectional study, 2244 tuberculosis patients were assessed two months after the start of treatment. Anti-TB drug-induced liver injury (ATLI) was defined as an ALT, AST or bilirubin value more than twice the upper limit of normal. NAT2, CYP2E1, GSTM1 and GSTT1 genotypes were determined using the PCR/ligase detection reaction assays. Results: 2244 patients were evaluated, there were 89 cases of ATLI, a prevalence of 4% 9 patients (0.4%) had ALT levels more than 5 times the upper limit of normal. The prevalence of ATLI was greater among men than women, and there was a weak association with NAT2*5 genotypes, with ATLI more common among patients with the NAT2*5*CT genotype. The sensitivity of the CT genotype for identifying patients with ATLI was 42% and the positive predictive value 5.9%. CT ATLI was more common among slow acetylators (prevalence ratio 2.0 (95% CI 0.95,4.20)) compared to rapid acetylators. There was no evidence that ATLI was associated with CYP2E1 RsaIc1/c1genotype, CYP2E1 RsaIc1/c2 or c2/c2 genotypes, or GSTM1/GSTT1 null genotypes. Conclusions: In Xinjiang Uyghur TB patients, liver injury was associated with the genetic variant NAT2*5, however the genetic markers studied are unlikely to be useful for screening patients due to the low sensitivity and low positive predictive values for identifying persons at risk of liver injury.	[Xiang, Yang; Ma, Jinfeng; Cao, Mingqin; Wang, Qian; Yao, Xuemei; Yang, Lei; Wubuli, Atikaimu; Mao, Ying; Gu, Jiayi] Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Urumqi, Xinjiang, Peoples R China; [Ma, Long] Red Cross Xinjiang Uygur Autonomous Reg, Urumqi, Xinjiang, Peoples R China; [Wu, Weidong] Xinjiang Uygur Autonomous Reg Ctr Dis Control & P, Ctr TB Control & Prevent, Urumqi, Xinjiang, Peoples R China; [Liu, Wei] Xinjiang Ili Kazak Autonomous Prefecture Ctr Dis, Ili, Xinjiang, Peoples R China; [Li, Yongguang] Xinjiang Aksu Dist Ctr Dis Control & Prevent, Aksu, Xinjiang, Peoples R China; [Zhu, Xia] Lib Xinjiang Med Univ, Urumqi, Xinjiang, Peoples R China; [Wang, Qian] Xinjiang Med Univ, Grad Sch, Urumqi, Xinjiang, Peoples R China; [Merle, Corinne; Milligan, Paul] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Xin, Xiumei] Xinjiang Med Univ, Care Div, Affiliated Hosp 1, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; University of London; London School of Hygiene & Tropical Medicine; Xinjiang Medical University	Ma, L (corresponding author), Red Cross Xinjiang Uygur Autonomous Reg, Urumqi, Xinjiang, Peoples R China.	893664450@qq.com	Milligan, Paul/D-8985-2017	Milligan, Paul/0000-0003-3430-3395; Merle, Corinne/0000-0003-4229-365X	National Natural Science Foundation of China [30960328]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is funded by National Natural Science Foundation of China (NO. 30960328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HR, 2012, CLIN EXP PHARMACOL P, V39, P535, DOI 10.1111/j.1440-1681.2012.05713.x; An Hui-ru, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P36; BENICHOU C, 1990, J HEPATOL, V11, P272; Bose PD, 2011, J GASTROEN HEPATOL, V26, P312, DOI 10.1111/j.1440-1746.2010.06355.x; Burman WJ, 2001, AM J RESP CRIT CARE, V164, P1112, DOI 10.1164/ajrccm.164.7.2109052; Chatterjee S, 2010, J CLIN PHARM THER, V35, P465, DOI 10.1111/j.1365-2710.2009.01101.x; [陈怡 Chen Yi], 2010, [中华传染病杂志, Chinese Journal of Infections Diseases], V28, P748; Cho HJ, 2007, TUBERCULOSIS, V87, P551, DOI 10.1016/j.tube.2007.05.012; Das Roy P, 2008, PHARMACOGENOMICS, V9, P311, DOI 10.2217/14622416.9.3.311; Teixeira RLD, 2011, MEM I OSWALDO CRUZ, V106, P716, DOI 10.1590/S0074-02762011000600011; De Rosa HJ, 2007, BIOPHARM DRUG DISPOS, V28, P291, DOI 10.1002/bdd.557; Devarbhavi Harshad, 2011, Trop Gastroenterol, V32, P167; Dossing M, 1996, TUBERCLE LUNG DIS, V77, P335, DOI 10.1016/S0962-8479(96)90098-2; [郭梅 GUO Mei], 2010, [中华传染病杂志, Chinese Journal of Infections Diseases], V28, P99; Guo Mingruo, 2009, P1; HEIN DW, 1995, CANCER RES, V55, P3531; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Huang DS, 2011, ZHONGHUA SHENG WU YI, V17, P444; Huang YS, 2007, J HEPATOL, V47, P128, DOI 10.1016/j.jhep.2007.02.009; Huang YS, 2007, EXPERT OPIN DRUG MET, V3, P1, DOI 10.1517/17425255.3.1.1; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Kim SH, 2010, TUBERCULOSIS, V90, P39, DOI 10.1016/j.tube.2009.12.001; Kim SH, 2009, PHARMACOGENOMICS, V10, P1767, DOI 10.2217/PGS.09.100; Lee SW, 2010, INT J TUBERC LUNG D, V14, P622; LEE WM, 1995, NEW ENGL J MED, V333, P1118, DOI 10.1056/NEJM199510263331706; Leiro V, 2008, LIVER INT, V28, P835, DOI 10.1111/j.1478-3231.2008.01700.x; Lv XZ, 2012, ANN HEPATOL, V11, P700, DOI 10.1016/S1665-2681(19)31446-2; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; MITCHELL JR, 1975, CLIN PHARMACOL THER, V18, P70; Mohri T, 2010, BIOCHEM PHARMACOL, V79, P1045, DOI 10.1016/j.bcp.2009.11.015; Ohno M, 2000, INT J TUBERC LUNG D, V4, P256; Pande JN, 1996, THORAX, V51, P132, DOI 10.1136/thx.51.2.132; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Possuelo LG, 2008, EUR J CLIN PHARMACOL, V64, P673, DOI 10.1007/s00228-008-0484-8; Roy B, 2006, J GASTROEN HEPATOL, V21, P784, DOI 10.1111/j.1440-1746.2006.04197.x; Roy B, 2001, J GASTROEN HEPATOL, V16, P1033, DOI 10.1046/j.1440-1746.2001.02585.x; RungeMorris M, 1996, DRUG METAB DISPOS, V24, P734; Russmann S, 2010, HEPATOLOGY, V52, P748, DOI 10.1002/hep.23720; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Shakya R, 2004, ANN PHARMACOTHER, V38, P1074, DOI 10.1345/aph.1D525; Sharma SK, 2002, AM J RESP CRIT CARE, V166, P916, DOI 10.1164/rccm.2108091; Sotsuka T, 2011, IN VIVO, V25, P803; Strange RC, 2000, TOXICOL LETT, V112, P357, DOI 10.1016/S0378-4274(99)00230-1; SUNAHARA S, 1961, SCIENCE, V134, P1530, DOI 10.1126/science.134.3489.1530; Tang SW, 2012, J CLIN PHARM THER, V37, P588, DOI 10.1111/j.1365-2710.2012.01334.x; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Vieira I, 1996, EUR J BIOCHEM, V238, P476, DOI 10.1111/j.1432-1033.1996.0476z.x; Vuilleumier Nicolas, 2006, Eur J Clin Pharmacol, V62, P423; Wang JH, 2004, ACAD J PLA POSTGRAD, V25, P239; Wang T, 2010, J INT MED RES, V38, P977, DOI 10.1177/147323001003800324; Wang Tao, 2009, Zhonghua Jie He He Hu Xi Za Zhi, V32, P585; Wu Yu-Mei, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P467, DOI 10.3760/cma.j.issn.1007-3418.2010.06.017; Xie HG, 1997, PHARMACOGENETICS, V7, P503, DOI 10.1097/00008571-199712000-00009; Yamada S, 2009, PHARMACOGENOMICS, V10, P1433, DOI [10.2217/pgs.09.66, 10.2217/PGS.09.66]; YAMAMOTO T, 1986, HEPATOLOGY, V6, P295, DOI 10.1002/hep.1840060223; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Yew WW, 2006, RESPIROLOGY, V11, P699, DOI 10.1111/j.1440-1843.2006.00941.x; Zhu Dong-lin, 2011, Zhongguo Kangshengsu Zazhi, V36, P864	61	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85905	10.1371/journal.pone.0085905	http://dx.doi.org/10.1371/journal.pone.0085905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465778	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000032
J	Assayag, EI; Beaulieu, MJ; Cormier, Y				Assayag, Evelyne Israael; Beaulieu, Marie-Josee; Cormier, Yvon			Bronchodilatory and Anti-Inflammatory Effects of ASM-024, a Nicotinic Receptor Ligand, Developed for the Treatment of Asthma	PLOS ONE			English	Article							NONNEURONAL CHOLINERGIC SYSTEM; ACETYLCHOLINE-RECEPTORS; AIRWAY INFLAMMATION; VAGUS NERVE; MODULATION; ACTIVATION; RESISTANCE; AGONIST; MACROPHAGES; SMOKING	Conventional asthma and COPD treatments include the use of bronchodilators, mainly beta 2-adrenergic agonists, muscarinic receptor antagonists and corticosteroids or leukotriene antagonists as anti-inflammatory agents. These active drugs are administered either separately or given as a fixed-dose combination medication into a single inhaler. ASM-024, a homopiperazinium compound, derived from the structural modification of diphenylmethylpiperazinium (DMPP), has been developed to offer an alternative mechanism of action that could provide symptomatic control through combined anti-inflammatory and bronchodilator properties in a single entity. A dose-dependent inhibition of cellular inflammation in bronchoalveolar lavage fluid was observed in ovalbumin-sensitized mice, subsequently treated for 3 days by nose-only exposure with aerosolized ASM-024 at doses up to 3.8 mg/kg (ED50 = 0.03 mg/kg). The methacholine ED250 values indicated that airway hyperresponsivenness (AHR) to methacholine decreased following ASM-024 administration by inhalation at a dose of 1.5 mg/kg, with a value of 0.145 +/- 0.032 mg/kg for ASM 024-treated group as compared to 0.088 +/- 0.023 mg/kg for untreated mice. In in vitro isometric studies, ASM-024 elicited dose-dependent relaxation of isolated mouse tracheal, human, and dog bronchial preparations contracted with methacholine and guinea pig tracheas contracted with histamine. ASM-024 showed also a dose and time dependant protective effect on methacholine-induced contraction. Overall, with its combined anti-inflammatory, bronchodilating and bronchoprotective properties, ASM-024 may represent a new class of drugs with a novel pharmacological approach that could prove useful for the chronic maintenance treatment of asthma and, possibly, COPD.	[Assayag, Evelyne Israael; Beaulieu, Marie-Josee; Cormier, Yvon] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Assayag, Evelyne Israael; Cormier, Yvon] Asmacure Ltee, Quebec City, PQ, Canada		Cormier, Y (corresponding author), Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	yvon.cormier@med.ulaval.ca			Asmacure Ltee, 2600 boul. Laurier, Suite 880, Quebec, QC	Asmacure Ltee, 2600 boul. Laurier, Suite 880, Quebec, QC	This work was supported by grants from Asmacure Ltee, 2600 boul. Laurier, Suite 880, Quebec, QC. G1V 4W2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, J ALLERGY; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Blanchet MR, 2007, J LEUKOCYTE BIOL, V81, P1245, DOI 10.1189/jlb.0906548; Blanchet MR, 2005, EUR RESPIR J, V26, P21, DOI 10.1183/09031936.05.00116104; Bousquet J, 2009, J ALLERGY CLIN IMMUN, V124, P428, DOI 10.1016/j.jaci.2009.06.027; Buccafusco JJ, 2009, J PHARMACOL EXP THER, V328, P364, DOI 10.1124/jpet.108.145292; Chojnacka K, 2013, BIOORG MED CHEM LETT, V23, P4145, DOI 10.1016/j.bmcl.2013.05.039; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Dorion G, 2005, AM J PHYSIOL-LUNG C, V288, pL1139, DOI 10.1152/ajplung.00406.2004; Durham A, 2011, CURR PHARM DESIGN, V17, P674, DOI 10.2174/138161211795428984; Floto RA, 2003, LANCET, V361, P1069, DOI 10.1016/S0140-6736(03)12902-9; Global Initiative for Asthma (GINA), 2011, GLOB STRAT ASTHM MAN; Godtfredsen NS, 2001, EUR RESPIR J, V18, P549, DOI 10.1183/09031936.01.00100801; Gwilt CR, 2007, PHARMACOL THERAPEUT, V115, P208, DOI 10.1016/j.pharmthera.2007.05.007; Hosur V, 2011, MOL PHARMACOL, V79, P167, DOI 10.1124/mol.110.066381; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Israel-Assayag E, 2010, NEW NIC REC AG AJRCC; Karakiulakis G, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/409580; Kistemaker LEM, 2012, LIFE SCI, V91, P1126, DOI 10.1016/j.lfs.2012.02.021; Kupczyk M, 2012, J INTERN MED, V272, P121, DOI 10.1111/j.1365-2796.2012.02558.x; Marrero MB, 2009, BRAIN RES, V1256, P1, DOI 10.1016/j.brainres.2008.11.053; Mikulski Z, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-133; O'Byrne PM, 2012, CLIN EXP ALLERGY, V42, P706, DOI 10.1111/j.1365-2222.2012.03965.x; Pavlov VA, 2008, INT J CLIN EXP MED, V1, P203; Pieper MP, 2012, LIFE SCI, V91, P1113, DOI 10.1016/j.lfs.2012.08.030; Sears Malcolm R., 2002, Journal of Allergy and Clinical Immunology, V110, pS322, DOI 10.1067/mai.2002.129966; Simard AR, 2013, IMMUNOL CELL BIOL, V91, P195, DOI 10.1038/icb.2013.1; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Stokes C, 2013, SOC NEUR NOV SAN DIE; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; TROISI RJ, 1995, CHEST, V108, P1557, DOI 10.1378/chest.108.6.1557; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Yates DH, 1997, AM J RESP CRIT CARE, V156, P988, DOI 10.1164/ajrccm.156.3.9610051	34	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86091	10.1371/journal.pone.0086091	http://dx.doi.org/10.1371/journal.pone.0086091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465890	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100106
J	Standage, D; Trappenberg, T; Blohm, G				Standage, Dominic; Trappenberg, Thomas; Blohm, Gunnar			Calcium-Dependent Calcium Decay Explains STDP in a Dynamic Model of Hippocampal Synapses	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; NMDA RECEPTORS; DECISION-MAKING; WORKING-MEMORY; SPIKE-TIME; LTP; DEPRESSION; INDUCTION; CA2+	It is widely accepted that the direction and magnitude of synaptic plasticity depends on post-synaptic calcium flux, where high levels of calcium lead to long-term potentiation and moderate levels lead to long-term depression. At synapses onto neurons in region CA1 of the hippocampus (and many other synapses), NMDA receptors provide the relevant source of calcium. In this regard, post-synaptic calcium captures the coincidence of pre- and post-synaptic activity, due to the blockage of these receptors at low voltage. Previous studies show that under spike timing dependent plasticity (STDP) protocols, potentiation at CA1 synapses requires post-synaptic bursting and an inter-pairing frequency in the range of the hippocampal theta rhythm. We hypothesize that these requirements reflect the saturation of the mechanisms of calcium extrusion from the post-synaptic spine. We test this hypothesis with a minimal model of NMDA receptor-dependent plasticity, simulating slow extrusion with a calcium-dependent calcium time constant. In simulations of STDP experiments, the model accounts for latency-dependent depression with either post-synaptic bursting or theta-frequency pairing (or neither) and accounts for latency-dependent potentiation when both of these requirements are met. The model makes testable predictions for STDP experiments and our simple implementation is tractable at the network level, demonstrating associative learning in a biophysical network model with realistic synaptic dynamics.	[Standage, Dominic; Blohm, Gunnar] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Standage, Dominic; Blohm, Gunnar] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Trappenberg, Thomas] Dalhousie Univ, Fac Comp Sci, Halifax, NS, Canada	Queens University - Canada; Queens University - Canada; Dalhousie University	Standage, D (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	standage@queensu.ca	Standage, Dominic/L-2399-2019	Standage, Dominic/0000-0002-1794-4505; Trappenberg, Thomas/0000-0002-6144-8963; Blohm, Gunnar/0000-0002-2297-3271	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by The Canadian Institutes of Health Research and The Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel HDI, 2003, BIOL CYBERN, V89, P214, DOI 10.1007/s00422-003-0422-x; Albantakis L, 2009, P NATL ACAD SCI USA, V106, P10308, DOI 10.1073/pnas.0901621106; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; AMARI SI, 1972, IEEE T COMPUT, VC 21, P1197, DOI 10.1109/T-C.1972.223477; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Buehlmann A, 2010, PLOS COMPUTATIONAL B, V6, P1; Buehlmann A, 2008, J NEUROSCI, V28, P7679, DOI 10.1523/JNEUROSCI.5640-07.2008; Burkitt AN, 2004, NEURAL COMPUT, V16, P885, DOI 10.1162/089976604773135041; Bush D, 2012, J COMPUT NEUROSCI, V33, P495, DOI 10.1007/s10827-012-0397-5; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Conti R, 2002, HIPPOCAMPUS, V12, P667, DOI 10.1002/hipo.10096; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Froemke RC, 2006, J NEUROPHYSIOL, V95, P1620, DOI 10.1152/jn.00910.2005; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Graupner M, 2012, P NATL ACAD SCI USA, V109, P3991, DOI 10.1073/pnas.1109359109; GRINIASTY M, 1993, NEURAL COMPUT, V5, P1, DOI 10.1162/neco.1993.5.1.1; Gutig R, 2003, J NEUROSCI, V23, P3697; Hansel C, 1996, J PHYSIOLOGY-PARIS, V90, P317, DOI 10.1016/S0928-4257(97)87906-5; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; Hartley M, 2006, NEUROCOMPUTING, V69, P2005, DOI 10.1016/j.neucom.2005.11.021; Hebb Donald O., 1949, ORG BEHAV; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Higley M. J., 2012, J COLD SPRING HARBOR, V4, P1; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Izhikevich EM, 2003, NEURAL COMPUT, V15, P1511, DOI 10.1162/089976603321891783; JAHR CE, 1990, J NEUROSCI, V10, P3178; Jensen O, 1996, LEARN MEMORY, V3, P264, DOI 10.1101/lm.3.2-3.264; Jensen O, 1996, LEARN MEMORY, V3, P243, DOI 10.1101/lm.3.2-3.243; Karmarkar UR, 2002, J NEUROPHYSIOL, V88, P507, DOI 10.1152/jn.2002.88.1.507; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; KOHONEN T, 1972, IEEE T COMPUT, VC 21, P353, DOI 10.1109/TC.1972.5008975; Kumar A, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00038; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lawrence M, 2006, NEUROCOMPUTING, V69, P634, DOI 10.1016/j.neucom.2005.12.003; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mayr CG, 2010, FRONTIERS COMPUTATIO, V2, P1, DOI DOI 10.3389/FNSYN.2010.00033; Mizuno T, 2001, EUR J NEUROSCI, V14, P701, DOI 10.1046/j.0953-816x.2001.01679.x; Ngezahayo A, 2000, J NEUROSCI, V20, P2451; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Pi HJ, 2008, J NEUROSCI, V28, P13132, DOI 10.1523/JNEUROSCI.2348-08.2008; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Rackham OJL, 2010, FRONTIERS SYNAPTIC N, V2, P1; Rosenkranz JA, 2009, J PHYSIOL-LONDON, V587, P115, DOI 10.1113/jphysiol.2008.158816; Rubin JE, 2005, J NEUROPHYSIOL, V93, P2600, DOI 10.1152/jn.00803.2004; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Scheuss V, 2006, J NEUROSCI, V26, P8183, DOI 10.1523/JNEUROSCI.1962-06.2006; Shouval HZ, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00019; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Simons SB, 2009, P NATL ACAD SCI USA, V106, P14080, DOI 10.1073/pnas.0904775106; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Standage D., 2007, P INT JOINT C NEUR N, P1359; Standage D, 2012, CAMBRIDGE HDB COGNIT; Standage D, 2007, BIOL CYBERN, V96, P615, DOI 10.1007/s00422-007-0152-6; Standage D, 2011, NEURAL NETWORKS, V24, P1062, DOI 10.1016/j.neunet.2011.05.004; Trappenberg TP, 2010, FUNDAMENTALS COMPUTA, P99; Tuckwell H.C., 1988, INTRO THEORETICAL NE, DOI [10.1017/CBO9780511623202, DOI 10.1017/CBO9780511623202]; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781	86	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86248	10.1371/journal.pone.0086248	http://dx.doi.org/10.1371/journal.pone.0086248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465987	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100132
J	Lee, Y; Kim, S; Kim, JY; Arooj, M; Kim, S; Hwang, S; Kim, BW; Park, KH; Lee, KW				Lee, Yuno; Kim, Songmi; Kim, Jun Young; Arooj, Mahreen; Kim, Siu; Hwang, Swan; Kim, Byeong-Woo; Park, Ki Hun; Lee, Keun Woo			Binding Mode Analyses and Pharmacophore Model Development for Stilbene Derivatives as a Novel and Competitive Class of alpha-Glucosidase Inhibitors	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; MECHANICAL CALCULATIONS; SULFONAMIDE CHALCONE; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; FORCE-FIELD; PROTEINS; IMPLEMENTATION; SIMULATIONS; AMBER	Stilbene urea derivatives as a novel and competitive class of non-glycosidic a-glucosidase inhibitors are effective for the treatment of type II diabetes and obesity. The main purposes of our molecular modeling study are to explore the most suitable binding poses of stilbene derivatives with analyzing the binding affinity differences and finally to develop a pharmacophore model which would represents critical features responsible for a-glucosidase inhibitory activity. Three-dimensional structure of S. cerevisiae a-glucosidase was built by homology modeling method and the structure was used for the molecular docking study to find out the initial binding mode of compound 12, which is the most highly active one. The initial structure was subjected to molecular dynamics (MD) simulations for protein structure adjustment at compound 12-bound state. Based on the adjusted conformation, the more reasonable binding modes of the stilbene urea derivatives were obtained from molecular docking and MD simulations. The binding mode of the derivatives was validated by correlation analysis between experimental K-i value and interaction energy. Our results revealed that the binding modes of the potent inhibitors were engaged with important hydrogen bond, hydrophobic, and p-interactions. With the validated compound 12-bound structure obtained from combining approach of docking and MD simulation, a proper four featured pharmacophore model was generated. It was also validated by comparison of fit values with the K-i values. Thus, these results will be helpful for understanding the relationship between binding mode and bioactivity and for designing better inhibitors from stilbene derivatives.	[Lee, Yuno; Kim, Songmi; Kim, Jun Young; Arooj, Mahreen; Kim, Siu; Hwang, Swan; Kim, Byeong-Woo; Park, Ki Hun; Lee, Keun Woo] GNU, RINS, PMBBRC, Div Appl Life Sci,BK21 Program,SSAC, Jinju, South Korea		Lee, KW (corresponding author), GNU, RINS, PMBBRC, Div Appl Life Sci,BK21 Program,SSAC, Jinju, South Korea.	kwlee@gnu.ac.kr	Arooj, Mahreen/AAC-7565-2020; Park, Ki Hun/A-1724-2012	Arooj, Mahreen/0000-0003-1975-5289	National Research Foundation of Korea (NRF); Korean Government (NRF); Basic Science Research Program [2012R1A1A4A01013657]; Pioneer Research Center Program [2009-0081539]; Management of Climate Change Program through the NRF [2010-0029084]; Ministry of Education, Science and Technology (MEST) of Republic of Korea; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea [PJ009486]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (NRF)(Korean Government); Basic Science Research Program; Pioneer Research Center Program; Management of Climate Change Program through the NRF(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea	This work was supported by National Research Foundation of Korea (NRF) Grant funded by the Korean Government (NRF-2012-Fostering Core Leaders of the Future Basic Science Program). This research was supported by Basic Science Research Program (2012R1A1A4A01013657), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the NRF funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. And this work was also supported by the Next-Generation BioGreen 21 Program (PJ009486) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys Software Inc, DISCOVERY STUDIO; Asano N, 1998, J MED CHEM, V41, P2565, DOI 10.1021/jm970836l; Aschenbrenner D, 2008, DRUG THERAPY NURSING; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bharatham K, 2008, J MOL GRAPH MODEL, V26, P1202, DOI 10.1016/j.jmgm.2007.11.002; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cheng A.Y.Y., 2004, DRUG DISCOV TODAY TH, V1, P201; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Melo EB, 2006, TETRAHEDRON, V62, P10277, DOI 10.1016/j.tet.2006.08.055; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ferreira SB, 2010, J MED CHEM, V53, P2364, DOI 10.1021/jm901265h; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Houston TA, 2003, MINI-REV MED CHEM, V3, P669, DOI 10.2174/1389557033487827; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kim JY, 2010, CHEMBIOCHEM, V11, P2125, DOI 10.1002/cbic.201000376; Kordik CP, 1999, J MED CHEM, V42, P181, DOI 10.1021/jm980521l; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang PH, 2006, CHEMBIOCHEM, V7, P165, DOI 10.1002/cbic.200500321; Matsui I, 2000, J BIOL CHEM, V275, P4871, DOI 10.1074/jbc.275.7.4871; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Muraki M, 2000, BIOCHEMISTRY-US, V39, P292, DOI 10.1021/bi991402q; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Park H, 2008, BIOORGAN MED CHEM, V16, P284, DOI 10.1016/j.bmc.2007.09.036; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Rapp C, 2011, J CHEM INFORM MODELI; Scott LJ, 2000, DRUGS, V59, P521, DOI 10.2165/00003495-200059030-00012; Seo WD, 2005, BIOORG MED CHEM LETT, V15, P5514, DOI 10.1016/j.bmcl.2005.08.087; Tomich CH, 2005, J COMPUT AID MOL DES, V19, P83, DOI 10.1007/s10822-005-1486-6; Umezawa Y, 1998, BIOORGAN MED CHEM, V6, P2507, DOI 10.1016/S0968-0896(98)80024-2; Van der Spoel D, 2006, GROMACS USER MANUAL, V4, P9747; Walker RC, 2008, J COMPUT CHEM, V29, P1019, DOI 10.1002/jcc.20857; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104	38	26	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85827	10.1371/journal.pone.0085827	http://dx.doi.org/10.1371/journal.pone.0085827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465730	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500122
J	Rombach-Riegraf, V; Karle, AC; Wolf, B; Sorde, L; Koepke, S; Gottlieb, S; Krieg, J; Djidja, MC; Baban, A; Spindeldreher, S; Koulov, AV; Kiessling, A				Rombach-Riegraf, Verena; Karle, Anette C.; Wolf, Babette; Sorde, Laetitia; Koepke, Stephan; Gottlieb, Sascha; Krieg, Jennifer; Djidja, Marie-Claude; Baban, Aida; Spindeldreher, Sebastian; Koulov, Atanas V.; Kiessling, Andrea			Aggregation of Human Recombinant Monoclonal Antibodies Influences the Capacity of Dendritic Cells to Stimulate Adaptive T-Cell Responses In Vitro	PLOS ONE			English	Article							FC-RECEPTORS; MATURATION; IMMUNITY; THERAPEUTICS; PERSPECTIVE; PARTICLES; MOLECULES; PATHWAY; INNATE	Subvisible proteinaceous particles which are present in all therapeutic protein formulations are in the focus of intense discussions between health authorities, academics and biopharmaceutical companies in the context of concerns that such particles could promote unwanted immunogenicity via anti-drug antibody formation. In order to provide further understanding of the subject, this study closely examines the specific biological effects proteinaceous particles may exert on dendritic cells (DCs) as the most efficient antigen-presenting cell population crucial for the initiation of the adaptive immune response. Two different model IgG antibodies were subjected to three different types of exaggerated physical stress to generate subvisible particles in far greater concentrations than the ones typical for the currently marketed biotherapeutical antibodies. The aggregated samples were used in in vitro biological assays in order to interrogate the early DC-driven events that initiate CD4 T-cell dependent humoral adaptive immune responses - peptide presentation capacity and co-stimulatory activity of DCs. Most importantly, antigen presentation was addressed with a unique approach called MHC-associated Peptide Proteomics (MAPPs), which allows for identifying the sequences of HLA-DR associated peptides directly from human dendritic cells. The experiments demonstrated that highly aggregated solutions of two model mAbs generated under controlled conditions can induce activation of human monocyte-derived DCs as indicated by upregulation of typical maturation markers including co-stimulatory molecules necessary for CD4 T-cell activation. Additional data suggest that highly aggregated proteins could induce in vitro T-cell responses. Intriguingly, strong aggregation-mediated changes in the pattern and quantity of antigen-derived HLA-DR associated peptides presented on DCs were observed, indicating a change in protein processing and presentation. Increasing the amounts of subvisible proteinaceous particles correlated very well with the pronounced increase in the peptide number and clusters presented in the context of class II HLA-DR molecules, suggesting a major involvement of a mass-action mechanism of altering the presentation.	[Rombach-Riegraf, Verena; Djidja, Marie-Claude; Koulov, Atanas V.] Novartis Pharma AG, Tech R&D, Biol Proc R&D, Late Phase Analyt & Pharmaceut Dev, Basel, Switzerland; [Karle, Anette C.; Sorde, Laetitia; Koepke, Stephan; Gottlieb, Sascha] Novartis Pharma AG, Integrated Biol Profiling Unit, Immunogen Risk Assessment, Basel, Switzerland; [Wolf, Babette; Krieg, Jennifer; Kiessling, Andrea] Novartis Pharma AG, Preclin Safety Biol Safety & Disposit, Expt Pathol, Immunosafety, Basel, Switzerland; [Baban, Aida; Spindeldreher, Sebastian] Novartis Pharma AG, Preclin Safety Biol Safety & Disposit, Bioanalyt, Basel, Switzerland	Novartis; Novartis; Novartis; Novartis	Rombach-Riegraf, V (corresponding author), Novartis Pharma AG, Tech R&D, Biol Proc R&D, Late Phase Analyt & Pharmaceut Dev, Basel, Switzerland.	verena.rombach-riegraf@novartis.com; anette.karle@novartis.com; andrea.kiessling@novartis.com		Koulov, Atanas/0000-0003-0262-7002	Novartis Pharma AG	Novartis Pharma AG	This study was funded by Novartis Pharma AG, the employer of all authors at the time of the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajtay Z, 2006, IMMUNOL LETT, V104, P46, DOI 10.1016/j.imlet.2005.11.023; Banki Z, 2003, J IMMUNOL, V170, P3963, DOI 10.4049/jimmunol.170.8.3963; Barnard JG, 2011, J PHARM SCI-US, V100, P492, DOI 10.1002/jps.22305; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Carpenter JF, 2009, J PHARM SCI-US, V98, P1201, DOI 10.1002/jps.21530; Chen YW, 2007, EUR J IMMUNOL, V37, P167, DOI 10.1002/eji.200636285; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Csomor E, 2007, MOL IMMUNOL, V44, P3389, DOI 10.1016/j.molimm.2007.02.014; De Baets G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002090; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; Filipe V, 2014, PHARM RES-DORDR, V31, P216, DOI 10.1007/s11095-013-1154-9; Filipe V, 2012, PHARM RES-DORDR, V29, P2202, DOI 10.1007/s11095-012-0749-x; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Granucci F, 1999, MICROBES INFECT, V1, P1079, DOI 10.1016/S1286-4579(99)00209-9; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Joubert MK, 2012, J BIOL CHEM, V287, P25266, DOI 10.1074/jbc.M111.330902; Karle AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031483; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Luheshi LM, 2009, FEBS LETT, V583, P2581, DOI 10.1016/j.febslet.2009.06.030; Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566; Morefield GL, 2005, VACCINE, V23, P1588, DOI 10.1016/j.vaccine.2004.07.050; Reis ES, 2008, MOL IMMUNOL, V45, P1952, DOI 10.1016/j.molimm.2007.10.031; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Sant AJ, 2005, IMMUNOL REV, V207, P261, DOI 10.1111/j.0105-2896.2005.00307.x; Sercarz EE, 2003, NAT REV IMMUNOL, V3, P621, DOI 10.1038/nri1149; Singh SK, 2010, J PHARM SCI-US, V99, P3302, DOI 10.1002/jps.22097; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; van Beers MMC, 2010, PHARM RES-DORDR, V27, P1812, DOI 10.1007/s11095-010-0172-0; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368	30	99	103	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86322	10.1371/journal.pone.0086322	http://dx.doi.org/10.1371/journal.pone.0086322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466023	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500224
J	Zhang, BJ; He, DY; Fan, Y; Liu, N; Chen, YJ				Zhang, Baojie; He, Dongyang; Fan, Yu; Liu, Nan; Chen, Yijun			Oral Delivery of Exenatide via Microspheres Prepared by Cross-Linking of Alginate and Hyaluronate	PLOS ONE			English	Article							SODIUM ALGINATE; DRUG-DELIVERY; GLUTARALDEHYDE; RELEASE; PEPTIDE; NANOPARTICLES; EXENDIN-4; BARRIERS; RECEPTOR; AGONIST	Exenatide is an FDA-approved glucose-lowering peptide drug for the treatment of type 2 diabetes by subcutaneous injection. To address the issues on the inconvenience for patient use and the difficulty of oral administration of peptide drugs, chemical cross-linking of two pH-responsive biomaterials, alginate and hyaluronate, was carried out to prepare a new material for the encapsulation of exenatide as a form of microspheres. The exenatide-loaded microspheres exhibited spherical structures with excellent loading and release behaviors in the simulated gastrointestinal tract environments. After oral administration of the microspheres in db/db mice, maximum plasma concentration of exenatide appeared at 4 hours, and blood glucose was effectively reduced to a normal level within 2 hours and maintained for another 4 hours. The bioavailability of the exenatide-loaded microspheres, relative to subcutaneous injection of exenatide, reached 10.2%. Collectively, the present study demonstrated the feasibility of orally delivering exenatide with the new cross-linked biomaterial and formulation, and showed therapeutic potential for clinical applications.	[Zhang, Baojie; He, Dongyang; Fan, Yu; Liu, Nan; Chen, Yijun] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Baojie; He, Dongyang; Fan, Yu; Liu, Nan; Chen, Yijun] China Pharmaceut Univ, Biol Chem Lab, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University	Liu, N (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	liunan0428@aliyun.com; yjchen@cpu.edu.cn	Chen, Yijun/H-3209-2019	Chen, Yijun/0000-0002-4920-152X	Ministry of Education of China; State Administration of Foreign Export Affairs of China [111-2-07]; National Science and Technology Major Projects of China [2012ZX09103-101-030]; State Key Laboratory of Natural Medicines, China Pharmaceutical University [SKLNMZZCX201301]	Ministry of Education of China(Ministry of Education, China); State Administration of Foreign Export Affairs of China; National Science and Technology Major Projects of China; State Key Laboratory of Natural Medicines, China Pharmaceutical University	This work was supported by the grants from the "111" Project from the Ministry of Education of China, and the State Administration of Foreign Export Affairs of China (No: 111-2-07), National Science and Technology Major Projects of China (2012ZX09103-101-030) and the Research Project of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No: SKLNMZZCX201301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel EA, 2012, BIOMATERIALS, V33, P4646, DOI 10.1016/j.biomaterials.2012.02.030; Bajpai SK, 2004, REACT FUNCT POLYM, V59, P129, DOI 10.1016/j.reactfunctpolym.2004.01.002; Colinet I, 2009, EUR J PHARM BIOPHARM, V73, P345, DOI 10.1016/j.ejpb.2009.07.008; Davidovich-Pinhas M, 2010, CARBOHYD POLYM, V79, P1020, DOI 10.1016/j.carbpol.2009.10.036; Davidson MB, 2005, NAT REV DRUG DISCOV, V4, P713, DOI 10.1038/nrd1828; Ensign LM, 2012, ADV DRUG DELIVER REV, V64, P557, DOI 10.1016/j.addr.2011.12.009; Esposito E, 2005, INT J PHARMACEUT, V288, P35, DOI 10.1016/j.ijpharm.2004.09.001; Fasano A, 1998, TRENDS BIOTECHNOL, V16, P152, DOI 10.1016/S0167-7799(97)01170-0; FEHMANN HC, 1992, MOL CELL ENDOCRINOL, V85, pC39, DOI 10.1016/0303-7207(92)90118-P; Fundueanu G, 1998, INT J PHARM, V170, P11, DOI 10.1016/S0378-5173(98)00063-5; Fundueanu G, 1999, BIOMATERIALS, V20, P1427, DOI 10.1016/S0142-9612(99)00050-2; Gedulin BR, 2008, INT J PHARM, V356, P231, DOI 10.1016/j.ijpharm.2008.01.015; GOKE R, 1993, J BIOL CHEM, V268, P19650; Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5; Gong NA, 2011, BRIT J PHARMACOL, V163, P399, DOI 10.1111/j.1476-5381.2011.01227.x; Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003; Jin CH, 2009, J CONTROL RELEASE, V133, P172, DOI 10.1016/j.jconrel.2008.09.091; Kim H, 2011, BIOMATERIALS, V32, P1685, DOI 10.1016/j.biomaterials.2010.10.045; Kulkarni AR, 2000, J CONTROL RELEASE, V63, P97, DOI 10.1016/S0168-3659(99)00176-5; Li M, 2008, INT J PHARMACEUT, V363, P26, DOI 10.1016/j.ijpharm.2008.07.018; Liew CV, 2006, INT J PHARMACEUT, V309, P25, DOI 10.1016/j.ijpharm.2005.10.040; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Morishita M, 2006, DRUG DISCOV TODAY, V11, P905, DOI 10.1016/j.drudis.2006.08.005; Nguyen HN, 2011, BIOMATERIALS, V32, P2673, DOI 10.1016/j.biomaterials.2010.12.044; Norback D, 1998, SCAND J WORK ENV HEA, V14, P366; Sung HW, 2012, ACCOUNTS CHEM RES, V45, P619, DOI 10.1021/ar200234q; Yeom CK, 1998, J APPL POLYM SCI, V67, P209, DOI 10.1002/(SICI)1097-4628(19980110)67:2<209::AID-APP3>3.0.CO;2-Y; Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8; Zeiger E, 2005, MUTAT RES-REV MUTAT, V589, P136, DOI 10.1016/j.mrrev.2005.01.001	29	10	14	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86064	10.1371/journal.pone.0086064	http://dx.doi.org/10.1371/journal.pone.0086064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465870	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500171
J	Zhao, W; Liu, NF				Zhao, Wei; Liu, Nai-fa			The Proximate Causes of Sexual Size Dimorphism in Phrynocephalus przewalskii	PLOS ONE			English	Article							BODY-SIZE; GEOGRAPHIC-VARIATION; MATING SUCCESS; LIZARD; GROWTH; TESTOSTERONE; PERFORMANCE; VICARIANCE; EVOLUTION; SELECTION	Sexual size dimorphism (SSD) is a common phenomenon and is a central topic in evolutionary biology. Recently, the importance of pursuing an ontogenetic perspective of SSD has been emphasized, to elucidate the proximate physiological mechanisms leading to its evolution. However, such research has seldom focused on the critical periods when males and females diverge. Using mark-recapture data, we investigated the development of SSD, sex-specific survivorship, and growth rates in Phrynocephalus przewalskii (Agamidae). We demonstrated that both male and female lizards are reproductively mature at age 10-11 months (including 5 months hibernation). Male-biased SSD in snout-vent length (SVL) was only found in adults and was fully expressed at age 11 months (June of the first full season of activity), just after sexual maturation. However, male-biased SSD in tail length (TL), hind-limb length (LL), and head width (HW) were fully expressed at age 9-10 months, just before sexual maturation. Analysis of age-specific linear growth rates identified sexually dimorphic growth during the fifth growth month (age 10-11 months) as the proximate cause of SSD in SVL. The males experienced higher mortality than females in the first 2 years and only survived better than females after SSD was well developed. This suggests that the critical period of divergence in the sizes of male and female P. przewalskii occurs between 10 and 11 months of age (May to June during the first full season of activity), and that the sexual difference in growth during this period is the proximate cause. However, the sexual difference in survivorship cannot explain the male-biased SSD in SVL. Our results indicate that performance-related characteristics, such as TL, HW, and LL diverged earlier than SVL. The physiological mechanisms underlying the different growth patterns of males and females may reflect different energy allocations associated with their different reproductive statuses.	[Zhao, Wei; Liu, Nai-fa] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China	Lanzhou University	Liu, NF (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.	naifaliu@sohu.com			National Nature grants [31200287]	National Nature grants	This research was funded by National Nature grants (31200287, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS RM, 1994, COPEIA, P613, DOI 10.2307/1447177; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Brecko J, 2008, BIOL J LINN SOC, V94, P251, DOI 10.1111/j.1095-8312.2008.00953.x; Christe P, 2006, OIKOS, V114, P381, DOI 10.1111/j.2006.0030-1299.15130.x; Cox RM, 2006, J ANIM ECOL, V75, P1361, DOI 10.1111/j.1365-2656.2006.01160.x; Cox RM, 2006, FUNCT ECOL, V20, P880, DOI 10.1111/j.1365-2435.2006.01177.x; Cox RM, 2009, J EVOLUTION BIOL, V22, P1586, DOI 10.1111/j.1420-9101.2009.01772.x; Cox RM, 2005, J EXP BIOL, V208, P4679, DOI 10.1242/jeb.01948; Cox RM, 2003, EVOLUTION, V57, P1653, DOI 10.1554/02-227; Cox Robert M., 2007, P38; Cox RM, 2010, EVOLUTION, V64, P1321, DOI 10.1111/j.1558-5646.2009.00906.x; Dubey S, 2011, AUSTRAL ECOL, V36, P68, DOI 10.1111/j.1442-9993.2010.02119.x; Haenel GJ, 2002, OIKOS, V96, P70, DOI 10.1034/j.1600-0706.2002.10915.x; Herrel A, 2010, BIOL J LINN SOC, V100, P287, DOI 10.1111/j.1095-8312.2010.01433.x; Husak JF, 2008, EVOL ECOL RES, V10, P213; Husk JF, 2006, EVOLUTION, V60, P2122; John-Alder HB, 2007, INTEGR COMP BIOL, V47, P258, DOI 10.1093/icb/icm010; Johnston G, 2011, AUSTRAL ECOL, V36, P117, DOI 10.1111/j.1442-9993.2010.02113.x; Kaliontzopoulou A, 2007, J MORPHOL, V268, P152, DOI 10.1002/jmor.10494; Kaliontzopoulou A, 2012, EVOL ECOL, V26, P825, DOI 10.1007/s10682-011-9538-y; KAUFMANN KW, 1981, OECOLOGIA, V49, P293, DOI 10.1007/BF00347588; Lappin AK, 2005, AM NAT, V166, P426, DOI 10.1086/432564; Liu N., 1996, ACTA ECOL SIN, V16, P276; MADSEN T, 1993, EVOLUTION, V47, P321, DOI 10.1111/j.1558-5646.1993.tb01222.x; Pearson D, 2002, OECOLOGIA, V131, P418, DOI 10.1007/s00442-002-0917-5; SHINE R, 1990, AM NAT, V135, P278, DOI 10.1086/285043; STAMPS JA, 1993, BIOL J LINN SOC, V50, P123, DOI 10.1111/j.1095-8312.1993.tb00921.x; Sun R, 2001, PRINCIPLES ANIMALS E, P146; Taylor EN, 2005, OECOLOGIA, V144, P206, DOI 10.1007/s00442-005-0056-x; Urquhart J, 2009, MOL ECOL, V18, P3714, DOI 10.1111/j.1365-294X.2009.04310.x; Vanhooydonck B, 2006, J EXP BIOL, V209, P4515, DOI 10.1242/jeb.02511; Wang YJ, 2011, ASIAN HERPETOL RES, V2, P97, DOI 10.3724/SP.J.1245.2011.00097; Wang Yuezhao, 1993, Asiatic Herpetological Research, V5, P65; Wang YZ, 2004, COPEIA, P199, DOI 10.1643/CG-03-082R1; XU HG, 1993, ECOL MODEL, V70, P127; Zhao Wei, 2012, Journal of Lanzhou University Natural Sciences, V48, P81; Zhao W, 2011, ASIAN HERPETOL RES, V2, P30, DOI 10.3724/SP.J.1245.2011.00030	37	3	3	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85963	10.1371/journal.pone.0085963	http://dx.doi.org/10.1371/journal.pone.0085963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465815	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500156
J	Winetsky, DE; Almukhamedov, O; Pulatov, D; Vezhnina, N; Dooronbekova, A; Zhussupov, B				Winetsky, Daniel E.; Almukhamedov, Olga; Pulatov, Dilshod; Vezhnina, Natalia; Dooronbekova, Aizhan; Zhussupov, Baurzhan			Prevalence, Risk Factors and Social Context of Active Pulmonary Tuberculosis among Prison Inmates in Tajikistan	PLOS ONE			English	Article							DRUG-RESISTANCE; RUSSIA; HEALTH; COUNTRIES; INTEGRATION; POPULATION; PROGRAMS; SUPPORT; TB	Setting: Tuberculosis (TB) is highly prevalent in prisons of the former Soviet Union. Objective: To understand the behavioral, demographic and biological factors placing inmates in Tajikistan at risk for active TB. Design: We administered a behavioral and demographic survey to 1317 inmates in two prison facilities in Sughd province, Tajikistan along with radiographic screening for pulmonary TB. Suspected cases were confirmed bacteriologically. Inmates undergoing TB treatment were also surveyed. In-depth interviews were conducted with former prisoners to elicit relevant social and behavioral characteristics. Results: We identified 59 cases of active pulmonary TB (prevalence 4.5%). Factors independently associated with increased prevalence of active TB were: HIV-infection by self-report (PR 7.88; 95%CI 3.40-18.28), history of previous TB (PR 10.21; 95%CI 6.27-16.63) and infrequent supplemental nutrition beyond scheduled meals (PR 3.00; 95%CI 1.67-5.62). Access to supplemental nutrition was associated with frequency of visits from friends and family and ability to rely on other inmates for help. Conclusion: In prison facilities of Tajikistan, HIV-infection, injection drug use and low access to supplemental nutrition were associated with prevalent cases of active pulmonary TB. Policies that reduce HIV transmission among injection drug users and improve the nutritional status of socially isolated inmates may alleviate the TB burden in Tajikistan's prisons.	[Winetsky, Daniel E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Almukhamedov, Olga; Pulatov, Dilshod] AIDS Fdn East West, Dept Programs, Dushanbe, Tajikistan; [Vezhnina, Natalia] AIDS Fdn East West, Dept Programs, Alma Ata, Kazakhstan; [Dooronbekova, Aizhan; Zhussupov, Baurzhan] AIDS Fdn East West, Dept Monitoring & Evaluat, Alma Ata, Kazakhstan	University of Pennsylvania	Winetsky, DE (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	daniel.winetsky@uphs.upenn.edu	Zhussupov, Baurzhan/AAR-8305-2021		Aids Fonds, the Netherlands [2010010]; IREX (International Research & Exchanges Board); United States Department of State through the Title VIII Program	Aids Fonds, the Netherlands; IREX (International Research & Exchanges Board); United States Department of State through the Title VIII Program	This research was supported in part by a grant from Aids Fonds, the Netherlands (Grant 2010010). Daniel E. Winetsky was supported in part by a fellowship from IREX (International Research & Exchanges Board) with funds provided by the United States Department of State through the Title VIII Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts A, 2000, INT J TUBERC LUNG D, V4, P1104; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bobrik A, 2005, J PUBLIC HEALTH POL, V26, P30, DOI 10.1057/palgrave.jphp.3200002; Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438; Bonnet M, 2005, INT J TUBERC LUNG D, V9, P1147; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Coker RJ, 2003, INT J TUBERC LUNG D, V7, P920; Coninx R, 2000, BRIT MED J, V320, P440, DOI 10.1136/bmj.320.7232.440; Coninx R, 1998, BRIT MED J, V316, P1423, DOI 10.1136/bmj.316.7142.1423; Drobniewski FA, 2005, EUR RESPIR J, V26, P298, DOI 10.1183/09031936.05.00136004; Garden B, 2013, SCAND J CARING SCI, V27, P117, DOI 10.1111/j.1471-6712.2012.01009.x; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Jakubowiak WM, 2008, TUBERCULOSIS, V88, P495, DOI 10.1016/j.tube.2008.03.004; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P1210; Keshavjee S, 2000, JAMA-J AM MED ASSOC, V283, P1201, DOI 10.1001/jama.283.9.1201; Lindquist CH, 2000, SOCIOL FORUM, V15, P431, DOI 10.1023/A:1007524426382; Lobacheva T, 2007, EUR J EPIDEMIOL, V22, P121, DOI 10.1007/s10654-006-9068-z; Lonnroth K, 2009, INT J TUBERC LUNG D, V13, P171; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Makhmudov R, 2006, MAINTENANCE CONDITIO; Melchers NVSV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053644; Operario D, 2008, GUIDELINE QUALITATIV; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Republican Center for AIDS Prophylaxis, STAT REP CTR AIDS PR; Reyes H, 1997, BRIT MED J, V315, P1447, DOI 10.1136/bmj.315.7120.1447; Rieder HL, 2011, INT J TUBERC LUNG D, V15, P662, DOI 10.5588/ijtld.10.0433; Rivlin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068944; Rocha C, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P50, DOI 10.5588/ijtld.10.0447; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Stachowiak JA, 2006, DRUG ALCOHOL DEPEN, V82, pS7, DOI 10.1016/S0376-8716(06)80002-5; Stop TB Partnership (World Health Organization), 2008, ADVOCACY COMMUNICATI; Stuckler D, 2008, P NATL ACAD SCI USA, V105, P13280, DOI 10.1073/pnas.0801200105; Toungoussova OS, 2003, CLIN INFECT DIS, V37, P665, DOI 10.1086/377205; United Nations Development Program, INT HUM DEV IND; Wares DF, 1997, LANCET, V350, P957, DOI 10.1016/S0140-6736(05)63295-3; Weine S, 2008, J IMMIGR MINOR HEALT, V10, P461, DOI 10.1007/s10903-007-9103-5; WHO, 2007, IMPR DIAGN TREATM SM; World Health Organization, 2010, GLBO TUB CONTR WHO R	39	30	30	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86046	10.1371/journal.pone.0086046	http://dx.doi.org/10.1371/journal.pone.0086046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297FH	24465861	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500101
J	Sigruener, A; Kleber, ME; Heimerl, S; Liebisch, G; Schmitz, G; Maerz, W				Sigruener, Alexander; Kleber, Marcus E.; Heimerl, Susanne; Liebisch, Gerhard; Schmitz, Gerd; Maerz, Winfried			Glycerophospholipid and Sphingolipid Species and Mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study	PLOS ONE			English	Article							FREE FATTY-ACIDS; LIPIDOMICS REVEALS; GENETIC-VARIATION; CERAMIDE; PLASMA; APOPTOSIS; LYSOPHOSPHATIDYLCHOLINE; IDENTIFICATION; DISEASE; ROLES	Vascular and metabolic diseases cause half of total mortality in Europe. New prognostic markers would provide a valuable tool to improve outcome. First evidence supports the usefulness of plasma lipid species as easily accessible markers for certain diseases. Here we analyzed association of plasma lipid species with mortality in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Plasma lipid species were quantified by electrospray ionization tandem mass spectrometry and Cox proportional hazards regression was applied to assess their association with total and cardiovascular mortality. Overall no differences were detected between total and cardiovascular mortality. Highly polyunsaturated phosphatidylcholine species together with lysophosphatidylcholine species and long chain saturated sphingomyelin and ceramide species seem to be associated with a protective effect. The predominantly circulating phosphatidylcholine-based as well as phosphatidylethanolamine-based ether species and phosphatidylethanolamine species were positively associated with total and cardiovascular mortality. Saturated and monounsaturated phosphatidylcholine species, especially phosphatidylcholine 32:0 (most probably dipalmitoyl-phosphatidylcholine) and palmitate containing sphingomyelin and ceramide species showed together with 24:1 containing sphingomyelin and ceramide species strongest positive association with mortality. A quotient of the sums of the six most protective species and the six species with the strongest positive mortality association indicated an almost 3-fold increased risk of mortality, which was higher than the hazard ratio for known risk factors in our cohort. Plasma lipid species levels and especially ratios of certain species may be valuable prognostic marker for cardiovascular and total mortality.	[Sigruener, Alexander; Heimerl, Susanne; Liebisch, Gerhard; Schmitz, Gerd] Regensburg Univ Med Ctr, Inst Lab Med & Transfus Med, Regensburg, Germany; [Kleber, Marcus E.; Maerz, Winfried] Heidelberg Univ, Med Clin 5, Mannheim Med Fac, Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Inst Clin Med, Graz, Austria; [Maerz, Winfried] Med Univ Graz, Chem Lab Diagnost, Graz, Austria; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, Mannheim, Germany	University of Regensburg; Ruprecht Karls University Heidelberg; Medical University of Graz; Medical University of Graz; SYNLAB Group	Sigruener, A (corresponding author), Regensburg Univ Med Ctr, Inst Lab Med & Transfus Med, Regensburg, Germany.	alexander.sigruener@ukr.de	Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811; Kleber, Marcus/0000-0003-0663-7275	European Community [202272]; IP-Project LipidomicNet; BMBF ("SysMBo'') [0315494C]	European Community(European Commission); IP-Project LipidomicNet; BMBF ("SysMBo'')(Federal Ministry of Education & Research (BMBF))	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 202272, IP-Project LipidomicNet and BMBF ("SysMBo'', sponsorship number 0315494C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; Butler PL, 2010, J BIOL CHEM, V285, P6246, DOI 10.1074/jbc.M109.017350; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; Duan RD, 2003, J BIOL CHEM, V278, P38528, DOI 10.1074/jbc.M305437200; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Goncalves I, 2012, ARTERIOSCL THROM VAS, V32, P1505, DOI 10.1161/ATVBAHA.112.249854; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Horres CR, 2012, NEUROCHEM RES, V37, P1137, DOI 10.1007/s11064-011-0692-y; Hu CX, 2011, MOL BIOSYST, V7, P3271, DOI 10.1039/c1mb05342f; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Kleber ME, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-157; Kopf T., 2012, GENETICS MEETS METAB, P191; Leskinen T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012609; Li X, 2010, CELL PHYSIOL BIOCHEM, V26, P41, DOI 10.1159/000315104; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2005, BBA-MOL CELL BIOL L, V1734, P86, DOI 10.1016/j.bbalip.2005.01.002; Liebisch G, 2002, CLIN CHEM, V48, P2217; Liebisch G, 2013, J LIPID RES; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Lu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041681; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Merino DM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-63; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Orensic M, 2013, DIABETOLOGIA; Ottestad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042550; Paumen MB, 1997, J BIOL CHEM, V272, P3324, DOI 10.1074/jbc.272.6.3324; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pilz S, 2007, EUR HEART J, V28, P2763, DOI 10.1093/eurheartj/ehm343; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P2542, DOI 10.1210/jc.2006-0195; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Riboni L, 1997, PROG LIPID RES, V36, P153, DOI 10.1016/S0163-7827(97)00008-8; Scarborough P, 2010, CORONARY HEART DIS S; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Sorensen CM, 2010, CLIN BIOCHEM, V43, P948, DOI 10.1016/j.clinbiochem.2010.04.075; Spijkers LJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021817; Stojakovic T, 2010, ATHEROSCLEROSIS, V208, P564, DOI 10.1016/j.atherosclerosis.2009.07.026; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019477; Sysi-Aho M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015744; Winkelmann B. R., 2001, PHARMACOGENOMICS S1, V2, P1; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	45	98	98	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85724	10.1371/journal.pone.0085724	http://dx.doi.org/10.1371/journal.pone.0085724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465667	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000055
J	Zhao, RX; Tang, DQ; Yi, SN; Li, WJ; Wu, CL; Lu, YR; Hou, XG; Song, J; Lin, P; Chen, L; Sun, L				Zhao, Ruxing; Tang, Dongqi; Yi, Shounan; Li, Wenjuan; Wu, Chuanlong; Lu, Yiran; Hou, Xinguo; Song, Jun; Lin, Peng; Chen, Li; Sun, Lei			Elevated Peripheral Frequencies of Th22 Cells: A Novel Potent Participant in Obesity and Type 2 Diabetes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE INFLAMMATION; INDUCED INSULIN-RESISTANCE; TNF-ALPHA; T-CELLS; INTERLEUKIN 22; KAPPA-B; FAT; POPULATION; ACCUMULATION	Objective: Chronic low-grade inflammation has long been recognized as the central link between obesity and type 2 diabetes (T2D). The novel subset of T helper (Th) cells, Th22, plays an emerging role in chronic inflammation. We investigated the potential association between Th22 and the pathogenesis of obesity and T2D. Methods: Ninety T2D inpatients (T2D group), 30 healthy participants with BMI ranged from 19 to 23.9 kg/m2 (CTL group) and 30 metabolically healthy obese controls with BMI >= 30 kg/m2 (MHO group) were employed in our study. Peripheral frequencies of Th22 and Th1 and Th17 cells were determined by flow cytometry based on their specific cytokine patterns. Cytokine levels in fresh plasma were quantified by ELISA. Results: Compared to that in CTL group (1.18 +/- 0.06%, n = 28), peripheral frequency of Th22 cells was significantly increased in MHO group (1.88 +/- 0.10%, n = 30) and in T2D group (2.247 +/- 0.10%, n = 89). There was a consistent notable increase in plasma interleukin (IL)-22 of T2D patients [47.56 (30.55-76.89) pg/mL] as compared with that of MHO group [36.65 (29.52-55.70) pg/ml; *P<0.0001] and CTLs [36.33 (31.93-40.62) pg/mL; *P<0.0001]. Furthermore, other than Th1/Th17, previously frequently described participants in obesity and T2D, there was a strong correlation between Th22 frequency and the homeostasis model of assessment for insulin resistance index (r = 0.6771, *P<0.0001) and HOMA for beta-cell function (r = 20.7264, *P<0.0001). Conclusions: There were increased Th22 frequencies and IL-22 levels in obesity and T2D. Elevated Th22 and IL-22 also aided in the differentiation of MHO from T2D patients. The notable correlation implied that Th22 might play a more determinant role in both insulin resistance and b-cell impairment.	[Zhao, Ruxing; Li, Wenjuan; Wu, Chuanlong; Lu, Yiran; Hou, Xinguo; Song, Jun; Lin, Peng; Chen, Li; Sun, Lei] Shandong Univ, Dept Endocrinol, Qilu Hosp, Jinan 250100, Peoples R China; [Zhao, Ruxing; Chen, Li; Sun, Lei] Shandong Univ, Inst Endocrinol & Metab, Jinan 250100, Peoples R China; [Zhao, Ruxing; Tang, Dongqi] Shandong Univ, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250100, Peoples R China; [Yi, Shounan] Univ Sydney, Westmead Hosp, Ctr Transplant & Renal Res, Westmead Millennium Inst, Westmead, NSW 2145, Australia	Shandong University; Shandong University; Shandong University; University of Sydney; Westmead Institute for Medical Research	Chen, L (corresponding author), Shandong Univ, Dept Endocrinol, Qilu Hosp, Jinan 250100, Peoples R China.	sduchenli@gmail.com; sunlei1@medmail.com.cn	Stefanadis, Christodoulos/ABH-2232-2020; Lu, YiRan/GQO-9465-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; hou, xinguo/0000-0003-2045-1290	National Natural Science Foundation of China [81000326, 81100617]; China Postdoctoral Science Foundation [2012M521354]; Jinan Overseas Students Pioneer plan [20100205, 20110407]; Special Fund of Clinical Research of Chinese Medical Association [12030420342]; Shandong International Scientific Corporation Plan [2012GGE27126]; Shandong Natural Science Foundation [ZR2012HM014]; Shandong Provincial Health & Medical Development Project [2011HD005]; National Key Technology R D Program [2009BAI80B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jinan Overseas Students Pioneer plan; Special Fund of Clinical Research of Chinese Medical Association; Shandong International Scientific Corporation Plan; Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Provincial Health & Medical Development Project; National Key Technology R D Program(National Key Technology R&D Program)	This study was financially supported by the National Natural Science Foundation of China (Grant No. 81000326; 81100617), China Postdoctoral Science Foundation (Grant No. 2012M521354), Jinan Overseas Students Pioneer plan (Grant No. 20100205; 20110407), The Special Fund of Clinical Research of Chinese Medical Association(Grant No. 12030420342), Shandong International Scientific Corporation Plan(Grant No. 2012GGE27126), Shandong Natural Science Foundation (Grant No. ZR2012HM014), Shandong Provincial Health & Medical Development Project (Grant No. 2011HD005), National Key Technology R & D Program Grant No. 2009BAI80B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulet LP, 2008, CLIN INVEST MED, V31, pE386, DOI 10.25011/cim.v31i6.4926; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Festa A, 2001, INT J OBESITY, V25, P1407, DOI 10.1038/sj.ijo.0801792; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fink C, 2012, INFLAMM BOWEL DIS, V18, P1550, DOI 10.1002/ibd.22893; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Habib Samy L, 2013, ISRN Oncol, V2013, P583786, DOI 10.1155/2013/583786; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Hannan MT, 2013, ARTHRIT CARE RES, V65, P4, DOI 10.1002/acr.21904; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu Y, 2012, HUM IMMUNOL, V73, P629, DOI 10.1016/j.humimm.2012.04.015; Jagannathan-Bogdan M, 2011, J IMMUNOL, V186, P1162, DOI 10.4049/jimmunol.1002615; Kang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061411; Katsuki A, 1998, J CLIN ENDOCR METAB, V83, P859, DOI 10.1210/jc.83.3.859; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mashili F, 2013, DIABETES, V62, P457, DOI 10.2337/db12-0337; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Peng D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068446; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ramirez JM, 2010, EUR J IMMUNOL, V40, P2450, DOI 10.1002/eji.201040461; Shao LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051339; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Tian T, 2013, EXPERT OPIN THER TAR, V17, P113, DOI 10.1517/14728222.2013.736497; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Wunderlich Claudia M, 2013, JAKSTAT, V2, pe23878, DOI 10.4161/jkst.23878; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zeng C, 2012, J MOL MED, V90, P175, DOI 10.1007/s00109-011-0816-5; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031000, 10.1371/journal.pone.0037865]; Zhang N, 2011, MOL CELL BIOCHEM, V353, P41, DOI 10.1007/s11010-011-0772-y; Zinman B, 1999, J CLIN ENDOCR METAB, V84, P272, DOI 10.1210/jc.84.1.272	41	50	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85770	10.1371/journal.pone.0085770	http://dx.doi.org/10.1371/journal.pone.0085770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465695	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000063
J	Avanti, C; Saluja, V; van Streun, ELP; Frijlink, HW; Hinrichs, WLJ				Avanti, Christina; Saluja, Vinay; van Streun, Erwin L. P.; Frijlink, Henderik W.; Hinrichs, Wouter L. J.			Stability of Lysozyme in Aqueous Extremolyte Solutions during Heat Shock and Accelerated Thermal Conditions	PLOS ONE			English	Article							NATURALLY-OCCURRING OSMOLYTES; PROTEIN STABILIZATION; SOLVENT INTERACTIONS; COMPATIBLE SOLUTES; NILE RED; MANNOSYLGLYCERATE; TREHALOSE; RIBONUCLEASE; AGGREGATION; ADDITIVES	The purpose of this study was to investigate the stability of lysozyme in aqueous solutions in the presence of various extremolytes (betaine, hydroxyectoine, trehalose, ectoine, and firoin) under different stress conditions. The stability of lysozyme was determined by Nile red Fluorescence Spectroscopy and a bioactivity assay. During heat shock (10 min at 70 degrees C), betaine, trehalose, ectoin and firoin protected lysozyme against inactivation while hydroxyectoine, did not have a significant effect. During accelerated thermal conditions (4 weeks at 55 degrees C), firoin also acted as a stabilizer. In contrast, betaine, hydroxyectoine, trehalose and ectoine destabilized lysozyme under this condition. These findings surprisingly indicate that some extremolytes can stabilize a protein under certain stress conditions but destabilize the same protein under other stress conditions. Therefore it is suggested that for the screening extremolytes to be used for protein stabilization, an appropriate storage conditions should also be taken into account.	[Avanti, Christina] Univ Surabaya Ubaya, Fac Pharm, Dept Pharmaceut, Surabaya, Indonesia; [Avanti, Christina; Saluja, Vinay; van Streun, Erwin L. P.; Frijlink, Henderik W.; Hinrichs, Wouter L. J.] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands; [Saluja, Vinay] MSD, Dev Ctr Oss, Oss, Netherlands	Universitas Surabaya (UBAYA); University of Groningen; Merck & Company	Saluja, V (corresponding author), Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.	vinay.saluja@merck.com	Frijlink, Henderik Willem/AAD-7382-2020; Avanti, Christina/AAC-1699-2021; Hinrichs, Wouter/J-3893-2019	Frijlink, Henderik Willem/0000-0001-7901-8198; Hinrichs, Wouter/0000-0002-1481-2769; Avanti, Christina/0000-0002-1770-8684	Top Institute Pharma The Netherlands [D6-202]	Top Institute Pharma The Netherlands(Netherlands Government)	This project has funded by the Top Institute Pharma The Netherlands Project Number D6-202; http://www.tipharma.com/pharmaceutical-research-projects/production-technologies/oxytocin-hot-medicines.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050192; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; ARAKAWA T, 1991, PHARMACEUT RES, V8, P285, DOI 10.1023/A:1015825027737; Arakawa T, 2006, BBA-PROTEINS PROTEOM, V1764, P1677, DOI 10.1016/j.bbapap.2006.08.012; BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Bolen DW, 2008, ANNU REV BIOCHEM, V77, P339, DOI 10.1146/annurev.biochem.77.061306.131357; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Faria TQ, 2003, CHEMBIOCHEM, V4, P734, DOI 10.1002/cbic.200300574; Galinski EA, 1997, COMP BIOCHEM PHYS A, V117, P357, DOI 10.1016/S0300-9629(96)00275-7; GEKKO K, 1983, J BIOCHEM-TOKYO, V94, P199, DOI 10.1093/oxfordjournals.jbchem.a134330; GERLSMA SY, 1972, INT J PEPT PROT RES, V4, P377; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hedoux A, 2009, J PHYS CHEM B, V113, P6119, DOI 10.1021/jp900330r; Hoffmann C, 2009, EUR BIOPHYS J BIOPHY, V38, P557, DOI 10.1007/s00249-009-0404-6; Knapp S, 1999, EXTREMOPHILES, V3, P191, DOI 10.1007/s007920050116; Lentzen G, 2006, APPL MICROBIOL BIOT, V72, P623, DOI 10.1007/s00253-006-0553-9; Linhananta A, 2012, J PHYS C SERIES, P341; Maeda Y, 1996, PROTEIN ENG, V9, P461, DOI 10.1093/protein/9.5.461; Matsuoka T, 2007, J BIOSCI BIOENG, V103, P440, DOI 10.1263/jbb.103.440; Melo EP, 2001, PROTEINS, V42, P542, DOI 10.1002/1097-0134(20010301)42:4<542::AID-PROT120>3.3.CO;2-W; NEMETHY G, 1986, METHOD ENZYMOL, V127, P183; Rishi V, 1998, BIOCHEM J, V329, P137, DOI 10.1042/bj3290137; SACKETT DL, 1987, ANAL BIOCHEM, V167, P228, DOI 10.1016/0003-2697(87)90157-6; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P5278, DOI 10.1021/bi00138a006; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Sutter M, 2007, J FLUORESC, V17, P181, DOI 10.1007/s10895-007-0156-6; Ueda T, 2001, J BIOCHEM-TOKYO, V130, P491, DOI 10.1093/oxfordjournals.jbchem.a003011; Venkataramani Sathyadevi, 2013, J Pharm Bioallied Sci, V5, P148, DOI 10.4103/0975-7406.111821	29	24	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86244	10.1371/journal.pone.0086244	http://dx.doi.org/10.1371/journal.pone.0086244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465983	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000330288000072
J	Fifel, K; Vezoli, J; Dzahini, K; Claustrat, B; Leviel, V; Kennedy, H; Procyk, E; Dkhissi-Benyahya, O; Gronfier, C; Cooper, HM				Fifel, Karim; Vezoli, Julien; Dzahini, Kwamivi; Claustrat, Bruno; Leviel, Vincent; Kennedy, Henry; Procyk, Emmanuel; Dkhissi-Benyahya, Ouria; Gronfier, Claude; Cooper, Howard M.			Alteration of Daily and Circadian Rhythms following Dopamine Depletion in MPTP Treated Non-Human Primates	PLOS ONE			English	Article							PARKINSONS-DISEASE; NONMOTOR SYMPTOMS; IODINATED TRACER; LOCUS-COERULEUS; NEURONAL LOSS; BRIGHT LIGHT; CLOCK GENE; MELATONIN; MONKEYS; NUCLEUS	Disturbances of the daily sleep/wake cycle are common non-motor symptoms of Parkinson's disease (PD). However, the impact of dopamine (DA) depletion on circadian rhythms in PD patients or non-human primate (NHP) models of the disorder have not been investigated. We evaluated alterations of circadian rhythms in NHP following MPTP lesion of the dopaminergic nigro-striatal system. DA degeneration was assessed by in vivo PET ([C-11]-PE2I) and post-mortem TH and DAT quantification. In a light: dark cycle, control and MPTP-treated NHP both exhibit rest-wake locomotor rhythms, although DA-depleted NHP show reduced amplitude, decreased stability and increased fragmentation. In all animals, 6-sulphatoxymelatonin peaks at night and cortisol in early morning. When the circadian system is challenged by exposure to constant light, controls retain locomotor rest-wake and hormonal rhythms that free-run with stable phase relationships whereas in the DA-depleted NHP, locomotor rhythms are severely disturbed or completely abolished. The amplitude and phase relations of hormonal rhythms nevertheless remain unaltered. Use of a light-dark masking paradigm shows that expression of daily rest-wake activity in MPTP monkeys requires the stimulatory and inhibitory effects of light and darkness. These results suggest that following DA lesion, the central clock in the SCN remains intact but, in the absence of environmental timing cues, is unable to drive downstream rhythmic processes of striatal clock gene and dopaminergic functions that control locomotor output. These findings suggest that the circadian component of the sleep-wake disturbances in PD is more profoundly affected than previously assumed.	[Fifel, Karim; Vezoli, Julien; Dzahini, Kwamivi; Claustrat, Bruno; Leviel, Vincent; Kennedy, Henry; Procyk, Emmanuel; Dkhissi-Benyahya, Ouria; Gronfier, Claude; Cooper, Howard M.] INSERM, U846, Stem Cell & Brain Res Inst, F-69500 Bron, France; [Fifel, Karim; Vezoli, Julien; Dzahini, Kwamivi; Claustrat, Bruno; Leviel, Vincent; Kennedy, Henry; Procyk, Emmanuel; Dkhissi-Benyahya, Ouria; Gronfier, Claude; Cooper, Howard M.] Univ Lyon 1, UMR S 846, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Cooper, HM (corresponding author), INSERM, U846, Stem Cell & Brain Res Inst, F-69500 Bron, France.	howard.cooper@inserm.fr	fifel, karim/J-9262-2014; Vezoli, Julien/CAF-7700-2022; procyk, emmanuel/H-3037-2014; COOPER, HOWARD/M-7304-2014; Dkhissi-Benyahya, Ouria/M-5665-2014; Gronfier, Claude/C-1243-2008; Kennedy, Henry/B-9636-2013; Vezoli, Julien/E-4267-2012	fifel, karim/0000-0001-6259-9336; Vezoli, Julien/0000-0001-8319-5429; procyk, emmanuel/0000-0001-7486-4993; Dkhissi-Benyahya, Ouria/0000-0001-9168-3801; Gronfier, Claude/0000-0002-6549-799X; Kennedy, Henry/0000-0002-2796-7663; 	Fondation de France; Fondation Caisse d'Epargne Rhone Alpes Lyon; Rhone-Alpes Cible/CMIRA; Retina France; Volubilis; GDRI Neurosciences; Cluster Handicap Vieillissement Neurosciences;  [ANR-09-MNPS-040]	Fondation de France(Fondation de France); Fondation Caisse d'Epargne Rhone Alpes Lyon; Rhone-Alpes Cible/CMIRA(Region Auvergne-Rhone-Alpes); Retina France; Volubilis; GDRI Neurosciences; Cluster Handicap Vieillissement Neurosciences(Region Auvergne-Rhone-Alpes); 	Support was provided by the following: Fondation de France, Fondation Caisse d'Epargne Rhone Alpes Lyon, Rhone-Alpes Cible/CMIRA, ANR-09-MNPS-040, Retina France, Volubilis, GDRI Neurosciences, and Cluster Handicap Vieillissement Neurosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDHOUS ME, 1988, ANN CLIN BIOCHEM, V25, P298, DOI 10.1177/000456328802500319; Almirall H, 2001, NEUROPHYSIOL CLIN, V31, P161, DOI 10.1016/S0987-7053(01)00256-8; Arnulf I, 2009, PARKINSONISM RELAT D, V15, pS101, DOI 10.1016/S1353-8020(09)70792-8; Aschoff J, 1999, JPN J PHYSIOL, V49, P11, DOI 10.2170/jjphysiol.49.11; Aziz NA, 2011, J NEUROENDOCRINOL, V23, P519, DOI 10.1111/j.1365-2826.2011.02134.x; Barcia C, 2003, NEUROENDOCRINOLOGY, V78, P118, DOI 10.1159/000071967; Barraud Q, 2009, EXP NEUROL, V219, P574, DOI 10.1016/j.expneurol.2009.07.019; BENAZZOUZ A, 1995, EUR J PHARMACOL, V284, P299, DOI 10.1016/0014-2999(95)00362-O; Bezard E, 1997, BRAIN RES, V766, P107, DOI 10.1016/S0006-8993(97)00531-3; BOJKOWSKI CJ, 1987, CLIN CHEM, V33, P1343; Borbely A A, 1982, Hum Neurobiol, V1, P195; CARLSSON A, 1972, ACTA NEUROL SCAND, V48, P11; Castaneda TR, 2004, J PINEAL RES, V36, P177, DOI 10.1046/j.1600-079X.2003.00114.x; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chen MK, 2008, J NEUROCHEM, V105, P78, DOI 10.1111/j.1471-4159.2007.05108.x; Compta Y, 2009, BRAIN, V132, P3308, DOI 10.1093/brain/awp263; DEPEDROCUESTA J, 1991, ACTA NEUROL SCAND, V84, P382, DOI 10.1111/j.1600-0404.1991.tb04974.x; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Dzahini K, 2010, J NEUROCHEM, V113, P1459, DOI 10.1111/j.1471-4159.2010.06682.x; EIDELBERG E, 1986, NEUROSCIENCE, V18, P817, DOI 10.1016/0306-4522(86)90102-8; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339; Emond P, 1997, J MED CHEM, V40, P1366, DOI 10.1021/jm960795d; FERTL E, 1993, J NEURAL TRANSM-PARK, V5, P227, DOI 10.1007/BF02257677; Fifel K, 2013, CHRONOBIOL INT, V30, P741, DOI 10.3109/07420528.2012.762011; Forno Lysia S., 1993, V60, P600; Fulceri F, 2007, BRAIN RES, V1135, P219, DOI 10.1016/j.brainres.2006.12.030; GASPAR P, 1993, EXP BRAIN RES, V96, P100, DOI 10.1007/BF00230443; Gomez-Gallego M, 2007, J NEURAL TRANSM, V114, P319, DOI 10.1007/s00702-006-0547-x; Gravotta L, 2011, J MOL NEUROSCI, V45, P162, DOI 10.1007/s12031-011-9520-8; Halliday G, 2009, MOVEMENT DISORD, V24, P1519, DOI 10.1002/mds.22481; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; HARTHE C, 1991, CLIN CHEM, V37, P536; Hartmann A, 1997, NEUROBIOL AGING, V18, P285, DOI 10.1016/S0197-4580(97)80309-0; Hatfield CF, 2004, BRAIN, V127, P1061, DOI 10.1093/brain/awh129; HIRSCH EC, 1987, P NATL ACAD SCI USA, V84, P5976, DOI 10.1073/pnas.84.16.5976; Hirsh J, 2010, CURR BIOL, V20, P209, DOI 10.1016/j.cub.2009.11.037; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Imbesi M, 2009, NEUROSCIENCE, V158, P537, DOI 10.1016/j.neuroscience.2008.10.044; JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Linder J, 2010, MOVEMENT DISORD, V25, P341, DOI 10.1002/mds.22987; Liu AC, 2007, NAT CHEM BIOL, V3, P630, DOI 10.1038/nchembio.2007.37; Maetzler W, 2009, LANCET NEUROL, V8, P1158, DOI 10.1016/S1474-4422(09)70291-1; Masuda K, 2010, J BIOL RHYTHM, V25, P361, DOI 10.1177/0748730410379382; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; Meijer JH, 2012, PROG BRAIN RES, V199, P143, DOI 10.1016/B978-0-444-59427-3.00009-5; Mounayar S, 2007, BRAIN, V130, P2898, DOI 10.1093/brain/awm208; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Neumane S, 2012, NEUROBIOL DIS, V48, P27, DOI 10.1016/j.nbd.2012.06.002; NIEOULLON A, 1977, NATURE, V269, P340, DOI 10.1038/269340a0; Olanow CW, 2006, LANCET NEUROL, V5, P677, DOI 10.1016/S1474-4422(06)70521-X; Paakkonen T, 2006, J PINEAL RES, V40, P110, DOI 10.1111/j.1600-079X.2005.00300.x; Poyot T, 2001, J CEREBR BLOOD F MET, V21, P782, DOI 10.1097/00004647-200107000-00003; Redlin U, 2003, BRAIN RES, V965, P1, DOI 10.1016/S0006-8993(02)03844-1; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Riemersma-van Der Lek RF, 2008, JAMA-J AM MED ASSOC, V299, P2642, DOI 10.1001/jama.299.22.2642; Rye D, 2010, EXP NEUROL, V222, P179, DOI 10.1016/j.expneurol.2010.01.001; Shih Ming Chi, 2006, Sao Paulo Med. J., V124, P168, DOI 10.1590/S1516-31802006000300014; Sleipness EP, 2007, BRAIN RES, V1129, P34, DOI 10.1016/j.brainres.2006.10.063; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Thannickal TC, 2007, BRAIN, V130, P1586, DOI 10.1093/brain/awm097; TOKURA H, 1978, PFLUG ARCH EUR J PHY, V376, P241, DOI 10.1007/BF00584957; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238; VanSomeren EJW, 1997, BIOL PSYCHIAT, V41, P955, DOI 10.1016/S0006-3223(97)89928-3; Vezoli J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023952; Wermuth L, 2008, ACTA NEUROL SCAND, V118, P126, DOI 10.1111/j.1600-0404.2007.00991.x; Willis GL, 2012, REV NEUROSCIENCE, V23, P199, DOI 10.1515/revneuro-2011-0072; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337	73	42	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86240	10.1371/journal.pone.0086240	http://dx.doi.org/10.1371/journal.pone.0086240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465981	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000071
J	Eggeling, R; Gohr, A; Keilwagen, J; Mohr, M; Posch, S; Smith, AD; Grosse, I				Eggeling, Ralf; Gohr, Andre; Keilwagen, Jens; Mohr, Michaela; Posch, Stefan; Smith, Andrew D.; Grosse, Ivo			On the Value of Intra-Motif Dependencies of Human Insulator Protein CTCF	PLOS ONE			English	Article							FACTOR-BINDING SITES; TRANSCRIPTION FACTORS; HUMAN GENOME; REGULATORY ELEMENTS; DNA INTERACTIONS; SEQUENCE MOTIFS; SIMPLE-MODELS; ZINC FINGERS; EM ALGORITHM; SPECIFICITY	The binding affinity of DNA-binding proteins such as transcription factors is mainly determined by the base composition of the corresponding binding site on the DNA strand. Most proteins do not bind only a single sequence, but rather a set of sequences, which may be modeled by a sequence motif. Algorithms for de novo motif discovery differ in their promoter models, learning approaches, and other aspects, but typically use the statistically simple position weight matrix model for the motif, which assumes statistical independence among all nucleotides. However, there is no clear justification for that assumption, leading to an ongoing debate about the importance of modeling dependencies between nucleotides within binding sites. In the past, modeling statistical dependencies within binding sites has been hampered by the problem of limited data. With the rise of high-throughput technologies such as ChIP-seq, this situation has now changed, making it possible to make use of statistical dependencies effectively. In this work, we investigate the presence of statistical dependencies in binding sites of the human enhancer-blocking insulator protein CTCF by using the recently developed model class of inhomogeneous parsimonious Markov models, which is capable of modeling complex dependencies while avoiding overfitting. These findings lead to a more detailed characterization of the CTCF binding motif, which is only poorly represented by independent nucleotide frequencies at several positions, predominantly at the 3 ' end.	[Eggeling, Ralf; Gohr, Andre; Posch, Stefan; Grosse, Ivo] Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Germany; [Keilwagen, Jens] Fed Res Ctr Cultivated Plants, JKI, Inst Biosafety Plant Biotechnol, Quedlinburg, Germany; [Keilwagen, Jens; Mohr, Michaela; Grosse, Ivo] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Genebank, Seeland Ot Gatersleben, Germany; [Smith, Andrew D.] Univ So Calif, Los Angeles, CA USA; [Grosse, Ivo] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg; Julius Kuhn-Institut; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Southern California	Eggeling, R (corresponding author), Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Germany.	eggeling@informatik.uni-halle.de	Eggeling, Ralf/P-3403-2019; Smith, Andrew D./G-4104-2013	Eggeling, Ralf/0000-0002-3583-1029; Smith, Andrew D./0000-0002-3337-1970; Keilwagen, Jens/0000-0002-6792-7076	Reisestipendium des allg. Stiftungsfonds der MLU Halle-Wittenberg; DFG [GR3526_1-1]; BMBF [0312706A/D]	Reisestipendium des allg. Stiftungsfonds der MLU Halle-Wittenberg; DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was funded by "Reisestipendium des allg. Stiftungsfonds der MLU Halle-Wittenberg (website http://www.uni-halle.de), DFG (grant no. GR3526_1-1, website http://www.dfg.de) and BMBF (grant no. 0312706A/D, website http://www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao W, 2004, SCIENCE, V305, P1743, DOI 10.1126/science.1102216; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BARASH Y, 2003, P 7 ANN INT C RES CO, P28; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bourguignon PY, 2004, P JOBIM; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Eggeling R, 2013, SPRINGER LECT NOTES, P321; Grau J, 2012, J MACH LEARN RES, V13, P1967; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Keilwagen J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001070; Kim NK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-262; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morris Q, 2011, NAT BIOTECHNOL, V29, P483, DOI 10.1038/nbt.1892; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; O'Flanagan RA, 2005, BIOINFORMATICS, V21, P2254, DOI 10.1093/bioinformatics/bti361; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Pavesi G, 2001, Bioinformatics, V17 Suppl 1, pS207; Redhead E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-385; Schneider T, 1990, NUCLEIC ACIDS RES, V18; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Siddharthan R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000156; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-170; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2971, DOI 10.1093/nar/10.9.2971; The ENCODE Project Consortium, 2007, NATURE, V447, P7146; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; Thompson W, 2003, NUCLEIC ACIDS RES, V31, P3580, DOI 10.1093/nar/gkg608; Thompson WA, 2007, NUCLEIC ACIDS RES, V35, pW232, DOI 10.1093/nar/gkm265; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Wang H, 2012, GENOME RES, V9; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Wolfe SA, 1999, J MOL BIOL, V285, P1917, DOI 10.1006/jmbi.1998.2421; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; ZHANG MQ, 1993, COMPUT APPL BIOSCI, V9, P499; Zhao XY, 2005, J COMPUT BIOL, V12, P894, DOI 10.1089/cmb.2005.12.894; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zhou Q, 2004, BIOINFORMATICS, V20, P909, DOI 10.1093/bioinformatics/bth006	52	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85629	10.1371/journal.pone.0085629	http://dx.doi.org/10.1371/journal.pone.0085629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465627	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100054
J	Gieling, ET; Antonides, A; Fink-Gremmels, J; ter Haar, K; Kuller, WI; Meijer, E; Nordquist, RE; Stouten, JM; Zeinstra, E; van der Staay, FJ				Gieling, Elise T.; Antonides, Alexandra; Fink-Gremmels, Johanna; ter Haar, Kim; Kuller, Wikke I.; Meijer, Ellen; Nordquist, Rebecca E.; Stouten, Jacomijn M.; Zeinstra, Elly; van der Staay, Franz Josef			Chronic Allopurinol Treatment during the Last Trimester of Pregnancy in Sows: Effects on Low and Normal Birth Weight Offspring	PLOS ONE			English	Article							CHILDREN BORN; ATTENTIONAL PROBLEMS; GROWTH RESTRICTION; SPLEEN WEIGHT; BRAIN; PIGLETS; MEMORY; STRESS; INFANTS; PRETERM	Low-birth-weight (LBW) children are born with several risk factors for disease, morbidity and neonatal mortality, even if carried to term. Placental insufficiency leading to hypoxemia and reduced nutritional supply is the main cause for LBW. Brain damage and poor neurological outcome can be the consequence. LBW after being carried to term gives better chances for survival, but these children are still at risk for poor health and the development of cognitive impairments. Preventive therapies are not yet available. We studied the risk/efficacy of chronic prenatal treatment with the anti-oxidative drug allopurinol, as putative preventive treatment in piglets. LBW piglets served as a natural model for LBW. A cognitive holeboard test was applied to study the learning and memory abilities of these allopurinol treated piglets after weaning. Preliminary analysis of the plasma concentrations in sows and their piglets suggested that a daily dose of 15 mg.kg(-1) resulted in effective plasma concentration of allopurinol in piglets. No adverse effects of chronic allopurinol treatment were found on farrowing, birth weight, open field behavior, learning abilities, relative brain, hippocampus and spleen weights. LBW piglets showed increased anxiety levels in an open field test, but cognitive performance was not affected by allopurinol treatment. LBW animals treated with allopurinol showed the largest postnatal compensatory body weight gain. In contrast to a previous study, no differences in learning abilities were found between LBW and normal-birth-weight piglets. This discrepancy might be attributable to experimental differences. Our results indicate that chronic prenatal allopurinol treatment during the third trimester of pregnancy is safe, as no adverse side effects were observed. Compensatory weight gain of treated piglets is a positive indication for the chronic prenatal use of allopurinol in these animals. Further studies are needed to assess the possible preventive effects of allopurinol on brain functions in LBW piglets.	[Gieling, Elise T.; Antonides, Alexandra; Nordquist, Rebecca E.; Zeinstra, Elly; van der Staay, Franz Josef] Univ Utrecht, Fac Vet Med, Emot & Cognit Grp, Dept Farm Anim Hlth, Utrecht, Netherlands; [Fink-Gremmels, Johanna] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [ter Haar, Kim] Wageningen Univ, Adaptat Physiol Grp Anim Sci, NL-6700 AP Wageningen, Netherlands; [Kuller, Wikke I.; Stouten, Jacomijn M.] Univ Utrecht, Fac Vet Med, Pig Hlth Unit, Dept Farm Anim Hlth, Utrecht, Netherlands; [Meijer, Ellen] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Antonides, Alexandra; Nordquist, Rebecca E.; Zeinstra, Elly; van der Staay, Franz Josef] Univ Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands	Utrecht University; Utrecht University; Wageningen University & Research; Utrecht University; Utrecht University; Utrecht University	Gieling, ET (corresponding author), Univ Utrecht, Fac Vet Med, Emot & Cognit Grp, Dept Farm Anim Hlth, Utrecht, Netherlands.	elisegieling@gmail.com	Meijer, Ellen/Z-4621-2019; Fink-Gremmels, Johanna/G-3707-2012; Nordquist, Rebecca E./B-7455-2013	Nordquist, Rebecca E./0000-0002-8541-5285; van der Staay, F. Josef/0000-0002-8704-3366				ALBERTSSONWIKLAND K, 1993, ACTA PAEDIATR, V82, P438, DOI 10.1111/j.1651-2227.1993.tb12718.x; Arts JWM, 2009, BEHAV BRAIN RES, V205, P303, DOI 10.1016/j.bbr.2009.06.014; Barker DJP, 2004, J EPIDEMIOL COMMUN H, V58, P114, DOI 10.1136/jech.58.2.114; Barker DJP, 1997, BRIT MED BULL, V53, P96; Baron IS, 2010, NEUROPSYCHOLOGY, V24, P787, DOI 10.1037/a0020382; Bauer R, 1998, EXP TOXICOL PATHOL, V50, P59, DOI 10.1016/S0940-2993(98)80071-7; Beaulieu AD, 2010, J ANIM SCI, V88, P2767, DOI 10.2527/jas.2009-2222; Belai YI, 1998, AM J OBSTET GYNECOL, V178, P13, DOI 10.1016/S0002-9378(98)70619-2; Biri A, 2007, GYNECOL OBSTET INVES, V64, P187, DOI 10.1159/000106488; BLANCHARD DC, 1995, PSYCHONEUROENDOCRINO, V20, P117, DOI 10.1016/0306-4530(94)E0045-B; Blomberg LA, 2010, PLACENTA, V31, P549, DOI 10.1016/j.placenta.2010.03.005; Boda D, 1999, PRENAT NEONAT MED, V4, P130; Bos AF, 2001, DEV MED CHILD NEUROL, V43, P61, DOI 10.1017/S001216220100010X; Bouger PCM, 2005, EUR NEUROPSYCHOPHARM, V15, P331, DOI 10.1016/j.euroneuro.2004.11.006; Burke C, 2006, BRAIN RES, V1098, P19, DOI 10.1016/j.brainres.2006.04.129; Casey PH, 2008, SEMIN PERINATOL, V32, P20, DOI 10.1053/j.semperi.2007.12.004; Chaddha V, 2004, AM J OBSTET GYNECOL, V191, pS82, DOI 10.1016/j.ajog.2004.10.174; Chaudhari Sudha, 2004, Indian Pediatr, V41, P121; Cheema R, 2009, EARLY HUM DEV, V85, P467, DOI 10.1016/j.earlhumdev.2009.04.003; Dallwig R, 2010, J EXOT PET MED, V19, P255, DOI 10.1053/j.jepm.2010.07.001; DEHAAN HH, 1995, EUR J OBSTET GYN R B, V61, P123, DOI 10.1016/0301-2115(95)02127-S; DELAND FH, 1970, RADIOLOGY, V97, P589, DOI 10.1148/97.3.589; Donald RD, 2011, PHYSIOL BEHAV, V104, P906, DOI 10.1016/j.physbeh.2011.05.031; Frisk V, 2002, DEV NEUROPSYCHOL, V22, P565, DOI 10.1207/S15326942DN2203_2; Gagnon R, 2003, EUR J OBSTET GYN R B, V110, pS99, DOI 10.1016/S0301-2115(03)00179-9; Geva R, 2006, BRAIN RES, V1117, P186, DOI 10.1016/j.brainres.2006.08.004; Gieling E, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-4; Gieling ET, 2012, PEDIATR RES, V71, P71, DOI 10.1038/pr.2011.5; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; Graham S, 1996, BRIT J CLIN PHARMACO, V41, P299, DOI 10.1046/j.1365-2125.1996.03116.x; HACK M, 1986, PEDIATRICS, V77, P196; HARA C, 1981, PHYSIOL BEHAV, V27, P243, DOI 10.1016/0031-9384(81)90264-X; Hayes B, 2009, J MATERN-FETAL NEO M, V22, P849, DOI 10.1080/14767050902994507; Isaacs EB, 2000, PEDIATR RES, V47, P713, DOI 10.1203/00006450-200006000-00006; Kaandorp JJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-8; Kessenich M., 2003, NEWBORN INFANT NURS, P80; Koehl M, 2011, EUR J NEUROSCI, V33, P1101, DOI 10.1111/j.1460-9568.2011.07609.x; Kranendonk G, 2006, HORM BEHAV, V49, P663, DOI 10.1016/j.yhbeh.2005.12.008; LAIDLEY CW, 1988, COMP BIOCHEM PHYS A, V89, P495, DOI 10.1016/0300-9629(88)91063-8; Mallard C, 2000, NEUROSCIENCE, V100, P327, DOI 10.1016/S0306-4522(00)00271-2; MARSH JT, 1960, P SOC EXP BIOL MED, V104, P180; Martinussen M, 2009, J PEDIATR-US, V155, P848, DOI 10.1016/j.jpeds.2009.06.015; Masaoka N, 2005, J MATERN-FETAL NEO M, V18, P1, DOI 10.1080/14767050500127716; MOORHOUSE PC, 1987, FEBS LETT, V213, P23, DOI 10.1016/0014-5793(87)81458-8; O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301; O'Shea TM, 1998, PEDIATRICS, V101, P642, DOI 10.1542/peds.101.4.642; OADES RD, 1981, NEUROSCI LETT, V27, P75, DOI 10.1016/0304-3940(81)90208-1; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; PAZ I, 1995, OBSTET GYNECOL, V85, P452; Peeters C, 2001, BIOL NEONATE, V79, P274; Peeters-Scholte C, 2003, PEDIATR RES, V54, P516, DOI 10.1203/01.PDR.0000081297.53793.C6; POWELL SE, 1980, J ANIM SCI, V50, P860, DOI 10.2527/jas1980.505860x; Raikkonen K, 2008, ARCH GEN PSYCHIAT, V65, P290, DOI 10.1001/archgenpsychiatry.2007.40; RANDALL GCB, 1971, CAN J COMPARAT MED, V35, P141; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; RIFKIN L, 1994, BRIT J PSYCHIAT, V165, P357, DOI 10.1192/bjp.165.3.357; Roza SJ, 2008, AM J EPIDEMIOL, V168, P1145, DOI 10.1093/aje/kwn233; RUSHEN J, 2000, BIOL ANIMAL STRESS; Sankaran S, 2009, BEST PRACT RES CL OB, V23, P765, DOI 10.1016/j.bpobgyn.2009.05.003; Shum D, 2008, ARCH CLIN NEUROPSYCH, V23, P103, DOI 10.1016/j.acn.2007.08.006; Silva A, 2006, ANN EPIDEMIOL, V16, P469, DOI 10.1016/j.annepidem.2005.06.056; Streimish IG, 2012, EARLY HUM DEV, V88, P765, DOI 10.1016/j.earlhumdev.2012.04.004; TOFT PB, 1995, EARLY HUM DEV, V43, P15, DOI 10.1016/0378-3782(95)01657-O; Torrance HL, 2009, PEDIATRICS, V124, P350, DOI 10.1542/peds.2008-2228; TULI JS, 1995, LAB ANIM-UK, V29, P90, DOI 10.1258/002367795780740339; Van Bel F, 1998, PEDIATRICS, V101, P185, DOI 10.1542/peds.101.2.185; van Bel F, 2006, NCT00346463 US NIH; van der Staay FJ, 2012, NEUROSCI BIOBEHAV R, V36, P379, DOI 10.1016/j.neubiorev.2011.07.008; van der Staay FJ, 2010, PHYSIOL BEHAV, V100, P154, DOI 10.1016/j.physbeh.2010.02.020; vandenBerg PP, 1996, AM J OBSTET GYNECOL, V175, P1152, DOI 10.1016/S0002-9378(96)70021-2; VANDERLENDE T, 1991, LIVEST PROD SCI, V28, P73, DOI 10.1016/0301-6226(91)90056-V; Weary DM, 1997, APPL ANIM BEHAV SCI, V53, P249, DOI 10.1016/S0168-1591(96)01173-2; Wilson ME, 1998, BIOL REPROD, V58, P905, DOI 10.1095/biolreprod58.4.905; Xiong X, 2005, ANN EPIDEMIOL, V15, P658; Yanney Michael, 2004, Semin Fetal Neonatal Med, V9, P411, DOI 10.1016/j.siny.2004.03.005	75	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86396	10.1371/journal.pone.0086396	http://dx.doi.org/10.1371/journal.pone.0086396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466072	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100152
J	Le Laz, S; Kpebe, A; Bauzan, M; Lignon, S; Rousset, M; Brugna, M				Le Laz, Sebastien; Kpebe, Arlette; Bauzan, Marielle; Lignon, Sabrina; Rousset, Marc; Brugna, Myriam			A Biochemical Approach to Study the Role of the Terminal Oxidases in Aerobic Respiration in Shewanella oneidensis MR-1	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; CYDD GENE-PRODUCT; ESCHERICHIA-COLI; DESULFOVIBRIO-VULGARIS; MESSENGER-RNA; BD OXIDASE; AZOTOBACTER-VINELANDII; BACILLUS-SUBTILIS	The genome of the facultative anaerobic gamma-proteobacterium Shewanella oneidensis MR-1 encodes for three terminal oxidases: a bd-type quinol oxidase and two heme-copper oxidases, a A-type cytochrome c oxidase and a cbb(3)-type oxidase. In this study, we used a biochemical approach and directly measured oxidase activities coupled to mass-spectrometry analysis to investigate the physiological role of the three terminal oxidases under aerobic and microaerobic conditions. Our data revealed that the cbb(3)-type oxidase is the major terminal oxidase under aerobic conditions while both cbb(3)-type and bd-type oxidases are involved in respiration at low-O-2 tensions. On the contrary, the low O-2-affinity A-type cytochrome c oxidase was not detected in our experimental conditions even under aerobic conditions and would therefore not be required for aerobic respiration in S. oneidensis MR-1. In addition, the deduced amino acid sequence suggests that the A-type cytochrome c oxidase is a ccaa(3)-type oxidase since an uncommon extra-C terminal domain contains two c-type heme binding motifs. The particularity of the aerobic respiratory pathway and the physiological implication of the presence of a ccaa(3)-type oxidase in S. oneidensis MR-1 are discussed.	[Le Laz, Sebastien; Kpebe, Arlette; Rousset, Marc; Brugna, Myriam] Aix Marseille Univ, CNRS, UMR 7281, Lab Bioenerget & Ingn Prot,IMM, Marseille, France; [Bauzan, Marielle] Aix Marseille Univ, CNRS, Unite Fermentat, FR3479,IMM, Marseille, France; [Lignon, Sabrina] Aix Marseille Univ, CNRS, FR3479, IMM,MaP IBiSA, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Brugna, M (corresponding author), Aix Marseille Univ, CNRS, UMR 7281, Lab Bioenerget & Ingn Prot,IMM, Marseille, France.	mbrugna@imm.cnrs.fr		BRUGNA, Myriam/0000-0002-4017-3294	Agence Nationale de la Recherche; Centre National de la Recherche Scientifique (CNRS); Aix-Marseille Universite	Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite	This work was supported by research grants from the Agence Nationale de la Recherche (EngineeringH2cyano and Algo-H2 projects), the Centre National de la Recherche Scientifique (CNRS) and the Aix-Marseille Universite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Baker SC, 1998, MICROBIOL MOL BIOL R, V62, P1046, DOI 10.1128/MMBR.62.4.1046-1078.1998; BEBBINGTON KJ, 1993, FEMS MICROBIOL LETT, V112, P19; Belevich I, 2005, P NATL ACAD SCI USA, V102, P3657, DOI 10.1073/pnas.0405683102; Belevich I, 2005, FEBS LETT, V579, P4567, DOI 10.1016/j.febslet.2005.07.011; Belevich I, 2007, BIOCHEMISTRY-US, V46, P11177, DOI 10.1021/bi700862u; Borisov VB, 2004, FEBS LETT, V576, P201, DOI 10.1016/j.febslet.2004.09.013; Borisov VB, 2007, BIOCHEM BIOPH RES CO, V355, P97, DOI 10.1016/j.bbrc.2007.01.118; Borisov VB, 2013, FEBS LETT, V587, P2214, DOI 10.1016/j.febslet.2013.05.047; Borisov VB, 2011, P NATL ACAD SCI USA, V108, P17320, DOI 10.1073/pnas.1108217108; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Braun M, 2005, J BACTERIOL, V187, P5996, DOI 10.1128/JB.187.17.5996-6004.2005; Brochier-Armanet C, 2009, MOL BIOL EVOL, V26, P285, DOI 10.1093/molbev/msn246; Bueno E, 2012, ANTIOXID REDOX SIGN, V16, P819, DOI 10.1089/ars.2011.4051; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Carr HS, 2002, J BIOL CHEM, V277, P31237, DOI 10.1074/jbc.M204854200; Chang HY, 2010, BIOCHEMISTRY-US, V49, P7494, DOI 10.1021/bi1004574; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fu HH, 2013, ENVIRON MICROBIOL, V15, P2198, DOI 10.1111/1462-2920.12091; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; GEORGIOU CD, 1988, J BACTERIOL, V170, P961, DOI 10.1128/jb.170.2.961-966.1988; GEORGIOU CD, 1987, J BACTERIOL, V169, P2107, DOI 10.1128/jb.169.5.2107-2112.1987; Gilmour R, 1997, J BACTERIOL, V179, P863, DOI 10.1128/jb.179.3.863-870.1997; Giuffre A, 2012, FEBS LETT, V586, P622, DOI 10.1016/j.febslet.2011.07.035; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Guiral M, 2009, J PROTEOME RES, V8, P1717, DOI 10.1021/pr8007946; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hannappel A, 2012, BBA-BIOENERGETICS, V1817, P928, DOI 10.1016/j.bbabio.2011.09.007; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kawakami T, 2010, ENVIRON MICROBIOL, V12, P1399, DOI 10.1111/j.1462-2920.2009.02109.x; Koch HG, 2000, J MOL BIOL, V297, P49, DOI 10.1006/jmbi.2000.3555; KRUMMECK G, 1990, CURR GENET, V18, P13, DOI 10.1007/BF00321109; Kulajta C, 2006, J MOL BIOL, V355, P989, DOI 10.1016/j.jmb.2005.11.039; Lamrabet O, 2011, MICROBIOL-SGM, V157, P2720, DOI 10.1099/mic.0.049171-0; LAURAEUS M, 1991, EUR J BIOCHEM, V197, P699, DOI 10.1111/j.1432-1033.1991.tb15961.x; Le Laz S, 2014, APPL MICROBIOL BIOT, V98, P2699, DOI 10.1007/s00253-013-5208-z; Liu CX, 2002, BIOTECHNOL BIOENG, V80, P637, DOI 10.1002/bit.10430; Lobo SAL, 2008, BBA-BIOENERGETICS, V1777, P1528, DOI 10.1016/j.bbabio.2008.09.007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marritt SJ, 2012, BIOCHEM SOC T, V40, P1217, DOI 10.1042/BST20120150; MATHER MW, 1991, J BIOL CHEM, V266, P5025; Morris RL, 2013, NAT REV MICROBIOL, V11, P205, DOI 10.1038/nrmicro2970; Mouncey NJ, 1998, J BACTERIOL, V180, P2228, DOI 10.1128/JB.180.8.2228-2231.1998; NG TCN, 1995, BBA-BIOENERGETICS, V1230, P119, DOI 10.1016/0005-2728(95)00043-I; Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Nittis T, 2001, J BIOL CHEM, V276, P42520, DOI 10.1074/jbc.M107077200; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; POOLE RK, 1983, J GEN MICROBIOL, V129, P1335; POOLE RK, 1993, MOL MICROBIOL, V10, P421, DOI 10.1111/j.1365-2958.1993.tb02673.x; POOLE RK, 1994, FEMS MICROBIOL LETT, V117, P217, DOI 10.1111/j.1574-6968.1994.tb06768.x; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Preisig O, 1996, ARCH MICROBIOL, V165, P297, DOI 10.1007/s002030050330; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Rieske J. S., 1967, METHOD ENZYMOL, V10, P239; Sakamoto J, 1996, FEMS MICROBIOL LETT, V143, P151, DOI 10.1016/0378-1097(96)00312-6; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sone N, 1999, J BIOSCI BIOENG, V87, P495, DOI 10.1016/S1389-1723(99)80099-1; Swem DL, 2005, J BACTERIOL, V187, P8081, DOI 10.1128/JB.187.23.8081-8087.2005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; VanOrsdel CE, 2013, J BACTERIOL, V195, P3640, DOI 10.1128/JB.00324-13; Wan XF, 2004, J BACTERIOL, V186, P8385, DOI 10.1128/JB.186.24.8385-8400.2004; Winstedt L, 1998, J BACTERIOL, V180, P6571, DOI 10.1128/JB.180.24.6571-6580.1998; Yang K, 2008, FEBS LETT, V582, P3705, DOI 10.1016/j.febslet.2008.09.038; Zhou GQ, 2013, ISME J, V7, P1752, DOI 10.1038/ismej.2013.62	77	14	14	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86343	10.1371/journal.pone.0086343	http://dx.doi.org/10.1371/journal.pone.0086343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466040	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100144
J	Bragin, A; Almajano, J; Kheiri, F; Engel, J				Bragin, Anatol; Almajano, Joel; Kheiri, Farshad; Engel, Jerome, Jr.			Functional Connectivity in the Brain Estimated by Analysis of Gamma Events	PLOS ONE			English	Article							FEEDFORWARD INHIBITION; VISUAL-CORTEX; OSCILLATIONS; SYNCHRONIZATION; INTEGRATION; MECHANISMS; NETWORKS; STATE; RAT; ORGANIZATION	It is known that gamma activity is generated by local networks. In this paper we introduced a new approach for estimation of functional connectivity between neuronal networks by measuring temporal relations between peaks of gamma event amplitudes. We have shown in freely moving rats that gamma events recorded between electrodes 1.5 mm apart in the majority of cases, are generated by different neuronal modules interfering with each other. The map of functional connectivity between brain areas during the resting state, created based on gamma event temporal relationships is in agreement with anatomical connections and with maps described by fMRI methods during the resting state. The transition from the resting state to exploratory activity is accompanied by decreased functional connectivity between most brain areas. Our data suggest that functional connectivity between interhemispheric areas depends on GABAergic transmission, while intrahemispheric functional connectivity is kainate receptor dependent. This approach presents opportunities for merging electrographic and fMRI data on brain functional connectivity in normal and pathological conditions.	[Bragin, Anatol; Almajano, Joel; Kheiri, Farshad; Engel, Jerome, Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Bragin, Anatol; Engel, Jerome, Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bragin, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	abragin@ucla.edu; engel@ucla.edu		Bragin, Anatol/0000-0003-1207-8481	National Institute of Neurological Disorders and Stroke [NS065877, NS33310]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033310, R01NS065877, R37NS033310] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke: NS065877 (A. B) and NS33310 (J.E. Jr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; BUZSAKI G, 1989, J NEUROSCI METH, V28, P209, DOI 10.1016/0165-0270(89)90038-1; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Chu CJ, 2012, J NEUROSCI, V32, P2703, DOI 10.1523/JNEUROSCI.5669-11.2012; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; DAVEY NJ, 1986, J NEUROSCI METH, V17, P153, DOI 10.1016/0165-0270(86)90068-3; De Groof G, 2013, BEHAV BRAIN RES, V239, P43, DOI 10.1016/j.bbr.2012.10.044; ENGEL AK, 1992, TRENDS NEUROSCI, V15, P218, DOI 10.1016/0166-2236(92)90039-B; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; HUBEL DH, 1967, J NEUROPHYSIOL, V30, P1561, DOI 10.1152/jn.1967.30.6.1561; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kalthoff D, 2011, NEUROIMAGE, V54, P2828, DOI 10.1016/j.neuroimage.2010.10.053; Kheiri F, 2013, J NEUROSCI METH, V214, P184, DOI 10.1016/j.jneumeth.2013.01.007; Kim DJ, 2012, HUMAN BRAIN MAPPING; Kiss J, 1996, HIPPOCAMPUS, V6, P239, DOI 10.1002/(SICI)1098-1063(1996)6:3<239::AID-HIPO3>3.0.CO;2-I; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Le Van Quyen M, 2010, J NEUROSCI, V30, P7770, DOI 10.1523/JNEUROSCI.5049-09.2010; Legendre P., 1998, NUMERICAL ECOLOGY, V24; MANLY BFJ, 2007, RANDOMISATION BOOTST; MANTEL N, 1967, CANCER RES, V27, P209; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001	39	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85900	10.1371/journal.pone.0085900	http://dx.doi.org/10.1371/journal.pone.0085900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465774	Green Published, gold			2022-12-25	WOS:000330244500138
J	Musie, E; Moore, CC; Martin, EN; Scheld, WM				Musie, Edgar; Moore, Christopher C.; Martin, Edward N.; Scheld, W. Michael			Toll-Like Receptor 4 Stimulation before or after Streptococcus pneumoniae Induced Sepsis Improves Survival and Is Dependent on T-Cells	PLOS ONE			English	Article							BACTERIAL CLEARANCE; STAPHYLOCOCCUS-AUREUS; CECAL LIGATION; DECREASES INFLAMMATION; ENDOTOXIN TOLERANCE; INNATE IMMUNITY; MICE; MORTALITY; LIPOPOLYSACCHARIDE; EXPRESSION	Introduction: Endotoxin tolerance improves outcomes from gram negative sepsis but the underlying mechanism is not known. We determined if endotoxin tolerance before or after pneumococcal sepsis improved survival and the role of lymphocytes in this protection. Methods: Mice received lipopolysaccharide (LPS) or vehicle before or after a lethal dose of Streptococcus pneumoniae. Survival, quantitative bacteriology, liver function, and cytokine concentrations were measured. We confirmed the necessity of Toll-like receptor 4 (TLR4) for endotoxin tolerance using C3H/HeN (TLR4 replete) and C3H/HeJ (TLR4 deficient) mice. The role of complement was investigated through A/J mice deficient in C5 complement. CBA/CaHN-Btk(xid/)/J mice with dysfunctional B cells and Rag-1 knockout (KO) mice deficient in T and B cells delineated the role of lymphocytes. Results: Endotoxin tolerance improved survival from pneumococcal sepsis in mice with TLR4 that received LPS pretreatment or posttreatment. Survival was associated with reduced bacterial burden and serum cytokine concentrations. Death was associated with abnormal liver function and blood glucose concentrations. Endotoxin tolerance improved survival in A/J and CBA/CaHN-Btk(xid/)/J mice but not Rag-1 KO mice. Conclusions: TLR4 stimulation before or after S. pneumoniae infection improved survival and was dependent on T-cells but did not require an intact complement cascade or functional B cells.	[Musie, Edgar] Univ Venda, Dept Microbiol, Venda, South Africa; [Moore, Christopher C.; Martin, Edward N.; Scheld, W. Michael] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA	University of Venda; University of Virginia	Scheld, WM (corresponding author), Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.	wms@virginia.edu			NIH [1R56 AI064276-01A2, 1K08 AI 0655461-01AI]; University of Virginia Center for Global Health Pfizer Initiative in International Health fellowship award; Pfizer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI064276] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia Center for Global Health Pfizer Initiative in International Health fellowship award; Pfizer(Pfizer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sources of financial support included: NIH 1R56 AI064276-01A2 to WMS, NIH 1K08 AI 0655461-01AI to CCM, and a University of Virginia Center for Global Health Pfizer Initiative in International Health fellowship award to EM. This initiative was conceived to fund global infectious disease research and exchange programmes between post doctoral fellows and students from the University of Virginia and several international partners, to conduct research on global health issues. The major purpose of this program is to foster and enhance bidirectional research training. An independent board at the University of Virginia determines which research proposals are funded. Pfizer provided funds to promote the Initiative but has no role in the planning or execution of research protocols, including the study described in this article. In summary, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Appelbaum PC, 2002, CLIN INFECT DIS, V34, P1613, DOI 10.1086/340400; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chen YG, 2011, J MED MICROBIOL, V60, P995, DOI 10.1099/jmm.0.028647-0; Cook CH, 2002, J INFECT DIS, V185, P1395, DOI 10.1086/340508; Dai J, 2007, J IMMUNOL, V178, P3219, DOI 10.4049/jimmunol.178.5.3219; Dai J, 2009, INT IMMUNOPHARMACOL, V9, P528, DOI 10.1016/j.intimp.2009.01.027; Dremsizov T, 2006, CHEST, V129, P968, DOI 10.1378/chest.129.4.968; Enoh VT, 2007, SHOCK, V27, P507, DOI 10.1097/SHK.0b013e31802b5d9f; Feterowski C, 2001, EUR J IMMUNOL, V31, P1268, DOI 10.1002/1521-4141(200104)31:4<1268::AID-IMMU1268>3.0.CO;2-C; Jung E, 2012, SHOCK, V37, P85, DOI 10.1097/SHK.0b013e3182360faf; Kaufmann A, 2000, EUR J IMMUNOL, V30, P1562, DOI 10.1002/1521-4141(200006)30:6<1562::AID-IMMU1562>3.0.CO;2-Q; Khan AQ, 2002, INFECT IMMUN, V70, P749, DOI 10.1128/IAI.70.2.749-761.2002; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Landoni VI, 2012, CLIN EXP IMMUNOL, V168, P153, DOI 10.1111/j.1365-2249.2012.04560.x; Lehner MD, 2001, INFECT IMMUN, V69, P463, DOI 10.1128/IAI.69.1.463-471.2001; LeMessurier K, 2010, INFECT IMMUN, V78, P5287, DOI 10.1128/IAI.00431-10; Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; MATHISON JC, 1990, J CLIN INVEST, V85, P1108, DOI 10.1172/JCI114542; Matsushita H, 2010, INT IMMUNOL, V22, P739, DOI 10.1093/intimm/dxq062; Melo ES, 2010, IMMUNOBIOLOGY, V215, P435, DOI 10.1016/j.imbio.2009.09.002; MENGOZZI M, 1993, EUR CYTOKINE NETW, V4, P89; Muenzer JT, 2006, SHOCK, V26, P565, DOI 10.1097/01.shk.0000235130.82363.ed; Murphey ED, 2008, CRIT CARE MED, V36, P3067, DOI 10.1097/CCM.0b013e31818c6fb7; Murphey ED, 2008, SHOCK, V29, P512, DOI 10.1097/SHK.0b013e318150776f; Murphey ED, 2007, SHOCK, V27, P289, DOI 10.1097/01.shk.0000245024.93740.28; Murphey ED, 2008, MICROBES INFECT, V10, P1244, DOI 10.1016/j.micinf.2008.07.021; Napoli AM, 2012, SHOCK, V37, P257, DOI 10.1097/SHK.0b013e31823fca44; O'Brien GC, 2005, J IMMUNOL, V174, P1020, DOI 10.4049/jimmunol.174.2.1020; Peck-Palmer OM, 2008, J LEUKOCYTE BIOL, V83, P1009, DOI 10.1189/jlb.0807528; Restrepo AV, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-34; Roger PM, 2012, J CRIT CARE, V27, P384, DOI 10.1016/j.jcrc.2012.04.010; Unsinger J, 2009, J LEUKOCYTE BIOL, V85, P382, DOI 10.1189/jlb.0808491; Yoshimura A, 1999, CURRING EDGE RECOGNI, V2; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	37	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86015	10.1371/journal.pone.0086015	http://dx.doi.org/10.1371/journal.pone.0086015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465843	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500166
J	Zhou, HX; Ge, Y; Sun, LL; Ma, WJ; Wu, J; Zhang, XY; Hu, XH; Eaves, CJ; Wu, DP; Zhao, Y				Zhou, Haixia; Ge, Yue; Sun, Lili; Ma, Wenjuan; Wu, Jie; Zhang, Xiuyan; Hu, Xiaohui; Eaves, Connie J.; Wu, Depei; Zhao, Yun			Growth Arrest Specific 2 Is Up-Regulated in Chronic Myeloid Leukemia Cells and Required for Their Growth	PLOS ONE			English	Article							TYROSINE KINASE FAMILY; BETA-CATENIN; CANCER-THERAPY; STEM-CELLS; MICROFILAMENT REORGANIZATION; GAS2; APOPTOSIS; PROTEIN; EXPRESSION; PTK7	Although the generation of BCR-ABL is the molecular hallmark of chronic myeloid leukemia (CML), the comprehensive molecular mechanisms of the disease remain unclear yet. Growth arrest specific 2 (GAS2) regulates multiple cellular functions including cell cycle, apoptosis and calpain activities. In the present study, we found GAS2 was up-regulated in CML cells including CD34(+) progenitor cells compared to their normal counterparts. We utilized RNAi and the expression of dominant negative form of GAS2 (GAS2DN) to target GAS2, which resulted in calpain activity enhancement and growth inhibition of both K562 and MEG-01 cells. Targeting GAS2 also sensitized K562 cells to Imatinib mesylate (IM). GAS2DN suppressed the tumorigenic ability of MEG-01 cells and impaired the tumour growth as well. Moreover, the CD34(+) cells from CML patients and healthy donors were transduced with control and GAS2DN lentiviral vectors, and the CD34(+) transduced (YFP+) progeny cells (CD34(+)YFP(+)) were plated for colony-forming cell (CFC) assay. The results showed that GAS2DN inhibited the CFC production of CML cells by 5763% (n = 3), while affected those of normal hematopoietic cells by 3161% (n = 2). Next, we found the inhibition of CML cells by GAS2DN was dependent on calpain activity but not the degradation of beta-catenin. Lastly, we generated microarray data to identify the differentially expressed genes upon GAS2DN and validated that the expression of HNRPDL, PTK7 and UCHL5 was suppressed by GAS2DN. These 3 genes were up-regulated in CML cells compared to normal control cells and the growth of K562 cells was inhibited upon HNRPDL silence. Taken together, we have demonstrated that GAS2 is up-regulated in CML cells and the inhibition of GAS2 impairs the growth of CML cells, which indicates GAS2 is a novel regulator of CML cells and a potential therapeutic target of this disease.	[Zhou, Haixia; Hu, Xiaohui; Wu, Depei] Soochow Univ, Key Lab Thrombosis & Hemostasis, Affiliated Hosp 1, Jiangsu Inst Hematol,Minist Hlth, Suzhou, Jiangsu, Peoples R China; [Zhou, Haixia; Ge, Yue; Sun, Lili; Ma, Wenjuan; Wu, Jie; Zhang, Xiuyan; Zhao, Yun] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou, Jiangsu, Peoples R China; [Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	Soochow University - China; Soochow University - China; British Columbia Cancer Agency	Wu, DP (corresponding author), Soochow Univ, Key Lab Thrombosis & Hemostasis, Affiliated Hosp 1, Jiangsu Inst Hematol,Minist Hlth, Suzhou, Jiangsu, Peoples R China.	wudepei@medmail.com.cn; zhaoy@suda.edu.cn	Sun, lili/GQH-2057-2022	Eaves, Connie/0000-0002-3452-1926; , Yun/0000-0002-0065-4675	National Natural Science Foundation of China [31371392]; National Key Scientific Project of China (973 Program) [2011CB933501]; Jiangsu Province's Key Medical Center [ZX201102]; National Public Health Grand Research Foundation [201202017]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific Project of China (973 Program); Jiangsu Province's Key Medical Center; National Public Health Grand Research Foundation; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was funded by National Natural Science Foundation of China (#31371392), National Key Scientific Project of China (973 Program #2011CB933501), Jiangsu Province's Key Medical Center (ZX201102), National Public Health Grand Research Foundation (No. 201202017), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Benetti R, 2005, J BIOL CHEM, V280, P22070, DOI 10.1074/jbc.M501810200; BRANCOLINI C, 1992, J CELL BIOL, V117, P1251, DOI 10.1083/jcb.117.6.1251; BRANCOLINI C, 1995, EMBO J, V14, P5179, DOI 10.1002/j.1460-2075.1995.tb00202.x; BRANCOLINI C, 1994, J CELL BIOL, V124, P743, DOI 10.1083/jcb.124.5.743; Brancolini C, 1997, CELL DEATH DIFFER, V4, P247, DOI 10.1038/sj.cdd.4400232; Chen YJ, 2012, DIGEST DIS SCI, V57, P2310, DOI 10.1007/s10620-012-2181-9; Chen ZW, 2011, CELL BIOCHEM FUNCT, V29, P142, DOI 10.1002/cbf.1734; Coluccia AML, 2007, EMBO J, V26, P1456, DOI 10.1038/sj.emboj.7601485; D'Arcy P, 2012, INT J BIOCHEM CELL B, V44, P1729, DOI 10.1016/j.biocel.2012.07.011; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Daviet L, 2008, BIOCHIMIE, V90, P270, DOI 10.1016/j.biochi.2007.09.013; Diaz-Blanco E, 2007, LEUKEMIA, V21, P494, DOI 10.1038/sj.leu.2404549; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Guglielmelli P, 2007, STEM CELLS, V25, P165, DOI 10.1634/stemcells.2006-0351; Heidel FH, 2012, CELL STEM CELL, V10, P412, DOI 10.1016/j.stem.2012.02.017; Hu Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006257; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Jagani Z, 2009, CANCER RES, V69, P6546, DOI 10.1158/0008-5472.CAN-09-0605; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Janssen JJWM, 2005, LEUKEMIA, V19, P998, DOI 10.1038/sj.leu.2403735; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Lee HK, 2011, BLOOD, V117, P5762, DOI 10.1182/blood-2010-09-306928; MOSSIE K, 1995, ONCOGENE, V11, P2179; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Na HW, 2012, J BIOL CHEM, V287, P25001, DOI 10.1074/jbc.M112.348904; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Peradziryi H, 2012, ARCH BIOCHEM BIOPHYS, V524, P71, DOI 10.1016/j.abb.2011.12.019; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Perrotti D, 1998, EMBO J, V17, P4442, DOI 10.1093/emboj/17.15.4442; Perrotti D, 2007, CLIN CANCER RES, V13, P1638, DOI 10.1158/1078-0432.CCR-06-2320; Petroulakis E, 2009, CANCER CELL, V16, P439, DOI 10.1016/j.ccr.2009.09.025; Prebet T, 2010, BLOOD, V116, P2315, DOI 10.1182/blood-2010-01-262352; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Rolen U, 2006, MOL CARCINOGEN, V45, P260, DOI 10.1002/mc.20177; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sgorbissa A, 1999, J CELL SCI, V112, P4475; Sherbenou DW, 2007, J CLIN INVEST, V117, P2067, DOI 10.1172/JCI31988; Sloma I, 2010, LEUKEMIA, V24, P1823, DOI 10.1038/leu.2010.159; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Tsuchiya N, 1998, J BIOCHEM-TOKYO, V123, P499; Wagner G, 2010, BIOCHEM BIOPH RES CO, V402, P402, DOI 10.1016/j.bbrc.2010.10.044; Wu YY, 2008, CELL BIOCHEM FUNCT, V26, P467, DOI 10.1002/cbf.1468; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024698	47	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86195	10.1371/journal.pone.0086195	http://dx.doi.org/10.1371/journal.pone.0086195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465953	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500200
J	Heigh, RI; Yab, TC; Taylor, WR; Hussain, FTN; Smyrk, TC; Mahoney, DW; Domanico, MJ; Berger, BM; Lidgard, GP; Ahlquist, DA				Heigh, Russell I.; Yab, Tracy C.; Taylor, William R.; Hussain, Fareeda T. N.; Smyrk, Thomas C.; Mahoney, Douglas W.; Domanico, Michael J.; Berger, Barry M.; Lidgard, Graham P.; Ahlquist, David A.			Detection of Colorectal Serrated Polyps by Stool DNA Testing: Comparison with Fecal Immunochemical Testing for Occult Blood (FIT)	PLOS ONE			English	Article							HIGH DETECTION RATES; SCREEN-DETECTION; AVERAGE-RISK; CANCER; COLONOSCOPY; POPULATION; NEOPLASIA; ADENOMAS; PREVALENCE; CARCINOMA	Objectives: Precursors to 1/3 of colorectal cancer (CRC), serrated polyps have been under-detected by screening due to their inconspicuous, non-hemorrhagic, and proximal nature. A new multi-target stool DNA test (multi-target sDNA) shows high sensitivity for both CRC and advanced adenomas. Screen detection of serrated polyps by this approach requires further validation. We sought to assess and compare noninvasive detection of sessile serrated polyps (SSP) >= 1 cm by sDNA and an occult blood fecal immunochemical test (FIT). Methods: In a blinded prospective study, a single stool sample used for both tests was collected from 456 asymptomatic adults prior to screening or surveillance colonoscopy (criterion standard). All 29 patients with SSP >= 1 cm were included as cases and all 232 with no neoplastic findings as controls. Buffered stool samples were processed and frozen on receipt; Exact Sciences performed sDNA in batches using optimized analytical methods. The sDNA multi-marker panel targets methylated BMP3 (mBMP3) and NDRG4, mutant KRAS, beta-actin, and hemoglobin. FIT (Polymedco OC-FIT Check) was performed in separate lab <= 2 days post defecation and evaluated at cutoffs of 50 (FIT-50) and 100 ng/ml (FIT-100). Results: Median ages: cases 61 (range 57-77), controls 62 (52-70), p = NS. Women comprised 59% and 51%, p = NS, respectively. SSP median size was 1.2 cm (1-3 cm), 93% were proximal, and 64% had synchronous diminutive polyps. Among multi-target sDNA markers, mBMP3 proved highly discriminant for detection of SSP >= 1 cm (AUC = 0.87, p<0.00001); other DNA markers provided no incremental sensitivity. Hemoglobin alone showed no discrimination (AUC = 0.50, p = NS). At matched specificities, detection of SSP >= 1 cm by stool mBMP3 was significantly greater than by FIT-50 (66% vs 10%, p = 0.0003) or FIT-100 (63% vs 0%, p<0.0001). Conclusions: In a screening and surveillance setting, SSP >= 1 cm can be detected noninvasively by stool assay of exfoliated DNA markers, especially mBMP3. FIT appears to have no value in SSP detection.	[Heigh, Russell I.] Mayo Clin, Div Gastroenterol, Scottsdale, AZ 85259 USA; [Yab, Tracy C.; Taylor, William R.; Ahlquist, David A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Hussain, Fareeda T. N.] Mayo Clin & Mayo Fdn, Mayo Med Sch, Rochester, MN 55905 USA; [Smyrk, Thomas C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Mahoney, Douglas W.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA; [Domanico, Michael J.; Berger, Barry M.; Lidgard, Graham P.] Exact Sci Corp, Madison, WI USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Heigh, RI (corresponding author), Mayo Clin, Div Gastroenterol, Scottsdale, AZ 85259 USA.	heigh.russell@mayo.edu			Charles Oswald Foundation; Helen Vandendriesche; Exact Sciences Corporation; NATIONAL CANCER INSTITUTE [P30CA015083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	Charles Oswald Foundation; Helen Vandendriesche; Exact Sciences Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by grants from the Charles Oswald Foundation, Helen Vandendriesche, and Exact Sciences Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist D ZH, 2010, AACR M PHIL PA; Ahlquist DA, 2008, ANN INTERN MED, V149, P441, DOI 10.7326/0003-4819-149-7-200810070-00004; Ahlquist DA, 2012, CLIN GASTROENTEROL H, V10, P272, DOI 10.1016/j.cgh.2011.10.008; Ahlquist DA, 2012, GASTROENTEROLOGY, V142, P248, DOI 10.1053/j.gastro.2011.10.031; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Berger BM, 2012, PATHOLOGY, V44, P80, DOI 10.1097/PAT.0b013e3283502fdf; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gupta AK, 2005, CLIN GASTROENTEROL H, V3, P150, DOI 10.1016/S1542-3565(04)00664-0; Hussain FT, 2010, DDW; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Itzkowitz SH, 2007, CLIN GASTROENTEROL H, V5, P111, DOI 10.1016/j.cgh.2006.10.006; Jass JR, 2001, J PATHOL, V193, P283, DOI 10.1002/1096-9896(200103)193:3<283::AID-PATH799>3.0.CO;2-9; Jass JR, 2005, NAT CLIN PRACT ONCOL, V2, P398, DOI 10.1038/ncponc0248; Kahi CJ, 2011, CLIN GASTROENTEROL H, V9, P42, DOI 10.1016/j.cgh.2010.09.013; Lash RH, 2010, J CLIN PATHOL, V63, P681, DOI 10.1136/jcp.2010.075507; Lazarus R, 2005, AM J CLIN PATHOL, V123, P349, DOI 10.1309/VBAGV3BR96N2EQTR; Lidgard GP DM, 2012, AACR FRONTIERS CANC; Lidgard GP DM, 2012, GASTROENTEROLOGY, V142, pS1; Makinen MJ, 2001, J PATHOL, V193, P286, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH800>3.0.CO;2-2; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Noffsinger AE, 2009, ANNU REV PATHOL-MECH, V4, P343, DOI 10.1146/annurev.pathol.4.110807.092317; Oka S, 2004, GASTROINTEST ENDOSC, V59, P213, DOI 10.1016/S0016-5107(03)02693-2; Park DI, 2010, AM J GASTROENTEROL, V105, P2017, DOI 10.1038/ajg.2010.179; Park SJ, 2003, AM J PATHOL, V162, P815, DOI 10.1016/S0002-9440(10)63878-3; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Sheridan TB, 2006, AM J CLIN PATHOL, V126, P564, DOI 10.1309/C7JE88VL8420V5VT; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Snover DC, 2005, AM J CLIN PATHOL, V124, P380, DOI 10.1309/V2EPTPLJRB3FGHJL; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou HZ, 2009, GASTROENTEROLOGY, V136, P459, DOI 10.1053/j.gastro.2008.10.023	37	52	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85659	10.1371/journal.pone.0085659	http://dx.doi.org/10.1371/journal.pone.0085659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465639	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500066
J	Hoekman, P; Ide, G; Kassoumou, AS; Hayatou, MM				Hoekman, Patrick; Ide, Garba; Kassoumou, Akambi Sanoussi; Hayatou, Mahamadou Malam			Hip Arthrodesis with the Anterolateral Plate: An Innovating Technique for an Orphaned Procedure	PLOS ONE			English	Article							FOLLOW-UP; FUSION; TUBERCULOSIS; OSTEOTOMY; ARTHROPLASTY; REPLACEMENT; JOINT	Background: In developing countries hip osteoarthritis constitutes a major public health issue as it is highly prevalent in all age ranges of population, including the young. It often remains untreated because of the low accessibility of total hip prostheses. Hip arthrodesis still represents a major treatment option, but, for several reasons which are discussed in this paper, is nowadays infrequently performed. By means of reporting the results of a new simple technique, using a self-devised plate, the relevancy of hip arthrodesis in this particular environment is emphasized. Methods and Findings: Our series included 35 patients with painful hip osteoarthritis who underwent a hip fusion with the anterolateral arthrodesis plate. Two of them had a concurrent femoral osteotomy for correction of a vicious position of the limb and another patient had a femoral diaphysis osteotomy and placement of a Wagner elongating device in order to proceed with a limb lengthening by callotasis. The follow-up period averaged 16,9 months ( 9 to 34). All hips, except two, achieved solid fusion between 6 and 15 months after surgery. One failure of fusion was in the oldest patient, who presented a loosening of plate and screws due to an advanced degree of osteoporosis; the other was in a young patient who admitted having walked on his leg too soon. Patient satisfaction was high. We concluded that this technique is reliable and effective. Conclusions: The results of this study should convince the hesitant surgeon and patient to consider hip arthrodesis an acceptable treatment option for disabling hip arthritis, compared to no treatment at all.	[Hoekman, Patrick; Ide, Garba; Kassoumou, Akambi Sanoussi; Hayatou, Mahamadou Malam] Natl Hosp Niamey, Dept Orthopaed Surg, Niamey, Niger		Hoekman, P (corresponding author), Natl Hosp Niamey, Dept Orthopaed Surg, Niamey, Niger.	patrick_hoekman@yahoo.fr						ABBOTT LC, 1954, J BONE JOINT SURG AM, V36-A, P1129, DOI 10.2106/00004623-195436060-00002; APLEY AG, 1955, J BONE JOINT SURG BR, V37, P185, DOI 10.1302/0301-620X.37B2.185; AXER A, 1961, J BONE JOINT SURG AM, V43, P492, DOI 10.2106/00004623-196143040-00004; Banskota AK, 2009, INDIAN J ORTHOP, V43, P383, DOI 10.4103/0019-5413.55977; BARMADA R, 1976, J BONE JOINT SURG AM, V58, P541, DOI 10.2106/00004623-197658040-00018; Beaule Paul E, 2002, J Am Acad Orthop Surg, V10, P249; Benaroch TE, 1996, J PEDIATR ORTHOPED, V16, P30, DOI 10.1097/01241398-199601000-00007; BREWSTER RC, 1975, J BONE JOINT SURG AM, VA 57, P27, DOI 10.2106/00004623-197557010-00005; BRITTAIN HA, 1948, J BONE JOINT SURG BR, V30, P642, DOI 10.1302/0301-620X.30B4.642; CALLAGHAN JJ, 1985, J BONE JOINT SURG AM, V67A, P1328, DOI 10.2106/00004623-198567090-00004; CHAN KP, 1968, J BONE JOINT SURG AM, VA 50, P1341, DOI 10.2106/00004623-196850070-00004; CHOLMELEY JA, 1956, J BONE JOINT SURG BR, V38, P342, DOI 10.1302/0301-620X.38B1.342; Clohisy JC, 2008, J BONE JOINT SURG AM, V90A, P2267, DOI 10.2106/JBJS.G.01267; Clohisy JC, 2010, CLIN ORTHOP RELAT R, V468, P3207, DOI 10.1007/s11999-010-1468-4; DAUBIGNE RM, 1954, J BONE JOINT SURG AM, V36-A, P451, DOI 10.2106/00004623-195436030-00001; DOBSON J, 1948, J BONE JOINT SURG BR, V30, P95, DOI 10.1302/0301-620X.30B1.95; Dormans JP, 2002, J BONE JOINT SURG AM, V84A, P1086, DOI 10.2106/00004623-200206000-00039; Dudkiewicz I, 2003, ISR MED ASSOC J, V5, P709; Emms NW, 2010, J BONE JOINT SURG BR, V92B, P856, DOI 10.1302/0301-620X.92B6.23666; Fernandez-Fairen M, 2011, CLIN ORTHOP RELAT R, V469, P1971, DOI 10.1007/s11999-010-1704-y; FOLEY WB, 1949, J BONE JOINT SURG BR, V31, P222, DOI 10.1302/0301-620X.31B2.222; HAHN D, 1963, J BONE JOINT SURG BR, V45, P477, DOI 10.1302/0301-620X.45B3.477; HARDINGE K, 1986, CLIN ORTHOP RELAT R, P173; Karol LA, 2000, J BONE JOINT SURG AM, V82A, P561, DOI 10.2106/00004623-200004000-00011; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; LIPSCOMB PR, 1961, J BONE JOINT SURG AM, V43, P923, DOI 10.2106/00004623-196143070-00001; Lubega N, 2009, J BONE JOINT SURG BR, V91B, P341, DOI 10.1302/0301-620X.91B3.21706; Matta JM, 1997, CLIN ORTHOP RELAT R, P129; MURRELL GAC, 1994, CLIN ORTHOP RELAT R, P147; NIEBAUER JJ, 1946, J BONE JOINT SURG, V28, P103; Panagiotopoulos K P, 2001, Instr Course Lect, V50, P297; Peterson ED, 2009, CLIN ORTHOP RELAT R, V467, P2880, DOI 10.1007/s11999-009-1027-z; PRICE CT, 1980, J BONE JOINT SURG AM, V62, P1118, DOI 10.2106/00004623-198062070-00008; Roberts C S, 1990, J Arthroplasty, V5, P89, DOI 10.1016/S0883-5403(06)80015-X; Schafroth MU, 2010, INT ORTHOP, V34, P805, DOI 10.1007/s00264-009-0860-8; SCHNEIDER R, 1974, RECONS SURG, V14, P1; Schuh A, 2005, ORTHOPADE, V34, P218, DOI 10.1007/s00132-004-0723-3; Sidhu AS, 2009, J BONE JOINT SURG BR, V91B, P1301, DOI 10.1302/0301-620X.91B10.22541; SOFUE M, 1989, INT ORTHOP, V13, P129; SPONSELLER PD, 1984, J BONE JOINT SURG AM, V66A, P853, DOI 10.2106/00004623-198466060-00005; STINCHFIELD FE, 1950, J BONE JOINT SURG AM, V32-A, P48, DOI 10.2106/00004623-195032010-00004; Stover MD, 2004, CLIN ORTHOP RELAT R, P126; THOMPSON FR, 1956, J BONE JOINT SURG AM, V38, P13, DOI 10.2106/00004623-195638010-00002; Wager M, 1996, ORTHOPADE, V25, P129; WATSONJONES R, 1956, J BONE JOINT SURG BR, V38, P353, DOI 10.1302/0301-620X.38B1.353; Watts HG, 1996, J BONE JOINT SURG AM, V78A, P288, DOI 10.2106/00004623-199602000-00019; Wong K, 2008, J BONE JOINT SURG BR, V90B, P510, DOI 10.1302/0301-620X.90B4.20120; Wong T. C., 2004, SMJ Singapore Medical Journal, V45, P85	48	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85868	10.1371/journal.pone.0085868	http://dx.doi.org/10.1371/journal.pone.0085868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465757	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500083
J	Yamaguchi, K; Yamaguchi, R; Takahashi, N; Ikenoue, T; Fujii, T; Shinozaki, M; Tsurita, G; Hata, K; Niida, A; Imoto, S; Miyano, S; Nakamura, Y; Furukawa, Y				Yamaguchi, Kiyoshi; Yamaguchi, Rui; Takahashi, Norihiko; Ikenoue, Tsuneo; Fujii, Tomoaki; Shinozaki, Masaru; Tsurita, Giichiro; Hata, Keisuke; Niida, Atsushi; Imoto, Seiya; Miyano, Satoru; Nakamura, Yusuke; Furukawa, Yoichi			Overexpression of Cohesion Establishment Factor DSCC1 through E2F in Colorectal Cancer	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; APOPTOSIS RESISTANCE; GENETIC-ANALYSIS; TRANSCRIPTION; EXPRESSION; FAMILY; SURVIVAL; SUGGESTS; DISTINCT; TARGET	Ctf18-replication factor C complex including Dscc1 (DNA replication and sister chromatid cohesion 1) is implicated in sister chromatid cohesion, DNA replication, and genome stability in S. cerevisiae and C. elegans. We previously performed gene expression profiling in primary colorectal cancer cells in order to identify novel molecular targets for the treatment of colorectal cancer. A feature of the cancer-associated transcriptional signature revealed from this effort is the elevated expression of the proto-oncogene DSCC1. Here, we have interrogated the molecular basis for deviant expression of human DSCC1 in colorectal cancer and its ability to promote survival of cancer cells. Quantitative PCR and immunohistochemical analyses corroborated that the expression level of DSCC1 is elevated in 60-70% of colorectal tumors compared to their matched noncancerous colonic mucosa. An in silico evaluation of the presumptive DSCC1 promoter region for consensus DNA transcriptional regulatory elements revealed a potential role for the E2F family of DNA-binding proteins in controlling DSCC1 expression. RNAi-mediated reduction of E2F1 reduced expression of DSCC1 in colorectal cancer cells. Gain- and loss-of-function experiments demonstrated that DSCC1 is involved in the viability of cancer cells in response to genotoxic stimuli. We reveal that E2F-dependent expression of DSCC1 confers anti-apoptotic properties in colorectal cancer cells, and that its suppression may be a useful option for the treatment of colorectal cancer.	[Yamaguchi, Kiyoshi; Takahashi, Norihiko; Ikenoue, Tsuneo; Fujii, Tomoaki; Furukawa, Yoichi] Univ Tokyo, Inst Med Sci, Div Clin Genome Res, Adv Clin Res Ctr, Tokyo, Japan; [Yamaguchi, Rui; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan; [Shinozaki, Masaru; Tsurita, Giichiro; Hata, Keisuke] Univ Tokyo, Inst Med Sci, Dept Surg, Res Hosp, Tokyo, Japan; [Niida, Atsushi; Imoto, Seiya; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Lab DNA Informat Anal, Ctr Human Genome, Tokyo, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Yamaguchi, K (corresponding author), Univ Tokyo, Inst Med Sci, Div Clin Genome Res, Adv Clin Res Ctr, Tokyo, Japan.	kiyamagu@ims.u-tokyo.ac.jp		Hata, Keisuke/0000-0003-4064-8701; Miyano, Satoru/0000-0002-1753-6616	MEXT/JSPS, Japan [23790126]; Global COE Program "Center of education and research for the advanced genome-based medicine for personalized medicine and the control of worldwide infectious diseases'', MEXT/Japan Society for the Promotion of Science, Japan	MEXT/JSPS, Japan; Global COE Program "Center of education and research for the advanced genome-based medicine for personalized medicine and the control of worldwide infectious diseases'', MEXT/Japan Society for the Promotion of Science, Japan	This work was supported in part by Grant-in-Aid for Young Scientists (#23790126), MEXT/JSPS, Japan to K. Yamaguchi, and Global COE Program "Center of education and research for the advanced genome-based medicine for personalized medicine and the control of worldwide infectious diseases'', MEXT/Japan Society for the Promotion of Science, Japan to Y. Furukawa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee D, 2000, CANCER RES, V60, P2365; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; DeGregori J, 2006, CURR MOL MED, V6, P739; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Game JC, 2005, GENETICS, V169, P51, DOI 10.1534/genetics.104.028613; Gellon L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001298; Hirano G, 2010, MOL CANCER RES, V8, P864, DOI 10.1158/1541-7786.MCR-09-0458; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Lin YM, 2002, ONCOGENE, V21, P4120, DOI 10.1038/sj.onc.1205518; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; McLellan J, 2009, MOL BIOL CELL, V20, P5306, DOI 10.1091/mbc.E09-08-0699; Meijer GA, 1998, J CLIN PATHOL, V51, P901, DOI 10.1136/jcp.51.12.901; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Redon C, 2006, GENETICS, V172, P67, DOI 10.1534/genetics.105.046128; Shimokawa T, 2003, CANCER RES, V63, P6116; Suzuki T, 1999, INT J CANCER, V81, P535, DOI 10.1002/(SICI)1097-0215(19990517)81:4<535::AID-IJC5>3.0.CO;2-4; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587; Wikonkal NM, 2003, NAT CELL BIOL, V5, P655, DOI 10.1038/ncb1001; Wong JV, 2011, CELL CYCLE, V10; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yamaguchi K, 2010, BRIT J CANCER, V102, P325, DOI 10.1038/sj.bjc.6605500; Zacharatos P, 2004, J PATHOL, V203, P744, DOI 10.1002/path.1582; Zheng CG, 2009, CANCER RES, V69, P2324, DOI 10.1158/0008-5472.CAN-08-4113; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666	32	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85750	10.1371/journal.pone.0085750	http://dx.doi.org/10.1371/journal.pone.0085750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465681	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000059
J	Kulkarni, V; Valentin, A; Rosati, M; Alicea, C; Singh, AK; Jalah, R; Broderick, KE; Sardesai, NY; Le Gall, S; Mothe, B; Brander, C; Rolland, M; Mullins, JI; Pavlakis, GN; Felber, BK				Kulkarni, Viraj; Valentin, Antonio; Rosati, Margherita; Alicea, Candido; Singh, Ashish K.; Jalah, Rashmi; Broderick, Kate E.; Sardesai, Niranjan Y.; Le Gall, Sylvie; Mothe, Beatriz; Brander, Christian; Rolland, Morgane; Mullins, James I.; Pavlakis, George N.; Felber, Barbara K.			Altered Response Hierarchy and Increased T-Cell Breadth upon HIV-1 Conserved Element DNA Vaccination in Macaques	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE-RESPONSES; LYMPHOCYTE RESPONSES; RHESUS MACAQUES; VACCINES; REGIONS; EPITOPES; IMMUNIZATION; COVERAGE; VIREMIA	HIV sequence diversity and potential decoy epitopes are hurdles in the development of an effective AIDS vaccine. A DNA vaccine candidate comprising of highly conserved p24(gag) elements (CE) induced robust immunity in all 10 vaccinated macaques, whereas full-length gag DNA vaccination elicited responses to these conserved elements in only 5 of 11 animals, targeting fewer CE per animal. Importantly, boosting CE-primed macaques with DNA expressing full-length p55(gag) increased both magnitude of CE responses and breadth of Gag immunity, demonstrating alteration of the hierarchy of epitope recognition in the presence of pre-existing CE-specific responses. Inclusion of a conserved element immunogen provides a novel and effective strategy to broaden responses against highly diverse pathogens by avoiding decoy epitopes, while focusing responses to critical viral elements for which few escape pathways exist.	[Kulkarni, Viraj; Alicea, Candido; Jalah, Rashmi; Felber, Barbara K.] NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA; [Valentin, Antonio; Rosati, Margherita; Singh, Ashish K.; Pavlakis, George N.] NCI, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA; [Broderick, Kate E.; Sardesai, Niranjan Y.] Inovio Pharmaceut Inc, Blue Bell, PA USA; [Le Gall, Sylvie] Ragon Inst MGH MIT & Harvard, Boston, MA USA; [Mothe, Beatriz; Brander, Christian] Autonomous Univ Barcelona, IrsiCaixa AIDS Res Inst HIVACAT, Barcelona, Spain; [Brander, Christian] ICREA, Barcelona, Spain; [Rolland, Morgane; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Dept Med, Seattle, WA USA; [Mullins, James I.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Autonomous University of Barcelona; Institut de Recerca de la Sida - IrsiCaixa; ICREA; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pavlakis, GN (corresponding author), NCI, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA.	pavlakig@mail.nih.gov; felberb@mail.nih.gov		Brander, Christian/0000-0002-0548-5778; Sardesai, Niranjan/0000-0001-6920-1167; Mothe, Beatriz/0000-0001-9975-407X; Le Gall, Sylvie/0000-0003-0385-926X	Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH); Bill and Melinda Gates Foundation [A39748]; University of Washington Centers for AIDS Research Computational Biology Core [NIH P30 AI27757]; Red de Investigacion de Sida (RIS) [RD06/04]; Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Spanish FIPSE [36-0737-09]; NATIONAL CANCER INSTITUTE [ZIABC010350, ZIABC010749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, P30AI027757] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); University of Washington Centers for AIDS Research Computational Biology Core; Red de Investigacion de Sida (RIS); Instituto de Salud Carlos III (ISCIII), Madrid, Spain(Instituto de Salud Carlos III); Spanish FIPSE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	This work was funded in part by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH), the Bill and Melinda Gates Foundation (A39748) and the University of Washington Centers for AIDS Research Computational Biology Core (NIH P30 AI27757), and was supported in part by the Red de Investigacion de Sida (RIS) (RD06/04), Instituto de Salud Carlos III (ISCIII), Madrid, Spain and the Spanish FIPSE 36-0737-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045267; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; Bockl K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034723; Dahirel V, 2011, P NATL ACAD SCI USA, V108, P11530, DOI 10.1073/pnas.1105315108; De Groot AS, 2008, VACCINE, V26, P3059, DOI 10.1016/j.vaccine.2007.12.004; Doria-Rose NA, 2005, J VIROL, V79, P11214, DOI 10.1128/JVI.79.17.11214-11224.2005; Ferrari G, 2004, J IMMUNOL, V173, P2126, DOI 10.4049/jimmunol.173.3.2126; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fischer W, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040015; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Friedrich D, 2011, JAIDS-J ACQ IMM DEF, V58, P248, DOI 10.1097/QAI.0b013e318228f992; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Hertz T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003404; Hirao LA, 2008, VACCINE, V26, P3112, DOI 10.1016/j.vaccine.2008.02.036; Hovav AH, 2009, J VIROL, V83, P10941, DOI 10.1128/JVI.00394-09; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Jalah R, 2013, J BIOL CHEM, V288, P6763, DOI 10.1074/jbc.M112.436675; Kaufman DR, 2012, VACCINE, V30, P506, DOI 10.1016/j.vaccine.2011.11.079; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kulkarni V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060245; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Li FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020479; Lichterfeld M, 2005, TRENDS IMMUNOL, V26, P166, DOI 10.1016/j.it.2005.01.003; Liu JY, 2006, J VIROL, V80, P11991, DOI 10.1128/JVI.01348-06; Liu Y, 2009, J INFECT DIS, V200, P1825, DOI 10.1086/648401; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Maurer K, 2008, JAIDS-J ACQ IMM DEF, V48, P133, DOI 10.1097/QAI.0b013e31816fdc4a; Morozov VA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-67; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; Mothe B, 2009, DIS MARKERS, V27, P105, DOI [10.1155/2009/360362, 10.3233/DMA-2009-0655]; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Mullins James I, 2004, Expert Rev Vaccines, V3, pS151, DOI 10.1586/14760584.3.4.S151; Nickle DC, 2007, PLOS COMPUT BIOL, V3, P754, DOI 10.1371/journal.pcbi.0030075; Nickle DC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040025; Nickle DC, 2003, SCIENCE, V299, P1515; Niu LG, 2011, VACCINE, V29, P2110, DOI 10.1016/j.vaccine.2010.12.131; Pal R, 2006, VIROLOGY, V348, P341, DOI 10.1016/j.virol.2005.12.029; Patel V, 2013, P NATL ACAD SCI USA, V110, P2975, DOI 10.1073/pnas.1215393110; Patel V, 2010, VACCINE, V28, P4827, DOI 10.1016/j.vaccine.2010.04.064; Rao SS, 2006, VACCINE, V24, P367, DOI 10.1016/j.vaccine.2005.07.072; Ribeiro SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011072; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2007, J VIROL, V81, P8507, DOI 10.1128/JVI.02683-06; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rosa DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016921; Rosario M, 2012, AIDS, V26, P275, DOI 10.1097/QAD.0b013e32834ed9b2; Rosario M, 2010, EUR J IMMUNOL, V40, P1973, DOI 10.1002/eji.201040344; Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005; Rosati M, 2008, VACCINE, V26, P5223, DOI 10.1016/j.vaccine.2008.03.090; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Schneidewind A, 2009, J VIROL, V83, P3993, DOI 10.1128/JVI.01108-08; Stephenson KE, 2012, J VIROL, V86, P11434, DOI 10.1128/JVI.01779-12; Toapanta FR, 2007, CURR HIV RES, V5, P199, DOI 10.2174/157016207780077057; Valentin A, 2009, VACCINE, V27, P4840, DOI 10.1016/j.vaccine.2009.05.093; Valkenburg SA, 2013, P NATL ACAD SCI USA, V110, P5570, DOI 10.1073/pnas.1302935110; Vojnov L, 2011, VACCINE, V29, P7483, DOI 10.1016/j.vaccine.2011.07.048; von Gegerfelt A, 2010, J IMMUNOL, V185, P3348, DOI 10.4049/jimmunol.1000572; Wilson CC, 2003, J IMMUNOL, V171, P5611, DOI 10.4049/jimmunol.171.10.5611; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	62	45	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86254	10.1371/journal.pone.0086254	http://dx.doi.org/10.1371/journal.pone.0086254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465991	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000074
J	Kumar, A; Congiu, L; Lindstrom, L; Piiroinen, S; Vidotto, M; Grapputo, A				Kumar, Abhishek; Congiu, Leonardo; Lindstrom, Leena; Piiroinen, Saija; Vidotto, Michele; Grapputo, Alessandro			Sequencing, De Novo Assembly and Annotation of the Colorado Potato Beetle, Leptinotarsa decemlineata, Transcriptome	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS CRY3AA; GLUTATHIONE-S-TRANSFERASE; INSECTICIDE RESISTANCE; GENE-EXPRESSION; TETRATRICOPEPTIDE REPEAT; GENOMIC ORGANIZATION; MAINTENANCE PHASES; TOXIN-BINDING; SNP DETECTION; GAG PROTEINS	Background: The Colorado potato beetle (Leptinotarsa decemlineata) is a major pest and a serious threat to potato cultivation throughout the northern hemisphere. Despite its high importance for invasion biology, phenology and pest management, little is known about L. decemlineata from a genomic perspective. We subjected European L. decemlineata adult and larval transcriptome samples to 454-FLX massively-parallel DNA sequencing to characterize a basal set of genes from this species. We created a combined assembly of the adult and larval datasets including the publicly available midgut larval Roche 454 reads and provided basic annotation. We were particularly interested in diapause-specific genes and genes involved in pesticide and Bacillus thuringiensis (Bt) resistance. Results: Using 454-FLX pyrosequencing, we obtained a total of 898,048 reads which, together with the publicly available 804,056 midgut larval reads, were assembled into 121,912 contigs. We established a repository of genes of interest, with 101 out of the 108 diapause-specific genes described in Drosophila montana; and 621 contigs involved in insecticide resistance, including 221 CYP450, 45 GSTs, 13 catalases, 15 superoxide dismutases, 22 glutathione peroxidases, 194 esterases, 3 ADAM metalloproteases, 10 cadherins and 98 calmodulins. We found 460 putative miRNAs and we predicted a significant number of single nucleotide polymorphisms (29,205) and microsatellite loci (17,284). Conclusions: This report of the assembly and annotation of the transcriptome of L. decemlineata offers new insights into diapause-associated and insecticide-resistance-associated genes in this species and provides a foundation for comparative studies with other species of insects. The data will also open new avenues for researchers using L. decemlineata as a model species, and for pest management research. Our results provide the basis for performing future gene expression and functional analysis in L. decemlineata and improve our understanding of the biology of this invasive species at the molecular level.	[Kumar, Abhishek; Congiu, Leonardo; Vidotto, Michele; Grapputo, Alessandro] Univ Padua, Dept Biol, Padua, Italy; [Kumar, Abhishek] Univ Kiel, Inst Bot, Dept Genet & Mol Biol Bot, Kiel, Germany; [Lindstrom, Leena; Piiroinen, Saija] Univ Jyvaskyla, Ctr Excellence Biol Interact Res, Dept Biol & Environm Sci, Jyvaskyla, Finland	University of Padua; University of Kiel; University of Jyvaskyla	Grapputo, A (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	alessandro.grapputo@unipd.it	Congiu, Leonardo/G-7967-2011; Lindstrom, Leena/B-2326-2012; Grapputo, Alessandro/AAR-1252-2020; Kumar, Abhishek/A-8727-2012	Lindstrom, Leena/0000-0002-6452-4538; Grapputo, Alessandro/0000-0001-9255-4294; Kumar, Abhishek/0000-0003-4172-4059; CONGIU, LEONARDO/0000-0002-9293-9837	University of Padova (Progetto di Ateneo) [CPDA084531/08]; Academy of Finland [118456, 131406]	University of Padova (Progetto di Ateneo); Academy of Finland(Academy of Finland)	The research was funded by the University of Padova (Progetto di Ateneo 2008: CPDA084531/08) to AG and by the Academy of Finland (projects 118456 and 131406) to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alyokhin A., 2009, FRUIT VEG CEREAL SCI, V3, P10; Alyokhin A, 2013, INSECT PESTS OF POTATO: GLOBAL PERSPECTIVES ON BIOLOGY AND MANAGEMENT, P543, DOI 10.1016/B978-0-12-386895-4.00019-3; Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Baker MB, 2008, AGR FOREST ENTOMOL, V10, P181, DOI 10.1111/j.1461-9563.2008.00370.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009; Board PG, 1997, BIOCHEM J, V328, P929; Boivin T, 2004, BIOL J LINN SOC, V83, P341, DOI 10.1111/j.1095-8312.2004.00392.x; Boman S, 2008, BIOL INVASIONS, V10, P1135, DOI 10.1007/s10530-007-9191-0; CARRIERE Y, 1995, ECOLOGY, V76, P1497, DOI 10.2307/1938151; Casagrande R. A., 1987, Bulletin of the Entomological Society of America, V33, P142; Che-Mendoza A, 2009, AFR J BIOTECHNOL, V8, P1386; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Choi JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-703; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; de Wilde J, 1981, ADV POTATO PEST MANA; DEKORT CAD, 1990, ENTOMOL EXP APPL, V56, P1, DOI 10.1007/BF00579610; Denlinger David L., 2008, Entomological Research, V38, P1, DOI 10.1111/j.1748-5967.2008.00139.x; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; EPPO, 2003, DISTR MAPS QUAR PEST; Evans JD, 2013, J HERED, V104, P595, DOI 10.1093/jhered/est050; Fabrick J, 2009, J BIOL CHEM, V284, P18401, DOI 10.1074/jbc.M109.001651; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Forgash AG, 1985, P S COL POT BEETL 17, P256; Friedman R, 2011, MOL PHYLOGENET EVOL, V61, P924, DOI 10.1016/j.ympev.2011.08.027; Gauthier NL, 1981, ADV POTATO PEST MANA; Goodson HV, 2002, J CELL SCI, V115, P2619; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; Grewal PS, 2001, PEST MANAG SCI, V57, P852, DOI 10.1002/ps.373; HARE JD, 1990, ANNU REV ENTOMOL, V35, P81, DOI 10.1146/annurev.en.35.010190.000501; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; IOANNIDIS PM, 1991, J ECON ENTOMOL, V84, P1417, DOI 10.1093/jee/84.5.1417; Kankare Maaria, 2010, BMC Ecology, V10, P3, DOI 10.1186/1472-6785-10-3; Klug A, 1999, J MOL BIOL, V293, P215, DOI 10.1006/jmbi.1999.3007; Knudsen T, 2013, CLC GENOMICS BENCHWO, V6; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruger O, 2002, GENE, V293, P97, DOI 10.1016/S0378-1119(02)00697-2; Kumar A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-250; Liu ZY, 2004, DEV BIOL, V269, P36, DOI 10.1016/j.ydbio.2004.01.012; Loseva O, 2002, INSECT BIOCHEM MOLEC, V32, P567, DOI 10.1016/S0965-1748(01)00137-0; Marden JH, 2008, J EXP BIOL, V211, P3653, DOI 10.1242/jeb.023903; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Noronha C, 2006, ENVIRON ENTOMOL, V35, P590, DOI 10.1603/0046-225X-35.3.590; Ochoa-Campuzano C, 2007, BIOCHEM BIOPH RES CO, V362, P437, DOI 10.1016/j.bbrc.2007.07.197; Ochoa-Campuzano C, 2012, ARCH INSECT BIOCHEM, V81, P53, DOI 10.1002/arch.21044; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Park Y, 2009, APPL ENVIRON MICROB, V75, P3086, DOI 10.1128/AEM.00268-09; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Petek M, 2012, ARCH INSECT BIOCHEM, V79, P153, DOI 10.1002/arch.21017; RAHARDJA U, 1995, J ECON ENTOMOL, V88, P21, DOI 10.1093/jee/88.1.21; Rashkova S, 2002, P NATL ACAD SCI USA, V99, P3621, DOI 10.1073/pnas.032071999; Rashkova S, 2002, J CELL BIOL, V159, P397, DOI 10.1083/jcb.200205039; Reichhart JM, 2005, TRENDS CELL BIOL, V15, P659, DOI 10.1016/j.tcb.2005.10.001; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sayed A, 2010, INSECT MOL BIOL, V19, P381, DOI 10.1111/j.1365-2583.2010.00998.x; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Smith IM, 1998, DISTRIBUTION MAPS QU; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Tauber M.J., 1986, SEASONAL ADAPTATIONS; TAUBER MJ, 1973, NATURE, V244, P296, DOI 10.1038/244296a0; TAUBER MJ, 1988, ANN ENTOMOL SOC AM, V81, P748, DOI 10.1093/aesa/81.5.748; THURSTON MI, 2005, MSATFINDER DETECTION; Tower W.L., 1906, INVESTIGATION EVOLUT, V2, P13; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Weber D., 2003, Pesticide Outlook, V14, P256, DOI 10.1039/b314847p; Weber DC, 1994, ADV POTATO PEST BIOL, P256; WHALON ME, 1993, J ECON ENTOMOL, V86, P226, DOI 10.1093/jee/86.2.226; Yan LZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-609; Yocum GD, 2009, EUR J ENTOMOL, V106, P471, DOI 10.14411/eje.2009.059; Yocum GD, 2009, J INSECT PHYSIOL, V55, P32, DOI 10.1016/j.jinsphys.2008.10.003; Yu QY, 2008, INSECT BIOCHEM MOLEC, V38, P1158, DOI 10.1016/j.ibmb.2008.08.002; Zhang SZ, 2010, J INSECT PHYSIOL, V56, P1198, DOI 10.1016/j.jinsphys.2010.03.021; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	98	46	67	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86012	10.1371/journal.pone.0086012	http://dx.doi.org/10.1371/journal.pone.0086012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465841	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000039
J	Ross, IL; Dandara, C; Swart, M; Lacerda, M; Schatz, D; Blom, DJ				Ross, Ian Louis; Dandara, Collet; Swart, Marelize; Lacerda, Miguel; Schatz, Desmond; Blom, Dirk Jacobus			9 beta Polymorphism of the Glucocorticoid Receptor Gene Appears to Have Limited Impact in Patients with Addison's Disease	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ADRENAL INSUFFICIENCY; CARDIOVASCULAR-DISEASE; IN-VIVO; RISK; REPLACEMENT; PLASMA; CHOLESTEROL; CORTISOL; ASSOCIATION	Background: Addison's disease (AD) has been associated with an increased risk of cardiovascular disease. Glucocorticoid receptor polymorphisms that alter glucocorticoid sensitivity may influence metabolic and cardiovascular risk factors in patients with AD. The 9 beta polymorphism of the glucocorticoid receptor gene is associated with relative glucocorticoid resistance and has been reported to increase the risk of myocardial infarction in the elderly. We explored the impact of this polymorphism in patients with AD. Materials and Methods: 147 patients with AD and 147 age, gender and ethnicity matched healthy controls were recruited. Blood was taken in a non-fasted state for plasma lipid determination, measurement of cardiovascular risk factors and DNA extraction. Results: Genotype data for the 9 beta polymorphism was available for 139 patients and 146 controls. AD patients had a more atherogenic lipid profile characterized by an increase in the prevalence of small dense LDL (p = 0.003), increased triglycerides (p = 0.002), reduced HDLC (p<0.001) an elevated highly sensitive C-reactive protein (p = 0.01), compared with controls. The 9 beta polymorphism (at least one G allele) was found in 28% of patients and controls respectively. After adjusting for age, gender, ethnicity, BMI and hydrocortisone dose per metre square of body surface area in patients, there were no significant metabolic associations with this polymorphism and hydrocortisone doses were not higher in patients with the polymorphism. Conclusions: This study did not identify any associations between the 9 beta polymorphism and cardiovascular risk factors or hydrocortisone dose and determination of this polymorphism is therefore unlikely to be of clinical benefit in the management of patients with AD.	[Ross, Ian Louis] Univ Cape Town, Dept Med, Div Endocrinol, ZA-7925 Cape Town, South Africa; [Dandara, Collet; Swart, Marelize] Univ Cape Town, Dept Human Genet, ZA-7925 Cape Town, South Africa; [Lacerda, Miguel] Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa; [Schatz, Desmond] Univ Florida, Coll Med, Dept Paediat, Gainesville, FL USA; [Blom, Dirk Jacobus] Univ Cape Town, Dept Med, Div Lipidol, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; State University System of Florida; University of Florida; University of Cape Town	Ross, IL (corresponding author), Univ Cape Town, Dept Med, Div Endocrinol, ZA-7925 Cape Town, South Africa.	ian.ross@uct.ac.za	Dandara, Collet/ABD-8235-2021; Dandara, Collet/D-1978-2009; Ross, Ian Louis/N-7420-2017	Dandara, Collet/0000-0002-5925-4895; Dandara, Collet/0000-0002-5925-4895; Blom, Dirk/0000-0003-3965-5912; Ross, Ian Louis/0000-0002-5308-7563	Swedish Research Links [65390/2007]	Swedish Research Links	ILR is the recipient of the Swedish Research Links Grant No: 65390/2007. This research has not received funding or any other support from industry. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arlt W, 2006, CLIN ENDOCRINOL, V64, P384, DOI 10.1111/j.1365-2265.2006.02473.x; Bensing S, 2008, CLIN ENDOCRINOL, V69, P697, DOI 10.1111/j.1365-2265.2008.03340.x; Bergthorsdottir R, 2006, J CLIN ENDOCR METAB, V91, P4849, DOI 10.1210/jc.2006-0076; Bleicken B, 2008, EUR J ENDOCRINOL, V159, P811, DOI 10.1530/EJE-08-0578; Blom DJ, 2003, J LIPID RES, V44, P212, DOI 10.1194/jlr.D200013-JLR200; Braatvedt GD, 1999, OSTEOPOROSIS INT, V10, P435, DOI 10.1007/s001980050251; Chikada N, 2004, ENDOCR J, V51, P355, DOI 10.1507/endocrj.51.355; Chong JSWLV, 2001, CLIN ENDOCRINOL, V54, P267, DOI 10.1046/j.1365-2265.2001.01200.x; Donn R, 2007, CLIN ENDOCRINOL, V67, P342, DOI 10.1111/j.1365-2265.2007.02887.x; ENCIO IJ, 1991, J BIOL CHEM, V266, P7182; ESTEBAN NV, 1991, J CLIN ENDOCR METAB, V72, P39, DOI 10.1210/jcem-72-1-39; FEEK CM, 1981, CLIN ENDOCRINOL, V14, P451, DOI 10.1111/j.1365-2265.1981.tb00634.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GIDEZ LI, 1982, J LIPID RES, V23, P1206; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; Kuningas M, 2006, BIOGERONTOLOGY, V7, P231, DOI 10.1007/s10522-006-9021-2; Langsted A, 2011, J INTERN MED, V270, P65, DOI 10.1111/j.1365-2796.2010.02333.x; Lin RCY, 1999, BMJ-BRIT MED J, V319, P1337, DOI 10.1136/bmj.319.7221.1337; Lin RCY, 2003, HYPERTENSION, V41, P404, DOI 10.1161/01.HYP.0000055342.40301.DC; Lovas K, 2003, EXPERT OPIN PHARMACO, V4, P2145, DOI 10.1517/eoph.4.12.2145.22409; Monteiro CMC, 2010, BRAZ J MED BIOL RES, V43, P297, DOI 10.1590/S0100-879X2010005000008; Oakley RH, 1996, J BIOL CHEM, V271, P9550, DOI 10.1074/jbc.271.16.9550; R Core Team R, 2022, R LANG ENV STAT COMP; Ross IL, 2013, EUR J ENDOCRINOL, V168, P403, DOI 10.1530/EJE-12-0808; Sholter DE, 2000, CAN J CARDIOL, V16, P505; Thomson AH, 2007, CLIN ENDOCRINOL, V66, P789, DOI 10.1111/j.1365-2265.2007.02812.x; van den Akker ELT, 2008, ARCH INTERN MED, V168, P33, DOI 10.1001/archinternmed.2007.41; van der Westhuyzen DR, 2007, CURR OPIN LIPIDOL, V18, P147, DOI 10.1097/MOL.0b013e328051b4fe; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; van Rossum EFC, 2002, DIABETES, V51, P3128, DOI 10.2337/diabetes.51.10.3128; van Rossum EFC, 2003, CLIN ENDOCRINOL, V59, P585, DOI 10.1046/j.1365-2265.2003.01888.x; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yeo WW, 2001, DIABETIC MED, V18, P341, DOI 10.1046/j.1464-5491.2001.00510.x	33	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86350	10.1371/journal.pone.0086350	http://dx.doi.org/10.1371/journal.pone.0086350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466047	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000087
J	Yang, YY; Woodward, LA; Li, QX; Wang, J				Yang, Yuyi; Woodward, Lee Ann; Li, Qing X.; Wang, Jun			Concentrations, Source and Risk Assessment of Polycyclic Aromatic Hydrocarbons in Soils from Midway Atoll, North Pacific Ocean	PLOS ONE			English	Article							LUNG-CANCER RISK; SPATIAL-DISTRIBUTION; ORGANIC POLLUTANTS; PAHS; SEDIMENTS; ISLAND; ANTARCTICA; EXPOSURE; RATIOS; AREAS	This study was designed to determine concentrations of polycyclic aromatic hydrocarbons (PAHs) in soil samples collected from Midway Atoll and evaluate their potential risks to human health. The total concentrations of 16 PAHs ranged from 3.55 to 3200 mu g kg(-1) with a mean concentration of 198 mu g kg(-1). Higher molecular weight PAHs (4-6 ring PAHs) dominated the PAH profiles, accounting for 83.3% of total PAH mass. PAH diagnostic ratio analysis indicated that primary sources of PAHs in Midway Atoll could be combustion. The benzo[a] pyrene equivalent concentration (BaPeq) in most of the study area (86.5%) was less than 40 mu g kg(-1) BaPeq and total incremental lifetime cancer risks of PAHs ranged from 1.00 x 10(-10) to 9.20 x 10(-6) with a median value of 1.24 x 10(-7), indicating a minor carcinogenic risk of PAHs in Midway Atoll.	[Yang, Yuyi; Wang, Jun] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei Province, Peoples R China; [Woodward, Lee Ann] US Fish & Wildlife Serv, Pacific Reefs NWRC, Honolulu, HI USA; [Li, Qing X.; Wang, Jun] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; United States Department of the Interior; US Fish & Wildlife Service; University of Hawaii System; University of Hawaii Manoa	Li, QX (corresponding author), Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA.	qingl@hawaii.edu; wangjun@wbgcas.cn	Yang, Yuyi/N-5428-2015; Li, Qing/AAO-3938-2020; Wang, Jun/AAN-4446-2021; Wang, Jun/H-5837-2015; Yang, Yuyi/H-6600-2015	Yang, Yuyi/0000-0001-9807-6844; Wang, Jun/0000-0002-7574-9468; Yang, Yuyi/0000-0001-9807-6844	U.S. Fish and Wildlife Service; National Institute on Minority Health and Health Disparities [G12 MD007601]; Open Funding Project of the Key Laboratory of Aquatic Botany and Watershed Ecology; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Open Funding Project of the Key Laboratory of Aquatic Botany and Watershed Ecology; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by The U.S. Fish and Wildlife Service (QXL), the National Institute on Minority Health and Health Disparities grant G12 MD007601 (QXL), and Open Funding Project of the Key Laboratory of Aquatic Botany and Watershed Ecology (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cachada A, 2012, SCI TOTAL ENVIRON, V430, P184, DOI 10.1016/j.scitotenv.2012.04.075; Canadian Council of Ministers of the Environment (CCME), 2008, GUID CARC OTH POL AR, P218; Crnkovic D, 2007, ENVIRON MONIT ASSESS, V125, P75, DOI 10.1007/s10661-006-9240-7; Curtosi A, 2009, ANTARCT SCI, V21, P329, DOI 10.1017/S0954102009002004; Friday G.P., 1999, WSRCTR9800110; Inomata Y, 2012, ENVIRON SCI TECHNOL, V46, P4941, DOI 10.1021/es300391w; Jiang YF, 2011, ENVIRON MONIT ASSESS, V183, P139, DOI 10.1007/s10661-011-1913-1; Jones RJ, 2011, MAR POLLUT BULL, V62, P1362, DOI 10.1016/j.marpolbul.2011.01.021; Khairy MA, 2009, J HAZARD MATER, V170, P389, DOI 10.1016/j.jhazmat.2009.04.084; Kipopoulou AM, 1999, ENVIRON POLLUT, V106, P369, DOI 10.1016/S0269-7491(99)00107-4; Klanova J, 2008, ENVIRON POLLUT, V152, P416, DOI 10.1016/j.envpol.2007.06.026; Liao CM, 2006, CHEMOSPHERE, V63, P1610, DOI 10.1016/j.chemosphere.2005.08.051; Lodygin ED, 2008, EURASIAN SOIL SCI+, V41, P1321, DOI 10.1134/S1064229308120107; Martins CC, 2004, ANTARCT SCI, V16, P117, DOI 10.1017/S0954102004001932; Masih A, 2006, CHEMOSPHERE, V65, P449, DOI 10.1016/j.chemosphere.2006.01.062; Miao XS, 2000, SCI TOTAL ENVIRON, V257, P17, DOI 10.1016/S0048-9697(00)00484-8; Nam JJ, 2003, CHEMOSPHERE, V50, P1281, DOI 10.1016/S0045-6535(02)00764-6; NISBET ICT, 1992, REGUL TOXICOL PHARM, V16, P290, DOI 10.1016/0273-2300(92)90009-X; Olsson AC, 2010, OCCUP ENVIRON MED, V67, P98, DOI 10.1136/oem.2009.046680; Peng C, 2011, ENVIRON POLLUT, V159, P802, DOI 10.1016/j.envpol.2010.11.003; Seo JS, 2007, J AGR FOOD CHEM, V55, P5383, DOI 10.1021/jf0637630; Soclo HH, 2000, MAR POLLUT BULL, V40, P387, DOI 10.1016/S0025-326X(99)00200-3; Taylor S.K., 2009, LITTLE ECOLOGICAL RI; Tobiszewski M, 2012, ENVIRON POLLUT, V162, P110, DOI 10.1016/j.envpol.2011.10.025; United States Environmental Protection Agency (USEPA), 1993, EPA600R93089; VanBrummelen TC, 1996, CHEMOSPHERE, V32, P293, DOI 10.1016/0045-6535(95)00339-8; Wang J, 2011, CHEMOSPHERE, V84, P1002, DOI 10.1016/j.chemosphere.2011.04.001; Wang WT, 2010, ENVIRON POLLUT, V158, P1245, DOI 10.1016/j.envpol.2010.01.021; Wang Z, 2007, CHEMOSPHERE, V68, P965, DOI 10.1016/j.chemosphere.2007.01.017; Webster L, 2001, J ENVIRON MONITOR, V3, P591, DOI 10.1039/b106408h; Wickramasinghe AP, 2012, CHEMOSPHERE, V87, P1381, DOI 10.1016/j.chemosphere.2012.02.044; WILD SR, 1995, ENVIRON POLLUT, V88, P91, DOI 10.1016/0269-7491(95)91052-M; Yunker MB, 2002, ORG GEOCHEM, V33, P489, DOI 10.1016/S0146-6380(02)00002-5; Zhang XL, 2005, ENVIRON SCI TECHNOL, V39, P9109, DOI 10.1021/es0513741; Zhao ZY, 2012, ECOTOXICOLOGY, V21, P1743, DOI 10.1007/s10646-012-0948-6	35	35	37	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86441	10.1371/journal.pone.0086441	http://dx.doi.org/10.1371/journal.pone.0086441			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466100	gold, Green Submitted, Green Published			2022-12-25	WOS:000330288000097
J	Barros, AGD; Bridi, JC; de Souza, BR; de Castro, C; Torres, KCD; Malard, L; Jorio, A; de Miranda, DM; Ashrafi, K; Romano-Silva, MA				de Almeida Barros, Alexandre Guimaraes; Bridi, Jessika Cristina; de Souza, Bruno Rezende; de Castro Junior, Celio; de Lima Torres, Karen Cecilia; Malard, Leandro; Jorio, Ado; de Miranda, Debora Marques; Ashrafi, Kaveh; Romano-Silva, Marco Aurelio			Dopamine Signaling Regulates Fat Content through beta-Oxidation in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; FEEDING-BEHAVIOR; DEFICIENT MICE; D2 RECEPTORS; FOOD-INTAKE; SEROTONIN; OBESITY; DISTINCT; STORAGE; SYSTEM	The regulation of energy balance involves an intricate interplay between neural mechanisms that respond to internal and external cues of energy demand and food availability. Compelling data have implicated the neurotransmitter dopamine as an important part of body weight regulation. However, the precise mechanisms through which dopamine regulates energy homeostasis remain poorly understood. Here, we investigate mechanisms through which dopamine modulates energy storage. We showed that dopamine signaling regulates fat reservoirs in Caenorhabditis elegans. We found that the fat reducing effects of dopamine were dependent on dopaminergic receptors and a set of fat oxidation enzymes. Our findings reveal an ancient role for dopaminergic regulation of fat and suggest that dopamine signaling elicits this outcome through cascades that ultimately mobilize peripheral fat depots.	[de Almeida Barros, Alexandre Guimaraes; Bridi, Jessika Cristina; de Castro Junior, Celio; de Lima Torres, Karen Cecilia; de Miranda, Debora Marques; Romano-Silva, Marco Aurelio] Univ Fed Minas Gerais, Fac Med, Inst Nacl Ciencia & Tecnol Med Mol, Belo Horizonte, MG, Brazil; [de Souza, Bruno Rezende] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil; [Malard, Leandro; Jorio, Ado] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Fis, Belo Horizonte, MG, Brazil; [Ashrafi, Kaveh] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of California System; University of California San Francisco	Romano-Silva, MA (corresponding author), Univ Fed Minas Gerais, Fac Med, Inst Nacl Ciencia & Tecnol Med Mol, Belo Horizonte, MG, Brazil.	romanosilva@gmail.com	Romano-Silva, Marco Aurelio/A-1790-2008; Jorio, Ado/AFK-5647-2022; Souza, Bruno R/A-9854-2010; Castro, Célio J/K-2303-2014; Romano-Silva, Marco Aurelio/T-8321-2019; Miranda, Debora/AAQ-1952-2020; Souza, Bruno Rezende/Z-6035-2019; Jorio, Ado/F-2141-2010	Romano-Silva, Marco Aurelio/0000-0002-6558-4639; Jorio, Ado/0000-0002-5978-2735; Souza, Bruno R/0000-0002-7064-7956; Miranda, Debora/0000-0002-7081-8401; Souza, Bruno Rezende/0000-0002-7064-7956; Jorio, Ado/0000-0002-5978-2735	FAPEMIG; CNPq; INCT de Medicina Molecular; CAPES	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT de Medicina Molecular; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by FAPEMIG (http://www.fapemig.br/), CNPq (http://www.cnpq.br/), INCT de Medicina Molecular (http://www.medicina.ufmg.br/inct/) and CAPES (http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AT, 2011, GENETICS, V188, P579, DOI 10.1534/genetics.111.128512; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ashrafi Kaveh, 2007, WormBook, P1; AVERY L, 1993, GENETICS, V133, P897; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRENNER S, 1974, GENETICS, V77, P71; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Cohen M, 2009, CELL METAB, V9, P375, DOI 10.1016/j.cmet.2009.02.003; Cumming P, 2011, SYNAPSE, V65, P892, DOI 10.1002/syn.20916; Barros AGD, 2012, METHOD CELL BIOL, V107, P383, DOI 10.1016/B978-0-12-394620-1.00013-8; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; DiLeone RJ, 2009, INT J OBESITY, V33, pS25, DOI 10.1038/ijo.2009.68; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gallant P, 2003, EUR J BIOCHEM, V270, P664, DOI 10.1046/j.1432-1033.2003.03417.x; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Hare EE, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-24; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kimura KD, 2010, J NEUROSCI, V30, P16365, DOI 10.1523/JNEUROSCI.6023-09.2010; Kok P, 2006, AM J PHYSIOL-ENDOC M, V291, pE1038, DOI 10.1152/ajpendo.00567.2005; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potma E. O., 2008, HDB BIOMEDICAL NONLI, P164; Ringstad N, 2009, SCIENCE, V325, P96, DOI 10.1126/science.1169243; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Sugiura M, 2005, J NEUROCHEM, V94, P1146, DOI 10.1111/j.1471-4159.2005.03268.x; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Suo S, 2003, J NEUROCHEM, V86, P869, DOI 10.1046/j.1471-4159.2003.01896.x; Suo S, 2009, EMBO J, V28, P2437, DOI 10.1038/emboj.2009.194; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Szczypka MS, 2000, NAT GENET, V25, P102, DOI 10.1038/75484; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wang MC, 2011, NAT METHODS, V8, P135, DOI 10.1038/NMETH.1556; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	61	11	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85874	10.1371/journal.pone.0085874	http://dx.doi.org/10.1371/journal.pone.0085874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465759	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100085
J	Garde, A; Karlen, W; Ansermino, JM; Dumont, GA				Garde, Ainara; Karlen, Walter; Ansermino, J. Mark; Dumont, Guy A.			Estimating Respiratory and Heart Rates from the Correntropy Spectral Density of the Photoplethysmogram	PLOS ONE			English	Article								The photoplethysmogram (PPG) obtained from pulse oximetry measures local variations of blood volume in tissues, reflecting the peripheral pulse modulated by heart activity, respiration and other physiological effects. We propose an algorithm based on the correntropy spectral density (CSD) as a novel way to estimate respiratory rate (RR) and heart rate (HR) from the PPG. Time-varying CSD, a technique particularly well-suited for modulated signal patterns, is applied to the PPG. The respiratory and cardiac frequency peaks detected at extended respiratory (8 to 60 breaths/min) and cardiac (30 to 180 beats/min) frequency bands provide RR and HR estimations. The CSD-based algorithm was tested against the Capnobase benchmark dataset, a dataset from 42 subjects containing PPG and capnometric signals and expert labeled reference RR and HR. The RR and HR estimation accuracy was assessed using the unnormalized root mean square (RMS) error. We investigated two window sizes (60 and 120 s) on the Capnobase calibration dataset to explore the time resolution of the CSD-based algorithm. A longer window decreases the RR error, for 120-s windows, the median RMS error (quartiles) obtained for RR was 0.95 (0.27, 6.20) breaths/min and for HR was 0.76 (0.34, 1.45) beats/min. Our experiments show that in addition to a high degree of accuracy and robustness, the CSD facilitates simultaneous and efficient estimation of RR and HR. Providing RR every minute, expands the functionality of pulse oximeters and provides additional diagnostic power to this non-invasive monitoring tool.	[Garde, Ainara; Karlen, Walter; Ansermino, J. Mark; Dumont, Guy A.] Univ British Columbia, Elect & Comp Engn Med Grp, Vancouver, BC V5Z 1M9, Canada; [Garde, Ainara; Karlen, Walter; Ansermino, J. Mark; Dumont, Guy A.] BC Childrens Hosp, Vancouver, BC, Canada; [Garde, Ainara; Karlen, Walter; Ansermino, J. Mark; Dumont, Guy A.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; BC Childrens Hospital; University of British Columbia; University of British Columbia	Garde, A (corresponding author), Univ British Columbia, Elect & Comp Engn Med Grp, Vancouver, BC V5Z 1M9, Canada.	ainara.garde@cw.bc.ca	Karlen, Walter/C-6290-2008; Garde, Ainara/J-9442-2017; Karlen, Walter/AAN-9397-2020	Karlen, Walter/0000-0001-8643-3074; Garde, Ainara/0000-0002-9503-6908; Karlen, Walter/0000-0001-8643-3074; Dumont, Guy/0000-0003-2048-4391; Ansermino, J Mark/0000-0001-8427-2035	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by The Natural Sciences and Engineering Research Council of Canada (NSERC), and the Canadian Institutes of Health Research (CIHR) through Collaborative Health Research Projects Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Chon KH, 2009, IEEE T BIO-MED ENG, V56, P2054, DOI 10.1109/TBME.2009.2019766; Elgendi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076585; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Garde A, 2013, COMPUTING C IN PRESS; Garde A, 2013, IEEE ENG MED BIO, P2531, DOI 10.1109/EMBC.2013.6610055; Garde A, 2010, IEEE T BIO-MED ENG, V57, P1964, DOI 10.1109/TBME.2010.2044176; Genton MG, 2002, J MACH LEARN RES, V2, P299, DOI 10.1162/15324430260185646; Johansson A, 2003, MED BIOL ENG COMPUT, V41, P242, DOI 10.1007/BF02348427; Karlen W, 2005, ANN M SOC TECHN AN S, P25; Karlen W, 2013, IEEE T BIO-MED ENG, V60, P1946, DOI 10.1109/TBME.2013.2246160; Karlen W, 2011, IEEE ENG MED BIO, P1201, DOI 10.1109/IEMBS.2011.6090282; Lazaro J, 2013, MED BIOL ENG COMPUT, V51, P233, DOI 10.1007/s11517-012-0954-0; Lazaro J, 2011, COMPUT CARDIOL CONF, V38, P713; Leonard Paul, 2004, J Clin Monit Comput, V18, P309, DOI 10.1007/s10877-005-2697-z; Liu WF, 2007, IEEE T SIGNAL PROCES, V55, P5286, DOI 10.1109/TSP.2007.896065; Lovett PB, 2005, ANN EMERG MED, V45, P68, DOI 10.1016/j.annemergmed.2004.06.016; Lu Sheng, 2008, J Clin Monit Comput, V22, P23, DOI 10.1007/s10877-007-9103-y; Meredith D. J., 2012, Journal of Medical Engineering & Technology, V36, P1, DOI 10.3109/03091902.2011.638965; Nakajima K, 1996, MED ENG PHYS, V18, P365, DOI 10.1016/1350-4533(95)00066-6; Nilsson L, 2000, J CLIN MONIT COMPUT, V16, P309, DOI 10.1023/A:1011424732717; Olsson E, 2000, ACTA PAEDIATR, V89, P853, DOI 10.1080/080352500750043774; Orini M, 2011, COMPUT CARDIOL CONF, V38, P661; Patino M, 2013, PAEDIAT ANA IN PRESS; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Santamaria I, 2006, IEEE T SIGNAL PROCES, V54, P2187, DOI 10.1109/TSP.2006.872524; Shelley Kirk H, 2006, J Clin Monit Comput, V20, P81, DOI 10.1007/s10877-006-9010-7; Therrien C. W., 1992, DISCRETE RANDOM SIGN; Vapnik V., 1998, STAT LEARNING THEORY; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Yang P, 2009, J CLIN MONIT COMPUT, V23, P75, DOI 10.1007/s10877-009-9163-2	31	44	50	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86427	10.1371/journal.pone.0086427	http://dx.doi.org/10.1371/journal.pone.0086427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466088	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100161
J	Soler, NS; Garreta, AG; Siguan, MAR; Kapraun, DF				Soler, Noemi Salvador; Garreta, Amelia Gomez; Ribera Siguan, Ma Antonia; Kapraun, Donald F.			Nuclear DNA Content Variation in Life History Phases of the Bonnemasoniaceae (Rhodophyta)	PLOS ONE			English	Article							ZEALAND BONNEMAISONIACEAE BONNEMAISONIALES; ASPARAGOPSIS-TAXIFORMIS; GENOME SIZE; RED ALGA; QUANTIFICATION; FLORIDEOPHYCEAE; SYSTEMATICS; GREEN; BATRACHOSPERMALES; PHYLOGEOGRAPHY	Nuclear DNA content in gametophytes and sporophytes or the prostrate phases of the following species of Bonnemaisoniaceae (Asparagopsis armata, Asparagopsis taxiformis, Bonnemaisonia asparagoides, Bonnemaisonia clavata and Bonnemaisonia hamifera) were estimated by image analysis and static microspectrophotometry using the DNA-localizing fluorochrome DAPI (4', 6-diamidino-2-phenylindole, dilactate) and the chicken erythrocytes standard. These estimates expand on the Kew database of DNA nuclear content. DNA content values for 1C nuclei in the gametophytes (spermatia and vegetative cells) range from 0.5 pg to 0.8 pg, and for 2C nuclei in the sporophytes or the prostrate phases range from 1.15-1.7 pg. Although only the 2C and 4C values were observed in the sporophyte or the prostrate phase, in the vegetative cells of the gametophyte the values oscillated from 1C to 4C, showing the possible start of endopolyploidy. The results confirm the alternation of nuclear phases in these Bonnemaisoniaceae species, in those that have tetrasporogenesis, as well as those that have somatic meiosis. The availability of a consensus phylogenetic tree for Bonnemaisoniaceae has opened the way to determine evolutionary trends in DNA contents. Both the estimated genome sizes and the published chromosome numbers for Bonnemaisoniaceae suggest a narrow range of values consistent with the conservation of an ancestral genome.	[Soler, Noemi Salvador] Univ Autonoma Chile, Dept Educ, Temuco, Chile; [Garreta, Amelia Gomez; Ribera Siguan, Ma Antonia] Univ Barcelona, Fac Farm, Lab Bot, E-08028 Barcelona, Spain; [Kapraun, Donald F.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	Universidad Autonoma de Chile; University of Barcelona; University of North Carolina; University of North Carolina Wilmington	Garreta, AG (corresponding author), Univ Barcelona, Fac Farm, Lab Bot, E-08028 Barcelona, Spain.	ameliagomez@ub.edu			Spanish Government [CGL2005-02330/BOS, CGL2009-09589]	Spanish Government(Spanish GovernmentEuropean Commission)	This study was supported by the projects CGL2005-02330/BOS and CGL2009-09589 of the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano M, 2009, PHYCOLOGIA, V48, P3; Andreakis N, 2004, EUR J PHYCOL, V39, P273, DOI 10.1080/0967026042000236436; Andreakis N, 2007, MOL ECOL, V16, P2285, DOI 10.1111/j.1365-294X.2007.03306.x; [Anonymous], 1995, PLANT INVADERS; BOILLOT A, 1967, CR ACAD SCI D NAT, V264, P257; BONIN DR, 1987, NEW ZEAL J BOT, V25, P577, DOI 10.1080/0028825X.1987.10410088; BONIN DR, 1988, NEW ZEAL J BOT, V26, P619, DOI 10.1080/0028825X.1988.10410664; CHEN LCM, 1970, CAN J BOTANY, V48, P523, DOI 10.1139/b70-073; CHIHARA M, 1978, PHYCOLOGIA, V17, P382, DOI 10.2216/i0031-8884-17-4-382.1; Chihara M., 1961, SCI REP TOKYO KYOIKU, V10, P121; Chihara M., 1962, SCI REP TOKYO KYOI B, V11, P27; Choi HG, 1994, KOREAN J PHYCOLOGY, V9, P21, DOI DOI 10.4067/S0718-19572008000100003; Chualain FN, 2004, J PHYCOL, V40, P1112, DOI 10.1111/j.1529-8817.2004.03135.x; CLOWES AW, 1983, LAB INVEST, V49, P327; Cole K. M., 1990, BIOL RED ALGAE, P73; COLEMAN AW, 1981, J HISTOCHEM CYTOCHEM, V29, P959, DOI 10.1177/29.8.6168681; DIXON PS, 1982, BOT MAR, V25, P611, DOI 10.1515/botm.1982.25.12.611; Farnham WF, 1994, INTRO SPECIES EUROPE, P32; FELDMANN G, 1966, CR ACAD SCI D NAT, V262, P1695; Feldmann J., 1942, ANN SCI NAT BOT 11TH SER, V3, P75; FRESHWATER DW, 1994, P NATL ACAD SCI USA, V91, P7281, DOI 10.1073/pnas.91.15.7281; GALL JG, 1981, J CELL BIOL, V91, pS3, DOI 10.1083/jcb.91.3.3s; GARBARY DJ, 1990, BIOL RED ALGAE, P477; GOFF LJ, 1984, DEV BIOL, V102, P173, DOI 10.1016/0012-1606(84)90183-0; Goff LJ., 1990, BIOL RED ALGAE, P43; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; Haslin C, 2001, PLANTA MED, V67, P301, DOI 10.1055/s-2001-14330; Hawkes M.W., 1990, BIOL RED ALGAE, P455; Huth K, 1981, NOVA HEDWIGIA, V34, P177; Kapraun DF, 1998, PHYCOLOGIA, V37, P176, DOI 10.2216/i0031-8884-37-3-176.1; Kapraun DF, 2005, ANN BOT-LONDON, V95, P7, DOI 10.1093/aob/mci002; KAPRAUN DF, 1992, J APPL PHYCOL, V4, P129, DOI 10.1007/BF02442461; Kapraun DF, 2002, PHYCOLOGIA, V41, P507, DOI 10.2216/i0031-8884-41-5-507.1; KAPRAUN DF, 1994, PHYCOLOGIA, V33, P42, DOI 10.2216/i0031-8884-33-1-42.1; KAPRAUN DF, 1993, PHYCOLOGIA, V32, P1, DOI 10.2216/i0031-8884-32-1-1.1; KAPRAUN DF, 1993, HYDROBIOLOGIA, V261, P679; Kapraun DF, 1992, JAPANESE J PHYCOLOGY, V40, p15 26; Kapraun DF, 2007, PHYCOLOGIA, V46, P54, DOI 10.2216/06-18.1; Kapraun Donald F., 1993, Cryptogamic Botany, V4, P97; Kapraun Donald F., 1994, Cryptogamic Botany, V4, P410; Le Gall L, 2007, MOL PHYLOGENET EVOL, V43, P1118, DOI 10.1016/j.ympev.2006.11.012; LEGALL Y, 1993, PROTOPLASMA, V173, P123; LOPEZBAUTISTA J, 1995, J APPL PHYCOL, V7, P351, DOI 10.1007/BF00003792; MAGNE F, 1960, CR HEBD ACAD SCI, V250, P2742; MAGNE FRANCIS, 1964, CAH BIOL MAR, V5, P461; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; Necchi O, 2002, PHYCOLOGIA, V41, P340, DOI 10.2216/i0031-8884-41-4-340.1; PORTUGAL J, 1988, BIOCHIM BIOPHYS ACTA, V949, P158, DOI 10.1016/0167-4781(88)90079-6; PUESCHEL CM, 1989, J PHYCOL, V25, P625, DOI 10.1111/j.0022-3646.1989.00625.x; RUENESS J, 1982, BOT MAR, V25, P577, DOI 10.1515/botm.1982.25.12.577; Salvador N, 2008, PHYCOLOGIA, V47, P177, DOI 10.2216/07-24.1; Salvador N, 2007, SCI MAR, V71, P101, DOI 10.3989/scimar.2007.71n1101; Soler NS, 2009, EUR J PHYCOL, V44, P381, DOI 10.1080/09670260902780782; Sheath R. G., 1990, BIOL RED ALGAE, P305; Sherwood AR, 2008, PHYCOLOGIA, V47, P79, DOI 10.2216/07-39.1; SHEVLIN DE, 1978, J PHYCOL, V14, P282, DOI 10.1111/j.1529-8817.1978.tb00300.x; Siguan MAR, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P291; SVEDELIUS NILS, 1933, NOVA ACTA REG SOC SCI UPSALIENSIS SER 4, V9, P1	59	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86006	10.1371/journal.pone.0086006	http://dx.doi.org/10.1371/journal.pone.0086006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465835	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100094
J	Stoler-Barak, L; Moussion, C; Shezen, E; Hatzav, M; Sixt, M; Alon, R				Stoler-Barak, Liat; Moussion, Christine; Shezen, Elias; Hatzav, Miki; Sixt, Michael; Alon, Ronen			Blood Vessels Pattern Heparan Sulfate Gradients between Their Apical and Basolateral Aspects	PLOS ONE			English	Article							ENDOTHELIAL GLYCOCALYX; LYMPHOCYTE TRAFFICKING; LEUKOCYTE ADHESION; CELL-MIGRATION; CHEMOKINES; INFLAMMATION; VENULES; MICE; VISUALIZATION; HEMODYNAMICS	A hallmark of immune cell trafficking is directional guidance via gradients of soluble or surface bound chemokines. Vascular endothelial cells produce, transport and deposit either their own chemokines or chemokines produced by the underlying stroma. Endothelial heparan sulfate (HS) was suggested to be a critical scaffold for these chemokine pools, but it is unclear how steep chemokine gradients are sustained between the lumenal and ablumenal aspects of blood vessels. Addressing this question by semi-quantitative immunostaining of HS moieties around blood vessels with a pan anti-HS IgM mAb, we found a striking HS enrichment in the basal lamina of resting and inflamed post capillary skin venules, as well as in high endothelial venules (HEVs) of lymph nodes. Staining of skin vessels with a glycocalyx probe further suggested that their lumenal glycocalyx contains much lower HS density than their basolateral extracellular matrix (ECM). This polarized HS pattern was observed also in isolated resting and inflamed microvascular dermal cells. Notably, progressive skin inflammation resulted in massive ECM deposition and in further HS enrichment around skin post capillary venules and their associated pericytes. Inflammation-dependent HS enrichment was not compromised in mice deficient in the main HS degrading enzyme, heparanase. Our results suggest that the blood vasculature patterns steep gradients of HS scaffolds between their lumenal and basolateral endothelial aspects, and that inflammatory processes can further enrich the HS content nearby inflamed vessels. We propose that chemokine gradients between the lumenal and ablumenal sides of vessels could be favored by these sharp HS scaffold gradients.	[Stoler-Barak, Liat; Shezen, Elias; Hatzav, Miki; Alon, Ronen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Moussion, Christine; Sixt, Michael] IST Austria, Klosterneuburg, Austria	Weizmann Institute of Science; Institute of Science & Technology - Austria	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il	ALON, RONEN/GRX-6987-2022	Alon, Ronen/0000-0001-9161-6369; Sixt, Michael/0000-0002-6620-9179	Israel Science Foundation; U.S. Israel Binational Science Foundation (BSF), FAMRI; Flight Attendant Medical Research Institute Foundation; Minerva Foundation, Germany; European Research Council (ERC); FP7 ITN "Stroma''	Israel Science Foundation(Israel Science Foundation); U.S. Israel Binational Science Foundation (BSF), FAMRI; Flight Attendant Medical Research Institute Foundation; Minerva Foundation, Germany; European Research Council (ERC)(European Research Council (ERC)); FP7 ITN "Stroma''	R. Alon is an incumbent of the Linda Jacobs Chair in Immune and Stem Cell Research, and his research is supported by the Israel Science Foundation, the U.S. Israel Binational Science Foundation (BSF), FAMRI, the Flight Attendant Medical Research Institute Foundation, and the Minerva Foundation, Germany. Michael Sixt's research is supported by the European Research Council (ERC Starting grant) and by the FP7 ITN "Stroma''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon TI, 2011, SCIENCE, V333, P1898, DOI 10.1126/science.1208248; Attreed M, 2012, NAT METHODS, V9, P477, DOI [10.1038/nmeth.1945, 10.1038/NMETH.1945]; Axelsson J, 2012, BLOOD, V120, P1742, DOI 10.1182/blood-2012-03-417139; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bao X, 2010, IMMUNITY; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chappell D, 2010, SHOCK, V34, P133, DOI 10.1097/SHK.0b013e3181cdc363; Chen GP, 2004, BIOCHEMISTRY-US, V43, P4971, DOI 10.1021/bi0356552; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Damiano ER, 2004, J FLUID MECH, V512, P1, DOI 10.1017/S0022112004008766; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Gao LJ, 2010, MICROVASC RES, V80, P394, DOI 10.1016/j.mvr.2010.06.005; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lipowsky HH, 2011, AM J PHYSIOL-HEART C, V301, pH2235, DOI 10.1152/ajpheart.00803.2011; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Ostrovsky L, 1998, BLOOD, V91, P3028, DOI 10.1182/blood.V91.8.3028.3028_3028_3036; Overstreet MG, 2013, NAT IMMUNOL; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Patterson AM, 2005, ARTHRITIS RHEUM-US, V52, P2331, DOI 10.1002/art.21222; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Raats CJI, 2000, KIDNEY INT, V57, P385, DOI 10.1046/j.1523-1755.2000.00858.x; Rehm M, 2004, ANESTHESIOLOGY, V100, P1211, DOI 10.1097/00000542-200405000-00025; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Schmidt EP, 2012, NAT MED; Schreiber TH, 2007, BLOOD, V109, P1381, DOI 10.1182/blood-2006-07-032995; Severin IC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00293; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Tsuboi K, 2013, J IMMUNOL, V191, P448, DOI 10.4049/jimmunol.1203061; Vlodavsky I, 2013, MATRIX BIOL, V32, P220, DOI 10.1016/j.matbio.2013.03.001; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wolf M, 2008, INT J BIOCHEM CELL B, V40, P1185, DOI 10.1016/j.biocel.2007.12.009; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Yang BG, 2007, J IMMUNOL, V179, P4376, DOI 10.4049/jimmunol.179.7.4376; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181	53	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85699	10.1371/journal.pone.0085699	http://dx.doi.org/10.1371/journal.pone.0085699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465652	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100061
J	Grosser, S; Queenan, BN; Lalchandani, RR; Vicini, S				Grosser, Sabine; Queenan, Bridget N.; Lalchandani, Rupa R.; Vicini, Stefano			Hilar Somatostatin Interneurons Contribute to Synchronized GABA Activity in an In Vitro Epilepsy Model	PLOS ONE			English	Article							EPILEPTIFORM DISCHARGES; 4-AMINOPYRIDINE; POTENTIALS; MECHANISMS; MOUSE	Epilepsy is a disorder characterized by excessive synchronized neural activity. The hippocampus and surrounding temporal lobe structures appear particularly sensitive to epileptiform activity. Somatostatin (SST)-positive interneurons within the hilar region have been suggested to gate hippocampal activity, and therefore may play a crucial role in the dysregulation of hippocampal activity. In this study, we examined SST interneuron activity in the in vitro 4-aminopyridine (4-AP) model of epilepsy. We employed a multi-disciplinary approach, combining extracellular multi-electrode array (MEA) recordings with patch-clamp recordings and optical imaging using a genetically encoded calcium sensor. We observed that hilar SST interneurons are strongly synchronized during 4-AP-induced local field potentials (LFPs), as assayed by Ca2+ imaging as well as juxtacellular or intracellular recording. SST interneurons were particularly responsive to GABA-mediated LFPs that occurred in the absence of ionotropic glutamatergic transmission. Our results present evidence that the extensive synchronized activity of SST-expressing interneurons contribute to the generation of GABAergic LFPs in an in vitro model of temporal lobe seizures.	[Grosser, Sabine] Charite Univ Med Berlin, Inst Neurophysiol, Berlin, Germany; [Grosser, Sabine] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Berlin, Germany; [Queenan, Bridget N.; Vicini, Stefano] Georgetown Univ, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Queenan, Bridget N.; Vicini, Stefano] Georgetown Univ, Interdisciplinary Program Neurosci, Washington, DC USA; [Lalchandani, Rupa R.] Georgetown Univ, Grad Program Physiol & Biophys, Washington, DC USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Georgetown University; Georgetown University; Georgetown University	Vicini, S (corresponding author), Georgetown Univ, Dept Physiol & Pharmacol, Washington, DC 20007 USA.	svicin01@georgetown.edu		Vicini, Stefano/0000-0001-8671-5194; Tuan, Rupa Lalchandani/0000-0002-2525-4993	German Research Council;  [GRK1123]	German Research Council(German Research Foundation (DFG)); 	SG was supported by a grant (GRK1123) funded by the German Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVOLI M, 1993, J NEUROPHYSIOL, V70, P1018, DOI 10.1152/jn.1993.70.3.1018; Avoli M, 1996, J PHYSIOL-LONDON, V493, P707, DOI 10.1113/jphysiol.1996.sp021416; Avoli M, 1996, J NEUROSCI, V16, P3912; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fu LY, 2007, J PHYSIOL-LONDON, V579, P445, DOI 10.1113/jphysiol.2002.019356; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; Gonzalez-Sulser A, 2012, J NEUROPHYSIOL, V108, P2568, DOI 10.1152/jn.00363.2012; Gonzalez-Sulser A, 2011, NEUROPHARMACOLOGY, V60, P1142, DOI 10.1016/j.neuropharm.2010.10.007; Hazra A, 2012, J NEUROPHYSIOL, V108, P658, DOI 10.1152/jn.00708.2011; Hill AJ, 2010, J NEUROSCI METH, V185, P246, DOI 10.1016/j.jneumeth.2009.10.007; Lamsa K, 1997, J NEUROPHYSIOL, V78, P2582, DOI 10.1152/jn.1997.78.5.2582; Maccaferri G, 2003, TRENDS NEUROSCI, V26, P564, DOI 10.1016/j.tins.2003.08.002; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; PERREAULT P, 1992, J NEUROSCI, V12, P104; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Uva L, 2009, EUR J NEUROSCI, V29, P911, DOI 10.1111/j.1460-9568.2009.06672.x; VOSKUYL RA, 1985, BRAIN RES, V342, P54, DOI 10.1016/0006-8993(85)91352-6; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Ziburkus J, 2006, J NEUROPHYSIOL, V95, P3948, DOI 10.1152/jn.01378.2005	20	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86250	10.1371/journal.pone.0086250	http://dx.doi.org/10.1371/journal.pone.0086250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465989	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500213
J	Han, Y; Ling, MT; Mao, HW; Zheng, J; Liu, M; Lam, KT; Liu, Y; Tu, WW; Lau, YL				Han, Yan; Ling, Man To; Mao, Huawei; Zheng, Jian; Liu, Ming; Lam, Kwok Tai; Liu, Yuan; Tu, Wenwei; Lau, Yu-Lung			Influenza Virus-Induced Lung Inflammation Was Modulated by Cigarette Smoke Exposure in Mice	PLOS ONE			English	Article							T-CELLS; PANDEMIC H1N1; A VIRUS; NICOTINE; INFECTION; RESPONSES; EXPRESSION; IMMUNOPATHOLOGY; PATHOGENESIS; CONTRIBUTES	Although smokers have increased susceptibility and severity of seasonal influenza virus infection, there is no report about the risk of 2009 pandemic H1N1 (pdmH1N1) or avian H9N2 (H9N2/G1) virus infection in smokers. In our study, we used mouse model to investigate the effect of cigarette smoke on pdmH1N1 or H9N2 virus infection. Mice were exposed to cigarette smoke for 21 days and then infected with pdmH1N1 or H9N2 virus. Control mice were exposed to air in parallel. We found that cigarette smoke exposure alone significantly upregulated the lung inflammation. Such prior cigarette smoke exposure significantly reduced the disease severity of subsequent pdmH1N1 or H9N2 virus infection. For pdmH1N1 infection, cigarette smoke exposed mice had significantly lower mortality than the control mice, possibly due to the significantly decreased production of inflammatory cytokines and chemokines. Similarly, after H9N2 infection, cigarette smoke exposed mice displayed significantly less weight loss, which might be attributed to lower cytokines and chemokines production, less macrophages, neutrophils, CD4(+) and CD8(+) T cells infiltration and reduced lung damage compared to the control mice. To further investigate the underlying mechanism, we used nicotine to mimic the effect of cigarette smoke both in vitro and in vivo. Pre-treating the primary human macrophages with nicotine for 72 h significantly decreased their expression of cytokines and chemokines after pdmH1N1 or H9N2 infection. The mice subcutaneously and continuously treated with nicotine displayed significantly less weight loss and lower inflammatory response than the control mice upon pdmH1N1 or H9N2 infection. Moreover, alpha 7 nicotinic acetylcholine receptor knockout mice had more body weight loss than wild-type mice after cigarette smoke exposure and H9N2 infection. Our study provided the first evidence that the pathogenicity of both pdmH1N1 and H9N2 viruses was alleviated in cigarette smoke exposed mice, which might partially be attributed to the immunosuppressive effect of nicotine.	[Han, Yan; Ling, Man To; Mao, Huawei; Zheng, Jian; Lam, Kwok Tai; Liu, Yuan; Tu, Wenwei; Lau, Yu-Lung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Liu, Ming] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Tu, WW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	wwtu@hku.hk; lauylung@hku.hk	; Lau, Yu Lung/C-4322-2009	Liu, Yuan/0000-0003-4880-5185; Lau, Yu Lung/0000-0002-4780-0289	Area of Excellence program on Influenza, the University Grants Committee of the Hong Kong SAR, China [AoE/M-12/06]; General Research Fund, Research Grants Council of Hong Kong; Research Fund for the Control of Infectious Diseases (RFCID) of the Health, Welfare and Food Bureau of the Hong Kong SAR Government; Edward Sai-Kim Hotung Paediatric Education and Research Fund	Area of Excellence program on Influenza, the University Grants Committee of the Hong Kong SAR, China; General Research Fund, Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Research Fund for the Control of Infectious Diseases (RFCID) of the Health, Welfare and Food Bureau of the Hong Kong SAR Government; Edward Sai-Kim Hotung Paediatric Education and Research Fund	This work was supported by the Area of Excellence program on Influenza, the University Grants Committee of the Hong Kong SAR, China (AoE/M-12/06); General Research Fund, Research Grants Council of Hong Kong; a Commission Grant from the Research Fund for the Control of Infectious Diseases (RFCID) of the Health, Welfare and Food Bureau of the Hong Kong SAR Government (2009-2014, Lab-11); Edward Sai-Kim Hotung Paediatric Education and Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; [Anonymous], AC RESP INF; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Bauer CMT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013251; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Caschler GJ, 2008, AM J RESP CELL MOL, V38, P218, DOI 10.1165/rcmb.2007-0053OC; Chan KH, 2009, RESP MED, V103, P1746, DOI 10.1016/j.rmed.2009.04.027; Chen H, 2007, J IMMUNOL, V179, P6097, DOI 10.4049/jimmunol.179.9.6097; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; Darwish I, 2011, EXPERT REV ANTI-INFE, V9, P807, DOI [10.1586/ERI.11.56, 10.1586/eri.11.56]; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Dickson PE, 2011, PSYCHOPHARMACOLOGY, V215, P631, DOI 10.1007/s00213-010-2159-2; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Gardi C, 2012, ANN NY ACAD SCI, V1259, P104, DOI 10.1111/j.1749-6632.2012.06605.x; Goncalves RB, 2011, INFLAMM RES, V60, P409, DOI 10.1007/s00011-011-0308-7; Goodman AG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000438; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Guslandi M, 1999, BRIT J CLIN PHARMACO, V48, P481; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Herold S, 2008, J EXP MED, V205, P3065, DOI 10.1084/jem.20080201; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Huttunen R, 2011, J INTERN MED, V269, P258, DOI 10.1111/j.1365-2796.2010.02332.x; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson KJ, 2009, NEUROPHARMACOLOGY, V57, P347, DOI 10.1016/j.neuropharm.2009.07.020; Jaspers I, 2010, AM J RESP CELL MOL, V43, P368, DOI 10.1165/rcmb.2009-0254OC; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kang YM, 2011, ARCH VIROL, V156, P759, DOI 10.1007/s00705-010-0914-7; KARK JD, 1981, AM J PUBLIC HEALTH, V71, P530, DOI 10.2105/AJPH.71.5.530; KARK JD, 1982, NEW ENGL J MED, V307, P1042, DOI 10.1056/NEJM198210213071702; Khoufache K, 2013, J CLIN INVEST, V123, P206, DOI 10.1172/JCI61667; Kuiken T, 2012, CURR OPIN VIROL, V2, P276, DOI 10.1016/j.coviro.2012.02.013; Ling MT, 2012, J INFECT DIS, V205, P44, DOI 10.1093/infdis/jir691; Liu Y, 2012, MOL BIOL REP, V39, P1163, DOI 10.1007/s11033-011-0846-7; Longhi MP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000006; Lunney PC, 2012, ALIMENT PHARM THER, V36, P997, DOI 10.1111/apt.12086; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Misery L, 2004, EXP DERMATOL, V13, P665, DOI 10.1111/j.0906-6705.2004.00274.x; Moskophidis D, 1998, J EXP MED, V188, P223, DOI 10.1084/jem.188.2.223; Noah TL, 2011, ENVIRON HEALTH PERSP, V119, P78, DOI 10.1289/ehp.1002258; Paquette SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038214; Qin G, 2011, J VIROL, V85, P10109, DOI 10.1128/JVI.05341-11; Razani-Boroujerdi S, 2004, CELL IMMUNOL, V230, P1, DOI 10.1016/j.cellimm.2004.07.007; Robbins CS, 2006, AM J RESP CRIT CARE, V174, P1342, DOI 10.1164/rccm.200604-561OC; ROGOT E, 1980, PUBLIC HEALTH REP, V95, P213; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Sopori ML, 1998, PSYCHONEUROENDOCRINO, V23, P189, DOI 10.1016/S0306-4530(97)00076-0; Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; WHO, 1999, 1999 INFL H9N2 HONG; WHO, 2003, INFL H9N2 HONG KONG; Wilson KM, 2013, J PEDIATR-US, V162, P16, DOI 10.1016/j.jpeds.2012.06.043; Wittebole X, 2007, CLIN EXP IMMUNOL, V147, P28, DOI 10.1111/j.1365-2249.2006.03248.x; Wong HPS, 2009, DIGESTION, V80, P209, DOI 10.1159/000231898; Zheng J, 2009, J IMMUNOL, V183, P3742, DOI 10.4049/jimmunol.0901329; Zhou JF, 2006, J INFECT DIS, V194, P61, DOI 10.1086/504690	59	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86166	10.1371/journal.pone.0086166	http://dx.doi.org/10.1371/journal.pone.0086166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465940	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500197
J	Yang, CY; Liu, ZH; Liu, K; Yang, P				Yang, Chunyan; Liu, Zhonghui; Liu, Kai; Yang, Ping			Mechanisms of Ghrelin Anti-Heart Failure: Inhibition of Ang II-Induced Cardiomyocyte Apoptosis by Down-Regulating AT1R Expression	PLOS ONE			English	Article							MYOCYTE APOPTOSIS; TYPE-2 RECEPTOR; ANGIOTENSIN; RATS; PROLIFERATION; HYPERTROPHY; DYSFUNCTION; DISEASE; SYSTEM; INJURY	Background: Ghrelin is a novel growth hormone-releasing peptide administered to treat chronic heart failure (CHF). However, the underlying mechanism of its protective effects against heart failure (HF) remains unclear. Methods and Results: A total of 68 patients with CHF and 20 healthy individuals were included. The serum levels of Angiotensin II (Ang II) and ghrelin were measured using ELISA. The results showed that Ang II and ghrelin were both significantly increased in CHF patients and that the ghrelin levels were significantly positively correlated with Ang II. The left anterior descending coronary artery was ligated to establish a rat model of CHF, and cultured cardiomyocytes from neonatal rats were stimulated with Ang II to explore the role of ghrelin in CHF. The results showed that ghrelin inhibited cardiomyocyte apoptosis both in vivo and in vitro. Furthermore, caspase-3 expression was examined, and the results revealed that Ang II induces cardiomyocyte apoptosis through the caspase-3 pathway, whereas ghrelin inhibits this action. Lastly, to further elucidate the mechanism by which ghrelin inhibits Ang II action, the expression of the AT1 and AT2 receptors was evaluated; the results showed that Ang II up-regulates the AT1 and AT2 receptors in cardiomyocytes, whereas ghrelin inhibits AT1 receptor up-regulation but does not affect AT2 receptor expression. Conclusions: These data suggest that the serum levels of ghrelin are significantly positively correlated with Ang II in CHF patients and that ghrelin can inhibit Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R, thereby playing a role in preventing HF.	[Yang, Chunyan; Liu, Zhonghui; Yang, Ping] Jilin Univ, China Japan Union Hosp, Dept Cardiol, Changchun 130023, Peoples R China; [Liu, Zhonghui] Jilin Univ, Norman Bethune Coll Med, Dept Immunol, Changchun 130023, Peoples R China; [Liu, Kai] Jilin Univ, Hosp 1, Dept Hepatobiliary & Pancreat Surg, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Yang, P (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Cardiol, Changchun 130023, Peoples R China.	pyang@jlu.edu.cn			Natural Science Foundation of China [81270315]; Project of Science and Technology of Jilin Province [201115094]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Science and Technology of Jilin Province	This study was supported by grants provided by the Natural Science Foundation of China (Grant No. 81270315) and the Project of Science and Technology of Jilin Province (Grant No 201115094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscough JFX, 2009, CARDIOVASC RES, V81, P592, DOI 10.1093/cvr/cvn230; Chang L, 2004, J CARDIOVASC PHARM, V43, P165, DOI 10.1097/00005344-200402000-00001; Dell'Italia LJ, 2011, CIRC RES, V109, P437, DOI 10.1161/CIRCRESAHA.110.238550; Goldenberg I, 2001, J HYPERTENS, V19, P1681, DOI 10.1097/00004872-200109000-00022; Hurst PR, 2006, HUM REPROD, V21, P1974, DOI 10.1093/humrep/del109; Kang PM, 2000, CIRC RES, V86, P1107; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2001, TRENDS ENDOCRIN MET, V12, P118, DOI 10.1016/S1043-2760(00)00362-3; Kuranaga E, 2012, GENES CELLS, V17, P83, DOI 10.1111/j.1365-2443.2011.01579.x; Ledderose C, 2011, RECENT PATENTS ENDOC, V5, P1, DOI 10.2174/187221411794351897; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Lemarie CA, 2010, J RENIN-ANGIO-ALDO S, V11, P19, DOI 10.1177/1470320309347785; LOPEZ JJ, 1994, AM J PHYSIOL, V267, pH844, DOI 10.1152/ajpheart.1994.267.2.H844; Mel'nikova NP, 2006, INT J CARDIOL, V112, P219, DOI 10.1016/j.ijcard.2005.09.003; Nagaya N, 2001, CIRCULATION, V104, P1430, DOI 10.1161/hc3601.095575; Nishida Kazuhiko, 2008, Circ J, V72 Suppl A, pA17, DOI 10.1253/circj.CJ-08-0669; Pettersson I, 2002, J ENDOCRINOL, V175, P201, DOI 10.1677/joe.0.1750201; Qi YF, 2012, EXP PHYSIOL, V97, P89, DOI 10.1113/expphysiol.2011.060673; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Schroder D, 2006, J MOL MED, V84, P975, DOI 10.1007/s00109-006-0090-0; Soeki T, 2008, AM J PHYSIOL-HEART C, V294, pH426, DOI 10.1152/ajpheart.00643.2007; Tsutsui H, 2007, CIRC J, V71, P449, DOI 10.1253/circj.71.449; Ukkola O, 2012, J HUM HYPERTENS, V26, P452, DOI 10.1038/jhh.2011.51; Unger T, 2004, J RENIN-ANGIO-ALDO S, V5, pS7, DOI 10.3317/jraas.2004.024; van de Wal RMA, 2006, INT J CARDIOL, V106, P367, DOI 10.1016/j.ijcard.2005.02.016; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Wollert KC, 1999, CARDIOVASC RES, V43, P838, DOI 10.1016/S0008-6363(99)00145-5; Xu JP, 2010, J PEPT SCI, V16, P392, DOI 10.1002/psc.1253; Yang CY, 2012, J CARDIOVASC PHARM, V59, P465, DOI 10.1097/FJC.0b013e31824a7b60	30	34	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85785	10.1371/journal.pone.0085785	http://dx.doi.org/10.1371/journal.pone.0085785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465706	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500113
J	Broeckx, S; Zimmerman, M; Crocetti, S; Suls, M; Marien, T; Ferguson, SJ; Chiers, K; Duchateau, L; Franco-Obregon, A; Wuertz, K; Spaas, JH				Broeckx, Sarah; Zimmerman, Marieke; Crocetti, Sara; Suls, Marc; Marien, Tom; Ferguson, Stephen J.; Chiers, Koen; Duchateau, Luc; Franco-Obregon, Alfredo; Wuertz, Karin; Spaas, Jan H.			Regenerative Therapies for Equine Degenerative Joint Disease: A Preliminary Study	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PLATELET-RICH PLASMA; STROMAL CELLS; BONE-MARROW; TENDON; DIFFERENTIATION; MULTIPOTENT; HORSE; P63	Degenerative joint disease (DJD) is a major cause of reduced athletic function and retirement in equine performers. For this reason, regenerative therapies for DJD have gained increasing interest. Platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) were isolated from a 6-year-old donor horse. MSCs were either used in their native state or after chondrogenic induction. In an initial study, 20 horses with naturally occurring DJD in the fetlock joint were divided in 4 groups and injected with the following: 1) PRP; 2) MSCs; 3) MSCs and PRP; or 4) chondrogenic induced MSCs and PRP. The horses were then evaluated by means of a clinical scoring system after 6 weeks (T-1), 12 weeks (T-2), 6 months (T-3) and 12 months (T-4) post injection. In a second study, 30 horses with the same medical background were randomly assigned to one of the two combination therapies and evaluated at T-1. The protein expression profile of native MSCs was found to be negative for major histocompatibility (MHC) II and p63, low in MHC I and positive for Ki67, collagen type II (Col II) and Vimentin. Chondrogenic induction resulted in increased mRNA expression of aggrecan, Col II and cartilage oligomeric matrix protein (COMP) as well as in increased protein expression of p63 and glycosaminoglycan, but in decreased protein expression of Ki67. The combined use of PRP and MSCs significantly improved the functionality and sustainability of damaged joints from 6 weeks until 12 months after treatment, compared to PRP treatment alone. The highest short-term clinical evolution scores were obtained with chondrogenic induced MSCs and PRP. This study reports successful in vitro chondrogenic induction of equine MSCs. In vivo application of (induced) MSCs together with PRP in horses suffering from DJD in the fetlock joint resulted in a significant clinical improvement until 12 months after treatment.	[Broeckx, Sarah; Spaas, Jan H.] Global Stem Cell Technol, Meldert Lummen, Belgium; [Zimmerman, Marieke; Suls, Marc] Equine Vet Practice Dr Suls, Weert, Netherlands; [Crocetti, Sara; Ferguson, Stephen J.; Franco-Obregon, Alfredo; Wuertz, Karin] ETH, Dept Biomech, Zurich, Switzerland; [Marien, Tom] Equitom Equine Hosp, Meldert Lummen, Belgium; [Ferguson, Stephen J.; Franco-Obregon, Alfredo; Wuertz, Karin] Univ Zurich, Competence Ctr Appl Biotechnol & Mol Med CABMM, Zurich, Switzerland; [Chiers, Koen] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Poultry Dis, Merelbeke, Belgium; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, Merelbeke, Belgium; [Franco-Obregon, Alfredo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Ghent University; Ghent University; National University of Singapore	Wuertz, K (corresponding author), ETH, Dept Biomech, Zurich, Switzerland.	kwuertz@ethz.ch; janspaas@gst.be	Wuertz-Kozak, Karin/G-3144-2012; Franco-Obregon, Alfredo/F-3056-2019; Ferguson, Stephen J./A-4118-2012	Wuertz-Kozak, Karin/0000-0002-3281-4629; Ferguson, Stephen J./0000-0003-0650-5889; Franco-Obregon, Alfredo/0000-0002-2514-1083	agency for innovation by science and technology Flanders (IWT Vlaanderen) [130543]	agency for innovation by science and technology Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This study was supported by a grant (number 130543) to SB and JHS from the agency for innovation by science and technology Flanders (IWT Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerts C., 2013, J TISSUE SCI ENG, V4, P1, DOI DOI 10.4172/2157-7552.1000125; Berg LC, 2009, VET COMP ORTHOPAED, V22, P363, DOI 10.3415/VCOT-08-10-0107; Broeckx S., 2012, J TISSUE SCI ENG, P1, DOI [10.4172/2157-7552.S11-001, DOI 10.4172/2157-7552.S11-001]; Broeckx S, 2013, J STEM CELL RES THER, V3, P1; Carrade DD, 2011, CYTOTHERAPY, V13, P1180, DOI 10.3109/14653249.2011.602338; Carrade DD, 2011, CYTOTHERAPY, V13, P419, DOI 10.3109/14653249.2010.536213; Chen L, 2012, J ORTHOP RES, V30, P991, DOI 10.1002/jor.22033; Chong PP, 2012, J ORTHOP RES, V30, P634, DOI 10.1002/jor.21556; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fang BJ, 2007, PEDIATR TRANSPLANT, V11, P814, DOI 10.1111/j.1399-3046.2007.00780.x; Frisbie DD, 2006, VET COMP ORTHOPAED, V19, P142, DOI 10.1055/s-0038-1632990; Frisbie DD, 2009, J ORTHOP RES, V27, P1675, DOI 10.1002/jor.20933; Frisbie DD, 2005, VET CLIN N AM-EQUINE, V21, P713, DOI 10.1016/j.cveq.2005.07.001; Goodrich LR, 2006, VET J, V171, P51, DOI 10.1016/j.tvjl.2004.07.008; Guest DJ, 2008, EQUINE VET J, V40, P178, DOI 10.2746/042516408X276942; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; JEFFCOTT LB, 1982, EQUINE VET J, V14, P185, DOI 10.1111/j.2042-3306.1982.tb02389.x; Jing H, 2003, J LEUKOCYTE BIOL, V74, P868, DOI 10.1189/jlb.0303116; Jonitz A, 2012, INT J MOL MED, V30, P666, DOI 10.3892/ijmm.2012.1042; Koch TG, 2007, EXPERT OPIN BIOL TH, V7, P1621, DOI 10.1517/14712598.7.11.1621; Lim MN, 2012, MOL VIS, V18, P1289; Lu YJ, 2013, GENE, V519, P251, DOI 10.1016/j.gene.2013.02.021; Malone ED, 2002, VET CLIN N AM-EQUINE, V18, P411, DOI 10.1016/S0749-0739(02)00024-X; Martinello T, 2010, TISSUE ENG PART C-ME, V16, P771, DOI [10.1089/ten.tec.2009.0512, 10.1089/ten.TEC.2009.0512]; Martinello T, 2013, J ORTHOP RES, V31, P306, DOI 10.1002/jor.22205; McIlwraith CW, 2011, ARTHROSCOPY, V27, P1552, DOI 10.1016/j.arthro.2011.06.002; MCILWRAITH CW, 1982, J AM VET MED ASSOC, V180, P239; Mishra A, 2009, TISSUE ENG PART C-ME, V15, P431, DOI 10.1089/ten.tec.2008.0534; Mokbel AN, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-259; NIZOLEK DJH, 1981, CORNELL VET, V71, P355; Perry KJ, 2013, DEV BIOL, V374, P281, DOI 10.1016/j.ydbio.2012.12.005; Reinshagen H, 2011, ACTA OPHTHALMOL, V89, P741, DOI 10.1111/j.1755-3768.2009.01812.x; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Russell RP, 2013, SPORTS MED ARTHROSC, V21, P186, DOI 10.1097/JSA.0000000000000007; Smith RKW, 2005, BRIT J SPORT MED, V39, P582, DOI 10.1136/bjsm.2005.015834; Spaas JH, 2012, VLAAMS DIERGEN TIJDS, V81, P11; Spaas JH, 2013, VET J, V195, P107, DOI 10.1016/j.tvjl.2012.05.006; Spaas JH, 2012, SPORTS MED, V42, P871, DOI 10.2165/11635390-000000000-00000; Weber CF, 2012, ANASTH INTENSIV NOTF, V47, P425; Weber CF, 2012, ANASTH INTENSIV NOTF, V47, P418, DOI 10.1055/s-0032-1316484; Wilke MM, 2007, J ORTHOP RES, V25, P913, DOI 10.1002/jor.20382; Zubrod CJ, 2005, VET CLIN N AM-EQUINE, V21, P691, DOI 10.1016/j.cveq.2005.07.004	44	73	74	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85917	10.1371/journal.pone.0085917	http://dx.doi.org/10.1371/journal.pone.0085917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465787	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000330240500088
J	Guan, Z; Wang, JH; Guo, J; Wang, F; Wang, XW; Li, GN; Xie, Q; Han, X; Niu, B; Zhang, T				Guan, Zhen; Wang, Jianhua; Guo, Jin; Wang, Fang; Wang, Xiuwei; Li, Guannan; Xie, Qiu; Han, Xu; Niu, Bo; Zhang, Ting			The Maternal ITPK1 Gene Polymorphism Is Associated with Neural Tube Defects in a High-Risk Chinese Population	PLOS ONE			English	Article							INOSITOL 1,3,4-TRISPHOSPHATE 5/6-KINASE; SPINA-BIFIDA; HEXAKISPHOSPHATE; EXPRESSION; RAT; MYOINOSITOL; VARIANTS; DISEASE; INTRON; ACID	Background: Epidemiological surveys and animal studies have revealed that inositol metabolism is associated with NTDs, but the mechanisms are not clear. Inositol 1,3,4-trisphosphate 5/6-kinase (ITPK1) is a pivotal regulatory enzyme in inositol metabolic pathway. The objective was to assess the potential impact of the maternal ITPK1 genotypes on the inositol parameter and on the NTD risk in a NTD high-risk area in China. Methodology/Results: A case-control study of pregnant women affected with NTDs (n = 200) and controls (n = 320) was carried out. 13 tag SNPs of ITPK1 were selected and genotyped by the Sequenom MassArray system. We found that 4 tag SNPs were statistically significant in spina bifida group (P<0.05). MACH was used to impute the un-genotyped SNPs in ITPK1 locus and showed that 3 meaningful SNPs in the non-coding regions were significant. We also predicted the binding capacity of transcription factors in the positive SNPs using the bioinformatics method and found that only rs3783903 was located in the conserved sequence of activator protein-1 (AP-1). To further study the association between biochemical values and genotypes, maternal plasma inositol hexakisphosphate (IP6) levels were also assessed using LC-MS. The maternal plasma IP6 concentrations in the spina bifida subgroup were 7.1% lower than control (136.67 vs. 147.05 ng mL(-1), P<0.05), and significantly lower in rs3783903 GG genotype than others (P<0.05). EMSA showed a different allelic binding capacity of AP-1 in rs3783903, which was affected by an A -> G exchange. The RT-PCR suggested the ITPK1 expression was decreased significantly in mutant-type of rs3783903 compared with wild-type in the 60 healthy pregnancies (P<0.05). Conclusions/Significance: These results suggested that the maternal rs3783903 of ITPK1 might be associated with spina bifida, and the allele G of rs3783903 might affect the binding of AP-1 and the decrease of maternal plasma IP6 concentration in this Chinese population.	[Guan, Zhen; Wang, Jianhua; Guo, Jin; Wang, Fang; Wang, Xiuwei; Li, Guannan; Xie, Qiu; Han, Xu; Niu, Bo] Capital Inst Pediat, Dept Biotechnol, Beijing, Peoples R China; [Zhang, Ting] Capital Inst Pediat, Beijing Municipal Key Lab Child Dev & Nutri, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP); Capital Institute of Pediatrics (CIP)	Niu, B (corresponding author), Capital Inst Pediat, Dept Biotechnol, Beijing, Peoples R China.	niub2004@126.com; zhangtingcv@aliyun.com	wang, fang/GYD-4295-2022		National Natural Science Foundation [81070491]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation (81070491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FU, 2009, SURG NEUROL, V71, P353, DOI 10.1016/j.surneu.2007.08.030; Athanasiu L, 2011, PSYCHIAT RES, V185, P358, DOI 10.1016/j.psychres.2010.05.011; Au KS, 2010, DEV DISABIL RES REV, V16, P6, DOI 10.1002/ddrr.93; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cabaret AS, 2007, PRENATAL DIAG, V27, P738, DOI 10.1002/pd.1771; Chang SC, 2002, J BIOL CHEM, V277, P43836, DOI 10.1074/jbc.M206134200; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; De Grazia S, 2012, EXPERT OPIN DRUG DEL, V9, P1033, DOI 10.1517/17425247.2012.701616; Greene NDE, 1997, NAT MED, V3, P60, DOI 10.1038/nm0197-60; Groenen PM, 2003, AM J OBSTET GYNECOL, V189, P1713, DOI 10.1016/S0002-9378(03)00807-X; Gu X, 2007, BIRTH DEFECTS RES A, V79, P702, DOI 10.1002/bdra.20397; Khan SG, 2010, HUM MUTAT, V31, P167, DOI 10.1002/humu.21166; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Kubota T, 2011, HUM MUTAT, V32, P773, DOI 10.1002/humu.21501; Majumder AL, 1997, BBA-LIPID LIPID MET, V1348, P245, DOI 10.1016/S0005-2760(97)00122-7; Natarajan R, 1996, COMPUT METH PROG BIO, V49, P137, DOI 10.1016/0169-2607(96)01717-8; Park TJ, 2012, DIAGN MOL PATHOL, V27; Reardon HT, 2012, PROSTAG LEUKOTR ESS, V87, P25, DOI 10.1016/j.plefa.2012.04.011; Reese EA, 1997, AM J OBSTET GYNECOL, V176, P536, DOI 10.1016/S0002-9378(97)70543-X; Relton CL, 2003, CLIN GENET, V64, P424, DOI 10.1034/j.1399-0004.2003.00161.x; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Scioscia M, 2012, PLACENTA, V33, P882, DOI 10.1016/j.placenta.2012.07.007; Smith A. V., 2008, CSH PROTOC; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; THEIBERT AB, 1991, P NATL ACAD SCI USA, V88, P3165, DOI 10.1073/pnas.88.8.3165; Tur F, 2013, J CHROMATOGR B, V928, P146, DOI 10.1016/j.jchromb.2013.03.023; Uldry M, 2001, EMBO J, V20, P4467, DOI 10.1093/emboj/20.16.4467; Verbsky JW, 2005, J BIOL CHEM, V280, P1911, DOI 10.1074/jbc.M411528200; Verbsky JW, 2002, J BIOL CHEM, V277, P31857, DOI 10.1074/jbc.M205682200; WALD NJ, 1994, LANCET, V343, P307, DOI 10.1016/S0140-6736(94)91156-8; Weickert CS, 2008, HUM MOL GENET, V17, P2293, DOI 10.1093/hmg/ddn130; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wilson MP, 2009, P NATL ACAD SCI USA, V106, P9831, DOI 10.1073/pnas.0904172106; Wilson MP, 1996, J BIOL CHEM, V271, P11904, DOI 10.1074/jbc.271.20.11904; Yamaguchi Y, 2012, CELL MOL LIFE SCI, V15	36	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86145	10.1371/journal.pone.0086145	http://dx.doi.org/10.1371/journal.pone.0086145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465924	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500116
J	Ngo, V; Stefanovski, D; Haas, S; Farley, RA				Van Ngo; Stefanovski, Darko; Haas, Stephan; Farley, Robert A.			Non-Equilibrium Dynamics Contribute to Ion Selectivity in the KcsA Channel	PLOS ONE			English	Article							TETRAMERIC CATION CHANNELS; MOLECULAR-DYNAMICS; POTASSIUM CHANNELS; K+ CHANNEL; BROWNIAN DYNAMICS; BINDING-SITES; FORCE-FIELDS; CONDUCTION; PERMEATION; SIMULATIONS	The ability of biological ion channels to conduct selected ions across cell membranes is critical for the survival of both animal and bacterial cells. Numerous investigations of ion selectivity have been conducted over more than 50 years, yet the mechanisms whereby the channels select certain ions and reject others are not well understood. Here we report a new application of Jarzynski's Equality to investigate the mechanism of ion selectivity using non-equilibrium molecular dynamics simulations of Na+ and K+ ions moving through the KcsA channel. The simulations show that the selectivity filter of KcsA adapts and responds to the presence of the ions with structural rearrangements that are different for Na+ and K+. These structural rearrangements facilitate entry of K+ ions into the selectivity filter and permeation through the channel, and rejection of Na+ ions. A mechanistic model of ion selectivity by this channel based on the results of the simulations relates the structural rearrangement of the selectivity filter to the differential dehydration of ions and multiple-ion occupancy and describes a mechanism to efficiently select and conduct K+. Estimates of the K+/Na+ selectivity ratio and steady state ion conductance for KcsA from the simulations are in good quantitative agreement with experimental measurements. This model also accurately describes experimental observations of channel block by cytoplasmic Na+ ions, the "punch through" relief of channel block by cytoplasmic positive voltages, and is consistent with the knock-on mechanism of ion permeation.	[Van Ngo; Haas, Stephan] Univ So Calif, Dept Phys & Astron, Los Angeles, CA USA; [Stefanovski, Darko] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Stefanovski, Darko; Farley, Robert A.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA	University of Southern California; Cedars Sinai Medical Center; University of Southern California	Farley, RA (corresponding author), Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.	rfarley@usc.edu		Ngo, Van/0000-0001-8350-1203	 [DOE-FG03-01ER45908]		VN was supported by grant DOE-FG03-01ER45908 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksimentiev A., 2012, MEMBRANE PROTEINS TU; Alam A, 2011, J GEN PHYSIOL, V137, P397, DOI 10.1085/jgp.201010546; Alam A, 2009, NAT STRUCT MOL BIOL, V16, P35, DOI 10.1038/nsmb.1537; Allen TW, 2004, J GEN PHYSIOL, V124, P679, DOI 10.1085/jgp.200409111; Andersen OS, 2011, J GEN PHYSIOL, V137, P393, DOI 10.1085/jgp.201110651; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100; BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588; Bucher D, 2010, J GEN PHYSIOL, V135, P549, DOI 10.1085/jgp.201010404; Chung SH, 2002, BIOPHYS J, V83, P263, DOI 10.1016/S0006-3495(02)75167-9; Collins KD, 2012, BIOPHYS CHEM, V167, P43, DOI 10.1016/j.bpc.2012.04.002; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P319, DOI 10.1038/nsmb1070; Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861; Derebe MG, 2011, P NATL ACAD SCI USA, V108, P598, DOI 10.1073/pnas.1013636108; Domene C, 2009, METHOD ENZYMOL, V466, P155, DOI 10.1016/S0076-6879(09)66007-9; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Egwolf B, 2010, J MOL BIOL, V401, P831, DOI 10.1016/j.jmb.2010.07.006; ERMAK DL, 1978, J CHEM PHYS, V69, P1352, DOI 10.1063/1.436761; Furini S, 2011, J MOL BIOL, V409, P867, DOI 10.1016/j.jmb.2011.04.043; Grottesi A, 2005, IEEE T NANOBIOSCI, V4, P112, DOI 10.1109/TNB.2004.842473; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Hille B., 1992, IONIC CHANNELS EXCIT; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kim I, 2011, P NATL ACAD SCI USA, V108, P17963, DOI 10.1073/pnas.1110735108; Kiriukhin MY, 2002, BIOPHYS CHEM, V99, P155, DOI 10.1016/S0301-4622(02)00153-9; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Navarro B, 1996, SCIENCE, V272, P1950, DOI 10.1126/science.272.5270.1950; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; NEYTON J, 1988, J GEN PHYSIOL, V92, P549, DOI 10.1085/jgp.92.5.549; Ngo VA, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031127; Ngo VA, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036702; Nimigean CM, 2002, J GEN PHYSIOL, V120, P323, DOI 10.1085/jgp.20028614; Noskov SY, 2007, J GEN PHYSIOL, V129, P135, DOI 10.1085/jgp.200609633; Noskov SY, 2006, BIOPHYS CHEM, V124, P279, DOI 10.1016/j.bpc.2006.05.033; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Roux B, 2005, ANNU REV BIOPH BIOM, V34, P153, DOI 10.1146/annurev.biophys.34.040204.144655; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; Shrivastava IH, 2002, BIOPHYS J, V83, P633, DOI 10.1016/S0006-3495(02)75197-7; Thompson AN, 2009, NAT STRUCT MOL BIOL, V16, P1317, DOI 10.1038/nsmb.1703; Varma S, 2011, J GEN PHYSIOL, V137, P479, DOI 10.1085/jgp.201010579; Varma S, 2008, J MOL BIOL, V376, P13, DOI 10.1016/j.jmb.2007.11.059; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zwanzig RW, 1954, J CHEM PHYS, V22	55	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86079	10.1371/journal.pone.0086079	http://dx.doi.org/10.1371/journal.pone.0086079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465882	gold, Green Published			2022-12-25	WOS:000330237000086
J	Lee, SW; Oh, SY; Lee, JB; Choi, CM; Kim, HJ				Lee, Sei Won; Oh, Soo Yeon; Lee, Jin Beom; Choi, Chang Min; Kim, Hee Jin			Tuberculin Skin Test Distribution following a Change in BCG Vaccination Policy	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; LATENT TUBERCULOSIS; REACTIVITY; REVACCINATION; METAANALYSIS; INFECTION; DIAGNOSIS; ADULTS; ASSAY	Background: Epidemiologic data regarding tuberculin skin test (TST) responses are an important basis for TB control strategies. This study analyzed TST responses in Korea, which experienced a rapid change in BCG vaccination status. Methods: TST responses in young adults were examined over 5 years. Participants with active TB lesions were excluded. Results: A total of 5,552 participants were enrolled with median age of 21 years. When an induration diameter >= 10 mm was used as the criterion for a positive test, TST positivity fell (from 28.0% in 2005 to 15.3% in 2009); however, they remained steady when the criterion was >= 15-20 mm. A positive TST was associated with a personal or family of TB, the presence of a Bacille Calmette-Guerin (BCG) scar, and age (odds ratio [95% confidence interval] = 4.03 [2.61-6.22], 2.91 [1.80-4.71], 1.50 [1.31-1.72], and 1.15 [1.09-1.20], respectively). Among these factors, the decrease of participants with BCG scars was the most prominent change, which appeared to be associated with the change of TST positivity rate. Conclusion: Overall, the rate of TST positivity in Korea decreased. However, this trend seems associated with the change of BCG vaccination strategy rather than successful control of LTBI. This study showed that change in BCG vaccination strategy can have great impact on TB epidemiologic survey based on TST.	[Lee, Sei Won; Choi, Chang Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea; [Oh, Soo Yeon; Lee, Jin Beom; Kim, Hee Jin] Korean Inst TB, Osong, South Korea	University of Ulsan; Asan Medical Center	Kim, HJ (corresponding author), Korean Inst TB, Osong, South Korea.	hatchingbird@yahoo.co.kr	Lee, Sei Won/AAG-9977-2019		national health promotion fund [4800-4844-300-320-01]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0250]	national health promotion fund; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by the national health promotion fund (4800-4844-300-320-01) and a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Chan PC, 2008, INT J TUBERC LUNG D, V12, P1401; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; FINE PEM, 1989, B WORLD HEALTH ORGAN, V67, P35; Hong YP, 1998, INT J TUBERC LUNG D, V2, P27; Ildirim I, 1995, PEDIATR INFECT DIS J, V14, P1060, DOI 10.1097/00006454-199512000-00006; Joung SM, 2013, CLIN EXP VACCINE RES, V2, P83, DOI 10.7774/cevr.2013.2.2.83; Kang YA, 2007, CHEST, V132, P959, DOI 10.1378/chest.06-2805; *KOR CDCP, 2011, ANN REP TB NOT KOR; *KOR STAT INF SERV, 2012, KOR POP STAT; Lee SW, 2011, EUR RESPIR J, V37, P1447, DOI 10.1183/09031936.00089510; Lee SW, 2010, CHEST, V137, P1057, DOI 10.1378/chest.09-1513; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; McKay A, 1999, Can J Infect Dis, V10, P134; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; MENZIES R, 1992, AM REV RESPIR DIS, V146, P752, DOI 10.1164/ajrccm/146.3.752; MiretCuadras P, 1996, TUBERCLE LUNG DIS, V77, P52, DOI 10.1016/S0962-8479(96)90076-3; MORINO N, 1995, CLIN IMMUNOL IMMUNOP, V77, P52, DOI 10.1016/0090-1229(95)90136-1; Park YS, 2010, INT J TUBERC LUNG D, V14, P1069; Pineiro R, 2012, EUR J PEDIATR, V171, P1625, DOI 10.1007/s00431-012-1783-8; Reid JK, 2007, CHEST, V131, P1806, DOI 10.1378/chest.06-1133; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; SEPULVEDA RL, 1992, TUBERCLE LUNG DIS, V73, P372, DOI 10.1016/0962-8479(92)90043-J; Sterne JAC, 1996, TUBERCLE LUNG DIS, V77, P117, DOI 10.1016/S0962-8479(96)90025-8; Tala-Heikkila MM, 1998, AM J RESP CRIT CARE, V157, P1324, DOI 10.1164/ajrccm.157.4.9706037; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; *WHO, 2010, WHOHTMTB2007376; Yeh YP, 2005, T ROY SOC TROP MED H, V99, P509, DOI 10.1016/j.trstmh.2005.03.001	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86419	10.1371/journal.pone.0086419	http://dx.doi.org/10.1371/journal.pone.0086419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466082	Green Submitted, gold, Green Published			2022-12-25	WOS:000330288000093
J	Luan, HM; Meng, N; Fu, J; Chen, XM; Xu, X; Feng, Q; Jiang, H; Dai, J; Yuan, XE; Lu, YP; Roberts, AA; Luo, X; Chen, MS; Xu, ST; Li, J; Hamilton, CJ; Fang, CX; Wang, J				Luan, Hemi; Meng, Nan; Fu, Jin; Chen, Xiaomin; Xu, Xun; Feng, Qiang; Jiang, Hui; Dai, Jun; Yuan, Xune; Lu, Yanping; Roberts, Alexandra A.; Luo, Xiao; Chen, Maoshan; Xu, Shengtao; Li, Jun; Hamilton, Chris J.; Fang, Chengxiang; Wang, Jun			Genome-Wide Transcriptome and Antioxidant Analyses on Gamma-Irradiated Phases of Deinococcus radiodurans R1	PLOS ONE			English	Article							IONIZING-RADIATION; OXIDATIVE STRESS; DNA-DAMAGE; RESISTANCE; SURVIVAL; IDENTIFICATION; BIOSYNTHESIS; BACILLITHIOL; CAROTENOIDS; MECHANISMS	Adaptation of D. radiodurans cells to extreme irradiation environments requires dynamic interactions between gene expression and metabolic regulatory networks, but studies typically address only a single layer of regulation during the recovery period after irradiation. Dynamic transcriptome analysis of D. radiodurans cells using strand-specific RNA sequencing (ssRNA-seq), combined with LC-MS based metabolite analysis, allowed an estimate of the immediate expression pattern of genes and antioxidants in response to irradiation. Transcriptome dynamics were examined in cells by ssRNA-seq covering its predicted genes. Of the 144 non-coding RNAs that were annotated, 49 of these were transfer RNAs and 95 were putative novel antisense RNAs. Genes differentially expressed during irradiation and recovery included those involved in DNA repair, degradation of damaged proteins and tricarboxylic acid (TCA) cycle metabolism. The knockout mutant crtB (phytoene synthase gene) was unable to produce carotenoids, and exhibited a decreased survival rate after irradiation, suggesting a role for these pigments in radiation resistance. Network components identified in this study, including repair and metabolic genes and antioxidants, provided new insights into the complex mechanism of radiation resistance in D. radiodurans.	[Luan, Hemi; Meng, Nan; Fu, Jin; Chen, Xiaomin; Xu, Xun; Feng, Qiang; Jiang, Hui; Yuan, Xune; Lu, Yanping; Luo, Xiao; Chen, Maoshan; Xu, Shengtao; Li, Jun; Wang, Jun] BGI Shenzhen, Dept Sci & Technol, Shenzhen, Peoples R China; [Dai, Jun; Fang, Chengxiang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Dai, Jun] Hubei Univ Technol, Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Key Lab Fermentat Engn, Wuhan, Peoples R China; [Roberts, Alexandra A.; Hamilton, Chris J.] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Luan, Hemi] Hong Kong Baptist Univ, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	Beijing Genomics Institute (BGI); Wuhan University; Hubei University of Technology; University of East Anglia; Hong Kong Baptist University; University of Copenhagen; King Abdulaziz University	Fang, CX (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	cxfang@whu.edu.cn; wangj@genomics.cn	Luan, Hemi/M-5406-2016; Wang, Jun/A-7261-2013; Luo, Xiao/CAG-5937-2022; Xu, Xun/AAI-6763-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Luan, Hemi/0000-0002-3807-2363; Xu, Xun/0000-0002-5338-5173; Roberts, Alexandra/0000-0002-0705-1615; Dai, Jun/0000-0001-6143-4732; CHEN, MAOSHAN/0000-0002-3827-4969; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	Open Research Program of Shenzhen Key Laboratory of Environmental Genomics of Microbes and Applications; Shenzhen Key Laboratory of Trans-omics Biotechnologies; National Natural Science Foundation of China [31300003]	Open Research Program of Shenzhen Key Laboratory of Environmental Genomics of Microbes and Applications; Shenzhen Key Laboratory of Trans-omics Biotechnologies; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Open Research Program of Shenzhen Key Laboratory of Environmental Genomics of Microbes and Applications, Shenzhen Key Laboratory of Trans-omics Biotechnologies and National Natural Science Foundation of China (No. 31300003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baudet M, 2010, MOL CELL PROTEOMICS, V9, P415, DOI 10.1074/mcp.M900359-MCP200; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chi BK, 2013, ANTIOXID REDOX SIGN, V18, P1273, DOI 10.1089/ars.2012.4686; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Earl AM, 2002, J BACTERIOL, V184, P1003, DOI 10.1128/jb.184.4.1003-1009.2002; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Graf A, 2012, INT J BIOCH CELL BIO; HAGEN U, 1994, RADIAT ENVIRON BIOPH, V33, P45, DOI 10.1007/BF01255273; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin RX, 2009, J PROTEOME RES, V8, P390, DOI 10.1021/pr800699w; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lu HM, 2009, MOL CELL PROTEOMICS, V8, P481, DOI 10.1074/mcp.M800123-MCP200; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Obiero J, 2010, J BACTERIOL, V192, P494, DOI 10.1128/JB.01046-09; Omelchenko MV, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-57; POCKER Y, 1991, ADV EXP MED BIOL, V284, P315; Rivera S, 2011, ANAL BIOANAL CHEM, V400, P1339, DOI 10.1007/s00216-011-4825-6; Salsbury FR, 2006, NUCLEIC ACIDS RES, V34, P2173, DOI 10.1093/nar/gkl238; Schmid AK, 2005, J PROTEOME RES, V4, P709, DOI 10.1021/pr049815n; Sharov AA, 2003, PLOS BIOL, V1, P410, DOI 10.1371/journal.pbio.0000074; Shuryak I, 2009, J THEOR BIOL, V261, P305, DOI 10.1016/j.jtbi.2009.08.003; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; SMITH MD, 1988, J BACTERIOL, V170, P2126, DOI 10.1128/jb.170.5.2126-2135.1988; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Tian B, 2009, LETT APPL MICROBIOL, V49, P689, DOI 10.1111/j.1472-765X.2009.02727.x; TREMPY JE, 1989, J BACTERIOL, V171, P3348, DOI 10.1128/jb.171.6.3348-3353.1989; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; VILLEGAS CN, 1972, PLANT PHYSIOL, V50, P694, DOI 10.1104/pp.50.6.694; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wishart DS, 2011, BIOANALYSIS, V3, P1769, DOI [10.4155/bio.11.155, 10.4155/BIO.11.155]; Zhang HY, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2073-c1; Zhang L, 2007, ARCH MICROBIOL, V188, P411, DOI 10.1007/s00203-007-0262-5; Zhou ZF, 2011, MOL BIOSYST, V7, P1613, DOI 10.1039/c0mb00336k	43	33	36	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85649	10.1371/journal.pone.0085649	http://dx.doi.org/10.1371/journal.pone.0085649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465634	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000330288000020
J	Shi, Y; Wang, YY; Luan, WK; Wang, P; Tao, T; Zhang, JX; Qian, J; Liu, N; You, YP				Shi, Yan; Wang, Yingyi; Luan, Wenkang; Wang, Ping; Tao, Tao; Zhang, Junxia; Qian, Jin; Liu, Ning; You, Yongping			Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by Deriving miR-675	PLOS ONE			English	Article							IMPRINTED GENES; EXPRESSION; CANCER; OVEREXPRESSION; GROWTH; LOCUS; IGF2	H19 RNA has been characterized as an oncogenic long non-coding RNA (lncRNA) in breast and colon cancer. However, the role and function of lncRNA H19 in glioma development remain unclear. In this study, we identified that H19/miR-675 signaling was critical for glioma progression. By analyzing glioma gene expression data sets, we found increased H19 in high grade gliomas. H19 depletion via siRNA inhibited invasion in glioma cells. Further, we found H19 positively correlated with its derivate miR-675 expression and reduction of H19 inhibited miR-675 expression. Bioinformatics and luciferase reporter assays showed that miR-675 modulated Cadherin 13 expression by directly targeting the binding site within the 3' UTR. Finally, introduction of miR-675 abrogated H19 knockdown-induced cell invasion inhibition in glioma cells. To our knowledge, it is first time to demonstrate that H19 regulates glioma development by deriving miR-675 and provide important clues for understanding the key roles of lncRNA-miRNA functional network in glioma.	[Shi, Yan; Wang, Yingyi; Luan, Wenkang; Tao, Tao; Zhang, Junxia; Qian, Jin; Liu, Ning; You, Yongping] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Wang, Ping] Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China; [Tao, Tao] Southeast Univ, Sch Med, Surg Res Ctr, Nanjing, Jiangsu, Peoples R China; [Qian, Jin] Peoples Hosp Xuancheng City, Dept Neurosurg, Xuancheng City, Anhui, Peoples R China	Nanjing Medical University; Nanjing Medical University; Southeast University - China	You, YP (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	YYPL9@njmu.edu.cn	Shi, Yan/AAL-2436-2021		National High Technology Research and Development Program 863 [2012AA02A508]; China National Natural Scientific Fund [81072078, 81172389, 81101901]; Jiangsu Province's Natural Science Foundation [BK2010580, 2011847]; Jiangsu Province's Key Discipline of Medicine [XK201117]; Jiangsu Province's Medical Major Talent program [RC2011051]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Provincial Initiative Program for Excellency Disciplines, Jiangsu Province	National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); China National Natural Scientific Fund(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Key Discipline of Medicine; Jiangsu Province's Medical Major Talent program; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Provincial Initiative Program for Excellency Disciplines, Jiangsu Province	This work is supported by National High Technology Research and Development Program 863 (2012AA02A508), China National Natural Scientific Fund (81072078, 81172389 and 81101901), Jiangsu Province's Natural Science Foundation (BK2010580 and 2011847), Jiangsu Province's Key Discipline of Medicine (XK201117), Jiangsu Province's Medical Major Talent program (RC2011051), Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU and Provincial Initiative Program for Excellency Disciplines, Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens E, 1998, AM J PATHOL, V153, P1597, DOI 10.1016/S0002-9440(10)65748-3; Andreeva AV, 2010, GENE CHROMOSOME CANC, V49, P775, DOI 10.1002/gcc.20787; Ariel I, 2000, AM J MED GENET, V91, P46, DOI 10.1002/(SICI)1096-8628(20000306)91:1<46::AID-AJMG8>3.0.CO;2-I; Berteaux N, 2005, J BIOL CHEM, V280, P29625, DOI 10.1074/jbc.M504033200; BIRAN H, 1994, TUMOR BIOL, V15, P123, DOI 10.1159/000217882; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cooper MJ, 1996, J UROLOGY, V155, P2120, DOI 10.1016/S0022-5347(01)66120-2; Dudek KA, 2010, J BIOL CHEM, V285, P24381, DOI 10.1074/jbc.M110.111328; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Joubel A, 1996, CELL MOL BIOL, V42, P1159; Juan V, 2000, NUCLEIC ACIDS RES, V28, P1221, DOI 10.1093/nar/28.5.1221; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lottin S, 2002, CARCINOGENESIS, V23, P1885, DOI 10.1093/carcin/23.11.1885; LustigYariv O, 1997, ONCOGENE, V15, P169, DOI 10.1038/sj.onc.1201175; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Okamoto K, 1997, P NATL ACAD SCI USA, V94, P5367, DOI 10.1073/pnas.94.10.5367; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; PACHNIS V, 1984, P NATL ACAD SCI-BIOL, V81, P5523, DOI 10.1073/pnas.81.17.5523; RACHMILEWITZ J, 1995, ONCOGENE, V11, P863; Scrable H J, 1990, Adv Cancer Res, V54, P25, DOI 10.1016/S0065-230X(08)60807-6; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	31	101	115	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86295	10.1371/journal.pone.0086295	http://dx.doi.org/10.1371/journal.pone.0086295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466011	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000080
J	Wang, G; Chen, J; Li, ZB; Zhang, FP; Yang, DR				Wang, Gang; Chen, Jin; Li, Zong-Bo; Zhang, Feng-Ping; Yang, Da-Rong			Has Pollination Mode Shaped the Evolution of Ficus Pollen?	PLOS ONE			English	Article							FIG WASPS; MORPHOLOGY; MORACEAE; GENUS; PAPILIONOIDEAE; MUTUALISM; THRIPS; FAMILY; EXINE	Background: The extent to which co-evolutionary processes shape morphological traits is one of the most fascinating topics in evolutionary biology. Both passive and active pollination modes coexist in the fig tree (Ficus, Moraceae) and fig wasp (Agaonidae, Hymenoptera) mutualism. This classic obligate relationship that is about 75 million years old provides an ideal system to consider the role of pollination mode shifts on pollen evolution. Methods and Main Findings: Twenty-five fig species, which cover all six Ficus subgenera, and are native to the Xishuangbanna region of southwest China, were used to investigate pollen morphology with scanning electron microscope (SEM). Pollination mode was identified by the Anther/Ovule ratio in each species. Phylogenetic free regression and a correlated evolution test between binary traits were conducted based on a strong phylogenetic tree. Seventeen of the 25 fig species were actively pollinated and eight species were passively pollinated. Three pollen shape types and three kinds of exine ornamentation were recognized among these species. Pollen grains with ellipsoid shape and rugulate ornamentation were dominant. Ellipsoid pollen occurred in all 17 species of actively pollinated figs, while for the passively pollinated species, two obtuse end shapes were identified: cylinder and sphere shapes were identified in six of the eight species. All passively pollinated figs presented rugulate ornamentation, while for actively pollinated species, the smoother types - psilate and granulate-rugulate ornamentations - accounted for just five and two among the 17 species, respectively. The relationship between pollen shape and pollination mode was shown by both the phylogenetic free regression and the correlated evolution tests. Conclusions: Three pollen shape and ornamentation types were found in Ficus, which show characteristics related to passive or active pollination mode. Thus, the pollen shape is very likely shaped by pollination mode in this unique obligate mutualism.	[Wang, Gang; Chen, Jin; Yang, Da-Rong] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China; [Wang, Gang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Zong-Bo] Southwest Forestry Univ, Coll Forestry, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China; [Zhang, Feng-Ping] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Southwest Forestry University - China; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Yang, DR (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China.	yangdr@xtbg.ac.cn	LI, Zong-Bo/R-8103-2016; Zongbo, Li/GZL-4614-2022; Wang, Gang/F-9140-2013	LI, Zong-Bo/0000-0001-9023-0472; Zongbo, Li/0000-0001-9023-0472; Wang, Gang/0000-0003-1834-9561	National Natural Science Foundation of China (NSFC) [30970403, 31100279]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (NSFC grant no. 30970403, 31100279), http://www.nsfc.gov.cn/Portal0/default166.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo MTK, 1976, MEMOIRS NEW YORK BOT, V26, P1; Berg CC, 2005, FLORA MALESIANA, V17, P1, DOI DOI 10.1663/0007-196X(2006)58[; Burn MJ, 2008, REV PALAEOBOT PALYNO, V149, P187, DOI 10.1016/j.revpalbo.2007.12.003; BURNSBALOGH P, 1983, AM J BOT, V70, P1304, DOI 10.2307/2443421; Compton SG, 2010, BIOL LETTERS, V6, P838, DOI 10.1098/rsbl.2010.0389; Cook JM, 2004, J EVOLUTION BIOL, V17, P238, DOI 10.1111/j.1420-9101.2003.00683.x; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Datwyler SL, 2004, AM J BOT, V91, P767, DOI 10.3732/ajb.91.5.767; DILCHER DL, 1979, REV PALAEOBOT PALYNO, V27, P291, DOI 10.1016/0034-6667(79)90015-0; ERDTMAN G., 1960, SVENSK BOT TIDSKR, V54, P561; FERGUSON IK, 1982, BOT J LINN SOC, V84, P183, DOI 10.1111/j.1095-8339.1982.tb00533.x; FRANK S A, 1984, Psyche (Cambridge), V91, P289, DOI 10.1155/1984/35653; Freudenstein JV, 1999, AM J BOT, V86, P225, DOI 10.2307/2656939; GALIL J, 1977, NEW PHYTOL, V79, P163, DOI 10.1111/j.1469-8137.1977.tb02192.x; HEMSLEY AJ, 1985, ANN MO BOT GARD, V72, P570, DOI 10.2307/2399107; HOEN PP, 1989, REV PALAEOBOT PALYNO, V57, P187, DOI 10.1016/0034-6667(89)90020-1; Hu SS, 2008, P NATL ACAD SCI USA, V105, P240, DOI 10.1073/pnas.0707989105; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Jousselin E, 2003, EVOLUTION, V57, P1255, DOI 10.1111/j.0014-3820.2003.tb00334.x; KIM M, 1993, GRANA, V32, P327, DOI 10.1080/00173139309428959; Kjellberg F, 2001, P ROY SOC B-BIOL SCI, V268, P1113, DOI 10.1098/rspb.2001.1633; Linder H., 2000, POLLEN SPORES MORPHO, P73; Lumaga MRB, 2006, ANN BOT-LONDON, V98, P237, DOI 10.1093/aob/mcl094; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; Nefdt RJC, 1996, J ANIM ECOL, V65, P170, DOI 10.2307/5720; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Punt W, 2007, REV PALAEOBOT PALYNO, V143, P1, DOI 10.1016/j.revpalbo.2006.06.008; PUNT W, 1982, Grana, V21, P15, DOI 10.1080/00173138209427675; R Core Team, 2021, R LANG ENV STAT COMP; RAMIREZ W, 1969, SCIENCE, V163, P580, DOI 10.1126/science.163.3867.580; REITSMA T, 1970, REV PALAEOBOT PALYNO, V10, P39, DOI 10.1016/0034-6667(70)90021-7; Renoult JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-248; Sakai S, 2001, AM J BOT, V88, P1527, DOI 10.2307/3558396; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka N, 2004, J PLANT RES, V117, P265, DOI 10.1007/s10265-004-0155-5; Tzeng HY, 2009, FR RES Q, V31, P33; Walker J. W., 1976, The evolutionary significance of the exine, editors I. K. Ferguson and J. Muller., P251; Wang H, 2003, GRANA, V42, P82, DOI 10.1080/00173130310012530; Wang H, 2003, PLANT SYST EVOL, V237, P1, DOI 10.1007/s00606-002-0188-y; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; Xu L, 2011, J SYST EVOL, V49, P546, DOI 10.1111/j.1759-6831.2011.00155.x; Zerega NJC, 2005, MOL PHYLOGENET EVOL, V37, P402, DOI 10.1016/j.ympev.2005.07.004; Zerega NJC, 2004, INT J PLANT SCI, V165, P1017, DOI 10.1086/423869	46	14	17	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86231	10.1371/journal.pone.0086231	http://dx.doi.org/10.1371/journal.pone.0086231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465976	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000067
J	Bradley, CJ; Madigan, DJ; Block, BA; Popp, BN				Bradley, Christina J.; Madigan, Daniel J.; Block, Barbara A.; Popp, Brian N.			Amino Acid Isotope Incorporation and Enrichment Factors in Pacific Bluefin Tuna, Thunnus orientalis	PLOS ONE			English	Article							STABLE-ISOTOPES; TROPHIC POSITION; NORTH-ATLANTIC; NITROGEN; TISSUES; DELTA-N-15; FRACTIONATION; TURNOVER; RATIOS; CARBON	Compound specific isotopic analysis (CSIA) of amino acids has received increasing attention in ecological studies in recent years due to its ability to evaluate trophic positions and elucidate baseline nutrient sources. However, the incorporation rates of individual amino acids into protein and specific trophic discrimination factors (TDFs) are largely unknown, limiting the application of CSIA to trophic studies. We determined nitrogen turnover rates of individual amino acids from a long-term (up to 1054 days) laboratory experiment using captive Pacific bluefin tuna, Thunnus orientalis (PBFT), a large endothermic pelagic fish fed a controlled diet. Small PBFT (white muscle delta N-15 similar to 11.5 parts per thousand) were collected in San Diego, CA and transported to the Tuna Research and Conservation Center (TRCC) where they were fed a controlled diet with high delta N-15 values relative to PBFT white muscle (diet delta N-15 similar to 13.9 parts per thousand). Half-lives of trophic and source amino acids ranged from 28.6 to 305.4 days and 67.5 to 136.2 days, respectively. The TDF for the weighted mean values of amino acids was 3.0 parts per thousand, ranging from 2.2 to 15.8 parts per thousand for individual combinations of 6 trophic and 5 source amino acids. Changes in the delta N-15 values of amino acids across trophic levels are the underlying drivers of the trophic N-15 enrichment. Nearly all amino acid delta N-15 values in this experiment changed exponentially and could be described by a single compartment model. Significant differences in the rate of N-15 incorporation were found for source and trophic amino acids both within and between these groups. Varying half-lives of individual amino acids can be applied to migratory organisms as isotopic clocks, determining the length of time an individual has spent in a new environment. These results greatly enhance the ability to interpret compound specific isotope analyses in trophic studies.	[Bradley, Christina J.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Madigan, Daniel J.] Tuna Res & Conservat Ctr, Pacific Grove, CA USA; [Madigan, Daniel J.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Block, Barbara A.] Monterey Bay Aquarium, Monterey, CA USA; [Popp, Brian N.] Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA	University of Hawaii System; Stanford University; Monterey Bay Aquarium Research Institute; University of Hawaii System	Bradley, CJ (corresponding author), Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA.	cjbradle@hawaii.edu		Popp, Brian/0000-0001-7021-5478	National Science Foundation [OCE1041329]; Direct For Biological Sciences [1305791] Funding Source: National Science Foundation; Directorate For Geosciences [1041329] Funding Source: National Science Foundation; Division Of Ocean Sciences [1040810] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This material is based upon work supported by the National Science Foundation under Grant No. OCE1041329 to Brian N. Popp and Jeffrey C. Drazen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliff W.H., 1991, Inter-American Tropical Tuna Commission Bulletin, V20, P1; Bosley KL, 2002, MAR ECOL PROG SER, V236, P233, DOI 10.3354/meps236233; Buchheister A, 2010, CAN J FISH AQUAT SCI, V67, P445, DOI 10.1139/F09-196; Carleton SA, 2010, FUNCTIONAL ECOLOGY, P9999; Carleton SA, 2008, RAPID COMMUN MASS SP, V22, P3008, DOI 10.1002/rcm.3691; Cerling TE, 2007, OECOLOGIA, V151, P175, DOI 10.1007/s00442-006-0571-4; Chikaraishi Y., 2010, FURTHER EVALUATION T, P37; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Choy CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050133; Cowie GL, 1992, LIMNOLOGY OCEANOGRAP, V37; Dale JJ, 2011, MARINE ECOLOGY PROGR, V433; del Rio CM, 2008, OECOLOGIA, V156, P765, DOI 10.1007/s00442-008-1040-z; del Rio CM, 2012, J MAMMAL, V93, P353, DOI 10.1644/11-MAMM-S-165.1; Emmett RL, 2005, CAL COOP OCEAN FISH, V46, P122; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Guelinckx J, 2007, MAR ECOL PROG SER, V341, P205, DOI 10.3354/meps341205; Guelinckx J, 2008, OECOLOGIA, V157, P41, DOI 10.1007/s00442-008-1045-7; Hannides CCS, 2009, LIMNOL OCEANOGR, V54, P50, DOI 10.4319/lo.2009.54.1.0050; HARE PE, 1991, J ARCHAEOL SCI, V18, P277; Herzka SZ, 2005, ESTUAR COAST SHELF S, V64, P58, DOI 10.1016/j.ecss.2005.02.006; Herzka SZ, 2001, J EXP MAR BIOL ECOL, V265, P49, DOI 10.1016/S0022-0981(01)00324-0; Hesslein RH, 1993, CANADIAN J FISHERIES, V50; Hobson KA, 1992, CONDOR, V94; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lorrain A, 2009, MAR ECOL PROG SER, V391, P293, DOI 10.3354/meps08215; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; Madigan DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049220; Martinez-Montano E, 2010, AQUACULTURE, V299, P134, DOI 10.1016/j.aquaculture.2009.12.003; McCarthy MD, 2007, GEOCHIM COSMOCHIM AC, V71, P4727, DOI 10.1016/j.gca.2007.06.061; McCarthy MD, 2013, GEOCHIM COSMOCHIM AC, V103, P104, DOI 10.1016/j.gca.2012.10.037; McClelland JW, 2003, DEEP-SEA RES PT I, V50, P849, DOI 10.1016/S0967-0637(03)00073-6; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; McCullagh J, 2008, RAPID COMMUN MASS SP, V22, P1817, DOI 10.1002/rcm.3554; Metges CC, 1996, J MASS SPECTROM, V31, P367, DOI 10.1002/(SICI)1096-9888(199604)31:4<367::AID-JMS310>3.0.CO;2-V; Mill AC, 2007, FUNCT ECOL, V21, P1137, DOI 10.1111/j.1365-2435.2007.01330.x; Miller TW, 2010, MAR ECOL PROG SER, V420, P15, DOI 10.3354/meps08876; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2006, OECOLOGIA, V147, P195, DOI 10.1007/s00442-005-0292-0; Podlesak DW, 2005, OECOLOGIA, V142, P501, DOI 10.1007/s00442-004-1737-6; Popp B.N., 2007, INSIGHT TROPHIC ECOL; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Revill AT, 2009, MAR BIOL, V156, P1241, DOI 10.1007/s00227-009-1166-5; Rosas A, 2008, AQUACULT NUTR, V14, DOI 10.1111/j.1365-2095.2007.00553.x; Sherwood OA, 2011, P NATL ACAD SCI USA, V108, P1011, DOI 10.1073/pnas.1004904108; Styring AK, 2010, GEOCHIM COSMOCHIM AC, V74, P241, DOI 10.1016/j.gca.2009.09.022; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; UEDA K, 1989, ANAL CHEM, V61, P265, DOI 10.1021/ac00178a015; Vollaire Y, 2007, COMP BIOCHEM PHYS A, V148, P504, DOI 10.1016/j.cbpa.2007.06.419; Wolf N, 2009, FUNCTIONAL ECOLOGY, V23	50	51	51	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85818	10.1371/journal.pone.0085818	http://dx.doi.org/10.1371/journal.pone.0085818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465724	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100078
J	Yu, CG; Tonikian, R; Felsensteiner, C; Jhingree, JR; Desveaux, D; Sidhu, SS; Harris, TJC				Yu, Cao Guo; Tonikian, Raffi; Felsensteiner, Corinna; Jhingree, Jacquelyn R.; Desveaux, Darrell; Sidhu, Sachdev S.; Harris, Tony J. C.			Peptide Binding Properties of the Three PDZ Domains of Bazooka (Drosophila Par-3)	PLOS ONE			English	Article							LIPID PHOSPHATASE PTEN; CELL POLARITY; EPITHELIAL POLARITY; PROTEINS; COMPLEX; APKC; ESTABLISHMENT; LOCALIZATION; POLARIZATION; ASSOCIATION	The Par complex is a conserved cell polarity regulator. Bazooka/Par-3 is scaffold for the complex and contains three PDZ domains in tandem. PDZ domains can act singly or synergistically to bind the C-termini of interacting proteins. Sequence comparisons among Drosophila Baz and its human and C. elegans Par-3 counterparts indicate a divergence of the peptide binding pocket of PDZ1 and greater conservation for the pockets of PDZ2 and PDZ3. However, it is unclear whether the domains from different species share peptide binding preferences, or if their tandem organization affects their peptide binding properties. To investigate these questions, we first used phage display screens to identify unique peptide binding profiles for each single PDZ domain of Baz. Comparisons with published phage display screens indicate that Baz and C. elegans PDZ2 bind to similar peptides, and that the peptide binding preferences of Baz PDZ3 are more similar to C. elegans versus human PDZ3. Next we quantified the peptide binding preferences of each Baz PDZ domain using single identified peptides in surface plasmon resonance assays. In these direct binding studies, each peptide had a binding preference for a single PDZ domain (although the peptide binding of PDZ2 was weakest and the least specific). PDZ1 and PDZ3 bound their peptides with dissociation constants in the nM range, whereas PDZ2-peptide binding was in the mM range. To test whether tandem PDZ domain organization affects peptide binding, we examined a fusion protein containing all three PDZ domains and their normal linker regions. The binding strengths of the PDZ-specific peptides to single PDZ domains and to the PDZ domain tandem were indistinguishable. Thus, the peptide binding pockets of each PDZ domain in Baz are not obviously affected by the presence of neighbouring PDZ domains, but act as isolated modules with specific in vitro peptide binding preferences.	[Yu, Cao Guo; Desveaux, Darrell; Harris, Tony J. C.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Tonikian, Raffi; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Tonikian, Raffi; Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Tonikian, Raffi; Sidhu, Sachdev S.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Felsensteiner, Corinna; Jhingree, Jacquelyn R.; Desveaux, Darrell] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Harris, TJC (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	tony.harris@utoronto.ca			Canadian Institute of Health Research (CIHR) [MOP 82829, MOP 93684]; Natural Sciences and Engineering Research Council of Canada Discovery Grant	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	TJCH and DD hold Tier 2 Canada Research Chairs. Work supported by a Canadian Institute of Health Research (CIHR) operating grant (MOP 82829) to TH, a CIHR operating grant (MOP 93684) to SSS, and a Natural Sciences and Engineering Research Council of Canada Discovery Grant to DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Chau AH, 2012, CELL, V151, P320, DOI 10.1016/j.cell.2012.08.040; Feng W, 2003, NAT STRUCT BIOL, V10, P972, DOI 10.1038/nsb992; Feng W, 2008, J BIOL CHEM, V283, P23440, DOI 10.1074/jbc.M802482200; Fletcher GC, 2012, CURR BIOL, V22, P1116, DOI 10.1016/j.cub.2012.04.020; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Harris BZ, 2001, J CELL SCI, V114, P3219; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Krahn MP, 2010, CURR BIOL, V20, P636, DOI 10.1016/j.cub.2010.01.065; Lee AHY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002523; Li J, 2010, DEV BIOL, V340, P88, DOI 10.1016/j.ydbio.2010.01.023; Long JF, 2008, J MOL BIOL, V375, P1457, DOI 10.1016/j.jmb.2007.11.088; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McKinley RFA, 2012, J CELL SCI, V125, P1177, DOI 10.1242/jcs.091884; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nourry Claire, 2003, Sci STKE, V2003, pRE7; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wasserscheid I, 2007, DEV DYNAM, V236, P1064, DOI 10.1002/dvdy.21089; Wei SY, 2005, DEV CELL, V8, P493, DOI 10.1016/j.devcel.2005.03.015; Wiggin GR, 2005, DEV CELL, V8, P803, DOI 10.1016/j.devcel.2005.05.007; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yu CG, 2012, MOL BIOL CELL, V23, P3743, DOI 10.1091/mbc.E12-03-0196	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86412	10.1371/journal.pone.0086412	http://dx.doi.org/10.1371/journal.pone.0086412			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466078	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100157
J	Gou, HF; Huang, J; Shi, HS; Chen, XC; Wang, YS				Gou, Hong-Feng; Huang, Juan; Shi, Hua-Shan; Chen, Xin-chuan; Wang, Yong-Sheng			Chemo-Immunotherapy with Oxaliplatin and Interleukin-7 Inhibits Colon Cancer Metastasis in Mice	PLOS ONE			English	Article							T-CELLS COOPERATE; IN-VIVO; ADOPTIVE IMMUNOTHERAPY; GENE-TRANSFER; IL-7; EXPRESSION; EXPANSION; MELANOMA; CD8(+); HOMEOSTASIS	Combination of immunotherapy and chemotherapy has shown promise for cancer. Interleukin-7 (IL-7) can potentially enhance immune responses against tumor, while oxaliplatin (OXP), a platinum-based drug, can promote a favorable immune microenvironment and stimulate anticancer immune responses. We evaluated the anti-tumor activity of IL-7 combining OXP against a murine colon carcinoma in vitro and in vivo and studied the tumor immune microenvironment to investigate whether the combined treatment affects on the local immune cell populations. Utilizing lung and abdomen metastasis models by inoculation of CT26 mice colon cancer cells, we evaluated the anti-tumor efficacy of combining IL-7 and OXP in mice models. Tumor immune microenvironment was evaluated by flow cytometric analysis and immunohistochemical staining. Our study showed that the in vivo administration of IL-7 combined with OXP markedly inhibited the growth of tumors in lung and abdomen metastasis models of colon cancer. IL-7 alone had no effect on tumor growth in mice and IL-7 did not alter cell sensitivity to OXP in culture. The antitumor effect of combining IL-7 and OXP correlated with a marked increase in the number of tumor-infiltrating activated CD8+ T cells and a marked decrease in the number of regulatory T (Treg) cells in spleen. Our data suggest that OXP plus IL-7 treatment inhibits tumor cell growth by immunoregulation rather than direct cytotoxicity. Our findings justify further evaluation of combining IL-7 and chemotherapy as a novel experimental cancer therapy.	[Gou, Hong-Feng; Huang, Juan] Sichuan Univ, West China Med Sch, West China Hosp, Dept Abdominal Canc,Canc Ctr,State Key Lab Biothe, Chengdu 610064, Peoples R China; [Shi, Hua-Shan] Sichuan Univ, West China Med Sch, West China Hosp, Dept Head & Neck Canc,Canc Ctr,State Key Lab Biot, Chengdu 610064, Peoples R China; [Chen, Xin-chuan] Sichuan Univ, West China Med Sch, West China Hosp, Dept Hematol, Chengdu 610064, Peoples R China; [Wang, Yong-Sheng] Sichuan Univ, West China Med Sch, West China Hosp, Dept Thorac Canc,Canc Ctr,State Key Lab Biotherap, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Wang, YS (corresponding author), Sichuan Univ, West China Med Sch, West China Hosp, Dept Thorac Canc,Canc Ctr,State Key Lab Biotherap, Chengdu 610064, Peoples R China.	wangys75@gmail.com		Shi, Hua-shan/0000-0002-9958-9892				Andersson A, 2009, J IMMUNOL, V182, P6951, DOI 10.4049/jimmunol.0803340; AOKI T, 1992, P NATL ACAD SCI USA, V89, P3850, DOI 10.1073/pnas.89.9.3850; Aspinall R, 2004, ANN NY ACAD SCI, V1019, P116, DOI 10.1196/annals.1297.021; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chen G, 2013, CANCER IMMUNOL IMMUN, V62, P203, DOI 10.1007/s00262-012-1388-0; Cho Y, 2003, CANCER RES, V63, P1555; DUBINETT SM, 1993, J IMMUNOL, V151, P6670; FREITAS AA, 1993, IMMUNOL TODAY, V14, P25, DOI 10.1016/0167-5699(93)90320-K; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gonzalez-Aparicio M, 2011, GUT, V60, P341, DOI 10.1136/gut.2010.211722; Hernandez-Alcoceba R, 2012, ONCOIMMUNOLOGY, V1, P97, DOI 10.4161/onci.1.1.17930; HOCK H, 1991, J EXP MED, V174, P1291, DOI 10.1084/jem.174.6.1291; Huang M, 2002, J CLIN INVEST, V109, P931, DOI 10.1172/JCI200214685; Ives NJ, 2007, J CLIN ONCOL, V25, P5426, DOI 10.1200/JCO.2007.12.0253; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; JICHA DL, 1991, J EXP MED, V174, P1511, DOI 10.1084/jem.174.6.1511; Kilinc MO, 2009, J IMMUNOL, V183, P7656, DOI 10.4049/jimmunol.0902625; KOS FJ, 1993, J IMMUNOL, V150, P387; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lai LJ, 2011, CANCER RES, V71, P61, DOI 10.1158/0008-5472.CAN-10-3198; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Le Saout C, 2008, P NATL ACAD SCI USA, V105, P19414, DOI 10.1073/pnas.0807743105; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Li B, 2007, CLIN IMMUNOL, V123, P155, DOI 10.1016/j.clim.2007.01.002; Liu SJ, 2007, INT IMMUNOL, V19, P1213, DOI 10.1093/intimm/dxm093; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; MEHROTRA PT, 1995, J IMMUNOL, V154, P5093; MILLER AR, 1993, BLOOD, V82, P3686; Molino A, 1997, INT J CANCER, V74, P433, DOI 10.1002/(SICI)1097-0215(19970822)74:4<433::AID-IJC12>3.0.CO;2-A; Moller P, 1998, BRIT J CANCER, V77, P1907, DOI 10.1038/bjc.1998.317; MURPHY WJ, 1993, J CLIN INVEST, V92, P1918, DOI 10.1172/JCI116785; Overwijk WW, 2009, CLIN IMMUNOL, V132, P153, DOI 10.1016/j.clim.2009.03.512; Pellegrini M, 2009, NAT MED, V15, P528, DOI 10.1038/nm.1953; Ridolfi R, 2002, J CLIN ONCOL, V20, P1600, DOI 10.1200/JCO.20.6.1600; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Sharma S, 2003, HUM GENE THER, V14, P1511, DOI 10.1089/104303403322495025; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sin JI, 2000, CLIN DIAGN LAB IMMUN, V7, P751, DOI 10.1128/CDLI.7.5.751-758.2000; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356	45	37	38	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85789	10.1371/journal.pone.0085789	http://dx.doi.org/10.1371/journal.pone.0085789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465710	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500114
J	Lund, ME; O'Brien, BA; Hutchinson, AT; Robinson, MW; Simpson, AM; Dalton, JP; Donnelly, S				Lund, Maria E.; O'Brien, Bronwyn A.; Hutchinson, Andrew T.; Robinson, Mark W.; Simpson, Ann M.; Dalton, John P.; Donnelly, Sheila			Secreted Proteins from the Helminth Fasciola hepatica Inhibit the Initiation of Autoreactive T Cell Responses and Prevent Diabetes in the NOD Mouse	PLOS ONE			English	Article							TRICHURIS-SUIS THERAPY; SCHISTOSOMA-MANSONI; B-CELLS; TGF-BETA; AUTOIMMUNE; MACROPHAGES; INFECTION; ANTIGENS; MICE; IDENTIFICATION	Infections with helminth parasites prevent/attenuate auto-inflammatory disease. Here we show that molecules secreted by a helminth parasite could prevent Type 1 Diabetes (T1D) in nonobese diabetic (NOD) mice. When delivered at 4 weeks of age (coincident with the initiation of autoimmunity), the excretory/secretory products of Fasciola hepatica (FhES) prevented the onset of T1D, with 84% of mice remaining normoglycaemic and insulitis-free at 30 weeks of age. Disease protection was associated with suppression of IFN-gamma secretion from autoreactive T cells and a switch to the production of a regulatory isotype (from IgG2a to IgG1) of autoantibody. Following FhES injection, peritoneal macrophages converted to a regulatory M2 phenotype, characterised by increased expression levels of Ym1, Arg-1, TGF beta and PD-L1. Expression of these M2 genetic markers increased in the pancreatic lymph nodes and the pancreas of FhES-treated mice. In vitro, FhES-stimulated M2 macrophages induced the differentiation of Tregs from splenocytes isolated from naive NOD mice. Collectively, our data shows that FhES contains immune-modulatory molecules that mediate protection from autoimmune diabetes via the induction and maintenance of a regulatory immune environment.	[Lund, Maria E.; O'Brien, Bronwyn A.; Hutchinson, Andrew T.; Simpson, Ann M.] Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia; [Robinson, Mark W.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Dalton, John P.] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ, Canada; [Donnelly, Sheila] Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia	University of Technology Sydney; Queens University Belfast; McGill University; University of Technology Sydney	Donnelly, S (corresponding author), Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia.	sheila.donnelly@uts.edu.au	Dalton, John/K-4457-2014; Donnelly, Sheila/H-7733-2014	Donnelly, Sheila/0000-0003-2005-3698; Robinson, Mark/0000-0001-7191-0034; Lund, Maria/0000-0001-7360-5041	National Health and Medical Research Council (NHMRC) [APP1010197]; Juvenile Diabetes Research Foundation (JDRF) [4-2006-1025]; Canadian Institute of Health Research (CIHR); National Science and Engineering Research Council (NSERC)	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a National Health and Medical Research Council (NHMRC) project grant (APP1010197) and the Juvenile Diabetes Research Foundation (JDRF) research grant (4-2006-1025). J.P.D. is a Canada Research Chair in Infectious diseases and is funded by the Canadian Institute of Health Research (CIHR) and National Science and Engineering Research Council (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001368; Alam C, 2010, DIABETOLOGIA, V53, P346, DOI 10.1007/s00125-009-1599-x; Alleva DG, 2000, DIABETES, V49, P1106, DOI 10.2337/diabetes.49.7.1106; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Aravindhan V, 2010, AM J TROP MED HYG, V83, P1336, DOI 10.4269/ajtmh.2010.10-0410; Bilbo SD, 2011, MED HYPOTHESES, V77, P494, DOI 10.1016/j.mehy.2011.06.019; Boukli NM, 2011, J PARASITOL, V97, P852, DOI 10.1645/GE-2495.1; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002883; Burton OT, 2010, J IMMUNOL, V185, P2754, DOI 10.4049/jimmunol.1001365; Calderon B, 2008, J IMMUNOL, V181, P6964, DOI 10.4049/jimmunol.181.10.6964; Cooke A, 1999, PARASITE IMMUNOL, V21, P169, DOI 10.1046/j.1365-3024.1999.00213.x; Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067; Donnelly S, 2005, INFECT IMMUN, V73, P166, DOI 10.1128/IAI.73.1.166-173.2005; Donnelly S, 2008, FASEB J, V22, P4022, DOI 10.1096/fj.08-106278; Donnelly S, 2010, J BIOL CHEM, V285, P3383, DOI 10.1074/jbc.M109.060368; Dowling DJ, 2010, INFECT IMMUN, V78, P793, DOI 10.1128/IAI.00573-09; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Espinoza-Jimenez A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/850541; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Gaisford W, 2009, CURR OPIN RHEUMATOL, V21, P391, DOI 10.1097/BOR.0b013e32832c2dee; Gillan V, 2005, INT IMMUNOL, V17, P373, DOI 10.1093/intimm/dxh217; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Hernandez HJ, 1997, J IMMUNOL, V158, P4832; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hubner MP, 2009, IMMUNOLOGY, V127, P512, DOI 10.1111/j.1365-2567.2008.02958.x; Hussain S, 2007, J IMMUNOL, V179, P7225, DOI 10.4049/jimmunol.179.11.7225; Jaakkola I, 2003, EUR J IMMUNOL, V33, P3255, DOI 10.1002/eji.200324405; Jun HS, 1999, J EXP MED, V189, P347, DOI 10.1084/jem.189.2.347; Kodama K, 2008, CLIN IMMUNOL, V129, P195, DOI 10.1016/j.clim.2008.07.028; Liu Q, 2009, INFECT IMMUN, V77, P5347, DOI 10.1128/IAI.01170-08; Loke P, 2000, EUR J IMMUNOL, V30, P1127, DOI 10.1002/(SICI)1521-4141(200004)30:4&lt;1127::AID-IMMU1127&gt;3.0.CO;2-#; Maizels Rick M., 2008, V94, P112, DOI 10.1159/000154944; McKenna M, 2012, DIABETES MYSTERY WHY; Mishra PK, 2013, MUCOSAL IMMUNOL, V6, P297, DOI 10.1038/mi.2012.71; O'Neill SM, 2001, PARASITE IMMUNOL, V23, P541, DOI 10.1046/j.1365-3024.2001.00411.x; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Osada Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/743758; Parsa R, 2012, DIABETES, V61, P2881, DOI 10.2337/db11-1635; Robinson MW, 2012, FASEB J, V26, P4614, DOI 10.1096/fj.12-213876; Robinson MW, 2009, MOL CELL PROTEOMICS, V8, P1891, DOI 10.1074/mcp.M900045-MCP200; Saunders KA, 2007, INFECT IMMUN, V75, P397, DOI 10.1128/IAI.00664-06; Schebesch C, 1997, IMMUNOLOGY, V92, P478, DOI 10.1046/j.1365-2567.1997.00371.x; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Turley SJ, 2005, P NATL ACAD SCI USA, V102, P17729, DOI 10.1073/pnas.0509006102; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803; Wilson MS, 2010, EUR J IMMUNOL, V40, P1682, DOI 10.1002/eji.200939721; Zaccone P, 2006, PARASITE IMMUNOL, V28, P515, DOI 10.1111/j.1365-3024.2006.00879.x; Zaccone P, 2003, EUR J IMMUNOL, V33, P1439, DOI 10.1002/eji.200323910; Zaccone P, 2011, EUR J IMMUNOL, V41, P2709, DOI 10.1002/eji.201141429; Zaccone P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795210; Zaccone P, 2009, EUR J IMMUNOL, V39, P1098, DOI 10.1002/eji.200838871	53	48	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86289	10.1371/journal.pone.0086289	http://dx.doi.org/10.1371/journal.pone.0086289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466007	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500218
J	San Martin, A; Ceballo, S; Baeza-Lehnert, F; Lerchundi, R; Valdebenito, R; Contreras-Baeza, Y; Alegria, K; Barros, LF				San Martin, Alejandro; Ceballo, Sebastian; Baeza-Lehnert, Felipe; Lerchundi, Rodrigo; Valdebenito, Rocio; Contreras-Baeza, Yasna; Alegria, Karin; Felipe Barros, L.			Imaging Mitochondrial Flux in Single Cells with a FRET Sensor for Pyruvate	PLOS ONE			English	Article							IN-VIVO; GLYCOLYSIS; TRANSPORT; CARRIER; STIMULATION; ASTROCYTES; CALCIUM; LACTATE; CITRATE; MUSCLE	Mitochondrial flux is currently accessible at low resolution. Here we introduce a genetically-encoded FRET sensor for pyruvate, and methods for quantitative measurement of pyruvate transport, pyruvate production and mitochondrial pyruvate consumption in intact individual cells at high temporal resolution. In HEK293 cells, neurons and astrocytes, mitochondrial pyruvate uptake was saturated at physiological levels, showing that the metabolic rate is determined by intrinsic properties of the organelle and not by substrate availability. The potential of the sensor was further demonstrated in neurons, where mitochondrial flux was found to rise by 300% within seconds of a calcium transient triggered by a short theta burst, while glucose levels remained unaltered. In contrast, astrocytic mitochondria were insensitive to a similar calcium transient elicited by extracellular ATP. We expect the improved resolution provided by the pyruvate sensor will be of practical interest for basic and applied researchers interested in mitochondrial function.	[San Martin, Alejandro; Ceballo, Sebastian; Baeza-Lehnert, Felipe; Lerchundi, Rodrigo; Valdebenito, Rocio; Contreras-Baeza, Yasna; Alegria, Karin; Felipe Barros, L.] Ctr Estudios Cient, Valdivia, Chile; [San Martin, Alejandro; Lerchundi, Rodrigo; Contreras-Baeza, Yasna] Univ Austral Chile, Valdivia, Chile	Universidad Austral de Chile	Barros, LF (corresponding author), Ctr Estudios Cient, Valdivia, Chile.	fbarros@cecs.cl	Ceballo, Sebastian/B-2372-2016; Ceballo, Sebastian/M-2902-2019	Ceballo, Sebastian/0000-0001-7710-421X; San Martin, Alejandro/0000-0002-5608-5117	CONICYT-Chile; Deutsche Forschungsgemeinschaft [DFG-12, DE 231/25-1]; Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT	CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT	This work was partly funded by a joint grant from CONICYT-Chile and the Deutsche Forschungsgemeinschaft to L. Felipe Barros and Joachim W. Deitmer (DFG-12, DE 231/25-1). The Centro de Estudios Cientificos (CECs) is funded by the Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albensi BC, 2007, EXP NEUROL, V204, P1, DOI 10.1016/j.expneurol.2006.12.009; Barros LF, 2010, BRAIN RES REV, V63, P149, DOI 10.1016/j.brainresrev.2009.10.002; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Bittner CX, 2010, FRONT NEUROENERGETIC, V2, P1, DOI [10.3389/fnene.2010.00026, DOI 10.3389/FNENE.2010.00026]; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brennan AM, 2006, J CEREBR BLOOD F MET, V26, P1389, DOI 10.1038/sj.jcbfm.9600292; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brix B, 2012, J NEUROSCI, V32, P9727, DOI 10.1523/JNEUROSCI.0879-12.2012; Cerdan S, 2006, NEUROCHEM INT, V48, P523, DOI 10.1016/j.neuint.2005.12.036; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Gellerich FN, 2013, IUBMB LIFE, V65, P180, DOI 10.1002/iub.1131; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; KAUPPINEN RA, 1982, BIOCHIM BIOPHYS ACTA, V681, P286, DOI 10.1016/0005-2728(82)90033-0; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Ovens MJ, 2010, BIOCHEM J, V425, P523, DOI 10.1042/BJ20091515; PANDE SV, 1978, J BIOL CHEM, V253, P1565; PARADIES G, 1983, CANCER RES, V43, P5068; Pelkmans L, 2012, SCIENCE, V336, P425, DOI 10.1126/science.1222161; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; QUAIL MA, 1995, MOL MICROBIOL, V15, P519, DOI 10.1111/j.1365-2958.1995.tb02265.x; Ruminot I, 2011, J NEUROSCI, V31, P14264, DOI 10.1523/JNEUROSCI.2310-11.2011; Saha AK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1030, DOI 10.1152/ajpendo.1999.276.6.E1030; San Martin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057712; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SIESS EA, 1978, H-S Z PHYSIOL CHEM, V359, P785, DOI 10.1515/bchm2.1978.359.2.785; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; Xu P, 2008, J BIOSCI BIOENG, V105, P169, DOI 10.1263/jbb.105.169; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zhao YZ, 2011, CELL METAB, V14, P555, DOI 10.1016/j.cmet.2011.09.004	36	107	112	7	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85780	10.1371/journal.pone.0085780	http://dx.doi.org/10.1371/journal.pone.0085780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465702	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500111
J	Tomita, T; Tanaka, S; Sato, K; Nakaya, K				Tomita, Taketeru; Tanaka, Sho; Sato, Keiichi; Nakaya, Kazuhiro			Pectoral Fin of the Megamouth Shark: Skeletal and Muscular Systems, Skin Histology, and Functional Morphology	PLOS ONE			English	Article							MEGACHASMA-PELAGIOS	This is the first known report on the skeletal and muscular systems, and the skin histology, of the pectoral fin of the rare planktivorous megamouth shark Megachasma pelagios. The pectoral fin is characterized by three features: 1) a large number of segments in the radial cartilages; 2) highly elastic pectoral fin skin; and 3) a vertically-rotated hinge joint at the pectoral fin base. These features suggest that the pectoral fin of the megamouth shark is remarkably flexible and mobile, and that this flexibility and mobility enhance dynamic lift control, thus allowing for stable swimming at slow speeds. The flexibility and mobility of the megamouth shark pectoral fin contrasts with that of fast-swimming sharks, such as Isurus oxyrhinchus and Lamna ditropis, in which the pectoral fin is stiff and relatively immobile.	[Tomita, Taketeru] Hokkaido Univ Museum, Hakodate, Hokkaido, Japan; [Tomita, Taketeru] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Tanaka, Sho] Tokai Univ, Sch Marine Sci & Technol, Shimizu, Shizuoka, Japan; [Sato, Keiichi] Okinawa Churashima Fdn, Okinawa Churashima Res Ctr, Motobu, Okinawa, Japan; [Nakaya, Kazuhiro] Hokkaido Univ, Hakodate, Hokkaido, Japan	Hokkaido University; University of California System; University of California Davis; Tokai University; Hokkaido University	Tomita, T (corresponding author), Hokkaido Univ Museum, Hakodate, Hokkaido, Japan.	teruteru-saurus@hotmail.co.jp			Japanese Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [11J05588] Funding Source: KAKEN	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work project was supported by Japanese Society for the Promotion of Science (JSPS). http://www.jsps.go.jp/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Compagno L.J, 1984, SHARKS WORLD; Compagno L. J. V., 1990, NOAA TECHNICAL REPOR, V90, P357; Compagno L.J.V., 1988, SHARKS ORDER CARCHAR; COMPAGNO LJV, 1977, AM ZOOL, V17, P303; Fish FE, 2002, INTEGR COMP BIOL, V42, P85, DOI 10.1093/icb/42.1.85; Garman S., 1913, Memoirs of the Museum of Comparative Zoology at Harvard College Cambridge, V36; Goto T, 1997, MEM GRAD SCH FISH SC, V48, P1; Haswell WA, 1885, P LINN SOC N S W, V9, P71; JORDAN DS, 1898, P CALIFORNIA ACAD SC, V1, P199; MAISEY JG, 1985, COPEIA, P228; Matsumoto R, 2007, THESIS HOKKAIDO U; Nakaya K, 2008, J FISH BIOL, V73, P17, DOI 10.1111/j.1095-8649.2008.01880.x; NAKAYA K, 1975, Memoirs of the Faculty of Fisheries Hokkaido University, V23, P1; Nakaya Kazuhiro, 2001, Bulletin of Fisheries Sciences Hokkaido University, V52, P125; Nelson DR, 1997, ENVIRON BIOL FISH, V49, P389, DOI 10.1023/A:1007369619576; Shirai S., 1992, SQUALEAN PHYLOGENY N; TAYLOR L R, 1983, Proceedings of the California Academy of Sciences, V43, P87; Tomita T, 2011, J MORPHOL, V272, P513, DOI 10.1002/jmor.10905; Webb PW, 2006, FISH PHYSIOL, V23, P281, DOI 10.1016/S1546-5098(05)23008-X; WHITE E. GRACE, 1937, BULL AMER MUS NAT HIST, V74, P25; Wilga CD, 2002, J EXP BIOL, V205, P2365; Wilga CD, 2001, J MORPHOL, V249, P195, DOI 10.1002/jmor.1049; Wilga CD, 2000, J EXP BIOL, V203, P2261	23	11	11	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86205	10.1371/journal.pone.0086205	http://dx.doi.org/10.1371/journal.pone.0086205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465959	gold, Green Published			2022-12-25	WOS:000330244500202
J	Vera, J; Pezzoli, M; Pereira, U; Bacigalupo, J; Sanhueza, M				Vera, Jorge; Pezzoli, Maurizio; Pereira, Ulises; Bacigalupo, Juan; Sanhueza, Magdalena			Electrical Resonance in the theta Frequency Range in Olfactory Amygdala Neurons	PLOS ONE			English	Article							CORTEX LAYER-II; MEDIAL ENTORHINAL CORTEX; STELLATE CELLS; SUBTHRESHOLD OSCILLATIONS; HIPPOCAMPAL-NEURONS; PYRAMIDAL NEURONS; IN-VITRO; IONIC MECHANISMS; ELECTROPHYSIOLOGICAL PROPERTIES; INTRINSIC OSCILLATIONS	The cortical amygdala receives direct olfactory inputs and is thought to participate in processing and learning of biologically relevant olfactory cues. As for other brain structures implicated in learning, the principal neurons of the anterior cortical nucleus (ACo) exhibit intrinsic subthreshold membrane potential oscillations in the theta-frequency range. Here we show that nearly 50% of ACo layer II neurons also display electrical resonance, consisting of selective responsiveness to stimuli of a preferential frequency (2-6 Hz). Their impedance profile resembles an electrical band-pass filter with a peak at the preferred frequency, in contrast to the low-pass filter properties of other neurons. Most ACo resonant neurons displayed frequency preference along the whole subthreshold voltage range. We used pharmacological tools to identify the voltage-dependent conductances implicated in resonance. A hyperpolarization-activated cationic current depending on HCN channels underlies resonance at resting and hyperpolarized potentials; notably, this current also participates in resonance at depolarized subthreshold voltages. KV7/KCNQ K+ channels also contribute to resonant behavior at depolarized potentials, but not in all resonant cells. Moreover, resonance was strongly attenuated after blockade of voltage-dependent persistent Na+ channels, suggesting an amplifying role. Remarkably, resonant neurons presented a higher firing probability for stimuli of the preferred frequency. To fully understand the mechanisms underlying resonance in these neurons, we developed a comprehensive conductance-based model including the aforementioned and leak conductances, as well as Hodgkin and Huxley-type channels. The model reproduces the resonant impedance profile and our pharmacological results, allowing a quantitative evaluation of the contribution of each conductance to resonance. It also replicates selective spiking at the resonant frequency and allows a prediction of the temperature-dependent shift in resonance frequency. Our results provide a complete characterization of the resonant behavior of olfactory amygdala neurons and shed light on a putative mechanism for network activity coordination in the intact brain.	[Vera, Jorge; Pezzoli, Maurizio; Pereira, Ulises; Bacigalupo, Juan; Sanhueza, Magdalena] Univ Chile, Fac Sci, Dept Biol, Santiago, Chile	Universidad de Chile	Sanhueza, M (corresponding author), Univ Chile, Fac Sci, Dept Biol, Santiago, Chile.	masanhue@uchile.cl	Vera, Jorge/HDO-5376-2022	Pezzoli, Maurizio/0000-0002-5763-3031	Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN [ICM-P05-001-F]; Fondo Nacional de Ciencia y Tecnologia (FONDECYT) [1080630, 1100682]; Consejo Nacional de Ciencia y Tecnologia (CONICYT)	Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN; Fondo Nacional de Ciencia y Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Consejo Nacional de Ciencia y Tecnologia (CONICYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Supported by Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN ICM-P05-001-F (JB, MS), Fondo Nacional de Ciencia y Tecnologia (FONDECYT) 1080630 (MS), 1100682 (JB), Doctoral Fellowship and Thesis grant by the Consejo Nacional de Ciencia y Tecnologia (CONICYT) (JV, MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PR, 1982, J PHYSIOL-LONDON, V330, P537, DOI 10.1113/jphysiol.1982.sp014357; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Boehlen A, 2013, J NEUROPHYSIOL, V109, P445, DOI 10.1152/jn.00743.2011; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; Burton BG, 2008, J NEUROPHYSIOL, V100, P3144, DOI 10.1152/jn.90424.2008; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cang JH, 2003, J NEUROSCI, V23, P4108; Carnevale NT, 2006, NEURON BOOK; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Ehrlich DE, 2012, J PHYSIOL-LONDON, V590, P4819, DOI 10.1113/jphysiol.2012.237453; Erchova I, 2004, J PHYSIOL-LONDON, V560, P89, DOI 10.1113/jphysiol.2004.069930; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; FRENCH CR, 1990, J GEN PHYSIOL, V95, P1139, DOI 10.1085/jgp.95.6.1139; Gire DH, 2013, NAT NEUROSCI, V16, P991, DOI 10.1038/nn.3432; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; Haas JS, 2002, J NEUROPHYSIOL, V88, P2422, DOI 10.1152/jn.00598.2002; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; Hu H, 2009, J NEUROSCI, V29, P14472, DOI 10.1523/JNEUROSCI.0187-09.2009; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683, DOI 10.1152/jn.1996.76.2.683; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Kajiwara R, 2007, EUR J NEUROSCI, V25, P3648, DOI 10.1111/j.1460-9568.2007.05610.x; Kalimullina L B, 2004, Neurosci Behav Physiol, V34, P551, DOI 10.1023/B:NEAB.0000028283.55130.69; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kepecs A, 2007, J NEUROPHYSIOL, V98, P205, DOI 10.1152/jn.00071.2007; KLINK R, 1993, J NEUROPHYSIOL, V70, P144, DOI 10.1152/jn.1993.70.1.144; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; KOCH C, 1984, BIOL CYBERN, V50, P15, DOI 10.1007/BF00317936; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leung LS, 1998, J NEUROPHYSIOL, V79, P1592, DOI 10.1152/jn.1998.79.3.1592; LEUNG LWS, 1991, BRAIN RES, V553, P261, DOI 10.1016/0006-8993(91)90834-I; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Luthi A, 1999, NAT NEUROSCI, V2, P634, DOI 10.1038/10189; MACRIDES F, 1982, J NEUROSCI, V2, P1705; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Magee JC, 1998, J NEUROSCI, V18, P7613; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Miura K, 2012, NEURON, V74, P1087, DOI 10.1016/j.neuron.2012.04.021; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; Pape HC, 1998, J NEUROPHYSIOL, V79, P217, DOI 10.1152/jn.1998.79.1.217; Pape HC, 1998, J NEUROPHYSIOL, V79, P205, DOI 10.1152/jn.1998.79.1.205; Pare D, 2000, J NEUROSCI, V20, P2701; Paxinos G, 1999, CHEMOARCHITECTONIC A; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; PUIL E, 1987, J NEUROPHYSIOL, V58, P66, DOI 10.1152/jn.1987.58.1.66; Richardson MJE, 2003, J NEUROPHYSIOL, V89, P2538, DOI 10.1152/jn.00955.2002; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sanhueza M, 2005, EUR J NEUROSCI, V22, P1618, DOI 10.1111/j.1460-9568.2005.04341.x; Sevelinges Y, 2004, LEARN MEMORY, V11, P761, DOI 10.1101/lm.83604; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; SPAIN WJ, 1987, J NEUROPHYSIOL, V57, P1555, DOI 10.1152/jn.1987.57.5.1555; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Ulrich D, 2002, J NEUROPHYSIOL, V87, P2753, DOI 10.1152/jn.2002.87.6.2753; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang WT, 2006, NEUROSCIENCE, V140, P45, DOI 10.1016/j.neuroscience.2006.01.033; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wesson DW, 2008, CHEM SENSES, V33, P581, DOI 10.1093/chemse/bjn029; Wilson DA, 2001, CHEM SENSES, V26, P577, DOI 10.1093/chemse/26.5.577	70	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85826	10.1371/journal.pone.0085826	http://dx.doi.org/10.1371/journal.pone.0085826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465729	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500121
J	Wolfle, JV; Fiedler, J; Durselen, L; Reichert, J; Scharnweber, D; Forster, A; Schwenzer, B; Reichel, H; Ignatius, A; Brenner, RE				Woelfle, Julia V.; Fiedler, Joerg; Duerselen, Lutz; Reichert, Judith; Scharnweber, Dieter; Foerster, Anne; Schwenzer, Bernd; Reichel, Heiko; Ignatius, Anita; Brenner, Rolf E.			Improved Anchorage of Ti6Al4V Orthopaedic Bone Implants through Oligonucleotide Mediated Immobilization of BMP-2 in Osteoporotic Rats	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; MORPHOGENETIC PROTEINS; DENTAL IMPLANTS; CHEMOTACTIC MIGRATION; SURFACE MODIFICATION; OVARIECTOMIZED RATS; TITANIUM SURFACES; OSSEOINTEGRATION; OSTEOBLAST; WOMEN	The aim of the present study was to test the biocompatibility and functionality of orthopaedic bone implants with immobilized oligonucleotides serving as anchor stands for rhBMP-2 and rhVEGF-A conjugated with complementary oligonucleotides in an osteoporotic rat model. Al2O3-blasted acid etched Ti6Al4V implants, carrying oligonucleotide anchor strands and hybridized with rhBMP-2 or rhVEGF-A through complementary 31-mer oligonucleotide stands were inserted into the proximal tibia of ovariectomized rats. At the time of surgery (15 weeks after ovariectomy) microCT analysis showed significantly lower bone mineral density compared to non-ovariectomized animals. Bone-implant contact (BIC) and pullout-force were not negatively affected by non-hybridized anchor strands. Twelve weeks after surgery, a significantly higher pullout force was found for BMP-2 hybridized to the anchor strands compared to non-hybridized anchor strands or native samples, and on histomorphometric analysis BIC was highest in the BMP group. Thus, we could show the biocompatibility and in vivo functionality of this modular, self-organizing system for immobilization and subsequent release of BMP-2 in vivo.	[Woelfle, Julia V.; Reichel, Heiko] Univ Ulm, Dept Orthopaed Surg, Ctr Musculoskeletal Res, D-89069 Ulm, Germany; [Fiedler, Joerg; Brenner, Rolf E.] Univ Ulm, Div Biochem Joint & Connect Tissue Dis, Dept Orthopaed Surg, Ctr Musculoskeletal Res, D-89069 Ulm, Germany; [Duerselen, Lutz; Ignatius, Anita] Univ Ulm, Ctr Musculoskeletal Res, Inst Orthopaed Res & Biomech, D-89069 Ulm, Germany; [Reichert, Judith; Scharnweber, Dieter] Tech Univ Dresden, Max Bergmann Ctr Biomat, Dresden, Germany; [Foerster, Anne; Schwenzer, Bernd] Tech Univ Dresden, Inst Biochem, Dresden, Germany	Ulm University; Ulm University; Ulm University; Technische Universitat Dresden; Technische Universitat Dresden	Brenner, RE (corresponding author), Univ Ulm, Div Biochem Joint & Connect Tissue Dis, Dept Orthopaed Surg, Ctr Musculoskeletal Res, D-89069 Ulm, Germany.	rolf.brenner@uni-ulm.de	Scharnweber, Dieter/AAJ-8464-2020; Ignatius, Anita/M-6012-2013; Scharnweber, Dieter/B-3382-2010; Dürselen, Lutz/B-9447-2012	Ignatius, Anita/0000-0002-4782-1979; Dürselen, Lutz/0000-0002-5470-5423; Fiedler, Jorg/0000-0002-5834-3730	German Federal Ministry of Education and Research (BMBF) [FKZ 13N1006]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work has been funded by a grant from the German Federal Ministry of Education and Research (BMBF, FKZ 13N1006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm JJ, 2009, ACTA ORTHOP, V80, P531, DOI 10.3109/17453670903316801; Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P610, DOI 10.1111/j.1600-051X.2007.01077.x; Aro HT, 2012, ACTA ORTHOP, V83, P107, DOI 10.3109/17453674.2012.678798; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74; Beutner R, 2009, BIOMATERIALS, V30, P2774, DOI 10.1016/j.biomaterials.2009.01.047; Bornstein MM, 2009, INT J ORAL MAX IMPL, V24, P12; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Dao T T, 1993, Int J Oral Maxillofac Implants, V8, P137; Dayer R, 2006, J BONE MINER RES, V21, P258, DOI 10.1359/JBMR.051009; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Ding WG, 2011, CONNECT TISSUE RES, V52, P25, DOI 10.3109/03008201003783011; Dvorak G, 2011, J CLIN PERIODONTOL, V38, P950, DOI 10.1111/j.1600-051X.2011.01772.x; Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116; Francisco JI, 2011, J ORTHOP RES, V29, P189, DOI 10.1002/jor.21217; Gaetti-Jardim EC, 2011, J CRANIOFAC SURG, V22, P1111, DOI 10.1097/SCS.0b013e3182108ec9; Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701; Holahan CM, 2008, INT J ORAL MAX IMPL, V23, P905; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; KALU DN, 1989, ENDOCRINOLOGY, V124, P7, DOI 10.1210/endo-124-1-7; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; Makinen TJ, 2007, BONE, V40, P1041, DOI 10.1016/j.bone.2006.11.013; Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1; Michael J, 2007, J BIOMED MATER RES B, V80B, P146, DOI 10.1002/jbm.b.30579; Michael J, 2009, BIOCONJUGATE CHEM, V20, P710, DOI 10.1021/bc800372e; Modder UI, 2008, J CELL BIOCHEM, V103, P393, DOI 10.1002/jcb.21423; Moriyama Y, 2008, CLIN ORAL IMPLAN RES, V19, P600, DOI 10.1111/j.1600-0501.2007.01508.x; Moy PK, 2005, INT J ORAL MAX IMPL, V20, P569; Okamura A, 2004, J BIOMED MATER RES A, V70A, P497, DOI 10.1002/jbm.a.30110; Ozawa S, 2002, BONE, V30, P137, DOI 10.1016/S8756-3282(01)00646-9; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; Sarban S, 2009, CLIN ORTHOP RELAT R, V467, P3113, DOI 10.1007/s11999-009-1004-6; Schliephake H, 2008, J MATER CHEM, V18, P2404, DOI 10.1039/b715355b; Schliephake H, 2012, EUR CELLS MATER, V23, P161, DOI 10.22203/eCM.v023a12; Schliephake H, 2012, BIOMATERIALS, V33, P1315, DOI 10.1016/j.biomaterials.2011.10.027; Stadlinger B, 2013, EUR CELLS MATER, V25, P326, DOI 10.22203/eCM.v025a23; Thorey F, 2010, TECHNOL HEALTH CARE, V18, P217, DOI 10.3233/THC-2010-0584; van den Beucken JJJR, 2007, J BIOMED MATER RES B, V81B, P231, DOI 10.1002/jbm.b.30658; WRONSKI TJ, 1989, CALCIFIED TISSUE INT, V45, P360, DOI 10.1007/BF02556007; WRONSKI TJ, 1985, CALCIFIED TISSUE INT, V37, P324, DOI 10.1007/BF02554882; Yamazaki M, 1999, ORAL SURG ORAL MED O, V87, P411, DOI 10.1016/S1079-2104(99)70239-8	41	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86151	10.1371/journal.pone.0086151	http://dx.doi.org/10.1371/journal.pone.0086151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465929	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500195
J	Zhang, Y; Cai, XY; Xiong, WN; Jiang, H; Zhao, HT; Yang, XH; Li, C; Fu, ZQ; Chen, JW				Zhang, Yu; Cai, Xiyun; Xiong, Weina; Jiang, Hao; Zhao, Haitong; Yang, Xianhai; Li, Chao; Fu, Zhiqiang; Chen, Jingwen			Molecular Insights into the pH-Dependent Adsorption and Removal of Ionizable Antibiotic Oxytetracycline by Adsorbent Cyclodextrin Polymers	PLOS ONE			English	Article							GRANULAR ACTIVATED CARBON; BETA-CYCLODEXTRIN; INCLUSION COMPLEXES; AQUEOUS-SOLUTION; NATURAL ENVIRONMENTS; ORGANIC POLLUTANTS; RESISTANCE GENES; HUMIC ACIDS; SORPTION; TETRACYCLINE	Effects of pH on adsorption and removal efficiency of ionizable organic compounds (IOCs) by environmental adsorbents are an area of debate, because of its dual mediation towards adsorbents and adsorbate. Here, we probe the pH-dependent adsorption of ionizable antibiotic oxytetracycline (comprising OTCH2+, OTCH +/-, OTC-, and OTC2-) onto cyclodextrin polymers (CDPs) with the nature of molecular recognition and pH inertness. OTCH +/- commonly has high adsorption affinity, OTC- exhibits moderate affinity, and the other two species have negligible affinity. These species are evidenced to selectively interact with structural units (e. g., CD cavity, pore channel, and network) of the polymers and thus immobilized onto the adsorbents to different extents. The differences in adsorption affinity and mechanisms of the species account for the pH-dependent adsorption of OTC. The mathematical equations are derived from the multiple linear regression (MLR) analysis of quantitatively relating adsorption affinity of OTC at varying pH to adsorbent properties. A combination of the MLR analysis for OTC and molecular recognition of adsorption of the species illustrates the nature of the pH-dependent adsorption of OTC. Based on this finding, gamma-HP-CDP is chosen to adsorb and remove OTC at pH 5.0 and 7.0, showing high removal efficiency and strong resistance to the interference of coexisting components.	[Zhang, Yu; Cai, Xiyun; Xiong, Weina; Jiang, Hao; Zhao, Haitong; Yang, Xianhai; Li, Chao; Fu, Zhiqiang; Chen, Jingwen] Dalian Univ Technol, Sch Environm Sci & Technol, Minist Educ, Key Lab Ind Ecol & Environm Engn, Dalian, Peoples R China	Dalian University of Technology	Cai, XY (corresponding author), Dalian Univ Technol, Sch Environm Sci & Technol, Minist Educ, Key Lab Ind Ecol & Environm Engn, Dalian, Peoples R China.	xiyuncai@dlut.edu.cn	Cai, Xiyun/H-6181-2011; Chen, Jingwen/A-1658-2010; LI, CHAO/GQA-9140-2022; Yang, Xainhai/ABD-4938-2021	Cai, Xiyun/0000-0002-5011-1986; Chen, Jingwen/0000-0002-5756-3336; Yang, Xianhai/0000-0002-9469-2946	National Basic Research Program of China [2013CB430403]; National Natural Science Foundation of China [41171382, 21077020, 21137001]; Program for New Century Excellent Talents in University [NCET-11-0047]; Key Laboratory for Ecological Environmental in Coastal Areas, State Oceanic Administration [201105]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Laboratory for Ecological Environmental in Coastal Areas, State Oceanic Administration	This study was supported by the National Basic Research Program of China (No. 2013CB430403, http://www.most.gov.cn), the National Natural Science Foundation of China (Nos. 41171382, 21077020, and 21137001, http://www.nsfc.gov.cn), and the Program for New Century Excellent Talents in University (No. NCET-11-0047, http://www.dost.moe.edu.cn). We thank the Key Laboratory for Ecological Environmental in Coastal Areas, State Oceanic Administration (No. 201105, www.nmemc.gov.cn) for the support to X Cai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki H, 2004, THERMOCHIM ACTA, V416, P87, DOI 10.1016/j.tca.2003.01.004; Allabashi R, 2007, WATER RES, V41, P476, DOI 10.1016/j.watres.2006.10.011; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Bian HT, 2009, J AGR FOOD CHEM, V57, P7453, DOI 10.1021/jf9013422; Carrasquillo AJ, 2008, ENVIRON SCI TECHNOL, V42, P7634, DOI 10.1021/es801277y; Chen WR, 2010, CHEMOSPHERE, V79, P779, DOI 10.1016/j.chemosphere.2010.03.020; Choi KJ, 2008, J HAZARD MATER, V151, P38, DOI 10.1016/j.jhazmat.2007.05.059; Crini G, 2003, BIORESOURCE TECHNOL, V90, P193, DOI 10.1016/S0960-8524(03)00111-1; Crini G, 2005, PROG POLYM SCI, V30, P38, DOI 10.1016/j.progpolymsci.2004.11.002; Di Natale F, 2008, WATER RES, V42, P2007, DOI 10.1016/j.watres.2007.12.008; EFTINK MR, 1989, J AM CHEM SOC, V111, P6765, DOI 10.1021/ja00199a041; Figueroa RA, 2004, ENVIRON SCI TECHNOL, V38, P476, DOI 10.1021/es0342087; Franco A, 2010, INT J LIFE CYCLE ASS, V15, P321, DOI 10.1007/s11367-010-0165-6; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gao Y, 2012, J COLLOID INTERF SCI, V368, P540, DOI 10.1016/j.jcis.2011.11.015; Gundersen JL, 1997, ENVIRON SCI TECHNOL, V31, P188, DOI 10.1021/es960304e; Homem V, 2011, J ENVIRON MANAGE, V92, P2304, DOI 10.1016/j.jenvman.2011.05.023; Ji LL, 2010, ENVIRON TOXICOL CHEM, V29, P2713, DOI 10.1002/etc.350; Ji LL, 2010, ENVIRON SCI TECHNOL, V44, P3116, DOI 10.1021/es903716s; Kahle M, 2007, ENVIRON SCI TECHNOL, V41, P132, DOI 10.1021/es061198b; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Kulshrestha P, 2004, ENVIRON SCI TECHNOL, V38, P4097, DOI 10.1021/es034856q; Liu HH, 2013, ENVIRON SCI TECHNOL, V47, P5835, DOI 10.1021/es303724b; Liu HH, 2011, WATER RES, V45, P3499, DOI 10.1016/j.watres.2011.04.004; Liu L, 2002, J INCL PHENOM MACRO, V42, P1, DOI 10.1023/A:1014520830813; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Lutka Anna, 2006, Acta Pol Pharm, V63, P3; Martel B, 2001, J POLYM SCI POL CHEM, V39, P169, DOI 10.1002/1099-0518(20010101)39:1<169::AID-POLA190>3.0.CO;2-G; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Morillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044137; Morin-Crini N, 2013, PROG POLYM SCI, V38, P344, DOI 10.1016/j.progpolymsci.2012.06.005; Mudunkotuwa IA, 2010, J AM CHEM SOC, V132, P14986, DOI 10.1021/ja106091q; MURPHY EM, 1994, ENVIRON SCI TECHNOL, V28, P1291, DOI 10.1021/es00056a017; Nguyen TH, 2007, ENVIRON SCI TECHNOL, V41, P1212, DOI 10.1021/es0617845; Oana M, 2002, J PHYS CHEM B, V106, P257, DOI 10.1021/jp012198v; Oishi K, 2010, SCI TOTAL ENVIRON, V409, P112, DOI 10.1016/j.scitotenv.2010.09.031; Oleszczuk P, 2009, ENVIRON SCI TECHNOL, V43, P9167, DOI 10.1021/es901928q; Ozmen EY, 2008, BIORESOURCE TECHNOL, V99, P526, DOI 10.1016/j.biortech.2007.01.023; Putra EK, 2009, WATER RES, V43, P2419, DOI 10.1016/j.watres.2009.02.039; Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o; Sassman SA, 2005, ENVIRON SCI TECHNOL, V39, P7452, DOI 10.1021/es0480217; Sawicki R, 2006, ENVIRON SCI TECHNOL, V40, P1978, DOI 10.1021/es051441r; SCHOFIELD RK, 1949, J SOIL SCI, V1, P3; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Sebestyen Z, 2012, J INCL PHENOM MACRO, V73, P199, DOI 10.1007/s10847-011-0043-2; Srinivasan K, 2012, J INCL PHENOM MACRO, V73, P321, DOI 10.1007/s10847-011-0059-7; Sun HY, 2010, ENVIRON TOXICOL CHEM, V29, P1934, DOI 10.1002/etc.248; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Tamai H, 1996, CHEM MATER, V8, P454, DOI 10.1021/cm950381t; Teixido M, 2011, ENVIRON SCI TECHNOL, V45, P10020, DOI 10.1021/es202487h; Tommasini S, 2004, J PHARMACEUT BIOMED, V36, P327, DOI 10.1016/j.jpba.2004.06.013; Tongaree S, 1999, PHARM DEV TECHNOL, V4, P571, DOI 10.1081/PDT-100101396; Wang R, 2007, ACTA PHYS-CHIM SIN, V23, P1353, DOI 10.1016/S1872-1508(07)60071-0; Wang ZY, 2010, ENVIRON SCI TECHNOL, V44, P978, DOI 10.1021/es902775u; Yanez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041072; Zhao D, 2012, J INCL PHENOM MACRO, V73, P93, DOI 10.1007/s10847-011-0024-5; Zhao J, 2012, CARBOHYD POLYM, V90, P1764, DOI 10.1016/j.carbpol.2012.07.066; Zhao YP, 2012, GEODERMA, V183, P12, DOI 10.1016/j.geoderma.2012.03.004; Zhao YP, 2011, ECOTOXICOLOGY, V20, P1141, DOI 10.1007/s10646-011-0665-6	59	10	10	4	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86228	10.1371/journal.pone.0086228	http://dx.doi.org/10.1371/journal.pone.0086228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465975	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500210
J	Ravindranath, A; Cadigan, KM				Ravindranath, Aditi; Cadigan, Ken M.			Structure-Function Analysis of the C-clamp of TCF/Pangolin in Wnt/beta-catenin Signaling	PLOS ONE			English	Article							DNA-BINDING DOMAIN; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; ENHANCER FACTOR; STEM-CELLS; RISK LOCI; WNT; DROSOPHILA; WINGLESS; ACTIVATION	The evolutionarily conserved Wnt/beta-catenin (Wnt/beta-cat) pathway plays an important role in animal development in metazoans. Many Wnt targets are regulated by members of the TCF/LEF1 (TCF) family of transcription factors. All TCFs contain a High Mobility Group (HMG) domain that bind specific DNA sequences. Invertebrate TCFs and some vertebrate TCF isoforms also contain another domain, called the C-clamp, which allows TCFs to recognize an additional DNA motif known as the Helper site. While the C-clamp has been shown to be important for regulating several Wnt reporter genes in cell culture, its physiological role in regulating Wnt targets is less clear. In addition, little is known about this domain, except that two of the four conserved cysteines are functionally important. Here, we carried out a systematic mutagenesis and functional analysis of the C-clamp from the Drosophila TCF/Pangolin (TCF/Pan) protein. We found that the C-clamp is a zinc-binding domain that is sufficient for binding to the Helper site. In addition to this DNA-binding activity, the C-clamp also inhibits the HMG domain from binding its cognate DNA site. Point mutations were identified that specifically affected DNA-binding or reduced the inhibitory effect. These mutants were characterized in TCF/Pan rescue assays. The specific DNA-binding activity of the C-clamp was essential for TCF/Pan function in cell culture and in patterning the embryonic epidermis of Drosophila, demonstrating the importance of this C-clamp activity in regulating Wnt target gene expression. In contrast, the inhibitory mutation had a subtle effect in cell culture and no effect on TCF/Pan activity in embryos. These results provide important information about the functional domains of the C-clamp, and highlight its importance for Wnt/beta-cat signaling in Drosophila.	[Ravindranath, Aditi; Cadigan, Ken M.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Cadigan, KM (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	cadigan@umich.edu	Ravindranath, Aditi/J-2277-2019	Cadigan, Ken/0000-0003-2431-1703	NSF [0950348]; NIH [GM082994]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082994] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF grant 0950348 and NIH grant GM082994 to KMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Archbold HC, 2012, ACTA PHYSIOL, V204, P74, DOI 10.1111/j.1748-1716.2011.02293.x; Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; BEJSOVEC A, 1993, DEVELOPMENT, V119, P501; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Blauwkamp TA, 2008, EMBO J, V27, P1436, DOI 10.1038/emboj.2008.80; Boeckle S, 2002, VIROLOGY, V293, P103, DOI 10.1006/viro.2001.1231; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Cadigan KM, 2012, CURR TOP DEV BIOL, V98, P1, DOI 10.1016/B978-0-12-386499-4.00001-X; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chang MV, 2008, CURR BIOL, V18, P1877, DOI 10.1016/j.cub.2008.10.047; Duffy DJ, 2010, DEVELOPMENT, V137, P3057, DOI 10.1242/dev.046631; Elfert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061867; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P1703, DOI 10.1093/nar/29.8.1703; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hasegawa R, 2013, EXP CELL RES, V319, P68, DOI 10.1016/j.yexcr.2012.11.003; Hecht A, 2003, J BIOL CHEM, V278, P3776, DOI 10.1074/jbc.M210081200; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Hoverter NP, 2012, MOL CELL BIOL, V32, P3648, DOI 10.1128/MCB.06769-11; Hu X, 2003, MOL ENDOCRINOL, V17, P716, DOI 10.1210/me.2002-0287; Jackson BM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007948; KLINGENSMITH J, 1994, DEV BIOL, V166, P396, DOI 10.1006/dbio.1994.1325; Knight JB, 2003, P NATL ACAD SCI USA, V100, P14725, DOI 10.1073/pnas.2432756100; Knirr S, 2001, DEV BIOL, V238, P13, DOI 10.1006/dbio.2001.0397; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee HH, 2000, DEVELOPMENT, V127, P5497; Liu ZY, 2010, ADV EXP MED BIOL, V654, P391, DOI 10.1007/978-90-481-3271-3_17; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Nguyen TN, 2006, NAT METHODS, V3, P135, DOI 10.1038/nmeth0206-135; Niehrs C, 2010, DEVELOPMENT, V137, P845, DOI 10.1242/dev.039651; Parker DS, 2008, MOL CELL BIOL, V28, P1815, DOI 10.1128/MCB.01230-07; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Polakis P, 2012, COLD SPRING HARBOR P, V4; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; Schweizer L, 2003, P NATL ACAD SCI USA, V100, P5846, DOI 10.1073/pnas.1037533100; Sichtig N, 2007, ARCH BIOCHEM BIOPHYS, V467, P67, DOI 10.1016/j.abb.2007.08.015; Tanaka K, 2004, J BIOL CHEM, V279, P7275, DOI 10.1074/jbc.M310726200; Turner RB, 1998, NAT STRUCT BIOL, V5, P551, DOI 10.1038/805; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van Beest M, 2000, J BIOL CHEM, V275, P27266; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wallmen B, 2012, NUCLEIC ACIDS RES, V40, P9455, DOI 10.1093/nar/gks690; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yamamoto M, 2007, MECH DEVELOP, V124, P715, DOI 10.1016/j.mod.2007.07.002; Yazdani U, 2008, GENETICS, V178, P919, DOI 10.1534/genetics.107.078030	56	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86180	10.1371/journal.pone.0086180	http://dx.doi.org/10.1371/journal.pone.0086180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465946	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500119
J	Collemare, J; Griffiths, S; Iida, Y; Jashni, MK; Battaglia, E; Cox, RJ; de Wit, PJGM				Collemare, Jerome; Griffiths, Scott; Iida, Yuichiro; Jashni, Mansoor Karimi; Battaglia, Evy; Cox, Russell J.; de Wit, Pierre J. G. M.			Secondary Metabolism and Biotrophic Lifestyle in the Tomato Pathogen Cladosporium fulvum	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; SYNTHASE-ENCODING GENES; POLYKETIDE SYNTHASE; ELSINOCHROME PHYTOTOXIN; PHYLOGENOMIC ANALYSIS; MAGNAPORTHE-GRISEA; PKS-NRPS; BIOSYNTHESIS; FERRICHROME; VIRULENCE	Cladosporium fulvum is a biotrophic fungal pathogen that causes leaf mould of tomato. Analysis of its genome suggested a high potential for production of secondary metabolites (SM), which might be harmful to plants and animals. Here, we have analysed in detail the predicted SM gene clusters of C. fulvum employing phylogenetic and comparative genomic approaches. Expression of the SM core genes was measured by RT-qrtPCR and produced SMs were determined by LC-MS and NMR analyses. The genome of C. fulvum contains six gene clusters that are conserved in other fungal species, which have undergone rearrangements and gene losses associated with the presence of transposable elements. Although being a biotroph, C. fulvum has the potential to produce elsinochrome and cercosporin toxins. However, the corresponding core genes are not expressed during infection of tomato. Only two core genes, PKS6 and NPS9, show high expression in planta, but both are significantly down regulated during colonization of the mesophyll tissue. In vitro SM profiling detected only one major compound that was identified as cladofulvin. PKS6 is likely involved in the production of this pigment because it is the only core gene significantly expressed under these conditions. Cladofulvin does not cause necrosis on Solanaceae plants and does not show any antimicrobial activity. In contrast to other biotrophic fungi that have a reduced SM production capacity, our studies on C. fulvum suggest that down-regulation of SM biosynthetic pathways might represent another mechanism associated with a biotrophic lifestyle.	[Collemare, Jerome; Griffiths, Scott; Iida, Yuichiro; Jashni, Mansoor Karimi; Battaglia, Evy; de Wit, Pierre J. G. M.] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands; [Collemare, Jerome; de Wit, Pierre J. G. M.] Ctr Biosyst Genom, Wageningen, Netherlands; [Iida, Yuichiro] Natl Inst Vegetable & Tea Sci, Tsu, Mie, Japan; [Jashni, Mansoor Karimi] Tarbiat Modares Univ, Dept Plant Pathol, Tehran, Iran; [Cox, Russell J.] Univ Bristol, Sch Chem, Bristol, Avon, England	Wageningen University & Research; Centre for BioSystems Genomics; National Agriculture & Food Research Organization - Japan; Tarbiat Modares University; University of Bristol	Collemare, J (corresponding author), Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands.	jerome.collemare@wur.nl	de Wit, Pierre J. G.M./CAI-9966-2022; Cox, Russell John/F-9190-2015; Jashni, Mansoor/AAI-8218-2021; de Wit, Pierre/A-1998-2013; Jashni, Mansoor/AHB-5808-2022	Cox, Russell John/0000-0002-1844-0157; de Wit, Pierre/0000-0002-4208-288X; Collemare, Jerome/0000-0001-8152-6642; Karimi-Jashni, Mansoor/0000-0001-8464-6500	Wageningen University	Wageningen University(European Commission)	Funding from Wageningen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Awakawa T, 2009, CHEM BIOL, V16, P613, DOI 10.1016/j.chembiol.2009.04.004; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Baker SE, 2012, MICROBIOL-SGM, V158, P147, DOI 10.1099/mic.0.053462-0; Baker SE, 2006, MOL PLANT MICROBE IN, V19, P139, DOI 10.1094/MPMI-19-0139; Bok JW, 2006, CHEM BIOL, V13, P31, DOI 10.1016/j.chembiol.2005.10.008; Bradshaw RE, 2013, NEW PHYTOL, V198, P525, DOI 10.1111/nph.12161; Brown DW, 2012, FUNGAL BIOL-UK, V116, P318, DOI 10.1016/j.funbio.2011.12.005; Bushley KE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-26; Bushley KE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-328; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen HQ, 2007, MOL MICROBIOL, V64, P755, DOI 10.1111/j.1365-2958.2007.05689.x; Chettri P, 2013, FUNGAL GENET BIOL, V51, P12, DOI 10.1016/j.fgb.2012.11.006; Chiang YM, 2011, FUNGAL GENET BIOL, V48, P430, DOI 10.1016/j.fgb.2010.12.001; Chiang YM, 2010, APPL ENVIRON MICROB, V76, P2067, DOI 10.1128/AEM.02187-09; Choquer M, 2005, MOL PLANT MICROBE IN, V18, P468, DOI 10.1094/MPMI-18-0468; Chung KR, 2008, MICROBIOL-SGM, V154, P3556, DOI 10.1099/mic.0.2008/019414-0; Collemare J, 2012, EFFECTORS PLANT MICR, P377; Collemare J, 2008, MYCOL RES, V112, P207, DOI 10.1016/j.mycres.2007.08.003; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Dalmais B, 2011, MOL PLANT PATHOL, V12, P564, DOI [10.1111/j.1364-3703.2010.00692.x, 10.1111/J.1364-3703.2010.00692.X]; DAVIES DG, 1974, J CHEM SOC PERK T 1, P2403, DOI 10.1039/p19740002403; de Wit PJGM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003088; DEWIT PJGM, 1982, PHYSIOL PLANT PATHOL, V21, P1, DOI 10.1016/0048-4059(82)90002-9; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Fujii I, 2005, CHEM BIOL, V12, P1301, DOI 10.1016/j.chembiol.2005.09.015; Henrikson JC, 2009, ORG BIOMOL CHEM, V7, P435, DOI 10.1039/b819208a; Hof C, 2007, MOL PLANT PATHOL, V8, P163, DOI 10.1111/j.1364-3703.2007.00380.x; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Kopp F, 2007, NAT PROD REP, V24, P735, DOI 10.1039/b613652b; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Liao HL, 2008, MOL PLANT MICROBE IN, V21, P469, DOI 10.1094/MPMI-21-4-0469; Lim FY, 2012, APPL ENVIRON MICROB, V78, P6395, DOI 10.1128/AEM.01926-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Munawar A, 2013, CHEMBIOCHEM, V14, P388, DOI 10.1002/cbic.201200587; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Sambrook J, 2001, MOL CLONING LAB MANU; Schwecke T, 2006, CHEMBIOCHEM, V7, P612, DOI 10.1002/cbic.200500301; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Stergiopoulos I, 2013, FEMS MICROBIOL REV, V37, P67, DOI 10.1111/j.1574-6976.2012.00349.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka A, 2005, MOL MICROBIOL, V57, P1036, DOI 10.1111/j.1365-2958.2005.04747.x; Thomma BPHJ, 2005, MOL PLANT PATHOL, V6, P379, DOI 10.1111/J.1364-3703.2005.00292.X; Tokuoka M, 2008, FUNGAL GENET BIOL, V45, P1608, DOI 10.1016/j.fgb.2008.09.006; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Westerink N, 2004, MOL MICROBIOL, V54, P533, DOI 10.1111/j.1365-2958.2004.04288.x; Wight WD, 2009, MOL PLANT MICROBE IN, V22, P1258, DOI 10.1094/MPMI-22-10-1258; Winterberg B, 2010, MOL MICROBIOL, V75, P1260, DOI 10.1111/j.1365-2958.2010.07048.x; Wit P. J. G. M. de, 1977, Netherlands Journal of Plant Pathology, V83, P109, DOI 10.1007/BF01981556; Yuan WM, 2001, J BACTERIOL, V183, P4040, DOI 10.1128/JB.183.13.4040-4051.2001	55	45	53	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85877	10.1371/journal.pone.0085877	http://dx.doi.org/10.1371/journal.pone.0085877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465762	Green Submitted, gold, Green Published			2022-12-25	WOS:000330237000070
J	Stapp, AD; Gomez, BI; Gifford, CA; Hallford, DM; Gifford, JAH				Stapp, Andrea D.; Gomez, Belinda I.; Gifford, Craig A.; Hallford, Dennis M.; Gifford, Jennifer A. Hernandez			Canonical WNT Signaling Inhibits Follicle Stimulating Hormone Mediated Steroidogenesis in Primary Cultures of Rat Granulosa Cells	PLOS ONE			English	Article							REQUIRES BETA-CATENIN; PROTEIN-KINASE-A; GENE-EXPRESSION; REGULATED EXPRESSION; NEGATIVE REGULATOR; MESSENGER-RNA; UP-REGULATION; RODENT OVARY; PATHWAY; IDENTIFICATION	Beta-catenin (CTNNB1), a key component of wingless-type mouse mammary tumor virus integration site family (WNT) signaling, participates in follicle stimulated hormone-mediated regulation of estrogen (E-2) production. The purpose of these studies was to determine if CTNNB1's contribution to FSH-mediated steroidogenesis in primary rat granulosa cells was due in part to extracellular stimulation of the canonical WNT signaling pathway. To achieve this purpose, primary cultures of rat granulosa cells were exposed to vehicle or a canonical member of the WNT signaling pathway, WNT3A, before co-culture and in the presence or absence of FSH for 24 h. Activation of the canonical WNT signaling pathway was determined by dose-dependent induction of Axin2 mRNA expression and stimulation of the CTNNB1/T cell factor promoter-reporter TOPflash. WNT pathway induction was demonstrated at doses of 50 and 500 ng/mL of WNT3A. Granulosa cells treated with WNT3A in combination with FSH had enhanced CTNNB1/T cell factor transcriptional activity above cells treated with WNT3A alone. Steroidogenic enzymes and ovarian differentiation factor mRNAs were quantified via quantitative PCR. Expression of steroidogenic enzyme mRNAs aromatase (Cyp19a1), P450 side chain cleavage (Cyp11a1), and steroidogenic acute regulatory protein (Star) were increased following FSH treatment. Co-incubation of WNT3A and FSH reduced the ability of FSH to stimulate steroidogenic enzymes and subsequent E-2 and progesterone (P-4) production. Concomitant activation of FSH and WNT pathways results in marked reduction of ovarian differentiation factors, LH receptor (Lhcgr) and inhibin-alpha (Inha). Therefore, WNT inhibits FSH target genes and steroid production associated with maturation and differentiation of the ovarian follicle.	[Stapp, Andrea D.; Gomez, Belinda I.; Gifford, Craig A.; Gifford, Jennifer A. Hernandez] Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA; [Hallford, Dennis M.] New Mexico State Univ, Dept Anim & Range Sci, Las Cruces, NM 88003 USA	Oklahoma State University System; Oklahoma State University - Stillwater; New Mexico State University	Gifford, JAH (corresponding author), Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA.	jah.hernandez_gifford@okstate.edu			National Institutes of Health (NIH) from the Eunice Kennedy Shriver National Institutes of Child Health & Human Development [R15065668]; Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR10-030S]	National Institutes of Health (NIH) from the Eunice Kennedy Shriver National Institutes of Child Health & Human Development; Oklahoma Center for the Advancement of Science and Technology (OCAST)	This work was supported in part by National Institutes of Health (NIH) grant R15065668 from the Eunice Kennedy Shriver National Institutes of Child Health & Human Development; and Oklahoma Center for the Advancement of Science and Technology (OCAST) grant HR10-030S to JAHG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bienz M, 2003, NAT CELL BIOL, V5, P179, DOI 10.1038/ncb0303-179; Boerboom D, 2005, CANCER RES, V65, P9206, DOI 10.1158/0008-5472.CAN-05-1024; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Castanon BI, 2012, J ANIM SCI, V90, P3789, DOI 10.2527/jas.2011-4696; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen M, 2006, HORM METAB RES, V38, P549, DOI 10.1055/s-2006-950500; Cinnamon E, 2008, CURR OPIN GENET DEV, V18, P435, DOI 10.1016/j.gde.2008.07.010; Escamilla-Hernandez R, 2008, MOL ENDOCRINOL, V22, P1842, DOI 10.1210/me.2008-0103; Fan HY, 2011, MOL ENDOCRINOL, V25, P253, DOI 10.1210/me.2010-0318; Fan HY, 2010, MOL ENDOCRINOL, V24, P1529, DOI 10.1210/me.2010-0141; Finnson KW, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096396; Gifford CA, 2007, J DAIRY SCI, V90, P274, DOI 10.3168/jds.S0022-0302(07)72628-0; Gifford JAH, 2009, BIOL REPROD, V80, P1282, DOI 10.1095/biolreprod.108.072280; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Grado-Ahuir JA, 2011, J ANIM SCI, V89, P1769, DOI 10.2527/jas.2010-3463; Gummow BM, 2003, J BIOL CHEM, V278, P26572, DOI 10.1074/jbc.M212677200; Harwood BN, 2008, DEV DYNAM, V237, P1099, DOI 10.1002/dvdy.21491; Hsieh M, 2003, ENDOCRINOLOGY, V144, P4597, DOI 10.1210/en.2003-0048; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Komiya Yuko, 2008, Organogenesis, V4, P68; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Parakh TN, 2006, P NATL ACAD SCI USA, V103, P12435, DOI 10.1073/pnas.0603006103; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Richards JS, 2001, ENDOCRINOLOGY, V142, P2184, DOI 10.1210/en.142.6.2184; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rozen S, 2000, Methods Mol Biol, V132, P365; Salisbury TB, 2007, MOL ENDOCRINOL, V21, P963, DOI 10.1210/me.2006-0383; Salisbury TB, 2009, MOL ENDOCRINOL, V23, P402, DOI 10.1210/me.2008-0370; Schreiber NB, 2012, ENDOCRINOLOGY, V153, P4491, DOI 10.1210/en.2012-1003; Sousa KM, 2010, J BIOL CHEM, V285, P7246, DOI 10.1074/jbc.M109.079822; Stadeli R, 2005, MECH DEVELOP, V122, P1171, DOI 10.1016/j.mod.2005.07.004; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HX, 2010, BIOL REPROD, V82, P865, DOI 10.1095/biolreprod.109.080903; Wang HX, 2009, MOL HUM REPROD, V15, P11, DOI 10.1093/molehr/gan070; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498	46	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86432	10.1371/journal.pone.0086432	http://dx.doi.org/10.1371/journal.pone.0086432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24466091	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000099
J	Boncompain, G; Muller, C; Meas-Yedid, V; Schmitt-Kopplin, P; Lazarow, PB; Subtil, A				Boncompain, Gaelle; Mueller, Constanze; Meas-Yedid, Vannary; Schmitt-Kopplin, Philippe; Lazarow, Paul B.; Subtil, Agathe			The Intracellular Bacteria Chlamydia Hijack Peroxisomes and Utilize Their Enzymatic Capacity to Produce Bacteria-Specific Phospholipids	PLOS ONE			English	Article							LIPID DROPLETS; EPITHELIAL-CELLS; HOST-CELL; TRACHOMATIS; PLASMALOGENS; INFECTION; BIOSYNTHESIS; METABOLISM; DISORDERS; INCLUSION	Chlamydia trachomatis is an obligate intracellular pathogen responsible for loss of eyesight through trachoma and for millions of cases annually of sexually transmitted diseases. The bacteria develop within a membrane-bounded inclusion. They lack enzymes for several biosynthetic pathways, including those to make some phospholipids, and exploit their host to compensate. Three-dimensional fluorescence microscopy demonstrates that small organelles of the host, peroxisomes, are translocated into the Chlamydia inclusion and are found adjacent to the bacteria. In cells deficient for peroxisome biogenesis the bacteria are able to multiply and give rise to infectious progeny, demonstrating that peroxisomes are not essential for bacterial development in vitro. Mass spectrometry-based lipidomics reveal the presence in C. trachomatis of plasmalogens, ether phospholipids whose synthesis begins in peroxisomes and have never been described in aerobic bacteria before. Some of the bacterial plasmalogens are novel structures containing bacteria-specific odd-chain fatty acids; they are not made in uninfected cells nor in peroxisome-deficient cells. Their biosynthesis is thus accomplished by the metabolic collaboration of peroxisomes and bacteria.	[Boncompain, Gaelle; Lazarow, Paul B.; Subtil, Agathe] Inst Pasteur, Unite Biol Interact Cellulaires, Paris, France; [Boncompain, Gaelle; Meas-Yedid, Vannary; Lazarow, Paul B.; Subtil, Agathe] CNRS URA 2582, Paris, France; [Mueller, Constanze; Schmitt-Kopplin, Philippe] Helmholtz Zentrum Munchen, Inst Okol Chem, Dept BioGeoChem & Analyt, Neuherberg, Germany; [Meas-Yedid, Vannary] Inst Pasteur, Unite Anal Images Quantitat, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lazarow, PB (corresponding author), Inst Pasteur, Unite Biol Interact Cellulaires, Paris, France.	paul.lazarow@pasteur.fr; agathe.subtil@pasteur.fr	Boncompain, Gaelle/AAX-8374-2021; Schmitt-Kopplin, Philippe/H-6271-2011; Subtil, Agathe/C-7464-2017	Boncompain, Gaelle/0000-0003-4274-035X; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Subtil, Agathe/0000-0002-7481-4846	Ministere de l'Education Nationale; Ministere de l'Education Nationale, de la Recherche et de la Technologie; Agence Nationale pour la Recherche; Blaise Pascal International Research Chair from France; Ile-de-France region; ERA-NET PathoGenoMics 'Pathomics'; Institut Pasteur; Centre National de la Recherche Scientifique	Ministere de l'Education Nationale; Ministere de l'Education Nationale, de la Recherche et de la Technologie; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Blaise Pascal International Research Chair from France; Ile-de-France region(Region Ile-de-France); ERA-NET PathoGenoMics 'Pathomics'; Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	GB was funded by the Ministere de l'Education Nationale, de la Recherche et de la Technologie and by the Agence Nationale pour la Recherche. PBL was supported by a Blaise Pascal International Research Chair from France and the Ile-de-France region, administered by the Ecole Normale Superieure. This work was financed by the ERA-NET PathoGenoMics 'Pathomics', the Institut Pasteur and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; BEEMER FA, 1990, AM J MED GENET, V37, P425, DOI 10.1002/ajmg.1320370325; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Boleti H, 1999, J CELL SCI, V112, P1487; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Burton MJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000460; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Crowley JT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003109; da Silva TF, 2012, BBA-MOL BASIS DIS, V1822, P1501, DOI 10.1016/j.bbadis.2012.05.014; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Elwell CA, 2012, CELL MICROBIOL, V14, P1010, DOI 10.1111/j.1462-5822.2012.01794.x; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; FAN VSC, 1974, INFECT IMMUN, V10, P464, DOI 10.1128/IAI.10.3.464-470.1974; Fukuda EY, 2005, INFECT IMMUN, V73, P4017, DOI 10.1128/IAI.73.7.4017-4024.2005; Geisler WM, 2010, J INFECT DIS, V201, pS104, DOI 10.1086/652402; Goldfine H, 2010, PROG LIPID RES, V49, P493, DOI 10.1016/j.plipres.2010.07.003; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hatch GM, 1998, INFECT IMMUN, V66, P3727, DOI 10.1128/IAI.66.8.3727-3735.1998; Helle S. C., 2013, BIOCH BIOPHYS ACTA; Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4; Kanawati B, 2011, RAPID COMMUN MASS SP, V25, P806, DOI 10.1002/rcm.4908; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kohlwein SD, 2013, GENETICS, V193, P1, DOI 10.1534/genetics.112.143362; KONDRUP J, 1985, BIOCHIM BIOPHYS ACTA, V835, P147, DOI 10.1016/0005-2760(85)90041-4; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Larsson L, 1982, CHLAMYDIAL INFECTION, P37; Lazarow PB, 2011, CURR OPIN MICROBIOL, V14, P458, DOI 10.1016/j.mib.2011.07.009; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; MURPHY EJ, 1993, LIPIDS, V28, P565, DOI 10.1007/BF02536090; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Schrader M, 2001, J HISTOCHEM CYTOCHEM, V49, P1421, DOI 10.1177/002215540104901110; Scidmore MA, 2005, CURR PROTOCOLS MICRO; Scidmore MA, 2011, MICROBES INFECT, V13, P527, DOI 10.1016/j.micinf.2011.02.001; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Zhang B, 2008, I S BIOMED IMAGING, P1327	46	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86196	10.1371/journal.pone.0086196	http://dx.doi.org/10.1371/journal.pone.0086196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465954	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000064
J	Misra, J; Chanda, D; Kim, DK; Cho, SR; Koo, SH; Lee, CH; Back, SH; Choi, HS				Misra, Jagannath; Chanda, Dipanjan; Kim, Don-Kyu; Cho, Seung-Rye; Koo, Seung-Hoi; Lee, Chul-Ho; Back, Sung Hoon; Choi, Hueng-Sik			Orphan Nuclear Receptor Err gamma Induces C-Reactive Protein Gene Expression through Induction of ER-Bound Bzip Transmembrane Transcription Factor CREBH	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; ENDOPLASMIC-RETICULUM STRESS; HEPATIC GLUCONEOGENESIS; COACTIVATOR; LIVER; ACTIVATION; ALPHA; PGC-1-ALPHA; REGULATOR; LIPIN1	The orphan nuclear receptor estrogen-related receptor-gamma (ERR gamma) is a constitutively active transcription factor regulating genes involved in several important cellular processes, including hepatic glucose metabolism, alcohol metabolism, and the endoplasmic reticulum (ER) stress response. cAMP responsive element-binding protein H (CREBH) is an ER-bound bZIP family transcription factor that is activated upon ER stress and regulates genes encoding acute-phase proteins whose expression is increased in response to inflammation. Here, we report that ERR gamma directly regulates CREBH gene expression in response to ER stress. ERR gamma bound to the ERR gamma response element (ERRE) in the CREBH promoter. Overexpression of ERR gamma by adenovirus significantly increased expression of CREBH as well as C-reactive protein (CRP), whereas either knockdown of ERR gamma or inhibition of ERR gamma by ERR gamma specific inverse agonist, GSK5182, substantially inhibited ER stress-mediated induction of CREBH and CRP. The transcriptional coactivator PGC1 alpha was required for ERR gamma mediated induction of the CREBH gene as demonstrated by the chromatin immunoprecipitation (ChIP) assay showing binding of both ERR gamma and PGC1 alpha on the CREBH promoter. The ChIP assay also revealed that histone H3 and H4 acetylation occurred at the ERR gamma and PGC1 alpha binding site. Moreover, chronic alcoholic hepatosteatosis, as well as the diabetic obese condition significantly increased CRP gene expression, and this increase was significantly attenuated by GSK5182 treatment. We suggest that orphan nuclear receptor ERR gamma directly regulates the ER-bound transcription factor CREBH in response to ER stress and other metabolic conditions.	[Misra, Jagannath; Chanda, Dipanjan; Kim, Don-Kyu; Cho, Seung-Rye; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju, South Korea; [Koo, Seung-Hoi] Korea Univ, Div Life Sci, Coll Life Sci & Biotechnol, Seoul, South Korea; [Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon, South Korea; [Back, Sung Hoon] Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju, South Korea	Chonnam National University; Korea University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Ulsan; Chonnam National University	Choi, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju, South Korea.	hsc@chonnam.ac.kr	Chanda, Dipanjan/AAU-3996-2021; Koo, Seung-Hoi/E-2763-2015; Misra, Jagannath/AAW-8774-2021	Chanda, Dipanjan/0000-0003-0685-187X; Koo, Seung-Hoi/0000-0001-8769-2879; Misra, Jagannath/0000-0001-9713-0298	National Creative Research Initiatives Grant [20110018305]; Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea (NRF) [20100019512]; Korean government (Ministry of Science, ICT & Future Planning)	National Creative Research Initiatives Grant; Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea (NRF); Korean government (Ministry of Science, ICT & Future Planning)(Korean Government)	This work was supported by National Creative Research Initiatives Grant (20110018305) and Future-based Technology Development Program (BIO Fields), (20100019512) through the National Research Foundation of Korea (NRF) funded by the Korean government (Ministry of Science, ICT & Future Planning). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P181, DOI 10.2174/156802606776173483; Birjmohun RS, 2007, METABOLISM, V56, P1576, DOI 10.1016/j.metabol.2007.06.026; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Chanda D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068845; Chanda D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377978; Chanda D, 2011, J BIOL CHEM, V286, P27971, DOI 10.1074/jbc.M111.224352; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Chao EYH, 2006, BIOORG MED CHEM LETT, V16, P821, DOI 10.1016/j.bmcl.2005.11.030; Danno H, 2010, BIOCHEM BIOPH RES CO, V391, P1222, DOI 10.1016/j.bbrc.2009.12.046; Devaraj S, 2009, CLIN CHEM, V55, P229, DOI 10.1373/clinchem.2008.108886; Ding LH, 2003, NUCLEIC ACIDS RES, V31, P5266, DOI 10.1093/nar/gkg731; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Grad E, 2007, AM J PHYSIOL-HEART C, V293, pH489, DOI 10.1152/ajpheart.01418.2006; Hein TW, 2009, ATHEROSCLEROSIS, V206, P61, DOI 10.1016/j.atherosclerosis.2009.02.002; Ivashchenko Y, 2005, ARTERIOSCL THROM VAS, V25, P186, DOI 10.1161/01.ATV.0000150041.81963.68; Ji C, 2006, J HEPATOL, V45, P321, DOI 10.1016/j.jhep.2006.06.004; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Kim DK, 2013, GUT, V62, P1044, DOI 10.1136/gutjnl-2012-303347; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Kleemann R, 2003, BLOOD, V101, P545, DOI 10.1182/blood-2002-06-1762; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046324; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Lui K, 2006, PROSTATE, V66, P1600, DOI 10.1002/pros.20429; MAJELLO B, 1990, EMBO J, V9, P457, DOI 10.1002/j.1460-2075.1990.tb08131.x; Misra J, 2013, NUCLEIC ACIDS RES, V41, P6960, DOI 10.1093/nar/gkt429; Nagamori I, 2006, GENES CELLS, V11, P1161, DOI 10.1111/j.1365-2443.2006.01013.x; Nagaoka T, 2008, INVEST OPHTH VIS SCI, V49, P2053, DOI 10.1167/iovs.07-1387; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Radtke S, 2010, J CELL SCI, V123, P947, DOI 10.1242/jcs.065326; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ryu D, 2011, DIABETES, V60, P1072, DOI 10.2337/db10-1046; Seo HY, 2008, ENDOCRINOLOGY, V149, P3832, DOI 10.1210/en.2008-0015; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Verma S, 2006, CIRCULATION, V113, P2135; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	51	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86342	10.1371/journal.pone.0086342	http://dx.doi.org/10.1371/journal.pone.0086342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466039	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100143
J	Hong, IS; Lee, HY; Kim, HP				Hong, In-Sun; Lee, Hwa-Yong; Kim, Hyun-Pyo			Novel Therapeutic Approaches for Various Cancer Types Using a Modified Sleeping Beauty-Based Gene Delivery System	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS TYPE-2; TRANSPOSON-SYSTEM; TRANSGENE EXPRESSION; TELOMERASE ACTIVITY; THYMIDINE KINASE; MAMMALIAN-CELLS; IN-VIVO; GANCICLOVIR; VECTORS; PRODRUG	Successful gene therapy largely depends on the selective introduction of therapeutic genes into the appropriate target cancer cells. One of the most effective and promising approaches for targeting tumor tissue during gene delivery is the use of viral vectors, which allow for high efficiency gene delivery. However, the use of viral vectors is not without risks and safety concerns, such as toxicities, a host immune response towards the viral antigens or potential viral recombination into the host's chromosome; these risks limit the clinical application of viral vectors. The Sleeping Beauty (SB) transposon-based system is an attractive, non-viral alternative to viral delivery systems. SB may be less immunogenic than the viral vector system due to its lack of viral sequences. The SB-based gene delivery system can stably integrate into the host cell genome to produce the therapeutic gene product over the lifetime of a cell. However, when compared to viral vectors, the non-viral SB-based gene delivery system still has limited therapeutic efficacy due to the lack of long-lasting gene expression potential and tumor cell specific gene transfer ability. These limitations could be overcome by modifying the SB system through the introduction of the hTERT promoter and the SV40 enhancer. In this study, a modified SB delivery system, under control of the hTERT promoter in conjunction with the SV40 enhancer, was able to successfully transfer the suicide gene (HSV-TK) into multiple types of cancer cells. The modified SB transfected cancer cells exhibited a significantly increased cancer cell specific death rate. These data suggest that our modified SB-based gene delivery system can be used as a safe and efficient tool for cancer cell specific therapeutic gene transfer and stable long-term expression.	[Hong, In-Sun; Lee, Hwa-Yong] Seoul Natl Univ, Adult Stem Cell Res Ctr, Seoul, South Korea; [Hong, In-Sun; Lee, Hwa-Yong] Seoul Natl Univ, Lab Stem Cell & Tumor Biol, Dept Vet Publ Hlth, Seoul, South Korea; [Kim, Hyun-Pyo] Jungwon Univ, Dept Biomed Sci, Chungbuk, South Korea	Seoul National University (SNU); Seoul National University (SNU); Jungwon University	Kim, HP (corresponding author), Jungwon Univ, Dept Biomed Sci, Chungbuk, South Korea.	khpsss@jwu.ac.kr			Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs [Z-1541745-2012-13-09]	Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs	This study was supported by a grant (Project Code No.,Z-1541745-2012-13-09) from Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani R, 2000, MOL THER, V2, P539, DOI 10.1006/mthe.2000.0196; Aronovich EL, 2009, MOL THER, V17, P1136, DOI 10.1038/mt.2009.87; Avilion AA, 1996, CANCER RES, V56, P645; Balciunas D, 2005, ZEBRAFISH, V1, P335, DOI 10.1089/zeb.2005.1.335; Belur LR, 2003, MOL THER, V8, P501, DOI 10.1016/S1525-0016(03)00211-9; Bilsland AE, 2005, NEOPLASIA, V7, P1020, DOI 10.1593/neo.05385; Black ME, 1996, P NATL ACAD SCI USA, V93, P3525, DOI 10.1073/pnas.93.8.3525; Both Gerald W, 2009, Discov Med, V8, P97; Ciceri F, 2005, CYTOTHERAPY, V7, P144, DOI 10.1080/14653240510018136; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Fischer A, 2005, B ACAD NAT MED PARIS, V189, P779, DOI 10.1016/S0001-4079(19)33504-6; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; Grimm D, 1999, HUM GENE THER, V10, P2445, DOI 10.1089/10430349950016799; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Hedley D, 2007, NAT REV CANCER, V7, P870, DOI 10.1038/nrc2247; Huang X, 2008, MOL THER, V16, P580, DOI 10.1038/sj.mt.6300404; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2006, CURR GENE THER, V6, P593, DOI 10.2174/156652306778520647; Izsvak Z, 2004, MOL THER, V9, P147, DOI 10.1016/j.ymthe.2003.11.009; Kren BT, 2009, J CLIN INVEST, V119, P2086, DOI 10.1172/JCI34332; Li S, 2001, GENE THER, V8, P494, DOI 10.1038/sj.gt.3301419; LOHE AR, 1995, MOL BIOL EVOL, V12, P62, DOI 10.1093/oxfordjournals.molbev.a040191; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; MATTHEWS T, 1988, REV INFECT DIS, V10, pS490; MILLER AD, 1992, NATURE, V357, P455, DOI 10.1038/357455a0; Montini E, 2002, MOL THER, V6, P759, DOI 10.1006/mthe.2002.0812; Nair V, 2008, CURR OPIN MOL THER, V10, P431; Ortiz-Urda S, 2003, GENE THER, V10, P1099, DOI 10.1038/sj.gt.3301978; Pan RY, 1999, J VIROL, V73, P3410, DOI 10.1128/JVI.73.4.3410-3417.1999; Plasterk RHA, 1996, CURR TOP MICROBIOL, V204, P125; Plumb JA, 2001, ONCOGENE, V20, P7797, DOI 10.1038/sj.onc.1204954; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Portsmouth D, 2007, MOL ASPECTS MED, V28, P4, DOI 10.1016/j.mam.2006.12.001; Rainov NG, 1998, HUM GENE THER, V9, P1261, DOI 10.1089/hum.1998.9.9-1261; Rainov NG, 2000, HUM GENE THER, V11, P2389, DOI 10.1089/104303400750038499; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Singh Y, 2008, CURR MED CHEM, V15, P1802, DOI 10.2174/092986708785132997; Song JS, 2007, BIOCHEM BIOPH RES CO, V363, P253, DOI 10.1016/j.bbrc.2007.05.213; Song JS, 2009, BIOSCI BIOTECH BIOCH, V73, P165, DOI 10.1271/bbb.80581; Song JS, 2004, BIOSCI BIOTECH BIOCH, V68, P1634, DOI 10.1271/bbb.68.1634; Sterman DH, 2005, CLIN CANCER RES, V11, P7444, DOI 10.1158/1078-0432.CCR-05-0405; WINSTON DJ, 1995, LANCET, V346, P69, DOI 10.1016/S0140-6736(95)92110-9; Wright WE, 1996, DEV GENET, V18, P173; Yant SR, 2002, NAT BIOTECHNOL, V20, P999, DOI 10.1038/nbt738; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Yi XM, 1999, MOL CELL BIOL, V19, P3989; Zhou TA, 2010, AAPS J, V12, P692, DOI 10.1208/s12248-010-9231-z	51	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86324	10.1371/journal.pone.0086324	http://dx.doi.org/10.1371/journal.pone.0086324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466025	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500226
J	Miskimins, WK; Ahn, HJ; Kim, JY; Ryu, S; Jung, YS; Choi, JY				Miskimins, W. Keith; Ahn, Hyun Joo; Kim, Ji Yeon; Ryu, Sun; Jung, Yuh-Seog; Choi, Joon Young			Synergistic Anti-Cancer Effect of Phenformin and Oxamate	PLOS ONE			English	Article							BREAST-CANCER CELLS; TUMOR-CELLS; IN-VITRO; LACTIC-ACIDOSIS; NECK-CANCER; METFORMIN; INHIBITION; LACTATE; GROWTH; GLYCOLYSIS	Phenformin (phenethylbiguanide; an anti-diabetic agent) plus oxamate [lactate dehydrogenase (LDH) inhibitor] was tested as a potential anti-cancer therapeutic combination. In in vitro studies, phenformin was more potent than metformin, another biguanide, recently recognized to have anti-cancer effects, in promoting cancer cell death in the range of 25 times to 15 million times in various cancer cell lines. The anti-cancer effect of phenformin was related to complex I inhibition in the mitochondria and subsequent overproduction of reactive oxygen species (ROS). Addition of oxamate inhibited LDH activity and lactate production by cells, which is a major side effect of biguanides, and induced more rapid cancer cell death by decreasing ATP production and accelerating ROS production. Phenformin plus oxamate was more effective than phenformin combined with LDH knockdown. In a syngeneic mouse model, phenformin with oxamate increased tumor apoptosis, reduced tumor size and F-18-fluorodeoxyglucose (FDG) uptake on positron emission tomography/computed tomography compared to control. We conclude that phenformin is more cytotoxic towards cancer cells than metformin. Furthermore, phenformin and oxamate have synergistic anti-cancer effects through simultaneous inhibition of complex I in the mitochondria and LDH in the cytosol, respectively.	[Miskimins, W. Keith] Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD USA; [Miskimins, W. Keith] Univ S Dakota, Sanford Sch Med, Dept Obstet & Gynecol, Sioux Falls, SD USA; [Miskimins, W. Keith] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Sioux Falls, SD USA; [Ahn, Hyun Joo; Kim, Ji Yeon; Ryu, Sun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Jung, Yuh-Seog] Natl Canc Ctr, Res Inst & Hosp, Ctr Thyroid Canc, Head & Neck Oncol Clin,Ctr Specif Organs Canc, Goyang Si, Gyeonggi Do, South Korea; [Choi, Joon Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Nucl Med, Seoul, South Korea	Sanford Health; University of South Dakota; University of South Dakota; Sungkyunkwan University (SKKU); Samsung Medical Center; National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); Samsung Medical Center	Ahn, HJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	hyunjooahn@skku.edu	Choi, Joon Young/D-6140-2017	Ahn, Hyun Joo/0000-0003-1576-5308	Susan G. Komen for the Cure [KG100497]; National Cancer Institute of the National Institutes of Health [1R01CA180033]; National Institute of General Medical Sciences of the National Institutes of Health [015P20GM10358]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0013087]; Samsung Medical Center [SMR1120911]; NATIONAL CANCER INSTITUTE [R01CA180033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103548] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Samsung Medical Center(Samsung); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported in part by Susan G. Komen for the Cure award number KG100497 (WKM), by the National Cancer Institute of the National Institutes of Health award number 1R01CA180033 (WKM), by National Institute of General Medical Sciences of the National Institutes of Health award number 015P20GM10358 (WKM), by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology award number 2011-0013087, and by Samsung Medical Center grant award number SMR1120911. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; [Anonymous], 2013, Cancer Discov, V3, pOF14, DOI 10.1158/2159-8290.CD-RW2013-023; Appleyard MVCL, 2012, BRIT J CANCER, V106, P1117, DOI 10.1038/bjc.2012.56; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Chan DK, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-19; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Coppock JD, 2013, NEOPLASIA, V15, P620, DOI 10.1593/neo.13432; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Dykens JA, 2008, TOXICOL APPL PHARM, V233, P203, DOI 10.1016/j.taap.2008.08.013; ELWOOD JC, 1968, CANCER RES, V28, P2056; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Goetze K, 2011, INT J ONCOL, V39, P453, DOI 10.3892/ijo.2011.1055; GOLDBERG EB, 1965, J BIOL CHEM, V240, P2786; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3271, DOI 10.1200/JCO.2009.22.1630; Gottfried E, 2006, BLOOD, V107, P2013, DOI 10.1182/blood-2005-05-1795; GREINER EF, 1994, J BIOL CHEM, V269, P31484; Hadad S, 2011, BREAST CANCER RES TR, V128, P783, DOI 10.1007/s10549-011-1612-1; Hitchiler MJ, 2008, FREE RADICAL BIO MED, V45, P1573, DOI 10.1016/j.freeradbiomed.2008.09.005; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; KANNO H, 1988, ACTA HAEMATOL JAPON, V51, P715; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Koukourakis MI, 2011, CLIN CANCER RES, V17, P4892, DOI 10.1158/1078-0432.CCR-10-2918; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Lea MA, 2011, ANTICANCER RES, V31, P421; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; MARTINREQUERO A, 1986, J BIOL CHEM, V261, P13973; McLarty K, 2009, J NUCL MED, V50, P1848, DOI 10.2967/jnumed.109.067231; Ota S, 2009, BIOCHEM BIOPH RES CO, V388, P311, DOI 10.1016/j.bbrc.2009.07.164; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PAPACONSTANTINOU J, 1961, J BIOL CHEM, V236, P285; Quennet V, 2006, RADIOTHER ONCOL, V81, P130, DOI 10.1016/j.radonc.2006.08.012; REYNOLDS V H, 1963, Surg Forum, V14, P128; Rosand J, 1997, ANN INTERN MED, V127, P170, DOI 10.7326/0003-4819-127-2-199707150-00034; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Salpeter S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub2; SCHAFER G, 1983, DIABETES METAB, V9, P148; Soini Y, 2001, J PATHOL, V195, P156, DOI 10.1002/path.946; Spanos WC, 2009, ARCH OTOLARYNGOL, V135, P1137, DOI 10.1001/archoto.2009.159; Tesniere A, 2008, CURR OPIN IMMUNOL, V20, P504, DOI 10.1016/j.coi.2008.05.007; Thoren FB, 2006, J IMMUNOL, V176, P7301, DOI 10.4049/jimmunol.176.12.7301; Thornburg JM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2154; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Wieking BG, 2012, CANCER GENE THER, V19, P667, DOI 10.1038/cgt.2012.55; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Yaromina A, 2012, STRAHLENTHER ONKOL, V188, P431, DOI 10.1007/s00066-011-0054-3; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343	53	87	89	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85576	10.1371/journal.pone.0085576	http://dx.doi.org/10.1371/journal.pone.0085576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465604	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500077
J	Preston, C; Ehrsson, HH				Preston, Catherine; Ehrsson, H. Henrik			Illusory Changes in Body Size Modulate Body Satisfaction in a Way That Is Related to Non-Clinical Eating Disorder Psychopathology	PLOS ONE			English	Article							ANOREXIA-NERVOSA; MULTISENSORY ILLUSIONS; GENDER-DIFFERENCES; EXTERNAL OBJECTS; RUBBER HAND; MASS INDEX; IMAGE; DISSATISFACTION; WEIGHT; MEDIA	Historically, body size overestimation has been linked to abnormal levels of body dissatisfaction found in eating disorders. However, recently this relationship has been called into question. Indeed, despite a link between how we perceive and how we feel about our body seeming intuitive, until now lack of an experimental method to manipulate body size has meant that a causal link, even in healthy participants, has remained elusive. Recent developments in body perception research demonstrate that the perceptual experience of the body can be readily manipulated using multisensory illusions. The current study exploits such illusions to modulate perceived body size in an attempt to influence body satisfaction. Participants were presented with stereoscopic video images of slimmer and wider mannequin bodies viewed through head-mounted displays from first person perspective. Illusory ownership was induced by synchronously stroking the seen mannequin body with the unseen real body. Pre and post-illusion affective and perceptual measures captured changes in perceived body size and body satisfaction. Illusory ownership of a slimmer body resulted in participants perceiving their actual body as slimmer and giving higher ratings of body satisfaction demonstrating a direct link between perceptual and affective body representations. Change in body satisfaction following illusory ownership of a wider body, however, was related to degree of (non-clinical) eating disorder psychopathology, which can be linked to fluctuating body representations found in clinical samples. The results suggest that body perception is linked to body satisfaction and may be of importance for eating disorder symptomology.	[Preston, Catherine; Ehrsson, H. Henrik] Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden	Karolinska Institutet	Preston, C (corresponding author), Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden.	catherine.preston@ki.se			European Research Council; Swedish Foundation for Strategic Research; James S. McDonnell Foundation; Swedish Research Council; Soderberska Stiftelsen; Wednner-Gren Foundations; Marie Curie Actions	European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); James S. McDonnell Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberska Stiftelsen; Wednner-Gren Foundations; Marie Curie Actions(European Commission)	This study was funded by the European Research Council; the Swedish Foundation for Strategic Research; the James S. McDonnell Foundation; the Swedish Research Council; and Soderberska Stiftelsen. CP was funded by Wednner-Gren Foundations; and Marie Curie Actions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliata D, 2004, J SOC CLIN PSYCHOL, V23, P7, DOI 10.1521/jscp.23.1.7.26988; Algars M, 2009, J AGING HEALTH, V21, P1112, DOI 10.1177/0898264309348023; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Austin SB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-313; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Calzo JP, 2012, J ADOLESCENT HEALTH, V51, P517, DOI 10.1016/j.jadohealth.2012.02.021; Cash Thomas F, 2002, Eat Disord, V10, P103, DOI 10.1080/10640260290081678; Castro-Fornieles J, 2008, J PSYCHIATR RES, V43, P331, DOI 10.1016/j.jpsychires.2008.03.013; Cornelissen PL, 2013, BODY IMAGE, V10, P103, DOI 10.1016/j.bodyim.2012.09.003; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; Dodgson NA, 2004, PROC SPIE, V5291, P36, DOI 10.1117/12.529999; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2005, PLOS BIOL, V3, P2200, DOI 10.1371/journal.pbio.0030412; Espeset EMS, 2012, CLIN PSYCHOL PSYCHOT, V19, P518, DOI 10.1002/cpp.760; Espeset Ester M S, 2011, Eat Disord, V19, P175, DOI 10.1080/10640266.2011.551635; Fairburn CG, 2000, ARCH GEN PSYCHIAT, V57, P659, DOI 10.1001/archpsyc.57.7.659; Ferrer-Garcia M, 2012, BODY IMAGE, V9, P1, DOI 10.1016/j.bodyim.2011.10.001; Friederich HC, 2007, NEUROIMAGE, V37, P674, DOI 10.1016/j.neuroimage.2007.05.039; Gardner RM, 2010, PERS INDIV DIFFER, V48, P107, DOI 10.1016/j.paid.2009.08.017; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Guardia D, 2010, NEUROPSYCHOLOGIA, V48, P3961, DOI 10.1016/j.neuropsychologia.2010.09.004; Haggard P, 2009, PERCEPTION, V38, P1796, DOI 10.1068/p6399; Jansen A, 2005, BEHAV RES THER, V43, P183, DOI 10.1016/j.brat.2004.01.003; Keel PK, 2005, AM J PSYCHIAT, V162, P2263, DOI 10.1176/appi.ajp.162.12.2263; Keizer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064602; Keizer A, 2011, PSYCHIAT RES, V190, P115, DOI 10.1016/j.psychres.2011.04.031; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Mascolo M, 2012, INT J EAT DISORDER, V45, P977, DOI 10.1002/eat.22035; Mond JM, 2008, BEHAV RES THER, V46, P612, DOI 10.1016/j.brat.2008.02.003; Morry MM, 2001, CAN J BEHAV SCI, V33, P269, DOI 10.1037/h0087148; Myers TA, 2009, J ABNORM PSYCHOL, V118, P683, DOI 10.1037/a0016763; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; Pan XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032931; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Peterson CB, 2007, INT J EAT DISORDER, V40, P386, DOI 10.1002/eat.20373; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Petkova VI, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00035; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Pingitore R, 1997, OBES RES, V5, P402, DOI 10.1002/j.1550-8528.1997.tb00662.x; Preston C, 2012, PERCEPTION, V41, P247, DOI 10.1068/p7103; Preston C, 2011, RHEUMATOLOGY, V50, P2314, DOI 10.1093/rheumatology/ker104; Ramachandran VS, 2005, CLIN MED, V5, P368, DOI 10.7861/clinmedicine.5-4-368; RIDGEWAY RT, 2005, PSYCHOL MEN MASCULIN, V6, P209, DOI DOI 10.1037/1524-9220.6.3.209; Riva G, 2012, MED HYPOTHESES, V78, P254, DOI 10.1016/j.mehy.2011.10.039; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Schmalzl L, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00121; Schmalzl L, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00034; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SLADE PD, 1973, PSYCHOL MED, V3, P188, DOI 10.1017/S0033291700048510; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Smeets E, 2011, INT J EAT DISORDER, V44, P50, DOI 10.1002/eat.20776; Smeets MAM, 1999, J PSYCHOSOM RES, V46, P465, DOI 10.1016/S0022-3999(99)00005-7; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Soh NL, 2006, EUR EAT DISORD REV, V14, P54, DOI 10.1002/erv.678; Stice E, 2002, J PSYCHOSOM RES, V53, P985, DOI 10.1016/S0022-3999(02)00488-9; Stunkard AJ, 1983, GENETICS NEUROLOGICA, P115; THOMPSON JK, 1991, INT J EAT DISORDER, V10, P615, DOI 10.1002/1098-108X(199109)10:5<615::AID-EAT2260100514>3.0.CO;2-K; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; Wagner A, 2006, INT J EAT DISORDER, V39, P276, DOI 10.1002/eat.20251	61	78	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85773	10.1371/journal.pone.0085773	http://dx.doi.org/10.1371/journal.pone.0085773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465698	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500109
J	Mocco, J; Afzal, A; Ansari, S; Wolfe, A; Caldwell, K; Connolly, ES; Scott, EW				Mocco, J.; Afzal, Aqeela; Ansari, Saeed; Wolfe, Annemarie; Caldwell, Kenneth; Connolly, E. S.; Scott, Edward W.			SDF1-A Facilitates Lin-/Sca1+Cell Homing following Murine Experimental Cerebral Ischemia	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; HEMATOPOIETIC STEM-CELLS; MARROW STROMAL CELLS; BONE-MARROW; PERIPHERAL-BLOOD; CHEMOKINE SDF-1; CD34(+) CELLS; IN-VIVO; CXCR4; RECEPTOR	Background: Hematopoietic stem cells mobilize to the peripheral circulation in response to stroke. However, the mechanism by which the brain initiates this mobilization is uncharacterized. Methods: Animals underwent a murine intraluminal filament model of focal cerebral ischemia and the SDF1-A pathway was evaluated in a blinded manner via serum and brain SDF1-A level assessment, Lin-/Sca1+ cell mobilization quantification, and exogenous cell migration confirmation; all with or without SDF1-A blockade. Results: Bone marrow demonstrated a significant increase in Lin-/Sca1+ cell counts at 24 hrs (272+/-60%; P<0.05 vs sham). Mobilization of Lin-/Sca1+ cells to blood was significantly elevated at 24 hrs (607+/-159%; P<0.05). Serum SDF1-A levels were significant at 24 hrs (Sham (103614), 4 hrs (94+/-20%, p = NS) and 24 hrs (130617; p<0.05)). Brain SDF1-A levels were significantly elevated at both 4 hrs and 24 hrs (11367 pg/ml and 112610 pg/ml, respectively; p<0.05 versus sham 76611 pg/ml). Following administration of an SDF1-A antibody, Lin-/Sca1+ cells failed to mobilize to peripheral blood following stroke, despite continued up regulation in bone marrow (stroke bone marrow cell count: 536665, blood cell count 127624; p<0.05 versus placebo). Exogenously administered Lin-/Sca1+ cells resulted in a significant reduction in infarct volume: 42+/-5% (stroke alone), versus 21+/-15% (Stroke+Lin-/Sca1+cells), and administration of an SDF1-A antibody concomitant to exogenous administration of the Lin-/Sca1+ cells prevented this reduction. Following stroke, exogenously administered Lin-/Sca1+ FISH positive cells were significantly reduced when administered concomitant to an SDF1-A antibody as compared to without SDF1-A antibody (1064 vs 0.7+/-1, p<0.05). Conclusions: SDF1-A appears to play a critical role in modulating Lin-/Sca1+ cell migration to ischemic brain.	[Mocco, J.; Afzal, Aqeela] Vanderbilt Univ, Dept Neurol Surg, Nashville, TN 37235 USA; [Ansari, Saeed; Wolfe, Annemarie; Caldwell, Kenneth] Univ Florida, Dept Neurosurg, Gainesville, FL USA; [Connolly, E. S.] Columbia Univ, Dept Neurol Surg, New York, NY USA; [Scott, Edward W.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Vanderbilt University; State University System of Florida; University of Florida; Columbia University; State University System of Florida; University of Florida	Mocco, J (corresponding author), Vanderbilt Univ, Dept Neurol Surg, 221 Kirkland Hall, Nashville, TN 37235 USA.	j.mocco@vanderbilt.edu		Afzal, Aqeela/0000-0001-6406-2233; Caldwell, Kenneth/0000-0003-0654-8758	James and Esther King Foundation [2KN06]	James and Esther King Foundation	This study was funded by the James and Esther King Foundation; 2KN06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bonavia R, 2003, TOXICOL LETT, V139, P181, DOI 10.1016/S0378-4274(02)00432-0; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Caveliers V, 2007, Q J NUCL MED MOL IM, V51, P61; Chu K, 2008, STROKE, V39, P1441, DOI 10.1161/STROKEAHA.107.499236; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; Dai SJ, 2010, J MOL CELL CARDIOL, V49, P587, DOI 10.1016/j.yjmcc.2010.07.010; Dalakas E, 2005, FASEB J, V19, P1225, DOI 10.1096/fj.04-2604rev; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Deb Prabal, 2010, Pathophysiology, V17, P197, DOI 10.1016/j.pathophys.2009.12.001; DELALUZ SM, 2004, BLOOD, V103, P2452, DOI [DOI 10.1182/BL00D-2003-08-2857, 10.1182/blood-2003-08-2857]; Fadini GP, 2006, STROKE, V37, P2277, DOI 10.1161/01.STR.0000236064.19293.79; Haast RAM, 2012, J CEREBR BLOOD F MET, V32, P2100, DOI 10.1038/jcbfm.2012.141; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Hochsmann B, 2009, NEUROLOGY, V72, P1277, DOI 10.1212/01.wnl.0000345669.99690.e9; Huang CY, 2011, SURGERY, V150, P197, DOI 10.1016/j.surg.2011.05.010; Huang X, 2007, CELL DEATH DIFFER, V14, P1851, DOI 10.1038/sj.cdd.4402225; Juarez J, 2004, HISTOL HISTOPATHOL, V19, P299, DOI 10.14670/HH-19.299; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kucia M, 2004, J MOL HISTOL, V35, P233; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Liang X, 2010, INT J RADIAT BIOL, V86, P230, DOI 10.3109/09553000903422555; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lu DY, 2009, EUR J PHARMACOL, V613, P146, DOI 10.1016/j.ejphar.2009.03.001; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Paczkowska E, 2005, EUR J HAEMATOL, V75, P461, DOI 10.1111/j.1600-0609.2005.00536.x; Pituch-Noworolska A, 2003, FOLIA HISTOCHEM CYTO, V41, P13; Reddy K, 2008, INT J CANCER, V123, P831, DOI 10.1002/ijc.23582; Rouhl RPW, 2008, STROKE, V39, P2158, DOI 10.1161/STROKEAHA.107.507251; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Shyu WC, 2008, J PHARMACOL EXP THER, V324, P834, DOI 10.1124/jpet.107.127746; Sobrino T, 2007, STROKE, V38, P2759, DOI 10.1161/STROKEAHA.107.484386; Steiner B, 2012, NEUROSCI LETT, V513, P25, DOI 10.1016/j.neulet.2012.01.078; Tang YL, 2005, REGUL PEPTIDES, V125, P1, DOI 10.1016/j.regpep.2004.10.014; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Yu J, 2010, J CARDIOVASC PHARM, V55, P496, DOI 10.1097/FJC.0b013e3181d7a384; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286	46	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85615	10.1371/journal.pone.0085615	http://dx.doi.org/10.1371/journal.pone.0085615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465621	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500060
J	Ravussin, Y; Xiao, CY; Gavrilova, O; Reitman, ML				Ravussin, Yann; Xiao, Cuiying; Gavrilova, Oksana; Reitman, Marc L.			Effect of Intermittent Cold Exposure on Brown Fat Activation, Obesity, and Energy Homeostasis in Mice	PLOS ONE			English	Article							UNCOUPLING PROTEIN GENE; WHITE ADIPOSE-TISSUE; PLASMA LEPTIN; DIET; ANTAGONIST; EXPRESSION; AGONIST; THERMOGENESIS; EXPENDITURE; ADIPOCYTES	Homeotherms have specific mechanisms to maintain a constant core body temperature despite changes in thermal environment, food supply, and metabolic demand. Brown adipose tissue, the principal thermogenic organ, quickly and efficiently increases heat production by dissipating the mitochondrial proton motive force. It has been suggested that activation of brown fat, via either environmental (i.e. cold exposure) or pharmacologic means, could be used to increase metabolic rate and thus reduce body weight. Here we assess the effects of intermittent cold exposure (4 degrees C for one to eight hours three times a week) on C57BL/6J mice fed a high fat diet. Cold exposure increased metabolic rate approximately twofold during the challenge and activated brown fat. In response, food intake increased to compensate fully for the increased energy expenditure; thus, the mice showed no reduction in body weight or adiposity. Despite the unchanged adiposity, the cold-treated mice showed transient improvements in glucose homeostasis. Administration of the cannabinoid receptor-1 inverse agonist AM251 caused weight loss and improvements in glucose homeostasis, but showed no further improvements when combined with cold exposure. These data suggest that intermittent cold exposure causes transient, meaningful improvements in glucose homeostasis, but without synergy when combined with AM251. Since energy expenditure is significantly increased during cold exposure, a drug that dissociates food intake from metabolic demand during cold exposure may achieve weight loss and further metabolic improvements.	[Ravussin, Yann; Xiao, Cuiying; Reitman, Marc L.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Reitman, ML (corresponding author), NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA.	marc.reitman@nih.gov	Reitman, Marc/B-4448-2013; Ravussin, Yann/ABE-8061-2021; Ravussin, Yann/AAE-1440-2020	Reitman, Marc/0000-0002-0426-9475; Ravussin, Yann/0000-0002-6699-3944; 	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH [ZIA DK075062, ZIA DK075064, ZIA DK070002]; Swiss National Fund for Scientific Research (SNF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075062, ZICDK070002, ZIADK075064] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH; Swiss National Fund for Scientific Research (SNF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program (ZIA DK075062, ZIA DK075064, ZIA DK070002) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH. YR was supported by a grant from the Swiss National Fund for Scientific Research (SNF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; BARNETT SA, 1965, BIOL REV, V40, P5, DOI 10.1111/j.1469-185X.1965.tb00794.x; Bing C, 1998, AM J PHYSIOL-REG I, V274, pR62, DOI 10.1152/ajpregu.1998.274.1.R62; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Castillo M, 2011, DIABETES, V60, P1082, DOI 10.2337/db10-0758; CONTI PS, 1986, AM J CLIN ONCOL-CANC, V9, P537, DOI 10.1097/00000421-198612000-00014; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Gavrilova O, 2000, DIABETES, V49, P1910, DOI 10.2337/diabetes.49.11.1910; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Grujic D, 1997, J BIOL CHEM, V272, P17686, DOI 10.1074/jbc.272.28.17686; Haman F, FRONT BIOSCI SCHOL E, V2, P1155; Hamer M, 2010, CURR OPIN LIPIDOL, V21, P1, DOI 10.1097/MOL.0b013e328331dd21; Hildebrandt AL, 2003, EUR J PHARMACOL, V462, P125, DOI 10.1016/S0014-2999(03)01343-8; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; HOLLOSZY JO, 1986, J APPL PHYSIOL, V61, P1656, DOI 10.1152/jappl.1986.61.5.1656; Judge MK, 2009, J ENDOCRINOL, V203, P281, DOI 10.1677/JOE-09-0210; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lusk G., 1928, SCI NUTR; MAYER J, 1954, AM J PHYSIOL, V177, P544, DOI 10.1152/ajplegacy.1954.177.3.544; McLaughlin PJ, 2005, PSYCHOPHARMACOLOGY, V180, P286, DOI 10.1007/s00213-005-2171-0; Mercer JG, 1997, FEBS LETT, V402, P185, DOI 10.1016/S0014-5793(96)01525-6; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; Ravussin Y, 2013, INT J OBES LOND, V37, P473; Rippe C, 2000, AM J PHYSIOL-ENDOC M, V279, pE293, DOI 10.1152/ajpendo.2000.279.2.E293; Robidoux J, 2004, ANNU REV PHARMACOL, V44, P297, DOI 10.1146/annurev.pharmtox.44.101802.121659; Rosenbaum M, 1997, J CLIN ENDOCR METAB, V82, P3647, DOI 10.1210/jc.82.11.3647; Shefer VI, 1997, EXP GERONTOL, V32, P325, DOI 10.1016/S0531-5565(96)00131-3; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; TALAN MI, 1985, J GERONTOL, V40, P8, DOI 10.1093/geronj/40.1.8; TRAYHURN P, 1995, BIOCHEM J, V311, P729, DOI 10.1042/bj3110729; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; YOSHIDA T, 1994, EUR J ENDOCRINOL, V131, P97, DOI 10.1530/eje.0.1310097; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4	45	73	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85876	10.1371/journal.pone.0085876	http://dx.doi.org/10.1371/journal.pone.0085876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465761	gold, Green Submitted, Green Published			2022-12-25	WOS:000330237000069
J	Calhoun, KC; Padilla-Banks, E; Jefferson, WN; Liu, LW; Gerrish, KE; Young, SL; Wood, CE; Hunt, PA; VandeVoort, CA; Williams, CJ				Calhoun, Kathryn C.; Padilla-Banks, Elizabeth; Jefferson, Wendy N.; Liu, Liwen; Gerrish, Kevin E.; Young, Steven L.; Wood, Charles E.; Hunt, Patricia A.; VandeVoort, Catherine A.; Williams, Carmen J.			Bisphenol A Exposure Alters Developmental Gene Expression in the Fetal Rhesus Macaque Uterus	PLOS ONE			English	Article							FOOT-GENITAL SYNDROME; WIDESPREAD EXPOSURE; MACACA-FASCICULARIS; REPRODUCTIVE-TRACT; MAMMARY-GLAND; MONKEY; MOUSE; MUTATION; ADULT; WNT4	Bisphenol A (BPA) exposure results in numerous developmental and functional abnormalities in reproductive organs in rodent models, but limited data are available regarding BPA effects in the primate uterus. To determine if maternal oral BPA exposure affects fetal uterine development in a non-human primate model, pregnant rhesus macaques carrying female fetuses were exposed orally to 400 mu g/kg BPA or vehicle control daily from gestation day (GD) 50-100 or GD100-165. Fetal uteri were collected at the completion of treatment (GD100 or GD165); tissue histology, cell proliferation, and expression of estrogen receptor alpha (ER alpha) and progesterone receptor (PR) were compared to that of controls. Gene expression analysis was conducted using rhesus macaque microarrays. There were no significant differences in histology or in the percentage of cells expressing the proliferation marker Ki-67, ER alpha, or PR in BPA-exposed uteri compared to controls at GD100 or GD165. Minimal differences in gene expression were observed between BPA-exposed and control GD100 uteri. However, at GD165, BPA-exposed uteri had significant differences in gene expression compared to controls. Several of the altered genes, including HOXA13, WNT4, and WNT5A, are critical for reproductive organ development and/or adult function. We conclude that second or third trimester BPA exposure does not significantly affect fetal uterus development based on morphological, proliferation, and steroid hormone receptor assessments. However, differences in expression of key developmental genes after third trimester exposure suggest that BPA could alter transcriptional signals influencing uterine function later in life.	[Calhoun, Kathryn C.; Padilla-Banks, Elizabeth; Jefferson, Wendy N.; Williams, Carmen J.] NIEHS, Reprod Med Grp, Lab Reprod & Dev Toxicol, Res Triangle Pk, NC 27709 USA; [Calhoun, Kathryn C.; Young, Steven L.] Univ N Carolina, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Chapel Hill, NC USA; [Liu, Liwen; Gerrish, Kevin E.] NIEHS, Microarray Grp, Res Triangle Pk, NC 27709 USA; [Wood, Charles E.] US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA; [Hunt, Patricia A.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [VandeVoort, Catherine A.] Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA; [VandeVoort, Catherine A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); United States Environmental Protection Agency; Washington State University; University of California System; University of California Davis; University of California System; University of California Davis	Williams, CJ (corresponding author), NIEHS, Reprod Med Grp, Lab Reprod & Dev Toxicol, POB 12233, Res Triangle Pk, NC 27709 USA.	williamsc5@niehs.nih.gov	Williams, Carmen J/E-2170-2013; Young, Steven L/G-2304-2014	Williams, Carmen J/0000-0001-6440-7086; Young, Steven L/0000-0002-5205-4495	National Institutes of Health, National Institutes of Environmental Health Sciences [ES102405, ES016770, ES013527]; National Center for Research Resources, Office of the Director to the California National Primate Research Center [RR000169/OD011107]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102405, R01ES016770, R01ES013527, ZICES102445] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Research Resources, Office of the Director to the California National Primate Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institutes of Environmental Health Sciences [ES102405 to C.J.W.], National Institutes of Health, National Institutes of Environmental Health Sciences (http://www.niehs.nih.gov/) [ES016770 to C. A. V. and P. A. H. and ES013527 to P. A. H.], and the National Center for Research Resources (http://www.nih.gov/about/almanac/organization/NCRR.htm), Office of the Director to the California National Primate Research Center [RR000169/OD011107]. This manuscript was approved for publication by the National Health and Environmental Effects Research Laboratory of the Environmental Protection Agency but does not necessarily represent the opinions or policy of the agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DG, 1982, TOXICOL LETT, V11, P43, DOI 10.1016/0378-4274(82)90103-5; ATKINSON LE, 1975, BIOL REPROD, V12, P335, DOI 10.1095/biolreprod12.3.335; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; BERNASCONE I, 2013, TRENDS CELL BIOL; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Braun JM, 2011, CURR OPIN PEDIATR, V23, P233, DOI 10.1097/MOP.0b013e3283445675; Brisken C, 2000, GENE DEV, V14, P650; Bromer JG, 2010, FASEB J, V24, P2273, DOI 10.1096/fj.09-140533; Doerge DR, 2011, TOXICOL APPL PHARM, V255, P261, DOI 10.1016/j.taap.2011.07.009; DONNENFELD AE, 1992, AM J MED GENET, V44, P482, DOI 10.1002/ajmg.1320440419; Elsworth JD, 2013, NEUROTOXICOLOGY, V35, P113, DOI 10.1016/j.neuro.2013.01.001; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Hayashi K, 2009, BIOL REPROD, V80, P989, DOI 10.1095/biolreprod.108.075416; Hunt PA, 2012, P NATL ACAD SCI USA, V109, P17525, DOI 10.1073/pnas.1207854109; Illig R, 2013, DEV DYNAM, V242, P53, DOI 10.1002/dvdy.23893; Jaaskelainen M, 2010, MOL CELL ENDOCRINOL, V317, P106, DOI 10.1016/j.mce.2009.11.013; Jefferson WN, 2011, ENVIRON HEALTH PERSP, V119, P1575, DOI 10.1289/ehp.1104018; Kwon HE, 2004, ANN NY ACAD SCI, V1034, P1, DOI 10.1196/annals.1335.001; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; Mandel H, 2008, AM J HUM GENET, V82, P39, DOI 10.1016/j.ajhg.2007.08.005; Markey CM, 2005, BIOL REPROD, V72, P1344, DOI 10.1095/biolreprod.104.036301; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Naillat F, 2010, HUM MOL GENET, V19, P1539, DOI 10.1093/hmg/ddq027; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Roarty K, 2010, CURR OPIN PHARMACOL, V10, P643, DOI 10.1016/j.coph.2010.07.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Simmen RCM, 2010, J ENDOCRINOL, V204, P223, DOI 10.1677/JOE-09-0329; Smith CC, 2007, FASEB J, V21, P239, DOI 10.1096/fj.06-6635com; STILLMAN RJ, 1982, AM J OBSTET GYNECOL, V142, P905, DOI 10.1016/S0002-9378(16)32540-6; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; Taylor HS, 1997, BIOL REPROD, V57, P1338, DOI 10.1095/biolreprod57.6.1338; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Tharp AP, 2012, P NATL ACAD SCI USA, V109, P8190, DOI 10.1073/pnas.1120488109; Valdes-Dapena M.A, 1973, THE UTERUS, P40; Van Esch E, 2008, TOXICOL PATHOL, V36, p67S, DOI 10.1177/0192623308326149; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Weinbauer GF, 2008, TOXICOL PATHOL, V36, p7S, DOI 10.1177/0192623308327412; Yin Y, 2005, J BIOCHEM, V137, P677, DOI 10.1093/jb/mvi087; Young T, 2009, CURR TOP DEV BIOL, V88, P235, DOI 10.1016/S0070-2153(09)88008-3	43	37	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85894	10.1371/journal.pone.0085894	http://dx.doi.org/10.1371/journal.pone.0085894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465770	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000031
J	Gregoire, CA; Bonenfant, D; Le Nguyen, A; Aumont, A; Fernandes, KJL				Gregoire, Catherine-Alexandra; Bonenfant, David; Le Nguyen, Adalie; Aumont, Anne; Fernandes, Karl J. L.			Untangling the Influences of Voluntary Running, Environmental Complexity, Social Housing and Stress on Adult Hippocampal Neurogenesis	PLOS ONE			English	Article							DENTATE GRANULE CELLS; PSYCHOSOCIAL STRESS; PHYSICAL-EXERCISE; PROLIFERATION; ENRICHMENT; BRAIN; NEURONS; MEMORY; GYRUS; ACTIVATION	Environmental enrichment (EE) exerts powerful effects on brain physiology, and is widely used as an experimental and therapeutic tool. Typical EE paradigms are multifactorial, incorporating elements of physical exercise, environmental complexity, social interactions and stress, however the specific contributions of these variables have not been separable using conventional housing paradigms. Here, we evaluated the impacts of these individual variables on adult hippocampal neurogenesis by using a novel "Alternating EE" paradigm. For 4 weeks, adult male CD1 mice were alternated daily between two enriched environments; by comparing groups that differed in one of their two environments, the individual and combinatorial effects of EE variables could be resolved. The Alternating EE paradigm revealed that (1) voluntary running for 3 days/week was sufficient to increase both mitotic and post-mitotic stages of hippocampal neurogenesis, confirming the central importance of exercise; (2) a complex environment (comprised of both social interactions and rotated inanimate objects) had no effect on neurogenesis itself, but enhanced depolarization-induced c-Fos expression (attributable to social interactions) and buffered stress-induced plasma corticosterone levels (attributable to inanimate objects); and (3) neither social isolation, group housing, nor chronically increased levels of plasma corticosterone had a prolonged impact on neurogenesis. Mouse strain, handling and type of running apparatus were tested and excluded as potential confounding factors. These findings provide valuable insights into the relative effects of key EE variables on adult neurogenesis, and this "Alternating EE" paradigm represents a useful tool for exploring the contributions of individual EE variables to mechanisms of neural plasticity.	Univ Montreal, Dept Pathol & Cell Biol, GRSNC, Montreal, PQ, Canada; Univ Montreal, CENUM, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Fernandes, KJL (corresponding author), Univ Montreal, Fac Med, Dept Neurosci, Montreal, PQ H3C 3J7, Canada.	karl.jl.fernandes@umontreal.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by the Natural Sciences and Engineering Research Council (NSERC) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg MAI, 2009, P NATL ACAD SCI USA, V106, P20906, DOI 10.1073/pnas.0905307106; Ambrogini P, 2002, NEUROENDOCRINOLOGY, V76, P366, DOI 10.1159/000067581; Bednarczyk MR, 2011, HIPPOCAMPUS, V21, P1334, DOI 10.1002/hipo.20831; BENNETT EL, 1969, SCIENCE, V163, P825, DOI 10.1126/science.163.3869.825; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Cacioppo JT, 2011, ANN NY ACAD SCI, V1231, P17, DOI 10.1111/j.1749-6632.2011.06028.x; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Clark PJ, 2011, GENES BRAIN BEHAV, V10, P345, DOI 10.1111/j.1601-183X.2010.00674.x; Clark PJ, 2012, HIPPOCAMPUS, V22, P1860, DOI 10.1002/hipo.22020; Clark PJ, 2009, HIPPOCAMPUS, V19, P937, DOI 10.1002/hipo.20543; Clark PJ, 2011, GENES BRAIN BEHAV; Czeh B, 2002, BIOL PSYCHIAT, V52, P1057, DOI 10.1016/S0006-3223(02)01457-9; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; FIALA BA, 1978, EXP NEUROL, V59, P372, DOI 10.1016/0014-4886(78)90229-7; Glasper ER, 2012, BEHAV BRAIN RES, V227, P380, DOI 10.1016/j.bbr.2011.05.013; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; GREEN EJ, 1986, J NEUROPHYSIOL, V55, P739, DOI 10.1152/jn.1986.55.4.739; Hebb DO., 1947, AM PSYCHOL, V2, P306; Herting MM, 2012, BEHAV BRAIN RES, V233, P517, DOI 10.1016/j.bbr.2012.05.012; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Kannangara TS, 2009, HIPPOCAMPUS, V19, P889, DOI 10.1002/hipo.20514; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, BIPOLAR DISORD, V4, P17, DOI 10.1034/j.1399-5618.2002.40101.x; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kempermann G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00189; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kobilo T, 2011, LEARN MEMORY, V18, P605, DOI 10.1101/lm.2283011; Komitova M, 2005, EUR J NEUROSCI, V21, P2397, DOI 10.1111/j.1460-9568.2005.04072.x; Kozorovitskiy Y, 2004, J NEUROSCI, V24, P6755, DOI 10.1523/JNEUROSCI.0345-04.2004; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; LATORRE JC, 1968, EXP NEUROL, V22, P493, DOI 10.1016/0014-4886(68)90144-1; Leasure JL, 2009, HIPPOCAMPUS, V19, P907, DOI 10.1002/hipo.20563; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Leuner B, 2004, J NEUROSCI, V24, P7477, DOI 10.1523/JNEUROSCI.0204-04.2004; Leuner B, 2007, HIPPOCAMPUS, V17, P434, DOI 10.1002/hipo.20278; Leuner B, 2010, TRENDS NEUROSCI, V33, P465, DOI 10.1016/j.tins.2010.07.003; Leuner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011597; Lieberwirth C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00118; Liu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030803; Mak GK, 2010, NAT NEUROSCI, V13, P753, DOI 10.1038/nn.2550; MANOSEVITZ M, 1973, J COMP PHYSIOL PSYCH, V85, P373, DOI 10.1037/h0035041; Mathews EA, 2010, J COMP NEUROL, V518, P4479, DOI 10.1002/cne.22489; McCormick CM, 2012, HIPPOCAMPUS, V22, P1300, DOI 10.1002/hipo.20966; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mitra R, 2006, PHYSIOL BEHAV, V89, P123, DOI 10.1016/j.physbeh.2006.05.047; Mustroph ML, 2012, NEUROSCIENCE; Naylor AS, 2005, J NEUROPHYSIOL, V93, P2406, DOI 10.1152/jn.01085.2004; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Pang TYC, 2013, NEUROPHARMACOLOGY, V64, P515, DOI 10.1016/j.neuropharm.2012.06.029; Proulx MJ, 2012, NEUROSCI BIOBEHAV RE; Risedal A, 2002, BRAIN RES BULL, V58, P315, DOI 10.1016/S0361-9230(02)00796-7; Roozendaal B, 2006, NEUROSCIENCE, V138, P901, DOI 10.1016/j.neuroscience.2005.07.049; ROSENZWEIG MR, 1962, J COMP PHYSIOL PSYCH, V55, P429, DOI 10.1037/h0041137; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schloesser RJ, 2009, NEUROREPORT, V20, P553, DOI 10.1097/WNR.0b013e3283293e59; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Schwabe L, 2012, J NEUROSCI, V32, P11042, DOI 10.1523/JNEUROSCI.1484-12.2012; Simon M, 2005, BRAIN RES, V1049, P244, DOI 10.1016/j.brainres.2005.05.006; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Thomas RM, 2006, EXP NEUROL, V201, P308, DOI 10.1016/j.expneurol.2006.04.010; Todkar K, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00056; Van Bokhoven P, 2011, EUR J NEUROSCI, V33, P1833, DOI 10.1111/j.1460-9568.2011.07668.x; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VANEEKELEN JAM, 1988, J NEUROSCI RES, V21, P88, DOI 10.1002/jnr.490210113; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; WELCH BL, 1974, BRAIN RES, V75, P71, DOI 10.1016/0006-8993(74)90771-9; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1060, DOI 10.1152/jn.1965.28.6.1060; Woollett K, 2011, CURR BIOL, V21, P2109, DOI 10.1016/j.cub.2011.11.018; Wosiski-Kuhn M, 2012, AGEING RES REV, V11, P399, DOI 10.1016/j.arr.2011.11.003	89	78	80	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86237	10.1371/journal.pone.0086237	http://dx.doi.org/10.1371/journal.pone.0086237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465980	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000070
J	Takahata, C; Nielsen, SE; Takii, A; Izumiyama, S				Takahata, Chihiro; Nielsen, Scott Eric; Takii, Akiko; Izumiyama, Shigeyuki			Habitat Selection of a Large Carnivore along Human-Wildlife Boundaries in a Highly Modified Landscape	PLOS ONE			English	Article							GRIZZLY BEAR MOVEMENTS; WEST-CENTRAL ALBERTA; ASIATIC BLACK BEAR; RESOURCE SELECTION; AGRICULTURAL LANDSCAPE; BEHAVIORAL-RESPONSES; BRITISH-COLUMBIA; CONSERVATION; WASHINGTON; CONFLICTS	When large carnivores occupy peripheral human lands conflict with humans becomes inevitable, and the reduction of human-carnivore interactions must be the first consideration for those concerned with conflict mitigation. Studies designed to identify areas of high human-bear interaction are crucial for prioritizing management actions. Due to a surge in conflicts, against a background of social intolerance to wildlife and the prevalent use of lethal control throughout Japan, Asiatic black bears (Ursus thibetanus) are now threatened by high rates of mortality. There is an urgent need to reduce the frequency of human-bear encounters if bear populations are to be conserved. To this end, we estimated the habitats that relate to human-bear interactions by sex and season using resource selection functions (RSF). Significant seasonal differences in selection for and avoidance of areas by bears were estimated by distance-effect models with interaction terms of land cover and sex. Human-bear boundaries were delineated on the basis of defined bear-habitat edges in order to identify areas that are in most need of proactive management strategies. Asiatic black bears selected habitats in close proximity to forest edges, forest roads, rivers, and red pine and riparian forests during the peak conflict season and this was correctly predicted in our human-bear boundary maps. Our findings demonstrated that bears selected abandoned forests and agricultural lands, indicating that it should be possible to reduce animal use near human lands by restoring season-specific habitat in relatively remote areas. Habitat-based conflict mitigation may therefore provide a practical means of creating adequate separation between humans and these large carnivores.	[Takahata, Chihiro] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Nagano, Japan; [Nielsen, Scott Eric] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Takii, Akiko; Izumiyama, Shigeyuki] Shinshu Univ, Fac Agr, Educ & Res Ctr Alpine Field Sci, Nagano, Japan	Shinshu University; University of Alberta; Shinshu University	Takahata, C (corresponding author), Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Nagano, Japan.	takahatacat@nifty.com	Nielsen, Scott/O-7482-2019; Nielsen, Scott/C-2842-2013	Nielsen, Scott/0000-0002-9754-0630; Nielsen, Scott/0000-0002-9754-0630; Takahata, Chihiro/0000-0002-8207-7612	 [23310030]		This research was funded in part by Grants-in-Aid for Scientific Research (B; 23310030) https://kaken.nii.ac.jp/d/p/23310030.en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. And no additional external funding received for this study.	[Anonymous], 1990, URSUS; [Anonymous], MULT V 3 2 1; Apps CD, 2004, J WILDLIFE MANAGE, V68, P138, DOI 10.2193/0022-541X(2004)068[0138:EGBDAA]2.0.CO;2; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Beckmann JP, 2003, J ZOOL, V261, P207, DOI 10.1017/S0952836903004126; Brodeur V, 2008, CAN J ZOOL, V86, P1307, DOI 10.1139/Z08-118; Cunningham SC, 2003, WILDLIFE SOC B, V31, P786; Davis H, 2006, URSUS, V17, P41, DOI 10.2192/1537-6176(2006)17[41:IOPOSS]2.0.CO;2; Elfstrom M, 2012, MAMMAL REV, V43, P167; Ferguson SH, 2002, ANIM CONSERV, V5, P1, DOI 10.1017/S1367943002001014; Forestry Agency Ministry of Agriculture Forestry and Fisheries Japan, 2011, ANN REP FOR FOR JAP; Fujiwara S, 2012, MAMM, V78, P34; Gaines WL, 2005, BIOL CONSERV, V125, P411, DOI 10.1016/j.biocon.2005.03.023; Gibeau ML, 2002, BIOL CONSERV, V103, P227, DOI 10.1016/S0006-3207(01)00131-8; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Glikman JA, 2012, EUR J WILDLIFE RES, V58, P295, DOI 10.1007/s10344-011-0579-x; Hashimoto Y, 2003, ECOL RES, V18, P485, DOI 10.1046/j.1440-1703.2003.00572.x; Hayward MW, 2009, BIOL CONSERV, V142, P1, DOI 10.1016/j.biocon.2008.09.022; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huygens OC, 2004, URSUS, V15, P197, DOI 10.2192/1537-6176(2004)015<0197:RBABBK>2.0.CO;2; Huygens Oscar C., 2003, Ursus, V14, P236; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Jones Mark D., 2003, Ursus (Knoxville), V14, P188; Katoh K, 2009, BIOL CONSERV, V142, P1930, DOI 10.1016/j.biocon.2009.02.030; Kishimoto R, 2009, BIOL BEAR INTRUSIONS, V35; Koike S, 2010, MAMM BIOL, V75, P17, DOI 10.1016/j.mambio.2009.03.008; Lyons AL, 2003, BIOL CONSERV, V113, P55, DOI 10.1016/S0006-3207(02)00349-X; Manly B.F.J., 2002, RESOURCE SELECTION A; May R, 2008, J APPL ECOL, V45, P1382, DOI 10.1111/j.1365-2664.2008.01527.x; Merkle JA, 2011, J WILDLIFE MANAGE, V75, P1121, DOI 10.1002/jwmg.153; Ministry of Agriculture Forestry and Fisheries, 2012, FY2011 ANN REP FOOD; Ministry of the Environment, 2008, MAN RESP BEAR APP; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P51, DOI 10.1016/j.foreco.2004.04.014; Nielsen SE, 2003, ECOSCIENCE, V10, P1; Ordiz A, 2013, J APPL ECOL, V50, P306, DOI 10.1111/1365-2664.12047; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; Pereira M, 2010, J APPL ECOL, V47, P611, DOI 10.1111/j.1365-2664.2010.01804.x; Reynolds-Hogland MJ, 2007, J MAMMAL, V88, P1050, DOI 10.1644/06-MAMM-A-072R1.1; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Sakurai Ryo, 2011, Human-Wildlife Interactions, V5, P123; SCHOEN JW, 1990, INT C BEAR, V8, P143; Singleton PH, 2004, URSUS, V15, P90, DOI 10.2192/1537-6176(2004)015<0090:LPFGBM>2.0.CO;2; Spencer RD, 2007, URSUS, V18, P217, DOI 10.2192/1537-6176(2007)18[217:HARTHB]2.0.CO;2; Stewart BP, 2013, J WILDL MANAGE; Takahata C, 2013, URSUS, V24, P16, DOI 10.2192/URSUS-D-11-00018.1; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Van Manen FT, 2012, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.7; Waller JS, 2005, J WILDLIFE MANAGE, V69, P985, DOI 10.2193/0022-541X(2005)069[0985:EOTIOG]2.0.CO;2; Wilson SM, 2006, BIOL CONSERV, V130, P47, DOI 10.1016/j.biocon.2005.12.001	52	29	36	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86181	10.1371/journal.pone.0086181	http://dx.doi.org/10.1371/journal.pone.0086181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465947	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000060
J	Baumann-Pickering, S; Roch, MA; Brownell, RL; Simonis, AE; McDonald, MA; Solsona-Berga, A; Oleson, EM; Wiggins, SM; Hildebrand, JA				Baumann-Pickering, Simone; Roch, Marie A.; Brownell, Robert L., Jr.; Simonis, Anne E.; McDonald, Mark A.; Solsona-Berga, Alba; Oleson, Erin M.; Wiggins, Sean M.; Hildebrand, John A.			Spatio-Temporal Patterns of Beaked Whale Echolocation Signals in the North Pacific	PLOS ONE			English	Article							ZIPHIUS-CAVIROSTRIS; KILLER WHALES; MESOPLODON; STRANDINGS; MOVEMENTS; WORLDWIDE; HABITAT; DOLPHIN; WATERS; ISLAND	At least ten species of beaked whales inhabit the North Pacific, but little is known about their abundance, ecology, and behavior, as they are elusive and difficult to distinguish visually at sea. Six of these species produce known species-specific frequency modulated (FM) echolocation pulses: Baird's, Blainville's, Cuvier's, Deraniyagala's, Longman's, and Stejneger's beaked whales. Additionally, one described FM pulse (BWC) from Cross Seamount, Hawai'i, and three unknown FM pulse types (BW40, BW43, BW70) have been identified from almost 11 cumulative years of autonomous recordings at 24 sites throughout the North Pacific. Most sites had a dominant FM pulse type with other types being either absent or limited. There was not a strong seasonal influence on the occurrence of these signals at any site, but longer time series may reveal smaller, consistent fluctuations. Only the species producing BWC signals, detected throughout the Pacific Islands region, consistently showed a diel cycle with nocturnal foraging. By comparing stranding and sighting information with acoustic findings, we hypothesize that BWC signals are produced by ginkgo-toothed beaked whales. BW43 signal encounters were restricted to Southern California and may be produced by Perrin's beaked whale, known only from Californian waters. BW70 signals were detected in the southern Gulf of California, which is prime habitat for Pygmy beaked whales. Hubb's beaked whale may have produced the BW40 signals encountered off central and southern California; however, these signals were also recorded off Pearl and Hermes Reef and Wake Atoll, which are well south of their known range.	[Baumann-Pickering, Simone; Roch, Marie A.; Simonis, Anne E.; Solsona-Berga, Alba; Wiggins, Sean M.; Hildebrand, John A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Roch, Marie A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Brownell, Robert L., Jr.] NOAA, SW Fisheries Sci Ctr, Pacific Grove, CA USA; [McDonald, Mark A.] WhaleAcoustics, Bellvue, CO USA; [Solsona-Berga, Alba] Univ Barcelona, Barcelona, Spain; [Oleson, Erin M.] NOAA, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; California State University System; San Diego State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Barcelona; National Oceanic Atmospheric Admin (NOAA) - USA	Baumann-Pickering, S (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	sbaumann@ucsd.edu	Baumann-Pickering, Simone/AFO-9717-2022; Simonis, Anne/ABB-2031-2021; Oleson, Erin/AAA-9681-2019; Simonis, Anne/AAU-5542-2021	Baumann-Pickering, Simone/0000-0002-3428-3577; Oleson, Erin/0000-0002-4889-6059; Simonis, Anne/0000-0002-8026-6233; Solsona Berga, Alba/0000-0003-4096-742X; Hildebrand, John/0000-0002-5418-9799	United States Office of Naval Research; United States Navy Living Marine Resources; United States Pacific Fleet; Pacific Life Foundation; Naval Postgraduate School; Pacific Islands Fisheries Science Center (PIFSC), National Oceanic and Atmospheric Administration	United States Office of Naval Research(Office of Naval Research); United States Navy Living Marine Resources; United States Pacific Fleet; Pacific Life Foundation; Naval Postgraduate School(United States Department of Defense); Pacific Islands Fisheries Science Center (PIFSC), National Oceanic and Atmospheric Administration	Funding provided by United States Office of Naval Research, M. Weise (http://www.onr.navy.mil/en/Science-Technology/Departments/Code-32/All-Programs/Atmosphere-Research-322/Marine-Mammals-Biology.aspx), United States Navy Living Marine Resources, B. Gisiner and F. Stone (http://www.lmr.navy.mil), United States Pacific Fleet, C. Johnson (https://portal.navfac.navy.mil), Pacific Life Foundation, B. Haskell (http://www.pacificlife.com/PL/FoundationCommunity/Overview/Corp_PLF_Home.htm), Ocean Foundation, M. Spaulding (http://www.oceanfdn.org), Naval Postgraduate School, C. Collins and J. Joseph (http://www.nps.edu) and Pacific Islands Fisheries Science Center (PIFSC), National Oceanic and Atmospheric Administration (http://www.pifsc.noaa.gov/cetacean). The funders (except for PIFSC, EMO) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BM, 2012, REV CURRENT KNOWLEDG; Anderson R. Charles, 1999, Journal of South Asian Natural History, V4, P187; Au WWL, 2012, J ACOUST SOC AM, V131, P569, DOI 10.1121/1.3662077; AZZAROLI M L, 1968, Monitore Zoologico Italiano, V2, P67; Baird Robin W., 2010, Endangered Species Research, V10, P107, DOI 10.3354/esr00258; Baird RW, 2013, PSRG2013B09, P1; Baker A.N, 1983, WHALES DOLPHINS AUST; Baker AN, 1999, J ROY SOC NEW ZEAL, V29, P235, DOI 10.1080/03014223.1999.9517594; Baker CS, 2006, ANIM CONSERV, V9, P474, DOI 10.1111/j.1469-1795.2006.00062.x; Balcomb III K.C., 1989, HDB MARINE MAMMALS, V4, P261; Bannister J, 1996, ACTION PLAN AUSTR CE; Barlow Jay, 2005, Journal of Cetacean Research and Management, V7, P263; Baumann-Pickering S, 2013, J ACOUST SOC AM, V134, P2293, DOI 10.1121/1.4817832; Baumann-Pickering S, 2013, J ACOUST SOC AM, V133, P4321, DOI 10.1121/1.4804316; Baumann-Pickering S, 2013, MAR MAMMAL SCI, V29, P221, DOI 10.1111/j.1748-7692.2011.00550.x; Baumann-Pickering S, 2010, J ACOUST SOC AM, V127, P3790, DOI 10.1121/1.3409478; Carretta J, 2012, US PACIFIC MARINE MA; Cowan I. McT., 1952, Murrelet, V33, P10, DOI 10.2307/3534656; Dalebout ML, 2007, MAR MAMMAL SCI, V23, P954, DOI 10.1111/j.1748-7692.2007.00143.x; Dalebout ML, 2005, MOL ECOL, V14, P3353, DOI 10.1111/j.1365-294X.2005.02676.x; Dalebout ML, 2003, MAR MAMMAL SCI, V19, P421, DOI 10.1111/j.1748-7692.2003.tb01314.x; Dalebout ML, MAR MAMM SC IN PRESS; Danil Kerri, 2010, Journal of Cetacean Research and Management, V11, P163; Dawson S, 1998, MAR MAMMAL SCI, V14, P335, DOI 10.1111/j.1748-7692.1998.tb00724.x; Delarue J, 2009, J ACOUST SOC AM, V125, P1774, DOI 10.1121/1.3068454; Dolar M. Louella L., 1998, Asian Marine Biology, V14, P61; ELDREDGE L G, 1991, Micronesica, V24, P217; Falcone EA, 2009, MAR BIOL, V156, P2631, DOI 10.1007/s00227-009-1289-8; Ferguson Megan C., 2005, Journal of Cetacean Research and Management, V7, P287; Fiedler PC, 2006, PROG OCEANOGR, V69, P143, DOI 10.1016/j.pocean.2006.03.008; FORD JKB, 1991, CAN J ZOOL, V69, P1454, DOI 10.1139/z91-206; Galbreath E. C., 1963, Journal of Mammalogy, V44, P422, DOI 10.2307/1377219; Gillespie D, 2009, J ACOUST SOC AM, V125, P3428, DOI 10.1121/1.3110832; Hamilton TA, 2009, 440 NOAA NMFS; Heyning JE, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P294; HUBBS CL, 1946, J MAMMAL, V27, P242, DOI 10.2307/1375435; HUBBS CL, 1951, J MAMMAL, V32, P365, DOI 10.1093/jmammal/32.3.365; Jefferson T.A., 2015, COMPREHENSIVE GUIDE; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Johnson M, 2006, J EXP BIOL, V209, P5038, DOI 10.1242/jeb.02596; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Jr Brownell RL, 2012, REV PERRINS BEAKED W, VSC/64/SM31; KASUYA T, 1971, SCI REPORTS WHALES R, V23, P129; Kim Z.G., 2000, WHALES DOLPHINS KORE; Leatherwood S, 1988, WHALES DOLPHINS PORP; LONGMAN HEBER A., 1926, MEM QUEENS LAND MUS, V8, P266; LYNN SK, 1992, MAR MAMMAL SCI, V8, P299, DOI 10.1111/j.1748-7692.1992.tb00413.x; MacLeod Colin D., 2005, Journal of Cetacean Research and Management, V7, P271; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Marten Ken, 2000, Aquatic Mammals, V26, P45; May-Collado L, 2005, REV BIOL TROP, V53, P249; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; McDonald MA, 2009, J ACOUST SOC AM, V125, P624, DOI 10.1121/1.3050317; McSweeney DJ, 2007, MAR MAMMAL SCI, V23, P666, DOI 10.1111/j.1748-7692.2007.00135.x; Mead J.G., 1982, Smithsonian Contributions to Zoology, V344, P1; Mead J.G., 1989, P349; Mead JG, 1988, DISTRIBUTION EXPLOIT; MITCHELL E, 1968, CAN J ZOOLOG, V46, P265, DOI 10.1139/z68-040; Miyazaki N., 1986, CATALOGUE MARINE MAM; MOORE JC, 1965, NATURE, V205, P1239, DOI 10.1038/2051239a0; Moore JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052770; Nakajima M, 1984, GEIKEN TSUSHIN, V356, P94; Nino Torres CA, 2013, PUBLICATION ESPECIAL, V2; Nishiwaki M., 1959, Scientific Reports of the Whales Research Institute Tokyo, VNo. 14, P35; Nishiwaki M, 1958, SCI REPORTS WHALES R, V13; Nishiwaki M., 1972, SCI REP WHALES RES, V24, P43; Nitta E, 1991, MARINE MAMMAL STRAND, P56; ORR RT, 1966, J MAMMAL, V47, P339, DOI 10.2307/1378138; Palacios DM, 1996, MAR MAMMAL SCI, V12, P444; Park KB, 1999, J I HIST FISHERIES, V6, P119; Pike G. C., 1969, Bulletin Fisheries Research Board of Canada, V171, P1; PITMAN RL, 1987, MAR MAMMAL SCI, V3, P345, DOI 10.1111/j.1748-7692.1987.tb00321.x; Pitman RL, 2012, REV CURRENT KNOWLEDG; Pitman R, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P721; Rankin S, 2011, J ACOUST SOC AM, V130, pEL339, DOI 10.1121/1.3646026; RICHARDS LP, 1952, J MAMMAL, V33, P255, DOI 10.1093/jmammal/33.2.255; Sanino G. P., 2007, B MUSEO NACL HIST NA, V56, P89; Scheffer V. B., 1949, Pacific Science, V3, P353; SCHEFFER VB, 1948, AM MIDL NAT, V39, P257, DOI 10.2307/2421587; Schorr Gregory S., 2010, Endangered Species Research, V10, P203, DOI 10.3354/esr00229; Shi YaXW, 1984, T LIAONING ZOOLOGICA, V5, P111; Soldevilla MS, 2008, J ACOUST SOC AM, V124, P609, DOI 10.1121/1.2932059; Stejneger L., 1883, Proceedings of the United States National Museum, Vvi, P58; Tidemann C.R., 1980, Victorian Naturalist (Blackburn), V97, P64; True F.W., 1885, P US NATL MUS, V8, P584; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; URBANRAMIREZ J, 1992, MAR MAMMAL SCI, V8, P420, DOI 10.1111/j.1748-7692.1992.tb00058.x; Vidal Omar, 1993, Proceedings of the San Diego Society of Natural History, V28, P1; Walker WA, 1999, MAR MAMMAL SCI, V15, P1314, DOI 10.1111/j.1748-7692.1999.tb00893.x; WANG P, 1999, CHINESE CETACEANS; Waring GT, 2001, MAR MAMMAL SCI, V17, P703, DOI 10.1111/j.1748-7692.2001.tb01294.x; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; West KL, 2012, MAR MAMM SCI; Wiggins SM, 2007, HIGH FREQUENCY ACOUS, P551; Willis Pamela M., 1998, Aquatic Mammals, V24, P21; Yamada TK, 2012, 64 M INT WHAL COMM P; Zimmer WMX, 2008, J ACOUST SOC AM, V124, P2823, DOI 10.1121/1.2988277; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225	98	43	43	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86072	10.1371/journal.pone.0086072	http://dx.doi.org/10.1371/journal.pone.0086072			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465877	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100103
J	Noorlander, CW; Tijsseling, D; Hessel, EVS; de Vries, WB; Derks, JB; Visser, GHA; de Graan, PNE				Noorlander, Cornelle W.; Tijsseling, Deodata; Hessel, Ellen V. S.; de Vries, Willem B.; Derks, Jan B.; Visser, Gerard H. A.; de Graan, Pierre N. E.			Antenatal Glucocorticoid Treatment Affects Hippocampal Development in Mice	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; NMDA RECEPTOR ACTIVATION; FETAL LUNG MATURATION; RAT DENTATE GYRUS; ADULT NEUROGENESIS; FOLLOW-UP; DEXAMETHASONE TREATMENT; CELL-PROLIFERATION; ADRENAL-STEROIDS	Synthetic glucocorticoids are administered to pregnant women at risk for preterm delivery, to enhance fetal lung maturation. The benefit of this treatment is well established, however caution is necessary because of possible unwanted side effects on development of different organ systems, including the brain. Actions of glucocorticoids are mediated by corticosteroid receptors, which are highly expressed in the hippocampus, a brain structure involved in cognitive functions. Therefore, we analyzed the effects of a single antenatal dexamethasone treatment on the development of the mouse hippocampus. A clinically relevant dose of dexamethasone (0.4 mg/kg) was administered to pregnant mice at embryonic day 15.5 and the hippocampus was analyzed from embryonic day 16 until adulthood. We investigated the effects of dexamethasone treatment on anatomical changes, apoptosis and proliferation in the hippocampus, hippocampal volume and on total body weight. Our results show that dexamethasone treatment reduced body weight and hippocampal volume transiently during development, but these effects were no longer detected at adulthood. Dexamethasone treatment increased the number of apoptotic cells in the hippocampus until birth, but postnatally no effects of dexamethasone treatment on apoptosis were found. During the phase with increased apoptosis, dexamethasone treatment reduced the number of proliferating cells in the subgranular zone of the dentate gyrus. The number of proliferative cells was increased at postnatal day 5 and 10, but was decreased again at the adult stage. This latter long-term and negative effect of antenatal dexamethasone treatment on the number of proliferative cells in the hippocampus may have important implications for hippocampal network function.	[Noorlander, Cornelle W.; Hessel, Ellen V. S.; de Graan, Pierre N. E.] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Noorlander, Cornelle W.; Tijsseling, Deodata; Derks, Jan B.; Visser, Gerard H. A.] Univ Med Ctr Utrecht, Dept Obstet, Utrecht, Netherlands; [de Vries, Willem B.] Univ Med Ctr Utrecht, Dept Neonatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Tijsseling, D (corresponding author), Univ Med Ctr Utrecht, Dept Obstet, Utrecht, Netherlands.	d.tijsseling-2@umcutrecht.nl	hessel, ellen/ABB-4007-2021	Hessel, Ellen/0000-0003-3960-7523; Hessel, Volker/0000-0002-9494-1519	Hersenstichting Nederland [8F00(2).32]	Hersenstichting Nederland	Funding source: Hersenstichting Nederland, Grant number: 8F00(2).32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnea A, 1996, P NATL ACAD SCI USA, V93, P714, DOI 10.1073/pnas.93.2.714; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cameron HA, 1998, NEUROSCIENCE, V82, P349; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Crowther CA, 2006, LANCET, V367, P1913, DOI 10.1016/S0140-6736(06)68846-6; Derks JB, 1997, J PHYSIOL-LONDON, V499, P217, DOI 10.1113/jphysiol.1997.sp021922; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Fisher BJ, 2002, INT J RADIAT ONCOL, V52, P996, DOI 10.1016/S0360-3016(01)02720-1; Fletcher AJW, 2002, J PHYSIOL-LONDON, V545, P649, DOI 10.1113/jphysiol.2001.015693; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; French NP, 2004, AM J OBSTET GYNECOL, V190, P588, DOI 10.1016/j.ajog.2003.12.016; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GOULD E, 1991, J COMP NEUROL, V313, P479, DOI 10.1002/cne.903130308; GOULD E, 1990, NEUROSCIENCE, V37, P367, DOI 10.1016/0306-4522(90)90407-U; Gould E, 1996, DEV NEUROSCI-BASEL, V18, P22, DOI 10.1159/000111392; Gould E, 1997, J NEUROSCI, V17, P2492; Guinn DA, 2001, JAMA-J AM MED ASSOC, V286, P1581, DOI 10.1001/jama.286.13.1581; Halliday HL, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001145.pub2, 10.1002/14651858.CD001146.pub2]; Hassan AHS, 1996, EXP NEUROL, V140, P43, DOI 10.1006/exnr.1996.0113; Haynes LE, 2001, NEUROSCIENCE, V104, P57, DOI 10.1016/S0306-4522(01)00070-7; Kanagawa T, 2006, AM J OBSTET GYNECOL, V194, P231, DOI 10.1016/j.ajog.2005.06.015; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kim JB, 2004, BRAIN RES, V1027, P1, DOI 10.1016/j.brainres.2004.070.93; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LIGGINS GC, 1994, REPROD FERT DEVELOP, V6, P141, DOI 10.1071/RD9940141; MACARTHUR BA, 1982, PEDIATRICS, V70, P99; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Meijer OC, 1998, CRIT REV NEUROBIOL, V12, P1; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; MOSIER HD, 1987, PEDIATR RES, V22, P92; MUNCK A, 1971, PERSPECT BIOL MED, V14, P265; Murphy KE, 2008, LANCET, V372, P2143, DOI 10.1016/S0140-6736(08)61929-7; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Newnham J P, 2001, Semin Neonatol, V6, P285, DOI 10.1053/siny.2001.0064; Nichols NR, 2005, BRAIN RES REV, V48, P287, DOI 10.1016/j.brainresrev.2004.12.019; Noguchi KK, 2008, CELL DEATH DIFFER, V15, P1582, DOI 10.1038/cdd.2008.97; Noorlander CW, 2006, J COMP NEUROL, V499, P924, DOI 10.1002/cne.21162; Noorlandler CW, 2008, DEV NEUROBIOL, V68, P237, DOI 10.1002/dneu.20583; O'Shea TM, 2007, PEDIATRICS, V120, P594, DOI 10.1542/peds.2007-0486; Quinlivan JA, 2002, J PERINAT MED, V30, P209, DOI 10.1515/JPM.2002.029; Reagan LP, 1997, J CHEM NEUROANAT, V13, P149, DOI 10.1016/S0891-0618(97)00031-8; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Rodriiguez-Pinilla E, 2006, MED CLIN-BARCELONA, V127, P361, DOI 10.1157/13092436; Sandau US, 2007, NEUROSCIENCE, V144, P482, DOI 10.1016/j.neuroscience.2006.10.003; SAPOLSKY RM, 1985, BRAIN RES, V359, P300, DOI 10.1016/0006-8993(85)91440-4; SAPOLSKY RM, 1986, NEUROENDOCRINOLOGY, V43, P440, DOI 10.1159/000124561; Scheepens A, 2003, J PHYSIOL-LONDON, V552, P163, DOI 10.1113/jphysiol.2003.043414; SCHMAND B, 1990, PEDIATRICS, V86, P58; Sinha A, 2000, BRIT J OBSTET GYNAEC, V107, P578, DOI 10.1111/j.1471-0528.2000.tb13291.x; SMOLDERSDEHAAS H, 1990, PEDIATRICS, V86, P65; Sze CI, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/628094; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Tauber SC, 2006, BRAIN PATHOL, V16, P209, DOI 10.1111/j.1750-3639.2006.00021.x; Tijsseling D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033369; UNO H, 1994, HORM BEHAV, V28, P336, DOI 10.1006/hbeh.1994.1030; Weiler HA, 1997, BIOL NEONATE, V71, P53, DOI 10.1159/000244397; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; ZARROW MX, 1970, NATURE, V226, P1058, DOI 10.1038/2261058a0; Zuloaga DG, 2012, J NEUROSCI RES, V90, P1403, DOI 10.1002/jnr.23026	65	46	47	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85671	10.1371/journal.pone.0085671	http://dx.doi.org/10.1371/journal.pone.0085671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465645	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100058
J	Nooten, SS; Andrew, NR; Hughes, L				Nooten, Sabine S.; Andrew, Nigel R.; Hughes, Lesley			Potential Impacts of Climate Change on Insect Communities: A Transplant Experiment	PLOS ONE			English	Article							PREDICTING SPECIES DISTRIBUTION; LATITUDINAL GRADIENT; BIOTIC INTERACTIONS; ELEVATIONAL RANGE; GLOBAL CHANGE; ELEVATED CO2; RESPONSES; ASSEMBLAGES; TEMPERATURE; TRANSLOCATION	Climate change will have profound impacts on the distribution, abundance and ecology of all species. We used a multi-species transplant experiment to investigate the potential effects of a warmer climate on insect community composition and structure. Eight native Australian plant species were transplanted into sites approximately 2.5 degrees C (mean annual temperature) warmer than their native range. Subsequent insect colonisation was monitored for 12 months. We compared the insect communities on transplanted host plants at the warmer sites with control plants transplanted within the species' native range. Comparisons of the insect communities were also made among transplanted plants at warmer sites and congeneric plant species native to the warmer transplant area. We found that the morphospecies composition of the colonising Coleoptera and Hemiptera communities differed markedly between transplants at the control compared to the warmer sites. Community structure, as described by the distribution of feeding guilds, was also found to be different between the controls and transplants when the entire Coleoptera and Hemiptera community, including non-herbivore feeding guilds, was considered. However, the structure of the herbivorous insect community showed a higher level of consistency between plants at control and warm sites. There were marked differences in community composition and feeding guild structure, for both herbivores and non-herbivores, between transplants and congenerics at the warm sites. These results suggest that as the climate warms, considerable turnover in the composition of insect communities may occur, but insect herbivore communities may retain elements of their present-day structure.	[Nooten, Sabine S.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia; [Andrew, Nigel R.] Univ New England, Ctr Behav & Physiol Ecol, Armidale, NSW, Australia; [Hughes, Lesley] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Western Sydney University; University of New England; Macquarie University	Nooten, SS (corresponding author), Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia.	s.nooten@uws.edu.au	Andrew, Nigel/B-7162-2008	Andrew, Nigel/0000-0002-2850-2307; Hughes, Lesley/0000-0003-0313-9780; Nooten, Sabine/0000-0002-1798-315X	Macquarie University research excellence scholarship (iMQRES)	Macquarie University research excellence scholarship (iMQRES)	This study was supported by a Macquarie University research excellence scholarship (iMQRES) to Sabine Nooten. URL http://www.hdr.mq.edu.au/information_about/scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew NR, 2007, GLOBAL CHANGE BIOL, V13, P1539, DOI 10.1111/j.1365-2486.2007.01393.x; Andrew NR, 2013, PEERJ, V1, DOI 10.7717/peerj.11; Andrew Nigel R., 2012, Open Journal of Ecology, V2, P202, DOI 10.4236/oje.2012.24024; Andrew NR, 2004, ECOL ENTOMOL, V29, P527, DOI 10.1111/j.0307-6946.2004.00639.x; Andrew NR, 2005, GLOBAL ECOL BIOGEOGR, V14, P249, DOI 10.1111/j.1466-822x.2005.00149.x; ANDREW NR, 2013, LIVING WARMER WORLD, P38; Austin AD, 2004, AUST J ENTOMOL, V43, P216, DOI 10.1111/j.1326-6756.2004.00448.x; Australian Bureau of Meteorology, 2010, CLIM STAT AUSTR LOC; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Beaumont LJ, 2007, GLOBAL CHANGE BIOL, V13, P1368, DOI 10.1111/j.1365-2486.2007.01357.x; Briones MJI, 1997, APPL SOIL ECOL, V6, P117; Bruelheide H, 2003, APPL VEG SCI, V6, P23, DOI 10.1111/j.1654-109X.2003.tb00561.x; Budge K, 2011, SOIL BIOL BIOCHEM, V43, P1148, DOI 10.1016/j.soilbio.2011.02.001; CHAPMAN AD, 2009, NUMBERS LIVING SPECI, V2, P1; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Clarke K.R, 2006, PRIMER VERSION 6; Coll M, 2008, AGR ECOSYST ENVIRON, V123, P271, DOI 10.1016/j.agee.2007.06.003; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cornelissen T, 2011, NEOTROP ENTOMOL, V40, P155, DOI 10.1590/S1519-566X2011000200001; Cranston Peter S., 2009, P83, DOI 10.1002/9781444308211.ch6; CSIRO, 2012, STAT CLIM; De Frenne P, 2011, GLOBAL CHANGE BIOL, V17, P3240, DOI 10.1111/j.1365-2486.2011.02449.x; Egli M, 2004, J PLANT NUTR SOIL SC, V167, P457, DOI 10.1002/jpln.200321333; Emmerson M, 2005, GLOBAL CHANGE BIOL, V11, P490, DOI 10.1111/j.1365-2486.2005.00919.x; Field C. B., 2012, IPCC 2012 MANAGING R; Fletcher MJ., 2009, IDENTIFICATION KEYS; Forister ML, 2003, GLOBAL CHANGE BIOL, V9, P1130, DOI 10.1046/j.1365-2486.2003.00643.x; Garibaldi Lucas A., 2011, Oecologia (Berlin), V167, P117, DOI 10.1007/s00442-011-1978-0; Gonzalez-Megias A, 2008, GLOBAL CHANGE BIOL, V14, P1464, DOI 10.1111/j.1365-2486.2008.01592.x; Groves R.H., 1994, AUSTR VEGETATION; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Haggerty BP, 2011, J ECOL, V99, P242, DOI 10.1111/j.1365-2745.2010.01744.x; Harrington R, 2001, AGR FOREST ENTOMOL, V3, P233, DOI 10.1046/j.1461-9555.2001.00120.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hughes Lesley, 2012, P337; Ibanez I, 2008, ECOL APPL, V18, P1664, DOI 10.1890/07-1594.1; Johns CV, 2003, ENTOMOL EXP APPL, V108, P169, DOI 10.1046/j.1570-7458.2003.00076.x; Kardol P, 2011, APPL SOIL ECOL, V47, P37, DOI 10.1016/j.apsoil.2010.11.001; Kearney MR, 2010, BIOL LETTERS, V6, P674, DOI 10.1098/rsbl.2010.0053; Keith D.A., 2004, OCEAN SHORES DESERT; Lawrence JF, 1991, INSECTS AUSTR, VII; Lessard JP, 2011, OIKOS, V120, P333, DOI 10.1111/j.1600-0706.2010.18772.x; MacArthur R.H., 1972, pvii; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; Marsico TD, 2009, OIKOS, V118, P1783, DOI 10.1111/j.1600-0706.2009.17698.x; Merrill RM, 2008, J ANIM ECOL, V77, P145, DOI 10.1111/j.1365-2656.2007.01303.x; Moir ML, 2012, J INSECT CONSERV, V16, P367, DOI 10.1007/s10841-011-9422-7; Murray SJ, 2012, J HYDROL, V448, P14, DOI 10.1016/j.jhydrol.2012.02.044; Musolin DL, 2007, GLOBAL CHANGE BIOL, V13, P1565, DOI 10.1111/j.1365-2486.2007.01395.x; Netherer S, 2010, FOREST ECOL MANAG, V259, P831, DOI 10.1016/j.foreco.2009.07.034; Nipperess DA, 2012, BIODIVERS CONSERV, V21, P323, DOI 10.1007/s10531-011-0185-y; Nooten SS, 2013, AUST J ENTOMOL, V52, P309, DOI 10.1111/aen.12043; Novotny V, 2005, J BIOGEOGR, V32, P1303, DOI 10.1111/j.1365-2699.2005.01225.x; NSW Department of Environment Climate Change and Water, 2010, NSW CLIM IMP PROF IM; OLIVER I, 1993, CONSERV BIOL, V7, P562, DOI 10.1046/j.1523-1739.1993.07030562.x; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parmesan C, 2011, NAT CLIM CHANGE, V1, P2, DOI 10.1038/nclimate1056; Pelini SL, 2011, METHODS ECOL EVOL, V2, P534, DOI 10.1111/j.2041-210X.2011.00100.x; Pelini SL, 2009, P NATL ACAD SCI USA, V106, P11160, DOI 10.1073/pnas.0900284106; R Development Core Team, 2011, R LANG ENV STAT COMP; Rand TA, 2003, ECOLOGY, V84, P1517, DOI 10.1890/0012-9658(2003)084[1517:HACBTS]2.0.CO;2; Rey M, 2007, EUR J SOIL SCI, V58, P1233, DOI 10.1111/j.1365-2389.2007.00912.x; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Roubicek AJ, 2010, ECOL MODEL, V221, P2280, DOI 10.1016/j.ecolmodel.2010.06.021; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Shaw MR, 2001, ECOL APPL, V11, P1206, DOI 10.2307/3061022; Sheldon KS, 2011, ECOL LETT, V14, P1191, DOI 10.1111/j.1461-0248.2011.01689.x; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; Sohlenius B, 1999, NEMATOLOGY, V1, P695, DOI 10.1163/156854199508720; SOUTHWOOD TRE, 1979, BIOL J LINN SOC, V12, P327, DOI 10.1111/j.1095-8312.1979.tb00063.x; Strong D.R., 1984, INSECTS PLANTS COMMU; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Van der Veken S, 2012, BASIC APPL ECOL, V13, P10, DOI 10.1016/j.baae.2011.10.007; Villalpando SN, 2009, GLOBAL CHANGE BIOL, V15, P930, DOI 10.1111/j.1365-2486.2008.01721.x; Visser ME, 2010, PHILOS T R SOC B, V365, P3113, DOI 10.1098/rstb.2010.0111; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Wang Y, 2012, MVABUND STAT METHODS; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579; Wilson, 1988, BIODIVERSITY, P170; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; Woodcock BA, 2007, ECOL ENTOMOL, V32, P302, DOI 10.1111/j.1365-2311.2007.00869.x	90	44	45	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85987	10.1371/journal.pone.0085987	http://dx.doi.org/10.1371/journal.pone.0085987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465827	Green Submitted, gold, Green Published			2022-12-25	WOS:000330283100093
J	O'Shea, TJ; Bowen, RA; Stanley, TR; Shankar, V; Rupprecht, CE				O'Shea, Thomas J.; Bowen, Richard A.; Stanley, Thomas R.; Shankar, Vidya; Rupprecht, Charles E.			Variability in Seroprevalence of Rabies Virus Neutralizing Antibodies and Associated Factors in a Colorado Population of Big Brown Bats (Eptesicus fuscus)	PLOS ONE			English	Article							UNITED-STATES; IMMUNE-RESPONSE; TADARIDA-BRASILIENSIS; INSECTIVOROUS BATS; NEW-MEXICO; NATIONAL SURVEILLANCE; LYSSAVIRUS TYPE-1; CAPTIVE COLONY; SURVIVAL; ECOLOGY	In 2001-2005 we sampled permanently marked big brown bats (Eptesicus fuscus) at summer roosts in buildings at Fort Collins, Colorado, for rabies virus neutralizing antibodies (RVNA). Seroprevalence was higher in adult females (17.9%, n = 2,332) than males (9.4%, n = 128; P = 0.007) or volant juveniles (10.2%, n = 738; P<0.0001). Seroprevalence was lowest in a drought year with local insecticide use and highest in the year with normal conditions, suggesting that environmental stress may suppress RVNA production in big brown bats. Seroprevalence also increased with age of bat, and varied from 6.2 to 26.7% among adult females at five roosts sampled each year for five years. Seroprevalence of adult females at 17 other roosts sampled for 1 to 4 years ranged from 0.0 to 47.1%. Using logistic regression, the only ranking model in our candidate set of explanatory variables for serological status at first sampling included year, day of season, and a year by day of season interaction that varied with relative drought conditions. The presence or absence of antibodies in individual bats showed temporal variability. Year alone provided the best model to explain the likelihood of adult female bats showing a transition to seronegative from a previously seropositive state. Day of the season was the only competitive model to explain the likelihood of a transition from seronegative to seropositive, which increased as the season progressed. We found no rabies viral RNA in oropharyngeal secretions of 261 seropositive bats or in organs of 13 euthanized seropositive bats. Survival of seropositive and seronegative bats did not differ. The presence of RVNA in serum of bats should not be interpreted as evidence for ongoing rabies infection.	[O'Shea, Thomas J.; Stanley, Thomas R.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [Bowen, Richard A.; Shankar, Vidya] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Shankar, Vidya] Ctr Dis Control & Prevent, Atlanta, GA USA; [Rupprecht, Charles E.] Ross Univ, Sch Vet Med, Basseterre, St Kitts & Nevi; [Rupprecht, Charles E.] Global Alliance Rabies Control, Manhattan, KS USA	United States Department of the Interior; United States Geological Survey; Colorado State University; Centers for Disease Control & Prevention - USA	O'Shea, TJ (corresponding author), US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA.	osheat@usgs.gov	O'Shea, Thomas/AAY-5848-2021; Rupprecht, Charles/AAI-1544-2020		National Science Foundation Ecology of Infectious Diseases (EID) [0094959]; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate (US Department of Homeland Security); Fogarty International Center (National Institutes of Health)	National Science Foundation Ecology of Infectious Diseases (EID); Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate (US Department of Homeland Security); Fogarty International Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Financial support was provided via a National Science Foundation Ecology of Infectious Diseases (EID) grant 0094959 (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5269&org=EF) to Colorado State University. RAB and TJO were supported by the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate (US Department of Homeland Security) and the Fogarty International Center (National Institutes of Health; http://www.fic.nih.gov/about/staff/pages/epidemiology-population.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Gomez JM, 2013, PHYSIOL BIOCHEM ZOOL, V86, P354, DOI 10.1086/670733; Allen LC, 2011, CONSERV BIOL, V25, P374, DOI 10.1111/j.1523-1739.2010.01624.x; Amengual B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000566; [Anonymous], 1992, J MAMMAL, V73, P707; Anthony E.L.P., 1988, P47; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Baker MR, 2013, J NAT CONSERV, V21, P309, DOI 10.1016/j.jnc.2013.03.003; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038; Bogan MA, 2003, MONITORING TRENDS BA; Bolling BG, 2007, J AM MOSQUITO CONTR, V23, P37, DOI 10.2987/8756-971X(2007)23[37:ESATCF]2.0.CO;2; Bowen RA, 2013, J WILDLIFE DIS, V49, P367, DOI 10.7589/2012-05-124; Brookes SM, 2005, EMERG INFECT DIS, V11, P572, DOI 10.3201/eid1104.040920; Burnham, 2002, MODEL SELECTION MULT, P514; Burnham KP, 1987, MONOGR AM FISH SOC, V5, P1; BURNS KF, 1956, AM J PUBLIC HEALTH N, V46, P1089, DOI 10.2105/AJPH.46.9.1089; Burton RS, 1999, FUNCT ECOL, V13, P232, DOI 10.1046/j.1365-2435.1999.00302.x; Canale CI, 2011, FUNCT ECOL, V25, P557, DOI 10.1111/j.1365-2435.2010.01815.x; Colorado Climate Center, 2013, DROUGHT RES; Colorado Mosquito Control, 2004, 2004 ANN REP CIT FOR; Constantine D.G., 1988, P491; CONSTANTINE DG, 1968, PUBLIC HEALTH REP, V83, P303, DOI 10.2307/4593275; Cryan PM, 2012, J MAMMAL, V93, P381, DOI 10.1644/11-MAMM-S-162.1; Davis A, 2012, VECTOR-BORNE ZOONOT, V12, P55, DOI 10.1089/vbz.2011.0674; Davis AD, 2007, J INFECT DIS, V195, P1144, DOI 10.1086/512616; Davis AD, 2013, ARCH VIROL, V158, P809, DOI 10.1007/s00705-012-1551-0; Dean D. J., 1996, LAB TECHNIQUES RABIE; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; Ellison LE, 2007, ACTA CHIROPTEROL, V9, P149, DOI 10.3161/1733-5329(2007)9[149:ACOCCV]2.0.CO;2; Ellison LE, 2007, ECOL APPL, V17, P620, DOI 10.1890/06-0315; Ellison LE, 2006, J WILDLIFE DIS, V42, P849, DOI 10.7589/0090-3558-42.4.849; Fair JM, 2008, WILSON J ORNITHOL, V120, P813, DOI 10.1676/06-052.1; Frick WF, 2007, ECOL APPL, V17, P1213, DOI 10.1890/06-1021; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Georgea DB, 2011, P NATL ACAD SCI USA, V108, P10208, DOI 10.1073/pnas.1010875108; Harris SL, 2009, J WILDLIFE DIS, V45, P1030, DOI 10.7589/0090-3558-45.4.1030; Hawley DM, 2011, FUNCT ECOL, V25, P48, DOI 10.1111/j.1365-2435.2010.01753.x; Jackson FR, 2008, J WILDLIFE DIS, V44, P612, DOI 10.7589/0090-3558-44.3.612; King JM, 2010, GEN COMP ENDOCR, V167, P60, DOI 10.1016/j.ygcen.2010.02.018; Kurta A., 1990, MAMM SPECIES, V356, P1, DOI DOI 10.2307/3504258; Lewanzik D, 2012, GEN COMP ENDOCR, V177, P104, DOI 10.1016/j.ygcen.2012.02.021; MARASCUILO LA, 1966, PSYCHOL BULL, V65, P280, DOI 10.1037/h0023189; McAfee SA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034828; Messenger SL, 2003, BAT ECOLOGY, P622; Mondul A, 2003, J AM VET MED ASSOC, V222, P633, DOI 10.2460/javma.2003.222.633; Murray SE, 2001, J IMMUNOL, V167, P691, DOI 10.4049/jimmunol.167.2.691; National Climatic Data Center, 2013, PALM DROUGHT SEV IND; Neubaum DJ, 2007, J WILDLIFE MANAGE, V71, P728, DOI 10.2193/2005-684; Neubaum DJ, 2006, J MAMMAL, V87, P470, DOI 10.1644/05-MAMM-A-252R1.1; Neubaum MA, 2007, J MAMMAL, V88, P1230, DOI 10.1644/06-MAMM-A-228R1.1; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Niezgoda Michael, 2002, P163; O'Shea Thomas J., 2004, P297; O'Shea TJ, 2011, URBAN ECOSYST, V14, P665, DOI 10.1007/s11252-011-0182-7; O'Shea TJ, 2011, J MAMMAL, V92, P433, DOI 10.1644/10-MAMM-A-162.1; O'Shea Thomas J., 2011, Monographs of the Western North American Naturalist, V5, P1; O'Shea TJ, 2010, J MAMMAL, V91, P418, DOI 10.1644/08-MAMM-A-295.1; O'Shea Thomas J., 2009, P500; Pape WJ, 1999, EMERG INFECT DIS, V5, P433, DOI 10.3201/eid0503.990315; Patyk K, 2012, VECTOR-BORNE ZOONOT, V12, P666, DOI 10.1089/vbz.2011.0839; Pearce RD, 2007, VECTOR-BORNE ZOONOT, V7, P489, DOI 10.1089/vbz.2007.0572; PEREZJORDA JL, 1995, J WILDLIFE DIS, V31, P372, DOI 10.7589/0090-3558-31.3.372; Prendergast BJ, 2002, AM J PHYSIOL-REG I, V282, pR1054, DOI 10.1152/ajpregu.00562.2001; Rhodes M, 2007, J MAMMAL, V88, P1252, DOI 10.1644/06-MAMM-A-374R1.1; Salas-Rojas M, 2004, T ROY SOC TROP MED H, V98, P577, DOI 10.1016/j.trstmh.2003.10.019; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Schatz J, 2013, ZOONOSES PUBLIC HLTH, V60, P22, DOI 10.1111/zph.12002; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Serra-Cobo J, 2002, EMERG INFECT DIS, V8, P413, DOI 10.3201/eid0804.010263; Serra-Cobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064467; Shankar V, 2005, VECTOR-BORNE ZOONOT, V5, P330, DOI 10.1089/vbz.2005.5.330; Shankar V, 2004, J WILDLIFE DIS, V40, P403, DOI 10.7589/0090-3558-40.3.403; SIGOUNAS G, 1994, J CLIN IMMUNOL, V14, P134, DOI 10.1007/BF01541346; Silberman DM, 2003, J NEUROIMMUNOL, V144, P53, DOI 10.1016/j.jneuroim.2003.08.031; Smith JS, 1996, CLIN MICROBIOL REV, V9, P166, DOI 10.1128/CMR.9.2.166; Smith JS, 1996, LAB TECHNIQUES RABIE, P200; Snider EA, 2009, THESIS; STEECE R, 1989, J WILDLIFE DIS, V25, P490, DOI 10.7589/0090-3558-25.4.490; SULKIN SE, 1966, AM J TROP MED HYG, V15, P418, DOI 10.4269/ajtmh.1966.15.418; TRIMARCHI CV, 1977, J WILDLIFE DIS, V13, P366, DOI 10.7589/0090-3558-13.4.366; Turmelle AS, 2010, J GEN VIROL, V91, P2360, DOI 10.1099/vir.0.020073-0; Turmelle AS, 2010, J ZOO WILDLIFE MED, V41, P140, DOI 10.1638/2008-0161.1; Turmelle AS, 2010, VECTOR-BORNE ZOONOT, V10, P165, DOI 10.1089/vbz.2008.0163; Vazquez-Moron S, 2008, EMERG INFECT DIS, V14, P1263, DOI [10.3201/eid1408.080068, 10.3201/1408.080068]; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221; Willis CKR, 2004, ANIM BEHAV, V68, P495, DOI 10.1016/j.anbehav.2003.08.028; Wimsatt J, 2005, J WILDLIFE DIS, V41, P87, DOI 10.7589/0090-3558-41.1.87	90	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86261	10.1371/journal.pone.0086261	http://dx.doi.org/10.1371/journal.pone.0086261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465996	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100134
J	van Wilgenburg, B; Moore, MD; James, WS; Cowley, SA				van Wilgenburg, Bonnie; Moore, Michael D.; James, William S.; Cowley, Sally A.			The Productive Entry Pathway of HIV-1 in Macrophages Is Dependent on Endocytosis through Lipid Rafts Containing CD4	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MONOCYTE-DERIVED MACROPHAGES; PROTEIN-TYROSINE KINASE; T-CELL-ACTIVATION; ENVELOPE GLYCOPROTEIN; MEMBRANE MICRODOMAINS; IMMUNOLOGICAL SYNAPSE; DETERGENT-RESISTANT; SERINE PHOSPHORYLATION; MONOCLONAL-ANTIBODY	Macrophages constitute an important reservoir of HIV-1 infection, yet HIV-1 entry into these cells is poorly understood due to the difficulty in genetically manipulating primary macrophages. We developed an effective genetic approach to manipulate the sub-cellular distribution of CD4 in macrophages, and investigated how this affects the HIV-1 entry pathway. Pluripotent Stem Cells (PSC) were transduced with lentiviral vectors designed to manipulate CD4 location and were then differentiated into genetically modified macrophages. HIV-1 infection of these cells was assessed by performing assays that measure critical steps of the HIV-1 lifecycle (fusion, reverse transcription, and expression from HIV-1 integrants). Expression of LCK (which tethers CD4 to the surface of T cells, but is not normally expressed in macrophages) in PSC-macrophages effectively tethered CD4 at the cell surface, reducing its normal endocytic recycling route, and increasing surface CD4 expression 3-fold. This led to a significant increase in HIV-1 fusion and reverse transcription, but productive HIV-1 infection efficiency (as determined by reporter expression from DNA integrants) was unaffected. This implies that surface-tethering of CD4 sequesters HIV-1 into a pathway that is unproductive in macrophages. Secondly, to investigate the importance of lipid rafts (as detergent resistant membranes - DRM) in HIV-1 infection, we generated genetically modified PSC-macrophages that express CD4 mutants known to be excluded from DRM. These macrophages were significantly less able to support HIV-1 fusion, reverse-transcription and integration than engineered controls. Overall, these results support a model in which productive infection by HIV-1 in macrophages occurs via a CD4-raft-dependent endocytic uptake pathway.	[van Wilgenburg, Bonnie; Moore, Michael D.; James, William S.; Cowley, Sally A.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England	University of Oxford	Cowley, SA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.	sally.cowley@path.ox.ac.uk	james, william/H-4289-2013	james, william/0000-0002-2506-1198; Cowley, Sally/0000-0003-0297-6675	Wellcome Trust [WT082260]; University of Oxford D.Phil scholarship (Medical Research Council); University of Oxford D.Phil scholarship (Edward Penley Abraham Research Fund).; Oxford Stem Cell Institute Fellowship (Oxford Martin School)	Wellcome Trust(Wellcome TrustEuropean Commission); University of Oxford D.Phil scholarship (Medical Research Council); University of Oxford D.Phil scholarship (Edward Penley Abraham Research Fund).; Oxford Stem Cell Institute Fellowship (Oxford Martin School)	The work was supported by the Wellcome Trust (Career Re-entry Fellowship WT082260 to SC http://www.wellcome.ac.uk/). BvW has been supported by a University of Oxford D.Phil scholarship (Medical Research Council and Edward Penley Abraham Research Fund). MM is supported by an Oxford Stem Cell Institute Fellowship (Oxford Martin School http://www.oxfordmartin.ox.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Arrildt K, 2012, C RETR OPP INF CROI; ARTHOS J, 1989, CELL, V57, P469, DOI 10.1016/0092-8674(89)90922-7; Bacso Z, 2004, CYTOM PART A, V61A, P105, DOI 10.1002/cyto.a.20081; Balamuth F, 2004, J IMMUNOL, V172, P5887, DOI 10.4049/jimmunol.172.10.5887; Bannert N, 2000, J VIROL, V74, P10984, DOI 10.1128/JVI.74.23.10984-10993.2000; BENNETT S, 1994, J LEUKOCYTE BIOL, V56, P236; Bol SM, 2009, VIROLOGY, V390, P205, DOI 10.1016/j.virol.2009.05.027; BRODSKY MH, 1990, J IMMUNOL, V144, P3078; BROWN MH, 1994, PROTEIN ENG, V7, P515, DOI 10.1093/protein/7.4.515; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Carter GC, 2011, VIROLOGY, V409, P234, DOI 10.1016/j.virol.2010.10.018; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; Cassol E, 2006, J LEUKOCYTE BIOL, V80, P1018, DOI 10.1189/jlb.0306150; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; COLE JA, 1989, J IMMUNOL, V143, P397; COLLIN M, 1993, RES VIROLOGY, V144, P13, DOI 10.1016/S0923-2516(06)80006-3; COLLMAN R, 1990, J VIROL, V64, P4468, DOI 10.1128/JVI.64.9.4468-4476.1990; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Cowley SA, 2012, MACROPHAGES LIFE CYC; CRISE B, 1992, J BIOL CHEM, V267, P13593; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Dimitrov DS, 1999, VIROLOGY, V259, P1, DOI 10.1006/viro.1999.9747; Eisert V, 2001, VIROLOGY, V286, P31, DOI 10.1006/viro.2001.0940; Filipp D, 2003, J EXP MED, V197, P1221, DOI 10.1084/jem.20022112; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Garcia-Exposito L, 2011, MOL BIOL CELL, V22, P1148, DOI 10.1091/mbc.E10-08-0722; Garofalo T, 1998, J BIOL CHEM, V273, P35153, DOI 10.1074/jbc.273.52.35153; GARTNER S, 1986, JAMA-J AM MED ASSOC, V256, P2365, DOI 10.1001/jama.256.17.2365; Gobeil LA, 2012, J VIROLOGY; Gobeil LA, 2013, J VIROL, V87, P735, DOI 10.1128/JVI.01802-12; Gombos I, 2004, IMMUNOL LETT, V92, P117, DOI 10.1016/j.imlet.2003.11.022; Gombos I, 2004, CYTOM PART A, V61A, P117, DOI 10.1002/cyto.a.20080; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gray L, 2005, VIROLOGY, V337, P384, DOI 10.1016/j.virol.2005.04.034; Hammache D, 1999, J VIROL, V73, P5244, DOI 10.1128/JVI.73.6.5244-5248.1999; Hammache D, 1998, J BIOL CHEM, V273, P7967, DOI 10.1074/jbc.273.14.7967; HARBISON MA, 1990, J INFECT DIS, V161, P1, DOI 10.1093/infdis/161.1.1; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; HAROUSE JM, 1991, SCIENCE, V253, P320, DOI 10.1126/science.1857969; HE YF, 1995, J BIOL CHEM, V270, P28887, DOI 10.1074/jbc.270.48.28887; Henderson RA, 2004, NEWS PHYSIOL SCI, V19, P39, DOI 10.1152/nips.01505.2003; HO WZ, 1992, J VIROL, V66, P573, DOI 10.1128/JVI.66.1.573-579.1992; Honda Y, 1998, J EXP MED, V188, P1255, DOI 10.1084/jem.188.7.1255; Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000; HUSSEY RE, 1988, NATURE, V331, P78, DOI 10.1038/331078a0; JAMESON BA, 1988, SCIENCE, V240, P1335, DOI 10.1126/science.2453925; JORDAN CA, 1991, J VIROL, V65, P736, DOI 10.1128/JVI.65.2.736-742.1991; Kadiu I, 2011, J NEUROIMMUNE PHARM, V6, P658, DOI 10.1007/s11481-011-9298-z; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Karlsson KR, 2008, EXP HEMATOL, V36, P1167, DOI 10.1016/j.exphem.2008.04.009; Karsten V, 1996, IMMUNOLOGY, V88, P55, DOI 10.1046/j.1365-2567.1996.d01-648.x; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Kiss E, 2008, CYTOM PART A, V73A, P599, DOI 10.1002/cyto.a.20572; KWONG J, 1995, BIOCHEM BIOPH RES CO, V207, P868, DOI 10.1006/bbrc.1995.1266; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Laguette N, 2009, J VIROL, V83, P7117, DOI 10.1128/JVI.01648-08; Lee SK, 2005, BLOOD, V106, P818, DOI 10.1182/blood-2004-10-3959; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahfoud R, 2002, J BIOL CHEM, V277, P11292, DOI 10.1074/jbc.M111679200; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8; MEYLAN PRA, 1993, VIROLOGY, V193, P256, DOI 10.1006/viro.1993.1121; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nyakeriga AM, 2009, J VIROL, V83, P1193, DOI 10.1128/JVI.01023-08; Ostrom Rennolds S., 2007, V400, P459; Pelchen-Matthews A, 1998, EUR J IMMUNOL, V28, P3639, DOI 10.1002/(SICI)1521-4141(199811)28:11<3639::AID-IMMU3639>3.0.CO;2-Q; PELCHENMATTHEWS A, 1992, J CELL BIOL, V117, P279, DOI 10.1083/jcb.117.2.279; PELCHENMATTHEWS A, 1991, J EXP MED, V173, P575, DOI 10.1084/jem.173.3.575; PELCHENMATTHEWS A, 1995, J VIROL, V69, P8164, DOI 10.1128/JVI.69.12.8164-8168.1995; Percherancier Y, 2003, J BIOL CHEM, V278, P3153, DOI 10.1074/jbc.M207371200; PERLMUTTER RM, 1988, J CELL BIOCHEM, V38, P117, DOI 10.1002/jcb.240380206; Permanyer M, 2010, TRENDS MICROBIOL, V18, P543, DOI 10.1016/j.tim.2010.09.003; Peters PJ, 2004, J VIROL, V78, P6915, DOI 10.1128/JVI.78.13.6915-6926.2004; PETERSON A, 1988, CELL, V54, P65, DOI 10.1016/0092-8674(88)90180-8; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; Puri A, 1998, P NATL ACAD SCI USA, V95, P14435, DOI 10.1073/pnas.95.24.14435; Rawat SS, 2005, BIOSCIENCE REP, V25, P329, DOI 10.1007/s10540-005-2894-5; RODGERS W, 1994, MOL CELL BIOL, V14, P5384, DOI 10.1128/MCB.14.8.5384; Rousso I, 2000, P NATL ACAD SCI USA, V97, P13523, DOI 10.1073/pnas.240459697; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Raposo RAS, 2011, J IMMUNOL, V187, P748, DOI 10.4049/jimmunol.1003678; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SIMPSON SC, 1989, ONCOGENE, V4, P1141; Spear M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-45; Stolp B, 2011, VIRUSES-BASEL, V3, P293, DOI 10.3390/v3040293; Thanakiatkrai P, 2012, INT J LEGAL MED, V126, P161, DOI 10.1007/s00414-011-0558-5; Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200; Van Mau N, 2000, J MEMBRANE BIOL, V177, P251, DOI 10.1007/s002320010007; van Wilgenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071098; Wilsie LC, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-23; Wolf Z, 2006, CYTOM PART A, V69A, P192, DOI 10.1002/cyto.a.20238; Wolf Z, 2007, CYTOM PART A, V71A, P486, DOI 10.1002/cyto.a.20403; YAMADA S, 1986, BIOCHEMISTRY-US, V25, P3703, DOI 10.1021/bi00360a034; YANG CL, 1995, P NATL ACAD SCI USA, V92, P9871, DOI 10.1073/pnas.92.21.9871; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zybarth G, 1999, J IMMUNOL, V162, P400	106	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86071	10.1371/journal.pone.0086071	http://dx.doi.org/10.1371/journal.pone.0086071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465876	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100102
J	Weiler, J; Mitchell, T; Heath, M				Weiler, Jeffrey; Mitchell, Trina; Heath, Matthew			Response Suppression Delays the Planning of Subsequent Stimulus-Driven Saccades	PLOS ONE			English	Article							EVENT-RELATED FMRI; PRIMATE SUPERIOR COLLICULUS; NEURAL PROCESSES; ONLINE CONTROL; ANTI-SACCADES; PRO-SACCADES; TASK; ANTISACCADES; PROSACCADES; PERFORMANCE	The completion of an antisaccade selectively increases the reaction time (RT) of a subsequent prosaccade: a result that has been interpreted to reflect the residual inhibition of stimulus-driven saccade networks [1,2]. In the present investigation we sought to determine whether the increase in prosaccade RT is contingent on the constituent antisaccade planning processes of response suppression and vector inversion or is limited to response suppression. To that end, in one block participants alternated between pro-and antisaccades after every second trial (task-switching block), and in another block participants completed a series of prosaccades that were randomly (and infrequently) interspersed with no-go catch-trials (go/no-go block). Notably, such a design provides a framework for disentangling whether response suppression and/or vector inversion delays the planning of subsequent prosaccades. As expected, results for the task-switching block showed that antisaccades selectively increased the RTs of subsequent prosaccades. In turn, results for the go/no-go block showed that prosaccade RTs were increased when preceded by a no-go catch-trial. Moreover, the magnitude of the RT 'cost' was equivalent across the task-switching and go/no-go blocks. That prosaccades preceded by an antisaccade or a no-go catch-trial produced equivalent RT costs indicates that the conjoint processes of response suppression and vector inversion do not drive the inhibition of saccade planning mechanisms. Rather, the present findings indicate that a general consequence of response suppression is a residual inhibition of stimulus-driven saccade networks.	[Weiler, Jeffrey; Mitchell, Trina; Heath, Matthew] Univ Western Ontario, Sch Kinesiol, London, ON, Canada; [Heath, Matthew] Univ Western Ontario, Grad Program Neurosci, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Weiler, J (corresponding author), Univ Western Ontario, Sch Kinesiol, London, ON, Canada.	jweiler2@uwo.ca		Mitchell, Trina/0000-0002-0442-9985	Natural Sciences and Engineering Research Council of Canada; University of Western Ontario; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Western Ontario; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was funded by a grant from the Natural Sciences and Engineering Research Council of Canada, a Major Academic Development and a Faculty Scholar Award from the University of Western Ontario and an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown MRG, 2007, J NEUROPHYSIOL, V98, P1751, DOI 10.1152/jn.00460.2007; Brown MRG, 2006, NEUROIMAGE, V33, P644, DOI 10.1016/j.neuroimage.2006.07.002; Chan JL, 2013, EXP BRAIN RES, V227, P301, DOI 10.1007/s00221-013-3452-1; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Curtis CE, 2003, J COGNITIVE NEUROSCI, V15, P409, DOI 10.1162/089892903321593126; DeSimone J, 2013, M PROGR MOT CONTR MO; DeSouza JFX, 2003, J NEUROPHYSIOL, V89, P1016, DOI 10.1152/jn.00562.2002; Emeric EE, 2007, VISION RES, V47, P35, DOI 10.1016/j.visres.2006.08.032; Everling S, 1999, J NEUROSCI, V19, P2740; Everling S, 1998, J NEUROPHYSIOL, V80, P1584, DOI 10.1152/jn.1998.80.3.1584; Fischer B, 1996, EXP BRAIN RES, V109, P507; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Heath M, 2011, EXP BRAIN RES, V209, P117, DOI 10.1007/s00221-010-2525-7; Heath M, 2010, EXP BRAIN RES, V203, P743, DOI 10.1007/s00221-010-2290-7; Kelly AMC, 2004, EUR J NEUROSCI, V19, P3105, DOI 10.1111/j.0953-816X.2004.03429.x; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Mostofsky SH, 2003, COGNITIVE BRAIN RES, V17, P419, DOI 10.1016/S0926-6410(03)00144-7; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; Pouget P, 2011, J NEUROSCI, V31, P12604, DOI 10.1523/JNEUROSCI.1868-11.2011; Schlicht EJ, 2007, EXP BRAIN RES, V182, P47, DOI 10.1007/s00221-007-0970-8; Weiler J, 2013, ACTA PSYCHO IN PRESS; Weiler J, 2012, NEUROSCI LETT, V530, P150, DOI 10.1016/j.neulet.2012.10.007; Weiler J, 2012, EXP BRAIN RES, V216, P545, DOI 10.1007/s00221-011-2958-7; Westwood DA, 2003, SPATIAL VISION, V16, P243, DOI 10.1163/156856803322467518; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201	28	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86408	10.1371/journal.pone.0086408	http://dx.doi.org/10.1371/journal.pone.0086408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466076	Green Submitted, gold, Green Published			2022-12-25	WOS:000330283100155
J	Abu Awad, D; Gallina, S; Bonamy, C; Billiard, S				Abu Awad, Diala; Gallina, Sophie; Bonamy, Cyrille; Billiard, Sylvain			The Interaction between Selection, Demography and Selfing and How It Affects Population Viability	PLOS ONE			English	Article							MUTATIONS AFFECTING FITNESS; INBREEDING DEPRESSION; DELETERIOUS MUTATIONS; EXTINCTION; EVOLUTION; FERTILIZATION; LOAD; DOMINANCE; GENETICS; HETEROGENEITY	Population extinction due to the accumulation of deleterious mutations has only been considered to occur at small population sizes, large sexual populations being expected to efficiently purge these mutations. However, little is known about how the mutation load generated by segregating mutations affects population size and, eventually, population extinction. We propose a simple analytical model that takes into account both the demographic and genetic evolution of populations, linking population size, density dependence, the mutation load, and self-fertilisation. Analytical predictions were found to be relatively good predictors of population size and probability of population viability when verified using an explicit individual based stochastic model. We show that initially large populations do not always reach mutation-selection balance and can go extinct due to the accumulation of segregating deleterious mutations. Population survival depends not only on the relative fitness and demographic stochasticity, but also on the interaction between the two. When deleterious mutations are recessive, self-fertilisation affects viability non-monotonically and genomic cold-spots could favour the viability of outcrossing populations.	[Abu Awad, Diala; Gallina, Sophie; Billiard, Sylvain] Univ Lille 1, UMR CNRS 8198, Lab Genet & Evolut Populat Vegetales, F-59655 Villeneuve Dascq, France; [Bonamy, Cyrille] Univ Lille 1, CRI, F-59655 Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Abu Awad, D (corresponding author), Univ Lille 1, UMR CNRS 8198, Lab Genet & Evolut Populat Vegetales, F-59655 Villeneuve Dascq, France.	diala.abu-awad@ed.univ-lille1.fr	billiard, sylvain/A-2108-2009; bonamy, cyrille/GXH-4496-2022; Abu Awad, Diala/O-1764-2018	billiard, sylvain/0000-0003-2135-3246; bonamy, cyrille/0000-0003-3868-7090; Abu Awad, Diala/0000-0002-2680-1223; Gallina, Sophie/0000-0002-6194-3649	Chair "Modelisation Mathemathique et Biodiversite" of Veolia Environnement - Ecole Polytechnique - Museum National d'Histoire Naturelle - Fondation X; French Agence Nationale de la Recherche [ANR-11-BSV7-013-03]	Chair "Modelisation Mathemathique et Biodiversite" of Veolia Environnement - Ecole Polytechnique - Museum National d'Histoire Naturelle - Fondation X; French Agence Nationale de la Recherche(French National Research Agency (ANR))	This work benefited from the support of the Chair "Modelisation Mathemathique et Biodiversite" of Veolia Environnement - Ecole Polytechnique - Museum National d'Histoire Naturelle - Fondation X and the French Agence Nationale de la Recherche ANR-11-BSV7-013-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2012, ANNU REV ECOL EVOL S, V43, P115, DOI 10.1146/annurev-ecolsys-110411-160257; Agrawal AF, 2011, GENETICS, V187, P553, DOI 10.1534/genetics.110.124560; Baer CF, 2005, P NATL ACAD SCI USA, V102, P5785, DOI 10.1073/pnas.0406056102; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Bataillon T, 2000, GENET RES, V75, P75, DOI 10.1017/S0016672399004048; Bell TJ, 2013, J WILDLIFE MANAGE, V77, P1104, DOI 10.1002/jwmg.525; BERNARDES AT, 1995, J PHYS I, V5, P1501, DOI 10.1051/jp1:1995213; CABALLERO A, 1992, GENETICS, V131, P493; Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; CHARLESWORTH D, 1993, GENET RES, V61, P39, DOI 10.1017/S0016672300031086; Chevin LM, 2010, EVOLUTION, V64, P1143, DOI 10.1111/j.1558-5646.2009.00875.x; CLARKE B, 1973, HEREDITY, V31, P367, DOI 10.1038/hdy.1973.92; Coron C, 2013, AM NATURALI IN PRESS; Costin BJ, 2001, BIOL CONSERV, V98, P273, DOI 10.1016/S0006-3207(00)00165-8; Dostalek T, 2010, CONSERV GENET, V11, P773, DOI 10.1007/s10592-009-9879-z; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Fischer M, 1998, ECOGRAPHY, V21, P269, DOI 10.1111/j.1600-0587.1998.tb00564.x; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 2001, CONSERV GENET, V2, P279, DOI 10.1023/A:1012299230482; Fredrickson RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2365, DOI 10.1098/rspb.2007.0785; Gelatt TS, 2010, CONSERV GENET, V11, P721, DOI 10.1007/s10592-009-9856-6; Gioti A, 2013, EVOLUTION IN PRESS; Glemin S, 2003, EVOLUTION, V57, P2678; Glemin S, 2013, EVOLUTION, V67, P225, DOI 10.1111/j.1558-5646.2012.01778.x; Goldberg EE, 2010, SCIENCE, V330, P493, DOI 10.1126/science.1194513; Haag CR, 2007, GENETICS, V176, P1663, DOI 10.1534/genetics.107.073080; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Heber S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2228; Hedrick PW, 2004, FOREST ECOL MANAG, V197, P3, DOI 10.1016/j.foreco.2004.05.002; Higgins K, 2001, P NATL ACAD SCI USA, V98, P2928, DOI 10.1073/pnas.031358898; Jarne P, 2006, EVOLUTION, V60, P1816; Keightley PD, 2009, GENETICA, V136, P359, DOI 10.1007/s10709-008-9304-4; KONDRASHOV AS, 1982, GENET RES, V40, P325, DOI 10.1017/S0016672300019194; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; LANDE R, 1994, EVOLUTION, V48, P1460, DOI [10.2307/2410240, 10.1111/j.1558-5646.1994.tb02188.x]; Lynch M, 1995, EVOLUTION, V49, P1067, DOI [10.1111/j.1558-5646.1995.tb04434.x, 10.2307/2410432]; LYNCH M, 1990, EVOLUTION, V44, P1725, DOI [10.2307/2409502, 10.1111/j.1558-5646.1990.tb05244.x]; Manna F, 2011, GENETICS, V189, P923, DOI 10.1534/genetics.111.132944; Newman D, 1997, EVOLUTION, V51, P354, DOI [10.2307/2411107, 10.1111/j.1558-5646.1997.tb02422.x]; PACKER C, 1991, CONSERV BIOL, V5, P219, DOI 10.1111/j.1523-1739.1991.tb00127.x; Perez-Barrales R, 2006, NEW PHYTOL, V171, P553, DOI 10.1111/j.1469-8137.2006.01819.x; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Phadnis N, 2005, GENETICS, V171, P385, DOI 10.1534/genetics.104.039016; Robert A, 2002, ANIM CONSERV, V5, P153, DOI 10.1017/S1367943002002214; Roze D, 2004, GENETICS, V167, P1001, DOI 10.1534/genetics.103.025148; Roze D, 2005, GENETICS, V170, P841, DOI 10.1534/genetics.104.036384; Roze D, 2012, HEREDITY, V109, P137, DOI 10.1038/hdy.2012.24; Roze D, 2009, AM NAT, V174, pS79, DOI 10.1086/599083; Saccheri I, 2006, TRENDS ECOL EVOL, V21, P341, DOI 10.1016/j.tree.2006.03.018; Sakai S, 2008, BIOL J LINN SOC, V93, P125, DOI 10.1111/j.1095-8312.2007.00890.x; Schodelbauerova I, 2010, BIODIVERS CONSERV, V19, P637, DOI 10.1007/s10531-009-9724-1; Schoen DJ, 1997, EVOLUTION, V51, P1090, DOI [10.2307/2411038, 10.1111/j.1558-5646.1997.tb03956.x]; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Takebayashi N, 2001, AM J BOT, V88, P1143, DOI 10.2307/3558325; Vassilieva LL, 1999, GENETICS, V151, P119; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Whitlock Michael C., 2004, P155, DOI 10.1017/CBO9780511542022.013; Wootton JT, 2013, ECOLOGY, V94, P2117, DOI 10.1890/12-1828.1; Wright S, 1931, GENETICS, V16, P0097; Zeyl C, 2001, EVOLUTION, V55, P909, DOI 10.1554/0014-3820(2001)055[0909:MMILYP]2.0.CO;2	66	3	3	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86125	10.1371/journal.pone.0086125	http://dx.doi.org/10.1371/journal.pone.0086125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465911	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500190
J	Arp, JM; ter Horst, JP; Kanatsou, S; Fernandez, G; Joels, M; Krugers, HJ; Oitzl, MS				Arp, J. Marit; ter Horst, Judith P.; Kanatsou, Sofia; Fernandez, Guillen; Joels, Marian; Krugers, Harm J.; Oitzl, Melly S.			Mineralocorticoid Receptors Guide Spatial and Stimulus-Response Learning in Mice	PLOS ONE			English	Article							MULTIPLE MEMORY-SYSTEMS; CAUDATE-NUCLEUS; STRESS; BRAIN; STRATEGIES; CORTICOSTEROIDS; BLOCKADE; OVEREXPRESSION; PERFORMANCE; MODULATION	Adrenal corticosteroid hormones act via mineralocorticoid (MR) and glucocorticoid receptors (GR) in the brain, influencing learning and memory. MRs have been implicated in the initial behavioral response in novel situations, which includes behavioral strategies in learning tasks. Different strategies can be used to solve navigational tasks, for example hippocampus-dependent spatial or striatum-dependent stimulus-response strategies. Previous studies suggested that MRs are involved in spatial learning and induce a shift between learning strategies when animals are allowed a choice between both strategies. In the present study, we further explored the role of MRs in spatial and stimulus-response learning in two separate circular holeboard tasks using female mice with forebrain-specific MR deficiency and MR overexpression and their wildtype control littermates. In addition, we studied sex-specific effects using male and female MR-deficient mice. First, we found that MR-deficient compared to control littermates and MR-overexpressing mice display altered exploratory and searching behavior indicative of impaired acquisition of novel information. Second, female (but not male) MR-deficient mice were impaired in the spatial task, while MR-overexpressing female mice showed improved performance in the spatial task. Third, MR-deficient mice were also impaired in the stimulus-response task compared to controls and (in the case of females) MR-overexpressing mice. We conclude that MRs are important for coordinating the processing of information relevant for spatial as well as stimulus-response learning.	[Arp, J. Marit; ter Horst, Judith P.; Kanatsou, Sofia; Krugers, Harm J.; Oitzl, Melly S.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands; [Joels, Marian] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Fernandez, Guillen] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Krugers, HJ (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands.	h.krugers@uva.nl	Joëls, Marian/P-6415-2016; Fernandez, Guillen/B-3771-2009	Fernandez, Guillen/0000-0002-5522-0604; Joels, Marian/0000-0002-4826-6209	European Science Foundation [07-EuroSTRESS-FP-005];  [NWO-NIBC433-09-251];  [NWO-DN-95-420]	European Science Foundation(European Science Foundation (ESF)European Commission); ; 	This study was supported by grant NWO-NIBC433-09-251 to MA, GF, MJ, HJK, MSO, NWO-DN-95-420 to MSO, the European Science Foundation (07-EuroSTRESS-FP-005) to JPtH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger S, 2006, P NATL ACAD SCI USA, V103, P195, DOI 10.1073/pnas.0503878102; Bettis TJ, 2009, BEHAV PROCESS, V82, P249, DOI 10.1016/j.beproc.2009.07.004; Bohbot VD, 2011, NEUROBIOL LEARN MEM, V96, P173, DOI 10.1016/j.nlm.2011.04.007; Brinks V, 2009, HORM BEHAV, V56, P232, DOI 10.1016/j.yhbeh.2009.05.003; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Cornelisse S, 2011, NEUROPSYCHOPHARMACOL, V36, P2720, DOI 10.1038/npp.2011.162; Dalm S, 2009, BEHAV BRAIN RES, V198, P98, DOI 10.1016/j.bbr.2008.10.016; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Ferguson D, 2008, HIPPOCAMPUS, V18, P1103, DOI 10.1002/hipo.20467; Harris AP, 2013, PSYCHONEUROENDOCRINO, V38, P648, DOI 10.1016/j.psyneuen.2012.08.007; Joels M, 2008, TRENDS NEUROSCI, V31, P1, DOI 10.1016/j.tins.2007.10.005; Joels M, 2009, BRAIN RES, V1293, P91, DOI 10.1016/j.brainres.2009.03.036; Lai M, 2007, EUR J NEUROSCI, V25, P1832, DOI 10.1111/j.1460-9568.2007.05427.x; Leea AS, 2008, P NATL ACAD SCI USA, V105, P17163, DOI 10.1073/pnas.0807749105; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Oitzl MS, 2010, NEUROSCI BIOBEHAV R, V34, P853, DOI 10.1016/j.neubiorev.2009.07.006; OITZL MS, 1992, BEHAV NEUROSCI, V106, P62, DOI 10.1037/0735-7044.106.1.62; OITZL MS, 1994, EUR J NEUROSCI, V6, P1072, DOI 10.1111/j.1460-9568.1994.tb00604.x; Otte C, 2007, NEUROPSYCHOPHARMACOL, V32, P232, DOI 10.1038/sj.npp.1301217; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roozendaal B, 2009, J NEUROSCI, V29, P14299, DOI 10.1523/JNEUROSCI.3626-09.2009; SANDI C, 1994, BRAIN RES, V647, P106, DOI 10.1016/0006-8993(94)91404-4; Schwabe L, 2008, NEUROBIOL LEARN MEM, V90, P495, DOI 10.1016/j.nlm.2008.07.015; Schwabe L, 2007, LEARN MEMORY, V14, P109, DOI 10.1101/lm.435807; Schwabe L, 2013, BIOL PSYCHIAT, V74, P801, DOI 10.1016/j.biopsych.2013.06.001; Schwabe L, 2013, HIPPOCAMPUS, V23, P1035, DOI 10.1002/hipo.22175; Schwabe L, 2013, PSYCHONEUROENDOCRINO, V38, P2319, DOI 10.1016/j.psyneuen.2013.05.001; Schwabe L, 2013, TRENDS COGN SCI, V17, P60, DOI 10.1016/j.tics.2012.12.001; Schwabe L, 2012, J NEUROSCI, V32, P11042, DOI 10.1523/JNEUROSCI.1484-12.2012; Schwabe L, 2010, BEHAV BRAIN RES, V213, P50, DOI 10.1016/j.bbr.2010.04.029; Schwabe L, 2010, J COGNITIVE NEUROSCI, V22, P1362, DOI 10.1162/jocn.2009.21278; Schwabe L, 2009, PSYCHONEUROENDOCRINO, V34, P358, DOI 10.1016/j.psyneuen.2008.09.018; ter Horst JP, 2013, BEHAV BRAIN RES, V241, P92, DOI 10.1016/j.bbr.2012.11.040; Horst JP, 2012, EUR J NEUROSCI, V36, P3096, DOI 10.1111/j.1460-9568.2012.08237.x; ter Horst JP, 2012, NEUROBIOL LEARN MEM, V98, P33, DOI 10.1016/j.nlm.2012.04.006; ter Horst J, 2012, CELL MOL NEUROBIOL, V32, P725, DOI 10.1007/s10571-011-9774-2; ter Horst JP, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00056; Whishaw IQ, 1996, PHYSIOL BEHAV, V60, P1191, DOI 10.1016/S0031-9384(96)00176-X; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Zhou M, 2010, NEUROBIOL LEARN MEM, V94, P530, DOI 10.1016/j.nlm.2010.09.005	43	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86236	10.1371/journal.pone.0086236	http://dx.doi.org/10.1371/journal.pone.0086236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465979	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500211
J	Goddard, CA; Mysore, SP; Bryant, AS; Huguenard, JR; Knudsen, EI				Goddard, C. Alex; Mysore, Shreesh P.; Bryant, Astra S.; Huguenard, John R.; Knudsen, Eric I.			Spatially Reciprocal Inhibition of Inhibition within a Stimulus Selection Network in the Avian Midbrain	PLOS ONE			English	Article							OWL OPTIC TECTUM; FLEXIBLE CATEGORIZATION; GAMMA OSCILLATIONS; ENTORHINAL CORTEX; RANGE INHIBITION; VISUAL-CORTEX; CONNECTIONS; NUCLEUS; NEURONS; CIRCUIT	Reciprocal inhibition between inhibitory projection neurons has been proposed as the most efficient circuit motif to achieve the flexible selection of one stimulus among competing alternatives. However, whether such a motif exists in networks that mediate selection is unclear. Here, we study the connectivity within the nucleus isthmi pars magnocellularis (Imc), a GABAergic nucleus that mediates competitive selection in the midbrain stimulus selection network. Using laser photostimulation of caged glutamate, we find that feedback inhibitory connectivity is global within the Imc. Unlike typical lateral inhibition in other circuits, intra-Imc inhibition remains functionally powerful over long distances. Anatomically, we observed long-range axonal projections and retrograde somatic labeling from focal injections of bi-directional tracers in the Imc, consistent with spatial reciprocity of intra-Imc inhibition. Together, the data indicate that spatially reciprocal inhibition of inhibition occurs throughout the Imc. Thus, the midbrain selection circuit possesses the most efficient circuit motif possible for fast, reliable, and flexible selection.	[Goddard, C. Alex; Mysore, Shreesh P.; Bryant, Astra S.; Knudsen, Eric I.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Huguenard, John R.] Stanford Med Sch, Dept Neurol, Stanford, CA USA	Stanford University; Stanford University	Goddard, CA (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	alex.goddard@gmail.com	Huguenard, John/I-5016-2012; Huguenard, John/K-6429-2019	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Bryant, Astra/0000-0002-0887-2044; Mysore, Shreesh/0000-0002-7781-8252	Stanford Dean's Postdoctoral fellowship; NEI [F32 EY018787, EY019179-31]; NINDS [NS34774]; Stanford Neuroscience Microscopy Service; NIH [NS069375]; NATIONAL EYE INSTITUTE [R01EY019179, F32EY018787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034774, P30NS069375, R01NS034774, R01NS006477] Funding Source: NIH RePORTER	Stanford Dean's Postdoctoral fellowship; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stanford Neuroscience Microscopy Service; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Stanford Dean's Postdoctoral fellowship (CAG, SPM), NEI F32 EY018787 (CAG), NINDS NS34774 (JRH), NEI EY019179-31 (EIK), and the Stanford Neuroscience Microscopy Service, supported by NIH NS069375. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadollahi A, 2011, J NEUROSCI, V31, P6088, DOI 10.1523/JNEUROSCI.0023-11.2011; Bolzon DM, 2009, J NEUROSCI, V29, P14143, DOI 10.1523/JNEUROSCI.2857-09.2009; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Deleuze C, 2006, J NEUROSCI, V26, P8633, DOI 10.1523/JNEUROSCI.2333-06.2006; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Goddard CA, 2012, NEURON, V73, P567, DOI 10.1016/j.neuron.2011.11.028; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Hull C, 2012, NEURON, V73, P149, DOI 10.1016/j.neuron.2011.10.030; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Knudsen EI, 2011, EUR J NEUROSCI, V33, P1961, DOI 10.1111/j.1460-9568.2011.07696.x; Marin G, 2007, J NEUROSCI, V27, P8112, DOI 10.1523/JNEUROSCI.1420-07.2007; Matsui R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048730; MCDONALD CT, 1993, J NEUROSCI, V13, P768; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; Mysore SP, 2013, NAT NEUROSCI, V16, P473, DOI 10.1038/nn.3352; Mysore SP, 2012, NEURON, V73, P193, DOI 10.1016/j.neuron.2011.10.037; Mysore SP, 2011, J NEUROSCI, V31, P7745, DOI 10.1523/JNEUROSCI.5425-10.2011; Mysore SP, 2011, J NEUROSCI, V31, P5186, DOI 10.1523/JNEUROSCI.4592-10.2011; Mysore SP, 2010, J NEUROSCI, V30, P1727, DOI 10.1523/JNEUROSCI.3740-09.2010; Papadopoulou M, 2011, SCIENCE, V332, P721, DOI 10.1126/science.1201835; PETERS A, 1990, J COMP NEUROL, V302, P124, DOI 10.1002/cne.903020110; Pinto A, 2006, J COMP NEUROL, V495, P722, DOI 10.1002/cne.20905; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; SIK A, 1994, SCIENCE, V265, P1722, DOI 10.1126/science.8085161; Spiro JE, 1999, J NEUROPHYSIOL, V81, P3007, DOI 10.1152/jn.1999.81.6.3007; Tiesinga P, 2009, NEURON, V63, P727, DOI 10.1016/j.neuron.2009.09.009; Tombol T, 1998, CELL TISSUE RES, V291, P255, DOI 10.1007/s004410050995; Traub RD, 1998, PROG NEUROBIOL, V55, P563, DOI 10.1016/S0301-0082(98)00020-3; Wang Y, 2004, J COMP NEUROL, V469, P275, DOI 10.1002/cne.11007; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035	33	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85865	10.1371/journal.pone.0085865	http://dx.doi.org/10.1371/journal.pone.0085865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465755	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500133
J	Lin, YT; Kuo, CH; Hwang, IS				Lin, Yen-Ting; Kuo, Chia-Hua; Hwang, Ing-Shiou			Fatigue Effect on Low-Frequency Force Fluctuations and Muscular Oscillations during Rhythmic Isometric Contraction	PLOS ONE			English	Article							SIGNAL-DEPENDENT NOISE; MANUAL TRACKING; MUSCLE FATIGUE; CORTICOMUSCULAR COHERENCE; OUTPUT VARIABILITY; DISCHARGE PATTERNS; LIMB ACCELERATION; MOTOR DRIVE; INTERMITTENCY; TASK	Continuous force output containing numerous intermittent force pulses is not completely smooth. By characterizing force fluctuation properties and force pulse metrics, this study investigated adaptive changes in trajectory control, both force-generating capacity and force fluctuations, as fatigue progresses. Sixteen healthy subjects (20-24 years old) completed rhythmic isometric gripping with the non-dominant hand to volitional failure. Before and immediately following the fatigue intervention, we measured the gripping force to couple a 0.5 Hz sinusoidal target in the range of 50-100% maximal voluntary contraction. Dynamic force output was off-line decomposed into 1) an ideal force trajectory spectrally identical to the target rate; and 2) a force pulse trace pertaining to force fluctuations and error-correction attempts. The amplitude of ideal force trajectory regarding to force-generating capacity was more suppressed than that of the force pulse trace with increasing fatigue, which also shifted the force pulse trace to lower frequency bands. Multi-scale entropy analysis revealed that the complexity of the force pulse trace at high time scales increased with fatigue, contrary to the decrease in complexity of the force pulse trace at low time scales. Statistical properties of individual force pulses in the spatial and temporal domains varied with muscular fatigue, concurrent with marked suppression of gamma muscular oscillations (4060 Hz) in the post-fatigue test. In conclusion, this study first reveals that muscular fatigue impairs the amplitude modulation of force pattern generation more than it affects the amplitude responsiveness of fine-tuning a force trajectory. Besides, motor fatigue results disadvantageously in enhancement of motor noises, simplification of short-term force-tuning strategy, and slow responsiveness to force errors, pertaining to dimensional changes in force fluctuations, scaling properties of force pulse, and muscular oscillation.	[Lin, Yen-Ting] Asia Univ, Phys Educ Off, Taichung, Taiwan; [Lin, Yen-Ting; Kuo, Chia-Hua] Univ Taipei, Dept Sports Sci, Taipei, Taiwan; [Hwang, Ing-Shiou] Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan 70101, Taiwan; [Hwang, Ing-Shiou] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Tainan 70101, Taiwan	Asia University Taiwan; University of Taipei; National Cheng Kung University; National Cheng Kung University	Hwang, IS (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan 70101, Taiwan.	ishwang@mail.ncku.edu.tw		Kuo, Chia-Hua/0000-0002-1731-4984				Allen TJ, 2010, J PHYSIOL-LONDON, V588, P1369, DOI 10.1113/jphysiol.2010.187732; Andersen B, 2012, J APPL PHYSIOL, V112, P832, DOI 10.1152/japplphysiol.00917.2009; Andrykiewicz A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-101; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; Bedrov YA, 2007, BIOSYSTEMS, V89, P50, DOI 10.1016/j.biosystems.2006.04.011; Boonstra TW, 2012, J NEUROPHYSIOL, V107, P796, DOI 10.1152/jn.00066.2011; Carpentier A, 2001, J PHYSIOL-LONDON, V534, P903, DOI 10.1111/j.1469-7793.2001.00903.x; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074273; Contessa P, 2009, J APPL PHYSIOL, V107, P235, DOI 10.1152/japplphysiol.00035.2009; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; DESMEDT JE, 1978, J PHYSIOL-LONDON, V285, P185, DOI 10.1113/jphysiol.1978.sp012566; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Dipietro L, 2009, CORTEX, V45, P318, DOI 10.1016/j.cortex.2008.02.008; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Feldman A G, 1998, Motor Control, V2, P189; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Gwin JT, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00258; Househam E, 2004, MUSCLE NERVE, V29, P401, DOI 10.1002/mus.10564; Huang CT, 2007, EUR J APPL PHYSIOL, V100, P675, DOI 10.1007/s00421-007-0460-5; Huang CT, 2006, EUR J APPL PHYSIOL, V97, P362, DOI 10.1007/s00421-006-0166-0; IYER MB, 1994, NEUROSCI LETT, V170, P94, DOI 10.1016/0304-3940(94)90247-X; Jones LA, 1995, ADV EXP MED BIOL, V384, P305; Jordan K, 2004, EXP BRAIN RES, V156, P451, DOI 10.1007/s00221-003-1806-9; Kuznetsov NA, 2010, NEUROSCI LETT, V470, P121, DOI 10.1016/j.neulet.2009.12.068; Li K, 2013, NEUROSCI LETT, V545, P1, DOI 10.1016/j.neulet.2013.04.011; Masuda K, 1999, J ELECTROMYOGR KINES, V9, P39, DOI 10.1016/S1050-6411(98)00021-2; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; Missenard O, 2008, NEUROSCI LETT, V437, P154, DOI 10.1016/j.neulet.2008.03.090; Missenard O, 2009, MUSCLE NERVE, V40, P1019, DOI 10.1002/mus.21331; Mottram CJ, 2005, J NEUROPHYSIOL, V93, P1381, DOI 10.1152/jn.00837.2004; Muthukumaraswamy SD, 2010, J NEUROPHYSIOL, V104, P2873, DOI 10.1152/jn.00607.2010; Myers LJ, 2003, J NEUROSCI METH, V124, P157, DOI 10.1016/S0165-0270(03)00004-9; NAVAS F, 1968, BIOPHYS J, V8, P252, DOI 10.1016/S0006-3495(68)86488-4; Omlor W, 2007, NEUROIMAGE, V34, P1191, DOI 10.1016/j.neuroimage.2006.10.018; Park WH, 2007, EXP BRAIN RES, V182, P169, DOI 10.1007/s00221-007-0978-0; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Roitman AV, 2004, J NEUROPHYSIOL, V91, P901, DOI 10.1152/jn.00261.2003; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Schoffelen JM, 2011, J NEUROSCI, V31, P6750, DOI 10.1523/JNEUROSCI.4882-10.2011; Selen LPJ, 2006, J NEUROPHYSIOL, V96, P2750, DOI 10.1152/jn.00552.2006; Singh T, 2010, NEUROSCI LETT, V485, P204, DOI 10.1016/j.neulet.2010.09.012; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Slifkin AB, 2000, J NEUROPHYSIOL, V84, P1708, DOI 10.1152/jn.2000.84.4.1708; Slifkin AB, 2000, J MOTOR BEHAV, V32, P141, DOI 10.1080/00222890009601366; Sosnoff JJ, 2005, J MOTOR BEHAV, V37, P325, DOI 10.3200/JMBR.37.4.325-336; Sosnoff JJ, 2005, BEHAV BRAIN RES, V158, P301, DOI 10.1016/j.bbr.2004.09.009; Stegeman DF, 2010, CLIN NEUROPHYSIOL, V121, P1633, DOI 10.1016/j.clinph.2010.03.052; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Taylor JL, 2000, EUR J APPL PHYSIOL, V83, P106, DOI 10.1007/s004210000269; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002; Vila-Cha C, 2012, MED SCI SPORT EXER, V44, P616, DOI 10.1249/MSS.0b013e318235d81d; Westad C, 2003, J PHYSIOL-LONDON, V552, P645, DOI 10.1113/jphysiol.2003.044990; Z'Graggen WJ, 2005, CLIN NEUROPHYSIOL, V116, P1628, DOI 10.1016/j.clinph.2005.03.012	56	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85578	10.1371/journal.pone.0085578	http://dx.doi.org/10.1371/journal.pone.0085578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465605	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500078
J	Liu, LJ; Wu, CF				Liu, Lijuan; Wu, Chun-Fang			Distinct Effects of Abelson Kinase Mutations on Myocytes and Neurons in Dissociated Drosophila Embryonic Cultures: Mimicking of High Temperature	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH CONE MOTILITY; ABL TYROSINE KINASE; CELL CULTURES; MYOBLAST FUSION; MEMORY MUTANTS; MORPHOGENESIS; DIFFERENTIATION; NEUROBLASTS; DYNAMICS	Abelson tyrosine kinase (Abl) is known to regulate axon guidance, muscle development, and cell-cell interaction in vivo. The Drosophila primary culture system offers advantages in exploring the cellular mechanisms mediated by Abl with utilizing various experimental manipulations. Here we demonstrate that single-embryo cultures exhibit stage-dependent characteristics of cellular differentiation and developmental progression in neurons and myocytes, as well as nerve-muscle contacts. In particular, muscle development critically depends on the stage of dissociated embryos. In wild-type (WT) cultures derived from embryos before stage 12, muscle cells remained within cell clusters and were rarely detected. Interestingly, abundant myocytes were spotted in Abl mutant cultures, exhibiting enhanced myocyte movement and fusion, as well as neuron-muscle contacts even in cultures dissociated from younger, stage 10 embryos. Notably, Abl myocytes frequently displayed well-expanded lamellipodia. Conversely, Abl neurons were characterized with fewer large veil-like lamellipodia, but instead had increased numbers of filopodia and darker nodes along neurites. These distinct phenotypes were equally evident in both homo-and hetero-zygous cultures (Abl/Abl vs. Abl/+) of different alleles (Abl(1) and Abl(4)) indicating dominant mutational effects. Strikingly, in WT cultures derived from stage 10 embryos, high temperature (HT) incubation promoted muscle migration and fusion, partially mimicking the advanced muscle development typical of Abl cultures. However, HT enhanced neuronal growth with increased numbers of enlarged lamellipodia, distinct from the characteristic Abl neuronal morphology. Intriguingly, HT incubation also promoted Abl lamellipodia expansion, with a much greater effect on nerve cells than muscle. Our results suggest that Abl is an essential regulator for myocyte and neuron development and that high-temperature incubation partially mimics the faster muscle development typical of Abl cultures. Despite the extensive alterations by Abl mutations, we observed myocyte fusion events and nerve-muscle contact formation between WT and Abl cells in mixed WT and Abl cultures derived from labeled embryos.	[Liu, Lijuan; Wu, Chun-Fang] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China; [Liu, Lijuan; Wu, Chun-Fang] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	Southeast University - China; University of Iowa	Liu, LJ (corresponding author), Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China.	lijuan-liu@seu.edu.cn			China Scholarship Council; National Natural Science Foundation of China [31171041]; United States National Institute of Health grant [GM088804]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088804] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States National Institute of Health grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by The China Scholarship Council (LL), the National Natural Science Foundation of China 31171041 (Wei Xie, Southeast University) and the United States National Institute of Health grant GM088804 (CFW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JW, 2009, NAT PROTOC, V4, P1502, DOI 10.1038/nprot.2009.147; BATE M, 1990, DEVELOPMENT, V110, P791; Beckett K, 2007, DEV BIOL, V309, P113, DOI 10.1016/j.ydbio.2007.06.024; BENNETT RL, 1992, DEVELOPMENT, V116, P953; Berke B, 2002, J NEUROSCI, V22, P4437, DOI 10.1523/JNEUROSCI.22-11-04437.2002; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Counce S.J., 1973, DEV SYSTEMS INSECTS, P1; Dobi KC, 2011, FLY, V5, P68, DOI 10.4161/fly.5.2.15031; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; Fox DT, 2007, DEVELOPMENT, V134, P567, DOI 10.1242/dev.02748; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; HENKEMEYER MJ, 1987, CELL, V51, P821, DOI 10.1016/0092-8674(87)90105-X; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Homem CCF, 2009, MOL BIOL CELL, V20, P5138, DOI 10.1091/mbc.E09-02-0144; Hossain Sajjad, 2012, Genes Cancer, V3, P402, DOI 10.1177/1947601912460051; HUFF R, 1989, DEV BIOL, V134, P146, DOI 10.1016/0012-1606(89)90085-7; IFeng Peng, 2007, J NEUROPHYSIOL, V97, P780; Jia L, 2012, AM J PHYSIOL-CELL PH, V302, pC1026, DOI 10.1152/ajpcell.00373.2011; KIM YT, 1991, J NEUROBIOL, V22, P263, DOI 10.1002/neu.480220306; KIM YT, 1987, J NEUROSCI, V7, P3245; Kim YT, 1996, J NEUROSCI, V16, P5593; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Kuppers-Munther B, 2004, DEV BIOL, V269, P459, DOI 10.1016/j.ydbio.2004.01.038; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Lin TY, 2009, DEVELOPMENT, V136, P3099, DOI 10.1242/dev.033324; Luer K, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-30; LUER K, 1992, DEVELOPMENT, V116, P377; Michael M, 2010, CURR BIOL, V20, P783, DOI 10.1016/j.cub.2010.03.048; NOWELL PC, 1960, SCIENCE, V132, P1497; Onel SF, 2009, DEV DYNAM, V238, P1513, DOI 10.1002/dvdy.21961; Peng IF, 2007, J NEUROSCI, V27, P12611, DOI 10.1523/JNEUROSCI.2179-07.2007; Prokop A., 2012, MAKING UNMAKING NEUR; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Rowley JD, 2013, SCIENCE, V340, P1412, DOI 10.1126/science.1241318; SAITO M, 1991, J NEUROSCI, V11, P2135; Schejter ED, 2010, CURR OPIN CELL BIOL, V22, P566, DOI 10.1016/j.ceb.2010.08.009; SEECOF RL, 1972, P NATL ACAD SCI USA, V69, P566, DOI 10.1073/pnas.69.3.566; SEECOF RL, 1971, EXP CELL RES, V69, P161, DOI 10.1016/0014-4827(71)90321-1; Seecof RL, 1972, MECH AGEING DEV, V1, P165, DOI 10.1016/0047-6374(72)90064-4; SHIELDS G, 1970, Journal of Embryology and Experimental Morphology, V23, P53; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Stevens TL, 2008, MOL BIOL CELL, V19, P378, DOI 10.1091/mbc.E07-01-0008; Taft PJ, 1999, ABSTR SOC NEUROSCI, V25, P1025; Tamada M, 2012, DEV CELL, V22, P309, DOI 10.1016/j.devcel.2011.12.025; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; WU CF, 1990, J NEUROBIOL, V21, P499, DOI 10.1002/neu.480210310; WU CF, 1983, J NEUROSCI, V3, P1888; Wu CF, 1988, CELL CULTURE APPROAC, P149; Yao WD, 2001, J NEUROPHYSIOL, V85, P1384, DOI 10.1152/jn.2001.85.4.1384; Yao WD, 2000, J NEUROSCI, V20, P2626; Zhao ML, 1997, J NEUROSCI, V17, P2187	53	0	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86438	10.1371/journal.pone.0086438	http://dx.doi.org/10.1371/journal.pone.0086438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466097	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500244
J	Surmacz-Chwedoruk, W; Malka, I; Bozycki, L; Nieznanska, H; Dzwolak, W				Surmacz-Chwedoruk, Weronika; Malka, Iwona; Bozycki, Lukasz; Nieznanska, Hanna; Dzwolak, Wojciech			On the Heat Stability of Amyloid-Based Biological Activity: Insights from Thermal Degradation of Insulin Fibrils	PLOS ONE			English	Article							PEPTIDE NANOTUBES; PRION PROTEIN; INACTIVATION; INFECTIVITY; RESISTANCE; FIBRILLATION; SURVIVAL; WATER	Formation of amyloid fibrils in vivo has been linked to disorders such as Alzheimer's disease and prion-associated transmissible spongiform encephalopathies. One of the characteristic features of amyloid fibrils is the high thermodynamic stability relative both to native and disordered states which is also thought to underlie the perplexingly remarkable heat resistance of prion infectivity. Here, we are comparing high-temperature degradation of native and fibrillar forms of human insulin. Decomposition of insulin amyloid has been studied under helium atmosphere and in the temperature range from ambient conditions to 750 degrees C using thermogravimetry and differential scanning calorimetry coupled to mass spectrometry. While converting native insulin into amyloid does upshift onset of thermal decomposition by ca. 75 degrees C, fibrils remain vulnerable to covalent degradation at temperatures below 300 degrees C, as reflected by mass spectra of gases released upon heating of amyloid samples, as well as morphology and infrared spectra of fibrils subjected to incubation at 250 degrees C. Mass spectra profiles of released gases indicate that degradation of fibrils is much more cooperative than degradation of native insulin. The data show no evidence of water of crystallization trapped within insulin fibrils. We have also compared untreated and heated amyloid samples in terms of capacity to seed daughter fibrils. Kinetic traces of seed-induced insulin fibrillation have shown that the seeding potency of amyloid samples decreases significantly already after exposure to 200 degrees C, even though corresponding electron micrographs indicated persisting fibrillar morphology. Our results suggest that amyloid-based biological activity may not survive extremely high temperature treatments, at least in the absence of other stabilizing factors.	[Surmacz-Chwedoruk, Weronika] Inst Biotechnol & Antibiot, Warsaw, Poland; [Surmacz-Chwedoruk, Weronika; Malka, Iwona; Bozycki, Lukasz; Dzwolak, Wojciech] Polish Acad Sci, Inst High Pressure Phys, Warsaw, Poland; [Nieznanska, Hanna] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland; [Dzwolak, Wojciech] Univ Warsaw, Dept Chem, Warsaw, Poland	Institute of Biotechnology & Antibiotics (IBA); Polish Academy of Sciences; Institute of High Pressure Physics of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Warsaw	Dzwolak, W (corresponding author), Polish Acad Sci, Inst High Pressure Phys, Warsaw, Poland.	wdzwolak@chem.uw.edu.pl	Koltsov, Iwona/W-5737-2018	Koltsov, Iwona/0000-0001-6523-3719; Dzwolak, Wojciech/0000-0002-1407-1497; Bozycki, Lukasz/0000-0002-3295-6301; Nieznanska, Hanna/0000-0001-7055-5018	National Science Centre of Poland [DEC-2012/07/B/NZ1/02642]	National Science Centre of Poland(National Science Centre, Poland)	This work was supported by the National Science Centre of Poland, grant DEC-2012/07/B/NZ1/02642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Abramovich L, 2006, LANGMUIR, V22, P1313, DOI 10.1021/la052409d; Appel TR, 2001, J GEN VIROL, V82, P465, DOI 10.1099/0022-1317-82-2-465; Arora A, 2004, PROTEIN SCI, V13, P2429, DOI 10.1110/ps.04823504; Bocian W, 2008, BIOPOLYMERS, V89, P820, DOI 10.1002/bip.21018; BROWN P, 1990, J INFECT DIS, V161, P467, DOI 10.1093/infdis/161.3.467; Brown P, 2003, P NATL ACAD SCI USA, V100, P6093, DOI 10.1073/pnas.1031826100; Brown P, 2000, P NATL ACAD SCI USA, V97, P3418, DOI 10.1073/pnas.050566797; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Dirix C, 2005, J MOL BIOL, V347, P903, DOI 10.1016/j.jmb.2005.01.073; Dzwolak W, 2006, BIOCHEMISTRY-US, V45, P8143, DOI 10.1021/bi060341a; Dzwolak W, 2004, PROTEIN SCI, V13, P1927, DOI 10.1110/ps.03607204; Dzwolak W, 2003, BIOCHEMISTRY-US, V42, P11347, DOI 10.1021/bi034879h; El Moustaine D, 2011, J BIOL CHEM, V286, P13448, DOI 10.1074/jbc.M110.192872; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fernie K, 2007, BIOTECHNOL APPL BIOC, V47, P175, DOI 10.1042/BA20060249; Fodera V, 2008, J PHYS CHEM B, V112, P3853, DOI 10.1021/jp710131u; Fodera V, 2010, SOFT MATTER, V6, P4413, DOI 10.1039/c0sm00169d; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Garcia AF, 2004, J GEN VIROL, V85, P261, DOI 10.1099/vir.0.19410-0; Gazit E, 2002, ANGEW CHEM INT EDIT, V41, P257, DOI 10.1002/1521-3773(20020118)41:2<257::AID-ANIE257>3.0.CO;2-M; Huson MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052308; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kol N, 2005, NANO LETT, V5, P1343, DOI 10.1021/nl0505896; Kurouski D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036989; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; Mohammed ZH, 2000, J FOOD SCI, V65, P221, DOI 10.1111/j.1365-2621.2000.tb15983.x; NORDSTEDT C, 1994, J BIOL CHEM, V269, P30773; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Ryu J, 2010, BIOTECHNOL BIOENG, V105, P221, DOI 10.1002/bit.22544; SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220; Surmacz-Chwedoruk W, 2012, BIOCHEMISTRY-US, V51, P9460, DOI 10.1021/bi301144d; Suyama K, 2007, BIOCHEM BIOPH RES CO, V356, P245, DOI 10.1016/j.bbrc.2007.02.113; Taylor DM, 1999, J HOSP INFECT, V43, pS69, DOI 10.1016/S0195-6701(99)90067-1; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Westermark GT, 2010, TRENDS MOL MED, V16, P501, DOI 10.1016/j.molmed.2010.08.004; Wiggins RC, 2009, NEUROCHEM RES, V34, P158, DOI 10.1007/s11064-008-9741-6	41	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86320	10.1371/journal.pone.0086320	http://dx.doi.org/10.1371/journal.pone.0086320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466022	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500223
J	Dai, Q; Zhan, XJ; Lu, B; Fu, JZ; Wang, Q; Qi, DW				Dai, Qiang; Zhan, Xiangjiang; Lu, Bin; Fu, Jinzhong; Wang, Qian; Qi, Dunwu			Spatial Genetic Structure Patterns of Phenotype-Limited and Boundary-Limited Expanding Populations: A Simulation Study	PLOS ONE			English	Article							RANGE EXPANSION; CLIMATE-CHANGE; DIVERSITY; DIFFERENTIATION; DISTRIBUTIONS; AMERICAN; FRONT	Range expansions may create a unique spatial genetic pattern characterized by alternate genetically homogeneous domains and allele frequency clines. Previous attempts to model range expansions have mainly focused on the loss of genetic diversity during expansions. Using individual-based models, we examined spatial genetic patterns under two expansion scenarios, boundary-limited range expansions (BLRE) and phenotype-limited range expansions (PhLRE). Our simulation revealed that the genetic diversity within populations lost quickly during the range expansion, while the genetic difference accumulated between populations. Consequently, accompanying the expansions, the overall diversity featured a slow decrease. Specifically, during BLREs, high speed of boundary motion facilitated the maintenance of total genetic diversity and sharpened genetic clines. Very slight constraints on boundary motion of BLREs drastically narrowed the homogeneous domains and increased the allele frequency fluctuations from those levels exhibited by PhLREs. Even stronger constraints, however, surprisingly brought the width of homogeneous domains and the allele frequency fluctuations back to the normal levels of PhLREs. Furthermore, high migration rates maintained a higher total genetic diversity than low ones did during PhLREs. Whereas, the total genetic diversities during BLREs showed a contrary pattern: higher when migration was low than those when migration was high. Besides, the increase of migration rates helped maintain a greater number of homogeneous domains during PhLREs, but their effects on the number of homogeneous domains during BLREs were not monotonous. Previous studies have showed that the homogenous domains can merge to form a few broad domains as the expansion went on, leading to fewer homogeneous domains. Our simulations, meanwhile, revealed that the range expansions could also rebuild homogeneous domains from the clines during the range expansion. It is possible that that the number of homogeneous domains was determined by the interaction of merging and newly emerging homogeneous domains.	[Dai, Qiang; Lu, Bin; Fu, Jinzhong; Wang, Qian] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Zhan, Xiangjiang] Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Cardiff CF10 3AX, S Glam, Wales; [Dai, Qiang; Qi, Dunwu] Chengdu Res Base Giant Panda Breeding, Key Lab Conservat Biol Endangered Wildlife, Chengdu, Sichuan, Peoples R China; [Fu, Jinzhong] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Cardiff University; University of Guelph	Dai, Q (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.	daiqiang@cib.ac.cn	Dai, Qiang/L-6867-2019	Dai, Qiang/0000-0002-7850-997X	National Natural Science Foundation of China; National Sciences and Engineering Research Council; Leading Foundation of the Chinese Academy of Sciences [XDA05050404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Leading Foundation of the Chinese Academy of Sciences	This project is supported by a National Natural Science Foundation of China grant and a National Sciences and Engineering Research Council Discovery grant to JF and Leading Foundation of the Chinese Academy of Sciences (XDA05050404) to QW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W.C, 1931, ANIMAL AGGREGATION S; Armbruster P, 1998, EVOLUTION, V52, P1697, DOI 10.1111/j.1558-5646.1998.tb02249.x; Behrman KD, 2011, J EVOLUTION BIOL, V24, P665, DOI 10.1111/j.1420-9101.2010.02195.x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; D'Andrea L, 2009, J BIOGEOGR, V36, P1573, DOI 10.1111/j.1365-2699.2008.02060.x; Edmonds CA, 2004, P NATL ACAD SCI USA, V101, P975, DOI 10.1073/pnas.0308064100; EPPERSON BK, 1995, GENETICS, V140, P1431; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Ficetola GF, 2007, BIOL INVASIONS, V9, P767, DOI 10.1007/s10530-006-9080-y; Gasperi G, 2002, GENETICA, V116, P125, DOI 10.1023/A:1020971911612; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; Habel JC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-215; Hallatschek O, 2008, THEOR POPUL BIOL, V73, P158, DOI 10.1016/j.tpb.2007.08.008; Hallatschek O, 2007, P NATL ACAD SCI USA, V104, P19926, DOI 10.1073/pnas.0710150104; Hallatschek O, 2010, EVOLUTION, V64, P193, DOI 10.1111/j.1558-5646.2009.00809.x; Hallatschek O, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108103; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hill JK, 2006, BIOL LETTERS, V2, P152, DOI 10.1098/rsbl.2005.0401; Holt RD, 2003, EVOL ECOL RES, V5, P159; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kluver J, 2011, COMPLEXITY, V16, P10, DOI 10.1002/cplx.20317; Korolev KS, 2010, REV MOD PHYS, V82, P1691, DOI 10.1103/RevModPhys.82.1691; Korolev KS, 2011, AM NAT, V178, P538, DOI 10.1086/661897; Kuhr JT, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/113013; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lihova J, 2010, AM J BOT, V97, P1058, DOI 10.3732/ajb.0900361; Maclean IMD, 2008, GLOBAL CHANGE BIOL, V14, P2489, DOI 10.1111/j.1365-2486.2008.01666.x; McInerny GJ, 2009, P ROY SOC B-BIOL SCI, V276, P1527, DOI 10.1098/rspb.2008.1567; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nullmeier J, 2013, EVOLUTION, V67, P1307, DOI 10.1111/evo.12037; Pluess AR, 2011, MOL ECOL, V20, P473, DOI 10.1111/j.1365-294X.2010.04972.x; Provan J, 2012, P ROY SOC B-BIOL SCI, V279, P39, DOI 10.1098/rspb.2011.0536; R Core Team, 2012, R LANG ENV STAT COMP; Roques L, 2012, P NATL ACAD SCI USA, V109, P8828, DOI 10.1073/pnas.1201695109; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schmitt T, 2002, HEREDITY, V89, P20, DOI 10.1038/sj.hdy.6800087; SOKAL RR, 1983, GENETICS, V105, P219; SOKAL RR, 1989, GENETICS, V121, P845; TAKAHATA N, 1985, GENETICS, V110, P325; Vandewoestijne S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013810; Wang R, 2006, DIVERS DISTRIB, V12, P397, DOI 10.1111/j.1366-9516.2006.00250.x	41	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85778	10.1371/journal.pone.0085778	http://dx.doi.org/10.1371/journal.pone.0085778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465700	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500071
J	Handtke, S; Schroeter, R; Jurgen, B; Methling, K; Schluter, R; Albrecht, D; van Hijum, SAFT; Bongaerts, J; Maurer, KH; Lalk, M; Schweder, T; Hecker, M; Voigt, B				Handtke, Stefan; Schroeter, Rebecca; Juergen, Britta; Methling, Karen; Schlueter, Rabea; Albrecht, Dirk; van Hijum, Sacha A. F. T.; Bongaerts, Johannes; Maurer, Karl-Heinz; Lalk, Michael; Schweder, Thomas; Hecker, Michael; Voigt, Birgit			Bacillus pumilus Reveals a Remarkably High Resistance to Hydrogen Peroxide Provoked Oxidative Stress	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MOLECULAR-WEIGHT THIOL; TRANSCRIPTIONAL CONTROL; ESCHERICHIA-COLI; GLOBAL REGULATOR; SUBTILIS-FUR; KATX GENE; PROTEIN; DNA; BACILLITHIOL	Bacillus pumilus is characterized by a higher oxidative stress resistance than other comparable industrially relevant Bacilli such as B. subtilis or B. licheniformis. In this study the response of B. pumilus to oxidative stress was investigated during a treatment with high concentrations of hydrogen peroxide at the proteome, transcriptome and metabolome level. Genes/proteins belonging to regulons, which are known to have important functions in the oxidative stress response of other organisms, were found to be upregulated, such as the Fur, Spx, SOS or CtsR regulon. Strikingly, parts of the fundamental PerR regulon responding to peroxide stress in B. subtilis are not encoded in the B. pumilus genome. Thus, B. pumilus misses the catalase KatA, the DNA-protection protein MrgA or the alkyl hydroperoxide reductase AhpCF. Data of this study suggests that the catalase KatX2 takes over the function of the missing KatA in the oxidative stress response of B. pumilus. The genome-wide expression analysis revealed an induction of bacillithiol (Cys-GlcN-malate, BSH) relevant genes. An analysis of the intracellular metabolites detected high intracellular levels of this protective metabolite, which indicates the importance of bacillithiol in the peroxide stress resistance of B. pumilus.	[Handtke, Stefan; Schlueter, Rabea; Albrecht, Dirk; Hecker, Michael; Voigt, Birgit] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany; [Schroeter, Rebecca; Juergen, Britta; Schweder, Thomas] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Greifswald, Germany; [Methling, Karen; Lalk, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Greifswald, Germany; [van Hijum, Sacha A. F. T.] Radboud Univ Nijmegen, Med Ctr, CMBI, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [van Hijum, Sacha A. F. T.] NIZO Food Res BV, Div Proc & Safety, Ede, Netherlands; [Bongaerts, Johannes] Aachen Univ Appl Sci, Dept Chem & Biotechnol, Julich, Germany; [Maurer, Karl-Heinz] AB Enzymes GmbH, Darmstadt, Germany; [Schweder, Thomas; Hecker, Michael; Voigt, Birgit] Inst Marine Biotechnol, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Radboud University Nijmegen; NIZO Food Research	Voigt, B (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany.	birgit.voigt@uni-greifswald.de	van Hijum, Sacha/F-6445-2014; Lalk, Michael/C-1618-2010	Lalk, Michael/0000-0002-9230-0267; Voigt, Birgit/0000-0003-4534-6315; van Hijum, Sacha/0000-0003-0741-2991; Schweder, Thomas/0000-0002-7213-3596	Competence Network "Mipro - Microbes for production: A genomics-based approach to engineer novel industrial production strains" [0315594B]; German Federal Ministry of Education and Research (BMBF); project "Ausbau und Profilierung von COAST Fun-Gene" of the Bildungsministerium of Mecklenburg-Vorpommern [UG11043, ESF/IV-BM-B35-0003/12]; Henkel KGaA	Competence Network "Mipro - Microbes for production: A genomics-based approach to engineer novel industrial production strains"; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); project "Ausbau und Profilierung von COAST Fun-Gene" of the Bildungsministerium of Mecklenburg-Vorpommern; Henkel KGaA	This work was financially supported by funds of the Competence Network "Mipro - Microbes for production: A genomics-based approach to engineer novel industrial production strains" (0315594B) by the German Federal Ministry of Education and Research (BMBF, www.bmbf.de) and the project "Ausbau und Profilierung von COAST Fun-Gene" (UG11043, ESF/IV-BM-B35-0003/12) of the Bildungsministerium of Mecklenburg-Vorpommern (www.regierung-mv.de). The transcriptome analysis was financially supported by the Henkel KGaA (www.henkel.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUOMA OI, 1991, BIOCHEM J, V273, P601, DOI 10.1042/bj2730601; Bagyan I, 1998, J BACTERIOL, V180, P2057, DOI 10.1128/JB.180.8.2057-2062.1998; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Benardini JN, 2003, ASTROBIOLOGY, V3, P709, DOI 10.1089/153110703322736033; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Borodovsky M., 2003, CURRENT PROTOCOLS BI; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chi BK, 2013, ANTIOXID REDOX SIGN, V18, P1273, DOI 10.1089/ars.2012.4686; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Choi SY, 2006, J BACTERIOL, V188, P5741, DOI 10.1128/JB.00443-06; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Even S, 2006, J BACTERIOL, V188, P2184, DOI 10.1128/JB.188.6.2184-2197.2006; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; FERNANDO MR, 1992, EUR J BIOCHEM, V209, P917, DOI 10.1111/j.1432-1033.1992.tb17363.x; Fuangthong M, 2002, J BACTERIOL, V184, P3276, DOI 10.1128/JB.184.12.3276-3286.2002; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Gaballa A, 2007, MOL MICROBIOL, V66, P164, DOI 10.1111/j.1365-2958.2007.05905.x; Gaballa A, 2013, MICROBIOL-SGM, V159, P2025, DOI 10.1099/mic.0.070482-0; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Gioia J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000928; Guo FB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-9; Hecker M, 2001, ADV MICROB PHYSIOL, V44, P35, DOI 10.1016/S0065-2911(01)44011-2; Hecker M, 2009, RES MICROBIOL, V160, P245, DOI 10.1016/j.resmic.2009.03.008; Hoi LT, 2006, PROTEOMICS, V6, P3582, DOI 10.1002/pmic.200500842; Homuth G, 1997, J BACTERIOL, V179, P1153, DOI 10.1128/jb.179.4.1153-1164.1997; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Ito M, 1999, J BACTERIOL, V181, P2394, DOI 10.1128/JB.181.8.2394-2402.1999; Kajiyama Y, 2007, J BACTERIOL, V189, P7511, DOI 10.1128/JB.00968-07; Kawai Y, 2003, MOL MICROBIOL, V47, P1113, DOI 10.1046/j.1365-2958.2003.03360.x; KEMPF B, 1995, J BIOL CHEM, V270, P16701, DOI 10.1074/jbc.270.28.16701; Kempf MJ, 2005, ASTROBIOLOGY, V5, P391, DOI 10.1089/ast.2005.5.391; Krishnamurthy M, 2010, NUCLEIC ACIDS RES, V38, P455, DOI 10.1093/nar/gkp909; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Leichert LIO, 2003, J BACTERIOL, V185, P1967, DOI 10.1128/JB.185.6.1967-1975.2003; LOVE PE, 1985, P NATL ACAD SCI USA, V82, P6201, DOI 10.1073/pnas.82.18.6201; Matsuoka H, 2007, J BIOL CHEM, V282, P5180, DOI 10.1074/jbc.M606831200; Miller MC, 1996, J BIOL CHEM, V271, P33502, DOI 10.1074/jbc.271.52.33502; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; PEREGO M, 1988, MOL MICROBIOL, V2, P689, DOI 10.1111/j.1365-2958.1988.tb00079.x; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Petersohn A, 1999, MOL GEN GENET, V262, P173, DOI 10.1007/s004380051072; Pothera DC, 2013, INT J MED MICROBIOL, V303, P114, DOI 10.1016/j.ijmm.2013.01.003; Pother DC, 2009, J BACTERIOL, V191, P7520, DOI 10.1128/JB.00937-09; Schroeter R, 2011, PROTEOMICS, V11, P2851, DOI 10.1002/pmic.201000461; Schweder T, 2004, ADV BIOCHEM ENG BIOT, V89, P47; Sharma SV, 2011, ANGEW CHEM INT EDIT, V50, P7101, DOI 10.1002/anie.201100196; SPECTOR A, 1988, J BIOL CHEM, V263, P4984; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Tu WY, 2012, J BACTERIOL, V194, P925, DOI 10.1128/JB.06005-11; Upton H, 2012, FEBS LETT, V586, P1004, DOI 10.1016/j.febslet.2012.02.028; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829; Voigt B, 2004, PROTEOMICS, V4, P1465, DOI 10.1002/pmic.200300684; VOLKER U, 1994, MICROBIOL-UK, V140, P741, DOI 10.1099/00221287-140-4-741; Wernersson R, 2007, NAT PROTOC, V2, P2677, DOI 10.1038/nprot.2007.370; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	69	36	37	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85625	10.1371/journal.pone.0085625	http://dx.doi.org/10.1371/journal.pone.0085625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465625	Green Published, gold			2022-12-25	WOS:000330240500061
J	Mokuwa, A; Nuijten, E; Okry, F; Teeken, B; Maat, H; Richards, P; Struik, PC				Mokuwa, Alfred; Nuijten, Edwin; Okry, Florent; Teeken, Bela; Maat, Harro; Richards, Paul; Struik, Paul C.			Processes Underpinning Development and Maintenance of Diversity in Rice in West Africa: Evidence from Combining Morphological and Molecular Markers	PLOS ONE			English	Article							ORYZA-SATIVA-L; CULTIVATED RICE; GENETIC DIVERSITY; UPLAND RICE; GLABERRIMA; ORIGIN; VARIETIES; GUINEA; PROGENIES; CROSSES	We assessed the interplay of artificial and natural selection in rice adaptation in low-input farming systems in West Africa. Using 20 morphological traits and 176 molecular markers, 182 farmer varieties of rice (Oryza spp.) from 6 West African countries were characterized. Principal component analysis showed that the four botanical groups (Oryza sativa ssp. indica, O. sativa ssp. japonica, O. glaberrima, and interspecific farmer hybrids) exhibited different patterns of morphological diversity. Regarding O. glaberrima, morphological and molecular data were in greater conformity than for the other botanical groups. A clear difference in morphological features was observed between O. glaberrima rices from the Togo hills and those from the Upper Guinea Coast, and among O. glaberrima rices from the Upper Guinea Coast. For the other three groups such clear patterns were not observed. We argue that this is because genetic diversity is shaped by different environmental and socio-cultural selection pressures. For O. glaberrima, recent socio-cultural selection pressures seemed to restrict genetic diversity while this was not observed for the other botanical groups. We also show that O. glaberrima still plays an important role in the selection practices of farmers and resulting variety development pathways. This is particularly apparent in the case of interspecific farmer hybrids where a relationship was found between pericarp colour, panicle attitude and genetic diversity. Farmer varieties are the product of long and complex trajectories of selection governed by local human agency. In effect, rice varieties have emerged that are adapted to West African farming conditions through genotype x environment x society interactions. The diversity farmers maintain in their rice varieties is understood to be part of a risk-spreading strategy that also facilitates successful and often serendipitous variety innovations. We advocate, therefore, that farmers and farmer varieties should be more effectively involved in crop development.	[Mokuwa, Alfred; Nuijten, Edwin; Okry, Florent; Teeken, Bela; Maat, Harro] Wageningen Univ, Knowledge Technol & Innovat Grp KTI, NL-6700 AP Wageningen, Netherlands; [Nuijten, Edwin] Louis Bolk Inst, Driebergen, Netherlands; [Okry, Florent] Africa Rice Ctr, Cotonou, Benin; [Richards, Paul] Njala Univ, Sch Environm Sci, Njala, Sierra Leone; [Struik, Paul C.] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; CGIAR; Africa Rice Center; Njala University; Wageningen University & Research	Struik, PC (corresponding author), Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands.	paul.struik@wur.nl	Maat, Harro/D-2142-2012	Maat, Harro/0000-0001-7338-7910; Richards, Paul/0000-0001-5813-0228; Teeken, Bela/0000-0002-3150-1532	NWO WOTRO (Science for Global Development, part of the Netherlands Organisation for Scientific Research); CSG (Centre for Society and Genomics); NUFFIC (Netherlands Organisation for International Cooperation in Higher Education); AfricaRice Center	NWO WOTRO (Science for Global Development, part of the Netherlands Organisation for Scientific Research); CSG (Centre for Society and Genomics); NUFFIC (Netherlands Organisation for International Cooperation in Higher Education); AfricaRice Center(CGIAR)	Funding was provided by NWO WOTRO (Science for Global Development, part of the Netherlands Organisation for Scientific Research), CSG (Centre for Society and Genomics), NUFFIC (Netherlands Organisation for International Cooperation in Higher Education) and AfricaRice Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amy EL, 1991, HORT SCI, V26, P334, DOI 10.21273/HORTSCI.26.4.334; Balasubramanian V, 2007, ADV AGRON, V94, P55, DOI 10.1016/S0065-2113(06)94002-4; Barry MB, 2007, GENET RESOUR CROP EV, V54, P1675, DOI 10.1007/s10722-006-9176-3; Barry MB, 2007, EUPHYTICA, V154, P127, DOI 10.1007/s10681-006-9278-1; Barry MB, 2008, GENET RESOUR CROP EV, V55, P723, DOI 10.1007/s10722-007-9280-z; Bioversity International IRRI & WARDA, 2007, DESCR WILD CULT RIC; CHANG TT, 1976, EUPHYTICA, V25, P425, DOI 10.1007/BF00041576; Chevalier A, 1932, REV BOT APPL, V136, P1014; Cox TS, 1999, AGROBIODIVERSITY: CHARACTERIZATION, UTILIZATION AND MANAGEMENT, P35; Dalton TJ, 2003, WORLD DEV, V31, P359, DOI 10.1016/S0305-750X(02)00189-4; DEKOCHKO A, 1987, EVOL TREND PLANT, V1, P105; Dingkuhn M, 1998, FIELD CROP RES, V57, P57, DOI 10.1016/S0378-4290(97)00115-9; Gross BL, 2010, J EVOLUTION BIOL, V23, P2747, DOI 10.1111/j.1420-9101.2010.02125.x; Harlan Jack R., 1976, ORIGINS AFRICAN PLAN, P3, DOI DOI 10.1515/9783110806373.465; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Jones MP, 1997, EUPHYTICA, V94, P237, DOI 10.1023/A:1002969932224; Jusu Malcolm, 1999, THESIS WAGENINGEN U; Li ZM, 2011, THEOR APPL GENET, V123, P21, DOI 10.1007/s00122-011-1563-2; Linares OF, 2002, P NATL ACAD SCI USA, V99, P16360, DOI 10.1073/pnas.252604599; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Mokuwa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0034801; Mouser B, 2012, COMMODITY ANTICOMMOD; Nuijten E, 2007, GENET RESOUR CROP EV, V54, P989, DOI 10.1007/s10722-006-9191-4; Nuijten E, 2011, PLANT GENET RESOUR-C, V9, P361, DOI 10.1017/S1479262110000481; Nuijten E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007335; Nuijten Edwin, 2005, THESIS WAGENINGEN U; Okry F, 2011, EXP AGR, V47, P137, DOI 10.1017/S001447971000089X; Okry Florent, 2011, PHD DISS; Olsen KM, 2001, AM J BOT, V88, P131, DOI 10.2307/2657133; PHAM JL, 1993, HEREDITY, V70, P466, DOI 10.1038/hdy.1993.68; Pham JL, 1996, HEREDITAS, V124, P179, DOI 10.1111/j.1601-5223.1996.00179.x; Porteres R., 1976, ORIGINS AFRICAN PLAN, P409, DOI DOI 10.1515/9783110806373.409; PORTERES ROLAND, 1950, AGRON TROP, V5, P489; Pusadee T, 2009, P NATL ACAD SCI USA, V106, P13880, DOI 10.1073/pnas.0906720106; Richards P., 1986, COPING HUNGER HAZARD; Roy SKS, 1996, J AGRON CROP SCI, V176, P79, DOI 10.1111/j.1439-037X.1996.tb00449.x; Saito K, 2009, FIELD CROP RES, V111, P243, DOI 10.1016/j.fcr.2008.12.011; SANO Y, 1989, HEREDITY, V63, P353, DOI 10.1038/hdy.1989.109; SANO Y, 1980, JPN J GENET, V55, P19, DOI 10.1266/jjg.55.19; SECOND G, 1982, JPN J GENET, V57, P25, DOI 10.1266/jjg.57.25; Second G, 1985, THESIS ORSTOM PARIS; Semon M, 2005, GENETICS, V169, P1639, DOI 10.1534/genetics.104.033175; Smith S, 2000, ENCOURAGING DIVERSITY, P175; Teeken B, 2012, HUM ECOL, V40, P879, DOI 10.1007/s10745-012-9528-x; WARDA (West African Rice Development Association-Africa Rice Center), 2004, WARDA ANN REP; WARDA (West African Rice Development Association-Africa Rice Center), 2003, WARDA ANN REP; Wood D, 1997, BIODIVERS CONSERV, V6, P109, DOI 10.1023/A:1018331800939; Wopereis MCS, 2013, REALIZING AFRICA'S RICE PROMISE, P1, DOI 10.1079/9781845938123.0000; YABUNO T, 1977, EUPHYTICA, V26, P451, DOI 10.1007/BF00027007	50	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85953	10.1371/journal.pone.0085953	http://dx.doi.org/10.1371/journal.pone.0085953			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465809	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500094
J	Oikonomou, G; Bicalho, ML; Meira, E; Rossi, RE; Foditsch, C; Machado, VS; Teixeira, AGV; Santisteban, C; Schukken, YH; Bicalho, RC				Oikonomou, Georgios; Bicalho, Marcela Lucas; Meira, Enoch; Rossi, Rodolfo Elke; Foditsch, Carla; Machado, Vinicius Silva; Teixeira, Andre Gustavo Vieira; Santisteban, Carlos; Schukken, Ynte Hein; Bicalho, Rodrigo Carvalho			Microbiota of Cow's Milk; Distinguishing Healthy, Sub-Clinically and Clinically Diseased Quarters	PLOS ONE			English	Article							SOMATIC-CELL COUNTS; COAGULASE-NEGATIVE STAPHYLOCOCCI; RIBOSOMAL-RNA SEQUENCES; MASTITIS PATHOGENS; DAIRY-COWS; IDENTIFICATION; BACTERIA; LIFE; HERD; LACTATION	The objective of this study was to use pyrosequencing of the 16S rRNA genes to describe the microbial diversity of bovine milk samples derived from clinically unaffected quarters across a range of somatic cell counts (SCC) values or from clinical mastitis, culture negative quarters. The obtained microbiota profiles were used to distinguish healthy, subclinically and clinically affected quarters. Two dairy farms were used for the collection of milk samples. A total of 177 samples were used. Fifty samples derived from healthy, culture negative quarters with a SCC of less than 20,000 cells/ml (group 1); 34 samples derived from healthy, culture negative quarters, with a SCC ranging from 21,000 to 50,000 cells/ml (group 2); 26 samples derived from healthy, culture negative quarters with a SCC greater than 50,000 cells/ml (group 3); 34 samples derived from healthy, culture positive quarters, with a SCC greater than 400,000 (group 4, subclinical); and 33 samples derived from clinical mastitis, culture negative quarters (group 5, clinical). Bacterial DNA was isolated from these samples and the 16S rRNA genes were individually amplified and pyrosequenced. All samples analyzed revealed great microbial diversity. Four bacterial genera were present in every sample obtained from healthy quarters (Faecalibacterium spp., unclassified Lachnospiraceae, Propionibacterium spp. and Aeribacillus spp.). Discriminant analysis models showed that samples derived from healthy quarters were easily discriminated based on their microbiota profiles from samples derived from clinical mastitis, culture negative quarters; that was also the case for samples obtained from different farms. Staphylococcus spp. and Streptococcus spp. were among the most prevalent genera in all groups while a general multivariable linear model revealed that Sphingobacterium and Streptococcus prevalences were associated with increased 10 log SCC. Conversely, Nocardiodes and Paenibacillus were negatively correlated, and a higher percentage of the genera was associated with a lower 10 log SCC.	[Oikonomou, Georgios; Bicalho, Marcela Lucas; Meira, Enoch; Rossi, Rodolfo Elke; Foditsch, Carla; Machado, Vinicius Silva; Teixeira, Andre Gustavo Vieira; Santisteban, Carlos; Schukken, Ynte Hein; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Schukken, Ynte H/C-3405-2008; Schukken, Ynte/ABD-3352-2021	Schukken, Ynte H/0000-0002-8250-4194; Schukken, Ynte/0000-0002-8250-4194; Rossi, Rodolfo/0000-0002-4776-1232				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bar D, 2008, J DAIRY SCI, V91, P2205, DOI 10.3168/jds.2007-0573; Boyer PJ, 1997, VET REC, V141, P55; Bradley AJ, 2007, VET REC, V160, P253, DOI 10.1136/vr.160.8.253; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Chen H, 2012, INT J SYST EVOL MICR, V62, P2835, DOI 10.1099/ijs.0.039636-0; Debois D, 2013, J AM SOC MASS SPECTR; Eberl G, 2009, MUCOSAL IMMUNOL, V2, P478, DOI 10.1038/mi.2009.114; Elad D, 2004, EMERG INFECT DIS, V10, P505, DOI 10.3201/eid1003.020592; Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Green MJ, 2004, J DAIRY SCI, V87, P1256, DOI 10.3168/jds.S0022-0302(04)73276-2; Grohn YT, 2005, PREV VET MED, V71, P105, DOI 10.1016/j.prevetmed.2005.06.002; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hertl JA, 2010, J DAIRY SCI, V93, P1551, DOI 10.3168/jds.2009-2599; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Jara S, 2011, ANAEROBE, V17, P474, DOI 10.1016/j.anaerobe.2011.07.008; Jost T, 2013, BR J NUTR, P1; Koskinen MT, 2010, J DAIRY SCI, V93, P5707, DOI 10.3168/jds.2010-3167; Kuehn JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061959; Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805; Li MJ, 2012, VET MICROBIOL, V155, P72, DOI 10.1016/j.vetmic.2011.08.007; Luthje P, 2006, J ANTIMICROB CHEMOTH, V57, P966, DOI 10.1093/jac/dk1061; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Norman HD, 2000, J DAIRY SCI, V83, P2782, DOI 10.3168/jds.S0022-0302(00)75175-7; Oikonomou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047671; Peeler EJ, 2003, PREV VET MED, V59, P169, DOI 10.1016/S0167-5877(03)00076-X; Pyorala S, 2009, VET MICROBIOL, V134, P3, DOI 10.1016/j.vetmic.2008.09.015; Ranieri ML, 2012, APPL ENVIRON MICROB, V78, P5855, DOI 10.1128/AEM.01361-12; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; ROBERSON JR, 1994, J DAIRY SCI, V77, P3354, DOI 10.3168/jds.S0022-0302(94)77277-5; Rozen S, 2000, Methods Mol Biol, V132, P365; Schepers AJ, 1997, J DAIRY SCI, V80, P1833, DOI 10.3168/jds.S0022-0302(97)76118-6; Schukken YH, 2003, VET RES, V34, P579, DOI 10.1051/vetres:2003028; Shome BR, 2011, J APPL MICROBIOL, V111, P1349, DOI 10.1111/j.1365-2672.2011.05169.x; Shu MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055380; Suriyasathaporn W, 2000, J DAIRY SCI, V83, P1248, DOI 10.3168/jds.S0022-0302(00)74991-5; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Zadoks RN, 2005, VET MICROBIOL, V109, P257, DOI 10.1016/j.vetmic.2005.05.008; Zadoks RN, 2011, J MAMMARY GLAND BIOL, V16, P357, DOI 10.1007/s10911-011-9236-y	42	130	133	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85904	10.1371/journal.pone.0085904	http://dx.doi.org/10.1371/journal.pone.0085904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465777	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500086
J	Potokar, M; Korva, M; Jorgacevski, J; Avsic-Zupanc, T; Zorec, R				Potokar, Maja; Korva, Misa; Jorgacevski, Jernej; Avsic-Zupanc, Tatjana; Zorec, Robert			Tick-Borne Encephalitis Virus Infects Rat Astrocytes but Does Not Affect Their Viability	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; HEPARAN-SULFATE PROTEOGLYCANS; ENDOCYTIC PATHWAY; VESICLE MOBILITY; DENGUE-VIRUS; MEDIATED ENDOCYTOSIS; ENDOTHELIAL-CELLS; WEST-NILE; IN-VIVO; ENTRY	Tick-borne encephalitis virus (TBEV) causes one of the most dangerous human neuroinfections in Europe and Asia. To infect neurons it must cross the blood-brain-barrier (BBB), and presumably also cells adjacent to the BBB, such as astrocytes, the most abundant glial cell type. However, the knowledge about the viral infection of glial cells is fragmental. Here we studied whether TBEV infects rat astrocytes. Rats belong to an animal group serving as a TBEV amplifying host. We employed high resolution quantitative fluorescence microscopy to investigate cell entry and cytoplasmic mobility of TBEV particles along with the effect on the cell cytoskeleton and cell survival. We report that infection of astrocytes with TBEV increases with time of exposure to TBEV and that with post-infection time TBEV particles gained higher mobility. After several days of infection actin cytoskeleton was affected, but cell survival was unchanged, indicating that rat astrocytes resist TBEV-mediated cell death, as reported for other mammalian cells. Therefore, astrocytes may present an important pool of dormant TBEV infections and a new target for therapeutic intervention.	[Potokar, Maja; Jorgacevski, Jernej; Zorec, Robert] Celica Biomed Ctr, Ljubljana, Slovenia; [Potokar, Maja; Jorgacevski, Jernej; Zorec, Robert] Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Ljubljana, Slovenia; [Korva, Misa; Avsic-Zupanc, Tatjana] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Avsic-Zupanc, T (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	tatjana.avsic@mf.uni-lj.si; robert.zorec@mf.uni-lj.si	Zorec, Robert/AAD-7180-2021; JORGACEVSKI, JERNEJ/AAH-5425-2019; Favoreel, Herman/H-8712-2013	Zorec, Robert/0000-0002-7478-3875; JORGACEVSKI, JERNEJ/0000-0003-3550-2011; Korva, Misa/0000-0003-1501-1004; AVSIC ZUPANC, TATJANA/0000-0001-6243-0688; Favoreel, Herman/0000-0003-4993-6857	EVA (EC) [228292];  [P3 310];  [J3 0133];  [J3 4146];  [P 4051];  [P3 0083]	EVA (EC); ; ; ; ; 	This work was supported by grants P3 310, J3 0133, J3 4146, P 4051, P3 0083 (http://www.arrs.gov.si/en/dobrodoslica.asp), EVA (EC Grant Agreement no228292)(http://www.european-virus-archive.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Achazi K, 2011, VECTOR-BORNE ZOONOT, V11, P641, DOI 10.1089/vbz.2010.0236; Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; AVSICZUPANC T, 1995, CLIN DIAGN VIROL, V4, P51, DOI 10.1016/0928-0197(94)00062-Y; Bernacki J, 2008, PHARMACOL REP, V60, P600; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Carmignoto G, 2010, BRAIN RES REV, V63, P138, DOI 10.1016/j.brainresrev.2009.11.007; Chambers TJ, 2003, ADV VIRUS RES, V60, P273, DOI 10.1016/S0065-3527(03)60008-4; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chu JJH, 2006, VIROLOGY, V349, P463, DOI 10.1016/j.virol.2006.01.022; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Greene W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000512; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Grummer B, 2004, J VET MED B, V51, P427, DOI 10.1111/j.1439-0450.2004.00798.x; Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hung SL, 1999, VIROLOGY, V257, P156, DOI 10.1006/viro.1999.9633; Knap N, 2012, VECTOR-BORNE ZOONOT, V12, P236, DOI 10.1089/vbz.2011.0728; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P54, DOI 10.1016/j.chom.2012.10.021; Kozlovskaya LI, 2010, VIROLOGY, V398, P262, DOI 10.1016/j.virol.2009.12.012; Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Mandl CW, 2005, VIRUS RES, V111, P161, DOI 10.1016/j.virusres.2005.04.007; Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MARTIN DL, 1992, GLIA, V5, P81, DOI 10.1002/glia.440050202; Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; NIEDRIG M, 1994, ACTA VIROL, V38, P141; Pangrsic T, 2006, J NEUROCHEM, V99, P514, DOI 10.1111/j.1471-4159.2006.04042.x; Parpura V., 2010, NEUROCHEM INT; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008; Potokar M, 2005, BIOCHEM BIOPH RES CO, V329, P678, DOI 10.1016/j.bbrc.2005.02.030; Potokar M, 2008, GLIA, V56, P135, DOI 10.1002/glia.20597; Potokar M, 2007, TRAFFIC, V8, P12, DOI 10.1111/j.1600-0854.2006.00509.x; Potokar M, 2012, GLIA, V60, P594, DOI 10.1002/glia.22293; Potokar M, 2011, HISTOL HISTOPATHOL, V26, P277, DOI 10.14670/HH-26.277; Potokar M, 2010, GLIA, V58, P1208, DOI 10.1002/glia.21000; Properzi F, 2008, EUR J NEUROSCI, V27, P593, DOI 10.1111/j.1460-9568.2008.06042.x; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Ruzek D, 2008, VIRUS RES, V137, P142, DOI 10.1016/j.virusres.2008.05.013; Ruzek D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020472; Ruzek D, 2009, J GEN VIROL, V90, P1649, DOI 10.1099/vir.0.010058-0; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; SCHWARTZ JP, 1992, GLIA, V5, P75, DOI 10.1002/glia.440050111; Senigl F, 2006, INTERVIROLOGY, V49, P239, DOI 10.1159/000091471; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; Stenovec M, 2007, EXP CELL RES; Studahl M, 2000, J NEUROL, V247, P636, DOI 10.1007/s004150070134; TAOCHENG JH, 1987, J NEUROSCI, V7, P3293; Tonteri E, 2011, EMERG INFECT DIS, V17, P72, DOI 10.3201/eid1701.100051; Trkov S, 2012, GLIA, V60, P1406, DOI 10.1002/glia.22361; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Vaughan JC, 2009, BIOPHYS J, V97, P1647, DOI 10.1016/j.bpj.2009.07.011; WOLBURG H, 1994, J CELL SCI, V107, P1347; Zorec R, 2012, ASN NEURO, V4, P103, DOI 10.1042/AN20110061	66	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86219	10.1371/journal.pone.0086219	http://dx.doi.org/10.1371/journal.pone.0086219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465969	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500121
J	Azcarate, IG; Marin-Garcia, P; Kamali, AN; Perez-Benavente, S; Puyet, A; Diez, A; Bautista, JM				Azcarate, Isabel G.; Marin-Garcia, Patricia; Kamali, Ali N.; Perez-Benavente, Susana; Puyet, Antonio; Diez, Amalia; Bautista, Jose M.			Differential Immune Response Associated to Malaria Outcome Is Detectable in Peripheral Blood following Plasmodium yoelii Infection in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; B-CELLS; IN-VITRO; PROTECTIVE IMMUNITY; KNOWLESI MEROZOITES; ACQUIRED-IMMUNITY; DENDRITIC CELLS; B-1 CELLS; FALCIPARUM; PARASITE	Malaria infection in humans elicits a wide range of immune responses that can be detected in peripheral blood, but we lack detailed long-term follow-up data on the primary and subsequent infections that lead to naturally acquired immunity. Studies on antimalarial immune responses in mice have been based on models yielding homogenous infection profiles. Here, we present a mouse model in which a heterogeneous course of Plasmodium yoelii lethal malaria infection is produced in a non-congenic ICR strain to allow comparison among different immunological and clinical outcomes. Three different disease courses were observed ranging from a fatal outcome, either early or late, to a self-resolved infection that conferred long-term immunity against re-infection. Qualitative and quantitative changes produced in leukocyte subpopulations and cytokine profiles detected in peripheral blood during the first week of infection revealed that monocytes, dendritic cells and immature B cells were the main cell subsets present in highly-parasitized mice dying in the first week after infection. Besides, CD4(+)CD25(high) T cells expanded at an earlier time point in early deceased mice than in surviving mice and expressed higher levels of intracellular Foxp3 protein. In contrast, survivors showed a limited increase of cytokines release and stable circulating innate cells. From the second week of infection, mice that would die or survive showed similar immune profiles, although CD4(+)CD25(high) T cells number increased earlier in mice with the worst prognosis. In surviving mice the expansion of activated circulating T cell and switched-class B cells with a long-term protective humoral response from the second infection week is remarkable. Our results demonstrate that the follow-up studies of immunological blood parameters during a malaria infection can offer information about the course of the pathological process and the immune response.	[Azcarate, Isabel G.; Marin-Garcia, Patricia; Kamali, Ali N.; Perez-Benavente, Susana; Puyet, Antonio; Diez, Amalia; Bautista, Jose M.] Univ Complutense Madrid, Fac Vet, Dept Biochem & Mol Biol 4, Madrid, Spain; [Azcarate, Isabel G.; Puyet, Antonio; Diez, Amalia; Bautista, Jose M.] Univ Hosp 12 Octubre, Res Inst Hosp 12 Octubre, Madrid, Spain	Complutense University of Madrid; Hospital Universitario 12 de Octubre	Bautista, JM (corresponding author), Univ Complutense Madrid, Fac Vet, Dept Biochem & Mol Biol 4, Ciudad Univ, Madrid, Spain.	jmbau@ucm.es	Bautista, José M./B-7899-2013; Marin-Garcia, Patricia/I-5497-2014; Diez, Amalia/I-4852-2014; Gonzalez Azcarate, Isabel/I-4856-2014; Diez, Amalia/AAG-4274-2021; Kamali, Ali/AAO-2926-2021; Puyet, Antonio/I-4720-2014	Bautista, José M./0000-0001-8926-881X; Marin-Garcia, Patricia/0000-0002-2168-6668; Diez, Amalia/0000-0002-2619-9252; Gonzalez Azcarate, Isabel/0000-0003-4545-1254; Diez, Amalia/0000-0002-2619-9252; Puyet, Antonio/0000-0002-2026-7955; Kamali, Ali Naghi/0000-0002-6225-9726	Spanish Ministry of Innovation and Science [BIO2010-17039, BIO2007-67885]; Programme of Consolidated Research Teams from the UCM-Comunidad de Madrid [920267]	Spanish Ministry of Innovation and Science(Spanish Government); Programme of Consolidated Research Teams from the UCM-Comunidad de Madrid	This work was supported by the Spanish Ministry of Innovation and Science (grant BIO2010-17039) and by the Programme of Consolidated Research Teams from the UCM-Comunidad de Madrid (Research Team 920267). I. G. A. holds a fellowship awarded by the Spanish Ministry of Innovation and Science (grant BIO2007-67885). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; ALLMAN DM, 1992, J IMMUNOL, V149, P2533; Ardavin C, 1999, J IMMUNOL, V162, P2538; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Benschop RJ, 1999, J EXP MED, V190, P749, DOI 10.1084/jem.190.6.749; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Chandele A, 2011, IMMUNOLOGY, V132, P273, DOI 10.1111/j.1365-2567.2010.03363.x; Chen G, 2009, PARASITOLOGY, V136, P1107, DOI 10.1017/S0031182009990370; Chung JB, 2003, TRENDS IMMUNOL, V24, P343, DOI 10.1016/S1471-4906(03)00119-4; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Couper KN, 2007, INFECT IMMUN, V75, P5806, DOI 10.1128/IAI.01005-07; Cox-Singh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020541; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; EPSTEIN N, 1981, J IMMUNOL, V127, P212; FERRANTE A, 1990, IMMUNOL LETT, V25, P179, DOI 10.1016/0165-2478(90)90112-4; Finney CAM, 2007, EUR J IMMUNOL, V37, P1874, DOI 10.1002/eji.200636751; FREEMAN RR, 1981, EXP PARASITOL, V52, P18, DOI 10.1016/0014-4894(81)90056-4; Good MF, 2011, NAT MED, V17, P49, DOI 10.1038/nm0111-49; GREY HM, 1971, J EXP MED, V133, P289, DOI 10.1084/jem.133.2.289; GROUX H, 1990, RES IMMUNOL, V141, P529, DOI 10.1016/0923-2494(90)90021-P; Helmby H, 2000, INFECT IMMUN, V68, P1485, DOI 10.1128/IAI.68.3.1485-1490.2000; Hisaeda H, 2005, INT J BIOCHEM CELL B, V37, P700, DOI 10.1016/j.biocel.2004.10.009; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Imai T, 2010, EUR J IMMUNOL, V40, P1053, DOI 10.1002/eji.200939525; JAYAWARDENA AN, 1978, IMMUNOLOGY, V34, P157; Kamali AN, 2012, IMMUNOBIOLOGY, V217, P823, DOI 10.1016/j.imbio.2012.05.002; Kanda Y, 2010, CELL IMMUNOL, V263, P49, DOI 10.1016/j.cellimm.2010.02.015; Kawabe S, 2004, CLIN EXP IMMUNOL, V135, P200, DOI 10.1111/j.1365-2249.2003.02361.x; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinyanjui SM, 2004, J INFECT DIS, V190, P1527, DOI 10.1086/424675; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; LANGHORNE J, 1991, J IMMUNOL, V146, P2771; Li C, 2001, MED MICROBIOL IMMUN, V189, P115, DOI 10.1007/s430-001-8017-8; LISSE IM, 1994, T ROY SOC TROP MED H, V88, P709, DOI 10.1016/0035-9203(94)90242-9; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; LUNEL F, 1989, INFECT IMMUN, V57, P2043, DOI 10.1128/IAI.57.7.2043-2049.1989; Luyendyk J, 2002, INFECT IMMUN, V70, P2941, DOI 10.1128/IAI.70.6.2941-2949.2002; MASUZAWA T, 1994, J CLIN INVEST, V94, P1090, DOI 10.1172/JCI117424; MILLER LH, 1975, J IMMUNOL, V114, P1237; Moneriz C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-103; Nduati EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015007; Perlmann P, 2002, CHEM IMMUNOL, V80, P229; Petritus PM, 2008, J IMMUNOL, V180, P444, DOI 10.4049/jimmunol.180.1.444; Sagaert X, 2007, LEUKEMIA, V21, P1378, DOI 10.1038/sj.leu.2404737; Sakaguchi S, 2007, EUR J IMMUNOL, V37, pS116, DOI 10.1002/eji.200737593; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; Sanni Latifu A, 2002, Methods Mol Med, V72, P57, DOI 10.1385/1-59259-271-6:57; Scholzen A, 2010, TRENDS PARASITOL, V26, P16, DOI 10.1016/j.pt.2009.10.004; Schwarzer E, 1998, INFECT IMMUN, V66, P1601, DOI 10.1128/IAI.66.4.1601-1606.1998; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Singh B, 2000, MICROBES INFECT, V2, P473, DOI 10.1016/S1286-4579(00)00321-X; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Stevenson MM, 2011, INT J BIOL SCI, V7, P1311, DOI 10.7150/ijbs.7.1311; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; STEVENSON MM, 1993, CLIN EXP IMMUNOL, V92, P77, DOI 10.1111/j.1365-2249.1993.tb05951.x; Tachikawa S, 2008, CLIN EXP IMMUNOL, V153, P448, DOI 10.1111/j.1365-2249.2008.03709.x; Taylor MD, 2005, J IMMUNOL, V174, P4924, DOI 10.4049/jimmunol.174.8.4924; Taylor-Robinson AW, 1998, SCAND J IMMUNOL, V48, P527; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; Urban Britta C, 2006, J Biol, V5, P4, DOI 10.1186/jbiol37; VINETZ JM, 1990, J IMMUNOL, V144, P1069; vonderWeid T, 1996, J IMMUNOL, V156, P2510; Wang QH, 2009, EXP PARASITOL, V121, P268, DOI 10.1016/j.exppara.2008.11.013; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Weaver JL, 2002, TOXICOL MECH METHOD, V12, P95, DOI 10.1080/10517230290075341; WEINBAUM FI, 1976, J IMMUNOL, V117, P1999; WHITE WI, 1991, INFECT IMMUN, V59, P3547, DOI 10.1128/IAI.59.10.3547-3554.1991; Witney AA, 2001, MOL BIOCHEM PARASIT, V118, P233, DOI 10.1016/S0166-6851(01)00372-3; Worku S, 1997, CLIN EXP IMMUNOL, V108, P34, DOI 10.1046/j.1365-2249.1997.d01-981.x; Wu Y, 2007, EXP PARASITOL, V115, P301, DOI 10.1016/j.exppara.2006.09.015; Wykes MN, 2007, PLOS PATHOG, V3, P904, DOI 10.1371/journal.ppat.0030096	86	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85664	10.1371/journal.pone.0085664	http://dx.doi.org/10.1371/journal.pone.0085664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465641	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000021
J	Costa, A; Monaco, M; Zabberoni, S; Peppe, A; Perri, R; Fadda, L; Iannarelli, F; Caltagirone, C; Carlesimo, GA				Costa, Alberto; Monaco, Marco; Zabberoni, Silvia; Peppe, Antonella; Perri, Roberta; Fadda, Lucia; Iannarelli, Francesca; Caltagirone, Carlo; Carlesimo, Giovanni A.			Free and Cued Recall Memory in Parkinson's Disease Associated with Amnestic Mild Cognitive Impairment	PLOS ONE			English	Article							VERBAL MEMORY; DIAGNOSTIC-CRITERIA; RECOGNITION MEMORY; ALZHEIMERS-DISEASE; NORMATIVE DATA; DEMENTIA; RECOLLECTION; MULTICENTER; RELIABILITY; DEFICIT	The hypothesis has been advanced that memory disorders in individuals with Parkinson's disease (PD) are related to either retrieval or consolidation failure. However, the characteristics of the memory impairments of PD patients with amnestic mild cognitive impairment have not been clarified. This study was aimed at investigating whether memory deficits in PD patients with amnestic mild cognitive impairment (PDaMCI) are due to failure of retrieval or consolidation processes. Sixteen individuals with PDaMCI, 20 with amnestic mild cognitive impairment without PD (aMCINPD), and 20 healthy controls were recruited. Participants were administered the Free and Cued Selective Reminding Test. An index of cueing was computed for each subject to capture the advantage in retrieval of cued compared to free recall. Individuals with PDaMCI performed worse than healthy controls on the free recall (p<0.01) but not the cued recall (p>0.10) task, and they performed better than aMCINPD subjects on both recall measures (p<0.01). The index of cueing of subjects with PD was comparable to that of healthy controls (p>0.10) but it was significantly higher than that of the aMCINPD sample (p<0.01). Moreover, PD patients' performance on free recall trials was significantly predicted by scores on a test investigating executive functions (i.e., the Modified Card Sorting Test; p = 0.042). Findings of the study document that, in subjects with amnestic mild cognitive impairment associated to PD, episodic memory impairment is related to retrieval rather than to consolidation failure. The same data suggest that, in these individuals, memory deficits might be due to altered frontal-related executive functioning.	[Costa, Alberto; Monaco, Marco; Zabberoni, Silvia; Peppe, Antonella; Perri, Roberta; Fadda, Lucia; Iannarelli, Francesca; Caltagirone, Carlo; Carlesimo, Giovanni A.] IRCCS Fdn S Lucia, Behav & Clin Neurol Lab, Rome, Italy; [Fadda, Lucia; Caltagirone, Carlo; Carlesimo, Giovanni A.] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata	Costa, A (corresponding author), IRCCS Fdn S Lucia, Behav & Clin Neurol Lab, Rome, Italy.	a.costa@hsantalucia.it	Costa, Alberto/AAA-7038-2019; Zabberoni, Silvia/J-7799-2016; Peppe, Antonella/AAB-7903-2019	Zabberoni, Silvia/0000-0001-8061-0738; COSTA, Alberto/0000-0002-4784-5524; Fadda, Lucia/0000-0003-0659-9416				Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beyer MK, 2013, J NEUROL NEUROSUR PS, V84, P23, DOI 10.1136/jnnp-2012-303054; Buschke H, 1997, NEUROLOGY, V48, P989, DOI 10.1212/WNL.48.4.989; Capasso R., 2001, ESAME NEUROPSICOLOGI; Carlesimo G., 2002, NUOVA RIV NEUROL, V12, P1, DOI DOI 10.1080/17408989.2016.1268591; Carlesimo GA, 2012, NEUROLOGY, V78, P1939, DOI 10.1212/WNL.0b013e318259e1c5; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Cohn M, 2010, NEUROPSYCHOLOGIA, V48, P4142, DOI 10.1016/j.neuropsychologia.2010.10.013; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cummings JL, 2013, MED CLIN N AM, V97, P363, DOI 10.1016/j.mcna.2013.01.001; Davidson PSR, 2006, BRAIN, V129, P1768, DOI 10.1093/brain/awl115; Drago V, 2011, J ALZHEIMERS DIS, V26, P159, DOI 10.3233/JAD-2011-0043; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Dujardin K, 2003, CURR OPIN NEUROL, V16, pS11, DOI 10.1097/00019052-200312002-00003; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Higginson CI, 2005, J CLIN EXP NEUROPSYC, V27, P516, DOI 10.1080/13803390490515469; Higginson CI, 2003, BRAIN COGNITION, V52, P343, DOI 10.1016/S0278-2626(03)00180-5; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Janvin CC, 2006, MOVEMENT DISORD, V21, P337, DOI 10.1002/mds.20726; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Leentjens AFG, 2008, MOVEMENT DISORD, V23, P2004, DOI 10.1002/mds.22229; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823; MacDonald P.A., 2011, PARKINSONS DIS-US, V2011, DOI DOI 10.4061/2011/572743; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; Monaco M, 2013, NEUROL SCI, V34, P749, DOI 10.1007/s10072-012-1130-x; Nocentini U., 2002, NUOVA RIV NEUROL, V12, P13; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Saka E, 2009, PARKINSONISM RELAT D, V15, P688, DOI 10.1016/j.parkreldis.2009.04.008; Sarazin M, 2007, NEUROLOGY, V69, P1859, DOI 10.1212/01.wnl.0000279336.36610.f7; Stewart CC, 2009, BRAIN COGNITION, V69, P65, DOI 10.1016/j.bandc.2008.05.005; Svenningsson P, 2012, LANCET NEUROL, V11, P697, DOI 10.1016/S1474-4422(12)70152-7; Visser M, 2006, MOVEMENT DISORD, V21, P668, DOI 10.1002/mds.20792; Weintraub Daniel, 2004, Cogn Behav Neurol, V17, P195; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; YETERIAN EH, 1991, J COMP NEUROL, V312, P43, DOI 10.1002/cne.903120105	46	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86233	10.1371/journal.pone.0086233	http://dx.doi.org/10.1371/journal.pone.0086233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465977	gold, Green Submitted, Green Published			2022-12-25	WOS:000330288000068
J	Ferenczi, MA; Bershitsky, SY; Koubassova, NA; Kopylova, GV; Fernandez, M; Narayanan, T; Tsaturyan, AK				Ferenczi, Michael A.; Bershitsky, Sergey Y.; Koubassova, Natalia A.; Kopylova, Galina V.; Fernandez, Manuel; Narayanan, Theyencheri; Tsaturyan, Andrey K.			Why Muscle is an Efficient Shock Absorber	PLOS ONE			English	Article							X-RAY-DIFFRACTION; FROG SKELETAL-MUSCLE; FORCE GENERATION; MYOSIN HEADS; ISOMETRIC CONTRACTION; SINGLE FIBERS; INSECT FLIGHT; MECHANISM; RABBIT; ACTIN	Skeletal muscles power body movement by converting free energy of ATP hydrolysis into mechanical work. During the landing phase of running or jumping some activated skeletal muscles are subjected to stretch. Upon stretch they absorb body energy quickly and effectively thus protecting joints and bones from impact damage. This is achieved because during lengthening, skeletal muscle bears higher force and has higher instantaneous stiffness than during isometric contraction, and yet consumes very little ATP. We wish to understand how the actomyosin molecules change their structure and interaction to implement these physiologically useful mechanical and thermodynamical properties. We monitored changes in the low angle x-ray diffraction pattern of rabbit skeletal muscle fibers during ramp stretch compared to those during isometric contraction at physiological temperature using synchrotron radiation. The intensities of the off-meridional layer lines and fine interference structure of the meridional M3 myosin x-ray reflection were resolved. Mechanical and structural data show that upon stretch the fraction of actin-bound myosin heads is higher than during isometric contraction. On the other hand, the intensities of the actin layer lines are lower than during isometric contraction. Taken together, these results suggest that during stretch, a significant fraction of actin-bound heads is bound non-stereo-specifically, i.e. they are disordered azimuthally although stiff axially. As the strong or stereo-specific myosin binding to actin is necessary for actin activation of the myosin ATPase, this finding explains the low metabolic cost of energy absorption by muscle during the landing phase of locomotion.	[Ferenczi, Michael A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Ferenczi, Michael A.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Bershitsky, Sergey Y.; Kopylova, Galina V.] Russian Acad Sci, Ural Branch, Inst Immunol & Physiol, Ekaterinburg, Russia; [Koubassova, Natalia A.; Tsaturyan, Andrey K.] Moscow MV Lomonosov State Univ, Inst Mech, Moscow, Russia; [Fernandez, Manuel; Narayanan, Theyencheri] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Imperial College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Institute of Immunology & Physiology UB RAS; Russian Academy of Sciences; Lomonosov Moscow State University; European Synchrotron Radiation Facility (ESRF)	Ferenczi, MA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	m.ferenczi@ntu.edu.sg	Tsaturyan, Andrey/GXF-8722-2022; Tsaturyan, Andrey K/B-1037-2014; Kopylova, Galina/ABF-2117-2020; Bershitsky, Sergey/AAE-6814-2019; Ferenczi, Michael/F-9510-2015; Koubassova, Natalia/AAI-6490-2021; Bershitsky, Sergey/S-4829-2016	Tsaturyan, Andrey K/0000-0002-0447-7725; Kopylova, Galina/0000-0003-2976-2108; Ferenczi, Michael/0000-0002-0349-331X; Koubassova, Natalia/0000-0002-0238-4920; Bershitsky, Sergey/0000-0001-5342-1739; Narayanan, Theyencheri/0000-0003-1957-1041	Russian Foundation for Basic Research (RFBR) [11-04-00908, 11-04-00750]; Presidium of the Russian Academy of Sciences; Medical Research Council (UK) [G0501704]; EBSA Travel Fellowship; Royal Society Travel award; MRC [G0501704] Funding Source: UKRI; Medical Research Council [G0501704] Funding Source: researchfish	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EBSA Travel Fellowship; Royal Society Travel award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Russian Foundation for Basic Research (RFBR) grants 11-04-00908 to A. K. T. and 11-04-00750 to S.Y.B., by the Presidium of the Russian Academy of Sciences to S. Y. B., by the Medical Research Council (UK) G0501704 to M. A. F, by an EBSA Travel Fellowship to G. V. K., and by a Royal Society Travel award to N.A.K. and A. K. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bershitsky SY, 2009, FRONT BIOSCI-LANDMRK, V14, P3188, DOI 10.2741/3444; Bershitsky SY, 2002, J PHYSIOL-LONDON, V540, P971, DOI 10.1113/jphysiol.2001.013483; BERSHITSKY SY, 1995, BIOPHYS J, V69, P1011, DOI 10.1016/S0006-3495(95)79976-3; Bickham DC, 2011, BIOPHYS J, V101, P2445, DOI 10.1016/j.bpj.2011.10.007; Brunello E, 2007, P NATL ACAD SCI USA, V104, P20114, DOI 10.1073/pnas.0707626104; COOKE R, 1980, BIOCHEMISTRY-US, V19, P2265, DOI 10.1021/bi00551a042; COOKE R, 1986, CRIT REV BIOCHEM MOL, V21, P53, DOI 10.3109/10409238609113609; Curtin N A, 1975, J Mechanochem Cell Motil, V3, P147; Ferenczi MA, 2005, STRUCTURE, V13, P131, DOI 10.1016/j.str.2004.11.007; Fusi L, 2010, J PHYSIOL-LONDON, V588, P495, DOI 10.1113/jphysiol.2009.178137; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Herzog W, 2013, J APPL PHYSIOL; Holmes KC, 1997, CURR BIOL, V7, pR112, DOI 10.1016/S0960-9822(06)00051-0; HUXLEY HE, 1983, J MOL BIOL, V169, P469, DOI 10.1016/S0022-2836(83)80062-X; Koubassova NA, 2008, BIOPHYS J, V95, P2880, DOI 10.1529/biophysj.107.120832; Kubasova N A, 2009, Mol Biol (Mosk), V43, P689; Linari M, 2000, J PHYSIOL-LONDON, V526, P589, DOI 10.1111/j.1469-7793.2000.00589.x; Linari M, 2000, P NATL ACAD SCI USA, V97, P7226, DOI 10.1073/pnas.97.13.7226; Linari M, 1998, BIOPHYS J, V74, P2459, DOI 10.1016/S0006-3495(98)77954-8; Linari M, 2003, J PHYSIOL-LONDON, V548, P461, DOI 10.1113/jphysiol.2002.032185; Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549; LOMBARDI V, 1990, J PHYSIOL-LONDON, V431, P141, DOI 10.1113/jphysiol.1990.sp018324; LOVELL SJ, 1981, NATURE, V293, P664, DOI 10.1038/293664a0; MALINCHIK SB, 1992, J MUSCLE RES CELL M, V13, P406, DOI 10.1007/BF01738036; PIAZZESI G, 1992, J PHYSIOL-LONDON, V445, P659, DOI 10.1113/jphysiol.1992.sp018945; Piazzesi G, 2003, J PHYSIOL-LONDON, V549, P93, DOI 10.1113/jphysiol.2002.038703; Piazzesi G, 2002, NATURE, V415, P659, DOI 10.1038/415659a; Taylor KA, 1999, CELL, V99, P421, DOI 10.1016/S0092-8674(00)81528-7; Tsaturyan AK, 2011, BIOPHYS J, V101, P404, DOI 10.1016/j.bpj.2011.06.008	29	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85739	10.1371/journal.pone.0085739	http://dx.doi.org/10.1371/journal.pone.0085739			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465673	Green Published, gold			2022-12-25	WOS:000330288000022
J	Gu, LH; Xu, TS; Huang, W; Xie, M; Sun, SD; Hou, SS				Gu, Lihong; Xu, Tieshan; Huang, Wei; Xie, Ming; Sun, Shiduo; Hou, Shuisheng			Identification and Profiling of MicroRNAs in the Embryonic Breast Muscle of Pekin Duck	PLOS ONE			English	Article							SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; EXPRESSION; GROWTH; MIR-206; PROTEIN; PROLIFERATION; MECHANISMS; MIRNAS; LEPTIN	MicroRNAs (miRNAs) regulate gene expression by fully or partially binding to complementary sequences and play important roles in skeletal muscle development. However, the roles of miRNAs in embryonic breast muscle of duck are unclear. In this study, we analyzed the miRNAs profiling in embryonic breast muscle of Pekin duck at E13 (the 13th day of hatching), E19, and E27 by high-throughput sequencing. A total of 382 miRNAs including 359 preciously identified miRNAs 23 novel miRNA candidates were obtained. The nucleotide bias analysis of identified miRNAs showed that the miRNAs in Pekin duck was high conserved. The expression of identified miRNAs were significantly different between E13 and E19 as well as between E27 and E19. Fifteen identified miRNAs validated using stem-loop qRT-PCR can be divided into three groups: those with peak expression at E19, those with minimal expression at E19, and those with continuous increase from E11 to E27. Considering that E19 is the fastest growth stage of embryonic Pekin duck breast muscle, these three groups of miRNAs might be the potential promoters, the potential inhibitors, and the potential sustainer for breast muscle growth. Among the 23 novel miRNAs, novel-miRNA-8 and novel-miRNA-14 had maximal expression at some stages. The stem-loop qRT-PCR analysis of the two novel miRNAs and their two targets (MAP2K1 and PPAR alpha) showed that the expression of novel-mir-8 and PPAR alpha reached the lowest points at E19, while that of novel-mir-14 and MAP2K1 peaked at E19, suggesting novel-miRNA-8 and novel-miRNA-14 may be a potential inhibitor and a potential promoter for embryonic breast muscle development of duck. In summary, these results not only provided an overall insight into the miRNAs landscape in embryonic breast muscle of duck, but also a basis for the further investigation of the miRNAs roles in duck skeletal muscle development.	[Gu, Lihong; Xu, Tieshan; Sun, Shiduo] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Gu, Lihong; Xu, Tieshan; Huang, Wei; Xie, Ming; Hou, Shuisheng] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Sun, SD (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	sunshiduo2008@yeah.net; houss2010@126.com			Shaanxi pig Industry Technology System [K332021221]; earmarked fund for China Agriculture Research System [CARS-43-1]	Shaanxi pig Industry Technology System; earmarked fund for China Agriculture Research System	Financial support was provided by "The Shaanxi pig Industry Technology System (K332021221)", and "the earmarked fund for China Agriculture Research System (CARS-43-1)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Arita Y, 2012, BIOCHEM BIOPH RES CO, V425, P560, DOI 10.1016/j.bbrc.2012.08.024; Biggar KK, 2009, CRYOBIOLOGY, V59, P317, DOI 10.1016/j.cryobiol.2009.08.009; Bodary PF, 2002, JAMA-J AM MED ASSOC, V287, P1706, DOI 10.1001/jama.287.13.1706; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2009, J CELL SCI, V122, P13, DOI 10.1242/jcs.041723; Cheng YS, 2003, WORLD POULTRY SCI J, V59, P509, DOI 10.1079/WPS20030032; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Drummond MJ, 2009, J NUTR, V139, P2279, DOI 10.3945/jn.109.112797; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; FOWLER SP, 1980, GROWTH, V44, P235; FUENTES EN, 2011, AM J PHYSIOL-REG I, V300, P1532, DOI DOI 10.1152/AJPREGU.00535.2010; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hicks JA, 2008, POULTRY SCI, V87, P2335, DOI 10.3382/ps.2008-00114; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Jo C, 2009, CELL SIGNAL, V21, P1910, DOI 10.1016/j.cellsig.2009.08.008; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kablar B, 2000, HISTOL HISTOPATHOL, V15, P649, DOI 10.14670/HH-15.649; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; Kuhn DE, 2008, BIOCHEM BIOPH RES CO, V370, P473, DOI 10.1016/j.bbrc.2008.03.120; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Liu HH, 2012, J CELL PHYSIOL, V227, P1465, DOI 10.1002/jcp.22862; Liu J, 2010, J BIOL CHEM, V285, P26599, DOI 10.1074/jbc.M110.115824; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Marie-Etancelin C, 2008, WORLD POULTRY SCI J, V64, P187, DOI 10.1017/S0043933907001791; Mau M, 2008, IN VITRO CELL DEV-AN, V44, P1, DOI 10.1007/s11626-007-9069-6; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Panguluri SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008760; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Powder KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035111; Pruimboom-Brees IM, 2005, TOXICOL PATHOL, V33, P86, DOI 10.1080/01926230590881817; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rosenbaum M, 1999, NEW ENGL J MED, V341, P913, DOI 10.1056/NEJM199909163411211; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Roth RJ, 2009, J CLIN INVEST, V119, P3817, DOI 10.1172/JCI39054; Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610; Shi H, 2008, FASEB J, V22, P2990, DOI 10.1096/fj.07-097600; SMITH JH, 1963, POULTRY SCI, V42, P283, DOI 10.3382/ps.0420283; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Sweetman D, 2006, DEV DYNAM, V235, P2185, DOI 10.1002/dvdy.20881; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Tuyen DX, 2007, P IMPROVED DUCK PROD, P123; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wancket LM, 2012, LIFE SCI, V90, P237, DOI 10.1016/j.lfs.2011.11.017; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yu DB, 2013, J INTEGR AGR, V12, P136, DOI 10.1016/S2095-3119(13)60214-2; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhang L, 2013, GENE, V519, P77, DOI 10.1016/j.gene.2013.01.043; Zhang YY, 2002, AM J PHYSIOL-REG I, V282, pR226, DOI 10.1152/ajpregu.00392.2001; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	76	14	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86150	10.1371/journal.pone.0086150	http://dx.doi.org/10.1371/journal.pone.0086150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465928	gold, Green Submitted, Green Published			2022-12-25	WOS:000330288000057
J	Kinoshita, K; Akiyama, T; Mizutani, M; Shinomiya, A; Ishikawa, A; Younis, HH; Tsudzuki, M; Namikawa, T; Matsuda, Y				Kinoshita, Keiji; Akiyama, Toyoko; Mizutani, Makoto; Shinomiya, Ai; Ishikawa, Akira; Younis, Hassan Hassan; Tsudzuki, Masaoki; Namikawa, Takao; Matsuda, Yoichi			Endothelin Receptor B2 (EDNRB2) Is Responsible for the Tyrosinase-Independent Recessive White (mo(w)) and Mottled (mo) Plumage Phenotypes in the Chicken	PLOS ONE			English	Article							MELANOCYTE DEVELOPMENT; GENE; COLOR; MUTATION; MIGRATION; CLONING; LOCUS; EXPRESSION; PANDA; PROLIFERATION	A mutation that confers white plumage with black eyes was identified in the Minohiki breed of Japanese native chicken (Gallus gallus domesticus). The white plumage, with a few partially pigmented feathers, was not associated with the tyrosinase gene, and displayed an autosomal recessive mode of inheritance against the pigmented phenotype. All F-1 offspring derived from crosses with mottled chickens (mo/mo), which show characteristic pigmented feathers with white tips, had plumage with a mottled-like pattern. This result indicates that the white plumage mutation is a novel allele at the mo locus; we propose the gene symbol mo(w) for this mutant allele. Furthermore, the F-1 hybrid between the mo(w)/mo(w) chicken and the panda (s/s) mutant of Japanese quail (Coturnix japonica), whose causative gene is the endothelin receptor B2 (EDNRB2) gene, showed a mo(w)/mo(w) chicken-like plumage, suggesting the possibility that the mutations in parental species are alleles of the same gene, EDNRB2. Nucleotide sequencing of the entire coding region of EDNRB2 revealed a non-synonymous G1008T substitution, which causes Cys244Phe amino acid substitution in exon 5 (which is part of the extracellular loop between the putative fourth and fifth transmembrane domains of EDNRB2) in the mutant chicken. This Cys244Phe mutation was also present in individuals of four Japanese breeds with white plumage. We also identified a non-synonymous substitution leading to Arg332His substitution that was responsible for the mottled (mo/mo) plumage phenotype. These results suggest that the EDN3 (endothelin 3)-EDNRB2 signaling is essential for normal pigmentation in birds, and that the mutations of EDNRB2 may cause defective binding of the protein with endothelins, which interferes with melanocyte differentiation, proliferation, and migration.	[Kinoshita, Keiji; Mizutani, Makoto; Namikawa, Takao; Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi 4648601, Japan; [Akiyama, Toyoko; Shinomiya, Ai] Keio Univ, Dept Biol, Yokohama, Kanagawa 223, Japan; [Ishikawa, Akira; Younis, Hassan Hassan; Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet, Nagoya, Aichi 4648601, Japan; [Younis, Hassan Hassan] Kafr El Sheikh Univ, Fac Agr, Dept Poultry Prod, Kafr Al Sheikh, Egypt; [Tsudzuki, Masaoki] Hiroshima Univ, Grad Sch Biosphere Sci, Lab Anim Breeding & Genet, Higashihiroshima 724, Japan; [Tsudzuki, Masaoki] Hiroshima Univ, Japanese Avian Bioresource Project Res Ctr, Higashihiroshima 724, Japan	Nagoya University; Keio University; Nagoya University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Hiroshima University; Hiroshima University	Matsuda, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi 4648601, Japan.	yoimatsu@agr.nagoya-u.ac.jp	Ishikawa, Akira/I-6856-2014; Kinoshita, Keiji/GVS-4163-2022	Ishikawa, Akira/0000-0002-8275-4230; SHINOMIYA, Ai/0000-0003-3784-0532	National BioResource Project (NBRP) Chicken/Quail; Ministry of Education, Culture, Sports, Science and Technology, Japan [23113004, 20310143]; Keio University	National BioResource Project (NBRP) Chicken/Quail; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keio University	This research was supported by the National BioResource Project (NBRP) Chicken/Quail and Grants-in-Aid for Scientific Research on Innovative Areas (no. 23113004) and Scientific Research (B) (no. 20310143) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and grants from Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2009, DEVELOPMENT, V136, P2511, DOI 10.1242/dev.037168; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Borovansky J, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P1, DOI 10.1002/9783527636150; Braasch I, 2009, MOL BIOL EVOL, V26, P783, DOI 10.1093/molbev/msp015; BRUMBAUGH JA, 1983, J HERED, V74, P331, DOI 10.1093/oxfordjournals.jhered.a109804; CAREFOOT WC, 1987, BRIT POULTRY SCI, V28, P753, DOI 10.1080/00071668708417013; Chang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-19; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Dupin E, 2000, P NATL ACAD SCI USA, V97, P7882, DOI 10.1073/pnas.97.14.7882; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Harris ML, 2008, DEVELOPMENT, V135, P4113, DOI 10.1242/dev.023119; HIRAI M, 1991, LIFE SCI, V48, P2359, DOI 10.1016/0024-3205(91)90273-E; Hirata Y, 1996, Curr Opin Nephrol Hypertens, V5, P12, DOI 10.1097/00041552-199601000-00004; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Hutt F.B., 1949, GENETICS OF THE FOWL; IMOKAWA G, 1992, J BIOL CHEM, V267, P24675; Kawasaki-Nishihara A, 2011, DEV DYNAM, V240, P1454, DOI 10.1002/dvdy.22649; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kusserow H, 2004, BASIC CLIN PHARMACOL, V94, P5; Lahav R, 1998, P NATL ACAD SCI USA, V95, P14214, DOI 10.1073/pnas.95.24.14214; Lahav R, 1996, P NATL ACAD SCI USA, V93, P3892, DOI 10.1073/pnas.93.9.3892; Lamoureux ML, 2010, COLOR MICE MODEL GEN; Le Douarin N. M, 2009, NEURAL CREST; Lecoin L, 1998, P NATL ACAD SCI USA, V95, P3024, DOI 10.1073/pnas.95.6.3024; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; McCallion AS, 2001, PIGM CELL RES, V14, P161, DOI 10.1034/j.1600-0749.2001.140305.x; Metallinos DL, 1998, MAMM GENOME, V9, P426, DOI 10.1007/s003359900790; Miwa M, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-2; Miwa M, 2007, ANIM GENET, V38, P103, DOI 10.1111/j.1365-2052.2007.01568.x; Mizutani M., 1974, Experimental Animals, V23, P59; Nataf V, 1998, MECH DEVELOP, V73, P217, DOI 10.1016/S0925-4773(98)00048-3; Nobukuni Y, 1996, AM J HUM GENET, V59, P76; Oana H., 1951, HIST NATIVE JAPANESE; Opdecamp K, 1998, BIOCHEM CELL BIOL, V76, P1093, DOI 10.1139/bcb-76-6-1093; Opgenorth T J, 1995, Adv Pharmacol, V33, P1, DOI 10.1016/S1054-3589(08)60665-1; Osman SAM, 2005, ASIAN AUSTRAL J ANIM, V18, P755, DOI 10.5713/ajas.2005.755; PAVAN WJ, 1994, P NATL ACAD SCI USA, V91, P7159, DOI 10.1073/pnas.91.15.7159; Pla P, 2005, PIGM CELL RES, V18, P181, DOI 10.1111/j.1600-0749.2005.00230.x; Reid K, 1996, DEVELOPMENT, V122, P3911; Roulin A, 2013, SEMIN CELL DEV BIOL, V24, P594, DOI 10.1016/j.semcdb.2013.05.005; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SAKURAI T, 1992, TRENDS PHARMACOL SCI, V13, P103; Saldana-Caboverde A, 2010, PIGM CELL MELANOMA R, V23, P160, DOI 10.1111/j.1755-148X.2010.00678.x; Sarna T, 2006, PIGMENTARY SYSTEM PH, P311; Sato S, 2007, POULTRY SCI, V86, P2126, DOI 10.1093/ps/86.10.2126; Shinomiya A, 2012, GENETICS, V190, P627, DOI 10.1534/genetics.111.136705; Smyth J.R., 1990, POULTRY BREEDING GEN, P22; SMYTH J R JR, 1986, Poultry Science, V65, P129; SOMES RG, 1980, POULTRY SCI, V59, P1370, DOI 10.3382/ps.0591370; TACHIBANA M, 1994, HUM MOL GENET, V3, P553, DOI 10.1093/hmg/3.4.553; Tadano R, 2007, POULTRY SCI, V86, P460, DOI 10.1093/ps/86.3.460; Tobita-Teramoto T, 2000, POULTRY SCI, V79, P46, DOI 10.1093/ps/79.1.46; TSUDZUKI M, 1993, J HERED, V84, P225, DOI 10.1093/oxfordjournals.jhered.a111325; Uehara S, 2009, PIGM CELL MELANOMA R, V22, P111, DOI 10.1111/j.1755-148X.2008.00513.x; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yoshida H, 2001, J INVEST DERM SYMP P, V6, P1, DOI 10.1046/j.0022-202x.2001.00006.x; ZIEHL MA, 1987, IOWA STATE J RES, V62, P337	62	34	40	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86361	10.1371/journal.pone.0086361	http://dx.doi.org/10.1371/journal.pone.0086361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466053	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000089
J	Zhao, JY; Liu, ML; Jiang, L; Ding, L; Yan, SS; Zhang, J; Dong, ZB; Ren, HZ; Zhang, XL				Zhao, Jianyu; Liu, Meiling; Jiang, Li; Ding, Lian; Yan, Shuang Shuang; Zhang, Juan; Dong, Zhaobin; Ren, Huazhong; Zhang, Xiaolan			Cucumber SUPERMAN Has Conserved Function in Stamen and Fruit Development and a Distinct Role in Floral Patterning	PLOS ONE			English	Article							ARABIDOPSIS-SUPERMAN; HOMEOTIC GENES; ECTOPIC EXPRESSION; CELL-PROLIFERATION; SEX DETERMINATION; REPRESSION DOMAIN; FLOWERING PLANTS; DNA METHYLATION; THALIANA; TOBACCO	The Arabidopsis SUPERMAN (SUP) gene encodes a C2H2 type zinc finger protein that is required for maintaining the boundaries between stamens and carpels, and for regulating development of ovule outer integument. Orthologs of SUP have been characterized in bisexual flowers as well as dioecious species, but it remains elusive in monoecious plants with unisexual flowers on the same individual. Here we isolate the SUP ortholog in Cucumis sativus L (CsSUP), a monoecious vegetable. CsSUP is predominantly expressed in female specific organs: the female flower buds and ovules. Ectopic expression of CsSUP in Arabidopsis can partially complement the fruit development in sup-5 mutant, and its over-expression in wide-type leads to reduced silique length, suppressed stamen development and distorted petal patterning. Our data suggest that CsSUP plays conserved as well as distinct roles during flower and fruit development, and it may function in the boundaries and ovules to balance petal patterning, stamen and ovule development in Arabidopsis.	[Zhao, Jianyu; Liu, Meiling; Jiang, Li; Ding, Lian; Yan, Shuang Shuang; Zhang, Juan; Ren, Huazhong; Zhang, Xiaolan] China Agr Univ, Beijing Key Lab Growth & Dev Regulat Protected Ve, Dept Vegetable Sci, Beijing 100094, Peoples R China; [Dong, Zhaobin] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Key Lab Crop Genet Improvement & Genome, Natl Maize Improvement Ctr China,Minist Agr, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Zhang, XL (corresponding author), China Agr Univ, Beijing Key Lab Growth & Dev Regulat Protected Ve, Dept Vegetable Sci, Beijing 100094, Peoples R China.	zhxiaolan@cau.edu.cn	Dong, Zhaobin/O-7266-2018	Dong, Zhaobin/0000-0002-1275-581X; Liu, Meiling/0000-0001-6157-2182	National basic research of China 973 program [2012CB113900]; National Natural Science Foundation of China [31171399]; Chinese Universities Scientific Fund [2011JS067, 2013RC030]	National basic research of China 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund	This work was supported by National basic research of China 973 program [2012CB113900], National Natural Science Foundation of China [31171399], and Chinese Universities Scientific Fund [2011JS067, 2013RC030] to XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai SL, 2004, PLANTA, V220, P230, DOI 10.1007/s00425-004-1342-2; Bereterbide A, 2002, PLANT J, V29, P607, DOI 10.1046/j.0960-7412.2001.01243.x; Bereterbide A, 2001, PLANTA, V214, P22, DOI 10.1007/s004250100584; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1992, DEVELOPMENT, V114, P599; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; COLOMBO L, 1995, PLANT CELL, V7, P1859, DOI 10.1105/tpc.7.11.1859; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; GAISER JC, 1995, PLANT CELL, V7, P333, DOI 10.1105/tpc.7.3.333; Hiratsu K, 2004, BIOCHEM BIOPH RES CO, V321, P172, DOI 10.1016/j.bbrc.2004.06.115; Hiratsu K, 2002, FEBS LETT, V514, P351, DOI 10.1016/S0014-5793(02)02435-3; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Kater MM, 2000, PLANT J, V23, P407, DOI 10.1046/j.1365-313x.2000.00785.x; Kazama Y, 2009, PLANT CELL PHYSIOL, V50, P1127, DOI 10.1093/pcp/pcp064; LebelHardenack S, 1997, TRENDS PLANT SCI, V2, P130, DOI 10.1016/S1360-1385(97)01012-1; MALEPSZY S, 1991, PLANT SCI, V80, P39, DOI 10.1016/0168-9452(91)90271-9; Nakagawa H, 2004, PLANT CELL, V16, P920, DOI 10.1105/tpc.018838; Nandi AK, 2000, CURR BIOL, V10, P215, DOI 10.1016/S0960-9822(00)00341-9; Nibau C, 2011, J EXP BOT, V62, P949, DOI 10.1093/jxb/erq325; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAKAI H, 1995, NATURE, V378, P199, DOI 10.1038/378199a0; SCHULTZ EA, 1991, PLANT CELL, V3, P1221, DOI 10.1105/tpc.3.11.1221; Sridhar VV, 2006, DEVELOPMENT, V133, P3159, DOI 10.1242/dev.02498; Takeda S, 2004, DEVELOPMENT, V131, P425, DOI 10.1242/dev.00938; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Yampolsky C., 1922, BIBLIOTHECA GENETICA, V3, P1; Yun JY, 2002, PLANT CELL PHYSIOL, V43, P52, DOI 10.1093/pcp/pcf018; Zhang X, 2007, PLOS GENET, V3, P1040, DOI 10.1371/journal.pgen.0030101	38	8	10	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86192	10.1371/journal.pone.0086192	http://dx.doi.org/10.1371/journal.pone.0086192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465952	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000063
J	Lin, WH; Wang, MC; Wang, WM; Yang, DC; Lam, CF; Roan, JN; Li, CY				Lin, Wei-Hung; Wang, Ming-Cheng; Wang, Wei-Ming; Yang, Deng-Chi; Lam, Chen-Fuh; Roan, Jun-Neng; Li, Chung-Yi			Incidence of and Mortality from Type I Diabetes in Taiwan From 1999 through 2010: A Nationwide Cohort Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; LONG-TERM MORTALITY; ASSOCIATION COHORT; RISK-FACTORS; POPULATION; MELLITUS; CHILDHOOD; CHILDREN; ONSET; ADOLESCENTS	Objective: To evaluate the secular trend in incidence of and mortality from Type 1 diabetes mellitus (T1DM) in Taiwan, 1999-2010. Methods: All 7,225 incident cases of T1DM were retrospectively retrieved from Taiwan's National Health Insurance Research Database from 1999 to 2010. Trend of bi-annual age-and sex-specific incidence rates of T1DM was calculated and tested with Poisson regression model. Standardized mortality ratios (SMRs) were calculated, using age-, sex-, and calendar years-specific mortality rates of the general population as the reference, to estimate the relative mortality risk of T1DM. Results: The number of male and female T1DM was 3,471 (48%) and 3,754 (52%), respectively. The annual number of incident T1DM increased from 543 in 1999 to 737 in 2010. The overall bi-annual incidence rate rose from 1999-00 to 200304 and mildly declined thereafter rose to 2009-10, with an insignificant trend (P = 0.489) over the study period. Regardless of gender, the higher age-specific incidence rate was noted in the younger groups (<30 years) and highest at <15 years. The incidence rates in younger groups were constantly higher in female population than in male one. The SMR from all causes was significantly increased at 3.00 (95% Confidence Interval (CI) 2.83-3.16) in patients with T1DM. The sex-specific SMR was 2.66 (95% CI 2.46-2.85) and 3.58 (95% CI 3.28-3.87) for male and female patients, respectively. For both sexes, the age-specific SMR peaked at 15-29 years. Conclusions: Among T1DM patients in Taiwan, there were significant increasing trends in males and female aged <15 years. We also noted a significantly increased overall and sex-specific SMR from all causes in patients with TIDM which suggests a need for improvements in treatment and care of patients with T1DM.	[Lin, Wei-Hung; Roan, Jun-Neng] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Inst Clin Med, Tainan 70101, Taiwan; [Lin, Wei-Hung; Wang, Ming-Cheng; Yang, Deng-Chi] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Div Nephrol,Dept Internal Med, Tainan 70101, Taiwan; [Wang, Ming-Cheng] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan; [Wang, Wei-Ming] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Biostat Consulting Ctr, Tainan 70101, Taiwan; [Lam, Chen-Fuh] Natl Cheng Kung Univ, Coll Med, Dept Anesthesiol, Tainan 70101, Taiwan; [Roan, Jun-Neng] Natl Cheng Kung Univ Hosp, Dept Surg, Div Cardiovasc Surg, Tainan 70428, Taiwan; [Roan, Jun-Neng] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan; [Li, Chung-Yi] Natl Cheng Kung Univ, Coll Med, Dept & Grad Inst Publ Hlth, Tainan 70101, Taiwan; [Li, Chung-Yi] China Med Univ, Dept Publ Hlth, Coll Publ Hlth, Taichung, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; China Medical University Taiwan	Li, CY (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept & Grad Inst Publ Hlth, Tainan 70101, Taiwan.	cyli99@mail.ncku.edu.tw	Lin, Wei-Hung/ABE-1927-2021; LI, CHUNG-YI/ABI-1419-2020; Roan, Jun-Neng/AFK-1022-2022	LI, CHUNG-YI/0000-0002-0321-8908; Roan, Jun-Neng/0000-0002-0312-0628	National Scientific Council [NSC101-2314-B-006-076-MY3]	National Scientific Council	This study was supported by a grant from the National Scientific Council (grant number: NSC101-2314-B-006-076-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Asao K, 2003, DIABETES CARE, V26, P2037, DOI 10.2337/diacare.26.7.2037; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; BORCHJOHNSEN K, 1986, DIABETOLOGIA, V29, P767, DOI 10.1007/BF00873214; Burnet DL, 2007, DIABETES CARE, V30, P2559, DOI 10.2337/dc07-0216; Chen F, 2004, DIABETES RES CLIN PR, V63, P113, DOI 10.1016/j.diabres.2003.09.002; Chen HF, 2011, DIABETES CARE, V34, P1177, DOI 10.2337/dc10-2006; Chiu YM, 2010, LUPUS, V19, P1250, DOI 10.1177/0961203310373780; Dawson SI, 2008, DIABETES RES CLIN PR, V80, P16, DOI 10.1016/j.diabres.2007.10.033; DECKERT T, 1978, DIABETOLOGIA, V14, P363, DOI 10.1007/BF01228130; FU H, 1994, DIABETES CARE, V17, P1206, DOI 10.2337/diacare.17.10.1206; GOLDSTEIN DE, 1980, DIABETES CARE, V3, P503, DOI 10.2337/diacare.3.4.503; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Jiang YD, 2012, J FORMOS MED ASSOC, V111, P599, DOI 10.1016/j.jfma.2012.09.014; KARVONEN M, 1993, DIABETOLOGIA, V36, P883, DOI 10.1007/BF02374468; Laing SP, 2005, DIABETES CARE, V28, P1618, DOI 10.2337/diacare.28.7.1618; Laing SP, 1999, DIABETIC MED, V16, P459, DOI 10.1046/j.1464-5491.1999.00075.x; Laing SP, 1999, DIABETIC MED, V16, P466, DOI 10.1046/j.1464-5491.1999.00076.x; LAPORTE RE, 1991, AM J EPIDEMIOL, V133, P577; Lawrence JM, 2014, AM J EPIDEMIOL, V179, P27, DOI 10.1093/aje/kwt230; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Liu CC, 2010, J FORMOS MED ASSOC, V109, P725, DOI 10.1016/S0929-6646(10)60117-9; Meltzer LJ, 2001, DIABETES CARE, V24, P678, DOI 10.2337/diacare.24.4.678; Nishimura R, 2001, DIABETES CARE, V24, P823, DOI 10.2337/diacare.24.5.823; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Orchard TJ, 2010, DIABETOLOGIA, V53, P2312, DOI 10.1007/s00125-010-1860-3; Patterson CC, 2007, DIABETOLOGIA, V50, P2439, DOI 10.1007/s00125-007-0824-8; RILEY MD, 1995, DIABETES RES CLIN PR, V29, P27, DOI 10.1016/0168-8227(95)01106-N; RODIN GM, 1992, DIABETES CARE, V15, P1402, DOI 10.2337/diacare.15.10.1402; Secrest AM, 2010, DIABETES CARE, V33, P2573, DOI 10.2337/dc10-1170; Shankar A, 2007, AM J EPIDEMIOL, V166, P393, DOI 10.1093/aje/kwm096; Shen SX, 1996, J PEDIATR ENDOCR MET, V9, P469; Skrivarhaug T, 2006, DIABETOLOGIA, V49, P298, DOI 10.1007/s00125-005-0082-6; Ting Wei-Hsin, 2007, Acta Paediatrica Taiwanica, V48, P119; U S Renal Data System. USRDS, 2012, ANN DAT REP ATL CHRO; Usher-Smith JA, 2012, DIABETOLOGIA, V55, P2878, DOI 10.1007/s00125-012-2690-2; Wei JN, 2003, JAMA-J AM MED ASSOC, V290, P1345, DOI 10.1001/jama.290.10.1345; Wei JN, 2006, DIABETES RES CLIN PR, V74, P309, DOI 10.1016/j.diabres.2006.04.018; Ziegler R, 2011, PEDIATR DIABETES, V12, P11, DOI 10.1111/j.1399-5448.2010.00650.x	39	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86172	10.1371/journal.pone.0086172	http://dx.doi.org/10.1371/journal.pone.0086172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465941	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100120
J	McCarville, MT; Soh, DH; Tylka, GL; O'Neal, ME				McCarville, Michael T.; Soh, David H.; Tylka, Gregory L.; O'Neal, Matthew E.			Aboveground Feeding by Soybean Aphid, Aphis glycines, Affects Soybean Cyst Nematode, Heterodera glycines, Reproduction Belowground	PLOS ONE			English	Article							UNITED-STATES; YIELD; RESISTANT; ROOT; POPULATIONS; MANAGEMENT; FIELD	Heterodera glycines is a cyst nematode that causes significant lost soybean yield in the U. S. Recent studies observed the aphid Aphis glycines and H. glycines interacting via their shared host, soybean, Glycine max. A greenhouse experiment was conducted to discern the effect of A. glycines feeding on H. glycines reproduction. An H. glycines-susceptible cultivar, Kenwood 94, and a resistant cultivar, Dekalb 27-52, were grown in H. glycines-infested soil for 30 and 60 d. Ten days after planting, plants were infested with either zero, five, or ten aphids. At 30 and 60 d, the number of H. glycines females and cysts (dead females) and the number of eggs within were counted. In general, H. glycines were less abundant on the resistant than the susceptible cultivar, and H. glycines abundance increased from 30 to 60 d. At 30 d, 33% more H. glycines females and eggs were produced on the resistant cultivar in the ten-aphid treatment compared to the zero-aphid treatment. However, at 30 d the susceptible cultivar had 50% fewer H. glycines females and eggs when infested with ten aphids. At 60 d, numbers of H. glycines females and cysts and numbers of eggs on the resistant cultivar were unaffected by A. glycines feeding, while numbers of both were decreased by A. glycines on the susceptible cultivar. These results indicate that A. glycines feeding improves the quality of soybean as a host for H. glycines, but at higher herbivore population densities, this effect is offset by a decrease in resource quantity.	[McCarville, Michael T.; O'Neal, Matthew E.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; [Soh, David H.; Tylka, Gregory L.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA	Iowa State University; Iowa State University	O'Neal, ME (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.	oneal@iastate.edu			Iowa Soybean Association	Iowa Soybean Association	This research was funded by the soybean checkoff through a grant from the Iowa Soybean Association (www.iasoybeans.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEDO JR, 1984, J NEMATOL, V16, P48; ALSTON DG, 1993, J NEMATOL, V25, P42; ALSTON DG, 1988, J NEMATOL, V20, P366; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Chiozza MV, 2010, ENVIRON ENTOMOL, V39, P856, DOI 10.1603/EN09338; Faghihi J, 2000, J NEMATOL, V32, P411; Fehr W.R., 1977, IOWA AGR HOME EC EXP; Heeren JR, 2012, J APPL ENTOMOL, V136, P646, DOI 10.1111/j.1439-0418.2011.01701.x; Hill CB, 2012, EUPHYTICA, V186, P635, DOI 10.1007/s10681-012-0695-z; Hong SC, 2011, J ECON ENTOMOL, V104, P1568, DOI 10.1603/EC11084; Hong SC, 2010, ENVIRON ENTOMOL, V39, P1561, DOI 10.1603/EN10091; Johnson SN, 2012, ECOLOGY, V93, P2208, DOI 10.1890/11-2272.1; Johnson SN, 2009, FUNCT ECOL, V23, P699, DOI 10.1111/j.1365-2435.2009.01550.x; Klink VP, 2011, PLANT MOL BIOL, V75, P141, DOI 10.1007/s11103-010-9715-3; Koenning SR, 1999, J NEMATOL, V31, P587; MASTERS GJ, 1993, OIKOS, V66, P148, DOI 10.2307/3545209; McCarville MT, 2012, ENTOMOL EXP APPL, V143, P55, DOI 10.1111/j.1570-7458.2012.01227.x; Niblack TL, 2006, ANNU REV PHYTOPATHOL, V44, P283, DOI 10.1146/annurev.phyto.43.040204.140218; Niblack T.L., 2009, PLANT HLTH PROG, V10, P33, DOI [10.1094/PHP-2009-0513-01-RV, DOI 10.1094/PHP-2009-0513-01-RV]; Niblack TL, 2002, J NEMATOL, V34, P279; O'Neal ME, 2010, SOYBEAN: BOTANY, PRODUCTION AND USES, P300, DOI 10.1079/9781845936440.0300; Pedersen P, 2010, CROP SCI, V50, P1458, DOI 10.2135/cropsci2009.08.0432; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; RUSSIN JS, 1993, J NEMATOL, V25, P50; RUSSIN JS, 1989, J NEMATOL, V21, P108; Schmitt D.P., 1989, Agricultural Zoology Reviews, V3, P253; Soler R, 2013, TRENDS PLANT SCI, V18, P149, DOI 10.1016/j.tplants.2012.08.010; Soler R, 2012, J CHEM ECOL, V38, P755, DOI 10.1007/s10886-012-0104-z; Studham ME, 2012, PLANT MICROBE INTERA, V26, P116; Tylka GL, 2013, IOWA STATE U EXTENSI; Tylka GL, 2006, IOWA STATE U EXTENSI; Tylka GL, 2005, IOWA STATE U EXTENSI; Tylka GL, 2008, IOWA STATE U EXTENSI; Tylka GL, 2012, IOWA STATE U EXTEION; Tylka GL, 2007, IOWA STATE U EXTENSI; Tylka GL, 2009, IOWA STATE U EXTENSI; Tylka GL, 2010, IOWA STATE U EXTENSI; Villamil MB, 2012, AGRON J, V104, P881, DOI 10.2134/agronj2012.0018n; Wheeler TA, 1997, J NEMATOL, V29, P703; Wondafrash M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00087; Workneh F, 1999, PHYTOPATHOLOGY, V89, P204, DOI 10.1094/PHYTO.1999.89.3.204; Wrather A, 2010, PLANT HLTH PROGR, DOI [10.1094/PHP-2010-0125-01-RS, DOI 10.1094/PHP-2010-0125-01-RS]; Wrather JA, 2006, J NEMATOL, V38, P173	43	15	15	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86415	10.1371/journal.pone.0086415	http://dx.doi.org/10.1371/journal.pone.0086415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466080	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100158
J	Feng, L; Nian, SY; Zhang, JH				Feng, Lei; Nian, Shi-yan; Zhang, Jihong			The GG Genotype of Telomerase Reverse Transcriptase at Genetic Locus rs2736100 Is Associated with Human Atherosclerosis Risk in the Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; FUTURE; TERT	A single nucleotide polymorphism (SNP) in the second intron of human TERT (hTERT), rs2736100, acts as a critical factor in hTERT synthesis and activation. The rs2736100 SNP was found to be associated with susceptibility to many cancers. Recently, inhibition of telomerase and marked telomere shortening were determined to be closely associated with the increasing severity of atherosclerosis. The association between the SNP of rs2736100 and the presence of atherosclerosis was evaluated in 84 atherosclerosis patients and 257 healthy controls using multivariate logistic regression analyses. The proportion of the GG genotype in atherosclerosis patients (17.9%) was significantly higher than in the control group (9.7%). Eight variables, including age, gender, cholesterol, high density lipoprotein, homocysteine, total bilirubin, indirect bilirubin, and rs2736100 GG genotype, were associated with atherosclerosis with odds ratios of 1.88, 2.11, 1.66, 0.23, 1.27, 1.29, 1.53, and 1.74, respectively, using multivariate logistic regression analyses. Homozygous GG was demonstrated to be associated with the presence of atherosclerosis in our population.	[Feng, Lei] Peoples Hosp Yuxi City, Dept Lab, Yuxi, Yunnan Province, Peoples R China; [Nian, Shi-yan] Peoples Hosp Yuxi City, Intens Care Unit, Yuxi, Yunnan Province, Peoples R China; [Zhang, Jihong] Kunming Univ Sci & Technol, Fac Med, Kunming, Yunnan Province, Peoples R China	Kunming University of Science & Technology	Zhang, JH (corresponding author), Kunming Univ Sci & Technol, Fac Med, Kunming, Yunnan Province, Peoples R China.	zhjihong2000@126.com			National Natural Science Foundation of China [81260501]; Natural Science Foundation of Yunnan Province Education Department [KKSA201126061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province Education Department(Natural Science Foundation of Yunnan Province)	This work was supported by the National Natural Science Foundation of China (No. 81260501), the Natural Science Foundation of Yunnan Province Education Department (KKSA201126061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babizhayev MA, 2011, AM J THER, V18, pE209, DOI 10.1097/MJT.0b013e3181cf8ebb; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Kanter JE, 2013, CIRC RES, V113, P352, DOI 10.1161/CIRCRESAHA.113.301998; Katsanis SH, 2013, NAT REV GENET, V14, P415, DOI 10.1038/nrg3493; Leem SH, 2002, ONCOGENE, V21, P769, DOI 10.1038/sj.onc.1205122; Lu WS, 2013, EXP CELL RES, V319, P133, DOI 10.1016/j.yexcr.2012.09.005; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Melin BS, 2012, GENET EPIDEMIOL, V36, P368, DOI 10.1002/gepi.21630; Mushiroda T, 2008, J MED GENET, V45, P654, DOI 10.1136/jmg.2008.057356; Narducci ML, 2007, J AM COLL CARDIOL, V50, P2369, DOI 10.1016/j.jacc.2007.08.048; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Park ES, 2013, ATHEROSCLEROSIS, V228, P53, DOI 10.1016/j.atherosclerosis.2013.02.002; Pletcher MJ, 2013, CIRCULATION IN PRESS; Raynaud CM, 2008, CRIT REV ONCOL HEMAT, V66, P99, DOI 10.1016/j.critrevonc.2007.11.006; Reddy KS, 1998, CIRCULATION, V97, P596; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Smith JS, 2011, NAT STRUCT MOL BIOL, V18, P478, DOI 10.1038/nsmb.2033; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Wang Y, 2003, HEPATOLOGY, V37, P65, DOI 10.1053/jhep.2003.50017	27	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85719	10.1371/journal.pone.0085719	http://dx.doi.org/10.1371/journal.pone.0085719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465664	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500096
J	Havarushka, N; Fischer-Schrader, K; Lamkemeyer, T; Schwarz, G				Havarushka, Nastassia; Fischer-Schrader, Katrin; Lamkemeyer, Tobias; Schwarz, Guenter			Structural Basis of Thermal Stability of the Tungsten Cofactor Synthesis Protein MoaB from Pyrococcus furiosus	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CONFORMATIONAL FLEXIBILITY; TRIOSEPHOSPHATE ISOMERASE; GLUTAMATE-DEHYDROGENASE; MOLYBDENUM INSERTION; ENZYME STABILITY; KEY ROLE; THERMOSTABILITY; MOLYBDOPTERIN	Molybdenum and tungsten cofactors share a similar pterin-based scaffold, which hosts an ene-dithiolate function being essential for the coordination of either molybdenum or tungsten. The biosynthesis of both cofactors involves a multistep pathway, which ends with the activation of the metal binding pterin (MPT) by adenylylation before the respective metal is incorporated. In the hyperthermophilic organism Pyrococcus furiosus, the hexameric protein MoaB (PfuMoaB) has been shown to catalyse MPT-adenylylation. Here we determined the crystal structure of PfuMoaB at 2.5 angstrom resolution and identified key residues of alpha 3-helix mediating hexamer formation. Given that PfuMoaB homologues from mesophilic organisms form trimers, we investigated the impact on PfuMoaB hexamerization on thermal stability and activity. Using structure-guided mutagenesis, we successfully disrupted the hexamer interface in PfuMoaB. The resulting PfuMoaB-H3 variant formed monomers, dimers and trimers as determined by size exclusion chromatography. Circular dichroism spectroscopy as well as chemical cross-linking coupled to mass spectrometry confirmed a wild-type-like fold of the protomers as well as inter-subunits contacts. The melting temperature of PfuMoaB-H3 was found to be reduced by more than 15 degrees C as determined by differential scanning calorimetry, thus demonstrating hexamerization as key determinant for PfuMoaB thermal stability. Remarkably, while a loss of activity at temperatures higher than 50 degrees C was observed in the PfuMoaB-H3 variant, at lower temperatures, we determined a significantly increased catalytic activity. The latter suggests a gain in conformational flexibility caused by the disruption of the hexamerization interface.	[Havarushka, Nastassia; Fischer-Schrader, Katrin; Schwarz, Guenter] Univ Cologne, Inst Biochem, Dept Chem, D-50931 Cologne, Germany; [Lamkemeyer, Tobias; Schwarz, Guenter] Univ Cologne, Cluster Excellence Cellular Stress Responses Agin, D-50931 Cologne, Germany; [Schwarz, Guenter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Schwarz, G (corresponding author), Univ Cologne, Inst Biochem, Dept Chem, D-50931 Cologne, Germany.	gschwarz@uni-koeln.de	Schrader, Katrin/GWM-7389-2022; Schwarz, Guenter/ABE-9643-2021	Schrader, Katrin/0000-0003-4532-8918; Schwarz, Guenter/0000-0002-2118-9338	DFG [Schw759/9-1]	DFG(German Research Foundation (DFG))	DFG Schw759/9-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop E, 2003, PROTEIN ENG, V16, P871, DOI 10.1093/protein/gzg131; Antonyuk SV, 2009, ACTA CRYSTALLOGR F, V65, P1200, DOI 10.1107/S1744309109043772; Arnott MA, 2000, J MOL BIOL, V304, P657, DOI 10.1006/jmbi.2000.4240; Bader G, 2004, ACTA CRYSTALLOGR D, V60, P1068, DOI 10.1107/S0907444904007164; Belaidi AA, 2013, BIOCHEM J, V450, P149, DOI 10.1042/BJ20121078; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bevers LE, 2008, BIOCHEMISTRY-US, V47, P949, DOI 10.1021/bi7020487; Bevers LE, 2009, COORDIN CHEM REV, V253, P269, DOI 10.1016/j.ccr.2008.01.017; Bhuiya MW, 2005, J MOL BIOL, V345, P325, DOI 10.1016/j.jmb.2004.10.063; Buchanan CL, 1999, BIOCHEM J, V343, P563, DOI 10.1042/0264-6021:3430563; DELBONI LF, 1995, PROTEIN SCI, V4, P2594, DOI 10.1002/pro.5560041217; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hajdu I, 2008, EUR BIOPHYS J BIOPHY, V37, P1139, DOI 10.1007/s00249-008-0332-x; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; Herweg J, 2012, J BIOL CHEM, V287, P12645, DOI 10.1074/jbc.M112.341826; Hille R, 2013, DALTON T, V42, P3029, DOI 10.1039/c2dt32376a; Kanaujia SP, 2011, ACTA CRYSTALLOGR F, V67, P2, DOI 10.1107/S1744309110035037; Kozmin SG, 2013, RES MICROBIOLOGOY, P1, DOI [10.1016/j.resmic.2013.05.001, DOI 10.1016/J.RES-MIC.2013.05.001]; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Kuper J, 2000, P NATL ACAD SCI USA, V97, P6475, DOI 10.1073/pnas.110568497; Kuper J, 2004, NATURE, V430, P803, DOI 10.1038/nature02681; Lassalle MW, 1998, J MOL BIOL, V279, P987, DOI 10.1006/jmbi.1998.1776; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Liu MT, 2000, CRYSTAL STRUCTURE GE; Llamas A, 2006, J BIOL CHEM, V281, P18343, DOI 10.1074/jbc.M601415200; Magalon A, 2002, J BIOL CHEM, V277, P48199, DOI 10.1074/jbc.M205806200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nichols JD, 2005, J BIOL CHEM, V280, P7817, DOI 10.1074/jbc.M413783200; PANAYOTATOS N, 1993, J BIOL CHEM, V268, P19000; Petsko GA, 2001, METHOD ENZYMOL, V334, P469; Pfeil W, 1997, J MOL BIOL, V272, P591, DOI 10.1006/jmbi.1997.1278; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065; Rothery RA, 2012, P NATL ACAD SCI USA, V109, P14773, DOI 10.1073/pnas.1200671109; Russell RJM, 1997, BIOCHEMISTRY-US, V36, P9983, DOI 10.1021/bi9705321; Sanishvili R, 2004, J BIOL CHEM, V279, P42139, DOI 10.1074/jbc.M407694200; Santamaria-Araujo JA, 2012, J BIOL INORG CHEM, V17, P113, DOI 10.1007/s00775-011-0835-2; Schrag JD, 2001, J MOL BIOL, V310, P419, DOI 10.1006/jmbi.2001.4771; Schwarz G, 1997, J BIOL CHEM, V272, P26811, DOI 10.1074/jbc.272.43.26811; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi YH, 2012, PROTEIN SCI, V21, P1197, DOI 10.1002/pro.2107; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P2597, DOI 10.1021/bi951988q; Thoma R, 2000, STRUCTURE, V8, P265, DOI 10.1016/S0969-2126(00)00106-4; Thomas TM, 1998, BIOCHEM J, V330, P1087; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Villeret V, 1998, P NATL ACAD SCI USA, V95, P2801, DOI 10.1073/pnas.95.6.2801; Walden H, 2004, J MOL BIOL, V342, P861, DOI 10.1016/j.jmb.2004.07.067; Wallon G, 1997, J MOL BIOL, V266, P1016, DOI 10.1006/jmbi.1996.0797; WATANABE K, 1994, EUR J BIOCHEM, V226, P277, DOI 10.1111/j.1432-1033.1994.tb20051.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	64	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86030	10.1371/journal.pone.0086030	http://dx.doi.org/10.1371/journal.pone.0086030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465852	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500100
J	Gypens, N; Borges, AV; Speeckaert, G; Lancelot, C				Gypens, Nathalie; Borges, Alberto V.; Speeckaert, Gaelle; Lancelot, Christiane			The Dimethylsulfide Cycle in the Eutrophied Southern North Sea: A Model Study Integrating Phytoplankton and Bacterial Processes	PLOS ONE			English	Article							BELGIAN COASTAL WATERS; MARINE SURFACE WATERS; DMSP-LYASE ACTIVITY; MICROBIAL FOOD-WEB; EMILIANIA-HUXLEYI; DIMETHYLSULFONIOPROPIONATE DMSP; PHAEOCYSTIS BLOOMS; SULFIDE PRODUCTION; SULFUR-COMPOUNDS; DISSOLVED DMSP	We developed a module describing the dimethylsulfoniopropionate (DMSP) and dimethylsulfide (DMS) dynamics, including biological transformations by phytoplankton and bacteria, and physico-chemical processes (including DMS air-sea exchange). This module was integrated in the MIRO ecological model and applied in a 0D frame in the Southern North Sea (SNS). The DMS(P) module is built on parameterizations derived from available knowledge on DMS(P) sources, transformations and sinks, and provides an explicit representation of bacterial activity in contrast to most of existing models that only include phytoplankton process (and abiotic transformations). The model is tested in a highly productive coastal ecosystem (the Belgian coastal zone, BCZ) dominated by diatoms and the Haptophyceae Phaeocystis, respectively low and high DMSP producers. On an annual basis, the particulate DMSP (DMSPp) production simulated in 1989 is mainly related to Phaeocystis colonies (78%) rather than diatoms (13%) and nanoflagellates (9%). Accordingly, sensitivity analysis shows that the model responds more to changes in the sulfur: carbon (S: C) quota and lyase yield of Phaeocystis. DMS originates equally from phytoplankton and bacterial DMSP-lyase activity and only 3% of the DMS is emitted to the atmosphere. Model analysis demonstrates the sensitivity of DMS emission towards the atmosphere to the description and parameterization of biological processes emphasizing the need of adequately representing in models both phytoplankton and bacterial processes affecting DMS(P) dynamics. This is particularly important in eutrophied coastal environments such as the SNS dominated by high non-diatom blooms and where empirical models developed from data-sets biased towards open ocean conditions do not satisfactorily predict the timing and amplitude of the DMS seasonal cycle. In order to predict future feedbacks of DMS emissions on climate, it is needed to account for hotspots of DMS emissions from coastal environments that, if eutrophied, are dominated not only by diatoms.	[Gypens, Nathalie; Speeckaert, Gaelle; Lancelot, Christiane] Univ Libre Bruxelles, Brussels, Belgium; [Borges, Alberto V.] Univ Liege, Unite Oceanog Chim, Liege, Belgium	Universite Libre de Bruxelles; University of Liege	Gypens, N (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	ngypens@ulb.ac.be	Borges, Alberto Vieira/C-4989-2008	Borges, Alberto Vieira/0000-0002-5434-2247; Gypens, Nathalie/0000-0002-8154-5613	Fonds de la Recherche Fondamentale Collective DMS-SNS [1882638]; Fonds de la Recherche Scientifique	Fonds de la Recherche Fondamentale Collective DMS-SNS(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS)	The present work is a contribution to the Fonds de la Recherche Fondamentale Collective DMS-SNS project (1882638) funded by the Fonds de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2001, J MARINE SYST, V30, P1, DOI 10.1016/S0924-7963(01)00028-8; Archer SD, 2004, CAN J FISH AQUAT SCI, V61, P765, DOI 10.1139/F04-028; Archer SD, 2002, DEEP-SEA RES PT II, V49, P3067, DOI 10.1016/S0967-0645(02)00072-3; Archer SD, 2001, AQUAT MICROB ECOL, V24, P225, DOI 10.3354/ame024225; Archer SD, 2010, LIMNOL OCEANOGR, V55, P1579, DOI 10.4319/lo.2010.55.4.1579; Aumont O, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/1999JC000111; Belviso S, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002193; BELVISO S, 1990, LIMNOL OCEANOGR, V35, P1810, DOI 10.4319/lo.1990.35.8.1810; Bopp L, 2008, DEEP-SEA RES PT II, V55, P901, DOI 10.1016/j.dsr2.2007.12.002; BRIMBLECOMBE P, 1986, MAR CHEM, V19, P343, DOI 10.1016/0304-4203(86)90055-1; Brugger A, 1998, MAR CHEM, V59, P321, DOI 10.1016/S0304-4203(97)00090-X; Cadee GC, 2002, J SEA RES, V48, P97, DOI 10.1016/S1385-1101(02)00161-2; Cameron-Smith P, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047069; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; DACEY JWH, 1986, SCIENCE, V233, P1314, DOI 10.1126/science.233.4770.1314; del Valle DA, 2007, MAR CHEM, V103, P197, DOI 10.1016/j.marchem.2006.07.005; DICKSON DMJ, 1987, NEW PHYTOL, V106, P645, DOI 10.1111/j.1469-8137.1987.tb00165.x; Evans C, 2006, LIMNOL OCEANOGR, V51, P2468, DOI 10.4319/lo.2006.51.5.2468; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Fredrickson KA, 2009, J PLANKTON RES, V31, P135, DOI 10.1093/plankt/fbn112; GABRIC A, 1993, J GEOPHYS RES-OCEANS, V98, P22805, DOI 10.1029/93JC01773; Gabric A., 2001, CHEMOSPHERE GLOBAL C, V3, P377, DOI [10.1016/S1465-9972(01)00018-6, DOI 10.1016/S1465-9972(01)00018-6]; Gasparini S, 2000, J SEA RES, V43, P345, DOI 10.1016/S1385-1101(00)00016-2; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P3810; Gypens N, 2009, GLOBAL CHANGE BIOL, V15, P1040, DOI 10.1111/j.1365-2486.2008.01773.x; Gypens N, 2007, J SEA RES, V57, P19, DOI 10.1016/j.seares.2006.07.004; Halloran PR, 2010, BIOGEOSCIENCES, V7, P1645, DOI 10.5194/bg-7-1645-2010; Harada H, 2009, AQUAT BOT, V90, P37, DOI 10.1016/j.aquabot.2008.05.004; Hatton AD, 2012, BIOGEOCHEMISTRY, V110, P131, DOI 10.1007/s10533-012-9702-7; Ho DT, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026817; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Jodwalis CM, 2000, J GEOPHYS RES-ATMOS, V105, P14387, DOI 10.1029/2000JD900023; Karsten U, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P143; KARSTEN U, 1992, POLAR BIOL, V12, P603; Keller MD, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P131; KELLER MD, 1989, ACS SYM SER, V393, P167; Kettle AJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P399, DOI 10.1029/1999GB900004; Kieber DJ, 1996, J GEOPHYS RES-OCEANS, V101, P3715, DOI 10.1029/95JC03624; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 2000, GEOCHIM COSMOCHIM AC, V64, P2797, DOI 10.1016/S0016-7037(00)00399-9; Kiene RP, 2006, LIMNOL OCEANOGR-METH, V4, P80, DOI 10.4319/lom.2006.4.80; KIENE RP, 1990, APPL ENVIRON MICROB, V56, P3292, DOI 10.1128/AEM.56.11.3292-3297.1990; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; KIENE RP, 1990, NATURE, V345, P702, DOI 10.1038/345702a0; Kiene RP, 1996, MAR CHEM, V54, P69, DOI 10.1016/0304-4203(96)00006-0; Kiene RP, 2000, LIMNOL OCEANOGR, V45, P849, DOI 10.4319/lo.2000.45.4.0849; Kirst GO, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P121; Kwint RLJ, 1996, MAR ECOL PROG SER, V134, P217, DOI 10.3354/meps134217; Lana A, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003850; Lana A, 2012, BIOGEOCHEMISTRY, V110, P173, DOI 10.1007/s10533-011-9677-9; Lancelot C, 2005, MAR ECOL PROG SER, V289, P63, DOI 10.3354/meps289063; LANCELOT C, 1995, SCI TOTAL ENVIRON, V165, P83, DOI 10.1016/0048-9697(95)04545-C; LANCELOT C, 1987, MAR ECOL PROG SER, V37, P239, DOI 10.3354/meps037239; Laroche D, 1999, MAR ECOL PROG SER, V180, P37, DOI 10.3354/meps180037; Le Clainche Y, 2004, CAN J FISH AQUAT SCI, V61, P788, DOI 10.1139/F04-027; Le Clainche Y, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003721; LECK C, 1990, J GEOPHYS RES-OCEANS, V95, P3353, DOI 10.1029/JC095iC03p03353; Lefevre M, 2002, DEEP-SEA RES PT I, V49, P2221, DOI 10.1016/S0967-0637(02)00121-8; Levasseur M, 2011, NAT GEOSCI, V4, P351, DOI 10.1038/ngeo1175; LISS PS, 1994, J MARINE SYST, V5, P41, DOI 10.1016/0924-7963(94)90015-9; LISS PS, 1993, PHILOS T ROY SOC A, V343, P531, DOI 10.1098/rsta.1993.0064; Malin G, 1998, LIMNOL OCEANOGR, V43, P1389, DOI 10.4319/lo.1998.43.6.1389; MATRAI PA, 1994, MAR BIOL, V119, P61, DOI 10.1007/BF00350107; Miles CJ, 2012, BIOGEOCHEMISTRY, V110, P201, DOI 10.1007/s10533-011-9697-5; NGUYEN BC, 1988, MAR CHEM, V24, P133, DOI 10.1016/0304-4203(88)90044-8; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; Niki T, 2000, MAR BIOL, V136, P759, DOI 10.1007/s002279900235; Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614; Polimene L, 2012, BIOGEOCHEMISTRY, V110, P243, DOI 10.1007/s10533-011-9674-z; Quinn PK, 2011, NATURE, V480, P51, DOI 10.1038/nature10580; Rousseau V, 2002, MAR ECOL PROG SER, V236, P61, DOI 10.3354/meps236061; Ruiz-Gonzalez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045545; SALTZMAN ES, 1993, J GEOPHYS RES-OCEANS, V98, P16481, DOI 10.1029/93JC01858; Simo R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001829; Simo R, 2002, LIMNOL OCEANOGR, V47, P53, DOI 10.4319/lo.2002.47.1.0053; Simo R, 1999, GLOBAL BIOGEOCHEM CY, V13, P1173, DOI 10.1029/1999GB900081; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Six KD, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002674; Six KD, 2013, NAT CLIM CHANGE, V3, P975, DOI [10.1038/NCLIMATE1981, 10.1038/nclimate1981]; Slezak D, 2007, AQUAT SCI, V69, P377, DOI 10.1007/s00027-007-0896-z; Spielmeyer A, 2012, J EXP MAR BIOL ECOL, V413, P121, DOI 10.1016/j.jembe.2011.12.004; Spielmeyer A, 2011, CHEMBIOCHEM, V12, P2276, DOI 10.1002/cbic.201100416; Stefels J, 1996, MAR ECOL PROG SER, V131, P307, DOI 10.3354/meps131307; STEFELS J, 1995, MAR ECOL PROG SER, V123, P235, DOI 10.3354/meps123235; STEFELS J, 1993, MAR ECOL PROG SER, V97, P11, DOI 10.3354/meps097011; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Stefels J, 2007, BIOGEOCHEMISTRY, V83, P245, DOI 10.1007/s10533-007-9091-5; Steiner N, 2008, DEEP-SEA RES PT I, V55, P847, DOI 10.1016/j.dsr.2008.02.010; Steinke M, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P317; Steinke M, 1998, MAR ECOL PROG SER, V175, P215, DOI 10.3354/meps175215; Steinke M, 2002, AQUAT MICROB ECOL, V26, P259, DOI 10.3354/ame026259; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Taylor BF, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P265; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Toole DA, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000426; TURNER SM, 1988, LIMNOL OCEANOGR, V33, P364, DOI 10.4319/lo.1988.33.3.0364; Turner SM, 1996, MAR CHEM, V54, P245, DOI 10.1016/0304-4203(96)00028-X; VAIRAVAMURTHY A, 1985, LIMNOL OCEANOGR, V30, P59, DOI 10.4319/lo.1985.30.1.0059; Vallina SM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000415; Vallina SM, 2007, SCIENCE, V315, P506, DOI 10.1126/science.1133680; van Duyl FC, 1998, J SEA RES, V40, P221, DOI 10.1016/S1385-1101(98)00024-0; vandenBerg AJ, 1996, MAR ECOL PROG SER, V145, P233, DOI 10.3354/meps145233; Vezina AF, 2004, CAN J FISH AQUAT SCI, V61, P845, DOI 10.1139/F04-025; Vila-Costa M, 2008, LIMNOL OCEANOGR, V53, P198, DOI 10.4319/lo.2008.53.1.0198; Vila-Costa M, 2006, ENVIRON MICROBIOL, V8, P2189, DOI 10.1111/j.1462-2920.2006.01102.x; Vila-Costa M, 2006, SCIENCE, V314, P652, DOI 10.1126/science.1131043; Watanabe YW, 2007, MAR CHEM, V103, P347, DOI 10.1016/j.marchem.2006.10.004; Wolfe GV, 1996, LIMNOL OCEANOGR, V41, P1151, DOI 10.4319/lo.1996.41.6.1151; Wolfe GV, 1999, AQUAT MICROB ECOL, V18, P197, DOI 10.3354/ame018197; Yang M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006526; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Zubkov M, 2004, MAR ECOL PROG SER, V271, P77, DOI 10.3354/meps271077; Zubkov MV, 2001, ENVIRON MICROBIOL, V3, P304, DOI 10.1046/j.1462-2920.2001.00196.x; Zubkov MV, 2002, DEEP-SEA RES PT II, V49, P3017, DOI 10.1016/S0967-0645(02)00069-3	117	12	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85862	10.1371/journal.pone.0085862	http://dx.doi.org/10.1371/journal.pone.0085862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465753	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000068
J	Kulma, K; Low, M; Bensch, S; Qvarnstrom, A				Kulma, Katarzyna; Low, Matthew; Bensch, Staffan; Qvarnstrom, Anna			Malaria-Infected Female Collared Flycatchers (Ficedula albicollis) Do Not Pay the Cost of Late Breeding	PLOS ONE			English	Article							AVIAN BLOOD PARASITES; HISTORY TRADE-OFF; REPRODUCTIVE EFFORT; TERMINAL INVESTMENT; FOOD ABUNDANCE; BLUE TITS; WILD; PLASMODIUM; COEXISTENCE; PREVALENCE	Life-history theory predicts that the trade-off between parasite defense and other costly traits such as reproduction may be most evident when resources are scarce. The strength of selection that parasites inflict on their host may therefore vary across environmental conditions. Collared flycatchers (Ficedula albicollis) breeding on the Swedish island Oland experience a seasonal decline in their preferred food resource, which opens the possibility to test the strength of life-history trade-offs across environmental conditions. We used nested-PCR and quantitative-PCR protocols to investigate the association of Haemosporidia infection with reproductive performance of collared flycatcher females in relation to a seasonal change in the external environment. We show that despite no difference in mean onset of breeding, infected females produced relatively more of their fledglings late in the season. This pattern was also upheld when considering only the most common malaria lineage (hPHSIB1), however there was no apparent link between the reproductive output and the intensity of infection. Infected females produced heavier-than-average fledglings with higher-than-expected recruitment success late in the season. This reversal of the typical seasonal trend in reproductive output compensated them for lower fledging and recruitment rates compared to uninfected birds earlier in the season. Thus, despite different seasonal patterns of reproductive performance the overall number of recruits was the same for infected versus uninfected birds. A possible explanation for our results is that infected females breed in a different microhabitat where food availability is higher late in the season but also is the risk of infection. Thus, our results suggest that another trade-off than the one we aimed to test is more important for explaining variation in reproductive performance in this natural population: female flycatchers appear to face a trade-off between the risk of infection and reproductive success late in the season.	[Kulma, Katarzyna; Qvarnstrom, Anna] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Low, Matthew] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Bensch, Staffan] Lund Univ, Dept Biol, Lund, Sweden	Uppsala University; Swedish University of Agricultural Sciences; Lund University	Kulma, K (corresponding author), Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden.	katarzyna.kulma@ebc.uu.se		Qvarnstrom, Anna/0000-0002-1178-4053; Low, Matthew/0000-0002-7345-6063	Swedish Research Council; Swedish Research Council for Environment, Agricultural and Spatial Planning; European Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural and Spatial Planning(Swedish Research Council Formas); European Research Foundation(European Science Foundation (ESF))	Our work is funded by the Swedish Research Council (VR to AQ) and the Swedish Research Council for Environment, Agricultural and Spatial Planning (Formas to ML) and the European Research Foundation (AQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albon SD, 2002, P ROY SOC B-BIOL SCI, V269, P1625, DOI 10.1098/rspb.2002.2064; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Asghar M, 2011, J AVIAN BIOL, V42, P530, DOI 10.1111/j.1600-048X.2011.05281.x; Atkinson C.T., 2009, PARASITIC DIS WILD B; Barton K., 2012, MUMIN MULTIMODEL INF; Bates D., 2011, PACKAGE LME4 LINEAR; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Christe P, 2001, OECOLOGIA, V126, P333, DOI 10.1007/s004420000527; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; DOBSON A, 1994, TRENDS ECOL EVOL, V9, P393, DOI 10.1016/0169-5347(94)90062-0; Ebert Dieter, 1996, Trends in Ecology and Evolution, V11, P79, DOI 10.1016/0169-5347(96)81047-0; French SS, 2007, AM NAT, V170, P79, DOI 10.1086/518569; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Ilmonen P, 1999, OIKOS, V86, P79, DOI 10.2307/3546571; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; Knowles SCL, 2011, MOL ECOL, V20, P1062, DOI 10.1111/j.1365-294X.2010.04909.x; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Kulma K, 2013, MOL ECOL, V22, P4591, DOI 10.1111/mec.12409; Loye J.E., 1991, BIRD PARASITE INTERA; Lundberg A, 1992, PIED FLYCATCHER; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; Marzal A, 2012, MALARIA PARASITES, P135, DOI DOI 10.5772/33730; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; Messina FJ, 1999, PHYSIOL ENTOMOL, V24, P358, DOI 10.1046/j.1365-3032.1999.00151.x; Messina FJ, 2003, J EVOLUTION BIOL, V16, P501, DOI 10.1046/j.1420-9101.2003.00535.x; Mullarney K, 2000, BIRDS EUROPE; Palinauskas V, 2008, EXP PARASITOL, V120, P372, DOI 10.1016/j.exppara.2008.09.001; PART T, 1992, AM NAT, V140, P868, DOI 10.1086/285445; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; Qvarnstrom A, 2005, BIOL LETTERS, V1, P68, DOI 10.1098/rsbl.2004.0265; Qvarnstrom A, 2010, PHILOS T R SOC B, V365, P1841, DOI 10.1098/rstb.2009.0306; Qvarnstrom A, 2009, ECOLOGY, V90, P1948, DOI 10.1890/08-0494.1; R Development Core Team, 2012, R LANG ENV STAT COMP; Raberg L, 2000, ECOL LETT, V3, P382, DOI 10.1046/j.1461-0248.2000.00154.x; Rice AM, 2013, HORM BEHAV, V63, P813, DOI 10.1016/j.yhbeh.2013.03.019; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santiago-Alarcon D, 2012, BIOL REV, V87, P928, DOI 10.1111/j.1469-185X.2012.00234.x; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Siikamaki P, 1998, ECOLOGY, V79, P1789, DOI 10.1890/0012-9658(1998)079[1789:LORSBF]2.0.CO;2; Stearns S.C., 1992, pi; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Thomas DW, 2007, FUNCT ECOL, V21, P947, DOI 10.1111/j.1365-2435.2007.01301.x; Valkiunas G, 2005, AVIAN MALARIA PARASI; Veen T, 2010, OECOLOGIA, V162, P873, DOI 10.1007/s00442-009-1544-1; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x	49	10	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85822	10.1371/journal.pone.0085822	http://dx.doi.org/10.1371/journal.pone.0085822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465726	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000027
J	Musinguzi, G; Bwayo, D; Kiwanuka, N; Coutinho, S; Mukose, A; Kabanda, J; Sekabembe, L; Nuwaha, F				Musinguzi, Geofrey; Bwayo, Denis; Kiwanuka, Noah; Coutinho, Sheila; Mukose, Aggrey; Kabanda, Joseph; Sekabembe, Lilian; Nuwaha, Fred			Sexual Behavior among Persons Living with HIV in Uganda: Implications for Policy and Practice	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RISK BEHAVIOR; URBAN UGANDA; PREVENTION; HIV/AIDS; PREVALENCE; WOMEN; MEN	Introduction: HIV epidemics are sustained and propagated by new cases of infection which result from transmission from infected persons to uninfected susceptible individuals. People living with HIV (PLHIV) play a critical role in prevention if they adopt safer sexual behaviors. This study estimated the prevalence of and factors associated with safer sexual behaviors among PLHIV seeking care from civil society organizations (CSOs). Methods: In a cross sectional study PLHIV were interviewed about their sexual practices, use of alcohol, HIV status of their regular sexual partners, desire for more children and about their socio-demographic characteristics. We calculated the proportion of PLHIV who abstained and consistently used condoms in the previous twelve months. Independent associations between safer sex and other variables were estimated using adjusted prevalence ratios (aPR) and their 95% confidence intervals (CI). \Results: Of the 939 PLHIV, 54% (508) were either abstaining or using condoms consistently and 291 (31%) desired more children. The prevalence of consistent condom use among the sexually active was 41.3% (300/ 731). Consistent condom use was higher among PLHIV who: didn't use alcohol (aPR 1.30, CI 1.03-1.63); were educated about re-infection with a new strain of HIV (aPR 1.84, CI 1.08-3.12) and had regular sexual partner who was HIV negative (aPR 1.29, CI 1.05-1.57). Prevalence of abstinence was 22.2% (208/ 939). Abstinence increased with age from 9.4% among PLHIV<25 years to 40.5% among those >50 years. Abstinence was extremely low (2.5%) among PLHIV who were married. Conclusions: Effective interventions that reduce alcohol consumption among PLHIV are needed to avert HIV transmission, prevent acquisition of new HIV strains and STIs. In addition, strategies are needed to address needs of PLHIV who desire more children.	[Musinguzi, Geofrey; Nuwaha, Fred] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Bwayo, Denis; Coutinho, Sheila; Kabanda, Joseph; Sekabembe, Lilian] Civil Soc Fund, Kampala, Uganda; [Kiwanuka, Noah; Mukose, Aggrey] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda	Makerere University; Makerere University	Musinguzi, G (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.				United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The study was funded by the United States Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2011, CULT HEALTH SEX, V13, P529, DOI 10.1080/13691058.2011.558593; Amirkhanian YA, 2005, AIDS, V19, P1897, DOI 10.1097/01.aids.0000189867.74806.fb; [Anonymous], 2009, STUD FAMILY PLANN, V40, P161; AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; Bateganya M, 2005, AIDS PATIENT CARE ST, V19, P760, DOI 10.1089/apc.2005.19.760; Berry S., 2006, WHY IS UGANDA INTERE; Biraro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055060; Chakrapani V, 2010, AIDS PATIENT CARE ST, V24, P49, DOI 10.1089/apc.2009.0214; Diabate S, 2007, AIDS, V21, P1799, DOI 10.1097/QAD.0b013e3282a5667b; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; Kirungi WL, 2006, SEX TRANSM INFECT, V82, pI36, DOI 10.1136/sti.2005.017111; Kish L, 1965, SURVEY SAMPLING; Manjunatha R, 2011, AUSTRALAS MED J, V4, P150, DOI 10.4066/AMJ.2011.577; Matovu SN, 2012, OCCUP THER INT, V19, P176, DOI 10.1002/oti.1330; MoH, 2011, STAT ANT THER SERV U; Moore AR, 2007, SOC SCI MED, V64, P1057, DOI 10.1016/j.socscimed.2006.10.004; MPFED, 2012, KEY FACTS UG POP; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Ncube N M, 2012, Ghana Med J, V46, P27; Republic of Mozambique National AIDS Control Council 2012, 2012, GLOB AIDS RESP PROGR; Saniel OP, 2010, INT MARIT HEALTH, V61, P215; Sarna A, 2008, INT J STD AIDS, V19, P85, DOI 10.1258/ijsa.2007.007097; Sarna A, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-9; Schackman BR, 2008, AIDS PATIENT CARE ST, V22, P123, DOI 10.1089/apc.2007.0037; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; Shah M, 2011, AIDS, V25, P1093, DOI 10.1097/QAD.0b013e32834670b9; Signorelli D, 1998, Clin Podiatr Med Surg, V15, P179; Tumukunde D, 2010, East Afr Med J, V87, P91; UAC, 2011, UG AIDS IND SURV 201; UAC, 2010, NAT HIV PREV STRAT 2; Wandera B, 2011, JAIDS-J ACQ IMM DEF, V57, P62, DOI 10.1097/QAI.0b013e318211b3f2; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E	32	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85646	10.1371/journal.pone.0085646	http://dx.doi.org/10.1371/journal.pone.0085646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297XI	24465631	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000019
J	Mustafa, MB; Salim, SS; Mohamed, N; Al-Qatab, B; Siong, CE				Mustafa, Mumtaz Begum; Salim, Siti Salwah; Mohamed, Noraini; Al-Qatab, Bassam; Siong, Chng Eng			Severity-Based Adaptation with Limited Data for ASR to Aid Dysarthric Speakers	PLOS ONE			English	Article							SPEECH	Automatic speech recognition (ASR) is currently used in many assistive technologies, such as helping individuals with speech impairment in their communication ability. One challenge in ASR for speech-impaired individuals is the difficulty in obtaining a good speech database of impaired speakers for building an effective speech acoustic model. Because there are very few existing databases of impaired speech, which are also limited in size, the obvious solution to build a speech acoustic model of impaired speech is by employing adaptation techniques. However, issues that have not been addressed in existing studies in the area of adaptation for speech impairment are as follows: (1) identifying the most effective adaptation technique for impaired speech; and (2) the use of suitable source models to build an effective impaired-speech acoustic model. This research investigates the above-mentioned two issues on dysarthria, a type of speech impairment affecting millions of people. We applied both unimpaired and impaired speech as the source model with well-known adaptation techniques like the maximum likelihood linear regression (MLLR) and the constrained-MLLR(C-MLLR). The recognition accuracy of each impaired speech acoustic model is measured in terms of word error rate (WER), with further assessments, including phoneme insertion, substitution and deletion rates. Unimpaired speech when combined with limited high-quality speech-impaired data improves performance of ASR systems in recognising severely impaired dysarthric speech. The C-MLLR adaptation technique was also found to be better than MLLR in recognising mildly and moderately impaired speech based on the statistical analysis of the WER. It was found that phoneme substitution was the biggest contributing factor in WER in dysarthric speech for all levels of severity. The results show that the speech acoustic models derived from suitable adaptation techniques improve the performance of ASR systems in recognising impaired speech with limited adaptation data.	[Mustafa, Mumtaz Begum; Salim, Siti Salwah; Mohamed, Noraini; Al-Qatab, Bassam] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia; [Siong, Chng Eng] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore	Universiti Malaya; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mustafa, MB (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia.	mumtaz@um.edu.my	Mustafa, Mumtaz Begum/A-7277-2013; SALIM, SITI SALWAH/B-7848-2010; Eng-Siong, CHNG/ABH-6779-2020	Mustafa, Mumtaz Begum/0000-0002-2835-4084; SALIM, SITI SALWAH/0000-0002-0594-1382; Eng-Siong, CHNG/0000-0001-6257-7399	Ministry of Higher Education Malaysia [C/HIR/MOHE/FCSIT/05]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	This research is supported by UM High Impact Research Grant UM-MOHE UM. C/HIR/MOHE/FCSIT/05 from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beukelman D, 1992, AUGMENTATIVE ALTERNA; Carlson G.S., 1987, P 10 ANN C REH TECHN, P165; COLEMAN C L, 1991, AAC (Augmentative and Alternative Communication), V7, P34, DOI 10.1080/07434619112331275663; Deng L, 2009, HUMAN MACHINE LEARNI; Deng YB, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P632; DIGALAKIS VV, 1995, IEEE T SPEECH AUDI P, V3, P357, DOI 10.1109/89.466659; Ferras M, 2007, INT CONF ACOUST SPEE, P53; Ferras M, 2010, IEEE T AUDIO SPEECH, V18, P1366, DOI 10.1109/TASL.2009.2034187; FRIEDOKEN M, 1985, ARCH PHYS MED REHAB, V66, P678; Gauvain J, 1991, P HLT 91 P WORKSH SP; Green P., 2003, EUROSPEECH; Jing Lung JW, 2011, INT C INF COMM MAN I, P16; Kim H, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P1741; Kotler AL., 1997, AUGMENTATIVE ALTERNA, V13, P71, DOI DOI 10.1080/07434619712331277858; Lamel L, 1986, SAIC861546 DARPA SPE, P100; LaPointe L, 1994, INTRO COMMUNICATION, P351; LEGGETTER CJ, 1995, COMPUT SPEECH LANG, V9, P171, DOI 10.1006/csla.1995.0010; Liu HM, 2005, J ACOUST SOC AM, V117, P3879, DOI 10.1121/1.1898623; MenendezPidal X, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P1962, DOI 10.1109/ICSLP.1996.608020; Mengistu KT, 2011, P CAN C ART INT ST J; Mokbel C, 1997, SPEECH COMMUN, V23, P141, DOI 10.1016/S0167-6393(97)00042-3; Morales OC, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P1761; Morales SOC, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/308340; NEY H, 1990, SIGNAL PROCESSING V : THEORIES AND APPLICATIONS, VOLS 1-3, P65; Patel R, 1999, ETRW DIALOGUE PROSOD; Polikoff J., 1999, P INT C PHON SCI, P783; Raghavendra P., 2001, AUGMENTATIVE ALTERN, V17, P265, DOI DOI 10.1080/AAC.17.4.265.275; Rosengren E, 1995, EUROPEAN CONTEXT ASS, P336; Rudzicz F, 2010, PROC ANN C NEURAL IN, P70; Rudzicz F, 2007, P 9 INT ACM SIGACCES, P256; Rudzicz F, 2012, LANG RESOUR EVAL, V46, P523, DOI 10.1007/s10579-011-9145-0; Sanders E., 2002, P INTERSPEECH, P661; Schuster-Bockler Benjamin, 2007, Curr Protoc Bioinformatics, VAppendix 3, p3A, DOI 10.1002/0471250953.bia03as18; Sharma H. V., 2010, P NAACL HLT 2010 WOR, P72; Sid-Ahmed S, 2009, EURASIP J ADV SIG PR, V2009; Vijayalakshmi P, 2006, P 28 IEEE EMBS ANN I; Wang Z, 2003, ICASSP 2003, V1, P540; Yakcoub MS, 2008, P 3 INT S COMM CONTR, P12; Yampolsky, 2000, AUGMENTATIVE ALTERNA, V16, P48, DOI [DOI 10.1080/07434610012331278904, 10.1080/07434610012331278904]; Yin SC, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P2218; Young S., 2000, HTK BOOK VERSION 3 0	41	30	30	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86285	10.1371/journal.pone.0086285	http://dx.doi.org/10.1371/journal.pone.0086285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466004	Green Published, gold			2022-12-25	WOS:000330288000076
J	Schroeder, NM; Matteucci, SD; Moreno, PG; Gregorio, P; Ovejero, R; Taraborelli, P; Carmanchahi, PD				Schroeder, Natalia M.; Matteucci, Silvia D.; Moreno, Pablo G.; Gregorio, Pablo; Ovejero, Ramiro; Taraborelli, Paula; Carmanchahi, Pablo D.			Spatial and Seasonal Dynamic of Abundance and Distribution of Guanaco and Livestock: Insights from Using Density Surface and Null Models	PLOS ONE			English	Article							SPECIES COOCCURRENCE; NORTHERN PATAGONIA; LARGE HERBIVORES; LAMA-GUANICOE; DISTANCE; POPULATION; MOVEMENTS; MIGRATION	Monitoring species abundance and distribution is a prerequisite when assessing species status and population viability, a difficult task to achieve for large herbivores at ecologically meaningful scales. Co-occurrence patterns can be used to infer mechanisms of community organization (such as biotic interactions), although it has been traditionally applied to binary presence/absence data. Here, we combine density surface and null models of abundance data as a novel approach to analyze the spatial and seasonal dynamics of abundance and distribution of guanacos (Lama guanicoe) and domestic herbivores in northern Patagonia, in order to visually and analytically compare the dispersion and co-occurrence pattern of ungulates. We found a marked seasonal pattern in abundance and spatial distribution of L. guanicoe. The guanaco population reached its maximum annual size and spatial dispersion in spring-summer, decreasing up to 6.5 times in size and occupying few sites of the study area in fall-winter. These results are evidence of the seasonal migration process of guanaco populations, an increasingly rare event for terrestrial mammals worldwide. The maximum number of guanacos estimated for spring (25951) is higher than the total population size (10000) 20 years ago, probably due to both counting methodology and population growth. Livestock were mostly distributed near human settlements, as expected by the sedentary management practiced by local people. Herbivore distribution was non-random; i.e., guanaco and livestock abundances co-varied negatively in all seasons, more than expected by chance. Segregation degree of guanaco and small-livestock (goats and sheep) was comparatively stronger than that of guanaco and large-livestock, suggesting a competition mechanism between ecologically similar herbivores, although various environmental factors could also contribute to habitat segregation. The new and compelling combination of methods used here is highly useful for researchers who conduct counts of animals to simultaneously estimate population sizes, distributions, assess temporal trends and characterize multi-species spatial interactions.	[Schroeder, Natalia M.; Taraborelli, Paula] Consejo Nacl Invest Cient & Tecn, Inst Argentino Invest Zonas Aridas IADIZA, Mendoza, Argentina; [Schroeder, Natalia M.; Moreno, Pablo G.; Gregorio, Pablo; Ovejero, Ramiro; Taraborelli, Paula; Carmanchahi, Pablo D.] Consejo Nacl Invest Cient & Tecn, GIEFAS INIBIOMA AUSMA UNCo, San Martin, Neuquen, Argentina; [Matteucci, Silvia D.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Moreno, Pablo G.] Consejo Nacl Invest Cient & Tecn, ICiVet Litoral, LEcEn, FCV UNL, Santa Fe, Argentina; [Ovejero, Ramiro] Consejo Nacl Invest Cient & Tecn, GIB IADIZA, Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Schroeder, NM (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Argentino Invest Zonas Aridas IADIZA, Mendoza, Argentina.	natalias@mendoza-conicet.gob.ar	Moreno, Pablo/AAC-7057-2020	Moreno, Pablo/0000-0002-9856-1679	IDEA WILD; Sigma Xi; Cleveland Metro Park Zoo-Scott Neotropical Fund; CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)	IDEA WILD; Sigma Xi; Cleveland Metro Park Zoo-Scott Neotropical Fund; CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was partially financed by IDEA WILD (www.ideawild.org/apply.html), Sigma Xi-Grants-in-Aid of Research Program (www.sigmaxi.org/programs/giar/index.shtml) and Cleveland Metro Park Zoo-Scott Neotropical Fund (www.clemetzoo.com/conservation/grants/scott/). The financial support was exclusively for field equipment and fieldwork. N.S. was supported by a doctoral fellowship from CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas, www.conicet.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DR, 1983, ECOLOGY, V64, P674, DOI 10.2307/1937188; Augustine DJ, 2001, ECOLOGY, V82, P3149, DOI 10.1890/0012-9658(2001)082[3149:EOMGOS]2.0.CO;2; Bagchi S, 2004, ANIM CONSERV, V7, P121, DOI 10.1017/S1367943003001148; Baldi R, 2001, OECOLOGIA, V129, P561, DOI 10.1007/s004420100770; BALLARD WB, 1997, WILDLIFE MONOGR, V135, P3; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Bhola N, 2012, BIODIVERS CONSERV, V21, P1509, DOI 10.1007/s10531-012-0261-y; Bolger DT, 2008, ECOL LETT, V11, P63; Buckland S.T., 2001, pi; Buckland ST, 2012, J APPL ECOL, V49, P960, DOI 10.1111/j.1365-2664.2012.02150.x; Burgi MV, 2005, RADIO ACCION USO HAB; Candia R., 1993, MULTEQUINA, V2, P5; Contreras M., 2006, MINERIA BIODIVERSIDA; Efron B., 1994, INTRO BOOTSTRAP; Faas CJ, 2010, J WILDLIFE MANAGE, V74, P698, DOI 10.2193/2009-135; FRANKLIN W, 1983, ADV STUDY MAMMALIAN; Franklin W.L., 1991, P317; Franklin W. L., 1982, MAMMALIAN BIOL S AM, P457; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.1890/0012-9658(2002)083[2091:SCOAMA]2.0.CO;2; Gregory RD, 1998, J APPL ECOL, V35, P785, DOI 10.1046/j.1365-2664.1998.355349.x; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hedley SL, 2004, ADV DISTANCE SAMPLIN; Herr H, 2009, MAR BIOL, V156, P811, DOI 10.1007/s00227-008-1105-x; Iranzo EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059326; Jathanna D, 2003, J ZOOL, V261, P285, DOI 10.1017/S0952836903004278; Joseph LN, 2006, CONSERV BIOL, V20, P1679, DOI 10.1111/j.1523-1739.2006.00529.x; Katsanevakis S, 2007, MAR BIOL, V152, P77, DOI 10.1007/s00227-007-0659-3; Katsanevakis S, 2009, AQUAT BIOL, V8, P45, DOI 10.3354/ab00204; Kaufmann J, 2013, APPL ANIM BEHAV SCI, V146, P1, DOI 10.1016/j.applanim.2013.03.014; Madhusudan MD, 2004, J APPL ECOL, V41, P858, DOI 10.1111/j.0021-8901.2004.00950.x; Martinez Carretero E., 2004, B SOC ARGENT BOT, V39, P195; Novaro AJ, 2000, BIOL CONSERV, V92, P25, DOI 10.1016/S0006-3207(99)00065-8; Ogutu JO, 2010, ECOL MONOGR, V80, P241, DOI 10.1890/09-0439.1; Ortega IM, 1995, REV CHIL HIST NAT, V68, P489; Pedrana J, 2010, BIODIVERS CONSERV, V19, P3499, DOI 10.1007/s10531-010-9910-1; Petersen IK, 2011, 20111 CTR RES EC ENV; Pink M, 2007, N AM J FISH MANAGE, V27, P246, DOI 10.1577/M06-004.1; Puig S, 1997, J ARID ENVIRON, V36, P343, DOI 10.1006/jare.1996.0186; Puig S, 2001, J ARID ENVIRON, V47, P291, DOI 10.1006/jare.2000.0677; Puig Silvia, 2003, Multequina, V12, P37; Raedeke K.J., 1979, POPULATION DYNAMICS; Ruette S, 2003, J APPL ECOL, V40, P32, DOI 10.1046/j.1365-2664.2003.00776.x; Schroeder NM, 2013, J ZOOL, DOI [10.1111/jzo.12065, DOI 10.1111/JZ0.12065]; Smith GW, 2002, J WILDLIFE MANAGE, V66, P463, DOI 10.2307/3803179; Somveille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070907; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Turner MD, 2002, LANDSCAPE ECOL, V17, P367, DOI 10.1023/A:1021238208019; Ulrich W, 2010, ECOLOGY, V91, P3384, DOI 10.1890/09-2157.1; Burgi MV, 2012, ORYX, V46, P99, DOI 10.1017/S0030605311000214; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	53	31	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85960	10.1371/journal.pone.0085960	http://dx.doi.org/10.1371/journal.pone.0085960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465812	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100090
J	Thorner, J; Kumar, L; Smith, SDA				Thorner, Jaqueline; Kumar, Lalit; Smith, Stephen D. A.			Impacts of Climate-Change-Driven Sea Level Rise on Intertidal Rocky Reef Habitats Will Be Variable and Site Specific	PLOS ONE			English	Article							COASTAL WETLANDS; PROTECTED AREAS; BIODIVERSITY; SHORES; LIDAR	Intertidal rocky reefs are complex and rich ecosystems that are vulnerable to even the smallest fluctuations in sea level. We modelled habitat loss associated with sea level rise for intertidal rocky reefs using GIS, high-resolution digital imagery, and LIDAR technology at fine-scale resolution (0.1 m per pixel). We used projected sea levels of +0.3 m, +0.5 m and +1.0 m above current Mean Low Tide Level (0.4 m). Habitat loss and changes were analysed for each scenario for five headlands in the Solitary Islands Marine Park (SIMP), Australia. The results indicate that changes to habitat extent will be variable across different shores and will not necessarily result in net loss of area for some habitats. In addition, habitat modification will not follow a regular pattern over the projected sea levels. Two of the headlands included in the study currently have the maximum level of protection within the SIMP. However, these headlands are likely to lose much of the habitat known to support biodiverse assemblages and may not continue to be suitable sanctuaries into the future. The fine-scale approach taken in this study thus provides a protocol not only for modelling habitat modification but also for future proofing conservation measures under a scenario of changing sea levels.	[Thorner, Jaqueline; Kumar, Lalit] Univ New England UNE, Sch Rural & Environm Sci, Armidale, NSW, Australia; [Thorner, Jaqueline; Smith, Stephen D. A.] Southern Cross Univ SCU, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia	University of New England; Southern Cross University	Thorner, J (corresponding author), Univ New England UNE, Sch Rural & Environm Sci, Armidale, NSW, Australia.	jduraubu@myune.edu.au	Smith, Stephen D A/I-1945-2012; Kumar, Lalit/A-6397-2011	Smith, Stephen D A/0000-0002-3372-5441; Kumar, Lalit/0000-0002-9205-756X	University of New England	University of New England	University of New England funded the research (www.une.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Adams JC, 2002, PHOTOGRAMM REC, V17, P405, DOI 10.1111/0031-868X.00195; Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583; Akumu CE, 2011, J COAST CONSERV, V15, P15, DOI 10.1007/s11852-010-0114-3; Bray MJ, 1997, J COASTAL RES, V13, P453; Brock JC, 2002, J COASTAL RES, V18, P1; Brooks SM, 2012, GLOBAL PLANET CHANGE, V80-81, P165, DOI 10.1016/j.gloplacha.2011.10.008; Cazenave A, 2009, GLOBAL PLANET CHANGE, V65, P83, DOI 10.1016/j.gloplacha.2008.10.004; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Church JA, 2008, SUSTAIN SCI, V3, P9, DOI 10.1007/s11625-008-0042-4; Chust G, 2008, ESTUAR COAST SHELF S, V78, P633, DOI 10.1016/j.ecss.2008.02.003; Cooper HM, 2012, CLIMATIC CHANGE, P1; Environmental Systems Research Institute, 2012, ARCGIS DESKT REL 10; Fish MR, 2008, OCEAN COAST MANAGE, V51, P330, DOI 10.1016/j.ocecoaman.2007.09.002; Foremann MGG, 1977, MANUAL TIDAL HEIGHTS; Garcia A, 2012, FACTORS INFLUENCING; Gilman E, 2007, ENVIRON MONIT ASSESS, V124, P105, DOI 10.1007/s10661-006-9212-y; Gregory JM, 2006, PHILOS T R SOC A, V364, P1709, DOI 10.1098/rsta.2006.1796; HAILS JR, 1965, AUST GEOGR STUD, V3, P63, DOI 10.1111/j.1467-8470.1965.tb00038.x; Hall RK, 2009, ENVIRON MONIT ASSESS, V159, P63, DOI 10.1007/s10661-008-0613-y; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Hanski I, 2011, AMBIO, V40, P248, DOI 10.1007/s13280-011-0147-3; Harrysson M., 2012, MCKINSEY Q, V4, P1; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Horton R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032486; Jackson AC, 2011, J EXP MAR BIOL ECOL, V400, P314, DOI 10.1016/j.jembe.2011.02.012; JOHNSON ME, 1988, J GEOL, V96, P469, DOI 10.1086/629241; Kappelle M, 1999, BIODIVERS CONSERV, V8, P1383, DOI 10.1023/A:1008934324223; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; KORSCH RJ, 1981, J GEOL SOC AUST, V28, P205, DOI 10.1080/00167618108729157; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Malcolm HA, 2011, DEEP-SEA RES PT II, V58, P616, DOI 10.1016/j.dsr2.2010.09.030; Malcolm Hamish A., 2010, Marine Biodiversity, V40, P181, DOI 10.1007/s12526-010-0042-3; Marine Parks, 2002, SOL ISL MAR PARK ZON; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Menge BA, 2001, MARINE COMMUNITY ECOLOGY, P221; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Murray SN, 2006, MONITORING ROCKY SHORES, P1, DOI 10.1525/california/9780520247284.001.0001; Nicholls RJ, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P315; Pethick J, 2001, CATENA, V42, P307, DOI 10.1016/S0341-8162(00)00143-0; Runting RK, 2013, GLOBAL CHANGE BIOL, V19, P352, DOI 10.1111/gcb.12064; Russell GL, 2000, CLIM DYNAM, V16, P789, DOI 10.1007/s003820000090; Senior CA, 2002, PHILOS T ROY SOC A, V360, P1301, DOI 10.1098/rsta.2002.1001; Shepherd A, 2007, SCIENCE, V315, P1529, DOI 10.1126/science.1136776; Smith SDA, 2005, BIODIVERS CONSERV, V14, P3565, DOI 10.1007/s10531-004-0828-3; Smith SDA, 2008, MAR POLLUT BULL, V56, P525, DOI 10.1016/j.marpolbul.2007.11.016; Solomon S, 2005, CLIMATE CHANGE 2007; Thorner J, 2013, J COASTAL RES, V29, P1184, DOI 10.2112/JCOASTRES-D-12-00142.1; Willis JK, 2012, SCIENCE, V336, P550, DOI 10.1126/science.1220366; [No title captured]	53	15	16	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86130	10.1371/journal.pone.0086130	http://dx.doi.org/10.1371/journal.pone.0086130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465915	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100110
J	Thresher, R; Althaus, F; Adkins, J; Gowlett-Holmes, K; Alderslade, P; Dowdney, J; Cho, W; Gagnon, A; Staples, D; McEnnulty, F; Williams, A				Thresher, Ronald; Althaus, Franziska; Adkins, Jess; Gowlett-Holmes, Karen; Alderslade, Phil; Dowdney, Jo; Cho, Walter; Gagnon, Alex; Staples, David; McEnnulty, Felicity; Williams, Alan			Strong Depth-Related Zonation of Megabenthos on a Rocky Continental Margin (similar to 700-4000 m) off Southern Tasmania, Australia	PLOS ONE			English	Article							DEEP-SEA; MEGAFAUNAL BIOMASS; SPECIES-DIVERSITY; NEW-ENGLAND; SEAMOUNTS; OCEAN; ATLANTIC; COMMUNITIES; TEMPERATURE; CHEMISTRY	Assemblages of megabenthos are structured in seven depth-related zones between similar to 700 and 4000 m on the rocky and topographically complex continental margin south of Tasmania, southeastern Australia. These patterns emerge from analysis of imagery and specimen collections taken from a suite of surveys using photographic and in situ sampling by epibenthic sleds, towed video cameras, an autonomous underwater vehicle and a remotely operated vehicle (ROV). Seamount peaks in shallow zones had relatively low biomass and low diversity assemblages, which may be in part natural and in part due to effects of bottom trawl fishing. Species richness was highest at intermediate depths (1000-1300 m) as a result of an extensive coral reef community based on the bioherm-forming scleractinian Solenosmilia variabilis. However, megabenthos abundance peaked in a deeper, low diversity assemblage at 2000-2500 m. The S. variabilis reef and the deep biomass zone were separated by an extensive dead, sub-fossil S. variabilis reef and a relatively low biomass stratum on volcanic rock roughly coincident with the oxygen minimum layer. Below 2400 m, megabenthos was increasingly sparse, though punctuated by occasional small pockets of relatively high diversity and biomass. Nonetheless, megabenthic organisms were observed in the vast majority of photographs on all seabed habitats and to the maximum depths observed - a sandy plain below 3950 m. Taxonomic studies in progress suggest that the observed depth zonation is based in part on changing species mixes with depth, but also an underlying commonality to much of the seamount and rocky substrate biota across all depths. Although the mechanisms supporting the extraordinarily high biomass in 2000-2500 m depths remains obscure, plausible explanations include equatorwards lateral transport of polar production and/or a response to depth-stratified oxygen availability.	[Thresher, Ronald; Althaus, Franziska; Gowlett-Holmes, Karen; Alderslade, Phil; Dowdney, Jo; McEnnulty, Felicity; Williams, Alan] CSIRO Wealth Oceans Flagship, Hobart, Tas, Australia; [Adkins, Jess; Gagnon, Alex] CALTECH, Pasadena, CA 91125 USA; [Cho, Walter] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Staples, David] Museum Victoria, Melbourne, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); California Institute of Technology; Woods Hole Oceanographic Institution; Museum Victoria	Thresher, R (corresponding author), CSIRO Wealth Oceans Flagship, Hobart, Tas, Australia.	Ron.Thresher@csiro.au	Althaus, Franziska/E-4660-2017; Williams, Alan/C-6999-2012; Althaus, Franziska/B-6873-2015; McEnnulty, Felicity R/K-6741-2018; Adkins, Jess/GYI-8778-2022	Althaus, Franziska/0000-0002-5336-4612; Williams, Alan/0000-0002-2867-7713; McEnnulty, Felicity R/0000-0002-3819-044X; Gagnon, Alexander/0000-0003-0717-2916	National Science Foundation; Australian Department of Environment, Water, Heritage, and the Arts; Australian Commonwealth Environmental Research Fund; CSIRO Wealth from Oceans and Climate Adaptation Flagships; Directorate For Geosciences [1204211] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Australian Department of Environment, Water, Heritage, and the Arts(Australian Government); Australian Commonwealth Environmental Research Fund; CSIRO Wealth from Oceans and Climate Adaptation Flagships; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Components of this work were supported by the National Science Foundation, the Australian Department of Environment, Water, Heritage, and the Arts, the Australian Commonwealth Environmental Research Fund, a grant of ship time by the Australian National Research Facility, and the CSIRO Wealth from Oceans and Climate Adaptation Flagships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Anderson TJ, 2011, DEEP-SEA RES PT II, V58, P979, DOI 10.1016/j.dsr2.2010.10.053; Biscoito M, 1998, CAH BIOL MAR, V39, P223; Buckeridge JS, 1999, NEW ZEAL J MAR FRESH, V33, P521, DOI 10.1080/00288330.1999.9516897; Cairns SD, 2007, P BIOL SOC WASH, V120, P243, DOI 10.2988/0006-324X(2007)120[243:SOWAOG]2.0.CO;2; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Cho W, 2008, THESIS MIT; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Dodds LA, 2007, J EXP MAR BIOL ECOL, V349, P205, DOI 10.1016/j.jembe.2007.05.013; Druffel ERM, 2000, GEOPHYS RES LETT, V27, P1495, DOI 10.1029/1999GL002398; Fallon SJ, CORAL REEFS IN PRESS; Freiwald A., 2005, COLD WATER CORALS EC; German CR, 2008, DEEP-SEA RES PT I, V55, P203, DOI 10.1016/j.dsr.2007.11.004; Glover AG, 2003, ENVIRON CONSERV, V30, P219, DOI 10.1017/S0376892903000225; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; HAEDRICH RL, 1980, MAR BIOL, V57, P165, DOI 10.1007/BF00390735; HAEDRICH RL, 1977, NATURE, V269, P141, DOI 10.1038/269141a0; Herring R, 2002, BIOL DEEP OCEAN; Honjo S, 2000, DEEP-SEA RES PT II, V47, P3521, DOI 10.1016/S0967-0645(00)00077-1; Howell KL, 2002, DEEP-SEA RES PT I, V49, P1901, DOI 10.1016/S0967-0637(02)00090-0; KAUFMANN RS, 1989, DEEP-SEA RES, V36, P1863, DOI 10.1016/0198-0149(89)90116-7; Koslow J.A., 2007, SILENT DEEP; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; LAMPITT RS, 1986, MAR BIOL, V93, P69, DOI 10.1007/BF00428656; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Lundsten L, 2009, MAR ECOL PROG SER, V374, P23, DOI 10.3354/meps07745; LUTZ RA, 1993, REV GEOPHYS, V31, P211, DOI 10.1029/93RG01280; McClain CR, 2005, OIKOS, V109, P555, DOI 10.1111/j.0030-1299.2005.13529.x; McClain CR, 2001, MAR BIOL, V139, P681; McClain CR, 2010, MAR ECOL-EVOL PERSP, V31, P14, DOI 10.1111/j.1439-0485.2010.00367.x; O'Hara TD, 2008, DIVERS DISTRIB, P1; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Rintoul SR, 1999, DEEP-SEA RES PT I, V46, P1417, DOI 10.1016/S0967-0637(99)00013-8; Roberts J. M., 2009, COLD WATER CORALS; Rogers A.D., 2007, SEAMOUNTS ECOLOGY FI, P3343; Rogers AD, 2000, DEEP-SEA RES PT II, V47, P119, DOI 10.1016/S0967-0645(99)00107-1; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; Sautya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016162; Shortis MR, 2008, MAR TECHNOL SOC J, V42, P28, DOI 10.4031/002533208787157624; Thiagarajan N, 2013, PALEOCEANOGRAPHY, V28, P227, DOI 10.1002/palo.20023; Thresher RE, 2011, SCI REP-UK, V1, DOI 10.1038/srep00119; Thresher RE, 2011, MAR ECOL PROG SER, V442, P87, DOI 10.3354/meps09400; Thresher RE, 2010, GEOCHIM COSMOCHIM AC, V74, P4655, DOI 10.1016/j.gca.2010.05.024; Waller RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016153; Wei CL, 2010, MAR ECOL PROG SER, V399, P1, DOI 10.3354/meps08388; Yesson C, 2012, J BIOGEOGR, V39, P1278, DOI 10.1111/j.1365-2699.2011.02681.x	48	34	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85872	10.1371/journal.pone.0085872	http://dx.doi.org/10.1371/journal.pone.0085872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465758	gold, Green Published			2022-12-25	WOS:000330283100084
J	Xu, MJ; Wen, XF; Wang, HM; Zhang, WJ; Dai, XQ; Song, J; Wang, YD; Fu, XL; Liu, YF; Sun, XM; Yu, GR				Xu, Mingjie; Wen, Xuefa; Wang, Huimin; Zhang, Wenjiang; Dai, Xiaoqin; Song, Jie; Wang, Yidong; Fu, Xiaoli; Liu, Yunfen; Sun, Xiaomin; Yu, Guirui			Effects of Climatic Factors and Ecosystem Responses on the Inter-Annual Variability of Evapotranspiration in a Coniferous Plantation in Subtropical China	PLOS ONE			English	Article							ASIAN SUMMER MONSOON; TROPICAL RAIN-FOREST; SAP-FLOW; CANOPY CONDUCTANCE; ENERGY-EXCHANGE; CARBON-DIOXIDE; WATER-VAPOR; SEASONAL-VARIATION; SOIL RESPIRATION; DECIDUOUS FOREST	Because evapotranspiration (ET) is the second largest component of the water cycle and a critical process in terrestrial ecosystems, understanding the inter-annual variability of ET is important in the context of global climate change. Eight years of continuous eddy covariance measurements (2003-2010) in a subtropical coniferous plantation were used to investigate the impacts of climatic factors and ecosystem responses on the inter-annual variability of ET. The mean and standard deviation of annual ET for 2003-2010 were 786.9 and 103.4 mm (with a coefficient of variation of 13.1%), respectively. The inter-annual variability of ET was largely created in three periods: March, May-June, and October, which are the transition periods between seasons. A set of look-up table approaches were used to separate the sources of inter-annual variability of ET. The annual ETs were calculated by assuming that (a) both the climate and ecosystem responses among years are variable (Vcli-eco), (b) the climate is variable but the ecosystem responses are constant (V-cli), and (c) the climate is constant but ecosystem responses are variable (V-eco). The ETs that were calculated under the above assumptions suggested that the inter-annual variability of ET was dominated by ecosystem responses and that there was a negative interaction between the effects of climate and ecosystem responses. These results suggested that for long-term predictions of water and energy balance in global climate change projections, the ecosystem responses must be taken into account to better constrain the uncertainties associated with estimation.	[Xu, Mingjie; Wen, Xuefa; Wang, Huimin; Dai, Xiaoqin; Fu, Xiaoli; Liu, Yunfen; Sun, Xiaomin; Yu, Guirui] Chinese Acad Sci, Qianyanzhou Ecol Stn, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Xu, Mingjie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Wenjiang] Sichuan Univ, State Key Lab Hydraul & Mt River Engn, Chengdu 610064, Peoples R China; [Song, Jie] No Illinois Univ, Dept Geog, De Kalb, IL USA; [Wang, Yidong] Tianjin Normal Univ, Tianjin Key Lab Water Resources & Environm, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sichuan University; Northern Illinois University; Tianjin Normal University	Wang, HM (corresponding author), Chinese Acad Sci, Qianyanzhou Ecol Stn, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	wanghm@igsnrr.ac.cn	于, 贵瑞/C-1768-2014; Wang, Yidong/I-4027-2014; wang, huimin/HDM-8421-2022	于, 贵瑞/0000-0002-1859-8966; Wang, Yidong/0000-0002-5399-2803; Xu, Mingjie/0000-0002-5923-2901	National Key Basic Research Special Foundation Project [2010CB833501]; Major Program of National Natural Science Foundation of China [31290221]; National Natural Science Foundation of China [31070559, 31210103920]; National Key Basic Research Program of China [2012CB416903]	National Key Basic Research Special Foundation Project(National Basic Research Program of China); Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was funded by the National Key Basic Research Special Foundation Project (2010CB833501), Major Program of National Natural Science Foundation of China (31290221), National Natural Science Foundation of China (31070559, 31210103920) and the National Key Basic Research Program of China (2012CB416903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiral SW, 2006, AGR FOREST METEOROL, V140, P308, DOI 10.1016/j.agrformet.2006.03.017; Alfieri JG, 2007, J HYDROMETEOROL, V8, P207, DOI 10.1175/JHM569.1; Bader MKF, 2010, PLANTA, V232, P1115, DOI 10.1007/s00425-010-1240-8; BALDOCCHI DD, 1988, ECOLOGY, V69, P1331, DOI 10.2307/1941631; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Bernier PY, 2006, AGR FOREST METEOROL, V140, P64, DOI 10.1016/j.agrformet.2006.03.019; Betts AK, 1999, J CLIMATE, V12, P1601, DOI 10.1175/1520-0442(1999)012<1601:COEIAB>2.0.CO;2; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bracho R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000469; Bucci SJ, 2008, AGR FOREST METEOROL, V148, P839, DOI 10.1016/j.agrformet.2007.11.013; BUTLER DR, 1976, AGR METEOROL, V16, P277, DOI 10.1016/0002-1571(76)90047-9; Cernusak LA, 2013, FUNCT PLANT BIOL, V40, P531, DOI 10.1071/FP12309; Chang XX, 2006, AGR FOREST METEOROL, V138, P132, DOI 10.1016/j.agrformet.2006.04.003; Ding YH, 2005, METEOROL ATMOS PHYS, V89, P117, DOI 10.1007/s00703-005-0125-z; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; FAO, 2006, FAO FORESTRY PAPER; FAVER KL, 1989, AGR FOREST METEOROL, V48, P175, DOI 10.1016/0168-1923(89)90015-4; Fisher JB, 2011, GLOBAL ECOL BIOGEOGR, V20, P1, DOI 10.1111/j.1466-8238.2010.00578.x; Ge ZM, 2011, ECOL MODEL, V222, P1626, DOI 10.1016/j.ecolmodel.2011.02.022; Gholz HL, 2002, AGR FOREST METEOROL, V112, P87, DOI 10.1016/S0168-1923(02)00059-X; Granier A, 2007, AGR FOREST METEOROL, V143, P123, DOI 10.1016/j.agrformet.2006.12.004; Granier A, 2000, AGR FOREST METEOROL, V100, P291, DOI [10.1016/S0168-1923(99)00151-3, 10.1016/0168-1923(95)02252-X]; Ham JM, 1998, AGR FOREST METEOROL, V89, P1, DOI 10.1016/S0168-1923(97)00062-2; Hollinger DY, 2004, GLOBAL CHANGE BIOL, V10, P1689, DOI 10.1111/j.1365-2486.2004.00847.x; Holtum JAM, 2010, FUNCT PLANT BIOL, V37, P694, DOI 10.1071/FP10001; Hui DF, 2003, TREE PHYSIOL, V23, P433, DOI 10.1093/treephys/23.7.433; Huntington TG, 2006, J HYDROL, V319, P83, DOI 10.1016/j.jhydrol.2005.07.003; Iida S, 2006, J HYDROL, V326, P166, DOI 10.1016/j.jhydrol.2005.11.002; Jassal RS, 2009, AGR FOREST METEOROL, V149, P1168, DOI 10.1016/j.agrformet.2009.02.004; [戴丽君 Dai Lijun], 2012, [生态环境学报, Ecology and Environmental Sciences], V21, P1266; Kelliher FM, 1997, AGR FOREST METEOROL, V85, P135, DOI 10.1016/S0168-1923(96)02424-0; Kim W, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048521; Kochendorfer J, 2011, AGR FOREST METEOROL, V151, P544, DOI 10.1016/j.agrformet.2010.12.012; Komatsu H, 2012, J HYDROL, V420, P380, DOI 10.1016/j.jhydrol.2011.12.030; Kosugi Y, 2007, J HYDROL, V337, P269, DOI 10.1016/j.jhydrol.2007.01.039; Kumagai T, 2004, ADV WATER RESOUR, V27, P1135, DOI 10.1016/j.advwatres.2004.10.002; Kume T, 2008, AGR FOREST METEOROL, V148, P1181, DOI 10.1016/j.agrformet.2008.02.010; Kume T, 2011, AGR FOREST METEOROL, V151, P1183, DOI 10.1016/j.agrformet.2011.04.005; Li J, 2006, ACTA ECOLOGICA SINIC, V26, P2449; Li ZH, 2010, HYDROL PROCESS, V24, P2405, DOI 10.1002/hyp.7643; Liu SG, 1998, ECOL MODEL, V114, P19, DOI 10.1016/S0304-3800(98)00103-3; Lundquist JD, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010050; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2110, DOI 10.1111/j.1365-2486.2007.01432.x; Marcolla B, 2011, AGR FOREST METEOROL, V151, P1233, DOI 10.1016/j.agrformet.2011.04.015; Maximov T, 2008, AGR FOREST METEOROL, V148, P2013, DOI 10.1016/j.agrformet.2008.10.004; McCaughey JH, 2006, AGR FOREST METEOROL, V140, P79, DOI 10.1016/j.agrformet.2006.08.010; McPhaden MJ, 2004, B AM METEOROL SOC, V85, P677, DOI 10.1175/BAMS-85-5-677; Miao HX, 2009, AGR FOREST METEOROL, V149, P1810, DOI 10.1016/j.agrformet.2009.06.011; Monteith J., 1965, EVAPORATION ENV, P4; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Ohta T, 2008, AGR FOREST METEOROL, V148, P1941, DOI 10.1016/j.agrformet.2008.04.012; Oishi AC, 2010, ECOSYSTEMS, V13, P421, DOI 10.1007/s10021-010-9328-3; Parka H, 2008, AGR FOREST METEOROL, V148, P1990, DOI 10.1016/j.agrformet.2008.06.018; Parry M. L., 2007, CLIMATE CHANGE 2007; Pejam MR, 2006, HYDROL PROCESS, V20, P3709, DOI 10.1002/hyp.6384; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Piao SL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028205; Powell TL, 2005, CAN J FOREST RES, V35, P1568, DOI 10.1139/X05-075; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Richardson AD, 2007, GLOBAL CHANGE BIOL, V13, P788, DOI 10.1111/j.1365-2486.2007.01330.x; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Ryu Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009263; Saleska SR, 2003, SCIENCE, V302, P1554, DOI 10.1126/science.1091165; SAUGIER B, 1991, AGR FOREST METEOROL, V54, P263, DOI 10.1016/0168-1923(91)90009-F; Scott RL, 2004, AGR FOREST METEOROL, V122, P65, DOI 10.1016/j.agrformet.2003.09.001; SHUKLA J, 1982, SCIENCE, V215, P1498, DOI 10.1126/science.215.4539.1498; SHUTTLEWORTH WJ, 1985, Q J ROY METEOR SOC, V111, P839, DOI 10.1256/smsqj.46909; Si JH, 2007, J INTEGR PLANT BIOL, V49, P425, DOI 10.1111/j.1744-7909.2007.00388.x; Stoy PC, 2006, GLOBAL CHANGE BIOL, V12, P2115, DOI 10.1111/j.1365-2486.2006.01244.x; Sumner DM, 2005, ESTUARIES, V28, P844, DOI 10.1007/BF02696014; Tanaka N, 2008, AGR FOREST METEOROL, V148, P807, DOI 10.1016/j.agrformet.2008.01.011; Taylor G, 2008, GLOBAL CHANGE BIOL, V14, P264, DOI 10.1111/j.1365-2486.2007.01473.x; Tian FX, 2011, J ARID ENVIRON, V75, P648, DOI 10.1016/j.jaridenv.2011.02.001; Tognetti R, 2009, AGR FOREST METEOROL, V149, P1229, DOI 10.1016/j.agrformet.2009.02.008; Tu Jie, 2008, Scientia Silvae Sinicae, V44, P46; Urban O, 2012, PLANT PHYSIOL BIOCH, V58, P135, DOI 10.1016/j.plaphy.2012.06.023; Wang B, 2002, J CLIMATE, V15, P386, DOI 10.1175/1520-0442(2002)015<0386:RSOTAP>2.0.CO;2; Wang B, 2001, J CLIMATE, V14, P4073, DOI 10.1175/1520-0442(2001)014<4073:IVOTAS>2.0.CO;2; Wang KC, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000373; Wang YD, 2012, CAN J FOREST RES, V42, P657, DOI [10.1139/x2012-017, 10.1139/X2012-017]; Wang YD, 2011, CAN J FOREST RES, V41, P1897, DOI [10.1139/X11-105, 10.1139/x11-105]; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; [魏焕奇 Wei Huanqi], 2012, [自然资源学报, Journal of Natural Resources], V27, P778; Wen XF, 2010, BIOGEOSCIENCES, V7, P357, DOI 10.5194/bg-7-357-2010; Wen XF, 2006, AGR FOREST METEOROL, V137, P166, DOI 10.1016/j.agrformet.2006.02.005; Wilson KB, 2000, AGR FOREST METEOROL, V100, P1, DOI 10.1016/S0168-1923(99)00088-X; Wilson KB, 2001, AGR FOREST METEOROL, V106, P153, DOI 10.1016/S0168-1923(00)00199-4; Wu J, 2012, BIOGEOSCIENCES, V9, P13, DOI 10.5194/bg-9-13-2012; Xue BL, 2012, HYDROL PROCESS, V26, P2360, DOI 10.1002/hyp.9195; Yoshida M, 2010, J HYDROL, V395, P180, DOI 10.1016/j.jhydrol.2010.10.023; Yu GR, 2008, NEW PHYTOL, V177, P927, DOI 10.1111/j.1469-8137.2007.02316.x; Zha TS, 2010, AGR FOREST METEOROL, V150, P1476, DOI 10.1016/j.agrformet.2010.08.003; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zhang LM, 2006, SCI CHINA SER D, V49, P47, DOI 10.1007/s11430-006-8047-2; Zhang WJ, 2011, BIOGEOSCIENCES, V8, P1667, DOI 10.5194/bg-8-1667-2011; Zhu Z, 2005, SCI CHINA D, V48	96	25	31	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85593	10.1371/journal.pone.0085593	http://dx.doi.org/10.1371/journal.pone.0085593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465610	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100049
J	Chen, J; Liu, WB; Jia, WD; Xu, GL; Ma, JL; Ren, Y; Chen, H; Sun, SN; Huang, M; Li, JS				Chen, Jing; Liu, Wen-Bin; Jia, Wei-Dong; Xu, Ge-Liang; Ma, Jin-Liang; Ren, Yun; Chen, Hao; Sun, Si-Nan; Huang, Mei; Li, Jian-Sheng			Embryonic Morphogen Nodal Is Associated with Progression and Poor Prognosis of Hepatocellular Carcinoma	PLOS ONE			English	Article							IN-VIVO SELECTION; MOLECULAR-MECHANISMS; CELL-MIGRATION; CANCER; EXPRESSION; PROMOTES; PROLIFERATION; ANGIOGENESIS; METASTASIS; APOPTOSIS	Background: Nodal, a TGF-b-related embryonic morphogen, is involved in multiple biologic processes. However, the expression of Nodal in hepatocellular carcinoma (HCC) and its correlation with tumor angiogenesis, epithelial-mesenchymal transition, and prognosis is unclear. Methods: We used real-time PCR and Western blotting to investigate Nodal expression in 6 HCC cell lines and 1 normal liver cell line, 16 pairs of tumor and corresponding paracarcinomatous tissues from HCC patients. Immunohistochemistry was performed to examine Nodal expression in HCC and corresponding paracarcinomatous tissues from 96 patients. CD34 and Vimentin were only examined in HCC tissues of patients mentioned above. Nodal gene was silenced by shRNA in MHCC97H and HCCLM3 cell lines, and cell migration and invasion were detected. Statistical analyses were applied to evaluate the prognostic value and associations of Nodal expression with clinical parameters. Results: Nodal expression was detected in HCC cell lines with high metastatic potential alone. Nodal expression is up-regulated in HCC tissues compared with paracarcinomatous and normal liver tissues. Nodal protein was expressed in 70 of the 96 (72.9%) HCC tumors, and was associated with vascular invasion (P = 0.000), status of metastasis (P = 0.004), AFP (P = 0.049), ICGR15 (indocyanine green retention rate at 15 min) (P = 0.010) and tumor size (P = 0.000). High Nodal expression was positively correlated with high MVD (microvessal density) (P = 0.006), but not with Vimentin expression (P = 0.053). Significantly fewer migrated and invaded cells were seen in shRNA group compared with blank group and negative control group (P<0.05). High Nodal expression was found to be an independent factor for predicting overall survival of HCC. Conclusions: Our study demonstrated that Nodal expression is associated with aggressive characteristics of HCC. Its aberrant expression may be a predictive factor of unfavorable prognosis for HCC after surgery.	[Chen, Jing; Liu, Wen-Bin; Jia, Wei-Dong; Xu, Ge-Liang; Ma, Jin-Liang; Ren, Yun; Chen, Hao; Sun, Si-Nan] Anhui Med Univ, Anhui Prov Hosp, Dept Hepat Surg, Hefei, Peoples R China; [Huang, Mei] Anhui Med Univ, Anhui Prov Hosp, Anhui Prov Key Lab Hepatopancreatobiliary Surg, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University	Li, JS (corresponding author), Anhui Med Univ, Anhui Prov Hosp, Dept Hepat Surg, Hefei, Peoples R China.	lijiansheng1953@gmail.com			National Natural Science Foundation of China [81272398]; Science and Technological Fund of Anhui Province [12010402112]; Anhui Provincial Natural Science Foundation of Institution of Higher Education [KJ2011A171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technological Fund of Anhui Province; Anhui Provincial Natural Science Foundation of Institution of Higher Education	This work was supported by the National Natural Science Foundation of China (No. 81272398, http://www.nsfc.gov.cn), the Science and Technological Fund of Anhui Province (No. 12010402112, http://www.ahkjt.gov.cn), and Anhui Provincial Natural Science Foundation of Institution of Higher Education (No. KJ2011A171, http://www.ahedu.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen MHS, 2008, MODERN PATHOL, V21, P1183, DOI 10.1038/modpathol.2008.90; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kimura H, 1998, LIVER, V18, P14; Lawrence MG, 2011, PROSTATE, V71, P1198, DOI 10.1002/pros.21335; Lee CC, 2010, ONCOGENE, V29, P3110, DOI 10.1038/onc.2010.55; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Munir S, 2004, J BIOL CHEM, V279, P31277, DOI 10.1074/jbc.M400641200; Papageorgiou I, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-122; Postovit LM, 2008, PIGM CELL MELANOMA R, V21, P348, DOI 10.1111/j.1755-148X.2008.00463.x; Quail DF, 2013, INT J BIOCHEM CELL B, V45, P885, DOI 10.1016/j.biocel.2012.12.021; Quail DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048237; Quail DF, 2012, CANCER RES, V72, P3851, DOI 10.1158/0008-5472.CAN-11-3951; Quail DF, 2013, ONCOGENE; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Strizzi L, 2012, CANCER RES, V72, P1915, DOI 10.1158/0008-5472.CAN-11-3419; Strizzi Luigi, 2008, Breast Dis, V29, P91; Sun C, 2013, INT J BIOCHEM CELL B, V45, P1099, DOI 10.1016/j.biocel.2013.02.017; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Xu GX, 2004, J CLIN ENDOCR METAB, V89, P5523, DOI 10.1210/jc.2004-0893; Yu LM, 2010, MODERN PATHOL, V23, P1209, DOI 10.1038/modpathol.2010.101; Zhong Yu, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P83	35	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85840	10.1371/journal.pone.0085840	http://dx.doi.org/10.1371/journal.pone.0085840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465741	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500129
J	Kuchenbuch, A; Paraskevopoulos, E; Herholz, SC; Pantev, C				Kuchenbuch, Anja; Paraskevopoulos, Evangelos; Herholz, Sibylle C.; Pantev, Christo			Audio-Tactile Integration and the Influence of Musical Training	PLOS ONE			English	Article							MISMATCH NEGATIVITY MMN; PREFRONTAL CORTEX; MUSICIANS BRAIN; RESPONSES; DISCRIMINATION; DURATION; FREQUENCY; NETWORKS; PIANISTS; AUDITION	Perception of our environment is a multisensory experience; information from different sensory systems like the auditory, visual and tactile is constantly integrated. Complex tasks that require high temporal and spatial precision of multisensory integration put strong demands on the underlying networks but it is largely unknown how task experience shapes multisensory processing. Long-term musical training is an excellent model for brain plasticity because it shapes the human brain at functional and structural levels, affecting a network of brain areas. In the present study we used magnetoencephalography (MEG) to investigate how audio-tactile perception is integrated in the human brain and if musicians show enhancement of the corresponding activation compared to non-musicians. Using a paradigm that allowed the investigation of combined and separate auditory and tactile processing, we found a multisensory incongruency response, generated in frontal, cingulate and cerebellar regions, an auditory mismatch response generated mainly in the auditory cortex and a tactile mismatch response generated in frontal and cerebellar regions. The influence of musical training was seen in the audio-tactile as well as in the auditory condition, indicating enhanced higher-order processing in musicians, while the sources of the tactile MMN were not influenced by long-term musical training. Consistent with the predictive coding model, more basic, bottom-up sensory processing was relatively stable and less affected by expertise, whereas areas for top-down models of multisensory expectancies were modulated by training.	[Kuchenbuch, Anja; Paraskevopoulos, Evangelos; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Herholz, Sibylle C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Herholz, Sibylle C.] Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Herholz, Sibylle C.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	University of Munster; McGill University; Universite de Montreal; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Pantev, C (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany.	pantev@uni-muenster.de		Paraskevopoulos, Evangelos/0000-0003-4063-4182	Deutsche Forschungsgemeinschaft [PA392/12-2, HE6067-3/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft [PA392/12-2 and HE6067-3/1]. (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka K, 2005, CLIN NEUROPHYSIOL, V116, P1930, DOI 10.1016/j.clinph.2005.04.021; Akatsuka K, 2007, EXP BRAIN RES, V181, P607, DOI 10.1007/s00221-007-0958-4; Akatsuka K, 2007, CLIN NEUROPHYSIOL, V118, P403, DOI 10.1016/j.clinph.2006.09.030; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Butler JS, 2012, J NEUROSCI, V32, P15338, DOI 10.1523/JNEUROSCI.1796-12.2012; Butler JS, 2011, J NEUROSCI, V31, P3400, DOI 10.1523/JNEUROSCI.3296-10.2011; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; DiGirolamo GJ, 2001, NEUROREPORT, V12, P2065, DOI 10.1097/00001756-200107030-00054; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Green AE, 2006, BRAIN RES, V1096, P125, DOI 10.1016/j.brainres.2006.04.024; Haslinger B, 2005, J COGNITIVE NEUROSCI, V17, P282, DOI 10.1162/0898929053124893; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Ito M, 2000, BRAIN RES, V886, P237, DOI 10.1016/S0006-8993(00)03142-5; Jancke L, 2009, RESTOR NEUROL NEUROS, V27, P521, DOI 10.3233/RNN-2009-0519; James CE, 2008, NEUROIMAGE, V42, P1597, DOI 10.1016/j.neuroimage.2008.06.025; Jancke Lutz, 2009, F1000 Biol Rep, V1, P78, DOI 10.3410/B1-78; Kekoni J, 1997, BIOL PSYCHOL, V46, P125, DOI 10.1016/S0301-0511(97)05249-6; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Lee H, 2011, P NATL ACAD SCI USA, V108, pE1441, DOI 10.1073/pnas.1115267108; Liu HG, 2013, J NEUROSCI, V33, P6782, DOI 10.1523/JNEUROSCI.4882-12.2013; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; NAATANEN R, 1989, NEUROSCI LETT, V107, P347, DOI 10.1016/0304-3940(89)90844-6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pakarinen S, 2009, BIOL PSYCHOL, V82, P219, DOI 10.1016/j.biopsycho.2009.07.008; Paraskevopoulos E, 2012, J NEUROSCI, V32, P18196, DOI 10.1523/JNEUROSCI.1947-12.2012; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pastor MA, 2004, J NEUROSCI, V24, P2585, DOI 10.1523/JNEUROSCI.4210-03.2004; Pazo-Alvarez P, 2003, BIOL PSYCHOL, V63, P199, DOI 10.1016/S0301-0511(03)00049-8; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Pieszek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053634; Pleger B, 2006, J NEUROSCI, V26, P12596, DOI 10.1523/JNEUROSCI.4275-06.2006; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Reed CL, 2004, HUM BRAIN MAPP, V21, P236, DOI 10.1002/hbm.10162; Restuccia D, 2007, BRAIN, V130, P276, DOI 10.1093/brain/awl236; Rinne T, 2000, NEUROIMAGE, V12, P14, DOI 10.1006/nimg.2000.0591; Schon D, 2005, J COGNITIVE NEUROSCI, V17, P694, DOI 10.1162/0898929053467532; Schulze K, 2011, HUM BRAIN MAPP, V32, P771, DOI 10.1002/hbm.21060; Shinozaki N, 1998, COGNITIVE BRAIN RES, V7, P165, DOI 10.1016/S0926-6410(98)00020-2; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spackman LA, 2007, EXP BRAIN RES, V177, P21, DOI 10.1007/s00221-006-0650-0; Stewart L, 2004, PERCEPT PSYCHOPHYS, V66, P183, DOI 10.3758/BF03194871; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Vuust P, 2009, CORTEX, V45, P80, DOI 10.1016/j.cortex.2008.05.014; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	58	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85743	10.1371/journal.pone.0085743	http://dx.doi.org/10.1371/journal.pone.0085743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465675	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500102
J	Lo, YH; Chuang, CN; Wang, TF				Lo, Yu-Hui; Chuang, Chi-Ning; Wang, Ting-Fang			Pch2 Prevents Mec1/Tel1-Mediated Hop1 Phosphorylation Occurring Independently of Red1 in Budding Yeast Meiosis	PLOS ONE			English	Article							MEIOTIC CHECKPOINT CONTROL; SISTER-CHROMATID COHESION; AXIAL-ELEMENT PROTEIN; STRAND BREAK REPAIR; SYNAPTONEMAL COMPLEX; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SYNAPSIS; DNA-DAMAGE; INTERHOMOLOG RECOMBINATION; PHOSPHATASE COMPLEX	A prominent feature of meiosis in most sexually reproducing organisms is interhomolog recombination whereby a significant fraction of the programmed meiotic double-strand breaks are repaired using intact homologous non-sister chromatids rather than sister chromatids. Budding yeast DNA damage checkpoint kinases Mec1 and Tel1 act together with the axial element protein Red1 to promote interhomolog recombination by phosphorylating another axial element protein Hop1. Mec1 and Tel1 also phosphorylate gamma H2A and the synaptonemal complex protein Zip1 independently of Red1 to facilitate premeiotic DNA replication and to destabilize homology-independent centromere pairing, respectively. It has been unclear why Hop1 phosphorylation is Red1-dependent. Here, we report that the pachytene checkpoint protein 2 (Pch2) specifically prevents Red1-independent Hop1 phosphorylation. Our findings reveal a new function for Pch2 in linking two axial element proteins Red1 and Hop1 thus coordinating their effects in meiotic recombination and the checkpoint network.	[Lo, Yu-Hui; Wang, Ting-Fang] Natl Def Med Ctr, Inst Life Sci, Taipei, Taiwan; [Lo, Yu-Hui; Chuang, Chi-Ning; Wang, Ting-Fang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan	Wang, TF (corresponding author), Natl Def Med Ctr, Inst Life Sci, Taipei, Taiwan.	tfwang@gate.sinica.edu.tw	Wang, Ting-Fang/ABI-3818-2020	Wang, Ting-Fang/0000-0001-6306-9505	National Science Council; Academia Sinica, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by grants to TFW from the National Science Council and Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Carballo JA, 2007, CHROMOSOME RES, V15, P539, DOI 10.1007/s10577-007-1145-y; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Carballo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003545; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Cheng YH, 2013, MOL CELL BIOL, V33, P3365, DOI 10.1128/MCB.00438-13; Chuang CN, 2012, NUCLEIC ACIDS RES, V40, P11416, DOI 10.1093/nar/gks920; Falk JE, 2010, DEV CELL, V19, P599, DOI 10.1016/j.devcel.2010.09.006; Farmer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039724; Gobbini E, 2013, DNA REPAIR, V12, P791, DOI 10.1016/j.dnarep.2013.07.009; Goldfarb T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000520; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Ho HC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002351; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Kironmai KM, 1998, MOL CELL BIOL, V18, P1424, DOI 10.1128/MCB.18.3.1424; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lin FM, 2010, EMBO J, V29, P586, DOI 10.1038/emboj.2009.362; Lui DY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003197; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; Ontoso D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003262; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; ROCKMILL B, 1991, GENE DEV, V5, P2392, DOI 10.1101/gad.5.12b.2392; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Shima H, 2005, GENETICS, V170, P71, DOI 10.1534/genetics.104.037580; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Storlazzi A, 2008, GENE DEV, V22, P796, DOI 10.1101/gad.459308; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Szilard RK, 2010, NAT STRUCT MOL BIOL, V17, P299, DOI 10.1038/nsmb.1754; Terentyev Y, 2010, NUCLEIC ACIDS RES, V38, P4349, DOI 10.1093/nar/gkq137; Tsubouchi T, 2005, SCIENCE, V308, P870, DOI 10.1126/science.1108283; Vader G, 2011, NATURE, V477, P115, DOI 10.1038/nature10331; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wan LH, 2004, MOL BIOL CELL, V15, P11, DOI 10.1091/mbc.E03-07-0499; Wu HY, 2006, CURR BIOL, V16, P2473, DOI 10.1016/j.cub.2006.10.069	43	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85687	10.1371/journal.pone.0085687	http://dx.doi.org/10.1371/journal.pone.0085687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465650	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500091
J	Nykky, J; Vuento, M; Gilbert, L				Nykky, Jonna; Vuento, Matti; Gilbert, Leona			Role of Mitochondria in Parvovirus Pathology	PLOS ONE			English	Article							CELL-DEATH; CANINE PARVOVIRUS; INDUCED APOPTOSIS; INTRACELLULAR CALCIUM; OXIDATIVE STRESS; VIRUS; PROTEIN; DYSFUNCTION; REPLICATION; MECHANISMS	Proper functioning of the mitochondria is crucial for the survival of the cell. Viruses are able to interfere with mitochondrial functions as they infect the host cell. Parvoviruses are known to induce apoptosis in infected cells, but the role of the mitochondria in parvovirus induced cytopathy is only partially known. Here we demonstrate with confocal and electron microscopy that canine parvovirus (CPV) associated with the mitochondrial outer membrane from the onset of infection. During viral entry a transient depolarization of the mitochondrial transmembrane potential and increase in ROS level was detected. Subsequently, mitochondrial homeostasis was normalized shortly, as detected by repolarization of the mitochondrial membrane and decrease of ROS. Indeed, activation of cell survival signalling through ERK1/2 cascade was observed early in CPV infected cells. At 12 hours post infection, concurrent with the expression of viral non-structural protein 1, damage to the mitochondrial structure and depolarization of its membrane were apparent. Results of this study provide additional insight of parvovirus pathology and also more general information of virus-mitochondria association.	[Gilbert, Leona] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland	University of Jyvaskyla; University of Jyvaskyla	Gilbert, L (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	leona.k.gilbert@jyu.fi	Gilbert, Leona/AAF-4258-2021	Gilbert, Leona/0000-0002-7470-5770; Nykky, Jonna/0000-0001-7873-2285				Abdel-Latif L, 2006, J GEN VIROL, V87, P2539, DOI 10.1099/vir.0.81915-0; Bhowmick R, 2012, J BIOL CHEM, V287, P35004, DOI 10.1074/jbc.M112.369595; Boyapalle S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029386; Brisac C, 2010, J VIROL, V84, P12226, DOI 10.1128/JVI.00994-10; Brumatti G, 2010, CELL MOL LIFE SCI, V67, P1619, DOI 10.1007/s00018-010-0288-8; Brunet JP, 2000, J VIROL, V74, P2323, DOI 10.1128/JVI.74.5.2323-2332.2000; Burns K, 2007, FIELDS VIROLOGY, P2437; Chen AY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002088; Chen EI, 2012, J BIOENERG BIOMEMBR, V44, P619, DOI 10.1007/s10863-012-9465-9; Chowdhury SKR, 2013, NEUROBIOL DIS, V51, P56, DOI 10.1016/j.nbd.2012.03.016; Chu VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028551; Cohen S, 2005, J GEN VIROL, V86, P3243, DOI 10.1099/vir.0.80967-0; Degli Esposti Davide, 2012, Biochem Res Int, V2012, P387626, DOI 10.1155/2012/387626; Dussmann H, 2003, J CELL SCI, V116, P525, DOI 10.1242/jcs.00236; Duverger V, 2002, INT J CANCER, V97, P706, DOI 10.1002/ijc.10077; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; El-Bacha T, 2013, INT J BIOCHEM CELL B, V45, P41, DOI 10.1016/j.biocel.2012.09.021; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Geng X, 2012, P NATL ACAD SCI USA, V109, P18471, DOI 10.1073/pnas.1204668109; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; He XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061677; Heegaard ED, 2002, CLIN MICROBIOL REV, V15, P485, DOI 10.1128/CMR.15.3.485-505.2002; Hristov G, 2010, J VIROL, V84, P5909, DOI 10.1128/JVI.01797-09; Huang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033657; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Huttunen P, 1998, VIROLOGY, V250, P85, DOI 10.1006/viro.1998.9343; Ikeda Y, 1998, J VIROL, V72, P6932, DOI 10.1128/JVI.72.8.6932-6936.1998; Johnson RA, 2001, J GEN VIROL, V82, P493, DOI 10.1099/0022-1317-82-3-493; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Kivovich V, 2012, INT J BIOL SCI, V8, P79, DOI 10.7150/ijbs.8.79; Kivovich V, 2010, INT J MED SCI, V7, P110; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Luo HL, 2002, J VIROL, V76, P3365, DOI 10.1128/JVI.76.7.3365-3373.2002; Lupescu A, 2006, J VIROL, V80, P11370, DOI 10.1128/JVI.01041-06; MACARTNEY L, 1984, VET REC, V115, P453, DOI 10.1136/vr.115.18.453; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; Moffatt S, 1998, J VIROL, V72, P3018, DOI 10.1128/JVI.72.4.3018-3028.1998; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Murgia M, 2009, J MOL CELL CARDIOL, V46, P781, DOI 10.1016/j.yjmcc.2009.03.003; Nakashima A, 2006, VIROLOGY, V349, P254, DOI 10.1016/j.virol.2006.03.029; Nuesch JPF, 2007, P NATL ACAD SCI USA, V104, P12482, DOI 10.1073/pnas.0705533104; Nykky J, 2010, INT J NANOMED, V5, P417; Ohta A, 2011, MITOCHONDRION, V11, P1, DOI 10.1016/j.mito.2010.08.006; PARRISH CR, 1988, VIROLOGY, V163, P230, DOI 10.1016/0042-6822(88)90255-3; PARRISH CR, 1991, VIROLOGY, V183, P195, DOI 10.1016/0042-6822(91)90132-U; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Pollock R. V. H., 1990, CRC Handbook of Parvoviruses. Volume II., P113; Poole BD, 2006, J VIROL, V80, P4114, DOI 10.1128/JVI.80.8.4114-4121.2006; Poole BD, 2004, J VIROL, V78, P7775, DOI 10.1128/JVI.78.14.7775-7783.2004; Poole BD, 2011, INT J MED SCI, V8, P88, DOI 10.7150/ijms.8.88; Pucci B, 2009, J CELL BIOCHEM, V108, P1166, DOI 10.1002/jcb.22345; Quarato G, 2012, HEPATOLOGY, V55, P1333, DOI 10.1002/hep.25514; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rayet B, 1998, J VIROL, V72, P8893, DOI 10.1128/JVI.72.11.8893-8903.1998; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Saffran HA, 2007, EMBO REP, V8, P188, DOI 10.1038/sj.embor.7400878; Sasaki M, 1996, VIROLOGY, V224, P18, DOI 10.1006/viro.1996.0502; Sasaki M, 2002, J VIROL, V76, P416, DOI 10.1128/JVI.76.1.416-420.2002; Saxena Lovleen, 2013, Virus Res, V173, P426, DOI 10.1016/j.virusres.2013.01.020; Schweneker M, 2012, J VIROL, V86, P2323, DOI 10.1128/JVI.06166-11; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Suikkanen S, 2002, J VIROL, V76, P4401, DOI 10.1128/JVI.76.9.4401-4411.2002; Tzang BS, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-13; VARGAS JL, 1987, FEBS LETT, V224, P182, DOI 10.1016/0014-5793(87)80444-1; Wang B, 2012, ANTIVIR RES, V93, P110, DOI 10.1016/j.antiviral.2011.11.001; WIKOFF WR, 1994, STRUCTURE, V2, P595, DOI 10.1016/S0969-2126(00)00062-9; Williamson Chad D., 2012, Infectious Disorders - Drug Targets, V12, P18; Yang XY, 1999, J VIROL, V73, P3460, DOI 10.1128/JVI.73.4.3460-3466.1999; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661	75	20	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86124	10.1371/journal.pone.0086124	http://dx.doi.org/10.1371/journal.pone.0086124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465910	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500189
J	Yang, Q; Du, XL; Fang, Z; Xiong, W; Li, GH; Liao, H; Xiao, J; Wang, GP; Li, F				Yang, Qin; Du, Xingli; Fang, Zhong; Xiong, Wei; Li, Guanghui; Liao, Hui; Xiao, Jun; Wang, Guoping; Li, Feng			Effect of Calcitonin Gene-Related Peptide on the Neurogenesis of Rat Adipose-Derived Stem Cells In Vitro	PLOS ONE			English	Article							MARROW STROMAL CELLS; SPINAL-CORD-INJURY; NEURAL CELLS; DIFFERENTIATION; TISSUE; EXPRESSION; MURINE; BRAIN; TRANSPLANTATION; PROLIFERATION	Calcitonin gene-related peptide (CGRP) promotes neuron recruitment and neurogenic activity. However, no evidence suggests that CGRP affects the ability of stem cells to differentiate toward neurogenesis. In this study, we genetically modified rat adipose-derived stem cells (ADSCs) with the CGRP gene (CGRP-ADSCs) and subsequently cultured in complete neural-induced medium. The formation of neurospheres, cellular morphology, and proliferative capacity of ADSCs were observed. In addition, the expression of the anti-apoptotic protein Bcl-2 and special markers of neural cells, such as Nestin, MAP2, RIP and GFAP, were evaluated using Western blot and immunocytochemistry analysis. The CGRP-ADSCs displayed a greater proliferation than un-transduced (ADSCs) and Vector-transduced (Vector-ADSCs) ADSCs (p < 0.05), and lower rates of apoptosis, associated with the incremental expression of Bcl-2, were also observed for CGRP-ADSCs. Moreover, upon neural induction, CGRP-ADSCs formed markedly more and larger neurospheres and showed round cell bodies with more branching extensions contacted with neighboring cells widely. Furthermore, the expression levels of Nestin, MAP2, and RIP in CGRP-ADSCs were markedly increased, resulting in higher levels than the other groups (p < 0.05); however, GFAP was distinctly undetectable until day 7, when slight GFAP expression was detected among all groups. Wnt signals, primarily Wnt 3a, Wnt 5a and beta-catenin, regulate the neural differentiation of ADSCs, and CGRP gene expression apparently depends on canonical Wnt signals to promote the neurogenesis of ADSCs. Consequently, ADSCs genetically modified with CGRP exhibit stronger potential for differentiation and neurogenesis in vitro, potentially reflecting the usefulness of ADSCs as seed cells in therapeutic strategies for spinal cord injury.	[Yang, Qin; Du, Xingli; Fang, Zhong; Xiong, Wei; Li, Guanghui; Liao, Hui; Xiao, Jun; Li, Feng] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Orthoped, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China; [Yang, Qin; Wang, Guoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pathol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Fang, Z (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Orthoped, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China.	zhongfangtjh@gmail.com	liao, hui/GSE-5758-2022		National Science Foundation of China [30772206]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported through Grant NO. 30772206 from the National Science Foundation of China. The funders have a role in study design, analysis and decision to publish.	Alessandri G, 2004, ANN NY ACAD SCI, V1015, P271, DOI 10.1196/annals.1302.023; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Blesch A, 2001, J COMP NEUROL, V436, P399, DOI 10.1002/cne.1076; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Brilli E, 2013, STEM CELLS DEV, V22, P538, DOI 10.1089/scd.2012.0530; Bunnell BA, 2006, BIOCHEM BIOPH RES CO, V343, P762, DOI 10.1016/j.bbrc.2006.03.033; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Chan JJ, 2009, J PEDIATR SURG, V44, P1497, DOI 10.1016/j.jpedsurg.2008.11.039; Chen LJ, 2010, J CLIN NEUROSCI, V17, P87, DOI 10.1016/j.jocn.2009.03.042; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; David S, 2003, ANNU REV NEUROSCI, V26, P411, DOI 10.1146/annurev.neuro.26.043002.094946; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fang Z, 2010, J HUAZHONG U SCI-MED, V30, P75, DOI 10.1007/s11596-010-0113-5; Fitch MT, 1999, J NEUROSCI, V19, P8182; Lambert APF, 2009, DIFFERENTIATION, V77, P221, DOI 10.1016/j.diff.2008.10.016; Fujimura J, 2005, BIOCHEM BIOPH RES CO, V333, P116, DOI 10.1016/j.bbrc.2005.05.096; Gottlieb DI, 2002, ANNU REV NEUROSCI, V25, P381, DOI 10.1146/annurev.neuro.25.112701.142904; Houle JD, 2003, EXP NEUROL, V182, P247, DOI 10.1016/S0014-4886(03)00029-3; Ii M, 2009, CIRC RES, V105, P860, DOI 10.1161/CIRCRESAHA.109.199299; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Jia LW, 2008, BIOCHEM BIOPH RES CO, V368, P483, DOI 10.1016/j.bbrc.2008.01.097; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; KASHIHARA Y, 1989, J NEUROSCI, V9, P3796; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim JH, 2008, STEM CELLS, V26, P2724, DOI 10.1634/stemcells.2008-0184; Kitamura T, 2007, NEUROPHARMACOLOGY, V52, P506, DOI 10.1016/j.neuropharm.2006.08.022; Lenoir N, 2000, SCIENCE, V287, P1425, DOI 10.1126/science.287.5457.1425; McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; National Spinal Cord Injury Statistical Center, 2010, J Spinal Cord Med, V33, P439; Olson L, 2002, NATURE, V416, P589, DOI 10.1038/416589a; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Song SW, 2009, HEPATO-GASTROENTEROL, V56, P1724; Sun XZ, 2011, CHINESE MED J-PEKING, V124, P3093, DOI 10.3760/cma.j.issn.0366-6999.2011.19.026; Uzan B, 2008, J CELL PHYSIOL, V215, P122, DOI 10.1002/jcp.21294; Wang KH, 2008, BIOTECHNOL APPL BIOC, V51, P159, DOI 10.1042/BA20070201; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	43	40	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86334	10.1371/journal.pone.0086334	http://dx.doi.org/10.1371/journal.pone.0086334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466033	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500230
J	Yasaka, R; Nguyen, HD; Ho, SYW; Duchene, S; Korkmaz, S; Katis, N; Takahashi, H; Gibbs, AJ; Ohshima, K				Yasaka, Ryosuke; Nguyen, Huy D.; Ho, Simon Y. W.; Duchene, Sebastian; Korkmaz, Savas; Katis, Nikolaos; Takahashi, Hideki; Gibbs, Adrian J.; Ohshima, Kazusato			The Temporal Evolution and Global Spread of Cauliflower mosaic virus, a Plant Pararetrovirus	PLOS ONE			English	Article							MOLECULAR EVOLUTION; GENETIC-STRUCTURE; STREAK-VIRUS; RECOMBINATION; POPULATIONS; SEQUENCES; PROGRAM; TIME; DIVERSIFICATION; PHYLOGENETICS	Cauliflower mosaic virus (CaMV) is a plant pararetrovirus with a double-stranded DNA genome. It is the type member of the genus Caulimovirus in the family Caulimoviridae. CaMV is transmitted by sap inoculation and in nature by aphids in a semi-persistent manner. To investigate the patterns and timescale of CaMV migration and evolution, we sequenced and analyzed the genomes of 67 isolates of CaMV collected mostly in Greece, Iran, Turkey, and Japan together with nine published sequences. We identified the open-reading frames (ORFs) in the genomes and inferred their phylogeny. After removing recombinant sequences, we estimated the substitution rates, divergence times, and phylogeographic patterns of the virus populations. We found that recombination has been a common feature of CaMV evolution, and that ORFs I-V have a different evolutionary history from ORF VI. The ORFs have evolved at rates between 1.71 and 5.81x10(-4) substitutions/site/year, similar to those of viruses with RNA or ssDNA genomes. We found four geographically confined lineages. CaMV probably spread from a single population to other parts of the world around 400-500 years ago, and is now widely distributed among Eurasian countries. Our results revealed evidence of frequent gene flow between populations in Turkey and those of its neighboring countries, with similar patterns observed for Japan and the USA. Our study represents the first report on the spatial and temporal spread of a plant pararetrovirus.	[Yasaka, Ryosuke; Nguyen, Huy D.; Ohshima, Kazusato] Saga Univ, Fac Agr, Lab Plant Virol, Saga 840, Japan; [Nguyen, Huy D.; Ohshima, Kazusato] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Ho, Simon Y. W.; Duchene, Sebastian] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Korkmaz, Savas] Univ Canakkale Onsekiz Mart, Fac Agr, Dept Plant Protect, Canakkale, Turkey; [Katis, Nikolaos] Aristotle Univ Thessaloniki, Fac Agr, Plant Pathol Lab, GR-54006 Thessaloniki, Greece; [Takahashi, Hideki] Tohoku Univ, Fac Agr, Grad Sch Agr Sci, Sendai, Miyagi, Japan; [Gibbs, Adrian J.] Australian Natl Univ, Emeritus Fac, Canberra, ACT, Australia	Saga University; Kagoshima University; University of Sydney; Canakkale Onsekiz Mart University; Aristotle University of Thessaloniki; Tohoku University; Australian National University	Ohshima, K (corresponding author), Saga Univ, Fac Agr, Lab Plant Virol, Saga 840, Japan.	ohshimak@cc.saga-u.ac.jp	Ho, Simon YW/A-8417-2008	Ho, Simon YW/0000-0002-0361-2307; Yasaka, Ryosuke/0000-0002-2240-1767; Duchene, Sebastian/0000-0002-2863-0907	Saga University; Japan Society for the Promotion of Science (JSPS) KAKENHI [18405022, 24405026]; JSPS [21.09320]	Saga University; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was in part funded by Saga University, and supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 18405022 and 24405026. This work was in part supported by JSPS Postdoctoral Fellowships for Foreign Researchers Grant Number 21.09320 to KO and S. Farzadfar (Saga University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; BUCK P. A., 1956, ECON BOT, V10, P250, DOI 10.1007/BF02899000; CHENAULT KD, 1994, J MOL EVOL, V39, P496, DOI 10.1007/BF00173419; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Crisp P., 1995, EVOLUTION CROP PLANT, P86; Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duffy S, 2008, J VIROL, V82, P957, DOI 10.1128/JVI.01929-07; Etherington GJ, 2005, BIOINFORMATICS, V21, P278, DOI 10.1093/bioinformatics/bth500; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Farzadfar S, 2013, VIRUS GENES, V47, P347, DOI 10.1007/s11262-013-0948-5; Firth C, 2010, MOL BIOL EVOL, V27, P2038, DOI 10.1093/molbev/msq088; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; FRANCK A, 1980, CELL, V21, P285, DOI 10.1016/0092-8674(80)90136-1; Froissart R, 2005, PLOS BIOL, V3, P389, DOI 10.1371/journal.pbio.0030089; Garcia-Arenal F, 2003, INT MICROBIOL, V6, P225, DOI 10.1007/s10123-003-0142-z; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; Gayral P, 2010, J VIROL, V84, P7346, DOI 10.1128/JVI.00401-10; Gibbs AJ, 2010, J GEN VIROL, V91, P13, DOI 10.1099/vir.0.015925-0; Gibbs A, 2010, ANNU REV PHYTOPATHOL, V48, P205, DOI 10.1146/annurev-phyto-073009-114404; Gibbs AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002523; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; GRAY AR, 1982, ECON BOT, V36, P397, DOI 10.1007/BF02862698; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas M, 2002, MOL PLANT PATHOL, V3, P419, DOI 10.1046/j.1364-3703.2002.00136.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hapiak M, 2008, VIRUS RES, V138, P119, DOI 10.1016/j.virusres.2008.09.002; Harkins GW, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-104; Harlan J.R., 1998, ORIGINS AGR CROP DOM, P1; Hemingway JS, 1995, EVOLUTION CROP PLANT, P82; Hodgkin T, 1995, EVOLUTION CROP PLANT, P76; Hohn T, 2013, CURR OPIN VIROL, V3, P1; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Katz SH, 2003, ENCY FOOD CULTURE, P284; King AMQ, 2012, 9 INT COMM TAX VIR, P432; Kobayashi K, 2004, MOL PLANT MICROBE IN, V17, P475, DOI 10.1094/MPMI.2004.17.5.475; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefeuvre P, 2007, J GEN VIROL, V88, P3458, DOI 10.1099/vir.0.83252-0; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; MacNaughton IH, 1995, EVOLUTION CROP PLANT, P62; MacNaughton IH, 1995, EVOLUTION CROP PLANT, P68; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Monjane AL, 2011, J VIROL, V85, P9623, DOI 10.1128/JVI.00640-11; Monsion B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000174; Nguyen HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055336; Ohshima K, 2002, J GEN VIROL, V83, P1511, DOI 10.1099/0022-1317-83-6-1511; Ohshima K, 2007, J GEN VIROL, V88, P298, DOI 10.1099/vir.0.82335-0; Ohshima K, 2010, J GEN VIROL, V91, P788, DOI 10.1099/vir.0.016055-0; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Podevin Nancy, 2012, GM Crops Food, V3, P296, DOI 10.4161/gmcr.21406; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; Rocha CS, 2013, J VIROL, V87, P5784, DOI 10.1128/JVI.00155-13; Rodelo-Urrego M, 2013, MOL ECOL, V22, P2325, DOI 10.1111/mec.12232; Roossinck MJ, 1997, ANNU REV PHYTOPATHOL, V35, P191, DOI 10.1146/annurev.phyto.35.1.191; Sacristan S, 2008, MOL PLANT PATHOZ; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Sawyer S, 1999, GENECONV COMPUTER PA; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shepherd RJ, 1981, CMI AAB DESCRIPTIONS; SHOCKEY MW, 1980, VIROLOGY, V105, P575, DOI 10.1016/0042-6822(80)90057-4; SMITH JM, 1992, J MOL EVOL, V34, P126; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomimura K, 2004, VIROLOGY, V330, P408, DOI 10.1016/j.virol.2004.09.040; Tomitaka Y, 2006, MOL ECOL, V15, P4437, DOI 10.1111/j.1365-294X.2006.03094.x; Traore O, 2005, MOL ECOL, V14, P2097, DOI 10.1111/j.1365-294X.2005.02578.x; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929; Zhang CL, 2011, VIRUS RES, V158, P188, DOI 10.1016/j.virusres.2011.03.031	74	37	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85641	10.1371/journal.pone.0085641	http://dx.doi.org/10.1371/journal.pone.0085641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465629	Green Published, gold			2022-12-25	WOS:000330244500086
J	Zhang, ZC; Li, YY; Wang, HY; Fu, S; Wang, XP; Zeng, MS; Zeng, YX; Shao, JY				Zhang, Zi-Chen; Li, Yang-Yang; Wang, Hai-Yun; Fu, Sha; Wang, Xiao-Pai; Zeng, Mu-Sheng; Zeng, Yi-Xin; Shao, Jian-Yong			Knockdown of miR-214 Promotes Apoptosis and Inhibits Cell Proliferation in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							BAX-DEPENDENT APOPTOSIS; HUMAN BREAST-CANCER; EPITHELIAL-CELLS; TUMOR-SUPPRESSOR; OVARIAN-CANCER; REGULATES BIM; HELA-CELLS; IN-VIVO; EXPRESSION; PHOSPHORYLATION	MicroRNA-214 (MiR-214) is aberrantly expressed in several human tumors such as ovarian cancer and breast cancer. However, the role of miR-214 in nasopharyngeal carcinoma (NPC) is still unknown. In this study, we report that miR-214 was overexpressed in NPC cell lines and tissues. Silencing of miR-214 by LNA-antimiR-214 in NPC cells resulted in promoting apoptosis and suppressing cell proliferation in vitro, and suppressed tumor growth in nude mice in vivo. Luciferase reporter assay was performed to identify Bim as a direct target of miR-214. Furthermore, this study showed that low Bim expression in NPC tissues correlated with poor survival of NPC patients. Taken together, our findings suggest that miR-214 plays an important role in NPC carcinogenesis.	[Zhang, Zi-Chen; Li, Yang-Yang; Wang, Hai-Yun; Fu, Sha; Wang, Xiao-Pai; Shao, Jian-Yong] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Mol Diagnost,Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Mu-Sheng; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Expt Res,Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Shao, JY (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Mol Diagnost,Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China.	shaojy@sysucc.org.cn			National High Technology Research and Development Program of China (863 Program) [2012AA02A501]; Chinese State Key Basic Research Project [2011CB504805]; National Natural Science Fund [81272952]; State Key Laboratory Grant	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Chinese State Key Basic Research Project; National Natural Science Fund(National Natural Science Foundation of China (NSFC)); State Key Laboratory Grant	This work was supported grants from the National High Technology Research and Development Program of China (863 Program) (No. 2012AA02A501); the Chinese State Key Basic Research Project (No. 2011CB504805); The National Natural Science Fund (No. 81272952); and a State Key Laboratory Grant to the Sun Yat-sen University Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Chen C, 2013, ONCOL REP, V30, P1773, DOI 10.3892/or.2013.2618; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Clybouw C, 2012, CELL DEATH DIFFER, V19, P1060, DOI 10.1038/cdd.2011.198; Deng M, 2013, TUMOR BIOL, V34, P1793, DOI 10.1007/s13277-013-0718-y; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gillings AS, 2009, FEBS J, V276, P6050, DOI 10.1111/j.1742-4658.2009.07329.x; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Letai A, 2003, EXPERT OPIN BIOL TH, V3, P293, DOI 10.1517/eobt.3.2.293.21155; Liao YL, 2010, J NUTR, V140, P1552, DOI 10.3945/jn.110.124289; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MIN HQ, 1994, INT J RADIAT ONCOL, V30, P1037; Narducci MG, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.32; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Qiang R, 2011, INT J BIOCHEM CELL B, V43, P632, DOI 10.1016/j.biocel.2011.01.002; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Shih TC, 2012, J HEPATOL; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tsubaki M, 2013, EUR J CANC; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Vo TT, 2010, ADV EXP MED BIOL, V687, P49; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wakeyama H, 2007, ANN NY ACAD SCI, V1116, P271, DOI 10.1196/annals.1402.001; Wang HY, 2011, J CLIN ONCOL, V29, P4516, DOI 10.1200/JCO.2010.33.7741; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Zhang XJ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-46; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435	44	46	53	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86149	10.1371/journal.pone.0086149	http://dx.doi.org/10.1371/journal.pone.0086149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465927	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500194
J	Hindra; Moody, MJ; Jones, SE; Elliot, MA				Hindra; Moody, Matthew J.; Jones, Stephanie E.; Elliot, Marie A.			Complex Intra-Operonic Dynamics Mediated by a Small RNA in Streptomyces coelicolor	PLOS ONE			English	Article							SMALL NONCODING RNAS; ANTIBIOTIC PRODUCTION; GENOME SEQUENCE; GENES; DIFFERENTIATION; BIOSYNTHESIS; A3(2); TRANSCRIPTOME; AVERMITILIS; REGULATORS	Streptomyces are predominantly soil-dwelling bacteria that are best known for their multicellular life cycle and their prodigious metabolic capabilities. They are also renowned for their regulatory capacity and flexibility, with each species encoding >60 sigma factors, a multitude of transcription factors, and an increasing number of small regulatory RNAs. Here, we describe our characterization of a conserved small RNA (sRNA), scr4677. In the model species Streptomyces coelicolor, this sRNA is located in the intergenic region separating SCO4677 (an anti-sigma factor-encoding gene) and SCO4676 (a putative regulatory protein-encoding gene), close to the SCO4676 translation start site in an antisense orientation. There appears to be considerable genetic interplay between these different gene products, with wild type expression of scr4677 requiring function of the anti-sigma factor SCO4677, and scr4677 in turn influencing the abundance of SCO4676-associated transcripts. The scr4677-mediated effects were independent of RNase III (a double stranded RNA-specific nuclease), with RNase III having an unexpectedly positive influence on the level of SCO4676-associated transcripts. We have shown that both SCO4676 and SCO4677 affect the production of the blue-pigmented antibiotic actinorhodin under specific growth conditions, and that this activity appears to be independent of scr4677.	[Elliot, Marie A.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; McMaster Univ, Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University	Elliot, MA (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	melliot@mcmaster.ca	Hindra, Hindra/I-9753-2019	Hindra, Hindra/0000-0002-8411-8123; jones, stephanie/0000-0001-9290-6835	Natural Sciences and Engineering Research Council of Canada [312495]; Canada Research Chairs (CRC) program; Province of Ontario; NSERC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs (CRC) program(Canada Research Chairs); Province of Ontario; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Grant No. 312495), the Canada Research Chairs (CRC) program, and graduate student awards from the Province of Ontario (to H and MJM) and NSERC (to SEJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceti DJ, 1998, J BACTERIOL, V180, P3100, DOI 10.1128/JB.180.12.3100-3106.1998; ADAMIDIS T, 1992, J BACTERIOL, V174, P4622, DOI 10.1128/JB.174.14.4622-4628.1992; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Castro-Melchor M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-578; CHATER KF, 1993, ANNU REV MICROBIOL, V47, P685, DOI 10.1146/annurev.micro.47.1.685; D'Alia D, 2010, J BACTERIOL, V192, P1160, DOI 10.1128/JB.01374-09; DAVIS NK, 1990, MOL MICROBIOL, V4, P1679, DOI 10.1111/j.1365-2958.1990.tb00545.x; den Hengst CD, 2010, MOL MICROBIOL, V78, P361, DOI 10.1111/j.1365-2958.2010.07338.x; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Duong A, 2012, MOL MICROBIOL, V83, P992, DOI 10.1111/j.1365-2958.2012.07983.x; Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002520; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Fedoryshyn M, 2008, GENE, V419, P43, DOI 10.1016/j.gene.2008.04.011; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; Gatewood ML, 2012, J BACTERIOL, V194, P2228, DOI 10.1128/JB.06541-11; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Haiser HJ, 2009, J BACTERIOL, V191, P6501, DOI 10.1128/JB.00767-09; Hindra, 2010, J BACTERIOL, V192, P4973, DOI 10.1128/JB.00681-10; Huang J, 2005, MOL MICROBIOL, V58, P1276, DOI 10.1111/j.1365-2958.2005.04879.x; JANSSEN GR, 1993, GENE, V124, P133, DOI 10.1016/0378-1119(93)90774-W; Kang SG, 1998, FEMS MICROBIOL LETT, V168, P221, DOI 10.1111/j.1574-6968.1998.tb13277.x; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Kelemen GH, 1998, J BACTERIOL, V180, P2515, DOI 10.1128/JB.180.9.2515-2521.1998; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim ES, 2008, J BACTERIOL, V190, P7559, DOI 10.1128/JB.00470-08; Kirby R, 2011, FEMS MICROBIOL LETT, V319, P1, DOI 10.1111/j.1574-6968.2011.02242.x; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Moody MJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-558; Nicholson AW, 2011, NUCLEIC ACIDS MOL BI, V26, P269, DOI 10.1007/978-3-642-21078-5_11; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004; Opdyke JA, 2011, J MOL BIOL, V406, P29, DOI 10.1016/j.jmb.2010.12.009; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Panek J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-217; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; Resch A, 2008, RNA, V14, P454, DOI 10.1261/rna.603108; SAMBROOK J, 2000, MOL CLONING LAB MANU; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Sello JK, 2008, J BACTERIOL, V190, P4079, DOI 10.1128/JB.01889-07; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; STUTTARD C, 1982, J GEN MICROBIOL, V128, P115; Swiercz JP, 2012, BACTERIAL SPORES: CURRENT RESEARCH AND APPLICATIONS, P39; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Ulrych A, 2013, MOL BIOSYST, V9, P1453, DOI 10.1039/c3mb25542e; VARA J, 1989, J BACTERIOL, V171, P5872, DOI 10.1128/jb.171.11.5872-5881.1989; Vockenhuber MP, 2011, RNA BIOL, V8, P468, DOI 10.4161/rna.8.3.14421	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85856	10.1371/journal.pone.0085856	http://dx.doi.org/10.1371/journal.pone.0085856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465751	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500080
J	Shigematsu, H; Kumagai, K; Kobayashi, H; Eguchi, T; Kitaura, K; Suzuki, S; Horikawa, T; Matsutani, T; Ogasawara, K; Hamada, Y; Suzuki, R				Shigematsu, Hiroaki; Kumagai, Kenichi; Kobayashi, Hiroshi; Eguchi, Takanori; Kitaura, Kazutaka; Suzuki, Satsuki; Horikawa, Tatsuya; Matsutani, Takaji; Ogasawara, Kouetsu; Hamada, Yoshiki; Suzuki, Ryuji			Accumulation of Metal-Specific T Cells in Inflamed Skin in a Novel Murine Model of Chromium-Induced Allergic Contact Dermatitis	PLOS ONE			English	Article							ECZEMATOUS DERMATITIS; INNATE IMMUNITY; IFN-GAMMA; NICKEL; RECEPTOR; HYPERSENSITIVITY; RECOGNITION; EXPRESSION; REGION; USAGE	Chromium (Cr) causes delayed-type hypersensitivity reactions possibly mediated by accumulating T cells into allergic inflamed skin, which are called irritants or allergic contact dermatitis. However, accumulating T cells during development of metal allergy are poorly characterized because a suitable animal model is not available. This study aimed to elucidate the skewing of T-cell receptor (TCR) repertoire and cytokine profiles in accumulated T cells in inflamed skin during elucidation of Cr allergy. A novel model of Cr allergy was induced by two sensitizations of Cr plus lipopolysaccharide solution into mouse groin followed by single Cr challenge into the footpad. TCR repertoires and nucleotide sequences of complementary determining region 3 were assessed in accumulated T cells from inflamed skin. Cytokine expression profiles and T-cell phenotypes were determined by qPCR. CD3+CD4+ T cells accumulated in allergic footpads and produced increased T helper 1 (Th1) type cytokines, Fas, and Fas ligand in the footpads after challenge, suggesting CD4+ Th1 cells locally expanded in response to Cr. Accumulated T cells included natural killer (NK) T cells and Cr-specific T cells with VA11-1/VB14-1 usage, suggesting metal-specific T cells driven by invariant NKT cells might contribute to the pathogenesis of Cr allergy.	[Shigematsu, Hiroaki; Kumagai, Kenichi; Kobayashi, Hiroshi; Eguchi, Takanori; Kitaura, Kazutaka; Matsutani, Takaji; Suzuki, Ryuji] Natl Hosp Org, Sagamihara Natl Hosp, Clin Res Ctr Rheumatol & Allergy, Dept Rheumatol & Clin Immunol, Sagamihara, Kanagawa, Japan; [Shigematsu, Hiroaki; Kumagai, Kenichi; Kobayashi, Hiroshi; Eguchi, Takanori; Hamada, Yoshiki] Tsurumi Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa, Japan; [Kobayashi, Hiroshi] Nagano Matsushiro Gen Hosp, Dept Oral & Maxillofacial Surg, Nagano, Japan; [Eguchi, Takanori] Toshiba Rinkan Hosp, Dept Oral & Maxillofacial Surg, Sagamihara, Kanagawa, Japan; [Suzuki, Satsuki] Nippon Dent Univ Tokyo, Res Ctr Odontol, Sect Biol Sci, Tokyo, Japan; [Horikawa, Tatsuya] Nishi Kobe Med Ctr, Dept Dermatol, Kobe, Hyogo, Japan; [Ogasawara, Kouetsu] Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Sendai, Miyagi 980, Japan	Tsurumi University; Toshiba Corporation; Nippon Dental University; Kobe City Medical Center General Hospital; Tohoku University	Suzuki, R (corresponding author), Natl Hosp Org, Sagamihara Natl Hosp, Clin Res Ctr Rheumatol & Allergy, Dept Rheumatol & Clin Immunol, Sagamihara, Kanagawa, Japan.	r-suzuki@sagamihara-hosp.gr.jp	Suzuki, Satsuki/ABE-1283-2020; Ogasawara, Kouetsu/G-9892-2011	Eguchi, Takanori/0000-0003-4608-1347	Ministry of Education, Culture, Sports, Science and Technology, Japan [70373470, 23593004]; Ministry of Health, Labour and Welfare of Japan [H22-meneki-ippan-004]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a Grant-in-Aid for Scientific Research C 70373470, and 23593004 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Y.H. and R.S.); and by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare of Japan H22-meneki-ippan-004 (K.O. and R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1996, J INVEST DERMATOL, V107, P360, DOI 10.1111/1523-1747.ep12363337; AUSTYN JM, 1987, IMMUNOLOGY, V62, P161; Balato A, 2009, J INVEST DERMATOL, V129, P1628, DOI 10.1038/jid.2009.30; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Bowerman NA, 2011, J IMMUNOL, V187, P3694, DOI 10.4049/jimmunol.1101872; BRASCH J, 1992, J INVEST DERMATOL, V98, P166, DOI 10.1111/1523-1747.ep12555804; BRUYNZEEL DP, 1988, CONTACT DERMATITIS, V19, P175, DOI 10.1111/j.1600-0536.1988.tb02889.x; Budinger L, 2001, J IMMUNOL, V167, P6038, DOI 10.4049/jimmunol.167.10.6038; Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032; ENK AH, 1993, J IMMUNOL, V150, P3698; Estlander T, 2000, CONTACT DERMATITIS, V43, P114; Federici M, 2002, J IMMUNOL, V169, P434, DOI 10.4049/jimmunol.169.1.434; Fujii Y, 2008, JPN J INFECT DIS, V61, P40; Gamerdinger K, 2003, J EXP MED, V197, P1345, DOI 10.1084/jem.20030121; Gober MD, 2008, J INVEST DERMATOL, V128, P1460, DOI 10.1038/sj.jid.5701199; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Hashizume H, 2008, J IMMUNOL, V181, P8096, DOI 10.4049/jimmunol.181.11.8096; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; KALISH RS, 1991, ARCH DERMATOL, V127, P1558, DOI 10.1001/archderm.127.10.1558; Kanerva L, 2000, Am J Contact Dermat, V11, P155, DOI 10.1053/ajcd.2000.7186; Kerstan A, 2011, ARCH DERMATOL RES, V303, P651, DOI 10.1007/s00403-011-1149-5; Kitaura K, 2011, J IMMUNOL, V187, P3919, DOI 10.4049/jimmunol.1100442; Kobayashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076385; KURIMOTO I, 1995, IMMUNOLOGY, V85, P621; Macedo MS, 2007, CONTACT DERMATITIS, V56, P232, DOI 10.1111/j.1600-0536.2007.01085.x; Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x; Matsutani T, 1997, HUM IMMUNOL, V56, P57, DOI 10.1016/S0198-8859(97)00102-X; NIELSEN NH, 1992, ACTA DERM-VENEREOL, V72, P456; Nosbaum A, 2009, EUR J DERMATOL, V19, P325, DOI 10.1684/ejd.2009.0686; Raap U, 2009, CONTACT DERMATITIS, V60, P339, DOI 10.1111/j.1600-0536.2009.01524.x; Rui F, 2010, CONTACT DERMATITIS, V62, P225, DOI 10.1111/j.1600-0536.2009.01650.x; Saint-Mezard P, 2004, EUR J DERMATOL, V14, P284; Saint-Mezard P, 2004, EUR J DERMATOL, V14, P131; Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Shelnutt SR, 2007, CRIT REV TOXICOL, V37, P375, DOI 10.1080/10408440701266582; Shrivastava R, 2002, FEMS IMMUNOL MED MIC, V34, P1, DOI 10.1111/j.1574-695X.2002.tb00596.x; Silvennoinen-Kassinen S, 1998, SCAND J IMMUNOL, V48, P99, DOI 10.1046/j.1365-3083.1998.00367.x; Simon D, 2009, ALLERGY, V64, P1681, DOI 10.1111/j.1398-9995.2009.02097.x; Sumiwi YAA, 2010, CUTAN OCUL TOXICOL, V29, P30, DOI 10.3109/15569520903496746; Summer B, 2001, ALLERGY, V56, P767, DOI 10.1034/j.1398-9995.2001.056008767.x; Thomas P, 2000, ALLERGY, V55, P969, DOI 10.1034/j.1398-9995.2000.00619.x; Trautmann A, 2000, J CLIN INVEST, V106, P25, DOI 10.1172/JCI9199; Trautmann A, 2001, J INVEST DERMATOL, V117, P927, DOI 10.1046/j.0022-202x.2001.01474.x; TSURUTA Y, 1993, J IMMUNOL METHODS, V161, P7, DOI 10.1016/0022-1759(93)90193-B; Vollmer J, 1997, EUR J IMMUNOL, V27, P1865, DOI 10.1002/eji.1830270808; Vollmer J, 1999, J IMMUNOL, V163, P2723; Yin L, 2012, P NATL ACAD SCI USA, V109, P18517, DOI 10.1073/pnas.1215928109; Yoshida R, 2000, IMMUNOGENETICS, V52, P35, DOI 10.1007/s002510000248	50	14	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85983	10.1371/journal.pone.0085983	http://dx.doi.org/10.1371/journal.pone.0085983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465826	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500097
J	van Gennip, RGP; van de Water, SGP; van Rijn, PA				van Gennip, Rene G. P.; van de Water, Sandra G. P.; van Rijn, Piet A.			Bluetongue Virus Nonstructural Protein NS3/NS3a Is Not Essential for Virus Replication	PLOS ONE			English	Article							CELL-LINES; EPITHELIAL-CELLS; INFECTED-CELLS; RELEASE; TRAFFICKING; PARTICLES; SYSTEMS; NS3	Orbiviruses form the largest genus of the family Reoviridae consisting of at least 23 different virus species. One of these is the bluetongue virus (BTV) and causes severe hemorrhagic disease in ruminants, and is transmitted by bites of Culicoides midges. BTV is a non-enveloped virus which is released from infected cells by cell lysis and/or a unique budding process induced by nonstructural protein NS3/NS3a encoded by genome segment 10 (Seg-10). Presence of both NS3 and NS3a is highly conserved in Culicoides borne orbiviruses which is suggesting an essential role in virus replication. We used reverse genetics to generate BTV mutants to study the function of NS3/NS3a in virus replication. Initially, BTV with small insertions in Seg-10 showed no CPE but after several passages these BTV mutants reverted to CPE phenotype comparable to wtBTV, and NS3/NS3a expression returned by repair of the ORF. These results show that there is a strong selection for functional NS3/NS3a. To abolish NS3 and/or NS3a expression, Seg-10 with one or two mutated start codons (mutAUG1, mutAUG2 and mutAUG1+ 2) were used to generate BTV mutants. Surprisingly, all three BTV mutants were generated and the respective AUG(Met)-> GCC(Ala) mutations were maintained. The lack of expression of NS3, NS3a, or both proteins was confirmed by westernblot analysis and immunostaining of infected cells with NS3/NS3a Mabs. Growth of mutAUG1 and mutAUG1+ 2 virus in BSR cells was retarded in both insect and mammalian cells, and particularly virus release from insect cells was strongly reduced. Our findings now enable research on the role of RNA sequences of Seg-10 independent of known gene products, and on the function of NS3/NS3a proteins in both types of cells as well as in the host and insect vector.	[van Gennip, Rene G. P.; van de Water, Sandra G. P.; van Rijn, Piet A.] Cent Vet Inst Wageningen UR CVI, Dept Virol, Lelystad, Netherlands	Wageningen University & Research	van Gennip, RGP (corresponding author), Cent Vet Inst Wageningen UR CVI, Dept Virol, Lelystad, Netherlands.	rene.vangennip@wur.nl	van Rijn, Piet A/C-1163-2017; van Rijn, Piet A./AAG-7398-2019	van Rijn, Piet A/0000-0002-2594-1232; van Rijn, Piet A./0000-0002-2594-1232; van Gennip, Rene/0000-0002-5450-3493	Dutch Ministry of Economic Affairs	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This research was funded by the Dutch Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Celma CCP, 2011, J VIROL, V85, P4783, DOI 10.1128/JVI.02352-10; Celma CCP, 2009, J VIROL, V83, P6806, DOI 10.1128/JVI.00263-09; CLAYSON ET, 1989, J VIROL, V63, P2278, DOI 10.1128/JVI.63.5.2278-2288.1989; FRENCH TJ, 1990, J VIROL, V64, P1530, DOI 10.1128/JVI.64.4.1530-1536.1990; Griffin SDC, 2009, P NATL ACAD SCI USA, V106, P12567, DOI 10.1073/pnas.0906760106; Han ZY, 2004, J BIOL CHEM, V279, P43092, DOI 10.1074/jbc.M403663200; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HOMAN EJ, 1988, VET MICROBIOL, V16, P15, DOI 10.1016/0378-1135(88)90123-X; HYATT AD, 1989, VIROLOGY, V173, P21, DOI 10.1016/0042-6822(89)90218-3; HYATT AD, 1991, J GEN VIROL, V72, P2263, DOI 10.1099/0022-1317-72-9-2263; JENNINGS M, 1979, ARCH VIROL, V59, P121, DOI 10.1007/BF01317901; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Meiring TL, 2009, ARCH VIROL, V154, P263, DOI 10.1007/s00705-008-0302-8; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Noad R, 2009, BIOL ANIM INFECT, P53, DOI 10.1016/B978-012369368-6.50008-3; OIE, 2006, MANUAL DIAGNOSTIC TE; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; Roy P, 2005, ADV VIRUS RES, V64, P69, DOI 10.1016/S0065-3527(05)64004-3; Roy P, 2008, CELL BIOCHEM BIOPHYS, V50, P143, DOI 10.1007/s12013-008-9009-4; SATO M, 1977, ARCH VIROL, V54, P333, DOI 10.1007/BF01314778; TUCKER SP, 1993, J VIROL, V67, P4274, DOI 10.1128/JVI.67.7.4274-4282.1993; van Gennip RGP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044619; van Gennip RGP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030540; Watanabe S, 2009, J VIROL, V83, P5947, DOI 10.1128/JVI.00450-09; WECHSLER SJ, 1988, J CLIN MICROBIOL, V26, P2324, DOI 10.1128/JCM.26.11.2324-2327.1988; WECHSLER SJ, 1989, J INVERTEBR PATHOL, V54, P385, DOI 10.1016/0022-2011(89)90123-7; Wirblich C, 2006, J VIROL, V80, P460, DOI 10.1128/JVI.80.1.460-473.2006; WU XY, 1992, J VIROL, V66, P7104, DOI 10.1128/JVI.66.12.7104-7112.1992	31	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85788	10.1371/journal.pone.0085788	http://dx.doi.org/10.1371/journal.pone.0085788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465709	Green Published, gold			2022-12-25	WOS:000330240500074
J	De Naeyer, H; Bogaert, V; De Spaey, A; Roef, G; Vandewalle, S; Derave, W; Taes, Y; Kaufman, JM				De Naeyer, Helene; Bogaert, Veerle; De Spaey, Annelies; Roef, Greet; Vandewalle, Sara; Derave, Wim; Taes, Youri; Kaufman, Jean-Marc			Genetic Variations in the Androgen Receptor Are Associated with Steroid Concentrations and Anthropometrics but Not with Muscle Mass in Healthy Young Men	PLOS ONE			English	Article							SERUM TESTOSTERONE LEVELS; DIGIT RATIO; REPEAT POLYMORPHISM; PHYSICAL-ACTIVITY; PROSTATE-CANCER; SEX-HORMONES; ELDERLY-MEN; BODY-MASS; ESTROGEN; STRENGTH	Objective: The relationship between serum testosterone (T) levels, muscle mass and muscle force in eugonadal men is incompletely understood. As polymorphisms in the androgen receptor (AR) gene cause differences in androgen sensitivity, no straightforward correlation can be observed between the interindividual variation in T levels and different phenotypes. Therefore, we aim to investigate the relationship between genetic variations in the AR, circulating androgens and muscle mass and function in young healthy male siblings. Design: 677 men (25-45 years) were recruited in a cross-sectional, population-based sibling pair study. Methods: Relations between genetic variation in the AR gene (CAGn, GGNn, SNPs), sex steroid levels (by LC-MS/MS), body composition (by DXA), muscle cross-sectional area (CSA) (by pQCT), muscle force (isokinetic peak torque, grip strength) and anthropometrics were studied using linear mixed-effect modelling. Results: Muscle mass and force were highly heritable and related to age, physical activity, body composition and anthropometrics. Total T (TT) and free T (FT) levels were positively related to muscle CSA, whereas estradiol (E-2) and free E-2 (FE2) concentrations were negatively associated with muscle force. Subjects with longer CAG repeat length had higher circulating TT, FT, and higher E-2 and FE2 concentrations. Weak associations with TT and FT were found for the rs5965433 and rs5919392 SNP in the AR, whereas no association between GGN repeat polymorphism and T concentrations were found. Arm span and 2D:4D finger length ratio were inversely associated, whereas muscle mass and force were not associated with the number of CAG repeats. Conclusions: Age, physical activity, body composition, sex steroid levels and anthropometrics are determinants of muscle mass and function in young men. Although the number of CAG repeats of the AR are related to sex steroid levels and anthropometrics, we have no evidence that these variations in the AR gene also affect muscle mass or function.	[De Naeyer, Helene; Bogaert, Veerle; De Spaey, Annelies; Roef, Greet; Vandewalle, Sara; Taes, Youri; Kaufman, Jean-Marc] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium; [De Naeyer, Helene; Derave, Wim] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Kaufman, Jean-Marc] Ghent Univ Hosp, Unit Osteoporosis & Metab Bone Dis, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University Hospital	Kaufman, JM (corresponding author), Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium.	Jean.Kaufman@ugent.be	Derave, Wim/B-2554-2014	Derave, Wim/0000-0002-2225-5587	Research Foundation - Flanders (FWO-Vlaanderen) [G.0332.02, G.0404.00]; Roche; GSK Belgium; Research Foundation Flanders (FWO)	Research Foundation - Flanders (FWO-Vlaanderen)(FWO); Roche(Roche Holding); GSK Belgium(GlaxoSmithKline); Research Foundation Flanders (FWO)(FWO)	This study is supported by grants from the Research Foundation - Flanders (FWO-Vlaanderen grants #G.0332.02 and #G.0404.00) and an unrestricted grant from Roche and GSK Belgium. S. V. is holder of a PhD fellowship and Y.T. is holder of a postdoctoral fellowship from the Research Foundation Flanders (FWO) (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden NK, 1997, J BONE MINER RES, V12, P2076, DOI 10.1359/jbmr.1997.12.12.2076; Auyeung TW, 2011, EUR J ENDOCRINOL, V164, P811, DOI 10.1530/EJE-10-0952; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; Barros RPA, 2006, P NATL ACAD SCI USA, V103, P1605, DOI 10.1073/pnas.0510391103; Baumgartner RN, 1999, MECH AGEING DEV, V107, P123, DOI 10.1016/S0047-6374(98)00130-4; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/nejm199607043350101; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P407, DOI 10.1210/jc.82.2.407; Black BE, 2004, MOL ENDOCRINOL, V18, P834, DOI 10.1210/me.2003-0145; Bogaert V, 2009, EUR J ENDOCRINOL, V161, P171, DOI 10.1530/EJE-09-0123; Brown M, 2009, AM J PHYSIOL-ENDOC M, V296, pE854, DOI 10.1152/ajpendo.90696.2008; Butovskaya ML, 2012, BEHAV GENET, V42, P647, DOI 10.1007/s10519-012-9533-2; Crabbe P, 2007, J CLIN ENDOCR METAB, V92, P3604, DOI 10.1210/jc.2007-0117; Davis-Dao CA, 2007, J CLIN ENDOCR METAB, V92, P4319, DOI 10.1210/jc.2007-1110; Fiers T, 2012, J CHROMATOGR B, V893, P57, DOI 10.1016/j.jchromb.2012.02.034; Folland JP, 2012, EXP GERONTOL, V47, P437, DOI 10.1016/j.exger.2012.03.013; Gallagher D, 1998, APPL RADIAT ISOTOPES, V49, P733, DOI 10.1016/S0969-8043(97)00096-1; Geirsdottir OG, 2012, J NUTR HEALTH AGING, V16, P62, DOI 10.1007/s12603-011-0076-7; Giwercman YL, 2005, EUR UROL, V48, P679, DOI 10.1016/j.eururo.2005.06.011; Guadalupe-Grau A, 2011, BRIT J SPORT MED, V45, P95, DOI 10.1136/bjsm.2009.060285; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Huhtaniemi IT, 2009, J CLIN ENDOCR METAB, V94, P277, DOI 10.1210/jc.2008-0848; Hurd PL, 2011, BEHAV GENET, V41, P543, DOI 10.1007/s10519-010-9404-7; IHEMELANDU EC, 1981, ACTA ANAT, V110, P311; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Jin GF, 2012, HUM MOL GENET, V21, P5222, DOI 10.1093/hmg/dds361; Kahlert S, 1997, BIOCHEM BIOPH RES CO, V232, P373, DOI 10.1006/bbrc.1997.6223; Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013; Knickmeyer RC, 2011, HORM BEHAV, V60, P256, DOI 10.1016/j.yhbeh.2011.05.009; KOBORI M, 1989, CLIN ORTHOP RELAT R, P306; Lapauw BM, 2009, J BONE MINER RES, V24, P1075, DOI [10.1359/JBMR.081260, 10.1359/jbmr.081260]; Lee JS, 2006, J CLIN ENDOCR METAB, V91, P3791, DOI 10.1210/jc.2005-2378; Li WH, 2005, MOL ENDOCRINOL, V19, P2273, DOI 10.1210/me.2005-0134; Lowndes J, 2009, J STRENGTH COND RES, V23, P1915, DOI 10.1519/JSC.0b013e3181b94b35; Lundin KB, 2006, EUR J ENDOCRINOL, V155, P347, DOI 10.1530/eje.1.02204; MACDONALD PC, 1979, J CLIN ENDOCR METAB, V49, P905, DOI 10.1210/jcem-49-6-905; Manning JT, 2002, MED HYPOTHESES, V59, P334, DOI 10.1016/S0306-9877(02)00181-0; Martin RM, 2003, J CLIN ENDOCR METAB, V88, P3027, DOI 10.1210/jc.2002-021780; McClung JM, 2006, J APPL PHYSIOL, V100, P2012, DOI 10.1152/japplphysiol.01583.2005; McCormick KM, 2004, J MUSCLE RES CELL M, V25, P21, DOI 10.1023/B:JURE.0000021398.78327.39; McIntyre MH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-10; MEIKLE AW, 1988, J CLIN ENDOCR METAB, V67, P104, DOI 10.1210/jcem-67-1-104; Moran AL, 2007, J APPL PHYSIOL, V102, P1387, DOI 10.1152/japplphysiol.01305.2006; Muller DC, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-57; Nielsen TL, 2010, EUR J ENDOCRINOL, V162, P795, DOI 10.1530/EJE-09-0763; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; PHILLIPS SK, 1993, CLIN SCI, V84, P95, DOI 10.1042/cs0840095; Quigley CA, 2004, MECH AGEING DEV, V125, P683, DOI 10.1016/j.mad.2004.08.007; Ring HJZ, 2005, J CLIN ENDOCR METAB, V90, P3653, DOI 10.1210/jc.2004-1025; Storer TW, 2008, J AM GERIATR SOC, V56, DOI 10.1111/j.1532-5415.2008.01927.x; Stratakis CA, 1998, J CLIN ENDOCR METAB, V83, P1348, DOI 10.1210/jc.83.4.1348; SUZUKI S, 1985, EXP NEUROL, V87, P291, DOI 10.1016/0014-4886(85)90219-5; Szulc P, 2004, CLIN ENDOCRINOL, V61, P447, DOI 10.1111/j.1365-2265.2004.02117.x; Tobler Andreas R, 2005, J Biomol Tech, V16, P398; Ukkola O, 2001, EUR J ENDOCRINOL, V145, P1, DOI 10.1530/eje.0.1450001; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wang C, 2004, J CLIN ENDOCR METAB, V89, P534, DOI 10.1210/jc.2003-031287; Weise M, 2001, P NATL ACAD SCI USA, V98, P6871, DOI 10.1073/pnas.121180498; Zhang C, 2013, AM J HUM BIOL, V25, P101, DOI 10.1002/ajhb.22347	59	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86235	10.1371/journal.pone.0086235	http://dx.doi.org/10.1371/journal.pone.0086235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465978	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000069
J	Schall, S; von Kriegstein, K				Schall, Sonja; von Kriegstein, Katharina			Functional Connectivity between Face-Movement and Speech-Intelligibility Areas during Auditory-Only Speech Perception	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; CONGENITAL PROSOPAGNOSIA; AUDIOVISUAL SPEECH; MULTISENSORY INTEGRATION; LANGUAGE COMPREHENSION; RHESUS-MONKEY; TALKING FACES; CORTEX; RECOGNITION; VOICE	It has been proposed that internal simulation of the talking face of visually-known speakers facilitates auditory speech recognition. One prediction of this view is that brain areas involved in auditory-only speech comprehension interact with visual face-movement sensitive areas, even under auditory-only listening conditions. Here, we test this hypothesis using connectivity analyses of functional magnetic resonance imaging (fMRI) data. Participants (17 normal participants, 17 developmental prosopagnosics) first learned six speakers via brief voice-face or voice-occupation training (<2 min/speaker). This was followed by an auditory-only speech recognition task and a control task (voice recognition) involving the learned speakers' voices in the MRI scanner. As hypothesized, we found that, during speech recognition, familiarity with the speaker's face increased the functional connectivity between the face-movement sensitive posterior superior temporal sulcus (STS) and an anterior STS region that supports auditory speech intelligibility. There was no difference between normal participants and prosopagnosics. This was expected because previous findings have shown that both groups use the face-movement sensitive STS to optimize auditory-only speech comprehension. Overall, the present findings indicate that learned visual information is integrated into the analysis of auditory-only speech and that this integration results from the interaction of task-relevant face-movement and auditory speech-sensitive areas.	[Schall, Sonja; von Kriegstein, Katharina] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [von Kriegstein, Katharina] Humboldt Univ, D-10099 Berlin, Germany	Max Planck Society; Humboldt University of Berlin	Schall, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	schall@cbs.mpg.de	von Kriegstein, Katharina/C-3135-2008	von Kriegstein, Katharina/0000-0001-7989-5860	Max Planck Research Group	Max Planck Research Group(Max Planck Society)	This work was supported by a Max Planck Research Group grant (www.mpg.de) to Katharina von Kriegstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3585; Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Avidan G, 2009, CURR BIOL, V19, P1146, DOI 10.1016/j.cub.2009.04.060; Azanon E, 2010, CURR BIOL, V20, P1304, DOI 10.1016/j.cub.2010.05.063; Beauchamp MS, 2010, J NEUROSCI, V30, P2414, DOI 10.1523/JNEUROSCI.4865-09.2010; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Bishop CW, 2009, J COGNITIVE NEUROSCI, V21, P1790, DOI 10.1162/jocn.2009.21118; Blank H, 2012, NEUROIMAGE; Blank H, 2011, J NEUROSCI, V31, P12906, DOI 10.1523/JNEUROSCI.2091-11.2011; Bolognini N, 2007, CURR BIOL, V17, P1890, DOI 10.1016/j.cub.2007.09.057; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Davis MH, 2003, J NEUROSCI, V23, P3423; DeWitt I, 2012, P NATL ACAD SCI USA, V109, pE505, DOI 10.1073/pnas.1113427109; Dobel C, 2007, CORTEX, V43, P718, DOI 10.1016/S0010-9452(08)70501-X; Ellis HD, 1997, BRIT J PSYCHOL, V88, P14; Falchier A, 2002, J NEUROSCI, V22, P5749; Friederici AD, 2010, HUM BRAIN MAPP, V31, P448, DOI 10.1002/hbm.20878; Friston K, 1995, HUM BRAIN MAPP, V2, P12; Garrido L, 2009, BRAIN, V132, P3443, DOI 10.1093/brain/awp271; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Grant KW, 2000, J ACOUST SOC AM, V108, P1197, DOI 10.1121/1.1288668; Hall AJ, 2008, EXP BRAIN RES, V190, P413, DOI 10.1007/s00221-008-1485-7; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Hasson U, 2007, NEURON, V56, P1116, DOI 10.1016/j.neuron.2007.09.037; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Humphreys K, 2007, EXP BRAIN RES, V176, P356, DOI 10.1007/s00221-006-0621-5; Kim J, 2011, INT C PHON SCI HONG, P4; Lange J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007414; Leff AP, 2008, J NEUROSCI, V28, P13209, DOI 10.1523/JNEUROSCI.2903-08.2008; Macaluso E, 2004, NEUROIMAGE, V21, P725, DOI 10.1016/j.neuroimage.2003.09.049; Matsumoto R, 2011, NEUROPSYCHOLOGIA, V49, P1350, DOI 10.1016/j.neuropsychologia.2011.01.023; MCCONACHIE HR, 1976, CORTEX, V12, P76, DOI 10.1016/S0010-9452(76)80033-0; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; Nath AR, 2011, J NEUROSCI, V31, P1704, DOI 10.1523/JNEUROSCI.4853-10.2011; Obleser J, 2007, J NEUROSCI, V27, P2283, DOI 10.1523/JNEUROSCI.4663-06.2007; Ojanen V, 2005, NEUROIMAGE, V25, P333, DOI 10.1016/j.neuroimage.2004.12.001; Renzi C, 2013, J COGNITIVE NEUROSCI, V25, P790, DOI 10.1162/jocn_a_00362; Rosen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024672; Rosenblum LD, 2007, PSYCHOL SCI, V18, P392, DOI 10.1111/j.1467-9280.2007.01911.x; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SELTZER B, 1984, EXP BRAIN RES, V55, P301; Sheffert SM, 2004, PERCEPT PSYCHOPHYS, V66, P352, DOI 10.3758/BF03194884; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; Steede LL, 2007, COGN NEUROPSYCHOL, V24, P451, DOI 10.1080/02643290701381879; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; von Kriegstein K, 2005, J COGNITIVE NEUROSCI, V17, P367, DOI 10.1162/0898929053279577; von Kriegstein K., 2012, NEURAL BASES MULTISE; von Kriegstein K, 2008, P NATL ACAD SCI USA, V105, P6747, DOI 10.1073/pnas.0710826105; von Kriegstein K, 2006, PLOS BIOL, V4, P1809, DOI 10.1371/journal.pbio.0040326; von Kriegstein K, 2006, CEREB CORTEX, V16, P1314, DOI 10.1093/cercor/bhj073	60	14	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86325	10.1371/journal.pone.0086325	http://dx.doi.org/10.1371/journal.pone.0086325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297XI	24466026	Green Published, gold			2022-12-25	WOS:000330288000084
J	Boesveldt, S; Lundstrom, JN				Boesveldt, Sanne; Lundstrom, Johan N.			Detecting Fat Content of Food from a Distance: Olfactory-Based Fat Discrimination in Humans	PLOS ONE			English	Article							ORAL-SENSITIVITY; TIME-INTENSITY; OIL PREFERENCE; ACIDS; RETRONASAL; MICE	The desire to consume high volumes of fat is thought to originate from an evolutionary pressure to hoard calories, and fat is among the few energy sources that we can store over a longer time period. From an ecological perspective, however, it would be beneficial to detect fat from a distance, before ingesting it. Previous results indicate that humans detect high concentrations of fatty acids by their odor. More important though, would be the ability to detect fat content in real food products. In a series of three sequential experiments, using study populations from different cultures, we demonstrated that individuals are able to reliably detect fat content of food via odors alone. Over all three experiments, results clearly demonstrated that humans were able to detect minute differences between milk samples with varying grades of fat, even when embedded within a milk odor. Moreover, we found no relation between this performance and either BMI or dairy consumption, thereby suggesting that this is not a learned ability or dependent on nutritional traits. We argue that our findings that humans can detect the fat content of food via odors may open up new and innovative future paths towards a general reduction in our fat intake, and future studies should focus on determining the components in milk responsible for this effect.	[Boesveldt, Sanne] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Boesveldt, Sanne; Lundstrom, Johan N.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Lundstrom, Johan N.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lundstrom, Johan N.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	Wageningen University & Research; Monell Chemical Senses Center; Karolinska Institutet; University of Pennsylvania	Boesveldt, S (corresponding author), Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.	Sanne.boesveldt@wur.nl	Lundström, Johan N./AAK-5002-2020; Lundström, Johan N/E-9482-2014	Lundström, Johan N./0000-0002-3529-8981; Lundström, Johan N/0000-0002-3529-8981	Knut and Alice Wallenberg Foundation [KAW 2012.0141]; Netherlands Organization for Scientific Research (NWO) [451-11-021]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Support was provided by the Knut and Alice Wallenberg Foundation (KAW 2012.0141), awarded to JNL, and a grant from the Netherlands Organization for Scientific Research (NWO; 451-11-021) awarded to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, FOOD AGR ORG UN FAO; Bolton B, 2010, CHEM SENSES, V35, P229, DOI 10.1093/chemse/bjq002; Chale-Rush A, 2007, AM J PHYSIOL-GASTR L, V292, pG1206, DOI 10.1152/ajpgi.00471.2006; Chale-Rush A, 2007, CHEM SENSES, V32, P423, DOI 10.1093/chemse/bjm007; Chukir T, 2013, CHEM SENSES, V38, P343, DOI 10.1093/chemse/bjt005; CLARK CC, 1994, CHEM SENSES, V19, P583, DOI 10.1093/chemse/19.6.583; Drewnowski A, 1997, J AM DIET ASSOC, V97, pS58, DOI 10.1016/S0002-8223(97)00732-3; Elmadfa I, 2009, ANN NUTR METAB, V55, P56, DOI 10.1159/000228996; Galindo MM, 2012, CHEM SENSES, V37, P123, DOI 10.1093/chemse/bjr069; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Kallas O, 2011, CHEMOSENS PERCEPT, V4, P16, DOI 10.1007/s12078-011-9085-5; Kinney NE, 1996, PHYSIOL BEHAV, V59, P475, DOI 10.1016/0031-9384(95)02086-1; Mabayo RT, 1996, PHYSIOL BEHAV, V59, P1185, DOI 10.1016/0031-9384(95)02152-3; Mattes RD, 2009, CHEM SENSES, V34, P145, DOI 10.1093/chemse/bjn072; Miettinen SM, 2004, J AGR FOOD CHEM, V52, P8111, DOI 10.1021/jf040218v; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; RAMIREZ I, 1993, AM J PHYSIOL, V265, pR1404, DOI 10.1152/ajpregu.1993.265.6.R1404; Roberts DD, 2003, J AGR FOOD CHEM, V51, P3636, DOI 10.1021/jf026230+; Stewart JE, 2012, INT J OBESITY, V36, P834, DOI 10.1038/ijo.2011.155; Stewart JE, 2010, BRIT J NUTR, V104, P145, DOI 10.1017/S0007114510000267; Takeda M, 2001, LIFE SCI, V69, P847, DOI 10.1016/S0024-3205(01)01180-8; US Department of Agriculture ARS, 2011, USDA NAT NUTR DAT ST; Wajid NA, 2012, CHEM SENSES, V37, P595, DOI 10.1093/chemse/bjs041	23	27	27	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85977	10.1371/journal.pone.0085977	http://dx.doi.org/10.1371/journal.pone.0085977			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465822	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100091
J	Faas, MM; Kunnen, A; Dekker, DC; Harmsen, HJM; Aarnoudse, JG; Abbas, F; De Vos, P; Van Pampus, MG				Faas, Marijke M.; Kunnen, Alina; Dekker, Daphne C.; Harmsen, Hermie J. M.; Aarnoudse, Jan G.; Abbas, Frank; De Vos, Paul; Van Pampus, Maria G.			Porphyromonas Gingivalis and E-coli Induce Different Cytokine Production Patterns in Pregnant Women	PLOS ONE			English	Article							DOSE ENDOTOXIN INFUSION; TOLL-LIKE RECEPTORS; PERIODONTAL-DISEASE; PRETERM BIRTH; KAPPA-B; PREECLAMPSIA; INFLAMMATION; ASSOCIATION; INNATE; SUPPRESSION	Objective: Pregnant individuals of many species, including humans, are more sensitive to various bacteria or their products as compared with non-pregnant individuals. Pregnant individuals also respond differently to different bacteria or their products. Therefore, in the present study, we evaluated whether the increased sensitivity of pregnant women to bacterial products and their heterogeneous response to different bacteria was associated with differences in whole blood cytokine production upon stimulation with bacteria or their products. Methods: Blood samples were taken from healthy pregnant and age-matched non-pregnant women and ex vivo stimulated with bacteria or LPS from Porphyromonas Gingivalis (Pg) or E-coli for 24 hrs. TNF alpha, IL-1 beta, IL-6, IL-12 and IL-10 were measured using a multiplex Luminex system. Results: We observed a generally lower cytokine production after stimulation with Pg bacteria or it's LPS as compared with E-coli bacteria. However, there was also an effect of pregnancy upon cytokine production: in pregnant women the production of IL-6 upon Pg stimulation was decreased as compared with non-pregnant women. After stimulation with E-coli, the production of IL-12 and TNF alpha was decreased in pregnant women as compared with non-pregnant women. Conclusion: Our results showed that cytokine production upon bacterial stimulation of whole blood differed between pregnant and non-pregnant women, showing that the increased sensitivity of pregnant women may be due to differences in cytokine production. Moreover, pregnancy also affected whole blood cytokine production upon Pg or E-coli stimulation differently. Thus, the different responses of pregnant women to different bacteria or their products may result from variations in cytokine production.	[Faas, Marijke M.; Dekker, Daphne C.; De Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, NL-9713 AV Groningen, Netherlands; [Faas, Marijke M.; Kunnen, Alina; Dekker, Daphne C.; Harmsen, Hermie J. M.; Aarnoudse, Jan G.; Abbas, Frank; De Vos, Paul; Van Pampus, Maria G.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Kunnen, Alina; Abbas, Frank] Univ Groningen, Univ Med Ctr Groningen, Dept Periodontol, Ctr Dent & Oral Hyg, NL-9713 AV Groningen, Netherlands; [Kunnen, Alina] Hanze Univ Appl Sci Groningen, Sch Hlth Care Studies, Groningen, Netherlands; [Harmsen, Hermie J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands; [Aarnoudse, Jan G.; Van Pampus, Maria G.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Faas, MM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, NL-9713 AV Groningen, Netherlands.	m.m.faas@umcg.nl	de Vos, Paul/A-3170-2013	van Pampus, Maria/0000-0002-3020-8908; de vos, paul/0000-0001-9618-2408	NVvP (Dutch Society of Periodontology)	NVvP (Dutch Society of Periodontology)	This study was supported by a grant from the NVvP (Dutch Society of Periodontology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLER FK, 1972, GYNECOL OBSTET INVES, V3, P176, DOI 10.1159/000301773; Belstrom D, 2012, MICROBES INFECT, V14, P411, DOI 10.1016/j.micinf.2011.12.004; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Blanchard F, 2009, CYTOKINE GROWTH F R, V20, P19, DOI 10.1016/j.cytogfr.2008.11.004; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Faas MM, 2002, CLIN EXP IMMUNOL, V127, P337, DOI 10.1046/j.1365-2249.2002.01765.x; FAAS MM, 1994, AM J OBSTET GYNECOL, V171, P158, DOI 10.1016/0002-9378(94)90463-4; Faas MM, 1997, AM J OBSTET GYNECOL, V177, P429, DOI 10.1016/S0002-9378(97)70210-2; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Hadfield KA, 2011, J REPROD IMMUNOL, V89, P1, DOI 10.1016/j.jri.2010.11.008; Hawiger J, 2001, IMMUNOL RES, V23, P99, DOI 10.1385/IR:23:2-3:099; Hayashi C, 2010, MOL ORAL MICROBIOL, V25, P305, DOI 10.1111/j.2041-1014.2010.00582.x; Hennessy A, 2003, AM J REPROD IMMUNOL, V49, P377, DOI 10.1034/j.1600-0897.2003.00053.x; Horton AL, 2012, OBSTET GYN CLIN N AM, V39, P17, DOI 10.1016/j.ogc.2011.12.008; Katz J, 2009, J DENT RES, V88, P575, DOI 10.1177/0022034509338032; Kikkert R, 2007, ORAL MICROBIOL IMMUN, V22, P145, DOI 10.1111/j.1399-302X.2007.00335.x; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; Kunnen A, 2013, ORAL DIS; Kunnen A, 2012, ARCH ORAL BIOL, V57, P1558, DOI 10.1016/j.archoralbio.2012.07.013; Lakschevitz F, 2011, CURR DIABETES REV, V7, P433, DOI 10.2174/157339911797579205; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Martin M, 2001, J IMMUNOL, V167, P5278, DOI 10.4049/jimmunol.167.9.5278; McCracken SA, 2003, J REPROD IMMUNOL, V58, P27, DOI 10.1016/S0165-0378(02)00081-5; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Sfyroeras GS, 2012, J VASC SURG, V55, P1178, DOI 10.1016/j.jvs.2011.10.008; Siqueira FM, 2007, J PERIODONTOL, V78, P2266, DOI 10.1902/jop.2007.070196; Starkie R, 2003, FASEB J, V17, P884, DOI 10.1096/fj.02-0670fje; Sunderland NS, 2011, CYTOKINE, V56, P192, DOI 10.1016/j.cyto.2011.06.003; Swati P, 2012, ARCH GYNECOL OBSTET, V285, P613, DOI 10.1007/s00404-011-2012-9; Van der Velden U, 2009, J CLIN PERIODONTOL, V36, P1018, DOI 10.1111/j.1600-051X.2009.01495.x; van Nieuwenhoven ALV, 2003, AM J OBSTET GYNECOL, V188, P1073, DOI 10.1067/mob.2003.263; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3	37	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86355	10.1371/journal.pone.0086355	http://dx.doi.org/10.1371/journal.pone.0086355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466049	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100147
J	Hamrefors, V; Hedblad, B; Hindy, G; Smith, JG; Almgren, P; Engstrom, G; Sjogren, M; Gransbo, K; Orho-Melander, M; Melander, O				Hamrefors, Viktor; Hedblad, Bo; Hindy, George; Smith, J. Gustav; Almgren, Peter; Engstrom, Gunnar; Sjogren, Marketa; Gransbo, Klas; Orho-Melander, Marju; Melander, Olle			Smoking Modifies the Associated Increased Risk of Future Cardiovascular Disease by Genetic Variation on Chromosome 9p21	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; LOCUS; POPULATION; COHORT; STROKE	Aims: Genetic predisposition for cardiovascular disease (CVD) is likely to be modified by environmental exposures. We tested if the associated risk of CVD and CVD-mortality by the single nucleotide polymorphism rs4977574 on chromosome 9p21 is modified by life-style factors. Methods and results: A total of 24944 middle-aged subjects (62% females) from the population-based Malmo-Diet-and-Cancer-Cohort were genotyped. Smoking, education and physical activity-levels were recorded. Subjects were followed for 15 years for incidence of coronary artery disease (CAD; N = 2309), ischemic stroke (N = 1253) and CVD-mortality (N = 1156). Multiplicative interactions between rs4977574 and life-style factors on endpoints were tested in Cox-regression-models. We observed an interaction between rs4977574 and smoking on incident CAD (P = 0.035) and CVD-mortality (P = 0.012). The hazard ratios (HR) per risk allele of rs4977574 were highest in never smokers (N = 9642) for CAD (HR = 1.26; 95% CI 1.13-1.40; P < 0.001) and for CVD-mortality (HR = 1.40; 95% CI 1.20-1.63; P < 0.001), whereas the risk increase by rs4977574 was attenuated in current smokers (N = 7000) for both CAD (HR = 1.05; 95% CI 0.95-1.16; P = 0.326) and CVD-mortality (HR = 1.08; 95% CI 0.94-1.23; P = 0.270). A meta-analysis supported the finding that the associated increased risk of CAD by the risk-allele was attenuated in smokers. Neither education nor physical activity-levels modified the associated risk of CAD, ischemic stroke and CVD mortality conferred by rs4977574. Conclusion: Smoking may modify the associated risk of CAD and CVD-mortality conferred by genetic variation on chromosome 9p21. Whether the observed attenuation of the genetic risk reflects a pathophysiological mechanism or is a result of smoking being such a strong risk-factor that it may eliminate the associated genetic effect, requires further investigation.	[Hamrefors, Viktor; Hedblad, Bo; Hindy, George; Smith, J. Gustav; Almgren, Peter; Engstrom, Gunnar; Sjogren, Marketa; Gransbo, Klas; Orho-Melander, Marju; Melander, Olle] Lund Univ, Fac Med, Dept Clin Sci, Malmo, Sweden; [Hamrefors, Viktor] Skane Univ Hosp, Clin Physiol & Nucl Med Unit, Malmo, Sweden; [Smith, J. Gustav] Lund Univ, Fac Med, Dept Cardiol, Lund, Sweden; [Smith, J. Gustav] Skane Univ Hosp, Dept Cardiol, Lund, Sweden; [Smith, J. Gustav] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Gransbo, Klas; Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Lund University; Skane University Hospital	Hamrefors, V (corresponding author), Lund Univ, Fac Med, Dept Clin Sci, Malmo, Sweden.	Viktor.Hamrefors@med.lu.se		Hindy, George/0000-0002-7257-9299; Engstrom, Gunnar/0000-0002-8618-9152; Melander, Olle/0000-0002-2581-484X	European Research Council [StG-282255]; Swedish Medical Research Council; Swedish Heart and Lung Foundation; Medical Faculty of Lund University; LUA/ALF from the Sahlgrenska Academy at Goteborg University; MalmoUniversity Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Novo Nordic Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Marianne and Marcus Wallenberg Foundation; Novo Nordisk Fonden [NNF13OC0005339, NNF14OC0009819, NNF14OC0011049] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University; LUA/ALF from the Sahlgrenska Academy at Goteborg University; MalmoUniversity Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Novo Nordic Foundation(Novo Nordisk Foundation); Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Marianne and Marcus Wallenberg Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the European Research Council (StG-282255), the Swedish Medical Research Council, the Swedish Heart and Lung Foundation, the Medical Faculty of Lund University, LUA/ALF from the Sahlgrenska Academy at Goteborg University, MalmoUniversity Hospital, the Albert Pahlsson Research Foundation, the Crafoord Foundation, the Ernhold Lundstroms Research Foundation, Novo Nordic Foundation, the Region Skane, Hulda and Conrad Mossfelt Foundation and King Gustaf V and Queen Victoria Foundation, the Lennart Hanssons Memorial Fund and the Marianne and Marcus Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah KG, 2008, ANN HUM GENET, V72, P654, DOI 10.1111/j.1469-1809.2008.00454.x; Anderson CD, 2010, STROKE, V41, P1123, DOI 10.1161/STROKEAHA.110.580589; Assimes TL, 2008, HUM MOL GENET, V17, P2320, DOI 10.1093/hmg/ddn132; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Brautbar A, 2009, CIRC-CARDIOVASC GENE, V2, P279, DOI 10.1161/CIRCGENETICS.108.817338; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Folsom AR, 2012, ATHEROSCLEROSIS, V224, P435, DOI 10.1016/j.atherosclerosis.2012.08.007; Germano G, 2012, EUR HEART J, V33, P137; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hiura Y, 2008, CIRC J, V72, P1213, DOI 10.1253/circj.72.1213; Holdt LM, 2012, ARTERIOSCL THROM VAS, V32, P196, DOI 10.1161/ATVBAHA.111.232678; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khan FA, 2004, STROKE, V35, P2054, DOI 10.1161/01.STR.0000135761.18954.0b; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Li C, 2009, EUR J CLIN NUTR, V63, P1448, DOI 10.1038/ejcn.2009.69; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Manolio TA, 2009, NAT GENET, V41, P5, DOI 10.1038/ng0109-5; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Ordovas JM, 2008, CURR OPIN LIPIDOL, V19, P158, DOI 10.1097/MOL.0b013e3282f6a809; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; The Swedish National Board of Health and Welfare, 2000, EV QUAL DIAGN AC MYO; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055	27	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85893	10.1371/journal.pone.0085893	http://dx.doi.org/10.1371/journal.pone.0085893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465769	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100087
J	Liu, B; Lopez, JJ; Biesiadecki, BJ; Davis, JP				Liu, Bin; Lopez, Joseph J.; Biesiadecki, Brandon J.; Davis, Jonathan P.			Protein Kinase C Phosphomimetics Alter Thin Filament Ca2+ Binding Properties	PLOS ONE			English	Article							CARDIAC TROPONIN-I; MYOFILAMENT CALCIUM SENSITIVITY; COOPERATIVE ACTIVATION; SENSITIZING MUTATIONS; PHOSPHORYLATION SITES; ALPHA-TROPOMYOSIN; MUSCLE; EXCHANGE; IDENTIFICATION; DOMAIN	Adrenergic stimulation modulates cardiac function by altering the phosphorylation status of several cardiac proteins. The Troponin complex, which is the Ca2+ sensor for cardiac contraction, is a hot spot for adrenergic phosphorylation. While the effect of beta-adrenergic related PKA phosphorylation of troponin I at Ser23/24 is well established, the effects of alpha-adrenergic induced PKC phosphorylation on multiple sites of TnI (Ser43/45, Thr144) and TnT (Thr194, Ser198, Thr203 and Thr284) are much less clear. By utilizing an IAANS labeled fluorescent troponin C, TnC(IAANS)(T53C), we systematically examined the site specific effects of PKC phosphomimetic mutants of TnI and TnT on TnC's Ca2+ binding properties in the Tn complex and reconstituted thin filament. The majority of the phosphomemetics had little effect on the Ca2+ binding properties of the isolated Tn complex. However, when incorporated into the thin filament, the phosphomimetics typically altered thin filament Ca2+ sensitivity in a way consistent with their respective effects on Ca2+ sensitivity of skinned muscle preparations. The altered Ca2+ sensitivity could be generally explained by a change in Ca2+ dissociation rates. Within TnI, phosphomimetic Asp and Glu did not always behave similar, nor were Ala mutations (used to mimic non-phosphorylatable states) benign to Ca2+ binding. Our results suggest that Troponin may act as a hub on the thin filament, sensing physiological stimuli to modulate the contractile performance of the heart.	[Liu, Bin; Lopez, Joseph J.; Biesiadecki, Brandon J.; Davis, Jonathan P.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Davis, JP (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	davis.812@osu.edu		lopez, joseph/0000-0003-0821-7530	American Heart Association; NIH [HL114940, HL091986]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL091986, R01HL091986, R01HL114940] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the American Heart Association (to BL and JPD), and NIH grants HL114940 (to BJB) and HL091986 (to JPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Davis JP, 2008, CARDIOVASC RES, V77, P619, DOI 10.1093/cvr/cvm098; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Du JF, 2008, AM J PHYSIOL-HEART C, V294, pH2604, DOI 10.1152/ajpheart.91506.2007; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Jideama NM, 1996, J BIOL CHEM, V271, P23277, DOI 10.1074/jbc.271.38.23277; Kasahara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2879; Kirk JA, 2009, CIRC RES, V105, P1232, DOI 10.1161/CIRCRESAHA.109.205427; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kreutziger KL, 2011, J MOL CELL CARDIOL, V50, P165, DOI 10.1016/j.yjmcc.2010.10.025; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038259; Liu B, 2012, J BIOL CHEM, V287, P20027, DOI 10.1074/jbc.M111.334953; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; Manning EP, 2012, J MOL BIOL, V421, P54, DOI 10.1016/j.jmb.2012.05.008; Nixon BR, 2012, J BIOL CHEM, V287, P19136, DOI 10.1074/jbc.M111.323048; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pi YQ, 2002, CIRC RES, V90, P649, DOI 10.1161/01.RES.0000014080.82861.5F; ROBERTSON S, 1984, METHOD PHARMACOL, V5, P63, DOI DOI 10.1007/978-1-4684-4778-1_6; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Sumandea MP, 2004, ANN NY ACAD SCI, V1015, P39, DOI 10.1196/annals.1302.004; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Tachampa K, 2008, J BIOL CHEM, V283, P15114, DOI 10.1074/jbc.M801636200; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2002, BIOCHEMISTRY-US, V41, P6697, DOI 10.1021/bi011763h; Tikunova SB, 2010, BIOCHEMISTRY-US, V49, P1975, DOI 10.1021/bi901867s; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Westfall MV, 2005, J BIOL CHEM, V280, P41324, DOI 10.1074/jbc.M506043200	35	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86279	10.1371/journal.pone.0086279	http://dx.doi.org/10.1371/journal.pone.0086279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466001	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100137
J	Ortega-Gonzalez, M; de Medina, FS; Molina-Santiago, C; Lopez-Posadas, R; Pacheco, D; Krell, T; Martinez-Augustin, O; Abdelali, D				Ortega-Gonzalez, Mercedes; Sanchez de Medina, Fermin; Molina-Santiago, Carlos; Lopez-Posadas, Rocio; Pacheco, Daniel; Krell, Tino; Martinez-Augustin, Olga; Abdelali, Daddaoua			Fructooligosacharides Reduce Pseudomonas aeruginosa PAO1 Pathogenicity through Distinct Mechanisms	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; BIOFILM FORMATION; EPITHELIAL-CELLS; SECRETION SYSTEM; II SECRETION; ANTIMICROBIAL ACTIVITY; PROTEIN SECRETION; GENE-EXPRESSION; LUNG INFECTION; IV PILI	Pseudomonas aeruginosa is ubiquitously present in the environment and acts as an opportunistic pathogen on humans, animals and plants. We report here the effects of the prebiotic polysaccharide inulin and its hydrolysed form FOS on this bacterium. FOS was found to inhibit bacterial growth of strain PAO1, while inulin did not affect growth rate or yield in a significant manner. Inulin stimulated biofilm formation, whereas a dramatic reduction of the biofilm formation was observed in the presence of FOS. Similar opposing effects were observed for bacterial motility, where FOS inhibited the swarming and twitching behaviour whereas inulin caused its stimulation. In co-cultures with eukaryotic cells ( macrophages) FOS and, to a lesser extent, inulin reduced the secretion of the inflammatory cytokines IL-6, IL-10 and TNF-alpha. Western blot experiments indicated that the effects mediated by FOS in macrophages are associated with a decreased activation of the NF-kappa B pathway. Since FOS and inulin stimulate pathway activation in the absence of bacteria, the FOS mediated effect is likely to be of indirect nature, such as via a reduction of bacterial virulence. Further, this modulatory effect is observed also with the highly virulent ptxS mutated strain. Co-culture experiments of P. aeruginosa with IEC18 eukaryotic cells showed that FOS reduces the concentration of the major virulence factor, exotoxin A, suggesting that this is a possible mechanism for the reduction of pathogenicity. The potential of these compounds as components of antibacterial and anti-inflammatory cocktails is discussed.	[Ortega-Gonzalez, Mercedes; Martinez-Augustin, Olga] Univ Granada, Sch Pharm, Ctr Networked Biomed Res Hepat & Digest Dis, Dept Biochem & Mol Biol 2, Granada, Spain; [Molina-Santiago, Carlos; Pacheco, Daniel; Krell, Tino; Abdelali, Daddaoua] CSIC, Environm Protect Dept, Granada, Spain; [Sanchez de Medina, Fermin; Lopez-Posadas, Rocio] Univ Granada, Sch Pharm, Ctr Networked Biomed Res Hepat & Digest Dis, Dept Pharmacol, Granada, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Granada	Abdelali, D (corresponding author), CSIC, Environm Protect Dept, C Prof Albareda 1, Granada, Spain.	abdelali.daddaoua@eez.csic.es	de Medina, Fermin Sanchez/B-3782-2013; Molina, Carlos/AAS-5053-2020; Krell, Tino/G-7296-2015; Sánchez, Daniel Pacheco/AAC-1354-2021; Lorente, M Dolores/N-1313-2014; Augustin, Olga Martínez/K-6720-2014; Daddaoua, Abdelali/D-6930-2014	de Medina, Fermin Sanchez/0000-0002-4516-5824; Molina, Carlos/0000-0002-1131-8917; Krell, Tino/0000-0002-9040-3166; Sánchez, Daniel Pacheco/0000-0002-2293-7721; Augustin, Olga Martínez/0000-0001-8291-3468; Daddaoua, Abdelali/0000-0002-7348-6393	FEDER funds; Fondo Social Europeo through grants from the Spanish Ministry of Economy and Competitiveness [SAF2011-22922, SAF2011-22812]; Andalusian regional government Junta de Andalucia [CVI-7335]; Centre of Networked Biomedical Research on Hepatic and Digestive Diseases (CIBERehd); Carlos III Health Institute; Ramon Areces Foundation, Spain	FEDER funds(European Commission); Fondo Social Europeo through grants from the Spanish Ministry of Economy and Competitiveness; Andalusian regional government Junta de Andalucia(Junta de Andalucia); Centre of Networked Biomedical Research on Hepatic and Digestive Diseases (CIBERehd); Carlos III Health Institute(Instituto de Salud Carlos III); Ramon Areces Foundation, Spain	The authors acknowledge financial support from FEDER funds and Fondo Social Europeo through grants from the Spanish Ministry of Economy and Competitiveness (grants SAF2011-22922, SAF2011-22812) the Andalusian regional government Junta de Andalucia (grant CVI-7335) and the Centre of Networked Biomedical Research on Hepatic and Digestive Diseases (CIBERehd) which is funded by the Carlos III Health Institute and the Ramon Areces Foundation, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRIL MA, 1989, J BACTERIOL, V171, P6782, DOI 10.1128/jb.171.12.6782-6790.1989; Amer LS, 2010, BIOCHEM BIOPH RES CO, V396, P246, DOI 10.1016/j.bbrc.2010.04.073; Babu US, 2012, VET IMMUNOL IMMUNOP, V149, P92, DOI 10.1016/j.vetimm.2012.05.003; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bosscher D, 2006, NUTR RES REV, V19, P216, DOI 10.1017/S0954422407249686; Bosscher D, 2003, NUTRITION, V19, P641, DOI 10.1016/S0899-9007(03)00063-7; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; Buddington KK, 2002, J NUTR, V132, P472, DOI 10.1093/jn/132.3.472; Cao H, 2001, ANNU REV PHYTOPATHOL, V39, P259, DOI 10.1146/annurev.phyto.39.1.259; Chang JH, 2006, BRIT J OPHTHALMOL, V90, P103, DOI 10.1136/bjo.2005.072686; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Ciofu O, 2012, FEMS IMMUNOL MED MIC, V65, P215, DOI 10.1111/j.1574-695X.2012.00983.x; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Colmer JA, 1998, MOL GEN GENET, V258, P250, DOI 10.1007/s004380050729; Daddaoua A, 2006, J NUTR, V136, P672, DOI 10.1093/jn/136.3.672; Daddaoua A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039390; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Durand E., 2009, Infectious Disorders - Drug Targets, V9, P518; FLEISZIG SMJ, 1995, INFECT IMMUN, V63, P4072, DOI 10.1128/IAI.63.10.4072-4077.1995; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Fredheim EGA, 2009, J CLIN MICROBIOL, V47, P1172, DOI 10.1128/JCM.01891-08; Garrido D, 2012, ADV NUTR, V3, p415S, DOI 10.3945/an.111.001586; GIBSON GR, 1995, GASTROENTEROLOGY, V108, P975, DOI 10.1016/0016-5085(95)90192-2; Giltner CL, 2006, MOL MICROBIOL, V59, P1083, DOI 10.1111/j.1365-2958.2005.05002.x; GREEN SK, 1974, APPL MICROBIOL, V28, P987, DOI 10.1128/AEM.28.6.987-991.1974; HALPRIN KM, 1966, J INVEST DERMATOL, V47, P222, DOI 10.1038/jid.1966.133; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hay ID, 2009, APPL ENVIRON MICROB, V75, P1110, DOI 10.1128/AEM.02416-08; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Hoiby Niels, 2005, Ugeskr Laeger, V167, P2429; Hosono A, 2003, BIOSCI BIOTECH BIOCH, V67, P758, DOI 10.1271/bbb.67.758; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Jyot J, 2011, J INFECT DIS, V203, P1369, DOI 10.1093/infdis/jir045; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Knol J, 2005, ACTA PAEDIATR, V94, P31, DOI 10.1080/08035320510043529; Kondepudi KK, 2012, ANAEROBE, V18, P489, DOI 10.1016/j.anaerobe.2012.08.005; Lattimer JM, 2010, NUTRIENTS, V2, P1266, DOI 10.3390/nu2121266; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Martinez-Ferez A RS, 2005, INT DAIRY J, V16, P8; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Munoz M, 2012, ANAEROBE, V18, P321, DOI 10.1016/j.anaerobe.2012.01.007; Nenaah G, 2013, WORLD J MICROB BIOT, V29, P1255, DOI 10.1007/s11274-013-1288-2; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Olivas AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044326; Paolillo R, 2011, INT J IMMUNOPATH PH, V24, P961, DOI 10.1177/039463201102400414; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; PERITI P, 1992, CLIN PHARMACOKINET, V23, P106, DOI 10.2165/00003088-199223020-00004; Perkins SD, 2010, INT J MED MICROBIOL, V300, P503, DOI 10.1016/j.ijmm.2010.02.005; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; RAK J, 1995, J CELL BIOL, V131, P1587, DOI 10.1083/jcb.131.6.1587; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Schultz MJ, 2000, FEMS IMMUNOL MED MIC, V29, P227, DOI 10.1016/S0928-8244(00)00209-1; Scott KP, 2011, P NATL ACAD SCI USA, V108, P4672, DOI 10.1073/pnas.1000091107; SMITH AJ, 1985, J IMMUNOL METHODS, V84, P125, DOI 10.1016/0022-1759(85)90421-1; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Velez E, 2013, BRIT J NUTR, V109, P1971, DOI 10.1017/S0007114512004230; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Walker TS, 2004, PLANT PHYSIOL, V134, P320, DOI 10.1104/pp.103.027888; Worthington RJ, 2012, ORG BIOMOL CHEM, V10, P7457, DOI 10.1039/c2ob25835h; Yasuda A, 2012, BIOCHEM BIOPH RES CO, V422, P546, DOI 10.1016/j.bbrc.2012.05.007; Yu FSX, 2006, INVEST OPHTH VIS SCI, V47, P1255, DOI 10.1167/iovs.05-0956	74	14	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85772	10.1371/journal.pone.0085772	http://dx.doi.org/10.1371/journal.pone.0085772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465697	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100072
J	Ricotta, C; Celesti-Grapow, L; Kuhn, I; Rapson, G; Pysek, P; La Sorte, FA; Thompson, K				Ricotta, Carlo; Celesti-Grapow, Laura; Kuehn, Ingolf; Rapson, Gillian; Pysek, Petr; La Sorte, Frank A.; Thompson, Ken			Geographical Constraints Are Stronger than Invasion Patterns for European Urban Floras	PLOS ONE			English	Article							ALIEN PLANTS; PROPAGULE PRESSURE; BIOTIC HOMOGENIZATION; BIOLOGICAL INVASIONS; SPECIES RICHNESS; TEMPORAL TRENDS; RESIDENCE TIME; TRAITS; COMMUNITIES; INVASIVENESS	Understanding the mechanisms that affect invasion success of alien species is an important prerequisite for the effective management of present and future aliens. To gain insight into this matter we asked the following questions: Are the geographical patterns of species distributions in urban floras different for native compared with alien plant species? Does the introduction of alien species contribute to the homogenization of urban floras? We used a Mantel test on Jaccard dissimilarity matrices of 30 urban floras across the British Isles, Italy and central Europe to compare the spatial distribution of native species with four classes of alien species: archaeophytes, all neophytes, non-invasive neophytes, and invasive neophytes. Archaeophytes and neophytes are species that were introduced into Europe before and after 1500 AD, respectively. To analyze the homogenizing effect of alien species on the native urban floras, we tested for differences in the average dissimilarity of individual cities from their group centroid in ordination space. Our results show that the compositional patterns of native and alien species seem to respond to the same environmental drivers, such that all four classes of alien species were significantly related to native species across urban floras. In this framework, alien species may have an impact on biogeographic patterns of urban floras in ways that reflect their history of introduction and expansion: archaeophytes and invasive neophytes tended to homogenize, while non-invasive neophytes tended to differentiate urban floras.	[Ricotta, Carlo; Celesti-Grapow, Laura] Univ Roma La Sapienza, Dept Environm Biol, I-00185 Rome, Italy; [Kuehn, Ingolf] Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany; [Kuehn, Ingolf] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Rapson, Gillian] Massey Univ, Ecol Grp, Inst Agr & Environm, Palmerston North, New Zealand; [Pysek, Petr] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Pysek, Petr] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [La Sorte, Frank A.] Cornell Lab Ornithol, Ithaca, NY USA; [Thompson, Ken] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Sapienza University Rome; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Massey University; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; Cornell University; University of Sheffield	Ricotta, C (corresponding author), Univ Roma La Sapienza, Dept Environm Biol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	carlo.ricotta@uniroma1.it	Kühn, Ingolf/B-9756-2009; Pysek, Petr/B-1957-2012; CELESTI, Laura/ABA-2552-2021	Kühn, Ingolf/0000-0003-1691-8249; CELESTI, Laura/0000-0002-9533-6919; RICOTTA, Carlo/0000-0003-0818-3959	University of Rome 'La Sapienza'; Academy of Sciences of the Czech Republic [RVO 67985939]; Praemium Academiae award from the Academy of Sciences of the Czech Republic	University of Rome 'La Sapienza'; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Praemium Academiae award from the Academy of Sciences of the Czech Republic	Funding provided by the University of Rome 'La Sapienza'. PP was supported by long-term research development project no. RVO 67985939 (Academy of Sciences of the Czech Republic), institutional resources of Ministry of Education, Youth and Sports of the Czech Republic, and acknowledges the support by Praemium Academiae award from the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; [Anonymous], 2004, PERMDISP FORTRAN COM; [Anonymous], 1998, STANDARDLISTE FARN B; [Anonymous], 1983, MANS IMPACT VEGETATI, DOI DOI 10.1007/978-94-009-7269-8_19; [Anonymous], 2008, EXKUSIONSFLORA OSTER; Baiser B, 2012, P ROY SOC B-BIOL SCI, V279, P4772, DOI 10.1098/rspb.2012.1651; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Botham MS, 2009, DIVERS DISTRIB, V15, P338, DOI 10.1111/j.1472-4642.2008.00539.x; Catford JA, 2012, GLOBAL CHANGE BIOL, V18, P44, DOI 10.1111/j.1365-2486.2011.02549.x; Celesti-Grapow L, 2009, PLANT BIOSYST, V143, P386, DOI 10.1080/11263500902722824; Chytry M, 2008, ECOLOGY, V89, P1541, DOI 10.1890/07-0682.1; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Conti F., 2005, ANNOTATED CHECKLIST, V4, P227; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Gasso N., 2012, NeoBiota, P25; Gasso N, 2009, DIVERS DISTRIB, V15, P50, DOI 10.1111/j.1472-4642.2008.00501.x; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Hill MO, 2003, PLANTATT ATTRIBUTES; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2011, TRENDS ECOL EVOL, V26, P318, DOI 10.1016/j.tree.2011.03.018; Kent M, 1999, J BIOGEOGR, V26, P1281, DOI 10.1046/j.1365-2699.1999.00350.x; Knapp S, 2012, ECOL LETT, V15, P696, DOI 10.1111/j.1461-0248.2012.01787.x; Krivanek M, 2006, CONSERV BIOL, V20, P1487, DOI 10.1111/j.1523-1739.2006.00477.x; Kubesova M, 2010, PRESLIA, V82, P81; Kuehn Ingolf, 2007, V193, P181; Kuster EC, 2008, J ECOL, V96, P860, DOI 10.1111/j.1365-2745.2008.01406.x; Kuhn I, 2006, BIOL CONSERV, V127, P292, DOI 10.1016/j.biocon.2005.06.033; Kuhn I, 2004, EVOL ECOL RES, V6, P749; Kuhn I., 2003, FEDDES REPERT, V114, P559, DOI DOI 10.1002/FEDR.200311015; La Sorte FA, 2008, GLOBAL ECOL BIOGEOGR, V17, P363, DOI 10.1111/j.1466-8238.2007.00369.x; La Sorte FA, 2006, DIVERS DISTRIB, V12, P679, DOI 10.1111/j.1472-4642.2006.00276.x; La Sorte FA, 2009, ECOLOGY, V90, P2589, DOI 10.1890/08-1528.1; Lambdon PW, 2008, PRESLIA, V80, P101; Mack RN, 1996, BIOL CONSERV, V78, P107, DOI 10.1016/0006-3207(96)00021-3; Maskell LC, 2006, J ECOL, V94, P1052, DOI 10.1111/j.1365-2745.2006.01172.x; McKinney ML, 2007, GLOBAL ECOL BIOGEOGR, V16, P394, DOI 10.1111/j.1466-8238.2007.00296.x; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2005, DIVERS DISTRIB, V11, P367, DOI 10.1111/j.1366-9516.2005.00181.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Moravcova L, 2010, PRESLIA, V82, P365; Owen S. J, 1997, ECOLOGICAL WEEDS CON; Preston C, 2002, NEW ATLAS BRIT IRISH; Preston CD, 2004, BOT J LINN SOC, V145, P257, DOI 10.1111/j.1095-8339.2004.00284.x; Pysek P, 2005, INVASIVE PLANTS: ECOLOGICAL AND AGRICULTURAL ASPECTS, P77, DOI 10.1007/3-7643-7380-6_5; Pysek P, 2005, ECOLOGY, V86, P772, DOI 10.1890/04-0012; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek P, 1998, J BIOGEOGR, V25, P155, DOI 10.1046/j.1365-2699.1998.251177.x; Pysek Petr, 2007, V193, P97; Pysek P, 2012, PRESLIA, V84, P575; Pysek P, 2012, PRESLIA, V84, P155; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Pysek P, 2011, ECOL MONOGR, V81, P277, DOI 10.1890/10-0630.1; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Qian H, 2008, BASIC APPL ECOL, V9, P617, DOI 10.1016/j.baae.2007.11.004; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Ricotta C, 2012, GLOBAL ECOL BIOGEOGR, V21, P751, DOI 10.1111/j.1466-8238.2011.00715.x; Ricotta C, 2009, J ECOL, V97, P1243, DOI 10.1111/j.1365-2745.2009.01548.x; Rouget M, 2003, AM NAT, V162, P713, DOI 10.1086/379204; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Stace C., 1997, NEW FLORA BRIT ISLES; Stohlgren TJ, 1999, ECOL MONOGR, V69, P25, DOI 10.1890/0012-9615(1999)069[0025:EPSIHS]2.0.CO;2; Stohlgren TJ, 2003, FRONT ECOL ENVIRON, V1, P11; Thompson K, 2008, J ECOL, V96, P853, DOI 10.1111/j.1365-2745.2008.01383.x; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; van Kleunen M, 2011, TRENDS ECOL EVOL, V26, P317, DOI 10.1016/j.tree.2011.03.019; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vila M, 2001, BIOL CONSERV, V100, P397, DOI 10.1016/S0006-3207(01)00047-7; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Webb D., 1985, WATSONIA, V15, P231; Williamson M., 1996, BIOL INVASIONS; Williamson M, 2009, DIVERS DISTRIB, V15, P158, DOI 10.1111/j.1472-4642.2008.00528.x; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x; Winter M, 2010, GLOBAL ECOL BIOGEOGR, V19, P332, DOI 10.1111/j.1466-8238.2010.00520.x; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106	82	18	19	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85661	10.1371/journal.pone.0085661	http://dx.doi.org/10.1371/journal.pone.0085661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465640	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100056
J	Ashtari, M; Cyckowski, L; Yazdi, A; Viands, A; Marshall, K; Bokkon, I; Maguire, A; Bennett, J				Ashtari, Manzar; Cyckowski, Laura; Yazdi, Alborz; Viands, Amanda; Marshall, Kathleen; Bokkon, Istvan; Maguire, Albert; Bennett, Jean			fMRI of Retina-Originated Phosphenes Experienced by Patients with Leber Congenital Amaurosis	PLOS ONE			English	Article							MAGNETIC STIMULATION; ELECTRICAL-STIMULATION; GENE-THERAPY; PROSTHESIS; THRESHOLDS; SUBJECT; VISION; SINGLE; SAFETY; CORTEX	A phenomenon characterized by the experience of seeing light without any light actually entering the eye is called phosphenes or photopsias. Phosphenes can occur spontaneously or via induction by external stimuli. Previous reports regarding phosphenes have primarily focused on externally induced phosphenes such as by applying alternating or direct current to the cortex. A few of these reports used functional magnetic resonance (fMRI) to study activations induced by cortical phosphenes. However, there are no fMRI reports on spontaneous phosphenes originating from the retina and the resulting pattern of cortical activations. We performed fMRI during a reversing checkerboard paradigm in three LCA patients who underwent unilateral gene therapy and reported experiencing frequent phosphene on a daily basis. We observed bilateral cortical activation covering the entire visual cortices when patients reported experiencing phosphenes. In contrast, in the absence of phosphenes, activation was regulated by patient's visual ability and demonstrated improved cortical activation due to gene therapy. These fMRI results illustrate the potential impact of phosphene perception on visual function and they may explain some of the variability that clinicians find in visual function testing in retinal degeneration. Although we did not perform correlations between visual function and phosphenes, we hope data presented here raises awareness of this phenomenon and its potential effect on visual function and the implications for clinical testing. We recommend a thorough history for phosphene experiences be taken in patients with retinal disease who are candidates for gene or molecular therapy. Lastly, these data illustrate the potential power of fMRI as an outcome measure of gene therapy and the negative impact phosphenes may have on vision testing. fMRI has proven to be a sensitive, non-invasive, and reproducible test paradigm for these purposes and can complement standard visual function testing.	[Ashtari, Manzar; Cyckowski, Laura; Yazdi, Alborz; Viands, Amanda] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA; [Marshall, Kathleen; Maguire, Albert; Bennett, Jean] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Bokkon, Istvan] Vis Res Inst, Lowell, MA USA; [Maguire, Albert] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Maguire, Albert] Childrens Hosp Philadelphia, Dept Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Ashtari, M (corresponding author), Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA.	ashtari@email.chop.edu			National Eye Institute [R21EY020662]; Center for Cellular and Molecular Therapeutics at CHOP; Foundation Fighting Blindness; Research to Prevent Blindness; National Institutes of Health [R24EY019861, 8DP1EY023177]; TreatRush (European Union); Mackall Foundation Trust; F. M. Kirby Foundation; NATIONAL EYE INSTITUTE [DP1EY023177, R21EY020662, R24EY019861] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Center for Cellular and Molecular Therapeutics at CHOP; Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TreatRush (European Union); Mackall Foundation Trust; F. M. Kirby Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was in part supported by grant R21EY020662 from the National Eye Institute, The Center for Cellular and Molecular Therapeutics at CHOP, Foundation Fighting Blindness, Research to Prevent Blindness, National Institutes of Health R24EY019861 and 8DP1EY023177, TreatRush (European Union), the Mackall Foundation Trust, and the F. M. Kirby Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos J F, 1999, J Am Optom Assoc, V70, P485; Antal A, 2003, SUPPL CLIN NEUROPHYS, V56, P291; Antal A, 2001, NEUROREPORT, V12, P3553, DOI 10.1097/00001756-200111160-00036; Ashtari M, 2011, J CLIN INVEST, V121, P2160, DOI 10.1172/JCI57377; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Bittner AK, 2009, RETINA, V29, P9; Bittner AK, 2011, INVEST OPHTH VIS SCI, V52, P6370, DOI 10.1167/iovs.11-7195; Bokkon I, 2008, BIOSYSTEMS, V92, P168, DOI 10.1016/j.biosystems.2008.02.002; Caparelli E C, 2010, Open Neuroimag J, V4, P100, DOI 10.2174/1874440001004010100; Catala A, 2006, INT J BIOCHEM CELL B, V38, P1482, DOI 10.1016/j.biocel.2006.02.010; Cervetto L, 2007, BRIT J PHARMACOL, V150, P383, DOI 10.1038/sj.bjp.0706998; DAVIS FA, 1976, NEUROLOGY, V26, P1100, DOI 10.1212/WNL.26.11.1100; DOBELLE WH, 1974, J PHYSIOL-LONDON, V243, P553, DOI 10.1113/jphysiol.1974.sp010766; Dobelle WH, 2000, ASAIO J, V46, P3, DOI 10.1097/00002480-200001000-00002; DOLY M, 1980, RADIAT RES, V82, P430, DOI 10.2307/3575310; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; GRUSSER OJ, 1990, DOC OPHTHALMOL, V74, P57, DOI 10.1007/BF00165665; HIKICHI T, 1994, AM J OPHTHALMOL, V117, P593, DOI 10.1016/S0002-9394(14)70065-0; Kammer T, 1999, NEUROPSYCHOLOGIA, V37, P191; Kammer T, 2010, CLIN NEUROPHYSIOL, V121, P376, DOI 10.1016/j.clinph.2009.12.002; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; MARG E, 1994, OPTOMETRY VISION SCI, V71, P301, DOI 10.1097/00006324-199405000-00001; Margalit E, 2002, SURV OPHTHALMOL, V47, P335, DOI 10.1016/S0039-6257(02)00311-9; Marzi CA, 2009, EXPT BRAIN RES, V192, P10; Meister IG, 2003, SUPPL CLIN NEUROPHYS, V56, P305; Missimer JH, 2010, J MAGN RESON IMAGING, V31, P821, DOI 10.1002/jmri.22122; Narici L, 2012, FREE RADICAL BIO MED, V53, P482, DOI 10.1016/j.freeradbiomed.2012.05.030; Narici L, 2013, INT J RADIAT BIOL, V22, P22; Oishi A, 2006, CAN J OPHTHALMOL, V41, P603, DOI 10.1016/S0008-4182(06)80031-1; Roman AJ, 2013, INVEST OPHTH VIS SCI, V54, P1378, DOI 10.1167/iovs.12-11341; Sannita WG, 2006, VISION RES, V46, P2159, DOI 10.1016/j.visres.2005.12.002; Schutter DJLG, 2010, CLIN NEUROPHYSIOL, V121, P1080, DOI 10.1016/j.clinph.2009.10.038; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; STEIDLEY KD, 1989, INT J RADIAT ONCOL, V17, P685, DOI 10.1016/0360-3016(89)90125-9; Stewart LM, 2001, NEUROPSYCHOLOGIA, V39, P415, DOI 10.1016/S0028-3932(00)00130-5; Tani N, 2011, BRAIN STIMUL, V4, P28, DOI 10.1016/j.brs.2010.03.006; Taylor PCJ, 2010, HUM BRAIN MAPP, V31, P1408, DOI 10.1002/hbm.20941; Tobias CA, 1971, LETT NATURE, V230, P3; Wang C, 2011, BRAIN RES, V1369, P1, DOI 10.1016/j.brainres.2010.10.077; Zibrandtsen N, 2008, ACTA OPHTHALMOL, V86, P913, DOI 10.1111/j.1600-0420.2007.01140.x	42	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86068	10.1371/journal.pone.0086068	http://dx.doi.org/10.1371/journal.pone.0086068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465873	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500174
J	Avtar, R; Suzuki, R; Sawada, H				Avtar, Ram; Suzuki, Rikie; Sawada, Haruo			Natural Forest Biomass Estimation Based on Plantation Information Using PALSAR Data	PLOS ONE			English	Article							LEAF-AREA INDEX; ABOVEGROUND BIOMASS; RADAR BACKSCATTER; ALOS PALSAR; TREE HEIGHT; DEFORESTATION; MANAGEMENT; EMISSIONS; MISSION; REGION	Forests play a vital role in terrestrial carbon cycling; therefore, monitoring forest biomass at local to global scales has become a challenging issue in the context of climate change. In this study, we investigated the backscattering properties of Advanced Land Observing Satellite (ALOS) Phased Array L-band Synthetic Aperture Radar (PALSAR) data in cashew and rubber plantation areas of Cambodia. The PALSAR backscattering coefficient (sigma(0)) had different responses in the two plantation types because of differences in biophysical parameters. The PALSAR sigma(0) showed a higher correlation with field-based measurements and lower saturation in cashew plants compared with rubber plants. Multiple linear regression (MLR) models based on field-based biomass of cashew (C-MLR) and rubber (R-MLR) plants with PALSAR sigma(0) were created. These MLR models were used to estimate natural forest biomass in Cambodia. The cashew plant-based MLR model (C-MLR) produced better results than the rubber plant-based MLR model (R-MLR). The C-MLR-estimated natural forest biomass was validated using forest inventory data for natural forests in Cambodia. The validation results showed a strong correlation (R-2 = 0.64) between C-MLR-estimated natural forest biomass and field-based biomass, with RMSE = 23.2 Mg/ha in deciduous forests. In high-biomass regions, such as dense evergreen forests, this model had a weaker correlation because of the high biomass and the multiple-story tree structure of evergreen forests, which caused saturation of the PALSAR signal.	[Avtar, Ram; Sawada, Haruo] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Avtar, Ram; Suzuki, Rikie] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokohama, Kanagawa, Japan; [Avtar, Ram] United Nations Univ, Inst Sustainabil & Peace, Tokyo, Japan	University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); United Nations University	Avtar, R (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	ram.envjnu@gmail.com	Avtar, Ram/C-7394-2012	Avtar, Ram/0000-0003-3653-5771	Monbukagakusho Japanese Government Fellowship; Ministry of Environment, Japan [F-1101]	Monbukagakusho Japanese Government Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Environment, Japan(Ministry of the Environment, Japan)	Monbukagakusho Japanese Government Fellowship to pursue research at The University of Tokyo, Japan. Global Center of Excellence programme to support field visit to Cambodia to collect ground data. Environmental Research and Technology Development Fund (F-1101) of the Ministry of Environment, Japan for preparation of manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2004, REMOTE SENS ENVIRON, V92, P447, DOI 10.1016/j.rse.2004.03.019; Angelsen A., 2009, REDUCING EMISSIONS D; Ashwall D, 2011, ASSISTING CAMBODIAN, P45; Avtar Ram, 2011, Seisan Kenkyu, V63, P51; Avtar R, 2011, SYNTH AP RAD APSAR 2, p[1, 4]; Avtar R., 2013, ENVIRON MONIT ASSESS, V185, P2013; Avtar R, 2012, ARAB J GEOSCI, DOI 101007/s12517-012-0768-2; Avtar R, 2013, ENVIRON DEV SUSTAIN, DOI 101007/s10668-013-9448-y; Avtar Ram, 2014, Environment Development and Sustainability, V16, P995, DOI 10.1007/s10668-013-9507-4; Avtar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074807; Avtar R, 2012, GEOCARTO INT, V27, P119, DOI 10.1080/10106049.2011.626081; Avtar R, 2013, INT J DIGIT EARTH, V6, P255, DOI 10.1080/17538947.2011.620639; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Carle J, 2008, FOREST PROD J, V58, P6; Cartus O, 2012, REMOTE SENS ENVIRON, V124, P466, DOI 10.1016/j.rse.2012.05.029; Clark ML, 2004, REMOTE SENS ENVIRON, V91, P68, DOI 10.1016/j.rse.2004.02.008; Cohn SA, 1998, B AM METEOROL SOC, V79, P1329, DOI 10.1175/1520-0477(1998)079<1329:TLIFTL>2.0.CO;2; DeFries R, 2007, ENVIRON SCI POLICY, V10, P385, DOI 10.1016/j.envsci.2007.01.010; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; DOBSON MC, 1992, IEEE T GEOSCI REMOTE, V30, P412, DOI 10.1109/36.134090; Drake JB, 2003, GLOBAL ECOL BIOGEOGR, V12, P147, DOI 10.1046/j.1466-822X.2003.00010.x; Drake JB, 2002, REMOTE SENS ENVIRON, V79, P305, DOI 10.1016/S0034-4257(01)00281-4; Dudley RG, 2010, MITIG ADAPT STRAT GL, V15, P53, DOI 10.1007/s11027-009-9204-7; Englhart S, 2011, REMOTE SENS ENVIRON, DOI 101016/jrse201101008; Evans J, 2009, FORESTS USES IMPACTS; Evans J., 2004, PLANTATION FOREST TR, V3rd; Fassnacht KS, 1997, REMOTE SENS ENVIRON, V61, P229, DOI 10.1016/S0034-4257(97)00005-9; Foody GM, 2003, REMOTE SENS ENVIRON, V85, P463, DOI 10.1016/S0034-4257(03)00039-7; FRA, 2010, 2010 GLOB FOR RES AS; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Gillis MD, 2001, ENVIRON MONIT ASSESS, V67, P121, DOI 10.1023/A:1006405820244; Hair JF, 1998, MULTIVARIATE DATA AN, P730; Hamdan O, 2011, J TROP FOR SCI, V23, P318; IMHOFF ML, 1995, IEEE T GEOSCI REMOTE, V33, P511, DOI 10.1109/36.377953; International Finance Corporation, 2010, 1 INT FIN CORP; Islam MN, 2010, CAN J FOREST RES, V40, P2427, DOI 10.1139/X10-185; Kasischke ES, 1997, REMOTE SENS ENVIRON, V59, P141, DOI 10.1016/S0034-4257(96)00148-4; Kiyono Y, 2010, JARQ-JPN AGR RES Q, V44, P81, DOI 10.6090/jarq.44.81; Kongrattanachok P, 2005, THESIS MAHIDOL U; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; Lamb D, 2011, EGREENING BARE HILLS; Le Toan T, 2011, REMOTE SENS ENVIRON, V115, P2850, DOI 10.1016/j.rse.2011.03.020; Lefsky MA, 2002, GLOBAL ECOL BIOGEOGR, V11, P393, DOI 10.1046/j.1466-822x.2002.00303.x; LETOAN T, 1992, IEEE T GEOSCI REMOTE, V30, P403, DOI 10.1109/36.134089; Lu DS, 2006, INT J REMOTE SENS, V27, P1297, DOI 10.1080/01431160500486732; Lucas R, 2010, IEEE J-STARS, V3, P576, DOI 10.1109/JSTARS.2010.2086436; Luckman A, 1997, REMOTE SENS ENVIRON, V60, P1, DOI 10.1016/S0034-4257(96)00121-6; MAFF, 2010, MIN AGR FOR FISH REP; Mitchard ETA, 2011, REMOTE SENS ENVIRON, V115, P2861, DOI 10.1016/j.rse.2010.02.022; Mitchard ETA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040692; Naesset E, 1997, ISPRS J PHOTOGRAMM, V52, P49, DOI 10.1016/S0924-2716(97)83000-6; Nilsson M, 1996, REMOTE SENS ENVIRON, V56, P1, DOI 10.1016/0034-4257(95)00224-3; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Putz FE, 2008, PLOS BIOL, V6, P1368, DOI 10.1371/journal.pbio.0060166; Rajaona AM, 2008, THESIS U BONN; Ranson KJ, 1997, REMOTE SENS ENVIRON, V59, P203, DOI 10.1016/S0034-4257(96)00154-X; RAUSTE Y, 1994, INT J REMOTE SENS, V15, P2797, DOI 10.1080/01431169408954285; Ribbes F, 1997, ESA SP PUBL, V414, P351; RIGNOT E, 1994, REMOTE SENS ENVIRON, V49, P131, DOI 10.1016/0034-4257(94)90049-3; Rosenqvist A, 2003, ENVIRON SCI POLICY, V6, P441, DOI 10.1016/S1462-9011(03)00070-4; Rosenqvist A, 2007, IEEE T GEOSCI REMOTE, V45, P3307, DOI 10.1109/TGRS.2007.901027; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; SADER SA, 1989, REMOTE SENS ENVIRON, V28, P143, DOI 10.1016/0034-4257(89)90112-0; Santoro M, 2006, INT J REMOTE SENS, V27, P3425, DOI 10.1080/01431160600646037; Santos JR, 2003, REMOTE SENS ENVIRON, V87, P482, DOI 10.1016/j.rse.2002.12.001; Shimada M, 2009, IEEE T GEOSCI REMOTE, V47, P3915, DOI 10.1109/TGRS.2009.2023909; Steininger MK, 2000, INT J REMOTE SENS, V21, P1139, DOI 10.1080/014311600210119; Stephens SS, 2007, J FOREST, V105, P307; Sun G, 2011, REMOTE SENS ENVIRON, DOI 101016/jrse201103021; Ulaby F. T., 1982, MICROWAVE REMOTE SEN, V2, P609; UNEP, 2009, CAMB ENV OUTL REP PU; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Wang Q, 2005, REMOTE SENS ENVIRON, V94, P244, DOI 10.1016/j.rse.2004.10.006; Watson RT, 2000, LAND USE LAND USE CH	74	33	34	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86121	10.1371/journal.pone.0086121	http://dx.doi.org/10.1371/journal.pone.0086121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465908	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500188
J	Chen, DY; Yao, L; Chen, YM; Lin, CC; Huang, KC; Chen, ST; Lan, JL; Hsieh, SLE				Chen, Der-Yuan; Yao, Ling; Chen, Yi-Ming; Lin, Chi-Chen; Huang, Kui-Chou; Chen, Szu-Ting; Lan, Joung-Liang; Hsieh, Shie-Liang Edmond			A Potential Role of Myeloid DAP12-Associating Lectin (MDL)-1 in the Regulation of Inflammation in Rheumatoid Arthritis Patients	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DOUBLE-BLIND; ACTIVATION MOTIF; TYROSINE KINASE; DAP12; DISEASE; BONE; EXPRESSION; PROTEINS; CLASSIFICATION	The pathogenic roles of myeloid DAP12-associating lectin-1(MDL-1) and DAP12 in human rheumatoid arthritis (RA) remain unknown. Frequencies of MDL-1-expressing monocytes in 22 active RA patients, 16 inactive RA patients, 12 osteoarthritis (OA) patients and 10 healthy controls (HC) were determined by flow-cytometry analysis. The mRNA expression levels of MDL-1 and DAP12 on PBMCs were evaluated by quantitative PCR, and their protein expression levels in the synovium were examined by immunohistochemistry. Significantly higher median percentages of circulating MDL-1-expressing monocytes were observed in active RA patients (53.6%) compared to inactive RA patients (34.1%), OA patients (27.9%), and HC (21.2%). Levels of MDL-1 and DAP12 gene expression in PBMCs and their protein expression in the synovium were significantly higher in active RA patients than in inactive RA or OA patients. MDL-1 levels were positively correlated with parameters of disease activity, articular damage, and levels of proinflammatory cytokines. MDL-1 activator (Dengue virus type 2 antigen) stimulation on PBMCs resulted in significantly enhanced levels of proinflammatory cytokines in RA patients compared to those in OA patients or HC, indicating that MDL-1 activation is functional. Frequencies of MDL-1-expressing monocytes and levels of MDL-1 and DAP12 gene expression significantly decreased after effective therapy. Concordant overexpression of MDL-1 and DAP12 were correlated with increased production of proinflammatory cytokines in RA patients, suggesting their roles in regulating articular inflammation.	[Chen, Der-Yuan; Chen, Yi-Ming; Lan, Joung-Liang] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Chen, Der-Yuan; Yao, Ling; Chen, Yi-Ming; Lan, Joung-Liang] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Der-Yuan; Lin, Chi-Chen] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, Der-Yuan] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Szu-Ting; Hsieh, Shie-Liang Edmond] Natl Yang Ming Univ, Infect & Immun Res Ctr, Taipei 112, Taiwan; [Huang, Kui-Chou] Taichung Vet Gen Hosp, Dept Orthoped & Traumatol, Taichung, Taiwan; [Lan, Joung-Liang] China Med Univ Hosp, Div Rheumatol & Immunol, Taichung, Taiwan; [Lan, Joung-Liang] China Med Univ, Coll Chinese Med, Taichung, Taiwan; [Hsieh, Shie-Liang Edmond] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Chung Hsing University; Chung Shan Medical University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University	Lan, JL (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan.	dychen@vghtc.gov.tw; slhsieh@ym.edu.tw	Hsieh, Shie-Liang Edmond/ABA-9184-2021; 陳, 斯婷/GVU-2169-2022; Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065; Hsieh, Shie-Liang/0000-0001-9415-346X; Lin, Chi-Chien/0000-0002-1464-0231; Yao, Ling/0000-0002-0482-9604	Taichung Veterans General Hospital [TCVGH-YM1000204]; National Yang-Ming University	Taichung Veterans General Hospital; National Yang-Ming University	This work was supported by a grant (TCVGH-YM1000204) from Taichung Veterans General Hospital and National Yang-Ming University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Aoki N, 2009, J LEUKOCYTE BIOL, V85, P508, DOI 10.1189/jlb.0508329; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Chabaud M, 2001, ARTHRITIS RES, V3, P168, DOI 10.1186/ar294; Chen DY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4193; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Cohen SB, 2004, ANN RHEUM DIS, V63, P1062, DOI 10.1136/ard.2003.016014; Crotti TN, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4088; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Genant HK, 1998, ARTHRITIS RHEUM, V41, P1583, DOI 10.1002/1529-0131(199809)41:9<1583::AID-ART8>3.0.CO;2-H; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Genovese MC, 2011, ARTHRITIS RHEUM-US, V63, P337, DOI 10.1002/art.30114; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Gingras MC, 2002, MOL IMMUNOL, V38, P817, DOI 10.1016/S0161-5890(02)00004-4; Goldring SR, 2000, CURR OPIN RHEUMATOL, V12, P195, DOI 10.1097/00002281-200005000-00006; Heimans L, 2013, ANN RHEUM DIS; Humphrey MB, 2004, J BONE MINER RES, V19, P224, DOI 10.1359/JBMR.0301234; Inui M, 2009, P NATL ACAD SCI USA, V106, P4816, DOI 10.1073/pnas.0900463106; Joyce-Shaikh B, 2010, J EXP MED, V207, P579, DOI 10.1084/jem.20090516; Kievit W, 2011, RHEUMATOLOGY, V50, P196, DOI 10.1093/rheumatology/keq325; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Olcese L, 1997, J IMMUNOL, V158, P5083; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Tomasello E, 2000, EUR J IMMUNOL, V30, P2147, DOI 10.1002/1521-4141(2000)30:8<2147::AID-IMMU2147>3.0.CO;2-1; van Bezooijen RL, 2002, ANN RHEUM DIS, V61, P870, DOI 10.1136/ard.61.10.870; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P1063, DOI 10.1002/art.21655; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Xiao-Meng Y, 2010, COMP IMMUNOL MICROB, V33, pE75, DOI 10.1016/j.cimid.2010.01.002; Yazici Y, 2012, ANN RHEUM DIS, V71, P198, DOI 10.1136/ard.2010.148700	41	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86105	10.1371/journal.pone.0086105	http://dx.doi.org/10.1371/journal.pone.0086105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465901	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500183
J	Kim, DH; Kim, HR; Choi, EJ; Kim, DY; Kim, KK; Kim, BS; Park, JW; Lee, BJ				Kim, Dong Hee; Kim, Han Rae; Choi, Eun Jung; Kim, Dong Yeol; Kim, Kwang Kon; Kim, Byung Sam; Park, Jeong Woo; Lee, Byung Ju			Neural Epidermal Growth Factor-Like Like Protein 2 (NELL2) Promotes Aggregation of Embryonic Carcinoma P19 Cells by Inducing N-Cadherin Expression	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEIN; EGF-LIKE REPEATS; NEURONAL DIFFERENTIATION; RETINOIC-ACID; RAT-BRAIN; RXR HETERODIMERS; STEM-CELLS; GENE; ADHESION; TRANSCRIPTION	NELL2 was first identified as a mammalian homolog of chick NEL (Neural EGF-like) protein. It is almost exclusively expressed in neurons of the rat brain and has been suggested to play a role in neural differentiation. However, there is still no clear evidence for the detailed function of NELL2 in the differentiation of neurons. In this study, we identified NELL2 function during neural differentiation of mouse embryonic carcinoma P19 cells. Endogenous expression of NELL2 in the P19 cells increased in parallel with the neuronal differentiation induced by retinoic acid (RA). We found that the mouse NELL2 promoter contains RA response elements (RAREs) and that treatment with RA increased NELL2 promoter activity. Transfection of P19 cells with NELL2 expression vectors induced a dramatic increase in cell aggregation, resulting in the facilitation of neural differentiation. Moreover, NELL2 significantly increased N-cadherin expression in the P19 cell. These data suggest that NELL2 plays an important role in the regulation of neuronal differentiation via control of N-cadherin expression and cell aggregation.	[Kim, Dong Hee; Kim, Han Rae; Choi, Eun Jung; Kim, Dong Yeol; Kim, Kwang Kon; Kim, Byung Sam; Park, Jeong Woo; Lee, Byung Ju] Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea	University of Ulsan	Lee, BJ (corresponding author), Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea.	bjlee@ulsan.ac.kr		Kim, Han Rae/0000-0002-9108-2421	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [NRF-2009-0073730]; Original Technology Research Program for Brain Science through the NRF; Ministry of Science, ICT & Future Planning [NRF-2011-0019235]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Original Technology Research Program for Brain Science through the NRF(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF: www.nrf.re.kr) funded by the Ministry of Education, Science and Technology (NRF-2009-0073730), and was also supported by the Original Technology Research Program for Brain Science through the NRF funded by the Ministry of Science, ICT & Future Planning (NRF-2011-0019235). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Aihara K, 2003, MOL BRAIN RES, V116, P86, DOI 10.1016/S0169-328X(03)00256-0; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Choi EJ, 2010, J BIOL CHEM, V285, P25074, DOI 10.1074/jbc.M110.100545; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Guo XX, 2001, ELECTROPHORESIS, V22, P3067, DOI 10.1002/1522-2683(200108)22:14<3067::AID-ELPS3067>3.0.CO;2-V; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; Hung SP, 2005, J CELL BIOCHEM, V96, P1061, DOI 10.1002/jcb.20626; IMRIK P, 1991, ACTA PHYSIOL HUNG, V78, P345; Jeong JK, 2008, MOL CELLS, V26, P186; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kim H, 2002, J NEUROCHEM, V83, P1389, DOI 10.1046/j.1471-4159.2002.01245.x; KUHN R, 1991, MOL CELL BIOL, V11, P4642, DOI 10.1128/MCB.11.9.4642; Le Mee S, 2005, EXP CELL RES, V302, P129, DOI 10.1016/j.yexcr.2004.08.028; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Li ZG, 2006, DEV GROWTH DIFFER, V48, P513, DOI 10.1111/j.1440-169x.2006.00889.x; Lyu J, 2003, J BIOL CHEM, V278, P13487, DOI 10.1074/jbc.M300591200; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Maden M, 2001, INT REV CYTOL, V209, P1; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Maret D, 2010, NEOPLASIA, V12, P1066, DOI 10.1593/neo.10954; MATSUHASHI S, 1995, DEV DYNAM, V203, P212, DOI 10.1002/aja.1002030209; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; MUMMERY CL, 1991, DIFFERENTIATION, V46, P51, DOI 10.1111/j.1432-0436.1991.tb00865.x; Nelson BR, 2004, DEV BIOL, V270, P322, DOI 10.1016/j.ydbio.2004.03.004; Nelson BR, 2002, MECH DEVELOP, V119, pS11, DOI 10.1016/S0925-4773(03)00084-4; Oyasu M, 2000, MOL BRAIN RES, V76, P151, DOI 10.1016/S0169-328X(99)00342-3; REDIES C, 1993, DEV DYNAM, V197, P26, DOI 10.1002/aja.1001970104; Ryu BJ, 2011, MOL CELLS, V32, P203, DOI 10.1007/s10059-011-0086-7; SMITH SC, 1987, J CELL PHYSIOL, V131, P74, DOI 10.1002/jcp.1041310112; STAINES WA, 1994, NEUROSCIENCE, V58, P735, DOI 10.1016/0306-4522(94)90451-0; Szabo PE, 2004, MOL CELL BIOL, V24, P4858, DOI 10.1128/MCB.24.11.4858-4868.2004; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tang K, 2002, BIOCHEM BIOPH RES CO, V293, P167, DOI 10.1016/S0006-291X(02)00215-2; Wang C, 2006, MOL BIOL CELL, V17, P3075, DOI 10.1091/mbc.E05-11-1087; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; XIAO JH, 1995, J BIOL CHEM, V270, P3001, DOI 10.1074/jbc.270.7.3001; YOSHIDA C, 1982, CELL, V28, P217, DOI 10.1016/0092-8674(82)90339-7	44	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85898	10.1371/journal.pone.0085898	http://dx.doi.org/10.1371/journal.pone.0085898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465772	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500137
J	Knudsen, L; Atochina-Vasserman, EN; Guo, CJ; Scott, PA; Haenni, B; Beers, MF; Ochs, M; Gow, AJ				Knudsen, Lars; Atochina-Vasserman, Elena N.; Guo, Chang-Jiang; Scott, Pamela A.; Haenni, Beat; Beers, Michael F.; Ochs, Matthias; Gow, Andrew J.			NOS2 Is Critical to the Development of Emphysema in Sftpd Deficient Mice but Does Not Affect Surfactant Homeostasis	PLOS ONE			English	Article							NITRIC-OXIDE METABOLISM; II CELL CHANGES; NF-KAPPA-B; PROTEIN-D; IN-VIVO; STEREOLOGICAL ESTIMATION; PULMONARY ABNORMALITIES; ALVEOLAR MACROPHAGES; S-NITROSYLATION; LUNG-FUNCTION	Rationale: Surfactant protein D (SP-D) has important immuno-modulatory properties. The absence of SP-D results in an inducible NO synthase (iNOS, coded by NOS2 gene) related chronic inflammation, development of emphysema-like pathophysiology and alterations of surfactant homeostasis. Objective: In order to test the hypothesis that SP-D deficiency related abnormalities in pulmonary structure and function are a consequence of iNOS induced inflammation, we generated SP-D and iNOS double knockout mice (DiNOS). Methods: Structural data obtained by design-based stereology to quantify the emphysema-like phenotype and disturbances of the intracellular surfactant were correlated to invasive pulmonary function tests and inflammatory markers including activation markers of alveolar macrophages and compared to SP-D (Sftpd(-/-)) and iNOS single knockout mice (NOS2(-/-)) as well as wild type (WT) littermates. Measurements and Results: DiNOS mice had reduced inflammatory cells in BAL and BAL-derived alveolar macrophages showed an increased expression of markers of an alternative activation as well as reduced inflammation. As evidenced by increased alveolar numbers and surface area, emphysematous changes were attenuated in DiNOS while disturbances of the surfactant system remained virtually unchanged. Sftpd(-/-) demonstrated alterations of intrinsic mechanical properties of lung parenchyma as shown by reduced stiffness and resistance at its static limits, which could be corrected by additional ablation of NOS2 gene in DiNOS. Conclusion: iNOS related inflammation in the absence of SP-D is involved in the emphysematous remodeling leading to a loss of alveoli and associated alterations of elastic properties of lung parenchyma while disturbances of surfactant homeostasis are mediated by different mechanisms.	[Knudsen, Lars; Haenni, Beat; Ochs, Matthias] Univ Bern, Inst Anat, Bern, Switzerland; [Knudsen, Lars; Ochs, Matthias] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Knudsen, Lars; Ochs, Matthias] Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Atochina-Vasserman, Elena N.; Beers, Michael F.] Univ Penn, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Guo, Chang-Jiang; Scott, Pamela A.; Gow, Andrew J.] Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA; [Ochs, Matthias] REBIRTH Cluster Excellence, Hannover, Germany	University of Bern; Hannover Medical School; University of Pennsylvania; Rutgers State University New Brunswick	Gow, AJ (corresponding author), Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA.	Gow@rci.rutgers.edu	Gow, Andrew/AAR-2309-2020; Gow, Andrew/N-8566-2013; Knudsen, Lars/G-3146-2013; Atochina-Vasserman, Elena/AAN-2286-2020	Gow, Andrew/0000-0003-0876-5158; Gow, Andrew/0000-0003-0876-5158; Knudsen, Lars/0000-0002-7926-3879; Guo, Changjiang/0000-0002-7447-3762; Atochina-Vasserman, Elena N/0000-0001-7950-7004	Schweizerischer Nationalfonds [SNF 3100-116417]; NIH ES [P30-013508]; NIH [HL086621]; NIEHS [NIEHS P30E5S005022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, P30ES005022] Funding Source: NIH RePORTER	Schweizerischer Nationalfonds(Swiss National Science Foundation (SNSF)); NIH ES; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support for this work has been provided by Schweizerischer Nationalfonds (Grant Number SNF 3100-116417, to MO), NIH ES P30-013508 (to MFB), and NIH HL086621 (to AJG). Additional support has been provided by the NIEHS sponsored Center for Environmental Exposures and Disease (CEED-Grant Number NIEHS P30E5S005022) at EOHSI (to CJG and AJG). This work has not been reviewed by and does not represent the opinions of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atochina EN, 2004, J INFECT DIS, V189, P1528, DOI 10.1086/383130; Atochina EN, 2004, AM J RESP CELL MOL, V30, P271, DOI 10.1165/rcmb.2003-0091OC; Atochina-Vasserman EN, 2009, B EXP BIOL MED+, V147, P415, DOI 10.1007/s10517-009-0525-z; Atochina-Vasserman EN, 2007, J IMMUNOL, V179, P8090, DOI 10.4049/jimmunol.179.12.8090; Bates JHT, 2005, RESP PHYSIOL NEUROBI, V148, P153, DOI 10.1016/j.resp.2005.04.021; Betsuyaku T, 2004, EUR RESPIR J, V24, P964, DOI 10.1183/09031936.04.00064004; Botas C, 1998, P NATL ACAD SCI USA, V95, P11869, DOI 10.1073/pnas.95.20.11869; Collins RA, 2003, PEDIATR RES, V53, P463, DOI 10.1203/01.PDR.0000049464.46191.BF; Fehrenbach A, 1999, J ANAT, V194, P127, DOI 10.1046/j.1469-7580.1999.19410127.x; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Groves AM, 2012, AM J RESP CELL MOL, V47, P776, DOI 10.1165/rcmb.2011-0433OC; GUNDERSEN HJG, 1985, J MICROSC-OXFORD, V138, P127, DOI 10.1111/j.1365-2818.1985.tb02607.x; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Honda Y, 1996, CHEST, V109, P1006, DOI 10.1378/chest.109.4.1006; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hyde DM, 2004, ANAT REC PART A, V277A, P216, DOI 10.1002/ar.a.20012; Ichinose M, 2000, AM J RESP CRIT CARE, V162, P701, DOI 10.1164/ajrccm.162.2.9908132; Ito S, 2004, J APPL PHYSIOL, V97, P204, DOI 10.1152/japplphysiol.01246.2003; Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC; Jung A, 2005, ANAT REC PART A, V286A, P885, DOI 10.1002/ar.a.20225; Kingma PS, 2006, J BIOL CHEM, V281, P24496, DOI 10.1074/jbc.M600651200; Knudsen L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-70; Knudsen L, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-79; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Kobayashi A, 1998, CHEST, V113, P1632, DOI 10.1378/chest.113.6.1632; Korfhagen TR, 1998, J BIOL CHEM, V273, P28438, DOI 10.1074/jbc.273.43.28438; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Maestrelli P, 2003, EUR RESPIR J, V21, P971, DOI 10.1183/09031936.03.00098203; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Muhlfeld Christian, 2013, Methods Mol Biol, V931, P367, DOI 10.1007/978-1-62703-056-4_18; Ochs M, 2004, AM J PHYSIOL-LUNG C, V287, pL1333, DOI 10.1152/ajplung.00137.2004; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Scotton CJ, 2005, J IMMUNOL, V174, P834, DOI 10.4049/jimmunol.174.2.834; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Weibel ER, 2009, SWISS MED WKLY, V139, P375, DOI smw-12270; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; WRIGHT JR, 1991, ANNU REV PHYSIOL, V53, P395, DOI 10.1146/annurev.physiol.53.1.395; Yoshida M, 2001, J IMMUNOL, V166, P7514, DOI 10.4049/jimmunol.166.12.7514; Zhang LQ, 2002, J BIOL CHEM, V277, P22453, DOI 10.1074/jbc.M201632200; Zhang LQ, 2001, J BIOL CHEM, V276, P19214, DOI 10.1074/jbc.M010191200	43	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85722	10.1371/journal.pone.0085722	http://dx.doi.org/10.1371/journal.pone.0085722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465666	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500098
J	Zhang, YL; Song, FL; Gao, ZY; Ding, W; Qiao, LX; Yang, SF; Chen, X; Jin, RH; Chen, DX				Zhang, Yulin; Song, Fengli; Gao, Ziyun; Ding, Wei; Qiao, Luxin; Yang, Sufang; Chen, Xi; Jin, Ronghua; Chen, Dexi			Long-Term Exposure of Mice to Nucleoside Analogues Disrupts Mitochondrial DNA Maintenance in Cortical Neurons	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; ACTIVE ANTIRETROVIRAL THERAPY; LACTIC-ACIDOSIS; TOXICITY; DYSFUNCTION; BRAIN; HYPERLACTATEMIA; HIV/AIDS; CAPTURE; GENOME	Nucleoside analogue reverse transcriptase inhibitor (NRTI), an integral component of highly active antiretroviral therapy (HAART), was widely used to inhibit HIV replication. Long-term exposure to NRTIs can result in mitochondrial toxicity which manifests as lipoatrophy, lactic acidosis, cardiomyopathy and myopathy, as well as polyneuropathy. But the cerebral neurotoxicity of NRTIs is still not well known partly due to the restriction of blood-brain barrier (BBB) and the complex microenvironment of the central nervous system (CNS). In this study, the Balb/c mice were administered 50 mg/kg stavudine (D4T), 100 mg/kg zidovudine (AZT), 50 mg/kg lamivudine (3TC) or 50 mg/kg didanosine (DDI) per day by intraperitoneal injection, five days per week for one or four months, and primary cortical neurons were cultured and exposed to 25 mu M D4T, 50 mu M AZT, 25 mu M 3TC or 25 mu M DDI for seven days. Then, single neuron was captured from mouse cerebral cortical tissues by laser capture microdissection. Mitochondrial DNA (mtDNA) levels of the primary cultured cortical neurons, and captured neurons or glial cells, and the tissues of brains and livers and muscles were analyzed by relative quantitative real-time PCR. The data showed that mtDNA did not lose in both NRTIs exposed cultured neurons and one month NRTIs treated mouse brains. In four months NRTIs treated mice, brain mtDNA levels remained unchanged even if the mtDNA levels of liver (except for 3TC) and muscle significantly decreased. However, mtDNA deletion was significantly higher in the captured neurons from mtDNA unchanged brains. These results suggest that long-term exposure to NRTIs can result in mtDNA deletion in mouse cortical neurons.	[Zhang, Yulin; Song, Fengli; Ding, Wei; Qiao, Luxin; Yang, Sufang; Jin, Ronghua; Chen, Dexi] Capital Med Univ, Beijing You An Hosp, Dept Infect Dis, Beijing, Peoples R China; [Gao, Ziyun] Nanchang Univ, Affiliated Hosp 2, Dept Neurosurg, Nanchang, Jiangxi, Peoples R China; [Chen, Xi] Nanjing Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Nanjing, Jiangsu, Peoples R China	Capital Medical University; Nanchang University; Nanjing Medical University	Chen, X (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Nanjing, Jiangsu, Peoples R China.	jsxycx@sina.com; jin_eagle@sina.com; dexi0963@yahoo.com			National Natural Science Foundation of China [81371399, 81272266, 30910103915]; Twelfth Key Science and Technology Five Year Plan of China [2012ZX10001-002, 2012ZX10001-003, 2012ZX10001-004]; Beijing Natural Science Foundation [7092045, 7101005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Twelfth Key Science and Technology Five Year Plan of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by The National Natural Science Foundation of China (81371399, 81272266, 30910103915) and The Twelfth Key Science and Technology Five Year Plan of China (2012ZX10001-002, 2012ZX10001-003, 2012ZX10001-004). and Beijing Natural Science Foundation (7092045, 7101005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brogly SB, 2011, AIDS RES HUM RETROV, V27, P777, DOI [10.1089/aid.2010.0204, 10.1089/AID.2010.0204]; Dagan T, 2002, MITOCHONDRION, V1, P397, DOI 10.1016/S1567-7249(02)00003-X; Dalakas MC, 2001, J PERIPHER NERV SYST, V6, P14, DOI 10.1046/j.1529-8027.2001.006001014.x; Davison FD, 1996, J NEUROL, V243, P648, DOI 10.1007/BF00878661; Dragovic G, 2012, BIOMED PHARMACOTHER, V66, P308, DOI 10.1016/j.biopha.2011.09.016; Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2&lt;107::AID-DVG3&gt;3.0.CO;2-D; Einsiedel L, 2010, MITOCHONDRION, V10, P534, DOI 10.1016/j.mito.2010.05.010; Ewings EL, 2000, J ACQ IMMUN DEF SYND, V24, P100; FELDMAN D, 1994, ACTA NEUROPATHOL, V87, P71; FLINT OP, 1994, TOXICOL IN VITRO, V8, P677, DOI 10.1016/0887-2333(94)90042-6; Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25; Gallagher RI, 2012, METHODS MOL BIOL, V823, P157, DOI 10.1007/978-1-60327-216-2_11; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Kandanearatchi A, 2003, BRAIN PATHOL, V13, P104, DOI 10.1111/j.1750-3639.2003.tb00011.x; Koczor C, 2010, METHODS, V51, P399, DOI 10.1016/j.ymeth.2009.12.013; Kohler JJ, 2008, CARDIOVASC TOXICOL, V8, P57, DOI 10.1007/s12012-008-9015-1; Kohler JJ, 2011, METHODS MOL BIOL, V755, P267, DOI 10.1007/978-1-61779-163-5_22; Lanoy E, 2011, NEUROLOGY, V76, P644, DOI 10.1212/WNL.0b013e31820c3089; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Mothobi NZ, 2012, CURR OPIN INFECT DIS, V25, P4, DOI 10.1097/QCO.0b013e32834ef586; Moyle G, 2000, DRUG SAFETY, V23, P467, DOI 10.2165/00002018-200023060-00001; Nolan D, 2004, ANTIVIR THER, V9, P849; Obiako O R, 2011, West Afr J Med, V30, P354; Papp E, 2008, J ANTIMICROB CHEMOTH, V61, P1048, DOI 10.1093/jac/dkn067; Pavili L, 2010, FERTIL STERIL, V94, P2151, DOI 10.1016/j.fertnstert.2009.12.080; Rook MS, 2004, AM J PATHOL, V164, P23, DOI 10.1016/S0002-9440(10)63092-1; Seok JI, 2009, HEPATOLOGY, V49, P2080, DOI 10.1002/hep.22959; Smurzynski M, 2011, AIDS, V25, P357, DOI 10.1097/QAD.0b013e32834171f8; Tozzi V, 2001, J ACQ IMMUN DEF SYND, V28, P19, DOI 10.1097/00042560-200109010-00004; Walker UA, 2002, AIDS, V16, P2165, DOI 10.1097/00002030-200211080-00009; Wester CW, 2012, AIDS RES HUM RETROV, V28, P759, DOI [10.1089/aid.2011.0303, 10.1089/AID.2011.0303]; Zhang YL, 2012, BRAIN RES, V1458, P1, DOI 10.1016/j.brainres.2012.04.001	32	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85637	10.1371/journal.pone.0085637	http://dx.doi.org/10.1371/journal.pone.0085637			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465628	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500063
J	Bilican, B; Livesey, MR; Haghi, G; Qiu, J; Burr, K; Siller, R; Hardingham, GE; Wyllie, DJA; Chandran, S				Bilican, Bilada; Livesey, Matthew R.; Haghi, Ghazal; Qiu, Jing; Burr, Karen; Siller, Rick; Hardingham, Giles E.; Wyllie, David J. A.; Chandran, Siddharthan			Physiological Normoxia and Absence of EGF Is Required for the Long-Term Propagation of Anterior Neural Precursors from Human Pluripotent Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; OXYGEN-TENSION; CEREBRAL-CORTEX; SELF-RENEWAL; SPECIFICATION; SURVIVAL; NEURONS; CALCIUM; GROWTH	Widespread use of human pluripotent stem cells (hPSCs) to study neuronal physiology and function is hindered by the ongoing need for specialist expertise in converting hPSCs to neural precursor cells (NPCs). Here, we describe a new methodology to generate cryo-preservable hPSC-derived NPCs that retain an anterior identity and are propagatable long-term prior to terminal differentiation, thus abrogating regular de novo neuralization. Key to achieving passagable NPCs without loss of identity is the combination of both absence of EGF and propagation in physiological levels (3%) of O-2. NPCs generated in this way display a stable long-term anterior forebrain identity and importantly retain developmental competence to patterning signals. Moreover, compared to NPCs maintained at ambient O-2(21%), they exhibit enhanced uniformity and speed of functional maturation, yielding both deep and upper layer cortical excitatory neurons. These neurons display multiple attributes including the capability to form functional synapses and undergo activity-dependent gene regulation. The platform described achieves long-term maintenance of anterior neural precursors that can give rise to forebrain neurones in abundance, enabling standardised functional studies of neural stem cell maintenance, lineage choice and neuronal functional maturation for neurodevelopmental research and disease-modelling.	[Bilican, Bilada; Livesey, Matthew R.; Haghi, Ghazal; Burr, Karen; Chandran, Siddharthan] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland; [Bilican, Bilada; Burr, Karen; Siller, Rick; Chandran, Siddharthan] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Bilican, Bilada; Livesey, Matthew R.; Haghi, Ghazal; Burr, Karen; Siller, Rick; Chandran, Siddharthan] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [Livesey, Matthew R.; Haghi, Ghazal; Qiu, Jing; Hardingham, Giles E.; Wyllie, David J. A.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Wyllie, DJA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	dwyllie1@staffmail.ed.ac.uk; siddharthan.chandran@ed.ac.uk	Wyllie, David J A/AAK-4678-2021; Qiu, Jing/GQH-8027-2022	Wyllie, David J A/0000-0002-4957-6049; Hardingham, Giles/0000-0002-7629-5314; Siller, Richard/0000-0001-6691-9261; Livesey, Matthew/0000-0002-3441-7977	Wellcome Trust [092742/Z/10/Z]; MRC; Euan MacDonald Centre; MRC [G0902044] Funding Source: UKRI; Medical Research Council [G0902044] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Euan MacDonald Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by a grant from The Wellcome Trust (www.wellcome.ac.uk) funding the salary of M. R. L. and G. H. (D.J.A.W., G.E.H., S.C.; No: 092742/Z/10/Z), an MRC (www.mrc.ac.uk) Senior Non-Clinical Research Fellowship (G. E. H.) and funds from the Euan MacDonald Centre (www.euanmacdonaldcentre.com) (S.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bahrey HLP, 2003, J NEUROPHYSIOL, V89, P1761, DOI 10.1152/jn.00972.2002; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Bithell A, 2008, STEM CELLS, V26, P1565, DOI 10.1634/stemcells.2007-0832; Bouhon IA, 2006, STEM CELLS, V24, P1908, DOI 10.1634/stemcells.2006-0031; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Chen HL, 2007, STEM CELLS, V25, P2291, DOI 10.1634/stemcells.2006-0609; Clarke L, 2009, STEM CELLS, V27, P1879, DOI 10.1002/stem.96; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; DRAGO J, 1991, J NEUROSCI METH, V37, P251, DOI 10.1016/0165-0270(91)90031-T; Ebert AD, 2013, STEM CELL RES, V10, P417, DOI 10.1016/j.scr.2013.01.009; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Falk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029597; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Fu LJ, 2003, J COMP NEUROL, V462, P265, DOI 10.1002/cne.10727; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Joannides AJ, 2007, STEM CELLS, V25, P731, DOI 10.1634/stemcells.2006-0562; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; KAPLAN FS, 1986, BRAIN RES, V384, P199, DOI 10.1016/0006-8993(86)91240-0; KILPATRICK TJ, 1995, J NEUROSCI, V15, P3653; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kornblum HI, 1999, EUR J NEUROSCI, V11, P3236, DOI 10.1046/j.1460-9568.1999.00744.x; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Li DD, 2005, EUR J NEUROSCI, V22, P1319, DOI 10.1111/j.1460-9568.2005.04335.x; Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Machon O, 2005, MOL CELL NEUROSCI, V30, P388, DOI 10.1016/j.mcn.2005.08.003; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Melo A, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/467180; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; MINTA A, 1989, J BIOL CHEM, V264, P8171; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Muzio L, 2003, CEREB CORTEX, V13, P641, DOI 10.1093/cercor/13.6.641; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Stacpoole SRL, 2011, NAT PROTOC, V6, P1229, DOI 10.1038/nprot.2011.380; Stacpoole SRL, 2011, CELL DEATH DIFFER, V18, P1016, DOI 10.1038/cdd.2010.171; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Tiede LM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.128; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhu J, 2012, J NEUROSCI RES, V90, P422, DOI 10.1002/jnr.22765	63	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85932	10.1371/journal.pone.0085932	http://dx.doi.org/10.1371/journal.pone.0085932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465796	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000077
J	Porto, M; Correia, O; Beja, P				Porto, Miguel; Correia, Otilia; Beja, Pedro			Optimization of Landscape Services under Uncoordinated Management by Multiple Landowners	PLOS ONE			English	Article							CORK OAK FORESTS; ECOSYSTEM SERVICES; DECISION-MAKING; FUEL-MANAGEMENT; CONSERVATION; BIODIVERSITY; FIRE; HABITAT; STRATEGIES; HETEROGENEITY	Landscapes are often patchworks of private properties, where composition and configuration patterns result from cumulative effects of the actions of multiple landowners. Securing the delivery of services in such multi-ownership landscapes is challenging, because it is difficult to assure tight compliance to spatially explicit management rules at the level of individual properties, which may hinder the conservation of critical landscape features. To deal with these constraints, a multi-objective simulation-optimization procedure was developed to select non-spatial management regimes that best meet landscape-level objectives, while accounting for uncoordinated and uncertain response of individual landowners to management rules. Optimization approximates the non-dominated Pareto frontier, combining a multi-objective genetic algorithm and a simulator that forecasts trends in landscape pattern as a function of management rules implemented annually by individual landowners. The procedure was demonstrated with a case study for the optimum scheduling of fuel treatments in cork oak forest landscapes, involving six objectives related to reducing management costs (1), reducing fire risk (3), and protecting biodiversity associated with mid-and late-successional understories (2). There was a trade-off between cost, fire risk and biodiversity objectives, that could be minimized by selecting management regimes involving ca. 60% of landowners clearing the understory at short intervals (around 5 years), and the remaining managing at long intervals (ca. 75 years) or not managing. The optimal management regimes produces a mosaic landscape dominated by stands with herbaceous and low shrub understories, but also with a satisfactory representation of old understories, that was favorable in terms of both fire risk and biodiversity. The simulation-optimization procedure presented can be extended to incorporate a wide range of landscape dynamic processes, management rules and quantifiable objectives. It may thus be adapted to other socio-ecological systems, particularly where specific patterns of landscape heterogeneity are to be maintained despite imperfect management by multiple landowners.	[Porto, Miguel; Correia, Otilia] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Dept Biol Vegetal, Lisbon, Portugal; [Beja, Pedro] Univ Porto, EDP Biodivers Chair, CIBIO Res Ctr Biodivers & Genet Resources InBIO, Vairao, Portugal; [Porto, Miguel] Univ Porto, CIBIO Res Ctr Biodivers & Genet Resources InBIO, Vairao, Portugal	Universidade de Lisboa; Universidade do Porto; Universidade do Porto	Porto, M (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Dept Biol Vegetal, Lisbon, Portugal.	mpbertolo@gmail.com	Porto, Miguel/L-7365-2013; Beja, Pedro/A-7851-2008; Correia, Otilia/K-1928-2012	Porto, Miguel/0000-0001-7640-0623; Beja, Pedro/0000-0001-8164-0760; Correia, Otilia/0000-0002-1053-0561	IFADAP-Program AGRO 8.1 [458 - 2003.09.002326.2]; Portuguese Science and Technology Foundation [SFRH/BD/28974/2006]	IFADAP-Program AGRO 8.1; Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology)	This study was funded by IFADAP-Program AGRO 8.1 (www.programa-agro.net), project 458 - 2003.09.002326.2; and by the Portuguese Science and Technology Foundation (www.fct.pt) through grant SFRH/BD/28974/2006 to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acacio V, 2009, AGROFOREST SYST, V76, P389, DOI 10.1007/s10457-008-9165-y; Baskent EZ, 2005, ECOL MODEL, V188, P145, DOI 10.1016/j.ecolmodel.2005.01.059; Beja P, 2007, WILDLIFE BIOL, V13, P28, DOI 10.2981/0909-6396(2007)13[28:ROCHIM]2.0.CO;2; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bettinger P, 2005, FOREST ECOL MANAG, V217, P171, DOI 10.1016/j.foreco.2005.05.060; Bettinger P, 2003, ECOL MODEL, V169, P215, DOI 10.1016/S0304-3800(03)00271-0; Blasco X, 2008, INFORM SCIENCES, V178, P3908, DOI 10.1016/j.ins.2008.06.010; Cha S, 2007, CITY, V1, DOI DOI 10.1007/S00167-009-0884-Z; Chomitz KM, 2006, ECOL SOC, V11; Costa A, 2010, EUR J FOREST RES, V129, P233, DOI 10.1007/s10342-009-0326-y; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Drechsler M, 2009, ECOL MODEL, V220, P438, DOI 10.1016/j.ecolmodel.2008.11.013; Ducheyne EI, 2006, INT J GEOGR INF SCI, V20, P917, DOI 10.1080/13658810600711287; Fonseca CM, 1995, EVOL COMPUT, V3, P1, DOI 10.1162/evco.1995.3.1.1; Fonseca CM, 2006, IEEE C EVOL COMPUTAT, P1142; Gonzalez J, 2005, LANDSCAPE ECOL, V20, P957, DOI 10.1007/s10980-005-5388-8; Gonzalez-Olabarria JR, 2011, FOREST ECOL MANAG, V261, P278, DOI 10.1016/j.foreco.2010.10.017; Groot JCJ, 2010, EUR J AGRON, V32, P112, DOI 10.1016/j.eja.2009.07.002; Gustafson EJ, 2007, LANDSCAPE ECOL, V22, P141, DOI 10.1007/s10980-006-9017-y; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hartig F, 2009, BIOL CONSERV, V142, P779, DOI 10.1016/j.biocon.2008.12.014; Holzkamper A, 2006, ECOL MODEL, V198, P277, DOI 10.1016/j.ecolmodel.2006.05.001; HUDSON BJ, 1986, GEOGRAPHY, V71, P116; Johnson KN, 2007, ECOL APPL, V17, P34, DOI 10.1890/1051-0761(2007)017[0034:SFSTPA]2.0.CO;2; Juutinen A, 2009, ECOL ECON, V68, P2974, DOI 10.1016/j.ecolecon.2009.06.015; Kashian DM, 2005, ECOLOGY, V86, P643, DOI 10.1890/03-0828; Kennedy MC, 2008, J APPL ECOL, V45, P181, DOI 10.1111/j.1365-2664.2007.01367.x; Kennedy MC, 2011, BIOSCIENCE, V61, P994, DOI 10.1525/bio.2011.61.12.9; Kurttila M, 2003, LANDSCAPE ECOL, V18, P529, DOI 10.1023/A:1026054227874; Lewis DJ, 2007, LAND ECON, V83, P109, DOI 10.3368/le.83.2.109; Lewis DJ, 2011, RESOUR ENERGY ECON, V33, P192, DOI 10.1016/j.reseneeco.2010.04.012; Lindenmayer DB, 2006, BIOL CONSERV, V131, P433, DOI 10.1016/j.biocon.2006.02.019; Liu GL, 2000, ECOL MODEL, V127, P269, DOI 10.1016/S0304-3800(99)00217-3; Loehle C, 2004, FOREST ECOL MANAG, V198, P261, DOI 10.1016/j.foreco.2004.04.010; Lu F, 2000, FOREST ECOL MANAG, V130, P57, DOI 10.1016/S0378-1127(99)00185-1; MacFarlane R., 2000, Landscape Research, V25, P229, DOI 10.1080/713684671; McGarigal K, 2009, LANDSCAPE ECOL, V24, P433, DOI 10.1007/s10980-009-9327-y; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nelson E, 2008, P NATL ACAD SCI USA, V105, P9471, DOI 10.1073/pnas.0706178105; O'Farrell PJ, 2010, CURR OPIN ENV SUST, V2, P59, DOI 10.1016/j.cosust.2010.02.005; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Palma L, 1999, J APPL ECOL, V36, P812, DOI 10.1046/j.1365-2664.1999.00436.x; Palma L, 2006, J APPL ECOL, V43, P1075, DOI 10.1111/j.1365-2664.2006.01213.x; Parkhurst GM, 2002, ECOL ECON, V41, P305, DOI 10.1016/S0921-8009(02)00036-8; Pausas JC, 2008, INT J WILDLAND FIRE, V17, P713, DOI 10.1071/WF07151; Pinol J, 2005, ECOL MODEL, V183, P397, DOI 10.1016/j.ecolmodel.2004.09.001; Polasky S, 2005, ECOL APPL, V15, P1387, DOI 10.1890/03-5423; Polasky S, 2001, LAND ECON, V77, P68, DOI 10.2307/3146981; Porto M, 2013, FOREST ECOL MANAG, V302, P221, DOI 10.1016/j.foreco.2013.03.028; Porto M, 2011, BIODIVERS CONSERV, V20, P2669, DOI 10.1007/s10531-011-0098-9; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; R Development Core Team, 2012, R LANG ENV STAT COMP; Roman-Cuesta RM, 2009, FOREST ECOL MANAG, V258, P71, DOI 10.1016/j.foreco.2009.03.041; Rytwinski A, 2010, FOREST ECOL MANAG, V260, P1, DOI 10.1016/j.foreco.2010.03.013; Santana J, 2012, J APPL ECOL, V49, P632, DOI 10.1111/j.1365-2664.2012.02141.x; Santana J, 2011, FOREST ECOL MANAG, V261, P447, DOI 10.1016/j.foreco.2010.10.030; STRANLUND JK, 1995, J ENVIRON ECON MANAG, V28, P205, DOI 10.1006/jeem.1995.1014; Sturtevant BR, 2009, ECOSYSTEMS, V12, P445, DOI 10.1007/s10021-009-9234-8; Trautmann H., 2010, MCO MULTICRITERIA OP; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; Turner MG, 2013, LANDSCAPE ECOL, V28, P1081, DOI 10.1007/s10980-012-9741-4; Van Deusen PC, 2001, SILVA FENN, V35, P85, DOI 10.14214/sf.605; Van Veldhuizen D. A., 2007, EVOLUTIONARY ALGORIT, V5; Verdasca MJ, 2012, BIOL CONSERV, V146, P14, DOI 10.1016/j.biocon.2011.10.031; Viedma O, 2009, INT J WILDLAND FIRE, V18, P575, DOI 10.1071/WF08030; Visconti P, 2010, BIOL CONSERV, V143, P756, DOI 10.1016/j.biocon.2009.12.018; Wear DN, 1996, ECOL APPL, V6, P1173, DOI 10.2307/2269600; Wintle BA, 2005, CONSERV BIOL, V19, P1930, DOI 10.1111/j.1523-1739.2005.00276.x	73	11	12	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86001	10.1371/journal.pone.0086001	http://dx.doi.org/10.1371/journal.pone.0086001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465833	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000082
J	Quang, T; Marquez, M; Blanco, G; Zhao, YX				Quang, Tara; Marquez, Maribel; Blanco, Giselle; Zhao, Yuanxiang			Dosage and Cell Line Dependent Inhibitory Effect of bFGF Supplement in Human Pluripotent Stem Cell Culture on Inactivated Human Mesenchymal Stem Cells	PLOS ONE			English	Article							PROLONGED UNDIFFERENTIATED GROWTH; HUMAN FEEDER CELLS; SELF-RENEWAL; HUMAN FIBROBLASTS; DERIVATION; DIFFERENTIATION; MAINTENANCE; MAINTAIN; SYSTEM; MEDIA	Many different culture systems have been developed for expanding human pluripotent stem cells (hESCs and hiPSCs). In general, 4-10 ng/ml of bFGF is supplemented in culture media in feeder-dependent systems regardless of feeder cell types, whereas in feeder-free systems, up to 100 ng/ml of bFGF is required for maintaining long-term culture on various substrates. The amount of bFGF required in native hESCs growth niche is unclear. Here we report using inactivated adipose-derived human mesenchymal stem cells as feeder cells to examine long-term parallel cultures of two hESCs lines (H1 and H9) and one hiPSCs line (DF19-9-7T) in media supplemented with 0, 0.4 or 4 ng/ml of bFGF for up to 23 passages, as well as parallel cultures of H9 and DF19 in media supplemented with 4, 20 or 100 ng/ml bFGF for up to 13 passages for comparison. Across all cell lines tested, bFGF supplement demonstrated inhibitory effect over growth expansion, single cell colonization and recovery from freezing in a dosage dependent manner. In addition, bFGF exerted differential effects on different cell lines, inducing H1 and DF19 differentiation at 4 ng/ml or higher, while permitting long-term culture of H9 at the same concentrations with no apparent dosage effect. Pluripotency was confirmed for all cell lines cultured in 0, 0.4 or 4 ng/ml bFGF excluding H1-4 ng, as well as H9 cultured in 4, 20 and 100 ng/ml bFGF. However, DF19 demonstrated similar karyotypic abnormality in both 0 and 4 ng/ml bFGF media while H1 and H9 were karyotypically normal in 0 ng/ml bFGF after long-term culture. Our results indicate that exogenous bFGF exerts dosage and cell line dependent effect on human pluripotent stem cells cultured on mesenchymal stem cells, and implies optimal use of bFGF in hESCs/hiPSCs culture should be based on specific cell line and its culture system.	[Quang, Tara; Marquez, Maribel; Blanco, Giselle; Zhao, Yuanxiang] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona	Zhao, YX (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	zhao@csupomona.edu		Zhao, Yuanxiang/0000-0003-1611-4590	NIH [1SC3GM094078]; CSUPERB Faculty-Student Collaborative Research Seed grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM094078] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSUPERB Faculty-Student Collaborative Research Seed grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant no. 1SC3GM094078 and the 2009-2010 CSUPERB Faculty-Student Collaborative Research Seed grant, both awarded to YX Zhao. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Anchan RM, 2011, HUM MOL GENET, V20, P962, DOI 10.1093/hmg/ddq542; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Chavez SL, 2008, STEM CELLS DEV, V17, P535, DOI 10.1089/scd.2007.0216; Chen G, NAT METHODS, V8, P424; Choo A, 2008, METHOD CELL BIOL, V86, P15, DOI 10.1016/S0091-679X(08)00002-2; Cortes JL, 2009, HUM REPROD, V24, P1844, DOI 10.1093/humrep/dep107; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Ellerstrom C, 2006, STEM CELLS, V24, P2170, DOI 10.1634/stemcells.2006-0130; Fletcher J, 2006, TLS-TIMES LIT SUPPL, P8; Genbacev O, 2005, FERTIL STERIL, V83, P1517, DOI 10.1016/j.fertnstert.2005.01.086; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Jin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050880; Kim SJ, 2007, STEM CELLS DEV, V16, P421, DOI 10.1089/scd.2006.0098; Liu T, 2012, EXP CELL RES, V318, P424, DOI 10.1016/j.yexcr.2011.12.004; Liu YX, 2006, BIOCHEM BIOPH RES CO, V346, P131, DOI 10.1016/j.bbrc.2006.05.086; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; MacArthur CC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/564612; Meng G, STEM CELLS DEV, V21, P2036; Montes R, 2009, CELL RES, V19, P698, DOI 10.1038/cr.2009.35; Park Y, 2011, STEM CELLS DEV, V20, P1901, DOI 10.1089/scd.2010.0496; Park Y, 2010, STEM CELLS DEV, V19, P1713, DOI 10.1089/scd.2010.0014; Peltz L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037162; Rajala K, 2007, HUM REPROD, V22, P1231, DOI 10.1093/humrep/del523; Rajala K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010246; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248; Sanchez L, TISSUE ENG C, V18, P387; Sidhu KS, 2006, STEM CELLS DEV, V15, P741, DOI 10.1089/scd.2006.15.741; Stojkovic P, 2005, STEM CELLS, V23, P306, DOI 10.1634/stemcells.2004-0137; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008067; Unger C, 2009, HUM REPROD, V24, P2567, DOI 10.1093/humrep/dep232; Wang GW, 2005, BIOCHEM BIOPH RES CO, V330, P934, DOI 10.1016/j.bbrc.2005.03.058; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang X, 2006, STEM CELLS, V24, P2669, DOI 10.1634/stemcells.2006-0377; Zhou J, 2008, STEM CELLS DEV, V17, P737, DOI 10.1089/scd.2007.0186	50	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86031	10.1371/journal.pone.0086031	http://dx.doi.org/10.1371/journal.pone.0086031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465853	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000084
J	Kim, MJ; Jeong, HJ; Kim, DW; Sohn, EJ; Jo, HS; Kim, DS; Kim, HA; Park, EY; Park, JH; Son, O; Han, KH; Park, J; Eum, WS; Choi, SY				Kim, Mi Jin; Jeong, Hoon Jae; Kim, Dae Won; Sohn, Eun Jeong; Jo, Hyo Sang; Kim, Duk-Soo; Kim, Hyun Ah; Park, Eun Young; Park, Jong Hoon; Son, Ora; Han, Kyu Hyung; Park, Jinseu; Eum, Won Sik; Choi, Soo Young			PEP-1-PON1 Protein Regulates Inflammatory Response in Raw 264.7 Macrophages and Ameliorates Inflammation in a TPA-Induced Animal Model	PLOS ONE			English	Article							NF-KAPPA-B; MURINE ALVEOLAR MACROPHAGES; NEURONAL CELL-DEATH; DISEASE MOUSE MODEL; OXIDATIVE STRESS; PARKINSONS-DISEASE; COX-2 EXPRESSION; ANTIINFLAMMATORY ACTIVITIES; SERUM PARAOXONASE; MICE	Paraoxonase 1 (PON1) is an antioxidant enzyme which plays a central role in various diseases. However, the mechanism and function of PON1 protein in inflammation are poorly understood. Since PON1 protein alone cannot be delivered into cells, we generated a cell permeable PEP-1-PON1 protein using protein transduction domains, and examined whether it can protect against cell death in lipopolysaccharide (LPS) or hydrogen peroxide (H2O2)-treated Raw 264.7 cells as well as mice with 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced skin inflammation. We demonstrated that PEP-1-PON1 protein transduced into Raw 264.7 cells and markedly protected against LPS or H2O2-induced cell death by inhibiting cellular reactive oxygen species (ROS) levels, the inflammatory mediator's expression, activation of mitogen-activated protein kinases (MAPKs) and cellular apoptosis. Furthermore, topically applied PEP-1-PON1 protein ameliorates TPA-treated mice skin inflammation via a reduction of inflammatory response. Our results indicate that PEP-1-PON1 protein plays a key role in inflammation and oxidative stress in vitro and in vivo. Therefore, we suggest that PEP-1-PON1 protein may provide a potential protein therapy against oxidative stress and inflammation.	[Kim, Mi Jin; Jeong, Hoon Jae; Sohn, Eun Jeong; Jo, Hyo Sang; Son, Ora; Han, Kyu Hyung; Park, Jinseu; Eum, Won Sik; Choi, Soo Young] Hallym Univ, Dept Biomed Sci, Chunchon, Gangwondo, South Korea; [Kim, Mi Jin; Jeong, Hoon Jae; Sohn, Eun Jeong; Jo, Hyo Sang; Son, Ora; Han, Kyu Hyung; Park, Jinseu; Eum, Won Sik; Choi, Soo Young] Hallym Univ, Res Inst Biosci & Biotechnol, Chunchon, Gangwondo, South Korea; [Kim, Dae Won] Kangnung Wonju Natl Univ, Dept Biochem & Mol Biol, Res Inst Oral Sci, Coll Dent, Kangnung, Gangwondo, South Korea; [Kim, Duk-Soo] Soonchunhyang Univ, Dept Anat, Coll Med, Cheonan Si, Chungcheonnamdo, South Korea; [Kim, Hyun Ah] Hallym Univ, Sacred Heart Hosp, Div Rheumatol, Dept Internal Med, Pyongchon, Kyunggido, South Korea; [Park, Eun Young; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea	Hallym University; Hallym University; Kangnung Wonju National University; Soonchunhyang University; Hallym University; Sookmyung Women's University	Eum, WS (corresponding author), Hallym Univ, Dept Biomed Sci, Chunchon, Gangwondo, South Korea.	wseum@hallym.ac.kr; sychoi@hallym.ac.kr	Kim, Mi Jin/GXH-9639-2022		Priority Research Centers Program through National Research Foundation of Korea [2009-0093812]; Mid-Career Researcher Program grant through National Research Foundation of Korea [2012R1A2A2A06043084]; Ministry of Science, ICT & Future Planning in the Republic Korea; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120960]	Priority Research Centers Program through National Research Foundation of Korea(National Research Foundation of Korea); Mid-Career Researcher Program grant through National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning in the Republic Korea; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a Priority Research Centers Program grant (2009-0093812) and in part by a Mid-Career Researcher Program grant (2012R1A2A2A06043084) through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning in the Republic Korea, and in part by a grant of the Korean Health Technology R&D Project (A120960), Ministry of Health & Welfare, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni S, 2013, ATHEROSCLEROSIS, V228, P353, DOI 10.1016/j.atherosclerosis.2013.03.005; Ahn EH, 2013, FREE RADICAL BIO MED, V55, P36, DOI 10.1016/j.freeradbiomed.2012.11.008; Aviram M, 2004, FREE RADICAL BIO MED, V37, P1304, DOI 10.1016/j.freeradbiomed.2004.06.030; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bertolini A, 2002, CURR MED CHEM, V9, P1033, DOI 10.2174/0929867024606650; Blahova L, 2013, TOXICON, V76, P187, DOI 10.1016/j.toxicon.2013.10.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi C, 2003, BIOSCI BIOTECH BIOCH, V67, P1916, DOI 10.1271/bbb.67.1916; Costa LG, 2005, BIOCHEM PHARMACOL, V69, P541, DOI 10.1016/j.bcp.2004.08.027; Costa LG, 2003, ANNU REV MED, V54, P371, DOI 10.1146/annurev.med.54.101601.152421; Dietz GPH, 2010, CURR PHARM BIOTECHNO, V11, P167, DOI 10.2174/138920110790909731; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Du ZJ, 2013, INT J BIOL MACROMOL, V58, P329, DOI 10.1016/j.ijbiomac.2013.04.037; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; Embury J, 2001, DIABETES, V50, P1706, DOI 10.2337/diabetes.50.8.1706; Eum WS, 2004, FREE RADICAL BIO MED, V37, P1656, DOI 10.1016/j.freeradbiomed.2004.07.028; Fagerlund R, 2008, CELL SIGNAL, V20, P1442, DOI 10.1016/j.cellsig.2008.03.012; Fu R, 2013, J ETHNOPHARMACOL, V147, P517, DOI 10.1016/j.jep.2013.03.058; Gardner AM, 1997, FREE RADICAL BIO MED, V22, P73, DOI 10.1016/S0891-5849(96)00235-3; Goraca A, 2013, PHARMACOL REP, V65, P179; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Han S, 2013, IMMUNOPHARM IMMUNOT, V35, P34, DOI 10.3109/08923973.2012.736522; HEWETT JA, 1993, PHARMACOL REV, V45, P381; Hofer SE, 2006, J DIABETES COMPLICAT, V20, P322, DOI 10.1016/j.jdiacomp.2005.08.008; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Ikeda Y, 2008, METABOLISM, V57, P1725, DOI 10.1016/j.metabol.2008.07.032; Ito T, 2002, HUM GENET, V110, P89, DOI 10.1007/s00439-001-0654-6; Karakucuk S, 2004, BRIT J OPHTHALMOL, V88, P1256, DOI 10.1136/bjo.2004.043398; Kim DW, 2013, BMB REP, V46, P124, DOI 10.5483/BMBRep.2013.46.2.272; Kim DS, 2012, BMB REP, V45, P532, DOI 10.5483/BMBRep.2012.45.9.083; Kim MJ, 2013, FREE RADICAL BIO MED, V63, P432, DOI 10.1016/j.freeradbiomed.2013.06.005; Kim SY, 2011, J INVEST DERMATOL, V131, P1477, DOI 10.1038/jid.2011.49; Kim SY, 2011, IMMUNOBIOLOGY, V216, P771, DOI 10.1016/j.imbio.2010.12.008; Kubo E, 2008, AM J PHYSIOL-CELL PH, V294, pC842, DOI 10.1152/ajpcell.00540.2007; Kwon DJ, 2013, FOOD CHEM TOXICOL, V58, P479, DOI 10.1016/j.fct.2013.05.031; Lee YP, 2012, FEBS J, V279, P1929, DOI 10.1111/j.1742-4658.2012.08574.x; Mackness MI, 1996, CURR OPIN LIPIDOL, V7, P69, DOI 10.1097/00041433-199604000-00004; Marsillach J, 2008, FREE RADICAL BIO MED, V45, P146, DOI 10.1016/j.freeradbiomed.2008.03.023; Marsillach J, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-3; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Mrak RE, 2009, J ALZHEIMERS DIS, V18, P473, DOI 10.3233/JAD-2009-1158; Ng DS, 2008, CARDIOVASC PATHOL, V17, P226, DOI 10.1016/j.carpath.2007.10.001; Park MK, 2012, BIOMOL THER, V20, P380, DOI 10.4062/biomolther.2012.20.4.380; Precourt LP, 2011, ATHEROSCLEROSIS, V214, P20, DOI 10.1016/j.atherosclerosis.2010.08.076; Ramana KV, 2006, CYTOKINE, V36, P115, DOI 10.1016/j.cyto.2006.11.003; Rozenberg O, 2005, ATHEROSCLEROSIS, V181, P9, DOI 10.1016/j.atherosclerosis.2004.12.030; Schwab C, 2008, J ALZHEIMERS DIS, V13, P359; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shin EK, 2010, INFLAMMATION, V33, P110, DOI 10.1007/s10753-009-9164-9; Sohn EJ, 2012, BBA-GEN SUBJECTS, V1820, P1647, DOI 10.1016/j.bbagen.2012.06.012; Sony HY, 2008, BIOCHEM PHARMACOL, V75, P1348, DOI 10.1016/j.bcp.2007.11.015; Tiwari M, 2010, FOOD CHEM TOXICOL, V48, P2913, DOI 10.1016/j.fct.2010.07.027; Tomas M, 2004, REV ESP CARDIOL, V57, P557, DOI 10.1157/13062921; Uto T, 2010, AM J CHINESE MED, V38, P985, DOI 10.1142/S0192415X10008408; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Xian YF, 2012, J ETHNOPHARMACOL, V142, P851, DOI 10.1016/j.jep.2012.06.013; Yoshino S, 2000, IMMUNOLOGY, V99, P607, DOI 10.1046/j.1365-2567.2000.00015.x; Zhao BQ, 2012, APPL BIOCHEM BIOTECH, V166, P1463, DOI 10.1007/s12010-012-9540-z; Zidek Z, 2013, NITRIC OXIDE-BIOL CH, V28, P1, DOI 10.1016/j.niox.2012.08.078; Zintzaras E, 2004, J HUM GENET, V49, P474, DOI 10.1007/s10038-004-0176-x	63	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86034	10.1371/journal.pone.0086034	http://dx.doi.org/10.1371/journal.pone.0086034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465855	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000041
J	Russo, T; Parisi, A; Garofalo, G; Gristina, M; Cataudella, S; Fiorentino, F				Russo, Tommaso; Parisi, Antonio; Garofalo, Germana; Gristina, Michele; Cataudella, Stefano; Fiorentino, Fabio			SMART: A Spatially Explicit Bio-Economic Model for Assessing and Managing Demersal Fisheries, with an Application to Italian Trawlers in the Strait of Sicily	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; IDEAL FREE DISTRIBUTION; MARINE PROTECTED AREAS; MANAGEMENT MEASURES; FISHING EFFORT; SHORT-TERM; POPULATION; DYNAMICS; ECOSYSTEM; ALLOCATION	Management of catches, effort and exploitation pattern are considered the most effective measures to control fishing mortality and ultimately ensure productivity and sustainability of fisheries. Despite the growing concerns about the spatial dimension of fisheries, the distribution of resources and fishing effort in space is seldom considered in assessment and management processes. Here we propose SMART (Spatial MAnagement of demersal Resources for Trawl fisheries), a tool for assessing bio-economic feedback in different management scenarios. SMART combines information from different tasks gathered within the European Data Collection Framework on fisheries and is composed of: 1) spatial models of fishing effort, environmental characteristics and distribution of demersal resources; 2) an Artificial Neural Network which captures the relationships among these aspects in a spatially explicit way and uses them to predict resources abundances; 3) a deterministic module which analyzes the size structure of catches and the associated revenues, according to different spatially-based management scenarios. SMART is applied to demersal fishery in the Strait of Sicily, one of the most productive fisheries of the Mediterranean Sea. Three of the main target species are used as proxies for the whole range exploited by trawlers. After training, SMART is used to evaluate different management scenarios, including spatial closures, using a simulation approach that mimics the recent exploitation patterns. Results evidence good model performance, with a noteworthy coherence and reliability of outputs for the different components. Among others, the main finding is that a partial improvement in resource conditions can be achieved by means of nursery closures, even if the overall fishing effort in the area remains stable. Accordingly, a series of strategically designed areas of trawling closures could significantly improve the resource conditions of demersal fisheries in the Strait of Sicily, also supporting sustainable economic returns for fishermen if not applied simultaneously for different species.	[Russo, Tommaso; Cataudella, Stefano] Univ Roma Tor Vergata, Dept Biol, Lab Expt Ecol & Aquaculture, I-00173 Rome, Italy; [Parisi, Antonio] Univ Roma Tor Vergata, Fac Econ, Dept Econ & Finance, Rome, Italy; [Garofalo, Germana; Gristina, Michele; Fiorentino, Fabio] CNR, Inst Coastal Marine Environm IAMC, Mazara Del Vallo, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Russo, T (corresponding author), Univ Roma Tor Vergata, Dept Biol, Lab Expt Ecol & Aquaculture, Via Ric Sci Snc, I-00173 Rome, Italy.	Tommaso.Russo@Uniroma2.it	Russo, Tommaso/C-6157-2014; Fiorentino, Fabio/AAX-2883-2020	Russo, Tommaso/0000-0003-4047-959X; Fiorentino, Fabio/0000-0002-6302-649X; Gristina, Michele/0000-0003-3639-7655; Garofalo, Germana/0000-0001-9117-6252	Flag project RITMARE	Flag project RITMARE	This work was supported by Flag project RITMARE (http://www.ritmare.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2000, ICES J MAR SCI, V57, P761, DOI 10.1006/jmsc.2000.0721; Arendse CJ, 2007, FISH RES, V85, P93, DOI 10.1016/j.fishres.2007.01.001; Arreguin-Sanchez F, 2004, ECOL MODEL, V172, P421, DOI 10.1016/j.ecolmodel.2003.09.016; Ben Mariem S, 2011, GFCM SAC 13 SESS 7 1, P53; Bergmeir C, 2012, J STAT SOFTW, V46, P1; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Bethke E, 2004, FISH RES, V70, P113, DOI 10.1016/j.fishres.2004.05.012; Beverton R.J.H., 1957, FISH INVEST SER, P19; Booth AJ, 2000, ICES J MAR SCI, V57, P858, DOI 10.1006/jmsc.2000.0816; Caddy JF, 2009, MEDITERR MAR SCI, V10, P83, DOI 10.12681/mms.124; Cadrin SX, 2009, FISH FISH SER, V31, P405, DOI 10.1007/978-1-4020-9210-7_22; Cardinale M, 2010, SCI TECHNICAL EC C 2, DOI [10.2788/16368, DOI 10.2788/16368]; Cardinale M, 2010, SCI TECHNICAL EC C 1, DOI [10.2788/59974, DOI 10.2788/59974]; Caruana R, 2001, ADV NEUR IN, V13, P402; Chen ZZ, 2009, FISH RES, V100, P222, DOI 10.1016/j.fishres.2009.08.001; Chevalier P, 1990, 1014 FAO; Cochrane KL, 2009, FISHERY MANAGERS GUIDEBOOK, 2ND EDITION, P1, DOI 10.1002/9781444316315; Colloca F, 2011, FISH FISH, V14, P1; Colloca F, 1999, BIOL MAR MEDIT, P259; Currie DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030138; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Daures F, 2013, FISH RES, V146, P74, DOI 10.1016/j.fishres.2013.03.022; De Leo FC, 2010, P ROY SOC B-BIOL SCI, V277, P2783, DOI 10.1098/rspb.2010.0462; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Fiorentino F, 2010, ALCUNI SPUNTI MIGLIO, P138; Fiorentino F., 2004, MEDSUDMED TECHNICAL, V2, P50; Fiorentino F, 2008, MEDSUDMED TECHNICAL, V15, P67; Fiorentino F, 2000, TRAWL SELECTIVITY MA; Fouzai N, 2012, J MARINE SYST, V102, P39, DOI 10.1016/j.jmarsys.2012.05.003; Fromentin JM, 1997, MAR ECOL PROG SER, V155, P209, DOI 10.3354/meps155209; Fu CH, 2012, MAR ECOL PROG SER, V459, P169, DOI 10.3354/meps09805; Gancitano V., 2007, Biologia Marina Mediterranea, V14, P354; Garofalo G, 2011, J SEA RES, V66, P29, DOI 10.1016/j.seares.2011.04.008; Garson D.G., 1991, AI EXPERT, V6, P47; GFCM, 2012, TRANSV WORKSH SPAT B; GFCM, 2011, 35 SESS GEN FISH COM; Gillis DM, 2012, CAN J FISH AQUAT SCI, V69, P1610, DOI 10.1139/F2012-091; GILLIS DM, 1993, CAN J FISH AQUAT SCI, V50, P323, DOI 10.1139/f93-038; Goni R, 2008, MAR ECOL PROG SER, V366, P159, DOI 10.3354/meps07532; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Gruss A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019960; Haykin S, 1999, P842; HILBORN R, 1992; Holland DS, 2003, ICES J MAR SCI, V60, P915, DOI 10.1016/S1054-3139(03)00097-3; Huse G, 1999, SARSIA, V84, P457, DOI 10.1080/00364827.1999.10807351; IREPA, 2011, SIST DAT; Isaaks E.H., 1989, APPL GEOSTATISTICS; Jennings S., 2001, MARINE FISHERIES ECO; Jennings S, 2011, FISH FISH, V12, P125, DOI 10.1111/j.1467-2979.2011.00409.x; Joo R, 2011, ECOL MODEL, V222, P1048, DOI 10.1016/j.ecolmodel.2010.08.039; Langlois TJ, 2012, ECOL INDIC, V23, P524, DOI 10.1016/j.ecolind.2012.04.030; Le Floc'h P, 2008, MAR POLICY, V32, P421, DOI 10.1016/j.marpol.2007.08.010; Lek S, 1996, ECOL MODEL, V90, P39, DOI 10.1016/0304-3800(95)00142-5; Lek S, 2000, ENVIRONM SCI, P3; Lleonart J, 2003, SCI MAR, V67, P337, DOI 10.3989/scimar.2003.67s1337; Lleonart J, 2005, FAO FISHERIES TECHNI; Lorenzen K, 2010, B MAR SCI, V86, P169; Macdonald PDM, 1988, USERS GUIDE PRORAM I; Mahevas S, 2004, ECOL MODEL, V171, P65, DOI 10.1016/j.ecolmodel.2003.04.001; Maravelias CD, 2003, MAR ECOL PROG SER, V255, P249, DOI 10.3354/meps255249; MEDITS, 2007, INT BOTT TRAWL SURV; Moustakas A, 2006, ECOL MODEL, V192, P245, DOI 10.1016/j.ecolmodel.2005.07.007; Papaconstantinou C, 2000, MEDITERR MAR SCI, V1, P15; Pelletier D, 1996, CAN J FISH AQUAT SCI, V53, P1186, DOI 10.1139/cjfas-53-5-1186; Peres JM, 1982, MARINE ECOLOGY, V5; Piet GJ, 2009, ICES J MAR SCI, V66, P1985, DOI 10.1093/icesjms/fsp162; Poos JJ, 2010, ICES J MAR SCI, V67, P155, DOI 10.1093/icesjms/fsp219; R Core Team, 2013, R LANG ENV STAT COMP; Rassweiler A, 2012, P NATL ACAD SCI USA, V109, P11884, DOI 10.1073/pnas.1116193109; Relini G., 1999, BIOL MAR MEDIT S1, P276; Rijnsdorp AD, 2000, ICES J MAR SCI, V57, P894, DOI 10.1006/jmsc.2000.0576; Rouyer T, 2008, P NATL ACAD SCI USA, V105, P5420, DOI 10.1073/pnas.0709034105; Russo T, 2013, ECOL INDIC, V26, P141, DOI 10.1016/j.ecolind.2012.11.002; Russo T, 2011, FISH RES, V111, P53, DOI 10.1016/j.fishres.2011.06.011; Russo T, 2011, FISH RES, V108, P184, DOI 10.1016/j.fishres.2010.12.020; Russo T, 2009, ICES J MAR SCI, V66, P1718, DOI 10.1093/icesjms/fsp204; Russo T, 2009, J THEOR BIOL, V258, P521, DOI 10.1016/j.jtbi.2009.01.033; Salas S, 2004, CAN J FISH AQUAT SCI, V61, P374, DOI 10.1139/F04-007; Sarle W. S., 1995, Computing Science and Statistics. Vol.27. Proceedings of the 27th Symposium on the Interface. Statistics and Manufacturing with Subthemes in Environmental Statistics, Graphics and Imaging, P352; Scardi M, 1996, MAR ECOL PROG SER, V139, P289, DOI 10.3354/meps139289; Sobrino I., 2007, Boletin Instituto Espanol de Oceanografia, V23, P57; Sokal R. R., 2012, BIOMETRY; Soulie JC, 2006, MATH COMPUT MODEL, V44, P553, DOI 10.1016/j.mcm.2005.02.011; SOUPLET A, 1996, CAMP INT CHAL DEM ME, V3, P7; Trenkel VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070165; Vasilakopoulos P, 2011, ICES J MAR SCI, V68, P1525, DOI 10.1093/icesjms/fsr075; Vert-pre KA, 2013, P NATL ACAD SCI USA, V110, P1779, DOI 10.1073/pnas.1214879110; Walters CJ, 1999, CAN J FISH AQUAT SCI, V56, P601, DOI 10.1139/cjfas-56-4-601; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7	89	54	54	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86222	10.1371/journal.pone.0086222	http://dx.doi.org/10.1371/journal.pone.0086222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297XI	24465971	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000066
J	Cygan, HB; Tacikowski, P; Ostaszewski, P; Chojnicka, I; Nowicka, A				Cygan, Hanna B.; Tacikowski, Pawel; Ostaszewski, Pawel; Chojnicka, Izabela; Nowicka, Anna			Neural Correlates of Own Name and Own Face Detection in Autism Spectrum Disorder	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; PERSONALLY FAMILIAR FACES; BRAIN POTENTIALS; SELF-FACE; SOCIAL COGNITION; TEMPORAL CORTEX; ERP COMPONENTS; ATTENTION; CHILDREN; RECOGNITION	Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition clinically characterized by social interaction and communication difficulties. To date, the majority of research efforts have focused on brain mechanisms underlying the deficits in interpersonal social cognition associated with ASD. Recent empirical and theoretical work has begun to reveal evidence for a reduced or even absent self-preference effect in patients with ASD. One may hypothesize that this is related to the impaired attentional processing of self-referential stimuli. The aim of our study was to test this hypothesis. We investigated the neural correlates of face and name detection in ASD. Four categories of face/name stimuli were used: own, close-other, famous, and unknown. Event-related potentials were recorded from 62 electrodes in 23 subjects with ASD and 23 matched control subjects. P100, N170, and P300 components were analyzed. The control group clearly showed a significant self-preference effect: higher P300 amplitude to the presentation of own face and own name than to the close-other, famous, and unknown categories, indicating preferential attentional engagement in processing of self-related information. In contrast, detection of both own and close-other's face and name in the ASD group was associated with enhanced P300, suggesting similar attention allocation for self and close-other related information. These findings suggest that attention allocation in the ASD group is modulated by the personal significance factor, and that the self-preference effect is absent if self is compared to close-other. These effects are similar for physical and non-physical aspects of the autistic self. In addition, lateralization of face and name processing is attenuated in ASD, suggesting atypical brain organization.	[Cygan, Hanna B.; Tacikowski, Pawel; Nowicka, Anna] Nencki Inst Expt Biol, Dept Neurophysiol, Psychophysiol Lab, Warsaw, Poland; [Tacikowski, Pawel] Karolinska Inst, Dept Neurosci Brain Body & Self Lab, Stockholm, Sweden; [Ostaszewski, Pawel] Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland; [Chojnicka, Izabela] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Karolinska Institutet; SWPS University of Social Sciences & Humanities; Medical University of Warsaw	Nowicka, A (corresponding author), Nencki Inst Expt Biol, Dept Neurophysiol, Psychophysiol Lab, Warsaw, Poland.	a.nowicka@nencki.gov.pl	Tacikowski, Pawel/AAY-4055-2021; Tacikowski, Pawel/AAZ-1344-2021; Nowicka, Anna/R-9730-2016	Tacikowski, Pawel/0000-0003-2434-2112; Cygan, Hanna B/0000-0002-4518-8540; Nowicka, Anna/0000-0002-5791-7237; Ostaszewski, Pawel/0000-0003-0583-7697; Chojnicka, Izabela/0000-0001-8723-6873	National Science Centre, Warsaw, Poland [2011/01/B/HS6/00683]	National Science Centre, Warsaw, Poland	This work was supported by the National Science Centre, Warsaw, Poland (grant 2011/01/B/HS6/00683). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos T, 2012, EUR J SOC PSYCHOL, V42, P770, DOI 10.1002/ejsp.1882; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Baron-Cohen S., 2005, LOST SELF PATHOLOGIE; BaronCohen S, 1997, CHILD DEV, V68, P48; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; BERLAD I, 1995, EVOKED POTENTIAL, V96, P472, DOI 10.1016/0168-5597(95)00116-A; Briggs KE, 2009, INT J PSYCHOPHYSIOL, V72, P299, DOI 10.1016/j.ijpsycho.2009.01.009; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Brzezinski J., 2004, WAIS R PL SKALA INTE; Caharel S, 2002, INT J NEUROSCI, V112, P1499, DOI 10.1080/00207450290158368; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; Carbon CC, 2005, COGNITIVE BRAIN RES, V24, P544, DOI 10.1016/j.cogbrainres.2005.03.008; Carmody DP, 2007, J AUTISM DEV DISORD, V37, P1381, DOI 10.1007/s10803-006-0270-3; Carmody DP, 2006, BRAIN RES, V1116, P153, DOI 10.1016/j.brainres.2006.07.121; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; CHIRON C, 1995, DEV MED CHILD NEUROL, V37, P849; Coles MGH, 1995, ELECTROPHYSIOLOGY MI, P40; D'Cruz AM, 2009, BIOL PSYCHIAT, V66, P393, DOI 10.1016/j.biopsych.2009.01.008; Dawson G, 2002, CHILD DEV, V73, P700, DOI 10.1111/1467-8624.00433; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; DePape AMR, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00072; Dering B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00093; Dietrich DE, 2001, NEUROPSYCHOBIOLOGY, V43, P96, DOI 10.1159/000054874; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00119; Escalante-Mead PR, 2003, J AUTISM DEV DISORD, V33, P539, DOI 10.1023/A:1025887713788; Eyler LT, 2012, BRAIN, V135, P949, DOI 10.1093/brain/awr364; Floris DL, 2013, J AUTISM DEV DISORD, V43, P1758, DOI 10.1007/s10803-012-1720-8; Folmer RL, 1997, BRAIN LANG, V56, P306, DOI 10.1006/brln.1997.1828; Frith U, 2005, CONSCIOUS COGN, V14, P719, DOI 10.1016/j.concog.2005.04.006; Frith U, 1999, MIND LANG, V14, P1; Frith U., 2003, AUTISM EXPLAINING EN; Glezerman T, 2013, AUTISTIC PERSONS SEN, P194; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gunji A, 2009, BRAIN DEV-JPN, V31, P139, DOI 10.1016/j.braindev.2008.04.011; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Happe F, 2003, ANN NY ACAD SCI, V1001, P134, DOI 10.1196/annals.1279.008; Henderson HA, 2009, J CHILD PSYCHOL PSYC, V50, P853, DOI 10.1111/j.1469-7610.2008.02059.x; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Herrmann MJ, 2005, J NEURAL TRANSM, V112, P1073, DOI 10.1007/s00702-004-0250-8; Herzmann G, 2004, PSYCHOPHYSIOLOGY, V41, P688, DOI 10.1111/j.1469-8986.2004.00196.x; Herzmann G, 2007, PSYCHOPHYSIOLOGY, V44, P262, DOI 10.1111/j.1469-8986.2007.00505.x; Hileman CM, 2011, DEV NEUROPSYCHOL, V36, P214, DOI 10.1080/87565641.2010.549870; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hobson RP, 2006, MONOGR SOC RES CHILD, V71, pI; Holler Y, 2011, CLIN NEUROPHYSIOL, V122, P99, DOI 10.1016/j.clinph.2010.05.029; Holeckova I, 2008, BRAIN RES, V1189, P152, DOI 10.1016/j.brainres.2007.10.091; HURLBURT RT, 1994, PSYCHOL MED, V24, P385, DOI 10.1017/S0033291700027367; Itier RJ, 2004, NEUROIMAGE, V21, P1518, DOI 10.1016/j.neuroimage.2003.12.016; Jeste SS, 2009, J AUTISM DEV DISORD, V39, P495, DOI 10.1007/s10803-008-0652-9; JOHNSTON VS, 1986, PSYCHOPHYSIOLOGY, V23, P684, DOI 10.1111/j.1469-8986.1986.tb00694.x; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Kampe KKW, 2003, J NEUROSCI, V23, P5258; Kanner L, 1943, NERV CHILD, V2, P217; Kleinhans NM, 2008, BRAIN RES, V1221, P115, DOI 10.1016/j.brainres.2008.04.080; Knaus TA, 2010, BRAIN LANG, V112, P113, DOI 10.1016/j.bandl.2009.11.005; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Lombardo MV, 2010, WIRES COGN SCI, V1, P393, DOI 10.1002/wcs.45; Lombardo MV, 2010, BRAIN, V133, P611, DOI 10.1093/brain/awp306; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; McPartland J, 2004, J CHILD PSYCHOL PSYC, V45, P1235, DOI 10.1111/j.1469-7610.2004.00318.x; McPartland JC, 2011, SOC NEUROSCI-UK, V6, P436, DOI 10.1080/17470919.2011.586880; Mitsudo T, 2011, CLIN NEUROPHYSIOL, V122, P708, DOI 10.1016/j.clinph.2010.10.004; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; MORTON J, 1969, PSYCHOL REV, V76, P165, DOI 10.1037/h0027366; Morton J., 1979, PROCESSING VISIBLE L, P259, DOI [DOI 10.1007/978-1-4684-0994-9_15, 10.1007/978-1-4684-0994-9_15]; Muller HM, 1996, NEUROREPORT, V8, P221; Nuske HJ, 2013, COGNITION EMOTION, V27, P1042, DOI 10.1080/02699931.2012.762900; O'Connor K, 2005, BRAIN COGNITION, V59, P82, DOI 10.1016/j.bandc.2005.05.004; O'Connor K, 2007, INT J PSYCHOPHYSIOL, V63, P283, DOI 10.1016/j.ijpsycho.2006.12.001; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paller KA, 2000, NEUROIMAGE, V11, P98, DOI 10.1006/nimg.1999.0521; Perrin F, 2005, NEUROPSYCHOLOGIA, V43, P12, DOI 10.1016/j.neuropsychologia.2004.07.002; Pfister R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032402; Pfutze EM, 2002, PSYCHOL AGING, V17, P140, DOI 10.1037//0882-7974.17.1.140; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rogers S. J., 1991, DEV PSYCHOPATHOL, V3, P137, DOI DOI 10.1017/S0954579400000043; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Sadeh B, 2008, NEUROIMAGE, V42, P778, DOI 10.1016/j.neuroimage.2008.04.168; Samson F, 2012, HUM BRAIN MAPP, V33, P1553, DOI 10.1002/hbm.21307; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Schweinberger SR, 2006, BRAIN RES, V1117, P195, DOI 10.1016/j.brainres.2006.08.070; Scott L. S., 2005, ROMANIAN ASS COGNITI, V9, P211; Shapiro KL, 1997, J EXP PSYCHOL HUMAN, V23, P504, DOI 10.1037/0096-1523.23.2.504; Sui J, 2006, NEUROREPORT, V17, P423, DOI 10.1097/01.wnr.0000203357.65190.61; Tacikowski P, 2011, SOC NEUROSCI-UK, V6, P98, DOI 10.1080/17470919.2010.490665; Tacikowski P, 2013, HUM BRAIN MAPP, V34, P2069, DOI 10.1002/hbm.22048; Tacikowski P, 2011, INT J PSYCHOPHYSIOL, V79, P219, DOI 10.1016/j.ijpsycho.2010.10.010; Tacikowski P, 2010, BIOL PSYCHOL, V84, P318, DOI 10.1016/j.biopsycho.2010.03.009; Toichi M, 2002, AM J PSYCHIAT, V159, P1422, DOI 10.1176/appi.ajp.159.8.1422; Uddin LQ, 2011, NEUROCASE, V17, P201, DOI 10.1080/13554794.2010.509320; VALENTINE T, 1995, Q J EXP PSYCHOL-A, V48, P513, DOI 10.1080/14640749508401404; Wang AT, 2006, BRAIN, V129, P932, DOI 10.1093/brain/awl032; Webb SJ, 2010, INT J PSYCHOPHYSIOL, V77, P106, DOI 10.1016/j.ijpsycho.2010.04.011; Williams DL, 2007, NEUROIMAG CLIN N AM, V17, P495, DOI 10.1016/j.nic.2007.07.007; WOLFORD G, 1980, MEM COGNITION, V8, P521, DOI 10.3758/BF03213771; WOOD N, 1995, J EXP PSYCHOL LEARN, V21, P255, DOI 10.1037/0278-7393.21.1.255; Zhao K, 2009, NEUROSCI LETT, V464, P57, DOI 10.1016/j.neulet.2009.07.017	111	57	58	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86020	10.1371/journal.pone.0086020	http://dx.doi.org/10.1371/journal.pone.0086020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465847	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100098
J	Caradec, T; Pupin, M; Vanvlassenbroeck, A; Devignes, MD; Smail-Tabbone, M; Jacques, P; Leclere, V				Caradec, Thibault; Pupin, Maude; Vanvlassenbroeck, Aurelien; Devignes, Marie-Dominique; Smail-Tabbone, Malika; Jacques, Philippe; Leclere, Valerie			Prediction of Monomer Isomery in Florine: A Workflow Dedicated to Nonribosomal Peptide Discovery	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; IN-SILICO PREDICTION; SWARMING MOTILITY; CONDENSATION; SEQUENCE; IDENTIFICATION; CYCLIZATION; SYNTHETASE; DOMAINS; TOMATO	Nonribosomal peptides represent a large variety of natural active compounds produced by microorganisms. Due to their specific biosynthesis pathway through large assembly lines called NonRibosomal Peptide Synthetases (NRPSs), they often display complex structures with cycles and branches. Moreover they often contain non proteogenic or modified monomers, such as the D-monomers produced by epimerization. We investigate here some sequence specificities of the condensation (C) and epimerization (E) domains of NRPS that can be used to predict the possible isomeric state (D or L) of each monomer in a putative peptide. We show that C-and E-domains can be divided into 2 sub-regions called Up-Seq and Down-Seq. The Up-Seq region corresponds to an InterPro domain (IPR001242) and is shared by C-and E-domains. The Down-Seq region is specific to the enzymatic activity of the domain. Amino-acid signatures (represented as sequence logos) previously described for complete C-and E-domains have been restricted to the Down-Seq region and amplified thanks to additional sequences. Moreover a new Down-Seq signature has been found for Ct-domains found in fungi and responsible for terminal cyclization of the peptides. The identification of these signatures has been included in a workflow named Florine, aimed to predict nonribosomal peptides from NRPS sequence analyses. In some cases, the prediction of isomery is guided by genus-specific rules. Florine was used on a Pseudomonas genome to allow the determination of the type of pyoverdin produced, the update of syringafactin structure and the identification of novel putative products.	[Caradec, Thibault; Vanvlassenbroeck, Aurelien; Jacques, Philippe; Leclere, Valerie] Univ Lille1 Sci & Technol, Lab ProBioGEM, Villeneuve Dascq, France; [Pupin, Maude] Univ Lille 1, CNRS, UMR 8022, LIFL, F-59655 Villeneuve Dascq, France; [Pupin, Maude] INRIA Lille Nord Europe, Villeneuve Dascq, France; [Devignes, Marie-Dominique; Smail-Tabbone, Malika] CNRS, LORIA, UMR 7503, Vandoeuvre Les Nancy, France; [Devignes, Marie-Dominique; Smail-Tabbone, Malika] Univ Lorraine, LORIA, UMR 7503, Vandoeuvre Les Nancy, France; [Devignes, Marie-Dominique; Smail-Tabbone, Malika] INRIA, Villers Les Nancy, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Universite de Lorraine; Inria	Leclere, V (corresponding author), Univ Lille1 Sci & Technol, Lab ProBioGEM, Villeneuve Dascq, France.	valerie.leclere@univ-lille1.fr	Leclère, Valérie/Y-6312-2018; Devignes, Marie-Dominique/AAI-4554-2020; Pupin, Maude/I-7437-2015	Leclère, Valérie/0000-0003-2463-5361; Devignes, Marie-Dominique/0000-0002-0399-8713; Pupin, Maude/0000-0003-3197-0715; Caradec, Thibault/0000-0002-4461-654X	University of Lille; INRIA; Region Lorraine; European Funds of INTERREG IVa Phytobio project	University of Lille; INRIA; Region Lorraine(Region Grand-Est); European Funds of INTERREG IVa Phytobio project	The funders are: University of Lille, INRIA, Region Lorraine, and European Funds of INTERREG IVa Phytobio project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2011, APPL MICROBIOL BIOT, V92, P571, DOI 10.1007/s00253-011-3453-6; Abdo A, 2012, J COMPUT AID MOL DES, V26, P1187, DOI 10.1007/s10822-012-9608-4; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Balibar CJ, 2005, CHEM BIOL, V12, P1189, DOI 10.1016/j.chembiol.2005.08.010; Bechet M, 2012, APPL MICROBIOL BIOT, V95, P593, DOI 10.1007/s00253-012-4181-2; Berti AD, 2007, J BACTERIOL, V189, P6312, DOI 10.1128/JB.00725-07; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Caboche S, 2009, BMC STRUCT BIOL, V18, P9; Caboche S, 2008, NUCLEIC ACIDS RES, V36, pD326, DOI 10.1093/nar/gkm792; Caboche S, 2010, J BACTERIOL, V192, P5143, DOI 10.1128/JB.00315-10; Cochrane G, 2011, NUCLEIC ACIDS RES, V39, pD15, DOI 10.1093/nar/gkq1150; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Bruijn I, 2008, J BACTERIOL, V190, P2777, DOI 10.1128/JB.01563-07; di Salvo ML, 2013, ARCH BIOCHEM BIOPHYS, V529, P55, DOI 10.1016/j.abb.2012.11.011; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Gao X, 2012, NAT CHEM BIOL, V8, P823, DOI 10.1038/NCHEMBIO.1047; Gehring AM, 1998, CHEM BIOL, V5, P573, DOI 10.1016/S1074-5521(98)90115-6; Hou J, 2011, CHEM BIOL, V18, P655, DOI 10.1016/j.chembiol.2011.02.012; Hur GH, 2012, NAT PROD REP, V29, P1074, DOI 10.1039/c2np20025b; Jenke-Kodama H, 2009, NAT PROD REP, V26, P874, DOI 10.1039/b810283j; Johnston C, 2012, MEDCHEMCOMM, V3, P932, DOI 10.1039/c2md20120h; Jones AM, 2007, J BACTERIOL, V189, P6773, DOI 10.1128/JB.00827-07; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Konz D, 1997, CHEM BIOL, V4, P927, DOI 10.1016/S1074-5521(97)90301-X; Li J, 2008, CHEM BIOL, V15, P118, DOI 10.1016/j.chembiol.2007.12.014; Li MHT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-185; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martinez JS, 2003, P NATL ACAD SCI USA, V100, P3754, DOI 10.1073/pnas.0637444100; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Minowa Y, 2007, J MOL BIOL, V368, P1500, DOI 10.1016/j.jmb.2007.02.099; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Pauwelyn E, 2013, MOL PLANT MICROBE IN, V26, P585, DOI 10.1094/MPMI-11-12-0258-R; Peypoux F, 1999, APPL MICROBIOL BIOT, V51, P553, DOI 10.1007/s002530051432; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Roongsawang N, 2011, INT J MOL SCI, V12, P141, DOI 10.3390/ijms12010141; Stachelhaus T, 1998, J BIOL CHEM, V273, P22773, DOI 10.1074/jbc.273.35.22773; Starcevic A, 2008, NUCLEIC ACIDS RES, V36, P6882, DOI 10.1093/nar/gkn685; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Tang GL, 2007, J BIOL CHEM, V282, P20273, DOI 10.1074/jbc.M702814200; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	50	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85667	10.1371/journal.pone.0085667	http://dx.doi.org/10.1371/journal.pone.0085667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465643	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500089
J	Das, S; Bhattacharyya, NP				Das, Srijit; Bhattacharyya, Nitai Pada			Transcription Regulation of HYPK by Heat Shock Factor 1	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; HUNTINGTIN INTERACTING PROTEIN; N-TERMINAL HUNTINGTIN; GENOME-WIDE ANALYSIS; MOLECULAR CHAPERONES; GENE-EXPRESSION; FACTOR-I; HSF1; INDUCTION; STRESS	HYPK (Huntingtin Yeast Partner K) was originally identified by yeast two-hybrid assay as an interactor of Huntingtin, the protein mutated in Huntington's disease. HYPK was characterized earlier as an intrinsically unstructured protein having chaperone-like activity in vitro and in vivo. HYPK has the ability of reducing rate of aggregate formation and subsequent toxicity caused by mutant Huntingtin. Further investigation revealed that HYPK is involved in diverse cellular processes and required for normal functioning of cells. In this study we observed that hyperthermia increases HYPK expression in human and mouse cells in culture. Expression of exogenous Heat Shock Factor 1 (HSF1), upon heat treatment could induce HYPK expression, whereas HSF1 knockdown reduced endogenous as well as heat-induced HYPK expression. Putative HSF1-binding site present in the promoter of human HYPK gene was identified and validated by reporter assay. Chromatin immunoprecipitation revealed in vivo interaction of HSF1 and RNA polymerase II with HYPK promoter sequence. Additionally, acetylation of histone H4, a known epigenetic marker of inducible HSF1 binding, was observed in response to heat shock in HYPK gene promoter. Overexpression of HYPK inhibited cells from lethal heat-induced death whereas knockdown of HYPK made the cells susceptible to lethal heat shock-induced death. Apart from elevated temperature, HYPK was also upregulated by hypoxia and proteasome inhibition, two other forms of cellular stress. We concluded that chaperone-like protein HYPK is induced by cellular stress and under transcriptional regulation of HSF1.	[Das, Srijit; Bhattacharyya, Nitai Pada] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India	Saha Institute of Nuclear Physics	Bhattacharyya, NP (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India.	nitai_sinp@yahoo.com	Das, Srijit/E-8457-2017	Das, Srijit/0000-0001-8302-7257	Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	Work was funded by Department of Atomic Energy, Government of India, as an Institutional Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Arnesen T, 2010, MOL CELL BIOL, V30, P1898, DOI 10.1128/MCB.01199-09; Baird NA, 2006, J BIOL CHEM, V281, P38675, DOI 10.1074/jbc.M608013200; BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; BENJAMIN IJ, 1990, P NATL ACAD SCI USA, V87, P6263, DOI 10.1073/pnas.87.16.6263; Bush KT, 1997, J BIOL CHEM, V272, P9086; Choudhury KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051415; Datta M, 2011, J BIOL CHEM, V286, P33759, DOI 10.1074/jbc.M111.265173; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Fortin A, 2000, INT J RADIAT ONCOL, V46, P1259, DOI 10.1016/S0360-3016(99)00410-1; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Gonsalves SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015934; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; HALLADAY JT, 1995, MOL CELL BIOL, V15, P4890; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Ibrahim NO, 2005, CANCER RES, V65, P11094, DOI 10.1158/0008-5472.CAN-05-1877; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; Lee J, 2013, J BIOL CHEM, V288, P1582, DOI 10.1074/jbc.M112.401554; LEWIS MJ, 1985, EMBO J, V4, P3137, DOI 10.1002/j.1460-2075.1985.tb04056.x; LI GC, 1982, P NATL ACAD SCI-BIOL, V79, P3218, DOI 10.1073/pnas.79.10.3218; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Moseley PL, 1997, J APPL PHYSIOL, V83, P1413, DOI 10.1152/jappl.1997.83.5.1413; Nagai Y, 2010, CURR PHARM BIOTECHNO, V11, P188, DOI 10.2174/138920110790909650; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Page TJ, 2006, MOL BIOSYST, V2, P627, DOI 10.1039/b606129j; Raychaudhuri S, 2008, PROTEINS, V71, P1686, DOI 10.1002/prot.21856; Raychaudhuri S, 2008, HUM MOL GENET, V17, P240, DOI 10.1093/hmg/ddm301; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031304; Saidi Y, 2011, NEW PHYTOL, V190, P556, DOI 10.1111/j.1469-8137.2010.03571.x; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; TILLY K, 1983, CELL, V34, P641, DOI 10.1016/0092-8674(83)90396-3; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Voellmy R, 2004, PROG NUCLEIC ACID RE, V78, P143, DOI 10.1016/S0079-6603(04)78004-6; WANG Y, 1994, NUCLEIC ACIDS RES, V22, P3113, DOI 10.1093/nar/22.15.3113; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Xia WL, 1999, CELL STRESS CHAPERON, V4, P8, DOI 10.1054/csac.1998.0113; Yoon YJ, 2011, J BIOL CHEM, V286, P1737, DOI 10.1074/jbc.M110.179440; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; ZUO JR, 1994, MOL CELL BIOL, V14, P7557, DOI 10.1128/MCB.14.11.7557; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	60	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85552	10.1371/journal.pone.0085552	http://dx.doi.org/10.1371/journal.pone.0085552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465598	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500074
J	Gow, DW; Nied, AC				Gow, David W., Jr.; Nied, A. Conrad			Rules from Words: A Dynamic Neural Basis for a Lawful Linguistic Process	PLOS ONE			English	Article							EVENT-RELATED FMRI; PREFRONTAL CORTEX; CORTICAL ORGANIZATION; SPEECH-PERCEPTION; LANGUAGE; BRAIN; COMPENSATION; PROBABILITY; SYNTAX; MODEL	Listeners show a reliable bias towards interpreting speech sounds in a way that conforms to linguistic restrictions (phonotactic constraints) on the permissible patterning of speech sounds in a language. This perceptual bias may enforce and strengthen the systematicity that is the hallmark of phonological representation. Using Granger causality analysis of magnetic resonance imaging (MRI)-constrained magnetoencephalography (MEG) and electroencephalography (EEG) data, we tested the differential predictions of rule-based, frequency-based, and top-down lexical influence-driven explanations of processes that produce phonotactic biases in phoneme categorization. Consistent with the top-down lexical influence account, brain regions associated with the representation of words had a stronger influence on acoustic-phonetic regions in trials that led to the identification of phonotactically legal (versus illegal) word-initial consonant clusters. Regions associated with the application of linguistic rules had no such effect. Similarly, high frequency phoneme clusters failed to produce stronger feedforward influences by acoustic-phonetic regions on areas associated with higher linguistic representation. These results suggest that top-down lexical influences contribute to the systematicity of phonological representation.	[Gow, David W., Jr.; Nied, A. Conrad] Massachusetts Gen Hosp, Neuropsychol Lab, Boston, MA 02114 USA; [Gow, David W., Jr.] Salem State Univ, Dept Psychol, Salem, MA USA; [Gow, David W., Jr.; Nied, A. Conrad] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Gow, David W., Jr.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Massachusetts System of Public Higher Education; Salem State University; Harvard University; Massachusetts General Hospital; Harvard University	Gow, DW (corresponding author), Massachusetts Gen Hosp, Neuropsychol Lab, Boston, MA 02114 USA.	gow@helix.mgh.harvard.edu			National Institute of Deafness and Communicative Disorders [R01 DC003108]; MIND Institute; NCRR Regional Resource Grant [41RR14075]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075, S10RR031599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003108] Funding Source: NIH RePORTER	National Institute of Deafness and Communicative Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); MIND Institute; NCRR Regional Resource Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute of Deafness and Communicative Disorders (R01 DC003108) to D. W. G. and benefited from support from the MIND Institute and the NCRR Regional Resource Grant (41RR14075) for the development of technology and analysis tools at the Athinoula A.Martinos Center for Biomedical Imaging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, PHONETICALLY BASED P; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Axer H, 2001, BRAIN LANG, V76, P317, DOI 10.1006/brln.2000.2425; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bailey TM, 2001, J MEM LANG, V44, P568, DOI 10.1006/jmla.2000.2756; Berent I, 2002, COGNITION, V83, P113, DOI 10.1016/S0010-0277(01)00167-6; Berent I., 2013, PHONOLOGICAL MIND; Berent I, 2008, P NATL ACAD SCI USA, V105, P5321, DOI 10.1073/pnas.0801469105; Berent I, 2007, COGNITION, V104, P591, DOI 10.1016/j.cognition.2006.05.015; Berent I, 2012, LINGUIST INQ, V43, P97, DOI 10.1162/LING_a_00075; Biran M, 2005, LANG COGN PROC, V20; Buchwald AB, 2007, LANG COGNITIVE PROC, V22, P910, DOI 10.1080/01690960701273532; Caplan D, 2012, BRAIN LANG, V120, P174, DOI 10.1016/j.bandl.2010.08.002; CHOMSKY N, 1965, J LINGUIST, V1, P97, DOI 10.1017/S0022226700001134; Chomsky N, 1980, RULES REPRESENTATION; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; Clements G.N., 1990, PAPERS LAB PHONOLOGY, P283, DOI [10.1017/CBO9780511627736.017, DOI 10.1017/CBO9780511627736.017]; Coady JA, 2008, INT J LANG COMM DIS, V43, P1, DOI 10.1080/13682820601116485; COSLETT HB, 1987, BRAIN LANG, V32, P362, DOI 10.1016/0093-934X(87)90133-7; Daland R, 2011, PHONOLOGY, V28, P197, DOI 10.1017/S0952675711000145; Davidson L., 2007, PHONOLOGY, V24, P261, DOI [10.1017/S0952675707001200, DOI 10.1017/S0952675707001200]; de Lacy P, 2013, NAT LANG LINGUIST TH, V31, P287, DOI 10.1007/s11049-013-9191-y; DENNETT DC, 1992, COGNITION : CONCEPTUAL AND METHODOLOGICAL ISSUES, P33, DOI 10.1037/10564-002; Dupoux E, 2001, LANG COGNITIVE PROC, V16, P491, DOI 10.1080/01690960143000191; Dupoux E, 1999, J EXP PSYCHOL HUMAN, V25, P1568, DOI 10.1037/0096-1523.25.6.1568; Edwards J, 2004, J SPEECH LANG HEAR R, V47, P421, DOI 10.1044/1092-4388(2004/034); Ellis NickC., 2002, STUD SECOND LANG ACQ, V24, P143, DOI [10.1017/S0272263102002024, DOI 10.1017/S0272263102002024]; Estes KG, 2011, INFANCY, V16, P180, DOI 10.1111/j.1532-7078.2010.00046.x; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Fitch WT, 2012, PHILOS T R SOC B, V367, P1933, DOI 10.1098/rstb.2012.0103; FODOR JA, 1988, COGNITION, V28, P3, DOI 10.1016/0010-0277(88)90031-5; Frisch SA, 2000, J MEM LANG, V42, P481, DOI 10.1006/jmla.1999.2692; GANONG WF, 1980, J EXP PSYCHOL HUMAN, V6, P110, DOI 10.1037/0096-1523.6.1.110; Goldrick M, 2009, PHONOLOGY, V26, P147, DOI 10.1017/S0952675709001742; Goodglass H, 1997, CLIN NEUROSCI, V4, P51; Gow DW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00506; Gow DW, 2012, BRAIN LANG, V121, P273, DOI 10.1016/j.bandl.2012.03.005; Gow DW, 2009, COGNITION, V110, P222, DOI 10.1016/j.cognition.2008.11.011; Gow DW, 2008, NEUROIMAGE, V43, P614, DOI 10.1016/j.neuroimage.2008.07.027; Gow DW, 2002, ROLE FEATURE PARSING, P55; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Graves WW, 2007, J COGNITIVE NEUROSCI, V19, P617, DOI 10.1162/jocn.2007.19.4.617; Grodzinsky Y, 2006, CURR OPIN NEUROBIOL, V16, P240, DOI 10.1016/j.conb.2006.03.007; Hammond Michael, 1999, PHONOLOGY ENGLISH PR; Hannagan T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00563; Hay J., 2004, PHONETIC INTERPRETAT, VVI, P58; Hayes B, 2008, LINGUIST INQ, V39, P379, DOI 10.1162/ling.2008.39.3.379; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Jacquemot C, 2003, J NEUROSCI, V23, P9541; Kaan E, 2002, TRENDS COGN SCI, V6, P350, DOI 10.1016/S1364-6613(02)01947-2; Kraljic T, 2008, COGNITION, V107, P54, DOI 10.1016/j.cognition.2007.07.013; Leben William, 1973, THESIS MIT CAMBRIDGE; Levin, 1985, METRICAL THEORY SYLL; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Lieberman MD, 2004, J COGNITIVE NEUROSCI, V16, P427, DOI 10.1162/089892904322926764; LINDBLOM B, 1990, NATO ADV SCI I D-BEH, V55, P403; Lovins JB, 1973, LOANWORDS PHONOLOGIC; Magnuson JS, 2003, COGNITIVE SCI, V27, P285, DOI 10.1016/S0364-0213(03)00004-1; Marcus Gary, 2003, ALGEBRAIC MIND INTEG; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; Marslen-Wilson WD, 2007, PHILOS T R SOC B, V362, P823, DOI 10.1098/rstb.2007.2091; MARSLENWILSON W, 1989, J EXP PSYCHOL HUMAN, V15, P576, DOI 10.1037/0096-1523.15.3.576; MASSARO DW, 1983, PERCEPT PSYCHOPHYS, V34, P338, DOI 10.3758/BF03203046; McCarthy J, 1979, LINGUIST INQ, V17, P207; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; McQueen JM, 2009, J MEM LANG, V61, P1, DOI 10.1016/j.jml.2009.03.002; Milde T, 2010, NEUROIMAGE, V50, P960, DOI 10.1016/j.neuroimage.2009.12.110; Monahan PJ, 2009, JAPANESE KOREAN LING, P391; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Myers EB, 2008, CEREB CORTEX, V18, P278, DOI 10.1093/cercor/bhm053; Norris D, 2000, BEHAV BRAIN SCI, V23, P299, DOI 10.1017/S0140525X00003241; Opitz B, 2003, NEUROIMAGE, V19, P1730, DOI 10.1016/S1053-8119(03)00170-8; Opitz B, 2004, J NEUROSCI, V24, P8436, DOI 10.1523/JNEUROSCI.2220-04.2004; Papoutsi M, 2011, NEUROIMAGE, V58, P656, DOI 10.1016/j.neuroimage.2011.06.036; Pierrehumbert Janet B., 2012, OXFORD HDB LAB PHONO, P173; Pitt MA, 1998, J MEM LANG, V39, P347, DOI 10.1006/jmla.1998.2571; PITT MA, 1995, COGNITIVE PSYCHOL, V29, P149, DOI 10.1006/cogp.1995.1014; Pitt MA, 1998, PERCEPT PSYCHOPHYS, V60, P941, DOI 10.3758/BF03211930; Prabhakaran R, 2006, NEUROPSYCHOLOGIA, V44, P2209, DOI 10.1016/j.neuropsychologia.2006.05.025; Prince Alan., 2004, OPTIMALITY THEORY CO; Reali F, 2009, COGNITION, V111, P317, DOI 10.1016/j.cognition.2009.02.012; Righi G, 2010, J COGNITIVE NEUROSCI, V22, P213, DOI 10.1162/jocn.2009.21200; Rossi S, 2011, J COGNITIVE NEUROSCI, V23, P1752, DOI 10.1162/jocn.2010.21547; Rugg MD, 2012, CURR OPIN NEUROBIOL; SAMUEL AG, 1981, J EXP PSYCHOL GEN, V110, P474, DOI 10.1037/0096-3445.110.4.474; Samuel AG, 2003, J MEM LANG, V48, P416, DOI 10.1016/S0749-596X(02)00514-4; Samuel AG, 2001, PSYCHOL SCI, V12, P348, DOI 10.1111/1467-9280.00364; Selkirk Elisabeth, 1984, LANGUAGE SOUND STRUC, P107; Steriade D, 2009, CURR STUD LINGUIST, V47, P151; Strange BA, 2001, CEREB CORTEX, V11, P1040, DOI 10.1093/cercor/11.11.1040; Thompson-Schill SL, 2005, CURR OPIN NEUROBIOL, V15, P219, DOI 10.1016/j.conb.2005.03.006; Tyler LK, 2005, NEUROPSYCHOLOGIA, V43, P1963, DOI 10.1016/j.neuropsychologia.2005.03.008; Tyler LK, 2008, PHILOS T R SOC B, V363, P1037, DOI 10.1098/rstb.2007.2158; Tyler LK, 2011, BRAIN, V134, P415, DOI 10.1093/brain/awq369; Vance T., 1987, INTRO JAPANESE PHONO; Vitevitch MS, 2005, J MEM LANG, V52, P193, DOI 10.1016/j.jml.2004.10.003; Wagner M, 2012, BRAIN LANG, V123, P30, DOI 10.1016/j.bandl.2012.06.002; WARREN RM, 1970, SCIENCE, V167, P392, DOI 10.1126/science.167.3917.392; WITTER M, 2002, PARAHIPPOCAMPAL REGI; Wright Richard, 2004, PHONETICALLY BASED P, P34, DOI DOI 10.1017/CBO9780511486401.002	100	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86212	10.1371/journal.pone.0086212	http://dx.doi.org/10.1371/journal.pone.0086212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	297GT	24465965	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500207
J	Okusaga, O; Muravitskaja, O; Fuchs, D; Ashraf, A; Hinman, S; Giegling, I; Hartmann, AM; Konte, B; Friedl, M; Schiffman, J; Hong, E; Reeves, G; Groer, M; Dantzer, R; Rujescu, D; Postolache, TT				Okusaga, Olaoluwa; Muravitskaja, Olesja; Fuchs, Dietmar; Ashraf, Ayesha; Hinman, Sarah; Giegling, Ina; Hartmann, Annette M.; Konte, Bettina; Friedl, Marion; Schiffman, Jason; Hong, Elliot; Reeves, Gloria; Groer, Maureen; Dantzer, Robert; Rujescu, Dan; Postolache, Teodor T.			Elevated Levels of Plasma Phenylalanine in Schizophrenia: A Guanosine Triphosphate Cyclohydrolase-1 Metabolic Pathway Abnormality?	PLOS ONE			English	Article							NEUTRAL AMINO-ACIDS; SERUM PHENYLALANINE; HEALTHY-SUBJECTS; TYROSINE; TETRAHYDROBIOPTERIN; PHENYLKETONURIA; BIOPTERIN; PATHOPHYSIOLOGY; PEROXYNITRITE; ACTIVATION	Background: Phenylalanine and tyrosine are precursor amino acids required for the synthesis of dopamine, the main neurotransmitter implicated in the neurobiology of schizophrenia. Inflammation, increasingly implicated in schizophrenia, can impair the function of the enzyme Phenylalanine hydroxylase (PAH; which catalyzes the conversion of phenylalanine to tyrosine) and thus lead to elevated phenylalanine levels and reduced tyrosine levels. This study aimed to compare phenylalanine, tyrosine, and their ratio (a proxy for PAH function) in a relatively large sample of schizophrenia patients and healthy controls. Methods: We measured non-fasting plasma phenylalanine and tyrosine in 950 schizophrenia patients and 1000 healthy controls. We carried out multivariate analyses to compare log transformed phenylalanine, tyrosine, and phenylalanine: tyrosine ratio between patients and controls. Results: Compared to controls, schizophrenia patients had higher phenylalanine (p < 0.0001) and phenylalanine: tyrosine ratio (p < 0.0001) but tyrosine did not differ between the two groups (p = 0.596). Conclusions: Elevated phenylalanine and phenylalanine: tyrosine ratio in the blood of schizophrenia patients have to be replicated in longitudinal studies. The results may relate to an abnormal PAH function in schizophrenia that could become a target for novel preventative and interventional approaches.	[Okusaga, Olaoluwa; Muravitskaja, Olesja; Ashraf, Ayesha; Hinman, Sarah; Postolache, Teodor T.] Univ Maryland, Sch Med, Mood & Anxiety Program, Baltimore, MD 21201 USA; [Okusaga, Olaoluwa] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Fuchs, Dietmar] Med Univ Innsbruck, Bioctr, Div Biol Chem, A-6020 Innsbruck, Austria; [Giegling, Ina; Hartmann, Annette M.; Konte, Bettina; Friedl, Marion; Rujescu, Dan] Univ Munich, Sect Mol & Clin Neurobiol, Munich, Germany; [Schiffman, Jason] Univ Maryland, Dept Psychol, Baltimore, MD 21201 USA; [Hong, Elliot] Univ Maryland, Sch Med, Dept Psychiat, MPRC, Baltimore, MD 21201 USA; [Reeves, Gloria] Univ Maryland, Sch Med, Div Child & Adolescent Psychiat, Baltimore, MD 21201 USA; [Reeves, Gloria; Postolache, Teodor T.] Univ Maryland, Child & Adolescent Mental Hlth Innovat Ctr, Baltimore, MD 21201 USA; [Groer, Maureen] Univ S Florida, Tampa, FL USA; [Dantzer, Robert] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Rujescu, Dan] Univ Halle Wittenberg, Dept Psychiat, D-06108 Halle, Germany; [Postolache, Teodor T.] Mental Illness Res Educ & Clin Ctr, VISN Capitol Hlth Care Network 5, Baltimore, MD USA; [Postolache, Teodor T.] VISN 19 MIRECC, Denver, CO USA	University System of Maryland; University of Maryland Baltimore; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Medical University of Innsbruck; University of Munich; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of South Florida; University of Texas System; UTMD Anderson Cancer Center; Martin Luther University Halle Wittenberg	Postolache, TT (corresponding author), Univ Maryland, Sch Med, Mood & Anxiety Program, Baltimore, MD 21201 USA.	tpostolache@psych.umaryland.edu	Hartmann, Annette/AAS-6331-2021; Konte, Bettina/AAT-1142-2021; Fuchs, Dietmar/AAL-8011-2021; Rujescu, Dan/GRS-3875-2022; Giegling, Ina/ABA-3677-2021	Konte, Bettina/0000-0001-5287-308X; Fuchs, Dietmar/0000-0003-1627-9563; Okusaga, Olaoluwa O/0000-0002-4263-9086; Postolache, Teodor/0000-0001-6056-4244; Dantzer, Robert/0000-0001-9399-6107	American Foundation for Suicide Prevention; VISN 5 Capitol Health Care Network Mental Illness Research Education and Clinical Center (MIRECC), Baltimore, MD, USA; VISN 19 MIRECC, Denver, Colorado, USA; University of Maryland Child and Adolescent Mental Health Innovations Center, Baltimore, Maryland, USA; Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston (Okusaga)	American Foundation for Suicide Prevention; VISN 5 Capitol Health Care Network Mental Illness Research Education and Clinical Center (MIRECC), Baltimore, MD, USA; VISN 19 MIRECC, Denver, Colorado, USA; University of Maryland Child and Adolescent Mental Health Innovations Center, Baltimore, Maryland, USA; Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston (Okusaga)	Financial support was provided by a Standard Research Grant (PI Postolache, coPI Rujescu) and a Distinguished Investigator Award (PI Postolache) from the American Foundation for Suicide Prevention, VISN 5 Capitol Health Care Network Mental Illness Research Education and Clinical Center (MIRECC), Baltimore, MD, USA and VISN 19 MIRECC, Denver, Colorado, USA (Postolache), University of Maryland Child and Adolescent Mental Health Innovations Center, Baltimore, Maryland, USA (Postolache), and Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston (Okusaga). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Bilder DA, 2013, MOL GENET METAB, V108, P155, DOI 10.1016/j.ymgme.2012.12.006; BJERKENSTEDT L, 1985, BRIT J PSYCHIAT, V147, P276, DOI 10.1192/bjp.147.3.276; Blau N., 2001, METABOLIC MOL BASIS, P1725; Couce ML, 2012, JIMD REP, V2, P91, DOI 10.1007/8904_2011_53; First MB, 2002, STRUCTURED CLIN INTE; Fuchs JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053005; Hoekstra R, 2001, PSYCHIAT RES, V103, P115, DOI 10.1016/S0165-1781(01)00282-7; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Kay S, 1987, SCHIZOPHR B, V1, P261, DOI DOI 10.1093/SCHBUL/13.2.261; Laursen JB, 2001, CIRCULATION, V103, P1282; LEEMING RJ, 1976, ARCH DIS CHILD, V51, P771, DOI 10.1136/adc.51.10.771; Leucht S, 2005, SCHIZOPHR RES, V79, P231, DOI 10.1016/j.schres.2005.04.008; Lopansri BK, 2006, INFECT IMMUN, V74, P3355, DOI 10.1128/IAI.02106-05; MAHER TJ, 1984, AM J CLIN NUTR, V39, P722, DOI 10.1093/ajcn/39.5.722; McTavish SFB, 2001, BRIT J PSYCHIAT, V179, P356, DOI 10.1192/bjp.179.4.356; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Milstien S, 1999, BIOCHEM BIOPH RES CO, V263, P681, DOI 10.1006/bbrc.1999.1422; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Neurauter G, 2008, CANCER LETT, V272, P141, DOI 10.1016/j.canlet.2008.07.002; Okusaga O, 2013, WORLD J BIOL PSYCHIA, V14, P509, DOI 10.3109/15622975.2012.747699; PERRY TL, 1973, NEW ENGL J MED, V289, P395, DOI 10.1056/NEJM197308232890803; Ploder M, 2008, AMINO ACIDS, V35, P303, DOI 10.1007/s00726-007-0625-x; POISNER AM, 1960, J NERV MENT DIS, V131, P74, DOI 10.1097/00005053-196007000-00009; POTKIN SG, 1983, ARCH GEN PSYCHIAT, V40, P749; RAO ML, 1990, PSYCHIAT RES, V34, P243, DOI 10.1016/0165-1781(90)90003-N; Richardson MA, 2005, NEUROPSYCHOBIOLOGY, V52, P190, DOI 10.1159/000089002; Richardson MA, 2007, NEUROCHEM RES, V32, P107, DOI 10.1007/s11064-006-9233-5; SMERALDI E, 1987, HUM GENET, V76, P138, DOI 10.1007/BF00284910; Teraishi T, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.48; van Spronsen FJ, 2009, J INHERIT METAB DIS, V32, P46, DOI 10.1007/s10545-008-0946-2; WEI J, 1995, SCHIZOPHR RES, V14, P257, DOI 10.1016/0920-9964(94)00080-R; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; WURTMAN RJ, 1968, NEW ENGL J MED, V279, P171, DOI 10.1056/NEJM196807252790401; Zangerle R, 2010, BRAIN BEHAV IMMUN, V24, P403, DOI 10.1016/j.bbi.2009.11.004; Zoller H, 2012, J INTERF CYTOK RES, V32, P216, DOI 10.1089/jir.2011.0093	36	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85945	10.1371/journal.pone.0085945	http://dx.doi.org/10.1371/journal.pone.0085945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465804	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500151
J	Pasanen, T; Koskela, S; Mero, S; Tarkka, E; Tissari, P; Vaara, M; Kirveskari, J				Pasanen, Tanja; Koskela, Suvi; Mero, Sointu; Tarkka, Eveliina; Tissari, Paivi; Vaara, Martti; Kirveskari, Juha			Rapid Molecular Characterization of Acinetobacter baumannii Clones with rep-PCR and Evaluation of Carbapenemase Genes by New Multiplex PCR in Hospital District of Helsinki and Uusimaa	PLOS ONE			English	Article							EPIDEMIOLOGY; THREAT	Multidrug-resistant Acinetobacter baumannii (MDRAB) is an increasing problem worldwide. Prevalence of carbapenem resistance in Acinetobacter spp. due to acquired carbapenemase genes is not known in Finland. The purpose of this study was to examine prevalence and clonal spread of multiresistant A. baumannii group species, and their carbapenemase genes. A total of 55 Acinetobacter isolates were evaluated with repetitive PCR (DiversiLab) to analyse clonality of isolates, in conjunction with antimicrobial susceptibility profile for ampicillin/sulbactam, colistin, imipenem, meropenem, rifampicin and tigecycline. In addition, a new real-time PCR assay, detecting most clinically important carbapenemase genes just in two multiplex reactions, was developed. The assay detects genes for KPC, VIM, IMP, GES-1/-10, OXA-48, NDM, GIM-1, SPM-1, IMI/NMC-A, SME, CMY-10, SFC-1, SIM-1, OXA-23-like, OXA-24/40-like, OXA-58 and ISAbaI-OXA-51-like junction, and allows confident detection of isolates harbouring acquired carbapenemase genes. There was a time-dependent, clonal spread of multiresistant A. baumannii strongly correlating with carbapenamase gene profile, at least in this geographically restricted study material. The new carbapenemase screening assay was able to detect all the genes correctly suggesting it might be suitable for epidemiologic screening purposes in clinical laboratories.	[Pasanen, Tanja; Koskela, Suvi; Mero, Sointu; Tarkka, Eveliina; Tissari, Paivi; Vaara, Martti; Kirveskari, Juha] Helsinki Univ Hosp, Div Clin Microbiol, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	Pasanen, T (corresponding author), Helsinki Univ Hosp, Div Clin Microbiol, Helsinki, Finland.	tanja.holma@hus.fi						Antikainen J, 2009, EUR J CLIN MICROBIOL, V28, P899, DOI 10.1007/s10096-009-0720-x; Carretto E, 2008, DIAGN MICR INFEC DIS, V60, P1, DOI [10.1016/j.diagmicrobio.2007.07.002, 10.1016/S0732-8893(07)00539-1]; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Fontana C, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-79; Grisold AJ, 2010, J INFECTION, V60, P44, DOI 10.1016/j.jinf.2009.10.045; Healy M, 2005, J CLIN MICROBIOL, V43, P199, DOI 10.1128/JCM.43.1.199-207.2005; Higgins PG, 2012, J MED MICROBIOL, V61, P137, DOI 10.1099/jmm.0.036046-0; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Higgins PG, 2012, J CLIN MICROBIOL, V15; Kaase M, 2012, J CLIN MICROBIOL, V50, P3115, DOI 10.1128/JCM.00991-12; Kempf M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031676; Kohlenberg A, 2009, J MED MICROBIOL, V58, P1499, DOI 10.1099/jmm.0.012302-0; Miriagou V, 2010, CLIN MICROBIOL INFEC, V16, P112, DOI 10.1111/j.1469-0691.2009.03116.x; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Osterblad M, 2012, J ANTIMICROB CHEMOTH, V31; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217/17460913.2.5.501; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4896, DOI 10.1128/AAC.00481-11; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Runnegar N, 2010, J CLIN MICROBIOL, V48, P4051, DOI 10.1128/JCM.01208-10; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Yan ZQ, 2010, INT J ANTIMICROB AG, V35, P269, DOI 10.1016/j.ijantimicag.2009.10.016	25	35	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85854	10.1371/journal.pone.0085854	http://dx.doi.org/10.1371/journal.pone.0085854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465749	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500132
J	Bouvaine, S; Faure, ML; Grebenok, RJ; Behmer, ST; Douglas, AE				Bouvaine, Sophie; Faure, Marie-Line; Grebenok, Robert J.; Behmer, Spencer T.; Douglas, Angela E.			A Dietary Test of Putative Deleterious Sterols for the Aphid Myzus persicae	PLOS ONE			English	Article							HOST-PLANT SUITABILITY; GENERALIST; PHYSIOLOGY; NUTRITION	The aphid Myzus persicae displays high mortality on tobacco plants bearing a transgene which results in the accumulation of the ketosteroids cholestan-3-one and cholest-4-en-3-one in the phloem sap. To test whether the ketosteroids are the basis of the plant resistance to the aphids, M. persicae were reared on chemically-defined diets with different steroid contents at 0.1-10 mu g ml(-1). Relative to sterol-free diet and dietary supplements of the two ketosteroids and two phytosterols, dietary cholesterol significantly extended aphid lifespan and increased fecundity at one or more dietary concentrations tested. Median lifespan was 50% lower on the diet supplemented with cholest-4-en-3-one than on the cholesterol-supplemented diet. Aphid feeding rate did not vary significantly across the treatments, indicative of no anti-feedant effect of any sterol/steroid. Aphids reared on diets containing equal amounts of cholesterol and cholest-4-en-3-one showed fecundity equivalent to aphids on diets containing only cholesterol. Aphids were reared on diets that reproduced the relative steroid abundance in the phloem sap of the control and modified tobacco plants, and their performance on the two diet formulations was broadly equivalent. We conclude that, at the concentrations tested, plant ketosteroids support weaker aphid performance than cholesterol, but do not cause acute toxicity to the aphids. In plants, the ketosteroids may act synergistically with plant factors absent from artificial diets but are unlikely to be solely responsible for resistance of modified tobacco plants.	[Bouvaine, Sophie; Faure, Marie-Line; Douglas, Angela E.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Douglas, Angela E.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Grebenok, Robert J.] Canisius Coll, Dept Biol, Buffalo, NY 14208 USA; [Behmer, Spencer T.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Cornell University; Cornell University; Texas A&M University System; Texas A&M University College Station	Douglas, AE (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	aes326@cornell.edu		bouvaine, sophie/0000-0002-0788-3243; Behmer, Spencer/0000-0002-5038-1046	USDA/CSREES [2009-65104-05959]	USDA/CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	Funders: USDA/CSREES Grant No. 2009-65104-05959. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, JMP; Behmer ST, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00370; Behmer ST, 2011, FUNCT ECOL, V25, P484, DOI 10.1111/j.1365-2435.2010.01810.x; Behmer ST, 1999, J INSECT PHYSIOL, V45, P339, DOI 10.1016/S0022-1910(98)00131-0; Behmer ST, 2003, ADV INSECT PHYSIOL, V31, P1, DOI 10.1016/S0065-2806(03)31001-X; Bouvaine S, 2012, J INSECT PHYSIOL, V58, P1383, DOI 10.1016/j.jinsphys.2012.07.014; Buchanan B.B., 2000, BIOCH MOL BIOL PLANT; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Heyer J, 2004, PHYTOCHEMISTRY, V65, P2967, DOI 10.1016/j.phytochem.2004.09.012; Janson EM, 2009, J CHEM ECOL, V35, P1309, DOI 10.1007/s10886-009-9713-6; Jing XF, 2013, INSECT BIOCHEM MOLEC, V43, P580, DOI 10.1016/j.ibmb.2013.03.012; Jing XF, 2012, INSECT BIOCHEM MOLEC, V42, P835, DOI 10.1016/j.ibmb.2012.07.009; Jing XF, 2012, J INSECT PHYSIOL, V58, P235, DOI 10.1016/j.jinsphys.2011.11.013; Karley AJ, 2002, J EXP BIOL, V205, P3009; PROSSER WA, 1992, J INSECT PHYSIOL, V38, P301, DOI 10.1016/0022-1910(92)90130-6; SHIGEMATSU Y, 1982, AGR BIOL CHEM TOKYO, V46, P2877, DOI 10.1080/00021369.1982.10865529; WRIGHT JP, 1985, ENTOMOL EXP APPL, V37, P9, DOI 10.1007/BF00366802; Zar J. H., 1996, BIOSTATISTICAL ANAL; ZIEGLER H, 1975, ENCYCL PLANT PHYSIOL, V1, P59	19	17	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86256	10.1371/journal.pone.0086256	http://dx.doi.org/10.1371/journal.pone.0086256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465993	Green Submitted, gold, Green Published			2022-12-25	WOS:000330240500125
J	Hoenigl, M; Wallner, C; Allerberger, F; Schmoll, F; Seeber, K; Wagner, J; Valentin, T; Zollner-Schwetz, I; Flick, H; Krause, R				Hoenigl, Martin; Wallner, Carina; Allerberger, Franz; Schmoll, Friedrich; Seeber, Katharina; Wagner, Jasmin; Valentin, Thomas; Zollner-Schwetz, Ines; Flick, Holger; Krause, Robert			Autochthonous Leptospirosis in South-East Austria, 2004-2012	PLOS ONE			English	Article							DIAGNOSTIC-TESTS; EPIDEMIOLOGY; GERMANY; TRENDS	Background: Leptospirosis is one of the world's mostly spread zoonoses causing acute fever. Over years, leptospirosis has been reported to occur rarely in Austria and Germany (annual incidence of 0.06/100,000 in Germany). Only imported cases have been on the increase. Objectives of this case-series study were to retrospectively assess epidemiologic and clinical characteristics of leptospirosis illnesses in South-East Austria, to describe risk exposures for autochthonous infections, and to compare patients with imported versus autochthonous infection. Methodology/Principal Findings: During the 9-year period between 2004 and 2012, 127 adult patients (49 females, 78 males) who tested positive by rapid point-of-care test for Leptospira-specific IgM (Leptocheck (R)) were identified through electronic hospital databases. Follow-up telephone interviews were conducted with 82 patients. A total of 114 (89.8%) of the 127 patients enrolled had acquired leptospirosis within Austria and 13 (10.2%) had potentially imported infections. Most autochthonous cases were diagnosed during the months of June and July, whereas fewest were diagnosed during the winter months. Exposure to rodents, recreational activities in woods or wet areas, gardening, cleaning of basements or huts were the most common risk exposures found in autochthonous infection. Serogroups Australis (n = 23), Sejroe (n = 22), and Icterohaemorrhagiae (n = 11) were identified most frequently by MAT testing in autochthonous infections. Patients with imported leptospirosis were significantly younger, less likely to be icteric and had significantly lower liver transaminase levels (p = 0.004) than those with autochthonous infections. Conclusions/Significance: Leptospirosis is endemic in South-East Austria. In contrast to reports from other countries we found a relatively high proportion of leptospirosis cases to be female (39% vs. similar to 10%), likely the result of differing risk exposures for South-East Austria.	[Hoenigl, Martin; Wallner, Carina; Seeber, Katharina; Wagner, Jasmin; Valentin, Thomas; Zollner-Schwetz, Ines; Krause, Robert] Med Univ Graz, Dept Med, Sect Infect Dis & Trop Med, Graz, Austria; [Hoenigl, Martin; Flick, Holger] Med Univ Graz, Dept Med, Div Pulmonol, Graz, Austria; [Allerberger, Franz; Schmoll, Friedrich] Austrian Agcy Hlth & Food Safety AGES, Vienna, Austria	Medical University of Graz; Medical University of Graz	Hoenigl, M (corresponding author), Med Univ Graz, Dept Med, Sect Infect Dis & Trop Med, Graz, Austria.	martin.hoenigl@medunigraz.at; robert.krause@medunigraz.at	Hoenigl, Martin/E-8802-2010	Hoenigl, Martin/0000-0002-1653-2824; Allerberger, Franz/0000-0002-0045-8164				Baranton G, 2006, INT J INFECT DIS, V10, P162, DOI 10.1016/j.ijid.2005.02.010; Forbes AE, 2012, QJM-INT J MED, V105, P1151, DOI 10.1093/qjmed/hcs145; Goris MGA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002290; Goris MGA, 2013, EMERG INFECT DIS, V19, P371, DOI 10.3201/eid1903.111260; Hoffmeister B, 2010, AM J TROP MED HYG, V83, P326, DOI 10.4269/ajtmh.2010.10-0040; Jansen A, 2005, EMERG INFECT DIS, V11, P1048, DOI 10.3201/eid1107.041172; Katz AR, 2011, EMERG INFECT DIS, V17, P221, DOI 10.3201/eid1702.101109; Lagi F, 2013, J TRAVEL MED, V20, P128, DOI 10.1111/j.1708-8305.2012.00669.x; Limmathurotsakul D, 2012, CLIN INFECT DIS, V55, P322, DOI 10.1093/cid/cis403; Perra A, 2002, Euro Surveill, V7, P131; Picardeau M, 2013, MED MALADIES INFECT, V43, P1, DOI 10.1016/j.medmal.2012.11.005; Poeppl W, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.25.20509; Radl C, 2011, WIEN KLIN WOCHENSCHR, V123, P751, DOI 10.1007/s00508-011-0100-2; Sejvar J, 2003, EMERG INFECT DIS, V9, P702; Spichler A, 2007, EMERG INFECT DIS, V13, P1559, DOI 10.3201/eid1310.070150; Tubiana S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001991; Vijayachari P, 2008, J BIOSCIENCES, V33, P557, DOI 10.1007/s12038-008-0074-z	17	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85974	10.1371/journal.pone.0085974	http://dx.doi.org/10.1371/journal.pone.0085974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465820	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500095
J	Yamashita, T; Suplido, SA; Ladines-Llave, C; Tanaka, Y; Senba, N; Matsuo, H				Yamashita, Tadashi; Ann Suplido, Sherri; Ladines-Llave, Cecilia; Tanaka, Yuko; Senba, Naomi; Matsuo, Hiroya			A Cross-Sectional Analytic Study of Postpartum Health Care Service Utilization in the Philippines	PLOS ONE			English	Article							POSTNATAL CARE; INCENTIVES; SURVIVAL; COVERAGE	Background: The maternal mortality ratio in the Philippines remains high; thus, it will be difficult to achieve the Millennium Development Goals 5 by 2015. Approximately two-thirds of all maternal deaths occur during the postpartum period. Therefore, we conducted the present study to examine the current state of postpartum health care service utilization in the Philippines, and identify challenges to accessing postpartum care. Methods: A questionnaire and knowledge test were distributed to postpartum women in the Philippines. The questionnaire collected demographical characteristics and information about their utilization of health care services during pregnancy and the postpartum period. The knowledge test consisted of 11 questions regarding 6 topics related to possible physical and mental symptoms after delivery. Sixty-four questionnaires and knowledge tests were analyzed. Results: The mean time of first postpartum health care visit was 5.1+/-5.2 days after delivery. Postpartum utilization of health care services was significantly correlated with delivery location (p<0.01). Women who delivered at home had a lower rate of postpartum health care service utilization than women who delivered at medical facilities. The majority of participants scored low on the knowledge test. Conclusion: We found inadequate postpartum health care service utilization, especially for women who delivered at home. Our results also suggest that postpartum women lack knowledge about postpartum health concerns. In the Philippines, Barangay health workers may play a role in educating postpartum women regarding health care service utilization to improve their knowledge of possible concerns and their overall utilization of health care services.	[Yamashita, Tadashi] Kobe City Coll Nursing, Kobe, Hyogo, Japan; [Yamashita, Tadashi; Matsuo, Hiroya] Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Kobe, Hyogo 657, Japan; [Ann Suplido, Sherri; Ladines-Llave, Cecilia] Philippine Gen Hosp, Dept Obstet & Gynecol, Manila, Philippines; [Ladines-Llave, Cecilia] Univ Philippines, Coll Med, Manila, Philippines; [Tanaka, Yuko] Seisen Univ, Dept Nursing, Hikone, Japan; [Senba, Naomi] Kobe Univ, Grad Sch Hlth Sci, Dept Matern Nursing, Kobe, Hyogo 657, Japan	Kobe University; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; Kobe University	Yamashita, T (corresponding author), Kobe City Coll Nursing, Kobe, Hyogo, Japan.	tadashi_y_kobe@yahoo.co.jp		YAMASHITA, TADASHI/0000-0001-5254-0082	Japanese Ministry of Education [24792581]; Grants-in-Aid for Scientific Research [23593299] Funding Source: KAKEN	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research no. 24792581 from the Japanese Ministry of Education(website; http://www.jsps.go.jp/english/e-grants/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; [Anonymous], 1999, Birth, V26, P255; Asia Pacific Observatory on Health Systems and Policies, 2011, PHIL HLTH SYST REV; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065772; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Chakraborty N, 2002, HEALTH SOC CARE COMM, V10, P492, DOI 10.1046/j.1365-2524.2002.00389.x; Ekirapa-Kiracho E, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S1-S11; Elo I T, 1992, Health Transit Rev, V2, P49; Health Philippines Department of Health, 2004, BAS EM OBST CAR TRAI; Kozhimannil KB, 2009, HEALTH POLICY, V92, P55, DOI 10.1016/j.healthpol.2009.02.009; Langlois EV, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-55; Morris SS, 2004, LANCET, V364, P2030, DOI 10.1016/S0140-6736(04)17515-6; National Statistical Coodination Board, 2009, NSCB REL 2009 PHIL S; National Statistics Office Manila Philippines, 2008, PHIL 2008 NAT DEM HL; Onah HE, 2006, SOC SCI MED, V63, P1870, DOI 10.1016/j.socscimed.2006.04.019; Philippine Obstetrical and Gynecological Society, 2010, CAP ENH PROJ MIDW MA; Philippines National Statistics Office, 2010, POP ANN GROWTH RAT P; Philippines National Statistics Office, 2012, 2010 CENS POP HOUS R; Ray Alison M, 2004, J Obstet Gynaecol, V24, P5, DOI 10.1080/01443610310001620206; Republic of the Philippines Department of Health National Epidemiology Center Manila, 2009, 2009 PHIL HLTH STAT; Republic of the Philippines National Statistics Office, 2010, 2003 NAT DEM HLTH SU; Republic of the Philippines National Statistics Office, 2004, INF MORT PHIL HIGH O; Ronsmans C, 2009, B WORLD HEALTH ORGAN, V87, P416, DOI 10.2471/BLT.08.051581; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Shanna E, 2004, FACTORS AFFECTING MA; Spector JM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-43; Titaley CR, 2009, J EPIDEMIOL COMMUN H, V63, P827, DOI 10.1136/jech.2008.081604; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-61; United Nations, 2012, MILLENNIUM DEV GOALS; World Health Organization Department of Making Pregnancy Safer, 2010, WHO TECHN CONS POSTP; World Health Organization WHO, 2012, RECOMMENDATIONS PREV; Zupan J, 2005, NEW ENGL J MED, V352, P2047, DOI 10.1056/NEJMp058032	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85627	10.1371/journal.pone.0085627	http://dx.doi.org/10.1371/journal.pone.0085627			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297FH	24465626	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500062
J	Zilverstand, A; Sorger, B; Zimmermann, J; Kaas, A; Goebel, R				Zilverstand, Anna; Sorger, Bettina; Zimmermann, Jan; Kaas, Amanda; Goebel, Rainer			Windowed Correlation: A Suitable Tool for Providing Dynamic fMRI-Based Functional Connectivity Neurofeedback on Task Difficulty	PLOS ONE			English	Article							REAL-TIME FMRI; MOOD-REGULATING CIRCUIT; RESTING-STATE; PHYSIOLOGICAL NOISE; BRAIN ACTIVATION; MOTOR CORTEX; NETWORK; MODULATION; DEMAND; FUTURE	The goal of neurofeedback training is to provide participants with relevant information on their ongoing brain processes in order to enable them to change these processes in a meaningful way. Under the assumption of an intrinsic brain-behavior link, neurofeedback can be a tool to guide a participant towards a desired behavioral state, such as a healthier state in the case of patients. Current research in clinical neuroscience regarding the most robust indicators of pathological brain processes in psychiatric and neurological disorders indicates that fMRI-based functional connectivity measures may be among the most important biomarkers of disease. The present study therefore investigated the general potential of providing fMRI neurofeedback based on functional correlations, computed from short-window time course data at the level of single task periods. The ability to detect subtle changes in task performance with block-wise functional connectivity measures was evaluated based on imaging data from healthy participants performing a simple motor task, which was systematically varied along two task dimensions representing two different aspects of task difficulty. The results demonstrate that fMRI-based functional connectivity measures may provide a better indicator for an increase in overall ( motor) task difficulty than activation level-based measures. Windowed functional correlations thus seem to provide relevant and unique information regarding ongoing brain processes, which is not captured equally well by standard activation level-based neurofeedback measures. Functional connectivity markers, therefore, may indeed provide a valuable tool to enhance and monitor learning within an fMRI neurofeedback setup.	[Zilverstand, Anna; Sorger, Bettina; Zimmermann, Jan; Kaas, Amanda; Goebel, Rainer] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Goebel, Rainer] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Neuroimaging & Neuromodeling, Amsterdam, Netherlands	Maastricht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Zilverstand, A (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	anna.zilverstand@maastrichtuniversity.nl	Zilverstand, Anna/AFR-0554-2022	Zilverstand, Anna/0000-0002-4889-9700; Goebel, Rainer/0000-0003-1780-2467; Sorger, Bettina/0000-0003-1393-3144; Zimmermann, Jan/0000-0003-3345-6074; Kaas, Amanda/0000-0002-2847-8167	Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science [SSM06011]	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	The authors gratefully acknowledge the support of the BrainGain Smart Mix Programme of The Netherlands Ministry of Economic Affairs and The Netherlands Ministry of Education, Culture and Science (grant number: SSM06011). http://www.government.nl/ministries/ocw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, P1334, DOI 10.1038/sj.npp.1300725; Anand A, 2007, J NEUROPSYCH CLIN N, V19, P274, DOI 10.1176/appi.neuropsych.19.3.274; Birn RM, 2012, NEUROIMAGE, V62, P864, DOI 10.1016/j.neuroimage.2012.01.016; Birn RM, 2009, NEUROIMAGE, V47, P1092, DOI 10.1016/j.neuroimage.2009.05.030; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bullmore ET, 2012, NEUROIMAGE, V62, P1267, DOI 10.1016/j.neuroimage.2012.01.026; Coynel D, 2010, NEUROIMAGE, V49, P759, DOI 10.1016/j.neuroimage.2009.08.048; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Engstrom M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00140; Esposito F, 2003, NEUROIMAGE, V20, P2209, DOI 10.1016/j.neuroimage.2003.08.012; Fall S, 2008, BIOL CYBERN, V98, P101, DOI 10.1007/s00422-007-0198-5; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Fu CHY, 2006, NEUROIMAGE, V30, P266, DOI 10.1016/j.neuroimage.2005.09.035; Goebel R., 2010, IMAGING MED, V2, P407; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Guo CC, 2012, NEUROIMAGE, V61, P1471, DOI 10.1016/j.neuroimage.2012.03.027; Haller S, 2010, EUR RADIOL, V20, P696, DOI 10.1007/s00330-009-1595-z; Hampson M, 2004, NEUROREPORT, V15, P1315, DOI 10.1097/01.wnr.0000129997.95055.15; Hutton C, 2011, NEUROIMAGE, V57, P101, DOI 10.1016/j.neuroimage.2011.04.018; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Koush Y, 2013, NEUROIMAGE, V81, P422, DOI 10.1016/j.neuroimage.2013.05.010; Koush Y, 2012, NEUROIMAGE, V59, P478, DOI 10.1016/j.neuroimage.2011.07.076; LaConte SM, 2011, NEUROIMAGE, V56, P440, DOI 10.1016/j.neuroimage.2010.06.052; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; Ma LS, 2011, NEUROIMAGE, V58, P226, DOI 10.1016/j.neuroimage.2011.06.014; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; Nagel IE, 2011, J COGNITIVE NEUROSCI, V23, P2030, DOI 10.1162/jocn.2010.21560; Newton AT, 2007, HUM BRAIN MAPP, V28, P663, DOI 10.1002/hbm.20294; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; Posse S, 2001, HUM BRAIN MAPP, V12, P25, DOI 10.1002/1097-0193(200101)12:1<25::AID-HBM30>3.0.CO;2-H; Posse S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00479; Poston KL, 2012, NEUROIMAGE, V62, P2261, DOI 10.1016/j.neuroimage.2011.12.021; Rao SM, 1996, J CEREBR BLOOD F MET, V16, P1250, DOI 10.1097/00004647-199611000-00020; Riecker A, 2003, NEUROIMAGE, V18, P731, DOI 10.1016/S1053-8119(03)00003-X; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Rogers BP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003708; Rubia K, 2009, NEUROPHARMACOLOGY, V57, P640, DOI 10.1016/j.neuropharm.2009.08.013; Ruiz Sergio, 2013, Front Psychiatry, V4, P17, DOI 10.3389/fpsyt.2013.00017; Sitaram Ranganatha, 2007, Comput Intell Neurosci, P25487, DOI 10.1155/2007/25487; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sorger B, 2012, CURR BIOL, V22, P1333, DOI 10.1016/j.cub.2012.05.022; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Subramanian L, 2011, J NEUROSCI, V31, P16309, DOI 10.1523/JNEUROSCI.3498-11.2011; Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033; Sun FT, 2007, CEREB CORTEX, V17, P1227, DOI 10.1093/cercor/bhl033; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Talairach G, 1988, COPLANAR STEREOTAXIC; Weiskopf N, 2004, J PHYSIOL-PARIS, V98, P357, DOI 10.1016/j.jphysparis.2005.09.019; Weiskopf N., 2011, NEUROIMAGE; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Yoo K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00049; Zaitsev M, 2006, NEUROIMAGE, V31, P1038, DOI 10.1016/j.neuroimage.2006.01.039	62	37	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85929	10.1371/journal.pone.0085929	http://dx.doi.org/10.1371/journal.pone.0085929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465794	Green Published, gold			2022-12-25	WOS:000330240500090
J	Choi, YJ; Li, H; Son, MY; Wang, XH; Fornsaglio, JL; Sobol, RW; Lee, M; Vijg, J; Imholz, S; Dolle, MET; van Steeg, H; Reiling, E; Hasty, P				Choi, Yong Jun; Li, Han; Son, Mi Young; Wang, Xiao-hong; Fornsaglio, Jamie L.; Sobol, Robert W.; Lee, Moonsook; Vijg, Jan; Imholz, Sandra; Dolle, Martijn E. T.; van Steeg, Harry; Reiling, Erwin; Hasty, Paul			Deletion of Individual Ku Subunits in Mice Causes an NHEJ-Independent Phenotype Potentially by Altering Apurinic/Apyrimidinic Site Repair	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DNA-POLYMERASE BETA; POLY(ADP-RIBOSE) POLYMERASE; V(D)J RECOMBINATION; DEFICIENT; DAMAGE; XRCC1; PROTEINS; CELLS; INTERACTS	Ku70 and Ku80 form a heterodimer called Ku that forms a holoenzyme with DNA dependent-protein kinase catalytic subunit (DNA-PKCS) to repair DNA double strand breaks (DSBs) through the nonhomologous end joining (NHEJ) pathway. As expected mutating these genes in mice caused a similar DSB repair-defective phenotype. However, ku70(-/-) cells and ku80(-/-) cells also appeared to have a defect in base excision repair (BER). BER corrects base lesions, apurinic/apyrimidinic (AP) sites and single stand breaks (SSBs) utilizing a variety of proteins including glycosylases, AP endonuclease 1 (APE1) and DNA Polymerase beta (Pol beta). In addition, deleting Ku70 was not equivalent to deleting Ku80 in cells and mice. Therefore, we hypothesized that free Ku70 (not bound to Ku80) and/or free Ku80 (not bound to Ku70) possessed activity that influenced BER. To further test this hypothesis we performed two general sets of experiments. The first set showed that deleting either Ku70 or Ku80 caused an NHEJ-independent defect. We found ku80(-/-) mice had a shorter life span than dna-pkcs(-/-) mice demonstrating a phenotype that was greater than deleting the holoenzyme. We also found Ku70-deletion induced a p53 response that reduced the level of small mutations in the brain suggesting defective BER. We further confirmed that Ku80-deletion impaired BER via a mechanism that was not epistatic to Pol beta. The second set of experiments showed that free Ku70 and free Ku80 could influence BER. We observed that deletion of either Ku70 or Ku80, but not both, increased sensitivity of cells to CRT0044876 (CRT), an agent that interferes with APE1. In addition, free Ku70 and free Ku80 bound to AP sites and in the case of Ku70 inhibited APE1 activity. These observations support a novel role for free Ku70 and free Ku80 in altering BER.	[Choi, Yong Jun; Li, Han; Son, Mi Young; Hasty, Paul] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Wang, Xiao-hong; Fornsaglio, Jamie L.; Sobol, Robert W.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Sobol, Robert W.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA USA; [Sobol, Robert W.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Lee, Moonsook; Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Imholz, Sandra; Dolle, Martijn E. T.; van Steeg, Harry; Reiling, Erwin] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands; [Reiling, Erwin] Erasmus MC, Ctr Biomed Genet, MGC Dept Cell Biol & Genet, Rotterdam, Netherlands	University of Texas System; University of Texas Health San Antonio; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yeshiva University; Albert Einstein College of Medicine; Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC	Hasty, P (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA.	hastye@uthscsa.edu	wang, xiao/HGB-7081-2022; Sobol, Robert W./E-4125-2013	wang, xiao/0000-0002-4088-3341; Sobol, Robert W./0000-0001-7385-3563; Hasty, Paul/0000-0003-3046-0131	American Cancer Society [NIH - UO1 ES11044, R01 CA76317-05A1, P01 AG17242, CA054174, RSG-05-246-01-GMC]; Susan G. Komen Breast Cancer Foundation [BCTR0403276]; NIH [GM087798, CA148629, ES019498]; Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [P30CA054174, P30CA013330, R01CA148629, R01CA076317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011044, R21ES019498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM087798, R44GM087798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH - UO1 ES11044, R01 CA76317-05A1, P01 AG17242, CA054174 to PH and by a Research Scholar grant (RSG-05-246-01-GMC) from the American Cancer Society, grants from the Susan G. Komen Breast Cancer Foundation (Grant # BCTR0403276), NIH (GM087798: CA148629: ES019498) and the Brain Tumor Foundation to RWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Brown KD, 2000, J BIOL CHEM, V275, P6651, DOI 10.1074/jbc.275.9.6651; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Busuttil RA, 2005, CANCER RES, V65, P11271, DOI 10.1158/0008-5472.CAN-05-2980; Busuttil RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003458; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Chao C, 2006, EMBO J, V25, P2615, DOI 10.1038/sj.emboj.7601167; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Dolle MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Espejel S, 2004, J CELL BIOL, V167, P627, DOI 10.1083/jcb.200407178; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Garcia Ana Maria, 2007, Methods Mol Biol, V371, P267; Goedecke W, 1999, NAT GENET, V23, P194, DOI 10.1038/13821; Gomez JA, 2007, BIOCHEM SOC T, V35, P797, DOI 10.1042/BST0350797; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Haracska L, 2003, GENE DEV, V17, P2777, DOI 10.1101/gad.1146103; Holcomb VB, 2008, CANCER RES, V68, P9497, DOI 10.1158/0008-5472.CAN-08-2085; Holcomb VB, 2007, MECH AGEING DEV, V128, P601, DOI 10.1016/j.mad.2007.08.006; Holmquist GP, 1998, MUTAT RES-FUND MOL M, V400, P59, DOI 10.1016/S0027-5107(98)00051-7; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Ilina ES, 2008, BBA-PROTEINS PROTEOM, V1784, P1777, DOI 10.1016/j.bbapap.2008.08.001; Ju YJ, 2006, EXP MOL MED, V38, P686, DOI 10.1038/emm.2006.81; Koike M, 2000, BIOCHEM BIOPH RES CO, V276, P1105, DOI 10.1006/bbrc.2000.3567; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Li H, 2009, ONCOGENE, V28, P1875, DOI 10.1038/onc.2009.57; Li H, 2013, MUTAT RES; Li H, 2008, MECH AGEING DEV, V129, P416, DOI 10.1016/j.mad.2008.02.002; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Lieberman J, 2010, IMMUNOL REV, V235, P93, DOI 10.1111/j.0105-2896.2010.00902.x; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Lim JW, 2008, INT J BIOCHEM CELL B, V40, P2065, DOI 10.1016/j.biocel.2008.02.015; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Marple T, 2004, MUTAT RES-FUND MOL M, V554, P253, DOI 10.1016/j.mrfmmm.2004.05.004; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Mazumder S, 2007, MOL CELL BIOL; Mutamba JT, 2011, DNA REPAIR, V10, P1282, DOI 10.1016/j.dnarep.2011.10.008; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Parsons JL, 2003, MUTAT RES-FUND MOL M, V531, P165, DOI 10.1016/j.mrfmmm.2003.05.001; Priestley A, 1998, NUCLEIC ACIDS RES, V26, P1965, DOI 10.1093/nar/26.8.1965; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Song K, 2000, FEBS LETT, V481, P81, DOI 10.1016/S0014-5793(00)01958-X; Song KY, 2001, J BIOL CHEM, V276, P8321, DOI 10.1074/jbc.M008779200; Svilar D, 2012, J VIS EXP IN PRESS; Tang JB, 2011, NEURO-ONCOLOGY, V13, P471, DOI 10.1093/neuonc/nor011; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang JS, 1998, J BIOL CHEM, V273, P842, DOI 10.1074/jbc.273.2.842; Wilson DM, 2010, CELL MOL LIFE SCI, V67, P3621, DOI 10.1007/s00018-010-0488-2; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7; Zhu PC, 2006, EMBO REP, V7, P431, DOI 10.1038/sj.embor.7400622	59	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86358	10.1371/journal.pone.0086358	http://dx.doi.org/10.1371/journal.pone.0086358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466051	Green Published, gold			2022-12-25	WOS:000330288000088
J	Damodaram, KJP; Kempraj, V; Aurade, RM; Venkataramanappa, RK; Nandagopal, B; Verghese, A; Bruce, T				Damodaram, Kamala Jayanthi Pagadala; Kempraj, Vivek; Aurade, Ravindra Mahadappa; Venkataramanappa, Ravindra Kothapalli; Nandagopal, Bakthavatsalam; Verghese, Abraham; Bruce, Toby			Oviposition Site-Selection by Bactrocera dorsalis Is Mediated through an Innate Recognition Template Tuned to gamma-Octalactone	PLOS ONE			English	Article							PHEROMONE; EVOLUTION; DIPTERA	Innate recognition templates (IRTs) in insects are developed through many years of evolution. Here we investigated olfactory cues mediating oviposition behavior in the oriental fruit fly, Bactrocera dorsalis, and their role in triggering an IRT for oviposition site recognition. Behavioral assays with electrophysiologically active compounds from a preferred host, mango, revealed that one of the volatiles tested, c-octalactone, had a powerful effect in eliciting oviposition by gravid B. dorsalis females. Electrophysiological responses were obtained and flies clearly differentiated between treated and untreated substrates over a wide range of concentrations of c-octalactone. It triggered an innate response in flies, overriding inputs from other modalities required for oviposition site evaluation. A complex blend of mango volatiles not containing c-octalactone elicited low levels of oviposition, whereas c-octalactone alone elicited more oviposition response. Naive flies with different rearing histories showed similar responses to c-octalactone. Taken together, these results indicate that oviposition site selection in B. dorsalis is mediated through an IRT tuned to c-octalactone. Our study provides empirical data on a cue underpinning innate behavior and may also find use in control operations against this invasive horticultural pest.	[Damodaram, Kamala Jayanthi Pagadala; Kempraj, Vivek; Aurade, Ravindra Mahadappa; Nandagopal, Bakthavatsalam] Indian Inst Hort Res, Div Entomol & Nematol, Natl Fellow Lab, Bangalore, Karnataka, India; [Venkataramanappa, Ravindra Kothapalli; Verghese, Abraham] Natl Bur Agr Important Insects, Dept Ecol, Bangalore, Karnataka, India; [Bruce, Toby] Rothamsted Res, Biol Chem & Crop Protect, Harpenden, Herts, England	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Horticultural Research; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Agricultural Insect Resources; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Damodaram, KJP (corresponding author), Indian Inst Hort Res, Div Entomol & Nematol, Natl Fellow Lab, Bangalore, Karnataka, India.	jaiinsect@gmail.com	parepally, saravan kumar/AAH-7186-2019; Bruce, Toby JA/H-3131-2011	Bruce, Toby JA/0000-0002-9912-0605; Kempraj, Vivek/0000-0002-6151-8618	Indian Council for Agricultural Research's [ICAR]; BBSRC [BBS/E/C/00005194] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194] Funding Source: researchfish	Indian Council for Agricultural Research's [ICAR]; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Indian Council for Agricultural Research's [ICAR] National Fellow Project awarded to PDKJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVITAL E, 1994, ANIM BEHAV, V48, P1195, DOI 10.1006/anbe.1994.1351; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; Bernays EA, 1996, ENTOMOL EXP APPL, V80, P125, DOI 10.1007/BF00194741; COURTNEY SP, 1983, OECOLOGIA, V59, P317, DOI 10.1007/BF00378856; del Campo ML, 2001, NATURE, V411, P186, DOI 10.1038/35075559; DETHIER VG, 1982, J GEN PHYSIOL, V79, P549, DOI 10.1085/jgp.79.4.549; Dukas R, 2000, P NATL ACAD SCI USA, V97, P2637, DOI 10.1073/pnas.050461497; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Hudson Robyn, 1993, Current Opinion in Neurobiology, V3, P548, DOI 10.1016/0959-4388(93)90054-3; Jaenike J, 1989, INSECT CHEM ECOLOGY, P245; Jayanthi PDK, 2012, J CHEM ECOL, V38, P361, DOI 10.1007/s10886-012-0093-y; Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106; Kishimoto Noriaki, 2005, Biocontrol Science, V10, P31; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Martelli C, 2013, J NEUROSCI, V33, P6285, DOI 10.1523/JNEUROSCI.0426-12.2013; Martin JP, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00159; Miller PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016436; Pandit SS, 2009, J SCI FOOD AGR, V89, P2071, DOI 10.1002/jsfa.3692; Paukku S, 2008, J INSECT BEHAV, V21, P505, DOI 10.1007/s10905-008-9146-z; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; Riffell JA, 2013, SCIENCE, V339, P200, DOI 10.1126/science.1225483; ROTHSCHILD M, 1977, NATURE, V266, P352, DOI 10.1038/266352a0; Schwartz NU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037910; Shelly TE, 2000, ANN ENTOMOL SOC AM, V93, P559, DOI 10.1603/0013-8746(2000)093[0559:FOFOFF]2.0.CO;2; Sherman Paul W., 1997, P69; Simone BG, 1998, THESIS DURHAM U; Spathe A, 2013, CHEM SENSES, V38, P147, DOI 10.1093/chemse/bjs089; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; TIERNEY AJ, 1986, ANIM LEARN BEHAV, V14, P339, DOI 10.3758/BF03200077; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Wertheim B, 2002, ENTOMOL EXP APPL, V103, P61, DOI 10.1023/A:1019832101537; Yuan M., 2008, J ANHUI AGR SCI, V22, P9619	33	27	26	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85764	10.1371/journal.pone.0085764	http://dx.doi.org/10.1371/journal.pone.0085764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465690	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000023
J	Korir, A; Mauti, N; Moats, P; Gurka, MJ; Mutuma, G; Metheny, C; Mwamba, PM; Oyiro, PO; Fisher, M; Ayers, LW; Rochford, R; Mwanda, WO; Remick, SC				Korir, Anne; Mauti, Nathan; Moats, Pamela; Gurka, Matthew J.; Mutuma, Geoffrey; Metheny, Christine; Mwamba, Peter M.; Oyiro, Peter O.; Fisher, Melanie; Ayers, Leona W.; Rochford, Rosemary; Mwanda, Walter O.; Remick, Scot C.			Developing Clinical Strength-of-Evidence Approach to Define HIV-Associated Malignancies for Cancer Registration in Kenya	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED PERSONS; RISK; IMMUNODEFICIENCY; CHALLENGE; MORTALITY; UGANDA; PEOPLE	Background: Sub-Saharan Africa cancer registries are beset by an increasing cancer burden further exacerbated by the AIDS epidemic where there are limited capabilities for cancer-AIDS match co-registration. We undertook a pilot study based on a "strength-of-evidence" approach using clinical data that is abstracted at the time of cancer registration for purposes of linking cancer diagnosis to AIDS diagnosis. Methods/Findings: The standard Nairobi Cancer Registry form was modified for registrars to abstract the following clinical data from medical records regarding HIV infection/AIDS in a hierarchal approach at time of cancer registration from highest-to-lowest strength-of-evidence: 1) documentation of positive HIV serology; 2) antiretroviral drug prescription; 3) CD4+ lymphocyte count; and 4) WHO HIV clinical stage or immune suppression syndrome (ISS), which is Kenyan terminology for AIDS. Between August 1 and October 31, 2011 a total of 1,200 cancer cases were registered. Of these, 171 cases (14.3%) met clinical strength-of-evidence criteria for association with HIV infection/AIDS; 69% (118 cases were tumor types with known HIV association - Kaposi's sarcoma, cervical cancer, non-Hodgkin's and Hodgkin's lymphoma, and conjunctiva carcinoma) and 31% (53) were consistent with non-AIDS defining cancers. Verifiable positive HIV serology was identified in 47 (27%) cases for an absolute seroprevalence rate of 4% among the cancer registered cases with an upper boundary of 14% among those meeting at least one of strength-of-evidence criteria. Conclusions/Significance: This pilot demonstration of a hierarchal, clinical strength-of-evidence approach for cancer-AIDS registration in Kenya establishes feasibility, is readily adaptable, pragmatic, and does not require additional resources for critically under staffed cancer registries. Cancer is an emerging public health challenge, and African nations need to develop well designed population-based studies in order to better define the impact and spectrum of malignant disease in the backdrop of HIV infection.	[Korir, Anne; Mauti, Nathan; Mutuma, Geoffrey] Nairobi Canc Registry, Kenya Med Res Inst, Nairobi, Kenya; [Moats, Pamela; Metheny, Christine] West Virginia Univ Hosp, Hlth Informat Management Canc Registry, Morgantown, WV USA; [Gurka, Matthew J.] W Virginia Univ, Dept Biostat, Sch Publ Hlth, Morgantown, WV 26506 USA; [Mwamba, Peter M.; Oyiro, Peter O.; Mwanda, Walter O.] Univ Nairobi, Coll Hlth Sci, UNITID, Nairobi, Kenya; [Mwamba, Peter M.; Oyiro, Peter O.; Mwanda, Walter O.] Kenyatta Natl Hosp, Nairobi, Kenya; [Fisher, Melanie; Remick, Scot C.] W Virginia Univ, Dept Med, Sch Med, Global Hlth Program MF, Morgantown, WV 26506 USA; [Fisher, Melanie; Remick, Scot C.] W Virginia Univ, Mary Babb Randolph Canc Ctr SCR, Sch Med, Morgantown, WV 26506 USA; [Ayers, Leona W.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Rochford, Rosemary] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA	Kenya Medical Research Institute; West Virginia University; West Virginia University; University of Nairobi; Kenyatta National Hospital; West Virginia University; West Virginia University; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Korir, A (corresponding author), Nairobi Canc Registry, Kenya Med Res Inst, Nairobi, Kenya.	annkroir@yahoo.com; sremick@hsc.wvu.edu			US Department of Health and Human Services National Institutes of Health [D43 CA153707, U54 GM104942]; NATIONAL CANCER INSTITUTE [D43CA153707, R01CA102667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	US Department of Health and Human Services National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by US Department of Health and Human Services National Institutes of Health grant nos.: D43 CA153707 and U54 GM104942. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach CJ, 2011, AIDS, V25, P691, DOI 10.1097/QAD.0b013e3283437f77; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Ferlay J, 2003, IARC CANCERBASE, V5; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; International Association of Cancer Registries (IACR), 2013, CANREG 5; International Association of Cancer Registries (IACR), 2001, CANREG 4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Lingwood RJ, 2008, NAT REV CANCER, V8, P398, DOI 10.1038/nrc2372; Mathers CD, PROJECTIONS GLOBAL M, DOI DOI 10.1371/J0URNAL.PMED.0030442.ACCESSED; Mbulaiteye SM, 2006, INT J CANCER, V118, P985, DOI 10.1002/ijc.21443; Nagaiah G, 2010, CURR OPIN ONCOL, V22, P437, DOI 10.1097/CCO.0b013e32833cfcf9; NASCOP NASCOP, 2005, GUID ANT DRUG THER K; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2003, IARC SCI PUBLICATION, V153; Parkin DM, 2010, INT J CANCER, V126, P1187, DOI 10.1002/ijc.24838; Remick SC, 2009, AM SOC CLIN ONCOL ED, P670; Sansom C, 2002, LANCET ONCOL, V3, P456, DOI 10.1016/S1470-2045(02)00826-4; Sasco AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008621; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Silverberg MJ, 2007, AIDS, V21, P1957, DOI 10.1097/QAD.0b013e3282ed6338; Stewart BW, 2003, WORLD CANC REPORT 20; Tyerman Z, 2012, AIDS REV, V14, P3; UNAIDS The Joint United Nations Programme on HIV/AIDS, 2009, AIDS EP UPD REG E SO; UNAIDS The Joint United Nations Programme on HIV/ AIDS, 2009, AIDS EP UPD; UNAIDS The Joint United Nations Programme on HIV/AIDS, 2009, COUNTR REP KEN; WHO, 2010, ANT THER HIV INF AD; Wikepedia, LARG CIT AFR; World Health Organization, 2009, GLOB SUMM HIV AIDS E; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2007, FUT HLTH PROJ DEATHS; World Health Organization, 2011, CANCER; Yu JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010477; Zucchetto A, 2010, CLIN INFECT DIS, V51, P1099, DOI 10.1086/656629	37	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85881	10.1371/journal.pone.0085881	http://dx.doi.org/10.1371/journal.pone.0085881			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465764	gold, Green Submitted, Green Published			2022-12-25	WOS:000330288000030
J	Pekin, BK; Wisdom, MJ; Endress, BA; Naylor, BJ; Parks, CG				Pekin, Burak K.; Wisdom, Michael J.; Endress, Bryan A.; Naylor, Bridgett J.; Parks, Catherine G.			Ungulate Browsing Maintains Shrub Diversity in the Absence of Episodic Disturbance in Seasonally-Arid Conifer Forest	PLOS ONE			English	Article							WHITE-TAILED DEER; VEGETATION DYNAMICS; HERBIVORY; MANAGEMENT; RESPONSES; IMPACT; PLANT; FIRE	Ungulates exert a strong influence on the composition and diversity of vegetation communities. However, little is known about how ungulate browsing pressure interacts with episodic disturbances such as fire and stand thinning. We assessed shrub responses to variable browsing pressure by cattle and elk in fuels treated (mechanical removal of fuels followed by prescribed burning) and non-fuels treated forest sites in northeastern Oregon, US. Seven treatment paddocks were established at each site; three with cattle exclusion and low, moderate and high elk browsing pressure, three with elk exclusion and low, moderate and high cattle browsing pressure, and one with both cattle and elk exclusion. The height, cover and number of stems of each shrub species were recorded at multiple plots within each paddock at the time of establishment and six years later. Changes in shrub species composition over the six year period were explored using multivariate analyses. Generalized Linear Mixed Models were used to determine the effect of browsing pressure on the change in shrub diversity and evenness. Vegetation composition in un-browsed paddocks changed more strongly and in different trajectories than in browsed paddocks at sites that were not fuels treated. In fuels treated sites, changes in composition were minimal for un-browsed paddocks. Shrub diversity and evenness decreased strongly in un-browsed paddocks relative to paddocks with low, moderate and high browsing pressure at non-fuels treated sites, but not at fuels treated sites. These results suggest that in the combined absence of fire, mechanical thinning and ungulate browsing, shrub diversity is reduced due to increased dominance by certain shrub species which are otherwise suppressed by ungulates and/or fuels removal. Accordingly, ungulate browsing, even at low intensities, can be used to suppress dominant shrub species and maintain diversity in the absence of episodic disturbance events.	[Pekin, Burak K.; Endress, Bryan A.] San Diego Zoo Global, Inst Conservat Res, Div Appl Plant Ecol, Escondido, CA 92027 USA; [Wisdom, Michael J.; Naylor, Bridgett J.; Parks, Catherine G.] US Forest Serv, Pacific NW Res Stn, USDA, La Grande, OR USA; [Endress, Bryan A.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); United States Forest Service; Oregon State University	Pekin, BK (corresponding author), San Diego Zoo Global, Inst Conservat Res, Div Appl Plant Ecol, Escondido, CA 92027 USA.	bpekin@sandiegozoo.org	Pekin, Burak K/S-1809-2017	Pekin, Burak K/0000-0002-4797-6962	United States Department of Agriculture (USDA) Forest Service Pacific Northwest Research Station, Oregon State University; San Diego Zoo's Institute for Conservation Research	United States Department of Agriculture (USDA) Forest Service Pacific Northwest Research Station, Oregon State University; San Diego Zoo's Institute for Conservation Research	Research was funded by the United States Department of Agriculture (USDA) Forest Service Pacific Northwest Research Station, Oregon State University, and San Diego Zoo's Institute for Conservation Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarrestad PA, 2011, J ARID ENVIRON, V75, P290, DOI 10.1016/j.jaridenv.2010.10.009; Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; Bakker JD, 2007, ECOLOGY, V88, P2305, DOI 10.1890/06-1775.1; Bull E.L., 2005, PNWRP564; Cook JG, 2004, WILDLIFE MONOGR, P1; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Endress BA, 2012, FOREST ECOL MANAG, V276, P33, DOI 10.1016/j.foreco.2012.03.019; Findholt SL, 2004, T N AM WILDL NAT RES, V69, P670; Franklin J.F., 1973, PNWGTR8; Group PC, 2012, US AV MONTH ANN CUM; Herbel C.H., 1998, RANGE MANAGEMENT PRI; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Hobbs NT, 1996, ECOL APPL, V6, P200, DOI 10.2307/2269564; Horsley SB, 2003, ECOL APPL, V13, P98, DOI 10.1890/1051-0761(2003)013[0098:WTDIOT]2.0.CO;2; Huntsinger L, 2010, PASTORALISM, V1, P1, DOI [10.3362/2041-7136.2010.002, DOI 10.3362/2041-7136.2010.002]; Kerns BK, 2011, ECOSPHERE, V2; Manier DJ, 2006, OECOLOGIA, V146, P641, DOI 10.1007/s00442-005-0065-9; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pekin BK, 2012, J VEG SCI, V23, P745, DOI 10.1111/j.1654-1103.2012.01386.x; Pekin BK, 2012, AUSTRAL ECOL, V37, P330, DOI 10.1111/j.1442-9993.2011.02280.x; Pekin BK, 2009, FOREST ECOL MANAG, V258, P2136, DOI 10.1016/j.foreco.2009.08.013; Peterson DW, 2001, ECOL APPL, V11, P914, DOI 10.1890/1051-0761(2001)011[0914:PFIOSF]2.0.CO;2; R Development Core Team, 2009, R FDN STAT COMP; Rambo JL, 1999, CONSERV BIOL, V13, P1047, DOI 10.1046/j.1523-1739.1999.98504.x; Randall JA, 2011, FOREST ECOL MANAG, V261, P408, DOI 10.1016/j.foreco.2010.10.026; Reimoser F, 1996, FOREST ECOL MANAG, V88, P107, DOI 10.1016/S0378-1127(96)03816-9; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Rowland M.M., 1997, PNWGTR396; Rowland MM, 1998, PNWGTR430; Royo AA, 2010, ECOLOGY, V91, P93, DOI 10.1890/08-1680.1; Russell-Smith J, 1998, J APPL ECOL, V35, P829, DOI 10.1111/j.1365-2664.1998.tb00002.x; SCHALL R, 1991, BIOMETRIKA, V78, P719; Suzuki M, 2008, ECOL RES, V23, P151, DOI 10.1007/s11284-007-0348-1; Tremblay JP, 2007, J APPL ECOL, V44, P552, DOI 10.1111/j.1365-2664.2007.01290.x; Tremblay JP, 2006, OECOLOGIA, V150, P78, DOI 10.1007/s00442-006-0504-2; Vavra M, 2004, TRANS N AM WILDL NAT, V69, P785; Vavra M, 2007, LANDSCAPE URBAN PLAN, V80, P212, DOI 10.1016/j.landurbplan.2006.10.005; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wisdom MJ, 2006, WILDLIFE SOC B, V34, P283, DOI 10.2193/0091-7648(2006)34[283:UUHDEO]2.0.CO;2; Wisdom MJ, 2005, STARKEY PROJECT SYNT; Wright BR, 2007, INT J WILDLAND FIRE, V16, P317, DOI 10.1071/WF06094	43	14	16	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86288	10.1371/journal.pone.0086288	http://dx.doi.org/10.1371/journal.pone.0086288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466006	Green Published, gold			2022-12-25	WOS:000330288000078
J	Sakan, H; Nakatani, K; Asai, O; Imura, A; Tanaka, T; Yoshimoto, S; Iwamoto, N; Kurumatani, N; Iwano, M; Nabeshima, Y; Konishi, N; Saito, Y				Sakan, Hirokazu; Nakatani, Kimihiko; Asai, Osamu; Imura, Akihiro; Tanaka, Tomohiro; Yoshimoto, Shuhei; Iwamoto, Noriyuki; Kurumatani, Norio; Iwano, Masayuki; Nabeshima, Yo-ichi; Konishi, Noboru; Saito, Yoshihiko			Reduced Renal alpha-Klotho Expression in CKD Patients and Its Effect on Renal Phosphate Handling and Vitamin D Metabolism	PLOS ONE			English	Article							TRANSCRIPTS ENCODING MEMBRANE; CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR 23; PROTEIN; GENE; FIBROBLAST-GROWTH-FACTOR-23; MICE; HOMEOSTASIS; MORTALITY; CLEAVAGE	Renal alpha-Klotho (alpha-KL) plays a fundamental role as a co-receptor for fibroblast growth factor 23 (FGF23), a phosphaturic hormone and regulator of 1,25(OH)(2) vitamin D-3 (1,25VitD(3)). Disruption of FGF23-alpha-KL signaling is thought to be an early hallmark of chronic kidney disease (CKD) involving reduced renal alpha-KL expression and a reciprocal rise in serum FGF23. It remains unclear, however, whether the rise in FGF23 is related to the loss of renal alpha-KL. We evaluated alpha-KL expression in renal biopsy samples and measured levels of several parameters of mineral metabolism, as well as soluble alpha-KL (sKL), in serum and urinary samples from CKD patients (n = 236). We found that although renal alpha-KL levels were significantly reduced and serum FGF23 levels were significantly elevated in early and intermediate CKD, serum phosphate levels remained within the normal range. Multiple regression analysis showed that the increases in FGF23 were significantly associated with reduced renal function and elevated serum phosphate, but were not associated with loss of renal alpha-KL. Moreover, despite falling renal alpha-KL levels, the increase in FGF23 enhanced urinary fractional excretion of phosphate and reduced serum 1,25VitD(3) levels in early and intermediate CKD, though not in advanced CKD. Serum sKL levels also fell significantly over the course of CKD, and renal alpha-KL was a significant independent determinant of sKL. These results demonstrate that FGF23 levels rise to compensate for renal failure-related phosphate retention in early and intermediate CKD. This enables FGF23-alpha-KL signaling and a neutral phosphate balance to be maintained despite the reduction in alpha-KL. In advanced CKD, however, renal alpha-KL declines further. This disrupts FGF23 signaling, and serum phosphate levels significantly increase, stimulating greater FGF23 secretion. Our results also suggest the serum sKL concentration may be a useful marker of renal alpha-KL expression levels.	[Sakan, Hirokazu; Nakatani, Kimihiko; Asai, Osamu; Yoshimoto, Shuhei; Iwano, Masayuki; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 634, Japan; [Nakatani, Kimihiko; Konishi, Noboru] Nara Med Univ, Dept Pathol, Kashihara, Nara 634, Japan; [Imura, Akihiro; Tanaka, Tomohiro; Nabeshima, Yo-ichi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Iwamoto, Noriyuki] Tojinkai Hosp, Dept Urol, Kyoto, Japan; [Kurumatani, Norio] Nara Med Univ, Dept Community Hlth, Kashihara, Nara 634, Japan; [Kurumatani, Norio] Nara Med Univ, Dept Epidemiol, Kashihara, Nara 634, Japan; [Iwano, Masayuki] Univ Fukui, Fac Med Sci, Dept Gen Med, Div Nephrol, Fukui, Japan; [Saito, Yoshihiko] Nara Med Univ, Dept Regulatory Med Blood Pressure, Kashihara, Nara 634, Japan	Nara Medical University; Nara Medical University; Kyoto University; Nara Medical University; Nara Medical University; University of Fukui; Nara Medical University	Nakatani, K (corresponding author), Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 634, Japan.	nkimihik@naramed-u.ac.jp	Schwarz, Norbert/B-3591-2008	Schwarz, Norbert/0000-0002-8868-7067	Ministry of Education and Science of Japan; Kidney Foundation of Japan [JKFB12-42]; Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [24659415] Funding Source: KAKEN	Ministry of Education and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kidney Foundation of Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a research grant from the Ministry of Education and Science of Japan, by a grant from The Kidney Foundation of Japan (JKFB12-42), and by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Intractable Disease, and Diabetic Nephropathy and Nephrosclerosis Research from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai O, 2012, KIDNEY INT, V81, P539, DOI 10.1038/ki.2011.423; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Gattineni J, 2011, AM J PHYSIOL-RENAL, V301, pF371, DOI 10.1152/ajprenal.00740.2010; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Nakatani K, 2004, KIDNEY INT, V65, P1290, DOI 10.1111/j.1523-1755.2004.00537.x; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Seiler S, 2010, NEPHROL DIAL TRANSPL, V25, P3983, DOI 10.1093/ndt/gfq309; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shimamura Y, 2012, CLIN EXP NEPHROL, V16, P722, DOI 10.1007/s10157-012-0621-7; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Takeshita K, 2004, CIRCULATION, V109, P1776, DOI 10.1161/01.CIR.0000124224.48962.32; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110; Yoshimoto S, 2007, AM J KIDNEY DIS, V50, P47, DOI 10.1053/j.ajkd.2007.04.012	27	96	104	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86301	10.1371/journal.pone.0086301	http://dx.doi.org/10.1371/journal.pone.0086301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466013	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000081
J	Caldovic, L; Haskins, N; Mumo, A; Majumdar, H; Pinter, M; Tuchman, M; Krufka, A				Caldovic, Ljubica; Haskins, Nantaporn; Mumo, Amy; Majumdar, Himani; Pinter, Mary; Tuchman, Mendel; Krufka, Alison			Expression Pattern and Biochemical Properties of Zebrafish N-Acetylglutamate Synthase	PLOS ONE			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; ORNITHINE-UREA CYCLE; ACETYL-L-GLUTAMATE; STINGRAY HIMANTURA-SIGNIFER; BREATHING WALKING CATFISH; TROUT ONCORHYNCHUS-MYKISS; EARLY-LIFE STAGES; FREE AMINO-ACIDS; FRESH-WATER; NITROGEN-METABOLISM	The urea cycle converts ammonia, a waste product of protein catabolism, into urea. Because fish dispose ammonia directly into water, the role of the urea cycle in fish remains unknown. Six enzymes, N-acetylglutamate synthase (NAGS), carbamylphosphate synthetase III, ornithine transcarbamylase, argininosuccinate synthase, argininosuccinate lyase and arginase 1, and two membrane transporters, ornithine transporter and aralar, comprise the urea cycle. The genes for all six enzymes and both transporters are present in the zebrafish genome. NAGS (EC 2.3.1.1) catalyzes the formation of N-acetylglutamate from glutamate and acetyl coenzyme A and in zebrafish is partially inhibited by L-arginine. NAGS and other urea cycle genes are highly expressed during the first four days of zebrafish development. Sequence alignment of NAGS proteins from six fish species revealed three regions of sequence conservation: the mitochondrial targeting signal (MTS) at the N-terminus, followed by the variable and conserved segments. Removal of the MTS yields mature zebrafish NAGS (zfNAGS-M) while removal of the variable segment from zfNAGS-M results in conserved NAGS (zfNAGS-C). Both zfNAGS-M and zfNAGS-C are tetramers in the absence of L-arginine; addition of L-arginine decreased partition coefficients of both proteins. The zfNAGS-C unfolds over a broader temperature range and has higher specific activity than zfNAGS-M. In the presence of L-arginine the apparent V-max of zfNAGS-M and zfNAGS-C decreased, their K-m(app) for acetyl coenzyme A increased while the K-m(app) for glutamate remained unchanged. The expression pattern of NAGS and other urea cycle genes in developing zebrafish suggests that they may have a role in citrulline and/or arginine biosynthesis during the first day of development and in ammonia detoxification thereafter. Biophysical and biochemical properties of zebrafish NAGS suggest that the variable segment may stabilize a tetrameric state of zfNAGS-M and that under physiological conditions zebrafish NAGS catalyzes formation of N-acetylglutamate at the maximal rate.	[Caldovic, Ljubica; Haskins, Nantaporn; Majumdar, Himani; Tuchman, Mendel] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Caldovic, Ljubica] George Washington Univ, Dept Integrat Syst Biol, Washington, DC USA; [Haskins, Nantaporn] Univ Maryland, Mol & Cellular Biol Program, College Pk, MD 20742 USA; [Mumo, Amy] Amer Soc Radiat Oncol, Fairfax, VA USA; [Pinter, Mary; Krufka, Alison] Rowan Univ, Dept Biol Sci, Glassboro, NJ USA	Children's National Health System; George Washington University; University System of Maryland; University of Maryland College Park; Rowan University	Caldovic, L (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	lcaldovic@cnmcresearch.org		Krufka, Alison/0000-0002-8921-6291	Public Health Service from the National Institutes of Health [R01DK064913]; Rowan University non-salary; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD061221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064913] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health; Rowan University non-salary; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service Grant R01DK064913 from the National Institutes of Health and by the Rowan University non-salary financial support grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; ANDERSON PM, 1980, SCIENCE, V208, P291, DOI 10.1126/science.6245445; ANDERSON PM, 1981, J BIOL CHEM, V256, P2228; ANDERSON PM, 1995, NITROGEN METABOLISM, P33; Atkinson B. G., 1995, NITROGEN METABOLISM, P133; BARBOSA P, 1991, J BIOL CHEM, V266, P22319; Braun MH, 2009, AM J PHYSIOL-RENAL, V296, pF994, DOI 10.1152/ajprenal.90656.2008; Brusilow S., 2001, METABOLIC MOL BASES, V8th, P1909; Brusilow S W, 1996, Adv Pediatr, V43, P127; Bucking C, 2013, J EXP ZOOL PART A, V319, P391, DOI 10.1002/jez.1802; Caldovic L, 2006, MOL GENET METAB, V87, P226, DOI 10.1016/j.ymgme.2005.10.003; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; Caldovic L, 2003, HUM GENET, V112, P364, DOI 10.1007/s00439-003-0909-5; Caldovic L, 2002, BIOCHEM BIOPH RES CO, V299, P581, DOI 10.1016/S0006-291X(02)02696-7; Caldovic L, 2007, HUM MUTAT, V28, P754, DOI 10.1002/humu.20518; Caldovic L, 2010, MOL GENET METAB, V100, pS13, DOI 10.1016/j.ymgme.2010.02.018; CARLISKY NJ, 1972, COMP BIOCHEM PHYSIOL, V41, P857, DOI 10.1016/0305-0491(72)90099-5; CASEY CA, 1983, J BIOL CHEM, V258, P8723; Chadwick TD, 1999, J EXP BIOL, V202, P2653; Chakraborty AR, 1999, BIOCHEMISTRY-US, V38, P2435, DOI 10.1021/bi982150g; Chew SF, 2006, J EXP BIOL, V209, P484, DOI 10.1242/jeb.02002; Chew SF, 2003, J EXP BIOL, V206, P3615, DOI 10.1242/jeb.00619; Chew SF, 2004, J EXP BIOL, V207, P777, DOI 10.1242/jeb.00813; CHIOU SH, 1991, BIOCHEM J, V273, P295, DOI 10.1042/bj2730295; CHIOU SH, 1994, BIOTECHNOL APPL BIOC, V19, P99; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DABROWSKI KR, 1986, COMP BIOCHEM PHYS A, V85, P639, DOI 10.1016/0300-9629(86)90272-0; de Cima S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034734; DKHAR J, 1991, BIOCHEM INT, V25, P1061; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Essex-Fraser PA, 2005, J BIOL CHEM, V280, P20268, DOI 10.1074/jbc.M412338200; FINN RN, 1995, COMP BIOCHEM PHYS A, V111, P647, DOI 10.1016/0300-9629(95)00048-C; FREEDLAND RA, 1985, FED PROC, V44, P2453; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; GOLDSTEIN L, 1971, COMP BIOCHEM PHYSIOL, V39, P415, DOI 10.1016/0305-0491(71)90186-6; GOLDSTEIN L, 1971, AM J PHYSIOL, V220, P742, DOI 10.1152/ajplegacy.1971.220.3.742; GOLDSTEIN L, 1995, NITROGEN METABOLISM, P91; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Haskins Nantaporn, 2008, BMC Biochemistry, V9, P24, DOI 10.1186/1471-2091-9-24; Hernandez C, 1999, AQUAT TOXICOL, V45, P195, DOI 10.1016/S0166-445X(98)00094-0; Horyn O, 2005, BIOCHEM J, V388, P419, DOI 10.1042/BJ20041260; Ip YK, 2003, J EXP BIOL, V206, P3625, DOI 10.1242/jeb.00612; Julsrud EA, 1998, ARCH BIOCHEM BIOPHYS, V350, P55, DOI 10.1006/abbi.1997.0511; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kharbuli ZY, 2006, COMP BIOCHEM PHYS B, V143, P44, DOI 10.1016/j.cbpb.2005.09.014; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Korte JJ, 1997, J BIOL CHEM, V272, P6270, DOI 10.1074/jbc.272.10.6270; LeMoine CMR, 2013, AM J PHYSIOL-REG I, V304, pR991, DOI 10.1152/ajpregu.00411.2012; Lindley TE, 1999, J BIOL CHEM, V274, P29858, DOI 10.1074/jbc.274.42.29858; Loong AM, 2005, J EXP ZOOL PART A, V303A, P354, DOI 10.1002/jez.a.147; MARVIL DK, 1977, J BIOL CHEM, V252, P3295; Min L, 2009, J BIOL CHEM, V284, P4873, DOI 10.1074/jbc.M805348200; Monzani PS, 2008, FISH PHYSIOL BIOCHEM, V34, P139, DOI 10.1007/s10695-007-9154-5; Morizono H, 2004, MOL GENET METAB, V81, pS4, DOI 10.1016/j.ymgme.2003.10.017; Nakada T, 2007, AM J PHYSIOL-REG I, V293, pR1743, DOI 10.1152/ajpregu.00248.2007; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Piatigorsky J, 1996, BBA-PROTEIN STRUCT M, V1295, P158, DOI 10.1016/0167-4838(96)00030-1; PIATIGORSKY J, 1988, P NATL ACAD SCI USA, V85, P3479, DOI 10.1073/pnas.85.10.3479; Rauch GJ, 2003, SUBMISSION CURATION; Rombough P, 2002, J EXP BIOL, V205, P1787; Rombough P.J., 1988, P59; RONNESTAD I, 1992, MAR ECOL PROG SER, V88, P195, DOI 10.3354/meps088195; Ronnestad I, 1999, AQUACULTURE, V177, P201, DOI 10.1016/S0044-8486(99)00082-4; RONNESTAD I, 1992, MAR BIOL, V114, P517, DOI 10.1007/BF00357249; Saha N, 2002, COMP BIOCHEM PHYS A, V132, P353, DOI 10.1016/S1095-6433(02)00044-2; Saha N, 2001, COMP BIOCHEM PHYS A, V128, P137, DOI 10.1016/S1095-6433(00)00282-8; Saha N, 1997, COMP BIOCHEM PHYS B, V116, P57, DOI 10.1016/S0305-0491(96)00193-9; Saheki T, 2002, METAB BRAIN DIS, V17, P335, DOI 10.1023/A:1021961919148; Sancho-Vaello E, 2008, FEBS LETT, V582, P1081, DOI 10.1016/j.febslet.2008.02.060; Shi D, 2008, J BIOL CHEM, V283, P7176, DOI 10.1074/jbc.M707678200; Shi DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028825; SHIGESADA K, 1978, EUR J BIOCHEM, V85, P385, DOI 10.1111/j.1432-1033.1978.tb12250.x; Shih TH, 2008, AM J PHYSIOL-CELL PH, V295, pC1625, DOI 10.1152/ajpcell.00255.2008; SIESS EA, 1976, FEBS LETT, V69, P265, DOI 10.1016/0014-5793(76)80701-6; SIESS EA, 1977, BIOCHEM J, V166, P225, DOI 10.1042/bj1660225; SMITH S, 1947, J EXP BIOL, V23, P357; STEWART PM, 1980, J BIOL CHEM, V255, P5270; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tam WL, 2003, J EXP BIOL, V206, P2931, DOI 10.1242/jeb.00510; Terjesen BF, 2000, COMP BIOCHEM PHYS B, V126, P521, DOI 10.1016/S0305-0491(00)00221-2; Thisse B, 2004, ZFIN DIRECT DATA SUB; Waterlow JC, 1999, NUTR RES REV, V12, P25, DOI 10.1079/095442299108728857; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wilkie MP, 1996, COMP BIOCHEM PHYS B, V113, P665, DOI 10.1016/0305-0491(95)02092-6; WISTOW G, 1990, P NATL ACAD SCI USA, V87, P6277, DOI 10.1073/pnas.87.16.6277; WRIGHT PA, 1995, J EXP BIOL, V198, P127; Xu Y, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-4	87	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85597	10.1371/journal.pone.0085597	http://dx.doi.org/10.1371/journal.pone.0085597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465614	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100051
J	Lau, NS; Foong, CP; Kurihara, Y; Sudesh, K; Matsui, M				Lau, Nyok-Sean; Foong, Choon Pin; Kurihara, Yukio; Sudesh, Kumar; Matsui, Minami			RNA-Seq Analysis Provides Insights for Understanding Photoautotrophic Polyhydroxyalkanoate Production in Recombinant Synechocystis Sp.	PLOS ONE			English	Article							POLY-BETA-HYDROXYBUTYRATE; ACETOACETYL-COENZYME; CARBON-SOURCES; PHOTOSYSTEM-I; CYANOBACTERIA; ACCUMULATION; YIELD; PHOTOSYNTHESIS; PROTEINS; SYNTHASE	The photosynthetic cyanobacterium, Synechocystis sp. strain 6803, is a potential platform for the production of various chemicals and biofuels. In this study, direct photosynthetic production of a biopolymer, polyhydroxyalkanoate (PHA), in genetically engineered Synechocystis sp. achieved as high as 14 wt%. This is the highest production reported in Synechocystis sp. under photoautotrophic cultivation conditions without the addition of a carbon source. The addition of acetate increased PHA accumulation to 41 wt%, and this value is comparable to the highest production obtained with cyanobacteria. Transcriptome analysis by RNA-seq coupled with real-time PCR was performed to understand the global changes in transcript levels of cells subjected to conditions suitable for photoautotrophic PHA biosynthesis. There was lower expression of most PHA synthesis-related genes in recombinant Synechocystis sp. with higher PHA accumulation suggesting that the concentration of these enzymes is not the limiting factor to achieving high PHA accumulation. In order to cope with the higher PHA production, cells may utilize enhanced photosynthesis to drive the product formation. Results from this study suggest that the total flux of carbon is the possible driving force for the biosynthesis of PHA and the polymerizing enzyme, PHA synthase, is not the only critical factor affecting PHA-synthesis. Knowledge of the regulation or control points of the biopolymer production pathways will facilitate the further use of cyanobacteria for biotechnological applications.	[Lau, Nyok-Sean; Foong, Choon Pin; Sudesh, Kumar] Univ Sains Malaysia, Sch Biol Sci, Ecobiomat Res Lab, George Town, Malaysia; [Lau, Nyok-Sean; Foong, Choon Pin; Kurihara, Yukio; Matsui, Minami] RIKEN Ctr Sustainable Resource Sci, Biomass Engn Program, Cooperat Div, Synthet Genom Res Team, Yokohama, Kanagawa, Japan	Universiti Sains Malaysia; RIKEN	Sudesh, K (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Ecobiomat Res Lab, George Town, Malaysia.	ksudesh@usm.my; minami@riken.jp	Matsui, Minami/A-5235-2016; Sudesh, Kumar/ABG-4333-2020; Kurihara, Yukio/C-9181-2017; Sudesh, Kumar/C-2942-2011; Foong, Choon Pin/C-4270-2017; Lau, Nyok-Sean/F-8826-2019; Lau, Nyok Sean/T-2702-2019	Matsui, Minami/0000-0001-5162-2668; Sudesh, Kumar/0000-0003-4756-9192; Kurihara, Yukio/0000-0002-3149-8097; Sudesh, Kumar/0000-0003-4756-9192; Foong, Choon Pin/0000-0002-7785-7702; Lau, Nyok-Sean/0000-0002-0708-5970; Lau, Nyok Sean/0000-0002-0708-5970	Biomass Engineering Program research by RIKEN; International Program Associate fellowship; Universiti Sains Malaysia Fellowship	Biomass Engineering Program research by RIKEN; International Program Associate fellowship; Universiti Sains Malaysia Fellowship(Universiti Sains Malaysia)	This research is supported by Biomass Engineering Program research by RIKEN and International Program Associate fellowship to N.-S.L. and C. P. F. organized by RIKEN. N.-S.L. is a recipient of the Universiti Sains Malaysia Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Bhubalan K, 2011, APPL ENVIRON MICROB, V77, P2926, DOI 10.1128/AEM.01997-10; Bradley RL, 1997, J BACTERIOL, V179, P4407, DOI 10.1128/jb.179.13.4407-4410.1997; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Brigham CJ, 2012, APPL ENVIRON MICROB, V78, P8033, DOI 10.1128/AEM.01693-12; CAMPBELL J, 1982, J BACTERIOL, V149, P361, DOI 10.1128/JB.149.1.361-363.1982; CAPON RJ, 1983, PHYTOCHEMISTRY, V22, P1181, DOI 10.1016/0031-9422(83)80217-9; CARR NG, 1966, BIOCHIM BIOPHYS ACTA, V120, P308, DOI 10.1016/0926-6585(66)90353-0; Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c; Covshoff S, 2012, CURR OPIN BIOTECH, V23, P209, DOI 10.1016/j.copbio.2011.12.011; Hankamer B, 2001, FEBS LETT, V504, P142, DOI 10.1016/S0014-5793(01)02766-1; Hein S, 1998, ARCH MICROBIOL, V170, P162, DOI 10.1007/s002030050629; Kalontarov M, 2013, RSC ADV, V3, P13203, DOI 10.1039/c3ra40454d; Kaneko T, 1996, DNA Res, V3, P109; Kumar K, 2011, BIORESOURCE TECHNOL, V102, P4945, DOI 10.1016/j.biortech.2011.01.054; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Miyake M, 1996, J FERMENT BIOENG, V82, P512, DOI 10.1016/S0922-338X(97)86995-4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Okamura E, 2010, P NATL ACAD SCI USA, V107, P11265, DOI 10.1073/pnas.1000532107; Osanai T, 2011, J BIOL CHEM, V286, P30962, DOI 10.1074/jbc.M111.231183; Panda B, 2007, LETT APPL MICROBIOL, V44, P194, DOI 10.1111/j.1472-765X.2006.02048.x; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; Pham TH, 2004, MICROBIOL-SGM, V150, P3405, DOI 10.1099/mic.0.27357-0; Raines CA, 2011, PLANT PHYSIOL, V155, P36, DOI 10.1104/pp.110.168559; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Raven JA, 1999, PLANT CELL ENVIRON, V22, P741, DOI 10.1046/j.1365-3040.1999.00419.x; Richards RA, 2000, J EXP BOT, V51, P447, DOI 10.1093/jexbot/51.suppl_1.447; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Satoh S, 2001, J BIOL CHEM, V276, P4293, DOI 10.1074/jbc.M008238200; Schwenkert S, 2007, PLANT PHYSIOL, V144, P1924, DOI 10.1104/pp.107.100131; Sharma L, 2005, BIORESOURCE TECHNOL, V96, P1304, DOI 10.1016/j.biortech.2004.10.009; STAL LJ, 1992, FEMS MICROBIOL LETT, V103, P169, DOI 10.1111/j.1574-6968.1992.tb05835.x; STAL LJ, 1990, NATO ADV SCI I E-APP, V186, P435; Sudesh K, 2008, CLEAN-SOIL AIR WATER, V36, P433, DOI 10.1002/clen.200700183; Taroncher-Oldenberg G, 2000, APPL ENVIRON MICROB, V66, P4440, DOI 10.1128/AEM.66.10.4440-4448.2000; Tian F, 2005, SCIENCE, V308, P1014, DOI 10.1126/science.1106983; Tsuge T, 2002, J BIOSCI BIOENG, V94, P579, DOI 10.1016/S1389-1723(02)80198-0; VINCENZINI M, 1990, J BACTERIOL, V172, P2791, DOI 10.1128/jb.172.5.2791-2792.1990; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Xu W, 2001, BBA-BIOENERGETICS, V1507, P32, DOI 10.1016/S0005-2728(01)00208-0	42	23	23	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86368	10.1371/journal.pone.0086368	http://dx.doi.org/10.1371/journal.pone.0086368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466058	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100148
J	Moiseeva, EP; Straatman, KR; Leyland, ML; Bradding, P				Moiseeva, Elena P.; Straatman, Kees R.; Leyland, Mark L.; Bradding, Peter			CADM1 Controls Actin Cytoskeleton Assembly and Regulates Extracellular Matrix Adhesion in Human Mast Cells	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; TUMOR-SUPPRESSOR; ADAPTIVE IMMUNITY; GENE-EXPRESSION; DIFFERENTIATION; MOLECULES; PROTEINS; PROLIFERATION; ASTHMA; INTERLEUKIN-4	CADM1 is a major receptor for the adhesion of mast cells (MCs) to fibroblasts, human airway smooth muscle cells (HASMCs) and neurons. It also regulates E-cadherin and alpha6beta4 integrin in other cell types. Here we investigated a role for CADM1 in MC adhesion to both cells and extracellular matrix (ECM). Downregulation of CADM1 in the human MC line HMC-1 resulted not only in reduced adhesion to HASMCs, but also reduced adhesion to their ECM. Time-course studies in the presence of EDTA to inhibit integrins demonstrated that CADM1 provided fast initial adhesion to HASMCs and assisted with slower adhesion to ECM. CADM1 downregulation, but not antibody-dependent CADM1 inhibition, reduced MC adhesion to ECM, suggesting indirect regulation of ECM adhesion. To investigate potential mechanisms, phosphotyrosine signalling and polymerisation of actin filaments, essential for integrin-mediated adhesion, were examined. Modulation of CADM1 expression positively correlated with surface KIT levels and polymerisation of cortical F-actin in HMC-1 cells. It also influenced phosphotyrosine signalling and KIT tyrosine autophosphorylation. CADM1 accounted for 46% of surface KIT levels and 31% of F-actin in HMC-1 cells. CADM1 downregulation resulted in elongation of cortical actin filaments in both HMC-1 cells and human lung MCs and increased cell rigidity of HMC-1 cells. Collectively these data suggest that CADM1 is a key adhesion receptor, which regulates MC net adhesion, both directly through CADM1-dependent adhesion, and indirectly through the regulation of other adhesion receptors. The latter is likely to occur via docking of KIT and polymerisation of cortical F-actin. Here we propose a stepwise model of adhesion with CADM1 as a driving force for net MC adhesion.	[Moiseeva, Elena P.; Bradding, Peter] Univ Leicester, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England; [Straatman, Kees R.] Univ Leicester, Ctr Core Biotechnol Serv, Leicester, Leics, England; [Leyland, Mark L.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Leicester; University of Leicester; University of Leicester	Moiseeva, EP (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England.	elena.moiseeva@sky.com		Straatman, Kornelis/0000-0002-9812-492X; Moiseeva, Elena/0000-0002-1590-1309; Bradding, Peter/0000-0001-8403-0319	Medical Research Council, United Kingdom [87834]; National Institute for Health Research Leicester Respiratory Biomedical Research Unit; MRC [G0801164] Funding Source: UKRI; Medical Research Council [G0801164] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Leicester Respiratory Biomedical Research Unit; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by project grant no. 87834 from the Medical Research Council, United Kingdom (PB and MLL) and was also supported in part by the National Institute for Health Research Leicester Respiratory Biomedical Research Unit. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the National Institute of Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Bassett JHD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002858; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Blank U, 2011, ADV EXP MED BIOL, V716, P107, DOI 10.1007/978-1-4419-9533-9_7; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bradding P, 2009, THORAX, V64, P278, DOI 10.1136/thx.2008.106427; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Byron A, 2010, CURR BIOL, V20, pR1063, DOI 10.1016/j.cub.2010.10.059; Classen CF, 2005, ANN HEMATOL, V84, P774, DOI 10.1007/s00277-005-1089-2; COLUMBO M, 1995, J IMMUNOL, V154, P6058; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Florian S, 2006, ALLERGY, V61, P1054, DOI 10.1111/j.1398-9995.2006.01171.x; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Furuno T, 2005, J IMMUNOL, V174, P6934, DOI 10.4049/jimmunol.174.11.6934; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Giangreco A, 2009, DEVELOPMENT, V136, P3505, DOI 10.1242/dev.038232; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Girodet PO, 2010, ALLERGY, V65, P1004, DOI 10.1111/j.1398-9995.2009.02308.x; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; Hasstedt SJ, 2009, BLOOD, V114, P3084, DOI 10.1182/blood-2009-05-219485; Hollins F, 2008, J IMMUNOL, V181, P2772, DOI 10.4049/jimmunol.181.4.2772; Hoy JL, 2009, MOL CELL NEUROSCI, V42, P466, DOI 10.1016/j.mcn.2009.09.010; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Ito A, 2004, BIOCHEM BIOPH RES CO, V319, P200, DOI 10.1016/j.bbrc.2004.04.172; Ito A, 2003, BLOOD, V101, P2601, DOI 10.1182/blood-2002-07-2265; Jensen BM, 2008, J PHARMACOL EXP THER, V324, P128, DOI 10.1124/jpet.107.125237; Kashiwakura J, 2004, J IMMUNOL, V173, P5247, DOI 10.4049/jimmunol.173.8.5247; Kaur D, 2006, AM J RESP CRIT CARE, V174, P1179, DOI 10.1164/rccm.200603-394OC; Kaur D, 2010, J IMMUNOL, V185, P6105, DOI 10.4049/jimmunol.1000638; Kawano S, 2009, J BIOL CHEM, V284, P23793, DOI 10.1074/jbc.M109.025155; KrugerKrasagakes S, 1996, J INVEST DERMATOL, V106, P538, DOI 10.1111/1523-1747.ep12343953; Kuipers JE, 2011, BLOOD, V117, P928, DOI 10.1182/blood-2010-05-286138; Lorentz A, 2002, BLOOD, V99, P966, DOI 10.1182/blood.V99.3.966; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Masuda M, 2010, J BIOL CHEM, V285, P15511, DOI 10.1074/jbc.M109.076653; Mizutani K, 2011, J BIOL CHEM, V286, P36667, DOI 10.1074/jbc.M110.200535; Moiseeva EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061579; Moiseeva EP, 2013, MOL IMMUNOL, V53, P345, DOI 10.1016/j.molimm.2012.08.024; Moiseeva EP, 2012, CELL MOL LIFE SCI, V69, P2751, DOI 10.1007/s00018-012-0948-y; Moiseeva EP, 2011, ADV EXP MED BIOL, V716, P235, DOI 10.1007/978-1-4419-9533-9_13; Moiseeva EP, 2000, CARDIOVASC RES, V45, P493, DOI 10.1016/S0008-6363(99)00276-X; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Nishida M, 2003, APMIS, V111, P1067, DOI 10.1111/j.1600-0463.2003.apm1111109.x; Ogita H, 2010, P JPN ACAD B-PHYS, V86, P621, DOI 10.2183/pjab.86.621; Paun A, 2012, RADIOTHER ONCOL, V105, P350, DOI 10.1016/j.radonc.2012.08.004; Sakisaka T, 2007, CURR OPIN CELL BIOL, V19, P593, DOI 10.1016/j.ceb.2007.09.007; Sakurai-Yageta M, 2009, BIOCHEM BIOPH RES CO, V390, P977, DOI 10.1016/j.bbrc.2009.10.088; Sanmugalingam D, 2000, J LEUKOCYTE BIOL, V68, P38; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Shelburne CP, 2011, ADV EXP MED BIOL, V716, P162, DOI 10.1007/978-1-4419-9533-9_10; Shimizu Y, 2002, CLIN EXP ALLERGY, V32, P872, DOI 10.1046/j.1365-2222.2002.01373.x; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; SPERR WR, 1992, ANN HEMATOL, V65, P10, DOI 10.1007/BF01715119; Stagi M, 2010, P NATL ACAD SCI USA, V107, P7568, DOI 10.1073/pnas.0911798107; Tachimoto H, 2001, J ALLERGY CLIN IMMUN, V107, P302, DOI 10.1067/mai.2001.111930; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Takeuchi K, 2003, J LEUKOCYTE BIOL, V74, P1026, DOI 10.1189/jlb.0602284; Terada N, 2010, REPRODUCTION, V139, P883, DOI 10.1530/REP-10-0005; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Toru H, 1997, BLOOD, V89, P3296, DOI 10.1182/blood.V89.9.3296; Trautmann A, 1997, ARCH DERMATOL RES, V289, P194, DOI 10.1007/s004030050180; van der Weyden L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-29; Woodman L, 2008, J IMMUNOL, V181, P5001, DOI 10.4049/jimmunol.181.7.5001; Wygrecka M, 2013, AM J PATHOL, V182, P2094, DOI 10.1016/j.ajpath.2013.02.013; Yageta M, 2002, CANCER RES, V62, P5129; Yang WD, 2006, J IMMUNOL, V176, P1238, DOI 10.4049/jimmunol.176.2.1238; Yang YX, 2006, INT J GYNECOL CANCER, V16, P1868, DOI 10.1111/j.1525-1438.2006.00656.x; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598; Zhiling Y, 2008, BIOCHEM BIOPH RES CO, V377, P926, DOI 10.1016/j.bbrc.2008.10.107	74	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85980	10.1371/journal.pone.0085980	http://dx.doi.org/10.1371/journal.pone.0085980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465823	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100092
J	Schalcher, TR; Borges, RS; Coleman, MD; Batista, J; Salgado, CG; Vieira, JLF; Romao, PRT; Oliveira, FR; Monteiro, MC				Schalcher, Taysa Ribeiro; Borges, Rosivaldo S.; Coleman, Michael D.; Batista Junior, Joao; Salgado, Claudio G.; Vieira, Jose Luiz F.; Romao, Pedro R. T.; Oliveira, Fabio R.; Monteiro, Marta Chagas			Clinical Oxidative Stress during Leprosy Multidrug Therapy: Impact of Dapsone Oxidation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SUPEROXIDE-DISMUTASE; ANTIOXIDANT CAPACITY; N-HYDROXYLATION; METABOLISM; TOXICITY; METHEMOGLOBINEMIA; CYTOCHROME-P450; GLUTATHIONE; GROWTH	This study aims to assess the oxidative stress in leprosy patients under multidrug therapy (MDT; dapsone, clofazimine and rifampicin), evaluating the nitric oxide (NO) concentration, catalase (CAT) and superoxide dismutase (SOD) activities, glutathione (GSH) levels, total antioxidant capacity, lipid peroxidation, and methemoglobin formation. For this, we analyzed 23 leprosy patients and 20 healthy individuals from the Amazon region, Brazil, aged between 20 and 45 years. Blood sampling enabled the evaluation of leprosy patients prior to starting multidrug therapy (called MDT 0) and until the third month of multidrug therapy (MDT 3). With regard to dapsone (DDS) plasma levels, we showed that there was no statistical difference in drug plasma levels between multibacillary (0.518 +/- 0.029 mu g/mL) and paucibacillary (0.662 +/- 0.123 mu g/mL) patients. The methemoglobin levels and numbers of Heinz bodies were significantly enhanced after the third MDT supervised dose, but this treatment did not significantly change the lipid peroxidation and NO levels in these leprosy patients. In addition, CAT activity was significantly reduced in MDT-treated leprosy patients, while GSH content was increased in these patients. However, SOD and Trolox equivalent antioxidant capacity levels were similar in patients with and without treatment. These data suggest that MDT can reduce the activity of some antioxidant enzyme and influence ROS accumulation, which may induce hematological changes, such as methemoglobinemia in patients with leprosy. We also explored some redox mechanisms associated with DDS and its main oxidative metabolite DDS-NHOH and we explored the possible binding of DDS to the active site of CYP2C19 with the aid of molecular modeling software.	[Schalcher, Taysa Ribeiro; Borges, Rosivaldo S.; Vieira, Jose Luiz F.; Oliveira, Fabio R.; Monteiro, Marta Chagas] Univ Fed Para UFPA, Fac Farm, Lab Microbiol & Imunol Clin UFPA, Belem, Para, Brazil; [Schalcher, Taysa Ribeiro; Borges, Rosivaldo S.; Vieira, Jose Luiz F.; Oliveira, Fabio R.; Monteiro, Marta Chagas] Univ Fed Para UFPA, Fac Farm, Programa Posgrad Ciencias Farmaceut, Belem, Para, Brazil; [Coleman, Michael D.] Aston Univ, Dept Pharmaceut Sci, Mechanisms Drug Tox Grp, Birmingham B4 7ET, W Midlands, England; [Batista Junior, Joao] SEP SUL EQ 704 904 CONJ A, Ctr Univ Dist Fed UDF, Brasilia, DF, Brazil; [Salgado, Claudio G.] Univ Fed Para UFPA, Inst Ciencias Biol, Programa Posgrad Neurociencias & Biol Celular, Belem, Para, Brazil; [Romao, Pedro R. T.] Univ Fed Ciencias Saude Porto Alegre, Programa Posgrad Ciencias Saude, Porto Alegre, RS, Brazil	Universidade Federal do Para; Universidade Federal do Para; Aston University; Centro Universitario do Distrito Federal; Universidade Federal do Para; Universidade Federal de Ciencias da Saude de Porto Alegre	Monteiro, MC (corresponding author), Univ Fed Para UFPA, Fac Farm, Lab Microbiol & Imunol Clin UFPA, Rua Augusto Correa, Belem, Para, Brazil.	martachagas2@yahoo.com.br	Borges, Rosivaldo/U-3039-2019; vieira, jose luiz/F-9032-2012; Borges, Rosivaldo RSB/K-4807-2016; Romao, Pedro R/N-4826-2015; Salgado, Claudio G/C-5206-2014; Monteiro, Marta C./F-6575-2010; Salgado, Claudio G/K-8931-2012; Coleman, Michael Damian/AAD-5503-2019; Júnior, João Batista/ABB-2303-2020	Borges, Rosivaldo/0000-0003-4072-7573; Romao, Pedro R/0000-0002-1039-2509; Salgado, Claudio G/0000-0003-3961-7764; Monteiro, Marta C./0000-0002-3328-5650; Salgado, Claudio G/0000-0003-3961-7764; Júnior, João Batista/0000-0002-8972-8131; Coleman, MIchael D/0000-0002-5510-6852	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos do Governo Federal, FAPESPA; Federal University of Para/PA; CNPq scholarship	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos do Governo Federal, FAPESPA; Federal University of Para/PA; CNPq scholarship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Financiadora de Estudos e Projetos do Governo Federal, FAPESPA and Federal University of Para/PA. PRTR and MCM were recipients of fellowships from CNPq, while CGS has a CNPq scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P317; Banerjee P, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nen090; Barnes J, 1951, LEPROSY REV, V12, P54; Imbiriba ENB, 2009, REV SAUDE PUBL, V43, P656, DOI 10.1590/S0034-89102009005000046; Beutler E., 1975, RED CELL METABOLISM, P8; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Bohm HJ, 2008, VIRTUAL SCREENING BI; Borges RS, 2013, J COMPUT THEOR NANOS, V10, P2029, DOI 10.1166/jctn.2013.3165; Carrazza MZN, 2000, REV SAUDE PUBL, V34, P396, DOI 10.1590/S0034-89102000000400013; Coleman MD, 2004, ENVIRON TOXICOL PHAR, V17, P55, DOI 10.1016/j.etap.2004.01.005; Coleman MD, 1996, DRUG SAFETY, V14, P394, DOI 10.2165/00002018-199614060-00005; COLEMAN MD, 1993, BRIT J DERMATOL, V129, P507, DOI 10.1111/j.1365-2133.1993.tb00476.x; Dalpino D., 1998, Hansenologia Internationalis, V23, P14; de Moraes NV, 2008, REV BRAS CIENC FARM, V44, P97, DOI 10.1590/S1516-93322008000100011; ELLARD GA, 1966, BRIT J PHARM CHEMOTH, V26, P212, DOI 10.1111/j.1476-5381.1966.tb01823.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Vieira JLF, 2010, BRAZ J INFECT DIS, V14, P319, DOI 10.1590/S1413-86702010000300022; FLEMING CM, 1992, MOL PHARMACOL, V41, P975; Ganesan S, 2010, J APPL TOXICOL, V30, P271, DOI 10.1002/jat.1493; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Gill HJ, 1995, BRIT J CLIN PHARMACO, V40, P531, DOI 10.1111/j.1365-2125.1995.tb05797.x; de Sousa MWG, 2012, AN BRAS DERMATOL, V87, P389, DOI 10.1590/S0365-05962012000300006; Grace Mary, 2011, Indian Dermatol Online J, V2, P88, DOI 10.4103/2229-5178.85999; Granger DL, 1999, METHOD ENZYMOL, V301, P49; Hummel MA, 2004, BIOCHEM PHARMACOL, V67, P1831, DOI 10.1016/j.bcp.2004.01.017; Jian WY, 2005, FREE RADICAL BIO MED, V39, P1162, DOI 10.1016/j.freeradbiomed.2005.06.008; Khanolkar-Young S, 1998, CLIN EXP IMMUNOL, V113, P438; Kwadijk S, 2002, BIOMED CHROMATOGR, V16, P203, DOI 10.1002/bmc.132; Mahmud R, 1997, TOXICOLOGY, V117, P1, DOI 10.1016/S0300-483X(96)03548-2; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mendes APS, 2011, J COMPUT THEOR NANOS, V8, P1428, DOI 10.1166/jctn.2011.1832; MITRA AK, 1995, CLIN PHARMACOL THER, V58, P556, DOI 10.1016/0009-9236(95)90176-0; Osadolor HB, 2008, CONTINENTAL J BIOMED, V2, P1; Patten AR, 2013, J NUTR BIOCHEM, V24, P760, DOI 10.1016/j.jnutbio.2012.04.003; Pinnell SR, 2003, J AM ACAD DERMATOL, V48, P1, DOI 10.1067/mjd.2003.16; Prasad CVB, 2007, LEPROSY REV, V78, P391; Price D, 1994, GOLDFRANKS TOXICOLOG, P1169; Queiroz R H, 1997, Pharm Acta Helv, V72, P209, DOI 10.1016/S0031-6865(97)00016-2; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; REIMER DL, 1994, GENOMICS, V21, P325, DOI 10.1006/geno.1994.1273; Reynald RL, 2012, J BIOL CHEM, V287, P44581, DOI 10.1074/jbc.M112.424895; RIMIOLLI LF, 2001, HANSENOL INT, V26, P93; Romao PRT, 2006, BRAZ J MED BIOL RES, V39, P355, DOI 10.1590/S0100-879X2006000300006; Sanches LAT, 2007, REV SOC BRAS MED TRO, V40, P541, DOI 10.1590/S0037-86822007000500010; Schalcher TR, 2013, REV SOC BRAS MED TRO, V46, P645, DOI 10.1590/0037-8682-1506-2013; Schon T, 2001, BRIT J DERMATOL, V145, P809, DOI 10.1046/j.1365-2133.2001.04491.x; SMITH RS, 1959, BMJ-BRIT MED J, V1, P625, DOI 10.1136/bmj.1.5122.625; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; Szabo A., 1989, MODERN QUANTUM CHEM; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Tingle MD, 1997, J PHARMACOL EXP THER, V283, P817; Trindade MAB, 2008, HANSEN INT, V33, P31; van den Berg R, 1999, FOOD CHEM, V66, P511, DOI 10.1016/S0308-8146(99)00089-8; Veggi LM, 2008, LIFE SCI, V83, P155, DOI 10.1016/j.lfs.2008.05.016; WHITE JC, 1959, BRIT MED BULL, V15, P33, DOI 10.1093/oxfordjournals.bmb.a069711; World Health Organization, 2012, WEEKLY EPIDEMIOLOGIC, V34, P87; WRIGHT JD, 1995, BRIT J CLIN PHARMACO, V39, P441, DOI 10.1111/j.1365-2125.1995.tb04474.x; Zoete V, 2009, J CELL MOL MED, V13, P238, DOI 10.1111/j.1582-4934.2008.00665.x; ZUIDEMA J, 1986, CLIN PHARMACOKINET, V11, P299, DOI 10.2165/00003088-198611040-00003	59	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85712	10.1371/journal.pone.0085712	http://dx.doi.org/10.1371/journal.pone.0085712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465659	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000330283100064
J	van Dommelen, P; de Kroon, MLA; Cameron, N; Schonbeck, Y; van Buuren, S				van Dommelen, Paula; de Kroon, Marlou L. A.; Cameron, Noel; Schonbeck, Yvonne; van Buuren, Stef			The Impact of Height during Childhood on the National Prevalence Rates of Overweight	PLOS ONE			English	Article							CHILDREN; OBESITY; GROWTH; ADIPOSITY; PATTERNS; RISK; BMI; AGE; STANDARDS; ADULTS	Background: It is known that height and body mass index (BMI) are correlated in childhood. However, its impact on the (trend of) national prevalence rates of overweight and obesity has never been investigated. The aim of our study is to investigate the relation between height and national prevalence rates of overweight and obesity in childhood between 1980, 1997, and 2009, and to calculate which fixed value of p (2.0,2.1,., 3.0) in kg/m(p) during childhood is most accurate in predicting adult overweight. Methods and findings: Cross-sectional growth data of children from three Dutch nationwide surveys in 1980, 1997, and 2009, and longitudinal data from the Terneuzen Birth Cohort and the Harpenden Growth Study were used. Relative risks (RR) and 95% confidence intervals (CI) were calculated. Our study showed that tall (. 1 standard deviation (SD)) girls aged 5.0-13.9 y were more often overweight (RR = 3.5,95% CI: 2.8-4.4) and obese (RR = 3.9,95% CI: 2.1-7.4) than short girls (, 21 SD). Similar results were found in boys aged 5.0-14.9 y (RR = 4.4,95% CI: 3.4-5.7 and RR = 5.3,95% CI: 2.6-11.0). No large differences were found in the other age groups and in comparison with children with an average stature. Tall boys aged 2.0-4.9 y had a significantly higher positive trend in overweight between 1980 and 1997 compared to short boys (RR = 4.0,95% CI: 1.38-11.9). For other age groups and in girls, no significant trends were found. The optimal Area Under the Curve (AUC) to predict adult overweight was found for p = 2.0. Conclusions and significance: Tall girls aged 5.0-13.9y and tall boys 5.0-14.9 have much higher prevalence rates of overweight and obesity than their shorter peers. We suggest taking into account the impact of height when evaluating trends and variations of BMI distributions in childhood, and to use BMI to predict adult overweight.	[van Dommelen, Paula; van Buuren, Stef] TNO, Dept Life Style, Leiden, Netherlands; [de Kroon, Marlou L. A.] Vrije Univ Amsterdam Med Ctr, Inst Res Extramural Med, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Cameron, Noel] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Schonbeck, Yvonne] TNO, Dept Child Hlth, Leiden, Netherlands; [van Buuren, Stef] Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands	Netherlands Organization Applied Science Research; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Loughborough University; Netherlands Organization Applied Science Research; Utrecht University	van Dommelen, P (corresponding author), TNO, Dept Life Style, Leiden, Netherlands.	Paula.vanDommelen@tno.nl	de Kroon, Marlou MLA/M-4040-2014	van Buuren, Stef/0000-0003-1098-2119; Schonbeck, Yvonne/0000-0002-4998-5117; de Kroon, Marlou/0000-0003-1730-4994				Agostoni C, 1999, ARCH DIS CHILD, V81, P395, DOI 10.1136/adc.81.5.395; Ambrosini GL, 2013, P NUTR SOC, P1; Bosy-Westphal A, 2009, BRIT J NUTR, V102, P453, DOI 10.1017/S0007114508190304; Buchan IE, 2007, INT J OBESITY, V31, P23, DOI 10.1038/sj.ijo.0803435; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COLE TJ, 1986, ANN HUM BIOL, V13, P433, DOI 10.1080/03014468600008621; Corvalan C, 2012, SKELETAL MATURATION; de Kroon MLA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013966; Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Freedman DS, 2004, OBES RES, V12, P846, DOI 10.1038/oby.2004.102; Freedman DS, 2004, INT J OBESITY, V28, P10, DOI 10.1038/sj.ijo.0802544; Freedman DS, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e23; Frontini MG, 2001, J CLIN EPIDEMIOL, V54, P817, DOI 10.1016/S0895-4356(01)00343-2; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; Johnson W, 2012, INT J OBESITY, V36, P535, DOI 10.1038/ijo.2011.238; MARUBINI E, 1972, HUM BIOL, V44, P511; McArdle WD, 2010, EXERCISE PHYSL NUTR, V7th; Metcalf BS, 2011, INT J OBESITY, V35, P541, DOI 10.1038/ijo.2010.258; Mulligan J, 1999, BRIT MED J, V319, P1103, DOI 10.1136/bmj.319.7217.1103; ROEDE MJ, 1985, TIJDSCHR SOC GEZON S, V63, P1, DOI DOI 10.1007/978-1-4471-1721-6_10; Schonbeck Y, 2013, PEDIATR RES, V73, P371, DOI 10.1038/pr.2012.189; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Stovitz SD, 2008, OBESITY, V16, P2336, DOI 10.1038/oby.2008.359; Stovitz SD, 2010, AM J PREV MED, V38, P74, DOI 10.1016/j.amepre.2009.09.033; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; Telford RD, 2008, OBESITY, V16, P2173, DOI 10.1038/oby.2008.332; van Buuren S, 2009, STAT MED, V28, P1569, DOI 10.1002/sim.3567; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007	32	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85769	10.1371/journal.pone.0085769	http://dx.doi.org/10.1371/journal.pone.0085769			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465694	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100071
J	Yin, HY; Zhang, CL; Guo, Y; Shao, XY; Zeng, T; Zhao, XL; Xie, KQ				Yin, Hongyin; Zhang, Chunling; Guo, Ying; Shao, Xiaoying; Zeng, Tao; Zhao, Xiulan; Xie, Keqin			Biological Exposure Indices of Pyrrole Adducts in Serum and Urine for Hazard Assessment of n-Hexane Exposure	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; METHYL ETHYL KETONE; PROTEIN-BINDING; ALLYL CHLORIDE; CROSS-LINKING; 2,5-HEXANEDIONE; NEUROTOXICITY; METABOLITES; WORKERS; RAT	Background: Pyrrole adducts might be used as a biomarker for monitoring occupational exposure to n-hexane, but the Biological Exposure Indices of pyrrole adducts in serum and urine are still unknown. The current study was designed to investigate the biological exposure limit of pyrrole adducts for hazard assessment of n-hexane. Methods: Male Wistar rats were given daily dose of 500, 1000, 1500, 2000, 4000 mg/kg bw n-hexane by gavage for 24 weeks. The levels of pyrrole adducts in serum and urine were determined at 8, 24 hours postdose once a week. The Biological Exposure Indices was evaluated by neurological evaluation and the levels of pyrrole adducts. The difference in pyrrole adducts formation between humans and rats were estimated by using in vitro test. Results: Dose-dependent effects were observed between the doses of n-hexane and pyrrole adducts in serum and urine, and the levels of pyrrole adduct in serum and urine approached a plateau at week 4. There was a significantly negative correlation between the time to paralysis and the level of pyrrole adducts in serum and urine, while a positive correlation between gait score and levels of pyrrole adducts in serum and urine was observed. In vitro, pyrrole adducts formed in human serum was about two times more than those in rat serum at the same level of 2,5-HD. Conclusion: It was concluded that the BEIs of pyrrole adducts in humans were 23.1 +/- 5.91 nmol/ml in serum 8 h postdose, 11.7 +/- 2.64 nmol/ml in serum 24 h postdose, 253.8 +/- 36.3 nmol/ml in urine 8 h postdose and 54.6 +/- 15.42 nmol/ml in urine 24 h postdose.	[Yin, Hongyin; Guo, Ying; Shao, Xiaoying; Zeng, Tao; Zhao, Xiulan; Xie, Keqin] Shandong Univ, Sch Publ Hlth, Inst Toxicol, Jinan 250100, Shandong, Peoples R China; [Yin, Hongyin] Jinan Municipal Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Zhang, Chunling] Shandong Jiaotong Hosp, Dept Nutr, Jinan, Shandong, Peoples R China	Shandong University	Xie, KQ (corresponding author), Shandong Univ, Sch Publ Hlth, Inst Toxicol, Jinan 250100, Shandong, Peoples R China.	keqinx@sdu.edu.cn			Doctoral Fund of Ministry of Education of China [20120131110058]; National Natural Science Foundation of China [81373044]	Doctoral Fund of Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from Doctoral Fund of Ministry of Education of China (20120131110058) and National Natural Science Foundation of China(81373044): (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/2012/12/1354173228937804.htm), (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batterman SA, 1998, INT ARCH OCC ENV HEA, V71, P325, DOI 10.1007/s004200050288; BENCZE K, 1991, SCI TOTAL ENVIRON, V101, P83, DOI 10.1016/0048-9697(91)90105-N; Borak J, 2002, J OCCUP ENVIRON MED, V44, P310, DOI 10.1097/00043764-200204000-00011; Buyens K, 2010, J CONTROL RELEASE, V141, P38, DOI 10.1016/j.jconrel.2009.08.026; COURI D, 1982, ANNU REV PHARMACOL, V22, P145, DOI 10.1146/annurev.pa.22.040182.001045; DeCaprio AP, 2009, J TOXICOL ENV HEAL A, V72, P861, DOI 10.1080/15287390902959508; DECAPRIO AP, 1982, TOXICOL APPL PHARM, V65, P440, DOI 10.1016/0041-008X(82)90389-1; DECAPRIO AP, 1983, TOXICOL APPL PHARM, V68, P297, DOI 10.1016/0041-008X(83)90014-5; DECAPRIO AP, 1987, NEUROTOXICOLOGY, V8, P199; DECAPRIO AP, 1986, MOL PHARMACOL, V30, P452; DECAPRIO AP, 1985, TOXICOL APPL PHARM, V78, P235, DOI 10.1016/0041-008X(85)90287-X; dos Santos CR, 2002, J CHROMATOGR B, V778, P237, DOI 10.1016/S1570-0232(02)00036-3; FEDTKE N, 1986, INT ARCH OCC ENV HEA, V2, P143; Genter St., 1988, CHEM RES TOXICOL, V1, P179, DOI DOI 10.1021/tx00003a009; GILBERT SG, 1982, J TOXICOL ENV HEALTH, V10, P31, DOI 10.1080/15287398209530228; GRAHAM DG, 1982, TOXICOL APPL PHARM, V64, P415, DOI 10.1016/0041-008X(82)90237-X; HATJIAN BA, 1995, TOXICOL LETT, V77, P271, DOI 10.1016/0378-4274(95)03307-6; JANG JY, 1993, INT ARCH OCC ENV HEA, V65, pS219, DOI 10.1007/BF00381345; Jones KD, 2012, J ENVIRON SCI HEAL A, V47, P949, DOI 10.1080/10934529.2012.667294; KAWAI T, 1990, INT ARCH OCC ENV HEA, V62, P403, DOI 10.1007/BF00381372; KESSLER W, 1990, ARCH TOXICOL, V64, P242, DOI 10.1007/BF02010731; LAGORIO S, 1994, OCCUP ENVIRON MED, V51, P739, DOI 10.1136/oem.51.11.739; Lehning EJ, 2000, TOXICOL APPL PHARM, V165, P127, DOI 10.1006/taap.2000.8937; Mateus ML, 2002, NEUROTOXICOLOGY, V23, P747, DOI 10.1016/S0161-813X(02)00011-6; Mateus ML, 2001, TOXICOL LETT, V119, P39, DOI 10.1016/S0378-4274(00)00298-8; MATTOCKS AR, 1970, ANAL BIOCHEM, V38, P529, DOI 10.1016/0003-2697(70)90478-1; Mayan O, 2002, BIOMARKERS, V7, P299, DOI 10.1080/13547500210136796; MERCIER MJ, 1993, INT ARCH OCC ENV HEA, V65, pS7, DOI 10.1007/BF00381300; Morgan Michael S., 1997, Environmental Health Perspectives, V105, P105, DOI 10.2307/3433400; Nichkova M, 2002, CHEM RES TOXICOL, V15, P1371, DOI 10.1021/tx025556+; PERBELLINI L, 1979, INT ARCH OCC ENV HEA, V42, P349, DOI 10.1007/BF00377790; PERBELLINI L, 1982, ARCH TOXICOL, V50, P203, DOI 10.1007/BF00310852; Prieto MJ, 2003, TOXICOL LETT, V145, P249, DOI 10.1016/S0378-4274(03)00302-3; Pyy L, 1997, SCI TOTAL ENVIRON, V199, P151, DOI 10.1016/S0048-9697(97)00065-X; Ripova D, 2001, PHYSIOL RES, V50, P119; SAITO I, 1991, BRIT J IND MED, V48, P568; SCHAUMBURG HH, 1976, BRAIN, V99, P183, DOI 10.1093/brain/99.2.183; Shibata E, 2002, INT ARCH OCC ENV HEA, V75, P399, DOI 10.1007/s00420-002-0325-5; SHIBATA E, 1990, ARCH TOXICOL, V64, P165, DOI 10.1007/BF01974405; SPENCER PS, 1980, CRC CR REV TOXICOL, V7, P279, DOI 10.3109/10408448009037489; Thomas RS, 1996, AM IND HYG ASSOC J, V57, P23, DOI 10.1202/0002-8894(1996)057<0023:VIBEIU>2.0.CO;2; Wang QS, 2007, TOXICOLOGY, V231, P58, DOI 10.1016/j.tox.2006.11.071; Wang QS, 2006, TOXICOLOGY, V227, P36, DOI 10.1016/j.tox.2006.07.006; Wilhelm M, 1996, TOXICOL LETT, V88, P221, DOI 10.1016/0378-4274(96)03741-1; ZHU MS, 1995, CHEM RES TOXICOL, V8, P764, DOI 10.1021/tx00047a017; ZHU MS, 1994, CHEM RES TOXICOL, V7, P551, DOI 10.1021/tx00040a011	46	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86108	10.1371/journal.pone.0086108	http://dx.doi.org/10.1371/journal.pone.0086108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465904	Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100107
J	Novick, D; Barak, S; Ilan, N; Vlodavsky, I				Novick, Daniela; Barak, Sara; Ilan, Neta; Vlodavsky, Israel			Heparanase Interacts with Resistin and Augments Its Activity	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; MAMMALIAN HEPARANASE; INSULIN-RESISTANCE; CELLULAR UPTAKE; SERUM RESISTIN; RECEPTOR; ANGIOGENESIS; PROTEIN; INFLAMMATION; EXPRESSION	In an attempt to isolate a heparanase receptor, postulated to mediate non-enzymatic functions of the heparanase protein, we utilized human urine collected from healthy volunteers. Affinity chromatography of this rich protein source on immobilized heparanase revealed resistin as a heparanase binding protein. Co-immunoprecipitation and ELISA further confirmed the interaction between heparanase and resistin. Importantly, we found that heparanase potentiates the bioactivity of resistin in its standard bioassay in which monocytic human leukemia cell line, THP1, differentiates into adherent macrophage-like foam cells. It is thus conceivable that this newly identified complex of heparanase and resistin exerts a stimulatory effect also in various inflammatory conditions known to be affected by the two proteins.	[Novick, Daniela; Barak, Sara] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Rappaport Fac Med, Canc & Vasc Biol Res Ctr, Haifa, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Novick, D (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	daniela.novick@weizmann.ac.il; vlodavsk@mail.huji.ac.il			National Institutes of Health (NIH) [CA106456]; Israel Science Foundation (ISF) [593/10]; Israel Ministry of Health; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation (ISF)(Israel Science Foundation); Israel Ministry of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Israel Vlodavsky is supported by National Institutes of Health (NIH) grant CA106456; the Israel Science Foundation (ISF grant 593/10); and the Israel Ministry of Health. Israel Vlodavsky is a Research Professor of the Israel Cancer Research Fund (ICRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Ben-Zaken O, 2008, INT J BIOCHEM CELL B, V40, P530, DOI 10.1016/j.biocel.2007.09.003; Benomar Y, 2013, DIABETES, V62, P102, DOI 10.2337/db12-0237; Blich M, 2013, ARTERIOSCL THROM VAS, V33, pE56, DOI 10.1161/ATVBAHA.112.254961; Burnett MS, 2005, ATHEROSCLEROSIS, V182, P241, DOI 10.1016/j.atherosclerosis.2005.02.014; Cohen I, 2006, INT J CANCER, V118, P1609, DOI 10.1002/ijc.21552; Cohen-Kaplan V, 2012, J BIOL CHEM, V287, P6668, DOI 10.1074/jbc.M111.271346; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Dalamaga M, 2013, CLIN BIOCHEM, V46, P584, DOI 10.1016/j.clinbiochem.2013.01.001; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Degawa-Yamauchi M, 2003, J CLIN ENDOCR METAB, V88, P5452, DOI 10.1210/jc.2002-021808; Edovitsky E, 2006, BLOOD, V107, P3609, DOI 10.1182/blood-2005-08-3301; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Efstathiou SP, 2007, CLIN CHIM ACTA, V378, P78, DOI 10.1016/j.cca.2006.10.023; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Fargnoli JL, 2010, EUR J ENDOCRINOL, V162, P281, DOI 10.1530/EJE-09-0555; Filkova M, 2009, CLIN IMMUNOL, V133, P157, DOI 10.1016/j.clim.2009.07.013; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Hermano E, 2012, CELL MOL LIFE SCI, V69, P2501, DOI 10.1007/s00018-012-0930-8; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003; Kusminski CM, 2007, J CLIN ENDOCR METAB, V92, P270, DOI 10.1210/jc.2006-1151; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Levy-Adam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002319; Li RW, 2008, ARTHRITIS RHEUM, V58, P1590, DOI 10.1002/art.23489; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Novick D, 2007, CYTOKINE GROWTH F R, V18, P525, DOI 10.1016/j.cytogfr.2007.06.024; Novick D, 2012, METHODS MOL BIOL, V820, P195, DOI 10.1007/978-1-61779-439-1_12; Osterholm C, 2013, ATHEROSCLEROSIS, V226, P67, DOI 10.1016/j.atherosclerosis.2012.09.030; Ostrovsky O, 2010, BLOOD, V115, P2319, DOI 10.1182/blood-2009-08-236455; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rae C, 2007, FEBS LETT, V581, P4877, DOI 10.1016/j.febslet.2007.09.014; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Seidler DG, 2011, J IMMUNOL, V187, P6108, DOI 10.4049/jimmunol.1100373; Steppan CM, 2004, J INTERN MED, V255, P439, DOI 10.1111/j.1365-2796.2004.01306.x; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Tarkowski A, 2010, J CELL MOL MED, V14, P1419, DOI 10.1111/j.1582-4934.2009.00899.x; Vazzana N, 2012, CURR MED CHEM, V19, P5837, DOI 10.2174/092986712804143349; Vlodavsky I, 2012, CANC MICROENVIRON; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Weikert C, 2008, J CLIN ENDOCR METAB, V93, P2647, DOI 10.1210/jc.2007-2735; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	57	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85944	10.1371/journal.pone.0085944	http://dx.doi.org/10.1371/journal.pone.0085944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465803	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500150
J	Suresh, BV; Roy, R; Sahu, K; Misra, G; Chattopadhyay, D				Suresh, B. Venkata; Roy, Riti; Sahu, Kamlesh; Misra, Gopal; Chattopadhyay, Debasis			Tomato Genomic Resources Database: An Integrated Repository of Useful Tomato Genomic Information for Basic and Applied Research	PLOS ONE			English	Article							DISEASE RESISTANCE; FRUIT SIZE; FUNCTIONAL GENOMICS; NUCLEOTIDE-BINDING; GENE; SEQUENCE; EVOLUTION; IDENTIFICATION; MICRORNAS; RESPONSES	Tomato Genomic Resources Database (TGRD) allows interactive browsing of tomato genes, micro RNAs, simple sequence repeats (SSRs), important quantitative trait loci and Tomato-EXPEN 2000 genetic map altogether or separately along twelve chromosomes of tomato in a single window. The database is created using sequence of the cultivar Heinz 1706. High quality single nucleotide polymorphic (SNP) sites between the genes of Heinz 1706 and the wild tomato S. pimpinellifolium LA1589 are also included. Genes are classified into different families. 5'-upstream sequences (5'-US) of all the genes and their tissue-specific expression profiles are provided. Sequences of the microRNA loci and their putative target genes are catalogued. Genes and 5'-US show presence of SSRs and SNPs. SSRs located in the genomic, genic and 5'-US can be analysed separately for the presence of any particular motif. Primer sequences for all the SSRs and flanking sequences for all the genic SNPs have been provided. TGRD is a user-friendly web-accessible relational database and uses CMAP viewer for graphical scanning of all the features. Integration and graphical presentation of important genomic information will facilitate better and easier use of tomato genome. TGRD can be accessed as an open source repository at http://59.163.192.91/tomato2/.	[Suresh, B. Venkata; Roy, Riti; Sahu, Kamlesh; Misra, Gopal; Chattopadhyay, Debasis] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Chattopadhyay, D (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	debasis@nipgr.ac.in	Bonthala, Venkata Suresh/G-9852-2013	Bonthala, Venkata Suresh/0000-0001-6550-1648; Chattopadhyay, Debasis/0000-0002-5754-4987	National Institute of Plant Genome Research, New Delhi, India; Department of Biotechnology, Government of India	National Institute of Plant Genome Research, New Delhi, India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was financially supported by the core grant of National Institute of Plant Genome Research, New Delhi, India and the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2004, TRENDS PLANT SCI, V9, P331, DOI 10.1016/j.tplants.2004.05.004; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bazzini AA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-240; Bombarely A, 2011, NUCLEIC ACIDS RES, V39, pD1149, DOI 10.1093/nar/gkq866; BRADY CJ, 1982, AUST J PLANT PHYSIOL, V9, P171, DOI 10.1071/PP9820171; Buckeridge MS, 2010, PLANT PHYSIOL, V154, P1017, DOI 10.1104/pp.110.158642; Causse M, 2002, J EXP BOT, V53, P2089, DOI 10.1093/jxb/erf058; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cong B, 2002, P NATL ACAD SCI USA, V99, P13606, DOI 10.1073/pnas.172520999; D'Agostino N, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-142; Emmanuel E, 2002, CURR OPIN PLANT BIOL, V5, P112, DOI 10.1016/S1369-5266(02)00237-6; Ercolano MR, 2012, PLANT CELL REP, V31, P973, DOI 10.1007/s00299-012-1234-z; Fei ZJ, 2011, NUCLEIC ACIDS RES, V39, pD1156, DOI 10.1093/nar/gkq991; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Grennan AK, 2009, PLANT PHYSIOL, V151, P1701, DOI 10.1104/pp.109.900308; GREVE LC, 1991, PLANT PHYSIOL, V97, P1456, DOI 10.1104/pp.97.4.1456; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Karlova R, 2013, J EXP BOT, V64, P1863, DOI 10.1093/jxb/ert049; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; KHUSH GS, 1964, SCIENCE, V145, P1432, DOI 10.1126/science.145.3639.1432; Klee HJ, 2013, TRENDS GENET, V29, P257, DOI 10.1016/j.tig.2012.12.003; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; MARTIN GB, 1991, P NATL ACAD SCI USA, V88, P2336, DOI 10.1073/pnas.88.6.2336; MILLER JC, 1990, THEOR APPL GENET, V80, P437, DOI 10.1007/BF00226743; Milligan SB, 1998, PLANT CELL, V10, P1307, DOI 10.1105/tpc.10.8.1307; Mueller LA, 2009, PLANT GENOME-US, V2, P78, DOI 10.3835/plantgenome2008.08.0005; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saito T, 2011, PLANT CELL PHYSIOL, V52, P283, DOI 10.1093/pcp/pcr004; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schornack S, 2004, PLANT J, V37, P46, DOI 10.1046/j.1365-313X.2003.01937.x; Shirasawa K, 2013, BREEDING SCI, V63, P21, DOI 10.1270/jsbbs.63.21; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Verlaan MG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003399; Youens-Clark K, 2009, BIOINFORMATICS, V25, P3040, DOI 10.1093/bioinformatics/btp458; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	48	31	31	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86387	10.1371/journal.pone.0086387	http://dx.doi.org/10.1371/journal.pone.0086387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466070	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500241
J	Yin, SN; Wu, HB; Lv, JX; Wu, XY; Zhang, Y; Du, J; Zhang, Y				Yin, Songna; Wu, Haibo; Lv, Jiaxing; Wu, Xinying; Zhang, Yan; Du, Juan; Zhang, Yong			SHP-1 Arrests Mouse Early Embryo Development through Downregulation of Nanog by Dephosphorylation of STAT3	PLOS ONE			English	Article							STEM-CELLS; TYROSINE-PHOSPHATASE; T-CELLS; PLURIPOTENCY; DIFFERENTIATION; IDENTIFICATION; CLONING; GENES; ROLES	Src-homology protein tyrosine phosphatase-1 (SHP-1) is a protein tyrosine phosphatase that is implicated in the regulation of growth, differentiation, survival, apoptosis and proliferation of hematopoietic cells and other cell types. Here, we found that SHP-1 is involved in regulation of early embryonic development. Embryos overexpressing SHP-1 were mainly arrested at the 8-cell stage, and Nanog mRNA expression was first observed in the morulae that showed down-regulation of SHP-1. These results suggested an antagonistic relationship between SHP-1 and Nanog during early embryonic development. Next, the specific mechanism was examined in mouse F9 embryonal carcinoma cells. We confirmed that signal transducer and activator of transcription 3 (STAT3) was a substrate for SHP-1 by co-immunoprecipitation. Using overexpression and knockdown strategies, we found that SHP-1 participated in regulation of Nanog expression. Furthermore, site mutation of STAT3 was performed to confirm that SHP-1 was responsible for rapid STAT3 dephosphorylation and a decrease of Nanog expression in F9 cells. These findings suggest that SHP-1 plays a crucial role during early embryonic development. Thus, SHP-1 may function as a key regulator for Nanog that specifically demarcates the nascent epiblast, coincident with the domain of X chromosome reprogramming.	[Yin, Songna; Wu, Haibo; Lv, Jiaxing; Wu, Xinying; Zhang, Yan; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Yin, Songna; Wu, Haibo; Lv, Jiaxing; Wu, Xinying; Zhang, Yan; Du, Juan; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China; [Du, Juan] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	YongZhang1956@126.com	Zhang, Yong/K-7945-2016	Zhang, Yong/0000-0001-8642-4071	National High Technology Research and Development Program of China (863 Program) [2011AA100303]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (863 Program) (No. 2011AA100303) (http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard Kaptein VrP, 1996, J BIOL CHEM, V271, P5961; ALONSO A, 1991, International Journal of Developmental Biology, V35, P389; Bhattacharya Resham, 2008, J Mol Signal, V3, P8, DOI 10.1186/1750-2187-3-8; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Bousquet C, 1999, J CLIN INVEST, V104, P1277, DOI 10.1172/JCI7924; Bragadin M, 2007, ANN NY ACAD SCI, V1095, P193, DOI 10.1196/annals.1397.023; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen KF, 2012, EUR J MED CHEM, V55, P220, DOI 10.1016/j.ejmech.2012.07.023; Cheng JH, 2004, LEUKEMIA RES, V28, P71, DOI 10.1016/S0145-2126(03)00158-9; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Dong Q, 1999, J IMMUNOL, V162, P3220; Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hui Peng YW, 2012, PLOS ONE, V7; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; LAWITTS JA, 1991, J REPROD FERTIL, V91, P543, DOI 10.1530/jrf.0.0910543; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; LEHTONEN E, 1989, International Journal of Developmental Biology, V33, P105; Lopez-Ruiz P, 2011, ANTI-CANCER AGENT ME, V11, P89, DOI 10.2174/187152011794941154; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyake T, 2009, J BIOL CHEM, V284, P19679, DOI 10.1074/jbc.M109.017319; Peng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030344; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; ROSENSTRAUS MJ, 1982, DEV BIOL, V89, P516, DOI 10.1016/0012-1606(82)90340-2; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Wang HH, 2008, DEV BIOL, V318, P112, DOI 10.1016/j.ydbio.2008.03.008; Wu H, 2013, STEM CELLS	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86330	10.1371/journal.pone.0086330	http://dx.doi.org/10.1371/journal.pone.0086330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466030	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500228
J	Zeng, WP; McFarland, MM				Zeng, Wei-ping; McFarland, Margaret M.			Rapid and Unambiguous Detection of DNase I Hypersensitive Site in Rare Population of Cells	PLOS ONE			English	Article							GENE-EXPRESSION; T-CELLS; CHROMATIN; PCR	DNase I hypersensitive (DHS) sites are important for understanding cis regulation of gene expression. However, existing methods for detecting DHS sites in small numbers of cells can lead to ambiguous results. Here we describe a simple new method, in which DNA fragments with ends generated by DNase I digestion are isolated and used as templates for two PCR reactions. In the first PCR, primers are derived from sequences up-and down-stream of the DHS site. If the DHS site exists in the cells, the first PCR will not produce PCR products due to the cuts of the templates by DNase I between the primer sequences. In the second PCR, one primer is derived from sequence outside the DHS site and the other from the adaptor. This will produce a smear of PCR products of different sizes due to cuts by DNase I at different positions at the DHS site. With this design, we detected a DHS site at the CD4 gene in two CD4 T cell populations using as few as 2x10(4) cells. We further validated this method by detecting a DHS site of the IL-4 gene that is specifically present in type 2 but not type 1 T helper cells. Overall, this method overcomes the interference by genomic DNA not cut by DNase I at the DHS site, thereby offering unambiguous detection of DHS sites in the cells.	[Zeng, Wei-ping; McFarland, Margaret M.] Marshall Univ, Dept Biochem & Microbiol, Huntington, WV 25755 USA; [Zeng, Wei-ping] Marshall Univ, Dept Paediat, Joan C Edwards Sch Med, Huntington, WV USA; [Zeng, Wei-ping] Marshall Univ, Coll Sci, Dept Biol, Ctr Cell Dev & Differentiat, Huntington, WV USA	Marshall University; Marshall University; Marshall University	Zeng, WP (corresponding author), Marshall Univ, Dept Biochem & Microbiol, Huntington, WV 25755 USA.	zengw@marshall.edu		zeng, wei-ping/0000-0002-8268-3583	WV Experimental Program to Stimulate Competitive Research National Science Foundation; West Virginia Research Challenge grant	WV Experimental Program to Stimulate Competitive Research National Science Foundation; West Virginia Research Challenge grant	This work is in part supported by WV Experimental Program to Stimulate Competitive Research National Science Foundation Research Infrastructure Improvement T1 grant and a West Virginia Research Challenge grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cockerill P N, 2000, Methods Mol Biol, V130, P29; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Follows GA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm108; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Itoh M, 1999, J IMMUNOL, V162, P5317; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ohnesorg T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-412; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Song Lingyun, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5384; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Young N, 2005, J IMMUNOL, V175, P8287, DOI 10.4049/jimmunol.175.12.8287; Zeng WP, 2011, MOL IMMUNOL, V48, P1932, DOI 10.1016/j.molimm.2011.05.023; Zeng WP, 2009, J IMMUNOL, V183, P3583, DOI 10.4049/jimmunol.0900146	19	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85740	10.1371/journal.pone.0085740	http://dx.doi.org/10.1371/journal.pone.0085740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465674	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500101
J	Kong, B; Guo, GL				Kong, Bo; Guo, Grace L.			Soluble Expression of Disulfide Bond Containing Proteins FGF15 and FGF19 in the Cytoplasm of Escherichia coli	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CHAIN FV ANTIBODIES; TRANSGENIC MICE; FIBROBLAST-GROWTH-FACTOR-19; STRATEGIES; SUBFAMILY; RECEPTOR; FGF-19; GENES	Fibroblast growth factor 19 (FGF19) is the human ortholog of mouse FGF15, and both proteins function as an endocrine signal to regulate various liver functions. FGF15/FGF19 protein contains two disulfide bonds. It is unfavorable to form disulfide bonds in Escherichia coli (E. coli) cytoplasm because of the bacterial cytoplasmic reducing environment. Modification of the cytoplasmic reducing environment and/or co-expression of protein chaperones are common strategies to express disulfide bond containing proteins in E. coli. In the current study, we report a method to produce soluble FGF15/FGF19 protein in cytoplasm of E. coli. Several commercial available strains with the disruption of thiol-redox pathways, and/or co-expression of redoxase or refolding chaperones were used to develop this novel method for expression of FGF15/FGF19 in E. coli. Mutation of the thiol-disulfide bond reducing pathway in E. coli or N-terminal fusion of thioredox (TRX) alone is not enough to support disulfide bond formation in FGF15/19 proteins. However, TRX fusion protein improved FGF19 solubility in strains of thiol-redox system mutants. In addition, DsbC co-expressed in thiol-redox system mutants alone improved and further enhanced FGF19 solubility with combination of TRX fusion tag. The soluble FGF19 proteins were easily purified through Ni-NTA affinity chromatography and anion exchange chromatography, and the purified protein maintained its biological activities, confirmed by suppressing hepatic Cyp7a1 gene transcription in mice and by activating ERK1/2 signaling pathway in HepG2 cells. In contrast, soluble FGF15 protein in cytoplasm remained very low using these strategies. In summary, we have successfully developed a method to express functional FGF19 protein in prokaryotic cells, and this strategy may be adapted for the expression of other disulfide-containing proteins.	[Kong, Bo; Guo, Grace L.] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Guo, GL (corresponding author), Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA.	guo@eohsi.rutgers.edu	Kong, Bo/G-7650-2014	Kong, Bo/0000-0002-8200-7817	National Institutes of Health [DK081343, DK090036]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081343, R56DK090036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health fund [DK081343 & DK090036 (GLG)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Beenken A, 2012, ADV EXP MED BIOL, V728, P1, DOI 10.1007/978-1-4614-0887-1_1; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; BRADLEY MK, 1990, METHODS ENZYMOL, V182, P112; Burgess RR, 2009, METHOD ENZYMOL, V463, P259, DOI 10.1016/S0076-6879(09)63017-2; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; DERMAN AI, 1993, SCIENCE, V262, P1744, DOI 10.1126/science.8259521; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Harmer NJ, 2004, BIOCHEMISTRY-US, V43, P629, DOI 10.1021/bi035320k; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jungbauer A, 2007, J BIOTECHNOL, V128, P587, DOI 10.1016/j.jbiotec.2006.12.004; Jurado P, 2006, J MOL BIOL, V357, P49, DOI 10.1016/j.jmb.2005.12.058; Katzen F, 2002, METHOD ENZYMOL, V348, P54, DOI 10.1016/S0076-6879(02)48626-0; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Kong B, 2012, HEPATOLOGY, V56, P1034, DOI 10.1002/hep.25740; Kong B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020307; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Nishimura T, 1999, BBA-GENE STRUCT EXPR, V1444, P148, DOI 10.1016/S0167-4781(98)00255-3; Palmer I., 2004, CURRENT PROTOCOLS PR, DOI DOI 10.1002/0471140864.PS0603S38.UNIT6.3; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Subedi GP, 2012, PROTEIN EXPRES PURIF, V82, P197, DOI 10.1016/j.pep.2011.12.010; Swietnicki W, 2006, CURR OPIN BIOTECH, V17, P367, DOI 10.1016/j.copbio.2006.05.011; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Uriarte I, 2013, GUT, V62, P899, DOI 10.1136/gutjnl-2012-302945; Wingfield P T, 2001, Curr Protoc Protein Sci, VChapter 6, DOI 10.1002/0471140864.ps0605s00; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485; Zhang Z, 2002, PROTEIN EXPRES PURIF, V26, P218, DOI 10.1016/S1046-5928(02)00502-8	30	36	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85890	10.1371/journal.pone.0085890	http://dx.doi.org/10.1371/journal.pone.0085890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465767	Green Submitted, gold, Green Published			2022-12-25	WOS:000330240500084
J	Liu, RS; Zhao, HY; Wang, YF; Wang, YL; Lu, CZ; Xiao, Y; Jia, N; Wang, B; Niu, WQ				Liu, Ruoshan; Zhao, Hongye; Wang, Yuefei; Wang, Yanli; Lu, Changzhu; Xiao, Yu; Jia, Nan; Wang, Bin; Niu, Wenquan			The Contributory Role of Angiotensin Receptor-Like 1 Gene Multiple Polymorphisms in Hypertension among Northeastern Han Chinese	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; ALDOSTERONE SYSTEM; APELIN; SUSCEPTIBILITY; POPULATION; EPISTASIS; NORTHERN; TRAITS	Background and Objective: Via direct sequencing, we have recently identified six common polymorphisms in angiotensin receptor-like 1 (AGTRL1) gene, and found only two polymorphisms were significantly associated with hypertension in a family-based analysis on 1,015 southern Han Chinese. Extending our previous work and considering the ubiquity of epistasis in determining disease susceptibility, we, in this study, sought to explore the potential interaction of AGTRL1 gene six polymorphisms with hypertension in a large northeastern Han Chinese population. Methods and Results: This was a case-control study involving 1,009 sporadic hypertensive patients and 756 normotensive controls. Data were analyzed by Haplo.Stats and multifactor dimensionality reduction (MDR) softwares. There were no deviations from Hardy-Weinberg equilibrium for all polymorphisms. The genotypes and alleles of rs7119675 and rs11544374 differed significantly between the two groups (P<0.0005), even after the Bonferroni correction. Under three genetic models, significant association was consistently observed for rs7119675 and rs11544374, and this association was independent of confounding factors. Taking rs7119375 as an example, the odds of having hypertension was 2.46 (95% confidence interval (95% CI): 2.06-2.94), 2.82 (95% CI: 2.29-3.46) and 3.97 (95% CI: 2.37-6.64) under additive, dominant and recessive models (P<0.001), respectively, whereas the adjusted risk estimates were slightly attenuated but still significant. The frequencies of most derived haplotypes differed significantly between patients and controls. Haplotype-phenotype analyses indicated marginal association for triglyceride (P-Sim = 0.011) and total cholesterol (P-Sim = 0.025) in patients and for triglyceride in controls (P-Sim = 0.023). The overall best MDR model included rs11544374, rs7119375 and rs948847 with the maximal testing accuracy of 0.737 and cross-validation consistency of 10 out of 10 (P<0.0001). Further interaction entropy graph suggested that the interaction of rs7119375 with rs11544374 and rs948847 was strongly antagonized. Conclusions: Our findings demonstrate that AGTRL1 genetic polymorphisms might contribute to the development of hypertension independently and/or through complex interaction.	[Liu, Ruoshan] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Anesthesiol, Beijing 100730, Peoples R China; [Liu, Ruoshan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhao, Hongye; Wang, Yuefei; Lu, Changzhu; Xiao, Yu; Wang, Bin] Qiqihar Med Univ, Dept Physiol, Qiqihar, Heilongjiang, Peoples R China; [Wang, Yanli] Qiqihar Med Univ, Affiliated Hosp 2, Dept Cardiol, Qiqihar, Heilongjiang, Peoples R China; [Jia, Nan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hypertens, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Qiqihar Medical University; Qiqihar Medical University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Wang, B (corresponding author), Qiqihar Med Univ, Dept Physiol, Qiqihar, Heilongjiang, Peoples R China.	wangbinqqhr@163.com; niuwenquan_shcn@163.com			National Natural Science Foundation of China [30900808]; Department of Education Science and Technology Research Project in Heilongjiang Province [12521621]; Shanghai Rising Star Program [11QA1405500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education Science and Technology Research Project in Heilongjiang Province; Shanghai Rising Star Program	This study received grants from the National Natural Science Foundation of China (30900808), the Department of Education Science and Technology Research Project in Heilongjiang Province (12521621), and the Shanghai Rising Star Program (11QA1405500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai YB, 2013, ENVIRON MONIT ASSESS, V185, P5111, DOI 10.1007/s10661-012-2929-x; Charita B, 2012, J RENIN-ANGIO-ALDO S, V13, P461, DOI 10.1177/1470320312444650; Chu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057231; Dray C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1161, DOI 10.1152/ajpendo.00598.2009; Falcao-Pires I, 2010, EXPERT OPIN THER TAR, V14, P633, DOI 10.1517/14728221003752743; Falcone C, 2012, MOL MED REP, V5, P321, DOI 10.3892/mmr.2011.685; Gu Jian-wei, 2009, Beijing Da Xue Xue Bao Yi Xue Ban, V41, P505; Gu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037970; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Jin W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051123; Kang YJ, 2013, CIRC RES, V113, P22, DOI 10.1161/CIRCRESAHA.113.301324; Khanna M, 1999, ONCOGENE, V18, P27, DOI 10.1038/sj.onc.1202291; Kidoya H, 2012, J BIOCHEM, V152, P125, DOI 10.1093/jb/mvs071; Li WW, 2009, J HYPERTENS, V27, P1194, DOI 10.1097/HJH.0b013e32832a3eb1; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Niu WQ, 2010, J HUM HYPERTENS, V24, P427, DOI 10.1038/jhh.2010.12; Niu WQ, 2009, J HUM HYPERTENS, V23, P68, DOI 10.1038/jhh.2008.77; Niu WQ, 2007, HYPERTENS RES, V30, P1129, DOI 10.1291/hypres.30.1129; Niu WQ, 2007, TRANSL RES, V150, P374, DOI 10.1016/j.trsl.2007.06.002; Niu WQ, 2010, J HYPERTENS, V28, P1854, DOI 10.1097/HJH.0b013e32833b1fad; Niu WQ, 2009, J HYPERTENS, V27, P1384, DOI 10.1097/HJH.0b013e32832b7e0d; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Qi Y, 2013, HYPERTENS RES; Qi Y, 2008, EUR J EPIDEMIOL, V23, P143, DOI 10.1007/s10654-007-9208-0; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Stolarz-Skrzypek K, 2013, CURR HYPERTENS REP, V15, P122, DOI 10.1007/s11906-013-0331-x; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Wang Y, 2013, J HUMAN HYPERTENSION; Zhang R, 2012, EXP DIABETES RES, DOI 10.1155/2012/917496; Zhao LC, 2004, HYPERTENSION, V43, P1332, DOI 10.1161/01.HYP.0000128243.06502.bc	35	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86095	10.1371/journal.pone.0086095	http://dx.doi.org/10.1371/journal.pone.0086095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465893	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500111
J	Zeng, Y; Tarbell, JM				Zeng, Ye; Tarbell, John M.			The Adaptive Remodeling of Endothelial Glycocalyx in Response to Fluid Shear Stress	PLOS ONE			English	Article							HEPARAN-SULFATE; ACTIN CYTOSKELETON; SURFACE GLYCOCALYX; CAVEOLAE; MECHANOTRANSDUCTION; MEMBRANE; PERMEABILITY; MICRODOMAINS; SYNDECAN-1; TRANSPORT	The endothelial glycocalyx is vital for mechanotransduction and endothelial barrier integrity. We previously demonstrated the early changes in glycocalyx organization during the initial 30 min of shear exposure. In the present study, we tested the hypothesis that long-term shear stress induces further remodeling of the glycocalyx resulting in a robust layer, and explored the responses of membrane rafts and the actin cytoskeleton. After exposure to shear stress for 24 h, the glycocalyx components heparan sulfate, chondroitin sulfate, glypican-1 and syndecan-1, were enhanced on the apical surface, with nearly uniform spatial distributions close to baseline levels that differed greatly from the 30 min distributions. Heparan sulfate and glypican-1 still clustered near the cell boundaries after 24 h of shear, but caveolin-1/caveolae and actin were enhanced and concentrated across the apical aspects of the cell. Our findings also suggest the GM(1)-labelled membrane rafts were associated with caveolae and glypican-1/heparan sulfate and varied in concert with these components. We conclude that remodeling of the glycocalyx to long-term shear stress is associated with the changes in membrane rafts and the actin cytoskeleton. This study reveals a space-and time-dependent reorganization of the glycocalyx that may underlie alterations in mechanotransduction mechanisms over the time course of shear exposure.	[Zeng, Ye; Tarbell, John M.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA; [Zeng, Ye] Sichuan Univ, Sch Preclin & Forens Med, Inst Biomed Engn, Chengdu 610064, Peoples R China	City University of New York (CUNY) System; City College of New York (CUNY); Sichuan University	Tarbell, JM (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	tarbell@ccny.cuny.edu	Zeng, Ye/E-3010-2010	Zeng, Ye/0000-0001-5440-6194	NIH [HL 094889]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094889] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH Grant HL 094889. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie KM, 2005, J APPL PHYSIOL, V98, P242, DOI 10.1152/japplphysiol.01006.2003; ARISAKA T, 1995, ANN NY ACAD SCI, V748, P543; Cancel LM, 2011, AM J PHYSIOL-HEART C, V300, pH769, DOI 10.1152/ajpheart.00445.2010; Carey DJ, 1996, J BIOL CHEM, V271, P15253, DOI 10.1074/jbc.271.25.15253; Chakravarti R, 2005, MOL BIOL CELL, V16, P3678, DOI 10.1091/mbc.E04-10-0907; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Curry FE, 2012, ANN BIOMED ENG, V40, P828, DOI 10.1007/s10439-011-0429-8; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Drake-Holland A. J., 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P76; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Fu BMM, 2013, WIRES SYST BIOL MED, V5, P381, DOI 10.1002/wsbm.1211; GOTLIEB AI, 1990, TOXICOL PATHOL, V18, P603; Gouverneur M, 2006, AM J PHYSIOL-HEART C, V290, pH458, DOI 10.1152/ajpheart.00592.2005; KOKENYESI R, 1994, J BIOL CHEM, V269, P12304; Koo A, 2011, FLOW REGULATED ENDOT; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; Lemkes BA, 2012, DIABETES TECHNOL THE, V14, pS3, DOI 10.1089/dia.2012.0011; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Lindner R, 2009, EXP CELL RES, V315, P2871, DOI 10.1016/j.yexcr.2009.07.020; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lipowsky Herbert H, 2011, Drug Discov Today Dis Models, V8, P57; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Malek AM, 1996, J CELL SCI, V109, P713; MARCUM JA, 1985, BIOCHEM BIOPH RES CO, V126, P365, DOI 10.1016/0006-291X(85)90615-1; Moon JJ, 2005, J CELL PHYSIOL, V203, P166, DOI 10.1002/jcp.20220; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Rizzo V, 2003, AM J PHYSIOL-HEART C, V285, pH1720, DOI 10.1152/ajpheart.00344.2002; SANGER JM, 1980, J CELL BIOL, V86, P568, DOI 10.1083/jcb.86.2.568; Satcher R, 1997, MICROCIRCULATION-LON, V4, P439, DOI 10.3109/10739689709146808; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146; Tarbell JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.140pt8; Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Warboys CM, 2010, AM J PHYSIOL-HEART C, V298, pH1850, DOI 10.1152/ajpheart.00114.2010; White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Yen WY, 2012, MICROVASC RES, V83, P337, DOI 10.1016/j.mvr.2012.02.005; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Zeng Y, 2013, AM J PHYSL HEART CIR; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043168; Zeng Y, 2011, CYTOKINE, V53, P42, DOI 10.1016/j.cyto.2010.09.007; Zhang J, 2012, AM J PHYSIOL-HEART C, V302, pH983, DOI 10.1152/ajpheart.00168.2011	53	91	93	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86249	10.1371/journal.pone.0086249	http://dx.doi.org/10.1371/journal.pone.0086249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465988	Green Published, gold			2022-12-25	WOS:000330240500123
J	Liang, YJ; Yan, ZR; Sun, BL; Cai, CZ; Jiang, H; Song, AQ; Qiu, CX				Liang, Yajun; Yan, Zhongrui; Sun, Binglun; Cai, Chuanzhu; Jiang, Hui; Song, Aiqin; Qiu, Chengxuan			Cardiovascular Risk Factor Profiles for Peripheral Artery Disease and Carotid Atherosclerosis among Chinese Older People: A Population-Based Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ANKLE-BRACHIAL INDEX; NUTRITION EXAMINATION SURVEY; VASCULAR-DISEASE; NATIONAL-HEALTH; PREVALENCE; ASSOCIATION; LIPOPROTEIN; CORONARY; STROKE	Objectives: Epidemiological data concerning atherosclerotic disease among older people in rural China are sparse. We seek to determine prevalence and cardiovascular risk factor profiles for peripheral artery disease (PAD) and carotid atherosclerosis (CAS) among Chinese older people living in a rural community. Methods: This cross-sectional study included 1499 participants (age >= 60 years, 59.0% women) of the Confucius Hometown Aging Project in Shandong, China. From June 2010-July 2011, data were collected through interviews, clinical examinations, and laboratory tests. PAD was defined as an ankle-brachial index <= 0.9. Carotid intima-media thickness (cIMT) and carotid artery stenosis were assessed by ultrasonography. We defined moderate stenosis as carotid stenosis >= 50%, and severe stenosis as carotid stenosis >= 70%. cIMT >= 1.81 mm was considered as an increased cIMT (a measure of CAS). Data were analyzed with multiple logistic models. Results: The prevalence was 5.7% for PAD, 8.9% for moderate stenosis, 1.8% for severe stenosis, and 11.2% for increased cIMT. After controlling for multiple potential confounders, diabetes, an increased low-density lipoprotein cholesterol (LDL-C)/high-density lipoprotein cholesterol (HDL-C) ratio, and hypertension were significantly or marginally associated with PAD. Ever smoking, hypertension, and an increased LDL-C/HDL-C ratio were significantly associated with an increased likelihood of increased cIMT. An increasing number of those cardiovascular risk factors were significantly associated with an increasing odds ratio of PAD and increased cIMT, respectively (p for linear trend < 0.001). Conclusion: Among Chinese older people living in a rural community, PAD, carotid artery stenosis, and an increased cIMT are relatively uncommon. Cardiovascular risk factor profiles for PAD and CAS are slightly different, with hypertension and an increased LDL-C/HDL-C ratio being associated with an increased likelihood of both PAD and increased cIMT.	[Liang, Yajun; Song, Aiqin] Jining Med Univ, Sch Publ Hlth, Jining, Shandong, Peoples R China; [Liang, Yajun; Qiu, Chengxuan] Stockholm Univ, Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, S-10691 Stockholm, Sweden; [Yan, Zhongrui] Jining First Peoples Hosp, Dept Neurol, Jining, Shandong, Peoples R China	Jining Medical University; Karolinska Institutet; Stockholm University	Liang, YJ (corresponding author), Jining Med Univ, Sch Publ Hlth, Jining, Shandong, Peoples R China.	yajun.liang@ki.se; chengxuan.qiu@ki.se		Qiu, Chengxuan/0000-0003-1922-4912	Department of Science and Technology [2008GG00221]; Department of Health [2009-067]; Natural Science Foundation of Shandong Province, China [ZR2010HL031]; Young Scholar Grant for Strategic Research in Epidemiology at Karolinska Institutet; Swedish Research Council and Karolinska Institutet, Stockholm, Sweden	Department of Science and Technology(Department of Science & Technology (India)); Department of Health; Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); Young Scholar Grant for Strategic Research in Epidemiology at Karolinska Institutet; Swedish Research Council and Karolinska Institutet, Stockholm, Sweden	The Confucius Hometown Aging Project was supported in part by grants from the Department of Science and Technology (2008GG00221), Department of Health (2009-067), and Natural Science Foundation (ZR2010HL031) of Shandong Province, China and by the Young Scholar Grant for Strategic Research in Epidemiology at Karolinska Institutet. Dr Qiu was supported by the Swedish Research Council and Karolinska Institutet, Stockholm, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Ariyo AA, 2003, NEW ENGL J MED, V349, P2108, DOI 10.1056/NEJMoa001066; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Chien KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003435; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; de Weerd M, 2010, STROKE, V41, P1294, DOI 10.1161/STROKEAHA.110.581058; de Weerd M, 2009, STROKE, V40, P1105, DOI 10.1161/STROKEAHA.108.532218; Elias-Smale SE, 2012, EUR J PREV CARDIOL, V19, P698, DOI 10.1177/1741826711414623; Enomoto M, 2011, J LIPIDS, V2011, DOI 10.1155/2011/549137; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Grenon S Marlene, 2009, N Engl J Med, V361, pe40, DOI 10.1056/NEJMvcm0807012; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gurdasani D, 2012, ARTERIOSCL THROM VAS, V32, P3058, DOI 10.1161/ATVBAHA.112.255521; He Y, 2006, J VASC SURG, V44, P333, DOI 10.1016/j.jvs.2006.03.032; Johansen Odd E, 2003, Am J Cardiovasc Drugs, V3, P283, DOI 10.2165/00129784-200303040-00007; Johnson HM, 2007, STROKE, V38, P900, DOI 10.1161/01.STR.0000258003.31194.0a; Joosten MM, 2012, JAMA-J AM MED ASSOC, V308, P1660, DOI 10.1001/jama.2012.13415; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Lim S, 2012, INT J CARDIOL, V155, P126, DOI 10.1016/j.ijcard.2011.05.054; Mathur R, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572454; McDermott MM, 2005, AM J EPIDEMIOL, V162, P33, DOI 10.1093/aje/kwi167; Momiyama Y, 2012, ATHEROSCLEROSIS, V222, P241, DOI 10.1016/j.atherosclerosis.2012.02.008; Nasr N, 2011, STROKE, V42, P3616, DOI 10.1161/STROKEAHA.111.624684; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Paramsothy P, 2012, AM J CARDIOL, V109, P658, DOI 10.1016/j.amjcard.2011.10.021; Prabhakaran S, 2006, STROKE, V37, P2696, DOI 10.1161/01.STR.0000244780.82190.a4; Sangiorgi G, 2013, J VASC SURG, V57, P338, DOI 10.1016/j.jvs.2012.07.052; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Song AQ, 2014, EUR J PREV CARDIOL, V21, P1267, DOI 10.1177/2047487313487621; Starke RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071954; van Oijen M, 2007, ANN NEUROL, V61, P403, DOI 10.1002/ana.21073; Welmer AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065815; Wendell CR, 2012, STROKE, V43, P3319, DOI 10.1161/STROKEAHA.112.672527; World Health Organization (WHO), STEPWISE APPR SURV S; Ylitalo KR, 2011, DIABETES CARE, V34, P1642, DOI 10.2337/dc10-2150; Zhan YQ, 2012, J EPIDEMIOL, V22, P454, DOI 10.2188/jea.JE20110140	38	24	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85927	10.1371/journal.pone.0085927	http://dx.doi.org/10.1371/journal.pone.0085927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465793	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000076
J	Liu, L; Hao, ZZ; Liu, YY; Wei, XX; Cun, YZ; Wang, XQ				Liu, Liu; Hao, Zhen-Zhen; Liu, Yan-Yan; Wei, Xiao-Xin; Cun, Yu-Zhi; Wang, Xiao-Quan			Phylogeography of Pinus armandii and Its Relatives: Heterogeneous Contributions of Geography and Climate Changes to the Genetic Differentiation and Diversification of Chinese White Pines	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; POPULATION-GROWTH; MITOCHONDRIAL; PINACEAE; CHLOROPLAST; PHYLOGENY; HISTORY; DIVERGENCE; SOFTWARE; IMPRINTS	Geographic barriers and Quaternary climate changes are two major forces driving the evolution, speciation, and genetic structuring of extant organisms. In this study, we used Pinus armandii and eleven other Asian white pines (subsection Strobus, subgenus Pinus) to explore the influences of geographic factors and Pleistocene climatic oscillations on species in South China, a region known to be centers of plant endemism and biodiversity hotspots. Range-wide patterns of genetic variation were investigated using chloroplast and mitochondrial DNA markers, with extensive sampling throughout the entire range of P. armandii. Both cpDNA and mtDNA revealed that P. armandii exhibits high levels of genetic diversity and significant population differentiation. Three geographically distinct subdivisions corresponding to the Qinling-Daba Mountains (QDM), Himalaya-Hengduan Mountains (HHM) and Yungui Plateau (YGP) were revealed in mainland China by cpDNA. Their break zone was located in the southeastern margin of the Qinghai-Tibetan Plateau (QTP). A series of massive mountains, induced by the QTP uplift, imposed significant geographic barriers to genetic exchange. The disjunct distribution patterns of ancestral haplotypes suggest that a large continuous population of the white pines may have existed from southwest to subtropical China. Repeated range shifts in response to the Pleistocene glaciations led to the isolation and diversification of the subtropical species. The two Taiwanese white pines share a common ancestor with the species in mainland China and obtain their chloroplasts via long-distance pollen dispersal from North Asian pines. Distinct genetic patterns were detected in populations from the Qinling-Daba Mountains, Yungui Plateau, Himalaya-Hengduan Mountains, and subtropical China, indicating significant contributions of geographic factors to the genetic differentiation in white pines. Our study depicts a clear picture of the evolutionary history of Chinese white pines and highlights the heterogeneous contributions of geography and Pleistocene climatic fluctuations to the extremely high plant species diversity and endemism in South China.	[Liu, Liu; Hao, Zhen-Zhen; Liu, Yan-Yan; Wei, Xiao-Xin; Wang, Xiao-Quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Liu, Liu; Hao, Zhen-Zhen; Liu, Yan-Yan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Cun, Yu-Zhi] Dali Univ, Dali, Yunnan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Dali University	Wei, XX (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	weixx@ibcas.ac.cn			National Natural Science Foundation of China [31270422, 30730010, 31160047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant nos. 31270422, 30730010, 31160047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa M, 2007, MOL ECOL, V16, P3393, DOI 10.1111/j.1365-294X.2007.03391.x; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Ann W, 2007, MOL BIOL EVOL, V24, P90, DOI 10.1093/molbev/msl131; Businsky Roman, 2004, Willdenowia, V34, P209, DOI 10.3372/wi.34.34120; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; [陈之端 Chen Zhiduan], 2012, [植物学报, Chinese Bulletin of Botany], V47, P551; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; CRITCHFIELD WB, 1984, P 8 N AM FOR BIOL WO, P70; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duminil J, 2002, MOL ECOL NOTES, V2, P428, DOI 10.1046/j.1471-8286.2002.00263.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farjon A, 2001, WORLD CHECKLIST BIBL; Fu LK, 1999, FLORA CHINA, V4; Fu YX, 1997, GENETICS, V147, P915; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gernandt DS, 2008, INT J PLANT SCI, V169, P1086, DOI 10.1086/590472; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harris N, 2006, PALAEOGEOGR PALAEOCL, V241, P4, DOI 10.1016/j.palaeo.2006.07.009; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Jaramillo-Correa JP, 2004, MOL ECOL, V13, P2735, DOI 10.1111/j.1365-294X.2004.02258.x; Jaramillo-Correa JP, 2006, MOL ECOL, V15, P2787, DOI 10.1111/j.1365-294X.2006.02974.x; Jia GD, 2003, GEOLOGY, V31, P1093, DOI 10.1130/G19992.1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ma C. G., 1992, S SEL OPT SEED SOURC; Ma XF, 2006, MOL BIOL EVOL, V23, P807, DOI 10.1093/molbev/msj100; Mayr E., 1942, SYSTEMATICS ORIGIN S; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Mittermeier R, 2005, HOTSPOTS REVISITED E; Nylander J, 2004, MR MODELTEST V2 PROG; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pons O, 1996, GENETICS, V144, P1237; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qin AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056243; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Ran JH, 2006, MOL PHYLOGENET EVOL, V41, P405, DOI 10.1016/j.ympev.2006.05.039; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Syring J, 2007, SYST BIOL, V56, P163, DOI 10.1080/10635150701258787; TAJIMA F, 1989, GENETICS, V123, P585; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian S, 2008, ANN BOT-LONDON, V102, P69, DOI 10.1093/aob/mcn068; Tian S, 2010, PLANT SYST EVOL, V284, P219, DOI 10.1007/s00606-009-0246-9; Tsutsui K, 2009, J PLANT RES, V122, P509, DOI 10.1007/s10265-009-0246-4; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Wang H., 2004, USDA SERV P RMRS P, V32, P73; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Wang J, 2009, J BIOGEOGR, V36, P2156, DOI 10.1111/j.1365-2699.2009.02165.x; Wang XQ, 2000, MOL BIOL EVOL, V17, P773, DOI 10.1093/oxfordjournals.molbev.a026356; Wei XX, 2011, TREE GENET GENOMES, V7, P1025, DOI 10.1007/s11295-011-0392-4; WILLYARD A, 2006, MOL BIOL EVOL, V23, P1; Wu SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055315; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yan F, 2013, MOL ECOL, V22, P1120, DOI 10.1111/mec.12153; Yang FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037196; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Zhang DC, 2009, NORD J BOT, V27, P405, DOI 10.1111/j.1756-1051.2008.00235.x	66	53	60	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85920	10.1371/journal.pone.0085920	http://dx.doi.org/10.1371/journal.pone.0085920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24533149	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500144
J	Li, CH; Yang, YC; Wu, JS; Huang, YH; Lee, CT; Lu, FH; Chang, CJ				Li, Chung-Hao; Yang, Yi-Ching; Wu, Jin-Shang; Huang, Ying-Hsiang; Lee, Chih-Ting; Lu, Feng-Hwa; Chang, Chih-Jen			Increased Tea Consumption Is Associated with Decreased Arterial Stiffness in a Chinese Population	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ALCOHOL-CONSUMPTION; INSULIN-RESISTANCE; AORTIC STIFFNESS; HEART-DISEASE; RISK	Background: Tea has attracted considerable attention for its potential cardioprotective effects. The primary chemical components of tea are thought to have a beneficial effect by reducing arterial stiffness. The objective of this study was to assess the association between tea consumption and brachial-ankle pulse wave velocity (baPWV) in a relatively healthy Chinese population. Methods: We enrolled 3,135 apparently healthy subjects from October 2006 to August 2009. Subjects taking medication for diabetes, hypertension, or hyperlipidemia, or with a history of cardiovascular disease, were excluded from the study. The subjects were categorized into three groups according to their tea-drinking habits: (1) none to low (n = 1615), defined as non-habitual tea drinkers, or drinking for <1 year, or drinking <= 150 mL per day for >= 1 year; (2) moderate tea consumption, defined as drinking for >= 1 year and consumption between 151 and 450 mL per day; and (3) heavy tea consumption, defined as a drinking for >= 1 year and consumption >450 mL per day. Multiple logistic regression was used to determine whether different levels of consumption were independently associated with the highest quartile of baPWV values, defined as >= 1428.5 cm/s. Results: Of the 3,135 subjects, 48.5% had drunk >150 mL of tea per day for at least 1 year. In multivariate regression analysis with adjustment for co-variables, including, age, sex, current smoking, alcohol use, habitual exercise, total cholesterol/high-density lipoprotein cholesterol (TC/HDL-C) ratio >5, obesity, newly diagnosed hypertension and diabetes, subjects with high tea consumption had a decreased risk of highest quartile of baPWV by 22% (odds ratio = 0.78, 95% confidence interval = 0.62-0.98, p = 0.032), while subjects with moderate tea consumption did not (p = 0.742), as compared subjects with none to low tea consumption. Conclusions: High, but not moderate, habitual tea consumption may decrease arterial stiffness.	[Li, Chung-Hao] China Med Univ, Tainan Municipal An Nan Hosp, Dept Family Med, Taichung, Taiwan; [Yang, Yi-Ching; Wu, Jin-Shang; Huang, Ying-Hsiang; Lee, Chih-Ting; Lu, Feng-Hwa; Chang, Chih-Jen] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan; [Yang, Yi-Ching; Wu, Jin-Shang; Lu, Feng-Hwa; Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan 70101, Taiwan	China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Chang, CJ (corresponding author), Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan.	smallhear@gmail.com	LI, CHUNG-HAO/W-6529-2019; Yang, Yi-Ching/C-7033-2014	LI, CHUNG-HAO/0000-0001-5062-8128; Yang, Yi-Ching/0000-0003-1391-8040	Department of Family Medicine, National Cheng-Kung University Hospital [NCKUHFM-101-001]; National Science Council, Taiwan, R.O.C.	Department of Family Medicine, National Cheng-Kung University Hospital; National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This study was supported by the grants from the Department of Family Medicine, National Cheng-Kung University Hospital (NCKUHFM-101-001). The authors would like to thank the National Science Council, Taiwan, R.O.C. for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; Arsenault Benoit J, 2009, J Am Coll Cardiol, V55, P35, DOI 10.1016/j.jacc.2009.07.057; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Deka A, 2011, PHARMACOL RES, V64, P136, DOI 10.1016/j.phrs.2011.03.009; Grassi D, 2009, J HYPERTENS, V27, P774, DOI 10.1097/HJH.0b013e328326066c; Hodgson JM, 2010, MOL ASPECTS MED, V31, P495, DOI 10.1016/j.mam.2010.09.004; Jatoi NA, 2007, HYPERTENSION, V49, P981, DOI 10.1161/HYPERTENSIONAHA.107.087338; Kawai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P609, DOI 10.1271/bbb.100785; Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Mattace-Raso FUS, 2005, J GERONTOL A-BIOL, V60, P1479, DOI 10.1093/gerona/60.11.1479; Miyai N, 2009, J HUM HYPERTENS, V23, P444, DOI 10.1038/jhh.2008.143; Motobe K, 2005, CIRC J, V69, P55, DOI 10.1253/circj.69.55; Nakanishi N, 2001, IND HEALTH, V39, P24, DOI 10.2486/indhealth.39.24; Rahman S, 2008, DIABETES RES CLIN PR, V80, P253, DOI 10.1016/j.diabres.2007.12.010; Ryu OH, 2006, DIABETES RES CLIN PR, V71, P356, DOI 10.1016/j.diabres.2005.08.001; Schmitt CA, 2009, NITRIC OXIDE-BIOL CH, V21, P77, DOI 10.1016/j.niox.2009.05.006; Stangl V, 2006, MOL NUTR FOOD RES, V50, P218, DOI 10.1002/mnfr.200500118; Tanaka H, 2005, AM J HYPERTENS, V18, P137, DOI 10.1016/j.amjhyper.2004.07.008; Todd AS, 2010, AM J CLIN NUTR, V91, P557, DOI 10.3945/ajcn.2009.28645; Tomiyama H, 2010, CIRC J, V74, P24, DOI 10.1253/circj.CJ-09-0534; Urbina EM, 2012, DIABETOLOGIA, V55, P625, DOI 10.1007/s00125-011-2412-1; Whaley MH, 2006, ACSMS GUIDELINES EXE, Vxxi; Wilkinson IB, 2009, HYPERTENSION, V54, P1213, DOI 10.1161/HYPERTENSIONAHA.109.142612; Wilkinson IB, 2002, CIRCULATION, V105, P213, DOI 10.1161/hc0202.101970; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	30	64	66	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86022	10.1371/journal.pone.0086022	http://dx.doi.org/10.1371/journal.pone.0086022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465848	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100099
J	Xiao, YH; Yan, Q; Ding, H; Luo, M; Hou, L; Zhang, M; Yao, D; Liu, HS; Li, X; Zhao, J; Pei, Y				Xiao, Yue-Hua; Yan, Qian; Ding, Hui; Luo, Ming; Hou, Lei; Zhang, Mi; Yao, Dan; Liu, Hou-Sheng; Li, Xin; Zhao, Jia; Pei, Yan			Transcriptome and Biochemical Analyses Revealed a Detailed Proanthocyanidin Biosynthesis Pathway in Brown Cotton Fiber	PLOS ONE			English	Article							PIGMENTATION; FLAVONOIDS; EVOLUTION; GENES; COLOR	Brown cotton fiber is the major raw material for colored cotton industry. Previous studies have showed that the brown pigments in cotton fiber belong to proanthocyanidins (PAs). To clarify the details of PA biosynthesis pathway in brown cotton fiber, gene expression profiles in developing brown and white fibers were compared via digital gene expression profiling and qRT-PCR. Compared to white cotton fiber, all steps from phenylalanine to PA monomers (flavan-3-ols) were significantly up-regulated in brown fiber. Liquid chromatography mass spectrometry analyses showed that most of free flavan-3-ols in brown fiber were in 2, 3-trans form (gallocatechin and catechin), and the main units of polymeric PAs were trihydroxylated on B ring. Consistent with monomeric composition, the transcript levels of flavonoid 3', 5'-hydroxylase and leucoanthocyanidin reductase in cotton fiber were much higher than their competing enzymes acting on the same substrates (dihydroflavonol 4-reductase and anthocyanidin synthase, respectively). Taken together, our data revealed a detailed PA biosynthesis pathway wholly activated in brown cotton fiber, and demonstrated that flavonoid 3', 5'-hydroxylase and leucoanthocyanidin reductase represented the primary flow of PA biosynthesis in cotton fiber.	[Xiao, Yue-Hua; Yan, Qian; Ding, Hui; Luo, Ming; Hou, Lei; Zhang, Mi; Yao, Dan; Liu, Hou-Sheng; Li, Xin; Zhao, Jia; Pei, Yan] Southwest Univ, Biotechnol Res Ctr, Chongqing, Peoples R China	Southwest University - China	Xiao, YH (corresponding author), Southwest Univ, Biotechnol Res Ctr, Chongqing, Peoples R China.	xiaoyuehua@swu.edu.cn	li, xia/HHZ-7468-2022; Xiao, Yun/A-8359-2013; Fan, Huihui/AGB-0221-2022	Fan, Huihui/0000-0003-4233-5389; Zhang, Mi/0000-0001-8180-2029; Ping, Yanyan/0000-0002-1810-1200; Arana, Tania/0000-0002-8121-2085	National Natural Science Foundation of China [31130039, 30971713, 31271769]; Genetically Modified Organisms Breeding Major Project of China [2013ZX08005005-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Breeding Major Project of China	This work was partially supported by the National Natural Science Foundation of China (31130039 to P.Y., 30971713 and 31271769 to X.Y.H) and by the Genetically Modified Organisms Breeding Major Project of China (2013ZX08005005-001 to X.Y.H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Castellarin SD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-12; Chaudhary B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-378; Efe Lale, 2009, Pak J Biol Sci, V12, P1346, DOI 10.3923/pjbs.2009.1346.1352; Feng HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058820; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gu LW, 2002, J AGR FOOD CHEM, V50, P4852, DOI 10.1021/jf020214v; HALLOIN JM, 1982, NEW PHYTOL, V90, P651, DOI 10.1111/j.1469-8137.1982.tb03274.x; He F, 2008, MOLECULES, V13, P2674, DOI 10.3390/molecules13102674; Hellstrom JK, 2008, J AGR FOOD CHEM, V56, P7617, DOI 10.1021/jf801336s; Hua SJ, 2007, CROP SCI, V47, P1540, DOI 10.2135/cropsci2006.12.0835; Hua SJ, 2009, CROP SCI, V49, P983, DOI 10.2135/cropsci2008.06.0371; Hustvedt G, 2005, J COTTON SCI, V9, P47; Jiang HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036522; Kimmel LB, 2001, AATCC REV, V1, P32; Li YJ, 2013, J PROTEOMICS, V78, P374, DOI 10.1016/j.jprot.2012.10.005; Ming L, 2003, J GENET GENOMICS, V30, P8; Murthy M.S.S., 2001, RESONANCE, V6, P29, DOI [10.1007/BF02913764, DOI 10.1007/BF02913764]; Parmar MS, 2001, TEXT RES J, V71, P1099, DOI 10.1177/004051750107101211; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tan JF, 2013, PLANT PHYSIOL, V162, P86, DOI 10.1104/pp.112.212142; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Woo HH, 2005, BIOTECHNOL LETT, V27, P365, DOI 10.1007/s10529-005-1521-7; Xiao YH, 2007, BIOCHEM BIOPH RES CO, V358, P73, DOI 10.1016/j.bbrc.2007.04.084; Yokozawa T, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/623879; Zhang ZS, 2005, EUPHYTICA, V144, P91, DOI 10.1007/s10681-005-4629-x; Zhao J, 2010, PLANT PHYSIOL, V153, P437, DOI 10.1104/pp.110.155432; Zhu YQ, 2003, PLANT PHYSIOL, V133, P580, DOI 10.1104/pp.103.027052	34	95	101	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86344	10.1371/journal.pone.0086344	http://dx.doi.org/10.1371/journal.pone.0086344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24776767	Green Submitted, gold, Green Published			2022-12-25	WOS:000330244500233
J	Li, SS; Fan, H; An, XP; Fan, HH; Jiang, HH; Chen, YB; Tong, YG				Li, Shasha; Fan, Hang; An, Xiaoping; Fan, Huahao; Jiang, Huanhuan; Chen, Yubao; Tong, Yigang			Scrutinizing Virus Genome Termini by High-Throughput Sequencing	PLOS ONE			English	Article							BACILLUS-SUBTILIS; DNA-REPLICATION; HOST-TAKEOVER; PHAGE; COMPONENT; REVEAL; GENE	Analysis of genomic terminal sequences has been a major step in studies on viral DNA replication and packaging mechanisms. However, traditional methods to study genome termini are challenging due to the time-consuming protocols and their inefficiency where critical details are lost easily. Recent advances in next generation sequencing (NGS) have enabled it to be a powerful tool to study genome termini. In this study, using NGS we sequenced one iridovirus genome and twenty phage genomes and confirmed for the first time that the high frequency sequences (HFSs) found in the NGS reads are indeed the terminal sequences of viral genomes. Further, we established a criterion to distinguish the type of termini and the viral packaging mode. We also obtained additional terminal details such as terminal repeats, multi-termini, asymmetric termini. With this approach, we were able to simultaneously detect details of the genome termini as well as obtain the complete sequence of bacteriophage genomes. Theoretically, this application can be further extended to analyze larger and more complicated genomes of plant and animal viruses. This study proposed a novel and efficient method for research on viral replication, packaging, terminase activity, transcription regulation, and metabolism of the host cell.	[Li, Shasha; Fan, Hang; An, Xiaoping; Fan, Huahao; Jiang, Huanhuan; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Chen, Yubao] Beijing Comp Ctr, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Chen, YB (corresponding author), Beijing Comp Ctr, Beijing, Peoples R China.	allexchen@126.com; tong.yigang@gmail.com	Fan, Huahao/AAR-8062-2021; Fan, Hang/AAA-8489-2022	Fan, Huahao/0000-0001-5007-2158; Fan, Hang/0000-0002-7927-1684; Tong, Yigang/0000-0002-8503-8045	National Natural Science Foundation of China [30872223]; National Hi-Tech Research and Development (863) Program of China [2012AA022-003]; China Mega-Project on Infectious Disease Prevention [2013ZX10004-605]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development (863) Program of China(National High Technology Research and Development Program of China); China Mega-Project on Infectious Disease Prevention	This research was supported by grants from the National Natural Science Foundation of China (NO. 30872223), the National Hi-Tech Research and Development (863) Program of China (No. 2012AA022-003), and the China Mega-Project on Infectious Disease Prevention (No. 2013ZX10004-605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BHATTACHARYYA SP, 1994, GENE, V146, P67, DOI 10.1016/0378-1119(94)90834-6; BHATTACHARYYA SP, 1993, VIROLOGY, V196, P34, DOI 10.1006/viro.1993.1452; Born Y, 2011, APPL ENVIRON MICROB, V77, P5945, DOI 10.1128/AEM.03022-10; Braid MD, 2004, J BACTERIOL, V186, P6560, DOI 10.1128/JB.186.19.6560-6574.2004; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; CATALANO CE, 1995, MOL MICROBIOL, V16, P1075, DOI 10.1111/j.1365-2958.1995.tb02333.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; ESCARMIS C, 1981, P NATL ACAD SCI-BIOL, V78, P1446, DOI 10.1073/pnas.78.3.1446; Fan HH, 2012, J VIROL, V86, P13861, DOI 10.1128/JVI.02684-12; Fouts DE, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-165; Fujisawa H, 1997, GENES CELLS, V2, P537, DOI 10.1046/j.1365-2443.1997.1450343.x; GOORHA R, 1982, P NATL ACAD SCI-BIOL, V79, P248, DOI 10.1073/pnas.79.2.248; GORDON A., 2011, FASTX TOOLKIT COMPUT; Jiang XF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-194; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Kutter E., 2005, BACTERIOPHAGES BIOL; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lobocka M, 2012, ADV VIRUS RES, V83, P143, DOI 10.1016/B978-0-12-394438-2.00005-0; MONTAG D, 1989, J BACTERIOL, V171, P4378, DOI 10.1128/JB.171.8.4378-4384.1989; OHMORI H, 1988, J MOL BIOL, V202, P1, DOI 10.1016/0022-2836(88)90512-8; Oliveira L, 2005, J MOL BIOL, V353, P529, DOI 10.1016/j.jmb.2005.08.063; Pennisi E, 2010, SCIENCE, V327, P1190, DOI 10.1126/science.327.5970.1190; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rao Venigalla B., 2005, P40; Sambrook J, 2001, MOL CLONING LAB MANU; Sampath A, 2004, J BACTERIOL, V186, P1785, DOI 10.1128/JB.186.6.1785-1792.2004; Sheng W, 2010, J MED COLL PLA, V25, P331; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stewart CR, 2009, VIROLOGY, V392, P271, DOI 10.1016/j.virol.2009.06.046; Stewart CR, 2009, J MOL BIOL, V388, P48, DOI 10.1016/j.jmb.2009.03.009; Stewart CR, 1998, VIROLOGY, V246, P329, DOI 10.1006/viro.1998.9197; Sun S, 2012, P NATL ACAD SCI USA, V109, P817, DOI 10.1073/pnas.1110224109; WEI P, 1993, J BACTERIOL, V175, P7887, DOI 10.1128/JB.175.24.7887-7900.1993; ZABALLOS A, 1986, GENE, V43, P103, DOI 10.1016/0378-1119(86)90013-2; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang J, 2011, J GENETICS GENOMICS	39	179	185	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85806	10.1371/journal.pone.0085806	http://dx.doi.org/10.1371/journal.pone.0085806			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465717	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500075
J	Shen, D; Mao, WD; Liu, T; Lin, QF; Lu, XD; Wang, Q; Lin, F; Ekelund, U; Wijndaele, K				Shen, Dong; Mao, Weidong; Liu, Tao; Lin, Qingfeng; Lu, Xiangdong; Wang, Qiong; Lin, Feng; Ekelund, Ulf; Wijndaele, Katrien			Sedentary Behavior and Incident Cancer: A Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							RECREATIONAL PHYSICAL-ACTIVITY; TELEVISION VIEWING TIME; ALL-CAUSE MORTALITY; NIH-AARP DIET; CARDIOVASCULAR-DISEASE; ENDOMETRIAL CANCER; BREAST-CANCER; SITTING TIME; RECTAL-CANCER; LARGE COHORT	Background: Sedentary behavior is ubiquitous in modern adults' daily lives and it has been suggested to be associated with incident cancer. However, the results have been inconsistent. In this study, we performed a systematic review and meta-analysis of prospective cohort studies to clarify the association between sedentary behavior and incident cancer. Method: PubMed and Embase databases were searched up to March 2014. All prospective cohort studies on the association between sedentary behavior and incident cancer were included. The summary relative risks (RRs) with 95% confidence intervals (CIs) were estimated using random effect model. Results: A total of 17 prospective studies from 14 articles, including a total of 857,581 participants and 18,553 cases, were included in the analysis for sedentary behavior and risk of incident cancer. The overall meta-analysis suggested that sedentary behavior increased risk of cancer (RR = 1.20, 95% CI = 1.12-1.28), with no evidence of heterogeneity between studies (I-2 = 7.3%, P = 0.368). Subgroup analyses demonstrated that there were statistical associations between sedentary behavior and some cancer types (endometrial cancer: RR = 1.28, 95% CI = 1.08-1.53; colorectal cancer: RR = 1.30, 95% CI = 1.12-1.49; breast cancer: RR = 1.17, 95% CI = 1.03-1.33; lung cancer: RR = 1.27, 95% CI = 1.06-1.52). However, there was no association of sedentary behavior with ovarian cancer (RR = 1.26, 95% CI = 0.87-1.82), renal cell carcinoma (RR = 1.11, 95% CI = 0.87-1.41) or non-Hodgkin lymphoid neoplasms (RR = 1.09, 95% CI = 0.82-1.43). Conclusion: The present meta-analysis suggested that prolonged sedentary behavior was independently associated with an increased risk of incident endometrial, colorectal, breast, and lung cancers, but not with ovarian cancer, renal cell carcinoma or non-Hodgkin lymphoid neoplasms.	[Shen, Dong; Mao, Weidong; Liu, Tao; Lin, Qingfeng; Lu, Xiangdong; Wang, Qiong; Lin, Feng] Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Oncol, Jiangyin, Peoples R China; [Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway; [Ekelund, Ulf; Wijndaele, Katrien] Univ Cambridge, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England	Southeast University - China; Norwegian School of Sport Sciences; University of Cambridge	Shen, D (corresponding author), Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Oncol, Jiangyin, Peoples R China.	dong_shen2000@126.com; weidmao@126.com	Zhou, Fan/GWU-9492-2022; Ekelund, Ulf/AAE-8471-2019; Wijndaele, Katrien/H-5465-2013	Ekelund, Ulf/0000-0003-2115-9267; Liu, Yang/0000-0002-3424-7111; Lin, Qingfeng/0000-0001-5615-5130; Wijndaele, Katrien/0000-0003-2199-7981	Medical Research Council [MC_UU_12015/3]; British Heart Foundation [FS/12/58/29709]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	This work is partially funded by the Medical Research Council (MC_UU_12015/3) and the British Heart Foundation (FS/12/58/29709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery L, 2012, DIABETES CARE, V35, P2681, DOI 10.2337/dc11-2452; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cohen SS, 2013, CANCER PREV RES, V6, P566, DOI 10.1158/1940-6207.CAPR-13-0045; Cong YJ, 2014, BRIT J CANCER, V110, P817, DOI 10.1038/bjc.2013.709; Craft LL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-122; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekelund U, 2012, INT J EPIDEMIOL, V41, P1353, DOI 10.1093/ije/dys128; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Friberg E, 2006, CANCER EPIDEM BIOMAR, V15, P2136, DOI 10.1158/1055-9965.EPI-06-0465; George SM, 2011, ANN EPIDEMIOL, V21, P787, DOI 10.1016/j.annepidem.2011.04.012; George SM, 2010, AM J PUBLIC HEALTH, V100, P2288, DOI 10.2105/AJPH.2009.180828; Gierach GL, 2009, INT J CANCER, V124, P2139, DOI 10.1002/ijc.24059; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Howard RA, 2008, CANCER CAUSE CONTROL, V19, P939, DOI 10.1007/s10552-008-9159-0; Lam TK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070672; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V19, P2691, DOI 10.1158/1055-9965.EPI-10-0815; MANTEL N, 1959, J NATL CANCER I, V22, P719; Patel AV, 2008, INT J CANCER, V123, P1877, DOI 10.1002/ijc.23716; Patel AV, 2006, AM J EPIDEMIOL, V163, P709, DOI 10.1093/aje/kwj098; Pronk A, 2011, BRIT J CANCER, V105, P1443, DOI 10.1038/bjc.2011.370; Robsahm TE, 2013, EUR J CANCER PREV, V22, P492, DOI 10.1097/CEJ.0b013e328360f434; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Simons CCJM, 2013, AM J EPIDEMIOL, V177, P514, DOI 10.1093/aje/kws280; Teras LR, 2012, INT J CANCER, V131, P1912, DOI 10.1002/ijc.27445; The Nielsen Company, 3 SCREEN REP; Ukawa S, 2013, CANCER CAUSE CONTROL, V24, P1547, DOI 10.1007/s10552-013-0231-z; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Xiao Q, 2013, CANCER EPIDEM BIOMAR, V22, P2000, DOI 10.1158/1055-9965.EPI-13-0154	35	114	122	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105709	10.1371/journal.pone.0105709	http://dx.doi.org/10.1371/journal.pone.0105709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	24466095	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200073
J	Garcia-Sherman, MC; Lysak, N; Filonenko, A; Richards, H; Sobonya, RE; Klotz, SA; Lipke, PN				Garcia-Sherman, Melissa C.; Lysak, Nataliya; Filonenko, Alexandra; Richards, Hazel; Sobonya, Richard E.; Klotz, Stephen A.; Lipke, Peter N.			Peptide Detection of Fungal Functional Amyloids in Infected Tissue	PLOS ONE			English	Article							CANDIDA-ALBICANS ADHESIN; ALS PROTEIN FAMILY; INVASIVE CANDIDIASIS; MICROBIAL AMYLOIDS; FORMING SEQUENCES; BIOFILM FORMATION; GENE-EXPRESSION; HOST; NANODOMAINS; DIVERSITY	Many fungal cell adhesion proteins form functional amyloid patches on the surface of adhering cells. The Candida albicans Agglutinin-like sequence (Als) adhesins are exemplars for this phenomenon, and have amyloid forming sequences that are conserved between family members. The Als5p amyloid sequence mediates amyloid fibril formation and is critical for cell adhesion and biofilm formation, and is also present in the related adhesins Als1p and Als3p. We have developed a fluorescent peptide probe containing the conserved Als amyloid-forming sequence. This peptide bound specifically to yeast expressing Als5p, but not to cells lacking the adhesin. The probe bound to both yeast and hyphal forms of C. albicans. Delta als1/Delta als3 single and double deletion strains exhibited reduced fluorescence, indicating that probe binding required expression of these proteins. Additionally, the Als peptide specifically stained fungal cells in abscesses in autopsy sections. Counterstaining with calcofluor white showed colocalization with the amyloid peptide. In addition, fungi in autopsy sections derived from the gastrointestinal tract showed colocalization of the amyloid-specific dye thioflavin T and the fluorescent peptide. Collectively, our data demonstrate that we can exploit amyloid sequence specificity for detection of functional amyloids in situ.	[Garcia-Sherman, Melissa C.; Lysak, Nataliya; Filonenko, Alexandra; Richards, Hazel; Lipke, Peter N.] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; [Sobonya, Richard E.] Univ Arizona, Dept Pathol, Tucson, AZ USA; [Klotz, Stephen A.] Univ Arizona, Div Infect Dis, Tucson, AZ USA	City University of New York (CUNY) System; Brooklyn College (CUNY); University of Arizona; University of Arizona	Garcia-Sherman, MC (corresponding author), CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA.	mgarcia@brooklyn.cuny.edu	Fowler, James H/C-2750-2008; Moro, Esteban/AAB-1159-2019; Lipke, Peter N./AAW-4914-2020; Garcia-Herranz, Manuel/ABB-2617-2021; Garcia-Herranz, Manuel/L-3213-2013	Fowler, James H/0000-0001-7795-1638; Moro, Esteban/0000-0003-2894-1024; Lipke, Peter N./0000-0003-1733-0690; Garcia-Sherman, Melissa/0000-0003-1409-4397; Garcia-Herranz, Manuel/0000-0002-4252-4975	National Institutes of Health [R01 GM098616, SC1 GM083756]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 GM098616 and SC1 GM083756 to PNL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035305; Alsteens D, 2012, ACS NANO, V6, P7703, DOI 10.1021/nn3025699; Alsteens D, 2010, P NATL ACAD SCI USA, V107, P20744, DOI 10.1073/pnas.1013893107; Aoki W, 2012, FEMS IMMUNOL MED MIC, V65, P121, DOI 10.1111/j.1574-695X.2012.00941.x; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Bois M, 2013, EUKARYOT CELL, V12, P703, DOI 10.1128/EC.00020-13; Chauhan Neeraj, 2009, V499, P197, DOI 10.1007/978-1-60327-151-6_18; Cheng G, 2005, INFECT IMMUN, V73, P1656, DOI 10.1128/IAI.73.3.1656-1663.2005; Dong JH, 2010, NEUROPHARMACOLOGY, V59, P268, DOI 10.1016/j.neuropharm.2010.04.007; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Falabella P, 2012, INSECT BIOCHEM MOLEC, V42, P203, DOI 10.1016/j.ibmb.2011.11.011; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frank AT, 2010, EUKARYOT CELL, V9, P405, DOI 10.1128/EC.00235-09; Fu Y, 2002, MOL MICROBIOL, V44, P61, DOI 10.1046/j.1365-2958.2002.02873.x; Ganguly S, 2011, CURR OPIN MICROBIOL, V14, P380, DOI 10.1016/j.mib.2011.06.001; Garcia MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017632; GAUTAM H, 2010, J INT ASS PHYS AIDS, P38112; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gilchrist KB, 2012, J INFECT DIS, V206, P1473, DOI 10.1093/infdis/jis464; Green CB, 2006, MED MYCOL, V44, P103, DOI 10.1080/13693780500086527; Harriott MM, 2010, ANTIMICROB AGENTS CH, V54, P3746, DOI 10.1128/AAC.00573-10; Hoyer LL, 2001, YEAST, V18, P49, DOI 10.1002/1097-0061(200101)18:1&lt;49::AID-YEA646&gt;3.0.CO;2-M; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Klotz SA, 2007, DIAGN MICR INFEC DIS, V59, P401, DOI 10.1016/j.diagmicrobio.2007.07.001; Klotz SA, 2007, MED MYCOL, V45, P363, DOI 10.1080/13693780701299333; Lipke PN, 2012, TRENDS MICROBIOL, V20, P59, DOI 10.1016/j.tim.2011.10.002; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Maury CPJ, 2009, J INTERN MED, V265, P329, DOI 10.1111/j.1365-2796.2008.02068.x; Morris KL, 2013, BIOCHEM J, V450, P275, DOI 10.1042/BJ20121773; Murciano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033362; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; Oli MW, 2012, MICROBIOL-SGM, V158, P2903, DOI 10.1099/mic.0.060855-0; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Pepys MB, 2012, J INFECT DIS, V206, P1339, DOI 10.1093/infdis/jis521; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Rauceo JM, 2006, EUKARYOT CELL, V5, P1664, DOI 10.1128/EC.00120-06; Rauceo JM, 2004, INFECT IMMUN, V72, P4948, DOI 10.1128/IAI.72.9.4948-4955.2004; Rautemaa R, 2011, CRIT REV MICROBIOL, V37, P328, DOI 10.3109/1040841X.2011.585606; Salgado PS, 2011, P NATL ACAD SCI USA, V108, P15775, DOI 10.1073/pnas.1103496108; Schwartz K, 2013, CURR OPIN MICROBIOL, V16, P93, DOI 10.1016/j.mib.2012.12.001; Sheppard DC, 2004, J BIOL CHEM, V279, P30480, DOI 10.1074/jbc.M401929200; Silverman RJ, 2010, INFECT IMMUN, V78, P4644, DOI 10.1128/IAI.00685-10; SOLL DR, 1991, J CLIN MICROBIOL, V29, P1702, DOI 10.1128/JCM.29.8.1702-1710.1991; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; Tokuraku K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008492; TUKEL C, 2009, CELL HOST, P38112; Zhao X, 2007, MED MYCOL, V45, P429, DOI 10.1080/13693780701377162	51	58	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86067	10.1371/journal.pone.0086067	http://dx.doi.org/10.1371/journal.pone.0086067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24718030	Green Published, gold			2022-12-25	WOS:000330244500173
J	Lv, YN; Qi, RQ; Xu, J; Di, ZH; Zheng, H; Huo, W; Zhang, L; Chen, HD; Gao, XH				Lv, Yani; Qi, Ruiqun; Xu, Jing; Di, Zhenghong; Zheng, Heng; Huo, Wei; Zhang, Li; Chen, Hongduo; Gao, Xinghua			Profiling of Serum and Urinary MicroRNAs in Children with Atopic Dermatitis	PLOS ONE			English	Article							CANCER; LUPUS; CELLS	Background: Atopic dermatitis (AD) is the most prevalent chronic inflammatory skin disease in children characterized by dermatitis and pruritus. MicroRNAs (miRNAs) have been shown as great potential biomarkers for disease fingerprints to predict prognostics. We aimed to identify miRNA signature from serum and urine for the prognosis of AD patient by genome-wide miRNA profiling analysis. Methods: Serum and urine from 30 children with AD and 28 healthy children were collected and their genome-wide miRNA expression profiles were measured by TaqMan-based array and confirmed by quantitative real-time PCR. Inflammatory factors in serum were detected by Antibody Array System. Results: miR-203 and miR-483-5p were significantly up-regulated in serum of children with AD compared with healthy children. The level of miR-483-5p in serum was significantly associated with other atopic conditions, such as rhinitis and/or asthma. However, miR-203 was markedly decreased in urine of children with AD compared with healthy children. Down-regulated miR-203 in urine was significant associated with abnormal level of serum IgE in AD patients. 7 inflammatory factors in serum were altered in children with AD compared with healthy children. Up-regulated miR-203 in serum was significantly associated with increased sTNFRI and sTNFRII. Conclusions: Up-regulated miR-483-5p in serum may be indicative of other atopic conditions in children with AD. Down-regulated miR-203 in urine may serve as a biomarker for the severity of inflammation in children with AD.	[Lv, Yani; Qi, Ruiqun; Huo, Wei; Zhang, Li; Chen, Hongduo; Gao, Xinghua] China Med Univ, Hosp 1, Dept Dermatol, Shenyang 110001, Liaoning, Peoples R China; [Xu, Jing; Di, Zhenghong; Zheng, Heng] China Med Univ, Shengjing Hosp, Dept Dermatol, Shenyang 110001, Liaoning, Peoples R China	China Medical University; China Medical University	Gao, XH (corresponding author), China Med Univ, Hosp 1, Dept Dermatol, Shenyang 110001, Liaoning, Peoples R China.	gaobarry@hotmail.com	Shan, Anshan/U-9119-2019	Wang, Jiajun/0000-0002-2086-2105	Public Welfare Research Fund for Healthcare [201202013]; Innovative Research Teams in Universities, Liaoning Bureau of Education [LT2012012]	Public Welfare Research Fund for Healthcare; Innovative Research Teams in Universities, Liaoning Bureau of Education	This work was supported by Public Welfare Research Fund for Healthcare (201202013) and Innovative Research Teams in Universities, Liaoning Bureau of Education (LT2012012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyropoulos C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054662; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; Di ZH, 2010, BRIT J DERMATOL, V163, P1132, DOI 10.1111/j.1365-2133.2010.09959.x; Ecelbarger CA, 1997, J CLIN INVEST, V99, P1852, DOI 10.1172/JCI119352; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Li A, 2013, INT J BIOCH CELL BIO; Lipozencic Jasna, 2011, Acta Medica Croatica, V65, P87; Luo Y, 2013, CLIN CHEM, V59, P658, DOI 10.1373/clinchem.2012.195297; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Qi RQ, 2012, HEPATOLOGY, V55, P1640, DOI 10.1002/hep.25558; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Sonkoly E, 2010, J ALLERGY CLIN IMMUN, V126, P581, DOI 10.1016/j.jaci.2010.05.045; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickery BP, 2007, CURR OPIN PEDIATR, V19, P89, DOI 10.1097/MOP.0b013e328012315a; Wang G, 2011, LUPUS, V20, P493, DOI 10.1177/0961203310389841; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038885; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051140; Wu TH, 2012, FISH PHYSIOL BIOCHEM, V38, P1299, DOI 10.1007/s10695-012-9617-1; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang XY, 2012, IN VITRO CELL DEV-AN, V48, P131, DOI 10.1007/s11626-012-9482-3; Zhou YF, 2014, MOL ONCOL, V8, P83, DOI 10.1016/j.molonc.2013.09.004	27	164	174	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115448	10.1371/journal.pone.0115448	http://dx.doi.org/10.1371/journal.pone.0115448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	24466055	gold, Green Published, Green Submitted			2022-12-25	WOS:000348845100067
J	Zhao, YL; Wang, HM; Chen, W; Li, YH				Zhao, Yunlei; Wang, Hongmei; Chen, Wei; Li, Yunhai			Genetic Structure, Linkage Disequilibrium and Association Mapping of Verticillium Wilt Resistance in Elite Cotton (Gossypium hirsutum L.) Germplasm Population	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEAT; QUANTITATIVE TRAIT LOCI; FIBER QUALITY; NUCLEOTIDE DIVERSITY; COMPUTER-PROGRAM; GENOME STRUCTURE; UPLAND COTTON; YIELD; QTL; SSR	Understanding the population structure and linkage disequilibrium in an association panel can effectively avoid spurious associations and improve the accuracy in association mapping. In this study, one hundred and fifty eight elite cotton (Gossypium hirsutum L.) germplasm from all over the world, which were genotyped with 212 whole genome-wide marker loci and phenotyped with an disease nursery and greenhouse screening method, were assayed for population structure, linkage disequilibrium, and association mapping of Verticillium wilt resistance. A total of 480 alleles ranging from 2 to 4 per locus were identified from all collections. Model-based analysis identified two groups (G1 and G2) and seven subgroups (G1a-c, G2a-d), and differentiation analysis showed that subgroup having a single origin or pedigree was apt to differentiate with those having a mixed origin. Only 8.12% linked marker pairs showed significant LD (P<0.001) in this association panel. The LD level for linked markers is significantly higher than that for unlinked markers, suggesting that physical linkage strongly influences LD in this panel, and LD level was elevated when the panel was classified into groups and subgroups. The LD decay analysis for several chromosomes showed that different chromosomes showed a notable change in LD decay distances for the same gene pool. Based on the disease nursery and greenhouse environment, 42 marker loci associated with Verticillium wilt resistance were identified through association mapping, which widely were distributed among 15 chromosomes. Among which 10 marker loci were found to be consistent with previously identified QTLs and 32 were new unreported marker loci, and QTL clusters for Verticillium wilt resistanc on Chr.16 were also proved in our study, which was consistent with the strong linkage in this chromosome. Our results would contribute to association mapping and supply the marker candidates for marker-assisted selection of Verticillium wilt resistance in cotton.	[Zhao, Yunlei; Wang, Hongmei; Chen, Wei; Li, Yunhai] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Wang, HM (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.	wanghm@cricaas.com.cn		Liang, Peng/0000-0001-8485-1694; Liu, Jin/0000-0002-2026-2513	National Natural Science Foundation of China [31000733]; National Hi-Tech Research and Development Program of China [2012AA101108-02-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This research was supported by the National Natural Science Foundation of China (Grant No. 31000733) and by the National Hi-Tech Research and Development Program of China (Grant No. 2012AA101108-02-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2009, GENETICA, V136, P401, DOI 10.1007/s10709-008-9337-8; Abdurakhmonov IY, 2008, MOL DIVERSITY ASS MA; [Anonymous], GENOMICS, V92, P478; Bolek Y, 2005, PLANT SCI, V168, P1581, DOI 10.1016/j.plantsci.2005.02.008; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Chen Guang, 2006, Acta Genetica Sinica, V33, P733, DOI 10.1016/S0379-4172(06)60106-6; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Bertini CHCD, 2006, GENET MOL BIOL, V29, P321, DOI 10.1590/S1415-47572006000200021; Ersoz E.S., 2007, GENOMICS ASSISTED CR, P97, DOI DOI 10.1007/978-1-4020-6295-7_5; Esbroeck G. van., 1998, Journal of Cotton Science, V2, P121; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Ha C, 2011, PLOS ONE, V6; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; He DH, 2005, EUPHYTICA, V144, P141, DOI 10.1007/s10681-005-5297-6; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Iqbal MJ, 2001, THEOR APPL GENET, V103, P547, DOI 10.1007/PL00002908; Jiang F, 2009, SCI CHINA SER C, V52, P872, DOI 10.1007/s11427-009-0110-8; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Lacape JM, 2007, MOL BREEDING, V19, P45, DOI 10.1007/s11032-006-9042-1; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Lacape JM, 2009, THEOR APPL GENET, V119, P281, DOI 10.1007/s00122-009-1037-y; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu S, 2000, CROP SCI, V40, P1459, DOI 10.2135/cropsci2000.4051459x; Ma XX, 2008, J INTEGR PLANT BIOL, V50, P491, DOI 10.1111/j.1744-7909.2008.00636.x; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Moiana L. D., 2012, African Journal of Biotechnology, V11, P11640; Morrell PL, 2005, P NATL ACAD SCI USA, V102, P2442, DOI 10.1073/pnas.0409804102; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Pritchard JK, 2000, GENETICS, V155, P945; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Rungis D, 2005, AUST J AGR RES, V56, P301, DOI 10.1071/AR04190; Schneider S, 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Song BH, 2009, GENETICS, V181, P1021, DOI 10.1534/genetics.108.095364; Stich B, 2005, THEOR APPL GENET, V111, P723, DOI 10.1007/s00122-005-2057-x; Wang Baohua, 2007, Journal of Genetics and Genomics, V34, P35, DOI 10.1016/S1673-8527(07)60005-8; WANG HM, 2007, J INTE PL BIO, V50, P174; Wang HM, 2008, J INTEGR PLANT BIOL, V50, P174, DOI 10.1111/j.1744-7909.2007.00612.x; Whitt Sr, 2003, METH MOL B, V236, P123; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang C, 2008, PLANT SCI, V174, P290, DOI 10.1016/j.plantsci.2007.11.016; Yu JW, 2007, J INTEGR PLANT BIOL, V49, P716, DOI 10.1111/j.1744-7909.2007.00459.x; Yu JW, 2013, THEOR APPL GENET, V126, P275, DOI 10.1007/s00122-012-1980-x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu JZ, 2012, G3-GENES GENOM GENET, V2, P43, DOI 10.1534/g3.111.001552; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-15; Zhang J, 2007, WORLD COTT RES C 4 L, P1014; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zhang TZ, 2003, THEOR APPL GENET, V106, P262, DOI 10.1007/s00122-002-1101-3; Zhang XueYong, 2007, Agricultural Sciences in China, V6, P255, DOI 10.1016/S1671-2927(07)60043-1; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	61	101	119	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86308	10.1371/journal.pone.0086308	http://dx.doi.org/10.1371/journal.pone.0086308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466016	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000082
J	Jia, H; Pustovyy, OM; Waggoner, P; Beyers, RJ; Schumacher, J; Wildey, C; Barrett, J; Morrison, E; Salibi, N; Denney, TS; Vodyanoy, VJ; Deshpande, G				Jia, Hao; Pustovyy, Oleg M.; Waggoner, Paul; Beyers, Ronald J.; Schumacher, John; Wildey, Chester; Barrett, Jay; Morrison, Edward; Salibi, Nouha; Denney, Thomas S.; Vodyanoy, Vitaly J.; Deshpande, Gopikrishna			Functional MRI of the Olfactory System in Conscious Dogs	PLOS ONE			English	Article							ADENYLATE-CYCLASE ACTIVITY; HUMAN BRAIN; SIGNAL CHANGES; FMRI; ACTIVATION; RESPONSES; CORTEX; BULB; RAT; STIMULATION	We depend upon the olfactory abilities of dogs for critical tasks such as detecting bombs, landmines, other hazardous chemicals and illicit substances. Hence, a mechanistic understanding of the olfactory system in dogs is of great scientific interest. Previous studies explored this aspect at the cellular and behavior levels; however, the cognitive-level neural substrates linking them have never been explored. This is critical given the fact that behavior is driven by filtered sensory representations in higher order cognitive areas rather than the raw odor maps of the olfactory bulb. Since sedated dogs cannot sniff, we investigated this using functional magnetic resonance imaging of conscious dogs. We addressed the technical challenges of head motion using a two pronged strategy of behavioral training to keep dogs' head as still as possible and a single camera optical head motion tracking system to account for residual jerky movements. We built a custom computer-controlled odorant delivery system which was synchronized with image acquisition, allowing the investigation of brain regions activated by odors. The olfactory bulb and piriform lobes were commonly activated in both awake and anesthetized dogs, while the frontal cortex was activated mainly in conscious dogs. Comparison of responses to low and high odor intensity showed differences in either the strength or spatial extent of activation in the olfactory bulb, piriform lobes, cerebellum, and frontal cortex. Our results demonstrate the viability of the proposed method for functional imaging of the olfactory system in conscious dogs. This could potentially open up a new field of research in detector dog technology.	[Jia, Hao; Beyers, Ronald J.; Denney, Thomas S.; Deshpande, Gopikrishna] Auburn Univ, Dept Elect & Comp Engn, MRI Res Ctr, Auburn, AL 36849 USA; [Pustovyy, Oleg M.; Morrison, Edward; Vodyanoy, Vitaly J.] Auburn Univ, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA; [Waggoner, Paul] Auburn Univ, Canine Detect Res Inst, Auburn, AL 36849 USA; [Schumacher, John] Auburn Univ, Dept Clin Sci, Auburn, AL 36849 USA; [Wildey, Chester] MRRA Inc, Euless, TX USA; [Barrett, Jay] Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA; [Salibi, Nouha] Siemens Healthcare, MR R&D, Malvern, PA USA; [Denney, Thomas S.; Deshpande, Gopikrishna] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Siemens AG; Auburn University System; Auburn University	Deshpande, G (corresponding author), Auburn Univ, Dept Elect & Comp Engn, MRI Res Ctr, Auburn, AL 36849 USA.	gopi@auburn.edu	; Wang, Nian/HDM-2087-2022	Deshpande, Gopikrishna/0000-0001-7471-5357; Denney, Thomas/0000-0002-6695-4777; Wang, Nian/0000-0001-7743-0728	Auburn University Intramural Level-3 from the Office of the Vice President for Research, Auburn University; Defense Advanced Research Projects Agency [W911QX-13-C-0123]	Auburn University Intramural Level-3 from the Office of the Vice President for Research, Auburn University; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The authors acknowledge financial support for this work from Auburn University Intramural Level-3 research grant from the Office of the Vice President for Research, Auburn University. This work was also supported by The Defense Advanced Research Projects Agency (government contract/grant number W911QX-13-C-0123). The views, opinions, and/or findings contained in this article are those of the authors and should not be interpreted as representing the official views or policies, either expressed or implied, of the Defense Advanced Research Projects Agency, Department of Defense or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Bear MF, 2007, NEUROSCIENCE EXPLORI, P265; Bednarski R, 2011, J AM ANIM HOSP ASSOC, V47, P377, DOI 10.5326/JAAHA-MS-5846; Bensafi M, 2008, NEUROSCIENCE, V154, P832, DOI 10.1016/j.neuroscience.2008.03.079; Berns GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038027; Boyett-Anderson JM, 2003, NEUROIMAGE, V20, P257, DOI 10.1016/S1053-8119(03)00288-X; BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769, DOI 10.1148/radiology.182.3.1535892; BUTTS K, 1994, MAGNET RESON MED, V31, P67, DOI 10.1002/mrm.1910310111; Datta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052140; De Groof G, 2013, BEHAV BRAIN RES, V239, P43, DOI 10.1016/j.bbr.2012.10.044; DOTY RL, 1990, BRAIN RES, V527, P130, DOI 10.1016/0006-8993(90)91070-W; Ferris CF, 2011, REV NEUROSCIENCE, V22, P665, DOI 10.1515/RNS.2011.050; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Frederick BR, 1962, J COMP PHYSIOL PSYCH, V55, P773; Frey S, 2011, NEUROIMAGE, V55, P1435, DOI 10.1016/j.neuroimage.2011.01.040; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Gottfried JA, 2005, BRAIN RES REV, V50, P287, DOI 10.1016/j.brainresrev.2005.08.004; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Harel D, 2003, COMPUT BIOL CHEM, V27, P121, DOI 10.1016/S1476-9271(02)00092-0; Hirai T, 1996, NEUROPATH APPL NEURO, V22, P531, DOI 10.1111/j.1365-2990.1996.tb01132.x; Howell TJ, 2012, BEHAV PROCESS, V89, P8, DOI 10.1016/j.beproc.2011.09.009; Jensen P, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P1, DOI 10.1079/9781845931872.0000; Kandel, 2000, PRICIPLES NEURAL SCI; Kondoh T, 2005, CHEM SENSES, V30, pI172, DOI 10.1093/chemse/bjh169; KRESTEL D, 1984, NEUROSCI BIOBEHAV R, V8, P169, DOI 10.1016/0149-7634(84)90037-X; Kruse A, 2007, DEFENSE SCI RES TECH; Kujala MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061818; Lorig TS, 1999, BEHAV RES METH INS C, V31, P370, DOI 10.3758/BF03207734; LOWE G, 1988, CHEM SENSES, V13, P710; Lowen SB, 2006, BEHAV RES METHODS, V38, P307, DOI 10.3758/BF03192782; MacFarlane DL, 2010, IEEE ENG MED BIO, P5673, DOI 10.1109/IEMBS.2010.5627894; Martin C, 2007, NEUROIMAGE, V36, P1288, DOI 10.1016/j.neuroimage.2007.04.029; Mori K, 2005, CHEM SENSES, V30, pI103, DOI 10.1093/chemse/bjh135; NADI NS, 1980, J NEUROCHEM, V34, P138, DOI 10.1111/j.1471-4159.1980.tb04632.x; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Orban GA, 2001, CURR OPIN NEUROL, V14, P47, DOI 10.1097/00019052-200102000-00008; OTTOSON D, 1955, Acta Physiol Scand Suppl, V35, P1; Oxley JC, 2009, ASPECTS OF EXPLOSIVES DETECTION, P27, DOI 10.1016/B978-0-12-374533-0.00003-9; PATHIRANA S, 1992, J AM CHEM SOC, V114, P1404, DOI 10.1021/ja00030a041; Peeters RR, 2001, MAGN RESON IMAGING, V19, P821, DOI 10.1016/S0730-725X(01)00391-5; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Popp R, 2004, ACTA NEUROBIOL EXP, V64, P171; PRICE S, 1978, CHEM SENS FLAV, V3, P51, DOI 10.1093/chemse/3.1.51; Qin L, 2009, MAGN RESON MED, V62, P924, DOI 10.1002/mrm.22076; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Ross H. E., 1996, EH WEBER TACTILE SEN, V2; Savic I, 2005, CHEM SENSES, V30, pI222, DOI 10.1093/chemse/bjh194; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Slotnick B, 2005, OLFACTOMETRY MICE; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Sommer JU, 2012, J NEUROSCI METH, V209, P189, DOI 10.1016/j.jneumeth.2012.05.026; Studzinski CM, 2005, PROG NEURO-PSYCHOPH, V29, P489, DOI 10.1016/j.pnpbp.2004.12.014; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Tornqvist H, 2013, ANIM COGN, V16, P973, DOI 10.1007/s10071-013-0630-2; Tremblay M, 2005, MAGN RESON MED, V53, P141, DOI 10.1002/mrm.20319; Viswaprakash N, 2009, CHEM SENSES, V34, P547, DOI 10.1093/chemse/bjp031; Vodyanoy V, 2005, US Patent, Patent No. [6,979,298, 69792982712]; Walker DB, 2006, APPL ANIM BEHAV SCI, V97, P241, DOI 10.1016/j.applanim.2005.07.009; Wildey C, 2011, APPL OPTICS, V50, P2088, DOI 10.1364/AO.50.002088; Williams M, 2002, APPL ANIM BEHAV SCI, V78, P55, DOI 10.1016/S0168-1591(02)00081-3; Williams M, 1998, P SOC PHOTO-OPT INS, V3575, P291, DOI 10.1117/12.334998; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; Youngentob SL, 2006, BEHAV NEUROSCI, V120, P1337, DOI 10.1037/0735-7044.120.6.1337; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; Zobel S, 2010, J NEUROL, V257, P2037, DOI 10.1007/s00415-010-5656-7	70	182	187	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86362	10.1371/journal.pone.0086362	http://dx.doi.org/10.1371/journal.pone.0086362			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24710347	gold, Green Published			2022-12-25	WOS:000330288000090
J	Wu, H; Jiang, TL; Huang, XB; Lin, HJ; Wang, HW; Wang, L; Niu, HX; Feng, J				Wu, Hui; Jiang, Tinglei; Huang, Xiaobin; Lin, Hongjun; Wang, Hongwei; Wang, Lei; Niu, Hongxing; Feng, Jiang			A Test of Rensch's Rule in Greater Horseshoe Bat (Rhinolophus ferrumequinum) with Female-Biased Sexual Size Dimorphism	PLOS ONE			English	Article							WING MORPHOLOGY; WATER STRIDER; BODY-SIZE; ALLOMETRY; SELECTION; CHIROPTERA; EVOLUTION; MAMMALIA; BERGMANN; FAILS	Sexual size dimorphism (SSD) is widespread within the animal kingdom. Rensch's rule describes a relationship between SSD and body size: SSD increases with body size when males are the larger sex, and decreases with body size when females are the larger sex. Rensch's rule is well supported for taxa that exhibit male-biased SSD but patterns of allometry among taxa with female-biased size dimorphism are mixed, there is evidence both for and against the rule. Furthermore, most studies have investigated Rensch's rule across a variety of taxa; but among-population studies supporting Rensch's rule are lacking, especially in taxa that display only slight SSD. Here, we tested whether patterns of intraspecific variation in SSD in greater horseshoe bats conform to Rensch's rule, and evaluated the contribution of latitude to Rensch's rule. Our results showed SSD was consistently female-biased in greater horseshoe bats, although female body size was only slightly larger than male body size. The slope of major axis regression of log(10) (male) on log(10) (female) was significantly different from 1. Forearm length for both sexes of greater horseshoe bats was significantly negatively correlated with latitude, and males displayed a slightly but nonsignificant steeper latitudinal cline in body size than females. We suggest that variation in patterns of SSD among greater horseshoe bat populations is consistent with Rensch's rule indicating that males were the more variable sex. Males did not have a steeper body size-latitude relationship than females suggesting that sex-specific latitudinal variation in body size may not be an important contributing factor to Rensch's rule. Future research on greater horseshoe bats might best focus on more comprehensive mechanisms driving the pattern of female-biased SSD variation.	[Wu, Hui; Jiang, Tinglei; Huang, Xiaobin; Lin, Hongjun; Wang, Hongwei; Wang, Lei; Feng, Jiang] NE Normal Univ, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchu, Peoples R China; [Wu, Hui; Jiang, Tinglei; Feng, Jiang] NE Normal Univ, Key Lab Wetland Ecol & Vegetat Restorat Natl Envi, Changchun, Peoples R China; [Niu, Hongxing] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Henan Normal University	Jiang, TL (corresponding author), NE Normal Univ, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchu, Peoples R China.	jiangtl730@nenu.edu.cn; fengj@nenu.edu.cn	Lin, Hongjun/G-8462-2011; Jiang, Tinglei/GQQ-9485-2022; Wu, Hao/AGE-4639-2022	Lin, Hongjun/0000-0003-1125-0681; Yang, Xiaofei/0000-0002-5118-7755; Wu, Hao/0000-0003-2340-9258	National Natural Science Foundation of China [31030011, 31100280, 31270414]; Research Fund for the Doctoral Program of Higher Education of China [20110043120015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This project was supported by grants from the National Natural Science Foundation of China (Grant No. 31030011, 31100280, 31270414), Research Fund for the Doctoral Program of Higher Education of China (20110043120015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1997, AM NAT, V149, P540, DOI 10.1086/286004; Altingham J., 1996, BATS BIOL BEHAV; ANDERSSON M, 1981, BIOL J LINN SOC, V15, P105, DOI 10.1111/j.1095-8312.1981.tb00752.x; Andersson Malte, 1994; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Benda Petr, 2007, Acta Societatis Zoologicae Bohemicae, V71, P71; Benda Petr, 2011, Acta Societatis Zoologicae Bohemicae, V75, P159; Benda Pets, 2006, Acta Societatis Zoologicae Bohemicae, V70, P1; Blanckenhorn WU, 2006, EVOLUTION, V60, P2004, DOI 10.1111/j.0014-3820.2006.tb01838.x; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Brunet-Rossinni Anja K., 2009, P315; CLUTTONBROCK TH, 1977, NATURE, V269, P797, DOI 10.1038/269797a0; Cox Robert M., 2007, P38; Dale J, 2007, P ROY SOC B-BIOL SCI, V274, P2971, DOI 10.1098/rspb.2007.1043; Darwin C, 1990, DESCENT MAN SELECTIO; Davis CM, 2008, BIOL J LINN SOC, V95, P141, DOI 10.1111/j.1095-8312.2008.01035.x; de Camargo NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049734; DeBlase A, 1980, FIELD M NAT HIST; Dietz C, 2006, J MAMMAL, V87, P1241, DOI 10.1644/05-MAMM-A-299R2.1; FAIRBAIRN DJ, 1994, AM NAT, V144, P101, DOI 10.1086/285663; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairbairn DJ, 2005, AM NAT, V166, pS69, DOI 10.1086/444600; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; FINDLEY JS, 1972, J MAMMAL, V53, P429, DOI 10.2307/1379035; Frydlova P, 2010, BIOL J LINN SOC, V100, P293, DOI 10.1111/j.1095-8312.2010.01430.x; GEIST V, 1987, CAN J ZOOL, V65, P1035, DOI 10.1139/z87-164; Hayssen V, 1996, J MAMMAL, V77, P476, DOI 10.2307/1382823; Herczeg G, 2010, J ANIM ECOL, V79, P581, DOI 10.1111/j.1365-2656.2010.01665.x; HUGHES PM, 1991, J EXP BIOL, V161, P285; KAWAI K, 2007, MAMMAL SCI, V47, P239; KOENIG WD, 1986, AM NAT, V127, P403, DOI 10.1086/284491; KRYSTUFEK B, 1993, ACTA THERIOL, V38, P67, DOI 10.4098/AT.arch.93-6; Kunz TH, 2006, BAT ECOLOGY; Lengkeek W, 2008, CAN J ZOOL, V86, P1173, DOI 10.1139/Z08-103; Liao WB, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-10; Lindenfors P, 2007, SEX SIZE GENDER ROLE, P19; Lison F, 2014, ACTA ZOOL-STOCKHOLM, V95, P137, DOI 10.1111/azo.12012; Mateju J, 2013, FRONT ZOOL, V10, P1, DOI 10.1186/1742-9994-10-27; Matthews LH, 1937, ZOOL SOC LOND, P224; MYERS P, 1978, AM NAT, V112, P701, DOI 10.1086/283312; Polak J, 2010, EVOL ECOL, V24, P1255, DOI 10.1007/s10682-010-9354-9; Preatoni D, 2000, ATTI MUS CIV ST NAT, V11, P89; R Core Team, 2021, R LANG ENV STAT COMP; Raihani G, 2006, ANIM BEHAV, V71, P833, DOI 10.1016/j.anbehav.2005.06.013; RALLS K, 1976, Q REV BIOL, V51, P245, DOI 10.1086/409310; Ransome R.D., 1991, P88; RANSOME RD, 1968, J ZOOL, V154, P77; Rossiter SJ, 2006, MOL ECOL, V15, P3035, DOI 10.1111/j.1365-294X.2006.02987.x; Serrano-Meneses MA, 2008, J EVOLUTION BIOL, V21, P1259, DOI 10.1111/j.1420-9101.2008.01567.x; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; SINHA Y P, 1973, Mammalia, V37, P603, DOI 10.1515/mamm.1973.37.4.603; Smith AT, 2010, GUIDE ESTIMATES PRB; Smith RJ, 2002, INT J PRIMATOL, V23, P1095, DOI 10.1023/A:1019654100876; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Stefen C, 2012, ACTA THERIOL, P1; Stephens PR, 2009, EVOLUTION, V63, P910, DOI 10.1111/j.1558-5646.2008.00597.x; Stevens RD, 2013, ACTA CHIROPTEROL, V15, P163, DOI 10.3161/150811013X667966; Storz JF, 2001, BIOL J LINN SOC, V72, P17, DOI 10.1006/bijl.2000.0482; Stuart-Fox D, 2009, EVOL ECOL, V23, P425, DOI 10.1007/s10682-008-9242-8; Szekely T, 2000, EVOLUTION, V54, P1404, DOI 10.1111/j.0014-3820.2000.tb00572.x; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tubaro PL, 2003, BIOL J LINN SOC, V80, P519, DOI 10.1046/j.1095-8312.2003.00252.x; Webb TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000897; WILLIAMS DF, 1979, AM MIDL NAT, V102, P113, DOI 10.2307/2425072; Wu Y., 2009, FAUNA HEBEI; Xiao Z, 1988, FAUNA LIAONING	68	49	55	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86085	10.1371/journal.pone.0086085	http://dx.doi.org/10.1371/journal.pone.0086085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465886	Green Submitted, gold, Green Published			2022-12-25	WOS:000330240500109
J	Heming, N; Urien, S; Fulda, V; Meziani, F; Gacouin, A; Clavel, M; Planquette, B; Faisy, C				Heming, Nicholas; Urien, Saik; Fulda, Virginie; Meziani, Ferhat; Gacouin, Arnaud; Clavel, Marc; Planquette, Benjamin; Faisy, Christophe			Population Pharmacodynamic Modeling and Simulation of the Respiratory Effect of Acetazolamide in Decompensated COPD Patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INTENSIVE-CARE-UNIT; MECHANICAL VENTILATION; METABOLIC ALKALOSIS; CRITICALLY-ILL; ACUTE EXACERBATION; SURVIVAL; FAILURE; PHARMACOKINETICS; DETERMINANTS	Background: Chronic obstructive pulmonary disease (COPD) patients may develop metabolic alkalosis during weaning from mechanical ventilation. Acetazolamide is one of the treatments used to reverse metabolic alkalosis. Methods: 619 time-respiratory (minute ventilation, tidal volume and respiratory rate) and 207 time-PaCO2 observations were obtained from 68 invasively ventilated COPD patients. We modeled respiratory responses to acetazolamide in mechanically ventilated COPD patients and then simulated the effect of increased amounts of the drug. Results: The effect of acetazolamide on minute ventilation and PaCO2 levels was analyzed using a nonlinear mixed effect model. The effect of different ventilatory modes was assessed on the model. Only slightly increased minute ventilation without decreased PaCO2 levels were observed in response to 250 to 500 mg of acetazolamide administered twice daily. Simulations indicated that higher acetazolamide dosage (>1000 mg daily) was required to significantly increase minute ventilation (P<.001 vs pre-acetazolamide administration). Based on our model, 1000 mg per day of acetazolamide would increase minute ventilation by >0.75 L min(-1) in 60% of the population. The model also predicts that 45% of patients would have a decrease of PaCO2>5 mmHg with doses of 1000 mg per day. Conclusions: Simulations suggest that COPD patients might benefit from the respiratory stimulant effect after the administration of higher doses of acetazolamide.	[Heming, Nicholas; Faisy, Christophe] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Sorbonne Paris Cite,Serv Reanimat Med, Paris, France; [Urien, Saik] Univ Paris 05, Hop Tarnier, AP HP,Unite Rech Clin, Sorbonne Paris Cite,CIC Cochin Necker INSERM 0110, Paris, France; [Fulda, Virginie] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Sorbonne Paris Cite,Ctr Reg Pharmacovigilance, Paris, France; [Meziani, Ferhat] Hop Civil, Serv Reanimat Med, Strasbourg, France; [Gacouin, Arnaud] Hop Pontchaillou, Serv Reanimat Med & Infect, Rennes, France; [Clavel, Marc] CHU Limoges, Serv Reanimat Polyvalente, Limoges, France; [Planquette, Benjamin] Hop Andre Mignot, Serv Reanimat Med Chirurg, Le Chesnay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; CHU Rennes; CHU Limoges; Centre Hospitalier de Versailles	Heming, N (corresponding author), Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Sorbonne Paris Cite,Serv Reanimat Med, Paris, France.	nicholas.heming@orange.fr	Urien, Saïk/G-3240-2013; PLANQUETTE, Benjamin/AAL-7166-2021	Urien, Saïk/0000-0002-1065-0600; 				Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; BERTHELSEN P, 1985, INTENS CARE MED, V11, P26; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; BRIMIOULLE S, 1989, CRIT CARE MED, V17, P232, DOI 10.1097/00003246-198903000-00006; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Faisy C, 2010, INTENS CARE MED, V36, P859, DOI 10.1007/s00134-010-1795-7; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Groenewegen KH, 2003, CHEST, V124, P459, DOI 10.1378/chest.124.2.459; Gunen H, 2005, EUR RESPIR J, V26, P234, DOI 10.1183/09031936.05.00024804; Gursel G, 2005, RESPIRATION, V72, P61, DOI 10.1159/000083402; Heming N, 2012, CRIT CARE, V16, DOI 10.1186/cc11323; Heming N, 2011, CRIT CARE, V15, DOI 10.1186/cc10448; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Khanna A, 2001, Respir Care, V46, P354; Kiwull-Schone HF, 2001, AM J RESP CRIT CARE, V163, P478, DOI 10.1164/ajrccm.163.2.9911075; Laghi F, 2012, MINERVA ANESTESIOL, V78, P201; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Mazur JE, 1999, CRIT CARE MED, V27, P1257, DOI 10.1097/00003246-199907000-00004; MENZIES R, 1989, CHEST, V95, P398, DOI 10.1378/chest.95.2.398; Moran JL, 1998, CRIT CARE MED, V26, P71, DOI 10.1097/00003246-199801000-00019; Nevins ML, 2001, CHEST, V119, P1840, DOI 10.1378/chest.119.6.1840; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ritschel WA, 1998, J CLIN PHARMACOL, V38, P533, DOI 10.1002/j.1552-4604.1998.tb05791.x; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Swenson ER, 1998, EUR RESPIR J, V12, P1242, DOI 10.1183/09031936.98.12061242; Teppema LJ, 1999, AM J RESP CRIT CARE, V160, P1592, DOI 10.1164/ajrccm.160.5.9903088; VOS PJE, 1994, EUR RESPIR J, V7, P850; Webster NR, 1999, CRIT REV CL LAB SCI, V36, P497, DOI 10.1080/10408369991239286; WONG DH, 1995, ANESTH ANALG, V80, P276, DOI 10.1097/00000539-199502000-00013; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101; Yano I, 1998, EUR J CLIN PHARMACOL, V54, P63, DOI 10.1007/s002280050422	32	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86313	10.1371/journal.pone.0086313	http://dx.doi.org/10.1371/journal.pone.0086313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24956152	Green Submitted, gold, Green Published			2022-12-25	WOS:000330237000090
J	Garcia-Herranz, M; Moro, E; Cebrian, M; Christakis, NA; Fowler, JH				Garcia-Herranz, Manuel; Moro, Esteban; Cebrian, Manuel; Christakis, Nicholas A.; Fowler, James H.			Using Friends as Sensors to Detect Global-Scale Contagious Outbreaks	PLOS ONE			English	Article								Recent research has focused on the monitoring of global-scale online data for improved detection of epidemics, mood patterns, movements in the stock market political revolutions, box-office revenues, consumer behaviour and many other important phenomena. However, privacy considerations and the sheer scale of data available online are quickly making global monitoring infeasible, and existing methods do not take full advantage of local network structure to identify key nodes for monitoring. Here, we develop a model of the contagious spread of information in a global-scale, publicly-articulated social network and show that a simple method can yield not just early detection, but advance warning of contagious outbreaks. In this method, we randomly choose a small fraction of nodes in the network and then we randomly choose a friend of each node to include in a group for local monitoring. Using six months of data from most of the full Twittersphere, we show that this friend group is more central in the network and it helps us to detect viral outbreaks of the use of novel hashtags about 7 days earlier than we could with an equal-sized randomly chosen group. Moreover, the method actually works better than expected due to network structure alone because highly central actors are both more active and exhibit increased diversity in the information they transmit to others. These results suggest that local monitoring is not just more efficient, but also more effective, and it may be applied to monitor contagious processes in global-scale networks.	[Garcia-Herranz, Manuel] Univ Autonoma Madrid, Escuela Politecn Super, Dept Comp Sci, Madrid, Spain; [Moro, Esteban] Univ Carlos III Madrid, Dept Math, Leganes, Spain; [Moro, Esteban] Univ Carlos III Madrid, GISC, Leganes, Spain; [Moro, Esteban] Univ Autonoma Madrid, Inst Ingn Conocimiento, Madrid, Spain; [Cebrian, Manuel] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92103 USA; [Cebrian, Manuel] MIT, Media Lab, Cambridge, MA 02139 USA; [Cebrian, Manuel] Natl Informat & Commun Technol Australia, Melbourne, Vic, Australia; [Christakis, Nicholas A.] Yale Univ, Dept Sociol, New Haven, CT USA; [Christakis, Nicholas A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Christakis, Nicholas A.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Fowler, James H.] Univ Calif San Diego, Sch Med, Div Med Genet, San Diego, CA 92103 USA; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, San Diego, CA 92103 USA	Autonomous University of Madrid; Universidad Carlos III de Madrid; Universidad Carlos III de Madrid; Autonomous University of Madrid; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Yale University; Yale University; Yale University; University of California System; University of California San Diego; University of California System; University of California San Diego	Garcia-Herranz, M (corresponding author), Univ Autonoma Madrid, Escuela Politecn Super, Dept Comp Sci, Madrid, Spain.	manuel.garciaherranz@uam.es	Fowler, James H/C-2750-2008; Moro, Esteban/AAB-1159-2019; Lipke, Peter N./AAW-4914-2020; Garcia-Herranz, Manuel/ABB-2617-2021; Garcia-Herranz, Manuel/L-3213-2013	Fowler, James H/0000-0001-7795-1638; Moro, Esteban/0000-0003-2894-1024; Lipke, Peter N./0000-0003-1733-0690; Garcia-Sherman, Melissa/0000-0003-1409-4397; Garcia-Herranz, Manuel/0000-0002-4252-4975	National Institute for General Medical Sciences [P-41 GM103504-03]; Pioneer Portfolio of the Robert Wood Johnson Foundation; NICTA; Australian Government; Army Research Office [W911NF-11-1-0363]; Ministerio de Educacion y Ciencia (Spain) [FIS2006-01485, FIS2010-22047-C05-04]; Spanish Government [TIN2010-17344]; R&D program of the Community of Madrid [S2009/TIC-1650]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pioneer Portfolio of the Robert Wood Johnson Foundation; NICTA(NICTA); Australian Government(Australian GovernmentCGIAR); Army Research Office; Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Spanish Government(Spanish GovernmentEuropean Commission); R&D program of the Community of Madrid; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute for General Medical Sciences (P-41 GM103504-03) (JHF) and a grant from the Pioneer Portfolio of the Robert Wood Johnson Foundation (NAC and JHF). MC acknowledges support from NICTA and the Australian Government, as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program; the DARPA/Lockheed Martin Guard Dog Program; and the Army Research Office under Grant W911NF-11-1-0363. EM acknowledges funding from Ministerio de Educacion y Ciencia (Spain) through projects i-Math, FIS2006-01485 (MOSAICO), and FIS2010-22047-C05-04. MGH acknowledges support from the Spanish Government (TIN2010-17344) and the R&D program of the Community of Madrid (S2009/TIC-1650). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achrekar H., 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P702, DOI 10.1109/INFCOMW.2011.5928903; [Anonymous], 2011, DECADE INTERNET TIME; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; Backstrom L., 2007, P 16 INT C WORLD WID, P181, DOI DOI 10.1145/1242572.1242598; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Borgs Christian, 2012, WINE, P406, DOI DOI 10.1007/978-3-642-35311-6; Brautbar Michael, 2010, INNOVATIONS THEORETI, P188; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Dodds PS, 2010, J HAPPINESS STUD, V11, P441, DOI 10.1007/s10902-009-9150-9; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Gross R., 2005, P WPES 2005, P71, DOI DOI 10.1145/1102199.1102214; Huang J., 2010, P 21 ACM C HYP HYP, P173, DOI [10.1145/1810617.1810647, DOI 10.1145/1810617.1810647]; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Leskovec J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P497; Liu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044459; Lotan G., 2011, INT J COMMUNICATION, V5, P31; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Romero D. M., 2011, P 20 INT C WORLD WID, P695, DOI [10.1145/1963405.1963503, DOI 10.1145/1963405.1963503]; Ross R, 1915, BRIT MED J, V1915, P546, DOI 10.1136/bmj.1.2830.546; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Shih HP, 2004, INFORM MANAGE-AMSTER, V41, P351, DOI 10.1016/S0378-7206(03)00079-X; Yang J., 2011, P 4 ACM INT C WEB SE, P177	31	58	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92413	10.1371/journal.pone.0092413	http://dx.doi.org/10.1371/journal.pone.0092413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718030	Green Submitted, Green Published, gold			2022-12-25	WOS:000334339000015
J	Xiao, Y; Camarillo, C; Ping, YY; Arana, TB; Zhao, HY; Thompson, PM; Xu, CH; Su, BB; Fan, HH; Ordonez, J; Wang, L; Mao, CX; Zhang, YP; Cruz, D; Escamilla, MA; Li, X; Xu, C				Xiao, Yun; Camarillo, Cynthia; Ping, Yanyan; Arana, Tania Bedard; Zhao, Hongying; Thompson, Peter M.; Xu, Chaohan; Su, Bin Brenda; Fan, Huihui; Ordonez, Javier; Wang, Li; Mao, Chunxiang; Zhang, Yunpeng; Cruz, Dianne; Escamilla, Michael A.; Li, Xia; Xu, Chun			The DNA Methylome and Transcriptome of Different Brain Regions in Schizophrenia and Bipolar Disorder	PLOS ONE			English	Article							RNA-SEQ; PSYCHIATRIC-DISORDERS; PREFRONTAL CORTEX; MAJOR DEPRESSION; POSTMORTEM-BRAIN; GENE-EXPRESSION; MESSENGER-RNA; METHYLATION; PROMOTER; REELIN	Extensive changes in DNA methylation have been observed in schizophrenia (SC) and bipolar disorder (BP), and may contribute to the pathogenesis of these disorders. Here, we performed genome-scale DNA methylation profiling using methylated DNA immunoprecipitation followed by sequencing (MeDIP-seq) on two brain regions (including frontal cortex and anterior cingulate) in 5 SC, 7 BP and 6 normal subjects. Comparing with normal controls, we identified substantial differentially methylated regions (DMRs) in these two brain regions of SC and BP. To our surprise, different brain regions show completely distinct distributions of DMRs across the genomes. In frontal cortex of both SC and BP subjects, we observed widespread hypomethylation as compared to normal controls, preferentially targeting the terminal ends of the chromosomes. In contrast, in anterior cingulate, both SC and BP subjects displayed extensive gain of methylation. Notably, in these two brain regions of SC and BP, only a few DMRs overlapped with promoters, whereas a greater proportion occurs in introns and intergenic regions. Functional enrichment analysis indicated that important psychiatric disorder-related biological processes such as neuron development, differentiation and projection may be altered by epigenetic changes located in the intronic regions. Transcriptome analysis revealed consistent dysfunctional processes with those determined by DMRs. Furthermore, DMRs in the same brain regions from SC and BP could successfully distinguish BP and/or SC from normal controls while differentially expressed genes could not. Overall, our results support a major role for brain-region-dependent aberrant DNA methylation in the pathogenesis of these two disorders.	[Arana, Tania Bedard; Escamilla, Michael A.; Xu, Chun] Texas Tech Univ Hlth Sci Ctr, Dept Psychiat, El Paso, TX USA; [Xiao, Yun; Ping, Yanyan; Zhao, Hongying; Xu, Chaohan; Su, Bin Brenda; Fan, Huihui; Wang, Li; Zhang, Yunpeng; Li, Xia; Xu, Chun] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Camarillo, Cynthia; Ordonez, Javier; Escamilla, Michael A.; Xu, Chun] Texas Tech Univ Hlth Sci Ctr, Ctr Excellence Neurosci, El Paso, TX USA; [Thompson, Peter M.; Cruz, Dianne] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, Southwest Brain Bank, San Antonio, TX 78229 USA; [Mao, Chunxiang] Univ Toronto, Toronto, ON, Canada	Texas Tech University System; Texas Tech University Health Science Center; Harbin Medical University; Texas Tech University System; Texas Tech University Health Science Center; University of Texas System; University of Texas Health San Antonio; University of Toronto	Li, X (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China.	lixia@hrbmu.edu.cn; chun.xu@ttuhsc.edu	li, xia/HHZ-7468-2022; Xiao, Yun/A-8359-2013; Fan, Huihui/AGB-0221-2022	Fan, Huihui/0000-0003-4233-5389; Zhang, Mi/0000-0001-8180-2029; Ping, Yanyan/0000-0002-1810-1200; Arana, Tania/0000-0002-8121-2085	National Natural Science Foundation of China [91129710, 31200997, 61170154]; National Science Foundation of Heilongjiang Province [C201207]; Center of Excellence in Neuroscience of the Paul L. Foster School of Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Heilongjiang Province; Center of Excellence in Neuroscience of the Paul L. Foster School of Medicine	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 91129710, 31200997, and 61170154), the National Science Foundation of Heilongjiang Province (Grant Nos. C201207) and the Center of Excellence in Neuroscience of the Paul L. Foster School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Carlson M., GO DB SET ANNOTATION; Catts VS, 2000, SCHIZOPHR RES, V41, P405, DOI 10.1016/S0920-9964(99)00077-8; Chen C, 2013, MOL PSYCHIATR, V18, P1308, DOI 10.1038/mp.2012.146; Chen C., 2012, MOL PSYCHIAT; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Gavin DP, 2010, NEUROSCI BIOBEHAV R, V34, P882, DOI 10.1016/j.neubiorev.2009.10.010; Glatt SJ, 2003, AM J PSYCHIAT, V160, P469, DOI 10.1176/appi.ajp.160.3.469; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Guintivano J, 2013, EPIGENETICS-US, V8, P290, DOI 10.4161/epi.23924; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jung S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052626; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; KINGSBURY AE, 1995, MOL BRAIN RES, V28, P311, DOI 10.1016/0169-328X(94)00219-5; Labrie V, 2012, TRENDS GENET, V28, P427, DOI 10.1016/j.tig.2012.04.002; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lam LL, 2012, P NATL ACAD SCI USA, V109, P17253, DOI 10.1073/pnas.1121249109; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Li N, 2010, METHODS, V52, P203, DOI 10.1016/j.ymeth.2010.04.009; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Mill J, 2006, AM J MED GENET B, V141B, P421, DOI 10.1002/ajmg.b.30316; Miller CL, 2004, BIOTECHNIQUES, V36, P628, DOI 10.2144/04364ST03; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishioka M, 2012, GENOME MED, V4, DOI 10.1186/gm397; Nohesara S, 2011, J PSYCHIATR RES, V45, P1432, DOI 10.1016/j.jpsychires.2011.06.013; Nothen Markus M, 2010, Dialogues Clin Neurosci, V12, P85; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290, DOI 10.1073/pnas.95.22.13290; Orozco IJ, 2014, MOL CELL NEUROSCI, V58, P76, DOI 10.1016/j.mcn.2013.12.003; Porton B, 2011, SEMIN CELL DEV BIOL, V22, P416, DOI 10.1016/j.semcdb.2011.07.007; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P323, DOI 10.1093/cercor/5.4.323; Rajkowska G, 2001, BIOL PSYCHIAT, V49, P741, DOI 10.1016/S0006-3223(01)01080-0; Rodriguez-Murillo L, 2012, ANNU REV MED, V63, P63, DOI 10.1146/annurev-med-072010-091100; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Strand AD, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030059; Tamura Y, 2007, MOL PSYCHIATR, V12, P593, DOI 10.1038/sj.mp.4001965; The Gene Ontology C, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI [10.1093/nar/gkp1018, DOI 10.1093/NAR/GKP1018]; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Veldic M, 2004, P NATL ACAD SCI USA, V101, P348, DOI 10.1073/pnas.2637013100; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	61	95	101	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e95875	10.1371/journal.pone.0095875	http://dx.doi.org/10.1371/journal.pone.0095875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776767	gold, Green Published, Green Submitted			2022-12-25	WOS:000346241800018
J	Moore, HA; Whitmore, D				Moore, Helen A.; Whitmore, David			Circadian Rhythmicity and Light Sensitivity of the Zebrafish Brain	PLOS ONE			English	Article							GENE-EXPRESSION; C-FOS; MESSENGER-RNA; DEEP BRAIN; CLOCK; SYSTEM; CELLS; PHOTORECEPTORS; DIVERSITY; PINEAL	Traditionally, circadian clocks have been thought of as a neurobiological phenomenon. This view changed somewhat over recent years with the discovery of peripheral tissue circadian oscillators. In mammals, however, the suprachiasmatic nucleus (SCN) in the hypothalamus still retains the critical role of a central synchronizer of biological timing. Zebrafish, in contrast, have always reflected a more highly decentralized level of clock organization, as individual cells and tissues contain directly light responsive circadian pacemakers. As a consequence, clock function in the zebrafish brain has remained largely unexplored, and the precise organization of rhythmic and light-sensitive neurons within the brain is unknown. To address this issue, we used the period3 (per3)-luciferase transgenic zebrafish to confirm that multiple brain regions contain endogenous circadian oscillators that are directly light responsive. In addition, in situ hybridization revealed localised neural expression of several rhythmic and light responsive clock genes, including per3, cryptochrome1a (cry1a) and per2. Adult brain nuclei showing significant clock gene expression include the teleost equivalent of the SCN, as well as numerous hypothalamic nuclei, the periventricular grey zone (PGZ) of the optic tectum, and granular cells of the rhombencephalon. To further investigate the light sensitive properties of neurons, expression of c-fos, a marker for neuronal activity, was examined. c-fos mRNA was upregulated in response to changing light conditions in different nuclei within the zebrafish brain. Furthermore, under constant dark (DD) conditions, c-fos shows a significant circadian oscillation. Taken together, these results show that there are numerous areas of the zebrafish central nervous system, which contain deep brain photoreceptors and directly light-entrainable circadian pacemakers. However, there are also multiple brain nuclei, which possess neither, demonstrating a degree of pacemaker complexity that was not previously appreciated.	[Moore, Helen A.; Whitmore, David] UCL, Ctr Cell & Mol Dynam, Dept Cell & Dev Biol, London, England	University of London; University College London	Whitmore, D (corresponding author), UCL, Ctr Cell & Mol Dynam, Dept Cell & Dev Biol, London, England.	d.whitmore@ucl.ac.uk	Zebrafish, UCL/A-3125-2009	Leary, Eileen/0000-0002-7389-6384	Biotechnology and Biological Sciences Research Council [BB/I004832/1, BB/I003592/1]; Medical Research Council Doctoral Training Account Studentship	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council Doctoral Training Account Studentship	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/I004832/1 and BB/I003592/1) and a Medical Research Council Doctoral Training Account Studentship (HAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Bally-Cuif L, 2010, FISH PHYSIOL, V29, P25, DOI 10.1016/S1546-5098(10)02902-X; Cahill GM, 1996, BRAIN RES, V708, P177, DOI 10.1016/0006-8993(95)01365-2; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Davies WIL, 2011, CELL MOL LIFE SCI, V68, P4115, DOI 10.1007/s00018-011-0785-4; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Foster RG, 1998, REV REPROD, V3, P145, DOI 10.1530/revreprod/3.3.145; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Kaneko M, 2006, P NATL ACAD SCI USA, V103, P14614, DOI 10.1073/pnas.0606563103; Kojima D, 2000, J NEUROSCI, V20, P2845; Kokel D, 2013, J NEUROSCI, V33, P3834, DOI 10.1523/JNEUROSCI.3689-12.2013; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Li XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040508; Matos-Cruz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025111; NIR I, 1993, MOL BRAIN RES, V19, P47, DOI 10.1016/0169-328X(93)90147-H; Noche RR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-7; Northcutt RG, 1987, SENSORY BIOL AQUATIC, V8, P515; Norton WHJ, 2008, J COMP NEUROL, V511, P521, DOI 10.1002/cne.21831; Novak CR, 1998, J CHEM NEUROANAT, V14, P87, DOI 10.1016/S0891-0618(97)10019-9; Onodera H, 1999, LIFE SCI, V64, P1127, DOI 10.1016/S0024-3205(99)00041-7; Pando MP, 2001, P NATL ACAD SCI USA, V98, P10178, DOI 10.1073/pnas.181228598; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; Ruuskanen JO, 2005, J NEUROCHEM, V94, P1559, DOI 10.1111/j.1471-4159.2005.03305.x; SCHWARTZ WJ, 1994, NEUROSCIENCE, V58, P573, DOI 10.1016/0306-4522(94)90082-5; Sumova A, 1998, BRAIN RES, V801, P254, DOI 10.1016/S0006-8993(98)00619-2; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Weger M, 2013, DEV BIOL, V380, P259, DOI 10.1016/j.ydbio.2013.04.035; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277; Ziv L, 2006, P NATL ACAD SCI USA, V103, P4146, DOI 10.1073/pnas.0600571103	37	77	80	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86176	10.1371/journal.pone.0086176	http://dx.doi.org/10.1371/journal.pone.0086176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465943	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100121
J	Li, SF; Gao, WJ; Zhao, XP; Dong, TY; Deng, CL; Lu, LD				Li, Shu-Fen; Gao, Wu-Jun; Zhao, Xin-Peng; Dong, Tian-Yu; Deng, Chuan-Liang; Lu, Long-Dou			Analysis of Transposable Elements in the Genome of Asparagus officinalis from High Coverage Sequence Data	PLOS ONE			English	Article							REPETITIVE SEQUENCES; SEX-CHROMOSOMES; SIZE VARIATION; RETROTRANSPOSONS	Asparagus officinalis is an economically and nutritionally important vegetable crop that is widely cultivated and is used as a model dioecious species to study plant sex determination and sex chromosome evolution. To improve our understanding of its genome composition, especially with respect to transposable elements (TEs), which make up the majority of the genome, we performed Illumina HiSeq2000 sequencing of both male and female asparagus genomes followed by bioinformatics analysis. We generated 17 Gb of sequence (126coverage) and assembled them into 163,406 scaffolds with a total cumulated length of 400 Mbp, which represent about 30% of asparagus genome. Overall, TEs masked about 53% of the A. officinalis assembly. Majority of the identified TEs belonged to LTR retrotransposons, which constitute about 28% of genomic DNA, with Ty1/copia elements being more diverse and accumulated to higher copy numbers than Ty3/gypsy. Compared with LTR retrotransposons, non-LTR retrotransposons and DNA transposons were relatively rare. In addition, comparison of the abundance of the TE groups between male and female genomes showed that the overall TE composition was highly similar, with only slight differences in the abundance of several TE groups, which is consistent with the relatively recent origin of asparagus sex chromosomes. This study greatly improves our knowledge of the repetitive sequence construction of asparagus, which facilitates the identification of TEs responsible for the early evolution of plant sex chromosomes and is helpful for further studies on this dioecious plant.	[Li, Shu-Fen; Gao, Wu-Jun; Zhao, Xin-Peng; Dong, Tian-Yu; Deng, Chuan-Liang; Lu, Long-Dou] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China; [Li, Shu-Fen; Gao, Wu-Jun; Deng, Chuan-Liang; Lu, Long-Dou] Univ Henan Prov, Key Lab Microorganisms & Funct Mol, Xinxiang, Peoples R China	Henan Normal University	Gao, WJ (corresponding author), Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China.	gaowujun1@163.com	Fan, Huahao/AAR-8062-2021; Fan, Hang/AAA-8489-2022	Fan, Huahao/0000-0001-5007-2158; Fan, Hang/0000-0002-7927-1684; Tong, Yigang/0000-0002-8503-8045	National Natural Science Foundation of China [30970211, 31300202, 31000165]; Key Science and Technology Research Project of Henan Province [132102110195]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [13IRTSTHN009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Research Project of Henan Province; Program for Innovative Research Team (in Science and Technology) in University of Henan Province	This work was supported by grants from the National Natural Science Foundation of China (30970211, 31300202 and 31000165), the Key Science and Technology Research Project of Henan Province (No. 132102110195) and the Program for Innovative Research Team (in Science and Technology) in University of Henan Province (13IRTSTHN009). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Bergero R, 2009, TRENDS ECOL EVOL, V24, P94, DOI 10.1016/j.tree.2008.09.010; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Charlesworth D, 2013, J EXP BOT, V64, P405, DOI 10.1093/jxb/ers322; Dassanayake M, 2011, NAT GENET, V43, P913, DOI 10.1038/ng.889; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Du JC, 2012, PLANT CELL, V24, P21, DOI [10.1105/tpc.111.092759, 10.1105/tpc.112.103630]; Ellision JH, 1986, BREEDING VEGETABLE C, P521; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Gao LH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-18; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hertweck KL, 2013, GENOME, V56, P487, DOI 10.1139/gen-2013-0042; Hill P, 2005, MOL GENET GENOMICS, V273, P371, DOI 10.1007/s00438-005-1141-x; Hribova E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-204; Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Kumar Amar, 2000, Trends in Plant Science, V5, P509, DOI 10.1016/S1360-1385(00)01760-X; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lepesant JMJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r14; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Macas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027335; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mende DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031386; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Negrutiu I, 2001, PLANT PHYSIOL, V127, P1418, DOI 10.1104/pp.010711; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Reamon-Buttner SM, 1998, MOL BREEDING, V4, P91, DOI 10.1023/A:1009650221460; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rick CM, 1943, AM J BOT, V30, P711, DOI 10.2307/2437718; Tenaillon MI, 2011, GENOME BIOL EVOL, V3, P219, DOI 10.1093/gbe/evr008; Vitte C, 2013, ANN BOT-LONDON, V112, P881, DOI 10.1093/aob/mct155; Vyskot B, 2004, TRENDS GENET, V20, P432, DOI 10.1016/j.tig.2004.06.006; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zuccolo A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-152	42	179	185	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e97189	10.1371/journal.pone.0097189	http://dx.doi.org/10.1371/journal.pone.0097189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24465717	Green Published, Green Submitted, gold			2022-12-25	WOS:000338213300131
J	Dong, J; Han, QF; Zhu, TY; Ren, YP; Chen, JH; Zhao, HP; Chen, MH; Xu, R; Wang, Y; Hao, CM; Zhang, R; Zhang, XH; Wang, M; Tian, N; Wang, HY				Dong, Jie; Han, Qing-Feng; Zhu, Tong-Ying; Ren, Ye-Ping; Chen, Jiang-Hua; Zhao, Hui-Ping; Chen, Meng-Hua; Xu, Rong; Wang, Yue; Hao, Chuan-Ming; Zhang, Rui; Zhang, Xiao-Hui; Wang, Mei; Tian, Na; Wang, Hai-Yan			The Associations of Uric Acid, Cardiovascular and All-Cause Mortality in Peritoneal Dialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; RENAL-FUNCTION DECLINE; HIGH BLOOD-PRESSURE; HEMODIALYSIS-PATIENTS; RISK-FACTOR; ENDOTHELIAL DYSFUNCTION; ATHEROSCLEROSIS RISK; LOWERING THERAPY; ARTERY-DISEASE	Aims: To investigate whether uric acid (UA) is an independent predictor of cardiovascular (CV) and all-cause mortality in peritoneal dialysis (PD) patients after controlling for recognized CV risk factors. Methods: A total of 2264 patients on chronic PD were collected from seven centers affiliated with the Socioeconomic Status on the Outcome of Peritoneal Dialysis (SSOP) Study. All demographic and laboratory data were recorded at baseline. Multivariate Cox regression was used to calculate the hazard ratio (HR) of CV and all-cause mortality with adjustments for recognized traditional and uremia-related CV factors. Results: There were no significant differences in baseline characteristics between patients with (n = 2193) and without (n = 71) UA measured. Each 1 mg/dL of increase in UA was associated with higher all-cause mortality with 1.05(1.00 similar to 1.10) of HR and higher CV mortality with 1.12 (1.05 similar to 1.20) of HR after adjusting for age, gender and center size. The highest gender-specific tertile of UA predicted higher all-cause mortality with 1.23(1.00 similar to 1.52) of HR and higher CV mortality with 1.69 (1.21 similar to 2.38) of HR after adjusting for age, gender and center size. The predictive value of UA was stronger in patients younger than 65 years without CV disease or diabetes at baseline. The prognostic value of UA as both continuous and categorical variable weakened or disappeared after further adjusted for uremia-related and traditional CV risk factors. Conclusions: The prognostic value of UA in CV and all-cause mortality was weak in PD patients generally, which was confounded by uremia-related and traditional CV risk factors.	[Dong, Jie; Xu, Rong; Wang, Hai-Yan] Peking Univ, Dept Med, Div Renal, Hosp 1, Beijing 100871, Peoples R China; [Dong, Jie; Xu, Rong; Wang, Hai-Yan] Peking Univ, Inst Nephrol, Beijing 100871, Peoples R China; [Dong, Jie; Xu, Rong; Wang, Hai-Yan] Minist Hlth, Key Lab Renal Dis, Beijing, Peoples R China; [Dong, Jie; Xu, Rong; Wang, Hai-Yan] Minist Educ, Key Lab Renal Dis, Beijing, Peoples R China; [Han, Qing-Feng; Wang, Yue] Peking Univ, Hosp 3, Dept Nephrol, Beijing 100871, Peoples R China; [Zhu, Tong-Ying] Fudan Univ, Dept Nephrol, Huashan Hosp, Shanghai 200433, Peoples R China; [Ren, Ye-Ping; Zhang, Rui] Harbin Med Univ, Dept Nephrol, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Zhang, Xiao-Hui] Zhejiang Univ, Affiliated Hosp 1, Kidney Dis Ctr, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Mei] Peking Univ, Peoples Hosp, Dept Nephrol, Beijing 100871, Peoples R China; [Chen, Meng-Hua; Tian, Na] Ningxia Med Univ, Gen Hosp, Dept Nephrol, Ningxia, Peoples R China	Peking University; Peking University; Peking University; Fudan University; Harbin Medical University; Zhejiang University; Peking University; Ningxia Medical University	Dong, J (corresponding author), Peking Univ, Dept Med, Div Renal, Hosp 1, Beijing 100871, Peoples R China.	dongjie@medmail.com.cn	tian, na/GVR-9226-2022; Dong, Jie/AFM-0048-2022; Dong, Jinwei/C-4949-2009	Biradar, Chandrashekhar/0000-0002-9532-9452; Xiao, Xiangming/0000-0003-0956-7428; Dong, Jinwei/0000-0001-5687-803X	Education Department, China; Baxer Clinical Research Award from Baxter Corp, China; ISN Research Award from the ISN GO RP Committee	Education Department, China; Baxer Clinical Research Award from Baxter Corp, China; ISN Research Award from the ISN GO RP Committee	This study is supported in part by New Century Excellent Talents from The Education Department, China, Baxer Clinical Research Award from Baxter Corp, China, and an ISN Research Award from the ISN GO R&P Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RW, 1994, NEW ENGL J MED, V331, P468, DOI 10.1056/NEJM199408183310709; Badve SV, 2011, NAT REV NEPHROL, V7, P295, DOI 10.1038/nrneph.2010.186; Caravaca F, 2005, NEFROLOGIA, V25, P645; Chen J, 2012, AM J CARDIOL, V110, P136, DOI 10.1016/j.amjcard.2012.02.061; Chen YM, 2011, AM J NEPHROL, V33, P97, DOI 10.1159/000322966; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Elsayed EF, 2007, ARCH INTERN MED, V167, P1130, DOI 10.1001/archinte.167.11.1130; Garg JP, 2005, ARTHRITIS RHEUM-US, V52, P290, DOI 10.1002/art.20781; Hsu SP, 2004, NEPHROL DIAL TRANSPL, V19, P457, DOI 10.1093/ndt/gfg563; Iuliano L, 2001, LIPIDS, V36, pS41, DOI 10.1007/s11745-001-0680-1; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Jonasson T, 2005, CLIN CHEM LAB MED, V43, P628, DOI 10.1515/CCLM.2005.108; Jun M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008176.pub2; Kanbay M, 2012, AM J NEPHROL, V36, P324, DOI 10.1159/000342390; Kanbay M, 2011, AM J NEPHROL, V33, P298, DOI 10.1159/000324847; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kuo CF, 2013, RHEUMATOLOGY, V52, P127, DOI 10.1093/rheumatology/kes223; Latif W, 2011, CLIN J AM SOC NEPHRO, V6, P2470, DOI 10.2215/CJN.00670111; Lee SMK, 2009, AM J NEPHROL, V29, P79, DOI 10.1159/000151292; Liu WC, 2012, CLIN J AM SOC NEPHRO, V7, P541, DOI 10.2215/CJN.09420911; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; Melendez-Ramirez G, 2012, ENDOCR RES, V37, P1, DOI 10.3109/07435800.2011.566235; Moriarity JT, 2000, ANN EPIDEMIOL, V10, P136, DOI 10.1016/S1047-2797(99)00037-X; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; Navaneethan SD, 2009, NEPHROL DIAL TRANSPL, V24, P1260, DOI 10.1093/ndt/gfn621; Navaneethan SD, 2009, COCHRANE DATABASE SY; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Palmer SC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001436; Pan Y, 2012, BRIT J NUTR, V108, P400, DOI 10.1017/S0007114511007033; Park JT, 2009, NEPHROL DIAL TRANSPL, V24, P3520, DOI 10.1093/ndt/gfp272; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Smith SC, 2004, CIRCULATION, V109, P3112, DOI 10.1161/01.CIR.0000133427.35111.67; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Suliman ME, 2006, AM J KIDNEY DIS, V48, P761, DOI 10.1053/j.ajkd.2006.08.019; Suzuki T, 2007, NITRIC OXIDE-BIOL CH, V16, P266, DOI 10.1016/j.niox.2006.10.008; Tangri N, 2010, AM J KIDNEY DIS, V56, P247, DOI 10.1053/j.ajkd.2010.06.004; Wang AYM, 2007, PERITON DIALYSIS INT, V27, pS228; Wannamethee SG, 1997, HEART, V78, P147, DOI 10.1136/hrt.78.2.147; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024; Xu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050766; Zhang LX, 2012, NEPHROL DIAL TRANSPL, V27, P1836, DOI 10.1093/ndt/gfr597	43	62	69	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82342	10.1371/journal.pone.0082342	http://dx.doi.org/10.1371/journal.pone.0082342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416142	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500015
J	Lv, YF; Wang, JJ; Gao, H; Wang, ZY; Dong, N; Ma, QQ; Shan, AS				Lv, Yinfeng; Wang, Jiajun; Gao, He; Wang, Zeyun; Dong, Na; Ma, Qingquan; Shan, Anshan			Antimicrobial Properties and Membrane-Active Mechanism of a Potential alpha-Helical Antimicrobial Derived from Cathelicidin PMAP-36	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITY; PEPTIDES; DESIGN; HYDROPHOBICITY; MODEL; PORE; IDENTIFICATION; TRANSLOCATION; SELECTIVITY; IMPROVEMENT	Antimicrobial peptides (AMPs), which present in the non-specific immune system of organism, are amongst the most promising candidates for the development of novel antimicrobials. The modification of naturally occurring AMPs based on their residue composition and distribution is a simple and effective strategy for optimization of known AMPs. In this study, a series of truncated and residue-substituted derivatives of antimicrobial peptide PMAP-36 were designed and synthesized. The 24-residue truncated peptide, GI24, displayed antimicrobial activity comparable to the mother peptide PMAP-36 with MICs ranging from 1 to 4 mu M, which is lower than the MICs of bee venom melittin. Although GI24 displayed high antimicrobial activity, its hemolytic activity was much lower than melittin, suggesting that GI24 have optimal cell selectivity. In addition, the crucial site of GI24 was identified through single site-mutation. An amino acid with high hydrophobicity at position 23 played an important role in guaranteeing the high antimicrobial activity of GI24. Then, lipid vesicles and whole bacteria were employed to investigate the membrane-active mechanisms. Membrane-simulating experiments showed that GI24 interacted strongly with negatively charged phospholipids and weakly with zwitterionic phospholipids, which corresponded well with the data of its biological activities. Membrane permeabilization and flow cytometry provide the evidence that GI24 killed microbial cells by permeabilizing the cell membrane and damaging membrane integrity. GI24 resulted in greater cell morphological changes and visible pores on cell membrane as determined using scanning electron microscopy (SEM) and transmission electron microscope (TEM). Taken together, the peptide GI24 may provide a promising antimicrobial agent for therapeutic applications against the frequently-encountered bacteria.	[Lv, Yinfeng; Wang, Jiajun; Gao, He; Wang, Zeyun; Dong, Na; Ma, Qingquan; Shan, Anshan] Northeast Agr Univ, Inst Anim Nutr, Lab Mol Nutr & Immun, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Shan, AS (corresponding author), Northeast Agr Univ, Inst Anim Nutr, Lab Mol Nutr & Immun, Harbin, Heilongjiang, Peoples R China.	asshan@neau.edu.cn	Shan, Anshan/U-9119-2019	Wang, Jiajun/0000-0002-2086-2105	National Natural Research Foundation of China [31272453]; National Basic Research Program [2012CB124703]; China Agriculture Research System [CARS-36]	National Natural Research Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); China Agriculture Research System	This work was supported by the National Natural Research Foundation of China (31272453), the National Basic Research Program (2012CB124703), and the China Agriculture Research System (CARS-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2012, CURR PROTEIN PEPT SC, V13, P211, DOI 10.2174/138920312800785076; Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817; Baek JH, 2010, TOXICON, V55, P711, DOI 10.1016/j.toxicon.2009.10.023; Brogden NK, 2011, INT J ANTIMICROB AG, V38, P217, DOI 10.1016/j.ijantimicag.2011.05.004; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Chou HT, 2008, INT J ANTIMICROB AG, V32, P130, DOI 10.1016/j.ijantimicag.2008.04.003; Dobrzynska I, 2005, MOL CELL BIOCHEM, V276, P113, DOI 10.1007/s11010-005-3557-3; Dong N, 2012, PROTEIN PEPTIDE LETT, V19, P1212, DOI 10.2174/092986612803217006; Dong N, 2012, ANTIMICROB AGENTS CH, V56, P2994, DOI 10.1128/AAC.06327-11; Dong N, 2012, PROTEIN PEPTIDE LETT, V19, P430, DOI 10.2174/092986612799789323; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Friedrich CL, 2001, J BIOL CHEM, V276, P24015, DOI 10.1074/jbc.M009691200; Gopal R, 2013, AMINO ACIDS, V44, P645, DOI 10.1007/s00726-012-1388-6; Haines LR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000373; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Kiyota T, 1996, BIOCHEMISTRY-US, V35, P13196, DOI 10.1021/bi961289t; Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0; Lee DL, 2004, J PEPT RES, V63, P69, DOI 10.1046/j.1399-3011.2003.00106.x; Lee EK, 2011, PEPTIDES, V32, P1123, DOI 10.1016/j.peptides.2011.03.024; Lee KH, 2006, BIOCHEM J, V394, P105, DOI 10.1042/BJ20051574; Li YM, 2012, PEPTIDES, V37, P207, DOI 10.1016/j.peptides.2012.07.001; Liu YF, 2013, BIOMATERIALS, V34, P237, DOI 10.1016/j.biomaterials.2012.09.032; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; Naito A, 2000, BIOPHYS J, V78, P2405, DOI 10.1016/S0006-3495(00)76784-1; Oren Z, 2000, BIOCHEMISTRY-US, V39, P6103, DOI 10.1021/bi992408i; Park SC, 2006, BIOCHEM BIOPH RES CO, V343, P222, DOI 10.1016/j.bbrc.2006.02.090; Park Y, 2004, BIOCHEM BIOPH RES CO, V321, P109, DOI 10.1016/j.bbrc.2004.06.113; Paulsen VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053326; PIERS KL, 1994, ANTIMICROB AGENTS CH, V38, P2311, DOI 10.1128/AAC.38.10.2311; Rabbani G, 2013, APPL MICROB IN PRESS; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Sang YM, 2009, DEV COMP IMMUNOL, V33, P334, DOI 10.1016/j.dci.2008.05.006; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Scocchi M, 2005, FEBS J, V272, P4398, DOI 10.1111/j.1742-4658.2005.04852.x; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585-3590.2002; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; STORICI P, 1994, FEBS LETT, V337, P303, DOI 10.1016/0014-5793(94)80214-9; Stromstedt AA, 2009, ANTIMICROB AGENTS CH, V53, P593, DOI 10.1128/AAC.00477-08; Strom MB, 2002, BIOCHEM CELL BIOL, V80, P65, DOI 10.1139/o01-236; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005; Vedovato N, 2007, EUR BIOPHYS J BIOPHY, V36, P771, DOI 10.1007/s00249-007-0152-4; Vila-Farres X, 2012, CLIN MICROBIOL INFEC, V18, P383, DOI 10.1111/j.1469-0691.2011.03581.x; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu WL, 2006, BIOCHEM BIOPH RES CO, V349, P769, DOI 10.1016/j.bbrc.2006.08.094	52	164	174	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86364	10.1371/journal.pone.0086364	http://dx.doi.org/10.1371/journal.pone.0086364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466055	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500238
J	Wu, FQ; Price, BW; Haider, W; Seufferheld, G; Nelson, R; Hanzawa, Y				Wu, Faqiang; Price, Brian William; Haider, Waseem; Seufferheld, Gabriela; Nelson, Randall; Hanzawa, Yoshie			Functional and Evolutionary Characterization of the CONSTANS Gene Family in Short-Day Photoperiodic Flowering in Soybean	PLOS ONE			English	Article							MAP-BASED CLONING; TIME GENE; LOCUS-T; ARABIDOPSIS; EXPRESSION; MATURITY; ORTHOLOG; SEQUENCE; NEOFUNCTIONALIZATION; DUPLICATION	CONSTANS (CO) plays a central role in photoperiodic flowering control of plants. However, much remains unknown about the function of the CO gene family in soybean and the molecular mechanisms underlying short-day photoperiodic flowering of soybean. We identified 26 CO homologs (GmCOLs) in the soybean genome, many of them previously unreported. Phylogenic analysis classified GmCOLs into three clades conserved among flowering plants. Two homeologous pairs in Clade I, GmCOL1a/GmCOL1b and GmCOL2a/GmCOL2b, showed the highest sequence similarity to Arabidopsis CO. The mRNA abundance of GmCOL1a and GmCOL1b exhibited a strong diurnal rhythm under flowering-inductive short days and peaked at dawn, which coincided with the rise of GmFT5a expression. In contrast, the mRNA abundance of GmCOL2a and GmCOL2b was extremely low. Our transgenic study demonstrated that GmCOL1a, GmCOL1b, GmCOL2a and GmCOL2b fully complemented the late flowering effect of the co-1 mutant in Arabidopsis. Together, these results indicate that GmCOL1a and GmCOL1b are potential inducers of flowering in soybean. Our data also indicate rapid regulatory divergence between GmCOL1a/GmCOL1b and GmCOL2a/GmCOL2b but conservation of their protein function. Dynamic evolution of GmCOL regulatory mechanisms may underlie the evolution of photoperiodic signaling in soybean.	[Wu, Faqiang; Price, Brian William; Haider, Waseem; Seufferheld, Gabriela; Hanzawa, Yoshie] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Nelson, Randall] Univ Illinois, Dept Crop Sci, USDA Agr Res Serv, Soybean Maize Germplasm Pathol & Genet Res Unit, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Hanzawa, Y (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	yhanzawa@illinois.edu	Haider, Waseem/AAD-6214-2019	Haider, Waseem/0000-0001-9200-6714; Hanzawa, Yoshie/0000-0003-4704-8872	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [USDA-NIFA2011-00078]; ARS [ARS-0424505] Funding Source: Federal RePORTER	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project is supported by the Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture (USDA-NIFA2011-00078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2003, THEOR APPL GENET, V106, P445, DOI 10.1007/s00122-002-1073-3; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Almada R, 2009, PLANT CELL REP, V28, P1193, DOI 10.1007/s00299-009-0720-4; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Borthwick HA, 1939, BOT GAZ, V101, P341, DOI 10.1086/334874; Campoli C, 2012, PLANT J, V69, P868, DOI 10.1111/j.1365-313X.2011.04839.x; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datta S, 2006, PLANT CELL, V18, P70, DOI 10.1105/tpc.105.038182; Datta S, 2007, PLANT CELL, V19, P3242, DOI 10.1105/tpc.107.054791; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gonzalez-Schain ND, 2008, BIOL PLANTARUM, V52, P251, DOI 10.1007/s10535-008-0054-z; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Gu XF, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001649; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; He YH, 2012, TRENDS PLANT SCI, V17, P556, DOI 10.1016/j.tplants.2012.05.001; Hecht V, 2007, PLANT PHYSIOL, V144, P648, DOI 10.1104/pp.107.096818; Herrmann D, 2010, THEOR APPL GENET, V121, P865, DOI 10.1007/s00122-010-1356-z; Hsu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045448; Imamura S, 1967, PHYSL FLOWERING PHAR; Jiang Y, 2011, RUSS J PLANT PHYSL+, V58, P928, DOI 10.1134/S1021443711040066; Jung CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038250; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kikuchi R, 2012, J EXP BOT, V63, P773, DOI 10.1093/jxb/err299; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ledger Susan, 2001, Plant Journal, V26, P15, DOI 10.1046/j.1365-313x.2001.01003.x; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu BH, 2010, J HERED, V101, P251, DOI 10.1093/jhered/esp113; Liu JY, 2001, PLANT PHYSIOL, V125, P1821, DOI 10.1104/pp.125.4.1821; Liu L, 2011, RUSS J PLANT PHYSL+, V58, P330, DOI 10.1134/S1021443711020105; Ma JinHua, 2009, Plant Physiology Communications, V46, P17; Martin J, 2004, PLANT MOL BIOL, V56, P159, DOI 10.1007/s11103-004-2647-z; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Molnar SJ, 2003, GENOME, V46, P1024, DOI [10.1139/g03-079, 10.1139/G03-079]; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nemoto Y, 2003, PLANT J, V36, P82, DOI 10.1046/j.1365-313X.2003.01859.x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Serrano G, 2009, CURR BIOL, V19, P359, DOI 10.1016/j.cub.2009.01.044; Song YH, 2012, SCIENCE, V336, P1045, DOI 10.1126/science.1219644; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Thakare D, 2010, PLANTA, V231, P951, DOI 10.1007/s00425-010-1100-6; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Valverde F, 2011, J EXP BOT, V62, P2453, DOI 10.1093/jxb/erq449; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wu F, 2014, HDB PLANT CROP PHYSL, P129; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zhang QingZhe, 2010, Acta Agronomica Sinica, V36, P539; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2	59	97	105	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85754	10.1371/journal.pone.0085754	http://dx.doi.org/10.1371/journal.pone.0085754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24489881	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500105
J	Zhang, KX; Xu, HH; Gong, W; Jin, Y; Shi, YY; Yuan, TT; Li, J; Lu, YT				Zhang, Kun-Xiao; Xu, Heng-Hao; Gong, Wen; Jin, Yan; Shi, Ya-Ya; Yuan, Ting-Ting; Li, Juan; Lu, Ying-Tang			Proper PIN1 Distribution Is Needed for Root Negative Phototropism in Arabidopsis	PLOS ONE			English	Article							AUXIN EFFLUX CARRIER; SIGNAL TRANSDUCER; PLANT TROPISMS; TRANSPORT; LIGHT; GRAVITROPISM; PHOSPHORYLATION; POLARITY; PROTEIN; GROWTH	Plants can be adapted to the changing environments through tropic responses, such as light and gravity. One of them is root negative phototropism, which is needed for root growth and nutrient absorption. Here, we show that the auxin efflux carrier PIN-FORMED (PIN) 1 is involved in asymmetric auxin distribution and root negative phototropism. In darkness, PIN1 is internalized and localized to intracellular compartments; upon blue light illumination, PIN1 relocalize to basal plasma membrane in root stele cells. The shift of PIN1 localization induced by blue light is involved in asymmetric auxin distribution and root negative phototropic response. Both blue-light-induced PIN1 redistribution and root negative phototropism is mediated by a BFA-sensitive trafficking pathway and the activity of PID/PP2A. Our results demonstrate that blue-light-induced PIN1 redistribution participate in asymmetric auxin distribution and root negative phototropism.	[Zhang, Kun-Xiao; Xu, Heng-Hao; Gong, Wen; Jin, Yan; Yuan, Ting-Ting; Li, Juan; Lu, Ying-Tang] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Shi, Ya-Ya] Hubei Acad Agr Sci, Inst Fruit & Tea, Wuhan, Peoples R China	Wuhan University; Hubei Academy of Agricultural Sciences	Lu, YT (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	yingtlu@whu.edu.cn	; Kitajima, Kaoru/M-8521-2018; Bagchi, Robert/F-1732-2011	Goodale, Eben/0000-0003-3403-2847; Kitajima, Kaoru/0000-0001-6822-8536; Zhang, Kai/0000-0002-9641-8043; Harrison, Rhett/0000-0001-9055-3546; Bagchi, Robert/0000-0003-4035-4105	National Natural Science Foundation of China [90917001]; Key Project of Chinese Ministry of Education [311026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (#90917001) and Key Project of Chinese Ministry of Education (#311026) to YT Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamins R, 2001, DEVELOPMENT, V128, P4057; Blakeslee JJ, 2004, PLANT PHYSIOL, V134, P28, DOI 10.1104/pp.103.031690; Boccalandro HE, 2008, PLANT PHYSIOL, V146, P108, DOI 10.1104/pp.107.106468; Cheng YF, 2008, P NATL ACAD SCI USA, V105, P21017, DOI 10.1073/pnas.0809761106; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Dhonukshe P, 2010, DEVELOPMENT, V137, P3245, DOI 10.1242/dev.052456; Ding ZJ, 2011, NAT CELL BIOL, V13, P447, DOI 10.1038/ncb2208; Esmon CA, 2005, INT J DEV BIOL, V49, P665, DOI 10.1387/ijdb.052028ce; Estelle M, 1996, CURR BIOL, V6, P1589, DOI 10.1016/S0960-9822(02)70780-X; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Haga K, 2012, PLANT PHYSIOL, V160, P763, DOI 10.1104/pp.112.202432; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Holland JJ, 2009, J EXP BOT, V60, P1969, DOI 10.1093/jxb/erp113; Huang F, 2010, PLANT CELL, V22, P1129, DOI 10.1105/tpc.109.072678; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Kleine-Vehn J, 2008, P NATL ACAD SCI USA, V105, P17812, DOI 10.1073/pnas.0808073105; Kleine-Vehn J, 2009, PLANT CELL, V21, P3839, DOI 10.1105/tpc.109.071639; Kutschera U, 2012, PLANTA, V235, P443, DOI 10.1007/s00425-012-1597-y; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Sakai T, 2000, PLANT CELL, V12, P225, DOI 10.1105/tpc.12.2.225; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sassi M, 2012, DEVELOPMENT, V139, P3402, DOI 10.1242/dev.078212; Shirakawa M, 2009, PLANT CELL PHYSIOL, V50, P1319, DOI 10.1093/pcp/pcp076; Sorefan K, 2009, NATURE, V459, P583, DOI 10.1038/nature07875; Sukumar P, 2009, PLANT PHYSIOL, V150, P722, DOI 10.1104/pp.108.131607; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Wan YL, 2012, PLANT CELL, V24, P551, DOI 10.1105/tpc.111.094284; WENT FW, 1974, ANNU REV PLANT PHYS, V25, P1, DOI 10.1146/annurev.pp.25.060174.000245; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029; Zhang J, 2010, P NATL ACAD SCI USA, V107, P918, DOI 10.1073/pnas.0909460107; Zhang KX, 2013, PLANT J	48	30	35	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85720	10.1371/journal.pone.0085720	http://dx.doi.org/10.1371/journal.pone.0085720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465665	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500097
J	Shen, DX; Liu, Y; Zhou, F; Wang, GR; An, CJ				Shen, Dongxu; Liu, Yang; Zhou, Fan; Wang, Guirong; An, Chunju			Identification of Immunity-Related Genes in Ostrinia furnacalis against Entomopathogenic Fungi by RNA-Seq Analysis	PLOS ONE			English	Article							BETA-1,3-GLUCAN RECOGNITION PROTEIN; PRO-PHENOL-OXIDASE; MANDUCA-SEXTA; INNATE IMMUNITY; PROPHENOLOXIDASE ACTIVATION; ANTIMICROBIAL PEPTIDES; TOBACCO HORNWORM; SERINE PROTEASES; PROTEOLYTIC ACTIVATION; ANTIBACTERIAL PROTEINS	Background: The Asian corn borer (Ostrinia furnacalis (Guenee)) is one of the most serious corn pests in Asia. Control of this pest with entomopathogenic fungus Beauveria bassiana has been proposed. However, the molecular mechanisms involved in the interactions between O. furnacalis and B. bassiana are unclear, especially under the conditions that the genomic information of O. furnacalis is currently unavailable. So we sequenced and characterized the transcriptome of O. furnacalis larvae infected by B. bassiana with special emphasis on immunity-related genes. Methodology/Principal Findings: Illumina Hiseq2000 was used to sequence 4.64 and 4.72 Gb of the transcriptome from water-injected and B. bassiana-injected O. furnacalis larvae, respectively. De novo assembly generated 62,382 unigenes with mean length of 729 nt. All unigenes were searched against Nt, Nr, Swiss-Prot, COG, and KEGG databases for annotations using BLASTN or BLASTX algorithm with an E-value cut-off of 10(-5). A total of 35,700 (57.2%) unigenes were annotated to at least one database. Pairwise comparisons resulted in 13,890 differentially expressed genes, with 5,843 up-regulated and 8,047 down-regulated. Based on sequence similarity to homologs known to participate in immune responses, we totally identified 190 potential immunity-related unigenes. They encode 45 pattern recognition proteins, 33 modulation proteins involved in the prophenoloxidase activation cascade, 46 signal transduction molecules, and 66 immune responsive effectors, respectively. The obtained transcriptome contains putative orthologs for nearly all components of the Toll, Imd, and JAK/STAT pathways. We randomly selected 24 immunity-related unigenes and investigated their expression profiles using quantitative RT-PCR assay. The results revealed variant expression patterns in response to the infection of B. bassiana. Conclusions/Significance: This study provides the comprehensive sequence resource and expression profiles of the immunity-related genes of O. furnacalis. The obtained data gives an insight into better understanding the molecular mechanisms of innate immune processes in O. furnacalis larvae against B. bassiana.	[Shen, Dongxu; Wang, Guirong; An, Chunju] China Agr Univ, Coll Agr & Biotechnol, Dept Entomol, Beijing 100094, Peoples R China; [Liu, Yang; Zhou, Fan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	An, CJ (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Dept Entomol, Beijing 100094, Peoples R China.	anchunju@cau.edu.cn	Zhou, Fan/GWU-9492-2022; Ekelund, Ulf/AAE-8471-2019; Wijndaele, Katrien/H-5465-2013	Ekelund, Ulf/0000-0003-2115-9267; Liu, Yang/0000-0002-3424-7111; Lin, Qingfeng/0000-0001-5615-5130; Wijndaele, Katrien/0000-0003-2199-7981	973 Program [2013CB114102, 2013CB127603]; National Natural Science Foundation of China [31172090, 31201578]; Program for New Century Excellent Talents in University [NCET-11-0476]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the 973 Program (2013CB114102 and 2013CB127603), National Natural Science Foundation of China (31172090, to C. A. and 31201578, to Y.L.), and Program for New Century Excellent Talents in University (NCET-11-0476, to C. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Afidchao MM, 2013, PEST MANAG SCI, V69, P792, DOI 10.1002/ps.3471; Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An CJ, 2011, CELL MOL LIFE SCI, V68, P1929, DOI 10.1007/s00018-010-0543-z; An CJ, 2010, FEBS J, V277, P148, DOI 10.1111/j.1742-4658.2009.07465.x; An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bachali S, 2002, J MOL EVOL, V54, P652, DOI 10.1007/s00239-001-0061-6; Bao YY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-160; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cheng TC, 2008, DEV COMP IMMUNOL, V32, P464, DOI 10.1016/j.dci.2007.03.010; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Clark KD, 2013, J BIOL CHEM, V288, P14476, DOI 10.1074/jbc.M113.459222; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Feng CJ, 2008, COMP BIOCHEM PHYS B, V151, P139, DOI 10.1016/j.cbpb.2008.05.012; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gandhe AS, 2007, INSECT BIOCHEM MOLEC, V37, P655, DOI 10.1016/j.ibmb.2007.03.013; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jang IH, 2008, BMB REP, V41, P102, DOI 10.5483/BMBRep.2008.41.2.102; Ji CY, 2004, J BIOL CHEM, V279, P34101, DOI 10.1074/jbc.M404584200; Jiang H, 2010, ADV EXP MED BIOL, V708, P181; Jiang HB, 2004, INSECT BIOCHEM MOLEC, V34, P89, DOI 10.1016/j.ibmb.2003.09.006; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Jimenez-Cantizano RM, 2008, FISH SHELLFISH IMMUN, V25, P57, DOI 10.1016/j.fsi.2007.12.009; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kanost MR, 2001, ADV EXP MED BIOL, V484, P319; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kanost MR, 2009, INNATE IMMUNE RESPON, P271; KAWABATA T, 1995, P NATL ACAD SCI USA, V92, P7774, DOI 10.1073/pnas.92.17.7774; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Knight JA, 2000, ANN CLIN LAB SCI, V30, P145; Koizumi N, 1999, FEBS LETT, V443, P139, DOI 10.1016/S0014-5793(98)01701-3; Kurata S, 2014, DEV COMP IMMUNOL, V42, P36, DOI 10.1016/j.dci.2013.06.006; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee KY, 2002, EUR J BIOCHEM, V269, P4375, DOI 10.1046/j.1432-1033.2002.03155.x; Lee SY, 1998, EUR J BIOCHEM, V254, P50, DOI 10.1046/j.1432-1327.1998.2540050.x; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LeshkoLindsay L, 1997, DEVELOPMENT, V124, P169; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Michel K, 2005, INSECT BIOCHEM MOLEC, V35, P677, DOI 10.1016/j.ibmb.2005.02.009; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nam HJ, 2012, EMBO J, V31, P1253, DOI 10.1038/emboj.2011.476; OCHIAI M, 1988, J BIOL CHEM, V263, P12056; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Osta MA, 2004, J EXP BIOL, V207, P2551, DOI 10.1242/jeb.01066; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qu MB, 2011, BIOCHEM BIOPH RES CO, V404, P302, DOI 10.1016/j.bbrc.2010.11.111; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Shao QM, 2012, J BIOL CHEM, V287, P14270, DOI 10.1074/jbc.M112.354548; Shin SW, 2000, FEBS LETT, V467, P70, DOI 10.1016/S0014-5793(00)01127-3; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Sumathipala N, 2010, INSECT BIOCHEM MOLEC, V40, P487, DOI 10.1016/j.ibmb.2010.04.008; Takahasi K, 2009, P NATL ACAD SCI USA, V106, P11679, DOI 10.1073/pnas.0901671106; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wagner BL, 2000, APPL ENVIRON MICROB, V66, P3468, DOI 10.1128/AEM.66.8.3468-3473.2000; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P731, DOI 10.1016/j.ibmb.2004.03.008; Wang Y, 2007, DEV COMP IMMUNOL, V31, P1002, DOI 10.1016/j.dci.2007.01.001; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; YASUHARA Y, 1995, ARCH BIOCHEM BIOPHYS, V320, P14, DOI 10.1006/abbi.1995.1337; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Yu XQ, 2004, DEV COMP IMMUNOL, V28, P891, DOI 10.1016/j.dci.2004.02.005; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Zhang Jianxian, 2011, Journal of Xidian University, V38, P95, DOI 10.3969/j.issn.1001-2400.2011.04.017; Zhou R, 2005, J BIOL CHEM, V280, P34048, DOI 10.1074/jbc.M506655200; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	111	114	122	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86436	10.1371/journal.pone.0086436	http://dx.doi.org/10.1371/journal.pone.0086436			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24466095	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000101
J	Liu, Y; Zhang, JW; Qian, WY; Dong, Y; Yang, YB; Liu, ZQ; Feng, YJ; Ma, D; Zhang, ZB; Wu, SF				Liu, Yuan; Zhang, Jiawen; Qian, Wenyan; Dong, Yu; Yang, Yongbin; Liu, Zhiqiang; Feng, Youji; Ma, Ding; Zhang, Zhenbo; Wu, Sufang			Gankyrin Is Frequently Overexpressed in Cervical High Grade Disease and Is Associated with Cervical Carcinogenesis and Metastasis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER-CELL PROLIFERATION; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; CLINICAL-SIGNIFICANCE; BREAST-CANCER; ONCOPROTEIN; PROMOTES; PATHWAY; PROGRESSION	Our previous studies have showed that Gankyrin expression is correlated with a malignant phenotype in endometrial carcinoma. Here, we investigated the possible role of Gankyrin in cervical disease. The increasing protein level of Gankyrin was observed in high-grade cervical intraepithelial neoplasia and carcinoma compared with benign cervical tissues and low-grade cervical intraepithelial neoplasia. In para-carcinoma tissues, it was found interestingly that there was no lymph node metastasis when nuclei Gankyrin was positively expressed, but lymph node metastasis rate was 30% (6/20) when nuclei Gankyrin was negatively expressed. In vitro, the transfection of Gankyrin resulted in markedly up-regulating of Vimentin, beta-catenin and Twist2, as well as down-regulating of E-cadherin in cervical carcinoma cells. Our results suggested that Gankyrin may be functional in cervical carcinogenesis and metastasis.	[Liu, Yuan; Dong, Yu; Yang, Yongbin; Feng, Youji; Zhang, Zhenbo; Wu, Sufang] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Zhang, Jiawen] Shanghai Tongji Univ, Shanghai Peoples Hosp 10, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Qian, Wenyan] Nanjing Univ Chinese Med, Kunshan Hosp Tradit Chinese Med, Dept Gynecol & Obstet, Nanjing, Jiangsu, Peoples R China; [Liu, Zhiqiang] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Dept Lymphoma & Myeloma, Div Canc Med, Houston, TX 77030 USA; [Ma, Ding] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Canc Biol Med Ctr, Wuhan 430074, Peoples R China	Shanghai Jiao Tong University; Tongji University; Nanjing University of Chinese Medicine; University of Texas System; UTMD Anderson Cancer Center; Huazhong University of Science & Technology	Zhang, ZB (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	zxdzzb@gmail.com; wsf_sfph@163.com		Kang, Chaogui/0000-0002-0122-9419; Zhang, Jiawen/0000-0003-0489-776X	National Natural Science Foundation of China (NSFC) [81201541]; Shanghai Pujiang Talent Program [12PJD002]; Science and Research Foundation for Public Welfare Industry of Ministry of Health of China [201002013]; Shanghai Science and Technology Committee Foundation [09411962500]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Talent Program; Science and Research Foundation for Public Welfare Industry of Ministry of Health of China; Shanghai Science and Technology Committee Foundation(Shanghai Science & Technology Committee)	The project was supported by grants from the National Natural Science Foundation of China (NSFC No. 81201541), Shanghai Pujiang Talent Program (12PJD002), Science and Research Foundation for Public Welfare Industry of Ministry of Health of China (201002013), Shanghai Science and Technology Committee Foundation(09411962500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZF, 2013, CANCER RES, V73, P4548, DOI 10.1158/0008-5472.CAN-12-4586; Cai Q, 2013, ARCH GYNECOL OBSTET, V287, P541, DOI 10.1007/s00404-012-2665-z; Chen Y, 2007, CELL RES, V17, P1020, DOI 10.1038/cr.2007.99; Dawson S, 2006, TRENDS CELL BIOL, V16, P229, DOI 10.1016/j.tcb.2006.03.001; Fu J, 2011, HEPATOLOGY, V53, P181, DOI 10.1002/hep.24015; Fu XY, 2002, WORLD J GASTROENTERO, V8, P638, DOI 10.3748/wjg.v8.i4.638; Kim YH, 2013, EXP MOL PATHOL, V94, P360, DOI 10.1016/j.yexmp.2012.12.002; Lee MY, 2012, AM J TRANSL RES, V4, P1; Levy L, 2002, ANN NY ACAD SCI, V963, P21; Li Y, 2012, GYNECOL ONCOL, V124, P112, DOI 10.1016/j.ygyno.2011.09.003; Mao YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078200; Meng Y, 2010, CANCER LETT, V297, P9, DOI 10.1016/j.canlet.2010.04.019; Ortiz CM, 2008, INT J CANCER, V122, P325, DOI 10.1002/ijc.23106; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song X, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-114; Wei YA, 2012, ONCOL REP, V27, P504, DOI 10.3892/or.2011.1536; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Wu Z, 2013, INT J GYNECOL CANCER, V23, P906, DOI 10.1097/IGC.0b013e318292da82; Yan M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-437; Zhang JW, 2013, CANCER LETT, V339, P279, DOI 10.1016/j.canlet.2012.10.037; Zhang ZB, 2012, CANCER LETT, V319, P89, DOI 10.1016/j.canlet.2011.12.033; Zhen C, 2013, ONCOGENE, V32, P3452, DOI 10.1038/onc.2012.356; Zheng T, 2013, HEPATOLOGY; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	24	251	254	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95043	10.1371/journal.pone.0095043	http://dx.doi.org/10.1371/journal.pone.0095043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24751719	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400027
J	Li, Y; Yang, D; Wang, JY; Yao, Y; Zhang, WZ; Wang, LJ; Cheng, DC; Yang, FK; Zhang, FM; Zhuang, M; Ling, H				Li, Yan; Yang, Dan; Wang, Jia-Ye; Yao, Yuan; Zhang, Wei-Zhe; Wang, Lu-Jing; Cheng, De-Chun; Yang, Feng-Kun; Zhang, Feng-Min; Zhuang, Min; Ling, Hong			Critical Amino Acids within the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein V4 N- and C-Terminals Contribute to Virus Entry	PLOS ONE			English	Article							HIV-1 GP120; NEUTRALIZING ANTIBODIES; DISEASE PROGRESSION; VIRAL ENTRY; V3 LOOP; CORECEPTOR; INFECTION; EVOLUTION; CCR5; REGIONS	The importance of the fourth variable (V4) region of the human immunodeficiency virus 1 (HIV-1) envelope glycoprotein (Env) in virus infection has not been well clarified, though the polymorphism of this region has been found to be associated with disease progression to acquired immunodeficiency syndrome (AIDS). In the present work, we focused on the correlation between HIV-1 gp120 V4 region polymorphism and the function of the region on virus entry, and the possible mechanisms for how the V4 region contributes to virus infectivity. Therefore, we analyzed the differences in V4 sequences along with coreceptor usage preference from CCR5 to CXCR4 and examined the importance of the amino acids within the V4 region for CCR5- and CXCR4-tropic virus entry. In addition, we determined the influence of the V4 amino acids on Env expression and gp160 processing intracellularly, as well as the amount of Env on the pseudovirus surface. The results indicated that V4 tended to have a shorter length, fewer potential N-linked glycosylation sites (PNGS), greater evolutionary distance, and a lower negative net charge when HIV-1 isolates switched from a coreceptor usage preference for CCR5 to CXCR4. The N- and C-terminals of the HIV-1 V4 region are highly conserved and critical to maintain virus entry ability, but only the mutation at position 417 in the context of ADA (a R5-tropic HIV-1 strain) resulted in the ability to utilize CXCR4. In addition, 390L, 391F, 414I, and 416L are critical to maintain gp160 processing and maturation. It is likely that the hydrophobic properties and the electrostatic surface potential of gp120, rather than the conformational structure, greatly contribute to this V4 functionality. The findings provide information to aid in the understanding of the functions of V4 in HIV-1 entry and offer a potential target to aid in the development of entry inhibitors.	[Li, Yan; Wang, Jia-Ye; Zhang, Feng-Min; Zhuang, Min; Ling, Hong] Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China; [Yang, Dan] Harbin Med Univ, Dept Forens Med, Harbin, Peoples R China; [Yao, Yuan] Harbin Inst Technol, Acad Fundamental & Interdisciplinary Sci, Harbin 150006, Peoples R China; [Zhang, Wei-Zhe; Cheng, De-Chun; Yang, Feng-Kun; Ling, Hong] Harbin Med Univ, Dept Parasitol, Harbin, Peoples R China; [Wang, Lu-Jing] Harbin Med Univ, Dept Biochem, Harbin, Peoples R China; [Li, Yan; Wang, Jia-Ye; Zhang, Wei-Zhe; Cheng, De-Chun; Yang, Feng-Kun; Zhang, Feng-Min; Zhuang, Min; Ling, Hong] Heilongjiang Prov Educ Bur, Key Lab Etiol, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Institute of Technology; Harbin Medical University; Harbin Medical University	Zhuang, M (corresponding author), Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China.	zhuangm@ems.hrbmu.edu.cn; lingh@ems.hrbmu.edu.cn	Sun, Duanping/M-4632-2017	Sun, Duanping/0000-0003-1760-2975; ling, hong/0000-0002-1886-1242	Scientific Research Foundation of Heilongjiang Provincial Education Department [12511184]; Heilongjiang Innovation Program in Graduate Education [YJSCX2009-222HLJ]; Harbin Medical University Innovation Program in Graduate Education [HCXB2009014]; Grant for Innovation Team Program of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province [ZJY0601-01]	Scientific Research Foundation of Heilongjiang Provincial Education Department; Heilongjiang Innovation Program in Graduate Education; Harbin Medical University Innovation Program in Graduate Education; Grant for Innovation Team Program of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported by Scientific Research Foundation of Heilongjiang Provincial Education Department (Grant 12511184); Heilongjiang Innovation Program in Graduate Education (YJSCX2009-222HLJ); Harbin Medical University Innovation Program in Graduate Education (HCXB2009014); Grant for Innovation Team Program of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province (Grant ZJY0601-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archary D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-92; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Belair M, 2009, AIDS RES HUM RETROV, V25, P199, DOI 10.1089/aid.2008.0162; Berger EA, 1997, AIDS, V11, pS3; Blay WM, 2007, J VIROL, V81, P13037, DOI 10.1128/JVI.01215-07; Boonchawalit S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027098; Brumme ZL, 2005, J INFECT DIS, V192, P466, DOI 10.1086/431519; Castro E, 2008, AIDS RES HUM RETROV, V24, P106, DOI 10.1089/aid.2007.0139; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; Coetzer M, 2008, J VIROL, V82, P11758, DOI 10.1128/JVI.01141-08; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Desormeaux A, 2013, J VIROL, V87, P2549, DOI 10.1128/JVI.03104-12; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Guo HY, 2012, J GEN VIROL, V93, P2635, DOI 10.1099/vir.0.046771-0; HATTORI T, 1987, JPN J CANCER RES, V78, P235; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Hu QX, 2000, J VIROL, V74, P11858, DOI 10.1128/JVI.74.24.11858-11872.2000; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Ling H, 2002, BIOCHEM BIOPH RES CO, V297, P625, DOI 10.1016/S0006-291X(02)02253-2; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Riddle TM, 2006, J VIROL, V80, P10591, DOI 10.1128/JVI.00644-06; Rivera-Amill V, 2007, VIROLOGY, V358, P373, DOI 10.1016/j.virol.2006.08.039; Sen J, 2008, BIOCHEMISTRY-US, V47, P7788, DOI 10.1021/bi800227z; Suphaphiphat P, 2007, VIROLOGY, V360, P182, DOI 10.1016/j.virol.2006.10.019; Tang HL, 2011, J VIROL, V85, P9286, DOI 10.1128/JVI.02286-10; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Wallace A, 2009, J VIROL, V83, P7883, DOI 10.1128/JVI.00582-09; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035; Wu F, 2012, J VIROL, V86, P8835, DOI 10.1128/JVI.00923-12; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2006, J VIROL, V80, P11404, DOI 10.1128/JVI.01102-06; Yeh WW, 2012, J VIROL, V86, P7052, DOI 10.1128/JVI.00107-12; Zhuang M, 2012, J BIOL CHEM, V287, P8297, DOI 10.1074/jbc.M111.324483	39	65	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86083	10.1371/journal.pone.0086083	http://dx.doi.org/10.1371/journal.pone.0086083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	25299226	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500179
J	Li, YP; Song, B; Fang, H; Gao, Y; Zhao, L; Xu, YM				Li, Yapeng; Song, Bo; Fang, Hui; Gao, Yuan; Zhao, Lu; Xu, Yuming			External Validation of the A(2)DS(2) Score to Predict Stroke-Associated Pneumonia in a Chinese Population: A Prospective Cohort Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; IN-HOSPITAL MORTALITY; MEDICAL COMPLICATIONS; RISK-FACTORS; INFECTION; CARE; TRANSIENT; OUTCOMES; COST	Background and Purpose: The A(2)DS(2) score was recently developed from the Berlin Stroke Registry for predicting in-hospital pneumonia after acute ischemic stroke and performed well in an external validation in the North-west Germany Stroke Registry. It could be a useful tool for risk stratification in clinical practice or stroke trials. We aimed to prospectively validate the predictive value of A(2)DS(2) score in a Chinese stroke population. Methods: The prognostic model was used to predict stroke-associated pneumonia (SAP) from Henan Province Stroke Registry (HNSR) in which data were prospectively collected. The receiver-operating characteristic curves were plotted, and the C statistics were calculated to assess the discrimination ability. The Hosmer-Lemeshow goodness-of-fit test and the plot of observed versus predicted SAP risk were used to assess model calibration. Results: Among 1142 eligible patients, the overall in-hospital SAP was 18.8%, which ranged from 9.0% in patients with lower A(2)DS(2) scores (0-4) to 65.0% in those with higher scores of 5 to 10 (P for trend <0.001). The C statistic was 0.836 (95% confidence interval, 0.803-0.868) through the A(2)DS(2) score, suggesting excellent discrimination in the HNSR. The A(2)DS(2) score also showed excellent calibration (Cox and Snell R-2 = 0.243) in the external validation sample from the HNSR. Conclusions: The A(2)DS(2) score could reliably predict in-hospital SAP in Chinese stroke patients. It might be helpful for the assessment of increased risk monitoring and prophylactic treatment in identified high-risk patients for SAP in clinical routine.	[Li, Yapeng; Song, Bo; Fang, Hui; Gao, Yuan; Zhao, Lu; Xu, Yuming] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan Province, Peoples R China	Zhengzhou University	Xu, YM (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan Province, Peoples R China.	xuyuming@zzu.edu.cn	Sun, Duanping/M-4632-2017	Sun, Duanping/0000-0003-1760-2975; ling, hong/0000-0002-1886-1242	Health Department of Henan Province [201202005]; Education Department of Henan Province [12A320046]	Health Department of Henan Province; Education Department of Henan Province	This study was funded by the Health Department of Henan Province (201202005) and the Education Department of Henan Province (12A320046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, Stroke, V20, P1407; Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Chumbler NR, 2010, NEUROEPIDEMIOLOGY, V34, P193, DOI 10.1159/000289350; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Forti P, 2013, NEUROLOGY, V80, P29, DOI 10.1212/WNL.0b013e31827b1a41; Galovic M, 2013, STROKE, V44, P2760, DOI 10.1161/STROKEAHA.113.001690; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Grube MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075719; Harms H, 2013, ACTA NEUROL SCAND, V128, P178, DOI 10.1111/ane.12095; Harms H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002158; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hoffmann S, 2012, STROKE, V43, P2617, DOI 10.1161/STROKEAHA.112.653055; Hong KS, 2008, EUR J NEUROL, V15, P1324, DOI 10.1111/j.1468-1331.2008.02310.x; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Ji RJ, 2013, STROKE, V44, P1303, DOI 10.1161/STROKEAHA.111.000598; Kammersgaard L P, 2001, J Stroke Cerebrovasc Dis, V10, P217, DOI 10.1053/jscd.2001.30366; Katzan IL, 2007, NEUROLOGY, V68, P1938, DOI 10.1212/01.wnl.0000263187.08969.45; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Kemmling A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071141; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Kumar Sandeep, 2010, Lancet Neurol, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Kwon HM, 2006, AM J INFECT CONTROL, V34, P64, DOI 10.1016/j.ajic.2005.06.011; Pandian JD, 2012, J STROKE CEREBROVASC, V21, P695, DOI 10.1016/j.jstrokecerebrovasdis.2011.03.003; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; Song B, 2013, STROKE, V44, P1244, DOI 10.1161/STROKEAHA.113.000969; Tong X, 2010, STROKE, V41, P980, DOI 10.1161/STROKEAHA.110.578674; Walter U, 2007, J NEUROL, V254, P1323, DOI 10.1007/s00415-007-0520-0; Westendorp WF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008530.pub2; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wilson RD, 2012, J STROKE CEREBROVASC, V21, P61, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.002	33	65	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109665	10.1371/journal.pone.0109665	http://dx.doi.org/10.1371/journal.pone.0109665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299226	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200068
J	Chen, YP; Chiao, CC				Chen, Yin-Peng; Chiao, Chuan-Chin			Spatial Distribution of Excitatory Synapses on the Dendrites of Ganglion Cells in the Mouse Retina	PLOS ONE			English	Article							PRIMATE RETINA; CAT RETINA; POSTSYNAPTIC DENSITIES; DIRECTION-SELECTIVITY; QUANTITATIVE-ANALYSIS; RECEPTOR SUBUNITS; MACAQUE RETINA; RABBIT RETINA; BIPOLAR CELLS; TOTAL NUMBER	Excitatory glutamatergic inputs from bipolar cells affect the physiological properties of ganglion cells in the mammalian retina. The spatial distribution of these excitatory synapses on the dendrites of retinal ganglion cells thus may shape their distinct functions. To visualize the spatial pattern of excitatory glutamatergic input into the ganglion cells in the mouse retina, particle-mediated gene transfer of plasmids expressing postsynaptic density 95-green fluorescent fusion protein (PSD95-GFP) was used to label the excitatory synapses. Despite wide variation in the size and morphology of the retinal ganglion cells, the expression of PSD95 puncta was found to follow two general rules. Firstly, the PSD95 puncta are regularly spaced, at 1-2 mu m intervals, along the dendrites, whereby the presence of an excitatory synapse creates an exclusion zone that rules out the presence of other glutamatergic synaptic inputs. Secondly, the spatial distribution of PSD95 puncta on the dendrites of diverse retinal ganglion cells are similar in that the number of excitatory synapses appears to be less on primary dendrites and to increase to a plateau on higher branch order dendrites. These observations suggest that synaptogenesis is spatially regulated along the dendritic segments and that the number of synaptic contacts is relatively constant beyond the primary dendrites. Interestingly, we also found that the linear puncta density is slightly higher in large cells than in small cells. This may suggest that retinal ganglion cells with a large dendritic field tend to show an increased connectivity of excitatory synapses that makes up for their reduced dendrite density. Mapping the spatial distribution pattern of the excitatory synapses on retinal ganglion cells thus provides explicit structural information that is essential for our understanding of how excitatory glutamatergic inputs shape neuronal responses.	[Chen, Yin-Peng; Chiao, Chuan-Chin] Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan; [Chiao, Chuan-Chin] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University	Chiao, CC (corresponding author), Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan.	ccchiao@life.nthu.edu.tw	Chiao, Chuan-Chin/L-7708-2019; Chen, Yeng/A-6873-2011	Chen, Yeng/0000-0002-0064-7678	National Science Council of Taiwan [NSC-98-2311-B-007-004-MY3, NSC-101-2628-B-007-001-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council of Taiwan NSC-98-2311-B-007-004-MY3 and NSC-101-2628-B-007-001-MY3 (to CCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Calkins DJ, 1998, J NEUROSCI, V18, P3373; Calkins DJ, 1996, NATURE, V381, P613, DOI 10.1038/381613a0; Chen YP, 2012, BRAIN RES, V1427, P10, DOI 10.1016/j.brainres.2011.10.019; COHEN E, 1991, J NEUROPHYSIOL, V65, P352, DOI 10.1152/jn.1991.65.2.352; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; De la Huerta I, 2012, P NATL ACAD SCI USA, V109, P17663, DOI 10.1073/pnas.1215806109; Ebihara T, 2003, J NEUROSCI, V23, P2170; FREED MA, 1988, J NEUROSCI, V8, P2303; Garcia-Lopez P, 2006, J NEUROSCI, V26, P11249, DOI 10.1523/JNEUROSCI.3543-06.2006; Gartland AJ, 2011, J NEUROSCI, V31, P18353, DOI 10.1523/JNEUROSCI.4212-11.2011; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jacoby R, 1996, J NEUROSCI, V16, P8041; Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795; Jeon CJ, 2002, J COMP NEUROL, V449, P195, DOI 10.1002/cne.10288; Jusuf PR, 2006, J COMP NEUROL, V494, P260, DOI 10.1002/cne.20804; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Klug K, 2003, J NEUROSCI, V23, P9881; Koizumi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000221; Koizumi A, 2011, J COMP NEUROL, V519, P341, DOI 10.1002/cne.22522; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Lin B, 2002, VISUAL NEUROSCI, V19, P453, DOI 10.1017/S0952523802194077; Lin B, 2000, EUR J NEUROSCI, V12, P4155, DOI 10.1111/j.1460-9568.2000.01311.x; Lye Ming H, 2007, J Vis Exp, P190, DOI 10.3791/190; MacNeil MA, 2004, J COMP NEUROL, V472, P73, DOI 10.1002/cne.20063; Macri J, 2000, VISUAL NEUROSCI, V17, P437, DOI 10.1017/S0952523800173109; Marshak DW, 2002, VISUAL NEUROSCI, V19, P299, DOI 10.1017/S0952523802192078; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; MCGUIRE BA, 1986, J NEUROSCI, V6, P907; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; Moritoh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054667; Moritoh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012917; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; Qin LX, 2001, J COMP NEUROL, V440, P284, DOI 10.1002/cne.1386; Sanchez AL, 2006, DEVELOPMENT, V133, P2477, DOI 10.1242/dev.02409; Schubert T, 2005, J COMP NEUROL, V490, P29, DOI 10.1002/cne.20621; Schubert T, 2005, J COMP NEUROL, V485, P191, DOI 10.1002/cne.20510; Soto F, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-31; STERLING P, 1983, ANNU REV NEUROSCI, V6, P149, DOI 10.1146/annurev.ne.06.030183.001053; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Taylor W, 2011, CURR OPIN NEUROBIOL; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Volgyi B, 2005, J COMP NEUROL, V492, P66, DOI 10.1002/cne.20700; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Xu Y, 2008, J COMP NEUROL, V507, P1871, DOI 10.1002/cne.21644; Zhang J, 2006, J COMP NEUROL, V498, P810, DOI 10.1002/cne.21089	53	84	87	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86159	10.1371/journal.pone.0086159	http://dx.doi.org/10.1371/journal.pone.0086159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465934	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000088
J	Chen, H; Luo, R; Gong, SZ; Matta, SG; Sharp, BM				Chen, Hao; Luo, Rui; Gong, Suzhen; Matta, Shannon G.; Sharp, Burt M.			Protection Genes in Nucleus Accumbens Shell Affect Vulnerability to Nicotine Self-Administration across Isogenic Strains of Adolescent Rat	PLOS ONE			English	Article							CUE-INDUCED REINSTATEMENT; AFRICAN-AMERICAN SMOKERS; GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMAS; CA2+ SENSOR VILIP-1; HIPPOCAMPAL-NEURONS; NEOSTRIATAL NEURONS; MOLECULAR-GENETICS; SMOKING-CESSATION; EUROPEAN-AMERICAN	Classical genetic studies show the heritability of cigarette smoking is 0.4-0.6, and that multiple genes confer susceptibility and resistance to smoking. Despite recent advances in identifying genes associated with smoking behaviors, the major source of this heritability and its impact on susceptibility and resistance are largely unknown. Operant self-administration (SA) of intravenous nicotine is an established model for smoking behavior. We recently confirmed that genetic factors exert strong control over nicotine intake in isogenic rat strains. Because the processing of afferent dopaminergic signals by nucleus accumbens shell (AcbS) is critical for acquisition and maintenance of motivated behaviors reinforced by nicotine, we hypothesized that differential basal gene expression in AcbS accounts for much of the strain-to-strain variation in nicotine SA. We therefore sequenced the transcriptome of AcbS samples obtained by laser capture microdissection from 10 isogenic adolescent rat strains and compared all RNA transcript levels with behavior. Weighted gene co-expression network analysis, a systems biology method, found 12 modules (i.e., unique sets of genes that covary across all samples) that correlated (p<0.05) with amount of self-administered nicotine; 9 of 12 correlated negatively, implying a protective role. PCR confirmed selected genes from these modules. Chilibot, a literature mining tool, identified 15 genes within 1 module that were nominally associated with cigarette smoking, thereby providing strong support for the analytical approach. This is the first report demonstrating that nicotine intake by adolescent rodents is associated with the expression of specific genes in AcbS of the mesolimbic system, which controls motivated behaviors. These findings provide new insights into genetic mechanisms that predispose or protect against tobacco addiction.	[Chen, Hao; Gong, Suzhen; Matta, Shannon G.; Sharp, Burt M.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Luo, Rui] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chen, H (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA.	hchen@uthsc.edu; bsharp@uthsc.edu	Sharp, Burt/X-6200-2019; Chen, Hao/AAX-5849-2020; Norenburg, Jon L/K-3481-2015	Sharp, Burt/0000-0002-3765-8848; Chen, Hao/0000-0002-2680-6921; Norenburg, Jon L/0000-0001-7776-1527; Zhou, Tan/0000-0002-9193-5113; Yu, Rongjie/0000-0001-9285-5783	NIH [RC2 DA 028962]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by NIH grant RC2 DA 028962. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anney RJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-46; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Beuten J, 2007, AM J MED GENET B, V144B, P285, DOI 10.1002/ajmg.b.30399; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bierut LJ, 2011, NEURON, V69, P618, DOI 10.1016/j.neuron.2011.02.015; Brower VG, 2002, BRAIN RES, V930, P12, DOI 10.1016/S0006-8993(01)03375-3; Brunzell DH, 2010, NEUROPSYCHOPHARMACOL, V35, P665, DOI 10.1038/npp.2009.171; Buczek Y, 1999, PSYCHOPHARMACOLOGY, V144, P183, DOI 10.1007/s002130050992; Cadoni C, 2009, NEUROPHARMACOLOGY, V57, P496, DOI 10.1016/j.neuropharm.2009.07.033; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Chen H, 2007, NEUROPSYCHOPHARMACOL, V32, P700, DOI 10.1038/sj.npp.1301135; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044234; Chen H, 2011, NEUROPSYCHOPHARMACOL, V36, P2629, DOI 10.1038/npp.2011.149; Chen H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00098; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; Dao JM, 2011, NEUROPSYCHOPHARMACOL, V36, P1319, DOI 10.1038/npp.2011.8; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Donny EC, 1998, PSYCHOPHARMACOLOGY, V136, P83, DOI 10.1007/s002130050542; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gold AB, 2012, NEUROPSYCHOPHARMACOL, V37, P1683, DOI 10.1038/npp.2012.13; Hafkamp HC, 2009, MODERN PATHOL, V22, P686, DOI 10.1038/modpathol.2009.23; Hamada M, 2005, J PHARMACOL EXP THER, V315, P872, DOI 10.1124/jpet.105.090852; Hamada M, 2004, J NEUROCHEM, V90, P1094, DOI 10.1111/j.1471-4159.2004.02574.x; Han SZ, 2010, BIOL PSYCHIAT, V67, P12, DOI 10.1016/j.biopsych.2009.08.028; Iancu OD, 2013, ALCOHOL CLIN EXP RES, V37, P1295, DOI 10.1111/acer.12100; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; JOSEPH R, 1994, BIOCHEM BIOPH RES CO, V201, P1227, DOI 10.1006/bbrc.1994.1836; Kalomenidis L, 2001, LUNG, V179, P265, DOI 10.1007/s0040800000067; Kendler KS, 2012, NAT NEUROSCI, V15, P181, DOI 10.1038/nn.3018; Keskitalo-Vuokko K, 2012, NICOTINE TOB RES, V14, P153, DOI 10.1093/ntr/ntr153; Konu O, 2001, BRAIN RES, V909, P194, DOI 10.1016/S0006-8993(01)02685-3; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Le Foll B, 2012, INT J NEUROPSYCHOPH, V15, P1265, DOI 10.1017/S1461145711001398; Lecca D, 2006, PSYCHOPHARMACOLOGY, V184, P435, DOI 10.1007/s00213-005-0280-4; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li MD, 2003, AM J MED SCI, V326, P168, DOI 10.1097/00000441-200310000-00003; Liechti ME, 2007, J NEUROSCI, V27, P9077, DOI 10.1523/JNEUROSCI.1766-07.2007; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu X, 2007, NEUROPSYCHOPHARMACOL, V32, P710, DOI 10.1038/sj.npp.1301129; Ma JZ, 2010, HUM GENET, V127, P503, DOI 10.1007/s00439-010-0787-6; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; Nussbaum J, 2008, HUM MOL GENET, V17, P1569, DOI 10.1093/hmg/ddn044; O'Dell LE, 2007, J PHARMACOL EXP THER, V320, P180, DOI 10.1124/jpet.106.105270; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-63; Oyang EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024879; Paterson NE, 2005, NEUROPSYCHOPHARMACOL, V30, P119, DOI 10.1038/sj.npp.1300524; Rose JE, 1999, DRUG ALCOHOL DEPEN, V56, P99, DOI 10.1016/S0376-8716(99)00025-3; Rose JE, 1997, PSYCHOPHARMACOLOGY, V130, P28, DOI 10.1007/s002130050209; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Sasaki H, 2012, MOL MED REP, V5, P725, DOI 10.3892/mmr.2011.715; Sato N, 2010, PSYCHIAT GENET, V20, P135, DOI 10.1097/YPG.0b013e32833a21f9; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sharp BM, 2011, GENES BRAIN BEHAV, V10, P778, DOI 10.1111/j.1601-183X.2011.00716.x; Shoaib M, 1997, PSYCHOPHARMACOLOGY, V129, P35, DOI 10.1007/s002130050159; Shoaib M, 1999, PSYCHOPHARMACOLOGY, V143, P318, DOI 10.1007/s002130050954; Slotkin TA, 2007, NEUROPSYCHOPHARMACOL, V32, P1082, DOI 10.1038/sj.npp.1301231; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Valentine JD, 1997, PSYCHOPHARMACOLOGY, V133, P300, DOI 10.1007/s002130050405; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Wei JX, 2012, ADDICT BEHAV, V37, P622, DOI 10.1016/j.addbeh.2012.01.009; Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Young RJ, 2013, ORAL ONCOL, V49, P576, DOI 10.1016/j.oraloncology.2013.01.006; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; Zhao CJ, 2009, CELL MOL NEUROBIOL, V29, P273, DOI 10.1007/s10571-008-9320-z; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	82	136	143	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86214	10.1371/journal.pone.0086214	http://dx.doi.org/10.1371/journal.pone.0086214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465966	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100127
J	Chen, HX; Sun, SC; Norenburg, JL; Sundberg, P				Chen, Haixia; Sun, Shichun; Norenburg, Jon L.; Sundberg, Per			Mutation and Selection Cause Codon Usage and Bias in Mitochondrial Genomes of Ribbon Worms (Nemertea)	PLOS ONE			English	Article							AMINO-ACID USAGE; TRANSFER-RNAS; TRANSLATIONAL SELECTION; EFFECTIVE NUMBER; GENE-EXPRESSION; EVOLUTION; PATTERNS; FREQUENCIES; NUCLEOTIDE; ABUNDANCE	The phenomenon of codon usage bias is known to exist in many genomes and it is mainly determined by mutation and selection. To understand the patterns of codon usage in nemertean mitochondrial genomes, we use bioinformatic approaches to analyze the protein-coding sequences of eight nemertean species. Neutrality analysis did not find a significant correlation between GC12 and GC3. ENc-plot showed a few genes on or close to the expected curve, but the majority of points with low-ENc values are below it. ENc-plot suggested that mutational bias plays a major role in shaping codon usage. The Parity Rule 2 plot (PR2) analysis showed that GC and AT were not used proportionally and we propose that codons containing A or U at third position are used preferentially in nemertean species, regardless of whether corresponding tRNAs are encoded in the mitochondrial DNA. Context-dependent analysis indicated that the nucleotide at the second codon position slightly affects synonymous codon choices. These results suggested that mutational and selection forces are probably acting to codon usage bias in nemertean mitochondrial genomes.	[Chen, Haixia; Sundberg, Per] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Sun, Shichun] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China; [Norenburg, Jon L.] Smithsonians Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC USA	University of Gothenburg; Ocean University of China; Smithsonian Institution; Smithsonian National Museum of Natural History	Chen, HX (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	chen_hai_xia@126.com; per.sundberg@bioenv.gu.se	Sharp, Burt/X-6200-2019; Chen, Hao/AAX-5849-2020; Norenburg, Jon L/K-3481-2015	Sharp, Burt/0000-0002-3765-8848; Chen, Hao/0000-0002-2680-6921; Norenburg, Jon L/0000-0001-7776-1527; Zhou, Tan/0000-0002-9193-5113; Yu, Rongjie/0000-0001-9285-5783	Swedish Research Council; National Natural Science Foundation of China [30970333]	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported (to PS) by the Swedish Research Council, and National Natural Science Foundation of China (to SCS, grant no. 30970333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Angellotti MC, 2007, NUCLEIC ACIDS RES, V35, pW132, DOI 10.1093/nar/gkm392; BULMER M, 1988, J EVOLUTION BIOL, V1, P15, DOI 10.1046/j.1420-9101.1988.1010015.x; Carullo M, 2008, J MOL EVOL, V66, P484, DOI 10.1007/s00239-008-9102-8; Chen HX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-139; Chen HX, 2011, MOL BIOL REP, V38, P4509, DOI 10.1007/s11033-010-0582-4; Chen HX, 2009, GENE, V442, P8, DOI 10.1016/j.gene.2009.04.015; Chiapello H, 1998, GENE, V209, pGC1, DOI 10.1016/S0378-1119(97)00671-9; Cutter AD, 2006, MOL BIOL EVOL, V23, P2303, DOI 10.1093/molbev/msl097; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Francino HP, 1999, NATURE, V400, P30, DOI 10.1038/21804; Fuglsang A, 2008, GENE, V410, P82, DOI 10.1016/j.gene.2007.12.001; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, P1893, DOI 10.1093/nar/8.9.1893; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ingvarsson PK, 2007, MOL BIOL EVOL, V24, P836, DOI 10.1093/molbev/msl212; Ingvarsson PK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-307; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Kamatani T, 2007, BIOSYSTEMS, V90, P362, DOI 10.1016/j.biosystems.2006.09.039; Le Thanh Hoa, 2004, Korean Journal of Parasitology, V42, P159, DOI 10.3347/kjp.2004.42.4.159; LOBRY JR, 1995, J MOL EVOL, V40, P326, DOI 10.1007/BF00163237; Mitreva M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r75; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Podsiadlowski L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-364; Powell JR, 1997, P NATL ACAD SCI USA, V94, P7784, DOI 10.1073/pnas.94.15.7784; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; SHARP PM, 1993, BIOCHEM SOC T, V21, P835, DOI 10.1042/bst0210835; Shioiri C, 2001, J MOL EVOL, V53, P364, DOI 10.1007/s002390010226; STENICO M, 1994, NUCLEIC ACIDS RES, V22, P2437, DOI 10.1093/nar/22.13.2437; Subramanian S, 2008, GENETICS, V178, P2429, DOI 10.1534/genetics.107.086405; Sueoka N, 1999, GENE, V238, P53, DOI 10.1016/S0378-1119(99)00320-0; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; SUEOKA N, 1995, J MOL EVOL, V40, P318, DOI 10.1007/BF00163236; Swire J, 2005, J MOL EVOL, V60, P128, DOI 10.1007/s00239-004-0077-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turbeville JM, 2007, MOL PHYLOGENET EVOL, V43, P1056, DOI 10.1016/j.ympev.2006.10.025; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Wang B, 2010, J INTEGR PLANT BIOL, V52, P1100, DOI 10.1111/j.1744-7909.2010.00998.x; Wang X, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-14; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xia XH, 2005, GENE, V345, P13, DOI 10.1016/j.gene.2004.11.019; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016147	48	136	143	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85631	10.1371/journal.pone.0085631	http://dx.doi.org/10.1371/journal.pone.0085631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24465966	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100110
J	Yang, YC; Huang, YT; Hsieh, CW; Yang, PM; Wung, BS				Yang, Yan-Chang; Huang, Yu-Ting; Hsieh, Chia-Wen; Yang, Po-Min; Wung, Being-Sun			Carbon Monoxide Induces Heme Oxygenase-1 to Modulate STAT3 Activation in Endothelial Cells via S-Glutathionylation	PLOS ONE			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM-STRESS; CO-RELEASING MOLECULES; THERAPEUTIC APPLICATIONS; GENE-EXPRESSION; UP-REGULATION; JNK PATHWAY; PHOSPHORYLATION; INHIBITION; APOPTOSIS	IL-6/STAT3 pathway is involved in a variety of biological responses, including cell proliferation, differentiation, apoptosis, and inflammation. In our present study, we found that CO releasing molecules (CORMs) suppress IL-6-induced STAT3 phosphorylation, nuclear translocation and transactivity in endothelial cells (ECs). CO is a byproduct of heme degradation mediated by heme oxygenase (HO-1). However, CORMs can induce HO-1 expression and then inhibit STAT3 phosphorylation. CO has been found to increase a low level ROS and which may induce protein glutathionylation. We hypothesized that CORMs increases protein glutathionylation and inhibits STAT3 activation. We found that CORMs increase the intracellular GSSG level and induce the glutathionylation of multiple proteins including STAT3. GSSG can inhibit STAT3 phosphorylation and increase STAT3 glutathionylation whereas the antioxidant enzyme catalase can suppress the glutathionylation. Furthermore, catalase blocks the inhibition of STAT3 phosphorylation by CORMs treatment. The inhibition of glutathione synthesis by BSO was also found to attenuate STAT3 glutathionylation and its inhibition of STAT3 phosphorylation. We further found that HO-1 increases STAT3 glutathionylation and that HO-1 siRNA attenuates CORM-induced STAT3 glutathionylation. Hence, the inhibition of STAT3 activation is likely to occur via a CO-mediated increase in the GSSG level, which augments protein glutathionylation, and CO-induced HO-1 expression, which may enhance and maintain its effects in IL-6-treated ECs.	[Yang, Yan-Chang; Huang, Yu-Ting; Hsieh, Chia-Wen; Wung, Being-Sun] Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Yang, Po-Min] Chiayi Christian Hosp, Dept Ophthalmol, Chiayi, Taiwan	National Chiayi University; Chia-Yi Christian Hospital	Wung, BS (corresponding author), Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan.	bswung@mail.ncyu.edu.tw	; Herrup, Karl/C-5313-2014	Chen, Ji-hua/0000-0002-1151-0693; wung, being sun/0000-0002-9378-2798; Hsieh, Chia-Wen/0000-0003-1188-1934; Herrup, Karl/0000-0001-7786-5844; Li, Jiali/0000-0002-0039-3671	National Science Council, Taiwan [102-2320-B-415-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants (102-2320-B-415-002-MY3) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EMG, 2012, ANTIOXID REDOX SIGN, V17, P1748, DOI 10.1089/ars.2012.4644; Bannenberg GL, 2009, EXPERT OPIN THER PAT, V19, P663, DOI 10.1517/13543770902858824; Brennan JP, 2006, MOL CELL PROTEOMICS, V5, P215, DOI 10.1074/mcp.M500212-MCP200; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Clark JE, 2000, AM J PHYSIOL-HEART C, V278, pH643, DOI 10.1152/ajpheart.2000.278.2.H643; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; GOSPODAROWICZ D, 1976, P NATL ACAD SCI USA, V73, P4120, DOI 10.1073/pnas.73.11.4120; GYLLENHAMMAR H, 1987, J IMMUNOL METHODS, V97, P209, DOI 10.1016/0022-1759(87)90461-3; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lian KC, 2010, TOXICOL APPL PHARM, V245, P21, DOI 10.1016/j.taap.2010.01.003; Liao BC, 2010, TOXICOL SCI, V116, P151, DOI 10.1093/toxsci/kfq098; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Morita T, 2005, ARTERIOSCL THROM VAS, V25, P1786, DOI 10.1161/01.ATV.0000178169.95781.49; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Pimentel D, 2012, ANTIOXID REDOX SIGN, V16, P524, DOI 10.1089/ars.2011.4336; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schipper HM, 2004, FREE RADICAL BIO MED, V37, P1995, DOI 10.1016/j.freeradbiomed.2004.09.015; Schuringa JJ, 2001, J BIOL CHEM, V276, P27709, DOI 10.1074/jbc.M009821200; Schwer CI, 2010, MOL PHARMACOL, V77, P660, DOI 10.1124/mol.109.059519; Shin DY, 2012, BLOOD, V119, P2523, DOI 10.1182/blood-2011-07-366690; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Wu CC, 2006, TOXICOL APPL PHARM, V214, P244, DOI 10.1016/j.taap.2005.12.013; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Wung BS, 2006, LIFE SCI, V78, P3035, DOI 10.1016/j.lfs.2005.12.013; Wung BS, 2005, LIFE SCI, V78, P389, DOI 10.1016/j.lfs.2005.04.052; Wung BS, 2005, J BIOMED SCI, V12, P91, DOI 10.1007/s11373-004-8170-z; Wung BS, 1997, CIRC RES, V81, P1, DOI 10.1161/01.RES.81.1.1; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yeh PY, 2014, FREE RADICAL BIO MED, V70, P1, DOI 10.1016/j.freeradbiomed.2014.01.042; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	40	112	121	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e100677	10.1371/journal.pone.0100677	http://dx.doi.org/10.1371/journal.pone.0100677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	24498369	Green Submitted, Green Published, gold			2022-12-25	WOS:000341307600004
J	Liu, J; Gaj, T; Patterson, JT; Sirk, SJ; Barbas, CF				Liu, Jia; Gaj, Thomas; Patterson, James T.; Sirk, Shannon J.; Barbas, Carlos F., III			Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; EMBRYO MICROINJECTION; VECTOR TOOLKIT; KNOCKOUT RATS; GENE-TRANSFER; BASIC DOMAIN; IN-VIVO; DNA; RECOGNITION; EFFECTORS	Transcription activator-like (TAL) effector nucleases (TALENs) have enabled the introduction of targeted genetic alterations into a broad range of cell lines and organisms. These customizable nucleases are comprised of programmable sequence-specific DNA-binding modules derived from TAL effector proteins fused to the non-specific FokI cleavage domain. Delivery of these nucleases into cells has proven challenging as the large size and highly repetitive nature of the TAL effector DNA-binding domain precludes their incorporation into many types of viral vectors. Furthermore, viral and non-viral gene delivery methods carry the risk of insertional mutagenesis and have been shown to increase the off-target activity of site-specific nucleases. We previously demonstrated that direct delivery of zinc-finger nuclease proteins enables highly efficient gene knockout in a variety of mammalian cell types with reduced off-target effects. Here we show that conjugation of cell-penetrating poly-Arg peptides to a surface-exposed Cys residue present on each TAL effector repeat imparted cell-penetrating activity to purified TALEN proteins. These modifications are reversible under reducing conditions and enabled TALEN-mediated gene knockout of the human CCR5 and BMPR1A genes at rates comparable to those achieved with transient transfection of TALEN expression vectors. These findings demonstrate that direct protein delivery, facilitated by conjugation of chemical functionalities onto the TALEN protein surface, is a promising alternative to current non-viral and viral-based methods for TALEN delivery into mammalian cells.	[Barbas, Carlos F., III] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell & Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Barbas, CF (corresponding author), Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	carlos@scripps.edu	Liu, Jia/E-5758-2014	Patterson, James/0000-0001-6006-7184; liu, juanjuan/0000-0001-6941-0372; Ma, Leina/0000-0003-3964-632X; Lin, Xiukun/0000-0002-0306-4953; Spincemaille, Pascal/0000-0002-8821-1341; Prince, Martin/0000-0002-9883-0584; Saloner, David/0000-0002-6989-8547	US National Institutes for Health [DP1CA174426]; NATIONAL CANCER INSTITUTE [DP1CA174426] Funding Source: NIH RePORTER	US National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institutes for Health (DP1CA174426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen Z, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt710; Choi JM, 2006, NAT MED, V12, P574, DOI 10.1038/nm1385; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jin LH, 2001, FREE RADICAL BIO MED, V31, P1509, DOI 10.1016/S0891-5849(01)00734-1; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kim SS, 2011, METHODS MOL BIOL, V721, P339, DOI 10.1007/978-1-61779-037-9_21; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056633; Mitsui H, 2006, J INVEST DERMATOL, V126, P1804, DOI 10.1038/sj.jid.5700335; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ru Renli, 2013, Cell Regen, V2, P5, DOI 10.1186/2045-9769-2-5; Segal DJ, 2013, ANNU REV GENOM HUM G, V14, P135, DOI 10.1146/annurev-genom-091212-153435; Stella S, 2013, ACTA CRYSTALLOGR D, V69, P1707, DOI 10.1107/S0907444913016429; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Van Tendeloo VFI, 2000, GENE THER, V7, P1431, DOI 10.1038/sj.gt.3301252; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009	48	200	240	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85755	10.1371/journal.pone.0085755	http://dx.doi.org/10.1371/journal.pone.0085755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24626155	gold, Green Published			2022-12-25	WOS:000330240500068
J	Chen, XX; Shi, Y; Chai, WM; Feng, HL; Zhuang, JX; Chen, QX				Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Zhuang, Jiang-Xing; Chen, Qing-Xi			Condensed Tannins from Ficus virens as Tyrosinase Inhibitors: Structure, Inhibitory Activity and Molecular Mechanism	PLOS ONE			English	Article							TOF MS ANALYSIS; MUSHROOM TYROSINASE; SKIN; PIGMENTATION; DOPAMINE; KINETICS; LEAVES; IONS; HPLC; NMR	Condensed tannins from Ficus virens leaves, fruit, and stem bark were isolated and their structures characterized by C-13 nuclear magnetic resonance spectrometry, high performance liquid chromatography electrospray ionization mass spectrometry, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The results showed that the leaves, fruit, and stem bark condensed tannins were complex mixtures of homo-and heteropolymers of B-type procyanidins and prodelphinidins with degrees of polymerization up to hexamer, dodecamer, and pentadecamer, respectively. Antityrosinase activities of the condensed tannins were studied. The results indicated that the condensed tannins were potent tyrosinase inhibitors. The concentrations for the leaves, fruit, and stem bark condensed tannins leading to 50% enzyme activity were determined to be 131.67, 99.89, and 106.22 mu g/ml on monophenolase activity, and 128.42, 43.07, and 74.27 mu g/ml on diphenolase activity. The inhibition mechanism, type, and constants of the condensed tannins on the diphenolase activity were further investigated. The results indicated that the condensed tannins were reversible and mixed type inhibitors. Fluorescence quenching, copper interacting, and molecular docking techniques were utilized to unravel the molecular mechanisms of the inhibition. The results showed that the hydroxyl group on the B ring of the condensed tannins could chelate the dicopper irons of the enzyme. Moreover, the condensed tannins could reduce the enzyme product o-quinones into colourless compounds. These results would contribute to the development and design of antityrosinase agents.	[Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Chen, Qing-Xi] Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Zhuang, Jiang-Xing] Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China	Xiamen University; Xiamen University	Zhuang, JX (corresponding author), Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China.	jiangxingzhuang@xmu.edu.cn; chenqx@xmu.edu.cn	Chen, Xin-Zu/G-6579-2014; Yang, Kun/A-4293-2010; Chen, Xin-Zu/K-2988-2019; Xue, Charlie C/F-1244-2014; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; Xue, Charlie/0000-0001-6937-9088; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Chen, Xin-lin/0000-0002-2650-8051	Natural Science Foundation of China [31071611, 31070522]; National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China [J1310027/J0106]; Science and Technology Foundation of Fujian Province [2010N5013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061763, R01HD038329, R01HD018269] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China; Science and Technology Foundation of Fujian Province(Natural Science Foundation of Fujian Province); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The present investigation was supported by the Natural Science Foundation of China (No. 31071611; No. 31070522), the National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China (Grant No. J1310027/J0106) and by the Science and Technology Foundation of Fujian Province (No. 2010N5013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hameed ESS, 2009, FOOD CHEM, V114, P1271, DOI 10.1016/j.foodchem.2008.11.005; Anandjiwala S, 2008, INDIAN J PHARM SCI, V70, P31, DOI 10.4103/0250-474X.40328; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Baby Joseph, 2010, International Journal of Pharma and Bio Sciences, V1, pP; Bawadi HA, 2005, CANCER LETT, V218, P153, DOI 10.1016/j.canlet.2004.06.021; Chai WM, 2012, J AGR FOOD CHEM, V60, P5013, DOI 10.1021/jf300740d; Chauhan S, 2013, J MED PLANTS STUD, V1, P3846; Chen QX, 2005, FOOD CHEM, V91, P269, DOI 10.1016/j.foodchem.2004.01.078; Chen XX, 2014, FOOD CHEM, V155, P1, DOI 10.1016/j.foodchem.2014.01.011; Chen XX, 2013, INT J BIOL MACROMOL, V62, P726, DOI 10.1016/j.ijbiomac.2013.09.052; Chen XX, 2013, J ZHEJIANG UNIV-SC B, V14, P903, DOI 10.1631/jzus.B1200365; Choi H, 2005, PIGM CELL RES, V18, P439, DOI 10.1111/j.1600-0749.2005.00266.x; Espin JC, 2001, BBA-PROTEIN STRUCT M, V1544, P289, DOI 10.1016/S0167-4838(00)00230-2; Chiari ME, 2011, BIOORGAN MED CHEM, V19, P3474, DOI 10.1016/j.bmc.2011.04.025; Haslam E., 1989, Plant polyphenols: vegetable tannins revisited.; Hummer W, 2008, MOL NUTR FOOD RES, V52, P1381, DOI 10.1002/mnfr.200700463; Jimenez M, 2001, J AGR FOOD CHEM, V49, P4060, DOI 10.1021/jf010194h; Khatib S, 2007, J MED CHEM, V50, P2676, DOI 10.1021/jm061361d; Kim D, 2006, J AGR FOOD CHEM, V54, P935, DOI 10.1021/jf0521855; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Kubo I, 1999, J AGR FOOD CHEM, V47, P4121, DOI 10.1021/jf990201q; Lee N, 2012, ACS CHEM BIOL, V7, P1687, DOI 10.1021/cb300222b; Lim YY, 2007, LWT-FOOD SCI TECHNOL, V40, P1664, DOI 10.1016/j.lwt.2006.12.013; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; McDonald M, 1996, J AGR FOOD CHEM, V44, P599, DOI 10.1021/jf950459q; Niranjan S, 2012, GLOBAL J PHARM RES, V1, P318; Sanjust E, 2003, ARCH BIOCHEM BIOPHYS, V412, P272, DOI 10.1016/S0003-9861(03)00053-5; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Sisti M, 2008, LWT-FOOD SCI TECHNOL, V41, P946, DOI 10.1016/j.lwt.2007.05.012; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Takahashi S, 2010, BIOORGAN MED CHEM, V18, P8112, DOI 10.1016/j.bmc.2010.08.056; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Xiang P, 2006, CHINESE J ANAL CHEM, V34, P1019, DOI 10.1016/S1872-2040(06)60047-9; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Zhang LL, 2008, MOLECULES, V13, P2986, DOI 10.3390/molecules13122986; Zhuang JX, 2010, J AGR FOOD CHEM, V58, P12993, DOI 10.1021/jf103723k	38	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91809	10.1371/journal.pone.0091809	http://dx.doi.org/10.1371/journal.pone.0091809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	25521114	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100063
J	Chen, XH; Scholl, TO				Chen, Xinhua; Scholl, Theresa O.			Maternal Biomarkers of Endothelial Dysfunction and Preterm Delivery	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ADHESION MOLECULE-1; RETROSPECTIVE COHORT; HEART-DISEASE; UNITED-STATES; SE-SELECTIN; PREECLAMPSIA; RISK; WOMEN; INFLAMMATION	Background: Endothelial dysfunction is key to the development of atherosclerosis. Preterm delivery foreshadows later maternal cardiovascular disease (CVD), but it is not known if endothelial dysfunction also occurs. We prospectively measured circulating biomarkers of endothelial dysfunction in pregnant women with preterm or term delivery. Methods: We conducted a case-control study nested within a large prospective epidemiological study of young, generally healthy pregnant women. Women who delivered preterm (, 37 completed weeks gestation, n = 240) and controls who delivered at term (n = 439) were included. Pregnancies complicated by preeclampsia were analyzed separately. Circulating endothelial dysfunction biomarkers included soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin). Results: Elevated levels of sICAM-1 and sVCAM-1 were positively associated with preterm delivery independent of usual risk factors. At entry (similar to 16 wks), the adjusted odds ratio (AOR) was 1.73 (95% confidence interval (CI) 1.09-2.74) for the highest quartile of sICAM-1 versus the lowest quartile and for sVCAM-1 the AOR was 2.17 (95% CI 1.36-3.46). When analysis was limited to cases with a spontaneous preterm delivery, the results were unchanged. Similar results were obtained for the 3rd trimester (similar to 30 wks). Elevated sE-selectin was increased only in preterm delivery complicated by preeclampsia; risk was increased at entry (AOR 2.32, 95% CI 1.22-4.40) and in the 3rd trimester (AOR 3.37, 95% CI 1.78-6.39). Conclusions: Impaired endothelial function as indicated by increased levels of soluble molecules commonly secreted by endothelial cells is a pathogenic precursor to CVD that is also present in women with preterm delivery. Our findings underscore the need for follow-up studies to determine if improving endothelial function prevents later CVD risk in women.	[Chen, Xinhua; Scholl, Theresa O.] Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine	Chen, XH (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA.	chenx1@rowan.edu	Chen, Xin-Zu/G-6579-2014; Yang, Kun/A-4293-2010; Chen, Xin-Zu/K-2988-2019; Xue, Charlie C/F-1244-2014; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; Xue, Charlie/0000-0001-6937-9088; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Chen, Xin-lin/0000-0002-2650-8051	National Institute of Child Health and Human Development [HD061763, HD18269, HD38329]; National Institute on Minority Health and Health Disparities [1R01MD007828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061763, R01HD038329, R01HD018269] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by research grants from the National Institute of Child Health and Human Development (HD061763 to Chen; HD18269 and HD38329 to Scholl) and the National Institute on Minority Health and Health Disparities (1R01MD007828 to Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatisa PK, 2004, AM J PHYSIOL-HEART C, V286, pH1389, DOI 10.1152/ajpheart.00298.2003; [Anonymous], 2006, INCOME EARNINGS POVE; Bartha JL, 2012, J WOMENS HEALTH, V21, P643, DOI 10.1089/jwh.2011.3013; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Bonamy AKE, 2011, CIRCULATION, V124, P2839, DOI 10.1161/CIRCULATIONAHA.111.034884; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V12, P19; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Clapp BR, 2004, CARDIOVASC RES, V64, P172, DOI 10.1016/j.cardiores.2004.06.020; Frieden Thomas R, 2011, MMWR Suppl, V60, P1; Glowinska B, 2005, METABOLISM, V54, P1020, DOI 10.1016/j.metabol.2005.03.004; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gong J, 2012, PAEDIATR PERINAT EP, V26, P45, DOI 10.1111/j.1365-3016.2011.01222.x; Hamilton SJ, 2009, DIABETES CARE, V32, P810, DOI 10.2337/dc08-1736; Hastie CE, 2011, INT J EPIDEMIOL, V40, P914, DOI 10.1093/ije/dyq270; Hediger ML, 1997, ANN EPIDEMIOL, V7, P400, DOI 10.1016/S1047-2797(97)00046-X; Jenny NS, 2006, J THROMB HAEMOST, V4, P107, DOI 10.1111/j.1538-7836.2005.01678.x; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim SY, 2004, J KOREAN MED SCI, V19, P688, DOI 10.3346/jkms.2004.19.5.688; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Martin Joyce A., 2011, Morbidity and Mortality Weekly Report, V60, P78; Marvin KW, 2000, AM J REPROD IMMUNOL, V43, P264, DOI 10.1111/j.8755-8920.2000.430504.x; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Pell JP, 2004, AM J EPIDEMIOL, V159, P336, DOI 10.1093/aje/kwh064; Pina IL, 2011, CARDIOL REV, V19, P71, DOI 10.1097/CRD.0b013e318209c233; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Steinborn A, 2000, OBSTET GYNECOL, V95, P671, DOI 10.1016/S0029-7844(99)00604-3; Stewart FM, 2007, J CLIN ENDOCR METAB, V92, P969, DOI 10.1210/jc.2006-2083; Veas CJ, 2011, J MATERN-FETAL NEO M, V24, P1371, DOI 10.3109/14767058.2011.556204; Velez DR, 2009, AJOG, V200; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Wolf M, 2004, J CLIN ENDOCR METAB, V89, P6239, DOI 10.1210/jc.2004-0548	33	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85716	10.1371/journal.pone.0085716	http://dx.doi.org/10.1371/journal.pone.0085716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	25521114	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100065
J	Chen, XK; May, B; Di, YM; Zhang, AL; Lu, CJ; Xue, CC; Lin, L				Chen, Xiankun; May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Lu, Chuanjian; Xue, Charlie Changli; Lin, Lin			Oral Chinese Herbal Medicine Combined with Pharmacotherapy for Stable COPD: A Systematic Review of Effect on BODE Index and Six Minute Walk Test	PLOS ONE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; CORDYCEPS-SINENSIS; ASTRAGALUS-MEMBRANACEUS; DISTANCE; COMPLEMENTARY; MANAGEMENT; PREDICTOR; CAPACITY; OUTCOMES	This systematic review evaluated the effects of Chinese herbal medicine (CHM) plus routine pharmacotherapy (RP) on the objective outcome measures BODE index, 6-minute walk test (6MWT), and 6-minute walk distance (6MWD) in individuals with stable chronic obstructive pulmonary disease (COPD). Searches were conducted of six English and Chinese databases (PubMed, EMBASE, CENTRAL, CINAHL, CNKI and CQVIP) from their inceptions until 18th November 2013 for randomized controlled trials involving oral administration of CHM plus RP compared to the same RP, with BODE Index and/or 6MWT/D as outcomes. Twenty-five studies were identified. BODE Index was used in nine studies and 6MWT/D was used in 22 studies. Methodological quality was assessed using the Cochrane Risk of Bias tool. Weaknesses were identified in most studies. Six studies were judged as 'low' risk of bias for randomisation sequence generation. Twenty-two studies involving 1,834 participants were included in the meta-analyses. The main meta-analysis results showed relative benefits for BODE Index in nine studies (mean difference [MD] -0.71, 95% confidence interval [CI] -0.94, -0.47) and 6MWT/D in 17 studies (MD 54.61 meters, 95% CI 33.30, 75.92) in favour of the CHM plus RP groups. The principal plants used were Astragalus membranaceus, Panax ginseng and Cordyceps sinensis. A. membranaceus was used in combination with other herbs in 18 formulae in 16 studies. Detailed sub-group and sensitivity analyses were conducted. Clinically meaningful benefits for BODE Index and 6MWT were found in multiple studies. These therapeutic effects were promising but need to be interpreted with caution due to variations in the CHMs and RPs used and methodological weakness in the studies. These issues should be addressed in future trials.	[Chen, Xiankun] Guangdong Prov Acad Chinese Med Sci, Evidence Based Med & Clin Res Serv Grp, Guangzhou, Guangdong, Peoples R China; [Chen, Xiankun; Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Xue, Charlie Changli] RMIT Univ, Sch Hlth Sci, Hlth Innovat Res Inst, Tradit & Complementary Med Res Program, Melbourne, Vic, Australia; [Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Acad Chinese Med Sci, Guangzhou, Guangdong, Peoples R China; [Lin, Lin] Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Royal Melbourne Institute of Technology (RMIT); Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Lin, L (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	drlinlin620@163.com	Chen, Xin-Zu/G-6579-2014; Yang, Kun/A-4293-2010; Chen, Xin-Zu/K-2988-2019; Xue, Charlie C/F-1244-2014; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; Xue, Charlie/0000-0001-6937-9088; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Chen, Xin-lin/0000-0002-2650-8051	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China [2012DFA31760]; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061763, R01HD038329, R01HD018269] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study is funded by a project grant from the International Science & Technology Cooperation Project of the Ministry of Science and Technology of China (Project Grant Number: 2012DFA31760, Project Title: Evaluation of Traditional and Scientific Evidence of Chinese Medicine). The project is partially supported by the China-Australia International Research Centre for Chinese Medicine, funded by Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS & GPHCM), Guangdong China, and RMIT University, Australia. The authors also acknowledge the support provided by the GPHCM and the School of Health Sciences, RMIT University to the first author (XKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 1999, AM J RESP CRIT CARE, V159, P1666; An XD, 2012, J ALTERN COMPLEM MED, V18, P731, DOI 10.1089/acm.2011.0389; An XD, 2011, RESP MED, V105, P165, DOI 10.1016/j.rmed.2010.11.007; Brown Cynthia D, 2007, COPD, V4, P217; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chen GC, 2012, SHANGHAI J TRADITION, V46, P42; Chen Ning, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P105, DOI 10.3736/jcim20090202; Chen Q, 2009, J FUJIAN U TRAD CHIN, V19, P12; Cote CG, 2008, EUR RESPIR J, V31, P571, DOI 10.1183/09031936.00104507; Cote CG, 2005, EUR RESPIR J, V26, P630, DOI 10.1183/09031936.05.00045505; CSRD, 2007, CHIN J INRERN MED, V46, P254; Cui Peng, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3451; Cui Zhao-bo, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P885; Denzler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012561; Faganello MM, 2010, AM J MED SCI, V339, P10, DOI 10.1097/MAJ.0b013e3181bb8111; Fan BD, 2012, J SICHUAN TRADITIONA, P83; George J, 2004, MED J AUSTRALIA, V181, P248, DOI 10.5694/j.1326-5377.2004.tb06262.x; Glaab T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-79; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Guo WX, 2008, HEBEI J TRADITIONAL, V30, P121; Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028696; Hu QG, 2012, J GUIYANG COLLAGE TR, V34, P135; [黄东晖 Huang Donghui], 2005, [第四军医大学学报, Journal of the Fourth Military Medical University], V26, P1611; Imfeld S, 2006, CHEST, V129, P873, DOI 10.1378/chest.129.4.873; Jian XY, 2012, J BEIJING U TRADITIO, V19, P32; Jones PW, 2001, THORAX, V56, P880, DOI 10.1136/thorax.56.11.880; Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047; Koh JH, 2002, BIOSCI BIOTECH BIOCH, V66, P407, DOI 10.1271/bbb.66.407; Kumar R, 2011, J ETHNOPHARMACOL, V136, P260, DOI 10.1016/j.jep.2011.04.040; Kuo YH, 2009, J ETHNOPHARMACOL, V122, P28, DOI 10.1016/j.jep.2008.11.025; Kuo YC, 1996, AM J CHINESE MED, V24, P111, DOI 10.1142/S0192415X96000165; Kuo YC, 2001, LIFE SCI, V68, P1067, DOI 10.1016/S0024-3205(00)01011-0; Li CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040824; Li SY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-197; Liang AW, 2013, J EMERGENCY TRADITIO, P1125; Liao Y.L., 2011, HERALD MED, V30, P63; Lin YZ, 2013, CHINESE MANIPULATION, P103; Liu CS, 2009, GUIDING J TRADITIONA, V11, P10; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mansori F, 2010, CLIN RESPIR J, V4, P241, DOI 10.1111/j.1752-699X.2010.00185.x; Marin JM, 2011, RESP MED, V105, P916, DOI 10.1016/j.rmed.2011.01.007; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ong KC, 2005, CHEST, V128, P3810, DOI 10.1378/chest.128.6.3810; Peng ZQ, 2013, THESIS FUJIAN U TRAD; Pinto-Plata V, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-71; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rao YK, 2007, J ETHNOPHARMACOL, V114, P78, DOI 10.1016/j.jep.2007.07.028; Shahed AR, 2001, TRANSPL P, V33, P2986, DOI 10.1016/S0041-1345(01)02282-5; Shan LN, 2011, J GUANGZHOU U TRADIT, V28, P590; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Shergis JL, 2013, PHYTOTHER RES, V27, P949, DOI 10.1002/ptr.4832; Shin IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045734; Spruit MA, 2012, J AM MED DIR ASSOC, V13, P291, DOI 10.1016/j.jamda.2011.06.009; Vickers A, 1999, BRIT MED J, V319, P1050, DOI 10.1136/bmj.319.7216.1050; Wise Robert A, 2005, COPD, V2, P125; Wu L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/705315; Xu JZ, 2012, YUNNAN J TRADITIONAL, V33, P31; Xu TingZhen, 2012, Chinese Archives of Traditional Chinese Medicine, V30, P570; Yang CM, 2013, MODERN J INTEGRATED, P729; Yu JY, 2011, J MED INFORM, P4019; Zeng JQ, 2013, J NEW CHINESE MED, P32; Zhang FY, 2007, SHANXI ZHONGYI J, V28, P1594; Zhang FY, 2007, J EMERGENCY TRADITIO, V19, P198; Zhang R.Z., 2011, CHINA PRACTICAL MED, V6, P118; Zhao YL, 2012, J TRADIT CHIN MED, V32, P203, DOI 10.1016/S0254-6272(13)60012-6; 茅蓉, 2009, [中国中西医结合杂志, Chinese Journal of Integrated Traditional and Western Medicine], V29, P362	70	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91830	10.1371/journal.pone.0091830	http://dx.doi.org/10.1371/journal.pone.0091830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	25521114	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300132
J	Chen, XF; Li, LZ; Zhou, T; Li, ZZ				Chen, Xiaofang; Li, Lezhi; Zhou, Tao; Li, Zhanzhan			Prevalence of Hypertension in Rural Areas of China: A Meta-Analysis of Published Studies	PLOS ONE			English	Article							STAGE RENAL-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; MEN; AWARENESS; MORTALITY	Background: Hypertension is one of the leading causes of disease burden across the world. In China, the latest nationwide survey of prevalence of hypertension was ten year ago, and data in rural areas is little known. More information about hypertension prevalence could help to improve overall antihypertensive health care. We aimed to estimate the pooled prevalence of hypertension in rural areas of China. Methods: Comprehensive electronic searches of PubMed, Web of Knowledge, Chinese Web of Knowledge, Wangfang, Weipu and SinoMed databases were conducted to identify any study in each database published from January 1, 2004 to December 31, 2013, reporting the prevalence of hypertension in Chinese rural areas. Prevalence estimates were stratified by age, area, sex, publication year, and sample size. All statistical calculations were made using the Stata Version 11.0 (College Station, Texas) and Statsdirect Version 2.7.9. Results: We identified 124 studies with a total population of 3,735,534 in the present meta-analysis. Among people aged 18 years old in Chinese rural areas, the summarized prevalence is 22.81% (19.41%-26.41%). Subgroup analysis shows the following results: for male 24.46% (21.19%-27.89%, for female 22.17% (18.25%-26.35%). For 2004-2006: 18.94% (14.41%-23.94%), for 2007-2009, 21.24% (15.98%-27.01%) for 2010-2013: 26.68%, (20.79%-33.02%). For Northern region 25.76% (22.36%-29.32%), for Southern region 19.30%, (15.48%-24.08%). Conclusions: The last decade witnessed the growth in prevalence of hypertension in rural areas of China compared with the fourth national investigation, which has climbed the same level as the urban area. Guidelines for screening and treatment of hypertension in rural areas need to be given enough attention.	[Chen, Xiaofang] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China; [Chen, Xiaofang] Southern Med Univ, Affiliated Hostipal 3, Dept Nursing, Guangzhou, Guangdong, Peoples R China; [Li, Lezhi] Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Zhou, Tao] Southern Med Univ, Dept Cardiol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Li, Zhanzhan] Cent South Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China	Central South University; Southern Medical University - China; Central South University; Southern Medical University - China; Central South University	Li, LZ (corresponding author), Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	lilz1988@126.com	Chen, Xin-Zu/G-6579-2014; Yang, Kun/A-4293-2010; Chen, Xin-Zu/K-2988-2019; Xue, Charlie C/F-1244-2014; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; Xue, Charlie/0000-0001-6937-9088; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Chen, Xin-lin/0000-0002-2650-8051	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061763, R01HD038329, R01HD018269] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Chen B, 2008, MOEDERN PREV MED, V35, P2823; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Department of Disease Control and Prevention Ministry of Health, 2006, REP CHRON DIS CHIN; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz AA, 2014, RURAL REMOTE HEALTH, V14; Dong CX, 2013, J INT MED RES, V41, P1291, DOI 10.1177/0300060513488498; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; FLACK JM, 1995, CIRCULATION, V92, P2437, DOI 10.1161/01.CIR.92.9.2437; Gong Jie, 2011, Chinese Preventive Medicine, V12, P227; Han B, 2009, J ZHENGZHOU U MED SC, V44, P337; He F, 2012, CHIN J DIS CONTROL P, V16, P560; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu HH, 2008, PREV TREATMENT CARDI, V8, P195; Hu XJ, 2013, CHIN HLTH SERVICE MA, V5, P391; Hu Y, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P177; Huang JP, 2011, KIDNEY BLOOD PRESS R, V34, P69, DOI 10.1159/000323164; Kannel WB, 1996, JAMA-J AM MED ASSOC, V276, P1269, DOI 10.1001/jama.276.15.1269; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Kokiwar Prashant R, 2012, J Assoc Physicians India, V60, P26; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Li LM, 2008, CHINESE REDIDENTS NU; Li Y, 2011, J SHENYANG MED COLL, V13, P228; Lin Kang, 2014, Wuhan Daxue Xuebao (Yixue Ban), V35, P114; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ma YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058302; Ministry of Health of the People's Republic of China, 2005, CHIN PREV CONTR HYP; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Ni GH, 2013, FOOD NUTR CHIN, V19, P70; O'Brien E, 2000, BMJ-BRIT MED J, V320, P1128, DOI 10.1136/bmj.320.7242.1128; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; PRC National Blood Pressure Survey Cooperative Group, 1995, CHIN J HYPERTENS, V3, P1; Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014; Rostom A, 2004, Evid Rep Technol Assess (Summ), P1; Stuart A, 1996, KENDALLS ADV THEORY; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; [王克伟 Wang Kewei], 2011, [中国公共卫生, China Public Health], V27, P1291; Wang YM., 2013, J BENBU MED COLL, V38, P321; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Xia YiYin, 2013, Journal of Tropical Medicine (Guangzhou), V13, P350; Xin RB, 2011, GUANGXI MED, V33, P963; Yang HJ, 2010, CHIN J GEN PRAC, V8, P896; Ye HaoFeng, 2005, China Tropical Medicine, V5, P1114; Ye ZW, 2011, ANHUI J PREV MED, V17, P190; Yin CG, 2009, PREV TREATMENT CARDI, V9, P137; Yu QH, 2011, WORLD HLTH DIG MED P, V8, P13; Yu YX, 2009, MED J CHIN PEOPLE HL, V21, P2364; Zhang AH, 2009, PREV MED TRIB, V15, P720; Zhang G, 2009, GONG GONG WEI SHENG, V20, P24; Zhang LJ, 2010, OCCUP HLTH, V26, P1872; Zhang Y., 2011, NINGXIA MED J, V33, P1222; Zhao JiQing, 2013, Bulletin of Disease Control and Prevention, V28, P27; Zheng YT, 2011, CHIN MED J METALL IN, V28, P573; Zheng ZH, 2010, CHINA CHLIN PRAC MED, V4, P219; Zhong DC, 2009, SICHUAN MED J, V30, P1056; Zhou YX, 2011, PRE MED TRIB, V17, P909	59	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115462	10.1371/journal.pone.0115462	http://dx.doi.org/10.1371/journal.pone.0115462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521114	Green Submitted, Green Published, gold			2022-12-25	WOS:000348845600050
J	Chen, XL; Chen, XZ; Lu, ZH; Wang, L; Yang, K; Hu, JK; Zhang, B; Chen, ZX; Chen, JP; Zhou, ZG				Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Wang, Li; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang			Comparison of Ultrasonic Scalpel versus Conventional Techniques in Open Gastrectomy for Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACTIVATED SHEARS; CANCER; LYMPHADENECTOMY	Objectives: To compare surgical efficacy and postoperative recovery of ultrasonic scalpel (USS) with conventional techniques for the resection of gastric carcinoma. Methods: A systematic search of major medical databases (PubMed, Embase, CCRT and CNKI) was conducted. Both randomized and non-randomized controlled trials (RCTs and nRCTs) were considered eligible. Operation time (OT), intraoperative blood loss (BL) and postoperative complications (POC) rates as well as postoperative hospitalization days, number of dissected lymph nodes, abdominal drainage volume and time for recovery of gastrointestinal functions were synthesized and compared. Results: Nineteen studies were included (7 RCTs and 12 nRCTs), in which 1930 patients were enrolled totally (946 in the USS group and 984 in the conventional group). Monopolar electrocautery and ligation were used as the conventional methods. Comparative meta-analysis showed perioperative outcomes were significantly improved using USS compared with conventional surgical instrumentation. OT was reduced from a weighted mean of 185.3 min in the conventional group to 151.0 min in the USS group (MD = -33.30, 95% CI [-41.75, -24.86], p<0.001) and intraoperative BL was decreased from a weighted mean of 217.9 ml in the conventional group to 111.6 ml in the USS group (MD = -113.42, 95% CI [-142.05, -84.79], p<0.001). Results from RCTs subgroup were consistent with those from nRCTs subgroup. The weighted cumulative risk of POC accounted for 8.9% (0%-25%) and 12.9% (5.5%-45%) in the USS and conventional groups, respectively. Pooled estimated results from nRCTs (OR = 0.54, 95% CI [0.27, 1.06], p = 0.07) and RCTs (RR = 0.75, 95% CI [0.44, 1.26], p = 0.27) showed no significant difference between the USS and control groups. Analysis of secondary outcomes showed the improvements of the USS group over control group regarding the number of dissected lymph nodes, postoperative hospitalization days, abdominal drainage volume and time for recovery of gastrointestinal functions. Conclusion: Compared with conventional electrosurgery, the USS is a safe and effective technique with more short-term advantages in open surgery for gastric cancer.	[Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Wang, Li] Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University	Hu, JK (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	hujkwch@126.com	Chen, Xin-Zu/G-6579-2014; Yang, Kun/A-4293-2010; Chen, Xin-Zu/K-2988-2019; Xue, Charlie C/F-1244-2014; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; Xue, Charlie/0000-0001-6937-9088; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Chen, Xin-lin/0000-0002-2650-8051	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China [2011SCU04B19]; Ministry of Education of China [2012SCU-NCET-11-0343]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061763, R01HD038329, R01HD018269] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Ministry of Education of China(Ministry of Education, China); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Domestic support from (1) Outstanding Young Scientific Scholarship Foundation of Sichuan University, from the Fundamental Research Funds for the Central Universities of China (No. 2011SCU04B19); and (2) New Century Excellent Talents in University support program, Ministry of Education of China (2012SCU-NCET-11-0343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 1998, ONCOLOGY-NY, V12, P44; Ajani JA, 2010, J NATL COMPR CANC NE, V8, P378, DOI 10.6004/jnccn.2010.0030; Chen CP, 2012, GUID CHIN MED, V10, P345; Chen XZ, 2010, J AM COLL SURGEONS, V210, P100, DOI 10.1016/j.jamcollsurg.2009.09.033; Chen Z, 2009, CHIN J MOD OPER SURG, V13, P257; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fu YM, 2011, CONT MED, V17, P104; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hu JK, 2009, SURG TODAY, V39, P207, DOI 10.1007/s00595-008-3856-x; Hu JK, 2008, CHIN J BASES CLIN GE, V15, P718; Inoue K, 2012, J GASTROINTEST SURG, V16, P1840, DOI 10.1007/s11605-012-1970-y; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Li G, 2010, J MED POSTGRA, V23, P1050; Li P, 2011, CHIN MED HERALD, V8, P177; Li ZR, 2009, CHIN ARCH GEN SURG E, V3, P510; Lin YH, 2011, CHIN J CLIN ELECT ED, V5, P975; [陆维祺 LU Weiqi], 2008, [中国实用外科杂志, Chinese Journal of Practical Surgery], V28, P203; Mahabaleshwar V, 2012, CAN J SURG, V55, P307, DOI 10.1503/cjs.000411; McCarus SD, 1996, J AM ASSOC GYN LAP, V3, P601, DOI 10.1016/S1074-3804(05)80174-4; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Mohri Y, 2007, SURG TODAY, V37, P1060, DOI 10.1007/s00595-007-3551-3; Pons Y, 2009, HEAD NECK ONCOL, V24, P1; Shi YF, 2012, GUID CHIN MED, V10, P154; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Tou S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007886.pub2; Tsimoyiannis EC, 2002, WORLD J SURG, V26, P158; Tu JC, 2010, MED J COMMUN, V24, P60; Tu XH, 2009, CHIN J MOD OPER SURG, V13, P407; Van Cutsem E, 2008, EUR J CANCER, V44, P182, DOI 10.1016/j.ejca.2007.11.001; Wei ZM, 2010, J MINI INVA MED, V5, P445; Wells G, 2009, OTTAWA HOSP RES I NE; Xu L, 2010, PEOPLES MIL SURG, V53, P490; Yang K, 2009, WORLD J GASTROENTERO, V15, P5352, DOI 10.3748/wjg.15.5352; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang ZY, 2012, CHIN J MOD DRUG APPL, V6, P3; Zhong L, 2012, ANN ACAD MED SINGAP, V41, P161; 尹蓓, 2011, [江苏医药, Jiangsu Medical Journal], V37, P2877; 宋小平, 2011, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V31, P590; 刘磊, 2010, [中国癌症杂志, China Oncology], V20, P799	41	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103330	10.1371/journal.pone.0103330	http://dx.doi.org/10.1371/journal.pone.0103330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25521114	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800038
